PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McGuire, CM; Forgac, M				McGuire, Christina M.; Forgac, Michael			Glucose starvation increases V-ATPase assembly and activity in mammalian cells through AMP kinase and phosphatidylinositide 3-kinase/Akt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; YEAST VACUOLAR; RAG GTPASES; SALIVARY-GLANDS; BAFILOMYCIN A1; PROTON PUMP; INFLUENZA-A; MTORC1; ACIDIFICATION; ACTIVATION	The vacuolar H+-ATPase (V-ATPase) is an ATP-driven proton pump involved in many cellular processes. An important mechanism by which V-ATPase activity is controlled is the reversible assembly of its two domains, namely the peripheralV 1 domain and the integral V 0 domain. Although reversible assembly is conserved across all eukaryotic organisms, the signaling pathways controlling it have not been fully characterized. Here, we identify glucose starvation as a novel regulator of V-ATPase assembly in mammalian cells. During acute glucose starvation, the V-ATPase undergoes a rapid and reversible increase in assembly and activity as measured by lysosomal acidification. Because the V-ATPase has recently been implicated in the activation of AMP kinase (AMPK), a critical cellular energy sensor that is also activated upon glucose starvation, we compared the time course of AMPK activation and V-ATPase assembly upon glucose starvation. We observe that AMPK activation precedes increased V-ATPase activity. Moreover, the starvation-induced increase in V-ATPase activity and assembly are prevented by the AMPK inhibitor dorsomorphin. These results suggest that increased assembly and activity of the V-ATPase upon glucose starvation are dependent upon AMPK. We also find that the PI3K/Akt pathway, which has previously been implicated in controlling V-ATPase assembly in mammalian cells, also plays a role in the starvation-induced increase in V-ATPase assembly and activity. These studies thus identify a novel stimulus of V-ATPase assembly and a novel signaling pathway involved in regulating this process. The possible function of starvation-induced increase in lysosomal V-ATPase activity is discussed.	[Forgac, Michael] Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; Tufts Univ, Program Biochem, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM34478 (to M. F.) and a Sackler Families Collaborative Cancer Biology Award from Tufts University (to C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Mitzutani Foundation, National Science Foundation, and Ministerio de Economia de Spain.	Alzamora R, 2013, AM J PHYSIOL-RENAL, V305, pF943, DOI 10.1152/ajprenal.00303.2013; Alzamora R, 2010, J BIOL CHEM, V285, P24676, DOI 10.1074/jbc.M110.106278; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Breton S, 2013, PHYSIOLOGY, V28, P318; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MacLeod KJ, 1999, J BIOL CHEM, V274, P32869, DOI 10.1074/jbc.274.46.32869; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; OCHIAI H, 1995, ANTIVIR RES, V27, P425, DOI 10.1016/0166-3542(95)00040-S; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	42	41	43	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9113	9123		10.1074/jbc.RA117.001327	http://dx.doi.org/10.1074/jbc.RA117.001327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29540478	hybrid, Green Published			2022-12-28	WOS:000434941900032
J	Melo-Gonzalez, F; Fenton, TM; Forss, C; Smedley, C; Goenka, A; MacDonald, AS; Thornton, DJ; Travis, MA				Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Thornton, David J.; Travis, Mark A.			Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendritic cell; inflammation; intestine; mucin; mucosal immunology	MUCUS; EXPRESSION; INTERLEUKIN-8; TAK-242; CLONING; LAYER; COLON	Cross-talk between different components of the intestinal barrier and the immune system may be important in maintaining gut homeostasis. A crucial part of the gut barrier is the mucus layer, a cross-linked gel on top of the intestinal epithelium that consists predominantly of the mucin glycoprotein MUC2. However, whether the mucin layer actively regulates intestinal immune cell responses is not clear. Because recent evidence suggests that intestinal dendritic cells (DCs) may be regulated by the mucus layer, we purified intestinal mucin, incubated it with human DCs, and determined the functional effects. Here we show that expression of the chemokine IL-8 and co-stimulatory DC markers CD86 and CD83 are significantly up-regulated on human DCs in the presence of intestinal mucins. Additionally, mucin-exposed DCs promoted neutrophil migration in an IL-8-dependent manner. The stimulatory effects of mucins on DCs were not due to mucin sample contaminants such as lipopolysaccharide, DNA, or contaminant proteins. Instead, mucin glycans are important for the pro-inflammatory effects on DCs. Thus, intestinal mucins are capable of inducing important pro-inflammatory functions in DCs, which could be important in driving inflammatory responses upon intestinal barrier damage.	[Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Travis, Mark A.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England; [Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Thornton, David J.; Travis, Mark A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9NT, Lancs, England; [Melo-Gonzalez, Felipe; Fenton, Thomas M.; Smedley, Catherine; MacDonald, Andrew S.; Travis, Mark A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Immunol Grp, Manchester M13 9NT, Lancs, England; [Fenton, Thomas M.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Frederiksberg C, Denmark	University of Manchester; University of Manchester; University of Manchester; Technical University of Denmark	Thornton, DJ (corresponding author), Univ Manchester, Fac Biol Med & Hlth, 4-016 AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Travis, MA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil 2 14b, Grafton St, Manchester M13 9NT, Lancs, England.	dave.thornton@manchester.ac.uk; mark.travis@manchester.ac.uk	Goenka, Anu/M-6700-2019; Travis, Mark/E-9643-2015	Goenka, Anu/0000-0002-8152-2155; Thornton, David/0000-0001-7148-1970; Melo-Gonzalez, Felipe/0000-0002-3711-2407; Fenton, Thomas/0000-0002-6200-6403; Travis, Mark/0000-0002-8485-2272	Wellcome Trust [203128/Z/16/Z]; Manchester Collaborative Centre for Inflammation Research; Medical Research Council; European Society of Paediatric Infectious Diseases; CONICYT Chile; Medical Research Council [MR/N001427/1]; MRC [MR/L011840/1, MR/N001427/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Manchester Collaborative Centre for Inflammation Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Society of Paediatric Infectious Diseases; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by core funding from the Wellcome Trust through Grant 203128/Z/16/Z (to the Wellcome Trust Centre for Cell-Matrix Research, University of Manchester), by core funding from the Manchester Collaborative Centre for Inflammation Research and the Medical Research Council (to M. A. T.), by a fellowship from the European Society of Paediatric Infectious Diseases and Medical Research Council Fellowship MR/N001427/1 (to A. G.), and by funds from CONICYT Chile (to F. M.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Boltin D, 2013, J CLIN GASTROENTEROL, V47, P106, DOI 10.1097/MCG.0b013e3182688e73; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Davies JR, 2012, METHODS MOL BIOL, V842, P27, DOI 10.1007/978-1-61779-513-8_2; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hong JC, 2000, GLYCOCONJUGATE J, V17, P691, DOI 10.1023/A:1011014404707; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thornton D J, 1994, Methods Mol Biol, V32, P119; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wenzel UA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130750; YOSHIMURA T, 1987, J IMMUNOL, V139, P788	35	17	19	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8543	8553		10.1074/jbc.M117.789305	http://dx.doi.org/10.1074/jbc.M117.789305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29581231	Green Published, hybrid			2022-12-28	WOS:000434205700018
J	Delporte, C; Boudjeltia, KZ; Furtmuller, PG; Maki, RA; Dieu, M; Noyon, C; Soudi, M; Dufour, D; Coremans, C; Nuyens, V; Reye, F; Rousseau, A; Raes, M; Moguilevsky, N; Vanhaeverbeek, M; Ducobu, J; Neve, J; Robaye, B; Vanhamme, L; Reynolds, WF; Obinger, C; Van Antwerpen, P				Delporte, Cedric; Boudjeltia, Karim Zouaoui; Furtmueller, Paul G.; Maki, Richard A.; Dieu, Marc; Noyon, Caroline; Soudi, Monika; Dufour, Damien; Coremans, Catherine; Nuyens, Vincent; Reye, Florence; Rousseau, Alexandre; Raes, Martine; Moguilevsky, Nicole; Vanhaeverbeek, Michel; Ducobu, Jean; Neve, Jean; Robaye, Bernard; Vanhamme, Luc; Reynolds, Wanda F.; Obinger, Christian; Van Antwerpen, Pierre			Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; cardiovascular disease; lipoprotein; myeloperoxidase; post-translational modification (PTM); cyanide; cyanate	LOW-DENSITY-LIPOPROTEIN; PEROXIDASE COMPOUND-I; HYDROGEN-CYANIDE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; HYPOCHLOROUS ACID; AIR-POLLUTION; THIOCYANATE; BINDING; EMISSIONS	Protein carbamylation by cyanate is a post-translational modification associated with several (patho)physiological conditions, including cardiovascular disorders. However, the biochemical pathways leading to protein carbamylation are incompletely characterized. This work demonstrates that the heme protein myeloperoxidase (MPO), which is secreted at high concentrations at inflammatory sites from stimulated neutrophils and monocytes, is able to catalyze the two-electron oxidation of cyanide to cyanate and promote the carbamylation of taurine, lysine, and low-density lipoproteins. We probed the role of cyanide as both electron donor and low-spin ligand by pre-steady-state and steady-state kinetic analyses and analyzed reaction products by MS. Moreover, we present two further pathways of carbamylation that involve reaction products of MPO, namely oxidation of cyanide by hypochlorous acid and reaction of thiocyanate with chloramines. Finally, using an in vivo approach with mice on a high-fat diet and carrying the human MPO gene, we found that during chronic exposure to cyanide, mimicking exposure to pollution and smoking, MPO promotes protein-bound accumulation of carbamyllysine (homocitrulline) in atheroma plaque, demonstrating a link between cyanide exposure and atheroma. In summary, our findings indicate that cyanide is a substrate for MPO and suggest an additional pathway for in vivo cyanate formation and protein carbamylation that involves MPO either directly or via its reaction products hypochlorous acid or chloramines. They also suggest that chronic cyanide exposure could promote the accumulation of carbamylated proteins in atherosclerotic plaques.	[Delporte, Cedric; Noyon, Caroline; Dufour, Damien; Coremans, Catherine; Reye, Florence; Neve, Jean; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Delporte, Cedric; Dufour, Damien; Coremans, Catherine; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Analyt Platform, B-1050 Brussels, Belgium; [Boudjeltia, Karim Zouaoui; Nuyens, Vincent; Rousseau, Alexandre; Vanhaeverbeek, Michel; Ducobu, Jean] Univ Libre Bruxelles, A Vesale Hosp, Lab Expt Med, CHU Charleroi, B-6110 Montignies le Tilleul, Belgium; [Furtmueller, Paul G.; Soudi, Monika; Obinger, Christian] Univ Nat Resources & Life Sci BOKU, Div Biochem, Dept Chem, A-1180 Vienna, Austria; [Maki, Richard A.] Torrey Pines Pharmaceut, Del Mar, CA 92014 USA; [Maki, Richard A.; Reynolds, Wanda F.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Dieu, Marc; Raes, Martine] Univ Namur, Lab Cellular Biol, B-5000 Namur, Belgium; [Moguilevsky, Nicole] Univ Namur, Technol Transfer Off, B-5000 Namur, Belgium; [Robaye, Bernard] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Inst Interdisciplinary Res, Fac Sci, B-6041 Gosselies, Belgium; [Vanhamme, Luc] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Lab Mol Parasitol, Fac Sci, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Natural Resources & Life Sciences, Vienna; Sanford Burnham Prebys Medical Discovery Institute; University of Namur; University of Namur; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Van Antwerpen, P (corresponding author), Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem Analyt Platform, Brussels, Belgium.	pvantwer@ulb.ac.be	Furtmüller, Paul G./Y-5819-2018; Obinger, Christian/AAV-3173-2021; Delporte, Cedric/C-2228-2013	Furtmüller, Paul G./0000-0002-1199-2469; Obinger, Christian/0000-0002-7133-3430; Delporte, Cedric/0000-0001-7453-7028; Dieu, Marc/0000-0002-3902-542X; Maki, Richard/0000-0002-9593-0723; Van Antwerpen, Pierre/0000-0002-4934-8863	Belgian Fund for Scientific Research (FRS-FNRS); Austrian Science Funds [FWF P 20664]; doctoral program BioToP Grant [W1224]; Belgian National Fund for Scientific Research (FRS) [3.4553.08, T.0136.13 PDR]; Universite Libre de Bruxelles Grant [FER-207]; Department of International Relationships of the Universite Libre de Bruxelles Grant [BRIC SJ/AL/BRIC/130]; National Institutes of Health [RO1-NS074303, R43 AG040935]; Institute of Pathology and Genetics (IRSPG, Loverval, Belgium); CHU of Charleroi; Sanford Burnham Prebys Medical Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG040935] Funding Source: NIH RePORTER	Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Austrian Science Funds(Austrian Science Fund (FWF)); doctoral program BioToP Grant; Belgian National Fund for Scientific Research (FRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles Grant; Department of International Relationships of the Universite Libre de Bruxelles Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Pathology and Genetics (IRSPG, Loverval, Belgium); CHU of Charleroi; Sanford Burnham Prebys Medical Discovery Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Austrian Science Funds Grant FWF P 20664 (to P. G. F.) and doctoral program BioToP Grant W1224 (to M. S.), Belgian National Fund for Scientific Research (FRS) Grants 3.4553.08 and T.0136.13 PDR, Universite Libre de Bruxelles Grant FER-207, and Department of International Relationships of the Universite Libre de Bruxelles Grant BRIC SJ/AL/BRIC/130. This study was also supported in part by National Institutes of Health Grants RO1-NS074303 (to W. F. R.) and R43 AG040935 (to R. A. M.). This work was also supported by the Institute of Pathology and Genetics (IRSPG, Loverval, Belgium) and the "CHU of Charleroi." Additional funds to support this work were provided by Sanford Burnham Prebys Medical Discovery Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Postdoctoral researcher supported by the Belgian Fund for Scientific Research (FRS-FNRS).	Abraham K, 2016, ARCH TOXICOL, V90, P559, DOI 10.1007/s00204-015-1479-8; Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Ansell M, 1970, J Forensic Med, V17, P148; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; Baum MM, 2007, ENVIRON SCI TECHNOL, V41, P857, DOI 10.1021/es061402v; BERDNIKO.VM, 1970, RUSS J PHYS CH USSR, V44, P395; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; BOXER GE, 1952, ARCH BIOCHEM BIOPHYS, V39, P7, DOI 10.1016/0003-9861(52)90256-7; CAILLEUX A, 1988, J MED, V19, P345; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; CHANCE B, 1949, J BIOL CHEM, V179, P1299; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Delporte C, 2012, TALANTA, V99, P603, DOI 10.1016/j.talanta.2012.06.044; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Franchini M, 2012, J THROMB HAEMOST, V10, P2438, DOI 10.1111/jth.12006; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Furtmuller PG, 2001, BBA-PROTEIN STRUCT M, V1548, P121, DOI 10.1016/S0167-4838(01)00230-8; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; IKEDASAITO M, 1987, BIOCHEMISTRY-US, V26, P4344, DOI 10.1021/bi00388a024; Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005; Jantschko W, 2003, BIOCHEM BIOPH RES CO, V312, P292, DOI 10.1016/j.bbrc.2003.10.117; Kraus LM, 1998, J LAB CLIN MED, V131, P425, DOI 10.1016/S0022-2143(98)90143-3; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Lemma K, 2009, CHEM RES TOXICOL, V22, P1622, DOI 10.1021/tx900212r; Lucking AJ, 2011, CIRCULATION, V123, P1721, DOI 10.1161/CIRCULATIONAHA.110.987263; LUNDQUIST P, 1987, CLIN CHEM, V33, P1228; Mahernia S, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0211-1; Malle E, 2006, BBA-MOL CELL BIOL L, V1761, P392, DOI 10.1016/j.bbalip.2006.03.024; Maricq MM, 2007, J AEROSOL SCI, V38, P1079, DOI 10.1016/j.jaerosci.2007.08.001; MARQUEZ LA, 1989, BIOCHEM CELL BIOL, V67, P187, DOI 10.1139/o89-029; Miller MR, 2012, FUTUR CARDIOL, V8, P577, DOI [10.2217/fca.12.43, 10.2217/FCA.12.43]; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Moussa SG, 2016, ATMOS ENVIRON, V131, P185, DOI 10.1016/j.atmosenv.2016.01.050; National Research Council of the National Academy of Sciences, 2011, GUIDE CARE USE LAB A; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; PALCIC MM, 1981, ARCH BIOCHEM BIOPHYS, V211, P245, DOI 10.1016/0003-9861(81)90451-3; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; ZENG J, 1991, METHOD ENZYMOL, V205, P433; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	56	27	28	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6374	6386		10.1074/jbc.M117.801076	http://dx.doi.org/10.1074/jbc.M117.801076			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496995	hybrid, Green Published			2022-12-28	WOS:000431108600013
J	Okada, H; Yamada, M; Kamimoto, K; Kok, CYY; Kaneko, K; Ema, M; Miyajima, A; Itoh, T				Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota; Ema, Masatsugu; Miyajima, Atsushi; Itoh, Tohru			The transcription factor Klf5 is essential for intrahepatic biliary epithelial tissue remodeling after cholestatic liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; P-GLYCOPROTEIN GENE; STEM-CELLS; PROGENITOR-CELL; HOMOZYGOUS DISRUPTION; ANIMAL-MODEL; BILE; DAMAGE; REPAIR; RAT	Under various conditions of liver injury, the intrahepatic biliary epithelium undergoes dynamic tissue expansion and remodeling, a process known as ductular reaction. Mouse models defective in inducing such a tissue-remodeling process are more susceptible to liver injury, suggesting a crucial role of this process in liver regeneration. However, the molecular mechanisms regulating the biliary epithelial cell (BEC) dynamics in the ductular reaction remain largely unclear. Here, we demonstrate that the transcription factor Kruppel-like factor 5 (Klf5) is highly enriched in mouse liver BECs and plays a key role in regulating the ductular reaction, specifically under cholestatic injury conditions. Although mice lacking Klf5 in the entire liver epithelium, including both hepatocytes and BECs (Klf5-LKO (liver epithelial-specific knockout) mice), did not exhibit any apparent phenotype in the hepatobiliary system under normal conditions, they exhibited significant defects in biliary epithelial tissue remodeling upon 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholangitis, concomitantly with exacerbated cholestasis and reduced survival rate. In contrast, mice lacking Klf5 solely in hepatocytes did not exhibit any such phenotypes, confirming Klf5's specific role in BECs. RNA-sequencing analyses of BECs isolated from the Klf5-LKO mouse livers revealed that the Klf5 deficiency primarily affected expression of cell cycle-related genes. Moreover, immunostaining analysis with the proliferation marker Ki67 disclosed that the Klf5-LKO mice had significantly reduced BEC proliferation levels upon injury. These results indicate that Klf5 plays a critical role in the ductular reaction and biliary epithelial tissue expansion and remodeling by inducing BEC proliferation and thereby contributing to liver regeneration.	[Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota; Miyajima, Atsushi; Itoh, Tohru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan; [Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Okada, Hajime; Yamada, Minami; Kamimoto, Kenji; Kok, Cindy Yuet-Yin; Kaneko, Kota] Japan Soc Promot Sci, Tokyo, Japan; [Kamimoto, Kenji] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Kok, Cindy Yuet-Yin] Westmead Inst Med Res, Ctr Heart Res, Westmead, NSW 2145, Australia; [Kaneko, Kota] Univ Calif San Diego, Sch Med, Dept Pathol, Div Biol Sci, La Jolla, CA 92093 USA	University of Tokyo; Shiga University of Medical Science; Japan Society for the Promotion of Science; Washington University (WUSTL); University of Sydney; Westmead Institute for Medical Research; University of California System; University of California San Diego	Itoh, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp	Itoh, Tohru/GYQ-8698-2022	Itoh, Tohru/0000-0002-6579-1638; Kok, Cindy/0000-0003-3086-7097; Okada, Hajime/0000-0002-3204-3633; Ema, Masatsugu/0000-0003-0645-6183; Yamada, Minami/0000-0002-2622-3195; Kamimoto, Kenji/0000-0003-3541-4353	Japan Society for the Promotion of Science KAKENHI Grants [22118006, 24112507, 24590342, 26112704, 26253023, 15H01369, 15J08420, 17H05497]; CREST from the Japan Science and Technology Agency [15652259]; Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi Sankyo Foundation of Life Science	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grants 22118006 (to A. M.), 24112507 (to T. I.), 24590342 (to T. I.), 26112704 (to T. I.), 26253023 (to A. M.), 15H01369 (to T. I.), 15J08420 (to H. O.), and 17H05497 (to T. I.); CREST from the Japan Science and Technology Agency Grant 15652259 (to A. M.); a research grant from the Takeda Science Foundation (to T. I.); and a research grant from the Daiichi Sankyo Foundation of Life Science (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Azami T, 2017, DEVELOPMENT, V144, P3706, DOI 10.1242/dev.150755; Bell K. A., 2016, THESIS; Bialkowska AB, 2017, DEVELOPMENT, V144, P737, DOI 10.1242/dev.145441; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Hayashi S, 2016, ELIFE, V5, DOI 10.7554/eLife.17462; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kamimoto K, 2016, ELIFE, V5, DOI 10.7554/eLife.15034; Kaneko K, 2015, HEPATOLOGY, V61, P2056, DOI 10.1002/hep.27685; Kiritsi D, 2013, CELL ADHES MIGR, V7, P135, DOI 10.4161/cam.22418; Kok CY, 2013, MOL THER, V21, P1823, DOI 10.1038/mt.2013.139; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Lesage G, 2001, AM J PHYSIOL-GASTR L, V281, pG182, DOI 10.1152/ajpgi.2001.281.1.G182; LeSage GD, 1999, HEPATOLOGY, V29, P307, DOI 10.1002/hep.510290242; Li M, 2015, INT J BIOL SCI, V11, P1458, DOI [10.7150/ijbs.13444, 10.7150/ijbs.10809]; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; Maehara O, 2015, CANCER BIOL THER, V16, P1453, DOI 10.1080/15384047.2015.1070992; MAUAD TH, 1994, AM J PATHOL, V145, P1237; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Nandan MO, 2014, DEV BIOL, V387, P191, DOI 10.1016/j.ydbio.2014.01.002; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okabe H, 2016, HEPATOLOGY, V64, P1652, DOI 10.1002/hep.28774; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Passman AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5702873; Shinoda Y, 2008, J BIOL CHEM, V283, P24682, DOI 10.1074/jbc.M709857200; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tanimizu N, 2012, J BIOL CHEM, V287, P28586, DOI 10.1074/jbc.M112.350488; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	63	10	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6214	6229		10.1074/jbc.RA118.002372	http://dx.doi.org/10.1074/jbc.RA118.002372			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523685	hybrid, Green Published			2022-12-28	WOS:000431108600001
J	Gao, HY; Azam, T; Randeniya, S; Couturier, J; Rouhier, N; Johnson, MK				Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Couturier, Jeremy; Rouhier, Nicolas; Johnson, Michael K.			Function and maturation of the Fe-S center in dihydroxyacid dehydratase from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; MAGNETIC CIRCULAR-DICHROISM; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; SCAFFOLD PROTEIN; ACID DEHYDRATASE; 2FE-2S FERREDOXIN; 4FE-4S CLUSTER; NITRIC-OXIDE	Dihydroxyacid dehydratase (DHAD) is the third enzyme required for branched-chain amino acid biosynthesis in bacteria, fungi, and plants. DHAD enzymes contain two distinct types of active-site Fe-S clusters. The best characterized examples are Escherichia coli DHAD, which contains an oxygen-labile [Fe4S4] cluster, and spinach DHAD, which contains an oxygen-resistant [Fe2S2] cluster. Although the Fe-S cluster is crucial for DHAD function, little is known about the cluster-coordination environment or the mechanism of catalysis and cluster biogenesis. Here, using the combination of UV-visible absorption and circular dichroism and resonance Raman and electron paramagnetic resonance, we spectroscopically characterized the Fe-S center in DHAD from Arabidopsis thaliana (At). Our results indicated that AtDHAD can accommodate [Fe2S2] and [Fe4S4] clusters. However, only the [Fe2S2] cluster-bound form is catalytically active. We found that the [Fe2S2] cluster is coordinated by at least one non-cysteinyl ligand, which can be replaced by the thiol group(s) of dithiothreitol. In vitro cluster transfer and reconstitution reactions revealed that [Fe2S2] cluster-containing NFU2 protein is likely the physiological cluster donor for in vivo maturation of AtDHAD. Insummary, AtDHAD binds either one[Fe4S4] or one [Fe2S2] cluster, with only the latter being catalytically competent and capable of substrate and product binding, and NFU2 appears to be the physiological [Fe2S2] cluster donor for DHAD maturation. This work represents the first in vitro characterization of recombinant AtDHAD, providing new insights into the properties, biogenesis, and catalytic role of the active-site Fe-S center in a plant DHAD.	[Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gao, Huanyao; Azam, Tamanna; Randeniya, Sajini; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA; [Couturier, Jeremy; Rouhier, Nicolas] Univ Lorraine, INRA, Fac Sci & Technol, Interact Arbres Microorganismes UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Gao, Huanyao] Mayo Clin, 200 1st St SW, Rochester, MN 55902 USA; [Randeniya, Sajini] Novavax Inc, 9920 Belward Campus Dr, Rockville, MD 20850 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; INRAE; Universite de Lorraine; Mayo Clinic	Johnson, MK (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	mkj@uga.edu	Couturier, Jérémy/AAF-6588-2020	Couturier, Jérémy/0000-0003-3127-2669; Rouhier, Nicolas/0000-0002-2036-7884	National Institutes of Health [R37GM62524]; French National Research Agency, "Investissements d'Avenir" Program [ANR-11-LABX-0002-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Research Agency, "Investissements d'Avenir" Program(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37GM62524 (to M.K.J.) and by a grant from the French National Research Agency as part of the "Investissements d'Avenir" Program (ANR-11-LABX-0002-01, Laboratory of Excellence (ARBRE)). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; ARFIN SM, 1969, J BIOL CHEM, V244, P2250; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BERTRAND P, 1985, BIOCHIM BIOPHYS ACTA, V831, P261, DOI 10.1016/0167-4838(85)90044-5; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; Duan XW, 2009, BIOCHEM J, V417, P783, DOI 10.1042/BJ20081423; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FLINT DH, 1993, J BIOL CHEM, V268, P25547; Flint DH, 1996, CHEM REV, V96, P2315, DOI 10.1021/cr950041r; FLINT DH, 1993, J BIOL CHEM, V268, P14732; FLINT DH, 1993, J BIOL CHEM, V268, P22369; FLINT DH, 1988, J BIOL CHEM, V263, P3558; Flint DH, 1996, J BIOL CHEM, V271, P16068; Flint DH, 1996, J BIOL CHEM, V271, P16053, DOI 10.1074/jbc.271.27.16053; FLINT DH, 1993, BIOORG CHEM, V21, P367, DOI 10.1006/bioo.1993.1031; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3871, DOI 10.1021/bi5014485; FU WG, 1992, J BIOL CHEM, V267, P15502; FUJINAGA J, 1993, BIOCHEM BIOPH RES CO, V194, P104, DOI 10.1006/bbrc.1993.1791; Gao HY, 2013, BIOCHEMISTRY-US, V52, P6633, DOI 10.1021/bi4007622; HAN S, 1989, J AM CHEM SOC, V111, P3496, DOI 10.1021/ja00192a002; HAN S, 1989, J AM CHEM SOC, V111, P3505, DOI 10.1021/ja00192a003; HILL RK, 1973, J AM CHEM SOC, V95, P7857, DOI 10.1021/ja00804a048; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jiang LX, 2016, J EXP BOT, V67, P379, DOI [10.1093/jxb/eru449, 10.1093/jxb/erv478]; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Kim S, 2006, J BIOCHEM, V139, P591, DOI 10.1093/jb/mvj057; Kiritani K., 1970, METHOD ENZYMOL, V17, P755; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; McCarthy EL, 2017, SCIENCE, V358, P373, DOI 10.1126/science.aan4574; MEYER J, 1994, BIOCHEMISTRY-US, V33, P13642, DOI 10.1021/bi00250a014; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nath K, 2016, PLANT PHYSIOL, V172, P2459, DOI 10.1104/pp.16.01564; NIELSEN BE, 1969, ACTA CHEM SCAND, V23, P967, DOI 10.3891/acta.chem.scand.23-0967; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Orio M, 2008, INORG CHEM, V47, P5394, DOI 10.1021/ic701730h; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PIRRUNG MC, 1991, J AM CHEM SOC, V113, P1020, DOI 10.1021/ja00003a042; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; RICHARDS AJM, 1990, SPECTROCHIM ACTA A, V46, P987, DOI 10.1016/0584-8539(90)80015-Q; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; Sellers VM, 1998, J BIOL CHEM, V273, P22311, DOI 10.1074/jbc.273.35.22311; Singh BK, 1999, BOOKS SOIL PLANT ENV, P227; SINGH BK, 1995, PLANT CELL, V7, P935; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Subramanian S, 2015, J AM CHEM SOC, V137, P4567, DOI 10.1021/jacs.5b01869; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Vranish JN, 2015, J AM CHEM SOC, V137, P390, DOI 10.1021/ja510998s; Wachnowsky C, 2016, J BIOL INORG CHEM, V21, P825, DOI 10.1007/s00775-016-1381-8; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	73	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4422	4433		10.1074/jbc.RA117.001592	http://dx.doi.org/10.1074/jbc.RA117.001592			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29425096	hybrid, Green Published			2022-12-28	WOS:000428204300014
J	Du, XM; Zadoorian, A; Lukmantara, IE; Qi, YF; Brown, AJ; Yang, HY				Du, Ximing; Zadoorian, Armella; Lukmantara, Ivan E.; Qi, Yanfei; Brown, Andrew J.; Yang, Hongyuan			Oxysterol-binding protein-related protein 5 (ORP5) promotes cell proliferation by activation of mTORC1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOSOMAL CHOLESTEROL TRAFFICKING; ENDOPLASMIC-RETICULUM; PHOSPHATIDYLSERINE; TRANSPORT; CANCER; OSBP; CONTACTS; PATHWAY; FAMILY; TARGET	Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) constitute a large family of proteins that mainly function in lipid transport and sensing. ORP5 is an endoplasmic reticulum (ER)-anchored protein implicated in lipid transfer at the contact sites between the ER and other membranes. Recent studies indicate that ORP5 is also involved in cancer cell invasion and tumor progression. However, the molecular mechanism underlying ORP5's involvement in cancer is unclear. Here, we report that ORP5 promotes cell proliferation and motility of HeLa cells, an effect that depends on its functional OSBP-related domain (ORD). We also found that ORP5 depletion or substitutions of key residues located within ORP5-ORD and responsible for interactions with lipids interfered with cell proliferation, migration, and invasion. ORP5 interacted with the protein mechanistic target of rapamycin (mTOR), and this interaction also required ORP5-ORD. Of note, whereas ORP5 overexpression induced mTOR complex 1 (mTORC1) activity, ORP5 down-regulation had the opposite effect. Finally, ORP5-depleted cells exhibited impaired mTOR localization to lysosomes, which may have accounted for the blunted mTORC1 activation. Together, our results suggest that ORP5 expression is positively correlated with mTORC1 signaling and that ORP5 stimulates cell proliferation, at least in part, by activating mTORC1.	[Du, Ximing; Zadoorian, Armella; Lukmantara, Ivan E.; Qi, Yanfei; Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Du, XM; Yang, HY (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	x.r.du@unsw.edu.au; h.rob.yang@unsw.edu.au	Qi, Yanfei/ABC-1242-2021; Yang, Hongyuan/AAR-1326-2020	Qi, Yanfei/0000-0003-1391-4111; Yang, Hongyuan/0000-0002-8482-6031; Lukmantara, Ivan/0000-0001-9759-5669	National Health and Medical Research Council, Australia [1041301, 1078117]; Australian Research Council [DP130100457]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Supported by Grants 1041301 and 1078117 from the National Health and Medical Research Council, Australia, and by Grant DP130100457 from the Australian Research Council. Senior Research Fellow of the National Health and Medical Research Council. To whom correspondence may be addressed. Tel.: 61-2-93858133; Fax: 61-2-93851483; E-mail: h.rob.yang@unsw.edu.au.	Bridges D, 2012, MOL BIOL CELL, V23, P2955, DOI 10.1091/mbc.E11-12-1034; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Du X., 2017, SEMIN CELL DEV BIOL, V2017; Du XM, 2012, CELL REP, V1, P29, DOI 10.1016/j.celrep.2011.10.004; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fei WH, 2011, BIOCHEM BIOPH RES CO, V415, P455, DOI 10.1016/j.bbrc.2011.10.091; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Ghai R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00861-5; Guo XH, 2017, ONCOL RES, V25, P799, DOI 10.3727/096504016X14783691306605; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Koga Y, 2008, CANCER SCI, V99, P2387, DOI 10.1111/j.1349-7006.2008.00987.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li JW, 2016, ONCOTARGET, V7, P65849, DOI 10.18632/oncotarget.11671; Li JW, 2016, J LIPID RES, V57, P1845, DOI 10.1194/jlr.M069906; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Nagano K, 2015, INT J ONCOL, V47, P195, DOI 10.3892/ijo.2015.3000; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200	36	19	19	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3806	3818		10.1074/jbc.RA117.001558	http://dx.doi.org/10.1074/jbc.RA117.001558			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358326	Green Published, hybrid			2022-12-28	WOS:000427030200032
J	Cribbs, A; Hookway, ES; Wells, G; Lindow, M; Obad, S; Oerum, H; Prinjha, RK; Athanasou, N; Sowman, A; Philpott, M; Penn, H; Soderstrom, K; Feldmann, M; Oppermann, U				Cribbs, Adam; Hookway, Edward S.; Wells, Graham; Lindow, Morten; Obad, Susanna; Oerum, Henrik; Prinjha, Rab K.; Athanasou, Nick; Sowman, Aneka; Philpott, Martin; Penn, Henry; Soderstrom, Kalle; Feldmann, Marc; Oppermann, Udo			Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NK CELLS; GENE-EXPRESSION; IFN-GAMMA; JMJD3; ACTIVATION; DIFFERENTIATION; METHYLATION; CHROMATIN; IDENTIFICATION; RECEPTORS	Natural killer (NK) cells are innate lymphocytes, important in immune surveillance and elimination of stressed, transformed, or virus-infected cells. They critically shape the inflammatory cytokine environment to orchestrate interactions of cells of the innate and adaptive immune systems. Some studies have reported that NK cell activation and cytokine secretion are controlled epigenetically but have yielded only limited insight into the mechanisms. Using chemical screening with small-molecule inhibitors of chromatin methylation and acetylation, further validated by knockdown approaches, we here identified Jumonji-type histone H3K27 demethylases as key regulators of cytokine production in human NK cell subsets. The prototypic JMJD3/UTX (Jumonji domain-containing protein 3) H3K27 demethylase inhibitor GSK-J4 increased global levels of the repressive H3K27me3 mark around transcription start sites of effector cytokine genes. Moreover, GSK-J4 reduced IFN-gamma, TNF alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), and interleukin-10 levels in cytokine-stimulated NK cells while sparing their cytotoxic killing activity against cancer cells. The anti-inflammatory effect of GSK-J4 in NK cell subsets, isolated from peripheral blood or tissue from individuals with rheumatoid arthritis (RA), coupled with an inhibitory effect on formation of bone-resorbing osteoclasts, suggested that histone demethylase inhibition has broad utility for modulating immune and inflammatory responses. Overall, our results indicate that H3K27me3 is a dynamic and important epigenetic modification during NK cell activation and that JMJD3/UTX-driven H3K27 demethylation is critical for NK cell function.	[Cribbs, Adam; Hookway, Edward S.; Wells, Graham; Athanasou, Nick; Sowman, Aneka; Philpott, Martin; Soderstrom, Kalle; Feldmann, Marc; Oppermann, Udo] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Natl Inst Hlth Res,Oxford Biomed Res Unit BRU, Oxford OX3 7DQ, England; [Cribbs, Adam; Feldmann, Marc] Univ Oxford, Natl Inst Hlth Res Oxford BRU, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Kennedy Inst Rheumatol, Oxford OX3 7LD, England; [Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7LD, England; [Lindow, Morten; Obad, Susanna; Oerum, Henrik] Roche Innovat Ctr Copenhagen AS, DK-2970 Horsholm, Denmark; [Prinjha, Rab K.] GlaxoSmithKline R&D, Epinova Discovery Performance Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Penn, Henry] Northwick Pk Hosp & Clin Res Ctr, Arthrit Ctr, Harrow HA1 3UJ, Middx, England; [Oppermann, Udo] Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Oppermann, Udo] Oxford Ctr Translat Myeloma Res Oxford, Oxford OX3 7DQ, England	University of Oxford; University of Oxford; University of Oxford; GlaxoSmithKline; Imperial College London	Oppermann, U (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Natl Inst Hlth Res,Oxford Biomed Res Unit BRU, Oxford OX3 7DQ, England.; Oppermann, U (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7LD, England.; Oppermann, U (corresponding author), Oxford Ctr Translat Myeloma Res Oxford, Oxford OX3 7DQ, England.; Cribbs, A (corresponding author), Univ Oxford, CGAT, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	adam.cribbs@imm.ox.ac.uk; udo.oppermann@sgc.ox.ac.uk	Cribbs, Adam/AAN-4387-2020; Cribbs, Adam/U-4055-2019; Hookway, Edward S/I-2613-2018	Cribbs, Adam/0000-0001-5288-3077; Hookway, Edward S/0000-0003-0528-7402; Philpott, Martin/0000-0003-3632-0084	Kennedy Trust for Rheumatology Research; Arthritis Research UK [20522]; National Institute of Health Research Oxford Biomedical Research Unit; Cancer Research UK; Rosetrees Trust; Medical Research Council CGAT [G1000902]; Abbvie; Bayer Healthcare; Boehringer Ingelheim; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Eli Lilly and Company; Genome Canada; Ontario Ministry of Economic Development and Innovation; Janssen; Novartis Research Foundation; Pfizer; Takeda; Wellcome Trust; People Programme (Marie Curie Actions) of European Union Seventh Framework Programme under Research Executive Agency (REA) [609305]; Rosetrees Trust [M289, M289-F1] Funding Source: researchfish; Versus Arthritis [20522] Funding Source: researchfish	Kennedy Trust for Rheumatology Research; Arthritis Research UK(Versus Arthritis); National Institute of Health Research Oxford Biomedical Research Unit; Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); Medical Research Council CGAT; Abbvie(AbbVie); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Eli Lilly and Company(Eli Lilly); Genome Canada(Genome Canada); Ontario Ministry of Economic Development and Innovation; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); People Programme (Marie Curie Actions) of European Union Seventh Framework Programme under Research Executive Agency (REA); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	This work was supported by Kennedy Trust for Rheumatology Research, Arthritis Research UK Program Grant 20522, the National Institute of Health Research Oxford Biomedical Research Unit, Cancer Research UK, and the Rosetrees Trust. This work is supported in part by Medical Research Council CGAT Program Grant G1000902 (to A. C.). The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from Abbvie, Bayer Healthcare, Boehringer Ingelheim, the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Eli Lilly and Company, Genome Canada, the Ontario Ministry of Economic Development and Innovation, Janssen, the Novartis Research Foundation, Pfizer, Takeda, and the Wellcome Trust. The research leading to these results has received funding from the People Programme (Marie Curie Actions) of European Union Seventh Framework Programme FP7/2007-2013 under Research Executive Agency (REA) Grant Agreement 609305. The authors declare that they have no conflicts of interest with the contents of this article .	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO;2-2; Cichocki F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00055; Cribbs A, 2015, THER ADV MUSCULOSKEL, V7, P206, DOI 10.1177/1759720X15598307; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finlay DK, 2015, BIOCHEM SOC T, V43, P758, DOI 10.1042/BST20150116; Gonzalez-Alvaro I, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1955; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Johansson C, 2016, NAT CHEM BIOL, V12, P539, DOI [10.1038/NCHEMBIO.2087, 10.1038/nchembio.2087]; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kling JC, 2017, J LEUKOCYTE BIOL, V101, P827, DOI 10.1189/jlb.1MR0616-272R; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2015, ONCOTARGET, V6, P17764, DOI 10.18632/oncotarget.3776; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luetke-Eversloh M, 2014, EUR J IMMUNOL, V44, P2074, DOI 10.1002/eji.201344072; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Nimmanapalli R, 2003, BLOOD, V101, P3236, DOI 10.1182/blood-2002-08-2675; Ogbomo H, 2007, FEBS LETT, V581, P1317, DOI 10.1016/j.febslet.2007.02.045; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; RITZ J, 1988, ADV IMMUNOL, V42, P181, DOI 10.1016/S0065-2776(08)60845-7; Rossi LE, 2012, J LEUKOCYTE BIOL, V91, P321, DOI 10.1189/jlb.0711339; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sims D, 2014, BIOINFORMATICS, V30, P1290, DOI 10.1093/bioinformatics/btt756; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Soderstrom K, 2010, P NATL ACAD SCI USA, V107, P13028, DOI 10.1073/pnas.1000546107; Sohlberg E, 2015, ONCOTARGET, V6, P34178, DOI 10.18632/oncotarget.6213; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; Tough DF, 2016, NAT REV DRUG DISCOV, V15, P835, DOI 10.1038/nrd.2016.185; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Wallin RPA, 2003, EUR J IMMUNOL, V33, P2727, DOI 10.1002/eji.200324070; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yin J, 2015, P NATL ACAD SCI USA, V112, P15988, DOI 10.1073/pnas.1521740112; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035	70	44	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2422	2437		10.1074/jbc.RA117.000698	http://dx.doi.org/10.1074/jbc.RA117.000698			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29301935	Green Published, hybrid			2022-12-28	WOS:000425308300016
J	de Jong, NWM; Ploscariu, NT; Ramyar, KX; Garcia, BL; Herrera, AI; Prakash, O; Katz, BB; Leidal, KG; Nauseef, WM; van Kessel, KPM; van Strijp, JAG; Geisbrecht, BV				de Jong, Nienke W. M.; Ploscariu, Nicoleta T.; Ramyar, Kasra X.; Garcia, Brandon L.; Herrera, Alvaro I.; Prakash, Om; Katz, Benjamin B.; Leidal, Kevin G.; Nauseef, William M.; van Kessel, Kok P. M.; van Strijp, Jos A. G.; Geisbrecht, Brian V.			A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL SERINE PROTEASES; IMMUNE-EVASION; CHEMICAL-SHIFTS; CATHEPSIN-G; MYELOPEROXIDASE; AUREUS; PROTEINS; MECHANISMS; ELASTASE; SYSTEM	The heme-containing enzyme myeloperoxidase (MPO) is critical for optimal antimicrobial activity of human neutrophils. We recently discovered that the bacterium Staphylococcus aureus expresses a novel immune evasion protein, called SPIN, that binds tightly to MPO, inhibits MPO activity, and contributes to bacterial survival following phagocytosis. A co-crystal structure of SPIN bound to MPO suggested that SPIN blocks substrate access to the catalytic heme by inserting an N-terminal beta-hairpin into the MPO active-site channel. Here, we describe a series of experiments that more completely define the structure/function relationships of SPIN. Whereas the SPIN N terminus adopts a beta-hairpin confirmation upon binding to MPO, the solution NMR studies presented here are consistent with this region of SPIN being dynamically structured in the unbound state. Curiously, whereas the N-terminal beta-hairpin of SPIN accounts for similar to 55% of the buried surface area in the SPIN-MPO complex, its deletion did not significantly change the affinity of SPIN for MPO but did eliminate the ability of SPIN to inhibit MPO. The flexible nature of the SPIN N terminus rendered it susceptible to proteolytic degradation by a series of chymotrypsin-like proteases found within neutrophil granules, thereby abrogating SPIN activity. Degradation of SPIN was prevented by the S. aureus immune evasion protein Eap, which acts as a selective inhibitor of neutrophil serine proteases. Together, these studies provide insight into MPO inhibition by SPIN and suggest possible functional synergy between two distinct classes of S. aureus immune evasion proteins.	[de Jong, Nienke W. M.; van Kessel, Kok P. M.; van Strijp, Jos A. G.] Univ Med Ctr Utrecht, Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Ploscariu, Nicoleta T.; Ramyar, Kasra X.; Garcia, Brandon L.; Herrera, Alvaro I.; Prakash, Om; Katz, Benjamin B.; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA; [Leidal, Kevin G.; Nauseef, William M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Inflammat Program, Iowa City, IA 52240 USA; [Nauseef, William M.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA 52246 USA	Utrecht University; Utrecht University Medical Center; Kansas State University; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Geisbrecht, BV (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA.	GeisbrechtB@ksu.edu	van Strijp, Jos A.G./J-9549-2014	van Strijp, Jos A.G./0000-0001-6253-0830; Nauseef, William/0000-0003-4032-757X; Ploscariu, Nicoleta/0000-0002-8317-3630; Katz, Benjamin/0000-0002-0716-9445; Herrera, Alvaro I./0000-0002-2108-0957	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Merit Review award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116546, R21AI111203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121511] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Merit Review award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	X-ray diffraction data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. Use of the facilities at the Iowa City, IA, Department of Veterans Affairs Medical Center, was supported by a Merit Review award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; de Jong NWM, 2017, P NATL ACAD SCI USA, V114, P9439, DOI 10.1073/pnas.1707032114; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denys GA, 2011, J ANTIMICROB CHEMOTH, V66, P335, DOI 10.1093/jac/dkq429; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fevre C, 2014, CELL MICROBIOL, V16, P1646, DOI 10.1111/cmi.12313; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Garcia BL, 2016, J IMMUNOL, V197, P2051, DOI 10.4049/jimmunol.1600863; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Greenlee-Wacker MC, 2014, J IMMUNOL, V192, P4709, DOI 10.4049/jimmunol.1302692; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Nauseef WM, 2014, METHODS MOL BIOL, V1124, P13, DOI 10.1007/978-1-62703-845-4_2; ODEBERG H, 1976, INFECT IMMUN, V14, P1276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ploscariu NT, 2017, BIOMOL NMR ASSIGN, V11, P285, DOI 10.1007/s12104-017-9764-5; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2010, PROTEIN SCI, V19, P349, DOI 10.1002/pro.303; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stapels DAC, 2016, CELL MICROBIOL, V18, P536, DOI 10.1111/cmi.12528; Stapels DAC, 2015, CURR OPIN MICROBIOL, V23, P42, DOI 10.1016/j.mib.2014.11.002; Stapels DAC, 2014, P NATL ACAD SCI USA, V111, P13187, DOI 10.1073/pnas.1407616111; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Woehl JL, 2016, BIOMOL NMR ASSIGN, V10, P301, DOI 10.1007/s12104-016-9688-5	48	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2260	2271		10.1074/jbc.RA117.000134	http://dx.doi.org/10.1074/jbc.RA117.000134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29306874	Green Published, hybrid			2022-12-28	WOS:000425308300003
J	Nielson, JR; Rutter, JP				Nielson, Jason R.; Rutter, Jared P.			Lipid-mediated signals that regulate mitochondrial biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM; MEMBRANE STEROLS; BINDING PROTEIN; CELL-SURFACE; SPHINGOSINE-1-PHOSPHATE; MITOPHAGY; STRESS; TRANSPORT; APOPTOSIS	For decades, lipids were assumed to fulfill roles only in energy storage and membrane structure. Recent studies have discovered critical roles for phospholipids, sphingolipids, and sterols in many cellular pathways, including cell signaling and transcriptional regulation. Frequently, lipids from these various classes work together to achieve defined cellular outcomes. Specific mitochondrial lipids are critical for proper assembly of the electron transport chain complexes and for effective responses to mitochondrial damage, including maintenance of mitochondrial protein homeostasis, regulation of mitophagy, and induction of apoptosis. In this Minireview, we will primarily focus on mitochondrial lipid signaling mediated by lipid-protein interactions.	[Nielson, Jason R.; Rutter, Jared P.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Nielson, Jason R.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rutter, JP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK091317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115129] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [T32 DK091317] Funding Source: Medline; NIGMS NIH HHS [R01 GM115129] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Bocking T, 2000, EUR J BIOCHEM, V267, P1607, DOI 10.1046/j.1432-1327.2000.01179.x; Chaurasia B, 2016, CELL METAB, V24, P820, DOI 10.1016/j.cmet.2016.10.002; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Edidin M, 1997, CURR OPIN STRUC BIOL, V7, P528, DOI 10.1016/S0959-440X(97)80117-0; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Izawa T, 2017, CELL, V171, P890, DOI 10.1016/j.cell.2017.10.002; Jain A, 2017, J CELL SCI, V130, P360, DOI 10.1242/jcs.194191; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kagan VE, 2016, CELL DEATH DIFFER, V23, P1140, DOI 10.1038/cdd.2015.160; Kimura K, 2007, J BIOL CHEM, V282, P5910, DOI 10.1074/jbc.M609025200; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lei YC, 2015, WORLD J GASTROENTERO, V21, P13438, DOI 10.3748/wjg.v21.i48.13438; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Myers BR, 2017, P NATL ACAD SCI USA, V114, pE11141, DOI 10.1073/pnas.1717891115; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nielson JR, 2017, MOL CELL, V68, P673, DOI 10.1016/j.molcel.2017.10.022; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; Schultz C, 2010, NAT CHEM BIOL, V6, P473, DOI 10.1038/nchembio.389; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen ZN, 2017, J BIOL CHEM, V292, P2916, DOI 10.1074/jbc.M116.753574; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Sivasubramanian M, 2015, NEUROSCIENCE, V290, P636, DOI 10.1016/j.neuroscience.2015.01.032; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Yabu T, 2015, CELL DEATH DIFFER, V22, P258, DOI 10.1038/cdd.2014.128	48	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7517	7521		10.1074/jbc.R117.001655	http://dx.doi.org/10.1074/jbc.R117.001655			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29348169	Green Published, hybrid			2022-12-28	WOS:000437256500005
J	Bak, LK; Walls, AB; Schousboe, A; Waagepetersen, HS				Bak, Lasse K.; Walls, Anne B.; Schousboe, Arne; Waagepetersen, Helle S.			Astrocytic glycogen metabolism in the healthy and diseased brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						astrocyte; brain; calcium; cyclic AMP (cAMP); glycogen; neurological disease; disease	OPERATED CALCIUM-ENTRY; ENERGY-METABOLISM; PHOSPHORYLASE INHIBITOR; OXIDATIVE-METABOLISM; MEMORY CONSOLIDATION; GLUCOSE DEPRIVATION; SENSORY STIMULATION; PRIMARY CULTURES; AXON FUNCTION; RAT-BRAIN	The brain contains a fairly low amount of glycogen, mostly located in astrocytes, a fact that has prompted the suggestion that glycogen does not have a significant physiological role in the brain. However, glycogen metabolism in astrocytes is essential for several key physiological processes and is adversely affected in disease. For instance, diminished ability to break down glycogen impinges on learning, and epilepsy, Alzheimer's disease, and type 2 diabetes are all associated with abnormal astrocyte glycogen metabolism. Glycogen metabolism supports astrocytic K+ and neurotransmitter glutamate uptake and subsequent glutamine synthesisthree fundamental steps in excitatory signaling at most brain synapses. Thus, there is abundant evidence for a key role of glycogen in brain function. Here, we summarize the physiological brain functions that depend on glycogen, discuss glycogen metabolism in disease, and investigate how glycogen breakdown is regulated at the cellular and molecular levels.	[Bak, Lasse K.; Walls, Anne B.; Schousboe, Arne; Waagepetersen, Helle S.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, 2 Univ Pk, DK-2100 Copenhagen, Denmark	University of Copenhagen	Bak, LK; Walls, AB (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, 2 Univ Pk, DK-2100 Copenhagen, Denmark.	laba@sund.ku.dk; abw@sund.ku.dk		Bak, Lasse K./0000-0003-0784-7864	Horslev Foundation; Faculty of Health and Medical Sciences at University of Copenhagen; Lundbeck Foundation [R165-2013-15334]	Horslev Foundation; Faculty of Health and Medical Sciences at University of Copenhagen; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Horslev Foundation and the Faculty of Health and Medical Sciences at University of Copenhagen (to L.K.B.) and Lundbeck Foundation Grant R165-2013-15334 (to A.B.W.). This is the third article in the Thematic Minireview series "Brain glycogen metabolism." The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1999, MOL CELL MED ASP; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bonde C, 2003, NEUROCHEM INT, V43, P371, DOI 10.1016/S0197-0186(03)00024-X; Boury-Jamot B, 2016, MOL PSYCHIATR, V21, P1070, DOI 10.1038/mp.2015.157; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Choi IY, 1999, J NEUROCHEM, V73, P1300, DOI 10.1046/j.1471-4159.1999.0731300.x; Choi IY, 2003, NEUROCHEM INT, V43, P317, DOI 10.1016/S0197-0186(03)00018-4; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; Dalsgaard MK, 2007, J CEREBR BLOOD F MET, V27, P1137, DOI 10.1038/sj.jcbfm.9600426; Dienel GA, 2007, J NEUROCHEM, V102, P466, DOI 10.1111/j.1471-4159.2007.04595.x; DiNuzzo M, 2015, METAB BRAIN DIS, V30, P307, DOI 10.1007/s11011-014-9524-5; DiNuzzo M, 2012, NEUROCHEM RES, V37, P2432, DOI 10.1007/s11064-012-0802-5; Duarte JMN, 2017, NEUROCHEM RES, V42, P1629, DOI 10.1007/s11064-017-2178-z; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Ellisdon AM, 2016, BIOCHEM SOC T, V44, P562, DOI 10.1042/BST20150236; Elsner P, 2002, J BIOL CHEM, V277, P4831, DOI 10.1074/jbc.M108226200; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Franken P, 2003, AM J PHYSIOL-REG I, V285, pR413, DOI 10.1152/ajpregu.00668.2002; Gentry MS, 2018, J BIOL CHEM, V293, P7117, DOI 10.1074/jbc.R117.803064; Gibbs ME, 2007, J NEUROSCI RES, V85, P3326, DOI 10.1002/jnr.21307; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; Gip P, 2002, AM J PHYSIOL-REG I, V283, pR54, DOI 10.1152/ajpregu.00735.2001; Hertz L, 2003, BRAIN RES, V994, P226, DOI 10.1016/j.brainres.2003.09.044; HERTZ L, 1989, BRAIN RES REV, V14, P335, DOI 10.1016/0165-0173(89)90017-9; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hertz L, 2010, NEUROCHEM INT, V57, P411, DOI 10.1016/j.neuint.2010.03.019; Holtman IR, 2015, GLIA, V63, P1495, DOI 10.1002/glia.22810; Hutchinson DS, 2008, BRAIN RES BULL, V76, P224, DOI 10.1016/j.brainresbull.2008.02.019; Jakobsen E, 2017, NEUROCHEM RES, V42, P2490, DOI 10.1007/s11064-017-2267-z; KARNOVSKY ML, 1983, J NEUROCHEM, V41, P1498, DOI 10.1111/j.1471-4159.1983.tb00853.x; Koivisto H, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00041; Kong JM, 2002, J NEUROSCI, V22, P5581; Kwon J, 2017, EXP NEUROBIOL, V26, P42, DOI 10.5607/en.2017.26.1.42; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; MEFFORD IN, 1982, BRAIN RES, V236, P339, DOI 10.1016/0006-8993(82)90719-3; Morgenthaler FD, 2009, NEUROCHEM INT, V55, P45, DOI 10.1016/j.neuint.2009.02.023; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Muller MS, 2014, GLIA, V62, P526, DOI 10.1002/glia.22623; Nadeau OW, 2018, J BIOL CHEM, V293, P7099, DOI 10.1074/jbc.R117.803023; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Obel L. F., 2011, THESIS; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Oz G, 2015, NEUROCHEM RES, V40, P2473, DOI 10.1007/s11064-015-1664-4; Oz G, 2012, J CEREBR BLOOD F MET, V32, P256, DOI 10.1038/jcbfm.2011.138; Oz G, 2007, AM J PHYSIOL-ENDOC M, V292, pE946, DOI 10.1152/ajpendo.00424.2006; Oz G, 2017, J CEREBR BLOOD F MET, V37, P2883, DOI 10.1177/0271678X16678240; Oz G, 2009, DIABETES, V58, P1978, DOI 10.2337/db09-0226; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Petit JM, 2015, METAB BRAIN DIS, V30, P263, DOI 10.1007/s11011-014-9629-x; Pfeiffer-Guglielmi B, 2000, NEUROCHEM RES, V25, P1485, DOI 10.1023/A:1007676109206; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Ransom BR, 1997, GLIA, V21, P134; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Schousboe A., 2015, C SERIES NEUROGLIA B, V2, P1, DOI DOI 10.4199/C00130ED1V01Y201506NGL007; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P457, DOI 10.1073/pnas.98.2.457; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P6417, DOI 10.1073/pnas.101129298; Sickmann HM, 2015, METAB BRAIN DIS, V30, P335, DOI 10.1007/s11011-014-9546-z; Sickmann HM, 2010, J CEREBR BLOOD F MET, V30, P1527, DOI 10.1038/jcbfm.2010.61; Sickmann HM, 2009, J NEUROCHEM, V109, P80, DOI 10.1111/j.1471-4159.2009.05915.x; Sickmann HM, 2005, NEUROCHEM RES, V30, P1295, DOI 10.1007/s11064-005-8801-4; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; SUBBARAO KV, 1990, BRAIN RES, V527, P346, DOI 10.1016/0006-8993(90)91157-C; SUBBARAO KV, 1990, BRAIN RES, V536, P220, DOI 10.1016/0006-8993(90)90028-A; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; SWANSON RA, 1993, J CEREBR BLOOD F MET, V13, P162, DOI 10.1038/jcbfm.1993.19; SWANSON RA, 1992, NEUROSCIENCE, V51, P451, DOI 10.1016/0306-4522(92)90329-Z; Tani H, 2010, J NEUROSCI, V30, P1288, DOI 10.1523/JNEUROSCI.0106-09.2010; Verkhratsky A, 2014, NEUROSCI BULL, V30, P125, DOI 10.1007/s12264-013-1343-x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Waagepetersen HS, 2005, NEUROCHEM INT, V47, P92, DOI 10.1016/j.neuint.2005.04.012; Waagepetersen HS, 2000, NEUROCHEM INT, V36, P435, DOI 10.1016/S0197-0186(99)00146-1; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Walls AB, 2014, J CEREBR BLOOD F MET, V34, P1340, DOI 10.1038/jcbfm.2014.88; WATANABE H, 1975, ARCH NEUROL-CHICAGO, V32, P181, DOI 10.1001/archneur.1975.00490450061008; WATANABE H, 1973, J NEUROCHEM, V20, P1543, DOI 10.1111/j.1471-4159.1973.tb00272.x; Weinshenker D, 2008, CURR ALZHEIMER RES, V5, P342, DOI 10.2174/156720508784533286; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Willoughby D, 2014, BIOCHEM J, V464, P73, DOI 10.1042/BJ20140766; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Xu JN, 2013, NEUROCHEM RES, V38, P472, DOI 10.1007/s11064-012-0938-3	96	71	71	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7108	7116		10.1074/jbc.R117.803239	http://dx.doi.org/10.1074/jbc.R117.803239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29572349	Green Published, hybrid			2022-12-28	WOS:000432174500004
J	Ramezanpour, M; Lee, J; Taneva, SG; Tieleman, DP; Cornell, RB				Ramezanpour, Mohsen; Lee, Jaeyong; Taneva, Svetla G.; Tieleman, D. Peter; Cornell, Rosemary B.			An auto-inhibitory helix in CTP:phosphocholine cytidylyltransferase hijacks the catalytic residue and constrains a pliable, domain-bridging helix pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein dynamic; molecular dynamics; allosteric regulation; lipid-protein interaction; protein cross-linking; CTP:phosphocholine cytidylyltransferase; regulation of catalysis; membrane activation; auto-inhibition; protein-membrane interaction; nucleotide transferase	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; MEMBRANE-BINDING DOMAIN; CAUSE SPONDYLOMETAPHYSEAL DYSPLASIA; CULTURED GLIOMA-CELLS; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; AMPHIPATHIC HELIX; ENZYME	The activity of CTP:phosphocholine cytidylyltransferase (CCT), a key enzyme in phosphatidylcholine synthesis, is regulated by reversible interactions of a lipid-inducible amphipathic helix (domain M) with membrane phospholipids. When dissociated from membranes, a portion of the M domain functions as an auto-inhibitory (AI) element to suppress catalysis. The AI helix from each subunit binds to a pair of helices (E) that extend from the base of the catalytic dimer to create a four-helix bundle. The bound AI helices make intimate contact with loop L2, housing a key catalytic residue, Lys(122). The impacts of the AI helix on active-site dynamics and positioning of Lys(122) are unknown. Extensive MD simulations with and without the AI helix revealed that backbone carbonyl oxygens at the point of contact between the AI helix and loop L2 can entrap the Lys(122) side chain, effectively competing with the substrate, CTP. In silico, removal of the AI helices dramatically increased E dynamics at a predicted break in the middle of these helices, enabling them to splay apart and forge new contacts with loop L2. In vitro cross-linking confirmed the reorganization of the E element upon membrane binding of the AI helix. Moreover, when E bending was prevented by disulfide engineering, CCT activation by membrane binding was thwarted. These findings suggest a novel two-part auto-inhibitory mechanism for CCT involving capture of Lys(122) and restraint of the pliable E helices. We propose that membrane binding enables bending of the E helices, bringing the active site closer to the membrane surface.	[Ramezanpour, Mohsen; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Lee, Jaeyong; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Calgary; Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.; Tieleman, DP (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Tieleman, DP (corresponding author), Univ Calgary, Ctr Mol Simulat, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	tieleman@ucalgary.ca; cornell@sfu.ca			Canadian Institutes of Health Research; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research (to R. B. C. and D. P. T.) and supported in part by the Canada Research Chairs program. The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; Brock JS, 2016, P NATL ACAD SCI USA, V113, P972, DOI 10.1073/pnas.1522891113; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demir O, 2012, J CHEM INF MODEL, V52, P1308, DOI 10.1021/ci3001327; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; EFTINK M, 1983, BIOPHYS J, V43, P323, DOI 10.1016/S0006-3495(83)84356-2; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; GEORGE TP, 1989, BIOCHIM BIOPHYS ACTA, V1004, P283, DOI 10.1016/0005-2760(89)90075-1; GEORGE TP, 1991, J BIOL CHEM, V266, P12419; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoover-Fong J, 2014, AM J HUM GENET, V94, P105, DOI 10.1016/j.ajhg.2013.11.018; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; McMaster CR, 2018, FEBS LETT, V592, P1256, DOI 10.1002/1873-3468.12919; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Testa F, 2017, EUR J HUM GENET, V25, P651, DOI 10.1038/ejhg.2017.23; Trenker R, 2016, CURR OPIN STRUC BIOL, V39, P115, DOI 10.1016/j.sbi.2016.07.001; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamamoto GL, 2014, AM J HUM GENET, V94, P113, DOI 10.1016/j.ajhg.2013.11.022; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	61	9	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7070	7084		10.1074/jbc.RA118.002053	http://dx.doi.org/10.1074/jbc.RA118.002053			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29519816	Green Published, hybrid			2022-12-28	WOS:000431487300039
J	Cheng, M; Niu, YQ; Fan, JJ; Chi, XJ; Liu, XY; Yang, W				Cheng, Min; Niu, Yuqiang; Fan, Jingjing; Chi, Xiaojing; Liu, Xiuying; Yang, Wei			Interferon down-regulation of miR-1225-3p as an antiviral mechanism through modulating Grb2-associated binding protein 3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; NONCODING RNA; I IFN; MICRORNA; GENES; LONG; IDENTIFICATION; RECOGNITION; RECEPTORS; PROFILES	Induction of interferons (IFNs) is a central event of antiviral innate immunity. As crucial posttranscriptional regulators, microRNAs (miRNAs) are important for IFN-mediated host defense. Although screening has indicated a substantial number of miRNAs to be differentially expressed after IFN stimulation, the detailed mechanisms of these miRNAs in the antiviral response are underexplored and of great significance. Here, we show that hsa-miR-1225-3p is specifically down-regulated by type I IFN through the IFN/JAK/STAT signaling pathway. Silencing endogenous miR-1225-3p inhibited infection by multiple IFN-susceptible viruses, including hepatitis C virus, Sendai virus, and Newcastle disease virus. In contrast, overexpression of miR-1225-3p impaired the antiviral effect of IFNs and facilitated viral infection. Regarding the mechanism, we identified growth factor receptor-bound protein 2-associated binding protein 3 (GAB3) as a direct target of miR-1225-3p. GAB3 expression was up-regulated by IFN, and overexpression of GAB3 demonstrated potent antiviral effects through enhancing IFN response and virus-triggered innate immune activation. Taken together, our findings reveal the biological function of miR-1225-3p for the first time and propose a novel antiviral regulation pathway in which miRNA and GAB3 participate. This study contributes to the understanding of host miRN A participation in antiviral processes of IFN.	Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100176, Peoples R China; [Yang, Wei] Peking Union Med Coll, Beijing 100176, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, W (corresponding author), Peking Union Med Coll, Beijing 100176, Peoples R China.; Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100176, Peoples R China.	wyang@ipb.pumc.edu.cn			National Natural Science Foundation of China [81401674, 81672030, 81471954]; National Basic Research Program of China [2015CB554301]; CAMS Initiative for Innovative Medicine [2016-I2M-3-020]; National Science and Technology Major Project [2017ZX10304402-001-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); CAMS Initiative for Innovative Medicine; National Science and Technology Major Project	This work was supported by National Natural Science Foundation of China Grants 81401674, 81672030, and 81471954; National Basic Research Program of China Grant 2015CB554301; CAMS Initiative for Innovative Medicine Grant 2016-I2M-3-020; and National Science and Technology Major Project 2017ZX10304402-001-013. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Cheng M, 2012, J ANTIMICROB CHEMOTH, V67, P1080, DOI 10.1093/jac/dks015; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ferdousi M, 2016, J BIOCHEM, V160, P325, DOI 10.1093/jb/mvw042; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Havens MA, 2012, NUCLEIC ACIDS RES, V40, P4626, DOI 10.1093/nar/gks026; Hotho DM, 2013, J VIRAL HEPATITIS, V20, pe78, DOI 10.1111/jvh.12012; Lee HM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00178; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Na YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S17; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Petersen J, 2016, J HEPATOL, V65, P835, DOI 10.1016/j.jhep.2016.05.043; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Su CH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-354; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Vaughan TY, 2011, AM J BLOOD RES, V1, P130; Wang P, 2012, MOL BIOSYST, V8, P2924, DOI 10.1039/c2mb25228g; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Yang CH, 2015, PHARMACEUTICALS, V8, P836, DOI 10.3390/ph8040836; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zhang Y, 2016, BIOCHEM BIOPH RES CO, V478, P1436, DOI 10.1016/j.bbrc.2016.08.142; Zheng QL, 2016, J IMMUNOL, V196, P1317, DOI 10.4049/jimmunol.1502134; Zheng YJ, 2010, J IMMUNOL, V184, P6447, DOI 10.4049/jimmunol.0901750	35	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5975	5986		10.1074/jbc.RA117.000738	http://dx.doi.org/10.1074/jbc.RA117.000738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496996	Green Published, hybrid			2022-12-28	WOS:000430497300018
J	Cairns, L; Tran, T; Fowl, BH; Patterson, A; Kim, YJ; Bothner, B; Kavran, JM				Cairns, Leah; Thao Tran; Fowl, Brendan H.; Patterson, Angela; Kim, Yoo Jin; Bothner, Brian; Kavran, Jennifer M.			Salvador has an extended SARAH domain that mediates binding to Hippo kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NDR-PROTEIN-KINASE; CELL-CYCLE EXIT; TUMOR-SUPPRESSOR; HELIX GEOMETRY; WW DOMAIN; PROLIFERATION ARREST; PROMOTES APOPTOSIS; STRUCTURAL BASIS; MST1 KINASE; DROSOPHILA	The Hippo pathway controls cell proliferation and differentiation through the precisely tuned activity of a core kinase cassette. The activity of Hippo kinase is modulated by interactions between its C-terminal coiled-coil, termed the SARAH domain, and the SARAH domains of either dRassF or Salvador. Here, we wanted to understand the molecular basis of SARAH domain-mediated interactions and their influence on Hippo kinase activity. We focused on Salvador, a positive effector of Hippo activity and the least well-characterized SARAH domain-containing protein. We determined the crystal structure of a complex between Salvador and Hippo SARAH domains from Drosophila. This structure provided insight into the organization of the Salvador SARAH domain including a folded N-terminal extension that expands the binding interface with Hippo SARAH domain. We also found that this extension improves the solubility of the Salvador SARAH domain, enhances binding to Hippo, and is unique to Salvador. We therefore suggest expanding the definition of the Salvador SARAH domain to include this extended region. The heterodimeric assembly observed in the crystal was confirmed by cross-linked MS and provided a structural basis for the mutually exclusive interactions of Hippo with either dRassF or Salvador. Of note, Salvador influenced the kinase activity of Mst2, the mammalian Hippo homolog. In co-transfected HEK293T cells, human Salvador increased the levels of Mst2 autophosphorylation and Mst2-mediated phosphorylation of select substrates, whereas Salvador SARAH domain inhibited Mst2 autophosphorylation in vitro. These results suggest Salvador enhances the effects of Hippo kinase activity at multiple points in the Hippo pathway.	[Cairns, Leah; Thao Tran; Fowl, Brendan H.; Kim, Yoo Jin; Kavran, Jennifer M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 20215 USA; [Patterson, Angela; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 20215 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 20215 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Montana State University System; Montana State University Bozeman; Johns Hopkins University; Johns Hopkins University	Kavran, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	jkavran@jhu.edu		Kim, Yoo Jin/0000-0002-3499-3990; Cairns, Leah/0000-0002-3907-001X	Murdock Charitable Trust; National Institutes of Health of the IDEA program [P20GM103474]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474, T32GM007445] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the IDEA program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Montana State University Proteomics, Metabolomics, and Mass Spectrometry Facility is supported in part by funding from the Murdock Charitable Trust and National Institutes of Health Grant P20GM103474 of the IDEA program. Plasmids encoding Renilla and firefly luciferase and Gal4DBD-Yki used in the reporter assay were provided by K. Irvine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bitra A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45020; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Hwang E, 2014, ACTA CRYSTALLOGR D, V70, P1944, DOI 10.1107/S139900471400947X; John MAS, 1999, NAT GENET, V21, P182, DOI DOI 10.1038/5965; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Liu GG, 2014, J STRUCT BIOL, V185, P366, DOI 10.1016/j.jsb.2014.01.008; Makbul C, 2013, BIOCHEMISTRY-US, V52, P1045, DOI 10.1021/bi3014642; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song J, 2015, J BIOCHEM, V158, P181, DOI 10.1093/jb/mvv031; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053	59	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5532	5543		10.1074/jbc.RA117.000923	http://dx.doi.org/10.1074/jbc.RA117.000923			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29519817	Green Published, hybrid			2022-12-28	WOS:000430044100016
J	Madacki, J; Laval, F; Grzegorzewicz, A; Lemassu, A; Zahorszka, M; Arand, M; McNeil, M; Daffe, M; Jackson, M; Laneelle, MA; Kordulakova, J				Madacki, Jan; Laval, Francoise; Grzegorzewicz, Anna; Lemassu, Anne; Zahorszka, Monika; Arand, Michael; McNeil, Michael; Daffe, Mamadou; Jackson, Mary; Laneelle, Marie-Antoinette; Kordulakova, Jana			Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; cell wall; fatty acid metabolism; lipid; mass spectrometry (MS); bacterial cell envelope; epoxide hydrolase; epoxymycolic acid; mycolic acids	MOLECULAR-MASS DETERMINATION; COMMON MECHANISM; TUBERCULOSIS; BIOSYNTHESIS; CYCLOPROPANATION; PHOSPHORYLATION; PURIFICATION; INHIBITION; EXPRESSION; TRANSPORT	nd H-1 NMR spectroscopy of mycolic acids and lipids isolated from EphD-overproducing M. smegmatis, we identified new oxygenated mycolic acid species that accumulated during epoxymycolate depletion. Disruption of the ephD gene in M. tuberculosis specifically impaired the synthesis of ketomycolates and caused accumulation of their precursor, hydroxymycolate, indicating either direct or indirect involvement of EphD in ketomycolate biosynthesis. Our results clearly indicate that EphD plays a role in met Mycolic acids are the hallmark of the cell envelope in mycobacteria, which include the important human pathogens Mycobacterium tuberculosis and Mycobacterium leprae. Mycolic acids are very long C60-C90 -alkyl -hydroxy fatty acids having a variety of functional groups on their hydrocarbon chain that define several mycolate types. Mycobacteria also produce an unusually large number of putative epoxide hydrolases, but the physiological functions of these enzymes are still unclear. Here, we report that the mycobacterial epoxide hydrolase EphD is involved in mycolic acid metabolism. We found that orthologs of EphD from M. tuberculosis and M. smegmatis are functional epoxide hydrolases, cleaving a lipophilic substrate, 9,10-cis-epoxystearic acid, in vitro and forming a vicinal diol. The results of EphD overproduction in M. smegmatis and M. bovis BCG hma strains producing epoxymycolic acids indicated that EphD is involved in the metabolism of these forms of mycolates in both fast- and slow-growing mycobacteria. Moreover, using MALDI-TOF-MS aabolism of oxygenated mycolic acids in mycobacteria.	[Madacki, Jan; Zahorszka, Monika; Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Laval, Francoise; Lemassu, Anne; Daffe, Mamadou; Laneelle, Marie-Antoinette] CNRS, Inst Pharmacol & Biol Struct, TB & Infect Biol Dept, F-31077 Toulouse, France; [Grzegorzewicz, Anna; McNeil, Michael; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Arand, Michael] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	Comenius University Bratislava; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Colorado State University; University of Zurich	Kordulakova, J (corresponding author), Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia.	jana.kordulakova@uniba.sk	Jackson, Mary/D-5345-2017; Arand, Michael/J-3926-2014; McNeil, Michael/G-3325-2019; Kordulakova, Jana/I-3887-2014; LAUZERAL-VIZCAINO, Françoise/W-8898-2019	Jackson, Mary/0000-0002-9212-0258; Arand, Michael/0000-0003-2413-3177; Kordulakova, Jana/0000-0003-2834-0165; LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Lemassu, Anne/0000-0002-9323-2497; Madacki, Jan/0000-0001-6534-4240	Slovak Research and Development Agency [APVV-0441-10]; Slovak Grant Agency VEGA Grant [1/0284/15]; Research and Development Operational Programe funded by European Regional Development Fund [ITMS 26240120027]; NIAID, National Institutes of Health [AI063054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054] Funding Source: NIH RePORTER	Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak Grant Agency VEGA Grant; Research and Development Operational Programe funded by European Regional Development Fund; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Slovak Research and Development Agency Grant APVV-0441-10 (to J. K.), Slovak Grant Agency VEGA Grant 1/0284/15 (to J. K.), the project supported by the Research and Development Operational Programe funded by European Regional Development Fund Contract ITMS 26240120027 (to J. K.), and NIAID, National Institutes of Health Grant AI063054 (to M. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhter Y, 2008, GENE, V407, P148, DOI 10.1016/j.gene.2007.10.017; Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Biswal BK, 2006, ACTA CRYSTALLOGR F, V62, P136, DOI 10.1107/S1744309106000637; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Derrick SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032959; Dhiman RK, 2004, J LIPID RES, V45, P1140, DOI 10.1194/jlr.M400047-JLR200; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita Y, 2005, MICROBIOL-SGM, V151, P1443, DOI 10.1099/mic.0.27791-0; Gavalda S, 2014, CHEM BIOL, V21, P1660, DOI 10.1016/j.chembiol.2014.10.011; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jang J, 2010, MICROBIOL-SGM, V156, P1619, DOI 10.1099/mic.0.038133-0; Johansson P, 2005, J MOL BIOL, V351, P1048, DOI 10.1016/j.jmb.2005.06.055; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; LANEELLE MA, 1970, EUR J BIOCHEM, V12, P296, DOI 10.1111/j.1432-1033.1970.tb00850.x; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; LEVYFREBAULT V, 1986, ANN INST PASTEUR MIC, V137A, P143, DOI 10.1016/S0769-2609(86)80019-9; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; MINNIKIN DE, 1985, ZBL BAKT-INT J MED M, V259, P446; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Morisseau C, 2013, BIOCHIMIE, V95, P91, DOI 10.1016/j.biochi.2012.06.011; Muller F, 1997, EUR J BIOCHEM, V245, P490, DOI 10.1111/j.1432-1033.1997.00490.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Quemard A, 2016, TRENDS MICROBIOL, V24, P725, DOI 10.1016/j.tim.2016.04.009; Rodriguez-Rivera FP, 2017, J AM CHEM SOC, V139, P3488, DOI 10.1021/jacs.6b12541; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Slama N, 2016, MOL MICROBIOL, V99, P794, DOI 10.1111/mmi.13266; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; TORIYAMA S, 1978, FEBS LETT, V95, P111, DOI 10.1016/0014-5793(78)80063-5; TORIYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V712, P427, DOI 10.1016/0005-2760(82)90363-0; Tortoli E, 2014, CLIN MICROBIOL REV, V27, P727, DOI 10.1128/CMR.00035-14; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; van Loo B, 2006, APPL ENVIRON MICROB, V72, P2905, DOI 10.1128/AEM.72.4.2905-2917.2006; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828	61	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5172	5184		10.1074/jbc.RA117.000246	http://dx.doi.org/10.1074/jbc.RA117.000246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29472294	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000429409300022
J	Roy, S; Mathew, MK				Roy, Samrat; Mathew, M. K.			Fluid flow modulates electrical activity in cardiac hERG potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; RAT VENTRICULAR MYOCYTES; MISSENSE MUTATION; K+ CHANNELS; PAS DOMAIN; PORE REGION; MECHANISM; INTEGRINS; ADHESION; MECHANOSENSITIVITY	Fluid movement within the heart generates substantial shear forces, but the effect of this mechanical stress on the electrical activity of the human heart has not been examined. The fast component of the delayed rectifier potassium currents responsible for repolarization of the cardiac action potential, Ikr, is encoded by the human ether-a-go-go related gene (hERG) channel. Here, we exposed hERG1a channel-expressing HEK293T cells to laminar shear stress (LSS) and observed that this mechanical stress increased the whole-cell current by 30-40%. LSS shifted the voltage dependence of steady-state activation of the hERG channel to the hyperpolarizing direction, accelerated the time course of activation and recovery from inactivation, slowed down deactivation, and shifted the steady-state inactivation to the positive direction, all of which favored the hERG open state. In contrast, the time course of inactivation was faster, favoring the closed state. Using specific inhibitors of focal adhesion kinase, a regulator of mechano-transduction via the integrin pathway, we also found that the LSS-induced modulation of the whole-cell current depended on the integrin pathway. The hERG1b channel variant, which lacks the Per-Arnt-Sim (PAS) domain, and long QT syndrome-associated variants having point mutations in the PAS domain were unaffected by LSS, suggesting that the PAS domain in hERG1a channel may be involved in sensing mechanical shear stress. We conclude that a mechano-electric feedback pathway modulates hERG channel activity through the integrin pathway, indicating that mechanical forces in the heart influence its electrical activity.	[Roy, Samrat; Mathew, M. K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India; [Roy, Samrat] Biocon Bristol Myers Squibb Res Ctr, Bengaluru 560099, India; [Roy, Samrat] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Bristol-Myers Squibb; Kalinga Institute of Industrial Technology (KIIT)	Mathew, MK (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	mathew@ncbs.res.in			Tata Institute of Fundamental Research	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	This work was supported by internal funds of the Tata Institute of Fundamental Research. The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto K, 1998, HUM MUTAT, pS184; Barakat AI, 1999, CIRC RES, V85, P820, DOI 10.1161/01.RES.85.9.820; Benson DW, 1996, CIRCULATION, V93, P1791, DOI 10.1161/01.CIR.93.10.1791; Beyder A, 2012, CIRCULATION, V125, P2698, DOI 10.1161/CIRCULATIONAHA.112.094714; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Borg TK, 2000, CARDIOVASC RES, V46, P277, DOI 10.1016/S0008-6363(99)00433-2; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; Browe DM, 2003, J GEN PHYSIOL, V122, P689, DOI 10.1085/jgp.200308899; Burgess ML, 2001, MECH AGEING DEV, V122, P1739, DOI 10.1016/S0047-6374(01)00296-2; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Cordeiro JM, 2005, CARDIOVASC RES, V67, P498, DOI 10.1016/j.cardiores.2005.02.018; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; DELUCA M, 1992, EXP CELL RES, V202, P142, DOI 10.1016/0014-4827(92)90413-3; GEHLSEN KR, 1988, J CELL BIOL, V106, P925, DOI 10.1083/jcb.106.3.925; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Harley CA, 2016, P NATL ACAD SCI USA, V113, P9916, DOI 10.1073/pnas.1601116113; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Isenberg G, 2003, PROG BIOPHYS MOL BIO, V82, P43, DOI 10.1016/S0079-6107(03)00004-X; Jones DK, 2014, P NATL ACAD SCI USA, V111, P18073, DOI 10.1073/pnas.1414945111; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Larsen AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009021; Lee S, 2008, AM J PHYSIOL-CELL PH, V294, pC966, DOI 10.1152/ajpcell.00381.2007; LEGRICE IJ, 1995, CIRC RES, V77, P182, DOI 10.1161/01.RES.77.1.182; Lorenzen-Schmidt I, 2006, CELL BIOCHEM BIOPHYS, V46, P113, DOI 10.1385/CBB:46:2:113; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; McPate MJ, 2008, BRIT J PHARMACOL, V155, P957, DOI 10.1038/bjp.2008.325; McPate MJ, 2009, J PHYSIOL PHARMACOL, V60, P23; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Morais-Cabral JH, 2015, J MOL BIOL, V427, P67, DOI 10.1016/j.jmb.2014.08.008; Morris CE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00025; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Pasipoularides A, 2012, HELL J CARDIOL, V53, P458; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Rosa AO, 2013, CELL CALCIUM, V53, P264, DOI 10.1016/j.ceca.2012.12.007; Ross RS, 2002, J CARD FAIL, V8, pS326, DOI 10.1054/jcaf.2002.129263; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Satler CA, 1996, AM J MED GENET, V65, P27, DOI 10.1002/(SICI)1096-8628(19961002)65:1<27::AID-AJMG4>3.3.CO;2-J; Satler CA, 1998, HUM GENET, V102, P265, DOI 10.1007/s004390050690; Schillaci G, 1996, HYPERTENSION, V28, P284, DOI 10.1161/01.HYP.28.2.284; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Strege PR, 2003, AM J PHYSIOL-CELL PH, V284, pC60, DOI 10.1152/ajpcell.00532.2001; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Tanaka T, 1997, CIRCULATION, V95, P565, DOI 10.1161/01.CIR.95.3.565; Trudeau MC, 2011, J GEN PHYSIOL, V138, P581, DOI 10.1085/jgp.201110683; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yoshida H, 1999, J CARDIOVASC ELECTR, V10, P1262, DOI 10.1111/j.1540-8167.1999.tb00304.x; ZHIDKOVA NI, 1995, BIOCHEM BIOPH RES CO, V214, P279, DOI 10.1006/bbrc.1995.2285	64	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4289	4303		10.1074/jbc.RA117.000432	http://dx.doi.org/10.1074/jbc.RA117.000432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29305421	Green Published, hybrid			2022-12-28	WOS:000428204300005
J	Crickard, JB; Kaniecki, K; Kwon, Y; Sung, P; Greene, EC				Crickard, J. Brooks; Kaniecki, Kyle; Kwon, YoungHo; Sung, Patrick; Greene, Eric C.			Spontaneous self-segregation of Rad51 and Dmc1 DNA recombinases within mixed recombinase filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; MEIOTIC RECOMBINATION; STRAND EXCHANGE; RECA PROTEIN; DYNAMICS; ATTRIBUTES; COMPLEXES; CURTAINS; MEIOSIS; BINDING	During meiosis, the two DNA recombinases Rad51 and Dmc1 form specialized presynaptic filaments that are adapted for performing recombination between homologous chromosomes. There is currently a limited understanding of how these two recombinases are organized within the meiotic presynaptic filament. Here, we used single molecule imaging to examine the properties of presynaptic complexes composed of both Rad51 and Dmc1. We demonstrate that Rad51 and Dmc1 have an intrinsic ability to self-segregate, even in the absence of any other recombination accessory proteins. Moreover, we found that the presence of Dmc1 stabilizes the adjacent Rad51 filaments, suggesting that cross-talk between these two recombinases may affect their biochemical properties. Based upon these findings, we describe a model for the organization of Rad51 and Dmc1 within the meiotic presynaptic complex, which is also consistent with in vivo observations, genetic findings, and biochemical expectations. This model argues against the existence of extensively intermixed filaments, and we propose that Rad51 and Dmc1 have intrinsic capacities to form spatially distinct filaments, suggesting that additional recombination cofactors are not required to segregate the Rad51 and Dmc1 filaments.	[Crickard, J. Brooks; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kaniecki, Kyle] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Columbia University; Columbia University; Yale University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu			National Institutes of Health [R35 GM118026, R01ES007061, RO1ES015632]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health Grants R35 GM118026 (to E.C.G.) and R01ES007061 and RO1ES015632 (to P.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bianco P R, 1998, Front Biosci, V3, pD570; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005653; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Busygina V, 2013, DNA REPAIR, V12, P707, DOI 10.1016/j.dnarep.2013.05.004; Busygina V, 2012, J BIOL CHEM, V287, P1566, DOI 10.1074/jbc.M111.297309; Callender TL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006226; Candelli A, 2014, P NATL ACAD SCI USA, V111, P15090, DOI 10.1073/pnas.1307824111; CAZENAVE C, 1983, EMBO J, V2, P2247, DOI 10.1002/j.1460-2075.1983.tb01730.x; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Crickard JB, 2018, EMBO J, V37, DOI 10.15252/embj.201798728; De Tullio L., 2018, METHODS ENZ IN PRESS; De Tullio L, 2017, CELL REP, V21, P570, DOI 10.1016/j.celrep.2017.09.073; Dresser ME, 1997, GENETICS, V147, P533; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kaniecki K, 2017, CELL REP, V21, P3166, DOI 10.1016/j.celrep.2017.11.047; Keeney S, 2014, ANNU REV GENET, V48, P187, DOI 10.1146/annurev-genet-120213-092304; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu Yang, 2014, ScientificWorldJournal, V2014, P476219, DOI 10.1155/2014/476219; Ma CJ, 2017, METHOD ENZYMOL, V582, P193, DOI 10.1016/bs.mie.2016.08.005; Ma CJ, 2017, J BIOL CHEM, V292, P11702, DOI 10.1074/jbc.M117.794545; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; STORY RM, 1993, SCIENCE, V259, P1892, DOI 10.1126/science.8456313; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Taylor MRG, 2016, MOL CELL, V64, P926, DOI 10.1016/j.molcel.2016.10.020; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D., 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A016626	56	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4191	4200		10.1074/jbc.RA117.001143	http://dx.doi.org/10.1074/jbc.RA117.001143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382724	Green Published, hybrid			2022-12-28	WOS:000427587500029
J	Faraz, M; Herdenberg, C; Holmlund, C; Henriksson, R; Hedman, H				Faraz, Mahmood; Herdenberg, Carl; Holmlund, Camilla; Henriksson, Roger; Hedman, Hakan			A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; NEGATIVE REGULATOR; TYROSINE KINASES; TUMOR-SUPPRESSOR; BREAST-CANCER; EXPRESSION; GENE; GLIOBLASTOMA; HOMEOSTASIS; ACTIVATION	Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a tumor suppressor and a negative regulator of several receptor tyrosine kinases. The molecular mechanisms by which LRIG1 mediates its tumor suppressor effects and regulates receptor tyrosine kinases remain incompletely understood. Here, we performed a yeast two-hybrid screen to identify novel LRIG1-interacting proteins and mined data from the Bio-Plex (biophysical interactions of ORFeome-based complexes) protein interaction data repository. The putative LRIG1 interactors identified in the screen were functionally evaluated using a triple co-transfection system in which HEK293 cells were co-transfected with platelet-derived growth factor receptor alpha, LRIG1, and shRNAs against the identified LRIG1 interactors. The effects of the shRNAs on the ability of LRIG1 to down-regulate platelet-derived growth factor receptor alpha expression were evaluated. On the basis of these results, we present an LRIG1 protein interaction network with many newly identified components. The network contains the apparently functionally important LRIG1-interacting proteins RAB4A, PON2, GAL3ST1, ZBTB16, LRIG2, CNPY3, HLA-DRA, GML, CNPY4, LRRC40, and LRIG3, together with GLRX3, PTPRK, and other proteins. In silico analyses of The Cancer Genome Atlas data sets revealed consistent correlations between the expression of the transcripts encoding LRIG1 and its interactors ZBTB16 and PTPRK and inverse correlations between the transcripts encoding LRIG1 and GLRX3. We further studied the LRIG1 function-promoting paraoxonase PON2 and found that it co-localized with LRIG1 in LRIG1-transfected cells. The proposed LRIG1 protein interaction network will provide leads for future studies aiming to understand the molecular functions of LRIG1 and the regulation of growth factor signaling.	[Faraz, Mahmood; Herdenberg, Carl; Holmlund, Camilla; Henriksson, Roger; Hedman, Hakan] Umea Univ, Oncol Res Lab, Dept Radiat Sci, SE-90187 Umea, Sweden	Umea University	Hedman, H (corresponding author), Umea Univ, Oncol Res Lab, Dept Radiat Sci, SE-90187 Umea, Sweden.	hakan.hedman@umu.se	Hedman, Håkan/F-9495-2012; Henriksson, Roger/AAI-8608-2020; Faraz, Mahmood/W-2796-2018	Herdenberg, Carl/0000-0001-8849-6810; Faraz, Mahmood/0000-0002-1965-6048	Kempe Foundations; Swedish Cancer Society; Cancer Research Foundation in Northern Sweden; Umea University; Vasterbotten County Council	Kempe Foundations; Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Umea University; Vasterbotten County Council	This work was supported by grants from the Kempe Foundations, the Swedish Cancer Society, and the Cancer Research Foundation in Northern Sweden and through the regional agreement between Umea University and Vasterbotten County Council on cooperation in the fields of medicine, odontology, and health. The authors declare that they have no conflicts of interest with the contents of this article.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Alsina FC, 2016, EMBO REP, V17, P601, DOI 10.15252/embr.201541218; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gumienny TL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000963; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Honke K, 1997, J BIOL CHEM, V272, P4864, DOI 10.1074/jbc.272.8.4864; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Johansson M, 2013, NEURO-ONCOLOGY, V15, P1200, DOI 10.1093/neuonc/not054; Kinnersley B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9559; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kvarnbrink S, 2015, ACTA ONCOL, V54, P1113, DOI 10.3109/0284186X.2015.1021427; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu TM, 2016, STEM CELLS, V34, P277, DOI 10.1002/stem.2270; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Meabon JS, 2016, MOL CELL NEUROSCI, V70, P1, DOI 10.1016/j.mcn.2015.11.002; Melin BS, 2017, NAT GENET, V49, P789, DOI 10.1038/ng.3823; Nagarajan A, 2017, MOL CELL, V67, P685, DOI 10.1016/j.molcel.2017.07.014; Neirinckx V, 2017, BBA-REV CANCER, V1868, P109, DOI 10.1016/j.bbcan.2017.02.007; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Nilsson J, 2001, BIOCHEM BIOPH RES CO, V284, P1155, DOI 10.1006/bbrc.2001.5092; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rondahl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073635; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sjodin A, 2003, J INVEST DERMATOL, V121, P428, DOI 10.1046/j.1523-1747.2003.12374.x; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Thompson PA, 2014, CANCER RES, V74, P2928, DOI 10.1158/0008-5472.CAN-13-2112; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005; Yokdang N, 2016, ONCOGENE, V35, P2932, DOI 10.1038/onc.2015.345; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734	61	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3421	3435		10.1074/jbc.M117.807487	http://dx.doi.org/10.1074/jbc.M117.807487			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317492	Green Published, hybrid			2022-12-28	WOS:000426562800032
J	Kuhaudomlarp, S; Patron, NJ; Henrissat, B; Rejzek, M; Saalbach, G; Field, RA				Kuhaudomlarp, Sakonwan; Patron, Nicola J.; Henrissat, Bernard; Rejzek, Martin; Saalbach, Gerhard; Field, Robert A.			Identification of Euglena gracilis beta-1,3-glucan phosphorylase and establishment of a new glycoside hydrolase (GH) family GH149	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE UTILIZATION LOCI; LAMINARIBIOSE PHOSPHORYLASE; CELLOBIOSE PHOSPHORYLASE; CELLODEXTRIN PHOSPHORYLASE; ENZYMATIC-SYNTHESIS; CRYSTAL-STRUCTURE; IN-VITRO; CARBOHYDRATE; PURIFICATION; SPECIFICITY	Glycoside phosphorylases (EC 2.4.x.x) carry out the reversible phosphorolysis of glucan polymers, producing the corresponding sugar 1-phosphate and a shortened glycan chain. beta-1,3-Glucan phosphorylase activities have been reported in the photosynthetic euglenozoan Euglena gracilis, but the cognate protein sequences have not been identified to date. Continuing our efforts to understand the glycobiology of E. gracilis, we identified a candidate phosphorylase sequence, designated EgP1, by proteomic analysis of an enriched cellular protein lysate. We expressed recombinant EgP1 in Escherichia coli and characterized it in vitro as a beta-1,3-glucan phosphorylase. BLASTP identified several hundred EgP1 orthologs, most of which were from Gram-negative bacteria and had 37-91% sequence identity to EgP1. We heterologously expressed a bacterial metagenomic sequence, Pro_7066 in E. coli and confirmed it as a beta-1,3-glucan phosphorylase, albeit with kinetics parameters distinct from those of EgP1. EgP1, Pro_7066, and their orthologs are classified as a new glycoside hydrolase (GH) family, designated GH149. Comparisons between GH94, EgP1, and Pro_7066 sequences revealed conservation of key amino acids required for the phosphorylase activity, suggesting a phosphorylase mechanism that is conserved between GH94 and GH149. We found bacterial GH149 genes in gene clusters containing sugar transporter and several other GH family genes, suggesting that bacterial GH149 proteins have roles in the degradation of complex carbohydrates. The Bacteroidetes GH149 genes located to previously identified polysaccharide utilization loci, implicated in the degradation of complex carbohydrates. In summary, we have identified a eukaryotic and a bacterial beta-1,3-glucan phosphorylase and uncovered a new family of phosphorylases that we name GH149.	[Kuhaudomlarp, Sakonwan; Rejzek, Martin; Saalbach, Gerhard; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Patron, Nicola J.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Henrissat, Bernard] Aix Marseille Univ, Architecture & Fonct Macromol Biol, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] CNRS, UMR 7257, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk	Patron, Nicola J/D-8778-2014; Kuhaudomlarp, Sakonwan/AAO-1251-2021; Henrissat, Bernard/J-2475-2012	Patron, Nicola J/0000-0002-8389-1851; Henrissat, Bernard/0000-0002-3434-8588; Field, Rob/0000-0001-8574-0275; Kuhaudomlarp, Sakonwan/0000-0003-4415-3781	BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET) [BB/J004561/1]; BBSRC; EPSRC; InnovateUK: IBCatalyst [BB/M02903411]; John Innes Foundation; Royal Thai Government Scholarship program; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BB/L014130/1, BB/M029026/1, BBS/E/T/000PR9819, BB/N005082/1, BBS/E/J/000PR9790] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/N033167/1] Funding Source: researchfish; BBSRC [BBS/E/J/000PR9790, BB/N005082/1, BBS/E/T/000PR9819, BBS/E/J/000C0618, BB/L014130/1, BB/M029026/1] Funding Source: UKRI; EPSRC [EP/N033167/1] Funding Source: UKRI	BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); InnovateUK: IBCatalyst(UK Research & Innovation (UKRI)Innovate UK); John Innes Foundation; Royal Thai Government Scholarship program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET) (Grant BB/J004561/1); the BBSRC, EPSRC, and InnovateUK: IBCatalyst (Grant BB/M02903411); the John Innes Foundation; and the Royal Thai Government Scholarship program. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHT GJ, 1971, PHYTOCHEMISTRY, V10, P1293, DOI 10.1016/S0031-9422(00)84330-7; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Buller C. S., 1990, US patent, Patent No. [4,908,310, 4908310]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Cruz IN, 2013, CHEM SCI, V4, P3442, DOI [10.1039/c3sc50826a, 10.1039/C3SC50826A]; De Groeve MRM, 2010, ANAL BIOCHEM, V401, P162, DOI 10.1016/j.ab.2010.02.028; Fushinobu S., 2011, Journal of Applied Glycoscience, V58, P91, DOI 10.5458/jag.jag.JAG-2010_022; GOLDEMBE.SH, 1966, J BIOL CHEM, V241, P45; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; Hrmova M, 2002, J BIOL CHEM, V277, P30102, DOI 10.1074/jbc.M203971200; Ivanova IM, 2017, CARBOHYD RES, V438, P26, DOI 10.1016/j.carres.2016.11.017; JAGODZINSKI PP, 1994, VIROLOGY, V202, P735, DOI 10.1006/viro.1994.1395; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Kitaoka M, 2015, APPL MICROBIOL BIOT, V99, P8377, DOI 10.1007/s00253-015-6927-0; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MANNERS DJ, 1967, ARCH BIOCHEM BIOPHYS, V121, P443, DOI 10.1016/0003-9861(67)90099-9; Marechal L. R., 1963, BIOCHEM BIOPH RES CO, V13, P2; MARECHAL LR, 1967, BIOCHIM BIOPHYS ACTA, V146, P417, DOI 10.1016/0005-2744(67)90226-4; Muller C, 2017, APPL BIOCHEM BIOTECH, V182, P197, DOI 10.1007/s12010-016-2320-4; Nam YW, 2015, J BIOL CHEM, V290, P18281, DOI 10.1074/jbc.M115.664664; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; O'Neill E., 2017, BIOL BASEL, V6, pE45, DOI DOI 10.3390/BI0L0GY6040045; O'Neill E. C., 2015, PERSPECTIVES SCI, V6, P84, DOI DOI 10.1016/J.PISC.2015.07.002; O'Neill EC, 2017, CARBOHYD RES, V451, P118, DOI 10.1016/j.carres.2017.07.005; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Ogawa Y, 2014, INT J BIOL MACROMOL, V64, P415, DOI 10.1016/j.ijbiomac.2013.12.027; Pergolizzi G, 2017, PROTEIN PEPTIDE LETT, V24, P696, DOI 10.2174/0929866524666170811125109; Rejzek M, 2017, METHOD ENZYMOL, V597, P209, DOI 10.1016/bs.mie.2017.06.005; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Shibakami M, 2015, CARBOHYD POLYM, V119, P1, DOI 10.1016/j.carbpol.2014.11.036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeda T, 2015, PHYTOCHEMISTRY, V116, P21, DOI 10.1016/j.phytochem.2015.05.010; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Trindade MI, 2003, APPL ENVIRON MICROB, V69, P24, DOI 10.1128/AEM.69.1.24-32.2003; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Van Hoorebeke A, 2010, ACTA CRYSTALLOGR F, V66, P346, DOI 10.1107/S1744309110002642; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu Y.Q., 2017, SCI REP, V7; Yamamoto Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1949, DOI 10.1271/bbb.130411; Yoshida Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2540-6; Zheng W, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.161107	60	26	27	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2865	2876		10.1074/jbc.RA117.000936	http://dx.doi.org/10.1074/jbc.RA117.000936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317507	Green Published, hybrid			2022-12-28	WOS:000426051900021
J	Winge, DR				Winge, Dennis R.			Filling the mitochondrial copper pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						copper; cytochrome c oxidase (Complex IV); superoxide dismutase (SOD); metal; metal homeostasis	OXIDASE; MATRIX; FAMILY	A host of critical metalloproteins reside in mitochondria, where metallation occurs within the organelle after protein import. Although the pathways by which proteins are imported into the mitochondria are well known, the mechanisms by which their metal partners are imported are more obscure. A new study by Boulet et al. demonstrates that the mammalian SLC25A3 inner membrane transporter, previously known as a phosphate carrier, is also a functional Cu(I) importer, clarifying the source of mitochondrial copper and raising new questions about cellular copper homeostasis.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT 84132 USA; [Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT 84132 USA.; Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA.	Dennis.winge@hsc.utah.edu			NIDDK NIH HHS [U54 DK110858] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Boulet A, 2018, J BIOL CHEM, V293, P1887, DOI 10.1074/jbc.RA117.000265; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Moore M. J., 2018, BIOCHEMISTRY-US, DOI [10. 1021/acs. biochem. 7b01034 29228768, DOI 10.1021/ACS.BIOCHEM.7B01034]; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036	10	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1897	1898		10.1074/jbc.H118.001457	http://dx.doi.org/10.1074/jbc.H118.001457			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29462794	Green Published, hybrid			2022-12-28	WOS:000424948000004
J	Perron, A; Nishikawa, Y; Iwata, J; Shimojo, H; Takaya, J; Kobayashi, K; Imayoshi, I; Mbenza, NM; Takenoya, M; Kageyama, R; Kodama, Y; Uesugi, M				Perron, Amelie; Nishikawa, Yoshihiro; Iwata, Jun; Shimojo, Hiromi; Takaya, Junichiro; Kobayashi, Kumiko; Imayoshi, Itaru; Mbenza, Naasson M.; Takenoya, Mihoko; Kageyama, Ryoichiro; Kodama, Yuzo; Uesugi, Motonari			Small-molecule screening yields a compound that inhibits the cancer-associated transcription factor Hes1 via the PHB2 chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; small molecule; Notch pathway; basic helix-loop-helix transcription factor; cell proliferation; chaperone; pancreatic cancer; Prohibitin 2	GAMMA-SECRETASE INHIBITORS; CELL-PROLIFERATION; NUCLEAR EXPORT; NOTCH; IDENTIFICATION; LOCALIZATION; ACTIVATION; PROHIBITIN; EXPRESSION; DOMAIN	The transcription factor Hes family basic helix-loop-helix transcription factor 1 (Hes1) is a downstream effector of Notch signaling and plays a crucial role in orchestrating developmental processes during the embryonic stage. However, its aberrant signaling in adulthood is linked to the pathogenesis of cancer. In the present study, we report the discovery of small organic molecules (JI051 and JI130) that impair the ability of Hes1 to repress transcription. Hes1 interacts with the transcriptional corepressor transducing-like enhancer of split 1 (TLE1) via an interaction domain comprising two tryptophan residues, prompting us to search a chemical library of 1,800 small molecules enriched for indole-like -electron-rich pharmacophores for a compound that blocks Hes1-mediated transcriptional repression. This screening identified a lead compound whose extensive chemical modification to improve potency yielded JI051, which inhibited HEK293 cell proliferation with an EC50 of 0.3 m. Unexpectedly, using immunomagnetic isolation and nanoscale LC-MS/MS, we found that JI051 does not bind TLE1 but instead interacts with prohibitin 2 (PHB2), a cancer-associated protein chaperone. We also found that JI051 stabilizes PHB2's interaction with Hes1 outside the nucleus, inducing G(2)/M cell-cycle arrest. Of note, JI051 dose-dependently reduced cell growth of the human pancreatic cancer cell line MIA PaCa-2, and JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model. These results suggest a previously unrecognized role for PHB2 in the regulation of Hes1 and may inform potential strategies for managing pancreatic cancer.	[Perron, Amelie; Takaya, Junichiro; Mbenza, Naasson M.; Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Perron, Amelie; Shimojo, Hiromi; Takenoya, Mihoko; Kageyama, Ryoichiro; Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Uji, Kyoto 6110011, Japan; [Nishikawa, Yoshihiro; Kodama, Yuzo] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan; [Shimojo, Hiromi; Kobayashi, Kumiko; Imayoshi, Itaru; Kageyama, Ryoichiro] Kyoto Univ, Grad Sch Med, Inst Frontier Life & Med Sci, Kyoto 6068507, Japan; [Imayoshi, Itaru] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Uesugi, M (corresponding author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.; Uesugi, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Uji, Kyoto 6110011, Japan.; Kodama, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan.	kodamayu@kuhp.kyoto-u.ac.jp; uesugi@scl.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020	Shimojo, Hiromi/0000-0001-5455-4218; Nishikawa, Yoshihiro/0000-0002-1113-6937	Kyoto University; AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT); MEXT (JSPS) KAKENHI [25870365, 26220206]; Grants-in-Aid for Scientific Research [17H06408] Funding Source: KAKEN	Kyoto University; AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT); MEXT (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a start-up grant from Kyoto University (to A.P.), AMED Project for Development for Innovative Research on Cancer Therapeutics (P-DIRECT), and MEXT (JSPS) KAKENHI Grants-in-aid for Scientific Research 25870365 (to A.P.) and 26220206 (to M.U.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai MA, 2016, CHEM SCI, V7, P1514, DOI 10.1039/c5sc03540f; Arai MA, 2009, BIOORG MED CHEM LETT, V19, P5778, DOI 10.1016/j.bmcl.2009.07.146; ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Cao Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0346-7; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Husberg C, 2003, BBA-MOL CELL RES, V1640, P143, DOI 10.1016/S0167-4889(03)00041-7; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kageyama R, 2015, CELL TISSUE RES, V359, P125, DOI 10.1007/s00441-014-1888-7; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kita M, 2013, J AM CHEM SOC, V135, P18089, DOI 10.1021/ja406580w; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-38; Mc Gee MM, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/146282; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Sail V, 2013, CHEM BIOL DRUG DES, V81, P334, DOI 10.1111/cbdd.12059; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033	56	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8285	8294		10.1074/jbc.RA118.002316	http://dx.doi.org/10.1074/jbc.RA118.002316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29523683	Green Published, hybrid			2022-12-28	WOS:000433224600032
J	Ohoka, N; Morita, Y; Nagai, K; Shimokawa, K; Ujikawa, O; Fujimori, I; Ito, M; Hayase, Y; Okuhira, K; Shibata, N; Hattori, T; Sameshima, T; Sano, O; Koyama, R; Imaeda, Y; Nara, H; Cho, N; Naito, M				Ohoka, Nobumichi; Morita, Yoko; Nagai, Katsunori; Shimokawa, Kenichiro; Ujikawa, Osamu; Fujimori, Ikuo; Ito, Masahiro; Hayase, Youji; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Sameshima, Tomoya; Sano, Osamu; Koyama, Ryokichi; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko			Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteasome; X-linked inhibitor of apoptosis protein (XIAP); estrogen receptor; tumor therapy; SNIPER; protein knockdown; ERalpha	X-LINKED INHIBITOR; RESISTANT PROSTATE-CANCER; ALPHA-DEPENDENT APOPTOSIS; SMALL-MOLECULE PROTACS; PEPTIDE-BASED INDUCER; ONCOGENIC BCR-ABL; CELL-DEATH; UBIQUITIN LIGASE; SMAC MIMETICS; BREAST-CANCER	Aberrant expression of proteins often underlies many diseases, including cancer. A recently developed approach in drug development is small molecule-mediated, selective degradation of dysregulated proteins. We have devised a protein-knockdown system that utilizes chimeric molecules termed specific and nongenetic IAP-dependent protein erasers (SNIPERs) to induce ubiquitylation and proteasomal degradation of various target proteins. SNIPER(ER)-87 consists of an inhibitor of apoptosis protein (IAP) ligand LCL161 derivative that is conjugated to the estrogen receptor (ER) ligand 4-hydroxytamoxifen by a PEG linker, and we have previously reported that this SNIPER efficiently degrades the ER protein. Here, we report that derivatization of the IAP ligand module yields SNIPER(ER)s with superior protein-knockdown activity. These improved SNIPER(ER)s exhibited higher binding affinities to IAPs and induced more potent degradation of ER than does SNIPER(ER)-87. Further, they induced simultaneous degradation of cellular inhibitor of apoptosis protein 1 (cIAP1) and delayed degradation of X-linked IAP (XIAP). Notably, these reengineered SNIPER(ER)s efficiently induced apoptosis in MCF-7 human breast cancer cells that require IAPs for continued cellular survival. We found that one of these molecules, SNIPER(ER)-110, inhibits the growth of MCF-7 tumor xenografts in mice more potently than the previously characterized SNIPER(ER)-87. Mechanistic analysis revealed that our novel SNIPER(ER)s preferentially recruit XIAP, rather than cIAP1, to degrade ER. Our results suggest that derivatized IAP ligands could facilitate further development of SNIPERs with potent protein-knockdown and cytocidal activities against cancer cells requiring IAPs for survival.	[Ohoka, Nobumichi; Okuhira, Keiichiro; Shibata, Norihito; Hattori, Takayuki; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan; [Morita, Yoko; Nagai, Katsunori; Shimokawa, Kenichiro; Ujikawa, Osamu; Fujimori, Ikuo; Ito, Masahiro; Hayase, Youji; Sameshima, Tomoya; Sano, Osamu; Koyama, Ryokichi; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Yokohama, Kanagawa 2518555, Japan; [Morita, Yoko; Nagai, Katsunori; Ujikawa, Osamu] Axcelead Drug Discovery Partners Inc, Yokohama, Kanagawa 2510012, Japan; [Okuhira, Keiichiro] Univ Tokushima, Grad Sch, Inst Biomed Sci, Tokushima 7708505, Japan; [Koyama, Ryokichi] SCOHIA PHARMA Inc, Fujisawa, Kanagawa 2518555, Japan; [Nara, Hiroshi] Pharmaceut Soc Japan, Tokyo 1500002, Japan; [Cho, Nobuo] RIKEN, Ctr Life Sci Technol, Wako Branch, Drug Discovery Chem Platform Unit, Wako, Saitama 3510198, Japan	National Institute of Health Sciences - Japan; Takeda Pharmaceutical Company Ltd; Tokushima University; RIKEN	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan.	miki-naito@nihs.go.jp		Shimokawa, Kenichiro/0000-0003-1982-0407; SHIBATA, NORIHITO/0000-0001-5792-8510	Japan Society for the Promotion of Science (KAKENHI) [26860049, 16H05090, 16K15121]; Japan Agency for Medical Research and Development (AMED Grants) [17ak0101073, JP17cm0106124, JP17ak0101073]; Takeda Science Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED Grants)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan Society for the Promotion of Science (KAKENHI Grants 26860049 (to N. O.) and 16H05090 and 16K15121 (to M. N.)), the Japan Agency for Medical Research and Development (AMED Grants JP 17ak0101073 (to M. N.) and JP17cm0106124 and JP17ak0101073 (to N. O.)), and Takeda Science Foundation (to N. O.). Y. M., K. N., K. S., O. U., I. F., M. I., Y. H., T. S., O. S., R. K., Y. I., H. N., and N. C. are employees of Takeda Pharmaceutical Co. Ltd.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bai LC, 2012, CANCER RES, V72, P1229, DOI 10.1158/0008-5472.CAN-11-2428; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Chan KH, 2018, J MED CHEM, V61, P504, DOI 10.1021/acs.jmedchem.6b01912; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Cohen F, 2010, BIOORG MED CHEM LETT, V20, P2229, DOI 10.1016/j.bmcl.2010.02.021; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Crew AP, 2018, J MED CHEM, V61, P583, DOI 10.1021/acs.jmedchem.7b00635; Demizu Y, 2016, BIOORG MED CHEM LETT, V26, P2655, DOI 10.1016/j.bmcl.2016.04.013; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Fulda S, 2015, CLIN CANCER RES, V21, P5030, DOI 10.1158/1078-0432.CCR-15-0365; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hennessy EJ, 2012, BIOORG MED CHEM LETT, V22, P1690, DOI 10.1016/j.bmcl.2011.12.109; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Itoh Y, 2010, J AM CHEM SOC, V132, P5820, DOI 10.1021/ja100691p; Jaffer S, 2007, HUM PATHOL, V38, P864, DOI 10.1016/j.humpath.2006.11.016; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Ohoka N, 2017, BIOORG MED CHEM LETT, V27, P4985, DOI 10.1016/j.bmcl.2017.10.011; Ohoka N, 2017, CANCER SCI, V108, P1032, DOI 10.1111/cas.13198; Ohoka N, 2017, J BIOL CHEM, V292, P4556, DOI 10.1074/jbc.M116.768853; Ohoka N, 2016, CURR CANCER DRUG TAR, V16, P136, DOI 10.2174/1568009616666151112122502; Okuhira K, 2013, CANCER SCI, V104, P1492, DOI 10.1111/cas.12272; Okuhira K, 2011, FEBS LETT, V585, P1147, DOI 10.1016/j.febslet.2011.03.019; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pilling AB, 2017, PROSTATE, V77, P866, DOI 10.1002/pros.23327; RAAM S, 1983, BREAST CANCER RES TR, V3, P179, DOI 10.1007/BF01803561; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Remillard D, 2017, ANGEW CHEM INT EDIT, V56, P5738, DOI 10.1002/anie.201611281; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schiedel M, 2018, J MED CHEM, V61, P482, DOI 10.1021/acs.jmedchem.6b01872; Sekine K, 2008, J BIOL CHEM, V283, P8961, DOI 10.1074/jbc.M709525200; Shibata N, 2018, J MED CHEM, V61, P543, DOI 10.1021/acs.jmedchem.7b00168; Shibata N, 2017, CANCER SCI, V108, P1657, DOI 10.1111/cas.13284; Shimokawa K, 2017, ACS MED CHEM LETT, V8, P1042, DOI 10.1021/acsmedchemlett.7b00247; Soares P, 2018, J MED CHEM, V61, P599, DOI 10.1021/acs.jmedchem.7b00675; Sumi H, 2016, BIOCHEM BIOPH RES CO, V479, P179, DOI 10.1016/j.bbrc.2016.09.019; Sun B, 2018, LEUKEMIA, V32, P343, DOI 10.1038/leu.2017.207; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2015, BIOCHEM J, V466, P45, DOI 10.1042/BJ20141195; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang JJ, 2010, HUM PATHOL, V41, P1186, DOI 10.1016/j.humpath.2010.01.013; Wang SM, 2012, J MAMMARY GLAND BIOL, V17, P217, DOI 10.1007/s10911-012-9265-1; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yang L, 2003, CANCER RES, V63, P6815; Zhou B, 2018, J MED CHEM, V61, P462, DOI 10.1021/acs.jmedchem.6b01816	67	67	70	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6776	6790		10.1074/jbc.RA117.001091	http://dx.doi.org/10.1074/jbc.RA117.001091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29545311	Green Published, hybrid			2022-12-28	WOS:000431487300013
J	Wichmann, L; Vowinkel, KS; Perniss, A; Manzini, I; Althaus, M				Wichmann, Lukas; Vowinkel, Kirsty Sophia; Perniss, Alexander; Manzini, Ivan; Althaus, Mike			Incorporation of the -subunit into the epithelial sodium channel (ENaC) generates protease-resistant ENaCs in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); Xenopus laevis; protease; furin; electrophysiology; patch clamp; delta-subunit; chymotrypsin	NA+ CHANNEL; DELTA-SUBUNIT; GAMMA-SUBUNIT; CUTTING EDGE; FURIN; ACTIVATION; EMBRYOGENESIS; INHIBITION; CLEAVAGE; PEPTIDE	The epithelial sodium channel (ENaC) is a critical regulator of vertebrate electrolyte homeostasis. ENaC is the only constitutively open ion channel in the degenerin/ENaC protein family, and its expression, membrane abundance, and open probability therefore are tightly controlled. The canonical ENaC is composed of three subunits (, , and ), but a fourth -subunit may replace and form atypical -ENaCs. Using Xenopus laevis as a model, here we found that mRNAs of the - and -subunits are differentially expressed in different tissues and that -ENaC predominantly is present in the urogenital tract. Using whole-cell and single-channel electrophysiology of oocytes expressing Xenopus - or -ENaC, we demonstrate that the presence of the -subunit enhances the amount of current generated by ENaC due to an increased open probability, but also changes current into a transient form. Activity of canonical ENaCs is critically dependent on proteolytic processing of the - and -subunits, and immunoblotting with epitope-tagged ENaC subunits indicated that, unlike -ENaC, the -subunit does not undergo proteolytic maturation by the endogenous protease furin. Furthermore, currents generated by -ENaC were insensitive to activation by extracellular chymotrypsin, and presence of the -subunit prevented cleavage of -ENaC at the cell surface. Our findings suggest that subunit composition constitutes an additional level of ENaC regulation, and we propose that the Xenopus -ENaC subunit represents a functional example that demonstrates the importance of proteolytic maturation during ENaC evolution.	[Wichmann, Lukas; Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wichmann, Lukas; Vowinkel, Kirsty Sophia; Perniss, Alexander; Manzini, Ivan; Althaus, Mike] Justus Liebig Univ, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35392 Giessen, Germany; [Vowinkel, Kirsty Sophia] Philipps Univ Marburg, Inst Physiol & Pathophysiol Vegetat Physiol, D-35037 Marburg, Germany; [Perniss, Alexander] Justus Liebig Univ, Inst Anat & Cell Biol, D-35392 Giessen, Germany	Newcastle University - UK; Justus Liebig University Giessen; Philipps University Marburg; Justus Liebig University Giessen	Althaus, M (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Althaus, M (corresponding author), Justus Liebig Univ, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35392 Giessen, Germany.	Mike.Althaus@newcastle.ac.uk	Manzini, Ivan/V-4545-2019	Manzini, Ivan/0000-0002-3575-9637; Althaus, Mike/0000-0002-3554-7538; Wichmann, Lukas/0000-0001-9808-8407				Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Baines Deborah, 2013, Curr Mol Pharmacol, V6, P50; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Fronius Martin, 2013, Curr Mol Pharmacol, V6, P13; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Giraldez T, 2012, AM J PHYSIOL-RENAL, V303, pF328, DOI 10.1152/ajprenal.00116.2012; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Iijima R, 1999, J BIOCHEM-TOKYO, V126, P912, DOI 10.1093/oxfordjournals.jbchem.a022534; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Schonberger M, 2014, NAT CHEM, V6, P712, DOI [10.1038/NCHEM.2004, 10.1038/nchem.2004]; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Thibodeau PH, 2013, CELL TISSUE RES, V351, P309, DOI 10.1007/s00441-012-1439-z; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Uchiyama M, 2012, P ROY SOC B-BIOL SCI, V279, P4795, DOI 10.1098/rspb.2012.1945; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411	32	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6647	6658		10.1074/jbc.RA118.002543	http://dx.doi.org/10.1074/jbc.RA118.002543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29576549	hybrid, Green Published			2022-12-28	WOS:000431487300002
J	Cao, K; Li, N; Wang, HC; Cao, X; He, JJ; Zhang, B; He, QY; Zhang, G; Sun, XS				Cao, Kun; Li, Nan; Wang, Hongcui; Cao, Xin; He, Jiaojiao; Zhang, Bing; He, Qing-Yu; Zhang, Gong; Sun, Xuesong			Two zinc-binding domains in the transporter AdcA from Streptococcus pyogenes facilitate high-affinity binding and fast transport of zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYLOGENETIC INFORMATION; FUNCTIONAL REGIONS; PROTEIN; IDENTIFICATION; CONSURF; PATHOGENESIS; SIMULATIONS; PNEUMONIAE; DEFICIENCY; MECHANISMS	Zinc is an essential metal in bacteria. One important bacterial zinc transporter is AdcA, and most bacteria possess AdcA homologs that are single-domain small proteins due to better efficiency of protein biogenesis. However, a double-domain AdcA with two zinc-binding sites is significantly overrepresented in Streptococcus species, many of which are major human pathogens. Using molecular simulation and experimental validations of AdcA from Streptococcus pyogenes, we found here that the two AdcA domains sequentially stabilize the structure upon zinc binding, indicating an organization required for both increased zinc affinity and transfer speed. This structural organization appears to endow Streptococcus species with distinct advantages in zinc-depleted environments, which would not be achieved by each single AdcA domain alone. This enhanced zinc transport mechanism sheds light on the significance of the evolution of the AdcA domain fusion, provides new insights into double-domain transporter proteins with two binding sites for the same ion, and indicates a potential target of antimicrobial drugs against pathogenic Streptococcus species.	[Cao, Kun; Li, Nan; Wang, Hongcui; Cao, Xin; He, Jiaojiao; Zhang, Bing; He, Qing-Yu; Zhang, Gong; Sun, Xuesong] Jinan Univ, Key Lab Funct Prot Res Guangdong Higher Educ Inst, Inst Life & Hlth Engn, Coll Life Sci & Technol, 601 Huang Pu Ave West, Guangzhou 510632, Guangdong, Peoples R China	Jinan University	He, QY; Zhang, G; Sun, XS (corresponding author), Jinan Univ, Key Lab Funct Prot Res Guangdong Higher Educ Inst, Inst Life & Hlth Engn, Coll Life Sci & Technol, 601 Huang Pu Ave West, Guangzhou 510632, Guangdong, Peoples R China.	tqyhe@email.jnu.edu.cn; zhanggong@qq.com; tsunxs@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Zhang, Gong/Q-7419-2017	He, Qing-Yu/0000-0003-0503-9492; Zhang, Gong/0000-0003-0418-3433	National Natural Science Foundation of China [21571082, 21271086]; National High-Tech Research and Development Program (863) of China [2014AA020504]; Guangdong Natural Science Research Grants [2015A030313334, 32213027/32215077]; Guangzhou Science and Technology Grant [201607010228]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020504] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Guangdong Natural Science Research Grants; Guangzhou Science and Technology Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Natural Science Foundation of China Grants 21571082 (to X.S.) and 21271086 (to Q.-Y.H.), National High-Tech Research and Development Program (863) of China Grant 2014AA020504 (to G.Z.), Guangdong Natural Science Research Grants 2015A030313334 (to X.S.) and 32213027/32215077 (to Q.-Y.H.), and Guangzhou Science and Technology Grant 201607010228 (to X.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anil B, 2004, J AM CHEM SOC, V126, P13194, DOI 10.1021/ja047119i; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Blindauer CA, 2015, CHEM COMMUN, V51, P4544, DOI 10.1039/c4cc10174j; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Capdevila DA, 2016, J BIOL CHEM, V291, P20858, DOI 10.1074/jbc.R116.742023; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Czub J, 2017, J AM CHEM SOC, V139, P4025, DOI 10.1021/jacs.6b11708; Ding BB, 2017, J BIOL CHEM, V292, P8531, DOI 10.1074/jbc.H116.762948; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Georgoulas G, 2015, MECH SYST SIGNAL PR, V60-61, P229, DOI 10.1016/j.ymssp.2015.01.033; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Graen T, 2016, J AM CHEM SOC, V138, P16620, DOI 10.1021/jacs.6b05609; Guo JM, 2015, MOL BIOSYST, V11, P370, DOI 10.1039/c4mb00462k; He Y, 2017, P NATL ACAD SCI USA, V114, P1578, DOI 10.1073/pnas.1621344114; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Jacob E, 2013, CELL REP, V3, P1051, DOI 10.1016/j.celrep.2013.03.032; Junejo IN, 2012, J VIS COMMUN IMAGE R, V23, P853, DOI 10.1016/j.jvcir.2012.05.001; Keogh E, 2005, KNOWL INF SYST, V8, P154, DOI 10.1007/s10115-004-0172-7; Kumar A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003318; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Li BJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15544; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065682; Li Junhua, 2014, Biomed Res Int, V2014, P708364, DOI 10.1155/2014/708364; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma L, 2015, METALLOMICS, V7, P1541, DOI 10.1039/c5mt00170f; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Manzetti S, 2003, J COMPUT AID MOL DES, V17, P551, DOI 10.1023/B:JCAM.0000005765.13637.38; Mayer LS, 2014, METALLOMICS, V6, P1288, DOI 10.1039/c4mt00051j; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Monecke T, 2013, P NATL ACAD SCI USA, V110, P960, DOI 10.1073/pnas.1215214110; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Pereira AR, 2016, MBIO, V7, DOI 10.1128/mBio.00908-16; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Rose AS, 2014, J AM CHEM SOC, V136, P11244, DOI 10.1021/ja5055109; Shafeeq S, 2013, MOL MICROBIOL, V88, P1047, DOI 10.1111/mmi.12256; Skjaerven L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002004; Sun XQ, 2014, J PHYS CHEM B, V118, P14737, DOI 10.1021/jp506579a; Tedde V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152835; Timmins A, 2017, J AM CHEM SOC, V139, P9855, DOI 10.1021/jacs.7b02839; Unissa AN, 2011, BIOINFORMATION, V7, P107; Valleriani A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042903; Van Gunsteren F., 1996, BIOMOLECULAR SIMULAT, P397; Van Gunsteren WF, 2002, ENCY COMPUTATIONAL C, V2, P1211; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Zalewski PD, 2005, PHARMACOL THERAPEUT, V105, P127, DOI 10.1016/j.pharmthera.2004.09.004; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang L, 2017, J INORG BIOCHEM, V167, P150, DOI 10.1016/j.jinorgbio.2016.08.015; Zhou XX, 2015, J BIOL CHEM, V290, P18361, DOI 10.1074/jbc.M115.663906	62	21	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6075	6089		10.1074/jbc.M117.818997	http://dx.doi.org/10.1074/jbc.M117.818997			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491141	Green Published, hybrid			2022-12-28	WOS:000430497300026
J	Cao, S; Anishkin, A; Zinkevich, NS; Nishijima, Y; Korishettar, A; Wang, ZH; Fang, J; Wilcox, DA; Zhang, DX				Cao, Sheng; Anishkin, Andriy; Zinkevich, Natalya S.; Nishijima, Yoshinori; Korishettar, Ankush; Wang, Zhihao; Fang, Juan; Wilcox, David A.; Zhang, David X.			Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); endothelial cell; hydrogen peroxide; protein kinase A (PKA); protein phosphorylation; signal transduction; transient receptor potential channels (TRP channels)	CATION CHANNEL TRPV4; HEAT-EVOKED ACTIVATION; INDUCED VASODILATATION; CARDIOVASCULAR-SYSTEM; MOLECULAR-DYNAMICS; SCORING FUNCTION; S4-S5 LINKER; CA2+ SIGNALS; SHEAR-STRESS; ION-CHANNEL	Transient receptor potential vanilloid 4 (TRPV4) is a Ca2+-permeable channel of the transient receptor potential (TRP) superfamily activated by diverse stimuli, including warm temperature, mechanical forces, and lipid mediators such as arachidonic acid (AA) and its metabolites. This activation is tightly regulated by protein phosphorylation carried out by various serine/threonine or tyrosine kinases. It remains poorly understood how phosphorylation differentially regulates TRPV4 activation in response to different stimuli. We investigated how TRPV4 activation by AA, an important signaling process in the dilation of coronary arterioles, is affected by protein kinase A (PKA)-mediated phosphorylation at Ser-824. Wildtype and mutant TRPV4 channels were expressed in human coronary artery endothelial cells (HCAECs). AA-induced TRPV4 activation was blunted in the S824A mutant but was enhanced in the phosphomimetic S824E mutant, whereas the channel activation by the synthetic agonist GSK1016790A was not affected. The low level of basal phosphorylation at Ser-824 was robustly increased by the redox signaling molecule hydrogen peroxide (H2O2). The H2O2-induced phosphorylation was accompanied by an enhanced channel activation by AA, and this enhanced response was largely abolished by PKA inhibition or S824A mutation. We further identified a potential structural context dependence of Ser-824 phosphorylation-mediated TRPV4 regulation involving an interplay between AA binding and the possible phosphorylation-induced rearrangements of the C-terminal helix bearing Ser-824. These results provide insight into how phosphorylation specifically regulates TRPV4 activation. Redox-mediated TRPV4 phosphorylation may contribute to pathologies associated with enhanced TRPV4 activity in endothelial and other systems.	[Cao, Sheng; Zinkevich, Natalya S.; Nishijima, Yoshinori; Korishettar, Ankush; Wang, Zhihao; Zhang, David X.] Med Coll Wisconsin, Dept Med, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [Fang, Juan; Wilcox, David A.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Anishkin, Andriy] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Zinkevich, Natalya S.] Carroll Univ, Dept Hlth & Med, Waukesha, WI 53186 USA; [Fang, Juan; Wilcox, David A.] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; University System of Maryland; University of Maryland College Park; Children's Hospital of Wisconsin	Zhang, DX (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	xfzhang@mcw.edu		, Yoshinori/0000-0002-5547-4508	National Institute of Health [HL096647]; Biology Department, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biology Department, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grant HL096647 (to D. X. Z.) and by the Biology Department, University of Maryland, College Park (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Andreucci E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-37; Berna-Erro A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11274-1; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Burgoyne JR, 2013, ANTIOXID REDOX SIGN, V18, P1042, DOI 10.1089/ars.2012.4817; Dalsgaard T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33841; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fang J, 2005, BLOOD, V106, P2671, DOI 10.1182/blood-2004-12-4619; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Ho WSV, 2015, BRIT J PHARMACOL, V172, P5251, DOI 10.1111/bph.13312; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Loukin SH, 2015, P NATL ACAD SCI USA, V112, P9400, DOI 10.1073/pnas.1510602112; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nishijima Y, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.199; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Randhawa PK, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0512-7; Rykunov Dmitry, 2009, Journal of Structural and Functional Genomics, V10, P95, DOI 10.1007/s10969-008-9044-9; Servin-Vences MR, 2017, ELIFE, V6, DOI 10.7554/eLife.21074; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Teng JF, 2016, P NATL ACAD SCI USA, V113, P11847, DOI 10.1073/pnas.1613523113; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1; Zhang XM, 2006, J GEN PHYSIOL, V128, P491, DOI 10.1085/jgp.200609676; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zheng XD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000080; Zuccolo E, 2016, VASC PHARMACOL, V87, P159, DOI 10.1016/j.vph.2016.09.005	75	30	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5307	5322		10.1074/jbc.M117.811075	http://dx.doi.org/10.1074/jbc.M117.811075			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462784	Green Published, hybrid			2022-12-28	WOS:000429409300034
J	Li, XL; Liu, LS; Li, R; Wu, AL; Lu, JQ; Wu, QZ; Jia, JL; Zhao, MJ; Song, H				Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Zhao, Mujun; Song, Hai			Hepatic loss of Lissencephaly 1 (Lis1) induces fatty liver and accelerates liver tumorigenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); Golgi; liver metabolism; liver cancer; hepatocyte; mouse genetics; Lis1; nonalcoholic fatty liver disease; ploidy; steatosis	ENDOPLASMIC-RETICULUM STRESS; HEMATOPOIETIC STEM-CELLS; MILLER-DIEKER-SYNDROME; NONALCOHOLIC STEATOHEPATITIS; MICROTUBULE ORGANIZATION; HEPATOCELLULAR-CARCINOMA; GLUCOSE-HOMEOSTASIS; METABOLIC DISEASE; INITIATION-FACTOR; MOUSE MODEL	The liver is a major organ in lipid metabolism, and its malfunction leads to various diseases. Nonalcoholic fatty liver disease, the most common chronic liver disorder in developed countries, is characterized by the abnormal retention of excess lipid within hepatocytes and predisposes individuals to liver cancer. We previously reported that the levels of Lissencephaly 1 (LIS1, also known as PAFAH1B1) are down-regulated in human hepatocellular carcinoma. Following up on this observation, we found that genetic deletion of Lis1 in the mouse liver increases lipid accumulation and inflammation in this organ. Further analysis revealed that loss of Lis1 triggers endoplasmic reticulum (ER) stress and reduces triglyceride secretion. Attenuation of ER stress by addition of tauroursodeoxycholic acid (TUDCA) diminished lipid accumulation in the Lis1-deficient hepatocytes. Moreover, the Golgi stacks were disorganized in Lis1-deficient liver cells. Of note, the Lis1 liver-knockout mice exhibited increased hepatocyte ploidy and accelerated development of liver cancer after exposure to the liver carcinogen diethylnitrosamine (DEN). Taken together, these findings suggest that reduced Lis1 levels can spur the development of liver diseases from steatosis to liver cancer and provide a useful model for delineating the molecular pathways that lead to these diseases.	[Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Song, Hai] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Xiaoling; Liu, Liansheng; Li, Ran; Wu, Ailing; Lu, Jinqiu; Wu, Qingzhe; Jia, Junling; Song, Hai] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Mujun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, H (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	haisong@zju.edu.cn	Lu, Jinqiu/HIR-7408-2022	Li, Xiaoling/0000-0002-1554-1569	National Natural Science Foundation of China [31471368]; Zhejiang Provincial Natural Science Foundation of China [LR16C120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the National Natural Science Foundation of China Grant 31471368 and Zhejiang Provincial Natural Science Foundation of China Grant LR16C120001 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chen XF, 2014, CELL RES, V24, P1013, DOI 10.1038/cr.2014.69; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Czuchlewski DR, 2008, J PEDIAT HEMATOL ONC, V30, P865, DOI 10.1097/MPH.0b013e31818a958a; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; DEHANDT HA, 1966, NATURE, V212, P827, DOI 10.1038/212827a0; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Jaarsma D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00397; Kammoun HL, 2009, CURR OPIN CLIN NUTR, V12, P575, DOI 10.1097/MCO.0b013e32833189db; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Koliaki C, 2013, MOL CELL ENDOCRINOL, V379, P35, DOI 10.1016/j.mce.2013.06.002; Kondratova AA, 2005, CELL CYCLE, V4, P1403, DOI 10.4161/cc.4.10.2041; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiner O, 2013, CURR OPIN NEUROBIOL, V23, P951, DOI 10.1016/j.conb.2013.08.001; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sipe CW, 2013, DEVELOPMENT, V140, P1785, DOI 10.1242/dev.089763; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Ueda S, 2006, ACTA PAEDIATR, V95, P113, DOI 10.1080/08035250510046731; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Xing Z, 2011, BIOCHEM BIOPH RES CO, V409, P193, DOI 10.1016/j.bbrc.2011.04.117; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	53	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5160	5171		10.1074/jbc.RA117.001474	http://dx.doi.org/10.1074/jbc.RA117.001474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29475944	Green Published, hybrid			2022-12-28	WOS:000429409300021
J	Rotwein, P				Rotwein, Peter			The complex genetics of human insulin-like growth factor 2 are not reflected in public databases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II GENE; IGF-II; INITIAL-CHARACTERIZATION; DEVELOPMENTAL REGULATION; SEQUENCE ELEMENTS; IMPRINTED GENES; MOUSE; EXPRESSION; PROMOTER; TRANSCRIPTION	Recent advances in genetics present unique opportunities for enhancing knowledge about human physiology and disease susceptibility. Understanding this information at the individual gene level is challenging and requires extracting, collating, and interpreting data from a variety of public gene repositories. Here, I illustrate this challenge by analyzing the gene for human insulin-like growth factor 2 (IGF2) through the lens of several databases. IGF2, a 67-amino acid secreted peptide, is essential for normal prenatal growth and is involved in other physiological and pathophysiological processes in humans. Surprisingly, none of the genetic databases accurately described or completely delineated human IGF2 gene structure or transcript expression, even though all relevant information could be found in the published literature. Although IGF2 shares multiple features with the mouse Igf2 gene, it has several unique properties, including transcription from five promoters. Both genes undergo parental imprinting, with IGF2/Igf2 being expressed primarily from the paternal chromosome and the adjacent H19 gene from the maternal chromosome. Unlike mouse Igf2, whose expression declines after birth, human IGF2 remains active throughout life. This characteristic has been attributed to a unique human gene promoter that escapes imprinting, but as shown here, it involves several different promoters with distinct tissue-specific expression patterns. Because new testable hypotheses could lead to critical insights into IGF2 actions in human physiology and disease, it is incumbent that our fundamental understanding is accurate. Similar challenges affecting knowledge of other human genes should promote attempts to critically evaluate, interpret, and correct human genetic data in publicly available databases.	[Rotwein, Peter] Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA		Rotwein, P (corresponding author), Texas Tech Hlth Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	peter.rotwein@ttuhsc.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health Research [R01 DK042748-28]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grant R01 DK042748-28 (to P.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Ben-Zaken S, 2017, GROWTH HORM IGF RES, V37, P26, DOI 10.1016/j.ghir.2017.10.001; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggermann Thomas, 2010, Pediatr Endocrinol Rev, V8, P86; Eun B, 2013, NUCLEIC ACIDS RES, V41, P8126, DOI 10.1093/nar/gkt597; Eun B, 2013, NUCLEIC ACIDS RES, V41, P817, DOI 10.1093/nar/gks1182; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GRAHAM DE, 1986, P NATL ACAD SCI USA, V83, P4519, DOI 10.1073/pnas.83.12.4519; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HOLTHUIZEN P, 1990, BIOCHIM BIOPHYS ACTA, V1087, P341, DOI 10.1016/0167-4781(90)90010-Y; IKEJIRI K, 1991, BIOCHEM J, V280, P439, DOI 10.1042/bj2800439; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Kaffer CR, 2000, GENE DEV, V14, P1908; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Katsanis N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1107-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEE JE, 1990, DEVELOPMENT, V110, P151; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lek M., 2016, BIORXIV; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Liu MZ, 2013, GENE DEV, V27, P2543, DOI 10.1101/gad.224170.113; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Mercader JM, 2017, DIABETES, V66, P2903, DOI 10.2337/db17-0187; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Quintana-Murci L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1093-y; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAIZIS AM, 1993, BIOCHEM J, V289, P133, DOI 10.1042/bj2890133; Rietveld LEG, 1999, BIOCHEM J, V338, P799, DOI 10.1042/0264-6021:3380799; Rodenburg RJT, 1997, MOL ENDOCRINOL, V11, P237, DOI 10.1210/me.11.2.237; RODENBURG RJT, 1995, MOL ENDOCRINOL, V9, P424, DOI 10.1210/me.9.4.424; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Rotwein P, 2017, J BIOL CHEM, V292, P9252, DOI 10.1074/jbc.M117.783639; SCHEPER W, 1995, MOL CELL BIOL, V15, P235, DOI 10.1128/MCB.15.1.235; Schwartz TS, 2016, INTEGR COMP BIOL, V56, P171, DOI 10.1093/icb/icw046; SOARES MB, 1985, NUCLEIC ACIDS RES, V13, P1119, DOI 10.1093/nar/13.4.1119; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Stranger BE, 2017, NAT GENET, V49, P1664, DOI 10.1038/ng.3969; SUSSENBACH JS, 1993, ADV EXP MED BIOL, V343, P63; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; van Dijk EL, 2000, J MOL BIOL, V300, P449, DOI 10.1006/jmbi.2000.3856; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; VANDIJK MA, 1991, MOL CELL ENDOCRINOL, V81, P81, DOI 10.1016/0303-7207(91)90207-9; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wallis M, 2009, GROWTH HORM IGF RES, V19, P12, DOI 10.1016/j.ghir.2008.05.001; Ward MC, 2017, NATURE, V550, P190, DOI 10.1038/550190a; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344	79	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4324	4333		10.1074/jbc.RA117.001573	http://dx.doi.org/10.1074/jbc.RA117.001573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414792	Green Published, hybrid			2022-12-28	WOS:000428204300007
J	Monge, EC; Tuveng, TR; Vaaje-Kolstad, G; Eijsink, VGH; Gardner, JG				Monge, Estela C.; Tuveng, Tina R.; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.; Gardner, Jeffrey G.			Systems analysis of the glycoside hydrolase family 18 enzymes from Cellvibrio japonicus characterizes essential chitin degradation functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASE; CELL WALL DEGRADATION; SERRATIA-MARCESCENS; ESCHERICHIA-COLI; ENZYMATIC-PROPERTIES; CRYSTAL-STRUCTURE; SIGNAL PEPTIDES; BINDING; PROCESSIVITY; DERIVATIVES	Understanding the strategies used by bacteria to degrade polysaccharides constitutes an invaluable tool for biotechnological applications. Bacteria are major mediators of polysaccharide degradation in nature; however, the complex mechanisms used to detect, degrade, and consume these substrates are not well-understood, especially for recalcitrant polysaccharides such as chitin. It has been previously shown that the model bacterial saprophyte Cellvibrio japonicus is able to catabolize chitin, but little is known about the enzymatic machinery underlying this capability. Previous analyses of the C. japonicus genome and proteome indicated the presence of four glycoside hydrolase family 18 (GH18) enzymes, and studies of the proteome indicated that all are involved in chitin utilization. Using a combination of in vitro and in vivo approaches, we have studied the roles of these four chitinases in chitin bioconversion. Genetic analyses showed that only the chi18D gene product is essential for the degradation of chitin substrates. Biochemical characterization of the four enzymes showed functional differences and synergistic effects during chitin degradation, indicating nonredundant roles in the cell. Transcriptomic studies revealed complex regulation of the chitin degradation machinery of C. japonicus and confirmed the importance of CjChi18D and CjLPMO10A, a previously characterized chitin-active enzyme. With this systems biology approach, we deciphered the physiological relevance of the glycoside hydrolase family 18 enzymes for chitin degradation in C. japonicus, and the combination of in vitro and in vivo approaches provided a comprehensive understanding of the initial stages of chitin degradation by this bacterium.	[Monge, Estela C.; Gardner, Jeffrey G.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA; [Tuveng, Tina R.; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1430 As, Norway	University System of Maryland; University of Maryland Baltimore; Norwegian University of Life Sciences	Gardner, JG (corresponding author), Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA.	jgardner@umbc.edu		Tuveng, Tina Rise/0000-0002-5926-2633	Meyerhoff Graduate Fellows Program under the NIGMS, National Institutes of Health Initiative for Maximizing Student Development [2-R25-GM55036]; Chemistry and Biology Interface Program [T32-GM066706]; Research Council of Norway [221576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036, T32GM066706] Funding Source: NIH RePORTER	Meyerhoff Graduate Fellows Program under the NIGMS, National Institutes of Health Initiative for Maximizing Student Development; Chemistry and Biology Interface Program; Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds (to J. G. G.); by Grant 2-R25-GM55036 from the Meyerhoff Graduate Fellows Program under the NIGMS, National Institutes of Health Initiative for Maximizing Student Development, by Chemistry and Biology Interface Program Grant T32-GM066706 (to E. C. M.); and Grant 221576 from the Research Council of Norway (to T. R. T., G. V. K., and V. G. H. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Blake AD, 2018, MOL MICROBIOL, V107, P610, DOI 10.1111/mmi.13903; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Gortari MC, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue3-fulltext-10; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.10007/10_2010_93, 10.1007/10_2010_93]; Gardner JG, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2068-6; Gardner JG, 2012, METHOD ENZYMOL, V510, P331, DOI 10.1016/B978-0-12-415931-0.00018-5; Gardner JG, 2010, APPL ENVIRON MICROB, V76, P5079, DOI 10.1128/AEM.00454-10; Gardner JG, 2014, MOL MICROBIOL, V95, P418; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gooday G.W., 1986, CHITIN NATURE TECHNO, P83, DOI DOI 10.1007/978-1-4613-2167-5_12; Hemsworth GR, 2016, BIOCHEM SOC T, V44, P94, DOI 10.1042/BST20150180; Hoell IA, 2006, FEBS J, V273, P4889, DOI 10.1111/j.1742-4658.2006.05487.x; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Matroodi S, 2013, WORLD J MICROB BIOT, V29, P1517, DOI 10.1007/s11274-013-1318-0; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Mekasha S, 2017, PROCESS BIOCHEM, V56, P132, DOI 10.1016/j.procbio.2017.02.021; Murthy N. K. S., 2017, INTERNET J MICROBIOL, V10; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nelson CE, 2017, ENVIRON MICROBIOL, V19, P5025, DOI 10.1111/1462-2920.13959; Nelson CE, 2017, MOL MICROBIOL, V104, P294, DOI 10.1111/mmi.13625; Nelson CE, 2016, J MICROBIOL METH, V130, P136, DOI 10.1016/j.mimet.2016.09.013; Nelson CE, 2015, APPL ENVIRON MICROB, V81, P5968, DOI 10.1128/AEM.00847-15; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Stoykov YM, 2015, ENG LIFE SCI, V15, P30, DOI 10.1002/elsc.201400173; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455; Tuveng TR, 2017, BBA-PROTEINS PROTEOM, V1865, P414, DOI 10.1016/j.bbapap.2017.01.007; Tuveng TR, 2016, PROTEOMICS, V16, P1904, DOI 10.1002/pmic.201500419; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Wang GQ, 2013, CURR MICROBIOL, V67, P688, DOI 10.1007/s00284-013-0422-6; Yan N., 2017, NATURE, V524, P155; Yan Q., 2015, BIORESOUR BIOPROCESS, V2, P1, DOI [10.1186/s40643-015-0057-5, DOI 10.1186/S40643-015-0057-5]; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zargar V, 2015, CHEMBIOENG REV, V2, P204, DOI 10.1002/cben.201400025	65	29	30	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3849	3859		10.1074/jbc.RA117.000849	http://dx.doi.org/10.1074/jbc.RA117.000849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29367339	hybrid, Green Published			2022-12-28	WOS:000427030200036
J	Zhang, JC; Huang, YJ; Chen, J; Zhu, HN; Whiteheart, SW				Zhang, Jinchao; Huang, Yunjie; Chen, Jing; Zhu, Haining; Whiteheart, Sidney W.			Dynamic cycling of t-SNARE acylation regulates platelet exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; MOLECULAR-MECHANISMS; CERULENIN ANALOGS; SYNTAXIN 11; SNAP-23; CHOLESTEROL; SECRETION; FUSION; PHOSPHORYLATION	Platelets regulate vascular integrity by secreting a host of molecules that promote hemostasis and its sequelae. Given the importance of platelet exocytosis, it is critical to understand how it is controlled. The t-SNAREs, SNAP-23 and syntaxin-11, lack classical transmembrane domains (TMDs), yet both are associated with platelet membranes and redistributed into cholesterol-dependent lipid rafts when platelets are activated. Using metabolic labeling and hydroxylamine (HA)/HCl treatment, we showed that both contain thioester-linked acyl groups. Mass spectrometry mapping further showed that syntaxin-11 was modified on cysteine 275, 279, 280, 282, 283, and 285, and SNAP-23 was modified on cysteine 79, 80, 83, 85, and 87. Interestingly, metabolic labeling studies showed incorporation of [3H] palmitate into the t-SNAREs increased although the protein levels were unchanged, suggesting that acylation turns over on the two t-SNAREs in resting platelets. Exogenously added fatty acids did compete with [3H] palmitate for t-SNARE labeling. To determine the effects of acylation, we measured aggregation, ADP/ATP release, as well as P-selectin exposure in platelets treated with the acyltransferase inhibitor cerulenin or the thioesterase inhibitor palmostatin B. We found that cerulenin pretreatment inhibited t-SNARE acylation and platelet function in a dose- and time-dependent manner whereas palmostatin B had no detectable effect. Interestingly, pretreatment with palmostatin B blocked the inhibitory effects of cerulenin, suggesting that maintaining the acylation state is important for platelet function. Thus, our work shows that t-SNARE acylation is actively cycling in platelets and suggests that the enzymes regulating protein acylation could be potential targets to control platelet exocytosis in vivo.	[Zhang, Jinchao; Huang, Yunjie; Chen, Jing; Zhu, Haining; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Huang, Yunjie] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA	University of Kentucky; Cincinnati Children's Hospital Medical Center	Whiteheart, SW (corresponding author), 741 South Limestone,BBSRB271, Lexington, KY 40536 USA.	whitehe@uky.edu	Huang, Yunjie/AAW-8751-2021; Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Huang, Yunjie/0000-0002-2151-9499	NHLBI, National Institutes of Health [HL56652, HL138179]; American Heart Association [AHA16GRNT27620001]; Veterans Affairs Merit Award; NIGMS, National Institutes of Health [P30GM110787]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138179, R01HL056652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110787] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Veterans Affairs Merit Award(US Department of Veterans Affairs); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants HL56652 and HL138179; American Heart Association Grant-in-Aid AHA16GRNT27620001; and Veterans Affairs Merit Award (to S. W. W.). This study was also supported in part by NIGMS, National Institutes of Health Grant P30GM110787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Arneson LN, 2007, J IMMUNOL, V179, P3397, DOI 10.4049/jimmunol.179.6.3397; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Chen D, 1999, BIOCHEM BIOPH RES CO, V255, P340, DOI 10.1006/bbrc.1999.0173; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; De Vos ML, 2001, BIOCHEM PHARMACOL, V62, P985, DOI 10.1016/S0006-2952(01)00739-0; Dowal L, 2011, BLOOD, V118, pE62, DOI 10.1182/blood-2011-05-353078; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Ge SC, 2010, ACS CHEM BIOL, V5, P819, DOI 10.1021/cb100130b; Golebiewska EM, 2015, J BIOL CHEM, V290, P1536, DOI 10.1074/jbc.M114.602615; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Grgurevich S, 2003, J THROMB HAEMOST, V1, P576, DOI 10.1046/j.1538-7836.2003.00087.x; Gue YX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091850; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Hellewell AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098900; HUANG EM, 1989, BIOCHIM BIOPHYS ACTA, V1011, P134, DOI 10.1016/0167-4889(89)90200-0; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Joshi S, 2017, PLATELETS, V28, P129, DOI 10.1080/09537104.2016.1240768; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Koseoglu S, 2015, BLOOD, V126, P651, DOI 10.1182/blood-2014-12-618744; Kreutzberger AJB, 2015, BIOPHYS J, V109, P319, DOI 10.1016/j.bpj.2015.06.022; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lawrence DS, 1999, J MED CHEM, V42, P4932, DOI 10.1021/jm980591s; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mancuso ME, 2017, BRIT J HAEMATOL, V178, P209, DOI 10.1111/bjh.14653; Martin BR, 2013, CURR PROTOC PROTEIN, V73, P5; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Menter DG, 2017, CANCER METAST REV, V36, P199, DOI 10.1007/s10555-017-9682-0; Munday AD, 2007, ARTERIOSCL THROM VAS, V27, P1496, DOI 10.1161/ATVBAHA.106.136226; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Pallavi B, 2003, J BIOL CHEM, V278, P12737, DOI 10.1074/jbc.M208598200; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Shiraishi M, 2010, J VET MED SCI, V72, P285, DOI 10.1292/jvms.09-0385; Sim DS, 2007, ARTERIOSCL THROM VAS, V27, P1478, DOI 10.1161/ATVBAHA.106.139287; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Valdez AC, 1999, J CELL SCI, V112, P845; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	61	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3593	3606		10.1074/jbc.RA117.000140	http://dx.doi.org/10.1074/jbc.RA117.000140			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352103	Green Published, hybrid			2022-12-28	WOS:000427030200015
J	Liao, Y; Du, W				Liao, Yang; Du, Wei			An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAVEOLIN-1 GENE-EXPRESSION; INCOMPLETE PENETRANCE; CELL-PROLIFERATION; EPITHELIAL-CELLS; IN-VIVO; CANCER; TUMORIGENESIS; DIFFERENTIATION; PROLACTIN; RETINOBLASTOMA	E2F transcription factors are regulated by binding to the retinoblastoma (Rb) tumor suppressor family of proteins. Previously, we reported an E2F(LQ) mutation that disrupts the binding with Rb proteins without affecting the transcriptional activity of E2F. We also showed that mouse embryonic fibroblasts with an E2F3(LQ) mutation exhibit increased E2F activity and more rapid cell proliferation. In this report, we analyzed E2F3(LQ) mice to further characterize the in vivo consequences of Rb family-independent E2F3 activity. We found that homozygous E2F3(LQ) mice were viable and had no obvious developmental defects or tumor growth. Our results also indicated that E2F3(LQ) cells largely retain normal control of cell proliferation in vivo. However, female E2F3(LQ) mice had partial nursing defects. Examination of the E2F3(LQ) mammary glands revealed increased caveolin-1 (CAV1) expression, reduced prolactin receptor/Stat5 signaling, and impaired pregnancy-induced cell proliferation and differentiation. Of note, ChIP experiments disclosed that E2F3 binds the CAV1 promoter. Furthermore, E2F3 overexpression induced CAV1 expression, and CRISPR/CAS9-mediated E2F3 knockout reduced CAV1 levels and also increased prolactin receptor-induced Stat5 signaling in mammary epithelial cells. Our results suggest that the Rb family-independent E2F3(LQ) variant inhibits pregnancy-induced mammary gland cell proliferation and differentiation by up-regulating CAV1 expression and inhibiting Stat5 signaling.	[Liao, Yang; Du, Wei] Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA	University of Chicago	Du, W (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wei@uchicago.edu		Du, Wei/0000-0003-3962-370X	University of Chicago Women's Board; NIGMS, National Institutes of Health [R01 GM120046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120046] Funding Source: NIH RePORTER	University of Chicago Women's Board; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the University of Chicago Women's Board and NIGMS, National Institutes of Health Grant R01 GM120046 (to W.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cecchini MJ, 2014, MOL CELL BIOL, V34, P2029, DOI 10.1128/MCB.01589-13; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 2000, DEVELOPMENT, V127, P367; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Francis SM, 2009, MOL CELL BIOL, V29, P4455, DOI 10.1128/MCB.00473-09; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gordon GM, 2013, J CELL SCI, V126, P2004, DOI 10.1242/jcs.121301; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Humbert PO, 2000, GENE DEV, V14, P690; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; KRATZKE RA, 1994, ONCOGENE, V9, P1321; Law YN, 2012, J MED IMAG HEALTH IN, V2, P352, DOI 10.1166/jmihi.2012.1109; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Liao Y, 2017, FEBS OPEN BIO, V7, P1611, DOI 10.1002/2211-5463.12306; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Park DS, 2001, J BIOL CHEM, V276, P48389, DOI 10.1074/jbc.M108210200; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sun HF, 2011, P NATL ACAD SCI USA, V108, P704, DOI 10.1073/pnas.1015027108; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tonko-Geymayer S, 2002, MOL ENDOCRINOL, V16, P1680, DOI 10.1210/me.16.7.1680; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zhang TY, 2015, DEV BIOL, V407, P246, DOI 10.1016/j.ydbio.2015.09.011; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	56	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3156	3167		10.1074/jbc.RA117.000583	http://dx.doi.org/10.1074/jbc.RA117.000583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330306	hybrid, Green Published			2022-12-28	WOS:000426562800011
J	Cheng, WWL; Chen, ZW; Bracamontes, JR; Budelier, MM; Krishnan, K; Shin, DJ; Wang, CD; Jiang, X; Covey, DF; Akk, G; Evers, AS				Cheng, Wayland W. L.; Chen, Zi-Wei; Bracamontes, John R.; Budelier, Melissa M.; Krishnan, Kathiresan; Shin, Daniel J.; Wang, Cunde; Jiang, Xin; Covey, Douglas F.; Akk, Gustav; Evers, Alex S.			Mapping two neurosteroid-modulatory sites in the prototypic pentameric ligand-gated ion channel GLIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL-1; GABA-A RECEPTOR; NEUROACTIVE STEROIDS; STRUCTURAL BASIS; BINDING-SITE; PHOTOAFFINITY LIGANDS; GENERAL-ANESTHETICS; POTENTIATION; ANALOG; STATE	Neurosteroids are endogenous sterols that potentiate or inhibit pentameric ligand-gated ion channels (pLGICs) and can be effective anesthetics, analgesics, or anti-epileptic drugs. The complex effects of neurosteroids on pLGICs suggest the presence of multiple binding sites in these receptors. Here, using a series of novel neurosteroid-photolabeling reagents combined with top-down and middle-down mass spectrometry, we have determined the stoichiometry, sites, and orientation of binding for 3 alpha,5 alpha-pregnane neurosteroids in the Gloeobacter ligand-gated ion channel (GLIC), a prototypic pLGIC. The neurosteroid-based reagents photolabeled two sites per GLIC subunit, both within the transmembrane domain; one site was an intra-subunit site, and the other was located in the interface between subunits. By using reagents with photoreactive groups positioned throughout the neurosteroid backbone, we precisely map the orientation of neurosteroid binding within each site. Amino acid substitutions introduced at either site altered neurosteroid modulation of GLIC channel activity, demonstrating the functional role of both sites. These results provide a detailed molecular model of multisite neurosteroid modulation of GLIC, which may be applicable to other mammalian pLGICs.	[Cheng, Wayland W. L.; Chen, Zi-Wei; Bracamontes, John R.; Budelier, Melissa M.; Shin, Daniel J.; Covey, Douglas F.; Akk, Gustav; Evers, Alex S.] Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; [Krishnan, Kathiresan; Wang, Cunde; Jiang, Xin; Covey, Douglas F.; Evers, Alex S.] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zi-Wei; Covey, Douglas F.; Akk, Gustav; Evers, Alex S.] Washington Univ, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Evers, AS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054, St Louis, MO 63110 USA.	eversa@wustl.edu	Akk, Gustav/CAG-1703-2022	Evers, Alex/0000-0002-0342-0575; Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [R01 GM108799, R01GM108580, T32GM108539]; International Anesthesia Research Society (IARS) mentored research award; Taylor Family Institute for Innovative Psychiatric Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108799, R01GM108580, K08GM126336, T32GM108539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society (IARS) mentored research award; Taylor Family Institute for Innovative Psychiatric Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM108799 (to A. S. E. and D. F. C.), R01GM108580 (to G. A.), and T32GM108539 (to A. S. E. and W. W. C.), an International Anesthesia Research Society (IARS) mentored research award (to W. W. C.), and the Taylor Family Institute for Innovative Psychiatric Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Akk G, 2004, J PHYSIOL-LONDON, V558, P59, DOI 10.1113/jphysiol.2004.066571; Akk G, 2010, CURR NEUROPHARMACOL, V8, P18, DOI 10.2174/157015910790909458; Alqazzaz M, 2011, BIOPHYS J, V101, P2912, DOI 10.1016/j.bpj.2011.10.055; Barrantes FJ, 2016, PROG LIPID RES, V63, P1, DOI 10.1016/j.plipres.2016.03.003; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; BERTRAND D, 1991, NEUROREPORT, V2, P277, DOI 10.1097/00001756-199105000-00016; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Budelier MM, 2017, J BIOL CHEM, V292, P9294, DOI 10.1074/jbc.M116.773069; Budelier MM, 2017, ANAL CHEM, V89, P2636, DOI 10.1021/acs.analchem.6b05003; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chen ZW, 2014, PSYCHOPHARMACOLOGY, V231, P3479, DOI 10.1007/s00213-014-3568-4; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chiara DC, 2014, BIOCHEMISTRY-US, V53, P135, DOI 10.1021/bi401492k; Chisari M, 2009, J NEUROPHYSIOL, V102, P1254, DOI 10.1152/jn.00346.2009; Covey DF, 2000, J PHARMACOL EXP THER, V293, P1009; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Evers AS, 2010, J PHARMACOL EXP THER, V333, P404, DOI 10.1124/jpet.109.164079; Fourati Z, 2017, J BIOL CHEM, V292, P1550, DOI 10.1074/jbc.M116.766964; Ghosh B, 2017, NEUROPHARMACOLOGY, V125, P343, DOI 10.1016/j.neuropharm.2017.08.007; Giansanti P, 2016, NAT PROTOC, V11, P993, DOI 10.1038/nprot.2016.057; GILLO B, 1984, BRIT J PHARMACOL, V82, P783, DOI 10.1111/j.1476-5381.1984.tb16474.x; Guner H, 2014, J AM SOC MASS SPECTR, V25, P464, DOI 10.1007/s13361-013-0789-4; HARRISON NL, 1984, BRAIN RES, V323, P287, DOI 10.1016/0006-8993(84)90299-3; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Jiang P, 2006, NEUROSCIENCE, V141, P2041, DOI 10.1016/j.neuroscience.2006.05.009; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Laurent B, 2016, STRUCTURE, V24, P595, DOI 10.1016/j.str.2016.02.014; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Li P, 2006, MOL PHARMACOL, V69, P2015, DOI 10.1124/mol.106.022590; Li WJ, 2007, J PHARMACOL EXP THER, V323, P236, DOI 10.1124/jpet.107.127365; Maksay G, 2001, NEUROPHARMACOLOGY, V41, P369, DOI 10.1016/S0028-3908(01)00071-5; Mensah-Nyagan Ayikoe G, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS169, DOI 10.1016/j.psyneuen.2009.06.004; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murail S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002710; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Savechenkov PY, 2017, EUR J MED CHEM, V136, P334, DOI 10.1016/j.ejmech.2017.04.043; Shu HJ, 2004, J NEUROSCI, V24, P6667, DOI 10.1523/JNEUROSCI.1399-04.2004; Vallee M, 2016, J STEROID BIOCHEM, V160, P78, DOI 10.1016/j.jsbmb.2015.09.030; Wang MD, 2002, J NEUROSCI, V22, P3366; Woll KA, 2016, ANESTH ANALG, V123, P1253, DOI 10.1213/ANE.0000000000001365; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zorumski CF, 2013, NEUROSCI BIOBEHAV R, V37, P109, DOI 10.1016/j.neubiorev.2012.10.005	57	20	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					3013	3027		10.1074/jbc.RA117.000359	http://dx.doi.org/10.1074/jbc.RA117.000359			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29301936	hybrid, Green Published			2022-12-28	WOS:000426051900033
J	Hussain, S; Bernstein, HD				Hussain, Sunyia; Bernstein, Harris D.			The Bam complex catalyzes efficient insertion of bacterial outer membrane proteins into membrane vesicles of variable lipid composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; BARREL ASSEMBLY MACHINERY; BETA-BARREL; ESCHERICHIA-COLI; IN-VITRO; CONFORMATIONAL-CHANGES; MOLECULAR-BASIS; YAET COMPLEX; AUTOTRANSPORTER; SECRETION	Most proteins that reside in the bacterial outer membrane (OM) have a distinctive "beta-barrel" architecture, but the assembly of these proteins is poorly understood. The spontaneous assembly of OM proteins (OMPs) into pure lipid vesicles has been studied extensively but often requires non-physiological conditions and time scales and is strongly influenced by properties of the lipid bilayer, including surface charge, thickness, and fluidity. Furthermore, the membrane insertion of OMPs in vivo is catalyzed by a heterooligomer called the beta-barrel assembly machinery (Bam) complex. To determine the role of lipids in the assembly of OMPs under more physiological conditions, we exploited an assay in which the Bam complex mediates their insertion into membrane vesicles. After reconstituting the Bam complex into vesicles that contain a variety of different synthetic lipids, we found that two model OMPs, EspP and OmpA, folded efficiently regardless of the lipid composition. Most notably, both proteins folded into membranes composed of a gel-phase lipid that mimics the rigid bacterial OM. Interestingly, we found that EspP, OmpA, and another model protein (OmpG) folded at significantly different rates and that an alpha-helix embedded inside the EspP beta-barrel accelerates folding. Our results show that the Bam complex largely overcomes effects that lipids exert on OMP assembly and suggest that specific interactions between the Bam complex and an OMP influence its rate of folding.	[Hussain, Sunyia; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052037] Funding Source: NIH RePORTER	Intramural Research Program of NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Bastiat G, 2007, LANGMUIR, V23, P7695, DOI 10.1021/la700824m; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Danoff EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132301; Danoff EJ, 2015, BIOCHEMISTRY-US, V54, P97, DOI 10.1021/bi501443p; Danoff EJ, 2011, BIOPHYS CHEM, V159, P194, DOI 10.1016/j.bpc.2011.06.013; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Doerner PA, 2017, BIOCHEMISTRY-US, V56, P3142, DOI 10.1021/acs.biochem.7b00281; Ellena JF, 2011, BIOPHYS J, V100, P1280, DOI 10.1016/j.bpj.2011.01.055; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fleming KG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0026; Fleming PJ, 2016, BIOPHYS J, V110, P2698, DOI 10.1016/j.bpj.2016.05.010; FREUDL R, 1986, J BIOL CHEM, V261, P1355; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2013, BIOCHEMISTRY-US, V52, P6108, DOI 10.1021/bi400865z; Hagan CL, 2011, BIOCHEMISTRY-US, V50, P7444, DOI 10.1021/bi2010784; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kleanthous C, 2015, CURR OPIN STRUC BIOL, V35, P109, DOI 10.1016/j.sbi.2015.10.007; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; LUGTENBERG EJJ, 1976, BIOCHIM BIOPHYS ACTA, V441, P38, DOI 10.1016/0005-2760(76)90279-4; Mahoney TF, 2016, J BACTERIOL, V198, P1984, DOI 10.1128/JB.00263-16; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2015, METHODS MOL BIOL, V1329, P51, DOI 10.1007/978-1-4939-2871-2_4; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Otzen DE, 2013, ARCH BIOCHEM BIOPHYS, V531, P34, DOI 10.1016/j.abb.2012.10.008; Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t; Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Rollauer SE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0023; Roman-Hernandez G, 2015, METHODS MOL BIOL, V1329, P203, DOI 10.1007/978-1-4939-2871-2_16; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schiffrin B, 2017, J MOL BIOL, V429, P3776, DOI 10.1016/j.jmb.2017.09.008; Sinnige T, 2014, J MOL BIOL, V426, P2009, DOI 10.1016/j.jmb.2014.02.007; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Vanounou S, 2003, MOL MICROBIOL, V49, P1067, DOI 10.1046/j.1365-2958.2003.03614.x; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wang H, 2013, BBA-PROTEINS PROTEOM, V1834, P127, DOI 10.1016/j.bbapap.2012.09.002; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035; WHITE DA, 1972, J BACTERIOL, V109, P686, DOI 10.1128/JB.109.2.686-690.1972; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; WULFING C, 1994, MOL MICROBIOL, V12, P685, DOI 10.1111/j.1365-2958.1994.tb01056.x	72	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2959	2973		10.1074/jbc.RA117.000349	http://dx.doi.org/10.1074/jbc.RA117.000349			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29311257	Green Published, hybrid			2022-12-28	WOS:000426051900029
J	Papakyriakou, A; Reeves, E; Beton, M; Mikolajek, H; Douglas, L; Cooper, G; Elliott, T; Werner, JM; James, E				Papakyriakou, Athanasios; Reeves, Emma; Beton, Mary; Mikolajek, Halina; Douglas, Leon; Cooper, Grace; Elliott, Tim; Werner, Jorn M.; James, Edward			The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-AMINOPEPTIDASE; ANTIGEN PRESENTATION; MOLECULAR-DYNAMICS; TRIMS PRECURSORS; COMPLEX; ERAP1; ERAAP; ASSOCIATION; PARAMETERS; AFFINITY	Endoplasmic reticulum aminopeptidase 1 (ERAP1) and ERAP2 process N-terminally extended antigenic precursors for optimal loading onto major histocompatibility complex class I (MHC I) molecules. We and others have demonstrated that ERAP1 processes peptides bound to MHC I, but the underlying mechanism is unknown. To this end, we utilized single-chain trimers (SCT) of the ovalbumin-derived epitope SIINFEKL (SL8) tethered to the H2-K-b MHC I determinant from mouse and introduced three substitutions, E63A, K66A, and W167A, at the A-pocket of the peptide-binding groove in the MHC I heavy chain, which interact with the N termini of peptides. These variants significantly decreased SL8-presenting SCT at the cell surface in the presence of ERAP1, but did not affect overall SCT expression, indicating that ERAP1 trims the SL8 N terminus. Comparison of the X-ray crystal structures of WT and three variant SCTs revealed only minor perturbations of the peptide-binding domain in the variants. However, molecular dynamics simulations suggested that SL8 can dissociate partially within a sub-microsecond timescale, exposing its N terminus to the solvent. We also found that the C terminus of MHC I-bound SL8 remains deeply buried in the F-pocket of MHC I. Furthermore, free-energy calculations revealed that the three SCT variants exhibit lower free-energy barriers of N terminus dissociation than the WT K-b. Taken together, our results are consistent with a previously observed model in which the partial dissociation of bound peptides from MHC I exposes their N terminus to trimming by ERAP1, whereas their C terminus is anchored at the F-pocket.	[Papakyriakou, Athanasios; Beton, Mary; Mikolajek, Halina; Werner, Jorn M.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Papakyriakou, Athanasios; Reeves, Emma; Beton, Mary; Mikolajek, Halina; Douglas, Leon; Cooper, Grace; Elliott, Tim; Werner, Jorn M.; James, Edward] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Reeves, Emma; Cooper, Grace; Elliott, Tim; James, Edward] Univ Southampton, Fac Med, Univ Hosp Southampton, Ctr Canc Immunol, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	James, E (corresponding author), Tremona Rd, Southampton SO16 6YD, Hants, England.	eddjames@soton.ac.uk	Papakyriakou, Athanasios/K-7033-2012	Papakyriakou, Athanasios/0000-0003-3931-6232; James, Edward/0000-0001-8638-7928; Cooper, Grace/0000-0002-4125-6278; Elliott, Tim/0000-0003-1097-0222; Werner, Jorn/0000-0002-4712-1833	EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS" [703530]; Cancer Research UK [A16997]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L010402/1]; BBSRC [BB/L010402/1] Funding Source: UKRI; EPSRC [EP/P030491/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS"; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS" Grant 703530 (to A. P.). This work was also supported by Cancer Research UK Programme Grant A16997 (to E. J. and T. E.) and Biotechnology and Biological Sciences Research Council (BBSRC) Project Grant BB/L010402/1 (to J. M. W. and T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abualrous ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135421; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chen LY, 2014, ARTHRITIS RHEUMATOL, V66, P284, DOI 10.1002/art.38249; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisette O, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00408; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Guerini FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029931; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hearn A, 2009, J IMMUNOL, V183, P5526, DOI 10.4049/jimmunol.0803663; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Knapp B, 2016, J CHEM INF MODEL, V56, P46, DOI 10.1021/acs.jcim.5b00511; Knapp B, 2016, BIOINFORMATICS, V32, P181, DOI 10.1093/bioinformatics/btv502; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Lehnert E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00010; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; Mehta AM, 2007, GENE CHROMOSOME CANC, V46, P577, DOI 10.1002/gcc.20441; Mitaksov V, 2006, J BIOL CHEM, V281, P10618, DOI 10.1074/jbc.M510511200; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Papakyriakou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00946; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Stamogiannos A, 2017, BIOCHEMISTRY-US, V56, P1546, DOI 10.1021/acs.biochem.6b01170; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Truscott SM, 2007, J IMMUNOL, V178, P6280, DOI 10.4049/jimmunol.178.10.6280; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zervoudi E, 2013, P NATL ACAD SCI USA, V110, P19890, DOI 10.1073/pnas.1309781110	60	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7538	7548		10.1074/jbc.RA117.000313	http://dx.doi.org/10.1074/jbc.RA117.000313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599287	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000437256500008
J	Sartain, SE; Turner, NA; Moake, JL				Sartain, Sarah E.; Turner, Nancy A.; Moake, Joel L.			Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); endothelial cell; inflammation; kidney; brain; alternative complement pathway; anaphylatoxin receptors; anaphylatoxins; C3a; C3aR	HEMOLYTIC-UREMIC SYNDROME; BONE-MARROW-TRANSPLANTATION; MEMBRANE COFACTOR PROTEIN; THROMBOTIC MICROANGIOPATHY; C3A RECEPTOR; CLINICAL CHARACTERISTICS; LISTERIA-MONOCYTOGENES; REDUCED-INTENSITY; C-3 CONVERTASES; C5 CONVERTASE	Atypical hemolytic uremic syndrome (aHUS) and bone marrow transplantation-associated thrombotic microangiopathy (TA-TMA) are associated with excessive activation of the alternative complement pathway (AP) and with severe renal, but rarely cerebral, microvascular damage. Here, we compared AP activation and regulation in human glomerular and brain microvascular endothelial cells (GMVECs and BMVECs, respectively) unstimulated or stimulated by the proinflammatory cytokine, tumor necrosis factor (TNF). Compared with GMVECs and under both experimental conditions, BMVECs had increased gene expression of the AP-related genes C3, CFB, and C5 and decreased expression of CFD. This was associated with increased expression in BMVECs (relative to GMVECs) of the genes for surface and soluble regulatory molecules (CD46, THBD, CD55, CFI, and CFH) suppressing formation of the AP C3 and C5 convertases. Of note, unlike GMVECs, BMVECs generated extremely low levels of C3a and C5a and displayed decreased activation of the AP (as measured by a lower percentage of Ba generation than GMVECs). Moreover, BMVECs exhibited increased function of CD141, mediating activation of the natural anticoagulant protein C, compared with GMVECs. We also found that the C3a receptor (C3aR) is present on both cell types and that TNF greatly increases C3AR1 expression in GMVECs, but only slightly in BMVECs. Higher AP activation and C3a generation in GMVECs than in BMVECs, coupled with an increase in C3aR production in TNF-stimulated GMVECs, provides a possible explanation for the predominance of renal damage, and the absence of cerebral injury, in individuals with episodes of aHUS and TA-TMA.	[Sartain, Sarah E.] Texas Childrens Hosp, Hematol Oncol Sect, Dept Pediat, Baylor Coll Med, Houston, TX 77030 USA; [Turner, Nancy A.; Moake, Joel L.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Baylor College of Medicine; Rice University	Sartain, SE (corresponding author), Texas Childrens Hosp, Dept Pediat, Baylor Coll Med, 6701 Fannin St,Ste 1580, Houston, TX 77030 USA.	sartain@bcm.edu			Baylor College of Medicine Pediatric Pilot Award; Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund	Baylor College of Medicine Pediatric Pilot Award; Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund	This work was supported by grants from the Baylor College of Medicine Pediatric Pilot Award, the Mary R. Gibson Foundation, and the Mabel and Everett Hinkson Memorial Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Bao LH, 2005, J IMMUNOL, V175, P1947, DOI 10.4049/jimmunol.175.3.1947; Batts ED, 2007, BONE MARROW TRANSPL, V40, P709, DOI 10.1038/sj.bmt.1705758; Bautsch W, 2000, J IMMUNOL, V165, P5401, DOI 10.4049/jimmunol.165.10.5401; BENGTSON A, 1988, ARCH SURG-CHICAGO, V123, P645; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Brodsky RA, 2015, BLOOD, V126, P2459, DOI 10.1182/blood-2015-06-640995; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Changsirikulchai S, 2009, CLIN J AM SOC NEPHRO, V4, P345, DOI 10.2215/CJN.02070508; Cofiell R, 2015, BLOOD, V125, P3253, DOI 10.1182/blood-2014-09-600411; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Fakhouri F, 2014, AM J KIDNEY DIS, V63, P40, DOI 10.1053/j.ajkd.2013.07.011; FEARON DT, 1973, J EXP MED, V138, P1305, DOI 10.1084/jem.138.6.1305; Feng SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073715; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; Hale GA, 2005, BIOL BLOOD MARROW TR, V11, P912, DOI 10.1016/j.bbmt.2005.07.012; HARRISON RA, 1980, MOL IMMUNOL, V17, P9, DOI 10.1016/0161-5890(80)90119-4; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jodele S, 2016, BLOOD, V127, P989, DOI 10.1182/blood-2015-08-663435; Jodele S, 2015, BLOOD REV, V29, P191, DOI 10.1016/j.blre.2014.11.001; Jodele S, 2013, BLOOD, V122, P2003, DOI 10.1182/blood-2013-05-501445; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018; Laskin BL, 2011, BLOOD, V118, P1452, DOI 10.1182/blood-2011-02-321315; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; Law SKA, 1997, PROTEIN SCI, V6, P263; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113639; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu L, 2014, J CLIN IMMUNOL, V34, P224, DOI 10.1007/s10875-013-9970-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loirat C, 2008, PEDIATR NEPHROL, V23, P1957, DOI 10.1007/s00467-008-0872-4; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Meri S, 2013, EUR J INTERN MED, V24, P496, DOI 10.1016/j.ejim.2013.05.009; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Mueller-Ortiz SL, 2017, J IMMUNOL, V198, P3237, DOI 10.4049/jimmunol.1601420; Mueller-Ortiz SL, 2014, J IMMUNOL, V193, P1278, DOI 10.4049/jimmunol.1302787; Nakamae H, 2006, AM J HEMATOL, V81, P525, DOI 10.1002/ajh.20648; NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; PANGBURN MK, 1983, FED PROC, V42, P139; Pangburn MK, 2002, BIOCHEM SOC T, V30, P1006, DOI 10.1042/bst0301006; PANGBURN MK, 1986, J IMMUNOL, V136, P2216; Patzelt J, 2015, ATHEROSCLEROSIS, V238, P289, DOI 10.1016/j.atherosclerosis.2014.12.002; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rosenthal J, 2011, PEDIATR BLOOD CANCER, V57, P142, DOI 10.1002/pbc.22861; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Sartain SE, 2016, J IMMUNOL, V196, P832, DOI 10.4049/jimmunol.1500960; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948; SEEBER C, 1992, THROMB RES, V66, P373, DOI 10.1016/0049-3848(92)90286-J; Selberg O, 2000, CRIT CARE MED, V28, P2793, DOI 10.1097/00003246-200008000-00019; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2392, DOI 10.1681/ASN.2006080811; Settmacher B, 1999, J IMMUNOL, V162, P7409; Settmacher B, 2003, EUR J IMMUNOL, V33, P920, DOI 10.1002/eji.200323293; SEYA T, 1989, BIOCHEM J, V264, P581, DOI 10.1042/bj2640581; Siami K, 2008, TRANSPLANTATION, V85, P22, DOI 10.1097/01.tp.0000297998.33418.7e; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Tang SJ, 2016, J BIOL CHEM, V291, P14311, DOI 10.1074/jbc.M115.710350; Tati R, 2013, J IMMUNOL, V191, P2184, DOI 10.4049/jimmunol.1301221; Trcka J, 2002, IMMUNITY, V16, P861, DOI 10.1016/S1074-7613(02)00327-8; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Uderzo C, 2006, TRANSPLANTATION, V82, P638, DOI 10.1097/01.tp.0000230373.82376.46; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Willems E, 2010, BONE MARROW TRANSPL, V45, P689, DOI 10.1038/bmt.2009.230; Nina W, 2007, TRANSFUS APHER SCI, V36, P297, DOI 10.1016/j.transci.2011.03.004; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	81	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7195	7208		10.1074/jbc.RA118.002639	http://dx.doi.org/10.1074/jbc.RA118.002639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29555686	hybrid, Green Published			2022-12-28	WOS:000432174500012
J	Huang, F; Shao, W; Fujinaga, K; Peterlin, BM				Huang, Fang; Shao, Wei; Fujinaga, Koh; Peterlin, B. Matija			Bromodomain-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; NF-kB transcription factor; transcription factor; chromatin; transcription promoter; gene expression; bromodomain-containing protein 4; epigenetic regulation	RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; P-TEFB; GENE-EXPRESSION; EUKARYOTIC TRANSCRIPTION; ACETYLATED CHROMATIN; SUPER-ENHANCERS; TARGET GENES; ELONGATION; BRD4	Autoimmune regulator (AIRE) and nuclear factor-B (NF-B) are transcription factors (TFs) that direct the expression of individual genes and gene clusters. Bromodomain-containing protein 4 (BRD4) is an epigenetic regulator that recognizes and binds to acetylated histones. BRD4 also has been reported to promote interactions between the positive transcription elongation factor b (P-TEFb) and AIRE or P-TEFb and NF-B subunit p65. Here, we report that AIRE and p65 bind to P-TEFb independently of BRD4. JQ1, a compound that disrupts interactions between BRD4 and acetylated proteins, does not decrease transcriptional activities of AIRE or p65. Moreover, siRNA-mediated inactivation of BRD4 alone or in combination with JQ1 had no effects on AIRE- and NF-B-targeted genes on plasmids and in chromatin and on interactions between P-TEFb and AIRE or NF-B. Finally, ChIP experiments revealed that recruitment of P-TEFb to AIRE or p65 to transcription complexes was independent of BRD4. We conclude that direct interactions between AIRE, NF-B, and P-TEFb result in efficient transcription of their target genes.	[Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.; Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Microbiol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.; Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Immunol, U432,Box 0703,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu		HUANG, FANG/0000-0002-0511-2568	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125104] Funding Source: NIH RePORTER	Nora Eccles Treadwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Nora Eccles Treadwell Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bi HL, 2014, MOL BIOL CELL, V25, P2499, DOI 10.1091/mbc.E13-12-0733; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Ebmeier CC, 2017, CELL REP, V20, P1173, DOI 10.1016/j.celrep.2017.07.021; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Gressel S, 2017, ELIFE, V6, DOI 10.7554/eLife.29736; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Krishnamurthy S, 2009, CURR BIOL, V19, pR153, DOI 10.1016/j.cub.2008.11.052; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Saenz DT, 2017, LEUKEMIA, V31, P1951, DOI 10.1038/leu.2016.393; Shao W, 2016, J BIOL CHEM, V291, P17953, DOI 10.1074/jbc.M116.724401; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112; Zumer K, 2013, J IMMUNOL, V190, P2479, DOI 10.4049/jimmunol.1203210; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11; Zumer K, 2011, NUCLEIC ACIDS RES, V39, P7908, DOI 10.1093/nar/gkr527	42	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4993	5004		10.1074/jbc.RA117.001518	http://dx.doi.org/10.1074/jbc.RA117.001518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29463681	hybrid, Green Published			2022-12-28	WOS:000429409300004
J	Guengerich, FP				Guengerich, F. Peter			Introduction to Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MINIREVIEW SERIES METALS; METABOLISM; TRANSPORT; DEFENSE; OXIDASE	This 11th Thematic Metals in Biology Thematic Series deals with copper, a transition metal with a prominent role in biochemistry. Copper is a very versatile element, and both deficiencies and excesses can be problematic. The five Minireviews in this series deal with several aspects of copper homeostasis in microorganisms and mammals and the role of this metal in two enzymes, copper-only superoxide dismutase and cytochrome c oxidase.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu						Ackerman CM, 2018, J BIOL CHEM, V293, P4628, DOI 10.1074/jbc.R117.000176; Ackerman CM, 2017, ANAL CHEM, V89, P22, DOI 10.1021/acs.analchem.6b04631; Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Chang CJ, 2015, NAT CHEM BIOL, V11, P744, DOI 10.1038/nchembio.1913; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Darwin KH, 2015, J BIOL CHEM, V290, P18962, DOI 10.1074/jbc.R115.640193; Dennison C, 2018, J BIOL CHEM, V293, P4616, DOI 10.1074/jbc.TM117.000180; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Finney J, 2014, ARCH BIOCHEM BIOPHYS, V546, P19, DOI 10.1016/j.abb.2013.12.022; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Guengerich FP, 2017, J BIOL CHEM, V292, P12725, DOI 10.1074/jbc.R117.801332; Guengerich FP, 2016, J BIOL CHEM, V291, P20838, DOI 10.1074/jbc.R116.749259; Guengerich FP, 2015, J BIOL CHEM, V290, P20700, DOI 10.1074/jbc.R115.675652; Guengerich FP, 2015, J BIOL CHEM, V290, P18943, DOI 10.1074/jbc.R115.670265; Guengerich FP, 2014, J BIOL CHEM, V289, P28094, DOI 10.1074/jbc.R114.607093; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Jett KA, 2018, J BIOL CHEM, V293, P4644, DOI 10.1074/jbc.R117.816132; Kenney GE, 2018, J BIOL CHEM, V293, P4606, DOI 10.1074/jbc.TM117.000185; Khaliullin B, 2017, J BIOL CHEM, V292, P13022, DOI 10.1074/jbc.M117.795682; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Koh EI, 2015, J BIOL CHEM, V290, P18967, DOI 10.1074/jbc.R115.644328; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Robinett NG, 2018, J BIOL CHEM, V293, P4636, DOI 10.1074/jbc.TM117.000182; Tokar EJ., 2013, CASARETT DOULLS ESSE, V8th, P1009; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200	32	20	20	7	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4603	4605		10.1074/jbc.TM118.002255	http://dx.doi.org/10.1074/jbc.TM118.002255			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425098	Green Published, hybrid			2022-12-28	WOS:000428848300002
J	Elgeti, M; Kazmin, R; Rose, AS; Szczepek, M; Hildebrand, PW; Bartl, FJ; Scheerer, P; Hofmann, KP				Elgeti, Matthias; Kazmin, Roman; Rose, Alexander S.; Szczepek, Michal; Hildebrand, Peter W.; Bartl, Franz J.; Scheerer, Patrick; Hofmann, Klaus Peter			The arrestin-1 finger loop interacts with two distinct conformations of active rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DOMINANT RETINITIS-PIGMENTOSA; CARBOXYLIC-ACID GROUP; CRYSTAL-STRUCTURE; METARHODOPSIN-II; TRANSDUCIN ACTIVATION; TRANSMEMBRANE HELICES; PROTON UPTAKE; GPCR; COMPLEX	Signaling of the prototypical G protein-coupled receptor (GPCR) rhodopsin through its cognate G protein transducin (G(t)) is quenched when arrestin binds to the activated receptor. Although the overall architecture of the rhodopsin/arrestin complex is known, many questions regarding its specificity remain unresolved. Here, using FTIR difference spectroscopy and a dual pH/peptide titration assay, we show that rhodopsin maintains certain flexibility upon binding the "finger loop" of visual arrestin (prepared as synthetic peptide ArrFL-1). We found that two distinct complexes can be stabilized depending on the protonation state of E3.49 in the conserved (D) ERY motif. Both complexes exhibit different interaction modes and affinities of ArrFL-1 binding. The plasticity of the receptor within the rhodopsin/ArrFL-1 complex stands in contrast to the complex with the C terminus of the G(t) alpha-subunit (G alpha CT), which stabilizes only one specific substate out of the conformational ensemble. However, G(t) alpha-subunit binding and both ArrFL-1-binding modes involve a direct interaction to conserved R3.50, as determined by site-directed mutagenesis. Our findings highlight the importance of receptor conformational flexibility and cytoplasmic proton uptake for modulation of rhodopsin signaling and thereby extend the picture provided by crystal structures of the rhodopsin/arrestin and rhodopsin/ArrFL-1 complexes. Furthermore, the two binding modes of ArrFL-1 identified here involve motifs of conserved amino acids, which indicates that our results may have elucidated a common modulation mechanism of class A GPCR-G protein/-arrestin signaling.	[Elgeti, Matthias; Kazmin, Roman; Rose, Alexander S.; Szczepek, Michal; Hildebrand, Peter W.; Bartl, Franz J.; Scheerer, Patrick; Hofmann, Klaus Peter] Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany; [Rose, Alexander S.] Humboldt Univ, Grp Proteinformat, Invalidenstr 42, D-10115 Berlin, Germany; [Szczepek, Michal; Scheerer, Patrick] Humboldt Univ, Grp Prot Xray Crystallog & Signal Transduct, Invalidenstr 42, D-10115 Berlin, Germany; [Bartl, Franz J.] Humboldt Univ, Inst Biol, Biophys Chem, Invalidenstr 42, D-10115 Berlin, Germany; [Hildebrand, Peter W.] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Leipzig University	Elgeti, M (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.; Elgeti, M (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	melgeti@ucla.edu		Scheerer, Patrick/0000-0001-5028-2075; Rose, Alexander/0000-0002-0893-5551	Deutsche Forschungsgemeinschaft [EL 779, SFB 1078, D3/E3-1, SFB 740]; European Research Council TUDOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council TUDOR	This work was supported by the Deutsche Forschungsgemeinschaft EL 779 (to M.E.), SFB 1078 (to F.J.B. and P.S.), Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" Research Field D3/E3-1 (to P.S.), and SFB 740 to (P.W.H., P.S., and K.P.H.), and the European Research Council TUDOR (to K.P.H.). The authors declare that they have no conflicts of interest with the contents of this article.	ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beck M, 1998, BIOCHEMISTRY-US, V37, P7630, DOI 10.1021/bi9801560; Beyriere F, 2015, J BIOL CHEM, V290, P12919, DOI 10.1074/jbc.M114.620898; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; FAHMY K, 1995, BIOPHYS CHEM, V56, P171, DOI 10.1016/0301-4622(95)00030-2; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hauser K, 2002, J PHYS CHEM A, V106, P3553, DOI 10.1021/jp012926e; Hoersch D, 2008, BIOCHEMISTRY-US, V47, P11518, DOI 10.1021/bi801397e; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MIN KC, 1993, J BIOL CHEM, V268, P9400; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerert P, 2017, CURR OPIN STRUC BIOL, V45, P160, DOI 10.1016/j.sbi.2017.05.001; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shi W, 1998, BIOCHEMISTRY-US, V37, P4869, DOI 10.1021/bi9731100; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Sommer ME, 2015, METHOD ENZYMOL, V556, P563, DOI 10.1016/bs.mie.2014.12.014; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Van Eps N., 2017, P NATL ACAD SCI USA; Vogel R, 2006, BIOCHEMISTRY-US, V45, P1640, DOI 10.1021/bi052196r; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2007, J MOL BIOL, V366, P1580, DOI 10.1016/j.jmb.2006.12.019; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	54	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4403	4410		10.1074/jbc.M117.817890	http://dx.doi.org/10.1074/jbc.M117.817890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29363577	hybrid, Green Published			2022-12-28	WOS:000428204300012
J	Hayama, R; Sparks, S; Hecht, LM; Dutta, K; Karp, JM; Cabana, CM; Rout, MP; Cowburn, D				Hayama, Ryo; Sparks, Samuel; Hecht, Lee M.; Dutta, Kaushik; Karp, Jerome M.; Cabana, Christina M.; Rout, Michael P.; Cowburn, David			Thermodynamic characterization of the multivalent interactions underlying rapid and selective translocation through the nuclear pore complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUZZY COMPLEXES; NUCLEOPORINS; TRANSPORT; PROTEINS; COMPENSATION; DIFFUSION; ENTROPY; REPEATS; BINDING; NTF2	Intrinsically disordered proteins (IDPs) play important roles in many biological systems. Given the vast conformational space that IDPs can explore, the thermodynamics of the interactions with their partners is closely linked to their biological functions. Intrinsically disordered regions of Phe-Gly nucleoporins (FG Nups) that contain multiple phenylalanine-glycine repeats are of particular interest, as their interactions with transport factors (TFs) underlie the paradoxically rapid yet also highly selective transport of macromolecules mediated by the nuclear pore complex. Here, we used NMR and isothermal titration calorimetry to thermodynamically characterize these multivalent interactions. These analyses revealed that a combination of low per-FG motif affinity and the enthalpy-entropy balance prevents high-avidity interaction between FG Nups and TFs, whereas the large number of FG motifs promotes frequent FG-TF contacts, resulting in enhanced selectivity. Our thermodynamic model underlines the importance of functional disorder of FG Nups. It helps explain the rapid and selective translocation of TFs through the nuclear pore complex and further expands our understanding of the mechanisms of "fuzzy" interactions involving IDPs.	[Hayama, Ryo; Hecht, Lee M.; Cabana, Christina M.; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA; [Sparks, Samuel; Karp, Jerome M.; Cowburn, David] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sparks, Samuel; Karp, Jerome M.; Cowburn, David] Albert Einstein Coll Med, Depts Physiol & Biophys, Bronx, NY 10461 USA; [Dutta, Kaushik] New York Struct Biol Ctr, New York, NY 10027 USA	Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA.; Cowburn, D (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.; Cowburn, D (corresponding author), Albert Einstein Coll Med, Depts Physiol & Biophys, Bronx, NY 10461 USA.	rout@mail.rockefeller.edu; cowburn@cowburnlab.org	Rout, Michael/Y-7090-2018; Sparks, Samuel/GZB-0815-2022	Cowburn, David/0000-0001-6770-7172; Cabana, Christina/0000-0002-0420-9552; Karp, Jerome/0000-0001-7266-0946; Hayama, Ryo/0000-0001-8706-213X	National Institutes of Health [R01 GM112108, P41 GM109824, U01 GM098256, R01 GM117212, S10 OD016305, P30 CA013330, T32 GM007288-39]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098256, R01GM117212, T32GM007288, R01GM112108, P41GM109824] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 GM112108, P41 GM109824, and U01 GM098256 (to M. P. R.); R01 GM117212 and S10 OD016305 (to D. C.); and P30 CA013330. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32 GM007288-39.	Arai M, 2012, J AM CHEM SOC, V134, P3792, DOI 10.1021/ja209936u; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Cloninger M. J., 2012, ANONYMOUS SUPRAMOLEC, P95; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gargano JM, 2001, J AM CHEM SOC, V123, P12909, DOI 10.1021/ja016305a; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; GRANOT J, 1983, J MAGN RESON, V55, P216, DOI 10.1016/0022-2364(83)90234-2; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lim RYH, 2015, NUCLEUS-PHILA, V6, P366, DOI 10.1080/19491034.2015.1090061; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Martinez-Veracoechea FJ, 2011, P NATL ACAD SCI USA, V108, P10963, DOI 10.1073/pnas.1105351108; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Moussavi-Baygi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29991; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Raveh B, 2016, P NATL ACAD SCI USA, V113, pE2489, DOI 10.1073/pnas.1522663113; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Shekhtman A, 2002, FEBS LETT, V524, P177, DOI 10.1016/S0014-5793(02)03051-X; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Tetenbaum-Novatt J, 2010, COLD SH Q B, V75, P567, DOI 10.1101/sqb.2010.75.033; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vovk A, 2016, ELIFE, V5, DOI 10.7554/eLife.10785; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weber M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739501; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201	44	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4555	4563		10.1074/jbc.AC117.001649	http://dx.doi.org/10.1074/jbc.AC117.001649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29374059	hybrid, Green Published			2022-12-28	WOS:000428204300026
J	Ding, KS; Tan, S; Huang, X; Wang, XN; Li, XC; Fan, R; Zhu, Y; Lobie, PE; Wang, WB; Wu, ZS				Ding, Keshuo; Tan, Sheng; Huang, Xing; Wang, Xiaonan; Li, Xiaocan; Fan, Rong; Zhu, Yong; Lobie, Peter E.; Wang, Wenbin; Wu, Zhengsheng			GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORTER 1; CELL-PROLIFERATION; BREAST-CANCER; CD98 EXPRESSION; MIGRATION; INVASION; LAT1; CONTRIBUTES; PROMOTES; FAMILY	Gastric cancer remains a malignancy with poor survival outcome. We herein report that GSE1, a proline-rich protein, possesses a role in the progression of human gastric cancer. The expression of GSE1 was observed to be much higher in human gastric cancer tissues compared with normal gastric tissues, and GSE1 expression correlated positively with lymph node metastasis, histological grade, depth of invasion, and clinical stage in gastric cancer patients. Moreover, GSE1 expression was also associated with decreased post-operative relapse-free survival and overall survival in the cohort. The forced expression of GSE1 in gastric cancer cell lines resulted in increased cell proliferation, increased colony formation, enhanced cell migration, and invasion. Furthermore, forced expression of GSE1 also increased tumor size and enhanced lung metastasis in xenograft models. The depletion of endogenous GSE1 with shRNAs decreased the oncogenicity and invasiveness of gastric cancer cells both in vitro and in vivo. In addition, GSE1 was determined to be a direct target of miR-200b and miR-200c. Furthermore, GSE1 positively regulated the downstream gene SLC7A5 (also known as LAT-1), which was scanned and verified from mRNA sequencing. GSE1 therefore possesses an oncogenic role in human gastric cancer, and targeted therapeutic approaches to inhibit GSE1 function in gastric cancer warrant further consideration.	[Ding, Keshuo; Wang, Wenbin] Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, 372 Tunxi Rd, Hefei 230022, Anhui, Peoples R China; [Ding, Keshuo; Li, Xiaocan; Wu, Zhengsheng] Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China; [Wang, Xiaonan] Anhui Med Univ, Lab Pathogen Microbiol & Immunol, Hefei 230032, Anhui, Peoples R China; [Tan, Sheng; Fan, Rong; Zhu, Yong] Univ Sci & Technol China, Sch Life Sci, Lab Mol Tumor Pathol, Hefei 230027, Anhui, Peoples R China; [Huang, Xing] Zhejiang Univ, Key Lab Precis Diag & Treatment Hepatobiliary & P, Affiliated Hosp 1, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China; [Huang, Xing] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch, Div Life Sci & Hlth, Shenzhen 518055, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Natl Univ Hlth Syst, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Pharmacol, Singapore 117599, Singapore	Anhui Medical University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang University; Southeast University - China; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; National University of Singapore	Wang, WB (corresponding author), Anhui Med Univ, Affiliated Hosp 4, Dept Gen Surg, 372 Tunxi Rd, Hefei 230022, Anhui, Peoples R China.; Wu, ZS (corresponding author), Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China.	nihao22009256@163.com; woozson@yahoo.com	黄, 星/AAB-2241-2019; tan, sheng/GSN-2599-2022	黄, 星/0000-0002-8886-2777; 	National Nature Science Foundation of China [81472493, 81500373, 81502282, 81672609, 81502975]; Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant [2013xkj006]; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant [2016H074]; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant [gxyqZD2016046]; Natural Science Foundation of Anhui Province Grant [1608085MH193]; Scientific Research Foundation of Anhui Medical University Grant [2015xkj043]; China Postdoctoral Science Foundation Grants [2016T90413, 2015M581693]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant; Natural Science Foundation of Anhui Province Grant(Natural Science Foundation of Anhui Province); Scientific Research Foundation of Anhui Medical University Grant; China Postdoctoral Science Foundation Grants(China Postdoctoral Science Foundation)	This work was supported in part by National Nature Science Foundation of China Grants 81472493, 81500373, 81502282, 81672609, and 81502975; Program for Excellent Talents and Scientific Research Program of Anhui Medical University Grant 2013xkj006; Anhui Provincial Academic and Technical Leader Reserve Candidate Grant 2016H074; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui Grant gxyqZD2016046; Natural Science Foundation of Anhui Province Grant 1608085MH193; Scientific Research Foundation of Anhui Medical University Grant 2015xkj043; and China Postdoctoral Science Foundation Grants 2016T90413 and 2015M581693. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad P, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/8245345; Chai P, 2016, BIOCHEM BIOPH RES CO, V471, P123, DOI 10.1016/j.bbrc.2016.01.168; Chang L, 2015, ONCOL LETT, V9, P2317, DOI 10.3892/ol.2015.3028; Chen LT, 2017, CANCER RES TREAT, V49, P851, DOI 10.4143/crt.2016.176; Oliveira KCD, 2016, WORLD J GASTROENTERO, V22, P7951, DOI 10.3748/wjg.v22.i35.7951; Damiano V, 2017, GENE CHROMOSOME CANC, V56, P147, DOI 10.1002/gcc.22422; Ding KS, 2017, ENDOCRINOLOGY, V158, P1595, DOI 10.1210/en.2016-1903; Ding KH, 2017, PATHOL RES PRACT, V213, P467, DOI 10.1016/j.prp.2017.01.026; Ding L, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0516-2; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Gui ZF, 2017, INT J ONCOL, V50, P111, DOI 10.3892/ijo.2016.3772; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0603-1; He L, 2017, MOL MED REP, V15, P3055, DOI 10.3892/mmr.2017.6347; Hong H, 2016, MED SCI MONITOR, V22, P1946, DOI 10.12659/MSM.896551; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Li GP, 2016, CELL RES, V26, P655, DOI 10.1038/cr.2016.32; Li Nan, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P809, DOI 10.3969/j.issn.1672-7347.2013.08.009; Li YR, 2016, FEBS OPEN BIO, V6, P1257, DOI 10.1002/2211-5463.12142; Lin Y, 2017, ONCOTARGET, V8, P11990, DOI 10.18632/oncotarget.14467; Liu YQ, 2017, ONCOL REP, V37, P2441, DOI 10.3892/or.2017.5488; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Luu HN, 2017, BMC UROL, V17, DOI 10.1186/s12894-017-0206-6; Oliveto Stefania, 2017, World J Biol Chem, V8, P45, DOI 10.4331/wjbc.v8.i1.45; Paik Woo Hyun, 2015, Korean J Gastroenterol, V66, P215, DOI 10.4166/kjg.2015.66.4.215; Pan Q, 2017, CANCER LETT, V392, P26, DOI 10.1016/j.canlet.2017.01.039; Rosilio C, 2015, LEUKEMIA, V29, P1253, DOI 10.1038/leu.2014.338; Shennan DB, 2008, ONCOL REP, V20, P885, DOI 10.3892/or_00000087; Shi RL, 2014, FRONT MED-PRC, V8, P456, DOI 10.1007/s11684-014-0353-z; Shimizu A, 2015, MELANOMA RES, V25, P399, DOI 10.1097/CMR.0000000000000181; Takeuchi K, 2010, LUNG CANCER, V68, P58, DOI 10.1016/j.lungcan.2009.05.020; Tan S, 2017, J BIOL CHEM, V292, P13551, DOI 10.1074/jbc.M117.780973; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang JQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166147; Wang JQ, 2013, BIOMED PHARMACOTHER, V67, P693, DOI 10.1016/j.biopha.2013.05.003; Xu MH, 2016, J UROLOGY, V195, P1588, DOI 10.1016/j.juro.2015.11.071; Yothaisong S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694545; Yu BQ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3096-9; Zhang HC, 2017, BIOMED PHARMACOTHER, V88, P285, DOI 10.1016/j.biopha.2017.01.023; Zhang S, 2017, ONCOTARGET, V8, P18848, DOI 10.18632/oncotarget.14473; Zhang Z, 2016, ONCOTARGET, V7, P37993, DOI 10.18632/oncotarget.9366; Zhao M, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691682; Zhou XL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0428-3	48	31	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3949	3964		10.1074/jbc.RA117.001103	http://dx.doi.org/10.1074/jbc.RA117.001103			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367342	hybrid, Green Published			2022-12-28	WOS:000427587500009
J	Ulaganathan, T; Helbert, W; Kopel, M; Banin, E; Cygler, M				Ulaganathan, ThirumalaiSelvi; Helbert, William; Kopel, Moran; Banin, Ehud; Cygler, Miroslaw			Structure-function analyses of a PL24 family ulvan lyase reveal key features and suggest its catalytic mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY; PERSICIVIRGA-ULVANIVORANS; POLYSACCHARIDE; ENZYMES; HYDROGELS	Ulvan is a major cell wall component of green algae of the genus Ulva, and some marine bacteria encode enzymes that can degrade this polysaccharide. The first ulvan-degrading lyases have been recently characterized, and several putative ulvan lyases have been recombinantly expressed, confirmed as ulvan lyases, and partially characterized. Two families of ulvan-degrading lyases, PL24 and PL25, have recently been established. The PL24 lyase LOR_107 from the bacterial Alteromonadales sp. strain LOR degrades ulvan endolytically, cleaving the bond at the C4 of a glucuronic acid. However, the mechanism and LOR_107 structural features involved are unknown. We present here the crystal structure of LOR_107, representing the first PL24 family structure. We found that LOR_107 adopts a seven-bladed beta-propeller fold with a deep canyon on one side of the protein. Comparative sequence analysis revealed a cluster of conserved residues within this canyon, and site-directed mutagenesis disclosed several residues essential for catalysis. We also found that LOR_107 uses the His/Tyr catalytic mechanism, common to several PL families. We captured a tetrasaccharide substrate in the structures of two inactive mutants, which indicated a two-step binding event, with the first substrate interaction near the top of the canyon coordinated by Arg(320), followed by sliding of the substrate into the canyon toward the active-site residues. Surprisingly, the LOR_107 structure was very similar to that of the PL25 family PLSV_3936, despite only similar to 14% sequence identity between the two enzymes. On the basis of our structural and mutational analyses, we propose a catalytic mechanism for LOR_107 that differs from the typical His/Tyr mechanism.	[Ulaganathan, ThirumalaiSelvi; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Helbert, William] Univ Grenoble Alpes, Rue Chim, F-38000 Grenoble, France; [Helbert, William] CERMAV, CNRS, UPR 5301 601, Rue Chim, F-38000 Grenoble, France; [Helbert, William] FR CNRS 2607, Inst Chim Mol Grenoble, ICMG, Grenoble, France; [Kopel, Moran; Banin, Ehud] Bar Ilan Univ, Inst Nanotechnol & Adv Mat & Mina & Everard Goodm, Fac Life Sci, IL-52900 Ramat Gan, Israel; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Bar Ilan University; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca			Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Drs. Jeremy Lee and David R. Palmer for helpful discussions. We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan, for access to the crystallization robot. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Abbott DW, 2010, J BIOL CHEM, V285, P39029, DOI 10.1074/jbc.M110.153981; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alves A, 2013, J BIOMED MATER RES A, V101, P998, DOI 10.1002/jbm.a.34403; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Cunha L, 2016, MAR DRUGS, V14, DOI 10.3390/md14030042; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delattre C, 2006, APPL MICROBIOL BIOT, V70, P437, DOI 10.1007/s00253-005-0077-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M., 2014, GENOME ANNOUNC, V2; Kopel M, 2016, J BIOL CHEM, V291, P5871, DOI 10.1074/jbc.M115.673947; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manivasagan P, 2016, INT J BIOL MACROMOL, V82, P315, DOI 10.1016/j.ijbiomac.2015.10.081; Morelli A, 2016, CARBOHYD POLYM, V136, P1108, DOI 10.1016/j.carbpol.2015.09.068; Popa EG, 2015, CRIT REV BIOTECHNOL, V35, P410, DOI 10.3109/07388551.2014.889079; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207	31	19	20	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4026	4036		10.1074/jbc.RA117.001642	http://dx.doi.org/10.1074/jbc.RA117.001642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382716	Green Published, hybrid			2022-12-28	WOS:000427587500015
J	Iwaoka, R; Kataoka, K				Iwaoka, Ryo; Kataoka, Kohsuke			RETRACTED: Glucose regulates MafA transcription factor abundance and insulin gene expression by inhibiting AMP-activated protein kinase in pancreatic beta-cells (Retracted article. See vol. 293, pg. 18403, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							KEY REGULATOR; PHOSPHORYLATION; IDENTIFICATION; METFORMIN; PDX-1; BINDING; SITE	Insulin mRNA expression in pancreatic islet beta-cells is up-regulated by extracellular glucose concentration, but the underlying mechanism remains incompletely understood. MafA is a transcriptional activator specifically enriched in beta-cells that binds to the insulin gene promoter. Its expression is transcriptionally and posttranscriptionally regulated by glucose. Moreover, AMP-activated protein kinase (AMPK), a regulator of cellular energy homeostasis, is inhibited by high glucose, and this inhibition is essential for the up-regulation of insulin gene expression and glucose-stimulated insulin secretion (GSIS). Here we mutagenized the insulin promoter and found that the MafA-binding element C1/RIPE3b is required for glucose- or AMPK-induced alterations in insulin gene promoter activity. Under high-glucose conditions, pharmacological activation of AMPK in isolated mouse islets or MIN6 cells by metformin or 5-aminoimidazole-4-carboxamide riboside decreased MafA protein levels and mRNA expression of insulin and GSIS-related genes (i.e. glut2 and sur1). Overexpression of constitutively active AMPK also reduced MafA and insulin expression. Conversely, pharmacological AMPK inhibition by dorsomorphin (compound C) or expression of a dominant-negative form of AMPK increased MafA and insulin expression under low-glucose conditions. However, AMPK activation or inhibition did not change the expression levels of the beta-cell-enriched transcription factors Pdx1 and Beta2/NeuroD1. AMPK activation accelerated MafA protein degradation, which is not dependent on the proteasome. We also noted that MafA overexpression prevents metformin-induced decreases in insulin and GSIS-related gene expression. These findings indicate that high glucose concentrations inhibit AMPK, thereby increasing MafA protein levels and activating the insulin promoter.	[Iwaoka, Ryo; Kataoka, Kohsuke] Yokohama City Univ, Grad Sch Med Life Sci, Lab Mol Med Biosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	Yokohama City University	Kataoka, K (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Lab Mol Med Biosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kkataoka@yokohama-cu.ac.jp			Japan Society for the Promotion of Science [25461352, 16K09763]; Grants-in-Aid for Scientific Research [16K09763] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science 25461352 and 16K09763 (to K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; Chen F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13215; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; El Khattabi I, 2013, MOL ENDOCRINOL, V27, P1078, DOI 10.1210/me.2012-1346; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GOTOH M, 1990, HORM METAB RES, V25, P10; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Han SI, 2016, ACTA DIABETOL, V53, P651, DOI 10.1007/s00592-016-0853-1; Han SI, 2011, J BIOL CHEM, V286, P10449, DOI 10.1074/jbc.M110.209510; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsuoka T, 2015, J BIOL CHEM, V290, P7647, DOI 10.1074/jbc.M114.595579; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Petersen HV, 2002, FEBS LETT, V528, P241, DOI 10.1016/S0014-5793(02)03318-5; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	49	6	6	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3524	3534		10.1074/jbc.M117.817932	http://dx.doi.org/10.1074/jbc.M117.817932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29348175	hybrid, Green Published			2022-12-28	WOS:000427030200006
J	Posey, AE; Ruff, KM; Harmon, TS; Crick, SL; Li, AM; Diamond, MI; Pappu, RV				Posey, Ammon E.; Ruff, Kiersten M.; Harmon, Tyler S.; Crick, Scott L.; Li, Aimin; Diamond, Marc I.; Pappu, Rohit V.			Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; L-PROLINE BINDING; PROTEIN AGGREGATION; POLYGLUTAMINE AGGREGATION; NEURODEGENERATIVE DISEASES; STRUCTURAL FEATURES; MUTANT HUNTINGTIN; POLYMER PHYSICS; LIQUID DROPLETS; EXON-1 PROTEIN	Huntingtin N-terminal fragments (Htt-NTFs) with expanded polyglutamine tracts form a range of neurotoxic aggregates that are associated with Huntington's disease. Here, we show that aggregation of Htt-NTFs, irrespective of polyglutamine length, yields at least three phases (designated M, S, and F) that are delineated by sharp concentration thresholds and distinct aggregate sizes and morphologies. We found that monomers and oligomers make up the soluble M phase, similar to 25-nm spheres dominate in the soluble S phase, and long, linear fibrils make up the insoluble F phase. Previous studies showed that profilin, an abundant cellular protein, reduces Htt-NTF aggregation and toxicity in cells. We confirm that profilin achieves its cellular effects through direct binding to the C-terminal proline-rich region of Htt-NTFs. We show that profilin preferentially binds to Htt-NTF M-phase species and destabilizes aggregation and phase separation by shifting the concentration boundaries for phase separation to higher values through a process known as polyphasic linkage. Our experiments, aided by coarse-grained computer simulations and theoretical analysis, suggest that preferential binding of profilin to the M-phase species of Htt-NTFs is enhanced through a combination of specific interactions between profilin and polyproline segments and auxiliary interactions between profilin and polyglutamine tracts. Polyphasic linkage may be a general strategy that cells utilize to regulate phase behavior of aggregation-prone proteins. Accordingly, detailed knowledge of phase behavior and an understanding of how ligands modulate phase boundaries may pave the way for developing new therapeutics against a variety of aggregation-prone proteins.	[Posey, Ammon E.; Ruff, Kiersten M.; Harmon, Tyler S.; Crick, Scott L.; Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Posey, Ammon E.; Ruff, Kiersten M.; Harmon, Tyler S.; Crick, Scott L.; Pappu, Rohit V.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Diamond, Marc I.] Univ Texas Southwestern Med Ctr Dallas, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Li, Aimin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63108 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Pappu, RV (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Pappu, RV (corresponding author), Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA.	pappu@wustl.edu			National Institutes of Health [R01NS056114, R01NS089932]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089932, R01NS056114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS056114 (to R. V. P.) and R01NS089932 (to M. I. D. and R. V. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Audas TE, 2016, DEV CELL, V39, P155, DOI 10.1016/j.devcel.2016.09.002; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Berchtold LA, 2011, P NATL ACAD SCI USA, V108, pE681, DOI 10.1073/pnas.1104384108; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Ciryam P, 2017, P NATL ACAD SCI USA, V114, pE3935, DOI 10.1073/pnas.1613854114; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Crook ZR, 2012, P NATL ACAD SCI USA, V109, P7487, DOI 10.1073/pnas.1204542109; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Freire E, 2009, METHOD ENZYMOL, V455, P127, DOI 10.1016/S0076-6879(08)04205-5; Fuentealba RA, 2012, HUM MOL GENET, V21, P664, DOI 10.1093/hmg/ddr500; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Garai K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822322; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; Greer SC, 2002, ANNU REV PHYS CHEM, V53, P173, DOI 10.1146/annurev.physchem.53.082301.111949; Gu XF, 2015, NEURON, V85, P726, DOI 10.1016/j.neuron.2015.01.008; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Hosp F, 2015, CELL REP, V11, P1134, DOI 10.1016/j.celrep.2015.04.030; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jacobs WM, 2017, BIOPHYS J, V112, P683, DOI 10.1016/j.bpj.2016.10.043; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Kaiser DA, 1996, J MOL BIOL, V256, P89, DOI 10.1006/jmbi.1996.0070; Kalathur Ravi Kiran Reddy, 2015, F1000Res, V4, P103, DOI 10.12688/f1000research.6358.2; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Kim WY, 2005, MOL CELL NEUROSCI, V29, P536, DOI 10.1016/j.mcn.2005.04.005; Kim YS, 2009, CURR PHARM DESIGN, V15, P637, DOI 10.2174/138161209787315648; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; Krishnamurthy V.M., 2006, FRAGMENT BASED APPRO, P11, DOI DOI 10.1002/3527608761.CH2; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056026; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu SP, 2010, INT J PEPT RES THER, V16, P199, DOI 10.1007/s10989-010-9230-z; Lundgren A, 2016, ACS NANO, V10, P9974, DOI 10.1021/acsnano.6b04160; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; O'Brien R, 2015, J BIOL CHEM, V290, P19287, DOI 10.1074/jbc.M114.623561; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Radhakrishnan A, 2012, J PHYS CHEM B, V116, P6862, DOI 10.1021/jp212637r; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Rennella E, 2017, BIOCHEMISTRY-US, V56, P692, DOI 10.1021/acs.biochem.6b01263; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Riechers SP, 2016, HUM MOL GENET, V25, P1600, DOI 10.1093/hmg/ddw036; Ripaud L, 2014, P NATL ACAD SCI USA, V111, P18219, DOI 10.1073/pnas.1421313111; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; SEDLAK M, 1992, J CHEM PHYS, V96, P826, DOI 10.1063/1.462468; SFATOS CD, 1994, PHYS REV E, V50, P2898, DOI 10.1103/PhysRevE.50.2898; SHAKHNOVICH EI, 1989, BIOPOLYMERS, V28, P1667, DOI 10.1002/bip.360281003; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shen K, 2016, ELIFE, V5, DOI 10.7554/eLife.18065; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Veldman MB, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0063-2; Vitalis A, 2009, J COMPUT CHEM, V30, P673, DOI 10.1002/jcc.21005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Warner JB, 2017, J AM CHEM SOC, V139, P14456, DOI 10.1021/jacs.7b06659; Wear MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136362; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; WYMAN J, 1980, P NATL ACAD SCI-BIOL, V77, P5239, DOI 10.1073/pnas.77.9.5239; Wyman J, 1990, BINDING LINKAGE FUNC; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zeng L, 2015, NEUROBIOL DIS, V82, P281, DOI 10.1016/j.nbd.2015.06.017; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang W, 2017, CURR OPIN STRUC BIOL, V45, P25, DOI 10.1016/j.sbi.2016.11.002	99	68	68	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3734	3746		10.1074/jbc.RA117.000357	http://dx.doi.org/10.1074/jbc.RA117.000357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358329	Green Published, hybrid			2022-12-28	WOS:000427030200026
J	Margulies, DH				Margulies, David H.			How MHC molecules grab citrullinated peptides to foster rheumatoid arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The molecular immunologist's dream is to elucidate a fundamental biochemical process that explains the basis of an affliction that affects millions of people, and that, precisely understood, might yield a rational approach to diagnosis, prevention, or therapy. In this issue of JBC, Ting et al. report proteomic, biochemical, and structural analyses that better explain how the antigen-presenting HLA-DR4 molecules bind citrullinated peptides to provoke rheumatoid arthritis (RA), a chronic autoimmune disease that affects 0.5-1% of the population.	[Margulies, David H.] NIAID, Lab Immune Syst Biol, NIH, Bldg 10,Rm 11D12,10 Ctr Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Lab Immune Syst Biol, NIH, Bldg 10,Rm 11D12,10 Ctr Dr, Bethesda, MD 20892 USA.	dhm@nih.gov	Margulies, David/W-2889-2019		NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000394, ZIAAI000622] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the NIAID, National Institutes of Health.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; PIKE RM, 1949, J IMMUNOL, V63, P447; Scally SW, 2017, ANN RHEUM DIS, V76, P1915, DOI 10.1136/annrheumdis-2017-211300; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Ting YT, 2018, J BIOL CHEM, V293, P3236, DOI 10.1074/jbc.RA117.001013	8	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3252	3253		10.1074/jbc.H118.001829	http://dx.doi.org/10.1074/jbc.H118.001829			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29500270	hybrid, Green Published			2022-12-28	WOS:000426562800018
J	Quaile, AT; Stogios, PJ; Egorova, O; Evdokinnova, E; Valleau, D; Nocek, B; Kompella, PS; Peisajovich, S; Yakunin, AF; Ensminger, AW; Savchenko, A				Quaile, Andrew T.; Stogios, Peter J.; Egorova, Olga; Evdokinnova, Elena; Valleau, Dylan; Nocek, Boguslaw; Kompella, Purnima S.; Peisajovich, Sergio; Yakunin, Alexander F.; Ensminger, Alexander W.; Savchenko, Alexei			The Legionella pneumophila effector Ceg4 is a phosphotyrosine phosphatase that attenuates activation of eukaryotic MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; CRYSTAL-STRUCTURE; PROTEIN-KINASE; SUPERFAMILY; EVOLUTIONARY; PATHOGEN; YEAST; CHRONOPHIN; EXPRESSION; PHAGOSOME	Host colonization by Gram-negative pathogens often involves delivery of bacterial proteins called "effectors" into the host cell. The pneumonia-causing pathogen Legionella pneumophila delivers more than 330 effectors into the host cell via its type IVB Dot/Icm secretion system. The collective functions of these proteins are the establishment of a replicative niche from which Legionella can recruit cellular materials to grow while evading lysosomal fusion inhibiting its growth. Using a combination of structural, biochemical, and in vivo approaches, we show that one of these translocated effector proteins, Ceg4, is a phosphotyrosine phosphatase harboring a haloacid dehalogenasehydrolase domain. Ceg4 could dephosphorylate a broad range of phosphotyrosine-containing peptides in vitro and attenuated activation of MAPK-controlled pathways in both yeast and human cells. Our findings indicate that L. pneumophila's infectious program includes manipulation of phosphorylation cascades in key host pathways. The structural and functional features of the Ceg4 effector unraveled here provide first insight into its function as a phosphotyrosine phosphatase, paving the way to further studies into L. pneumophila pathogenicity.	[Quaile, Andrew T.; Stogios, Peter J.; Egorova, Olga; Evdokinnova, Elena; Valleau, Dylan; Yakunin, Alexander F.; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Nocek, Boguslaw] Argonne Natl Lab, Struct Biol Ctr, Adv Photon Source, Lemont, IL 60439 USA; [Kompella, Purnima S.; Peisajovich, Sergio] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Ensminger, Alexander W.] Univ Toronto, Dept Biochem, Dept Mol Genet, Toronto, ON M5G 1M1, Canada; [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; University of Toronto; University of Calgary	Savchenko, A (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	alexei.savchenko@ucalgary.ca		Ensminger, Alexander/0000-0003-0824-3704; Stogios, Peter/0000-0001-8663-1425; Valleau, Dylan/0000-0002-1067-9067; Kompella, Purnima/0000-0002-7957-2727; Quaile, Andrew/0000-0002-1194-3712; Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health through the Midwest Center for Structural Genomics [GM094585]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	National Institutes of Health through the Midwest Center for Structural Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM094585 (to A. S.) through the Midwest Center for Structural Genomics. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashida H, 2017, CURR OPIN MICROBIOL, V35, P16, DOI 10.1016/j.mib.2016.11.001; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Biswas T, 2009, J BIOL CHEM, V284, P30594, DOI 10.1074/jbc.M109.012278; Brachmann CB, 1998, YEAST, V14, P115; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensminger AW, 2016, CURR OPIN MICROBIOL, V29, P74, DOI 10.1016/j.mib.2015.11.002; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12; Fortpied J, 2006, J BIOL CHEM, V281, P18378, DOI 10.1074/jbc.M513208200; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Haenssler E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00064; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Lahiri SD, 2006, BIOORG CHEM, V34, P394, DOI 10.1016/j.bioorg.2006.09.007; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lin DYW, 2012, P NATL ACAD SCI USA, V109, P1925, DOI 10.1073/pnas.1115025109; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Michard C, 2015, MBIO, V6, DOI 10.1128/mBio.00354-15; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; N'Guessan PD, 2007, AM J PHYSIOL-LUNG C, V292, pL267, DOI 10.1152/ajplung.00100.2006; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Proudfoot Michael, 2008, V426, P331, DOI 10.1007/978-1-60327-058-8_21; Quaile AT, 2015, STRUCTURE, V23, P1459, DOI 10.1016/j.str.2015.05.020; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Seifried A, 2014, J BIOL CHEM, V289, P3416, DOI 10.1074/jbc.M113.503359; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Tegtmeyer N, 2017, MOL MICROBIOL, V105, P358, DOI 10.1111/mmi.13707; Urbanus ML, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167381; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; Welsh CT, 2004, INFECT IMMUN, V72, P1512, DOI 10.1128/IAI.72.3.1512-1518.2004; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882; Zhang LL, 2016, POL J MICROBIOL, V65, P5, DOI 10.5604/17331331.1197324; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995	78	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3307	3320		10.1074/jbc.M117.812727	http://dx.doi.org/10.1074/jbc.M117.812727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29301934	Green Published, hybrid			2022-12-28	WOS:000426562800023
J	Kanack, AJ; Newsom, OJ; Scaglione, KM				Kanack, Adam J.; Newsom, Oliver J.; Scaglione, Kenneth Matthew			Most mutations that cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16) destabilize the protein quality-control E3 ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; AGGREGATION; DEGRADATION; CHAPERONES; COMPLEX; HSC70; NEURODEGENERATION; PHOSPHORYLATION; OVEREXPRESSION; IDENTIFICATION	The accumulation of misfolded proteins promotes protein aggregation and neuronal death in many neurodegenerative diseases. To counteract misfolded protein accumulation, neurons have pathways that recognize and refold or degrade aggregation-prone proteins. One U-box-containing E3 ligase, C terminus of Hsc70-interacting protein (CHIP), plays a key role in this process, targeting misfolded proteins for proteasomal degradation. CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability. Here, we systematically analyzed CHIP mutations that cause SCAR16 and found that most SCAR16 mutations destabilize CHIP. This destabilization caused mutation-specific defects in CHIP activity, including increased formation of soluble oligomers, decreased interactions with chaperones, diminished substrate ubiquitination, and reduced steady-state levels in cells. Consistent with decreased CHIP stability promoting its dysfunction in SCAR16, most mutant proteins recovered activity when the assays were performed below the mutants' melting temperature. Together, our results have uncovered the molecular basis of genetic defects in CHIP function that cause SCAR16. Our insights suggest that compounds that improve the thermostability of genetic CHIP variants may be beneficial for treating patients with SCAR16.	[Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Scaglione, KM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Scaglione, KM (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mscaglione@mcw.edu		Newsom, Oliver/0000-0002-7197-2726; Scaglione, Kenneth/0000-0002-3858-9418	National Institutes of Health [R00NS073936, R35GM119544]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; Peter G. Pentchev Research Fellowship from the National Niemann-Pick Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; Peter G. Pentchev Research Fellowship from the National Niemann-Pick Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R00NS073936 and R35GM119544 (to K. M. S.); a grant from the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin (to K. M. S.); and the Peter G. Pentchev Research Fellowship from the National Niemann-Pick Disease Foundation (to A. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Assimon VA, 2015, BIOCHEMISTRY-US, V54, P7120, DOI 10.1021/acs.biochem.5b00801; Braten O, 2012, BIOCHEM J, V444, P611, DOI 10.1042/BJ20111840; Choi YN, 2014, BIOCHEM BIOPH RES CO, V453, P192, DOI 10.1016/j.bbrc.2014.09.099; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Hayer SN, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0580-x; Heimdal K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0146-0; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nakasone N, 2014, J BIOL CHEM, V289, P19714, DOI 10.1074/jbc.M114.549915; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Synofzik M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-57; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	35	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2735	2743		10.1074/jbc.RA117.000477	http://dx.doi.org/10.1074/jbc.RA117.000477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317501	Green Published, hybrid			2022-12-28	WOS:000426051900010
J	Lach, A; Grzybek, M; Heger, E; Korycka, J; Wolny, M; Kubiak, J; Kolondra, A; Boguslawska, DM; Augoff, K; Majkowski, M; Podkalicka, J; Kaczor, J; Stefanko, A; Kuliczkowski, K; Sikorski, AF				Lach, Agnieszka; Grzybek, Michal; Heger, Elzbieta; Korycka, Justyna; Wolny, Marcin; Kubiak, Jakub; Kolondra, Adam; Boguslawska, Dzamila M.; Augoff, Katarzyna; Majkowski, Michal; Podkalicka, Joanna; Kaczor, Jakub; Stefanko, Adam; Kuliczkowski, Kazimierz; Sikorski, Aleksander F.			RETRACTION: Palmitoylation of MPP1 (membrane-palmitoylated protein 1)/p55 is crucial for lateral membrane organization in erythroid cells (Retraction of Vol 287, Pg 18974, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Sikorski, Aleksander/HGD-5159-2022	Kuliczkowski, Kazimierz/0000-0001-6812-1421; Kubiak, Jakub/0000-0002-6734-9763; Kolondra, Adam/0000-0001-5849-7185				Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981	1	0	0	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2786	2786		10.1074/jbc.W118.002209	http://dx.doi.org/10.1074/jbc.W118.002209			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29475958	Green Published, hybrid			2022-12-28	WOS:000426051900014
J	Salinas, G				Salinas, Gustavo			An isomerase completes the circuit for a redox switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRANSGLUTAMINASE 2; DISULFIDE BONDS; CELIAC-DISEASE	The activity of human transglutaminase 2 (TG2), which forms protein cross-links between glutamine and lysine residues, is controlled by an allosteric disulfide bond. However, the mechanism by which this bond is formed, like many systems regulated by oxidative cysteine modifications, was not clear. A new study from Khosla and colleagues shows that TG2 is oxidatively inactivated by the protein disulfide isomerase ERp57, providing the first example of a defined and reversible protein-controlled redox switch and pointing to new strategies to inhibit undesirable TG2 activity in pathological states.	[Salinas, Gustavo] Univ Republica, Fac Quim, Dept Biociencias, Montevideo 11800, Uruguay; [Salinas, Gustavo] Inst Pasteur Montevideo, Mataojo 2020, Montevideo 11400, Uruguay	Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Salinas, G (corresponding author), Univ Republica, Fac Quim, Dept Biociencias, Montevideo 11800, Uruguay.; Salinas, G (corresponding author), Inst Pasteur Montevideo, Mataojo 2020, Montevideo 11400, Uruguay.	gsalin@fq.edu.uy		Salinas, Gustavo/0000-0003-3350-3002				Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Plugis NM, 2017, J BIOL CHEM, V292, P2000, DOI 10.1074/jbc.M116.767988; Yi MC, 2018, J BIOL CHEM, V293, P2640, DOI 10.1074/jbc.RA117.001382	9	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2650	2651		10.1074/jbc.H118.001807	http://dx.doi.org/10.1074/jbc.H118.001807			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29475957	Green Published, hybrid			2022-12-28	WOS:000426051900002
J	Herrou, J; Czyz, DM; Fiebig, A; Willett, JW; Kim, Y; Wu, RY; Babnigg, G; Crosson, S				Herrou, Julien; Czyz, Daniel M.; Fiebig, Aretha; Willett, Jonathan W.; Kim, Youngchang; Wu, Ruiying; Babnigg, Gyorgy; Crosson, Sean			Molecular control of gene expression by Brucella BaaR, an IclR-type transcriptional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; gene regulation; fatty acid metabolism; metabolism; bacteria; adipic acid; aminocaproic acid; Brucella; caprolactone; IclR	INTRAMOLECULAR SIGNAL TRANSMISSION; EPSILON-AMINOCAPROIC ACID; ACYL-COA DEHYDROGENASES; STRESS-RESPONSE SYSTEM; SP STRAIN ADP1; STREPTOMYCES-COELICOLOR; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; AGROBACTERIUM-TUMEFACIENS; TARGETED MUTAGENESIS	The general stress response sigma factor sigma(E1) directly and indirectly regulates the transcription of dozens of genes that influence stress survival and host infection in the zoonotic pathogen Brucella abortus. Characterizing the functions of sigma(E1)-regulated genes therefore would contribute to our understanding of B. abortus physiology and infection biology. sigma(E1) indirectly activates transcription of the IclR family regulator Bab2_0215, but the function of this regulator remains undefined. Here, we present a structural and functional characterization of Bab2_0215, which we have named Brucella adipic acid-activated regulator (BaaR). We found that BaaR adopts a classic IclR-family fold and directly represses the transcription of two operons with predicted roles in carboxylic acid oxidation. BaaR binds two sites on chromosome II between baaR and a divergently transcribed hydratase/dehydrogenase (acaD2), and it represses transcription of both genes. We identified three carboxylic acids (adipic acid, tetradecanedioic acid, and E-aminocaproic acid) and a lactone (E-caprolactone) that enhance transcription from the baaR and acaD2 promoters. However, neither the activating acids nor caprolactone enhanced transcription by binding directly to BaaR. Induction of baaR transcription by adipic acid required the gene bab2_0213, which encodes a major facilitator superfamily transporter, suggesting that Bab2_0213 transports adipic acid across the inner membrane. We conclude that a suite of structurally related organic molecules activate transcription of genes repressed by BaaR. Our study provides molecular-level understanding of a gene expression program in B. abortus that is downstream of sigma(E1).	[Herrou, Julien; Czyz, Daniel M.; Willett, Jonathan W.; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Crosson, Sean] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Herrou, Julien; Czyz, Daniel M.; Fiebig, Aretha; Willett, Jonathan W.; Crosson, Sean] Univ Chicago, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Kim, Youngchang; Wu, Ruiying; Babnigg, Gyorgy] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Crosson, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Crosson, S (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.; Crosson, S (corresponding author), Univ Chicago, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022; Czyz, Daniel/GSE-1859-2022	Crosson, Sean/0000-0002-1727-322X; Fiebig, Aretha/0000-0002-0612-5029; Kim, Youngchang/0000-0002-1610-4889; Czyz, Daniel/0000-0002-7491-5292; Herrou, Julien/0000-0002-8585-8043	National Institutes of Health from NIAID [U19AI107792, R01AI107159]; National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship [F32GM109661]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI107792, R01AI107159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109661] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants U19AI107792 and R01AI107159 from NIAID (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship F32GM109661.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092920; ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Baric RS, 2016, MBIO, V7, DOI 10.1128/mBio.01245-16; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Berg J. M., 2012, BIOCHEMISTRY-US, P912; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brooks AN, 2011, WIRES SYST BIOL MED, V3, P544, DOI 10.1002/wsbm.136; Brune I, 2007, J BACTERIOL, V189, P2720, DOI 10.1128/JB.01876-06; Chao HJ, 2013, J BACTERIOL, V195, P1598, DOI 10.1128/JB.02216-12; Cooksley CM, 2012, METAB ENG, V14, P630, DOI 10.1016/j.ymben.2012.09.001; CORTAY JC, 1991, EMBO J, V10, P675, DOI 10.1002/j.1460-2075.1991.tb07996.x; Dotreppe D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-257; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Esikova TZ, 2015, MICROBIOLOGY+, V84, P726, DOI 10.1134/S0026261715050070; Fillet S, 2011, P NATL ACAD SCI USA, V108, P15372, DOI 10.1073/pnas.1018894108; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer R, 2008, MICROBIOL-SGM, V154, P3095, DOI 10.1099/mic.0.2008/016907-0; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; GERHARDT P, 1950, J BACTERIOL, V59, P777, DOI 10.1128/JB.59.6.777-782.1950; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GRIFFIN JD, 1978, SEMIN THROMB HEMOST, V5, P27; Guazzaroni MAE, 2005, J BIOL CHEM, V280, P20887, DOI 10.1074/jbc.M500783200; Gui LZ, 1996, J BACTERIOL, V178, P321, DOI 10.1128/jb.178.1.321-324.1996; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Hasegawa A, 2008, MICROBIOL-SGM, V154, P3366, DOI 10.1099/mic.0.2008/020016-0; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Herrou J, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00746-16; Herrou J, 2016, J BACTERIOL, V198, P1281, DOI 10.1128/JB.00982-15; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang H, 2000, J BACTERIOL, V182, P5521, DOI 10.1128/JB.182.19.5521-5529.2000; KATAGIRI M, 1957, J BIOL CHEM, V226, P439; Kim HS, 2014, MOL MICROBIOL, V94, P913, DOI 10.1111/mmi.12809; Kim HS, 2013, J BIOL CHEM, V288, P13906, DOI 10.1074/jbc.M113.459305; Kim JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1311-0; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; Kim SH, 2012, J BACTERIOL, V194, P6837, DOI 10.1128/JB.00695-12; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Lamontagne J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li QM, 2016, RSC ADV, V6, P54661, DOI 10.1039/c6ra07733a; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lu D, 2010, GENE DEV, V24, P2556, DOI 10.1101/gad.603510; Lu Y, 2011, J BACTERIOL, V193, P6674, DOI 10.1128/JB.05714-11; MARES F, 1978, IND ENG CHEM PROC DD, V17, P9, DOI 10.1021/i260065a003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Molina-Santiago C, 2014, J BACTERIOL, V196, P588, DOI 10.1128/JB.00589-13; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson D. L., 2013, LEHNINGER PRINCIPLES, P650; Nomura K, 1998, P NATL ACAD SCI USA, V95, P14034, DOI 10.1073/pnas.95.24.14034; Pan Y, 2013, MICROBIOL-SGM, V159, P814, DOI 10.1099/mic.0.065680-0; PARALES RE, 1993, J BACTERIOL, V175, P5829, DOI 10.1128/JB.175.18.5829-5838.1993; Parke D, 2001, APPL ENVIRON MICROB, V67, P4817, DOI 10.1128/AEM.67.10.4817-4827.2001; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; Rowe SE, 2016, METHODS MOL BIOL, V1373, P155, DOI 10.1007/7651_2015_277; Santamarta I, 2007, MOL MICROBIOL, V66, P511, DOI 10.1111/j.1365-2958.2007.05937.x; Shimizu T, 2014, MICROBIOL-SGM, V160, P623, DOI 10.1099/mic.0.074286-0; Sisson AL, 2013, POLYMER, V54, P4333, DOI 10.1016/j.polymer.2013.04.045; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Stuani L, 2014, METABOLOMICS, V10, P1223, DOI 10.1007/s11306-014-0662-x; Sycz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124058; Teran W, 2007, MOL MICROBIOL, V66, P1416, DOI 10.1111/j.1365-2958.2007.06004.x; Traag BA, 2004, MOL MICROBIOL, V53, P985, DOI 10.1111/j.1365-2958.2004.04186.x; Trautwein G, 2001, J BACTERIOL, V183, P873, DOI 10.1128/JB.183.3.873-881.2001; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Vesely M, 2007, APPL MICROBIOL BIOT, V76, P159, DOI 10.1007/s00253-007-0997-6; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Willett JW, 2016, VACCINE, V34, P5073, DOI 10.1016/j.vaccine.2016.08.076; Williams PA, 1997, J BACTERIOL, V179, P5935, DOI 10.1128/jb.179.18.5935-5942.1997; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Yang YH, 2009, APPL MICROBIOL BIOT, V82, P501, DOI 10.1007/s00253-008-1802-x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200; Zhou YX, 2012, CELL SIGNAL, V24, P1270, DOI 10.1016/j.cellsig.2012.02.008	85	3	3	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7437	7456		10.1074/jbc.RA118.002045	http://dx.doi.org/10.1074/jbc.RA118.002045			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567835	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000432174500035
J	Li, X; Shang, EC; Dong, Q; Li, YF; Zhang, J; Xu, SH; Zhao, ZD; Shao, W; Lv, C; Zheng, Y; Wang, HL; Lei, XG; Zhu, B; Zhang, ZQ				Li, Xiang; Shang, Erchang; Dong, Qiang; Li, Yingfeng; Zhang, Jing; Xu, Shaohua; Zhao, Zuodong; Shao, Wei; Lv, Cong; Zheng, Yong; Wang, Hailin; Lei, Xiaoguang; Zhu, Bing; Zhang, Zhuqiang			Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methylation; high-throughput screening (HTS); p38; mitogen-activated protein kinase (MAPK); gene regulation; gene activation	HISTONE DEACETYLASE INHIBITION; NECROSIS-FACTOR-ALPHA; MAP KINASE; CYCLIC-AMP; BINDING PROTEIN; SILENCED GENES; IDENTIFICATION; PROMOTER; DEMETHYLATION; EXPRESSION	Regulation of gene expression by epigenetic modifications such as DNA methylation is crucial for developmental and disease processes, including cell differentiation and cancer development. Genes repressed by DNA methylation can be derepressed by various compounds that target DNA methyltransferases, histone deacetylases, and other regulatory factors. However, some additional, unknown mechanisms that promote DNA methylation-mediated gene silencing may exist. Chemical agents that can counteract the effects of epigenetic repression that is not regulated by DNA methyltransferases or histone deacetylases therefore may be of research interest. Here, we report the results of a high-throughput screen using a 308,251-member chemical library to identify potent small molecules that derepress an EGFP reporter gene silenced by DNA methylation. Seven hit compounds were identified that did not directly target bulk DNA methylation or histone acetylation. Analyzing the effect of these compounds on endogenous gene expression, we discovered that three of these compounds (compounds LX-3, LX-4, and LX-5) selectively activate the p38 mitogen-activated protein kinase (MAPK) pathway and derepress a subset of endogenous genes repressed by DNA methylation. Selective agonists of the p38 pathway have been lacking, and our study now provides critical compounds for studying this pathway and p38 MAPK-targeted genes repressed by DNA methylation.	[Li, Xiang; Zhu, Bing] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Li, Xiang; Dong, Qiang; Li, Yingfeng; Zhao, Zuodong; Zheng, Yong; Zhu, Bing; Zhang, Zhuqiang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Li, Xiang; Dong, Qiang; Li, Yingfeng; Zhang, Jing; Xu, Shaohua; Zhao, Zuodong; Shao, Wei] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Shang, Erchang; Zhang, Jing; Lei, Xiaoguang] Peking Univ, Synthet & Funct Biomol Ctr, Key Lab Bioorgan Chem & Mol Engn,Minist Educ, Coll Chem & Mol Engn,Dept Chem Biol,Beijing Natl, Beijing 100871, Peoples R China; [Shang, Erchang; Zhang, Jing; Lei, Xiaoguang] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Li, Yingfeng] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Lv, Cong; Wang, Hailin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Zhu, Bing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Peking University; Peking University; Beijing Normal University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, B (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China.; Zhu, B; Zhang, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhu, B (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	zhubing@ibp.ac.cn; zhangzhuqiang@ibp.ac.cn	Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854	China Natural Science Foundation [31571344, 31521002, 31425013, 31730047, 31530037]; Chinese Ministry of Science and Technology [2015CB856200, 2016YFA0100400]; Strategic Priority Research Program [XDB08010103]; Youth Innovation Promotion Association Grant of the Chinese Academy of Sciences [2017133]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Strategic Priority Research Program(Chinese Academy of Sciences); Youth Innovation Promotion Association Grant of the Chinese Academy of Sciences	This work was primarily supported by China Natural Science Foundation Grant 31571344 (to Z. Z.). This work was also supported by China Natural Science Foundation Grants 31521002, 31425013, 31730047, and 31530037 (to B. Z.); Chinese Ministry of Science and Technology Grants 2015CB856200 and 2016YFA0100400 (to B. Z.); Strategic Priority Research Program Grant XDB08010103 (to B. Z.); and Youth Innovation Promotion Association Grant 2017133 (to Z. Z.) of the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Allis C. D., 2007, EPIGENETICS, P341; Benjamin D, 2001, NUCLEIC ACIDS RES, V29, P3603, DOI 10.1093/nar/29.17.3603; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Campion J, 2009, OBESITY, V17, P1293, DOI 10.1038/oby.2008.679; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Cano E, 1996, ONCOGENE, V12, P805; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dong T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7522; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fernandez J. M., 1998, GENE EXPRESSION SYST, P211; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kong HK, 2012, J BIOL CHEM, V287, P38889, DOI 10.1074/jbc.M112.394270; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li DR, 2016, CELL CHEM BIOL, V23, P257, DOI 10.1016/j.chembiol.2015.08.018; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Lynch Catherine A, 2002, Mol Cancer, V1, P2, DOI 10.1186/1476-4598-1-2; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Phong MS, 2010, MOL CELL BIOL, V30, P3816, DOI 10.1128/MCB.00949-09; Pieper HC, 2008, NEUROBIOL DIS, V32, P521, DOI 10.1016/j.nbd.2008.09.010; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tierney RJ, 2000, J VIROL, V74, P10468, DOI 10.1128/JVI.74.22.10468-10479.2000; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Widschwendter M, 2004, CANCER RES, V64, P4472, DOI 10.1158/0008-5472.CAN-04-0238; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xiong J, 2016, MOL CELL, V64, P913, DOI 10.1016/j.molcel.2016.10.013; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zer C, 2007, PHYSIOL GENOMICS, V31, P343, DOI 10.1152/physiolgenomics.00080.2007; Zhang C, 1997, J BIOL CHEM, V272, P13397, DOI 10.1074/jbc.272.20.13397; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090	84	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7423	7436		10.1074/jbc.RA117.000757	http://dx.doi.org/10.1074/jbc.RA117.000757			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29559556	hybrid, Green Published			2022-12-28	WOS:000432174500034
J	Chicco, AJ; Le, CH; Gnaiger, E; Dreyer, HC; Muyskens, JB; D'Alessandro, A; Nemkov, T; Hocker, AD; Prenni, JE; Wolfe, LM; Sindt, NM; Lovering, AT; Subudhi, AW; Roach, RC				Chicco, Adam J.; Le, Catherine H.; Gnaiger, Erich; Dreyer, Hans C.; Muyskens, Jonathan B.; D'Alessandro, Angelo; Nemkov, Travis; Hocker, Austin D.; Prenni, Jessica E.; Wolfe, Lisa M.; Sindt, Nathan M.; Lovering, Andrew T.; Subudhi, Andrew W.; Roach, Robert C.			Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: Lessons from AltitudeOmics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; bioenergetics; hypoxia; fatty acid oxidation; anaplerosis; glycolysis; one-carbon metabolism; oxidation-reduction (redox); beta-oxidation	OBSTRUCTIVE PULMONARY-DISEASE; PURINE NUCLEOTIDE CYCLE; AMINO-ACID-METABOLISM; AMP DEAMINATION; BETA-OXIDATION; HEART-FAILURE; WEIGHT-LOSS; ACCLIMATIZATION; EXERCISE; ADAPTATION	Metabolic responses to hypoxia play important roles in cell survival strategies and disease pathogenesis in humans. However, the homeostatic adjustments that balance changes in energy supply and demand to maintain organismal function under chronic low oxygen conditions remain incompletely understood, making it difficult to distinguish adaptive from maladaptive responses in hypoxia-related pathologies. We integrated metabolomic and proteomic profiling with mitochondrial respirometry and blood gas analyses to comprehensively define the physiological responses of skeletal muscle energy metabolism to 16 days of high-altitude hypoxia (5260 m) in healthy volunteers from the AltitudeOmics project. In contrast to the view that hypoxia down-regulates aerobic metabolism, results show that mitochondria play a central role in muscle hypoxia adaptation by supporting higher resting phosphorylation potential and enhancing the efficiency of long-chain acylcarnitine oxidation. This directs increases in muscle glucose toward pentose phosphate and one-carbon metabolism pathways that support cytosolic redox balance and help mitigate the effects of increased protein and purine nucleotide catabolism in hypoxia. Muscle accumulation of free amino acids favor these adjustments by coordinating cytosolic and mitochondrial pathways to rid the cell of excess nitrogen, but might ultimately limit muscle oxidative capacity in vivo. Collectively, these studies illustrate how an integration of aerobic and anaerobic metabolism is required for physiological hypoxia adaptation in skeletal muscle, and highlight protein catabolism and allosteric regulation as unexpected orchestrators of metabolic remodeling in this context. These findings have important implications for the management of hypoxia-related diseases and other conditions associated with chronic catabolic stress.	[Chicco, Adam J.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Chicco, Adam J.; Le, Catherine H.] Colorado State Univ, Dept Cell & Mol Biol, Ft Collins, CO 80523 USA; [Prenni, Jessica E.; Wolfe, Lisa M.; Sindt, Nathan M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Subudhi, Andrew W.] Univ Colorado, Dept Biol, Colorado Springs, CO 80918 USA; [Gnaiger, Erich] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Dreyer, Hans C.; Muyskens, Jonathan B.; Hocker, Austin D.; Lovering, Andrew T.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [D'Alessandro, Angelo; Nemkov, Travis] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO 80045 USA; [Roach, Robert C.] Univ Colorado, Altitude Res Ctr, Anschutz Med Campus, Aurora, CO 80045 USA	Colorado State University; Colorado State University; Colorado State University; University of Colorado System; University of Colorado at Colorado Springs; Medical University of Innsbruck; University of Oregon; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Chicco, AJ (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.; Chicco, AJ (corresponding author), Colorado State Univ, Dept Cell & Mol Biol, Ft Collins, CO 80523 USA.	adam.chicco@colostate.edu	Lovering, Andrew/AAV-4419-2021; D'Alessandro, Angelo/AAA-4695-2019; Roach, Robert/F-4729-2011	Lovering, Andrew/0000-0001-7826-4290; D'Alessandro, Angelo/0000-0002-2258-6490; Subudhi, Andrew/0000-0001-9719-7660; Gnaiger, Erich/0000-0003-3647-5895; Roach, Robert/0000-0002-7998-8976; Hocker, Austin/0000-0002-2941-2581	U.S. Department of Defense [W81XWH-11-2-0040 TATRC, W81XWH-10-2-0114]; National Institutes of Health NICHID Grant [K01HD057332]; National Institutes of Health, NHLBI [T32 HL007171]; Oroboros Instruments, Innsbruck, Austria; Mitochondrial Physiology Laboratory at Colorado State University; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Medicine, University of Colorado, Denver; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD057332] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007171] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); National Institutes of Health NICHID Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Oroboros Instruments, Innsbruck, Austria; Mitochondrial Physiology Laboratory at Colorado State University; Altitude Research Center; Charles S. Houston Endowed Professorship, Department of Medicine, University of Colorado, Denver; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. Department of Defense Grants W81XWH-11-2-0040 TATRC (to R.C.R.), W81XWH-10-2-0114 (to A.T.L.), National Institutes of Health NICHID Grant K01HD057332 (to H.C.D.), Grant T32 HL007171 from the National Institutes of Health, NHLBI (to T.N.), Oroboros Instruments, Innsbruck, Austria, the Mitochondrial Physiology Laboratory at Colorado State University, the Altitude Research Center, and the Charles S. Houston Endowed Professorship, Department of Medicine, University of Colorado, Denver. E. G. is Chief Executive Officer of Oroboros Instruments, Innsbruck, Austria. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; Arinze IJ, 2005, BIOCHEM MOL BIOL EDU, V33, P165, DOI 10.1002/bmb.2005.494033032469; BENDER PR, 1989, J APPL PHYSIOL, V66, P2733, DOI 10.1152/jappl.1989.66.6.2733; BOYER SJ, 1984, J APPL PHYSIOL, V57, P1580, DOI 10.1152/jappl.1984.57.5.1580; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR304, DOI 10.1152/ajpregu.00156.2002; Calbet JAL, 2009, HIGH ALT MED BIOL, V10, P123, DOI 10.1089/ham.2008.1099; Cerretelli P, 2009, HIGH ALT MED BIOL, V10, P165, DOI 10.1089/ham.2008.1096; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheviron ZA, 2012, P NATL ACAD SCI USA, V109, P8635, DOI 10.1073/pnas.1120523109; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Delample D, 2008, FREE RADICAL RES, V42, P807, DOI 10.1080/10715760802429039; Doehner W, 2014, J AM COLL CARDIOL, V64, P1388, DOI 10.1016/j.jacc.2014.04.083; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gelfi C, 2004, FASEB J, V18, P612, DOI 10.1096/fj.03-1077fje; GOODMAN MN, 1977, J BIOL CHEM, V252, P5054; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gosker HR, 2000, AM J CLIN NUTR, V71, P1033; Graham TE, 1998, MED SCI SPORT EXER, V30, P34, DOI 10.1097/00005768-199801000-00006; GREEN HJ, 1992, J APPL PHYSIOL, V73, P2701, DOI 10.1152/jappl.1992.73.6.2701; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; Hocker AD, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.52; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Horscroft JA, 2017, P NATL ACAD SCI USA, V114, P6382, DOI 10.1073/pnas.1700527114; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Jacobs RA, 2016, J PHYSIOL-LONDON, V594, P1151, DOI 10.1113/JP271118; Jacobs RA, 2012, FASEB J, V26, P5192, DOI 10.1096/fj.12-218206; KAYSER B, 1991, J APPL PHYSIOL, V70, P1938, DOI 10.1152/jappl.1991.70.5.1938; Kayser B, 1996, J APPL PHYSIOL, V81, P419, DOI 10.1152/jappl.1996.81.1.419; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Korzeniewski B, 2006, J BIOL CHEM, V281, P3057, DOI 10.1074/jbc.M510418200; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Levett DZH, 2015, PROTEOMICS, V15, P160, DOI 10.1002/pmic.201400306; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lundby C, 2004, J EXP BIOL, V207, P3865, DOI 10.1242/jeb.01225; Maher AC, 2010, MOL GENET METAB, V100, P163, DOI 10.1016/j.ymgme.2010.03.011; Marin T. L., SCI SIGNAL, V10; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; Martin DS, 2010, EXP PHYSIOL, V95, P463, DOI 10.1113/expphysiol.2009.047589; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murray AJ, 2016, J PHYSIOL-LONDON, V594, P1137, DOI 10.1113/JP270079; Murray AJ, 2014, BIOESSAYS, V36, P721, DOI 10.1002/bies.201400042; NADA MA, 1995, J BIOL CHEM, V270, P530, DOI 10.1074/jbc.270.2.530; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pouw EM, 1998, AM J RESP CRIT CARE, V157, P453, DOI 10.1164/ajrccm.157.2.9608064; Puente-Maestu L, 2013, J APPL PHYSIOL, V114, P1282, DOI 10.1152/japplphysiol.00815.2012; Roberts AC, 1996, J APPL PHYSIOL, V81, P1762, DOI 10.1152/jappl.1996.81.4.1762; SAHLIN K, 1990, INT J SPORTS MED, V11, pS62, DOI 10.1055/s-2007-1024856; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza Gregg L, 2007, Sci STKE, V2007, pcm8, DOI 10.1126/stke.4072007cm8; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P527, DOI 10.1007/s10545-010-9090-x; Subudhi AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092191; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; TARONI F, 1988, INT J BIOCHEM, V20, P857, DOI 10.1016/0020-711X(88)90075-4; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012; Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; WELBOURNE TC, 1987, AM J PHYSIOL, V253, pF1069, DOI 10.1152/ajprenal.1987.253.6.F1069; Wu J, 2015, J MOL CELL CARDIOL, V82, P194, DOI 10.1016/j.yjmcc.2015.01.014; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; YOUNG AJ, 1982, J APPL PHYSIOL, V52, P857, DOI 10.1152/jappl.1982.52.4.857; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	79	37	38	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6659	6671		10.1074/jbc.RA117.000470	http://dx.doi.org/10.1074/jbc.RA117.000470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540485	Green Published, hybrid			2022-12-28	WOS:000431487300003
J	Inoue, H; Shirakawa, J; Togashi, Y; Tajima, K; Okuyama, T; Kyohara, M; Tanaka, Y; Orime, K; Saisho, Y; Yamada, T; Shibue, K; Kulkarni, RN; Terauchi, Y				Inoue, Hideaki; Shirakawa, Jun; Togashi, Yu; Tajima, Kazuki; Okuyama, Tomoko; Kyohara, Mayu; Tanaka, Yui; Orime, Kazuki; Saisho, Yoshifumi; Yamada, Taketo; Shibue, Kimitaka; Kulkarni, Rohit N.; Terauchi, Yasuo			Signaling between pancreatic beta cells and macrophages via S100 calcium-binding protein A8 exacerbates beta-cell apoptosis and islet inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GLUCOKINASE ACTIVATION; GLYCEMIC CONTROL; EXPRESSION; STRESS; CHEMOATTRACTANTS; PROLIFERATION; IL-1-BETA; INHIBITOR; MONOCYTES	Chronic low-grade inflammation in the pancreatic islets is observed in individuals with type 2 diabetes, and macrophage levels are elevated in the islets of these individuals. However, the molecular mechanisms underlying the interactions between the pancreatic beta cells and macrophages and their involvement in inflammation are not fully understood. Here, we investigated the role of S100 calcium-binding protein A8 (S100A8), a member of the damage-associated molecular pattern molecules (DAMPs), in beta-cell inflammation. Co-cultivation of pancreatic islets with unstimulated peritoneal macrophages in the presence of palmitate (to induce lipotoxicity) and high glucose (to induce glucotoxicity) synergistically increased the expression and release of islet-produced S100A8 in a Toll-like receptor 4 (TLR4)-independent manner. Consistently, a significant increase in the expression of the S100a8 gene was observed in the islets of diabetic db/db mice. Furthermore, the islet-derived S100A8 induced TLR4-mediated inflammatory cytokine production by migrating macrophages. When human islet cells were co-cultured with U937 human monocyte cells, the palmitate treatment up-regulated S100A8 expression. This S100A8-mediated interaction between islets and macrophages evoked beta-cell apoptosis, which was ameliorated by TLR4 inhibition in the macrophages or S100A8 neutralization in the pancreatic islets. Of note, both glucotoxicity and lipotoxicity triggered S100A8 secretion from the pancreatic islets, which in turn promoted macrophage infiltration of the islets. Taken together, a positive feedback loop between islet-derived S100A8 and macrophages drives beta-cell apoptosis and pancreatic islet inflammation. We conclude that developing therapeutic approaches to inhibit S100A8 may serve to prevent beta-cellloss in patients with diabetes.	[Inoue, Hideaki; Shirakawa, Jun; Togashi, Yu; Tajima, Kazuki; Okuyama, Tomoko; Kyohara, Mayu; Tanaka, Yui; Orime, Kazuki; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan; [Saisho, Yoshifumi] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1088345, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 1088345, Japan; [Orime, Kazuki; Shibue, Kimitaka; Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Brigham & Womens Hosp,Dept Med, Sect Islet Cell & Regenerat Biol,Joslin Diabet Ct, Boston, MA 02138 USA	Yokohama City University; Keio University; Keio University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Shirakawa, J; Terauchi, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	jshira-tky@umin.ac.jp; terauchi-tky@umin.ac.jp	Terauchi, Yasuo/AAO-4347-2020; Saisho, Yoshifumi/H-2925-2019	Saisho, Yoshifumi/0000-0002-6071-4393; Shirakawa, Jun/0000-0002-0822-8750	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [16H05329]; Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd.(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant-in-Aid for Scientific Research (B) 16H05329 (to Y. Terauchi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a grant-in-aid from the Japan Foundation for Applied Enzymology (to J. S.), and a Junior Scientist Development Grant supported by Novo Nordisk Pharma Ltd. (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Basso D, 2011, J CELL PHYSIOL, V226, P456, DOI 10.1002/jcp.22355; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Bouma G, 2004, DIABETES, V53, P1979, DOI 10.2337/diabetes.53.8.1979; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burkhardt K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-10; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ikemoto M, 2007, ANN CLIN BIOCHEM, V44, P570, DOI 10.1258/000456307782268156; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Oh YS, 2014, EUR J PHARM SCI, V51, P137, DOI 10.1016/j.ejps.2013.09.005; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Roma LP, 2015, AM J PHYSIOL-ENDOC M, V309, pE632, DOI 10.1152/ajpendo.00154.2015; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Shirakawa J, 2017, CELL METAB, V25, P868, DOI 10.1016/j.cmet.2017.02.004; Shirakawa J, 2014, ENDOCRINOLOGY, V155, P2102, DOI 10.1210/en.2013-2032; Shirakawa J, 2013, DIABETES, V62, P3448, DOI 10.2337/db13-0052; Shirakawa J, 2011, J BIOL CHEM, V286, P25467, DOI 10.1074/jbc.M110.217216; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu YX, 2011, BIOCHEM BIOPH RES CO, V404, P159, DOI 10.1016/j.bbrc.2010.11.085	46	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5934	5946		10.1074/jbc.M117.809228	http://dx.doi.org/10.1074/jbc.M117.809228			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496993	hybrid, Green Published			2022-12-28	WOS:000430497300015
J	Dennison, C; David, S; Lee, J				Dennison, Christopher; David, Sholto; Lee, Jaeick			Bacterial copper storage proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR COPPER; CLUSTER FORMATION; CRYSTAL-STRUCTURE; SIGNAL PEPTIDES; METHANE; METAL; METHANOBACTIN	Copper is essential for most organisms as a cofactor for key enzymes involved in fundamental processes such as respiration and photosynthesis. However, copper also has toxic effects in cells, which is why eukaryotes and prokaryotes have evolved mechanisms for safe copper handling. A new family of bacterial proteins uses a Cys-rich four-helix bundle to safely store large quantities of Cu(I). The work leading to the discovery of these proteins, their properties and physiological functions, and how their presence potentially impacts the current views of bacterial copper handling and use are discussed in this review.	[Dennison, Christopher; David, Sholto; Lee, Jaeick] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Dennison, C (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	christopher.dennison@ncl.ac.uk		david, sholto/0000-0003-1619-0278; Dennison, Christopher/0000-0001-8665-052X	Natural Environment Research Council [NE/F00608X/1]; Biotechnology and Biological Sciences Research Council [BB/K008439/1]; Newcastle University; Biotechnology and Biological Sciences Research Council [1668110] Funding Source: researchfish; BBSRC [BB/K008439/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Environment Research Council Grant NE/F00608X/1, Biotechnology and Biological Sciences Research Council Grant BB/K008439/1, a studentship (to S. D.), and by Newcastle University. This is the second article in the Thematic Minireview series "Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes." The authors declare that they have no conflicts of interest with the contents of this article.	Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Badarau A, 2011, P NATL ACAD SCI USA, V108, P13007, DOI 10.1073/pnas.1101448108; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Banci L, 2001, BIOCHEMISTRY-US, V40, P15660, DOI 10.1021/bi0112715; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Basle A., 2018, CHEMISTRY IN PRESS; Basle A, 2017, ANGEW CHEM INT EDIT, V56, P8697, DOI 10.1002/anie.201703107; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Brantner CA, 2002, ARCH MICROBIOL, V178, P59, DOI 10.1007/s00203-002-0426-2; Brantner CA, 2000, CURR MICROBIOL, V40, P132, DOI 10.1007/s002849910026; Calderone V, 2005, P NATL ACAD SCI USA, V102, P51, DOI 10.1073/pnas.0408254101; Cao LL, 2018, ANGEW CHEM INT EDIT, V57, P162, DOI 10.1002/anie.201708977; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Darwin KH, 2015, J BIOL CHEM, V290, P18962, DOI 10.1074/jbc.R115.640193; Dassama LMK, 2017, METALLOMICS, V9, P7, DOI 10.1039/c6mt00208k; Dassama LMK, 2016, P NATL ACAD SCI USA, V113, P13027, DOI 10.1073/pnas.1603578113; DAVIES SL, 1970, J GEN MICROBIOL, V61, P227, DOI 10.1099/00221287-61-2-227; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; DiSpirito AA, 2016, MICROBIOL MOL BIOL R, V80, P387, DOI 10.1128/MMBR.00058-15; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Dwarakanath S, 2012, J BIOL CHEM, V287, P17833, DOI 10.1074/jbc.M112.352740; Ekici S, 2014, MBIO, V5, DOI 10.1128/mBio.01055-13; El Ghazouani A, 2012, P NATL ACAD SCI USA, V109, P8400, DOI 10.1073/pnas.1112921109; El Ghazouani A, 2011, INORG CHEM, V50, P1378, DOI 10.1021/ic101965j; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fu Y, 2014, ACCOUNTS CHEM RES, V47, P3605, DOI 10.1021/ar500300n; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; GREEN AR, 1994, INORG CHEM, V33, P4159, DOI 10.1021/ic00096a046; Gu WY, 2017, APPL MICROBIOL BIOT, V101, P8499, DOI 10.1007/s00253-017-8572-2; Gu WY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02619-16; Gu WY, 2016, APPL ENVIRON MICROB, V82, P1917, DOI 10.1128/AEM.03884-15; Han DF, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00866-17; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kalyuzhnaya MG, 2015, METAB ENG, V29, P142, DOI 10.1016/j.ymben.2015.03.010; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Koh EI, 2015, J BIOL CHEM, V290, P18967, DOI 10.1074/jbc.R115.644328; Krentz BD, 2010, BIOCHEMISTRY-US, V49, P10117, DOI 10.1021/bi1014375; Ladomersky E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00351-17; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lombardi A, 2015, NAT CHEM BIOL, V11, P760, DOI 10.1038/nchembio.1918; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Meydan S, 2017, MOL CELL, V65, P207, DOI 10.1016/j.molcel.2016.12.008; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nies DH, 2013, MOL MICROBIOL, V87, P447, DOI 10.1111/mmi.12123; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2013, J BACTERIOL, V195, P4553, DOI 10.1128/JB.00891-13; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quintana J, 2017, J BIOL CHEM, V292, P15691, DOI 10.1074/jbc.M117.804492; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Semrau JD, 2013, ENVIRON MICROBIOL, V15, P3077, DOI 10.1111/1462-2920.12150; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Stolle P, 2016, J BIOL CHEM, V291, P13520, DOI 10.1074/jbc.M116.729103; Straw ML, 2018, METALLOMICS, V10, P180, DOI 10.1039/c7mt00299h; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Vita N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39065; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Volpicella M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08934-7; Waldron KJ, 2010, J BIOL CHEM, V285, P32504, DOI 10.1074/jbc.M110.153080; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zhou L, 2008, BIOCHEM J, V413, P459, DOI 10.1042/BJ20080467	100	29	30	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4616	4627		10.1074/jbc.TM117.000180	http://dx.doi.org/10.1074/jbc.TM117.000180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414794	hybrid, Green Published			2022-12-28	WOS:000428848300004
J	Garg, A; Sanchez, AM; Shuman, S; Schwer, B				Garg, Angad; Sanchez, Ana M.; Shuman, Stewart; Schwer, Beate			A long noncoding (lnc)RNA governs expression of the phosphate transporter Pho84 in fission yeast and has cascading effects on the flanking prt lncRNA and pho1 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CTD CODE; TRANSCRIPTION; SITES; TERMINATION; PROTEOME; PATHWAY; EXOSOME	The expression of the phosphate transporter Pho84 in fission yeast Schizosaccharomyces pombe is repressed in phosphate-rich medium and induced during phosphate starvation. Two other phosphate-responsive genes in S. pombe (pho1 and tgp1) had been shown to be repressed in cis by transcription of a long noncoding (lnc) RNA from the upstream flanking gene, but whether pho84 expression is regulated in this manner is unclear. Here, we show that repression of pho84 is enforced by transcription of the SPBC8E4.02c locus upstream of pho84 to produce a lncRNA that we name prt2 (pho-repressive transcript 2). We identify two essential elements of the prt2 promoter, a HomolD box and a TATA box, mutations of which inactivate the prt2 promoter and de-repress the downstream pho84 promoter under phosphate-replete conditions. We find that prt2 promoter inactivation also elicits a cascade effect on the adjacent downstream prt (lncRNA) and pho1 (acid phosphatase) genes, whereby increased pho84 transcription down-regulates prt lncRNA transcription and thereby de-represses pho1. Our results establish a unified model for the repressive arm of fission yeast phosphate homeostasis, in which transcription of prt2, prt, and nc-tgp1 lncRNAs interferes with the promoters of the flanking pho84, pho1, and tgp1 genes, respectively.	[Garg, Angad; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA; [Sanchez, Ana M.; Schwer, Beate] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Shuman, S (corresponding author), Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA.; Schwer, B (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org; bschwer@med.cornell.edu	Garg, Angad/ABI-4903-2020	Garg, Angad/0000-0003-4494-6386; Sanchez, Ana/0000-0002-9119-7624; Schwer, Beate/0000-0002-3824-9819	National Institutes of Health [GM52470]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM52470 (to S.S. and B.S.).	Ard R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6576; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Carter-O'Connell I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-697; Chalamcharla VR, 2015, P NATL ACAD SCI USA, V112, P15548, DOI 10.1073/pnas.1522127112; Chatterjee D, 2016, RNA, V22, P1011, DOI 10.1261/rna.056515.116; Estill M, 2015, CURR GENET, V61, P175, DOI 10.1007/s00294-014-0466-6; Gross T, 1998, NUCLEIC ACIDS RES, V26, P3319, DOI 10.1093/nar/26.14.3319; Gunaratne J, 2013, MOL CELL PROTEOMICS, V12, P1741, DOI 10.1074/mcp.M112.023754; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Loya T. J., 2016, F1000RES, V5, P25; Mata J, 2013, RNA BIOL, V10, P1407, DOI 10.4161/rna.25758; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sanchez AM, 2018, RNA, V24, P237, DOI 10.1261/rna.063966.117; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Schwer B, 2017, MBIO, V8, DOI 10.1128/mBio.01218-17; Schwer B, 2015, RNA, V21, P1770, DOI 10.1261/rna.052555.115; Schwer B, 2014, P NATL ACAD SCI USA, V111, P4185, DOI 10.1073/pnas.1321842111; Schwer B, 2012, P NATL ACAD SCI USA, V109, P18024, DOI 10.1073/pnas.1208995109; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; Touat-Todeschini L, 2017, EMBO J, V36, P2626, DOI 10.15252/embj.201796571; WITT I, 1993, EMBO J, V12, P1201, DOI 10.1002/j.1460-2075.1993.tb05761.x; WITT I, 1995, NUCLEIC ACIDS RES, V23, P4296, DOI 10.1093/nar/23.21.4296	27	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4456	4467		10.1074/jbc.RA117.001352	http://dx.doi.org/10.1074/jbc.RA117.001352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414789	Green Published, hybrid			2022-12-28	WOS:000428204300017
J	Estrada, DF				Estrada, D. Fernando			The cytochrome P450 24A1 interaction with adrenodoxin relies on multiple recognition sites that vary among species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENODOXIN; ELECTRON-TRANSFER; STRUCTURAL BASIS; BINDING; MUTATIONS; CYP24A1; FERREDOXIN; REDUCTASE; DOMAIN; 17A1	Mitochondrial cytochromes P450 (P450s) are responsible for important metabolic reactions, including steps involved in steroid and vitamin D metabolism. The mitochondrial P450 24A1 (CYP24A1) is responsible for deactivation of the bioactive form of vitamin D, 1,25(OH) 2D3. Its function relies on formation of a P450-redox partner complex with the ferredoxin and electron donor adrenodoxin (Adx). However, very little is known about how the Adx-CYP24A1 complex forms. In this study, we report the results of solution NMR in which we monitor isotopically labeled full-length Adx as it binds CYP24A1 in complex with the P450 inhibitor clotrimazole. The NMR titration data suggested a mode for P450-Adx interactions in which formation of the complex relies on contributions from multiple recognition sites on the Adx core domain, some of which have not previously been reported. To evaluate differences among CYP24A1-Adx complexes from different mammalian species and displaying distinct regioselectivity for 1,25(OH) (D)3, all bound spectra were acquired in parallel for human (carbon-23 and -24 hydroxylase), rat (carbon-24 hydroxylase), and opossum (carbon-23 hydroxylase) CYP24A1 isoforms. Binding data from a series of single and double charge-neutralizing substitutions of Adx confirmed that species-specific CYP24A1 isoforms differ in binding to Adx, providing evidence that variations in redox partner interactions correlate with P450 regioselectivity. In summary, these findings reveal that CYP24A1-Adx interactions rely on several recognition sites and that variations in CYP24A1 isoforms modulate formation of the complex, thus providing insight into the variable and complex nature of mitochondrial P450-Adx interactions.	[Estrada, D. Fernando] Univ Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 3435 Main St, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Estrada, DF (corresponding author), Univ Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 3435 Main St, Buffalo, NY 14214 USA.	dfestrad@buffalo.edu			National Institutes of Health [R00 GM112862]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM112862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R00 GM112862 (to D. F. E.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Annalora A, 2004, ARCH BIOCHEM BIOPHYS, V425, P133, DOI 10.1016/j.abb.2004.01.025; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Behlke J, 2007, BIOPHYS CHEM, V125, P159, DOI 10.1016/j.bpc.2006.07.011; Beilke D, 2002, BIOCHEMISTRY-US, V41, P7969, DOI 10.1021/bi0160361; Bureik M, 2005, BIOCHEMISTRY-US, V44, P3821, DOI 10.1021/bi047697b; CHEN KS, 1993, P NATL ACAD SCI USA, V90, P4543, DOI 10.1073/pnas.90.10.4543; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; COGHLAN VM, 1992, J BIOL CHEM, V267, P8932; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Hartfield KA, 2013, J STEROID BIOCHEM, V136, P47, DOI 10.1016/j.jsbmb.2012.11.001; Heinz A, 2005, BIOCHEM BIOPH RES CO, V338, P491, DOI 10.1016/j.bbrc.2005.08.077; Hollingsworth SA, 2016, P NATL ACAD SCI USA, V113, P8723, DOI 10.1073/pnas.1606474113; HUANG JJ, 1973, BIOCHEMISTRY-US, V12, P406, DOI 10.1021/bi00727a007; Ishizuka S, 2005, ENDOCRINOLOGY, V146, P2023, DOI 10.1210/en.2004-1140; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; LAMBETH JD, 1980, J BIOL CHEM, V255, P4667; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Miller WL, 2017, J STEROID BIOCHEM, V165, P101, DOI 10.1016/j.jsbmb.2016.04.001; Mizwicki MT, 2009, J BIOL CHEM, V284, P36292, DOI 10.1074/jbc.M109.042069; O'Keeffe DT, 2016, OSTEOPOROSIS INT, V27, P3121, DOI 10.1007/s00198-016-3615-6; OHYAMA Y, 1989, FEBS LETT, V255, P405, DOI 10.1016/0014-5793(89)81133-0; Peng HM, 2017, BIOCHEMISTRY-US, V56, P2282, DOI 10.1021/acs.biochem.7b00034; Pikuleva IA, 2000, ARCH BIOCHEM BIOPHYS, V373, P44, DOI 10.1006/abbi.1999.1536; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Ritter CS, 2006, KIDNEY INT, V70, P654, DOI 10.1038/sj.ki.5000394; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Streeten EA, 2011, NEW ENGL J MED, V365, P1741, DOI 10.1056/NEJMc1110226; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; Weiss R, 2000, J BIOMOL NMR, V17, P355, DOI 10.1023/A:1008338800548; Yasutake Y, 2013, CHEMBIOCHEM, V14, P2284, DOI 10.1002/cbic.201300386; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08392	41	7	7	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4167	4179		10.1074/jbc.RA117.001145	http://dx.doi.org/10.1074/jbc.RA117.001145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29371396	Green Published, hybrid			2022-12-28	WOS:000427587500027
J	Munoz, SS; Li, HY; Ruberu, K; Chu, Q; Saghatelian, A; Ooi, L; Garner, B				Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Chu, Qian; Saghatelian, Alan; Ooi, Lezanne; Garner, Brett			The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; THROMBIN-CLEAVAGE FRAGMENT; HUMAN NEUROBLASTOMA-CELLS; NEURO-BLASTOMA CELLS; ALZHEIMERS-DISEASE; A-BETA; INFLAMMATORY RESPONSE; LIPOPROTEIN RECEPTORS; TERMINAL FRAGMENT; MIMETIC PEPTIDES	Apolipoprotein-E (apoE) is a glycoprotein highly expressed in the brain, where it appears to play a role in lipid transport, beta-amyloid clearance, and neuronal signaling. ApoE proteolytic fragments are also present in the brain, but the enzymes responsible for apoE fragmentation are unknown, and the biological activity of specific apoE fragments remains to be determined. Here we utilized SK-N-SH neuroblastoma cells differentiated into neurons with all-trans-retinoic acid (ATRA) to study extracellular apoE proteolysis. ApoE fragments were detectable in culture supernatants after 3 days, and their levels were increased for up to 9 days in the presence of ATRA. The concentration of apoE fragments was positively correlated with levels of the neuronal maturation markers (PSD95 and SMI32). The most abundant apoE fragments were 25-and 28-kDa N-terminal fragments that both contained sialylated glycosylation and bound to heparin. We detected apoE fragments only in the extracellular milieu and not in cell lysates, suggesting that an extracellular protease contributes to apoE fragmentation. Of note, siRNA-mediated knockdown of high-temperature requirement serine peptidase A1 (HtrA1) and a specific HtrA1 inhibitor reduced apoE 25-kDa fragment formation by 41 and 86%, respectively. Recombinant 25-kDa fragment apoE and full-length apoE both stimulated neuritogenesis in vitro, increasing neuroblastoma neurite growth by more than 2-fold over a 6-day period. This study provides a cellular model for assessing apoE proteolysis, indicates that HtrA1 regulates apoE 25-kDa fragment formation under physiological conditions, and reveals a new neurotrophic function for the apoE 25-kDa fragment.	[Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Ooi, Lezanne; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Munoz, Sonia Sanz; Li, Hongyun; Ruberu, Kalani; Ooi, Lezanne; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Chu, Qian; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	University of Wollongong; University of Wollongong; Salk Institute	Garner, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	brettg@uow.edu.au	; Li, Hongyun/G-2301-2011	Chu, Qian/0000-0001-6550-6975; Ooi, Lezanne/0000-0001-9241-8268; Li, Hongyun/0000-0003-3332-3132; Ruberu, Kalani/0000-0003-2575-5242; Sanz Munoz, Sonia/0000-0003-0970-3637	National Health and Medical Research Council (NHMRC) of Australia [1079995]; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NHMRC Dementia Research Leadership Fellowship [1135720]; NHMRC Senior Research Fellowship [1109831]; George E. Hewitt Foundation for medical research	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals(Ferring Pharmaceuticals); NHMRC Dementia Research Leadership Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); George E. Hewitt Foundation for medical research	This research was supported by National Health and Medical Research Council (NHMRC) of Australia Grant 1079995. The authors declare that they have no conflicts of interest with the contents of this article.; A postdoctoral fellow supported by the George E. Hewitt Foundation for medical research.; Supported by the Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals.; Supported by an NHMRC Dementia Research Leadership Fellowship (Grant 1135720).; Supported by an NHMRC Senior Research Fellowship (Grant 1109831).	Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Aizawa Y, 1997, BRAIN RES, V768, P208, DOI 10.1016/S0006-8993(97)00640-9; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Caillet-Boudin ML, 1998, NEUROSCI LETT, V250, P83, DOI 10.1016/S0304-3940(98)00448-0; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; Chu Q, 2016, J AM CHEM SOC, V138, P9473, DOI 10.1021/jacs.6b03463; CICCARONE V, 1989, CANCER RES, V49, P219; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; CLAY MA, 1995, BIOCHEMISTRY-US, V34, P11142, DOI 10.1021/bi00035a020; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRUTCHER KA, 1994, EXP NEUROL, V130, P120, DOI 10.1006/exnr.1994.1191; D'Angelo V, 2014, J NEURO-ONCOL, V117, P287, DOI 10.1007/s11060-014-1387-4; Dafnis I, 2012, NEUROSCIENCE, V210, P21, DOI 10.1016/j.neuroscience.2012.03.013; De Luca A, 2004, J HISTOCHEM CYTOCHEM, V52, P1609, DOI 10.1369/jhc.4A6330.2004; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Dupont-Wallois L, 1997, NEUROBIOL DIS, V4, P356, DOI 10.1006/nbdi.1997.0155; Elliott DA, 2007, NEUROSCI LETT, V416, P206, DOI 10.1016/j.neulet.2007.02.014; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Glanz S, 2016, STEM CELLS DEV, V25, P687, DOI 10.1089/scd.2015.0368; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Hussain A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-49; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Koch S, 2001, J LIPID RES, V42, P1143; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Lane-Donovan C, 2016, J NEUROSCI, V36, P10141, DOI 10.1523/JNEUROSCI.1054-16.2016; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li HY, 2012, CLIN SCI, V122, P409, DOI 10.1042/CS20110257; Li HY, 2010, BBA-MOL CELL BIOL L, V1801, P887, DOI 10.1016/j.bbalip.2010.05.012; Lorenzi T, 2013, INT J CANCER, V133, P2650, DOI 10.1002/ijc.28280; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marques MA, 1996, NEUROREPORT, V7, P2529, DOI 10.1097/00001756-199611040-00025; Marques MA, 2004, J MOL NEUROSCI, V24, P73, DOI 10.1385/JMN:24:1:073; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Mulder M, 2001, LAB INVEST, V81, P953, DOI 10.1038/labinvest.3780307; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Pirttila T, 1996, BRAIN RES, V722, P71, DOI 10.1016/0006-8993(96)00183-7; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; PREIS PN, 1988, CANCER RES, V48, P6530; Puttfarcken PS, 1997, J NEUROCHEM, V68, P760; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Rohn TT, 2012, BRAIN RES, V1475, P106, DOI 10.1016/j.brainres.2012.08.003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tamboli IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093120; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Tolar M, 1997, J NEUROSCI, V17, P5678; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Wellnitz S, 2005, J NEUROCHEM, V94, P1351, DOI 10.1111/j.1471-4159.2005.03295.x; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; Zhao N, 2018, BIOL PSYCHIAT, V83, P347, DOI 10.1016/j.biopsych.2017.03.003	87	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4071	4084		10.1074/jbc.RA117.001278	http://dx.doi.org/10.1074/jbc.RA117.001278			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414786	Green Published, hybrid			2022-12-28	WOS:000427587500019
J	Al-Akra, L; Bae, DH; Sahni, S; Huang, MLH; Park, KC; Lane, DJR; Jansson, PJ; Richardson, DR				Al-Akra, Lina; Bae, Dong-Hun; Sahni, Sumit; Huang, Michael L. H.; Park, Kyung Chan; Lane, Darius J. R.; Jansson, Patric J.; Richardson, Des R.			Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISONICOTINOYL HYDRAZONE CLASS; MULTIDRUG-RESISTANCE; IRON CHELATORS; MEMBRANE PERMEABILIZATION; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; CANCER; HYPOXIA; DI-2-PYRIDYLKETONE; MODULATION	Multidrug resistance (MDR) is a major obstacle in cancer treatment due to the ability of tumor cells to efflux chemotherapeutics via drug transporters (e.g. P-glycoprotein (Pgp; ABCB1)). Although the mechanism of Pgp-mediated drug efflux is known at the plasma membrane, the functional role of intracellular Pgp is unclear. Moreover, there has been intense focus on the tumor micro-environment as a target for cancer treatment. This investigation aimed to dissect the effects of tumor micro-environmental stress on subcellular Pgp expression, localization, and its role in MDR. These studies demonstrated that tumor micro-environment stressors (i.e. nutrient starvation, low glucose levels, reactive oxygen species, and hypoxia) induce Pgp-mediated drug resistance. This occurred by two mechanisms, where stressors induced 1) rapid Pgp internalization and redistribution via intracellular trafficking (within 1 h) and 2) hypoxia-inducible factor-1 alpha expression after longer incubations (4-24 h), which up-regulated Pgp and was accompanied by lysosomal biogenesis. These two mechanisms increased lysosomal Pgp and facilitated lysosomal accumulation of the Pgp substrate, doxorubicin, resulting in resistance. This was consistent with lysosomal Pgp being capable of transporting substrates into lysosomes. Hence, tumor micro-environmental stressors result in: 1) Pgp redistribution to lysosomes; 2) increased Pgp expression; 3) lysosomal biogenesis; and 4) potentiation of Pgp substrate transport into lysosomes. In contrast to doxorubicin, when stress stimuli increased lysosomal accumulation of the cytotoxic Pgp substrate, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone Dp44mT), this resulted in the agent overcoming resistance. Overall, this investigation describes a novel approach to overcoming resistance in the stressful tumor micro-environment.	[Jansson, Patric J.; Richardson, Des R.] Univ Sydney, Discipline Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Jansson, PJ; Richardson, DR (corresponding author), Univ Sydney, Discipline Pathol, Mol Pharmacol & Pathol Program, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	patric.jansson@sydney.edu.au; d.richardson@med.usyd.edu.au	Huang, Michael L.-H./AAK-2237-2020	Huang, Michael L.-H./0000-0003-0693-7833; Lane, Darius/0000-0001-8725-6903; Richardson, Des/0000-0003-0960-6415; Bae, Dong-Hun/0000-0002-4109-7190; Richardson, Des/0000-0002-5506-3274; Sahni, Sumit/0000-0002-2900-8845	National Health and Medical Research Council (NHMRC) Australia [1021607]; NHMRC Senior Principal Research Fellowship [1062607]; Cancer Institute NSW Fellowships; National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation project grant; Prostate Cancer Foundation Australia New Concept Grant; NHMRC Early Career Fellowship; Cure Cancer Australia Foundation Young Investigator PdCCRs grant; National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Fellowships; National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation project grant; Prostate Cancer Foundation Australia New Concept Grant; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia Foundation Young Investigator PdCCRs grant; National Breast Cancer Foundation	This work was supported by Project Grant 1021607 from the National Health and Medical Research Council (NHMRC) Australia (to D. R. R.), NHMRC Senior Principal Research Fellowship 1062607 (to D. R. R.), Cancer Institute NSW Fellowships (to P. J. J. and D. J. R. L.), a National Breast Cancer Foundation and Avner Pancreatic Cancer Foundation project grant (to D. R. R and P. J. J.), a Prostate Cancer Foundation Australia New Concept Grant (to D. R. R. and D. J. R. L.), and an NHMRC Early Career Fellowship (to M. L. H. H.). D. R. R. is a stakeholder in Oncochel Therapeutics LLC and Pty Ltd, which is developing the thiosemicarbazone, DpC, for the treatment of advanced and resistant cancer.; Recipient of a Cure Cancer Australia Foundation Young Investigator PdCCRs grant.	Akhtar N, 2011, EXPERT OPIN THER PAT, V21, P561, DOI 10.1517/13543776.2011.561784; Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; BROWN JP, 1981, J IMMUNOL, V127, P539; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Comerford KM, 2002, CANCER RES, V62, P3387; Cuvier C, 1997, CLIN EXP METASTAS, V15, P19; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Giampietri C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/417281; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; HYAFIL F, 1993, CANCER RES, V53, P4595; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jansson PJ, 2015, J BIOL CHEM, V290, P9588, DOI 10.1074/jbc.M114.631283; Kalinowski DS, 2016, BBA-MOL CELL RES, V1863, P727, DOI 10.1016/j.bbamcr.2016.01.026; KARIN M, 1981, J BIOL CHEM, V256, P3245; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kemper EM, 2004, EUR J CANCER, V40, P1269, DOI 10.1016/j.ejca.2004.01.024; Kim H, 1997, AM J PHYSIOL-CELL PH, V273, pC687, DOI 10.1152/ajpcell.1997.273.2.C687; Klostermann E, 2002, BIOCHEM J, V368, P777, DOI 10.1042/BJ20021291; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Murphy L, 2008, BBA-PROTEINS PROTEOM, V1784, P1184, DOI 10.1016/j.bbapap.2008.04.014; Nishimoto A, 2014, INT J ONCOL, V44, P2077, DOI 10.3892/ijo.2014.2367; Paterson JK, 2007, EXP CELL RES, V313, P3100, DOI 10.1016/j.yexcr.2007.04.019; Rajendran L, 2010, NAT REV DRUG DISCOV, V9, P29, DOI 10.1038/nrd2897; RICHARDSON DR, 1993, IMMUNOLOGY, V79, P305; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Seebacher NA, 2015, BRIT J PHARMACOL, V172, P2557, DOI 10.1111/bph.13079; Seebacher N, 2016, FREE RADICAL BIO MED, V96, P432, DOI 10.1016/j.freeradbiomed.2016.04.201; Seebacher NA, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.381; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; Shi L, 2017, FREE RADICAL BIO MED, V108, P904, DOI 10.1016/j.freeradbiomed.2017.04.368; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Stacy AE, 2016, J MED CHEM, V59, P4965, DOI 10.1021/acs.jmedchem.6b00238; Taatjes DJ, 2001, CURR MED CHEM, V8, P15, DOI 10.2174/0929867013374029; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Yang GL, 2016, MOL MED REP, V13, P2583, DOI 10.3892/mmr.2016.4836; Yeom CJ, 2012, INT J MOL SCI, V13, P13949, DOI 10.3390/ijms131113949; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345; Ziemann C, 1999, CARCINOGENESIS, V20, P407, DOI 10.1093/carcin/20.3.407	71	27	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3562	3587		10.1074/jbc.M116.772699	http://dx.doi.org/10.1074/jbc.M116.772699			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29305422	hybrid, Green Published			2022-12-28	WOS:000427030200009
J	Ha, J; Xu, Y; Kawano, T; Hendon, T; Baki, L; Garai, S; Papapetropoulos, A; Thakur, GA; Plant, LD; Logothetis, DE				Ha, Junghoon; Xu, Yu; Kawano, Takeharu; Hendon, Tyler; Baki, Lia; Garai, Sumanta; Papapetropoulos, Andreas; Thakur, Ganesh A.; Plant, Leigh D.; Logothetis, Diomedes E.			Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNELS; RECTIFYING POTASSIUM CHANNELS; G-PROTEINS; H2S; PHOSPHOINOSITIDES; CARDIOPROTECTION; SULFHYDRATION; ACTIVATION; MECHANISM	Inwardly rectifying potassium (Kir) channels establish and regulate the resting membrane potential of excitable cells in the heart, brain, and other peripheral tissues. Phosphatidylinositol 4,5-bisphosphate (PIP2) is a key direct activator of ion channels, including Kir channels. The gasotransmitter carbon monoxide has been shown to regulate Kir channel activity by altering channel-PIP2 interactions. Here, we tested in two cellular models the effects and mechanism of action of another gasotransmitter, hydrogen sulfide (H2S), thought to play a key role in cellular responses under ischemic conditions. Direct administration of sodium hydrogen sulfide as an exogenous H2S source and expression of cystathionine gamma-lyase, a key enzyme that produces endogenous H2S in specific brain tissues, resulted in comparable current inhibition of several Kir2 and Kir3 channels. This effect resulted from changes in channel-gating kinetics rather than in conductance or cell-surface localization. The extent of H2S regulation depended on the strength of the channel-PIP2 interactions. H2S regulation was attenuated when channel-PIP2 interactions were strengthened and was increased when channel-PIP2 interactions were weakened by depleting PIP2 levels. These H2S effects required specific cytoplasmic cysteine residues in Kir3.2 channels. Mutation of these residues abolished H2S inhibition, and reintroduction of specific cysteine residues back into the background of the cytoplasmic cysteine-lacking mutant rescued H2S inhibition. Molecular dynamics simulation experiments provided mechanistic insights into how potential sulfhydration of specific cysteine residues could lead to changes in channel-PIP2 interactions and channel gating.	[Ha, Junghoon; Hendon, Tyler; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Xu, Yu; Kawano, Takeharu; Baki, Lia; Garai, Sumanta; Thakur, Ganesh A.; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Papapetropoulos, Andreas] Univ Athens, Fac Pharm, Lab Pharmacol, Athens 15771, Greece; [Papapetropoulos, Andreas] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens 11527, Greece	Virginia Commonwealth University; Northeastern University; National & Kapodistrian University of Athens; Academy of Athens	Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharmaceut Sci, 805 Columbus Ave,428 ISEC, Boston, MA 02120 USA.	d.logothetis@northeastern.edu	Andreas, Papapetropoulos/AAJ-3089-2020; Garai, Sumanta/S-6193-2019; Xu, Yu/AAM-8492-2021	Garai, Sumanta/0000-0003-4071-8490	National Institutes of Health [R01 HL059949-19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL059949-19. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adney SK, 2015, J NEUROSCI, V35, P14397, DOI 10.1523/JNEUROSCI.1415-15.2015; Austgen JR, 2011, J NEUROPHYSIOL, V106, P1822, DOI 10.1152/jn.00463.2011; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Bodhinathan K, 2013, P NATL ACAD SCI USA, V110, P18309, DOI 10.1073/pnas.1311406110; Chen L, 2002, P NATL ACAD SCI USA, V99, P8430, DOI 10.1073/pnas.122682899; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0500-y; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Feng XM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-4; Gade AR, 2013, MOL PHARMACOL, V83, P294, DOI 10.1124/mol.112.081596; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Karschin C, 1996, J NEUROSCI, V16, P3559; Khademullah CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064495; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kuksis M, 2015, J NEUROPHYSIOL, V114, P1641, DOI 10.1152/jn.00252.2015; Logothetis DE, 2015, INT REV NEUROBIOL, V123, P1, DOI 10.1016/bs.irn.2015.05.013; Luo Y, 2014, CNS NEUROSCI THER, V20, P411, DOI 10.1111/cns.12228; McCune CD, 2016, ACS CENTRAL SCI, V2, P242, DOI 10.1021/acscentsci.6b00019; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Paul BD, 2015, TRENDS BIOCHEM SCI, V40, P687, DOI 10.1016/j.tibs.2015.08.007; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Plant LD, 2016, ELIFE, V5, DOI 10.7554/eLife.20054; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Salloum FN, 2015, PHARMACOL THERAPEUT, V152, P11, DOI 10.1016/j.pharmthera.2015.04.004; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wei HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050641; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhang Z, 2007, CAN J PHYSIOL PHARM, V85, P1248, DOI 10.1139/Y07-120	40	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3546	3561		10.1074/jbc.RA117.001679	http://dx.doi.org/10.1074/jbc.RA117.001679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29317494	Green Published, hybrid			2022-12-28	WOS:000427030200008
J	Viljoen, A; Richard, M; Nguyen, PC; Fourquet, P; Camoin, L; Paudal, RR; Gnawali, GR; Spilling, CD; Cavalier, JF; Canaan, S; Blaise, M; Kremer, L				Viljoen, Albertus; Richard, Matthias; Phuong Chi Nguyen; Fourquet, Patrick; Camoin, Luc; Paudal, Rishi R.; Gnawali, Giri R.; Spilling, Christopher D.; Cavalier, Jean-Francois; Canaan, Stephane; Blaise, Mickael; Kremer, Laurent			Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL COMPONENTS; BIOSYNTHESIS; ENVELOPE; COMPLEX; BIOGENESIS; PROTEIN; INACTIVATION; DISRUPTION; HYDROLASES; MECHANISM	An increasing prevalence of cases of drug-resistant tuberculosis requires the development of more efficacious chemotherapies. We previously reported the discovery of a new class of cyclipostins and cyclophostin (CyC) analogs exhibiting potent activity against Mycobacterium tuberculosis both in vitro and in infected macrophages. Competitive labeling/enrichment assays combined with MS have identified several serine or cysteine enzymes in lipid and cell wall metabolism as putative targets of these CyC compounds. These targets included members of the antigen 85 (Ag85) complex (i.e. Ag85A, Ag85B, and Ag85C), responsible for biosynthesis of trehalose dimycolate and mycolylation of arabinogalactan. Herein, we used biochemical and structural approaches to validate the Ag85 complex as a pharmacological target of the CyC analogs. We found that CyC7 beta, CyC8 beta, and CyC17 bind covalently to the catalytic Ser(124) residue in Ag85C; inhibit mycolyltransferase activity (i.e. the transfer of a fatty acid molecule onto trehalose); and reduce triacylglycerol synthase activity, a property previously attributed to Ag85A. Supporting these results, an X-ray structure of Ag85C in complex with CyC8 beta disclosed that this inhibitor occupies Ag85C's substrate-binding pocket. Importantly, metabolic labeling of M. tuberculosis cultures revealed that the CyC compounds impair both trehalose dimycolate synthesis and mycolylation of arabinogalactan. Overall, our study provides compelling evidence that CyC analogs can inhibit the activity of the Ag85 complex in vitro and in mycobacteria, opening the door to a new strategy for inhibiting Ag85. The high-resolution crystal structure obtained will further guide the rational optimization of new CyC scaffolds with greater specificity and potency against M. tuberculosis.	[Viljoen, Albertus; Richard, Matthias; Blaise, Mickael; Kremer, Laurent] Univ Montpellier, IRIM, CNRS, UMR9004, F-34293 Montpellier, France; [Kremer, Laurent] IRIM, INSERM, F-34293 Montpellier, France; [Phuong Chi Nguyen; Cavalier, Jean-Francois; Canaan, Stephane] Aix Marseille Univ, CNRS, EIPL, IMM FR3479, F-13009 Marseille, France; [Phuong Chi Nguyen; Cavalier, Jean-Francois; Canaan, Stephane] Aix Marseille Univ, CNRS, LISM, IMM FR3479, F-13009 Marseille, France; [Fourquet, Patrick; Camoin, Luc] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, Marseille Prote,INSERM,CRCM, F-13009 Marseille, France; [Paudal, Rishi R.; Gnawali, Giri R.; Spilling, Christopher D.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Missouri System; University of Missouri Saint Louis	Blaise, M; Kremer, L (corresponding author), Univ Montpellier, IRIM, CNRS, UMR9004, F-34293 Montpellier, France.; Kremer, L (corresponding author), IRIM, INSERM, F-34293 Montpellier, France.	mickael.blaise@irim.cnrs.fr; laurent.kremer@irim.cnrs.fr	Camoin, Luc/AAB-3856-2019; Blaise, Mickael/L-5585-2019; Viljoen, Albertus/O-6794-2019; Kremer, Laurent/M-4935-2017; Cavalier, JF/ABB-6445-2020	Camoin, Luc/0000-0002-1230-4787; Viljoen, Albertus/0000-0001-8949-7401; Kremer, Laurent/0000-0002-6604-4458; Cavalier, JF/0000-0003-0864-8314; Paudel, Rishi/0000-0002-8468-2381; Richard, Matthias/0000-0002-7999-7653; Blaise, Mickael/0000-0002-7860-3464; /0000-0002-1765-5746	Fondation pour la Recherche Medicale (FRM) [DEQ20150331719, ECO20160736031]; CNRS; INSERM; Ph.D. Training program of the University of Science and Technology of Hanoi	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ph.D. Training program of the University of Science and Technology of Hanoi	This work was supported by Fondation pour la Recherche Medicale (FRM) Grants DEQ20150331719 (to L. K.) and ECO20160736031 (to M. R.) and by CNRS and INSERM. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Ph.D. Training program of the University of Science and Technology of Hanoi.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CS, 2011, J AM CHEM SOC, V133, P13232, DOI 10.1021/ja204249p; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Coxon GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053162; Daffe M, 2000, TRENDS MICROBIOL, V8, P438, DOI 10.1016/S0966-842X(00)01844-8; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/s2213-2600(17)30079-6, 10.1016/S2213-2600(17)30079-6]; Dhouib R, 2011, BBA-MOL CELL BIOL L, V1811, P234, DOI 10.1016/j.bbalip.2011.01.001; Dupont C, 2016, MOL MICROBIOL, V101, P515, DOI 10.1111/mmi.13406; Elamin AA, 2011, MOL MICROBIOL, V81, P1577, DOI 10.1111/j.1365-2958.2011.07792.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favrot L, 2014, J BIOL CHEM, V289, P25031, DOI 10.1074/jbc.M114.582445; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Goins CM, 2017, ACS INFECT DIS, V3, P378, DOI 10.1021/acsinfecdis.7b00003; Harth G, 1996, INFECT IMMUN, V64, P3038, DOI 10.1128/IAI.64.8.3038-3047.1996; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kremer L, 2003, J BIOL CHEM, V278, P20547, DOI 10.1074/jbc.M302435200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Lakey DL, 2000, INFECT IMMUN, V68, P233, DOI 10.1128/IAI.68.1.233-238.2000; Lehmann J, 2018, ANGEW CHEM INT EDIT, V57, P348, DOI 10.1002/anie.201709365; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Nguyen P. C., 2017, INT J ANTIMICROB AG, DOI [10.1016/j.ijantimicag.2017.12.001CrossRefMedline, DOI 10.1016/J.IJANTIMICAG.2017.12.001CROSSREFMEDLINE]; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Nguyen PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11843-4; Point V, 2012, J MED CHEM, V55, P10204, DOI 10.1021/jm301216x; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Rose JD, 2002, CARBOHYD RES, V337, P105, DOI 10.1016/S0008-6215(01)00288-9; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sanki AK, 2009, MOL BIOSYST, V5, P945, DOI 10.1039/b902284h; Santucci P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00122; Scheich C, 2010, J MED CHEM, V53, P8362, DOI 10.1021/jm100993z; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Vasilieva E, 2015, BIOORGAN MED CHEM, V23, P944, DOI 10.1016/j.bmc.2015.01.028; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Viljoen A, 2016, MOL MICROBIOL, V102, P611, DOI 10.1111/mmi.13482; Warrier T, 2012, ANTIMICROB AGENTS CH, V56, P1735, DOI 10.1128/AAC.05742-11; Wilson RA, 2004, J MOL BIOL, V335, P519, DOI 10.1016/j.jmb.2003.11.001; Wilson RA, 2003, ACTA CRYSTALLOGR D, V59, P2303, DOI 10.1107/S0907444903020456	56	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2755	2769		10.1074/jbc.RA117.000760	http://dx.doi.org/10.1074/jbc.RA117.000760			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29301937	hybrid, Green Published			2022-12-28	WOS:000426051900012
J	Morales-Soto, N; Dunham, SJB; Baig, NF; Ellis, JF; Madukoma, CS; Bohn, PW; Sweedler, JV; Shrout, JD				Morales-Soto, Nydia; Dunham, Sage J. B.; Baig, Nameera F.; Ellis, Joanna F.; Madukoma, Chinedu S.; Bohn, Paul W.; Sweedler, Jonathan V.; Shrout, Joshua D.			Spatially dependent alkyl quinolone signaling responses to antibiotics in Pseudomonas aeruginosa swarms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); antibiotics; quorum sensing; Raman spectroscopy; mass spectrometry (MS); biofilm; N-oxide; PQS; quinolone; secondary ion mass spectrometry; swarming	BIOFILM FORMATION; MEMBRANE-VESICLES; CELL-DENSITY; TOLERANCE; VIRULENCE; MOTILITY; SYSTEM; GROWTH; DNA; AMINOGLYCOSIDES	There is a general lack of understanding about how communities of bacteria respond to exogenous toxins such as antibiotics. Most of our understanding of community-level stress responses comes from the study of stationary biofilm communities. Although several community behaviors and production of specific biomolecules affecting biofilm development and associated behavior have been described for Pseudomonas aeruginosa and other bacteria, we have little appreciation for the production and dispersal of secreted metabolites within the 2D and 3D sUpaces they occupy as they colonize, spread, and grow on surfaces. Here we specifically studied the phenotypic responses and spatial variability of alkyl quinolones, including the Pseudomonas quinolone signal (PQS) and members of the alkyl hydroxyquinoline (AQNO) subclass, in P. aeruginosa plate-assay swarming communities. We found that PQS production was not a universal signaling response to antibiotics, as tobramycin elicited an alkyl quinolone response, whereas carbenicillin did not. We also found that PQS and AQNO profiles in response to tobramycin were markedly distinct and influenced these swarms on different spatial scales. At some tobramycin exposures, P. aeruginosa swarms produced alkyl quinolones in the range of 150 m PQS and 400 m AQNO that accumulated as aggregates. Our collective findings show that the distribution of alkyl quinolones can vary by several orders of magnitude within the same swarming community. More notably, our results suggest that multiple intercellular signals acting on different spatial scales can be triggered by one common cue.	[Morales-Soto, Nydia; Madukoma, Chinedu S.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA; [Baig, Nameera F.; Bohn, Paul W.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Bohn, Paul W.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Shrout, Joshua D.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Dunham, Sage J. B.; Ellis, Joanna F.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Dunham, Sage J. B.; Ellis, Joanna F.; Sweedler, Jonathan V.; Shrout, Joshua D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shrout, JD (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	joshua.shrout@nd.edu	Shrout, Joshua D/C-4743-2012; Baig, Nameera/S-8481-2019; Sweedler, Jonathan V/A-9405-2009; Ellis, Joanna F/O-6007-2016	Shrout, Joshua D/0000-0001-9509-2187; Baig, Nameera/0000-0002-7414-6833; Sweedler, Jonathan V/0000-0003-3107-9922; Ellis, Joanna F/0000-0003-4807-6840; Morales-Soto, Nydia/0000-0003-1155-6293; Madukoma, Chinedu S/0000-0003-3268-2600	NIAID, National Institutes of Health [R01AI113219]; Springborn Endowment; National Science Foundation Graduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113219] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Springborn Endowment; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by NIAID, National Institutes of Health, Grant R01AI113219 (to J.D.S., P.W.B., and J.V.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the Springborn Endowment and the National Science Foundation Graduate Research Fellowship Program.r Supported by the Springborn Endowment.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anyan ME, 2014, P NATL ACAD SCI USA, V111, P18013, DOI 10.1073/pnas.1414661111; Baig NF, 2015, ANALYST, V140, P6544, DOI 10.1039/c5an01149c; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Calfee MW, 2005, INFECT IMMUN, V73, P878, DOI 10.1128/IAI.73.2.878-882.2005; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017; Cummins J, 2009, MICROBIOL-SGM, V155, P2826, DOI 10.1099/mic.0.025643-0; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Florez C, 2017, MBIO, V8, DOI 10.1128/mBio.01034-17; Formosa C, 2012, NANOMED-NANOTECHNOL, V8, P12, DOI 10.1016/j.nano.2011.09.009; Guo Q, 2014, J BASIC MICROB, V54, P633, DOI 10.1002/jobm.201300091; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jones EA, 2012, J PROTEOMICS, V75, P4962, DOI 10.1016/j.jprot.2012.06.014; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Lanni EJ, 2014, J AM SOC MASS SPECTR, V25, P1897, DOI 10.1007/s13361-014-0978-9; Lanni EJ, 2014, ANAL CHEM, V86, P9139, DOI 10.1021/ac5020222; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lopez-Diez EC, 2005, ANAL CHEM, V77, P2901, DOI 10.1021/ac048147m; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Masyuko R, 2013, ANALYST, V138, P1924, DOI 10.1039/c3an36416j; MENDELMAN PM, 1985, AM REV RESPIR DIS, V132, P761; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Morris JD, 2011, APPL ENVIRON MICROB, V77, P8310, DOI 10.1128/AEM.06644-11; NEU HC, 1983, AM J MED, V75, P9, DOI 10.1016/0002-9343(83)90089-X; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Phelan VV, 2015, J AM SOC MASS SPECTR, V26, P873, DOI 10.1007/s13361-015-1101-6; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reis RS, 2011, BIORESOURCE TECHNOL, V102, P6377, DOI 10.1016/j.biortech.2011.03.074; Szamosvari D, 2017, ANGEW CHEM INT EDIT, V56, P7271, DOI 10.1002/anie.201702944; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Viducic D, 2016, ANTIMICROB AGENTS CH, V60, P5752, DOI 10.1128/AAC.00260-16; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09	55	24	24	2	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9544	9552		10.1074/jbc.RA118.002605	http://dx.doi.org/10.1074/jbc.RA118.002605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29588364	Green Published, hybrid			2022-12-28	WOS:000435441400037
J	Debnath, S; Kosek, D; Tagad, HD; Durell, SR; Appella, DH; Acevedo, R; Grishaev, A; Dyda, F; Appella, E; Mazur, SJ				Debnath, Subrata; Kosek, Dalibor; Tagad, Harichandra D.; Durell, Stewart R.; Appella, Daniel H.; Acevedo, Roderico; Grishaev, Alexander; Dyda, Fred; Appella, Ettore; Mazur, Sharlyn J.			A trapped human PPM1A-phosphopeptide complex reveals structural features critical for regulation of PPM protein phosphatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; X-ray crystallography; enzyme structure; metalloenzyme; molecular dynamics; protein serine; threonine phosphatase (PSP); signal transduction; small-angle X-ray scattering (SAXS)	3RD METAL; SCATTERING DATA; MECHANISM; CONFORMATION; PP2C-ALPHA; ACTIVATION; TRANSITION; DYNAMICS; 2C-ALPHA; INSULIN	Metal-dependent protein phosphatases (PPM) are evolutionarily unrelated to other serine/threonine protein phosphatases and are characterized by their requirement for supplementation with millimolar concentrations of Mg2+ or Mn2+ ions for activity in vitro. The crystal structure of human PPM1A (also known as PP2C), the first PPM structure determined, displays two tightly bound Mn2+ ions in the active site and a small subdomain, termed the Flap, located adjacent to the active site. Some recent crystal structures of bacterial or plant PPM phosphatases have disclosed two tightly bound metal ions and an additional third metal ion in the active site. Here, the crystal structure of the catalytic domain of human PPM1A, PPM1A(cat), complexed with a cyclic phosphopeptide, c(MpSIpYVA), a cyclized variant of the activation loop of p38 MAPK (a physiological substrate of PPM1A), revealed three metal ions in the active site. The PPM1A(cat) D146E-c(MpSIpYVA) complex confirmed the presence of the anticipated third metal ion in the active site of metazoan PPM phosphatases. Biophysical and computational methods suggested that complex formation results in a slightly more compact solution conformation through reduced conformational flexibility of the Flap subdomain. We also observed that the position of the substrate in the active site allows solvent access to the labile third metal-binding site. Enzyme kinetics of PPM1A(cat) toward a phosphopeptide substrate supported a random-order, bi-substrate mechanism, with substantial interaction between the bound substrate and the labile metal ion. This work illuminates the structural and thermodynamic basis of an innate mechanism regulating the activity of PPM phosphatases.	[Debnath, Subrata; Tagad, Harichandra D.; Durell, Stewart R.; Appella, Ettore; Mazur, Sharlyn J.] NCI, Lab Cell Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Kosek, Dalibor; Dyda, Fred] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Appella, Daniel H.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; [Acevedo, Roderico; Grishaev, Alexander] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Grishaev, Alexander] NIST, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Standards & Technology (NIST) - USA	Mazur, SJ (corresponding author), Bldg 37,Rm 2140,37 Convent Dr, Bethesda, MD 20892 USA.	mazurs@mail.nih.gov	Košek, Dalibor/AAD-4715-2021; Tagad, HARICHANDRA D/S-2293-2018; Debnath, Subrata/X-8773-2019	Tagad, Harichandra/0000-0003-1595-6665; Mazur, Sharlyn/0000-0002-6378-0791	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC011197, ZIABC011379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075148, ZIADK075135, ZIADK031143] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work utilized the SAXS Core facility (CCR, NCI, National Institutes of Health) and the computational resources of the HPC Biowulf Cluster, National Institutes of Health. SAXS data were collected at beamline 12-ID-B at the Advanced Photon Source (Argonne, IL). The shared scattering beamline 12-ID-B resource is allocated under agreement PUP-24152 between the NCI and Argonne National Laboratory. Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility, was operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank Dr. Lixin Fan (NCI, National Institutes of Health), and Dr. Xiaobing Zuo (Argonne National Laboratory) for expert support.	Barford D., 2011, HDB CELL SIGNALING, V1, P677; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Bradshaw N, 2017, ELIFE, V6, DOI 10.7554/eLife.26111; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Cohen P. T., 2010, TRANSDUCTION MECH CE, P659; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Delva P, 2006, J ENDOCRINOL, V190, P711, DOI 10.1677/joe.1.06389; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frausto da Silva J.J.R., 2001, BIOL CHEM ELEMENTS I, P251; Geng J, 2014, ONCOTARGET, V5, P5700, DOI 10.18632/oncotarget.2144; Grishaev A, 2010, J AM CHEM SOC, V132, P15484, DOI 10.1021/ja106173n; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kerk D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132863; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krol E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174713; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Li R, 2013, FEBS J, V280, P2700, DOI 10.1111/febs.12275; Long YQ, 2003, BIOORGAN MED CHEM, V11, P3929, DOI 10.1016/S0968-0896(03)00411-5; Lu X, 2014, ONCOGENE, V33, P2918, DOI 10.1038/onc.2013.246; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Mazur SJ, 2017, BIOCHEMISTRY-US, V56, P2676, DOI 10.1021/acs.biochem.6b01220; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08560; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Stern A, 2007, J MOL EVOL, V64, P61, DOI 10.1007/s00239-006-0033-y; Su JY, 2013, FEBS J, V280, P694, DOI 10.1111/j.1742-4658.2011.08466.x; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tanoue K, 2013, BIOCHEMISTRY-US, V52, P5830, DOI 10.1021/bi4005649; Valdez CE, 2014, ACCOUNTS CHEM RES, V47, P3110, DOI 10.1021/ar500227u; Watson GM, 2015, J MED CHEM, V58, P7707, DOI 10.1021/acs.jmedchem.5b00609; Wei XP, 2015, PLANT CELL, V27, P1113, DOI 10.1105/tpc.15.00102; Westbrook JD, 2015, BIOINFORMATICS, V31, P1274, DOI 10.1093/bioinformatics/btu789; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	59	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7993	8008		10.1074/jbc.RA117.001213	http://dx.doi.org/10.1074/jbc.RA117.001213			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602904	Green Published, hybrid			2022-12-28	WOS:000433224600007
J	Huang, LP; Tepaamorndech, S; Kirschke, CP; Newman, JW; Keyes, WR; Pedersen, TL; Dumnil, J				Huang, Liping; Tepaamorndech, Surapun; Kirschke, Catherine P.; Newman, John W.; Keyes, William R.; Pedersen, Theresa L.; Dumnil, Jureeporn			Aberrant fatty acid metabolism in skeletal muscle contributes to insulin resistance in zinc transporter 7 (znt7)-knockout mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; GENE-EXPRESSION; ADIPOSE-TISSUE; MOUSE PROSTATE; GLUCOSE-UPTAKE; SLC30 FAMILY; ZNT7; OMEGA-3-FATTY-ACIDS; TRANSCRIPTION; OXIDATION	ZnT7 (Slc30a7) is a widely expressed zinc transporter involved in sequestration of zinc into the Golgi apparatus and vesicular compartments. znt7-knockout (KO) mice are mildly zinc-deficient and lean. Despite their lean phenotype, adult male znt7-KO mice are prone to insulin resistance. We hypothesized that fat partitioning from adipose to nonadipose tissues causes insulin resistance in znt7-KO mice. Here, we used biological and biochemical methods, including fatty acid and oxylipin profiling, EM, immunohistochemistry, quantitative RT-PCR, and Western blot analysis, to identify the underlying mechanism of insulin resistance in znt7-KO mice. We found that insulin resistance in this model was primarily associated with increased intracellular fatty acid levels in the skeletal muscle, which promoted intracellular lipid accumulation and production of bioactive lipid mediators, such as 12,13-dihydroxyoctadecanoic acid (12,13-DiHOME) and 12-hydroxyeicosatetraenoic acid (12-HETE). The expression of fatty acid-binding protein 3 (Fabp3) was dramatically up-regulated in the znt7-KO muscle cells accompanied by increased expression of Cd36, Slc27a1, and Slc27a4, the three major fatty acid transporters in the skeletal muscle. We also demonstrated that znt7-KO muscle cells had increased fatty acid oxidative capacity, indicated by enlarged mitochondria and increased mRNA or protein expression of key enzymes involved in the fatty acid mitochondrial shuttle and -oxidation. We conclude that increased fatty acid uptake in the znt7-KO skeletal muscle is a key factor that contributes to the excessive intracellular lipid deposit and elevated production of bioactive lipid mediators. These mediators may play pivotal roles in oxidative stress and inflammation, leading to insulin resistance.	[Huang, Liping; Kirschke, Catherine P.; Newman, John W.; Keyes, William R.; Pedersen, Theresa L.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, 430 West Hlth Sci Dr, Davis, CA 95616 USA; [Huang, Liping; Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Huang, Liping; Tepaamorndech, Surapun] Univ Calif Davis, Integrat Genet & Genom Grad Grp, Davis, CA 95616 USA; [Tepaamorndech, Surapun; Dumnil, Jureeporn] Natl Ctr Genet Engn & Biotechnol BIOTEC, Food Biotechnol Res Unit, 113 Thailand Sci Pk,Phahonyothin Rd, Pathum Thani 12120, Thailand; [Pedersen, Theresa L.] Adv Analyt, 1718 Amador Way, Woodland, CA 95695 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Huang, LP (corresponding author), ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, 430 West Hlth Sci Dr, Davis, CA 95616 USA.	liping.huang@ars.usda.gov		Huang, Liping/0000-0003-1217-0114; Newman, John/0000-0001-9632-6571	United States Department of Agriculture/Agricultural Research Service [2032-51000-004-00D]; BIOTEC, Thailand [P16-50170]	United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); BIOTEC, Thailand	This work was supported by United States Department of Agriculture/Agricultural Research Service/Research Project Plan no. 2032-51000-004-00D and Young Fellow Research Grant P16-50170 from BIOTEC, Thailand. The authors declare that they have no conflicts of interest with the contents of this article. USDA is an equal opportunity provider and employer.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bozzola JJ., 1992, ELECT MICROSCOPY PRI, P16; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Glatz JFC, 2003, ACTA PHYSIOL SCAND, V178, P367, DOI 10.1046/j.1365-201X.2003.01166.x; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang LP, 2012, J BIOL CHEM, V287, P33883, DOI 10.1074/jbc.M111.309666; Huang LP, 2010, EXP CELL RES, V316, P2630, DOI 10.1016/j.yexcr.2010.06.017; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; Kirschke CP, 2008, J MOL HISTOL, V39, P359, DOI 10.1007/s10735-008-9174-1; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Korotkova M, 2014, NAT REV RHEUMATOL, V10, P295, DOI 10.1038/nrrheum.2014.2; Kusudo T, 2011, GENES CELLS, V16, P681, DOI 10.1111/j.1365-2443.2011.01517.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Ogata T, 1997, ANAT REC, V248, P214; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shearer J, 2005, DIABETES, V54, P3133, DOI 10.2337/diabetes.54.11.3133; Smedes F, 1999, MAR POLLUT BULL, V38, P193, DOI 10.1016/S0025-326X(98)00170-2; Standage SW, 2017, AM J PHYSIOL-HEART C, V312, pH239, DOI 10.1152/ajpheart.00457.2016; Tepaamorndech S, 2016, FEBS J, V283, P378, DOI 10.1111/febs.13582; Tepaamorndech S, 2014, MAMM GENOME, V25, P335, DOI 10.1007/s00335-014-9512-4; Tepaamorndech S, 2011, CANCER LETT, V308, P33, DOI 10.1016/j.canlet.2011.04.011; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; ZSCHIESCHE W, 1995, HISTOCHEM CELL BIOL, V103, P147, DOI 10.1007/BF01454012	35	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7549	7563		10.1074/jbc.M117.817692	http://dx.doi.org/10.1074/jbc.M117.817692			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29555680	Green Published, hybrid			2022-12-28	WOS:000437256500009
J	Kojima, S; Iwamoto, M; Oiki, S; Tochigi, S; Takahashi, H				Kojima, Seiji; Iwamoto, Masayuki; Oiki, Shigetoshi; Tochigi, Saeko; Takahashi, Hideyuki			Thylakoid membranes contain a non-selective channel permeable to small organic molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cyanobacteria; membrane transport; permeability; liposome; photosynthesis; CpTPOR; diffusion channel; muroplast; porin; thylakoid membrane	SULFOCYSTEINE SYNTHASE ACTIVITY; CYANOPHORA-PARADOXA CYANELLES; ESCHERICHIA-COLI; PHOTOSYSTEM-II; OUTER-MEMBRANE; CRYOELECTRON TOMOGRAPHY; ARABIDOPSIS-THALIANA; CHLOROPLAST LUMEN; PORIN CHANNELS; HIGHER-PLANTS	The thylakoid lumen is a membrane-enclosed aqueous compartment. Growing evidence indicates that the thylakoid lumen is not only a sink for protons and inorganic ions translocated during photosynthetic reactions but also a place for metabolic activities, e.g. proteolysis of photodamaged proteins, to sustain efficient photosynthesis. However, the mechanism whereby organic molecules move across the thylakoid membranes to sustain these lumenal activities is not well understood. In a recent study of Cyanophora paradoxa chloroplasts (muroplasts), we fortuitously detected a conspicuous diffusion channel activity in the thylakoid membranes. Here, using proteoliposomes reconstituted with the thylakoid membranes from muroplasts and from two other phylogenetically distinct organisms, cyanobacterium Synechocystis sp. PCC 6803 and spinach, we demonstrated the existence of nonselective channels large enough for enabling permeation of small organic compounds (e.g. carbohydrates and amino acids with M-r < 1500) in the thylakoid membranes. Moreover, we purified, identified, and characterized a muroplast channel named here CpTPOR. Osmotic swelling experiments revealed that CpTPOR forms a nonselective pore with an estimated radius of approximate to 1.3 nm. A lipid bilayer experiment showed variable-conductance channel activity with a typical single-channel conductance of 1.8 nS in 1 m KCl with infrequent closing transitions. The CpTPOR amino acid sequence was moderately similar to that of a voltage-dependent anion-selective channel of the mitochondrial outer membrane, although CpTPOR exhibited no obvious selectivity for anions and no voltage-dependent gating. We propose that transmembrane diffusion pathways are ubiquitous in the thylakoid membranes, presumably enabling rapid transfer of various metabolites between the lumen and stroma.	[Kojima, Seiji; Tochigi, Saeko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808577, Japan; [Kojima, Seiji; Tochigi, Saeko; Takahashi, Hideyuki] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Iwamoto, Masayuki; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 9101193, Japan	Tohoku University; Tohoku University; University of Fukui	Kojima, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	skojima0801@gmail.com	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592; Oiki, Shigetoshi/0000-0002-8438-6750; Iwamoto, Masayuki/0000-0001-9505-2652	JSPS KAKENHI [15K20860, 17K07360, 16H00759, 17H04017]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Projects 15K20860 (to S. K.), 17K07360 (to M. I.), and 16H00759 and 17H04017 (to S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Albiniak AM, 2012, J EXP BOT, V63, P1689, DOI 10.1093/jxb/err444; Bermudez MA, 2012, PLANT PHYSIOL, V160, P274, DOI 10.1104/pp.112.201491; Bermudez MA, 2010, PLANT CELL, V22, P403, DOI 10.1105/tpc.109.071985; BOHNERT HJ, 1982, EUR J BIOCHEM, V126, P381; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carraretto L, 2016, MOL PLANT, V9, P371, DOI 10.1016/j.molp.2015.12.004; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Facchinelli F, 2013, PLANTA, V237, P637, DOI 10.1007/s00425-012-1819-3; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Hinnah SC, 1998, EUR J BIOCHEM, V253, P606, DOI 10.1046/j.1432-1327.1998.2530606.x; Homble F, 2012, BBA-BIOMEMBRANES, V1818, P1486, DOI 10.1016/j.bbamem.2011.11.028; Imai K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-79; Iwamoto M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07048-4; Iwamoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09110; Jarvi S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00434; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Kato Y, 2012, PLANT PHYSIOL, V159, P1428, DOI 10.1104/pp.112.199042; Kieselbach T, 2003, PHOTOSYNTH RES, V78, P249, DOI 10.1023/B:PRES.0000006913.86689.f1; Kohler D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00559; Koike H, 2000, PHOTOSYNTH RES, V65, P207, DOI 10.1023/A:1010734912776; Koike H, 2007, PHOTOSYNTH RES, V93, P45, DOI 10.1007/s11120-007-9156-2; Kojima S, 2016, J BIOL CHEM, V291, P20198, DOI 10.1074/jbc.M116.746131; Kojima S, 2016, BIOSCI BIOTECH BIOCH, V80, P1954, DOI 10.1080/09168451.2016.1194185; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Konorty M, 2008, J STRUCT BIOL, V161, P393, DOI 10.1016/j.jsb.2007.09.014; MANNELLA CA, 1975, BIOCHIM BIOPHYS ACTA, V413, P213, DOI 10.1016/0005-2736(75)90105-4; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; NAKATANI HY, 1977, BIOCHIM BIOPHYS ACTA, V461, P510, DOI 10.1016/0005-2728(77)90237-7; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; OMATA T, 1985, BIOCHIM BIOPHYS ACTA, V810, P354, DOI 10.1016/0005-2728(85)90221-X; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; SCHULTZ SG, 1961, J GEN PHYSIOL, V44, P1189, DOI 10.1085/jgp.44.6.1189; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; Spetea C, 2012, FEBS LETT, V586, P2946, DOI 10.1016/j.febslet.2012.07.005; Spetea Cornelia, 2010, Commun Integr Biol, V3, P122; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steiner JM, 2002, TRENDS PLANT SCI, V7, P72, DOI 10.1016/S1360-1385(01)02179-3; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Szabo I, 2017, J EXP BOT, V68, P3115, DOI 10.1093/jxb/erx063; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; Yusa F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-304	56	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7777	7785		10.1074/jbc.RA118.002367	http://dx.doi.org/10.1074/jbc.RA118.002367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29602906	Green Published, hybrid			2022-12-28	WOS:000437256500026
J	Fu, JX; Huang, DY; Yuan, FW; Xie, N; Li, Q; Sun, XP; Zhou, XH; Li, GD; Tong, TJ; Zhang, Y				Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Li, Qian; Sun, Xinpei; Zhou, Xuehong; Li, Guodong; Tong, Tanjun; Zhang, Yu			TRAF-interacting protein with forkhead-associated domain (TIFA) transduces DNA damage-induced activation of NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; NF-B transcription factor; ubiquitylation (ubiquitination); carcinogenesis; TNF receptor associated factor (TRAF); NEMO; TIFA; TRAF-interacting protein with forkhead-associated domain	KAPPA-B; CELLULAR SENESCENCE; FHA DOMAIN; BINDING; CANCER; OLIGOMERIZATION; OVEREXPRESSION; STIMULATION; FIBROBLASTS; P16(INK4A)	DNA damage-induced NF-B activation and the secretion of inflammatory cytokines play crucial roles in carcinogenesis and cellular senescence. However, the underlying mechanisms, especially the initial sensors and transducers connecting the nuclear DNA damage signal with cytoplasmic NF-B activation remain incompletely understood. Here, we report that TRAF-interacting protein with forkhead-associated domain (TIFA), an established NF-B activator in the cytosol, unexpectedly exhibited nuclear translocation and accumulation on damaged chromatin following genotoxic stress. Accordingly, we also found that DNA damage-induced transcriptional activation and the resulting secretion of classic NF-B targets, including interleukin (IL)-6 and IL-8, was greatly enhanced in TIFA-overexpressing cells compared with control cells. Mechanistically, DNA damage-induced TIFA phosphorylation at threonine 9 (pThr-9), and this phosphorylation event, involving the pThr-binding forkhead-associated domain, was crucial for its enrichment on damaged chromatin and subsequent NF-B activation. Moreover, in conjunction with its partner protein, the E3 ligase TNF receptor-associated factor 2 (TRAF2), TIFA relayed the DNA damage signals by stimulating ubiquitination of NF-B essential modulator (NEMO), whose sumoylation, phosphorylation, and ubiquitination were critical for NF-B's response to DNA damage. Consistently, TRAF2 knockdown suppressed TIFA overexpression-enhanced NEMO ubiquitination under genotoxic stress, and a unphosphorylatable Thr-9-mutated TIFA variant had only minor effects on NEMO poly-ubiquitination. Finally, in agreement with the model of DNA damage-associated secretory senescence barrier against carcinogenesis, ectopic TIFA expression limited proliferation of multiple myeloma cancer cells. In conclusion our results indicate that TIFA functions as a key transducer in DNA damage-induced NF-B activation.	[Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Sun, Xinpei; Li, Guodong; Tong, Tanjun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Res Ctr Aging, Beijing 100191, Peoples R China; [Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Sun, Xinpei; Zhou, Xuehong; Li, Guodong; Tong, Tanjun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Li, Qian] Peking Univ, Sch & Hosp Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Dept Orthodont,Beijing Key Lab Digital Stomatol, Beijing 100081, Peoples R China	Peking University; Peking University; Peking University	Tong, TJ; Zhang, Y (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn; zhang_yu@hsc.pku.edu.cn	ZHOU, XUE/F-6129-2013; Yuan, Fuwen/M-4704-2019	Yuan, Fuwen/0000-0001-5764-2504	National Natural Science Foundation of China [81771495, 81300254, 81372164]; National Basic Research Programs of China [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programs of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 81771495, 81300254, and 81372164 and National Basic Research Programs of China Grant 2013CB530801. The authors declare that they have no conflicts of interest with the contents of this article.	Barash U, 2014, LEUKEMIA, V28, P2178, DOI 10.1038/leu.2014.121; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Chen TD, 2012, J BIOL CHEM, V287, P37540, DOI 10.1074/jbc.M111.260679; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Duckworth C, 2016, ONCOGENE, V35, P4036, DOI 10.1038/onc.2015.472; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Huang CCF, 2012, MOL CELL BIOL, V32, P2664, DOI 10.1128/MCB.00438-12; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kanamori M, 2002, BIOCHEM BIOPH RES CO, V290, P1108, DOI 10.1006/bbrc.2001.6315; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; Lin TY, 2016, P NATL ACAD SCI USA, V113, P15078, DOI 10.1073/pnas.1618773114; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Wei TYW, 2017, CANCER RES, V77, P494, DOI 10.1158/0008-5472.CAN-16-1004; Weng JH, 2015, BIOCHEMISTRY-US, V54, P6219, DOI 10.1021/acs.biochem.5b00500; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhang Y, 2016, NAT GENET, V48, P1003, DOI 10.1038/ng.3635; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V453, P172, DOI 10.1016/j.bbrc.2014.09.092; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	36	11	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7268	7280		10.1074/jbc.RA117.001684	http://dx.doi.org/10.1074/jbc.RA117.001684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581234	Green Published, hybrid			2022-12-28	WOS:000432174500022
J	Baran, P; Hansen, S; Waetzig, GH; Akbarzadeh, M; Lamertz, L; Huber, HJ; Ahmadian, MR; Moll, JM; Scheller, J				Baran, Paul; Hansen, Selina; Waetzig, Georg H.; Akbarzadeh, Mohammad; Lamertz, Larissa; Huber, Heinrich J.; Ahmadian, M. Reza; Moll, Jens M.; Scheller, Juergen			The balance of interleukin (IL)-6, IL-6 center dot soluble IL-6 receptor (sIL-6R), and IL-6 center dot sIL-6R center dot sgp130 complexes allows simultaneous classic and trans-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; signal transduction; interleukin 6 (IL-6); interleukin 6 receptor (IL6R); glycoprotein; classic signaling; Trans-signaling	SOLUBLE INTERLEUKIN-6; CIRCULATING INTERLEUKIN-6; SERUM LEVELS; GP130; INFLAMMATION; CYTOKINES; BLOCKADE; CELLS; INHIBITOR; SEVERITY	Interleukin (IL-)6 is the major pro-inflammatory cytokine within the IL-6 family. IL-6 signals via glycoprotein 130 (gp130) and the membrane-bound or soluble IL-6 receptor (IL-6R), referred to as classic or trans-signaling, respectively. Whereas inflammation triggers IL-6 expression, eventually rising to nanogram/ml serum levels, soluble IL-6R (sIL-6R) and soluble gp130 (sgp130) are constitutively present in the upper nanogram/ml range. Calculations based on intermolecular affinities have suggested that systemic IL-6 is immediately trapped in IL-6<bold>sIL</bold>-6R and IL-6<bold>sIL</bold>-6R<bold>sgp</bold>130 complexes, indicating that sIL-6R and sgp130 constitute a buffer system that increases the serum half-life of IL-6 or restricts systemic IL-6 signaling. However, this scenario has not been experimentally validated. Here, we quantified IL-6<bold>sIL</bold>-6R and IL-6<bold>sIL</bold>-6R<bold>sgp</bold>130 complexes over a wide concentration range. The amounts of IL-6 used in this study reflect concentrations found during active inflammatory events. Our results indicated that most IL-6 is free and not complexed with sIL-6R or sgp130, indicating that the level of endogenous sgp130 in the bloodstream is not sufficient to block IL-6 trans-signaling via sIL-6R. Importantly, addition of the single-domain antibody VHH6, which specifically stabilizes IL-6<bold>sIL</bold>-6R complexes but did not bind to IL-6 or sIL-6R alone, drove free IL-6 into IL-6<bold>sIL</bold>-6R complexes and boosted trans-signaling but not classic signaling, demonstrating that endogenous sIL-6R has at least the potential to form complexes with IL-6. Our findings indicate that even though high concentrations of sIL-6R and sgp130 are present in human serum, the relative ratio of free IL-6 to IL-6<bold>sIL</bold>-6R allows for simultaneous classic and trans-signaling.	[Baran, Paul; Hansen, Selina; Akbarzadeh, Mohammad; Lamertz, Larissa; Ahmadian, M. Reza; Moll, Jens M.; Scheller, Juergen] Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany; [Huber, Heinrich J.] Otto von Guericke Univ, Inst Automat Engn, D-39106 Magdeburg, Germany	Heinrich Heine University Dusseldorf; Otto von Guericke University	Scheller, J (corresponding author), Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Waetzig, Georg/AAV-7486-2021		Deutsche Forschungsgemeinschaft [AH 92/8-1]; Bundesministerium fur Bildung und Forschung (BMBF) project InTraSig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) project InTraSig(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Project Grant AH 92/8-1 (to A. K. and M. R. A.), and the Bundesministerium fur Bildung und Forschung (BMBF) project InTraSig (to J. S.). G. H. W. is employed by CONARIS Research Institute AG (Kiel, Germany), which is commercially developing sgp130Fc proteins as therapeutics for inflammatory diseases.	Adams R, 2017, SCI REP-UK, V7, DOI 10.1038/srep37716; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Friederichs K, 2001, EUR J BIOCHEM, V268, P6401, DOI 10.1046/j.0014-2956.2001.02586.x; FRIELING JTM, 1995, J INFECT DIS, V171, P469, DOI 10.1093/infdis/171.2.469; Gaillard JP, 1999, EUR CYTOKINE NETW, V10, P337; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; MACKIEWICZ A, 1992, FEBS LETT, V306, P257, DOI 10.1016/0014-5793(92)81012-B; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Montero-Julian FA, 2001, CELL MOL BIOL, V47, P583; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Wolf J, 2016, J BIOL CHEM, V291, P16186, DOI 10.1074/jbc.M116.718551; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	31	88	92	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6762	6775		10.1074/jbc.RA117.001163	http://dx.doi.org/10.1074/jbc.RA117.001163			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29559558	hybrid, Green Published			2022-12-28	WOS:000431487300012
J	Delalande, O; Molza, AE; Morais, RD; Cheron, A; Pollet, E; Raguenes-Nicol, C; Tascon, C; Giudice, E; Guilbaud, M; Nicolas, A; Bondon, A; Leturcq, F; Ferey, N; Baaden, M; Perez, J; Roblin, P; Pietri-Rouxel, F; Hubert, JF; Czjzek, M; Le Rumeur, E				Delalande, Olivier; Molza, Anne-Elisabeth; Morais, Raphael Dos Santos; Cheron, Angelique; Pollet, Emeline; Raguenes-Nicol, Celine; Tascon, Christophe; Giudice, Emmanuel; Guilbaud, Marine; Nicolas, Aurelie; Bondon, Arnaud; Leturcq, France; Ferey, Nicolas; Baaden, Marc; Perez, Javier; Roblin, Pierre; Pietri-Rouxel, France; Hubert, Jean-Francois; Czjzek, Mirjam; Le Rumeur, Elisabeth			Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dystrophin; molecular docking; muscular dystrophy; nitric oxide synthase; small-angle X-ray scattering (SAXS); Becker muscular dystrophy; dystrophin central domain; multiresolution modeling	SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; PHENOTYPE; PROTEINS; REPEATS; BINDING; MODELS; SAXS	Dystrophin, encoded by the DMD gene, is critical for maintaining plasma membrane integrity during muscle contraction events. Mutations in the DMD gene disrupting the reading frame prevent dystrophin production and result in severe Duchenne muscular dystrophy (DMD); in-frame internal deletions allow production of partly functional internally deleted dystrophin and result in less severe Becker muscular dystrophy (BMD). Many known BMD deletions occur in dystrophin's central domain, generally considered to be a monotonous rod-shaped domain based on the knowledge of spectrin family proteins. However, the effects caused by these deletions, ranging from asymptomatic to severe BMD, argue against the central domain serving only as a featureless scaffold. We undertook structural studies combining small-angle X-ray scattering and molecular modeling in an effort to uncover the structure of the central domain, as dystrophin has been refractory to characterization. We show that this domain appears to be a tortuous and complex filament that is profoundly disorganized by the most severe BMD deletion (loss of exons 45-47). Despite the preservation of large parts of the binding site for neuronal nitric oxide synthase (nNOS) in this deletion, computational approaches failed to recreate the association of dystrophin with nNOS. This observation is in agreement with a strong decrease of nNOS immunolocalization in muscle biopsies, a parameter related to the severity of BMD phenotypes. The structural description of the whole dystrophin central domain we present here is a first necessary step to improve the design of microdystrophin constructs toward the goal of a successful gene therapy for DMD.	[Delalande, Olivier; Molza, Anne-Elisabeth; Morais, Raphael Dos Santos; Cheron, Angelique; Pollet, Emeline; Raguenes-Nicol, Celine; Tascon, Christophe; Giudice, Emmanuel; Guilbaud, Marine; Nicolas, Aurelie; Bondon, Arnaud; Hubert, Jean-Francois; Le Rumeur, Elisabeth] Univ Rennes, Inst Genet & Dev Rennes, CNRS, UMR 6290, F-35000 Rennes, France; [Morais, Raphael Dos Santos; Perez, Javier; Roblin, Pierre] Synchrotron SOLEIL, F-91190 St Aubin, France; [Morais, Raphael Dos Santos] Univ Paris Saclay, CEA Saclay, Lab Leon Brillouin, CNRS,UMR 12 CEA, F-91191 Gif Sur Yvette, France; [Guilbaud, Marine; Leturcq, France; Pietri-Rouxel, France] Sorbonne Univ, UPMC, INSERM, UMRS 97,CNRS,FRE 3617,Inst Myol, F-75013 Paris, France; [Bondon, Arnaud] Univ Rennes, Inst Sci Chim Rennes, CNRS, UMR 6226,PRISM, F-35000 Rennes, France; [Leturcq, France] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Lab Biochim & Genet Mol, F-75014 Paris, France; [Ferey, Nicolas] Univ Paris XI, CNRS, UPR3251, Orsay, France; [Baaden, Marc] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UPR9080, Paris, France; [Roblin, Pierre] INRA Biopolymeres Interact & Assemblages, F-44000 Nantes, France; [Czjzek, Mirjam] UPMC Univ Paris 06, Sorbonne Univ, F-75006 Paris, France; [Czjzek, Mirjam] CNRS, UMR 8227, Integrat Biol Marine Models, F-29688 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; SOLEIL Synchrotron; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Information Sciences & Technologies (INS2I); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Delalande, O (corresponding author), Inst Genet Dev Rennes, Fac Pharm, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	olivier.delalande@univ-rennes1.fr	Nicolas, Aurélie/AAE-9832-2019; Baaden, Marc/C-6623-2008; Raguenes-Nicol, Celine/I-2693-2015; Giudice, Emmanuel/AFT-2595-2022	Nicolas, Aurélie/0000-0002-6960-9362; Baaden, Marc/0000-0001-6472-0486; Raguenes-Nicol, Celine/0000-0001-8428-9558; bondon, arnaud/0000-0002-9229-6317; Pietri-Rouxel, France/0000-0002-6258-7594; GIUDICE, Emmanuel/0000-0001-7209-7890	Association Francaise Contre les Myopathies; AFM-Telethon; Conseil Regional de Bretagne; RTR Biologie-Sante of the Universite Europeenne de Bretagne; Grand Equipement National de Calcul Intensif-GENCI Program (DYSIM Project)	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); AFM-Telethon(Association Francaise contre les Myopathies); Conseil Regional de Bretagne(Region Bretagne); RTR Biologie-Sante of the Universite Europeenne de Bretagne; Grand Equipement National de Calcul Intensif-GENCI Program (DYSIM Project)	This work was supported by research grants from the Association Francaise Contre les Myopathies, AFM-Telethon, the Conseil Regional de Bretagne, RTR Biologie-Sante of the Universite Europeenne de Bretagne, and the Grand Equipement National de Calcul Intensif-GENCI Program (DYSIM Project). The authors declare that they have no conflicts of interest with the contents of this article.	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Bajanca F, 2015, ELIFE, V4, DOI 10.7554/eLife.06541; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Bressler I, 2015, J APPL CRYSTALLOGR, V48, P1587, DOI 10.1107/S1600576715016544; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Dorival J, 2016, J AM CHEM SOC, V138, P4155, DOI 10.1021/jacs.5b13372; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Findlay AR, 2015, ANN NEUROL, V77, P668, DOI 10.1002/ana.24365; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Gentil C, 2012, HUM MOL GENET, V21, P3449, DOI 10.1093/hmg/dds176; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kohlbrecher J., 2010, SASFIT; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Mirijanian DT, 2007, J MOL BIOL, V365, P523, DOI 10.1016/j.jmb.2006.10.003; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Molza AE, 2014, FARADAY DISCUSS, V169, P45, DOI 10.1039/c3fd00134b; Molza AE, 2015, J BIOL CHEM, V290, P29531, DOI 10.1074/jbc.M115.680660; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muthu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040066; Nicolas A, 2015, HUM MOL GENET, V24, P1267, DOI 10.1093/hmg/ddu537; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ribeiro ED, 2014, CELL, V159, P1447, DOI 10.1016/j.cell.2014.10.056; Ricotti V, 2015, NEUROMUSCULAR DISORD, V25, P932, DOI 10.1016/j.nmd.2015.10.007; Seto Jane T, 2014, Curr Pediatr Rep, V2, P102; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Wilton SD, 2015, TRENDS MOL MED, V21, P417, DOI 10.1016/j.molmed.2015.04.006; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Young C. S., 2016, CELL STEM CELL, V18, P1, DOI [10.1016/j.stem.2015.12.009, DOI 10.1016/J.STEM.2015.12.009]	48	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6637	6646		10.1074/jbc.M117.809798	http://dx.doi.org/10.1074/jbc.M117.809798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29535188	Green Published, hybrid			2022-12-28	WOS:000431487300001
J	Guan, RB; Li, HC; Fan, YJ; Hu, SR; Christiaens, O; Smagghe, G; Miao, XX				Guan, Ruo-Bing; Li, Hai-Chao; Fan, Yu-Jie; Hu, Shao-Ru; Christiaens, Olivier; Smagghe, Guy; Miao, Xue-Xia			A nuclease specific to lepidopteran insects suppresses RNAi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; SCHISTOCERCA-GREGARIA; DESERT LOCUST; BOMBYX-MORI; PIN DOMAINS; INTERFERENCE; GENE; EXPRESSION; INJECTION	More than 70% of all agricultural pests are insects in the order Lepidoptera, which, unlike other related insect orders, are not very sensitive to RNAi, limiting genetic studies of this insect group. However, the reason for this distinct lepidopteran characteristic is unknown. Previously, using transcriptome analysis of the Asian corn borer Ostrinia furnacalis, we identified a gene, termed up56, that is up-regulated in response to dsRNA. Here we report that this Lepidoptera-specific gene encodes a nuclease that contributes to RNAi insensitivity in this insect order. Its identity was experimentally validated, and sequence analysis indicated that up56 encodes a previously uncharacterized protein with homologous sequences in seven other lepidopteran species. Its computationally predicted three-dimensional structure revealed a high structural similarity to human exonuclease I. Exposure to dsRNA in O. furnacalis strongly up-regulated this gene's expression, and the protein could digest single-stranded RNA (ssRNA), dsRNA, and dsDNA both in vitro and in vivo. Of note, we found that this up-regulation of up56 expression is faster than that of the gene encoding the key RNAi-associated nuclease Dicer. up56 knockdown in O. furnacalis significantly enhanced RNAi efficiency. Moreover, up56 overexpression in Drosophila melanogaster suppressed RNAi efficiency. Finally, up56 knockdown significantly increased the amount and diversity of small RNAs. Therefore, we renamed this protein RNAi efficiency-related nuclease (REase). In conclusion, we propose that REase may explain why lepidopterans are refractory to RNAi and that it represents a target for further research of RNAi efficiency in this insect order.	[Guan, Ruo-Bing; Li, Hai-Chao; Fan, Yu-Jie; Hu, Shao-Ru; Miao, Xue-Xia] Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Hu, Shao-Ru] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Christiaens, Olivier; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ghent University	Miao, XX (corresponding author), Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.; Smagghe, G (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be; xxm@sibs.ac.cn	Li, Haichao/AGY-6004-2022; Smagghe, Guy/AAE-8914-2019; Christiaens, Olivier/AAB-3634-2019	Li, Haichao/0000-0002-1359-4640; Smagghe, Guy/0000-0001-8334-3313; Christiaens, Olivier/0000-0001-5850-340X	National Basic Research Program of China [2015CB755703]; National Key R&D Program of China [2017YFD0200900]; National Transgenic Great Subject from the Ministry of Agriculture of China [2016ZX08009003-001-002]; National Natural Science Foundation of China [31672354, 31702057]	National Basic Research Program of China(National Basic Research Program of China); National Key R&D Program of China; National Transgenic Great Subject from the Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2015CB755703), the National Key R&D Program of China (2017YFD0200900), the National Transgenic Great Subject from the Ministry of Agriculture of China (2016ZX08009003-001-002), and the National Natural Science Foundation of China (31672354 and 31702057). The authors declare that they have no conflicts of interest with the contents of this article.	Allen ML, 2012, J INSECT PHYSIOL, V58, P391, DOI 10.1016/j.jinsphys.2011.12.014; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arimatsu Y, 2007, INSECT BIOCHEM MOLEC, V37, P176, DOI 10.1016/j.ibmb.2006.11.004; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christiaens O, 2016, SCI REP-UK, V6, DOI 10.1038/srep38836; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Dowling D, 2016, GENOME BIOL EVOL, V8, P3784, DOI 10.1093/gbe/evw281; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garbutt JS, 2013, J INSECT PHYSIOL, V59, P171, DOI 10.1016/j.jinsphys.2012.05.013; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Guan RB, 2018, INSECT SCI, V25, P356, DOI 10.1111/1744-7917.12437; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ivashuta S, 2015, RNA, V21, P840, DOI 10.1261/rna.048116.114; Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553; Kennedy S., 2004, C ELEGANS NATURE, V427, P640; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Liu JH, 2012, J INSECT PHYSIOL, V58, P1166, DOI 10.1016/j.jinsphys.2012.05.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luo Y, 2013, INSECT MOL BIOL, V22, P574, DOI 10.1111/imb.12046; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meiss G, 1999, J MOL BIOL, V288, P377, DOI 10.1006/jmbi.1999.2694; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Page MF, 1999, MOL CELL BIOL, V19, P5943; Prentice K, 2017, PEST MANAG SCI, V73, P44, DOI 10.1002/ps.4337; Santos D, 2014, CURR OPIN INSECT SCI, V6, P9, DOI 10.1016/j.cois.2014.09.013; Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Spit J, 2017, INSECT BIOCHEM MOLEC, V81, P103, DOI 10.1016/j.ibmb.2017.01.004; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tijsterman M, 2004, CELL, V117, P1, DOI 10.1016/S0092-8674(04)00293-4; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Weinheimer I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004711; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	41	85	94	5	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6011	6021		10.1074/jbc.RA117.001553	http://dx.doi.org/10.1074/jbc.RA117.001553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29500196	hybrid, Green Published			2022-12-28	WOS:000430497300021
J	McCullough, LL; Connell, Z; Xin, H; Studitsky, VM; Feofanov, AV; Valieva, ME; Formosa, T				McCullough, Laura L.; Connell, Zaily; Xin, Hua; Studitsky, Vasily M.; Feofanov, Alexey V.; Valieva, Maria E.; Formosa, Tim			Functional roles of the DNA-binding HMGB domain in the histone chaperone FACT in nucleosome reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP BOX; SACCHAROMYCES-CEREVISIAE; CHROMATIN-STRUCTURE; PROTEIN NHP6A; TRANSCRIPTION; REPLICATION; REVEALS; POB3; H2A-H2B; COMPLEX	The essential histone chaperone FACT (facilitates chromatin transcription) promotes both nucleosome assembly and disassembly. FACT is a heterodimer of Spt16 with either SSRP1 or Pob3, differing primarily by the presence of a high-mobility group B (HMGB) DNA-binding domain furnished only by SSRP1. Yeast FACT lacks the intrinsic HMGB domain found in SSRP1-based homologs such as human FACT, but yeast FACT activity is supported by Nhp6, which is a freestanding, single HMGB-domain protein. The importance of histone binding by FACT domains has been established, but the roles of DNA-binding activity remain poorly understood. Here, we examined these roles by fusing single or multiple HMGB modules to Pob3 to mimic SSRP1 or to test the effects of extended DNA-binding capacity. Human FACT and a yeast mimic both required Nhp6 to support nucleosome reorganization in vitro, indicating that a single intrinsic DNA-binding HMGB module is insufficient for full FACT activity. Three fused HMGB modules supported activity without Nhp6 assistance, but this FACT variant did not efficiently release from nucleosomes and was toxic in vivo. Notably, intrinsic DNA-binding HMGB modules reduced the DNA accessibility and histone H2A-H2B dimer loss normally associated with nucleosome reorganization. We propose that DNA bending by HMGB domains promotes nucleosome destabilization and reorganization by exposing FACT's histone-binding sites, but DNA bending also produces DNA curvature needed to accommodate nucleosome assembly. Intrinsic DNA-bending activity therefore favors nucleosome assembly by FACT over nucleosome reorganization, but excessive activity impairs FACT release, suggesting a quality control checkpoint during nucleosome assembly.	[McCullough, Laura L.; Connell, Zaily; Xin, Hua; Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; [Studitsky, Vasily M.; Feofanov, Alexey V.; Valieva, Maria E.] Lomonosov Moscow State Univ, Biol Fac, Leninskie Gory 1, Moscow 119992, Russia; [Feofanov, Alexey V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Studitsky, Vasily M.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Utah System of Higher Education; University of Utah; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Fox Chase Cancer Center	Formosa, T (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr East,Rm 4100, Salt Lake City, UT 84112 USA.	tim@biochem.utah.edu	Valieva, Maria/AAP-1168-2021; Feofanov, Alexey V/K-3082-2012	Valieva, Maria/0000-0002-4419-2839; Feofanov, Alexey V/0000-0002-1596-9506	National Institutes of Health Grants [R01 GM064649, R01 GM119398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119398, R01GM064649] Funding Source: NIH RePORTER; Russian Science Foundation [17-24-00007] Funding Source: Russian Science Foundation	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by National Institutes of Health Grants R01 GM064649 (to T.F.) and R01 GM119398 (to V.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Evans DRH, 1998, GENETICS, V150, P1393; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hoffmann C, 2015, ACS CHEM BIOL, V10, P2753, DOI 10.1021/acschembio.5b00493; Hondele M, 2013, NUCLEUS-AUSTIN, V4, P443, DOI 10.4161/nucl.27235; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Khuong MT, 2015, COLD SH Q B, V80, P65, DOI 10.1101/sqb.2015.80.027300; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Kruppa M, 2001, MOL CELL, V7, P309, DOI 10.1016/S1097-2765(01)00179-4; Kurat CF, 2017, MOL CELL, V65, P117, DOI 10.1016/j.molcel.2016.11.016; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCullough L, 2015, GENETICS, V201, P1031, DOI 10.1534/genetics.115.180794; McCullough L, 2013, GENETICS, V195, P101, DOI 10.1534/genetics.113.153080; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Paull TT, 1996, GENE DEV, V10, P2769, DOI 10.1101/gad.10.21.2769; Prendergast L, 2016, GENE DEV, V30, P1313, DOI 10.1101/gad.275073.115; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Singer RA, 2004, BIOCHEM CELL BIOL, V82, P419, DOI 10.1139/O04-050; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; Valieva M. E., 2017, CANCERS, V9, pE3; Valieva ME, 2016, NAT STRUCT MOL BIOL, V23, P1111, DOI 10.1038/nsmb.3321; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yang JY, 2016, CELL REP, V14, P1128, DOI 10.1016/j.celrep.2015.12.096; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Yen YM, 1998, J BIOL CHEM, V273, P4424, DOI 10.1074/jbc.273.8.4424; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791	55	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6121	6133		10.1074/jbc.RA117.000199	http://dx.doi.org/10.1074/jbc.RA117.000199			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29514976	hybrid, Green Published			2022-12-28	WOS:000430497300029
J	DeMartino, GN				DeMartino, George N.			Introduction to the Thematic Minireview Series: Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; MUTANTS	Autophagy is a highly conserved, tightly regulated cellular process that degrades intracellular constituents via lysosomes. Autophagy mediates many normal cellular functions and is dys-regulated in numerous diseases. This Thematic Series consists of five Minireviews that highlight selected topics of current autophagy research ranging from the molecular mechanisms and regulation of autophagy to the roles of autophagy in health and disease.	[DeMartino, George N.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	gdemartino@asbmb.org						DEDUVE C, 1964, FED PROC, V23, P1045; Delorme-Axford E, 2018, J BIOL CHEM, V293, P5396, DOI 10.1074/jbc.R117.804641; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Grumati P, 2018, J BIOL CHEM, V293, P5404, DOI 10.1074/jbc.TM117.000117; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mercer TJ, 2018, J BIOL CHEM, V293, P5386, DOI 10.1074/jbc.R117.810366; NOVIKOFF AB, 1959, J BIOPHYS BIOCHEM CY, V6, P136, DOI 10.1083/jcb.6.1.136; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; Thorburn A, 2018, J BIOL CHEM, V293, P5425, DOI 10.1074/jbc.R117.810739; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E	14	6	7	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5384	5385		10.1074/jbc.TM118.002429	http://dx.doi.org/10.1074/jbc.TM118.002429			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29467224	Green Published, hybrid			2022-12-28	WOS:000430044100002
J	Nakayama, S; Yumimoto, K; Kawamura, A; Nakayama, KI				Nakayama, Shogo; Yumimoto, Kanae; Kawamura, Atsuki; Nakayama, Keiichi I.			Degradation of the endoplasmic reticulum-anchored transcription factor MyRF by the ubiquitin ligase SCFFbxw7 in a manner dependent on the kinase GSK-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; GENE REGULATORY FACTOR; TUMOR-SUPPRESSOR; CYCLIN-E; C-MYC; CAENORHABDITIS-ELEGANS; PHOSPHODEGRON MOTIFS; FBW7; PHOSPHORYLATION; CANCER	The ubiquitin-proteasome system regulates the abundance of many cellular proteins by mediating their targeted degradation. We previously developed a method-differential proteomics-based identification of ubiquitylation substrates (DiPIUS)-for the comprehensive identification of substrates for a given F-box protein subunit of SCF-type ubiquitin ligases. We have now applied DiPIUS to the F-box protein Fbxw7 in three cell lines (mHepa, Neuro2A, and C2C12) and thereby identified myelin regulatory factor (MyRF), an endoplasmic reticulum-anchored transcription factor that is essential for myelination of nerves in the central nervous system, as a candidate substrate of Fbxw7 specifically in mHepa cells. Co-immunoprecipitation analysis confirmed that the NH2-terminal cytoplasmic domain of MyRF interacted with Fbxw7 in these cells. Furthermore, an in vitro ubiquitylation assay revealed that MyRF undergoes polyubiquitylation in the presence of purified recombinant SCFFbxw7. In addition, the stability of MyRF in mHepa cells was increased by mutation of a putative phosphodegron sequence or by exposure of the cells to an inhibitor of glycogen synthase kinase-3 (GSK-3). We found that MyRF mRNA is not restricted to the central nervous system but is instead distributed widely among mouse tissues. Furthermore, with the use of RNA sequencing in mHepa cells overexpressing or depleted of MyRF, we identified many novel potential target genes of MyRF. Our results thus suggest that Fbxw7 controls the transcription of MyRF target genes in various tissues through regulation of MyRF protein stability in a manner dependent on MyRF phosphorylation by GSK-3.	[Nakayama, Shogo; Yumimoto, Kanae; Kawamura, Atsuki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	Kyushu University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25221303, 17H06301, 15H01186]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25221303 and 17H06301 (to K. I. N.) and 15H01186 (to K. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kanazawa K, 2003, J BONE MINER RES, V18, P443, DOI 10.1359/jbmr.2003.18.3.443; Katayama Y, 2016, NATURE, V537, P675, DOI 10.1038/nature19357; Kearns CA, 2015, J NEUROSCI, V35, P14861, DOI 10.1523/JNEUROSCI.4968-14.2015; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUNDARAM M, 1993, GENETICS, V135, P765; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	51	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5705	5714		10.1074/jbc.RA117.000741	http://dx.doi.org/10.1074/jbc.RA117.000741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29472293	Green Published, hybrid			2022-12-28	WOS:000430044100030
J	Thomas, ME; Grinshpon, R; Swartz, P; Clark, AC				Thomas, Melvin E., III; Grinshpon, Robert; Swartz, Paul; Clark, A. Clay			Modifications to a common phosphorylation network provide individualized control in caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; SEQUENCE; DIFFERENTIATION; INHIBITION; STABILITY; APOPTOSIS; DYNAMICS; MUSCLE; MODELS; PH	Caspase-3 activation and function have been well-defined during programmed cell death, but caspase activity, at low levels, is also required for developmental processes such as lymphoid proliferation and erythroid differentiation. Post-translational modification of caspase-3 is one method used by cells to fine-tune activity below the threshold required for apoptosis, but the allosteric mechanism that reduces activity is unknown. Phosphorylation of caspase-3 at a conserved allosteric site by p38-MAPK (mitogen-activated protein kinase) promotes survival in human neutrophils, and the modification of the loop is thought to be a key regulator in many developmental processes. We utilized phylogenetic, structural, and biophysical studies to define the interaction networks that facilitate the allosteric mechanism in caspase-3. We show that, within the modified loop, Ser(150) evolved with the apoptotic caspases, whereas Thr(152) is a more recent evolutionary event in mammalian caspase-3. Substitutions at Ser150 result in a pH-dependent decrease in dimer stability, and localized changes in the modified loop propagate to the active site of the same protomer through a connecting surface helix. Likewise, a cluster of hydrophobic amino acids connects the conserved loop to the active site of the second protomer. The presence of Thr152 in the conserved loop introduces a "kill switch" in mammalian caspase-3, whereas the more ancient Ser150 reduces without abolishing enzyme activity. These data reveal how evolutionary changes in a conserved allosteric site result in a common pathway for lowering activity during development or a more recent cluster-specific switch to abolish activity.	[Thomas, Melvin E., III; Grinshpon, Robert; Swartz, Paul] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27608 USA; [Clark, A. Clay] Univ Texas Arlington, Dept Biol, Box 19498,501 S Nedderman Dr,337 Life Sci Bldg, Arlington, TX 76019 USA	University of North Carolina; North Carolina State University; University of Texas System; University of Texas Arlington	Clark, AC (corresponding author), Univ Texas Arlington, Dept Biol, Box 19498,501 S Nedderman Dr,337 Life Sci Bldg, Arlington, TX 76019 USA.	clay.clark@uta.edu		Swartz, Paul/0000-0002-2064-9443	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-ENG-38]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Drs. Jeanne Hardy and Guy Salvesen for the donation of caspase-6 and caspase-7 plasmids, respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boehm D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062303; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bose K, 2005, PROTEIN SCI, V14, P24; Bose K, 2003, BIOCHEMISTRY-US, V42, P12298, DOI 10.1021/bi034998x; Bose K, 2001, BIOCHEMISTRY-US, V40, P14236, DOI 10.1021/bi0110387; Cade C, 2014, BIOCHEMISTRY-US, V53, P7582, DOI 10.1021/bi500874k; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Chen AA, 2007, J PHYS CHEM B, V111, P11884, DOI 10.1021/jp0765392; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Clark AC, 2016, CHEM REV, V116, P6666, DOI 10.1021/acs.chemrev.5b00540; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dagbay K, 2014, METHOD ENZYMOL, V544, P215, DOI 10.1016/B978-0-12-417158-9.00009-1; Denault JB, 2003, J BIOL CHEM, V278, P34042, DOI 10.1074/jbc.M305110200; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eron SJ, 2017, STRUCTURE, V25, P27, DOI 10.1016/j.str.2016.11.001; Feeney B, 2005, J BIOL CHEM, V280, P39772, DOI 10.1074/jbc.M505834200; Feeney B, 2004, BIOCHEM J, V384, P515, DOI 10.1042/BJ20040693; Feeney B, 2006, BIOCHEMISTRY-US, V45, P13249, DOI 10.1021/bi0611964; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Li X, 2011, J BIOL CHEM, V286, P22291, DOI 10.1074/jbc.M111.236596; Maciag JJ, 2016, P NATL ACAD SCI USA, V113, pE6080, DOI 10.1073/pnas.1603549113; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Makishima T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-102; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish Amanda B, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a008672; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Peng C, 2011, J BIOL CHEM, V286, P6946, DOI 10.1074/jbc.M110.172338; Pop C, 2003, BIOCHEMISTRY-US, V42, P12311, DOI 10.1021/bi034999p; Pop C, 2001, BIOCHEMISTRY-US, V40, P14224, DOI 10.1021/bi011037e; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Velazquez-Delgado EM, 2012, J BIOL CHEM, V287, P36000, DOI 10.1074/jbc.M112.397752; Walters J, 2012, BIOSCIENCE REP, V32, P401, DOI 10.1042/BSR20120037; Walters J, 2011, ARCH BIOCHEM BIOPHYS, V508, P31, DOI 10.1016/j.abb.2011.01.011; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	68	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5447	5461		10.1074/jbc.RA117.000728	http://dx.doi.org/10.1074/jbc.RA117.000728			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414778	Green Published, hybrid			2022-12-28	WOS:000430044100009
J	Blum, W; Henzi, T; Schwaller, B; Pecze, L				Blum, Walter; Henzi, Thomas; Schwaller, Beat; Pecze, Laszlo			Biological noise and positional effects influence cell stemness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; cancer biology; differentiation; cell differentiation; growth factor	MESOTHELIAL CELLS; REPORTER SYSTEM; CANCER; IDENTIFICATION; PROLIFERATION; POPULATIONS; CALRETININ; PROMOTE; GROWTH; VITRO	Biological (or cellular) noise is the random quantitative variability of proteins and other molecules in individual, genetically identical cells. As the result of biological noise in the levels of some transcription factors that determine a cell's differentiation status, differentiated cells may dedifferentiate to a stem cell state given a sufficiently long time period. Here, to provide direct evidence supporting this hypothesis, we used a live-cell monitoring system based on enhanced green fluorescent protein (eGFP) expression to continuously assess the stemness of individual human and murine malignant mesothelioma cells over a period of up to 3 months. Re-expression of the transcription factors, the top hierarchical stemness markers Sox2 (SRY-box 2) and Oct4 (octamer-binding transcription factor), monitored as cell eGFP expression was observed in a subpopulation of differentiated eGFP(-) malignant mesothelioma cells. However, we found that this transition was extremely rare. Of note, when it did occur, neighboring cells that were not direct descendants of a newly emerged eGFP(+) stem cell were more likely than non-neighboring cells to also become an eGFP(+) stem cell. This observation suggested a positional effect and led to a clustered mosaic reappearance of eGFP(+) stem cells. Moreover, stem cells reappeared even in cell cultures derived from one single differentiated eGFP(-) cell. On the basis of our experimental in vitro and in vivo findings, we developed a tumor growth model to predict the clustered localization of cancer stem cells within a tumor mass.	[Blum, Walter; Henzi, Thomas; Schwaller, Beat; Pecze, Laszlo] Univ Fribourg, Unit Anat, Med Sect, CH-1700 Fribourg, Switzerland	University of Fribourg	Schwaller, B; Pecze, L (corresponding author), Univ Fribourg, Dept Med, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch; laszlo.pecze@unifr.ch		Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 168449]; Forschungspool der Universitat Fribourg	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungspool der Universitat Fribourg	This work was supported by Swiss National Science Foundation Grants 130680 (to B.S.) and 168449 (to W.B.) and a grant from the Forschungspool der Universitat Fribourg (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akrap N, 2016, STEM CELL REP, V6, P121, DOI 10.1016/j.stemcr.2015.12.006; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Bartfeld S, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.261; Blum W, 2017, STEM CELL REP, V8, P1005, DOI 10.1016/j.stemcr.2017.02.005; Blum W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0311-6; Blum W, 2015, IN VITRO CELL DEV-AN, V51, P714, DOI 10.1007/s11626-015-9885-z; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; Dauleh S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158997; David Ebdon., 1985, STAT GEOGRAPHY; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enderling H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00076; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hale JS, 2012, CELL ADHES MIGR, V6, P346, DOI 10.4161/cam.21294; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kim HW, 2009, J KOREAN ACAD NURS, V39, P33, DOI 10.4040/jkan.2009.39.1.33; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Palle K, 2015, CANCERS, V7, P2330, DOI 10.3390/cancers7040894; Pasetto R, 2005, Med Lav, V96, P330; Pecze L, 2015, BBA-MOL CELL RES, V1853, P632, DOI 10.1016/j.bbamcr.2014.12.025; Poleszczuk J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3923527; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Smith Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep12617; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Tang BW, 2015, STEM CELL REP, V4, P155, DOI 10.1016/j.stemcr.2014.11.002; Thiagarajan PS, 2015, STEM CELLS, V33, P2114, DOI 10.1002/stem.2021; Toom A. L., 1978, LOCALLY INTERACTING; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; van Neerven SM, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1098791; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Yan K, 2014, GENE DEV, V28, P1085, DOI 10.1101/gad.235515.113; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	46	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5247	5258		10.1074/jbc.RA117.001643	http://dx.doi.org/10.1074/jbc.RA117.001643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440274	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000429409300029
J	Kontur, WS; Bingman, CA; Olmsted, CN; Wassarman, DR; Ulbrich, A; Gall, DL; Smith, RW; Yusko, LM; Fox, BG; Noguera, DR; Coon, JJ; Donohue, TJ				Kontur, Wayne S.; Bingman, Craig A.; Olmsted, Charles N.; Wassarman, Douglas R.; Ulbrich, Arne; Gall, Daniel L.; Smith, Robert W.; Yusko, Larissa M.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.			Novosphingobium aromaticivorans uses a Nu-class glutathione S-transferase as a glutathione lyase in breaking the beta-aryl ether bond of lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial metabolism; enzyme mechanism; enzyme structure; lignin degradation; Escherichia coli (E; coli); beta-aryl ether; deglutathionylation; glutathione S-transferases; Novosphingobium aromaticivorans; Nu-class	ESCHERICHIA-COLI; STRAIN; CLEAVAGE; BACTERIUM; IDENTIFICATION; MECHANISM; GUAIACYL; FEATURES; ENZYMES; SYSTEM	As a major component of plant cell walls, lignin is a potential renewable source of valuable chemicals. Several sphingomonad bacteria have been identified that can break the -aryl ether bond connecting most phenylpropanoid units of the lignin heteropolymer. Here, we tested three sphingomonads predicted to be capable of breaking the -aryl ether bond of the dimeric aromatic compound guaiacylglycerol--guaiacyl ether (GGE) and found that Novosphingobium aromaticivorans metabolizes GGE at one of the fastest rates thus far reported. After the ether bond of racemic GGE is broken by replacement with a thioether bond involving glutathione, the glutathione moiety must be removed from the resulting two stereoisomers of the phenylpropanoid conjugate -glutathionyl--hydroxypropiovanillone (GS-HPV). We found that the Nu-class glutathione S-transferase NaGST(Nu) is the only enzyme needed to remove glutathione from both (R)- and (S)-GS-HPV in N. aromaticivorans. We solved the crystal structure of NaGST(Nu) and used molecular modeling to propose a mechanism for the glutathione lyase (deglutathionylation) reaction in which an enzyme-stabilized glutathione thiolate attacks the thioether bond of GS-HPV, and the reaction proceeds through an enzyme-stabilized enolate intermediate. Three residues implicated in the proposed mechanism (Thr(51), Tyr(166), and Tyr(224)) were found to be critical for the lyase reaction. We also found that Nu-class GSTs from Sphingobium sp. SYK-6 (which can also break the -aryl ether bond) and Escherichia coli (which cannot break the -aryl ether bond) can also cleave (R)- and (S)-GS-HPV, suggesting that glutathione lyase activity may be common throughout this widespread but largely uncharacterized class of glutathione S-transferases.	[Kontur, Wayne S.; Olmsted, Charles N.; Wassarman, Douglas R.; Gall, Daniel L.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA; [Kontur, Wayne S.; Bingman, Craig A.; Olmsted, Charles N.; Wassarman, Douglas R.; Gall, Daniel L.; Smith, Robert W.; Fox, Brian G.; Noguera, Daniel R.; Coon, Joshua J.; Donohue, Timothy J.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Ulbrich, Arne; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Bingman, Craig A.; Smith, Robert W.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ulbrich, Arne; Yusko, Larissa M.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Gall, Daniel L.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	tdonohue@bact.wisc.edu	Ulbrich, Arne/ABG-8048-2021; Donohue, Timothy/C-3273-2015	Donohue, Timothy/0000-0001-8738-2467; Wassarman, Douglas/0000-0002-6922-9378; Noguera, Daniel/0000-0003-0372-3063	Federal funds from NCI, National Institutes of Health (NIH) [ACB-12002]; NIGMS, NIH [AGM-12006, P41-GM103311]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant [1S10OD012289-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012289] Funding Source: NIH RePORTER	Federal funds from NCI, National Institutes of Health (NIH); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Matthew Scarborough for assistance with phylogenetic analysis using RAxML. We thank Craig Ogata for beamline assistance. GM/CA@APS has been funded in whole or in part with Federal funds from NCI, National Institutes of Health (NIH), Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This research used resources of the Advanced Photon Source, a DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. The Eiger 16M detector was funded by NIH-Office of Research Infrastructure Programs High-End Instrumentation Grant 1S10OD012289-01A1. Molecular modeling was performed with the UCSF Chimera package, which is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, NIH, Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Casanas A, 2016, ACTA CRYSTALLOGR D, V72, P1036, DOI 10.1107/S2059798316012304; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; DOHERTY AJ, 1995, NUCLEIC ACIDS RES, V23, P2074, DOI 10.1093/nar/23.11.2074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREDRICKSON JK, 1991, APPL ENVIRON MICROB, V57, P796, DOI 10.1128/AEM.57.3.796-803.1991; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gall DL, 2017, CURR OPIN BIOTECH, V45, P120, DOI 10.1016/j.copbio.2017.02.015; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Notomista E, 2011, MICROB ECOL, V61, P582, DOI 10.1007/s00248-010-9786-3; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Pal R, 2006, INT J SYST EVOL MICR, V56, P667, DOI 10.1099/ijs.0.64161-0; Palamuru S, 2015, APPL ENVIRON MICROB, V81, P8164, DOI 10.1128/AEM.01573-15; Pereira JH, 2016, J BIOL CHEM, V291, P10228, DOI 10.1074/jbc.M115.700427; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robertson GJ, 2017, BIOPHYS CHEM, V224, P40, DOI 10.1016/j.bpc.2017.02.004; Roret T, 2015, FUNGAL GENET BIOL, V83, P103, DOI 10.1016/j.fgb.2015.09.002; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Stolz A, 2000, INT J SYST EVOL MICR, V50, P35, DOI 10.1099/00207713-50-1-35; Stourman NV, 2011, BIOCHEMISTRY-US, V50, P1274, DOI 10.1021/bi101861a; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanamura K, 2011, BIOSCI BIOTECH BIOCH, V75, P2404, DOI 10.1271/bbb.110525; Tavano CL, 2005, J BACTERIOL, V187, P5249, DOI 10.1128/JB.187.15.5249-5258.2005; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; United States Department of Energy, 2015, DOESC0170 OFF SCI; VICUNA R, 1987, APPL ENVIRON MICROB, V53, P2605; Wadington MC, 2010, BIOCHEMISTRY-US, V49, P10765, DOI 10.1021/bi101851x; Wadington MC, 2009, BIOCHEMISTRY-US, V48, P6559, DOI 10.1021/bi9008825; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	46	32	35	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4955	4968		10.1074/jbc.RA117.001268	http://dx.doi.org/10.1074/jbc.RA117.001268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449375	hybrid, Green Published			2022-12-28	WOS:000429409300001
J	Han, J; Lachance, C; Ricketts, MD; McCullough, CE; Gerace, M; Black, BE; Cote, J; Marmorstein, R				Han, Joseph; Lachance, Catherine; Ricketts, M. Daniel; McCullough, Cheryl E.; Gerace, Morgan; Black, Ben E.; Cote, Jacques; Marmorstein, Ronen			The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAT HBO1; CHROMATIN; ACETYLATION; NUCLEOSOME; MECHANISM; PARTICLE; COMPLEX; CANCER; TAIL; CODE	The human enzyme histone acetyltransferase binding to ORC1 (HBO1) regulates DNA replication, cell proliferation, and development. HBO1 is part of a multiprotein histone acetyltransferase (HAT) complex that also contains inhibitor of growth family member (ING) 4/5, MYST/Esa1-associated factor (MEAF) 6, and the scaffolding proteins Jade family PHD finger (JADE) 1/2/3 or bromodomain and PHD finger-containing protein (BRPF) 2/3 to acetylate histone H4 H4K5/8/12 or H3K14, respectively. Within this four-protein complex, JADE1 determines histone H4 substrate specificity of the HBO1-HAT complex. However, the mechanism by which JADE1 controls the H4-specific acetyltransferase activity of HBO1 is unknown. Here we used recombinant proteins in vitro to dissect the specific regions and activities of HBO1 and JADE1 that mediate histone H3-H4 acetylation via the HBO1-HAT domain. We found that JADE1 increases the catalytic efficiency of HBO1 acetylation of an H3-H4 substrate by about 5-fold through an N-terminal, 21-residue HBO1-and histone-binding domain and a nearby second histone core-binding domain. We also demonstrate that HBO1 contains an N-terminal histone-binding domain (HBD) that makes additional contacts with H3-H4 independent of JADE1 interactions with histones and that the HBO1 HBD does not significantly contribute to HBO1's overall HAT activity. Experiments with JADE1 deletions in vivo recapitulated these in vitro interactions and their roles in HBO1 histone acetylation activity. Together, these results indicate that the N-terminal region of JADE1 functions as a platform that brings together the catalytic HBO1 subunit with its cognate H3-H4 substrate for histone acetylation.	[Han, Joseph; Ricketts, M. Daniel; McCullough, Cheryl E.; Gerace, Morgan; Black, Ben E.; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Han, Joseph; Ricketts, M. Daniel; McCullough, Cheryl E.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel] Univ Penn, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Han, Joseph; McCullough, Cheryl E.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Lachance, Catherine; Cote, Jacques] Laval Univ, Canc Res Ctr, CHU Quebec, Res Ctr,Oncol Axis, Quebec City, PQ G1R 3S3, Canada	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Laval University	Marmorstein, R (corresponding author), Univ Penn, Dept Biochem & Biophys, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@upenn.edu	Cote, Jacques/I-8901-2014	Cote, Jacques/0000-0001-6751-555X	National Institutes of Health [R01 GM060293, R35 GM118090, R01 GM082989]; Ovarian Cancer Research Fund Alliance; Canadian Institutes of Health Research [FDN-143314]; DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania [NIH P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, R01GM082989, R01GM060293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund Alliance; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM060293 and R35 GM118090 and the Ovarian Cancer Research Fund Alliance (to R.M.), Canadian Institutes of Health Research Grant FDN-143314 (to J. C.), National Institutes of Health Grant R01 GM082989 (to B. E. B.), and the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Duong MT, 2013, CANCER RES, V73, P5556, DOI 10.1158/0008-5472.CAN-13-0013; Feng YP, 2016, EMBO J, V35, P176, DOI 10.15252/embj.201591293; Foy RL, 2008, J BIOL CHEM, V283, P28817, DOI 10.1074/jbc.M801407200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Havasi A, 2013, AM J PATHOL, V182, P152, DOI 10.1016/j.ajpath.2012.09.017; Iizuka M, 2009, GENE, V436, P108, DOI 10.1016/j.gene.2009.01.020; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Luger K, 1999, METHOD ENZYMOL, V304, P3; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Piche B, 2010, CELL MOL LIFE SCI, V67, P1987, DOI 10.1007/s00018-010-0312-z; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sapountzi V, 2011, CELL MOL LIFE SCI, V68, P1147, DOI 10.1007/s00018-010-0599-9; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tao Y, 2017, NUCLEIC ACIDS RES, V45, P5707, DOI 10.1093/nar/gkx142; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomas T, 2007, CELL CYCLE, V6, P696, DOI 10.4161/cc.6.6.4013; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Xu P, 2016, MOL CELL, V63, P965, DOI 10.1016/j.molcel.2016.07.024; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Ythier D, 2008, INT J CANCER, V123, P1483, DOI 10.1002/ijc.23790; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	34	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4498	4509		10.1074/jbc.RA117.000677	http://dx.doi.org/10.1074/jbc.RA117.000677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382722	hybrid, Green Published			2022-12-28	WOS:000428204300021
J	Rossi, P; Sterlini, B; Castroflorio, E; Marte, A; Onofri, F; Valtorta, F; Maragliano, L; Corradi, A; Benfenati, F				Rossi, Pia; Sterlini, Bruno; Castroflorio, Enrico; Marte, Antonella; Onofri, Franco; Valtorta, Flavia; Maragliano, Luca; Corradi, Anna; Benfenati, Fabio			A novel topology of proline-rich transmembrane protein 2 (PRRT2): Hints for an intracellular function at the synapse (vol 291, pg 6111, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Corradi, Anna/AAC-5209-2022; VALTORTA, Flavia/F-3450-2012	VALTORTA, Flavia/0000-0001-9556-4746	Italian Ministry of Health Ricerca Finalizzata [RF-2011-0234847]	Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	There was an error in the grant footnote. "... and Italian Ministry of Health Ricerca Finalizzata 2013 (to F. V. and F. B.)" should read "Italian Ministry of Health Ricerca Finalizzata (RF-2011-0234847 to F. V. and F. B.)."	Rossi P, 2016, J BIOL CHEM, V291, P6111, DOI 10.1074/jbc.M115.683888	1	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4581	4581		10.1074/jbc.AAC118.002651	http://dx.doi.org/10.1074/jbc.AAC118.002651			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572331	Green Published, hybrid			2022-12-28	WOS:000428204300033
J	Shumar, SA; Kerr, EW; Geldenhuys, WJ; Montgomery, GE; Fagone, P; Thirawatananond, P; Saavedra, H; Gabelli, SB; Leonardi, R				Shumar, Stephanie A.; Kerr, Evan W.; Geldenhuys, Werner J.; Montgomery, Grace E.; Fagone, Paolo; Thirawatananond, Puchong; Saavedra, Harry; Gabelli, Sandra B.; Leonardi, Roberta			Nudt19 is a renal CoA diphosphohydrolase with biochemical and regulatory properties that are distinct from the hepatic Nudt7 isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL NUDIX HYDROLASE; COENZYME-A; ACYL-COA; METABOLIC-REGULATION; LYSINE ACETYLATION; GENE ENCODES; PROTEIN; REVEALS; PYROPHOSPHATASE; ENZYME	CoA is the major acyl carrier in mammals and a key cofactor in energy metabolism. Dynamic regulation of CoA in different tissues and organs supports metabolic flexibility. Two mammalian Nudix hydrolases, Nudt19 and Nudt7, degrade CoA in vitro. Nudt19 and Nudt7 possess conserved Nudix and CoA signature sequences and specifically hydrolyze the diphosphate bond of free CoA and acyl-CoAs to form 3',5'-ADP and 4'-(acyl) phos-phopantetheine. Limited information is available on these enzymes, but the relatively high abundance of Nudt19 and Nudt7 mRNA in the kidney and liver, respectively, suggests that they play specific roles in the regulation of CoA levels in these organs. Here, we analyzed Nudt19(-/-) mice and found that deletion of Nudt19 elevates kidneyCoAlevels in mice fed ad libitum, indicating that Nudt19 contributes to the regulation of CoA in vivo. Unlike what was observed for the regulation of Nudt7 in the liver, Nudt19 transcript and protein levels in the kidney did not differ between fed and fasted states. Instead, we identified chenodeoxycholic acid as a specific Nudt19 inhibitor that competed with CoA for Nudt19 binding but did not bind to Nudt7. Exchange of the Nudix and CoA signature motifs between the two isoforms dramatically decreased their k(cat). Furthermore, substitutions of conserved residues within these motifs identified amino acids playing different roles in CoA binding and hydrolysis in Nudt19 and Nudt7. Our results reveal that the kidney and liver each possesses a distinct peroxisomal CoA diphosphohydrolase.	[Shumar, Stephanie A.; Kerr, Evan W.; Montgomery, Grace E.; Fagone, Paolo; Leonardi, Roberta] West Virginia Univ, Dept Biochem, 1 Med Ctr Dr, Morgantown, WV 26501 USA; [Geldenhuys, Werner J.] West Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26501 USA; [Thirawatananond, Puchong; Saavedra, Harry; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Thirawatananond, Puchong] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Montgomery, Grace E.] Wesleyan Coll, 59 Coll Ave, Buckhannon, WV 26201 USA	West Virginia University; West Virginia University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Leonardi, R (corresponding author), West Virginia Univ, Dept Biochem, 1 Med Ctr Dr, Morgantown, WV 26501 USA.	roleonardi@hsc.wvu.edu	; Gabelli, Sandra/A-3705-2008	Saavedra, Harry/0000-0002-8896-5020; Thirawatananond, Puchong/0000-0003-4973-7380; Gabelli, Sandra/0000-0003-1205-5204; Fagone, Paolo/0000-0002-0102-3701	West Virginia University's School of Medicine startup foundation funding; Allegheny Health Network-Johns Hopkins Cancer Research Fund; National Institutes of Health (NIH) [GM119528, F31 GM126838, P20 GM103434]; WVU Stroke CoBRE [P20 GM109098, CA062924]; WVU Cancer Institute; NIH [P20RR016440, P30RR032138/P30GM103488, U54GM104942]; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, P30RR032138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109098, P20GM103434, R35GM119528, U54GM104942, F31GM126838, P30GM103488] Funding Source: NIH RePORTER	West Virginia University's School of Medicine startup foundation funding; Allegheny Health Network-Johns Hopkins Cancer Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WVU Stroke CoBRE; WVU Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by West Virginia University's School of Medicine startup foundation funding (RL), the Allegheny Health Network-Johns Hopkins Cancer Research Fund (SBG), and National Institutes of Health (NIH) Grants GM119528 (RL), F31 GM126838 (SAS), P20 GM103434 awarded to the West Virginia IDeA Network for Biomedical Research Excellence (GEM), WVU Stroke CoBRE grant P20 GM109098 (WJG), and CA062924 (SBG). The West Virginia University Imaging Facilities were supported by the WVU Cancer Institute and NIH grants P20RR016440, P30RR032138/P30GM103488 and U54GM104942. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelghany HM, 2003, J BIOL CHEM, V278, P4435, DOI 10.1074/jbc.M211983200; AbdelRaheim SR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-5; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; [Anonymous], 2017, MOL OP ENV MOE 2013; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Boto AN, 2011, PROTEINS, V79, P2455, DOI 10.1002/prot.23069; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carreras-Puigvert J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01642-w; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Corbin DR, 2017, MOL GENET METAB, V120, P350, DOI 10.1016/j.ymgme.2017.02.001; Daniotti JL, 2017, TRAFFIC, V18, P699, DOI 10.1111/tra.12510; Dansie LE, 2014, BIOCHEM SOC T, V42, P1033, DOI 10.1042/BST20140096; de la Pena AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141716; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Ferdinandusse S, 2006, BBA-MOL CELL RES, V1763, P1427, DOI 10.1016/j.bbamcr.2006.09.001; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; HORIE S, 1981, J BIOCHEM, V90, P1691, DOI 10.1093/oxfordjournals.jbchem.a133645; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Iwai T, 2004, J BIOL CHEM, V279, P21732, DOI 10.1074/jbc.M312018200; Jackowski S, 2014, BIOCHEM SOC T, V42, P1118, DOI 10.1042/BST20140156; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; Kemp S, 2011, BRIT J PHARMACOL, V164, P1753, DOI 10.1111/j.1476-5381.2011.01435.x; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kupke T, 2009, PHYSIOL PLANTARUM, V135, P365, DOI 10.1111/j.1399-3054.2009.01205.x; Leonardi R, 2014, DIABETOLOGIA, V57, P1466, DOI 10.1007/s00125-014-3245-5; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Lin J, 1996, BIOCHEMISTRY-US, V35, P6715, DOI 10.1021/bi953071x; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; O'Handley SF, 2016, J BIOENERG BIOMEMBR, V48, P557, DOI 10.1007/s10863-016-9681-9; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Ortega-Galisteo AP, 2012, J EXP BOT, V63, P2089, DOI 10.1093/jxb/err414; Peng YJ, 2016, AUTOPHAGY, V12, P1051, DOI 10.1080/15548627.2016.1164369; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; RHEAUME C, 1989, MOL CELL BIOL, V9, P477, DOI 10.1128/MCB.9.2.477; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; SHIMADA K, 1994, J CHROMATOGR B, V659, P227, DOI 10.1016/0378-4347(93)E0444-U; Shumar SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130013; SNIDER LD, 1985, J BIOL CHEM, V260, P9884; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Swarbrick JD, 2000, J MOL BIOL, V302, P1165, DOI 10.1006/jmbi.2000.4085; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; VANBROEKHOVEN A, 1981, BIOCHEM BIOPH RES CO, V100, P305, DOI 10.1016/S0006-291X(81)80097-6; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	57	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4134	4148		10.1074/jbc.RA117.001358	http://dx.doi.org/10.1074/jbc.RA117.001358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29378847	Green Published, hybrid			2022-12-28	WOS:000427587500024
J	Wang, P; Li, JZ; Tao, JH; Sha, BD				Wang, Peng; Li, Jingzhi; Tao, Jiahui; Sha, Bingdong			The luminal domain of the ER stress sensor protein PERK binds misfolded proteins and thereby triggers PERK oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; IRE1; DIMERIZATION; ACTIVATION; MECHANISM; FRAGMENT; KINASE	PRKR-like endoplasmic reticulum kinase (PERK) is one of the major sensor proteins that detect protein folding imbalances during endoplasmic reticulum (ER) stress. However, it remains unclear how ER stress activates PERK to initiate a downstream unfolded protein response (UPR). Here, we found that PERK's luminal domain can recognize and selectively interact with mis-folded proteins but not with native proteins. Screening a phage-display library, we identified a peptide substrate, P16, of the PERK luminal domain and confirmed that P16 efficiently competes with misfolded proteins for binding this domain. To unravel the mechanism by which the PERK luminal domain interacts with misfolded proteins, we determined the crystal structure of the bovine PERK luminal domain complexed with P16 to 2.8-angstrom resolution. The structure revealed that PERK's luminal domain binds the peptide through a conserved hydrophobic groove. Substitutions within hydrophobic regions of the PERK luminal domain abolished the binding between PERK and misfolded proteins. We also noted that peptide binding results in major conformational changes in the PERK luminal domain that may favor PERK oligomerization. The structure of the PERK luminal domain-P16 complex suggested stacking of the luminal domain that leads to PERK oligomerization and activation via autophosphorylation after ligand binding. Collectively, our structural and biochemical results strongly support a ligand-driven model in which the PERK luminal domain interacts directly with misfolded proteins to induce PERK oligomerization and activation, resulting in ER stress signaling and the UPR.	[Wang, Peng; Li, Jingzhi; Tao, Jiahui; Sha, Bingdong] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol CDIB, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA; [Wang, Peng] Anhui Normal Univ, Inst Mol Biol & Biotechnol, Coll Life, Wuhu 241000, Peoples R China	University of Alabama System; University of Alabama Birmingham; Anhui Normal University	Sha, BD (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol CDIB, MCLM 364,1918 Univ Blvd, Birmingham, AL 35294 USA.	bdsha@uab.edu	Wang, Peng/AAW-9052-2020; Wang, Peng/I-8770-2018	Wang, Peng/0000-0002-5598-0996; Wang, Peng/0000-0002-5598-0996	National Institutes of Health NIGMS [R01 GM080261]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080261] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant R01 GM080261. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Carrara M, 2015, EMBO J, V34, P1589, DOI 10.15252/embj.201489183; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang P, 2016, ACTA CRYSTALLOGR D, V72, P1290, DOI 10.1107/S2059798316018064; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	35	72	76	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4110	4121		10.1074/jbc.RA117.001294	http://dx.doi.org/10.1074/jbc.RA117.001294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29386355	hybrid, Green Published			2022-12-28	WOS:000427587500022
J	Almasi, S; Kennedy, BE; El-Aghil, M; Sterea, AM; Gujar, S; Partida-Sanchez, S; El Hiani, Y				Almasi, Shekoufeh; Kennedy, Barry E.; El-Aghil, Mariam; Sterea, Andra M.; Gujar, Shashi; Partida-Sanchez, Santiago; El Hiani, Yassine			TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ADP-RIBOSE; ION-CHANNEL; CA2+ INFLUX; ANTISENSE TRANSCRIPTION; INSULIN-SECRETION; FLUFENAMIC ACID; TUMOR-GROWTH; APOPTOSIS; DEATH	A lack of effective treatment is one of the main factors contributing to gastric cancer-related death. Discovering effective targets and understanding their underlying anti-cancer mechanism are key to achieving the best response to treatment and to limiting side effects. Although recent studies have shown that the cation channel transient receptor potential melastatin-2 (TRPM2) is crucial for cancer cell survival, the exact mechanism remains unclear, limiting its therapeutic potential. Here, using molecular and functional assays, we investigated the role of TRPM2 in survival of gastric cancer cells. Our results indicated that TRPM2 knockdown in AGS and MKN-45 cells decreases cell proliferation and enhances apoptosis. We also observed that the TRPM2 knockdown impairs mitochondrial metabolism, indicated by a decrease in basal and maximal mitochondrial oxygen consumption rates and ATP production. These mitochondrial defects coincided with a decrease in autophagy and mitophagy,indicated by reduced levels of autophagy- and mitophagy-associated proteins (i.e. ATGs, LC3A/B II, and BNIP3). Moreover, we found that TRPM2 modulates autophagy through a c-Jun N-terminal kinase (JNK)-dependent and mechanistic target of rapamycin-independent pathway. We conclude that in the absence of TRPM2, down-regulation of the JNK-signaling pathway impairs autophagy, ultimately causing the accumulation of damaged mitochondria and death of gastric cancer cells. Of note, by inhibiting cell proliferation and promoting apoptosis, the TRPM2 down-regulation enhanced the efficacy of paclitaxel and doxorubicin in gastric cancer cells. Collectively, we provide compelling evidence that TRPM2 inhibition may benefit therapeutic approaches for managing gastric cancer.	[Almasi, Shekoufeh] Dalhousie Univ, Biophys Fac Life Sci, Dept Biol, Halifax, NS, Canada; [Kennedy, Barry E.; Gujar, Shashi] Dalhousie Univ, Biophys Fac Life Sci, Dept Pathol, Halifax, NS, Canada; [El-Aghil, Mariam; Gujar, Shashi] Dalhousie Univ, Biophys Fac Life Sci, Dept Microbiol & Immunol, Halifax, NS, Canada; [Sterea, Andra M.; El Hiani, Yassine] Dalhousie Univ, Biophys Fac Life Sci, Dept Physiol, Halifax, NS, Canada; [Gujar, Shashi] IWK Hlth Ctr, Ctr Innovat & Collaborat Hlth Serv Res, Qual & Syst Performance, Halifax, NS B3H 4R2, Canada; [Partida-Sanchez, Santiago] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Partida-Sanchez, Santiago] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	El Hiani, Y (corresponding author), Dalhousie Univ, Biophys Fac Life Sci, Dept Physiol, Halifax, NS, Canada.	yassine.elhiani@dal.ca	Almasi, Shekoufeh/AAN-2109-2021; Partida-Sanchez, Santiago/B-7523-2008	Almasi, Shekoufeh/0000-0002-3631-5931; Partida-Sanchez, Santiago/0000-0003-2996-9440; El Hiani, Yassine/0000-0002-1251-5066; Gujar, Shashi/0000-0002-5427-0829	Department of Physiology and Biophysics, Dalhousie University; Nova Scotia Graduate Scholarship; Beatrice Hunter Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120013] Funding Source: NIH RePORTER	Department of Physiology and Biophysics, Dalhousie University; Nova Scotia Graduate Scholarship; Beatrice Hunter Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by start-up funds (to Y. E. H.) from the Department of Physiology and Biophysics, Dalhousie University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Nova Scotia Graduate Scholarship.; Supported by the trainee awards from the Beatrice Hunter Cancer Research Institute.	Akpinar H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37196; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Aoki M, 2017, CURR TOP MICROBIOL, V407, P153, DOI 10.1007/82_2017_6; Bao L, 2016, J BIOL CHEM, V291, P24449, DOI 10.1074/jbc.M116.747147; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Beceiro S, 2017, MUCOSAL IMMUNOL, V10, P493, DOI 10.1038/mi.2016.60; Bencze M, 2015, EUR J PHARMACOL, V765, P533, DOI 10.1016/j.ejphar.2015.09.014; Bhardwaj R, 2000, PDA J PHARM SCI TECH, V54, P233; Blake SD, 2017, TRANSL CANCER RES, V6, pS342, DOI 10.21037/tcr.2017.03.11; Bost F, 1999, MOL CELL BIOL, V19, P1938; Brenkman HJF, 2016, WORLD J GASTROENTERO, V22, P4041, DOI 10.3748/wjg.v22.i15.4041; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; BRUGNARA C, 1995, J PHARMACOL EXP THER, V273, P266; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Cao QH, 2016, AM J TRANSL RES, V8, P3831; Chaanine AH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.5; Chadderton A, 2000, BREAST CANCER RES TR, V59, P231, DOI 10.1023/A:1006344200094; Chandel NS, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-8; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chattopadhyay E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00043; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen SJ, 2014, J BIOL CHEM, V289, P36284, DOI 10.1074/jbc.M114.620922; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Chung MK, 2015, NEUROSCIENCE, V297, P160, DOI 10.1016/j.neuroscience.2015.03.067; de Mestier L, 2016, DIGEST LIVER DIS, V48, P984, DOI 10.1016/j.dld.2016.04.010; Dello Sbarba P, 2015, ONCOTARGET, V6, P36924, DOI 10.18632/oncotarget.6244; Dong YQ, 2015, TUMOR BIOL, V36, P1477, DOI 10.1007/s13277-014-2631-4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Ge J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110293; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gonzalez CA, 2013, HELICOBACTER, V18, P34, DOI 10.1111/hel.12082; Ham HY, 2012, TOXICOL APPL PHARM, V258, P82, DOI 10.1016/j.taap.2011.10.010; Hamamoto Y, 2015, MOL CLIN ONCOL, V3, P539, DOI 10.3892/mco.2015.510; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; He YJ, 2016, ONCOTARGET, V7, P54537, DOI 10.18632/oncotarget.10402; Hopkins MM, 2015, INT J ONCOL, V46, P2267, DOI 10.3892/ijo.2015.2919; Huang Changzhou, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P39; Jeong HJ, 2017, BIOCHEM BIOPH RES CO, V485, P301, DOI 10.1016/j.bbrc.2017.02.087; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Jiang Q, 2017, ANTIOXID REDOX SIGN, V27, P1297, DOI 10.1089/ars.2016.6873; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kamm Gretel B, 2017, Temperature (Austin), V4, P21, DOI 10.1080/23328940.2016.1258445; Kashio M, 2017, CHANNELS, V11, P426, DOI 10.1080/19336950.2017.1344801; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Koh DW, 2015, ONCOL REP, V34, P1589, DOI 10.3892/or.2015.4131; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Lastraioli E, 2015, BBA-BIOMEMBRANES, V1848, P2685, DOI 10.1016/j.bbamem.2014.12.016; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu AJ, 2013, CHEM-BIOL INTERACT, V205, P20, DOI 10.1016/j.cbi.2013.06.004; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu J, 2014, ONCOL REP, V32, P567, DOI 10.3892/or.2014.3239; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Mortadza SAS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00407; Mortadza SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45032; Nakajo A, 2007, GASTRIC CANCER, V10, P58, DOI 10.1007/s10120-006-0394-3; Orfanelli U, 2015, ONCOGENE, V34, P2094, DOI 10.1038/onc.2014.144; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Ouadid-Ahidouch H, 2013, TRENDS MOL MED, V19, P117, DOI 10.1016/j.molmed.2012.11.004; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Potapova O, 2002, CANCER RES, V62, P3257; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Rae MG, 2012, NEUROCHEM INT, V60, P543, DOI 10.1016/j.neuint.2012.02.014; Rodrigues T, 2016, CHEM SOC REV, V45, P6130, DOI 10.1039/c5cs00916b; Rogalinska M, 2016, MINI-REV MED CHEM, V16, P524, DOI 10.2174/1389557515666151016124331; Sakamoto J, 2009, GASTRIC CANCER, V12, P69, DOI 10.1007/s10120-009-0505-z; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Santoni Giorgio, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P54; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Shulman K, 2012, ONCOL LETT, V3, P1154, DOI 10.3892/ol.2012.617; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Strohecker AM, 2014, CANCER DISCOV, V4, P766, DOI 10.1158/2159-8290.CD-14-0196; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tan CH, 2016, NATURE, V536, P460, DOI 10.1038/nature19074; Uchida K, 2011, ISLETS, V3, P209, DOI 10.4161/isl.3.4.16130; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Veldhoen RA, 2013, ONCOGENE, V32, P736, DOI 10.1038/onc.2012.92; Venerito M, 2014, HELICOBACTER, V19, P32, DOI 10.1111/hel.12164; Wang M, 2012, AUTOPHAGY, V8, P1273, DOI 10.4161/auto.20917; Wang Q, 2017, BBA-MOL CELL RES, V1864, P957, DOI 10.1016/j.bbamcr.2016.12.014; Wang Q, 2016, AUTOPHAGY, V12, P1340, DOI 10.1080/15548627.2016.1187365; Wang YY, 2014, DRUG DES DEV THER, V8, P1965, DOI 10.2147/DDDT.S64989; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Xia HHX, 2006, CANCER LETT, V241, P268, DOI 10.1016/j.canlet.2005.10.031; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Yazgan Y, 2017, MOL NEUROBIOL, V54, P7620, DOI 10.1007/s12035-016-0232-5; Yosida M, 2014, DIABETES, V63, P3394, DOI 10.2337/db13-1868; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052; Zhao LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38471; Zhong LM, 2017, J VIROL, V91, DOI 10.1128/JVI.00001-17; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141; Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274	114	64	65	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3637	3650		10.1074/jbc.M117.817635	http://dx.doi.org/10.1074/jbc.M117.817635			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29343514	Green Published, hybrid			2022-12-28	WOS:000427030200018
J	Chen, JC; Nagle, AM; Wang, YF; Boone, DN; Lee, AV				Chen, Jingci; Nagle, Alison M.; Wang, Yu-Fen; Boone, David N.; Lee, Adrian V.			Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; LIGAND-BINDING; ACTIVATION; HETERODIMERS; TRANSITION; EXPRESSION; SURVIVAL	Breast cancer development and progression are influenced by insulin-like growth factor receptor 1 (IGF1R) and insulin receptor (InsR) signaling, which drive cancer phenotypes such as cell growth, proliferation, and migration. IGF1R and InsR form IGF1R/InsR hybrid receptors (HybRs) consisting of one molecule of IGF1R and one molecule of InsR. The specific signaling and functions of HybR are largely unknown, as HybR is activated by both IGF1 and insulin, and no cellular system expresses HybR in the absence of holo-IGF1R or holo-InsR. Here we studied the role of HybR by constructing inducible chimeric receptors and compared HybR signaling with that of holo-IGF1R and holo-InsR. We cloned chemically inducible chimeric IGF1R and InsR constructs consisting of the extracellular domains of the p75 nerve growth factor receptor fused to the intracellular beta subunit of IGF1R or InsR and a dimerization domain. Dimerization with the drugs AP20187 or AP21967 allowed specific and independent activation of holo-IGF1R, holo-InsR, or HybR, resulting in activation of the PI3K pathway. Holo-IGF1R and HybR both promoted cell proliferation and glucose uptake, whereas holo-InsR only promoted glucose uptake, and only holo-IGF1R showed anti-apoptotic effects. We also found that the three receptors differentially regulated gene expression: holo-IGF1R and HybR up-regulated EGR3; holo-InsR specifically down-regulated JUN and BCL2L1; holo-InsR down-regulated but HybR up-regulated HK2; and HybR specifically up-regulated FHL2, ITGA6, and PCK2. Our findings suggest that, when expressed and activated in mammary epithelial cells, HybR acts in a manner similar to IGF1R and support further investigation of the role of HybR in breast cancer.	Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Nagle, Alison M.; Wang, Yu-Fen; Boone, David N.; Lee, Adrian V.] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15213 USA; [Nagle, Alison M.; Lee, Adrian V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Lee, Adrian V.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA; [Boone, David N.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA	Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, AV (corresponding author), Magee Womens Res Inst, 204 Craft Ave,Rm A412, Pittsburgh, PA 15213 USA.	avl10@pitt.edu		Lee, Adrian/0000-0001-9917-514X	China Scholarship Council; Breast Cancer Research Foundation; NCI, National Institutes of Health [R01CA94118, P30CA047904, T32 GM008424]; Susan G. Komen for the Cure postdoctoral fellowship; Scientific Advisory Council award from Susan G. Komenfor the Cure; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA094118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); Breast Cancer Research Foundation; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Scientific Advisory Council award from Susan G. Komenfor the Cure; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the China Scholarship Council (to J. C.); the Breast Cancer Research Foundation (to A. V. L.); NCI, National Institutes of Health Grants R01CA94118 (to A. V. L.), P30CA047904 (to A. V. L.), and T32 GM008424 (to A. M. N.); and a Susan G. Komen for the Cure postdoctoral fellowship (to D. N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Scientific Advisory Council award from Susan G. Komenfor the Cure and a Hillman Foundation Fellow. To whom correspondence should be addressed: Magee Women's Research Institute, 204 Craft Ave., Rm. A412, Pittsburgh, PA 15213. E-mail: avl10@pitt.edu.	Belardi V, 2013, J MAMMARY GLAND BIOL, V18, P277, DOI 10.1007/s10911-013-9303-7; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Christopoulos PF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0291-7; DeMeyts P., 2000, ENDOTEXT, P2000; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V129, P121, DOI 10.1016/S0303-7207(97)04050-1; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Motallebnezhad M, 2016, TUMOR BIOL, V37, P11711, DOI 10.1007/s13277-016-5176-x; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	22	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3700	3709		10.1074/jbc.M117.789503	http://dx.doi.org/10.1074/jbc.M117.789503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29330302	Green Published, hybrid			2022-12-28	WOS:000427030200023
J	Thompson, JL; Zhao, Y; Stathopulos, PB; Grossfield, A; Shuttleworth, TJ				Thompson, Jill L.; Zhao, Yue; Stathopulos, Peter B.; Grossfield, Alan; Shuttleworth, Trevor J.			Phosphorylation-mediated structural changes within the SOAR domain of stromal interaction molecule 1 enable specific activation of distinct Orai channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNELS; ARC CHANNEL; STIM1; STORE; CA2+; DYNAMICS; GLYCINE; ALANINE; ENTRY	Low-conductance, highly calcium-selective channels formed by the Orai proteins exist as store-operated CRAG channels and store-independent, arachidonic acid activated ARC channels. Both are activated by stromal interaction molecule 1 (STIM1), but CRAG channels are activated by STIM1 located in the endoplasmic reticulum membrane, whereas ARC channels are activated by the minor plasma membrane associated pool of STIM1. Critically, maximally activated CRAG channel and ARC channel currents are completely additive within the same cell, and their selective activation results in their ability to each induce distinct cellular responses. We have previously shown that specific ARC channel activation requires a PIG'S-mediated phosphorylation of a single threonine residue (Thr(389)) within the cytoplasmic region of STIM1. Here, examination of the molecular basis of this phosphorylation-dependent activation revealed that phosphorylation of the Thr(389) residue induces a significant structural change in the STIM1-Orai activating region (SOAR) that interacts with the Orai proteins, and it is this change that determines the selective activation of the store-independent ARC channels versus the store-operated CRAG channels. In conclusion, our findings reveal the structural changes underlying the selective activation of STIM1-induced CRAG or ARC channels that determine the specific stimulation of these two functionally distinct Ca2+ entry pathways.	[Thompson, Jill L.; Shuttleworth, Trevor J.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Grossfield, Alan] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Zhao, Yue; Stathopulos, Peter B.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	University of Rochester; University of Rochester; Western University (University of Western Ontario)	Shuttleworth, TJ (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	trevor_shuttleworth@URMC.rochester.edu		Stathopulos, Peter B./0000-0002-0536-6656	NIGMS, National Institutes of Health [GM040457]; Natural Sciences and Engineering Research Council [250225]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040457] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM040457 (to T.J.S.) and Natural Sciences and Engineering Research Council Grant 250225 (to P.B.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Espinoza-Fonseca LM, 2014, MOL BIOSYST, V10, P2693, DOI 10.1039/c4mb00364k; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Korzeniowski MK, 2017, J CELL SCI, V130, P2821, DOI 10.1242/jcs.205583; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Li YS, 2008, ARCH BIOCHEM BIOPHYS, V478, P110, DOI 10.1016/j.abb.2008.07.002; Lopez-Llano J, 2006, PROTEINS, V64, P769, DOI 10.1002/prot.21041; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mignen O, 2005, J PHYSIOL-LONDON, V564, P791, DOI 10.1113/jphysiol.2005.085704; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Romo TD, 2014, J COMPUT CHEM, V35, P2305, DOI 10.1002/jcc.23753; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2015, J PHYSIOL-LONDON, V593, P559, DOI 10.1113/jphysiol.2014.284182; Thompson JL, 2013, J PHYSIOL-LONDON, V591, P3507, DOI 10.1113/jphysiol.2013.256784; Thompson JL, 2012, CHANNELS, V6, P370, DOI 10.4161/chan.21947; Thompson JL, 2011, J PHYSIOL-LONDON, V589, P5057, DOI 10.1113/jphysiol.2011.214437; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeung-Yam-Wah V, 2010, CELL CALCIUM, V47, P77, DOI 10.1016/j.ceca.2009.11.007; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	44	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3145	3155		10.1074/jbc.M117.819078	http://dx.doi.org/10.1074/jbc.M117.819078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326165	Green Published, hybrid			2022-12-28	WOS:000426562800010
J	Nadeau, OW; Fontes, JD; Carlson, GM				Nadeau, Owen W.; Fontes, Joseph D.; Carlson, Gerald M.			The regulation of glycogenolysis in the brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						brain; energy metabolism; glycogen; neurobiology; phosphorylase	MUSCLE PHOSPHORYLASE-KINASE; DEBRANCHING ENZYME; ALPHA-SUBUNIT; BETA-SUBUNITS; CDNA CLONING; ALLOSTERIC ACTIVATION; CATALYTIC GAMMA; PROTEIN-KINASE; HUMAN-LIVER; SKELETAL	The key regulatory enzymes of glycogenolysis are phosphorylase kinase, a hetero-oligomer with four different types of subunits, and glycogen phosphorylase, a homodimer. Both enzymes are activated by phosphorylation and small ligands, and both enzymes have distinct isoforms that are predominantly expressed in muscle, liver, or brain; however, whole-transcriptome high-throughput sequencing analyses show that in brain both of these enzymes are likely composed of subunit isoforms representing all three tissues. This Minireview examines the regulatory properties of the isoforms of these two enzymes expressed in the three tissues, focusing on their potential regulatory similarities and differences. Additionally, the activity, structure, and regulation of the remaining enzyme necessary for glycogenolysis, glycogen-debranching enzyme, are also reviewed.	[Nadeau, Owen W.; Fontes, Joseph D.; Carlson, Gerald M.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Carlson, GM (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	gcarlson@kumc.edu		Fontes, Joseph/0000-0003-4796-343X				Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; ALBRECHT J, 1982, NEUROCHEM RES, V7, P489, DOI 10.1007/BF00965500; Arrizabalaga O, 2012, J BIOL CHEM, V287, P11878, DOI 10.1074/jbc.M111.297804; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BARFORD D, 1992, PROTEIN SCI, V1, P472; BARONVANEVERCOOREN A, 1991, J NEUROSCI RES, V28, P244, DOI 10.1002/jnr.490280212; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Boulatnikov IG, 2009, BIOCHEMISTRY-US, V48, P10183, DOI 10.1021/bi901429y; BROSTROM CO, 1971, J BIOL CHEM, V246, P1961; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Buchbinder JL, 2001, ANNU REV BIOPH BIOM, V30, P191, DOI 10.1146/annurev.biophys.30.1.191; BURGER D, 1982, BIOCHEM BIOPH RES CO, V105, P632, DOI 10.1016/0006-291X(82)91481-4; Burwinkel B, 1998, HUM MOL GENET, V7, P149, DOI 10.1093/hmg/7.1.149; Chen CM, 2017, P NATL ACAD SCI USA, V114, pE619, DOI 10.1073/pnas.1615792114; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; CHRISMAN TD, 1982, J BIOL CHEM, V257, P798; COHEN P, 1980, EUR J BIOCHEM, V111, P563, DOI 10.1111/j.1432-1033.1980.tb04972.x; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; DELANGE RJ, 1968, J BIOL CHEM, V243, P2200; Fernandez AM, 2017, DIABETES, V66, P64, DOI 10.2337/db16-0861; FITZGERALD TJ, 1984, J BIOL CHEM, V259, P3266; FRANCKE U, 1989, AM J HUM GENET, V45, P276; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; GRIFFITHS JR, 1976, EUR J BIOCHEM, V61, P243, DOI 10.1111/j.1432-1033.1976.tb10017.x; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; HARMANN B, 1991, J BIOL CHEM, V266, P15631; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hirono H, 1995, BIOCHEM MOL BIOL INT, V36, P505; Jeyasingham MD, 2008, J MOL BIOL, V377, P623, DOI 10.1016/j.jmb.2007.12.072; JOHNSON LN, 1993, J MOL BIOL, V232, P253, DOI 10.1006/jmbi.1993.1380; JONES TA, 1990, BIOCHIM BIOPHYS ACTA, V1048, P24, DOI 10.1016/0167-4781(90)90017-V; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; KREBS EG, 1956, BIOCHIM BIOPHYS ACTA, V20, P150, DOI 10.1016/0006-3002(56)90273-6; Lane LA, 2012, MOL CELL PROTEOMICS, V11, P1768, DOI 10.1074/mcp.M112.021394; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Liu Y, 2014, MOL NEUROBIOL, V49, P645, DOI 10.1007/s12035-013-8546-z; LOWRY OH, 1967, J BIOL CHEM, V242, P271; Mathieu C, 2017, FEBS J, V284, P546, DOI 10.1111/febs.13937; Mathieu C, 2016, J BIOL CHEM, V291, P23842, DOI 10.1074/jbc.M116.757062; Mathieu C, 2016, J BIOL CHEM, V291, P18072, DOI 10.1074/jbc.M116.738898; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Molina V, 2009, PSYCHIAT RES-NEUROIM, V173, P88, DOI 10.1016/j.pscychresns.2008.09.009; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Nadeau OW, 2005, PROTEIN SCI, V14, P914, DOI 10.1110/ps.041123905; Nadeau OW, 2007, J MOL BIOL, V365, P1429, DOI 10.1016/j.jmb.2006.10.061; Nadeau OW, 2012, J BIOL CHEM, V287, P36651, DOI 10.1074/jbc.M112.412874; Nadeau OW, 2010, BIOCHEMISTRY-US, V49, P6505, DOI 10.1021/bi101006j; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1987, AM J HUM GENET, V40, P351; NEWSHOLME P, 1992, BIOCHEM J, V283, P845, DOI 10.1042/bj2830845; OIKONOMAKOS NG, 1987, BIOCHEMISTRY-US, V26, P8381, DOI 10.1021/bi00399a053; OZAWA E, 1973, J NEUROCHEM, V20, P1487, DOI 10.1111/j.1471-4159.1973.tb00263.x; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Pfeiffer-Guglielmi B, 2000, NEUROCHEM RES, V25, P1485, DOI 10.1023/A:1007676109206; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; PICTON C, 1983, METHOD ENZYMOL, V102, P219; Pinacho R, 2016, SCHIZOPHR RES, V177, P37, DOI 10.1016/j.schres.2016.04.024; RAMACHANDRAN C, 1987, J BIOL CHEM, V262, P3210; Roach PJ, 2015, MOL ASPECTS MED, V46, P78, DOI 10.1016/j.mam.2015.08.003; ROACH PJ, 1978, J CYCLIC NUCL PROT, V4, P245; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; SAKAI K, 1979, J BIOL CHEM, V254, P6631; Sakoda H, 2005, AM J PHYSIOL-ENDOC M, V289, pE474, DOI 10.1152/ajpendo.00003.2005; Sarowar T, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8051861; SATO K, 1976, CANCER RES, V36, P487; SODERLING TR, 1979, FEBS LETT, V106, P181, DOI 10.1016/0014-5793(79)80723-1; SODERLING TR, 1979, P NATL ACAD SCI USA, V76, P2536, DOI 10.1073/pnas.76.6.2536; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Sylow L, 2013, DIABETES, V62, P1139, DOI 10.2337/db12-0491; TAIRA T, 1982, J BIOCHEM-TOKYO, V91, P883, DOI 10.1093/oxfordjournals.jbchem.a133776; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Thompson JA, 2015, PROTEIN SCI, V24, P1956, DOI 10.1002/pro.2804; Traxler KW, 2001, J STRUCT BIOL, V135, P231, DOI 10.1006/jsbi.2001.4411; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venien-Bryan C, 2009, STRUCTURE, V17, P117, DOI 10.1016/j.str.2008.10.013; VILA J, 1982, ARCH BIOCHEM BIOPHYS, V218, P1, DOI 10.1016/0003-9861(82)90313-7; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Watanabe Y, 2006, J BIOCHEM, V140, P135, DOI 10.1093/jb/mvj129; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wilkinson DA, 1997, J MOL BIOL, V265, P319, DOI 10.1006/jmbi.1996.0739; WILKINSON DA, 1994, J MOL BIOL, V235, P974, DOI 10.1006/jmbi.1994.1051; Yamamoto E, 2009, J BIOCHEM, V145, P585, DOI 10.1093/jb/mvp012; Yang J, 2015, NAT PROTOC, V10, P1022, DOI 10.1038/nprot.2015.062; YEAMAN SJ, 1975, EUR J BIOCHEM, V51, P93, DOI 10.1111/j.1432-1033.1975.tb03910.x; Zamboni V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34877; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929; Zhai LT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11229	94	26	26	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7099	7107		10.1074/jbc.R117.803023	http://dx.doi.org/10.1074/jbc.R117.803023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29483194	Green Published, hybrid			2022-12-28	WOS:000432174500003
J	Dayeh, DM; Kruithoff, BC; Nakanishi, K				Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro			Structural and functional analyses reveal the contributions of the C- and N-lobes of Argonaute protein to selectivity of RNA target cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; Argonaute; X-ray crystallography; ribonuclear protein (RNP); structural biology	CRYSTAL-STRUCTURE; GUIDE RNA; RECOGNITION; RISC; DNA; INSIGHTS; COMPLEX; DOMAIN; INTERFERENCE; SUPERFAMILY	Some gene transcripts have cellular functions as regulatory noncoding RNAs. For example, similar to 23-nucleotide (nt)-long siRNAs are loaded into Argonaute proteins. The resultant ribonucleoprotein assembly, the RNA-induced silencing complex (RISC), cleaves RNAs that are extensively base-paired with the loaded siRNA. To date, base complementarity is recognized as the major determinant of specific target cleavage (or slicing), but little is known about how Argonaute inspects base pairing before cleavage. A hallmark of Argonaute proteins is their bilobal structure, but despite the significance of this structure for curtailing slicing activity against mismatched targets, the molecular mechanism remains elusive. Here, our structural and functional studies of a bilobed yeast Argonaute protein and its isolated catalytic C-terminal lobe (C-lobe) revealed that the C-lobe alone retains almost all properties of bilobed Argonaute: siRNA-duplex loading, passenger cleavage/ejection, and siRNA-dependent RNA cleavage. A 2.1 angstrom-resolution crystal structure revealed that the catalytic C-lobe mirrors the bilobed Argonaute in terms of guide-RNA recognition and that all requirements for transitioning to the catalytically active conformation reside in the C-lobe. Nevertheless, we found that in the absence of the N-terminal lobe (N-lobe), target RNAs are scanned for complementarity only at positions 5-14 on a 23-nt guide RNA before endonucleolytic cleavage, thereby allowing for some off-target cleavage. Of note, acquisition of an N-lobe expanded the range of the guide RNA strand used for inspecting target complementarity to positions 2-23. These findings offer clues to the evolution of the bilobal structure of catalytically active Argonaute proteins.	[Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Dayeh, Daniel M.; Kruithoff, Bradley C.; Nakanishi, Kotaro] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Dayeh, Daniel M.; Nakanishi, Kotaro] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Nakanishi, K (corresponding author), Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA.; Nakanishi, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.; Nakanishi, K (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.	nakanishi.9@osu.edu		Nakanishi, Kotaro/0000-0002-9857-6010	NIGMS, National Institutes of Health [P41 GM103403]; National Institutes of Health-ORIP HEI Grant [S10OD021527]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM124320] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023582, S10OD021527] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health, Grant P41 GM103403. The Eiger 16M detector on 24-ID-E beam line is funded by National Institutes of Health-ORIP HEI Grant S10OD021527. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We thank V. Gopalan, M. Ibba, J. Jackman, K. Mohler, and A. Singh for help and discussion as well as the NE-CAT beamline staff at the Advanced Photon Source.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faehnle CR, 2013, CELL REP, V3, P1901, DOI 10.1016/j.celrep.2013.05.033; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Hirose T, 2014, EMBO REP, V15, P489, DOI 10.1002/embr.201338390; Hur JK, 2013, J BIOL CHEM, V288, P7829, DOI 10.1074/jbc.M112.441030; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2015, NATURE, V521, P533, DOI 10.1038/nature14254; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Matsumoto N, 2016, CELL, V167, P484, DOI 10.1016/j.cell.2016.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; Nakanishi K, 2016, WIRES RNA, V7, P637, DOI 10.1002/wrna.1356; Nakanishi K, 2013, CELL REP, V3, P1893, DOI 10.1016/j.celrep.2013.06.010; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park MS, 2017, NUCLEIC ACIDS RES, V45, P11867, DOI 10.1093/nar/gkx916; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schroedinger LLC, 2015, AXPYMOL MOL GRAPH PL; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yao CY, 2015, MOL CELL, V59, P125, DOI 10.1016/j.molcel.2015.05.015; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	67	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6308	6325		10.1074/jbc.RA117.001051	http://dx.doi.org/10.1074/jbc.RA117.001051			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29519815	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000431108600008
J	Huang, J; Garcia, GPC; Perugini, MA; Fox, AH; Bond, CS; Lee, M				Huang, Jie; Garcia, G. Patricia Casas; Perugini, Matthew A.; Fox, Archa H.; Bond, Charles S.; Lee, Mihwa			Crystal structure of a SFPQ/PSPC1 heterodimer provides insights into preferential heterodimerization of human DBHS family proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; HUMAN APOLIPOPROTEIN E3; SPLICING FACTOR; HUMAN NONO; SFPQ; RNA; PSPC1; ULTRACENTRIFUGATION; PARASPECKLES; DIMERIZATION	Members of the Drosophila behavior human splicing (DBHS) protein family are nuclear proteins implicated in many layers of nuclear functions, including RNA biogenesis as well as DNA repair. Definitive of the DBHS protein family, the conserved DBHS domain provides a dimerization platform that is critical for the structural integrity and function of these proteins. The three human DBHS proteins, splicing factor proline- and glutamine-rich (SFPQ), paraspeckle component 1 (PSPC1), and non-POU domain-containing octamer-binding protein (NONO), form either homo-or heterodimers; however, the relative affinity and mechanistic details of preferential heterodimerization are yet to be deciphered. Here we report the crystal structure of a SFPQ/PSPC1 heterodimer to 2.3-angstrom resolution and analyzed the subtle structural differences between the SFPQ/PSPC1 heterodimer and the previously characterized SFPQ homodimer. Analytical ultracentrifugation to estimate the dimerization equilibrium of the SFPQ-containing dimers revealed that the SFPQ-containing dimers dissociate at low micromolar concentrations and that the heterodimers have higher affinities than the homodimer. Moreover, we observed that the apparent dissociation constant for the SFPQ/PSPC1 heterodimer was over 6-fold lower than that of the SFPQ/NONO heterodimer. We propose that these differences in dimerization affinity may represent a potential mechanism by which PSPC1 at a lower relative cellular abundance can outcompete NONO to heterodimerize with SFPQ.	[Huang, Jie; Garcia, G. Patricia Casas; Perugini, Matthew A.; Lee, Mihwa] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Fox, Archa H.] Univ Western Australia, Sch Mol Sci, Crawley, WA 6009, Australia; [Bond, Charles S.] Univ Western Australia, Sch Mol Sci, Crawley, WA 6009, Australia	La Trobe University; University of Western Australia; University of Western Australia	Lee, M (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	mihwa.lee@latrobe.edu.au	Fox, Archa H/H-9219-2014; Bond, Charles/AAF-9608-2020	Fox, Archa H/0000-0003-1962-270X; Bond, Charles/0000-0002-9584-6783; Huang, Jie/0000-0003-4535-4489; Lee, Mihwa/0000-0003-3006-2483; Jie, Huang/0000-0003-0285-0132; Perugini, Matthew/0000-0001-8052-5584	Australian Research Council Discovery Early Career Research Award (ARC DECRA) Fellowship [DE150101243]; National Health and Medical Research Council of Australia (NHMRC) [1050585, 513880]	Australian Research Council Discovery Early Career Research Award (ARC DECRA) Fellowship(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council Discovery Early Career Research Award (ARC DECRA) Fellowship DE150101243 (to M. L.) and National Health and Medical Research Council of Australia (NHMRC) Project Grants 1050585 and 513880 (to A. H. F. and C. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bricogne G., 2016, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cosker KE, 2016, NAT NEUROSCI, V19, P690, DOI 10.1038/nn.4280; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.e05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Galietta A, 2007, BLOOD, V110, P2600, DOI 10.1182/blood-2006-01-028647; Hor L, 2013, J BIOL CHEM, V288, P9238, DOI 10.1074/jbc.M113.450148; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knott GJ, 2016, ACTA CRYSTALLOGR D, V72, P761, DOI 10.1107/S2059798316005830; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Knott GJ, 2015, PROTEIN SCI, V24, P2033, DOI 10.1002/pro.2816; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Lee M, 2011, ACTA CRYSTALLOGR D, V67, P981, DOI 10.1107/S0907444911039606; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mircsof D, 2015, NAT NEUROSCI, V18, P1731, DOI 10.1038/nn.4169; Myojin R, 2004, BIOL REPROD, V71, P926, DOI 10.1095/biolreprod.104.028159; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2002, EUR J BIOCHEM, V269, P5939, DOI 10.1046/j.1432-1033.2002.03319.x; Peverelli MG, 2016, J BIOL CHEM, V291, P9785, DOI 10.1074/jbc.M115.696591; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Snijders AP, 2015, RNA, V21, P347, DOI 10.1261/rna.045138.114; Thomas-Jinu S, 2017, NEURON, V94, P322, DOI 10.1016/j.neuron.2017.03.026; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6593	6602		10.1074/jbc.RA117.001451	http://dx.doi.org/10.1074/jbc.RA117.001451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29530979	Green Published, hybrid			2022-12-28	WOS:000431108600029
J	Matsumura, T; Hida, S; Kitazawa, M; Fujii, C; Kobayashi, A; Takeoka, M; Taniguchi, S; Miyagawa, S				Matsumura, Tomio; Hida, Shigeaki; Kitazawa, Masato; Fujii, Chifumi; Kobayashi, Akira; Takeoka, Michiko; Taniguchi, Shun-ichiro; Miyagawa, Shin-ichi			Fascin1 suppresses RIG-I-like receptor signaling and interferon-beta production by associating with I kappa B kinase epsilon (IKK epsilon) in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; interferon regulatory factor (IRF); invasion; RIG-I-like receptor (RLR); signal transducers and activators of transcription 1 (STAT1); IB Kinase E fascin1; poly(I.C)	CELL-PROLIFERATION; VIRUS-INFECTION; PROTEIN TANK; IFN-BETA; ACTIVATION; EXPRESSION; STAT1; METASTASIS; TARGET; DOMAIN	Fascin1 is an actin-bundling protein involved in cancer cell migration and has recently been shown also to have roles in virus-mediated immune cell responses. Because viral infection has been shown to activate immune cells and to induce interferon-beta expression in human cancer cells, we evaluated the effects of fascin1 on virus-dependent signaling via the membrane- and actin-associated protein RIG-I (retinoic acid-inducible gene I) in colon cancer cells. We knocked down fascin1 expression with shRNA retrovirally transduced into a DLD-1 colon cancer and L929 fibroblast-like cell lines and used luciferase reporter assays and co-immunoprecipitation to identify fascin1 targets. We found that intracellular poly(I.C) transfection to mimic viral infection enhances the RIG-I/MDA5 (melanoma differentiation-associated gene 5)-mediated dimerization of interferon regulatory factor 3 (IRF-3). The transfection also significantly increased the expression levels of IRF-7, interferon-beta, and interferon-inducible cytokine IP-10 in fascin1-deleted cells compared with controls while significantly suppressing cell growth, migration, and invasion. We also found that fascin1 constitutively interacts with I kappa B kinase epsilon (IKK epsilon) in the RIG-I signaling pathway. In summary, we have identified fascin1 as a suppressor of the RIG-I signaling pathway associating with I kappa B kinase epsilon in DLD-1 colon cancer cells to suppress immune responses to viral infection.	[Matsumura, Tomio; Fujii, Chifumi; Taniguchi, Shun-ichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 3908621, Japan; [Matsumura, Tomio] Shinshu Univ, Grad Sch Med, Dept Aging Biol, Matsumoto, Nagano 3908621, Japan; [Matsumura, Tomio; Kitazawa, Masato; Kobayashi, Akira; Takeoka, Michiko; Miyagawa, Shin-ichi] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan; [Fujii, Chifumi] Shinshu Univ, Inst Biomed Sci, Dept Adv Med Hlth Promot, Matsumoto, Nagano 3908621, Japan; [Hida, Shigeaki] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi 4678603, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University; Nagoya University	Miyagawa, S (corresponding author), Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan.; Hida, S (corresponding author), Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Hlth Sci, Nagoya, Aichi 4678603, Japan.	hida@phar.nagoya-cu.ac.jp; shinichi@shinshu-u.ac.jp		Fujii, Chifumi/0000-0001-8735-5274	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP20012020, JP26293300]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by General Scientific Research Grants JP20012020 and JP26293300 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Booy S, 2015, AM J CANCER RES, V5, P2035; Chen JJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0656-0; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Duewell P, 2014, CELL DEATH DIFFER, V21, P1825, DOI 10.1038/cdd.2014.96; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Harashima N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-217; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Huang FK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8465; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jiang LJ, 2011, P NATL ACAD SCI USA, V108, P1897, DOI 10.1073/pnas.1019059108; Kim JK, 2011, J IMMUNOL, V187, P6327, DOI 10.4049/jimmunol.1100612; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma YF, 2015, MELANOMA RES, V25, P169, DOI 10.1097/CMR.0000000000000135; Morosky SA, 2011, J BIOL CHEM, V286, P28574, DOI 10.1074/jbc.M111.227942; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sadik CD, 2009, NUCLEIC ACIDS RES, V37, P5041, DOI 10.1093/nar/gkp525; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Snyder M, 2014, J BIOL CHEM, V289, P30082, DOI 10.1074/jbc.M114.591719; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516; Verhelst K, 2013, BIOCHEM PHARMACOL, V85, P873, DOI 10.1016/j.bcp.2013.01.007; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 2009, CELL MOTIL CYTOSKEL, V66, P524, DOI 10.1002/cm.20356; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhang JJ, 2016, CELL REP, V16, P405, DOI 10.1016/j.celrep.2016.05.083; Zhao HX, 2009, VIROLOGY, V392, P186, DOI 10.1016/j.virol.2009.07.006	46	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6326	6336		10.1074/jbc.M117.819201	http://dx.doi.org/10.1074/jbc.M117.819201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496994	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000431108600009
J	Li, HR; Chiang, WC; Chou, PC; Wang, WJ; Huang, JR				Li, Hao-Ru; Chiang, Wan-Chin; Chou, Po-Chun; Wang, Won-Jing; Huang, Jie-Rong			TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-FIBRIL FORMATION; IN-VIVO; MEMBRANELESS ORGANELLES; GLOBULAR-PROTEINS; NMR-SPECTROSCOPY; SELF-ASSOCIATION; AGGREGATION; SEQUENCE	Eukaryotic cells contain distinct organelles, but not all of these compartments are enclosed by membranes. Some intrinsically disordered proteins mediate membraneless organelle formation through liquid-liquid phase separation (LLPS). LLPS facilitates many biological functions such as regulating RNA stability and ribonucleoprotein assembly, and disruption of LLPS pathways has been implicated in several diseases. Proteins exhibiting LLPS typically have low sequence complexity and specific repeat motifs. These motifs promote multivalent connections with other molecules and the formation of higher-order oligomers, and their removal usually prevents LLPS. The intrinsically disordered C-terminal domain of TAR DNA-binding protein 43 (TDP-43), a protein involved in motor neuron disease and dementia lacks a dominant LLPS motif, however, and how this domain forms condensates is unclear. Using extensive mutagenesis of TDP-43, we demonstrate here that three tryptophan residues and, to a lesser extent, four other aromatic residues are most important for TDP-43 to undergo LLPS. Our results also suggested that only a few residues may be required for TDP-43 LLPS because the alpha-helical segment (spanning similar to 20 residues) in the middle part of the C-terminal domain tends to self-assemble, reducing the number of motifs required for forming a multivalent connection. Our results indicating that a self-associating alpha-helical element with a few key residues regulates condensate formation highlight a different type of LLPS involving intrinsically disordered regions. The C-terminal domain of TDP-43 contains similar to 50 disease-related mutations, with no clear physicochemical link between them. We propose that they may disrupt LLPS indirectly by interfering with the key residues identified here.	[Li, Hao-Ru; Chiang, Wan-Chin; Chou, Po-Chun; Wang, Won-Jing; Huang, Jie-Rong] Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan; [Huang, Jie-Rong] Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.; Huang, JR (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.	jierongh@ym.edu.tw	Huang, Jie-rong/O-3661-2019	Huang, Jie-rong/0000-0003-3674-2228; Wang, Won-Jing/0000-0001-9733-0839	Ministry of Science and Technology of Taiwan Grants [106-2113-M-010-005-MY2, 106-2633-B-009-001, 105-2628-B-010-004-MY3]	Ministry of Science and Technology of Taiwan Grants	This work was supported by the Ministry of Science and Technology of Taiwan Grants 106-2113-M-010-005-MY2 (to J.R.H.), 106-2633-B-009-001, and 105-2628-B-010-004-MY3 (to W.J.W.). The authors declare that they have no conflicts of interest with the contents of this article. Downloaded from http://www.jbc.org/at ISI, Thomson Scientific on April 23, 2018	Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chen TC, 2016, PROTEIN PEPTIDE LETT, V23, P967, DOI 10.2174/0929866523666160920100045; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guo L, 2015, MOL CELL, V60, P189, DOI 10.1016/j.molcel.2015.10.006; He RY, 2015, CHEM COMMUN, V51, P8652, DOI 10.1039/c5cc00513b; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li HR, 2018, BBA-PROTEINS PROTEOM, V1866, P214, DOI 10.1016/j.bbapap.2017.10.001; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin YH, 2017, J BIOL CHEM, V292, P17845, DOI 10.1074/jbc.M117.802793; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2015, J PHYS CHEM LETT, V6, P2608, DOI 10.1021/acs.jpclett.5b00918; Mompean M, 2014, ARCH BIOCHEM BIOPHYS, V545, P53, DOI 10.1016/j.abb.2014.01.007; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Polling S, 2015, NAT STRUCT MOL BIOL, V22, P1008, DOI 10.1038/nsmb.3127; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Wilkins MR, 1999, METH MOL B, V112, P531; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	65	110	110	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6090	6098		10.1074/jbc.AC117.001037	http://dx.doi.org/10.1074/jbc.AC117.001037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29511089	Green Published, hybrid			2022-12-28	WOS:000430497300027
J	Shi, SY; Lu, YW; Liu, Z; Stevens, J; Murawsky, CM; Wilson, V; Hu, ZH; Richards, WG; Michaels, ML; Zhang, J; Yan, W; Li, Y				Shi, Sally Yu; Lu, Ya-Wen; Liu, Zhi; Stevens, Jennitte; Murawsky, Christopher M.; Wilson, Vicki; Hu, Zhonghua; Richards, William G.; Michaels, Mark Leo; Zhang, Jun; Yan, Wei; Li, Yang			A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; BISPECIFIC ANTIBODIES; METABOLIC-ACTIVITY; FGF21	Bispecific antibodies have become important formats for therapeutic discovery. They allow for potential synergy by simultaneously engaging two separate targets and enable new functions that are not possible to achieve by using a combination of two monospecific antibodies. Antagonistic antibodies dominate drug discovery today, but only a limited number of agonistic antibodies (i.e. those that activate receptor signaling) have been described. For receptors formed by two components, engaging both of these components simultaneously may be required for agonistic signaling. As such, bispecific antibodies may be particularly useful in activating multicomponent receptor complexes. Here, we describe a biparatopic (i.e. targeting two different epitopes on the same target) format that can activate the endocrine fibroblast growth factor (FGF) 21 receptor (FGFR) complex containing beta-Klotho and FGFR1c. This format was constructed by grafting two different antigen-specific VH domains onto the VH and VL positions of an IgG, yielding a tetravalent binder with two potential geometries, a close and a distant, between the two paratopes. Our results revealed that the biparatopic molecule provides activities that are not observed with each paratope alone. Our approach could help address the challenges with heterogeneity inherent in other bispecific formats and could provide the means to adjust intramolecular distances of the antibody domains to drive optimal activity in a bispecific format. In conclusion, this format is versatile, is easy to construct and produce, and opens a new avenue for agonistic antibody discovery and development.	[Shi, Sally Yu; Lu, Ya-Wen; Richards, William G.; Zhang, Jun; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Liu, Zhi; Stevens, Jennitte; Hu, Zhonghua; Michaels, Mark Leo; Yan, Wei] Amgen Inc, Thousand Oaks, CA 91320 USA; [Murawsky, Christopher M.; Wilson, Vicki] Amgen British Columbia Inc, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen	Li, Y (corresponding author), Dept Cardiometab Disorders, 1120 Vet Blvd, San Francisco, CA 94080 USA.	yangln3101@gmail.com	Lu, Ya-Wen/A-7813-2016	Lu, Ya-Wen/0000-0003-0479-1471; Murawsky, Christopher/0000-0002-9698-052X				Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Grujic O, 2017, BIOCHEM BIOPH RES CO, V486, P985, DOI 10.1016/j.bbrc.2017.03.145; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Janssens R, 2006, P NATL ACAD SCI USA, V103, P15130, DOI 10.1073/pnas.0601108103; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2014, MOL METAB, V3, P221, DOI 10.1016/j.molmet.2013.12.003; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zhang J, 2015, GERIATR ORTHOP SURG, V6, P168, DOI 10.1177/2151458515583111	22	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5909	5919		10.1074/jbc.RA118.001752	http://dx.doi.org/10.1074/jbc.RA118.001752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483191	Green Published, hybrid			2022-12-28	WOS:000430497300013
J	Carroll, RG; Zaslona, Z; Galvan-Pena, S; Koppe, EL; Sevin, DC; Angiari, S; Triantafilou, M; Triantafilou, K; Modis, LK; O'Neill, LA				Carroll, Richard G.; Zaslona, Zbigniew; Galvan-Pena, Silvia; Koppe, Emma L.; Sevin, Daniel C.; Angiari, Stefano; Triantafilou, Martha; Triantafilou, Kathy; Modis, Louise K.; O'Neill, Luke A.			An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL ACTIVATION; LIPID RAFTS; ALTERNATIVE ACTIVATION; FOAM CELL; METABOLISM; INHIBITOR; PROTEIN; SIGNAL; ACCUMULATION; INFLAMMATION	Different immune activation states require distinct metabolic features and activities in immune cells. For instance, inhibition of fatty acid synthase (FASN), which catalyzes the synthesis of long-chain fatty acids, prevents the proinflammatory response in macrophages; however, the precise role of this enzyme in this response remains poorly defined. Consistent with previous studies, we found here that FASN is essential for lipopolysaccha-ride-induced, Toll-like receptor (TLR)-mediated macrophage activation. Interestingly, only agents that block FASN upstream of acetoacetyl-CoA synthesis, including the well-characterized FASN inhibitor C75, inhibited TLR4 signaling, while those acting downstream had no effect. We found that acetoacetyl-CoA could overcome C75's inhibitory effect, whereas other FASN metabolites, including palmitate, did not prevent C75-mediated inhibition. This suggested an unexpected role for acetoacetyl-CoA in inflammation that is independent of its role in palmitate synthesis. Our evidence further suggested that acetoacetyl-CoA arising from FASN activity promotes cholesterol production, indicating a surprising link between fatty acid synthesis and cholesterol synthesis. We further demonstrate that this process is required for TLR4 to enter lipid rafts and facilitate TLR4 signaling. In conclusion, we have uncovered an unexpected link between FASN and cholesterol synthesis that appears to be required for TLR signal transduction and proinflammatory macrophage activation.	[Carroll, Richard G.; Zaslona, Zbigniew; Galvan-Pena, Silvia; Angiari, Stefano; O'Neill, Luke A.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Carroll, Richard G.; Galvan-Pena, Silvia; Koppe, Emma L.; Triantafilou, Martha; Triantafilou, Kathy; Modis, Louise K.; O'Neill, Luke A.] GlaxoSmithKline, Immunol Catalyst, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England; [Triantafilou, Martha; Triantafilou, Kathy] Cardiff Univ, Univ Hosp Wales, Inst Infect & Immun, Sch Med, Cardiff CF14 4XW, S Glam, Wales; [Sevin, Daniel C.] GlaxoSmithKline, Cellzome, Meyerhofstr 1, D-69117 Heidelberg, Germany	Trinity College Dublin; GlaxoSmithKline; Cardiff University; GlaxoSmithKline; Cellzome GmbH	O'Neill, LA (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		Angiari, Stefano/0000-0003-4434-2224; Galvan-Pena, Silvia/0000-0003-1639-2048; Carroll, Richard/0000-0001-9917-3443; O'Neill, Luke/0000-0002-4333-2748; Zaslona, Zbigniew/0000-0003-3361-4140	Science Foundation Ireland (SFI) [SFI12/IA/1531]; Wellcome Trust [109443/Z/15/Z]	Science Foundation Ireland (SFI)(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Science Foundation Ireland (SFI) Grant SFI12/IA/1531 and Wellcome Trust Grant 109443/Z/15/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Carlisle-Moore L, 2005, J BIOL CHEM, V280, P42612, DOI 10.1074/jbc.M507082200; Chen C, 2014, J BIOL CHEM, V289, P17184, DOI 10.1074/jbc.M114.550806; Choi MS, 2016, J LIPID RES, V57, P607, DOI 10.1194/jlr.M065805; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; Hegyi L, 1996, J PATHOL, V180, P423, DOI 10.1002/(SICI)1096-9896(199612)180:4<423::AID-PATH677>3.0.CO;2-1; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lehninger A. L., 1993, PRINCIPLES BIOCH; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ruysschaert JM, 2015, BBA-BIOMEMBRANES, V1848, P1860, DOI 10.1016/j.bbamem.2015.03.014; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Triantafilou M, 2002, J CELL SCI, V115, P2603; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	38	83	87	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5509	5521		10.1074/jbc.RA118.001921	http://dx.doi.org/10.1074/jbc.RA118.001921			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463677	Green Published, hybrid			2022-12-28	WOS:000430044100014
J	Jentsch, JA; Kiburu, I; Pandey, K; Timme, M; Ramlall, T; Levkau, B; Wu, J; Eliezer, D; Boudker, O; Menon, AK				Jentsch, Julian-Alexander; Kiburu, Irene; Pandey, Kalpana; Timme, Michael; Ramlall, Trudy; Levkau, Bodo; Wu, Jin; Eliezer, David; Boudker, Olga; Menon, Anant K.			Structural basis of sterol binding and transport by a yeast StARkin domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CONTACT SITES; LIPID TRANSFER PROTEINS; PLASMA-MEMBRANE; EVOLUTIONARY CONSERVATION; STRUCTURE REFINEMENT; LIGAND-BINDING; CHOLESTEROL; MECHANISM; STARD4; HOMEOSTASIS	The StARkin superfamily comprises proteins with steroidogenic acute regulatory protein-related lipid transfer (StART) domains that are implicated in intracellular, non-vesicular lipid transport. A new family of membrane-anchored StARkins was recently identified, including six members, Lam1-Lam6, in the yeast Saccharomyces cerevisiae. Lam1-Lam4 are anchored to the endoplasmic reticulum (ER) membrane at sites where the ER is tethered to the plasma membrane and proposed to be involved in sterol homeostasis in yeast. To better understand the biological roles of these proteins, we carried out a structure-function analysis of the second StARkin domain of Lam4, here termed Lam4S2. NMR experiments indicated that Lam4S2 undergoes specific conformational changes upon binding sterol, and fluorescence-based assays revealed that it catalyzes sterol transport between vesicle populations in vitro, exhibiting a preference for vesicles containing anionic lipids. Using such vesicles, we found that sterols are transported at a rate of similar to 50 molecules per Lam4S2 per minute. Crystal structures of Lam4S2, with and without bound sterol, revealed a largely hydrophobic but surprisingly accessible sterol-binding pocket with the 3-OH group of the sterol oriented toward its base. Single or multiple alanine or aspartic acid replacements of conserved lysine residues in a basic patch on the surface of Lam4S2 near the likely sterol entry/egress site strongly attenuated sterol transport. Our results suggest that Lam4S2 engages anionic membranes via a basic surface patch, enabling "head-first" entry of sterol into the binding pocket followed by partial closure of the entryway. Reversal of these steps enables sterol egress.	[Jentsch, Julian-Alexander; Pandey, Kalpana; Timme, Michael; Ramlall, Trudy; Wu, Jin; Eliezer, David; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA; [Kiburu, Irene; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA; [Boudker, Olga] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Jentsch, Julian-Alexander; Levkau, Bodo] Univ Hosp Essen, Inst Pathophysiol, West German Heart & Vasc Ctr, D-45122 Essen, Germany	Cornell University; Cornell University; Cornell University; Howard Hughes Medical Institute; University of Duisburg Essen	Eliezer, D; Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.; Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	dae2005@med.cornell.edu; olb2003@med.cornell.edu; akm2003@med.cornell.edu	Pandey, Kalpana/GNW-5078-2022; Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Pandey, Kalpana/0000-0002-7048-0690	Deutsche Forschungsgemeinschaft; Qatar National Research Fund [NPRP 7-082-1-014]; National Institutes of Health [R01 GM117518, R37 AG019391, R37 NS085318]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS085318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Qatar National Research Fund(Qatar National Research Fund (QNRF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Graduiertenkolleg 2098, Project 11, from the Deutsche Forschungsgemeinschaft (to J.-A.J., B.L., and A.K.M.); Qatar National Research Fund Grant NPRP 7-082-1-014 (to A.K.M.); and National Institutes of Health Grants R01 GM117518 (to D.E.), R37 AG019391 (to D.E.), and R37 NS085318 (to O.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barbar E, 2009, MOL CELL ENDOCRINOL, V300, P89, DOI 10.1016/j.mce.2008.12.007; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dittman JS, 2017, TRENDS BIOCHEM SCI, V42, P90, DOI 10.1016/j.tibs.2016.11.004; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gatta AT, 2018, BIOCHEM BIOPH RES CO, V495, P2270, DOI 10.1016/j.bbrc.2017.12.109; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Iaea DB, 2015, BIOCHEMISTRY-US, V54, P4623, DOI 10.1021/acs.biochem.5b00618; Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/BSE0570043, 10.1042/bse0570043]; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; Khafif M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-222; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Letourneau D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28486; Letourneau D, 2013, BBA-MOL CELL BIOL L, V1831, P1589, DOI 10.1016/j.bbalip.2013.07.005; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Murley A, 2015, J CELL BIOL, V209, P539, DOI 10.1083/jcb.201502033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reinisch KM, 2016, BBA-MOL CELL BIOL L, V1861, P924, DOI 10.1016/j.bbalip.2015.12.003; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saheki Y, 2016, NAT CELL BIOL, V18, P504, DOI 10.1038/ncb3339; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tong J, 2018, P NATL ACAD SCI USA, V115, pE856, DOI 10.1073/pnas.1719709115; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wong LH, 2016, BIOCHEM SOC T, V44, P517, DOI 10.1042/BST20150275	48	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5522	5531		10.1074/jbc.RA118.001881	http://dx.doi.org/10.1074/jbc.RA118.001881			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463678	Green Published, hybrid			2022-12-28	WOS:000430044100015
J	Esposito, D; Gunster, RA; Martino, L; El Omari, K; Wagner, A; Thurston, TLM; Rittinger, K				Esposito, Diego; Gunster, Regina A.; Martino, Luigi; El Omari, Kamel; Wagner, Armin; Thurston, Teresa L. M.; Rittinger, Katrin			Structural basis for the glycosyltransferase activity of the Salmonella effector SseK3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosyltransferase; Salmonella enterica; protein structure; enzyme mechanism; bacterial toxin; X-ray crystallography; arginine modification; bacterial effectors; glycosyltransferase type-A; SseK3; UDP-GlcNAc; GT-A family; structural analysis	CLOSTRIDIUM-DIFFICILE TOXIN; III SECRETION; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN; DOMAIN; HOST; SYSTEM; IDENTIFICATION	The Salmonella-secreted effector SseK3 translocates into host cells, targeting innate immune responses, including NF-B activation. SseK3 is a glycosyltransferase that transfers an N-acetylglucosamine (GlcNAc) moiety onto the guanidino group of a target arginine, modulating host cell function. However, a lack of structural information has precluded elucidation of the molecular mechanisms in arginine and GlcNAc selection. We report here the crystal structure of SseK3 in its apo form and in complex with hydrolyzed UDP-GlcNAc. SseK3 possesses the typical glycosyltransferase type-A (GT-A)-family fold and the metal-coordinating DXD motif essential for ligand binding and enzymatic activity. Several conserved residues were essential for arginine GlcNAcylation and SseK3-mediated inhibition of NF-B activation. Isothermal titration calorimetry revealed SseK3's preference for manganese coordination. The pattern of interactions in the substrate-bound SseK3 structure explained the selection of the primary ligand. Structural rearrangement of the C-terminal residues upon ligand binding was crucial for SseK3's catalytic activity, and NMR analysis indicated that SseK3 has limited UDP-GlcNAc hydrolysis activity. The release of free N-acetyl -d-glucosamine, and the presence of the same molecule in the SseK3 active site, classified it as a retaining glycosyltransferase. A glutamate residue in the active site suggested a double-inversion mechanism for the arginine N-glycosylation reaction. Homology models of SseK1, SseK2, and the Escherichia coli orthologue NleB1 reveal differences in the surface electrostatic charge distribution, possibly accounting for their diverse activities. This first structure of a retaining GT-A arginine N-glycosyltransferase provides an important step toward a better understanding of this enzyme class and their roles as bacterial effectors.	[Esposito, Diego; Martino, Luigi; Rittinger, Katrin] Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England; [Gunster, Regina A.; Thurston, Teresa L. M.] Imperial Coll London, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [El Omari, Kamel; Wagner, Armin] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	Francis Crick Institute; Imperial College London; Diamond Light Source	Rittinger, K (corresponding author), Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England.; Thurston, TLM (corresponding author), Imperial Coll London, Microbiol Sect, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	t.thurston@imperial.ac.uk; katrin.rittinger@crick.ac.uk	Thurston, Teresa/AAZ-9938-2020; Rittinger, Katrin/N-3344-2019	Thurston, Teresa/0000-0001-6139-3723; Rittinger, Katrin/0000-0002-7698-4435; Martino, Luigi/0000-0001-5871-3124; Guenster, Regina/0000-0003-1280-3006; Esposito, Diego/0000-0003-4042-8856	Francis Crick Institute [FC001142]; Cancer Research UK; UK Medical Research Council; Wellcome Trust; MRC [MC_U117565398, MR/P028225/1, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117565398, MC_U117533887] Funding Source: researchfish; The Francis Crick Institute [10029, 10142] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	The work was supported by Grant FC001142 from the Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albesa-Jove D, 2016, CURR OPIN STRUC BIOL, V40, P23, DOI 10.1016/j.sbi.2016.07.007; Ardevol A, 2016, BIOCHEM SOC T, V44, P51, DOI 10.1042/BST20150177; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; D'Urzo N, 2012, FEBS J, V279, P3085, DOI 10.1111/j.1742-4658.2012.08688.x; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; El Qaidi S, 2017, J BIOL CHEM, V292, P11423, DOI 10.1074/jbc.M117.790675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JAFFE EK, 1978, BIOCHEMISTRY-US, V17, P652, DOI 10.1021/bi00597a014; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Krafczyk R, 2017, MBIO, V8, DOI 10.1128/mBio.01412-17; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Li WQ, 2014, ACTA CRYSTALLOGR D, V70, P40, DOI 10.1107/S1399004713024619; Lu W, 2010, J MOL BIOL, V396, P321, DOI 10.1016/j.jmb.2009.11.044; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pan M, 2014, ANGEW CHEM INT EDIT, V53, P14517, DOI 10.1002/anie.201407824; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott NE, 2017, J BIOL CHEM, V292, P17337, DOI 10.1074/jbc.M117.805036; Shi WW, 2014, J BIOL CHEM, V289, P20898, DOI 10.1074/jbc.M114.581934; SINGH DG, 1995, FEBS LETT, V376, P61, DOI 10.1016/0014-5793(95)01247-6; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wagner A, 2016, ACTA CRYSTALLOGR D, V72, P430, DOI 10.1107/S2059798316001078; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	58	33	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5064	5078		10.1074/jbc.RA118.001796	http://dx.doi.org/10.1074/jbc.RA118.001796			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449376	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000429409300014
J	Jez, JM				Jez, Joseph M.			Introduction to the Thematic Minireview Series: Green biological chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						plant biochemistry; cyanobacteria; photosynthesis; circadian clock; synthetic biology; metabolic engineering		Plants and their green cousins cyanobacteria and algae use sunlight to drive the chemistry that lets them grow, survive, and perform an amazing range of biochemical reactions. The ability of these organisms to use a freely available energy source makes them attractive as sustainable and renewable platforms for more than just food production. They are also a source of metabolic tools for engineering microbes for green chemistry. This Thematic Minireview Series discusses how green organisms capture light and protect their photosynthetic machinery from too much light; new structural snapshots of the clock complex that orchestrates signaling during the light/dark cycle; challenges for improving stress responses in crops; harnessing cyanobacteria as biofactories; and efforts to engineer microbes for green biopolymer production.	[Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu						Anderson LA, 2018, J BIOL CHEM, V293, P5053, DOI 10.1074/jbc.TM117.000368; Horn PJ, 2016, SCIENCE, V353, P1228, DOI 10.1126/science.aaf6206; Jez JM, 2016, SCIENCE, V353, P1241, DOI 10.1126/science.aag1698; Joshi R, 2018, J BIOL CHEM, V293, P5035, DOI 10.1074/jbc.TM117.000232; Knoot CJ, 2018, J BIOL CHEM, V293, P5044, DOI 10.1074/jbc.R117.815886; Lomonossoff GP, 2016, SCIENCE, V353, P1237, DOI 10.1126/science.aaf6638; Magdaong NCM, 2018, J BIOL CHEM, V293, P5018, DOI 10.1074/jbc.TM117.000233; Swan JA, 2018, J BIOL CHEM, V293, P5026, DOI 10.1074/jbc.TM117.001433; Wurtzel ET, 2016, SCIENCE, V353, P1232, DOI 10.1126/science.aad2062	9	0	0	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5016	5017		10.1074/jbc.TM118.002424	http://dx.doi.org/10.1074/jbc.TM118.002424			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444823	Green Published, hybrid			2022-12-28	WOS:000429409300006
J	Joshi, R; Singla-Pareek, SL; Pareek, A				Joshi, Rohit; Singla-Pareek, Sneh L.; Pareek, Ashwani			Engineering abiotic stress response in plants for biomass production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						stress; plant; phytohormone; plant cell wall; microbiome; abiotic stress; biomass; plant-microbe interactions; secondary cell wall	DROUGHT TOLERANCE; IMPROVES DROUGHT; TRANSCRIPTION FACTOR; YIELD IMPROVEMENT; SEED-GERMINATION; GROWTH PROMOTION; LEAF SENESCENCE; INCREASES YIELD; ABSCISIC-ACID; SATIVA L.	One of the major challenges in today's agriculture is to achieve enhanced plant growth and biomass even under adverse environmental conditions. Recent advancements in genetics and molecular biology have enabled the identification of a complex signaling network contributing toward plant growth and development on the one hand and abiotic stress response on the other hand. As an outcome of these studies, three major approaches have been identified as having the potential to improve biomass production in plants under abiotic stress conditions. These approaches deal with having changes in the following: (i) plant-microbe interactions; (ii) cell wall biosynthesis; and (iii) phytohormone levels. At the same time, employing functional genomics and genetics-based approaches, a very large number of genes have been identified that play a key role in abiotic stress tolerance. Our Minireview is an attempt to unveil the cross-talk that has just started to emerge between the transcriptional circuitries for biomass production and abiotic stress response. This knowledge may serve as a valuable resource to eventually custom design the crop plants for higher biomass production, in a more sustainable manner, in marginal lands under variable climatic conditions.	[Joshi, Rohit; Pareek, Ashwani] Jawaharlal Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi 110067, India; [Singla-Pareek, Sneh L.] Int Ctr Genet Engn & Biotechnol, Plant Stress Biol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Pareek, Ashwani] Univ Western Australia, UWA Inst Agr, Sch Agr & Environm, Perth, WA 6009, Australia	Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Western Australia	Pareek, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi 110067, India.	ashwanip@mail.jnu.ac.in	JOSHI, ROHIT/V-1582-2019	Joshi, Rohit/0000-0002-6524-4722	International Atomic Energy Agency (Vienna, Austria); University Grants Commission-Resource Networking Center (UGC-RNW); University with Potential for Excellence (UPE-II) (India); UGC, Government of India; Indo-US Science and Technology Forum (IUSSTF) for Indo-US Advanced Bioenergy Consortium (IUABC)	International Atomic Energy Agency (Vienna, Austria)(International Atomic Energy Agency); University Grants Commission-Resource Networking Center (UGC-RNW); University with Potential for Excellence (UPE-II) (India); UGC, Government of India(University Grants Commission, India); Indo-US Science and Technology Forum (IUSSTF) for Indo-US Advanced Bioenergy Consortium (IUABC)	This work was supported by the International Atomic Energy Agency (Vienna, Austria), University Grants Commission-Resource Networking Center (UGC-RNW), and University with Potential for Excellence (UPE-II) (India). This is the third article in the Thematic Minireview series "Green biological chemistry." The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Dr. D. S. Kothari Postdoctoral Fellowship from UGC, Government of India.; Supported by funding from the Indo-US Science and Technology Forum (IUSSTF) for Indo-US Advanced Bioenergy Consortium (IUABC).	Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Berry P., 2013, PLANT GENETIC RESOUR, P78; Brijesh Gupta, 2017, Mechanism of plant hormone signaling under stress. Volume II, P533; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Clode PL, 2009, PLANT PHYSIOL, V151, P1751, DOI 10.1104/pp.109.141499; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Dimkpa CO, 2009, SOIL BIOL BIOCHEM, V41, P154, DOI 10.1016/j.soilbio.2008.10.010; Dkhar J, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-47; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Ghanem ME, 2011, PLANT CELL REP, V30, P807, DOI 10.1007/s00299-011-1005-2; Fahad S, 2015, ENVIRON SCI POLLUT R, V22, P4907, DOI 10.1007/s11356-014-3754-2; Fan L, 2006, PLANT PHYSIOL, V140, P603, DOI 10.1104/pp.105.073130; Farrar K, 2014, PLANT BIOTECHNOL J, V12, P1193, DOI 10.1111/pbi.12279; Gerbens-Leenes PW, 2009, ECOL ECON, V68, P1052, DOI 10.1016/j.ecolecon.2008.07.013; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Gonzalez N, 2009, CURR OPIN PLANT BIOL, V12, P157, DOI 10.1016/j.pbi.2008.11.003; Gou JQ, 2018, PLANT BIOTECHNOL J, V16, P951, DOI 10.1111/pbi.12841; Gravel V, 2007, SOIL BIOL BIOCHEM, V39, P1968, DOI 10.1016/j.soilbio.2007.02.015; Grover M, 2011, WORLD J MICROB BIOT, V27, P1231, DOI 10.1007/s11274-010-0572-7; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Haak DC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01564; Joshi R, 2018, PLANT CELL ENVIRON, V41, P936, DOI 10.1111/pce.12947; Joshi Rohit, 2016, Indian Journal of Plant Physiology, V21, P545, DOI 10.1007/s40502-016-0264-x; Ke QB, 2015, PLANT PHYSIOL BIOCH, V94, P19, DOI 10.1016/j.plaphy.2015.05.003; Khan A, 2016, ENVIRON EXP BOT, V124, P120, DOI 10.1016/j.envexpbot.2015.12.011; Koh LP, 2013, PEERJ, V1, DOI 10.7717/peerj.188; Koh S, 2007, PLANT MOL BIOL, V65, P453, DOI 10.1007/s11103-007-9213-4; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Kumari S, 2009, FUNCT INTEGR GENOMIC, V9, P109, DOI 10.1007/s10142-008-0088-5; Lakra N, 2018, PLANT CELL ENVIRON, V41, P947, DOI 10.1111/pce.12946; Lau JA, 2011, NEW PHYTOL, V192, P215, DOI 10.1111/j.1469-8137.2011.03790.x; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lee JT, 2003, PLANT CELL ENVIRON, V26, P1181, DOI 10.1046/j.1365-3040.2003.01048.x; Li KR, 2008, NEW FOREST, V35, P255, DOI 10.1007/s11056-007-9075-2; Li YJ, 2013, PLANT BIOTECHNOL J, V11, P747, DOI 10.1111/pbi.12066; Li ZF, 2011, PLANT J, V68, P88, DOI 10.1111/j.1365-313X.2011.04670.x; Liu MX, 2012, J INTEGR AGR, V11, P502, DOI 10.1016/S2095-3119(12)60036-7; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Maggio A, 2010, J PLANT GROWTH REGUL, V29, P63, DOI 10.1007/s00344-009-9114-7; Meena KK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00172; Meitzel T, 2011, PLANT J, V65, P517, DOI 10.1111/j.1365-313X.2010.04450.x; Merewitz EB, 2010, J AM SOC HORTIC SCI, V135, P230, DOI 10.21273/JASHS.135.3.230; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Nongpiur RC, 2016, CURR GENOMICS, V17, P343, DOI 10.2174/1389202917666160331202517; Pareek A., 2009, ABIOTIC STRESS ADAPT, P526; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pereira A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01123; Perrella G, 2013, PLANT CELL, V25, P3491, DOI 10.1105/tpc.113.114835; Placido DF, 2013, PLANT PHYSIOL, V161, P1806, DOI 10.1104/pp.113.214262; Pump J, 2014, PLANT SOIL, V384, P213, DOI 10.1007/s11104-014-2201-y; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Rao XL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00806; Risopatron JPM, 2010, PROTOPLASMA, V247, P145, DOI 10.1007/s00709-010-0211-z; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sanchez-Rodriguez C, 2017, P NATL ACAD SCI USA, V114, P3533, DOI 10.1073/pnas.1615005114; Schmidt R, 2013, PLANT J, V76, P258, DOI 10.1111/tpj.12286; Selvakumar G, 2008, WORLD J MICROB BIOT, V24, P955, DOI 10.1007/s11274-007-9558-5; Sharan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08076-w; Szechynska-Hebda M, 2016, PLANT CELL REP, V35, P527, DOI 10.1007/s00299-015-1901-y; Timmusk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096086; Tung SA, 2008, PLANT CELL ENVIRON, V31, P968, DOI 10.1111/j.1365-3040.2008.01812.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vardhini BV, 2003, PLANT GROWTH REGUL, V41, P25, DOI 10.1023/A:1027303518467; Viterbo A, 2010, FEMS MICROBIOL LETT, V305, P42, DOI 10.1111/j.1574-6968.2010.01910.x; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wu CH, 2009, MICROB BIOTECHNOL, V2, P428, DOI 10.1111/j.1751-7915.2009.00109.x; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xie LQ, 2011, J EXP BOT, V62, P4495, DOI 10.1093/jxb/err164; Xu JC, 2008, ENVIRON EXP BOT, V63, P240, DOI 10.1016/j.envexpbot.2007.11.011; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007	81	25	26	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5035	5043		10.1074/jbc.TM117.000232	http://dx.doi.org/10.1074/jbc.TM117.000232			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29339553	Green Published, hybrid			2022-12-28	WOS:000429409300009
J	Qu, C; Yan, M; Yang, SM; Wang, LB; Yin, Q; Liu, Y; Chen, YG; Li, JS				Qu, Chao; Yan, Meng; Yang, Suming; Wang, Lingbo; Yin, Qi; Liu, Yuan; Chen, Yeguang; Li, Jinsong			Haploid embryonic stem cells can be enriched and maintained by simple filtration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; CRISPR; Cas; cell sorting; cell biology; embryo; diploidization; FACS; filtration; haploid embryonic stem cells; haploidy	GENETICALLY-MODIFIED MICE; EFFICIENT GENERATION; CYTO-TOXICITY; MOUSE; GENOME; DERIVATION; HOECHST-33342; TECHNOLOGY; SYSTEMS; HALF	Mammalian haploid embryonic stem cells (haESCs) serve as a powerful tool for genetic analyses at both the cellular and organismal levels. However, spontaneous diploidization of haESCs limits their use in these analyses. Addition of small molecules to the culture medium to control the cell cycle can slow down diploidization, but cell-sorting methods such as FACS are still required to enrich haploid cells for long-term maintenance in vitro. Here, acting on our observation that haploid and diploidized cells differ in diameter, we developed a simplified filtration method to enrich haploid cells from cultured haESCs. We found that regular cell filtration with this system reliably maintained the haploidy of mouse haESCs for over 30 passages. Importantly, CRISPR/Cas9-mediated knockout and knockin were successfully achieved in the filtered cells, leading to stable haploid cell lines carrying the desired gene modifications. Of note, by injecting haESCs into metaphase II oocytes, we efficiently obtained live mice with the expected genetic traits, indicating that regular filtration maintained the functional integrity of haESCs. Moreover, this filtration system was also feasible for derivation of mouse haESCs from parthenogenetic haploid blastocysts and for human haESC maintenance. In conclusion, we have identified a reliable, efficient, and easy-to-handle technique for countering diploidization of haploid cells, a major obstacle in haESC applications.	[Qu, Chao; Yan, Meng; Yang, Suming; Wang, Lingbo; Yin, Qi; Li, Jinsong] Chinese Acad Sci, Shanghai Key Lab Mol Androl, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Univ Chinese Acad Sci,Ct, Shanghai 200031, Peoples R China; [Liu, Yuan; Chen, Yeguang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tsinghua University	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Key Lab Mol Androl, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Univ Chinese Acad Sci,Ct, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn		Wang, Lingbo/0000-0002-0962-8457; Yin, Qi/0000-0001-5628-5015; li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2014CB964803]; National Natural Science Foundation of China [31530048, 81672117, 31730062]; Chinese Academy of Sciences [XDB19010204, OYZDJ-SSW-SMC023, KJZD-EW-L13]; Facility-Based Open Research Program; Shanghai Municipal Commission for Science and Technology [16JC1420500, 17JC1400900, 17JC1420102, 17411954900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Facility-Based Open Research Program; Shanghai Municipal Commission for Science and Technology	This study was supported by Ministry of Science and Technology of China Grant 2014CB964803; National Natural Science Foundation of China Grants 31530048, 81672117, and 31730062; Chinese Academy of Sciences Grants XDB19010204, OYZDJ-SSW-SMC023, and KJZD-EW-L13 and the Facility-Based Open Research Program; and Shanghai Municipal Commission for Science and Technology Grants 16JC1420500, 17JC1400900, 17JC1420102, and 17411954900. The authors declare that they have no conflicts of interest with the contents of this article.	Bai M, 2016, J INTERN MED, V280, P236, DOI 10.1111/joim.12503; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Elling U, 2017, NATURE, V550, P114, DOI 10.1038/nature24027; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Freimann R, 2017, BIOMICROFLUIDICS, V11, DOI 10.1063/1.5006326; Guo A, 2017, STEM CELL REP, V8, P1124, DOI 10.1016/j.stemcr.2017.03.025; He ZQ, 2017, CELL REP, V20, P2227, DOI 10.1016/j.celrep.2017.07.081; Jin LF, 2016, ZOOL RES, V37, P205, DOI 10.13918/j.issn.2095-8137.2016.4.205; Kokubu C, 2014, CELL STEM CELL, V14, P265, DOI 10.1016/j.stem.2014.02.001; Kumar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186977; Leeb M, 2012, DEVELOPMENT, V139, P3301, DOI 10.1242/dev.083675; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13471-4; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Shi LY, 2012, PROTEIN CELL, V3, P806, DOI 10.1007/s13238-012-2096-4; Takahashi S, 2014, DEVELOPMENT, V141, P3842, DOI 10.1242/dev.110726; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Wei LX, 2017, J GENET GENOMICS, V44, P461, DOI 10.1016/j.jgg.2017.07.004; WIEZOREK C, 1984, HISTOCHEMISTRY, V81, P493, DOI 10.1007/BF00489756; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Yilmaz A, 2016, CELL STEM CELL, V19, P569, DOI 10.1016/j.stem.2016.10.009; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao HL, 2015, BIOCHEM BIOPH RES CO, V464, P1163, DOI 10.1016/j.bbrc.2015.07.098; Zhong CQ, 2017, METHODS MOL BIOL, V1498, P121, DOI 10.1007/978-1-4939-6472-7_8; Zhong CQ, 2016, CELL RES, V26, P743, DOI 10.1038/cr.2016.59; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	34	4	8	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5230	5235		10.1074/jbc.RA118.002029	http://dx.doi.org/10.1074/jbc.RA118.002029			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449377	Green Published, hybrid			2022-12-28	WOS:000429409300027
J	de Jong, NWM; Vrieling, M; Garcia, BL; Koop, G; Brettmann, M; Aerts, PC; Ruyken, M; van Strijp, JAG; Holmes, M; Harrison, EM; Geisbrecht, BV; Rooijakkers, SHM				de Jong, Nienke W. M.; Vrieling, Manouk; Garcia, Brandon L.; Koop, Gerrit; Brettmann, Matt; Aerts, Piet C.; Ruyken, Maartje; van Strijp, Jos A. G.; Holmes, Mark; Harrison, Ewan M.; Geisbrecht, Brian V.; Rooijakkers, Suzan H. M.			Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE EVASION; PROTEIN FAMILY; SCIN PROTEINS; INFECTIONS; ADAPTATION; CONVERTASE; NEUTROPHILS; EVOLUTION; GENOMICS; RUMINANT	Staphylococcus aureus is a versatile pathogen capable of causing a broad range of diseases in many different hosts. S. aureus can adapt to its host through modification of its genome (e.g. by acquisition and exchange of mobile genetic elements that encode host-specific virulence factors). Recently, the prophage phi Saeq1 was discovered in S. aureus strains from six different clonal lineages almost exclusively isolated from equids. Within this phage, we discovered a novel variant of staphylococcal complement inhibitor (SCIN), a secreted protein that interferes with activation of the human complement system, an important line of host defense. We here show that this equine variant of SCIN, eqSCIN, is a potent blocker of equine complement system activation and subsequent phagocytosis of bacteria by phagocytes. Mechanistic studies indicate that eqSCIN blocks equine complement activation by specific inhibition of the C3 convertase enzyme (C3bBb). Whereas SCIN-A from human S. aureus isolates exclusively inhibits human complement, eqSCIN represents the first animal-adapted SCIN variant that functions in a broader range of hosts (horses, humans, and pigs). Binding analyses suggest that the human-specific activity of SCIN-A is related to amino acid differences on both sides of the SCIN-C3b interface. These data suggest that modification of this phage-encoded complement inhibitor plays a role in the host adaptation of S. aureus and are important to understand how this pathogen transfers between different hosts.	[de Jong, Nienke W. M.; Vrieling, Manouk; Aerts, Piet C.; Ruyken, Maartje; van Strijp, Jos A. G.; Rooijakkers, Suzan H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Vrieling, Manouk] Univ Edinburgh, Roslin Inst, Easter Bush Campus, Roslin EH25 9RG, Midlothian, Scotland; [Garcia, Brandon L.; Brettmann, Matt; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Koop, Gerrit] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands; [Holmes, Mark] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Harrison, Ewan M.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	Utrecht University; Utrecht University Medical Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Kansas State University; Utrecht University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rooijakkers, SHM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.; Rooijakkers, SHM (corresponding author), Univ Utrecht, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	s.h.m.rooijakkers@umcutrecht.nl	van Strijp, Jos A.G./J-9549-2014; Harrison, Ewan/I-5003-2013	van Strijp, Jos A.G./0000-0001-6253-0830; Vrieling, Manouk/0000-0002-5465-4515; Harrison, Ewan/0000-0003-2720-0507	National Institutes of Health [AI113552, GM121511]; ERC [639209]; Health Innovation Challenge Fund [WT098600, HICF-T5-342]; Department of Health; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121511] Funding Source: NIH RePORTER; MRC [G1001787, MR/P007201/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Health Innovation Challenge Fund; Department of Health; Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Institutes of Health Grants AI113552 and GM121511 (to B.V.G.) and by ERC Starting Grant 639209 (to S.H.M.R.), and this publication presents independent research supported by the Health Innovation Challenge Fund (WT098600, HICF-T5-342), a parallel funding partnership between the Department of Health and Wellcome Trust.	Abdelbary MMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088083; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Garcia BL, 2013, J BIOL CHEM, V288, P2870, DOI 10.1074/jbc.M112.426858; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Garcia BL, 2010, J MOL BIOL, V402, P17, DOI 10.1016/j.jmb.2010.07.029; Garcia BL, 2009, ACTA CRYSTALLOGR F, V65, P482, DOI 10.1107/S174430910901207X; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gharsa H, 2015, VECTOR-BORNE ZOONOT, V15, P109, DOI 10.1089/vbz.2014.1655; Gharsa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-203; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Islam MZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00543; JOISEL F, 1983, J IMMUNOL METHODS, V59, P229, DOI 10.1016/0022-1759(83)90035-2; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Koop G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40660; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Siemsen Daniel W., 2007, V412, P21, DOI 10.1007/978-1-59745-467-4_3; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Summers BJ, 2015, MOL IMMUNOL, V67, P193, DOI 10.1016/j.molimm.2015.05.012; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	38	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4468	4477		10.1074/jbc.RA117.000599	http://dx.doi.org/10.1074/jbc.RA117.000599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414776	Green Published, hybrid			2022-12-28	WOS:000428204300018
J	Mulder, FAA				Mulder, Frans A. A.			Fuzzy and fast nuclear transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Exchange of macromolecules between the cytoplasm and the nucleus of all eukaryotic cells is controlled by nuclear pore complexes, which form a selective permeability barrier. The requirement for rapid but selective transport leads to a "transport paradox." A new experimental study now provides a thermodynamic explanation.	[Mulder, Frans A. A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Mulder, Frans A. A.] Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Mulder, FAA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.; Mulder, FAA (corresponding author), Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	fmulder@chem.au.dk	Mulder, Frans AA/C-7158-2017	Mulder, Frans AA/0000-0001-9427-8406				Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Bhowmick A, 2016, J AM CHEM SOC, V138, P9730, DOI 10.1021/jacs.6b06543; Fischer E, 1984, BER DEUT CHEM GES, V27, P2985; Hayama R, 2018, J BIOL CHEM, V293, P4555, DOI 10.1074/jbc.AC117.001649; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271	7	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4564	+		10.1074/jbc.H118.002129	http://dx.doi.org/10.1074/jbc.H118.002129			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572326	Green Published, hybrid			2022-12-28	WOS:000428204300027
J	Wojnacki, J; Galli, T				Wojnacki, Jose; Galli, Thierry			A new actin-binding domain glues autophagy together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							EXCHANGE FACTOR DENND3; RAB12	Autophagy breaks down nonessential cellular components to replenish macromolecular building blocks during starvation. Nevertheless, the downstream events regulating vesicle trafficking during this essential cellular process are not yet fully defined. Xu et al. combined approaches of crystallography, biochemistry, and cell biology to show that the guanine nucleotide exchange factor DENND3 contains an actin-binding site they call "PHenn domain" in a region previously thought to be unstructured. PHenn domain binding to microfilaments is necessary for DENND3's participation in autophagy, providing a new link between autophagic stimulation and actin microfilaments. The findings by Xu et al. shed important new light on how membrane trafficking participates in critical steps of autophagy in relationship with actin microfilaments.	[Wojnacki, Jose; Galli, Thierry] Univ Paris 05, Sorbonne Paris Cite, INSERM, U894,Ctr Psychiat & Neurosci,Membrane Traff Hlth, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Galli, T (corresponding author), INSERM, U894, 102-108 Rue Sante, F-75014 Paris, France.	thierry.galli@inserm.fr	Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455	INSERM; Fondation pour la Recherche Medicale (FRM); French National Research Agency [ANR-13-BSV2-0018-02, ANR-16-CE16-0012]; Ecole des Neurosciences de Paris (ENP); Association Robert Debre pour la Recherche Medicale; Fondation Bettencourt Schueller; Who am I? Labex [Idex ANR-11-IDEX-0005-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Research Agency(French National Research Agency (ANR)); Ecole des Neurosciences de Paris (ENP); Association Robert Debre pour la Recherche Medicale; Fondation Bettencourt Schueller; Who am I? Labex	This work was funded in part by INSERM, the Fondation pour la Recherche Medicale (FRM), the French National Research Agency (NeuroImmunoSynapse ANR-13-BSV2-0018-02 and MetDePaDi ANR-16-CE16-0012), the Ecole des Neurosciences de Paris (ENP), awards of the Association Robert Debre pour la Recherche Medicale and Fondation Bettencourt Schueller (to T. G.), and Who am I? Labex (Idex ANR-11-IDEX-0005-01). The authors declare that they have no conflicts of interest with the contents of this article.	Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Efergan A, 2016, J IMMUNOL, V196, P1091, DOI 10.4049/jimmunol.1500731; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Xu J, 2018, J BIOL CHEM, V293, P4566, DOI 10.1074/jbc.RA117.001446; Xu J, 2017, J BIOL CHEM, V292, P7274, DOI 10.1074/jbc.M116.772434; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yamamoto A, 2014, ANNU REV NEUROSCI, V37, P55, DOI 10.1146/annurev-neuro-071013-014149	10	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4575	+		10.1074/jbc.H118.002041	http://dx.doi.org/10.1074/jbc.H118.002041			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572327	hybrid, Green Published			2022-12-28	WOS:000428204300029
J	Streit, BR; Celis, AI; Moraski, GC; Shisler, KA; Shepard, EM; Rodgers, KR; Lukat-Rodgers, GS; DuBois, JL				Streit, Bennett R.; Celis, Arianna I.; Moraski, Garrett C.; Shisler, Krista A.; Shepard, Eric M.; Rodgers, Kenton R.; Lukat-Rodgers, Gudrun S.; DuBois, Jennifer L.			Decarboxylation involving a ferryl, propionate, and a tyrosyl group in a radical relay yields heme b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED ELECTRON-TRANSFER; CYTOCHROME-P450 COMPOUND I; RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; PEROXIDASE; MECHANISM; EPR; PROTEINS; ACIDS; IRON	The H2O2-dependent oxidative decarboxylation of coproheme III is the final step in the biosynthesis of heme b in many microbes. However, the coproheme decarboxylase reaction mechanism is unclear. The structure of the decarboxylase in complex with coproheme III suggested that the substrate iron, reactive propionates, and an active-site tyrosine convey a net 2e(-) /2H(+) from each propionate to an activated form of H2O2. Time-resolved EPR spectroscopy revealed that Tyr-145 formed a radical species within 30 s of the reaction of the enzyme-coproheme complex with H2O2. This radical disappeared over the next 270 s, consistent with a catalytic intermediate. Use of the harderoheme III intermediate as substrate or substitutions of redox-active side chains (W198F, W157F, or Y113S) did not strongly affect the appearance or intensity of the radical spectrum measured 30 s after initiating the reaction with H2O2, nor did it change the similar to 270 s required for the radical signal to recede to <= 10% of its initial intensity. These results suggested Tyr-145 as the site of a catalytic radical involved in decarboxylating both propionates. Tyr-145(center dot) was accompanied by partial loss of the initially present Fe(III) EPR signal intensity, consistent with the possible formation of Fe(IV) = O. Site-specifically deuterated coproheme gave rise to a kinetic isotope effect of similar to 2 on the decarboxylation rate constant, indicating that cleavage of the propionate C beta-H bond was partly rate-limiting. The inferred mechanism requires two consecutive hydrogen atom transfers, first from Tyr-145 to the substrate Fe/H2O2 intermediate and then from the propionate C beta-H to Tyr-145(center dot).	[Streit, Bennett R.; Celis, Arianna I.; Moraski, Garrett C.; Shisler, Krista A.; Shepard, Eric M.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Rodgers, Kenton R.; Lukat-Rodgers, Gudrun S.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA	Montana State University System; Montana State University Bozeman; North Dakota State University Fargo	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jennifer.dubois1@montana.edu	Moraski, Garrett/AAH-3616-2021	Celis, Arianna/0000-0002-5116-9768	NIGMS, National Institutes of Health [R01GM090260, R15GM114787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090260, R15GM114787] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grants R01GM090260 (to J.L.D.) and R15GM114787 (to G.S.L.-R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BARRY BA, 1990, J BIOL CHEM, V265, P20139; BENDER CJ, 1989, J AM CHEM SOC, V111, P8076, DOI 10.1021/ja00203a002; Brown KR, 2004, BIOCHEMISTRY-US, V43, P8616, DOI 10.1021/bi049056m; Celis AI, 2017, J AM CHEM SOC, V139, P1900, DOI 10.1021/jacs.6b11324; Celis AI, 2015, BIOCHEMISTRY-US, V54, P4022, DOI 10.1021/acs.biochem.5b00492; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; Di Bilio AJ, 2001, J AM CHEM SOC, V123, P3181, DOI 10.1021/ja0043183; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; Frey P. A., 2007, ENZYMATIC REACTION M, P91; Fujii H, 1996, INORG CHEM, V35, P2373, DOI 10.1021/ic9513752; Gorchein A, 2005, BIOMED CHROMATOGR, V19, P565, DOI 10.1002/bmc.480; Grant JL, 2015, J AM CHEM SOC, V137, P4940, DOI 10.1021/jacs.5b01965; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; Hofbauer S, 2016, BIOCHEMISTRY-US, V55, P5398, DOI 10.1021/acs.biochem.6b00701; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P13107, DOI 10.1021/bi961297+; Lash TD, 2010, J ORG CHEM, V75, P3183, DOI 10.1021/jo100083t; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Lin MT, 2011, METHODS, V55, P370, DOI 10.1016/j.ymeth.2011.08.019; Macdonald IK, 2006, BIOCHEMISTRY-US, V45, P7808, DOI 10.1021/bi0606849; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roston D, 2014, ARCH BIOCHEM BIOPHYS, V544, P96, DOI 10.1016/j.abb.2013.10.010; SCHULZ CE, 1979, FEBS LETT, V103, P102, DOI 10.1016/0014-5793(79)81259-4; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Streit BR, 2017, BIOCHEMISTRY-US, V56, P189, DOI 10.1021/acs.biochem.6b00958; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Warren JJ, 2011, J AM CHEM SOC, V133, P8544, DOI 10.1021/ja201663p; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Westerlund K, 2005, BBA-BIOENERGETICS, V1707, P103, DOI 10.1016/j.bbabio.2004.02.013; Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013; Yeh HC, 2009, BIOCHEMISTRY-US, V48, P917, DOI 10.1021/bi801382v	37	18	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3989	3999		10.1074/jbc.RA117.000830	http://dx.doi.org/10.1074/jbc.RA117.000830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414780	Green Published, hybrid			2022-12-28	WOS:000427587500012
J	Majumder, S; Ghoshal, K; Datta, J; Smith, DS; Bai, SM; Jacob, ST				Majumder, Sarmila; Ghoshal, Kalpana; Datta, Jharna; Smith, David Spencer; Bai, Shoumei; Jacob, Samson T.			RETRACTION: Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription (Retraction of Vol 281, Pg 22062, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200	1	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3591	3591		10.1074/jbc.W118.002433	http://dx.doi.org/10.1074/jbc.W118.002433			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523697	Green Published, hybrid			2022-12-28	WOS:000427030200013
J	Walling, LL				Walling, Linda L.			Extreme resistance: The GLK-Rx1 alliance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RECEPTOR RX1	Plant immune surveillance systems depend on nucleotide-binding leucine-rich repeat receptors (NLRs). A subset of NLRs are nuclear-localized, including Rx1, which confers an extreme immunity against potato virus X (PVX). As with many NLRs, the downstream signaling partners of Rx1 are unknown. Townsend et al. identify a Golden-like transcription factor that interacts with Rx1 and mediates antiviral immunity, providing the first insights into the specificity factors that enable the nonspecific DNA-binding Rx1 to confer extreme resistance to PVX.	[Walling, Linda L.] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Walling, LL (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	lwalling@ucr.edu			National Science Foundation [IOS EAGER-1450331]; Bill AMP; Melinda Gates Foundation (National Research Institute (NRI), University of Greenwich, UK) [B0426_5]	National Science Foundation(National Science Foundation (NSF)); Bill AMP; Melinda Gates Foundation (National Research Institute (NRI), University of Greenwich, UK)	This work was supported by a grant from the National Science Foundation (IOS EAGER-1450331) and a grant from the Bill & Melinda Gates Foundation (via subcontractB0426_5 from the National Research Institute (NRI), University of Greenwich, UK). The author declares that she has no conflicts of interests with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official view of the National Science Foundation, the NRI, or the Bill & Melinda Gates Foundation.	Baggs E, 2017, CURR OPIN PLANT BIOL, V38, P59, DOI 10.1016/j.pbi.2017.04.012; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Birkenbihl RP, 2017, CURR OPIN PLANT BIOL, V38, P1, DOI 10.1016/j.pbi.2017.04.004; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sukarta OCA, 2016, SEMIN CELL DEV BIOL, V56, P134, DOI 10.1016/j.semcdb.2016.05.012; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Townsend PD, 2018, J BIOL CHEM, V293, P3218, DOI 10.1074/jbc.RA117.000485	10	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3234	3235		10.1074/jbc.H118.001456	http://dx.doi.org/10.1074/jbc.H118.001456			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29500269	Green Published, hybrid			2022-12-28	WOS:000426562800016
J	Zhou, XC; Dong, SH; Liu, ZS; Liu, S; Zhang, CC; Liang, XZ				Zhou, Xing-chen; Dong, Si-han; Liu, Zhong-shun; Liu, Shuai; Zhang, Chao-can; Liang, Xiao-zhen			Regulation of gammaherpesvirus lytic replication by endoplasmic reticulum stress-induced transcription factors ATF4 and CHOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; B-CELLS; ER STRESS; BURKITT-LYMPHOMA; TRIGGERS REACTIVATION; INDUCED APOPTOSIS; GENE-EXPRESSION; VIRAL LATENCY	The stress-induced unfolded protein response (UPR) in the endoplasmic reticulum (ER) involves various signaling cross-talks and controls cell fate. B-cell receptor (BCR) signaling, which can trigger UPR, induces gammaherpesvirus lytic replication and serves as a physiological mechanism for gammaherpesvirus reactivation in vivo. However, how the UPR regulates BCR-mediated gammaherpesvirus infection is unknown. Here, we demonstrate that the ER stressors tunicamycin and thapsigargin inhibit BCR-mediated murine gammaherpesvirus 68 (MHV68) lytic replication by inducing expression of the UPR mediator Bip and blocking activation of Akt, ERK, and JNK. Both Bip and the downstream transcription factor ATF4 inhibited BCR-mediated MHV68 lytic gene expression, whereas UPR-induced C/EBP homologous protein (CHOP) was required for and promoted BCR-mediated MHV68 lytic replication by suppressing upstream Bip and ATF4 expression. Bip knockout was sufficient to rescue BCR-mediated MHV68 lytic gene expression in CHOP knockout cells, and this rescue was blocked by ectopic ATF4 expression. Furthermore, ATF4 directly inhibited promoter activity of the MHV68 lytic switch transactivator RTA. Altogether, we show that ER stress-induced CHOP inhibits Bip and ATF4 expression and that ATF4, in turn, plays a critical role in CHOP-mediated regulation of BCR-controlled MHV68 lytic replication. We conclude that ER stress-mediated UPR and BCR signaling pathways are interconnected and form a complex network to regulate the gammaherpesvirus infection cycle.	[Zhou, Xing-chen; Dong, Si-han; Liu, Zhong-shun; Liu, Shuai; Zhang, Chao-can; Liang, Xiao-zhen] Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Zhou, Xing-chen; Liu, Shuai] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liang, XZ (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.	xzliang@ips.ac.cn		Zhou, Xingchen/0000-0003-2291-8181; Liu, Zhongshun/0000-0001-5864-4608	National Key R&D Program of China [2016YFA0502100]; Natural Science Foundation of China [81371825]; Chinese Academy of Sciences "100 Talents" Program [2060299]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences "100 Talents" Program(Chinese Academy of Sciences)	This work was supported by Grant 2016YFA0502100 from the National Key R&D Program of China, Grant 81371825 from the Natural Science Foundation of China, and Grant 2060299 from the Chinese Academy of Sciences "100 Talents" Program. The authors declare that they have no conflicts of interest with the contents of this article.	Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Aragon IV, 2012, MOL IMMUNOL, V51, P347, DOI 10.1016/j.molimm.2012.04.001; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Bhende PM, 2007, J VIROL, V81, P7363, DOI 10.1128/JVI.00154-07; Bussey KA, 2014, J VIROL, V88, P9245, DOI 10.1128/JVI.00841-14; Cesarman E, 2014, ANNU REV PATHOL-MECH, V9, P349, DOI 10.1146/annurev-pathol-012513-104656; Chang PJ, 2014, J VIROL, V88, P10092, DOI 10.1128/JVI.01445-14; CHASTEL C, 1994, ACTA VIROL, V38, P309; DAIBATA M, 1990, J IMMUNOL, V144, P4788; Dalton-Griffin L, 2009, J VIROL, V83, P7202, DOI 10.1128/JVI.00076-09; Feederle R., 2000, EPSTEIN BARR VIRUS L; Forrest JC, 2008, J VIROL, V82, P7688, DOI 10.1128/JVI.02689-07; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Iwakiri D, 2004, J IMMUNOL, V172, P1561, DOI 10.4049/jimmunol.172.3.1561; Kati S, 2013, J VIROL, V87, P8004, DOI 10.1128/JVI.00506-13; Kenney SC, 2014, SEMIN CANCER BIOL, V26, P60, DOI 10.1016/j.semcancer.2014.01.002; Krysov S, 2014, BLOOD, V124, P3101, DOI 10.1182/blood-2014-04-567198; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Leung HJ, 2012, ANTIMICROB AGENTS CH, V56, P5794, DOI 10.1128/AAC.01126-12; Liang XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002220; Liang XZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000677; Liu SF, 2000, J VIROL, V74, P2029, DOI 10.1128/JVI.74.4.2029-2037.2000; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Matar CG, 2014, J VIROL, V88, P11600, DOI 10.1128/JVI.01876-14; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Moser JM, 2005, J VIROL, V79, P5227, DOI 10.1128/JVI.79.8.5227-5231.2005; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schulz TF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P490; Shirley CM, 2011, BLOOD, V117, P6297, DOI 10.1182/blood-2011-01-332379; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Stahl JA, 2012, J VIROL, V86, P13253, DOI 10.1128/JVI.01432-12; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Tan LB, 2016, J VIROL, V90, P9782, DOI 10.1128/JVI.00668-16; Taylor GM, 2011, BLOOD, V118, P5528, DOI 10.1182/blood-2011-04-347112; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; Yan BC, 2008, BIOCHEM BIOPH RES CO, V365, P143, DOI 10.1016/j.bbrc.2007.10.137; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	54	11	14	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2801	2814		10.1074/jbc.M117.813675	http://dx.doi.org/10.1074/jbc.M117.813675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29305424	Green Published, hybrid			2022-12-28	WOS:000426051900016
J	Chen, JJ; Teo, BHD; Cai, YT; Wee, SYK; Lu, JH				Chen, Junjie; Teo, Boon Heng Dennis; Cai, Yitian; Wee, Seng Yin Kelly; Lu, Jinhua			The linker histone H1.2 is a novel component of the nucleolar organizer regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C1 PROTEASE DEGRADATION; TRANSCRIPTION FACTOR; RIBOSOMAL DNA; RDNA TRANSCRIPTION; HIGH-MOBILITY; ACTINOMYCIN-D; RNA-SYNTHESIS; CELL; PROTEINS; GENES	The nucleoli accumulate rRNA genes and are the sites of rRNA synthesis and rRNA assembly into ribosomes. During mitosis, nucleoli dissociate, but nucleolar remnants remain on the rRNA gene loci, forming distinct nucleolar organizer regions (NORs). Little is known about the composition and structure of NORs, but upstream binding factor (UBF) has been established as its master organizer. In this study, we sought to establish new proteins in NORs. Using UBF-Sepharose to isolate UBF-binding proteins, we identified histone H1.2 as a candidate partner but were puzzled by this observation, given that UBF is known to be located predominantly in nucleoli, whereas H1.2 distributed broadly among the chromatins in interphase nuclei. We then examined cells undergoing mitosis and saw that both H1.2 and UBF were recruited into NORs in this state, reconciling the results of our UBF pulldowns. Inhibiting rRNA synthesis in interphase nuclei also induced NOR-like structures containing both UBF and H1.2. When chromosomes were isolated and spread on coverslips, NORs appeared separated from the chromosomes containing both UBF and H1.2. After chromosomes were fragmented by homogenization, intact NORs remained visible. Results collectively suggest that NORs are independent structures and that the linker histone H1.2 is a novel component of this structure.	[Lu, Jinhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Block MD4,5 Sci Dr 2, Singapore 117697, Singapore; Natl Univ Singapore, Immunol Programme, Singapore 117697, Singapore	National University of Singapore; National University of Singapore	Lu, JH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Block MD4,5 Sci Dr 2, Singapore 117697, Singapore.	miclujh@nus.edu.sg		Teo, Boon Heng Dennis/0000-0003-4696-9813; Lu, Jinhua/0000-0002-3699-9894	Singapore National Medical Research Council Open funding Individual Research Grant [NMRC/OFIRG/0013/2016]; Singapore Ministry of Education Tier 2 Grant [MOE2012-T2-2-122]; National University Health System Tier 1 Grant [T1-BSRG 2015-07]	Singapore National Medical Research Council Open funding Individual Research Grant(National Medical Research Council, Singapore); Singapore Ministry of Education Tier 2 Grant(Ministry of Education, Singapore); National University Health System Tier 1 Grant	This work was supported by Singapore National Medical Research Council Open funding Individual Research Grant NMRC/OFIRG/0013/2016, Singapore Ministry of Education Tier 2 Grant MOE2012-T2-2-122, and National University Health System Tier 1 Grant T1-BSRG 2015-07 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cai YT, 2017, J IMMUNOL, V199, P3981, DOI 10.4049/jimmunol.1700728; Cai YT, 2015, J BIOL CHEM, V290, P22570, DOI 10.1074/jbc.M115.670661; Cheutin T, 2002, J CELL SCI, V115, P3297; DESJARDINS R, 1963, CANCER RES, V23, P1819; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Fyodorov DV, 2017, NAT REV MOL CELL BIO; GebraneYounes J, 1997, J CELL SCI, V110, P2429; GHOSH S, 1990, CELL BIOL INT REP, V14, P681, DOI 10.1016/0309-1651(90)91187-9; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; Grob A, 2014, GENE DEV, V28, P220, DOI 10.1101/gad.234591.113; Grueneberg DA, 2003, MOL CELL BIOL, V23, P3936, DOI 10.1128/MCB.23.11.3936-3950.2003; Heitz E., 1931, PLANTA, V12, P69; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; Izzo A, 2016, BBA-GENE REGUL MECH, V1859, P486, DOI 10.1016/j.bbagrm.2015.09.003; JORDAN EG, 1981, J CELL SCI, V52, P373; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Koberna K, 2002, J CELL BIOL, V157, P743, DOI 10.1083/jcb.200202007; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; McClintock B., 1934, Z ZELLFORSCH, V21, P33; McStay B, 2016, GENE DEV, V30, P1598, DOI 10.1101/gad.283838.116; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Olson MOJ, 2002, INT REV CYTOL, V219, P199; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; ROUSSEL P, 1993, J CELL SCI, V104, P327; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sanij E, 2015, GENOME RES, V25, P201, DOI 10.1101/gr.176115.114; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; SCHEER U, 1994, CURR OPIN CELL BIOL, V6, P354, DOI 10.1016/0955-0674(94)90026-4; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Stefanovsky VY, 2001, NUCLEIC ACIDS RES, V29, P3241, DOI 10.1093/nar/29.15.3241; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Tani R, 2016, EPIGENETICS-US, V11, P288, DOI 10.1080/15592294.2016.1159369; YUNG BY, 1990, CANCER RES, V50, P5987; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110	50	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2358	2369		10.1074/jbc.M117.810184	http://dx.doi.org/10.1074/jbc.M117.810184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29301938	hybrid, Green Published			2022-12-28	WOS:000425308300010
J	Gold, HB; Jung, YH; Corces, VG				Gold, Hannah B.; Jung, Yoon Hee; Corces, Victor G.			Not just heads and tails: The complexity of the sperm epigenome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chromatin; transcription; histone; sperm; epigenetics; CTCF; epigenetic inheritance; protamine; sperm chromatin; transgenerational inheritance	DNA METHYLATION; MOUSE SPERM; PATERNAL GENOME; CHROMATIN; FERTILIZATION; DEMETHYLATION; REPLICATION; INHERITANCE; PATTERN; CTCF	Transgenerational inheritance requires mechanisms by which epigenetic information is transferred via gametes. Canonical thought holds that mammalian sperm chromatin would be incapable of carrying epigenetic information as post-translational modifications of histones because of their replacement with protamine proteins. Furthermore, compaction of the sperm genome would hinder DNA accessibility of proteins involved in transcriptional regulation and genome architecture. In this Minireview, we delineate the paternal chromatin remodeling events during spermatogenesis and fertilization. Sperm chromatin is epigenetically modified at various time points throughout its development. This allows for the addition of environment-specific modifications that can be passed from parents to offspring.	[Gold, Hannah B.; Jung, Yoon Hee; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vgcorces@gmail.com	Jung, Yoonhee/AAK-3414-2021	Corces, Victor/0000-0001-5140-4337	National Institutes of Health from United States Public Health Service [R01 ES027859]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027859] Funding Source: NIH RePORTER	National Institutes of Health from United States Public Health Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Award R01 ES027859 from United States Public Health Service. This is the fifth article in the Thematic Minireview series "Chromatin and Transcription." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Ausio J, 2014, J STRUCT BIOL, V188, P142, DOI 10.1016/j.jsb.2014.09.004; BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4074, DOI 10.1021/bi00637a021; BALHORN R, 1982, J CELL BIOL, V93, P298, DOI 10.1083/jcb.93.2.298; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barton LJ, 2016, CURR OPIN CELL BIOL, V42, P128, DOI 10.1016/j.ceb.2016.07.007; Battulin N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0642-0; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Carrell DT, 2011, ASIAN J ANDROL, V13, P620, DOI 10.1038/aja.2011.37; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; de Kretser D. M., 2016, ENDOCRINOLOGY ADULT; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GATEWOOD JM, 1987, SCIENCE, V236, P962, DOI 10.1126/science.3576213; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hernandez-Hernandez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28355; Inoue A, 2017, NATURE, V547, P419, DOI 10.1038/nature23262; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Lepikhov Konstantin, 2004, BMC Dev Biol, V4, P12, DOI 10.1186/1471-213X-4-12; Lumey LH, 2009, AM J CLIN NUTR, V89, P1737, DOI 10.3945/ajcn.2008.27038; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; NONCHEV S, 1990, MOL REPROD DEV, V25, P72, DOI 10.1002/mrd.1080250113; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; POGANY GC, 1981, EXP CELL RES, V136, P127, DOI 10.1016/0014-4827(81)90044-6; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Samans B, 2014, DEV CELL, V30, P23, DOI 10.1016/j.devcel.2014.05.023; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Teng F., 2013, J FERTIL VITRO IVF W, DOI [10.4172/2375-4508.1000114, DOI 10.4172/2375-4508.1000114]; Teperek Marta, 2013, Reproductive Medicine and Biology, V12, P133, DOI 10.1007/s12522-013-0155-z; WARD WS, 1991, BIOL REPROD, V44, P569, DOI 10.1095/biolreprod44.4.569; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; WYROBEK AJ, 1976, BIOPHYS J, V16, P811, DOI 10.1016/S0006-3495(76)85730-X; Yao CC, 2015, REPRODUCTION, V150, pR25, DOI 10.1530/REP-14-0643	64	26	28	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13815	13820		10.1074/jbc.R117.001561	http://dx.doi.org/10.1074/jbc.R117.001561			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29507096	hybrid, Green Published			2022-12-28	WOS:000444070700007
J	Moon, TM; Sheehe, JL; Nukareddy, P; Nausch, LW; Wohlfahrt, J; Matthews, DE; Blumenthal, DK; Dostmann, WR				Moon, Thomas M.; Sheehe, Jessica L.; Nukareddy, Praveena; Nausch, Lydia W.; Wohlfahrt, Jessica; Matthews, Dwight E.; Blumenthal, Donald K.; Dostmann, Wolfgang R.			An N-terminally truncated form of cyclic GMP-dependent protein kinase I (PKG I) is monomeric and autoinhibited and provides a model for activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); protein kinase; allosteric regulation; signal transduction; small-angle X-ray scattering (SAXS); surface plasmon resonance (SPR); AGC kinases; cGMP-dependent protein kinase	SMALL-ANGLE SCATTERING; LEUCINE-ZIPPER MOTIF; SMOOTH-MUSCLE-CELLS; CRYSTAL-STRUCTURE; REGULATORY SUBUNIT; CGMP-BINDING; BIOLOGICAL MACROMOLECULES; CATALYTIC SUBUNIT; STRUCTURE REVEALS; STRUCTURAL BASIS	The type I cGMP-dependent protein kinases (PKG I) serve essential physiological functions, including smooth muscle relaxation, cardiac remodeling, and platelet aggregation. These enzymes form homodimers through their N-terminal dimerization domains, a feature implicated in regulating their cooperative activation. Previous investigations into the activation mechanisms of PKG I isoforms have been largely influenced by structures of the cAMP-dependent protein kinase (PKA). Here, we examined PKG I activation by cGMP and cAMP by engineering a monomeric form that lacks N-terminal residues 1-53 (53). We found that the construct exists as a monomer as assessed by whole-protein MS, size-exclusion chromatography, and small-angle X-ray scattering (SAXS). Reconstruction of the SAXS 3D envelope indicates that 53 has a similar shape to the heterodimeric RI-C complex of PKA. Moreover, we found that the 53 construct is autoinhibited in its cGMP-free state and can bind to and be activated by cGMP in a manner similar to full-length PKG I as assessed by surface plasmon resonance (SPR) spectroscopy. However, we found that the 53 variant does not exhibit cooperative activation, and its cyclic nucleotide selectivity is diminished. These findings support a model in which, despite structural similarities, PKG I activation is distinct from that of PKA, and its cooperativity is driven by in trans interactions between protomers.	[Moon, Thomas M.; Sheehe, Jessica L.; Nausch, Lydia W.; Wohlfahrt, Jessica; Dostmann, Wolfgang R.] Univ Vermont, Larner Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA; [Moon, Thomas M.; Sheehe, Jessica L.; Nausch, Lydia W.; Wohlfahrt, Jessica; Dostmann, Wolfgang R.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Nausch, Lydia W.] Nuremberg Hosp, Med Sch PMU, Dept Physiol, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany	University of Vermont; University of Vermont; Utah System of Higher Education; University of Utah; Klinikum Nurnberg Nord	Dostmann, WR (corresponding author), Univ Vermont, Larner Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.; Moon, TM (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	thomasmoon@email.arizona.edu; wolfgang.dostmann@uvm.edu	Moon, Thomas/S-4084-2018	Moon, Thomas/0000-0003-1568-8808	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences at the National Institutes of Health (NIH) [P41GM103393]; Centers of Biomedical Research Excellence (COBRE) from the NIGMS, National Institutes of Health [P30-GM118228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, T32HL007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P30GM118228] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018126] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences at the National Institutes of Health (NIH); Centers of Biomedical Research Excellence (COBRE) from the NIGMS, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the beamline scientists, Tsutomu Mitsui and Thomas Weiss, at Stanford Synchrotron Radiation Lightsource (SSRL) BL4-2 for assistance with SEC-SAXS data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institute of General Medical Sciences at the National Institutes of Health (NIH) (including Grant P41GM103393). Mass spectrometry measurements were supported by Centers of Biomedical Research Excellence (COBRE) Grant P30-GM118228 from the NIGMS, National Institutes of Health. Mass spectrometry measurements were assisted by Bruce O'Rourke. We thank Werner Tegge at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany for synthesizing the W15 peptide substrate used in the phosphotransferase assays. We also thank Wolfgang Peti at the University of Arizona for the generous use of a Superdex 200 10/300 analytical column and Akta PURE FPLC system and Ross Buchan for helpful discussions regarding this manuscript.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Bian K, 2007, J AM SOC HYPERTENS, V1, P17, DOI 10.1016/j.jash.2006.11.007; Blanton RM, 2013, J GERONTOL A-BIOL, V68, P1351, DOI 10.1093/gerona/glt042; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Byeon IJL, 2010, J BIOL CHEM, V285, P14062, DOI 10.1074/jbc.M110.106666; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Dostmann WRG, 1996, FEBS LETT, V398, P206, DOI 10.1016/S0014-5793(96)01242-2; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 2005, FRONT BIOSCI-LANDMRK, V10, P2097, DOI 10.2741/1684; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kawabe J, 1996, J BIOL CHEM, V271, P20132, DOI 10.1074/jbc.271.33.20132; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026131; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LANDGRAF W, 1989, EUR J BIOCHEM, V181, P643, DOI 10.1111/j.1432-1033.1989.tb14771.x; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Moon TM, 2015, CHEM BIOL, V22, P1653, DOI 10.1016/j.chembiol.2015.11.005; Moon TM, 2013, BBA-PROTEINS PROTEOM, V1834, P1346, DOI 10.1016/j.bbapap.2013.02.009; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; OGREID D, 1988, J BIOL CHEM, V263, P17397; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Richie-Jannetta R, 2006, J BIOL CHEM, V281, P6977, DOI 10.1074/jbc.M510886200; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Ruth P, 1997, J BIOL CHEM, V272, P10522; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Schmidtko A, 2008, J NEUROSCI, V28, P1320, DOI 10.1523/JNEUROSCI.5037-07.2008; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; STEINBERG RA, 1987, J BIOL CHEM, V262, P2664; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TAKIO K, 1983, J BIOL CHEM, V258, P5531; Trivedi B, 1998, NEURON, V21, P895, DOI 10.1016/S0896-6273(00)80604-2; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; van de Waterbeemd M, 2014, ANGEW CHEM INT EDIT, V53, P9660, DOI 10.1002/anie.201404637; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200; Zhao JK, 1998, J BIOL CHEM, V273, P30448, DOI 10.1074/jbc.273.46.30448; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	71	7	7	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7916	7929		10.1074/jbc.RA117.000647	http://dx.doi.org/10.1074/jbc.RA117.000647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602907	Green Published, hybrid			2022-12-28	WOS:000433224600002
J	Normant, V; Mourer, T; Labbe, S				Normant, Vincent; Mourer, Thierry; Labbe, Simon			The major facilitator transporter Str3 is required for low-affinity heme acquisition in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; membrane protein; yeast physiology; Schizosaccharomyces pombe; transporter; heme transport; major facilitator transporter; fission yeast	BINDING FACTOR PHP4; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; IRON TRANSPORT; PROTEIN; TRAFFICKING; FEP1; DIFFERENTIATION; DEFICIENCY	In the fission yeast Schizosaccharomyces pombe, acquisition of exogenous heme is largely mediated by the cell membrane-associated Shu1. Here, we report that Str3, a member of the major facilitator superfamily of transporters, promotes cellular heme import. Using a strain that cannot synthesize heme de novo (hem1 Delta) and lacks Shu1, we found that the heme-dependent growth deficit of this strain is rescued by hemin supplementation in the presence of Str3. Microscopic analyses of a hem1 Delta shu1 Delta str3 Delta mutant strain in the presence of the heme analog zinc mesoporphyrin IX (ZnMP) revealed thatZnMPfails to accumulate within the mutant cells. In contrast, Str3-expressing hem1 Delta shu1 Delta cells could take up ZnMP at a 10-mu M concentration. The yeast Saccharomyces cerevisiae cannot efficiently transport exogenously supplied hemin. However, heterologous expression of Str3 from S. pombe in S. cerevisiae resulted in ZnMP accumulation within S. cerevisiae cells. Moreover, heminagarose pulldown assays revealed that Str3 binds hemin. In contrast, an Str3 mutant in which Tyr and Ser residues of two putative heme-binding motifs ((YX3Y534)-Y-530 and (SX4Y557)-S-552) had been replaced with alanines exhibited a loss of affinity for hemin. Furthermore, this Str3 mutant failed to rescue the heme-dependent growth deficit of a hem1 Delta shu1 Delta str3 Delta strain. Further analysis by absorbance spectroscopy disclosed that a predicted extracellular loop region in Str3 containing the two putative hemebinding motifs interacts with hemin, with a K-D of 6.6 mu M. Taken together, these results indicate that Str3 is a second cell-surface membrane protein for acquisition of exogenous heme in S. pombe.	[Normant, Vincent; Mourer, Thierry; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Mourer, Thierry/0000-0003-1651-6768	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015/2020-04878]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN-2015/2020-04878 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambesi A, 2000, J EXP BIOL, V203, P155; Askwith C, 1997, J BIOL CHEM, V272, P401; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Brachmann CB, 1998, YEAST, V14, P115; Brault A, 2015, IUBMB LIFE, V67, P801, DOI 10.1002/iub.1441; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Duffy SP, 2010, MOL CELL BIOL, V30, P5318, DOI 10.1128/MCB.00690-10; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honsa ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104794; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; KEENEY JB, 1994, GENETICS, V136, P849; Khan AA, 2013, MOL ASPECTS MED, V34, P669, DOI 10.1016/j.mam.2012.07.013; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Kim J, 1998, GENETICS, V149, P795; Korolnek T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00126; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mourer T, 2017, J BIOL CHEM, V292, P4898, DOI 10.1074/jbc.M117.776807; Mourer T, 2015, J BIOL CHEM, V290, P10176, DOI 10.1074/jbc.M115.642058; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Protchenko O, 2006, J BIOL CHEM, V281, P21445, DOI 10.1074/jbc.M512812200; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113	44	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6349	6362		10.1074/jbc.RA118.002132	http://dx.doi.org/10.1074/jbc.RA118.002132			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29549126	Green Published, hybrid			2022-12-28	WOS:000431108600011
J	Galan-Davila, AK; Ryu, J; Dong, K; Xiao, Y; Dai, Z; Zhang, DL; Li, Z; Dick, AM; Liu, KD; Kamat, A; Lu, M; Dong, QF; Liu, F; Dong, LQ				Galan-Davila, Amanda K.; Ryu, Jiyoon; Dong, Kun; Xiao, Yang; Dai, Zhe; Zhang, Deling; Li, Zhi; Dick, Amanda M.; Liu, Kevin D.; Kamat, Amrita; Lu, Min; Dong, Qunfeng; Liu, Feng; Dong, Lily Q.			Alternative splicing variant of the scaffold protein APPL1 suppresses hepatic adiponectin signaling and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-BETA; GLUCOSE-PRODUCTION; TARGET TISSUES; BAR-PH; INSULIN; RECEPTOR; AKT; PHOSPHORYLATION; HOMEOSTASIS; INHIBITION	Adiponectin is an adipocyte-derived hormone with antidiabetic activities that include increasing the sensitivity of cells to insulin. Adaptor protein containing pleckstrin homology domain, phosphotyrosine-binding domain, and leucine zipper motif (APPL1) stimulates adiponectin signaling and promotes adiponectin's insulin-sensitizing effects by binding to two adiponectin receptors, AdipoR1 and AdipoR2, and the insulin receptor. In this study, we report an alternative splicing variant of APPL1 (APPL1sv) that is highly expressed in mouse liver, pancreas, and spleen tissues. The expression levels of APPL1sv in liver tissues were enhanced in a mouse model of obesity and diabetic dyslipidemia (i.e. db/db mice) and reduced in calorie-restricted mice compared with ad libitum-fed mice. APPL1sv overexpression or suppression inhibited or enhanced, respectively, adiponectin-stimulated phosphorylation of AMP protein kinase (AMPK) in mouse hepatocytes. We also found that APPL1sv binds to AdipoR1 and AdipoR2 under basal conditions and that adiponectin treatment reduces this binding. Overexpression of APPL1sv blocked adiponectin-induced interactions of APPL1 with the adiponectin receptors. Moreover, adenovirus-mediated and short hairpin RNA-based suppression of APPL1sv greatly reduced high fat diet-induced insulin resistance and hepatic glucose production in mice. Our study identifies a key suppressor of hepatic adiponectin signaling and insulin sensitivity, a finding that may shed light on identifying effective therapeutic targets for treating insulin resistance and type 2 diabetes.	[Galan-Davila, Amanda K.; Ryu, Jiyoon; Dong, Kun; Xiao, Yang; Dai, Zhe; Zhang, Deling; Li, Zhi; Dick, Amanda M.; Liu, Kevin D.; Lu, Min; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kamat, Amrita; Liu, Feng; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Kamat, Amrita] South Texas Vet Hlth Care Syst, GRECC, San Antonio, TX 78229 USA; [Lu, Min] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lu, Min] Diabet Early Discovery, Merck Res Lab, Boston, MA 02115 USA; [Dong, Qunfeng] Loyola Univ, Chicago Stritch Sch Med, Ctr Biomed Informat, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Galan-Davila, Amanda K.] Univ Incarnate Word Sch Osteopath Med, Dept Clin & Appl Sci Educ, San Antonio, TX 78253 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California San Diego; Merck & Company; Loyola University Chicago	Dong, LQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	DongQ@uthscsa.edu	Liu, Feng/CAG-8962-2022; Ryu, Jiyoon/M-8573-2019; Xiao, Yang/N-5021-2017	Ryu, Jiyoon/0000-0001-7365-0555; Xiao, Yang/0000-0003-3927-1839	NIDDK, National Institutes of Health Pre-Doctoral Fellowship [PA-11-112]; National Institutes of Health Grant [DK76902, DK102965, R01]; Veterans Affairs Merit Review Award [1I01BX001744-01]; American Heart Association Research Award [15GRNT23230053]; American Diabetes Association Grant [7-13-BS-043]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102965, R01DK076902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001744] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health Pre-Doctoral Fellowship; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); American Heart Association Research Award(American Heart Association); American Diabetes Association Grant(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by NIDDK, National Institutes of Health Pre-Doctoral Fellowship PA-11-112 (to A.K. G.-D.); National Institutes of Health R01 Grant DK76902 (to F.L.), Veterans Affairs Merit Review Award 1I01BX001744-01 (to A.K.); and American Heart Association Research Award 15GRNT23230053, American Diabetes Association Grant 7-13-BS-043, and National Institutes of Health R01 Grant DK102965 (to L.Q.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Cheng KKY, 2014, BEST PRACT RES CL EN, V28, P3, DOI 10.1016/j.beem.2013.06.006; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; King GJ, 2012, J BIOL CHEM, V287, P40996, DOI 10.1074/jbc.M112.349803; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang C, 2013, DIABETOLOGIA, V56, P1999, DOI 10.1007/s00125-013-2971-4; Wang YJ, 2015, CIRCULATION, V131, P1392, DOI 10.1161/CIRCULATIONAHA.114.015248; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	35	10	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6064	6074		10.1074/jbc.RA118.002162	http://dx.doi.org/10.1074/jbc.RA118.002162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483192	Green Published, hybrid			2022-12-28	WOS:000430497300025
J	Bergmann, TJ; Fregno, I; Fumagalli, F; Rinaldi, A; Bertoni, F; Boersema, PJ; Picotti, P; Molinari, M				Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Rinaldi, Andrea; Bertoni, Francesco; Boersema, Paul J.; Picotti, Paola; Molinari, Maurizio			Chemical stresses fail to mimic the unfolded protein response resulting from luminal load with unfolded polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; CELL-DEATH; COMPUTATIONAL PLATFORM; MISFOLDED PROTEINS; HUMAN-DISEASE; ATF6; PROTEOSTASIS; CHAPERONES	The stress sensors ATF6, IRE1, and PERK monitor deviations from homeostatic conditions in the endoplasmic reticulum (ER), a protein biogenesis compartment of eukaryotic cells. Their activation elicits unfolded protein responses (UPR) to re-establish proteostasis. UPR have been extensively investigated in cells exposed to chemicals that activate ER stress sensors by perturbing calcium, N-glycans, or redox homeostasis. Cell responses to variations in luminal load with unfolded proteins are, in contrast, poorly characterized. Here, we compared gene and protein expression profiles in HEK293 cells challenged with ER stress-inducing drugs or expressing model polypeptides. Drug titration to limit up-regulation of the endogenous ER stress reporters heat shock protein family A (Hsp70) member 5 (BiP/HSPA5) and homocysteine-inducible ER protein with ubiquitin-like domain 1 (HERP/HERPUD1) to levels comparable with luminal accumulation of unfolded proteins substantially reduced the amplitude of both transcriptional and translational responses. However, these drug-induced changes remained pleiotropic and failed to recapitulate responses to ER load with unfolded proteins. These required unfolded protein association with BiP and induced a much smaller subset of genes participating in a chap-erone complex that binds unfolded peptide chains. In conclusion, UPR resulting from ER load with unfolded proteins proceed via a well-defined and fine-tuned pathway, whereas even mild chemical stresses caused by compounds often used to stimulate UPR induce cellular responses largely unrelated to the UPR or ER-mediated protein secretion.	[Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Rinaldi, Andrea; Bertoni, Francesco; Molinari, Maurizio] Univ Svizzera Italiana, CH-6900 Lugano, Switzerland; [Bergmann, Timothy J.; Fregno, Ilaria; Fumagalli, Fiorenza; Molinari, Maurizio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Bergmann, Timothy J.; Fregno, Ilaria; Boersema, Paul J.; Picotti, Paola] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Fumagalli, Fiorenza] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3001 Bern, Switzerland; [Rinaldi, Andrea; Bertoni, Francesco] Ist Oncol Ric, CH-6500 Bellinzona, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland	Universita della Svizzera Italiana; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Molinari, M (corresponding author), Via Vela 6, CH-6500 Bellinzona, Switzerland.	maurizio.molinari@irb.usi.ch	Bertoni, Francesco/G-6922-2014; Molinari, Maurizio/N-2587-2019	Bertoni, Francesco/0000-0001-5637-8983; Molinari, Maurizio/0000-0002-7636-5829; Fregno, Ilaria/0000-0003-0546-8764; Picotti, Paola/0000-0002-4109-3552	Signora Alessandra; Alpha-ONE Foundation; Foundation for Research on Neurodegenerative Diseases; Novartis Foundation; Swiss National Science Foundation (SNF); Comel Foundation; Gelu Foundation; Sinergia grant of the Swiss National Foundation	Signora Alessandra; Alpha-ONE Foundation; Foundation for Research on Neurodegenerative Diseases; Novartis Foundation(Novartis); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Comel Foundation; Gelu Foundation; Sinergia grant of the Swiss National Foundation	This work was supported in part by grants from Signora Alessandra, Alpha-ONE Foundation, Foundation for Research on Neurodegenerative Diseases, the Novartis Foundation, Swiss National Science Foundation (SNF), and Comel and Gelu Foundations (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Sinergia grant of the Swiss National Foundation.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonetti P, 2013, BLOOD, V122, P2233, DOI 10.1182/blood-2013-01-475772; Brown HC, 2011, J BIOL CHEM, V286, P24451, DOI 10.1074/jbc.M111.238758; Canova NK, 2007, CELL BIOL TOXICOL, V23, P337, DOI 10.1007/s10565-007-0185-6; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen KC, 2017, EMBO J, V36, P2296, DOI 10.15252/embj.201695616; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; Fujimori T, 2017, GENES CELLS, V22, P684, DOI 10.1111/gtc.12506; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Hagiwara M, 2016, MOL CELL, V63, P753, DOI 10.1016/j.molcel.2016.07.014; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kopp MC, 2018, ELIFE, V7, DOI 10.7554/eLife.30257; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Maurel M., 2014, TRENDS BIOCH SCI; Merulla J, 2015, MOL BIOL CELL, V26, P1532, DOI 10.1091/mbc.E14-12-1615; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Mori A, 2011, NEUROCHEM INT, V58, P344, DOI 10.1016/j.neuint.2010.12.010; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Oikawa T, 2010, BIOCHEM BIOPH RES CO, V393, P253, DOI 10.1016/j.bbrc.2010.01.113; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pisoni GB, 2016, TRAFFIC, V17, P341, DOI 10.1111/tra.12373; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Raina K, 2014, NAT CHEM BIOL, V10, P957, DOI [10.1038/NCHEMBIO.1638, 10.1038/nchembio.1638]; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sou SN, 2012, BIOCHEM BIOPH RES CO, V420, P473, DOI 10.1016/j.bbrc.2012.03.030; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Thibault G, 2011, P NATL ACAD SCI USA, V108, P20597, DOI 10.1073/pnas.1117184109; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	69	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5600	5612		10.1074/jbc.RA117.001484	http://dx.doi.org/10.1074/jbc.RA117.001484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29453283	Green Published, hybrid			2022-12-28	WOS:000430044100021
J	Jin, ZC; Kitajima, T; Dong, WJ; Huang, YF; Ren, WW; Guan, F; Chiba, Y; Gao, XD; Fujita, M				Jin, Ze-Cheng; Kitajima, Toshihiko; Dong, Weijie; Huang, Yi-Fan; Ren, Wei-Wei; Guan, Feng; Chiba, Yasunori; Gao, Xiao-Dong; Fujita, Morihisa			Genetic disruption of multiple alpha 1,2-mannosidases generates mammalian cells producing recombinant proteins with high-mannose-type N-glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; FAMILY-47 ALPHA-MANNOSIDASES; LYSOSOMAL STORAGE DISEASES; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MOLECULAR-CLONING; TERMINATED GLUCOCEREBROSIDASE; ALPHA-1,2-LINKED MANNOSE; TRIMMING STEP; GOLGI	Recombinant therapeutic proteins are becoming very important pharmaceutical agents for treating intractable diseases. Most biopharmaceutical proteins are produced in mammalian cells because this ensures correct folding and glycosylation for protein stability and function. However, protein production in mammalian cells has several drawbacks, including heterogeneity of glycans attached to the produced protein. In this study, we established cell lines with high-mannose-type N-linked, low-complexity glycans. We first knocked out two genes encoding Golgi mannosidases (MAN1A1 and MAN1A2) in HEK293 cells. Single knockout (KO) cells did not exhibit changes in N-glycan structures, whereas double KO cells displayed increased high-mannose-type and decreased complex-type glycans. In our effort to eliminate the remaining complex-type glycans, we found that knocking out a gene encoding the endoplasmic reticulum mannosidase I (MAN1B1) in the double KO cells reduced most of the complex-type glycans. In triple KO (MAN1A1, MAN1A2, and MAN1B1) cells, Man9GlcNAc2 and Man8GlcNAc2 were the major N-glycan structures. Therefore, we expressed two lysosomal enzymes, alpha-galactosidase-A and lysosomal acid lipase, in the triple KO cells and found that the glycans on these enzymes were sensitive to endoglycosidase H treatment. The N-glycan structures on recombinant proteins expressed in triple KO cells were simplified and changed from complex types to high-mannose types at the protein level. Our results indicate that the triple KO HEK293 cells are suitable for producing recombinant proteins, including lysosomal enzymes with high-mannose-type N-glycans.	[Jin, Ze-Cheng; Kitajima, Toshihiko; Huang, Yi-Fan; Ren, Wei-Wei; Guan, Feng; Gao, Xiao-Dong; Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China; [Dong, Weijie] Dalian Med Univ, Coll Basic Med Sci, Dalian 116044, Liaoning, Peoples R China; [Chiba, Yasunori] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan	Jiangnan University; Dalian Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Gao, XD; Fujita, M (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China.	xdgao@jiangnan.edu.cn; fujita@jiangnan.edu.cn	Kitajima, Toshihiko/D-2463-2016; Fujita, Morihisa/AAM-4142-2020; Chiba, Yasunori/L-7993-2018	Kitajima, Toshihiko/0000-0001-9677-5086; Chiba, Yasunori/0000-0002-6401-5071	National Natural Science Foundation of China [31770853, 31400693]; Natural Science Foundation of Jiangsu Province [BK20140141]; Young 1000 Program; Fundamental Research Funds for the Central Universities [JUSRP11540]; 111 Program Grant [111-2-06]; International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Young 1000 Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Program Grant; International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University	This work was supported by from the National Natural Science Foundation of China Grants-in-Aid 31770853 and 31400693, Natural Science Foundation of Jiangsu Province Grant BK20140141, the Young 1000 Program (to M.F.), Fundamental Research Funds for the Central Universities JUSRP11540 (to M.F.), 111 Program Grant (111-2-06), and the International Joint Research Laboratory for Production of Therapeutic Glycoproteins at Jiangnan University. The authors declare that they have no conflicts of interest with the contents of this article.	BAUSE E, 1993, EUR J BIOCHEM, V217, P535, DOI 10.1111/j.1432-1033.1993.tb18274.x; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Burrow Thomas A, 2011, Clin Investig (Lond), V1, P285; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COUSO R, 1986, J BIOL CHEM, V261, P6326; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; Dicker M, 2015, EXPERT OPIN BIOL TH, V15, P1501, DOI 10.1517/14712598.2015.1069271; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Filocamo Mirella, 2011, Human Genomics, V5, P156; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; FURBISH FS, 1981, BIOCHIM BIOPHYS ACTA, V673, P425, DOI 10.1016/0304-4165(81)90474-8; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gil GC, 2010, ANAL CHEM, V82, P6613, DOI 10.1021/ac1011377; Gonzalez DS, 1999, J BIOL CHEM, V274, P21375, DOI 10.1074/jbc.274.30.21375; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haas R, 1995, CYTOKINES MOL THER, V1, P249; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Iannotti MJ, 2014, J BIOL CHEM, V289, P11844, DOI 10.1074/jbc.M114.552091; Kaneda Y, 2002, J BIOL CHEM, V277, P16928, DOI 10.1074/jbc.M112382200; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Kosloski MP, 2009, AAPS J, V11, P424, DOI 10.1208/s12248-009-9119-y; Lachmann RH, 2011, CURR OPIN PEDIATR, V23, P588, DOI 10.1097/MOP.0b013e32834c20d9; Lagasse H A Daniel, 2017, F1000Res, V6, P113, DOI 10.12688/f1000research.9970.1; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Lee GH, 2016, J CELL BIOL, V215, P705, DOI 10.1083/jcb.201605121; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Murakami S, 2013, GLYCOBIOLOGY, V23, P736, DOI 10.1093/glycob/cwt012; MURRAY GJ, 1987, METHOD ENZYMOL, V149, P25; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Pan SJ, 2011, MOL BIOL CELL, V22, P2810, DOI 10.1091/mbc.E11-02-0118; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138553; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; SATO Y, 1993, J CLIN INVEST, V91, P1909, DOI 10.1172/JCI116409; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tadevosyan A, 2017, CURR RES TRANSL MED, V65, P10, DOI 10.1016/j.retram.2016.09.001; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Valayannopoulos V, 2017, MOL GENET METAB, V120, P62, DOI 10.1016/j.ymgme.2016.11.002; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Xiang Y, 2016, P NATL ACAD SCI USA, V113, pE7890, DOI 10.1073/pnas.1611213113; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Yamane-Ohnuki N, 2009, MABS-AUSTIN, V1, P230, DOI 10.4161/mabs.1.3.8328; Yang GL, 2015, J PROTEOME RES, V14, P639, DOI 10.1021/pr5006026	69	16	18	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5572	5584		10.1074/jbc.M117.813030	http://dx.doi.org/10.1074/jbc.M117.813030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475941	hybrid, Green Published			2022-12-28	WOS:000430044100019
J	Loughran, G; Jungreis, I; Tzani, I; Power, M; Dmitriev, RI; Ivanov, IP; Kellis, M; Atkins, JF				Loughran, Gary; Jungreis, Irwin; Tzani, Ioanna; Power, Michael; Dmitriev, Ruslan I.; Ivanov, Ivaylo P.; Kellis, Manolis; Atkins, John F.			Stop codon readthrough generates a C-terminally extended variant of the human vitamin D receptor with reduced calcitriol response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR TRANSFER-RNAS; COGNATE TRANSFER-RNAS; TRANSLATION TERMINATION; READ-THROUGH; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; RECODING SIGNALS; GENOME BROWSER; VEGF-AX; SEQUENCES	Although stop codon readthrough is used extensively by viruses to expand their gene expression, verified instances of mammalian readthrough have only recently been uncovered by systems biology and comparative genomics approaches. Previously, our analysis of conserved protein coding signatures that extend beyond annotated stop codons predicted stop codon readthrough of several mammalian genes, all of which have been validated experimentally. Four mRNAs display highly efficient stop codon readthrough, and these mRNAs have a UGA stop codon immediately followed by CUAG (UGA_CUAG) that is conserved throughout vertebrates. Extending on the identification of this readthrough motif, we here investigated stop codon readthrough, using tissue culture reporter assays, for all previously untested human genes containing UGA_CUAG. The readthrough efficiency of the annotated stop codon for the sequence encoding vitamin D receptor (VDR) was 6.7%. It was the highest of those tested but all showed notable levels of readthrough. The VDR is a member of the nuclear receptor superfamily of ligand-inducible transcription factors, and it binds its major ligand, calcitriol, via its C-terminal ligand-binding domain. Readthrough of the annotated VDR mRNA results in a 67 amino acid-long C-terminal extension that generates a VDR proteoform named VDRx. VDRx may form homodimers and heterodimers with VDR but, compared with VDR, VDRx displayed a reduced transcriptional response to calcitriol even in the presence of its partner retinoid X receptor.	[Loughran, Gary; Tzani, Ioanna; Power, Michael; Dmitriev, Ruslan I.; Ivanov, Ivaylo P.; Atkins, John F.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Jungreis, Irwin; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Tzani, Ioanna] Natl Inst Bioproc Res & Training, Dublin A94 X099, Ireland; [Power, Michael] Univ Tubingen, Inst Ophthalm Res, D-72076 Tubingen, Germany; [Ivanov, Ivaylo P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University College Cork; Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Loughran, G; Atkins, JF (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.; Atkins, JF (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	g.loughran@ucc.ie; j.atkins@ucc.ie	Kellis, Manolis/ABE-7385-2020; Dmitriev, Ruslan/F-8741-2017; Loughran, Gary/AAQ-8791-2020	Kellis, Manolis/0000-0001-7113-9630; Loughran, Gary/0000-0002-2683-5597; Ivanov, Ivaylo/0000-0002-6008-3261; Dmitriev, Ruslan/0000-0002-0347-8718; Power, Michael/0000-0003-3750-6454	Science Foundation Ireland [12/IP/1492, 13/1A/1853, 13/SIRG/2144]; National Institutes of Health [R01 HG004037]; GENCODE Wellcome Trust [U41 HG007234]; Health Research Board Award [PhD/2007/04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U41HG007234] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GENCODE Wellcome Trust; Health Research Board Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Science Foundation Ireland Grants 12/IP/1492 and 13/1A/1853 (to J.F.A.) and 13/SIRG/2144 (to R.I.D.). I. J. was supported by National Institutes of Health Grant R01 HG004037 and GENCODE Wellcome Trust Grant U41 HG007234. This work was also supported by a Health Research Board Award (PhD/2007/04) (to I.T.).	Andreev DE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0651-z; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Betney R, 2010, RNA, V16, P655, DOI 10.1261/rna.1796210; Beznoskova P, 2016, RNA, V22, P456, DOI 10.1261/rna.054452.115; Beznoskova P, 2015, NUCLEIC ACIDS RES, V43, P5099, DOI 10.1093/nar/gkv421; Blanchet S, 2014, NUCLEIC ACIDS RES, V42, P10061, DOI 10.1093/nar/gku663; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; BOSSI L, 1980, NATURE, V286, P123, DOI 10.1038/286123a0; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P6339, DOI 10.1093/nar/18.21.6339; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P2079, DOI 10.1093/nar/18.8.2079; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Chan CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059450; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Coldwell MJ, 2004, J CELL SCI, V117, P2545, DOI 10.1242/jcs.01106; Cridge A. G., 2018, NUCLEIC ACIDS RES; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; De Bellis M, 2017, GLIA, V65, P790, DOI 10.1002/glia.23126; Dmitriev RI, 2013, BIOMATERIALS, V34, P9307, DOI 10.1016/j.biomaterials.2013.08.065; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Feng T, 2014, MOL CELL, V53, P645, DOI 10.1016/j.molcel.2013.12.028; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Gardiner EM, 2004, J STEROID BIOCHEM, V89-90, P233, DOI 10.1016/j.jsbmb.2004.03.078; Grentzmann G, 1998, RNA, V4, P479; Harrell L, 2002, NUCLEIC ACIDS RES, V30, P2011, DOI 10.1093/nar/30.9.2011; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heaphy SM, 2016, MOL BIOL EVOL, V33, P2885, DOI 10.1093/molbev/msw166; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Iakoucheva LM, 2001, PROTEIN SCI, V10, P560, DOI 10.1110/ps.29401; Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jungreis I, 2016, MOL BIOL EVOL, V33, P3108, DOI 10.1093/molbev/msw189; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobayashi Y, 2010, J BIOL CHEM, V285, P19776, DOI 10.1074/jbc.M109.085621; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Lobanov AV, 2017, NAT STRUCT MOL BIOL, V24, P61, DOI 10.1038/nsmb.3330; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nyiko T, 2017, NUCLEIC ACIDS RES, V45, P4174, DOI 10.1093/nar/gkw1303; Pelechano V, 2017, NUCLEIC ACIDS RES, V45, P7326, DOI 10.1093/nar/gkx479; PIKE JW, 1979, P NATL ACAD SCI USA, V76, P5485, DOI 10.1073/pnas.76.11.5485; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Roy B, 2015, P NATL ACAD SCI USA, V112, P3038, DOI 10.1073/pnas.1424127112; SAIJO T, 1991, AM J HUM GENET, V49, P668; Schueren F, 2014, ELIFE, V3, DOI 10.7554/eLife.03640; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Stiebler AC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004685; Sunn KL, 2001, MOL ENDOCRINOL, V15, P1599, DOI 10.1210/me.15.9.1599; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Urakov VN, 2017, FEBS J, V284, P1914, DOI 10.1111/febs.14099; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; Xin H, 2016, CELL, V167, P275, DOI 10.1016/j.cell.2016.08.054; Yamaguchi Y, 2012, J BIOL CHEM, V287, P17765, DOI 10.1074/jbc.M111.314468; Yordanova MM, 2018, NATURE, V553, P356, DOI 10.1038/nature25174	79	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4434	4444		10.1074/jbc.M117.818526	http://dx.doi.org/10.1074/jbc.M117.818526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386352	Green Published, hybrid			2022-12-28	WOS:000428204300015
J	Maity, G; Haque, I; Ghosh, A; Dhar, G; Gupta, V; Sarkar, S; Azeem, I; McGregor, D; Choudhary, A; Campbell, DR; Kambhampati, S; Banerjee, SK; Banerjee, S				Maity, Gargi; Haque, Inamul; Ghosh, Arnab; Dhar, Gopal; Gupta, Vijayalaxmi; Sarkar, Sandipto; Azeem, Imaan; McGregor, Douglas; Choudhary, Abhishek; Campbell, Donald R.; Kambhampati, Suman; Banerjee, Sushanta K.; Banerjee, Snigdha			The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; K-RAS MUTATIONS; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-TUMOR CELLS; DUCTAL ADENOCARCINOMA; KRAS; MYC; EXPRESSION; PHOSPHORYLATION; ANGIOGENESIS	Myc-associated zinc-finger protein (MAZ) is a transcription factor with dual roles in transcription initiation and termination. Deregulation of MAZ expression is associated with the progression of pancreatic ductal adenocarcinoma (PDAC). However, the mechanism of action of MAZ in PDAC progression is largely unknown. Here, we present evidence that MAZ mRNA expression and protein levels are increased in human PDAC cell lines, tissue samples, a subcutaneous tumor xenograft in a nude mouse model, and spontaneous cancer in the genetically engineered PDAC mouse model. We also found that MAZ is predominantly expressed in pancreatic cancer stem cells. Functional analysis indicated that MAZ depletion in PDAC cells inhibits invasive phenotypes such as the epithelial-to-mesenchymal transition, migration, invasion, and the sphere-forming ability of PDAC cells. Mechanistically, we detected no direct effects of MAZ on the expression of K-Ras mutants, but MAZ increased the activity of CRAF-ERK signaling, a downstream signaling target of K-Ras. The MAZ-induced activation of CRAF-ERK signaling was mediated via p21-activated protein kinase (PAK) and protein kinase B (AKT/PKB) signaling cascades and promoted PDAC cell invasiveness. Moreover, we found that the matricellular oncoprotein cysteine-rich angiogenic inducer 61 (Cyr61/CCN1) regulates MAZ expression via Notch-1-sonic hedgehog signaling in PDAC cells. We propose that Cyr61/CCN1-induced expression of MAZ promotes invasive phenotypes of PDAC cells not through direct K-Ras activation but instead through the activation of CRAF-ERK signaling. Collectively, these results highlight key molecular players in PDAC invasiveness and may help inform therapeutic strategies to improve clinical management and outcomes of PDAC.	[Maity, Gargi; Haque, Inamul; Ghosh, Arnab; Dhar, Gopal; Gupta, Vijayalaxmi; Sarkar, Sandipto; Azeem, Imaan; McGregor, Douglas; Campbell, Donald R.; Kambhampati, Suman; Banerjee, Sushanta K.; Banerjee, Snigdha] Univ Kansas, Med Ctr, Vet Affairs Med Ctr, Canc Res Unit, Kansas City, KS 66103 USA; [Maity, Gargi; Haque, Inamul; McGregor, Douglas; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Ghosh, Arnab; Sarkar, Sandipto; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [McGregor, Douglas] Vet Affairs Med Ctr, Dept Pathol, Kansas City, MO 64128 USA; [Choudhary, Abhishek] Vet Affairs Med Ctr, Dept Gastroenterol, Kansas City, MO 64128 USA; [Campbell, Donald R.] Univ Missouri, Kansas City, MO 64110 USA; [Campbell, Donald R.] St Lukes Hosp, Kansas City, MO USA; [Kambhampati, Suman; Banerjee, Snigdha] HCA Midwest Hlth, Sarah Cannon Canc Ctr, Kansas City, MO 64131 USA; [Dhar, Gopal] Syngene Int Ltd, Biocon Bristol Myers Squibb R&D Ctr, Bangalore 56099, Karnataka, India	University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Missouri System; University of Missouri Kansas City; Saint Luke's Hospital - Missouri; Sarah Cannon Research Institute; Bristol-Myers Squibb; Syngene International Limited	Banerjee, SK; Banerjee, S (corresponding author), Vet Affairs Med Ctr, Canc Res Unit, Res Div 151,4801 E Linwood Blvd, Kansas City, MO 64128 USA.	sbanerjee2@kumc.edu; sbanerjee@kumc.edu	Banerjee, Sushanta/AAG-6534-2021; Haque, Inamul/I-2482-2019; Gupta, Viju/AAI-1017-2019; Ghosh, Arnab/ABE-6292-2020	Gupta, Viju/0000-0001-8915-3393; Banerjee, Sushanta/0000-0002-7698-0717; Ghosh, Arnab/0000-0003-0355-7763	Veterans Affairs Merit Award grants; Grace Hortense Greenley Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001002] Funding Source: NIH RePORTER	Veterans Affairs Merit Award grants; Grace Hortense Greenley Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Award grants (to S. K. B. and S. B.) and by the Grace Hortense Greenley Trust (to S. K. B., S. B., and S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramson Michael A, 2007, Gastrointest Cancer Res, V1, pS7; Banerjee J, 2016, ONCOTARGET, V7, P44430, DOI 10.18632/oncotarget.9790; Banerjee S, 2005, MOL CANCER RES, V3, P151, DOI 10.1158/1541-7786.MCR-04-0130; Banerjee SK, 1997, PANCREAS, V15, P16, DOI 10.1097/00006676-199707000-00003; Banerjee SK, 2000, PANCREAS, V20, P248, DOI 10.1097/00006676-200004000-00005; Banerjee SK, 2016, J CELL COMMUN SIGNAL, V10, P207, DOI 10.1007/s12079-016-0343-9; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; CALDAS C, 1994, CANCER RES, V54, P3568; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Cogoi S, 2010, CHEM COMMUN, V46, P7364, DOI 10.1039/c0cc01912g; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92; Eser S., 2014, BR J CANC; Feygenzon V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179862; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Ghosh P, 2017, METHODS MOL BIOL, V1489, P495, DOI 10.1007/978-1-4939-6430-7_41; Han S, 2017, ONCOTARGET, V8, P54054, DOI 10.18632/oncotarget.10722; Haque I, 2012, J BIOL CHEM, V287, P38569, DOI 10.1074/jbc.M112.389064; Haque I, 2011, J BIOL CHEM, V286, P43475, DOI 10.1074/jbc.M111.284158; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hesler RA, 2016, CARCINOGENESIS, V37, P1041, DOI 10.1093/carcin/bgw093; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Jiao L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0570-3; Jonckheere N, 2017, CRIT REV ONCOL HEMAT, V111, P7, DOI 10.1016/j.critrevonc.2017.01.002; Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Leask A, 2013, J CELL COMMUN SIGNAL, V7, P61, DOI 10.1007/s12079-012-0187-x; Leask A, 2011, J CELL COMMUN SIGNAL, V5, P123, DOI 10.1007/s12079-011-0127-1; Lee WP, 2016, CANCER LETT, V375, P9, DOI 10.1016/j.canlet.2016.02.023; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Maity G, 2015, LAB INVEST, V95, P702, DOI 10.1038/labinvest.2015.49; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Okada M, 2014, ONCOTARGET, V5, P5100, DOI 10.18632/oncotarget.2087; Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074; Poulin EJ, 2017, GENE DEV, V31, P333, DOI 10.1101/gad.297630.117; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Ray A, 1998, MOL CELL BIOL, V18, P7327, DOI 10.1128/MCB.18.12.7327; Ray A, 2015, CANCER MED-US, V4, P224, DOI 10.1002/cam4.362; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sarkar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.43; Shi WD, 2016, ONCOTARGET, V7, P73160, DOI 10.18632/oncotarget.12248; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 2003, INT J MOL MED, V11, P547; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Tao LY, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0888-3; Thomas A, 2000, ONCOGENE, V19, P5259, DOI 10.1038/sj.onc.1203895; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432; Wang P, 2015, ONCOTARGET, V6, P21148, DOI 10.18632/oncotarget.4125; Wang X, 2008, BREAST CANCER RES TR, V111, P103, DOI 10.1007/s10549-007-9765-7; Wang YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153312; Wu JG, 2016, ELIFE, V5, DOI 10.7554/eLife.10734; Xia LG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22005; Xu X, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/640757; Yan L, 2005, GASTROENTEROLOGY, V128, P2124, DOI 10.1053/j.gastro.2005.03.006; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zhu XN, 2016, ONCOTARGETS THER, V9, P7493, DOI 10.2147/OTT.S124118; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	77	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4334	4349		10.1074/jbc.RA117.000333	http://dx.doi.org/10.1074/jbc.RA117.000333			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414775	Green Published, hybrid			2022-12-28	WOS:000428204300008
J	Alpsoy, A; Dykhuizen, EC				Alpsoy, Aktan; Dykhuizen, Emily C.			Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERACTOME; CANCER; BRD4; COMPLEX; DISCOVERY; PROTEINS; BROMODOMAIN; REVEALS; TARGETS; BINDING	The mammalian SWI/SNF chromatin remodeling complex is a heterogeneous collection of related protein complexes required for gene regulation and genome integrity. It contains a central ATPase (BRM or BRG1) and various combinations of 10-14 accessory subunits (BAFs for BRM/BRG1 Associated Factors). Two distinct complexes differing in size, BAF and the slightly larger polybromo-BAF (PBAF), share many of the same core subunits but are differentiated primarily by having either AT-rich interaction domain 1A/B (ARID1A/B in BAF) or ARID2 (in PBAF). Using density gradient centrifugation and immunoprecipitation, we have identified and characterized a third and smaller SWI/SNF subcomplex. We termed this complex GBAF because it incorporates two mutually exclusive paralogs, GLTSCR1 (glioma tumor suppressor candidate region gene 1) or GLTSCR1L (GLTSCR1-like), instead of an ARID protein. In addition toGLTSCR1 or GLTSCR1L, the GBAF complex contains BRD9 (bromodomain-containing 9) and the BAF subunits BAF155, BAF60, SS18, BAF53a, and BRG1/BRM. We observed that GBAF does not contain the core BAF subunits BAF45, BAF47, or BAF57. Even without these subunits, GBAF displayed in vitro ATPase activity and bulk chromatin affinity comparable to those of BAF. GBAF associated with BRD4, but, unlike BRD4, the GBAF component GLTSCR1 was not required for the viability of the LNCaP prostate cancer cell line. In contrast, GLTSCR1 or GLTSCR1L knockouts in the metastatic prostate cancer cell line PC3 resulted in a loss in proliferation and colony-forming ability. Taken together, our results provide evidence for a compositionally novel SWI/SNF subcomplex with cell type-specific functions.	[Alpsoy, Aktan; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dykhuizen, EC (corresponding author), Dept Med Chem & Mol Pharmacol, HANS105A,201 S Univ St, W Lafayette, IN 47907 USA.	edykhui@purdue.edu		Alpsoy, Aktan/0000-0002-8940-8277	National Institutes of Health Grant [CA207532]; V Foundation for Cancer Research [V2014-004, D2016-030]; Lilly Foundation; National Institutes of Health through the Purdue University Center [P30 CA023168]; NATIONAL CANCER INSTITUTE [U01CA207532, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Lilly Foundation; National Institutes of Health through the Purdue University Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported with National Institutes of Health Grant CA207532, V Foundation for Cancer Research Grants V2014-004 and D2016-030 ( to E.C.D.), a graduate endowment from the Lilly Foundation (to A.A.), and National Institutes of Health Grant P30 CA023168 through the Purdue University Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Cardoso DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185409; Conrad RJ, 2017, MOL CELL, V67, P1001, DOI 10.1016/j.molcel.2017.07.025; Crowe BL, 2016, P NATL ACAD SCI USA, V113, P2086, DOI 10.1073/pnas.1516813113; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hohmann AF, 2016, NAT CHEM BIOL, V12, P672, DOI 10.1038/nchembio.2115; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kelso TWR, 2017, ELIFE, V6, DOI [10.7554/eLife.30506.001, 10.7554/eLife.30506]; Karmer KF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071537; Mani U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184445; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; Mathies LD, 2017, ALCOHOL CLIN EXP RES, V41, P2033, DOI 10.1111/acer.13514; Mathies LD, 2015, P NATL ACAD SCI USA, V112, P3032, DOI 10.1073/pnas.1413451112; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Mayes K, 2014, ADV CANCER RES, V121, P183, DOI 10.1016/B978-0-12-800249-0.00005-6; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Porter EG, 2017, JOVE-J VIS EXP, DOI 10.3791/55369; Porter EG, 2017, J BIOL CHEM, V292, P2601, DOI 10.1074/jbc.M116.746875; Raab JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005748; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Staahl BT, 2013, J NEUROSCI, V33, P10348, DOI 10.1523/JNEUROSCI.1258-13.2013; Stanton B. Z., 2017, GEN NONRADIOACTIVE A; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wurster AL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-9; Zinzalla G, 2016, CHEMBIOCHEM, V17, P677, DOI 10.1002/cbic.201500565; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	92	96	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3892	3903		10.1074/jbc.RA117.001065	http://dx.doi.org/10.1074/jbc.RA117.001065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374058	Green Published, hybrid			2022-12-28	WOS:000427587500004
J	Motiwala, T; Majumder, S; Ghoshal, K; Kutay, H; Datta, J; Roy, S; Lucas, DM; Jacob, ST				Motiwala, Tasneem; Majumder, Sarmila; Ghoshal, Kalpana; Kutay, Huban; Datta, Jharna; Roy, Satavisha; Lucas, David M.; Jacob, Samson T.			RETRACTION: PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells (Retraction of Vol 284, Pg 455, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Motiwala, Tasneem/AAB-9067-2021		NCI NIH HHS [P01 CA101956] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [T15LM011270] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Motiwala T, 2009, J BIOL CHEM, V284, P455, DOI 10.1074/jbc.M802840200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3589	3589		10.1074/jbc.W118.002431	http://dx.doi.org/10.1074/jbc.W118.002431			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523695	Green Published, hybrid			2022-12-28	WOS:000427030200011
J	von Heijne, G				von Heijne, Gunnar			Membrane protein serendipity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item							SIGNAL PEPTIDES; TRANSMEMBRANE HELICES; ENDOPLASMIC-RETICULUM; TOPOLOGY; TRANSLOCATION; PREDICTION; SECRETION; OVEREXPRESSION; IDENTIFICATION; RECOGNITION	Myscientific career has taken me from chemistry, via theoretical physics and bioinformatics, to molecular biology and even structural biology. Along the way, serendipity led me to work on problems such as the identification of signal peptides that direct protein trafficking, membrane protein biogenesis, and cotranslational protein folding. I've had some great collaborations that came about because of a stray conversation or from following up on an interesting paper. And I've had the good fortune to be asked to sit on the Nobel Committee for Chemistry, where I am constantly reminded of the amazing pace and often intricate history of scientific discovery. Could I have planned this? No way! I just went with the flow ...	[von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, Box 1031, SE-17121 Solna, Sweden	Stockholm University; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.; von Heijne, G (corresponding author), Stockholm Univ, Sci Life Lab, Box 1031, SE-17121 Solna, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019					Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Ismail N, 2015, NAT STRUCT MOL BIOL, V22, P145, DOI 10.1038/nsmb.2940; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Nilsson OB, 2017, NAT STRUCT MOL BIOL, V24, P221, DOI 10.1038/nsmb.3355; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Saaf A, 1998, EUR J BIOCHEM, V251, P821, DOI 10.1046/j.1432-1327.1998.2510821.x; Samelson AJ, 2016, P NATL ACAD SCI USA, V113, P13402, DOI 10.1073/pnas.1610272113; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Ulmschneider MB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5863; von Heijne G, 1999, J MOL BIOL, V293, P367, DOI 10.1006/jmbi.1999.2998; VONHEIJNE G, 1980, EUR J BIOCHEM, V103, P431; VONHEIJNE G, 1979, EUR J BIOCHEM, V97, P175; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1981, EUR J BIOCHEM, V120, P275; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842	40	1	1	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3470	3476		10.1074/jbc.X118.001958	http://dx.doi.org/10.1074/jbc.X118.001958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523692	Green Published, hybrid			2022-12-28	WOS:000427030200001
J	Macdonald, SS; Patel, A; Larmour, VLC; Morgan-Lang, C; Hallam, SJ; Mark, BL; Withers, SG				Macdonald, Spencer S.; Patel, Ankoor; Larmour, Veronica L. C.; Morgan-Lang, Connor; Hallam, Steven J.; Mark, Brian L.; Withers, Stephen G.			Structural and mechanistic analysis of a beta-glycoside phosphorylase identified by screening a metagenomic library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINIDASE; PURIFICATION; GLUCOSIDASE; CELLOBIOSE; EXPRESSION; EXTRACTS; GENOMICS; ENZYMES; CLONING; ACID	Glycoside phosphorylases have considerable potential as catalysts for the assembly of useful glycans for products ranging from functional foods and prebiotics to novel materials. However, the substrate diversity of currently identified phosphorylases is relatively small, limiting their practical applications. To address this limitation, we developed a high-throughput screening approach using the activated substrate 2,4-dinitrophenyl beta-D-glucoside (DNPGlc) and inorganic phosphate for identifying glycoside phosphorylase activity and used it to screen a large insert metagenomic library. The initial screen, based on release of 2,4-dinitrophenyl from DNPGlc in the presence of phosphate, identified the gene bglP, encoding a retaining beta-glycoside phosphorylase from the CAZy GH3 family. Kinetic and mechanistic analysis of the gene product, BglP, confirmed a double displacement ping-pong mechanism involving a covalent glycosyl-enzyme intermediate. X-ray crystallographic analysis provided insights into the phosphate-binding mode and identified a key glutamine residue in the active site important for substrate recognition. Substituting this glutamine for a serine swapped the substrate specificity from glucoside to N-acetylglucosaminide. In summary, we present a high-throughput screening approach for identifying beta-glycoside phosphorylases, which was robust, simple to implement, and useful in identifying active clones within a metagenomics library. Implementation	[Macdonald, Spencer S.; Withers, Stephen G.] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Macdonald, Spencer S.; Withers, Stephen G.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z1, Canada; [Hallam, Steven J.] Univ British Columbia, Peter Wall Inst Adv Studies, Vancouver, BC V6T 1Z1, Canada; [Patel, Ankoor; Larmour, Veronica L. C.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Hallam, Steven J.; Withers, Stephen G.] Univ British Columbia, ECOSCOPE Training Program, Vancouver, BC V6T 1Z3, Canada; [Macdonald, Spencer S.; Hallam, Steven J.; Withers, Stephen G.] Univ British Columbia, Genome Sci & Technol Program, Vancouver, BC V6T 1Z4, Canada; [Morgan-Lang, Connor] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z4, Canada; [Withers, Stephen G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Manitoba; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Morgan-Lang, Connor/P-5309-2014	Morgan-Lang, Connor/0000-0002-6714-0898; Macdonald, Spencer/0000-0001-9879-5507	Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE) through Natural Sciences and Engineering Research Council of Canada CREATE; Research Manitoba; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05310]; Canada Council for the Arts; Killam Foundation	Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE) through Natural Sciences and Engineering Research Council of Canada CREATE; Research Manitoba; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Council for the Arts; Killam Foundation	Supported by Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE), funded through Natural Sciences and Engineering Research Council of Canada CREATE.; Holds a studentship award from Research Manitoba.; Supported by Discovery Grants from Natural Sciences and Engineering Research Council of Canada and grants from the Canada Foundation for Innovation.; Supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05310.; Recipient of salary support from the Canada Council for the Arts and the Killam Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berini F, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx211; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchholz K, 2008, CARBOHYD RES, V343, P1966, DOI 10.1016/j.carres.2008.02.007; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cori GT, 1938, J BIOL CHEM, V123, P375; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; de Kok S, 2011, METAB ENG, V13, P518, DOI 10.1016/j.ymben.2011.06.001; Ducatti DRB, 2016, CARBOHYD RES, V435, P106, DOI 10.1016/j.carres.2016.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gaida SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8045; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KITAOKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P652, DOI 10.1271/bbb.56.652; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kitaoka M, 2015, APPL MICROBIOL BIOT, V99, P8377, DOI 10.1007/s00253-015-6927-0; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konwar KM, 2015, BIOINFORMATICS, V31, P3345, DOI 10.1093/bioinformatics/btv361; Kumar V, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-2005-0; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Lairson LL, 2007, CHEM COMMUN, P365, DOI 10.1039/b614636h; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2013, EURASIP J WIREL COMM, V2013, P1, DOI DOI 10.4236/C0CA2013.71001; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Mazzella LJ, 1996, J AM CHEM SOC, V118, P2111, DOI 10.1021/ja953537z; Mewis K, 2013, J BIOTECHNOL, V167, P462, DOI 10.1016/j.jbiotec.2013.07.015; Moure A, 2006, PROCESS BIOCHEM, V41, P1913, DOI 10.1016/j.procbio.2006.05.011; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nyyssonen M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00282; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; PEARCE PJ, 1968, CAN J CHEMISTRY, V46, P241, DOI 10.1139/v68-038; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; SHETH K, 1969, J BIOL CHEM, V244, P457; SIH CJ, 1957, SCIENCE, V126, P1116, DOI 10.1126/science.126.3283.1116; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Ulusu NN, 2015, J MOL EVOL, V80, P251, DOI 10.1007/s00239-015-9681-0; Valdes A., 2016, MATER SCI FORUM, V842, P182, DOI DOI 10.4028/www.scientific.net/MSF.842.182; Vocadlo DJ, 2000, METH MOL B, V146, P203, DOI 10.1385/1-59259-045-4:203; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren RL, 2008, GENOME RES, V18, P1798, DOI 10.1101/gr.080358.108; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang YHP, 2005, P NATL ACAD SCI USA, V102, P7321, DOI 10.1073/pnas.0408734102; Zhang YHP, 2004, APPL ENVIRON MICROB, V70, P1563, DOI 10.1128/AEM.70.3.1563-1569.2004	63	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3451	3467		10.1074/jbc.RA117.000948	http://dx.doi.org/10.1074/jbc.RA117.000948			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317495	Green Published, hybrid			2022-12-28	WOS:000426562800034
J	Ting, YT; Petersen, J; Ramarathinam, SH; Scally, SW; Loh, KL; Thomas, R; Suri, A; Baker, DG; Purcell, AW; Reid, HH; Rossjohn, J				Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Thomas, Ranjeny; Suri, Anish; Baker, Daniel G.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie			The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; CELIAC-DISEASE; ANTIGEN; MHC; ASSOCIATION; IDENTIFICATION; VIMENTIN; EPITOPES; CELLS	The HLA-DRB1 locus is strongly associated with rheumatoid arthritis (RA) susceptibility, whereupon citrullinated self-peptides bind to HLA-DR molecules bearing the shared epitope (SE) amino acid motif. However, the differing propensity for citrullinated/non-citrullinated self-peptides to bind given HLA-DR allomorphs remains unclear. Here, we used a fluorescence polarization assay to determine a hierarchy of binding affinities of 34 self-peptides implicated in RA against three HLA-DRB1 allomorphs (HLA-DRB1*04:01/*04:04/*04:05) each possessing the SE motif. For all three HLA-DRB1 allomorphs, we observed a strong correlation between binding affinity and citrullination at P4 of the bound peptide ligand. A differing hierarchy of peptide-binding affinities across the three HLA-DRB1 allomorphs was attributable to the beta-chain polymorphisms that resided outside the SE motif and were consistent with sequences of naturally presented peptide ligands. Structural determination of eight HLA-DR4-self-epitope complexes revealed strict conformational convergence of the P4-Cit and surrounding HLA beta-chain residues. Polymorphic residues that form part of the P1 and P9 pockets of the HLA-DR molecules provided a structural basis for the preferential binding of the citrullinated self-peptides to the HLA-DR4 allomorphs. Collectively, we provide a molecular basis for the interplay between citrullination of self-antigens and HLA polymorphisms that shape peptide-HLADR4 binding affinities in RA.	[Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Thomas, Ranjeny] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Suri, Anish] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Baker, Daniel G.] Janssen Res & Dev LLC, Spring House, PA 19002 USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Scally, Stephen W.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada	Monash University; Monash University; Monash University; University of Queensland; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Cardiff University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	hugh.reid@monash.edu; Jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013; Ramarathinam, Sri H/G-2278-2012; Thomas, Ranjeny/B-4504-2013; Purcell, Anthony/AAH-1942-2019	Rossjohn, Jamie/0000-0002-2020-7522; Ramarathinam, Sri H/0000-0002-2787-1282; Thomas, Ranjeny/0000-0002-0518-8386; Purcell, Anthony/0000-0003-0532-8331; Loh, Khai Lee/0000-0002-2211-2404; Ting, Yi Tian/0000-0001-7718-8396; Scally, Stephen/0000-0002-4264-7772	National Health and Medical Research Council; ARC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	Supported by National Health and Medical Research Council research fellowships.; Supported by an ARC Laureate Fellowship.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson KM, 2016, ARTHRITIS RHEUMATOL, V68, P1627, DOI 10.1002/art.39636; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Dudek NL, 2016, METHODS MOL BIOL, V1394, P189, DOI 10.1007/978-1-4939-3341-9_14; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; El-Gabalawy Hani, 2009, Best Pract Res Clin Rheumatol, V23, P49, DOI 10.1016/j.berh.2008.11.004; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Friede T, 1996, BBA-MOL BASIS DIS, V1316, P85, DOI 10.1016/0925-4439(96)00010-5; Fugger L, 2000, ARTHRITIS RES, V2, P208, DOI 10.1186/ar89; Gerstner C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00494; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hardy MY, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.58; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; KINOUCHI R, 1994, IMMUNOGENETICS, V40, P376, DOI 10.1007/BF01246679; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Scally SW, 2017, ANN RHEUM DIS, V76, P1915, DOI 10.1136/annrheumdis-2017-211300; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sidney J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177140; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Sohn DH, 2015, ARTHRITIS RHEUMATOL, V67, P2877, DOI 10.1002/art.39283; Trouw LA, 2017, NAT REV RHEUMATOL, V13, P331, DOI 10.1038/nrrheum.2017.15; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; van Beers JJBC, 2013, ARTHRITIS RHEUM-US, V65, P69, DOI 10.1002/art.37720; van Beers JJBC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3744; Van Steendam K, 2011, RHEUMATOLOGY, V50, P830, DOI 10.1093/rheumatology/keq419; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin L, 2014, CURR PROTOC IMMUNOL, V106, P5	52	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3236	3251		10.1074/jbc.RA117.001013	http://dx.doi.org/10.1074/jbc.RA117.001013			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317506	Green Published, hybrid			2022-12-28	WOS:000426562800017
J	Yuan, YS; Gaither, K; Kim, E; Liu, E; Hu, M; Lengel, K; Qian, DM; Xu, YD; Wang, B; Knipprath, H; Liu, DX				Yuan, Yunsheng; Gaither, Kari; Kim, Eugene; Liu, Edward; Hu, Ming; Lengel, Kathy; Qian, Dongmeng; Xu, Yidi; Wang, Bin; Knipprath, Henning; Liu, David X.			SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PROMOTES SURVIVAL; GLIOMA-CELLS; CANCER CELLS; C6 GLIOMA; SUMOYLATION; INTERFERENCE; APOPTOSIS; PATHWAY; DEGRADATION; TARGET	Activating transcription factor 5 (ATF5) is a member of the ATF/cAMP response element-binding protein family of transcription factors. ATF5 regulates stress responses and cell survival, proliferation, and differentiation and also plays a role in viral infections, cancer, diabetes, schizophrenia, and the olfactory system. Moreover, it was found to also have a critical cell cycle-dependent structural function at the centrosome. However, the mechanism that controls the localization of ATF5 at the centrosome is unclear. Here we report that ATF5 is small ubiquitin-like modifier (SUMO) 2/3-modified at a conserved SUMO-targeting consensus site in various types of mammalian cells. We found that SUMOylation of ATF5 is elevated in the G(1) phase of the cell cycle and diminished in the G(2)/M phase. ATF5 SUMOylation disrupted the interaction of ATF5 with several centrosomal proteins and dislodged ATF5 from the centrosome at the end of the M phase. Of note, blockade of ATF5 SUMOylation deregulated the centrosome cycle, impeded ATF5 translocation from the centrosome, and caused genomic instability and G(2)/M arrest in HeLa cells. Our results indicate that ATF5 SUMOylation is an essential mechanism that regulates ATF5 localization and function at the centrosome.	[Yuan, Yunsheng; Gaither, Kari; Kim, Eugene; Lengel, Kathy; Xu, Yidi; Liu, David X.] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Liu, Edward] Mead High Sch, Spokane, WA 99218 USA; [Hu, Ming; Qian, Dongmeng; Wang, Bin] Qingdao Univ, Coll Life Sci, Dept Microbiol, Shandong 266071, Peoples R China; [Knipprath, Henning] Whitworth Univ, Dept Chem, Spokane, WA 99208 USA; [Yuan, Yunsheng] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Shanghai, Peoples R China; [Lengel, Kathy] Penn State Univ, Coll Med, Dept Biochem, Hershey, PA 17033 USA	Washington State University; Qingdao University; Whitworth University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, DX (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	d.liu@wsu.edu		Gaither, Kari/0000-0003-2014-4362	Washington State University College of Pharmacy; American Cancer Society; NCI, National Institutes of Health R15 award; National Natural Science Foundation of China [31671388]; National Science Foundation graduate fellowship award; EMPEROR science award - PBS LearningMedia and Stand Up to Cancer (SU2C	Washington State University College of Pharmacy; American Cancer Society(American Cancer Society); NCI, National Institutes of Health R15 award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation graduate fellowship award; EMPEROR science award - PBS LearningMedia and Stand Up to Cancer (SU2C	This work was supported in part by a startup package from Washington State University College of Pharmacy, a research scholar grant from the American Cancer Society, and an NCI, National Institutes of Health R15 award (to D. X. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Natural Science Foundation of China Grant 31671388. Present address: School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China.; Supported in part by an National Science Foundation graduate fellowship award.; Supported in part by an EMPEROR science award sponsored by PBS LearningMedia and Stand Up to Cancer (SU2C).	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Angelastro JM, 2003, J NEUROSCI, V23, P4590; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Chen AP, 2012, INT J GYNECOL PATHOL, V31, P532, DOI 10.1097/PGP.0b013e31824df26b; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2016, CURR MOL MED, V16, P900, DOI 10.2174/1566524016666161223105201; Gong L, 2016, CURR MOL MED, V16, P871, DOI 10.2174/1566524016666161223104915; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hu M, 2017, ONCOTARGET, V8, P32157, DOI 10.18632/oncotarget.17150; Hu M, 2012, ANTICANCER RES, V32, P4385; Izumi S, 2012, J BIOL CHEM, V287, P36190, DOI 10.1074/jbc.M112.373746; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lengel K, 2015, CELL CYCLE, V14, P3215, DOI 10.1080/15384101.2015.1086202; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liang J, 2017, GENE DEV, V31, P802, DOI 10.1101/gad.296145.117; Liu DX, 2011, MOL CELL BIOL, V31, P3906, DOI 10.1128/MCB.05887-11; Liu FY, 2016, CURR MOL MED, V16, P893, DOI 10.2174/1566524017666170109125256; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Madarampalli B, 2015, CELL, V162, P580, DOI 10.1016/j.cell.2015.06.055; Mukherjee S, 2012, J BIOL CHEM, V287, P31195, DOI 10.1074/jbc.M112.395210; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200	28	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2939	2948		10.1074/jbc.RA117.001151	http://dx.doi.org/10.1074/jbc.RA117.001151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29326161	Green Published, hybrid			2022-12-28	WOS:000426051900027
J	Dahl, EF; Wu, SC; Healy, CL; Harsch, BA; Shearer, GC; O'Connell, TD				Dahl, Erika F.; Wu, Steven C.; Healy, Chastity L.; Harsch, Brian A.; Shearer, Gregory C.; O'Connell, Timothy D.			Subcellular compartmentalization of proximal G(q)-receptor signaling produces unique hypertrophic phenotypes in adult cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cell compartmentalization; cell signaling; G protein-coupled receptor (GPCR); adrenergic receptor; angiotensin II; signaling mechanism; myocardial biology; intracellular compartmentalization; G protein signaling; angiotensin receptor	B-SPLICE VARIANT; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ENDOTHELIN RECEPTORS; BETA; LOCALIZATION; OVEREXPRESSION; FAILURE; CARDIOMYOCYTES; ACTIVATION; PATHWAY	G protein-coupled receptors that signal through G(q) (G(q) receptors), such as (1)-adrenergic receptors ((1)-ARs) or angiotensin receptors, share a common proximal signaling pathway that activates phospholipase C1 (PLC1), which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. Despite these common proximal signaling mechanisms, G(q) receptors produce distinct physiological responses, yet the mechanistic basis for this remains unclear. In the heart, G(q) receptors are thought to induce myocyte hypertrophy through a mechanism termed excitation-transcription coupling, which provides a mechanistic basis for compartmentalization of calcium required for contraction versus IP3-dependent intranuclear calcium required for hypertrophy. Here, we identified subcellular compartmentalization of G(q)-receptor signaling as a mechanistic basis for unique G(q) receptor-induced hypertrophic phenotypes in cardiac myocytes. We show that (1)-ARs co-localize with PLC1 and PIP2 at the nuclear membrane. Further, nuclear (1)-ARs induced intranuclear PLC1 activity, leading to histone deacetylase 5 (HDAC5) export and a robust transcriptional response (i.e. significant up- or down-regulation of 806 genes). Conversely, we found that angiotensin receptors localize to the sarcolemma and induce sarcolemmal PLC1 activity, but fail to promote HDAC5 nuclear export, while producing a transcriptional response that is mostly a subset of (1)-AR-induced transcription. In summary, these results link G(q)-receptor compartmentalization in cardiac myocytes to unique hypertrophic transcription. They suggest a new model of excitation-transcription coupling in adult cardiac myocytes that accounts for differential G(q)-receptor localization and better explains distinct physiological functions of G(q) receptors.	[Dahl, Erika F.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Wu, Steven C.; Healy, Chastity L.; O'Connell, Timothy D.] Univ Minnesota, Dept Integrat Biol & Physiol, 2231 6th St SE,Canc & Cardiovasc Res Bldg,3-141, Minneapolis, MN 55455 USA; [Harsch, Brian A.; Shearer, Gregory C.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	O'Connell, TD (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, 2231 6th St SE,Canc & Cardiovasc Res Bldg,3-141, Minneapolis, MN 55455 USA.	tdoconne@umn.edu			University of Minnesota (Minneapolis, MN); Pennsylvania State University (University Park, PA)	University of Minnesota (Minneapolis, MN)(University of Minnesota System); Pennsylvania State University (University Park, PA)	This work was supported by start-up funds from the University of Minnesota (Minneapolis, MN) (to T.D.O.) and start-up funds from Pennsylvania State University (University Park, PA) (to G.C.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; BOHELER KR, 1992, J BIOL CHEM, V267, P12979; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Chang CWJ, 2013, J BIOL CHEM, V288, P192, DOI 10.1074/jbc.M112.382358; Chrysant SG, 2008, CLIN THER, V30, P2181, DOI 10.1016/j.clinthera.2008.12.002; COHN JN, 1993, CIRCULATION, V87, P1; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Jalili T, 1999, AM J PHYSIOL-HEART C, V277, pH2298, DOI 10.1152/ajpheart.1999.277.6.H2298; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kawada N, 2002, J AM SOC NEPHROL, V13, P2860, DOI 10.1097/01.ASN.0000035087.11758.ED; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mesaeli N, 2000, ARCH BIOCHEM BIOPHYS, V382, P48, DOI 10.1006/abbi.2000.2012; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Ponicke K, 1998, CIRCULATION, V97, P744, DOI 10.1161/01.CIR.97.8.744; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Robu VG, 2003, J BIOL CHEM, V278, P48154, DOI 10.1074/jbc.M304396200; Sekerkova G, 2014, BRAIN STRUCT FUNCT, V219, P719, DOI 10.1007/s00429-013-0531-9; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tadevosyan A, 2010, J BIOL CHEM, V285, P22338, DOI 10.1074/jbc.M110.121749; Vaniotis G, 2013, J MOL CELL CARDIOL, V62, P58, DOI 10.1016/j.yjmcc.2013.05.003; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wright CD, 2012, CELL SIGNAL, V24, P794, DOI 10.1016/j.cellsig.2011.11.014; Wu SC, 2015, J CARDIOVASC PHARM, V65, P91, DOI 10.1097/FJC.0000000000000165; Wu SC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000145; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhou GH, 2011, BIOORG MED CHEM LETT, V21, P5905, DOI 10.1016/j.bmcl.2011.07.122; Ziegelhoffer A, 2001, CARDIOVASC RES, V49, P118, DOI 10.1016/S0008-6363(00)00209-1; Zwart R, 2001, MOL CELL BIOL, V21, P4188, DOI 10.1128/MCB.21.13.4188-4196.2001	52	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8734	8749		10.1074/jbc.RA118.002283	http://dx.doi.org/10.1074/jbc.RA118.002283			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29610273	Green Published, hybrid			2022-12-28	WOS:000434941900002
J	Mantani, PT; Duner, P; Bengtsson, E; Ljungcrantz, I; Sundius, L; To, F; Nilsson, J; Bjorkbacka, H; Fredrikson, GN				Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Ljungcrantz, Irena; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin			Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); atherosclerosis; antibody; animal model; cellular immune response; cytokine; immunodeficiency; inflammation; T cell; innate lymphoid cells type 2; interleukin-25	SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; LOW-DENSITY-LIPOPROTEIN; INNATE LYMPHOID-CELLS; CARDIOVASCULAR EVENTS; TYPE-2 IMMUNITY; REDUCES ATHEROSCLEROSIS; HELMINTH EXPULSION; CYTOKINE RESPONSES; INTERFERON-GAMMA	Atherosclerosis is a chronic inflammatory disease characterized by the entrapment of apolipoprotein B-containing lipoproteins in the arterial intima, leading to local inflammation. T helper (Th) cell 1-mediated immune responses have been associated with atherosclerosis, and the cytokine interleukin-25 (IL-25 or IL-17E) has been reported to potentially regulate Th1 cell- and Th17 cell-related immune responses. In this study, we evaluated the effects of complete IL-25 deficiency or of a temporal IL-25 blockade on atherosclerosis development in apolipoprotein E-deficient (Apoe(-/-)) mice. Mice deficient in both apolipoprotein E and IL-25 (Apoe(-/-)/IL-25(-/-)) had more Th1 cells in the spleen, along with elevated plasma levels of IL-17 and an increased release of splenic interferon- (INF-). In support of this observation, a 4-week-long treatment of young Apoe(-/-) mice (at 10-14 weeks of age) with an IL-25-blocking antibody increased the release of Th1/Th17-associated cytokines in the spleen. In both mouse models, these findings were associated with increased atherosclerotic plaque formation in the aortic arch. We conclude that complete IL-25 deficiency and a temporal IL-25 blockade during early plaque development aggravate atherosclerosis development in the aortic arch of Apoe(-/-) mice, accompanied by an increase in Th1/Th17-mediated immune responses. Our finding that endogenous IL-25 has an atheroprotective role in the murine aortic arch has potential implications for atherosclerosis development and management in humans.	[Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Ljungcrantz, Irena; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, S-20213 Malmo, Sweden	Lund University; Skane University Hospital	Mantani, PT; Fredrikson, GN (corresponding author), CRC, Dept Clin Sci, Bldg 91 12,Jan Waldenstroms Gata 35, S-20213 Malmo, Sweden.	Polyxeni.Mantani@med.lu.se; gunilla.nordin_fredrikson@med.lu.se	Bengtsson, Eva/AGH-2754-2022; Bengtsson, Eva/AAA-1968-2019; Björkbacka, Harry/I-7157-2019	Bengtsson, Eva/0000-0001-7075-1772; Björkbacka, Harry/0000-0003-3918-0857; Duner, Pontus/0000-0003-4171-5646	Swedish Medical Research Council [521-2010-2929, 2015-02811]; Swedish Heart-Lung Foundation [20150273]; Albert Pahlsson Foundation [27.21.0145]; Skane University Hospital Foundation [16000109]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Albert Pahlsson Foundation; Skane University Hospital Foundation	This work was supported by Swedish Medical Research Council Grants 521-2010-2929 (to G.N.F.) and 2015-02811 (to J.N.), Swedish Heart-Lung Foundation Grant 20150273 (to G.N.F.), Albert Pahlsson Foundation Grant 27.21.0145 (to G.N.F.), and Skane University Hospital Foundation Grant 16000109 (to J.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Emami H, 2015, JACC-CARDIOVASC IMAG, V8, P121, DOI 10.1016/j.jcmg.2014.10.009; Engelbertsen D, 2015, ARTERIOSCL THROM VAS, V35, P2526, DOI 10.1161/ATVBAHA.115.306048; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Huber SA, 2001, CIRCULATION, V103, P2610; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath.2007.060857; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Mantani PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117255; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newland SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15781; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Wigren M, 2011, J INTERN MED, V269, P546, DOI 10.1111/j.1365-2796.2010.02311.x; Witztum JL, 2002, J CLIN INVEST, V109, P721, DOI 10.1172/JCI200215310	46	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6791	6801		10.1074/jbc.RA117.000292	http://dx.doi.org/10.1074/jbc.RA117.000292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29572351	Green Published, hybrid			2022-12-28	WOS:000431487300014
J	Gallo-Ebert, C; Francisco, J; Liu, HY; Draper, R; Modi, K; Hayward, MD; Jones, BK; Buiakova, O; McDonough, V; Nickels, JT				Gallo-Ebert, Christina; Francisco, Jamie; Liu, Hsing-Yin; Draper, Riley; Modi, Kinnari; Hayward, Michael D.; Jones, Beverly K.; Buiakova, Olesia; McDonough, Virginia; Nickels, Joseph T., Jr.			Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; BILE-ACID METABOLISM; FIBROBLAST GROWTH FACTOR-21; CHRONIC VIRAL-HEPATITIS; TRIGLYCERIDE SYNTHESIS; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; LIPID-METABOLISM; PROTECTS MICE	Metabolic syndrome (MetS) is a term used to characterize individuals having at least three of the following diseases: obesity, dyslipidemia, hyperglycemia, insulin resistance, hypertension, and nonalcoholic fatty liver disease (NAFLD). It is widespread, and the number of individuals with MetS is increasing. However, the events leading to the manifestation of MetS are not well-understood. Here, we show that loss of murine ARV1 (mARV1) results in resistance to acquiring diseases associated with MetS. Arv1(-/-) animals fed a high-fat diet were resistant to diet-induced obesity, had lower blood cholesterol and triglyceride levels, and retained glucose tolerance and insulin sensitivity. Livers showed no gross morphological changes, contained lower levels of cholesterol, triglycerides, and fatty acids, and showed fewer signs of NAFLD. Knockout animals had elevated levels of liver farnesol X receptor (FXR) protein and its target, small heterodimer protein (SHP). They also had decreased levels of CYP7 alpha 1, CYP8 beta 1, and mature SREBP1 protein, evidence suggesting that liver FXR signaling was activated. Strengthening this hypothesis was the fact that peroxisome proliferator-activating receptor alpha (PPAR alpha) protein was elevated, along with its target, fibroblast growth factor 21 (FGF21). Arv1(-/-) animals excreted more fecal cholesterol, free fatty acids, and bile acids. Their small intestines had 1) changes in bile acid composition, 2) an increase in the level of the intestinal FXR antagonist, tauromuricholic acid, and 3) showed signs of attenuated FXR signaling. Overall, we believe that ARV1 function is deleterious when consuming a high-fat diet. We further hypothesize that ARV1 is critical for initiating events required for the progression of diseases associated with MetS and NAFLD.	[Gallo-Ebert, Christina; Francisco, Jamie; Liu, Hsing-Yin; Modi, Kinnari; Nickels, Joseph T., Jr.] Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA; [Draper, Riley; McDonough, Virginia] Hope Coll, Holland, MI 49423 USA; [Hayward, Michael D.; Jones, Beverly K.; Buiakova, Olesia] Invivotek, Genesis Biotechnol Grp, Hamilton, NJ 08691 USA; [Nickels, Joseph T., Jr.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Hope College; Rutgers State University New Brunswick	Nickels, JT (corresponding author), Inst Metab Disorders, Genesis Biotechnol Grp, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Draper, Riley/0000-0002-7158-1936; Gallo-Ebert, Christina/0000-0003-0985-3547; Draper, Riley/0000-0002-4968-922X	Genesis Biotechnology Group	Genesis Biotechnology Group	This work was supported by the Genesis Biotechnology Group. The authors declare that they have no conflicts of interest with the contents of this article.	AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Balsan GA, 2015, REV ASSOC MED BRAS, V61, P72, DOI 10.1590/1806-9282.61.01.072; Banh T, 2015, J LIPID RES, V56, P379, DOI 10.1194/jlr.M055228; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee IA, 2010, NUTR RES REV, V23, P146, DOI 10.1017/S0954422410000028; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Crujeiras AB, 2015, LIFE SCI, V140, P57, DOI 10.1016/j.lfs.2015.05.003; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; de Boer JF, 2017, GASTROENTEROLOGY, V152, P1126, DOI 10.1053/j.gastro.2016.12.037; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; EDER K, 1993, CLIN CHIM ACTA, V219, P93, DOI 10.1016/0009-8981(93)90200-N; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Fazio S, 2001, FRONT BIOSCI-LANDMRK, V6, pD515, DOI 10.2741/Fazio; Feitosa MF, 2005, J LIPID RES, V46, P281, DOI 10.1194/jlr.M400252-JLR200; Ferrell JM, 2016, J LIPID RES, V57, P1144, DOI 10.1194/jlr.M064709; Flak JN, 2016, MOL ENDOCRINOL, V30, P3, DOI 10.1210/me.2015-1232; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Gallo-Ebert C, 2012, FUNGAL GENET BIOL, V49, P101, DOI 10.1016/j.fgb.2011.11.006; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Georgiev AG, 2013, TRAFFIC, V14, P912, DOI 10.1111/tra.12082; Gluchowski NL, 2017, J LIPID RES, V58, P1230, DOI 10.1194/jlr.P075119; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Gonzalez FJ, 2017, DIGEST DIS, V35, P178, DOI 10.1159/000450908; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; Huang-Doran I, 2010, J ENDOCRINOL, V207, P245, DOI 10.1677/JOE-10-0272; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Imaizumi S, 2011, CIRC J, V75, P1533, DOI 10.1253/circj.CJ-11-0460; Imbriglio JE, 2015, J MED CHEM, V58, P9345, DOI 10.1021/acs.jmedchem.5b01345; Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008; ISHIDA BY, 1991, J LIPID RES, V32, P559; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khan A, 2008, PHYSIOL BEHAV, V93, P588, DOI 10.1016/j.physbeh.2007.10.019; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Lagor WR, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.32; Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; McDonough VM, 2004, ANTON LEEUW INT J G, V86, P349, DOI 10.1007/s10482-004-0515-0; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Ni D., 2017, CURR PROTOC PROTEIN, V88, DOI DOI 10.10.1; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Ohshiro T, 2015, EXPERT OPIN THER PAT, V25, P145, DOI 10.1517/13543776.2014.989833; Padmalayam I, 2013, CURR PHARM DESIGN, V19, P5755, DOI 10.2174/13816128113199990360; PAIGEN B, 1987, BIOCHEM GENET, V25, P881, DOI 10.1007/BF00502607; Palmer EE, 2016, HUM MOL GENET, V25, P3042, DOI 10.1093/hmg/ddw157; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Qi YP, 2015, BBA-MOL CELL BIOL L, V1851, P19, DOI 10.1016/j.bbalip.2014.04.008; ROSSI SS, 1987, J LIPID RES, V28, P589; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Ruggles KV, 2014, J BIOL CHEM, V289, P4417, DOI 10.1074/jbc.M113.515197; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sun RB, 2017, MOL PHARMACOL, V91, P110, DOI 10.1124/mol.116.106617; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; Targher G, 2016, DIABETES METAB, V42, P142, DOI 10.1016/j.diabet.2016.04.002; Than NN, 2015, ATHEROSCLEROSIS, V239, P192, DOI 10.1016/j.atherosclerosis.2015.01.001; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Villasmil ML, 2011, FEMS YEAST RES, V11, P524, DOI 10.1111/j.1567-1364.2011.00737.x; Villasmil ML, 2011, GENETICS, V187, P455, DOI 10.1534/genetics.110.120725; Wall PM, 2000, BEHAV BRAIN RES, V109, P229, DOI 10.1016/S0166-4328(99)00177-1; Wang HY, 2013, FERTIL STERIL, V99, P241, DOI 10.1016/j.fertnstert.2012.08.030; Warita K, 2006, J VET MED SCI, V68, P1257, DOI 10.1292/jvms.68.1257; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Xie C, 2017, DIABETES, V66, P613, DOI 10.2337/db16-0663; Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	97	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5956	5974		10.1074/jbc.RA117.000800	http://dx.doi.org/10.1074/jbc.RA117.000800			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491146	hybrid, Green Published			2022-12-28	WOS:000430497300017
J	Basu, P; Sandhu, N; Bhatt, A; Singh, A; Balhana, R; Gobe, I; Crowhurst, NA; Mendum, TA; Gao, L; Ward, JL; Beale, MH; McFadden, J; Beste, DJV				Basu, Piyali; Sandhu, Noor; Bhatt, Apoorva; Singh, Albel; Balhana, Ricardo; Gobe, Irene; Crowhurst, Nicola A.; Mendum, Tom A.; Gao, Liang; Ward, Jane L.; Beale, Michael H.; McFadden, Johnjoe; Beste, Dany J. V.			The anaplerotic node is essential for the intracellular survival of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; CORYNEBACTERIUM-GLUTAMICUM; CHOLESTEROL CATABOLISM; RESISTANT TUBERCULOSIS; THERAPEUTIC TARGET; METABOLISM; MECHANISMS; GROWTH; VIRULENCE; REQUIRES	Enzymes at the phosphoenolpyruvate (PEP)-pyruvate-oxaloacetate or anaplerotic (ANA) node control the metabolic flux to glycolysis, gluconeogenesis, and anaplerosis. Here we used genetic, biochemical, and C-13 isotopomer analysis to characterize the role of the enzymes at the ANA node in intracellular survival of the world's most successful bacterial pathogen, Mycobacterium tuberculosis (Mtb). We show that each of the four ANA enzymes, pyruvate carboxylase (PCA), PEP carboxykinase (PCK), malic enzyme (MEZ), and pyruvate phosphate dikinase (PPDK), performs a unique and essential metabolic function during the intracellular survival of Mtb. We show that in addition to PCK, intracellular Mtb requires PPDK as an alternative gateway into gluconeogenesis. Propionate and cholesterol detoxification was also identified as an essential function of PPDK revealing an unexpected role for the ANA node in the metabolism of these physiologically important intracellular substrates and highlighting this enzyme as a tuberculosis (TB)-specific drug target. We show that anaplerotic fixation of CO2 through the ANA node is essential for intracellular survival of Mtb and that Mtb possesses three enzymes (PCA, PCK, and MEZ) capable of fulfilling this function. In addition to providing a back-up role in anaplerosis we show that MEZ also has a role in lipid biosynthesis. MEZ knockout strains have an altered cell wall and were deficient in the initial entry into macrophages. This work reveals that the ANA node is a focal point for controlling the intracellular replication of Mtb, which goes beyond canonical gluconeogenesis and represents a promising target for designing novel anti-TB drugs.	[Basu, Piyali; Sandhu, Noor; Balhana, Ricardo; Gobe, Irene; Crowhurst, Nicola A.; Mendum, Tom A.; McFadden, Johnjoe; Beste, Dany J. V.] Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England; [Bhatt, Apoorva; Singh, Albel] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Gao, Liang; Ward, Jane L.; Beale, Michael H.] Rothamsted Res, Dept Computat & Analyt Sci, Harpenden AL5 2JQ, Herts, England	University of Surrey; University of Birmingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Beste, DJV (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Microbial & Cellular Sci, Guildford GU2 7XH, Surrey, England.	d.beste@surrey.ac.uk		Beste, Dany/0000-0001-6579-1366; McFadden, Johnjoe/0000-0003-2145-0046; Gao, Liang/0000-0003-3700-1069	Medical Research Council [MR/K01224X/1]; Biotechnology and Biological Sciences Research Council [BB/L022869/1]; BBSRC [BB/L022869/1] Funding Source: UKRI; MRC [MR/K01224X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/K01224X/1 and Biotechnology and Biological Sciences Research Council Grant BB/L022869/1. The authors declare that they have no conflicts of interest with the contents of this article.	Abuhammad A, 2017, BRIT J PHARMACOL, V174, P2194, DOI 10.1111/bph.13694; Bar-Even A, 2010, P NATL ACAD SCI USA, V107, P8889, DOI 10.1073/pnas.0907176107; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Dobson G., 1985, SYSTEMATIC ANAL COMP; Ganapathy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8912; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hao GF, 2014, APPL ENVIRON MICROB, V80, P2672, DOI 10.1128/AEM.00140-14; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Kappelmann J, 2016, BIOTECHNOL BIOENG, V113, P661, DOI 10.1002/bit.25833; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MARUYAMA K, 1985, J BIOCHEM, V98, P819, DOI 10.1093/oxfordjournals.jbchem.a135340; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Petersen S, 2001, METAB ENG, V3, P344, DOI 10.1006/mben.2001.0198; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Rienksma RA, 2014, SEMIN IMMUNOL, V26, P610, DOI 10.1016/j.smim.2014.09.013; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WHO, 2016, GLOB TUB REP	37	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5695	5704		10.1074/jbc.RA118.001839	http://dx.doi.org/10.1074/jbc.RA118.001839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475946	Green Published, hybrid			2022-12-28	WOS:000430044100029
J	Mund, T; Pelham, HR				Mund, Thomas; Pelham, Hugh R.			Substrate clustering potently regulates the activity of WW-HECT domain-containing ubiquitin ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; ubiquitin; protein degradation; protein folding; protein motif	E3 LIGASE; NEDD4 FAMILY; DEP DOMAIN; ITCH; ACTIVATION; MECHANISM; PROTEINS; INSIGHTS; COMPLEX; PHOSPHORYLATION	The Nedd4 family of HECT domain-containing E3 ligases ubiquitinate many transcription factors and signaling proteins, and their activity is tightly regulated. Normally, intramolecular interactions curb the catalytic activity of the HECT domain, but these can be broken by the binding of PY motifs, found on substrate molecules and adaptors, to the WW domains characteristic of this E3 ligase family. This raises the prospect of substrates automatically activating the ligases, frustrating the purpose of ligase regulation. Here we show that soluble protein substrates and adaptors such as arrestins, even with multiple PY elements, cannot activate ligase activity efficiently. However, we found that polymerization or membrane tethering of these substrates dramatically increases the ligase activity both in vivo and in vitro. Aggregation of luciferase-containing substrates upon heat shock had a similar effect and could also expose cryptic PY elements in the substrates. We inferred that ligase activation critically requires a substantial array of clustered PY motifs and that the formation of such arrays on membranes or in polymeric aggregates may be an essential step in this mode of ligase regulation. We conclude that recruitment of arrestins to membrane receptors and aggregation of unstable proteins after heat shock may be physiologically relevant mechanisms for triggering ubiquitination by Nedd4 family HECT domain-containing E3 ligases.	[Mund, Thomas; Pelham, Hugh R.] MRC, Mol Biol Lab, Cambridge Biomed Campus, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Pelham, HR (corresponding author), MRC, Mol Biol Lab, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	hp@mrc-lmb.cam.ac.uk		Mund, Thomas/0000-0002-3957-1105	Medical Research Council [MC_U105178788]; MRC [MC_U105178788] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MC_U105178788). The authors declare that they have no conflicts of interest with the contents of this article.	Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mund T, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150185; Mund T, 2014, P NATL ACAD SCI USA, V111, P16736, DOI 10.1073/pnas.1412152111; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	44	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5200	5209		10.1074/jbc.RA117.000934	http://dx.doi.org/10.1074/jbc.RA117.000934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29463679	Green Published, hybrid			2022-12-28	WOS:000429409300024
J	Antenucci, L; Hytonen, VP; Ylanne, J				Antenucci, Lina; Hytonen, Vesa P.; Ylanne, Jari			Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MOUSE PLATELETS; SH2 DOMAINS; SYK; ADHESION; BINDING; ALPHA(IIB)BETA(3); NEUTROPHILS; LYMPHOMA; P72(SYK)	Spleen tyrosine kinase (Syk) is involved in cellular adhesion and also in the activation and development of hematopoietic cells. Syk activation induced by genomic rearrangement has been linked to certain T-cell lymphomas, and Syk inhibitors have been shown to prolong survival of patients with B-cell lineage malignancies. Syk is activated either by its interaction with a double-phosphorylated immunoreceptor tyrosine-based activation motif (pITAM), which induces rearrangements in the Syk structure, or by the phosphorylation of specific tyrosine residues. In addition to its immunoreceptor function, Syk is activated downstream of integrin pathways, and integrins bind to the same region in Syk as does pITAM. However, it is unknown whether integrins and pITAM use the same mechanism to activate Syk. Here, using purified Syk protein and fluorescence-based enzyme assay we investigated whether interaction of the integrin beta(3) cytoplasmic domain with the Syk regulatory domain causes changes in Syk activity similar to those induced by pITAM peptides. We observed no direct Syk activation by soluble integrin peptide, and integrin did not compete with pITAM-induced activation even though at high concentrations, the integrin cytoplasmic domain peptide competed with Syk's substrate. However, clustered integrin peptides induced Syk activation, presumably via a transphosphorylation mechanism. Moreover, the clustered integrins also activated a Syk variant in which tyrosines were replaced with phenylalanine (Y348F/Y352F), indicating that clustered integrin-induced Syk activation involved other phosphorylation sites. In conclusion, integrin cytoplasmic domains do not directly induce Syk conformational changes and do not activate Syk via the same mechanism as pITAM.	[Antenucci, Lina; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Survontie 9 C, Jyvaskyla 40014, Finland; [Antenucci, Lina; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Survontie 9 C, Jyvaskyla 40014, Finland; [Hytonen, Vesa P.] Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland; [Hytonen, Vesa P.] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Hytonen, Vesa P.] Fimlab Labs, Tampere 33014, Finland	University of Jyvaskyla; University of Jyvaskyla; Tampere University; Tampere University	Antenucci, L (corresponding author), Univ Jyvaskyla, Survontie 9 C,POB 35, Jyvaskyla 40014, Finland.	lina.antenucci@jyu.fi	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Antenucci, Lina/0000-0003-1201-9342; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [278668, 290506]; Jenny and Antti Wihuri Foundation	Academy of Finland(Academy of Finland); Jenny and Antti Wihuri Foundation	This work was supported by Academy of Finland Grants 278668 (to J. Y.) and 290506 (to V. P. H.) and a research sabbatical grant from the Jenny and Antti Wihuri Foundation (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Hughes CE, 2015, BLOOD, V125, P144, DOI 10.1182/blood-2014-05-579375; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; Liu DL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0512-1; Maartens AP, 2015, DEV BIOL, V401, P62, DOI 10.1016/j.ydbio.2014.12.038; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Schmitz R, 1996, J MOL BIOL, V260, P664, DOI 10.1006/jmbi.1996.0429; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Woodside DG, 2001, CURR BIOL, V11, P1799, DOI 10.1016/S0960-9822(01)00565-6; Woodside DG, 2002, J BIOL CHEM, V277, P39401, DOI 10.1074/jbc.M207657200; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yan SR, 1997, J IMMUNOL, V158, P1902; YANG C, 1994, EUR J BIOCHEM, V221, P973, DOI 10.1111/j.1432-1033.1994.tb18813.x; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Yuan YF, 2001, CANCER RES, V61, P5558	39	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4591	4602		10.1074/jbc.RA117.000660	http://dx.doi.org/10.1074/jbc.RA117.000660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440271	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000428848300001
J	Zhao, LL; Wang, XB; Yu, Y; Deng, L; Chen, L; Peng, XP; Jiao, CC; Gao, GL; Tan, X; Pan, WJ; Ge, X; Wang, P				Zhao, Linlin; Wang, Xinbo; Yu, Yue; Deng, Lu; Chen, Lei; Peng, Xiaoping; Jiao, Chenchen; Gao, Guoli; Tan, Xiao; Pan, Weijuan; Ge, Xin; Wang, Ping			OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TRCP; CELL-PROLIFERATION; SIGNALING PATHWAYS; COLORECTAL-CANCER; UBIQUITIN CODE; POOR-PROGNOSIS; ER-ALPHA; ENZYMES; DEGRADATION; GROWTH	Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates various environmental signals to regulate cell growth and metabolism. DEPTOR, also termed DEPDC6, is an endogenous inhibitor of mTORC1 and mTORC2 activities. The abundance of DEPTOR centrally orchestrates the mTOR signaling network. However, the mechanisms by which DEPTOR stability is regulated are still elusive. Here, we report that OTU domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) specifically deubiquitinates DEPTOR in a deubiquitination assay. We found that OTUB1 directly interacted with DEPTOR via its N-terminal domain, deubiquitinated DEPTOR, and there by stabilized DEPTOR in a Cys-91-independent but Asp-88-dependent manner, suggesting that OTUB1 targets DEPTOR for deubiquitination via a deubiquitinase activity-independent non-canonical mechanism. The interaction between OTUB1 and DEPTOR was enhanced when the cells were treated with amino acids. Moreover, OTUB1 suppressed amino acid-induced activation of mTORC1 in a DEPTOR-dependent manner and thereby ultimately controlled cellular autophagy, cell proliferation, and size. Our findings reveal a mechanism that stabilizes the mTORC1 inhibitor DEPTOR via OTUB1's deubiquitinase activity. Our insights may inform research into various mTOR activity-related diseases, such as cancer, and may contribute to the identification of new diagnostic markers and therapeutic strategies for cancer treatments.	[Zhao, Linlin; Wang, Xinbo; Yu, Yue; Pan, Weijuan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Zhao, Linlin; Wang, Xinbo; Yu, Yue; Pan, Weijuan] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Deng, Lu; Chen, Lei; Peng, Xiaoping; Jiao, Chenchen; Tan, Xiao; Wang, Ping] Tongji Univ, Sch Life Sci & Technol, Sch Med, Dept Cent Lab,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Ge, Xin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Gao, Guoli] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	East China Normal University; East China Normal University; Tongji University; Tongji University; Tongji University	Wang, P (corresponding author), Tongji Univ, Sch Life Sci & Technol, Sch Med, Dept Cent Lab,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.; Ge, X (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China.	xin.ge@tongji.edu.cn; wangp@tongji.edu.cn			National Key Research and Development Program of China [2016YFC0902102]; National Natural Science Foundation of China [81625019, 91440104, 91519322, 81402417]; Science Technology Commission of Shanghai Municipality [16JC1404500]; Fundamental Research Funds for the Central Universities [1501219106, 1500219121, 1500219133]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Research and Development Program of China Grant 2016YFC0902102; National Natural Science Foundation of China Grants 81625019, 91440104, 91519322, and 81402417; Science Technology Commission of Shanghai Municipality Grant 16JC1404500; and Fundamental Research Funds for the Central Universities Grants 1501219106, 1500219121, and 1500219133. The authors declare that they have no conflicts of interest with the contents of this article.	Chen L, 2016, ONCOL REP, V35, P1049, DOI 10.3892/or.2015.4442; Deng L, 2015, MOL CELL, V58, P804, DOI 10.1016/j.molcel.2015.03.033; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Goncharov T, 2013, EMBO J, V32, P1103, DOI 10.1038/emboj.2013.62; Herhaus L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3519; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iglesias-Gato D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0280-2; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin GX, 2015, MOL CELL, V58, P989, DOI 10.1016/j.molcel.2015.05.010; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rajalingam K, 2016, CELL, V164, DOI 10.1016/j.cell.2016.02.019; Ramanathan HN, 2012, CRIT REV BIOCHEM MOL, V47, P17, DOI 10.3109/10409238.2011.620943; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Song WJ, 2018, GYNECOL OBSTET INVES, V83, P124, DOI 10.1159/000464351; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wang YQ, 2016, ONCOTARGET, V7, P36681, DOI 10.18632/oncotarget.9160; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x; Yuan L, 2017, AM J CANCER RES, V7, P159; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-258	49	37	40	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4883	4892		10.1074/jbc.M117.809533	http://dx.doi.org/10.1074/jbc.M117.809533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382726	hybrid, Green Published			2022-12-28	WOS:000428848300027
J	Reyna-Beltran, E; Iranzo, M; Calderon-Gonzalez, KG; Mondragon-Flores, R; Labra-Barrios, ML; Mormeneo, S; Luna-Arias, JP				Reyna-Beltran, Elizabeth; Iranzo, Maria; Grisel Calderon-Gonzalez, Karla; Mondragon-Flores, Ricardo; Luisa Labra-Barrios, Maria; Mormeneo, Salvador; Pedro Luna-Arias, Juan			The Candida albicans ENO1 gene encodes a transglutaminase involved in growth, cell division, morphogenesis, and osmotic protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIFUNGAL DRUG DISCOVERY; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; TISSUE TRANSGLUTAMINASE; WALL PROTEINS; CROSS-LINKING; ENOLASE; PATHOGENICITY; INHIBITORS; INFECTION	Candida albicans is an opportunistic fungus that is part of the normal microflora commonly found in the human digestive tract and the normal mucosa or skin of healthy individuals. However, in immunocompromised individuals, it becomes a serious health concern and a threat to their lives and is ranked as the leading fungal infection in humans worldwide. As existing treatments for this infection are non-specific or under threat of developing resistance, there is a dire necessity to find new targets for designing specific drugs to defeat this fungus. Some authors reported the presence of the transglutaminase activity in Candida and Saccharomyces, but its identity remains unknown. We report here the phenotypic effects produced by the inhibition of transglutaminase enzymatic activity with cystamine, including growth inhibition of yeast cells, induction of autophagy in response to damage caused by cystamine, alteration of the normal yeast division pattern, changes in cell wall, and inhibition of the yeast-to-mycelium transition. The latter phenomenon was also observed in the C. albicans ATCC 26555 strain. Growth inhibition by cystamine was also determined in other Candida strains, demonstrating the importance of transglutaminase in these species. Finally, we identified enolase 1 as the cell wall protein responsible for TGase activity. After studying the inhibition of enzymatic activities with anti-CaEno1 antibodies and through bioinformatics studies, we suggest that the enolase and transglutaminase catalytic sites are localized in different domains of the protein. The aforementioned data indicate that TGase/Eno1 is a putative target for designing new drugs to control C. albicans infection.	[Reyna-Beltran, Elizabeth; Grisel Calderon-Gonzalez, Karla; Luisa Labra-Barrios, Maria; Pedro Luna-Arias, Juan] IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Biol Celular, Av IPN 2508, Ciudad De Mexico 07360, Mexico; [Mondragon-Flores, Ricardo] IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Bioquim, Ciudad De Mexico 07360, Mexico; [Iranzo, Maria; Mormeneo, Salvador] Univ Valencia, Dept Microbiol & Ecol, Fac Farm, Unidad Microbiol, E-46100 Valencia, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Valencia	Luna-Arias, JP (corresponding author), IPN, CINVESTAV, Ctr Invest & Estud Avanzados, Dept Biol Celular, Av IPN 2508, Ciudad De Mexico 07360, Mexico.	jpluna@cinvestav.mx	Luna-Arias, Juan Pedro/D-4395-2019	Luna-Arias, Juan Pedro/0000-0002-3602-8000; Reyna Beltran, Elizabeth/0000-0001-7896-0560	National Council of Science and Technology (Conacyt) of Mexico; Department of Cell Biology at Cinvestav-IPN; Spanish Ministry of Innovation and Science [AGL 2011-29382]	National Council of Science and Technology (Conacyt) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Department of Cell Biology at Cinvestav-IPN; Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported in part by the National Council of Science and Technology (Conacyt) of Mexico and the Department of Cell Biology at Cinvestav-IPN (to J.P.L.-A.) and Spanish Ministry of Innovation and Science Grant AGL 2011-29382 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Amberg DC., 2005, METHODS YEAST GENETI; Bharucha N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002058; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calderone R, 2014, FUTURE MICROBIOL, V9, P791, DOI [10.2217/FMB.14.32, 10.2217/fmb.14.32]; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chin VK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101643; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; Del Duca S, 2014, AMINO ACIDS, V46, P777, DOI 10.1007/s00726-013-1605-y; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Ecker M, 2006, J BIOL CHEM, V281, P11523, DOI 10.1074/jbc.M600314200; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Edwards SR, 1999, FEMS MICROBIOL LETT, V177, P211, DOI 10.1111/j.1574-6968.1999.tb13734.x; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Escalona-Montano AR, 2016, PARASITOLOGY, V143, P1409, DOI 10.1017/S0031182016000949; Herrera-Aguirre ME, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/734898; FALLER LD, 1977, BIOCHEMISTRY-US, V16, P3864, DOI 10.1021/bi00636a023; Fernandes C, 2014, ANTIMICROB AGENTS CH, V58, P2894, DOI 10.1128/AAC.02647-13; FONZI WA, 1993, GENETICS, V134, P717; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Furlaneto MC, 2012, SCANNING ELECTRON MICROSCOPY, P295; Gil-Bona A, 2015, J PROTEOME RES, V14, P142, DOI 10.1021/pr5007944; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Gutierrez-Escribano P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002683; Gutierrez-Escribano P, 2011, MOL BIOL CELL, V22, P2458, DOI 10.1091/mbc.E11-03-0205; Hani Umme, 2015, Infectious Disorders - Drug Targets, V15, P42; Hofs S, 2016, J MICROBIOL, V54, P149, DOI 10.1007/s12275-016-5514-0; Iranzo M, 2002, MICROBIOL-SGM, V148, P1329, DOI 10.1099/00221287-148-5-1329; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; JOHNSTONE SA, 1992, EXP CELL RES, V202, P458, DOI 10.1016/0014-4827(92)90099-T; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Keillor JW, 2016, EXPERT OPIN THER PAT, V26, P49, DOI 10.1517/13543776.2016.1115836; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Keillor JW, 2014, BIOORG CHEM, V57, P186, DOI 10.1016/j.bioorg.2014.06.003; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Klingspor L, 1997, ACTA PAEDIATR, V86, P30, DOI 10.1111/j.1651-2227.1997.tb08827.x; Ko HC, 2013, J MICROBIOL, V51, P345, DOI 10.1007/s12275-013-2577-z; Kustrzeba-Wojcicka I, 2000, COMP BIOCHEM PHYS B, V126, P109, DOI 10.1016/S0305-0491(00)00169-3; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; McNemar MD, 2002, J BACTERIOL, V184, P2058, DOI 10.1128/JB.184.7.2058-2061.2002; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; MORMENEO S, 1994, FEMS MICROBIOL LETT, V123, P131, DOI 10.1111/j.1574-6968.1994.tb07212.x; Munro CA, 2013, ADV APPL MICROBIOL, V83, P145, DOI 10.1016/B978-0-12-407678-5.00004-0; Poulain D, 2015, CRIT REV MICROBIOL, V41, P208, DOI 10.3109/1040841X.2013.813904; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; RUIZHERRERA J, 1995, ARCH MICROBIOL, V164, P186, DOI 10.1007/BF02529970; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Song Y, 2008, MOL BIOL CELL, V19, P5456, DOI 10.1091/mbc.E08-03-0272; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; US Department of Health and Human Services. Centers for Disease Control and Prevention (CDC), 2013, ANTIBIOTIC RESISTANC; Waffenschmidt S, 1999, PLANT PHYSIOL, V121, P1003, DOI 10.1104/pp.121.3.1003; Wang Y, 2015, VIRULENCE, V6, P307, DOI 10.1080/21505594.2014.1000752	61	23	25	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4304	4323		10.1074/jbc.M117.810440	http://dx.doi.org/10.1074/jbc.M117.810440			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386353	Green Published, hybrid			2022-12-28	WOS:000428204300006
J	Lin, JS; Pissaridou, P; Wu, HH; Tsai, MD; Filloux, A; Lai, EM				Lin, Jer-Sheng; Pissaridou, Panayiota; Wu, Hsin-Hui; Tsai, Ming-Daw; Filloux, Alain; Lai, Erh-Min			TagF-mediated repression of bacterial type VI secretion systems involves a direct interaction with the cytoplasmic protein Fha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICMF FAMILY PROTEIN; ACTIVATION; TRANSPORTER; LOCUS; GENE; TSSB	The bacterial type VI secretion system (T6SS) delivers effectors into eukaryotic host cells or toxins into bacterial competitor for survival and fitness. The T6SS is positively regulated by the threonine phosphorylation pathway (TPP) and negatively by the T6SS-accessory protein TagF. Here, we studied the mechanisms underlying TagF-mediated T6SS repression in two distinct bacterial pathogens, Agrobacterium tumefaciens and Pseudomonas aeruginosa. We found that in A. tumefaciens, T6SS toxin secretion and T6SS-dependent antibacterial activity are suppressed by a two-domain chimeric protein consisting of TagF and PppA, a putative phosphatase. Remarkably, this TagF domain is sufficient to post-translationally repress the T6SS, and this inhibition is independent of TPP. This repression requires interaction with a cytoplasmic protein, Fha, critical for activating T6SS assembly. In P. aeruginosa, PppA and TagF are two distinct proteins that repress T6SS in TPP-dependent and -independent pathways, respectively. P. aeruginosa TagF interacts with Fha1, suggesting that formation of this complex represents a conserved TagF-mediated regulatory mechanism. Using TagF variants with substitutions of conserved amino acid residues at predicted protein-protein interaction interfaces, we uncovered evidence that the TagF-Fha interaction is critical for TagF-mediated T6SS repression in both bacteria. TagF inhibits T6SS without affecting T6SS protein abundance in A. tumefaciens, but TagF overexpression reduces the protein levels of all analyzed T6SS components in P. aeruginosa. Our results indicate that TagF interacts with Fha, which in turn could impact different stages of T6SS assembly in different bacteria, possibly reflecting an evolutionary divergence in T6SS control.	[Lin, Jer-Sheng; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Wu, Hsin-Hui; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Pissaridou, Panayiota; Filloux, Alain] Imperial Coll London, Dept Life Sci, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Lin, Jer-Sheng] Max Planck Inst Terr Microbiol, Dept Organism Interact, Karl von Frisch Str 10, D-35043 Marburg, Germany; [Wu, Hsin-Hui] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, Chicago, IL 60064 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Imperial College London; Max Planck Society; Chicago Medical School; Rosalind Franklin University Medical & Science	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Lai, Erh-Min/ABG-9558-2020; Tsai, Ming-Daw/G-4689-2019; Pissaridou, Panayiota/AAJ-4261-2021	Lai, Erh-Min/0000-0003-3630-8683; Tsai, Ming-Daw/0000-0003-1374-0414; Pissaridou, Panayiota/0000-0003-4841-7676; Filloux, Alain/0000-0003-1307-0289	Ministry of Science and Technology of Taiwan (MOST) [104-2311-B-001-025-MY3]; MOST [105-0210-01-12-01, 106-0210-01-15-04]; Taiwan Protein Project [107-0210-01-19-02]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N002539/1]; Medical Research Council (MRC) [MR/N023250/1]; MOST-BBSRC International Partnering Award [105-2911-I-001-503, BB/M02735X/1]; BBSRC [BB/N002539/1, BB/M02735X/1] Funding Source: UKRI; MRC [MR/K001930/1, MR/N023250/1] Funding Source: UKRI	Ministry of Science and Technology of Taiwan (MOST); MOST; Taiwan Protein Project; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MOST-BBSRC International Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Ministry of Science and Technology of Taiwan (MOST) Grants 104-2311-B-001-025-MY3 (to E.-M. L.) and MOST Grants 105-0210-01-12-01 and 106-0210-01-15-04 and Taiwan Protein Project Grant 107-0210-01-19-02 (to M.-D.T.); Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N002539/1 and Medical Research Council (MRC) Grant MR/N023250/1 (to A.F.); and MOST-BBSRC International Partnering Award (Grant 105-2911-I-001-503) (to E.-M. L.) and Grant BB/M02735X/1 (to A. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allsopp LP, 2017, P NATL ACAD SCI USA, V114, P7707, DOI 10.1073/pnas.1700286114; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Basler M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0021; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brackmann M, 2017, TRENDS CELL BIOL, V27, P623, DOI 10.1016/j.tcb.2017.05.003; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Forster A, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.600510; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; LeRoux M, 2015, ELIFE, V4, DOI 10.7554/eLife.05701; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Lin JS, 2017, METHODS MOL BIOL, V1615, P177, DOI 10.1007/978-1-4939-7033-9_14; Lin JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003991; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Planamente S, 2016, EMBO J, V35, P1613, DOI 10.15252/embj.201694024; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Yang Z, 2018, ENVIRON MICROBIOL, V20, P903, DOI 10.1111/1462-2920.14039; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	47	18	20	3	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8829	8842		10.1074/jbc.RA117.001618	http://dx.doi.org/10.1074/jbc.RA117.001618			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29599293	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000434941900009
J	McCarthy, RC; Sosa, JC; Gardeck, AM; Baez, AS; Lee, CH; Wessling-Resnick, M				McCarthy, Ryan C.; Sosa, Jose Carlo; Gardeck, Andrew M.; Baez, Andrew S.; Lee, Chih-Hao; Wessling-Resnick, Marianne			Inflammation-induced iron transport and metabolism by brain microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE ELEMENTS; ACCUMULATION; CHAPERONE; HEPCIDIN; EXPRESSION; CELLS	Microglia are immune cells of the central nervous system and are implicated in brain inflammation. However, how brain microglia modulate transport and metabolism of the essential metal iron in response to pro- and anti-inflammatory environmental cues is unclear. Here, we characterized uptake of transferrin (Tf)-bound iron (TBI) and non-Tf-bound iron (NTBI) by immortalized microglial (IMG) cells. We found that these cells preferentially take up NTBI in response to the proinflammatory stimulus lipopolysaccharide (LPS) or -amyloid (A). In contrast, the anti-inflammatory cytokine interleukin 4 (IL-4) promoted TBI uptake. Concordant with these functional data, levels of the Tf receptor (TfR) in IMG cells were up-regulated in response to IL-4, whereas divalent metal transporter-1 (DMT1) and ferritin levels increased in response to LPS or A. Similar changes in expression were confirmed in isolated primary adult mouse microglia treated with pro- or anti-inflammatory inducers. LPS-induced changes in IMG cell iron metabolism were accompanied by notable metabolic changes, including increased glycolysis and decreased oxidative respiration. Under these conditions, the extracellular acidification rate was increased, compatible with changes in the cellular microenvironment that would support the pH-dependent function of DMT1. Moreover, LPS increased heme oxygenase-1 (HO1) expression in IMG cells, and iron released because of HO1 activity increased the intracellular labile free-iron pool. Together, this evidence indicates that brain microglia preferentially acquire iron from Tf or from non-Tf sources, depending on their polarization state; that NTBI uptake is enhanced by the proinflammatory response; and that under these conditions microglia sequester both extra- and intracellular iron.	[McCarthy, Ryan C.; Sosa, Jose Carlo; Gardeck, Andrew M.; Baez, Andrew S.; Lee, Chih-Hao; Wessling-Resnick, Marianne] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu			National Institutes of Health [NIDDK R01 DK064750, NIAID R21 AI131659, NIEHS T32 ES016645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants NIDDK R01 DK064750 (to M.W.-R), NIAID R21 AI131659 (to C.-H.L.), and NIEHS T32 ES016645 (to R.C.M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Barichello T, 2011, J NEUROIMMUNOL, V233, P12, DOI 10.1016/j.jneuroim.2010.10.035; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408; GUTTERIDGE JMC, 1992, CLIN SCI, V82, P315, DOI 10.1042/cs0820315; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kaur C, 1999, NEUROSCI LETT, V262, P183, DOI 10.1016/S0304-3940(99)00075-0; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; McCarthy RC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0484-z; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stefanova D, 2017, BLOOD, V130, P245, DOI 10.1182/blood-2017-03-772715; Thomsen MS, 2015, NEUROBIOL DIS, V81, P108, DOI 10.1016/j.nbd.2015.03.013; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wetli HA, 2006, CHEM BIOL, V13, P965, DOI 10.1016/j.chembiol.2006.08.005; Yanatori I, 2017, J BIOL CHEM, V292, P13205, DOI 10.1074/jbc.M117.776021; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Zechel S, 2006, J NEUROSCI RES, V84, P790, DOI 10.1002/jnr.20991; Zeineh MM, 2015, NEUROBIOL AGING, V36, P2483, DOI 10.1016/j.neurobiolaging.2015.05.022	33	78	79	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7853	7863		10.1074/jbc.RA118.001949	http://dx.doi.org/10.1074/jbc.RA118.001949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610275	hybrid, Green Published			2022-12-28	WOS:000437256500032
J	Herborg, F; Andreassen, TF; Berlin, F; Loland, CJ; Gether, U				Herborg, Freja; Andreassen, Thorvald F.; Berlin, Frida; Loland, Claus J.; Gether, Ulrik			Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; neurotransmitter transport; monoamine transporter; genetic polymorphism; autism; attention-deficit hyperactivity disorder; missense mutation; molecular genetics; psychiatric disease; rare variants	ZINC-BINDING SITE; DE-NOVO MUTATIONS; RARE VARIANTS; PSYCHIATRIC-DISORDERS; SEQUENCE VARIATION; BIPOLAR DISORDER; SCHIZOPHRENIA; NEUROTRANSMITTER; COCAINE; RISK	Genetic factors are known to significantly contribute to the etiology of psychiatric diseases such as attention deficit hyperactivity disorder (ADHD) and autism spectrum and bipolar disorders, but the underlying molecular processes remain largely elusive. The dopamine transporter (DAT) has received continuous attention as a potential risk factor for psychiatric disease, as it is critical for dopamine homeostasis and serves as principal target for ADHD medications. Constrain metrics for the DAT-encoding gene, solute carrier family 6 member 3 (SLC6A3), indicate that missense mutations are under strong negative selection, pointing to pathophysiological outcomes when DAT function is compromised. Here, we systematically characterized six rare genetic variants of DAT (I312F, T356M, D421N, A559V, E602G, and R615C) identified in patients with neuropsychiatric disorders. We evaluated dopamine uptake and ligand interactions, along with ion coordination and electrophysiological properties, to elucidate functional phenotypes, and applied Zn2+ exposure and a substituted cysteine-accessibility approach to identify shared structural changes. Three variants (I312F, T356M, and D421N) exhibited impaired dopamine uptake associated with changes in ligand binding, ion coordination, and distinct conformational disturbances. Remarkably, we found that all three variants displayed gain-of-function electrophysiological phenotypes. I312F mediated an increased uncoupled anion conductance previously suggested to modulate neuronal excitability. T356M and D421N both mediated a cocaine-sensitive leakage of cations, which for T356M was potentiated by Zn2+, concurrent with partial functional rescue. Collectively, our findings support that gain of disruptive functions due to missense mutations in SLC6A3 may be key to understanding how dopaminergic dyshomeostasis arises in heterozygous carriers.	[Herborg, Freja; Andreassen, Thorvald F.; Berlin, Frida; Loland, Claus J.; Gether, Ulrik] Univ Copenhagen, Panum Inst, Mol Neuropharmacol & Genet Lab, Dept Neurosci,Fac Hlth & Med Sci, Maersk Tower 07-05, DK-2200 Copenhagen, Denmark	University of Copenhagen	Herborg, F; Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Mol Neuropharmacol & Genet Lab, Dept Neurosci,Fac Hlth & Med Sci, Maersk Tower 07-05, DK-2200 Copenhagen, Denmark.	frejahh@sund.ku.dk; gether@sund.ku.dk	Loland, Claus/E-5975-2014	Loland, Claus/0000-0002-1773-1446; Berlin, Frida/0000-0002-3728-1729; Gether, Ulrik/0000-0002-0020-3807	Danish Council for Independent Research-Medical Sciences Grants [DFF-4183-00571, DFF 4004-00097B]; Lundbeck Foundation [R181-2014-3090]; National Institutes of Health Grant [P01 DA 12408]; Novo Nordisk Foundation [NNF16OC0023104]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	Danish Council for Independent Research-Medical Sciences Grants; Lundbeck Foundation(Lundbeckfonden); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Danish Council for Independent Research-Medical Sciences Grants DFF-4183-00571 (to F.H.), DFF 4004-00097B (to U.G.), Lundbeck Foundation R181-2014-3090 (to F.H.), National Institutes of Health Grant P01 DA 12408, and the Novo Nordisk Foundation NNF16OC0023104. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Bowton E, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.90; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Cartier E, 2015, EBIOMEDICINE, V2, P135, DOI 10.1016/j.ebiom.2015.01.007; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gainetdinov RR, 2008, N-S ARCH PHARMACOL, V377, P301, DOI 10.1007/s00210-007-0216-0; Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Grunhage F, 2000, MOL PSYCHIATR, V5, P275, DOI 10.1038/sj.mp.4000711; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hamilton PJ, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0002-7; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kovtun O, 2015, ACS CHEM NEUROSCI, V6, P526, DOI 10.1021/cn500202c; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Bustamante ML, 2017, AM J MED GENET B, V174, P663, DOI 10.1002/ajmg.b.32550; Li Y, 2017, J BIOL CHEM, V292, P4235, DOI 10.1074/jbc.M116.760140; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Martin J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.5; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Mazei-Robison MS, 2005, NEUROPHARMACOLOGY, V49, P737, DOI 10.1016/j.neuropharm.2005.08.012; Mazei-Robison MS, 2005, NEUROPHARMACOLOGY, V49, P724, DOI 10.1016/j.neuropharm.2005.08.003; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Mergy MA, 2014, NEUROCHEM INT, V73, P56, DOI 10.1016/j.neuint.2013.11.009; Mick E, 2009, CHILD ADOL PSYCH CL, V18, P441, DOI 10.1016/j.chc.2008.11.008; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng J, 2014, PEDIATR DRUGS, V16, P275, DOI 10.1007/s40272-014-0079-z; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Owen MJ, 2016, LANCET, V388, P86, DOI 10.1016/S0140-6736(15)01121-6; Pardinas AF, 2016, BIORXIV, DOI [10.1101/068593, DOI 10.1101/068593]; Pereira DB, 2012, FRONT BIOSCI-LANDMRK, V17, P2740, DOI 10.2741/4083; Reynolds GP, 2014, BRIT J CLIN PHARMACO, V77, P654, DOI 10.1111/bcp.12312; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Saiz PA, 2010, PROG NEURO-PSYCHOPH, V34, P26, DOI 10.1016/j.pnpbp.2009.09.008; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Singh T, 2017, NAT GENET, V49, P1167, DOI 10.1038/ng.3903; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sonders MS, 1997, J NEUROSCI, V17, P960; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Williams NM, 2012, AM J PSYCHIAT, V169, P195, DOI 10.1176/appi.ajp.2011.11060822; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295	76	20	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7250	7262		10.1074/jbc.RA118.001753	http://dx.doi.org/10.1074/jbc.RA118.001753			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	GF7UT	29559554	Green Published, hybrid			2022-12-28	WOS:000432174500016
J	Arora, D; Chawla, Y; Malakar, B; Singh, A; Nandicoori, VK				Arora, Divya; Chawla, Yogesh; Malakar, Basanti; Singh, Archana; Nandicoori, Vinay Kumar			The transpeptidase PbpA and noncanonical transglycosylase RodA of Mycobacterium tuberculosis play important roles in regulating bacterial cell lengths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID II FLIPPASE; ESCHERICHIA-COLI; IN-VITRO; GENE-EXPRESSION; CONDITIONAL LETHALITY; BACILLUS-SUBTILIS; STATIONARY-PHASE; PROTEIN; BINDING; SURVIVAL	The cell wall of Mycobacterium tuberculosis (Mtb) is a complex structure that protects the pathogen in hostile environments. Peptidoglycan (PG), which helps determine the morphology of the cell envelope, undergoes substantial remodeling under stress. This meshwork of linear chains of sugars, crosslinked through attached peptides, is generated through the sequential action of enzymes termed transglycosylases and transpeptidases. The Mtb genome encodes two classical transglycosylases and four transpeptidases, the functions of which are not fully elucidated. Here, we present work on the yet uncharacterized transpeptidase PbpA and a nonclassical transglycosylase RodA. We elucidate their roles in regulating in vitro growth and in vivo survival of pathogenic mycobacteria. We find that RodA and PbpA are required for regulating cell length, but do not affect mycobacterial growth. Biochemical analyses show PbpA to be a classical transpeptidase, whereas RodA is identified to be a member of an emerging class of noncanonical transglycosylases. Phosphorylation of RodA at Thr-463 modulates its biological function. In a guinea pig infection model, RodA and PbpA are found to be required for both bacterial survival and formation of granuloma structures, thus underscoring the importance of these proteins in mediating mycobacterial virulence in the host. Our results emphasize the fact that whereas redundant enzymes probably compensate for the absence of RodA or PbpA during in vitro growth, the two proteins play critical roles for the survival of the pathogen inside its host.	[Arora, Divya; Chawla, Yogesh; Malakar, Basanti; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Singh, Archana] CSIR Inst Genom & Integrat Biol, New Delhi 110025, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in		Nandicoori, Vinay/0000-0002-5682-4178; Singh, Archana/0000-0003-1388-9489	SERB, Department of Science and Technology, Government of India [EMR/2014/000877]; INSPIRE faculty grant from the Department of Science and Technology, Government of India [IFA12-LSBM35]	SERB, Department of Science and Technology, Government of India; INSPIRE faculty grant from the Department of Science and Technology, Government of India	This work was supported by the funding provided by SERB, Department of Science and Technology, Government of India Project EMR/2014/000877 (to V. K. N.). The authors declare that they have no conflicts of interest with the contents of this article. Supported by an INSPIRE faculty grant IFA12-LSBM35 from the Department of Science and Technology, Government of India.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boutte CC, 2016, ELIFE, V5, DOI 10.7554/eLife.14590; Boyle DS, 1997, MOL MICROBIOL, V24, P1263, DOI 10.1046/j.1365-2958.1997.4091773.x; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costa CS, 1999, CURR MICROBIOL, V38, P137, DOI 10.1007/PL00006777; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; de Kruijff B, 2008, PROSTAG LEUKOTR ESS, V79, P117, DOI 10.1016/j.plefa.2008.09.020; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Dephoure N, 2011, METHODS, V54, P379, DOI 10.1016/j.ymeth.2011.03.008; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Elhenawy W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161587; Emami K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.253; EMORI K, 1978, INFECT IMMUN, V19, P613, DOI 10.1128/IAI.19.2.613-620.1978; Fay A, 2009, J BACTERIOL, V191, P6020, DOI 10.1128/JB.00605-09; Fedarovich A, 2010, J MOL BIOL, V398, P54, DOI 10.1016/j.jmb.2010.02.046; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; IKEDA M, 1989, J BACTERIOL, V171, P6375, DOI 10.1128/jb.171.11.6375-6378.1989; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Jhingan GD, 2016, J BIOL CHEM, V291, P14257, DOI 10.1074/jbc.M115.666123; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Khan MZ, 2017, J BIOL CHEM, V292, P16093, DOI 10.1074/jbc.M117.797563; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kieser KJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005010; Kieser KJ, 2014, NAT REV MICROBIOL, V12, P550, DOI 10.1038/nrmicro3299; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kramer NE, 2004, FEMS MICROBIOL LETT, V239, P157, DOI 10.1016/j.femsle.2004.08.033; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leclercq S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43306; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu Y, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5030028; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; MATSUZAWA H, 1989, J BACTERIOL, V171, P558, DOI 10.1128/jb.171.1.558-560.1989; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Miesel L, 1998, J BACTERIOL, V180, P2459, DOI 10.1128/JB.180.9.2459-2467.1998; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nagarajan SN, 2015, J BIOL CHEM, V290, P9626, DOI 10.1074/jbc.M114.611822; Nakedi KC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00237; Nathan C, 2008, TUBERCULOSIS, V88, pS25, DOI 10.1016/S1472-9792(08)70034-9; Ostash B, 2010, NAT PROD REP, V27, P1594, DOI 10.1039/c001461n; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parker AE, 1997, MICROB PATHOGENESIS, V22, P193, DOI 10.1006/mpat.1996.0106; Patru MM, 2010, J BACTERIOL, V192, P3043, DOI 10.1128/JB.00025-10; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Qiao Y, 2017, NAT CHEM BIOL, V13, P793, DOI 10.1038/nchembio.2388; Richard-Greenblatt M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0005-2015; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Sharma AK, 2016, J BIOL CHEM, V291, P24215, DOI 10.1074/jbc.M116.754531; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Sieger B, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00738; Sieger B, 2013, MOL MICROBIOL, V90, P966, DOI 10.1111/mmi.12411; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; STOKER NG, 1983, J BACTERIOL, V155, P854, DOI 10.1128/JB.155.2.854-859.1983; STORM DR, 1974, J BIOL CHEM, V249, P1823; Straume D, 2017, MOL MICROBIOL, V103, P99, DOI 10.1111/mmi.13543; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van der Ploeg R, 2015, INT J MOL SCI, V16, P17637, DOI 10.3390/ijms160817637; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; van Teeseling MCF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01264; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Viswanathan G, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw294; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Yang DC, 2016, MICROBIOL MOL BIOL R, V80, P187, DOI 10.1128/MMBR.00031-15; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	95	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6497	6516		10.1074/jbc.M117.811190	http://dx.doi.org/10.1074/jbc.M117.811190			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29530985	hybrid, Green Published			2022-12-28	WOS:000431108600022
J	Yang, YB; Lee, M; Fairn, GD				Yang, Yanbo; Lee, Minhyoung; Fairn, Gregory D.			Phospholipid subcellular localization and dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						glycerophospholipid; phospholipase; phospholipid metabolism; membrane trafficking; organelle; membrane contact sites; nonvesicular transport; vesicular transport; phosphatidylinositol; sphingolipid; flippase; scramblase; phospholipids; lipid transfer proteins	CYTIDINE DIPHOSPHATE CHOLINE; TRANS-GOLGI NETWORK; P-TYPE ATPASES; PLASMA-MEMBRANE; PHOSPHATIDIC-ACID; LIPID TRANSFER; INTRACELLULAR-TRANSPORT; SCRAMBLASE ACTIVITY; LATERAL DIFFUSION; BINDING PROTEINS	Membrane biology seeks to understand how lipids and proteins within bilayers assemble into large structures such as organelles and the plasma membranes. Historically, lipids were thought to merely provide structural support for bilayer formation and membrane protein function. Research has now revealed that phospholipid metabolism regulates nearly all cellular processes. Sophisticated techniques helped identify >10,000 lipid species suggesting that lipids support many biological processes. Here, we highlight the synthesis of the most abundant glycerophospholipid classes and their distribution in organelles. We review vesicular and nonvesicular transport pathways shuttling lipids between organelles and discuss lipid regulators of membrane trafficking and second messengers in eukaryotic cells.	[Yang, Yanbo; Lee, Minhyoung; Fairn, Gregory D.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Yang, Yanbo; Lee, Minhyoung; Fairn, Gregory D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Fairn, Gregory D.] Univ Toronto, Dept Surg, Toronto, ON M5T 1P5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Fairn, GD (corresponding author), St Michaels Hosp, Off 614,209 Victoria St, Toronto, ON M5B 1W8, Canada.	fairng@smh.ca			Canadian Institutes of Health Research [MOP-133656]; Natural Sciences and Engineering Council of Canada; Li Ka Shing Knowledge Institute; Alzheimer Society of Canada; Government of Ontario Graduate Scholarship; Canadian Institutes of Health Research; Government of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Li Ka Shing Knowledge Institute(University of Toronto); Alzheimer Society of Canada; Government of Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Ontario	This work was supported in part by Operating Grant MOP-133656 from the Canadian Institutes of Health Research and a Discovery Grant from the Natural Sciences and Engineering Council of Canada (to G. D. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by scholarships from the Li Ka Shing Knowledge Institute and the Alzheimer Society of Canada.; Supported in part by scholarships from the Li Ka Shing Knowledge Institute and a Government of Ontario Graduate Scholarship.; Recipient of a New Investigator Award from Canadian Institutes of Health Research and an Early Researcher Award from the Government of Ontario.	Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Allan D, 1996, MOL MEMBR BIOL, V13, P81, DOI 10.3109/09687689609160580; Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5_4; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BATENBURG JJ, 1985, BIOCHIM BIOPHYS ACTA, V833, P17, DOI 10.1016/0005-2760(85)90248-6; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Bell R M, 1986, Symp Fundam Cancer Res, V39, P145; BELL RM, 1981, J LIPID RES, V22, P391; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BEVERS EM, 1989, BIOCHEMISTRY-US, V28, P2382, DOI 10.1021/bi00432a007; Bevers EM, 1998, LUPUS, V7, pS126, DOI 10.1177/096120339800700228; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; CARTER JR, 1966, J LIPID RES, V7, P678; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cockcroft Shamshad, 2013, Advances in Biological Regulation, V53, P280, DOI 10.1016/j.jbior.2013.07.007; Crawford AR, 1997, J CLIN INVEST, V100, P2562, DOI 10.1172/JCI119799; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Dekkers DWC, 1998, BLOOD, V91, P2133, DOI 10.1182/blood.V91.6.2133; Deng YQ, 2016, P NATL ACAD SCI USA, V113, P6677, DOI 10.1073/pnas.1602875113; DEVAUX P, 1972, J AM CHEM SOC, V94, P4475, DOI 10.1021/ja00768a600; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dittman JS, 2017, TRENDS BIOCHEM SCI, V42, P90, DOI 10.1016/j.tibs.2016.11.004; Eichmann TO, 2015, CELL MOL LIFE SCI, V72, P3931, DOI 10.1007/s00018-015-1982-3; EPAND RM, 1994, BIOPHYS J, V66, P1450, DOI 10.1016/S0006-3495(94)80935-X; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; FAMAEY JP, 1982, CLIN RHEUMATOL, V1, P84, DOI 10.1007/BF02275597; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Gyobu S, 2017, P NATL ACAD SCI USA, V114, P6274, DOI 10.1073/pnas.1703391114; Gyobu S, 2016, MOL CELL BIOL, V36, P645, DOI 10.1128/MCB.00919-15; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; HIGGINS JA, 1977, BIOCHIM BIOPHYS ACTA, V470, P342, DOI 10.1016/0005-2736(77)90126-2; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Kim YJ, 2016, BIOCHEM SOC T, V44, P197, DOI 10.1042/BST20150187; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; KORNBERG RD, 1971, P NATL ACAD SCI USA, V68, P2564, DOI 10.1073/pnas.68.10.2564; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; Krause MR, 2014, ACCOUNTS CHEM RES, V47, P3512, DOI 10.1021/ar500260t; KUGE O, 1991, J BIOL CHEM, V266, P24184; LANDS WEM, 1965, J BIOL CHEM, V240, P1905; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luquain C, 2003, TRENDS BIOCHEM SCI, V28, P377, DOI 10.1016/S0968-0004(03)00139-7; MANTSCH HH, 1981, BIOCHEMISTRY-US, V20, P3138, DOI 10.1021/bi00514a024; Martinez MC, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-20; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Merklinger E, 2016, J MEMBRANE BIOL, V249, P41, DOI 10.1007/s00232-015-9845-2; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morra G, 2018, STRUCTURE, V26, P356, DOI 10.1016/j.str.2017.11.020; Mouchlis Varnavas D., 2016, Advances in Biological Regulation, V61, P17, DOI 10.1016/j.jbior.2015.11.011; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; NICHOLS JW, 1988, BIOCHEMISTRY-US, V27, P1889, DOI 10.1021/bi00406a014; Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Schmidt JA, 2009, J CELL BIOL, V186, P211, DOI 10.1083/jcb.200904147; SCHWARZMANN G, 1990, BIOCHEMISTRY-US, V29, P10865, DOI 10.1021/bi00501a001; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TAKENAWA T, 1977, J BIOL CHEM, V252, P5419; Tanford C., 1987, BIOCH SOC T S, V15; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE JE, 1991, J BIOL CHEM, V266, P8241; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; VANDENBERG JJM, 1993, BIOCHEMISTRY-US, V32, P4962, DOI 10.1021/bi00069a035; Vasquez Alexis M., 2018, Advances in Biological Regulation, V67, P212, DOI 10.1016/j.jbior.2017.10.009; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vines CM, 2012, ADV EXP MED BIOL, V740, P235, DOI 10.1007/978-94-007-2888-2_10; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WEISS SB, 1958, J BIOL CHEM, V231, P53; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	129	92	94	10	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6230	6240		10.1074/jbc.R117.000582	http://dx.doi.org/10.1074/jbc.R117.000582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29588369	Green Published, hybrid			2022-12-28	WOS:000431108600002
J	Zeinert, R; Martinez, E; Schmitz, J; Senn, K; Usman, B; Anantharaman, V; Aravind, L; Waters, LS				Zeinert, Rilee; Martinez, Eli; Schmitz, Jennifer; Senn, Katherine; Usman, Bakhtawar; Anantharaman, Vivek; Aravind, L.; Waters, Lauren S.			Structure-function analysis of manganese exporter proteins across bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; PSI-BLAST; METAL; HOMEOSTASIS; TRANSPORT; SYSTEM; STRESS	Manganese (Mn) is an essential trace nutrient for organisms because of its role in cofactoring enzymes and providing protection against reactive oxygen species (ROS). Many bacteria require manganese to form pathogenic or symbiotic interactions with eukaryotic host cells. However, excess manganese is toxic, requiring cells to have manganese export mechanisms. Bacteria are currently known to possess two widely distributed classes of manganese export proteins, MntP and MntE, but other types of transporters likely exist. Moreover, the structure and function of MntP is not well understood. Here, we characterized the role of three structurally related proteins known or predicted to be involved in manganese transport in bacteria from the MntP, UPF0016, and TerC families. These studies used computational analysis to analyze phylogeny and structure, physiological assays to test sensitivity to high levels of manganese and ROS, and inductively coupled plasma-mass spectrometry (ICP-MS) to measure metal levels. We found that MntP alters cellular resistance to ROS. Moreover, we used extensive computational analyses and phenotypic assays to identify amino acids required for MntP activity. These negatively charged residues likely serve to directly bind manganese and transport it from the cytoplasm through the membrane. We further characterized two other potential manganese transporters associated with a Mn-sensing riboswitch and found that the UPF0016 family of proteins has manganese export activity. We provide here the first phenotypic and biochemical evidence for the role of Alx, a member of the TerC family, in manganese homeostasis. It does not appear to export manganese, but rather it intriguingly facilitates an increase in intracellular manganese concentration. These findings expand the available knowledge about the identity and mechanisms of manganese homeostasis proteins across bacteria and show that proximity to a Mn-responsive riboswitch can be used to identify new components of the manganese homeostasis machinery.	[Zeinert, Rilee; Martinez, Eli; Schmitz, Jennifer; Senn, Katherine; Usman, Bakhtawar; Waters, Lauren S.] Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA; [Anantharaman, Vivek; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Zeinert, Rilee] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Wisconsin System; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Massachusetts System; University of Massachusetts Amherst	Waters, LS (corresponding author), Univ Wisconsin, Dept Chem, Oshkosh, WI 54901 USA.; Aravind, L (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	aravind@ncbi.nlm.nih.gov; watersl@uwosh.edu	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009	Intramural Research Program of the National Library of Medicine, National Institutes of Health; Research Corporation for Scientific Advancement [22658, 23595]; Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh; University of Wisconsin, Oshkosh	Intramural Research Program of the National Library of Medicine, National Institutes of Health; Research Corporation for Scientific Advancement(Research Corporation for Science Advancement); Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh; University of Wisconsin, Oshkosh	This work was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health (to V. A. and L. A.), Grants 22658 and 23595 from the Research Corporation for Scientific Advancement (to L. S. W.), the Department of Education TRIO McNair Scholars Program at the University of Wisconsin, Oshkosh (to R. Z. and E. M.), and University of Wisconsin, Oshkosh, Faculty Development funds (to L. S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleshin VV, 1999, TRENDS BIOCHEM SCI, V24, P133, DOI 10.1016/S0968-0004(99)01367-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; BINGHAM RJ, 1990, J BACTERIOL, V172, P2184, DOI 10.1128/jb.172.4.2184-2186.1990; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cubillas C, 2014, METALLOMICS, V6, P1808, DOI 10.1039/c4mt00135d; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dambach M, 2015, MOL CELL, V57, P1099, DOI 10.1016/j.molcel.2015.01.035; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Fisher CR, 2016, J BACTERIOL, V198, P2810, DOI 10.1128/JB.00215-16; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Hohle TH, 2014, MOL MICROBIOL, V93, P736, DOI 10.1111/mmi.12687; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; Imlay JA, 2014, J BIOL CHEM, V289, P28121, DOI 10.1074/jbc.R114.588814; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Martin JE, 2017, MOL MICROBIOL, V104, P334, DOI 10.1111/mmi.13630; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; Martin JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004977; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P11334, DOI 10.1074/jbc.M112.448175; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Price IR, 2015, MOL CELL, V57, P1110, DOI 10.1016/j.molcel.2015.02.016; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Turner AG, 2015, MBIO, V6, DOI 10.1128/mBio.00278-15; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	58	20	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5715	5730		10.1074/jbc.M117.790717	http://dx.doi.org/10.1074/jbc.M117.790717			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440394	Green Published, hybrid			2022-12-28	WOS:000430044100031
J	Molinarolo, S; Lee, S; Leisle, L; Lueck, JD; Granata, D; Carnevale, V; Ahern, CA				Molinarolo, Steven; Lee, Sora; Leisle, Lilia; Lueck, John D.; Granata, Daniele; Carnevale, Vincenzo; Ahern, Christopher A.			Cross-kingdom auxiliary subunit modulation of a voltage-gated sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; protein evolution; membrane biophysics; bioinformatics; electrophysiology; auxiliary subunits; bacterial ion channels; electrical signalling	NA+ CHANNEL; BETA-SUBUNITS; FUNCTIONAL EXPRESSION; CRYSTAL-STRUCTURE; FEBRILE SEIZURES; ALPHA-SUBUNITS; MOLECULAR DETERMINANTS; NEURONAL EXCITABILITY; GENERALIZED EPILEPSY; EXTRACELLULAR DOMAIN	Voltage-gated, sodium ion-selective channels (Na-V) generate electrical signals contributing to the upstroke of the action potential in animals. Na(V)s are also found in bacteria and are members of a larger family of tetrameric voltage-gated channels that includes Ca(V)s, K(V)s, and Na(V)s. Prokaryotic Na(V)s likely emerged from a homotetrameric Ca2+-selective voltage-gated progenerator, and later developed Na+ selectivity independently. The Na-V signaling complex in eukaryotes contains auxiliary proteins, termed beta () subunits, which are potent modulators of the expression profiles and voltage-gated properties of the Na-V pore, but it is unknown whether they can functionally interact with prokaryotic Na-V channels. Herein, we report that the eukaryotic Na(V)1-subunit isoform interacts with and enhances the surface expression as well as the voltage-dependent gating properties of the bacterial Na-V, NaChBac in Xenopus oocytes. A phylogenetic analysis of the -subunit gene family proteins confirms that these proteins appeared roughly 420 million years ago and that they have no clear homologues in bacterial phyla. However, a comparison between eukaryotic and bacterial Na-V structures highlighted the presence of a conserved fold, which could support interactions with the -subunit. Our electrophysiological, biochemical, structural, and bioinformatics results suggests that the prerequisites for -subunit regulation are an evolutionarily stable and intrinsic property of some voltage-gated channels.	[Molinarolo, Steven; Lueck, John D.; Ahern, Christopher A.] Univ Iowa, Iowa Neurosci Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Lee, Sora; Leisle, Lilia] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [Granata, Daniele; Carnevale, Vincenzo] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA	University of Iowa; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ahern, CA (corresponding author), Univ Iowa, Iowa Neurosci Inst, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA.	christopher-ahern@uiowa.edu		Ahern, Christopher/0000-0002-7975-2744	National Institutes of Health NIGMS [GM122420]; American Heart Association Established Investigator [5EIA22180002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM122420] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association Established Investigator(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant GM122420 ( to C.A.A.) and American Heart Association Established Investigator Grant 5EIA22180002 ( to C.A.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Audenaert D, 2003, NEUROLOGY, V61, P854, DOI 10.1212/01.WNL.0000080362.55784.1C; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Barber AF, 2012, BBA-BIOMEMBRANES, V1818, P2120, DOI 10.1016/j.bbamem.2012.05.002; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brackenbury WJ, 2008, NEUROSCIENTIST, V14, P571, DOI 10.1177/1073858408320293; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; Dixon-Salazar TJ, 2004, J CHILD NEUROL, V19, P597, DOI 10.1177/088307380401900806; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finol-Urdaneta RK, 2014, J GEN PHYSIOL, V143, P157, DOI 10.1085/jgp.201311037; Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2002, J EXP BIOL, V205, P575; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Kasimova MA, 2016, CURR TOP MEMBR, V78, P261, DOI 10.1016/bs.ctm.2016.05.002; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kinde MN, 2016, P NATL ACAD SCI USA, V113, P13762, DOI 10.1073/pnas.1609939113; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Lee S, 2012, CHANNELS, V6, P403, DOI 10.4161/chan.21807; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; MACNAB RM, 1987, BIOPHYS J, V52, P637, DOI 10.1016/S0006-3495(87)83255-1; Makita N, 1996, J NEUROSCI, V16, P7117; Makita N, 1996, CIRC RES, V78, P244, DOI 10.1161/01.RES.78.2.244; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Malhotra JD, 2001, CIRCULATION, V103, P1303; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Micheletti C, 2009, BIOINFORMATICS, V25, P2663, DOI 10.1093/bioinformatics/btp506; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mio K, 2010, PROG BIOPHYS MOL BIO, V103, P111, DOI 10.1016/j.pbiomolbio.2010.05.002; Moran O, 2003, NEUROSCI LETT, V336, P175, DOI 10.1016/S0304-3940(02)01284-3; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Nguyen HM, 2012, P NATL ACAD SCI USA, V109, P18577, DOI 10.1073/pnas.1209142109; Nuss HB, 1995, J GEN PHYSIOL, V106, P1171, DOI 10.1085/jgp.106.6.1171; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ouyang W, 2007, J PHARMACOL EXP THER, V322, P1076, DOI 10.1124/jpet.107.122929; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin N, 2003, EUR J BIOCHEM, V270, P4762, DOI 10.1046/j.1432-1033.2003.03878.x; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Sula A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14205; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; Wallace RH, 2002, NEUROLOGY, V58, P1426, DOI 10.1212/WNL.58.9.1426; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Xiao YF, 2000, AM J PHYSIOL-HEART C, V279, pH35, DOI 10.1152/ajpheart.2000.279.1.H35; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yu FH, 2003, J NEUROSCI, V23, P7577; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zakon HH, 2011, MOL BIOL EVOL, V28, P1415, DOI 10.1093/molbev/msq325; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802; Zimmer T, 2002, J MEMBRANE BIOL, V186, P1, DOI 10.1007/s00232-001-0130-1	101	7	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4981	4992		10.1074/jbc.RA117.000852	http://dx.doi.org/10.1074/jbc.RA117.000852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29371400	hybrid, Green Published			2022-12-28	WOS:000429409300003
J	Sowers, CR; Wang, R; Bourne, RA; McGrath, BC; Hu, JJ; Bevilacqua, SC; Paton, JC; Paton, AW; Collardeau-Frachon, S; Nicolino, M; Cavener, DR				Sowers, Carrie R.; Wang, Rong; Bourne, Rebecca A.; McGrath, Barbara C.; Hu, Jingjie; Bevilacqua, Sarah C.; Paton, James C.; Paton, Adrienne W.; Collardeau-Frachon, Sophie; Nicolino, Marc; Cavener, Douglas R.			The protein kinase PERK/EIF2AK3 regulates proinsulin processing not via protein synthesis but by controlling endoplasmic reticulum chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; endoplasmic reticulum (ER); insulin secretion; intracellular trafficking; protein aggregation; BiP; PERK; beta cells	PANCREATIC BETA-CELLS; MESSENGER-RNA TRANSLATION; DISULFIDE-ISOMERASE; GLUCOSE-HOMEOSTASIS; PERK EIF2AK3; SUBTILASE CYTOTOXIN; DIABETES-MELLITUS; ESCHERICHIA-COLI; ADP-RIBOSYLATION; BINDING-PROTEIN	Loss-of-function mutations of the protein kinase PERK (EIF2AK3) in humans and mice cause permanent neonatal diabetes and severe proinsulin aggregation in the endoplasmic reticulum (ER), highlighting the essential role of PERK in insulin production in pancreatic cells. As PERK is generally known as a translational regulator of the unfolded protein response (UPR), the underlying cause of these cell defects has often been attributed to derepression of proinsulin synthesis, resulting in proinsulin overload in the ER. Using high-resolution imaging and standard protein fractionation and immunological methods we have examined the PERK-dependent phenotype more closely. We found that whereas proinsulin aggregation requires new protein synthesis, global protein and proinsulin synthesis are down-regulated in PERK-inhibited cells, strongly arguing against proinsulin overproduction being the root cause of their aberrant ER phenotype. Furthermore, we show that PERK regulates proinsulin proteostasis by modulating ER chaperones, including BiP and ERp72. Transgenic overexpression of BiP and BiP knockdown (KD) both promoted proinsulin aggregation, whereas ERp72 overexpression and knockdown rescued it. These findings underscore the importance of ER chaperones working in concert to achieve control of insulin production and identify a role for PERK in maintaining a functional balance among these chaperones.	[Sowers, Carrie R.; Wang, Rong; Bourne, Rebecca A.; McGrath, Barbara C.; Hu, Jingjie; Bevilacqua, Sarah C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Collardeau-Frachon, Sophie] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pathol, F-69677 Bron, France; [Collardeau-Frachon, Sophie] INSERM, Unit U1060, F-69677 Bron, France; [Nicolino, Marc] Hosp Civils Lyon, Serv Endocrinol & Dabetol Pediat & Malad Herediat, Hop Femme Mere Enfant, F-69677 Bron, France; [Sowers, Carrie R.] MedImmune LLC, Gaithersburg, MD 20878 USA; [Wang, Rong] Atila Biosyst, Mountain View, CA 94043 USA; [Bevilacqua, Sarah C.] CALTECH, Pasadena, CA 91125 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Adelaide; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; AstraZeneca; Medimmune; California Institute of Technology	Cavener, DR (corresponding author), 109 Life Sci Bldg, University Pk, PA 16802 USA.	drc9@psu.edu	Wang, Rong/M-4503-2019; Carmen, Team1/Y-7382-2019; wang, meng/GWZ-9558-2022; FRACHON, Sophie COLLARDEAU/H-2000-2014	Carmen, Team1/0000-0003-4234-1746; FRACHON, Sophie COLLARDEAU/0000-0001-8604-1089; Lab, Carmen/0000-0002-5935-3236	National Institutes of Health [R01 DK88140]; Huck Graduate Research Dissertation Award from the Huck Institutes of the Life Sciences at Penn State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Graduate Research Dissertation Award from the Huck Institutes of the Life Sciences at Penn State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK88140 and a Huck Graduate Research Dissertation Award (to C. R. S.) from the Huck Institutes of the Life Sciences at Penn State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Alarcon C, 2002, AV DIABETOL, V18, P168; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Collardeau-Frachon S, 2015, PEDIATR DIABETES, V16, P510, DOI 10.1111/pedi.12201; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Fabrizio G, 2015, CELL MOL LIFE SCI, V72, P1209, DOI 10.1007/s00018-014-1745-6; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Greeley SAW, 2011, CURR DIABETES REP, V11, P519, DOI 10.1007/s11892-011-0234-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Laitusis AL, 1999, J BIOL CHEM, V274, P486, DOI 10.1074/jbc.274.1.486; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NAGAMATSU S, 1987, ENDOCRINOLOGY, V120, P1225, DOI 10.1210/endo-120-4-1225; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Norez C, 2008, EUR J PHARMACOL, V592, P33, DOI 10.1016/j.ejphar.2008.06.103; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015; Shankar RK, 2013, PEDIATR DIABETES, V14, P174, DOI 10.1111/pedi.12003; Talbot UM, 2005, INFECT IMMUN, V73, P4432, DOI 10.1128/IAI.73.7.4432-4436.2005; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tiwari A, 2013, J CELL SCI, V126, P1962, DOI 10.1242/jcs.117374; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zito E, 2010, J CELL BIOL, V189, P769, DOI 10.1083/jcb.20091108620100423c	71	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5134	5149		10.1074/jbc.M117.813790	http://dx.doi.org/10.1074/jbc.M117.813790			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444822	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000429409300019
J	Zhou, ZQ; Ribas, V; Rajbhandari, P; Drew, BG; Moore, TM; Fluitt, AH; Reddish, BR; Whitney, KA; Georgia, S; Vergnes, L; Reue, K; Liesa, M; Shirihai, O; van der Bliek, AM; Chi, NW; Mahata, SK; Tiano, JP; Hewitt, SC; Tontonoz, P; Korach, KS; Mauvais-Jarvis, F; Hevener, AL				Zhou, Zhenqi; Ribas, Vicent; Rajbhandari, Prashant; Drew, Brian G.; Moore, Timothy M.; Fluitt, Amy H.; Reddish, Britany R.; Whitney, Kate A.; Georgia, Senta; Vergnes, Laurent; Reue, Karen; Liesa, Marc; Shirihai, Orian; van der Bliek, Alexander M.; Chi, Nai-Wen; Mahata, Sushil K.; Tiano, Joseph P.; Hewitt, Sylvia C.; Tontonoz, Peter; Korach, Kenneth S.; Mauvais-Jarvis, Franck; Hevener, Andrea L.			Estrogen receptor alpha protects pancreatic beta-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; HIGH-FAT DIET; INSULIN-RESISTANCE; ER-ALPHA; ISLET TRANSPLANTATION; OXIDATIVE STRESS; ADIPOSE-TISSUE; AUTOPHAGY; FISSION; METABOLISM	Estrogen receptor alpha (ER alpha) action plays an important role in pancreatic beta-cell function and survival; thus, it is considered a potential therapeutic target for the treatment of type 2 diabetes in women. However, the mechanisms underlying the protective effects of ER alpha remain unclear. Because ER alpha regulates mitochondrial metabolism in other cell types, we hypothesized that ER alpha may act to preserve insulin secretion and promote beta-cell survival by regulating mitochondrial-endoplasmic reticulum (EndoRetic) function. We tested this hypothesis using pancreatic islet-specific ER alpha knockout (PER alpha KO) mice and Min6 beta-cells in culture with Esr1 knockdown (KD). We found that Esr1-KD promoted reactive oxygen species production that associated with reduced fission/fusion dynamics and impaired mitophagy. Electron microscopy showed mitochondrial enlargement and a pro-fusion phenotype. Mitochondrial cristae and endoplasmic reticulum were dilated in Esr1-KD compared with ER alpha replete Min6 beta-cells. Increased expression of Oma1 and Chop was paralleled by increased oxygen consumption and apoptosis susceptibility in ER alpha-KD cells. In contrast, ER alpha overexpression and ligand activation reduced both Chop and Oma1 expression, likely by ER alpha binding to consensus estrogen-response element sites in the Oma1 and Chop promoters.	[Zhou, Zhenqi; Ribas, Vicent; Drew, Brian G.; Moore, Timothy M.; Fluitt, Amy H.; Reddish, Britany R.; Whitney, Kate A.; Georgia, Senta; Liesa, Marc; Shirihai, Orian; Hevener, Andrea L.] UCLA, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA; [Rajbhandari, Prashant; Tontonoz, Peter] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rajbhandari, Prashant; Tontonoz, Peter] UCLA, David Geffen Sch Med, Howard Hughes Res Inst, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] UCLA, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [van der Bliek, Alexander M.] UCLA, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Hevener, Andrea L.] Iris Cantor UCLA Womens Hlth Res Ctr, Los Angeles, CA 90095 USA; [Chi, Nai-Wen; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Tiano, Joseph P.; Mauvais-Jarvis, Franck] Tulane Univ, Hlth Sci Ctr, Dept Med & Pharmacol, New Orleans, LA 70112 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Georgia, Senta] Univ Southern Calif, Div Endocrinol, Keck Sch Med, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California	Hevener, AL (corresponding author), UCLA, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, 900 Vet Ave,Warren Hall Ste 24-130, Los Angeles, CA 90095 USA.	ahevener@mednet.ucla.edu	Hewitt, Sylvia/W-8752-2019; Liesa, Marc/K-8590-2019; Ribas, Vicent/K-1390-2014; Mahata, Sushil/AAF-8781-2021; Georgia, Senta/AAP-1971-2020	Hewitt, Sylvia/0000-0001-7713-0805; Liesa, Marc/0000-0002-5909-8570; Ribas, Vicent/0000-0003-3380-2256; Georgia, Senta/0000-0002-2016-7866; Rajbhandari, Prashant/0000-0002-8146-3861; Zhou, Zhenqi/0000-0001-6560-9704; vergnes, laurent/0000-0002-8804-589X; Moore, Timothy/0000-0003-4250-3370	UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation; UCLA CTSI Grant [ULTR000124]; UCLA Claude D. Pepper Older Americans Independence Center; UCSD-UCLA Diabetes Research Center; National Institutes of Health [DK060484, DK109724, P30DK063491, R01 DK074970]; NURSA NDSP [U24DK097748]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108657, U24DK097748, R01DK074970, R01DK099618, K01DK060484, P30DK063491, R01DK089109, R01DK107444, R01DK109724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM109764] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003725] Funding Source: NIH RePORTER	UCLA Department of Medicine; UCLA Iris Cantor Women's Health Foundation; UCLA CTSI Grant; UCLA Claude D. Pepper Older Americans Independence Center; UCSD-UCLA Diabetes Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NURSA NDSP; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the UCLA Department of Medicine, the UCLA Iris Cantor Women's Health Foundation, UCLA CTSI Grant ULTR000124, the UCLA Claude D. Pepper Older Americans Independence Center, UCSD-UCLA Diabetes Research Center, and National Institutes of Health Grants DK060484, DK109724, and P30DK063491, and NURSA NDSP U24DK097748 (to A. L. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant R01 DK074970.	Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Drew BG, 2015, J BIOL CHEM, V290, P5566, DOI 10.1074/jbc.M114.606459; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Frank A, 2014, FRONT NEUROENDOCRIN, V35, P550, DOI 10.1016/j.yfrne.2014.05.002; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gurlo T, 2016, MOL ENDOCRINOL, V30, P446, DOI 10.1210/me.2015-1255; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kilic G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087941; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim M, 2014, MOL METAB, V3, P642, DOI 10.1016/j.molmet.2014.05.007; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Liu S, 2013, DIABETOLOGIA, V56, P370, DOI 10.1007/s00125-012-2764-1; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Liu SH, 2010, ENDOCRINOLOGY, V151, P859, DOI 10.1210/en.2009-1107; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marchese E, 2015, DIABETES CARE, V38, pE176, DOI 10.2337/dc15-0723; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Rogers NH, 2009, BIOCHEM BIOPH RES CO, V382, P646, DOI 10.1016/j.bbrc.2009.02.154; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Watada H, 2015, MOL ENDOCRINOL, V29, P338, DOI 10.1210/me.2014-1367; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu L, 2014, AM J PHYSIOL-ENDOC M, V306, pE1188, DOI 10.1152/ajpendo.00579.2013; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	59	46	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4735	4751		10.1074/jbc.M117.805069	http://dx.doi.org/10.1074/jbc.M117.805069			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378845	Green Published, hybrid			2022-12-28	WOS:000428848300016
J	Zhu, F; Zhang, H; Yang, TD; Haslam, SM; Dell, A; Wu, H				Zhu, Fan; Zhang, Hua; Yang, Tiandi; Haslam, Stuart M.; Dell, Anne; Wu, Hui			Engineering and dissecting the glycosylation pathway of a streptococcal serine-rich repeat adhesion (vol 291, pg 27354, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4952	4952		10.1074/jbc.AAC118.002681	http://dx.doi.org/10.1074/jbc.AAC118.002681			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602879	Green Published, hybrid			2022-12-28	WOS:000428848300033
J	Haushalter, KJ; Casteel, DE; Raffeiner, A; Stefan, E; Patel, HH; Taylor, SS				Haushalter, Kristofer J.; Casteel, Darren E.; Raffeiner, Andrea; Stefan, Eduard; Patel, Hemal H.; Taylor, Susan S.			Phosphorylation of protein kinase A (PKA) regulatory subunit RI alpha by protein kinase G (PKG) primes PKA for catalytic activity in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; DILATED CARDIOMYOPATHY; HEART-FAILURE; SMOOTH-MUSCLE; I-ALPHA; HOLOENZYME; ACTIVATION; ISOFORM; STATE; LOCALIZATION	cAMP-dependent protein kinase (PKAc) is a pivotal signaling protein in eukaryotic cells. PKAc has two well-characterized regulatory subunit proteins, RI and RII (each having alpha and beta isoforms), which keep the PKAc catalytic subunit in a catalytically inactive state until activation by cAMP. Previous reports showed that the RI alpha regulatory subunit is phosphorylated by cGMP-dependent protein kinase (PKG) in vitro, whereupon phosphorylated RI alpha no longer inhibits PKAc at normal (1:1) stoichiometric ratios. However, the significance of this phosphorylation as a mechanism for activating type I PKA holoenzymes has not been fully explored, especially in cellular systems. In this study, we further examined the potential of RI alpha phosphorylation to regulate physiologically relevant "desensitization" of PKAc activity. First, the serine 101 site of RI alpha was validated as a target of PKGI alpha phosphorylation both in vitro and in cells. Analysis of a phosphomimetic substitution in RI alpha (S101E) showed that modification of this site increases PKAc activity in vitro and in cells, even without cAMP stimulation. Numerous techniques were used to show that although Ser(101) variants of RI alpha can bind PKAc, the modified linker region of the S101E mutant has a significantly reduced affinity for the PKAc active site. These findings suggest that RI alpha phosphorylation may be a novel mechanism to circumvent the requirement of cAMP stimulus to activate type I PKA in cells. We have thus proposed a model to explain how PKG phosphorylation of RI alpha creates a "sensitized intermediate" state that is in effect primed to trigger PKAc activity.	[Haushalter, Kristofer J.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Haushalter, Kristofer J.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Raffeiner, Andrea; Stefan, Eduard] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Patel, Hemal H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Innsbruck; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu		Stefan, Eduard/0000-0003-3650-4713	National Institutes of Health [R01 GM34921, DK54441, HL091071, HL107200]; Veterans Administration Grant [BX001963]; Austrian Science Fund [P27606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R01HL107200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Grant; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in whole or by part by National Institutes of Health Grants R01 GM34921 and DK54441 (to S.S.T.), HL091071 (to H.H.P.), and HL107200 (to H.H.P.) and Veterans Administration Grant BX001963 (HHP), and the Austrian Science Fund Grant P27606 (ES).	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Boeshans KM, 1999, PROTEIN SCI, V8, P1515, DOI 10.1110/ps.8.7.1515; Boras BW, 2014, J BIOL CHEM, V289, P30040, DOI 10.1074/jbc.M114.568907; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burgoyne JR, 2010, SENSORS-BASEL, V10, P2731, DOI 10.3390/s100402731; Burgoyne JR, 2009, J BIOL CHEM, V284, P29260, DOI 10.1074/jbc.M109.046722; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; GEAHLEN RL, 1982, ADV ENZYME REGUL, V20, P195, DOI 10.1016/0065-2571(82)90016-4; GEAHLEN RL, 1981, J BIOL CHEM, V256, P4536; Gupte RS, 2006, CELL CYCLE, V5, P653, DOI 10.4161/cc.5.6.2576; Han YS, 2013, ARCH BIOCHEM BIOPHYS, V538, P25, DOI 10.1016/j.abb.2013.08.002; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; KEELY SL, 1977, AM J PHYSIOL, V233, pH269, DOI 10.1152/ajpheart.1977.233.2.H269; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Saldanha SA, 2006, ANAL CHEM, V78, P8265, DOI 10.1021/ac061104g; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tschope C, 2016, INT J CARDIOL, V203, P1061, DOI 10.1016/j.ijcard.2015.10.208; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; van Heerebeek L, 2012, CIRCULATION, V126, P830, DOI 10.1161/CIRCULATIONAHA.111.076075; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Walter U, 1989, REV PHYSL BIOCH PHAR, V113, P41; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	42	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4411	4421		10.1074/jbc.M117.809988	http://dx.doi.org/10.1074/jbc.M117.809988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378851	Green Published, hybrid			2022-12-28	WOS:000428204300013
J	Abraham, MA; Rasti, M; Bauer, PV; Lam, TKT				Abraham, Mona A.; Rasti, Mozhgan; Bauer, Paige V.; Lam, Tony K. T.			Leptin enhances hypothalamic lactate dehydrogenase A (LDHA)-dependent glucose sensing to lower glucose production in high-fat-fed rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC INSULIN-RESISTANCE; DIET-INDUCED OBESITY; ASTROCYTES; SENSITIVITY; METABOLISM; ACTIVATION; NEURONS; ISOENZYMES; MECHANISM; RESPONSES	The responsiveness of glucose sensing per se to regulate whole-body glucose homeostasis is dependent on the ability of a rise in glucose to lower hepatic glucose production and increase peripheral glucose uptake in vivo. In both rodents and humans, glucose sensing is lost in diabetes and obesity, but the site(s) of impairment remains elusive. Here, we first report that shortterm high-fat feeding disrupts hypothalamic glucose sensing to lower glucose production in rats. Second, leptin administration into the hypothalamus of high-fat-fed rats restored hypothalamic glucose sensing to lower glucose production during a pancreatic (basal insulin)-euglycemic clamp and increased wholebody glucose tolerance during an intravenous glucose tolerance test. Finally, both chemical inhibition of hypothalamic lactate dehydrogenase (LDH) (achieved via hypothalamic LDH inhibitor oxamate infusion) and molecular knockdown of LDHA (achieved via hypothalamic lentiviral LDHA shRNA injection) negated the ability of hypothalamic leptin infusion to enhance glucose sensing to lower glucose production in high fat-fed rats. In summary, our findings illustrate that leptin enhances LDHA-dependent glucose sensing in the hypothalamus to lower glucose production in high-fat-fed rodents in vivo.	[Abraham, Mona A.; Rasti, Mozhgan; Bauer, Paige V.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON M5G 1L7, Canada; [Abraham, Mona A.; Bauer, Paige V.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON M5G 1L7, Canada.; Lam, TKT (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.; Lam, TKT (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada.; Lam, TKT (corresponding author), Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada.	tony.lam@uhnres.utoronto.ca			Diabetes Canada Operating Grant [OG-3-15-4901-TL]; Canadian Institutes of Health Research doctoral award; Banting and Best Diabetes Centre graduate scholarship; Ontario graduate scholarship	Diabetes Canada Operating Grant; Canadian Institutes of Health Research doctoral award(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate scholarship; Ontario graduate scholarship(Ontario Graduate Scholarship)	This work was supported by Diabetes Canada Operating Grant OG-3-15-4901-TL (to T.K.T.L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Canadian Institutes of Health Research doctoral award.; Supported by a Banting and Best Diabetes Centre graduate scholarship and an Ontario graduate scholarship.	Abraham MA, 2014, MOL METAB, V3, P202, DOI 10.1016/j.molmet.2013.11.007; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Arrieta-Cruz I, 2013, DIABETES, V62, P1152, DOI 10.2337/db12-0228; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Fam BC, 2007, DIABETES OBES METAB, V9, P840, DOI 10.1111/j.1463-1326.2006.00653.x; Filippi BM, 2017, CELL REP, V18, P2301, DOI 10.1016/j.celrep.2017.02.035; Garcia-Caceres C, 2016, CELL, V166, P867, DOI 10.1016/j.cell.2016.07.028; Hawkins M, 2002, DIABETES, V51, P2179, DOI 10.2337/diabetes.51.7.2179; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mevorach M, 1998, J CLIN INVEST, V102, P744, DOI 10.1172/JCI2720; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; THOLEY G, 1981, J NEUROCHEM, V36, P77, DOI 10.1111/j.1471-4159.1981.tb02379.x; VENKOV L, 1976, BRAIN RES, V109, P323, DOI 10.1016/0006-8993(76)90533-3; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Weiss R, 2015, DIABETES CARE, V38, P689, DOI 10.2337/dc14-2183; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yue JTY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13501; Zhu WL, 2010, AM J PHYSIOL-ENDOC M, V298, pE971, DOI 10.1152/ajpendo.00749.2009	34	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4159	4166		10.1074/jbc.RA117.000838	http://dx.doi.org/10.1074/jbc.RA117.000838			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374061	Green Published, hybrid			2022-12-28	WOS:000427587500026
J	Serrano-Perez, MC; Tilley, FC; Nevo, F; Arrondel, C; Sbissa, S; Martin, G; Tory, K; Antignac, C; Mollet, G				Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Tory, Kalman; Antignac, Corinne; Mollet, Geraldine			Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT NEPHROTIC SYNDROME; QUALITY-CONTROL; MEMBRANE TOPOLOGY; PROTEIN PODOCIN; SLIT DIAPHRAGM; N-GLYCANASE; CALNEXIN; DEGRADATION; NEPHRIN; NPHS2	Podocin is a key component of the slit diaphragm in the glomerular filtration barrier, and mutations in the podocin-encoding gene NPHS2 are a common cause of hereditary steroid-resistant nephrotic syndrome. A mutant allele encoding podocin with a p. R138Q amino acid substitution is the most frequent pathogenic variant in European and North American children, and the corresponding mutant protein is poorly expressed and retained in the endoplasmic reticulum both in vitro and in vivo. To better understand the defective trafficking and degradation of this mutant, we generated human podocyte cell lines stably expressing podocin(wt) or podocin(R138Q). Although it has been proposed that podocin has a hairpin topology, we present evidence for podocin(R138Q) N-glycosylation, suggesting that most of the protein has a transmembrane topology. We find that N-glycosylated podocin(R138Q) has a longer half-life than non-glycosylated podocin(R138Q) and that the latter is far more rapidly degraded than podocinwt. Consistent with its rapid degradation, podocin(R138Q) is exclusively degraded by the proteasome, whereas podocinwt is degraded by both the proteasomal and the lysosomal proteolytic machineries. In addition, we demonstrate an enhanced interaction of podocin(R138Q) with calnexin as the mechanism of endoplasmic reticulum retention. Calnexin knockdown enriches the podocin(R138Q) non-glycosylated fraction, whereas preventing exit from the calnexin cycle increases the glycosylated fraction. Altogether, we propose a model in which hairpin podocin(R138Q) is rapidly degraded by the proteasome, whereas transmembrane podocin(R138Q) degradation is delayed due to entry into the calnexin cycle.	[Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Antignac, Corinne; Mollet, Geraldine] INSERM, UMR 1163, Imagine Inst, Lab Hereditary Kidney Dis, F-75015 Paris, France; [Serrano-Perez, Maria-Carmen; Tilley, Frances C.; Nevo, Fabien; Arrondel, Christelle; Sbissa, Selim; Martin, Gaelle; Antignac, Corinne; Mollet, Geraldine] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Tory, Kalman] Semmelweis Univ, Hungarian Acad Sci, MTA SE Lendulet Nephrogenet Lab, H-1083 Budapest, Hungary; [Tory, Kalman] Semmelweis Univ, Dept Pediat 1, H-1083 Budapest, Hungary; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Mollet, G (corresponding author), INSERM, UMR1163, Imagine Inst, 24 Blvd Montparnasse, F-75015 Paris, France.	geraldine.mollet@inserm.fr	ANTIGNAC, Corinne/H-8945-2017; Mollet, Geraldine/E-8049-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Mollet, Geraldine/0000-0003-4685-5736	European Union [305608]; Agence Nationale de la Recherche under "Investissements d'avenir" program [ANR-10-IAHU-01]; Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche)	European Union(European Commission); Agence Nationale de la Recherche under "Investissements d'avenir" program(French National Research Agency (ANR)); Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche)	This work was supported by European Union's Seventh Framework Programme Grant FP7/2007-2013/no305608-EURenOmics (to C. Antignac), State funding from the Agence Nationale de la Recherche under "Investissements d'avenir" program Grant ANR-10-IAHU-01 (to C. Antignac), and Association des Malades d'un Syndrome Nephrotique (AMSN) (Programme Ambition Recherche 2008 - 2011 (to G. Mollet). The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Bubeck A, 2002, J BIOL CHEM, V277, P2216, DOI 10.1074/jbc.M104178200; Cannon KS, 1996, J BIOL CHEM, V271, P14280, DOI 10.1074/jbc.271.24.14280; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Drozdova T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.86; FAY D.S., 2013, BIOL GUIDE STAT THIN, P1; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Godel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057078; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hideshima Teru, 2003, Rev Clin Exp Hematol, V7, P191; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mekahli D, 2009, PEDIATR NEPHROL, V24, P1525, DOI 10.1007/s00467-009-1138-5; Ohashi T, 2003, HISTOCHEM CELL BIOL, V119, P257, DOI 10.1007/s00418-003-0511-x; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Philippe A, 2008, KIDNEY INT, V73, P1038, DOI 10.1038/ki.2008.27; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schurek EM, 2014, J BIOL CHEM, V289, P11262, DOI 10.1074/jbc.M113.521773; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tory K, 2014, NAT GENET, V46, P299, DOI 10.1038/ng.2898; Tune BM, 1997, J AM SOC NEPHROL, V8, P824; Volker LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-102; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	47	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4122	4133		10.1074/jbc.RA117.001159	http://dx.doi.org/10.1074/jbc.RA117.001159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382718	hybrid, Green Published			2022-12-28	WOS:000427587500023
J	Bai, SM; Ghoshal, K; Jacob, ST				Bai, Shoumei; Ghoshal, Kalpana; Jacob, Samson T.			RETRACTION: Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells (Retraction of Vol 281, Pg 13604, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bai SM, 2006, J BIOL CHEM, V281, P13604, DOI 10.1074/jbc.M513278200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3592	3592		10.1074/jbc.W118.002434	http://dx.doi.org/10.1074/jbc.W118.002434			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523698	hybrid, Green Published			2022-12-28	WOS:000427030200014
J	Stefanoska, K; Volkerling, A; Bertz, J; Poljak, A; Ke, YD; Ittner, LM; Ittner, A				Stefanoska, Kristie; Volkerling, Alexander; Bertz, Josefine; Poljak, Anne; Ke, Yazi D.; Ittner, Lars M.; Ittner, Arne			An N-terminal motif unique to primate tau enables differential protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA TOXICITY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYNAPTIC DYSFUNCTION; IN-VIVO; A-BETA; PHOSPHORYLATION; KINASE; NEUROGRANIN; MOUSE	Compared with other mammalian species, humans are particularly susceptible to tau-mediated neurodegenerative disorders. Differential interactions of the tau protein with other proteins are critical for mediating tau's physiological functions as well as tau-associated pathological processes. Primate tau harbors an 11-amino acid-long motif in its N- terminal region (residues 18-28), which is not present in non-primate species and whose function is unknown. Here, we used deletion mutagenesis to remove this sequence region from the longest human tau isoform, followed by glutathione S-transferase (GST) pulldown assays paired with isobaric tags for relative and absolute quantitation (iTRAQ) multiplex labeling, a quantitative method to measure protein abundance by mass spectrometry. Using this method, we found that the primate-specific N- terminal tau motif differentially mediates interactions with neuronal proteins. Among these binding partners are proteins involved in synaptic transmission (synapsin-1 and synaptotagmin-1) and signaling proteins of the 14-3-3 family. Furthermore, we identified an interaction of tau with a member of the annexin family (annexin A5) that was linked to the 11-residue motif. These results suggest that primate Tau has evolved specific residues that differentially regulate protein-protein interactions compared with tau proteins from other non-primate mammalian species. Our findings provide in vitro insights into tau's interactions with other proteins that may be relevant to human disease.	[Stefanoska, Kristie; Volkerling, Alexander; Bertz, Josefine; Ittner, Lars M.; Ittner, Arne] Univ New South Wales, Sch Med Sci, Dementia Res Unit, Sydney, NSW 2052, Australia; [Poljak, Anne] Univ New South Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Ke, Yazi D.] Univ New South Wales, Sch Med Sci, Motor Neuron Dis Unit, Sydney, NSW 2052, Australia; [Ittner, Lars M.] Neurosci Australia, Sydney, NSW 2031, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Ittner, LM (corresponding author), Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	l.ittner@unsw.edu.au	Ke, Yazi/ABC-3052-2020; Ittner, Arne/ABD-3072-2021	Ke, Yazi/0000-0002-1423-0451; Ittner, Arne/0000-0001-5244-6897; Poljak, Anne/0000-0001-9953-1984; Bertz, Josefine/0000-0001-7030-2096; Ittner, Lars/0000-0001-6738-3825; Stefanoska, Kristie/0000-0001-9322-9936	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); CurePSP; Dementia Australia	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); CurePSP; Dementia Australia	This work was supported in part by National Health and Medical Research Council (NHMRC), Australian Research Council (ARC), CurePSP, and Dementia Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Ashe KH, 2007, NEW ENGL J MED, V357, P933, DOI 10.1056/NEJMcibr073552; Bakota L, 2016, DRUGS, V76, P301, DOI 10.1007/s40265-015-0529-0; Burgmaier M, 2014, J CELL MOL MED, V18, P2117, DOI 10.1111/jcmm.12374; CROWE A, 1991, AM J PATHOL, V139, P1463; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Holzer M, 2004, GENE, V341, P313, DOI 10.1016/j.gene.2004.07.013; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner A, 2012, J EXP MED, V209, P2229, DOI 10.1084/jem.20120677; Ittner AA, 2014, DIABETOLOGIA, V57, P1410, DOI 10.1007/s00125-014-3230-z; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Latosinska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137048; Lee G, 1998, J CELL SCI, V111, P3167; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Morita S, 2013, CELL BIOCHEM FUNCT, V31, P400, DOI 10.1002/cbf.2914; Muenchhoff J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29078; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Poorkaj P, 2001, MAMM GENOME, V12, P700, DOI 10.1007/s00335-001-2044-8; PORTELIUS E, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV267; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Schmidt F, 2015, J NEUROPATH EXP NEUR, V74, P912, DOI 10.1097/NEN.0000000000000230; Smolek T, 2016, J COMP NEUROL, V524, P874, DOI 10.1002/cne.23877; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang CY, 2015, MOL CELL BIOL, V35, P1712, DOI 10.1128/MCB.01332-14; Wang P, 2017, ACTA NEUROPATHOL, V133, P731, DOI 10.1007/s00401-016-1663-9; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; WATSON JB, 1994, MOL BRAIN RES, V27, P323, DOI 10.1016/0169-328X(94)90017-5; Yamaguchi M, 2010, J NEUROSCI RES, V88, P2682, DOI 10.1002/jnr.22427; Zhong L, 2015, J NEUROSCI, V35, P7503, DOI 10.1523/JNEUROSCI.0274-15.2015; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	51	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3710	3719		10.1074/jbc.RA118.001784	http://dx.doi.org/10.1074/jbc.RA118.001784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29382714	Green Published, hybrid			2022-12-28	WOS:000427030200024
J	Han, Z; Wu, H; Kim, S; Yang, XK; Li, QJ; Huang, H; Cai, HJ; Bartlett, MG; Dong, AP; Zeng, H; Brown, PJ; Yang, XJ; Arrowsmith, CH; Zhao, YM; Zheng, YG				Han, Zhen; Wu, Hong; Kim, Sunjoo; Yang, Xiangkun; Li, Qianjin; Huang, He; Cai, Houjian; Bartlett, Michael G.; Dong, Aiping; Zeng, Hong; Brown, Peter J.; Yang, Xiang-jiao; Arrowsmith, Cheryl H.; Zhao, Yingming; Zheng, Y. George			Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE PROPIONYLATION; MSL COMPLEX; ACETYLATION; DISEASE; BUTYRYLATION; METABOLISM; MECHANISMS; PATHOLOGY; CANCER; MODEL	Short-chain acylation of lysine residues has recently emerged as a group of reversible posttranslational modifications in mammalian cells. The diversity of acylation further broadens the landscape and complexity of the proteome. Identification of regulatory enzymes and effector proteins for lysine acylation is critical to understand functions of these novel modifications at the molecular level. Here, we report that the MYST family of lysine acetyltransferases (KATs) possesses strong propionyltransferase activity both in vitro and in cellulo. Particularly, the propionyltransferase activity of MOF, MOZ, and HBO1 is as strong as their acetyltransferase activity. Overexpression of MOF in human embryonic kidney 293T cells induced significantly increased propionylation in multiple histone and nonhistone proteins, which shows that the function of MOF goes far beyond its canonical histone H4 lysine 16 acetylation. We also resolved the X-ray co-crystal structure of MOF bound with propionyl-coenzyme A, which provides a direct structural basis for the propionyltransferase activity of the MYST KATs. Our data together define a novel function for the MYST KATs as lysine propionyltransferases and suggest much broader physiological impacts for this family of enzymes.	[Han, Zhen; Yang, Xiangkun; Li, Qianjin; Cai, Houjian; Bartlett, Michael G.; Zheng, Y. George] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Wu, Hong; Dong, Aiping; Zeng, Hong; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Kim, Sunjoo; Huang, He; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yang, Xiang-jiao] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University System of Georgia; University of Georgia; University of Toronto; Structural Genomics Consortium; University of Chicago; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Zheng, YG (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	yzheng@uga.edu	Cai, Houjian/AAJ-1290-2020; Han, Zhen/AAA-4764-2022; Yang, Xiangkun/I-6141-2019; Han, Zhen/GQA-7275-2022	Han, Zhen/0000-0001-7362-7080; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250; Bartlett, Michael/0000-0003-0626-3234	National Science Foundation [1507741]; AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute; Innovative Medicines Initiative (EU/EFPIA) [115766]; Janssen; Merck Co; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; Chinese Scholarship Council; National Institutes of Health [R01CA172495, GM105933, DK107868, GM115961]; Department of Defense [W81XWH-15-1-0507]; Nancy and Leonard Florsheim Family Foundation; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115961] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Chinese Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nancy and Leonard Florsheim Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Science Foundation Grant 1507741 (to Y. G. Z.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation,Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a scholarship from the Chinese Scholarship Council.; Supported by National Institutes of Health Grant R01CA172495 and Department of Defense Grant W81XWH-15-1-0507.; Supported by National Institutes of Health Grants GM105933, DK107868, and GM115961 and the Nancy and Leonard Florsheim Family Foundation.	Avvakumov Nikita, 2007, Subcell Biochem, V41, P295; Bodai L, 2012, NEURODEGENER DIS, V9, P104, DOI 10.1159/000330505; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Chen QY, 2015, AIMS BIOPHYS, V2, P555, DOI 10.3934/biophy.2015.4.555; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chen ZW, 2014, BRIT J PHARMACOL, V171, P3196, DOI 10.1111/bph.12661; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao TL, 2013, ANAL BIOANAL CHEM, V405, P1361, DOI 10.1007/s00216-012-6522-5; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Han Z, 2017, ACS CHEM BIOL, V12, P1547, DOI 10.1021/acschembio.7b00114; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Klein BJ, 2017, STRUCTURE, V25, P650, DOI 10.1016/j.str.2017.02.003; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Leemhuis H, 2008, CHEMBIOCHEM, V9, P499, DOI 10.1002/cbic.200700556; Liu XG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.16; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Memarzadeh S, 2011, P NATL ACAD SCI USA, V108, P7962, DOI 10.1073/pnas.1105243108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nochi Z, 2017, J INHERIT METAB DIS, V40, P641, DOI 10.1007/s10545-017-0047-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pougovkina O, 2014, J INHERIT METAB DIS, V37, P709, DOI 10.1007/s10545-014-9684-9; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Scholl-Burgi S, 2012, J INHERIT METAB DIS, V35, P65, DOI 10.1007/s10545-010-9245-9; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Sun MW, 2016, J PROTEOME RES, V15, P4696, DOI 10.1021/acs.jproteome.6b00798; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Woo V, 2017, CURR OPIN IMMUNOL, V44, P52, DOI 10.1016/j.coi.2016.12.001; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang XK, 2017, ANAL CHEM, V89, P813, DOI 10.1021/acs.analchem.6b03623; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	42	31	32	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3410	3420		10.1074/jbc.RA117.000529	http://dx.doi.org/10.1074/jbc.RA117.000529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29321206	Green Published, hybrid			2022-12-28	WOS:000426562800031
J	Chen, W; Qu, MB; Zhou, Y; Yang, Q				Chen, Wei; Qu, Mingbo; Zhou, Yong; Yang, Qing			Structural analysis of group II chitinase (ChtII) catalysis completes the puzzle of chitin hydrolysis in insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYLOGENETIC ANALYSIS; GLYCOSIDE HYDROLASES; DOMAIN ORGANIZATION; FAMILY; IDENTIFICATION; PROTEINS; GENES; METABOLISM; MECHANISM; BACTERIAL	Chitin is a linear homopolymer of N-acetyl-beta-D-glucosamines and a major structural component of insect cuticles. Chitin hydrolysis involves glycoside hydrolase family 18 (GH18) chitinases. In insects, chitin hydrolysis is essential for periodic shedding of the old cuticle ecdysis and proceeds via a pathway different from that in the well studied bacterial chitinolytic system. Group II chitinase (ChtII) is a widespread chitinolytic enzyme in insects and contains the greatest number of catalytic domains and chitin-binding domains among chitinases. In Lepidopterans, ChtII and two other chitinases, ChtI and Chi-h, are essential for chitin hydrolysis. Although ChtI and Chi-h have been well studied, the role of ChtII remains elusive. Here, we investigated the structure and enzymology of OfChtII, a ChtII derived from the insect pest Ostrinia furnacalis. We present the crystal structures of two catalytically active domains of OfChtII, OfChtII-C1 and OfChtII-C2, both in unliganded form and complexed with chitooligosaccharide substrates. We found that OfChtII-C1 and OfChtII-C2 both possess long, deep substrate-binding clefts with endochitinase activities. OfChtII exhibited structural characteristics within the substrate-binding cleft similar to those in OfChi-h and OfChtI. However, OfChtII lacked structural elements favoring substrate binding beyond the active sites, including an extra wall structure present in OfChi-h. Nevertheless, the numerous domains in OfChtII may compensate for this difference; a truncation containing one catalytic domain and three chitin-binding modules (OfChtII-B4C1) displayed activity toward insoluble polymeric substrates that was higher than those of OfChi-h and OfChtI. Our observations provide the last piece of the puzzle of chitin hydrolysis in insects.	[Chen, Wei; Qu, Mingbo; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China; [Chen, Wei; Qu, Mingbo; Zhou, Yong; Yang, Qing] Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	qingyang@dlut.edu.cn	Qu, Mingbo/L-6231-2016; Yang, Qing/GZK-2526-2022; Qu, Mingbo/F-5037-2014	Qu, Mingbo/0000-0003-0397-1630; Yang, Qing/0000-0001-8623-7532; Qu, Mingbo/0000-0003-0397-1630	Program for National Natural Science Funds for Distinguished Young Scholars [31425021]; National Natural Science Foundation of China [31402015]; National Key Research and Development Project of China [2017YFD0200502, 2017YFD0201207]; Fundamental Research Funds for the Central Universities [DUT17RC(4)13]; China Postdoctoral Science Foundation [2017M611234]; Bayer Crop Science's initiative "Novel targets for crop protection" [612380044]	Program for National Natural Science Funds for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Bayer Crop Science's initiative "Novel targets for crop protection"	This work was supported by Program for National Natural Science Funds for Distinguished Young Scholars Grant 31425021, National Natural Science Foundation of China Grant 31402015, National Key Research and Development Project of China Grants 2017YFD0200502 and 2017YFD0201207, Fundamental Research Funds for the Central Universities Grant DUT17RC(4)13, China Postdoctoral Science Foundation Funded Project 2017M611234, and Bayer Crop Science's initiative "Novel targets for crop protection" (612380044). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrangi S, 2013, BIOTECHNOL ADV, V31, P1786, DOI 10.1016/j.biotechadv.2013.09.012; Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; He BC, 2013, ADV MATER, V25, P4580, DOI 10.1002/adma.201301201; Huang QS, 2012, GLYCOBIOLOGY, V22, P23, DOI 10.1093/glycob/cwr092; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liao ZH, 2016, B ENTOMOL RES, V106, P769, DOI 10.1017/S0007485316000511; Liu T, 2017, J BIOL CHEM, V292, P2080, DOI [10.1074/jbc.M116.755330, 10.1074/jbc.m116.755330]; Lu YM, 2002, INSECT BIOCHEM MOLEC, V32, P1369, DOI 10.1016/S0965-1748(02)00057-7; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moraes CD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00276; Nakabachi A, 2010, INSECT MOL BIOL, V19, P175, DOI 10.1111/j.1365-2583.2009.00985.x; Pan Y, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.15001; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Royer W, 2002, BIOCHEM J, V366, P921, DOI 10.1042/bj20011764; Stockinger LW, 2015, BBA-PROTEINS PROTEOM, V1854, P1494, DOI 10.1016/j.bbapap.2015.06.008; Su C, 2016, INSECT MOL BIOL, V25, P401, DOI 10.1111/imb.12227; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Wu QY, 2013, INSECT SCI, V20, P147, DOI 10.1111/j.1744-7917.2012.01512.x; Xi Y, 2015, INSECT MOL BIOL, V24, P29, DOI 10.1111/imb.12133; Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899; Zhu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-248; Zhu QS, 2008, INSECT BIOCHEM MOLEC, V38, P452, DOI 10.1016/j.ibmb.2007.06.010; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zhu QS, 2004, BIOINFORMATICS, V20, P161, DOI 10.1093/bioinformatics/bth020	41	34	42	2	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2652	2660		10.1074/jbc.RA117.000119	http://dx.doi.org/10.1074/jbc.RA117.000119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317504	Green Published, hybrid			2022-12-28	WOS:000426051900003
J	Senarath, K; Payton, JL; Kankanamge, D; Siripurapu, P; Tennakoon, M; Karunarathne, A				Senarath, Kanishka; Payton, John L.; Kankanamge, Dinesh; Siripurapu, Praneeth; Tennakoon, Mithila; Karunarathne, Ajith			G gamma identity dictates efficacy of G beta gamma signaling and macrophage migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHOSPHOLIPASE-C-BETA; G-PROTEIN-ACTIVITY; PLASMA-MEMBRANE; CELL-MIGRATION; COMPLEX TRANSLOCATION; RECEPTOR ACTIVATION; GOLGI-COMPLEX; CA2+ CHANNELS; SUBUNITS	G protein beta gamma subunit (G beta gamma) is a major signal transducer and controls processes ranging from cell migration to gene transcription. Despite having significant subtype heterogeneity and exhibiting diverse cell-and tissue-specific expression levels, G beta gamma is often considered a unified signaling entity with a defined functionality. However, the molecular and mechanistic basis of G beta gamma's signaling specificity is unknown. Here, we demonstrate that G gamma subunits, bearing the sole plasma membrane (PM)anchoring motif, control the PM affinity of G beta gamma and thereby differentially modulate G beta gamma effector signaling in a G gamma-specific manner. Both G beta gamma signaling activity and the migration rate of macrophages are strongly dependent on the PM affinity of G gamma. We also found that the type of C-terminal prenylation and five to six pre-CaaX motif residues at the PM-interacting region of G gamma control the PM affinity of G beta gamma. We further show that the overall PM affinity of the G beta gamma pool of a cell type is a strong predictor of its G beta gamma signaling-activation efficacy. A kinetic model encompassing multiple G gamma types and parameterized for empirical G beta gamma behaviors not only recapitulated experimentally observed signaling of G beta gamma, but also suggested a G gamma-dependent, active-inactive conformational switch for the PM-bound G beta gamma, regulating effector signaling. Overall, our results unveil crucial aspects of signaling and cell migration regulation by G gamma type-specific PM affinities of G beta gamma.	[Senarath, Kanishka; Payton, John L.; Kankanamge, Dinesh; Siripurapu, Praneeth; Tennakoon, Mithila; Karunarathne, Ajith] Univ Toledo, Dept Chem & Biochem, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Karunarathne, A (corresponding author), 2801 West Bancroft St, Toledo, OH 43606 USA.	karunarathne@utoledo.edu		Kankanamge, Dinesh/0000-0001-9647-0258; Senarath, Kanishka/0000-0003-3326-9738; Karunarathne, Ajith/0000-0003-3136-2015	University of Toledo	University of Toledo	This work was supported by start-up funding from the University of Toledo. The authors declare that they have no conflicts of interest with the contents of this article.	Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Braselmann S, 1997, CURR BIOL, V7, pR470, DOI 10.1016/S0960-9822(06)00239-9; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Cook LA, 2001, PROTEIN SCI, V10, P2548, DOI 10.1110/ps.ps.26401; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Faenza I, 2004, J CELL PHYSIOL, V200, P291, DOI 10.1002/jcp.20001; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Karunarathne WKA, 2012, BIOCHEM BIOPH RES CO, V421, P605, DOI 10.1016/j.bbrc.2012.04.054; Kawano T, 1999, FEBS LETT, V463, P355, DOI 10.1016/S0014-5793(99)01656-7; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Lim WK, 2001, BIOCHEMISTRY-US, V40, P10532, DOI 10.1021/bi010950c; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mahmoud S, 2016, NEUROSCI LETT, V627, P77, DOI 10.1016/j.neulet.2016.05.055; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Ratnayake K, 2017, METHOD CELL BIOL, V142, P1, DOI 10.1016/bs.mcb.2017.07.008; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Senarath K, 2016, ANAL CHEM, V88, P11450, DOI 10.1021/acs.analchem.6b02512; Siripurapu P, 2017, J BIOL CHEM, V292, P17482, DOI 10.1074/jbc.M117.787838; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wang DB, 2011, BIOCHEMISTRY-US, V50, P207, DOI 10.1021/bi101227y; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Xu Q, 2001, BIOCHEMISTRY-US, V40, P3232, DOI 10.1021/bi002326q	48	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2974	2989		10.1074/jbc.RA117.000872	http://dx.doi.org/10.1074/jbc.RA117.000872			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317505	Green Published, hybrid			2022-12-28	WOS:000426051900030
J	Sallmyr, A; Tomkinson, AE				Sallmyr, Annahita; Tomkinson, Alan E.			Repair of DNA double-strand breaks by mammalian alternative end-joining pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						genomic instability; DNA damage; DNA polymerase; DNA endonuclease; chromosomes; deletions; DNA ligation; microhomology; single-strand annealing; translocation; double-strand break; alternative end-joining pathway	CHROMOSOMAL TRANSLOCATION FORMATION; LIGASE-III-ALPHA; CLASS-SWITCH RECOMBINATION; MITOCHONDRIAL-DNA; HOMOLOGOUS-RECOMBINATION; POLYMERASE THETA; HUMAN-CELLS; GENE AMPLIFICATION; MRE11; NHEJ	Alternative end-joining (a-EJ) pathways, which repair DNA double-strand breaks (DSBs), are initiated by end resection that generates 3 single strands. This reaction is shared, at least in part, with homologous recombination but distinguishes a-EJ from the major nonhomologous end-joining pathway. Although the a-EJ pathways make only a minor and poorly understood contribution to DSB repair in nonmalignant cells, there is growing interest in these pathways, as they generate genomic rearrangements that are hallmarks of cancer cells. Here, we review and discuss the current understanding of the mechanisms and regulation of a-EJ pathways, the role of a-EJ in human disease, and the potential utility of a-EJ as a therapeutic target in cancer.	Univ New Mexico, Comprehens Canc Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; Univ New Mexico, Comprehens Canc Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Tomkinson, AE (corresponding author), Canc Res Facil, 915 Camino Salud,1 Univ New Mexico, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [CA118100]; NATIONAL CANCER INSTITUTE [P01CA092584, P30CA118100, P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047251, R01GM057479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all colleagues whose work has not been cited because of space limitations. The University of New Mexico Cancer Center (NCI-designated Comprehensive Cancer Center) was supported by National Institutes of Health Grant CA118100.	Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bakr A, 2016, ONCOTARGET, V7, P57679, DOI 10.18632/oncotarget.11023; Barton O, 2014, J CELL BIOL, V206, P877, DOI 10.1083/jcb.201401146; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Biehs R, 2017, MOL CELL, V65, P671, DOI 10.1016/j.molcel.2016.12.016; Boboila C, 2012, P NATL ACAD SCI USA, V109, P2473, DOI 10.1073/pnas.1121470109; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Dutta A, 2017, NUCLEIC ACIDS RES, V45, P2585, DOI 10.1093/nar/gkw1262; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; FAIRMAN MP, 1992, NUCLEIC ACIDS RES, V20, P4145, DOI 10.1093/nar/20.16.4145; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hammel M, 2016, J BIOL CHEM, V291, P26987, DOI 10.1074/jbc.M116.751867; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Ivanov EL, 1996, GENETICS, V142, P693; JEGGO PA, 1991, MUTAT RES, V254, P125, DOI 10.1016/0921-8777(91)90003-8; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Mason RM, 1996, NUCLEIC ACIDS RES, V24, P4946, DOI 10.1093/nar/24.24.4946; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Munoz MC, 2012, J BIOL CHEM, V287, P40618, DOI 10.1074/jbc.M112.410951; Muvarak N, 2015, MOL CANCER RES, V13, P699, DOI 10.1158/1541-7786.MCR-14-0422; Newman EA, 2015, MOL CANCER RES, V13, P470, DOI 10.1158/1541-7786.MCR-14-0337; Okano S, 2005, NUCLEIC ACIDS RES, V33, P422, DOI 10.1093/nar/gki190; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Pannunzio NR, 2017, MOL CELL, V68, P901, DOI 10.1016/j.molcel.2017.11.011; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sallmyr A, 2016, CANCER RES, V76, P5431, DOI 10.1158/0008-5472.CAN-15-3243; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; Seol JH, 2018, MUTAT RES-FUND MOL M, V809, P81, DOI 10.1016/j.mrfmmm.2017.07.002; Simsek D, 2011, CELL CYCLE, V10, P3636, DOI 10.4161/cc.10.21.18094; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Soni A, 2014, NUCLEIC ACIDS RES, V42, P6380, DOI 10.1093/nar/gku298; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; THOMPSON LH, 1995, MUTAT RES-DNA REPAIR, V337, P131, DOI 10.1016/0921-8777(95)00018-F; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Tomkinson AE, 2013, GENE, V531, P150, DOI 10.1016/j.gene.2013.08.061; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/NCHEMBIO.2102, 10.1038/nchembio.2102]; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xiong XH, 2015, NUCLEIC ACIDS RES, V43, P1659, DOI 10.1093/nar/gku1406; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	97	122	125	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10536	10546		10.1074/jbc.TM117.000375	http://dx.doi.org/10.1074/jbc.TM117.000375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29530982	Green Published, hybrid			2022-12-28	WOS:000437828400014
J	Sadana, P; Geyer, R; Pezoldt, J; Helmsing, S; Huehn, J; Hust, M; Dersch, P; Scrima, A				Sadana, Pooja; Geyer, Rebecca; Pezoldt, Joern; Helmsing, Saskia; Huehn, Jochen; Hust, Michael; Dersch, Petra; Scrima, Andrea			The invasin D protein from Yersinia pseudotuberculosis selectively binds the Fab region of host antibodies and affects colonization of the intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; protein chemistry; X-ray crystallography; phage display; small-angle X-ray scattering (SAXS); Fab-binding; invasin; InvD; Yersinia pseudotuberculosis	OUTER-MEMBRANE PROTEIN; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; MEDIATES BINDING; HIV-1 GP120; CELLS; IGA; RECEPTORS	Yersinia pseudotuberculosis is a Gram-negative bacterium and zoonotic pathogen responsible for a wide range of diseases, ranging from mild diarrhea, enterocolitis, lymphatic adenitis to persistent local inflammation. The Y. pseudotuberculosis invasin D (InvD) molecule belongs to the invasin (InvA)-type autotransporter proteins, but its structure and function remain unknown. In this study, we present the first crystal structure of InvD, analyzed its expression and function in a murine infection model, and identified its target molecule in the host. We found that InvD is induced at 37 degrees C and expressed in vivo 2-4 days after infection, indicating that InvD is a virulence factor. During infection, InvD was expressed in all parts of the intestinal tract, but not in deeper lymphoid tissues. The crystal structure of the C-terminal adhesion domain of InvD revealed a distinct Ig-related fold that, apart from the canonical -sheets, comprises various modifications of and insertions into the Ig-core structure. We identified the Fab fragment of host-derived IgG/IgA antibodies as the target of the adhesion domain. Phage display panning and flow cytometry data further revealed that InvD exhibits a preferential binding specificity toward antibodies with VH3/VK1 variable domains and that it is specifically recruited to a subset of B cells. This finding suggests that InvD modulates Ig functions in the intestine and affects direct interactions with a subset of cell surface-exposed B-cell receptors. In summary, our results provide extensive insights into the structure of InvD and its specific interaction with the target molecule in the host.	[Sadana, Pooja; Scrima, Andrea] Helmholtz Ctr Infect Res, Dept Struct & Funct Prot, Young Investigator Grp Struct Biol Autophagy, D-38124 Braunschweig, Germany; [Geyer, Rebecca; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany; [Pezoldt, Joern; Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, D-38124 Braunschweig, Germany; [Helmsing, Saskia; Hust, Michael] Tech Univ, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Scrima, A (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.	andrea.scrima@helmholtz-hzi.de		Hust, Michael/0000-0003-3418-6045	National Institutes of Health [GM62116, GM098791]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Petra Busing, Stefan Schmelz, Carina Schmuhl, Julius Rabl, and Maria Ebel for expert assistance and to the members of the contributing labs for useful discussions. We acknowledge the Consortium for Functional Glycomics for performing the glycan array screening (supported by National Institutes of Health Grants GM62116 and GM098791). We are grateful to the staff of beamlines P12 at PETRAIII EMBL Hamburg, Germany, and X06DA/PXIII Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland, for assistance with data collection and processing.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; AXCRONA K, 1995, SCAND J IMMUNOL, V42, P359, DOI 10.1111/j.1365-3083.1995.tb03668.x; Bao R, 2013, P NATL ACAD SCI USA, V110, P1065, DOI 10.1073/pnas.1212431110; Bartra SS, 2015, MICROBIOL-SGM, V161, P2174, DOI 10.1099/mic.0.000179; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Beckingham JA, 1999, BIOCHEM J, V340, P193, DOI 10.1042/0264-6021:3400193; BJORCK L, 1988, J IMMUNOL, V140, P1194; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chauhan N, 2016, PROTEOM CLIN APPL, V10, P949, DOI 10.1002/prca.201600012; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dube P, 2009, CURR TOP MICROBIOL, V337, P61, DOI 10.1007/978-3-642-01846-6_3; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Eitel J, 2005, CELL MICROBIOL, V7, P63, DOI 10.1111/j.1462-5822.2004.00434.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fan EG, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0009-2015; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Felek S, 2009, INFECT IMMUN, V77, P825, DOI 10.1128/IAI.00913-08; FLUGEL A, 1994, J BIOL CHEM, V269, P29732; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frenzel A, 2014, METHODS MOL BIOL, V1060, P215, DOI 10.1007/978-1-62703-586-6_12; Genovese A, 2000, INFECT IMMUN, V68, P5517, DOI 10.1128/IAI.68.10.5517-5524.2000; Goodyear CS, 2004, J IMMUNOL, V172, P2870, DOI 10.4049/jimmunol.172.5.2870; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; GUIGOU V, 1990, MOL IMMUNOL, V27, P935, DOI 10.1016/0161-5890(90)90161-R; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; ISBERG RR, 1988, INFECT IMMUN, V56, P2133, DOI 10.1128/IAI.56.8.2133-2138.1988; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Karray S, 1998, J IMMUNOL, V161, P6681; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozlowski LM, 1996, J IMMUNOL, V157, P1200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kugler J, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0125-0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leo JC, 2015, INT J MED MICROBIOL, V305, P276, DOI 10.1016/j.ijmm.2014.12.011; Leo JC, 2009, MOL IMMUNOL, V46, P1860, DOI 10.1016/j.molimm.2009.02.024; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Marone G., 2004, Clinical and Experimental Allergy Reviews, V4, P64, DOI 10.1111/j.1472-9725.2004.00036.x; Marone Gianni, 2007, Chem Immunol Allergy, V93, P195, DOI 10.1159/000100896; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer T, 2011, VET MICROBIOL, V147, P162, DOI 10.1016/j.vetmic.2010.06.023; Mikula KM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00169; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Patella V, 2000, J IMMUNOL, V164, P589, DOI 10.4049/jimmunol.164.2.589; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pisano F, 2012, INFECT IMMUN, V80, P1050, DOI 10.1128/IAI.05715-11; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Sadana P, 2017, PROTEIN SCI, V26, P1182, DOI 10.1002/pro.3171; Sandt CH, 2001, INFECT IMMUN, V69, P7293, DOI 10.1128/IAI.69.12.7293-7203.2001; SASANO M, 1993, J IMMUNOL, V151, P5822; SASSO EH, 1989, J IMMUNOL, V142, P2778; SCHULZEKOOPS H, 1993, INFECT IMMUN, V61, P2513, DOI 10.1128/IAI.61.6.2513-2519.1993; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Smith EJ, 2012, MOL MICROBIOL, V83, P789, DOI 10.1111/j.1365-2958.2011.07966.x; Smith EJ, 2011, INFECT IMMUN, V79, P3801, DOI 10.1128/IAI.05075-11; Strong PCR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-85; SULICA A, 1979, IMMUNOLOGY, V38, P173; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; TERTTI R, 1992, INFECT IMMUN, V60, P3021, DOI 10.1128/IAI.60.7.3021-3024.1992; Townsley-Fuchs J, 1997, Int Rev Immunol, V14, P325, DOI 10.3109/08830189709116523; Tsang TM, 2012, J BIOL CHEM, V287, P16759, DOI 10.1074/jbc.M112.358978; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wingren AG, 2002, J IMMUNOL, V168, P5582, DOI 10.4049/jimmunol.168.11.5582; Wu G, 2016, ONCOTARGET, V7, P79156, DOI 10.18632/oncotarget.13005; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang LH, 1998, MICROBIOL-UK, V144, P985, DOI 10.1099/00221287-144-4-985	94	13	13	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8672	8690		10.1074/jbc.RA117.001068	http://dx.doi.org/10.1074/jbc.RA117.001068			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29535184	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000434205700029
J	Goettge, MN; Cioni, JP; Ju, KS; Pallitsch, K; Metcalf, WW				Goettge, Michelle N.; Cioni, Joel P.; Ju, Kou-San; Pallitsch, Katharina; Metcalf, William W.			PcxL and HpxL are flavin-dependent, oxime-forming N-oxidases in phosphonocystoximic acid biosynthesis in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; flavin adenine dinucleotide (FAD); natural product biosynthesis; nicotinamide; oxidase; substrate specificity; oxime; phosphonates; phosphonic acid	NATURAL-PRODUCTS; GENE-CLUSTER; ANALOGS; CYTOCHROME-P450; IDENTIFICATION; MONOOXYGENASE; METABOLITES; NOCARDICIN; MECHANISM; INSIGHTS	Several oxime-containing small molecules have useful properties, including antimicrobial, insecticidal, anticancer, and immunosuppressive activities. Phosphonocystoximate and its hydroxylated congener, hydroxyphosphonocystoximate, are recently discovered oxime-containing natural products produced by Streptomyces sp. NRRL S-481 and Streptomyces regensis NRRL WC-3744, respectively. The biosynthetic pathways for these two compounds are proposed to diverge at an early step in which 2-aminoethylphosphonate (2AEPn) is converted to (S)-1-hydroxy-2-aminoethylphosphonate ((S)-1H2AEPn) in S. regensis but not in Streptomyces sp. NRRL S-481). Subsequent installation of the oxime moiety into either 2AEPn or (S)-1H2AEPn is predicted to be catalyzed by PcxL or HpxL from Streptomyces sp. NRRL S-481 and S. regensis NRRL WC-3744, respectively, whose sequence and predicted structural characteristics suggest they are unusual N-oxidases. Here, we show that recombinant PcxL and HpxL catalyze the FAD- and NADPH-dependent oxidation of 2AEPn and 1H2AEPn, producing a mixture of the respective aldoximes and nitrosylated phosphonic acid products. Measurements of catalytic efficiency indicated that PcxL has almost an equal preference for 2AEPn and (R)-1H2AEPn. 2AEPn was turned over at a 10-fold higher rate than (R)-1H2AEPn under saturating conditions, resulting in a similar but slightly lower k(cat)/K-m. We observed that (S)-1H2AEPn is a relatively poor substrate for PcxL but is clearly the preferred substrate for HpxL, consistent with the proposed biosynthetic pathway in S. regensis. HpxL also used both 2AEPn and (R)-1H2AEPn, with the latter inhibiting HpxL at high concentrations. Bioinformatic analysis indicated that PcxL and HpxL are members of a new class of oxime-forming N-oxidases that are broadly dispersed among bacteria.	[Goettge, Michelle N.; Cioni, Joel P.; Ju, Kou-San; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Goettge, Michelle N.; Cioni, Joel P.; Ju, Kou-San; Metcalf, William W.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Pallitsch, Katharina] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria; [Ju, Kou-San] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ju, Kou-San] Ohio State Univ, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Vienna; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Metcalf, WW (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.; Metcalf, WW (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	metcalf@illinois.edu	Pallitsch, Katharina/AAD-5247-2019	Pallitsch, Katharina/0000-0003-2648-1044; Ju, Kou-San/0000-0003-0438-6740	National Institutes of Health [S10-RR028833]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Petronikolou for constructing the HpxV expression vector. NMR spectroscopy data collected in this study was done at the Carl R. Woese Institute for Genomic Biology Core Facilities on a 600-MHz NMR funded by National Institutes of Health Grant S10-RR028833.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; ARABSHAHI L, 1987, J ORG CHEM, V52, P3584, DOI 10.1021/jo00392a016; Bacher M, 1999, PHYTOCHEMISTRY, V50, P991, DOI 10.1016/S0031-9422(98)00638-4; BENNETT R, 1993, PLANT PHYSIOL, V102, P1307, DOI 10.1104/pp.102.4.1307; Bennett RN, 1996, PLANT CELL ENVIRON, V19, P801, DOI 10.1111/j.1365-3040.1996.tb00417.x; CHEN CM, 1990, J BIOL CHEM, V265, P4461; Chen HP, 2016, CHEMISTRYOPEN, V5, P142, DOI 10.1002/open.201500198; Cioni JP, 2014, J NAT PROD, V77, P243, DOI 10.1021/np400722m; Cortina NS, 2011, CHEMBIOCHEM, V12, P1411, DOI 10.1002/cbic.201100154; Du LC, 1995, P NATL ACAD SCI USA, V92, P12505, DOI 10.1073/pnas.92.26.12505; Eyer Peter, 2003, Toxicological Reviews, V22, P165, DOI 10.2165/00139709-200322030-00004; Garcia I, 2013, CHEM BIOL, V20, P1022, DOI 10.1016/j.chembiol.2013.06.014; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hong S, 2015, EUR J MED CHEM, V96, P218, DOI 10.1016/j.ejmech.2015.04.001; Huang ZD, 2016, CHEM SCI, V7, P5219, DOI [10.1039/c6sc01389a, 10.1039/C6SC01389A]; Jang JH, 2007, J ORG CHEM, V72, P1211, DOI 10.1021/jo062010+; Ju KS, 2015, P NATL ACAD SCI USA, V112, P12175, DOI 10.1073/pnas.1500873112; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelly WL, 2005, J BACTERIOL, V187, P739, DOI 10.1128/JB.187.2.739-746.2005; Kelly WL, 2002, J AM CHEM SOC, V124, P8186, DOI 10.1021/ja025926g; Kim YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30726; Lin J, 1997, J PHARMACOL EXP THER, V282, P1269; Liu N, 2016, CHEM SCI, V7, P482, DOI 10.1039/c5sc03021h; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Moya P, 1997, J ORG CHEM, V62, P8544, DOI 10.1021/jo970397y; Pallitsch K, 2017, CHEM-EUR J, V23, P15655, DOI 10.1002/chem.201702904; Pretsch E., 2009, STRUCTURE DETERMINAT, P209; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugai Y, 2016, NAT CHEM BIOL, V12, P73, DOI [10.1038/NCHEMBIO.1991, 10.1038/nchembio.1991]; Tietz JI, 2017, NAT CHEM BIOL, V13, P470, DOI [10.1038/NCHEMBIO.2319, 10.1038/nchembio.2319]; van Staalduinen LM, 2014, P NATL ACAD SCI USA, V111, P5171, DOI 10.1073/pnas.1320039111; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wong L, 2000, BIOCHEMISTRY-US, V39, P5750, DOI 10.1021/bi992906r; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007; Yu XM, 2013, P NATL ACAD SCI USA, V110, P20759, DOI 10.1073/pnas.1315107110; Zhu YG, 2013, J AM CHEM SOC, V135, P18750, DOI 10.1021/ja410513g	40	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6859	6868		10.1074/jbc.RA118.001721	http://dx.doi.org/10.1074/jbc.RA118.001721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540479	hybrid, Green Published			2022-12-28	WOS:000431487300019
J	Helliwell, MV; Zhang, YH; El Harchi, A; Du, CY; Hancox, JC; Dempsey, CE				Helliwell, Matthew V.; Zhang, Yihong; El Harchi, Aziza; Du, Chunyun; Hancox, Jules C.; Dempsey, Christopher E.			Structural implications of hERG K+ channel block by a high-affinity minimally structured blocker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hERG; heart; drug action; molecular pharmacology; potassium channel; mutagenesis; molecular docking; alanine scan mutagenesis; long QT syndrome	LONG QT SYNDROME; 37 DEGREES-C; POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; DRUG-BINDING; INACTIVATED STATE; DOFETILIDE BLOCK; INHIBITION; MECHANISM; DOCKING	Cardiac potassium channels encoded by human ether-a-go-go-related gene (hERG) are major targets for structurally diverse drugs associated with acquired long QT syndrome. This study characterized hERG channel inhibition by a minimally structured high-affinity hERG inhibitor, Cavalli-2, composed of three phenyl groups linked by polymethylene spacers around a central amino group, chosen to probe the spatial arrangement of side chain groups in the high-affinity drug-binding site of the hERG pore. hERG current (I-hERG) recorded at physiological temperature from HEK293 cells was inhibited with an IC50 of 35.6 nm with time and voltage dependence characteristic of blockade contingent upon channel gating. Potency of Cavalli-2 action was markedly reduced for attenuated inactivation mutants located near (S620T; 54-fold) and remote from (N588K; 15-fold) the channel pore. The S6 Y652A and F656A mutations decreased inhibitory potency 17- and 75-fold, respectively, whereas T623A and S624A at the base of the selectivity filter also decreased potency (16- and 7-fold, respectively). The S5 helix F557L mutation decreased potency 10-fold, and both F557L and Y652A mutations eliminated voltage dependence of inhibition. Computational docking using the recent cryo-EM structure of an open channel hERG construct could only partially recapitulate experimental data, and the high dependence of Cavalli-2 block on Phe-656 is not readily explainable in that structure. A small clockwise rotation of the inner (S6) helix of the hERG pore from its configuration in the cryo-EM structure may be required to optimize Phe-656 side chain orientations compatible with high-affinity block.	[Helliwell, Matthew V.; Dempsey, Christopher E.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Helliwell, Matthew V.; Zhang, Yihong; El Harchi, Aziza; Du, Chunyun; Hancox, Jules C.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; Univ Bristol, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; University of Bristol	Dempsey, CE (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.; Hancox, JC (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Jules.Hancox@bristol.ac.uk; c.dempsey@bristol.ac.uk	Hancox, Jules C./Z-1550-2019	Dempsey, Christopher/0000-0002-1933-7805; EL HARCHI, Aziza/0000-0003-3329-6234	British Heart Foundation [FS/14/38/30868, PG/14/61/31015, PG/15/106/31915]; Heart Research UK [RG2640]; University of Bristol research fellowship	British Heart Foundation(British Heart Foundation); Heart Research UK; University of Bristol research fellowship	This work was supported by British Heart Foundation Grants FS/14/38/30868, PG/14/61/31015, and PG/15/106/31915. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Heart Research UK Grant RG2640.; Recipient of a University of Bristol research fellowship. To whom correspondence may be addressed: School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Bldg., University of Bristol, Bristol BS8 1TD, UK. Tel.: 44-117-3312292; E-mail: Jules.Hancox@bristol.ac.uk.	Alexandrou AJ, 2006, BRIT J PHARMACOL, V147, P905, DOI 10.1038/sj.bjp.0706678; Barchad-Avitzur O, 2016, BIOPHYS J, V111, P1396, DOI 10.1016/j.bpj.2016.08.035; Cavalli A, 2012, J MED CHEM, V55, P4010, DOI 10.1021/jm201194q; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Dempsey CE, 2014, J CHEM INF MODEL, V54, P601, DOI 10.1021/ci400707h; Du CY, 2011, J CARDIOVASC ELECTR, V22, P1163, DOI 10.1111/j.1540-8167.2011.02060.x; Du CY, 2010, J CARDIOVASC ELECTR, V21, P1160, DOI 10.1111/j.1540-8167.2010.01772.x; Du CY, 2014, J MOL CELL CARDIOL, V74, P220, DOI 10.1016/j.yjmcc.2014.05.013; El Harchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052451; El Harchi A, 2012, J MOL CELL CARDIOL, V52, P185, DOI 10.1016/j.yjmcc.2011.09.021; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gintant GA, 2006, TOXICOL PATHOL, V34, P81, DOI 10.1080/01926230500431376; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Herzberg IM, 1998, J PHYSIOL-LONDON, V511, P3, DOI 10.1111/j.1469-7793.1998.003bi.x; Imai YN, 2009, J MED CHEM, V52, P1630, DOI 10.1021/jm801236n; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kamiya K, 2001, MOL PHARMACOL, V60, P244, DOI 10.1124/mol.60.2.244; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; Katchman AN, 2006, J PHARMACOL EXP THER, V316, P1098, DOI 10.1124/jpet.105.093393; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 2014, BIOL PHARM BULL, V37, P1495, DOI 10.1248/bpb.b14-00244; Levi AJ, 1996, PFLUG ARCH EUR J PHY, V432, P930, DOI 10.1007/s004240050217; Macdonald LC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18448-x; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; Melgari D, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001813; Mergenthaler J, 2001, N-S ARCH PHARMACOL, V363, P472, DOI 10.1007/s002100000392; Milnes JT, 2003, BRIT J PHARMACOL, V139, P887, DOI 10.1038/sj.bjp.0705335; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mitcheson JS, 2003, CURR OPIN DRUG DISC, V6, P667; Myokai T, 2008, MOL PHARMACOL, V73, P1643, DOI 10.1124/mol.107.042085; Paul AA, 2002, BRIT J PHARMACOL, V136, P717, DOI 10.1038/sj.bjp.0704784; Paul AA, 2001, BIOCHEM BIOPH RES CO, V280, P1243, DOI 10.1006/bbrc.2001.4269; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Perry M, 2004, MOL PHARMACOL, V66, P240, DOI 10.1124/mol.104.000117; Perry M, 2010, J PHYSIOL-LONDON, V588, P3157, DOI 10.1113/jphysiol.2010.194670; Ridley JM, 2006, J MOL CELL CARDIOL, V40, P107, DOI 10.1016/j.yjmcc.2005.09.017; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Sanchez-Chapula JA, 2002, J BIOL CHEM, V277, P23587, DOI 10.1074/jbc.M200448200; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Saxena P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24182; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; Teschemacher AG, 1999, BRIT J PHARMACOL, V128, P479, DOI 10.1038/sj.bjp.0702800; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vaz RJ, 2018, BIOORG MED CHEM LETT, V28, P446, DOI 10.1016/j.bmcl.2017.12.020; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Weerapura M, 2002, PFLUG ARCH EUR J PHY, V443, P520, DOI 10.1007/s004240100720; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Witchel HJ, 2004, MOL PHARMACOL, V66, P1201, DOI 10.1124/mol.104.001743; Zhang YH, 2011, BBA-BIOMEMBRANES, V1808, P2477, DOI 10.1016/j.bbamem.2011.07.001; Zhang YH, 2010, J ELECTROCARDIOL, V43, P440, DOI 10.1016/j.jelectrocard.2010.04.007; Zhang YH, 2016, BIOCHEM PHARMACOL, V113, P24, DOI 10.1016/j.bcp.2016.05.013; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	61	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7040	7057		10.1074/jbc.RA117.000363	http://dx.doi.org/10.1074/jbc.RA117.000363			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29545312	Green Published, hybrid			2022-12-28	WOS:000431487300036
J	Lishko, VK; Yakubenko, VP; Ugarova, TP; Podolnikova, NP				Lishko, Valeryi K.; Yakubenko, Valentin P.; Ugarova, Tatiana P.; Podolnikova, Nataly P.			Leukocyte integrin Mac-1 (CD11b/CD18, (M2), CR3) acts as a functional receptor for platelet factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						platelet; integrin; chemokine; macrophage; phagocytosis; alarmins; Mac-1; PF4	PLATELET FACTOR-IV; ALPHA(M)BETA(2) MAC-1; GROWTH-FACTOR; INTERLEUKIN-8 RECEPTORS; HEPARIN-BINDING; CELL-MIGRATION; LIGAND; NEUTROPHILS; ADHESION; IDENTIFICATION	Platelet factor 4 (PF4) is one of the most abundant cationic proteins secreted from -granules of activated platelets. Based on its structure, PF4 was assigned to the CXC family of chemokines and has been shown to have numerous effects on myeloid leukocytes. However, the receptor for PF4 remains unknown. Here, we demonstrate that PF4 induces leukocyte responses through the integrin Mac-1 ((M2), CD11b/CD18). Human neutrophils, monocytes, U937 monocytic and HEK293 cells expressing Mac-1 strongly adhered to immobilized PF4 in a concentration-dependent manner. The cell adhesion was partially blocked by anti-Mac-1 mAb and inhibition was enhanced when anti-Mac-1 antibodies were combined with glycosaminoglycans, suggesting that cell-surface proteoglycans act cooperatively with Mac-1. PF4 also induced Mac-1-dependent migration of human neutrophils and murine WT, but not Mac-1-deficient macrophages. Coating of Escherichia coli bacteria or latex beads with PF4 enhanced their phagocytosis by macrophages by approximate to 4-fold, and this process was blocked by different Mac-1 antagonists. Furthermore, PF4 potentiated phagocytosis by WT, but not Mac-1-deficient macrophages. As determined by biolayer interferometry, PF4 directly bound the I-M-domain, the major ligand-binding region of Mac-1, and this interaction was governed by a K-d of 1.3 +/- 0.2 m. Using the PF4-derived peptide library, synthetic peptides duplicating the I-M-domain recognition sequences and recombinant mutant PF4 fragments, the binding sites for I-M-domain were identified in the PF4 segments Cys(12)-Ser(26) and Ala(57)-Ser(70). These results identify PF4 as a ligand for the integrin Mac-1 and suggest that many immune-modulating effects previously ascribed to PF4 are mediated through its interaction with Mac-1.	[Lishko, Valeryi K.; Ugarova, Tatiana P.; Podolnikova, Nataly P.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Yakubenko, Valentin P.] East Tennessee State Univ, Dept Biomed Sci, Johnson City, TN 37614 USA	Arizona State University; Arizona State University-Tempe; East Tennessee State University	Podolnikova, NP (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA.	Nataly.Podolnikova@asu.edu			National Institutes of Health [HL63199, DK102020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102020, R56DK102020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL63199 (to T. P. U.) and DK102020 (to V. P. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afshar-Kharghan V, 2006, CURR OPIN HEMATOL, V13, P34, DOI 10.1097/01.moh.0000190107.54790.de; BEBAWY ST, 1986, J LEUKOCYTE BIOL, V39, P423, DOI 10.1002/jlb.39.4.423; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Cai Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9277; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; El-Golli N, 2005, J BIOL CHEM, V280, P30329, DOI 10.1074/jbc.M503847200; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; Ghasemzadeh M, 2013, BLOOD, V121, P4555, DOI 10.1182/blood-2012-09-459636; Hagberg IA, 1998, THROMB HAEMOSTASIS, V80, P852; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; Johansson MW, 1997, J CELL SCI, V110, P1133; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Kramer A, 1998, METH MOL B, V87, P25; Krauel K, 2012, BLOOD, V120, P3345, DOI 10.1182/blood-2012-06-434985; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Lishko VK, 2010, J THROMB HAEMOST, V8, P799, DOI 10.1111/j.1538-7836.2010.03778.x; Lishko VK, 2016, RES REP BIOCHEM, V6, P39, DOI 10.2147/RRBC.S107070; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Lord MS, 2017, J BIOL CHEM, V292, P4054, DOI 10.1074/jbc.M116.760660; Ludwig A, 1997, BLOOD, V90, P4588; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; OSTERMAN DG, 1982, BIOCHEM BIOPH RES CO, V107, P130, DOI 10.1016/0006-291X(82)91679-5; PARK KS, 1990, BLOOD, V75, P1290; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Petersen F, 1996, J IMMUNOL, V156, P1954; PETERSEN F, 1994, J IMMUNOL, V152, P2467; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; Petersen F, 1998, J IMMUNOL, V161, P4347; Podolnikova NP, 2016, AM J PATHOL, V186, P2105, DOI 10.1016/j.ajpath.2016.04.001; Podolnikova NP, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0027-0; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; Rauova L, 2005, BLOOD, V105, P131, DOI 10.1182/blood-2004-04-1544; RUCINSKI B, 1979, BLOOD, V53, P47; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shen D, 2017, J BIOL CHEM, V292, P18848, DOI 10.1074/jbc.M116.773713; Soehnlein O, 2005, J IMMUNOL, V174, P6399, DOI 10.4049/jimmunol.174.10.6399; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; Xiao ZH, 2008, BLOOD, V112, P1091, DOI 10.1182/blood-2008-04-153288; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025	54	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6869	6882		10.1074/jbc.RA117.000515	http://dx.doi.org/10.1074/jbc.RA117.000515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540475	hybrid, Green Published			2022-12-28	WOS:000431487300020
J	Peoples, JNR; Maxmillian, T; Le, Q; Nadtochiy, SM; Brookes, PS; Porter, GA; Davidson, VL; Ebert, SN				Peoples, Jessica N. R.; Maxmillian, Timmi; Le, Quynh; Nadtochiy, Sergiy M.; Brookes, Paul S.; Porter, George A., Jr.; Davidson, Victor L.; Ebert, Steven N.			Metabolomics reveals critical adrenergic regulatory checkpoints in glycolysis and pentose-phosphate pathways in embryonic heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolomics; heart development; heart failure; glycolysis; pentose-phosphate pathway (PPP); ATP; dehydrogenase	ACTIVATED PROTEIN-KINASE; INDUCED OXIDATIVE STRESS; MOUSE FETAL-DEVELOPMENT; FATTY-ACID OXIDATION; ENERGY-METABOLISM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; RAT-HEART; MITOCHONDRIAL FISSION; TARGETED DISRUPTION; REDOX REGULATION	Cardiac energy demands during early embryonic periods are sufficiently met through glycolysis, but as development proceeds, the oxidative phosphorylation in mitochondria becomes increasingly vital. Adrenergic hormones are known to stimulate metabolism in adult mammals and are essential for embryonic development, but relatively little is known about their effects on metabolism in the embryonic heart. Here, we show that embryos lacking adrenergic stimulation have approximate to 10-fold less cardiac ATP compared with littermate controls. Despite this deficit in steady-state ATP, neither the rates of ATP formation nor degradation was affected in adrenergic hormone-deficient hearts, suggesting that ATP synthesis and hydrolysis mechanisms were fully operational. We thus hypothesized that adrenergic hormones stimulate metabolism of glucose to provide chemical substrates for oxidation in mitochondria. To test this hypothesis, we employed a metabolomics-based approach using LC/MS. Our results showed glucose 1-phosphate and glucose 6-phosphate concentrations were not significantly altered, but several downstream metabolites in both glycolytic and pentose-phosphate pathways were significantly lower compared with controls. Furthermore, we identified glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase as key enzymes in those respective metabolic pathways whose activity was significantly (p < 0.05) and substantially (80 and 40%, respectively) lower in adrenergic hormone-deficient hearts. Addition of pyruvate and to a lesser extent ribose led to significant recovery of steady-state ATP concentrations. These results demonstrate that without adrenergic stimulation, glucose metabolism in the embryonic heart is severely impaired in multiple pathways, ultimately leading to insufficient metabolic substrate availability for successful transition to aerobic respiration needed for survival.	[Peoples, Jessica N. R.; Maxmillian, Timmi; Le, Quynh; Brookes, Paul S.; Davidson, Victor L.; Ebert, Steven N.] Univ Cent Florida, Coll Med, Div Metab & Cardiovasc Sci, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Nadtochiy, Sergiy M.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14620 USA; [Porter, George A., Jr.] Univ Rochester, Med Ctr, Dept Pediat, Div Cardiol, Rochester, NY 14642 USA	State University System of Florida; University of Central Florida; University of Rochester; University of Rochester	Ebert, SN (corresponding author), Univ Cent Florida, Burnett Sch Biomed, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	steven.ebert@ucf.edu	Porter, George/E-7315-2013	Porter, George/0000-0003-0726-9988; Brookes, Paul/0000-0002-8639-8413	University of Central Florida College of Medicine; National Institutes of Health [R01-HL-071158]; American Heart Association Founder's Affiliate Grant [12GRNT12060233]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER	University of Central Florida College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Founder's Affiliate Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by University of Central Florida College of Medicine (to S. N. E.), National Institutes of Health Grant R01-HL-071158 (to P. S. B.), and American Heart Association Founder's Affiliate Grant 12GRNT12060233 (to G. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Wahab MH, 2003, PHARMACOL RES, V48, P461, DOI 10.1016/S1043-6618(03)00214-7; Arutyunova EI, 2003, BIOCHEM BIOPH RES CO, V307, P547, DOI 10.1016/S0006-291X(03)01222-1; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Baker C, 2012, BIOCHEM BIOPH RES CO, V423, P536, DOI 10.1016/j.bbrc.2012.05.163; Baker CN, 2015, AM J PHYSIOL-ENDOC M, V308, pE402, DOI 10.1152/ajpendo.00267.2014; Baker CN, 2013, OPEN ACCESS BIOTECHN, V2, P16, DOI DOI 10.13172/2052-0069-2-2-571; Barron JT, 1998, J MOL CELL CARDIOL, V30, P1571, DOI 10.1006/jmcc.1998.0722; Bartelds B, 2004, AM J PHYSIOL-HEART C, V286, pH2243, DOI 10.1152/ajpheart.00864.2003; Bartolommei G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058615; Beutner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113330; CARSTENSEN MH, 1983, PLACENTA, V4, P165, DOI 10.1016/S0143-4004(83)80029-0; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; CHAPMAN AG, 1973, J BIOL CHEM, V248, P8309; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; COX SJ, 1972, J EMBRYOL EXP MORPH, V28, P591; COX SJ, 1972, J EMBRYOL EXP MORPH, V28, P235; Dennery Phyllis A., 2007, Birth Defects Research, V81, P155, DOI 10.1002/bdrc.20098; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Ebert SN, 2008, ANN NY ACAD SCI, V1148, P317, DOI 10.1196/annals.1410.008; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Grant CM., 2008, J BIOL-LONDON, V7, P1, DOI DOI 10.1186/jbiol63; Hansen JM, 2001, FREE RADICAL BIO MED, V30, P1078, DOI 10.1016/S0891-5849(01)00502-0; Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hill MF, 1997, CIRCULATION, V96, P2414; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Cosen-Binker LI, 2006, WORLD J GASTROENTERO, V12, P1558; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jain M, 2003, CIRC RES, V93, pE9, DOI 10.1161/01.RES.0000083489.83704.76; JANERO DR, 1994, AM J PHYSIOL, V266, pC179, DOI 10.1152/ajpcell.1994.266.1.C179; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Land SC, 2005, ANTIOXID REDOX SIGN, V7, P92, DOI 10.1089/ars.2005.7.92; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nadtochiy SM, 2015, J MOL CELL CARDIOL, V88, P64, DOI 10.1016/j.yjmcc.2015.09.008; Nandhini A. T. A., 2005, SMJ Singapore Medical Journal, V46, P82; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Nicol CJ, 2000, FASEB J, V14, P111, DOI 10.1096/fasebj.14.1.111; Office of Laboratory Animal Welfare, 2017, VERT AN SECT; Osuala K, 2012, PHYSIOL GENOMICS, V44, P934, DOI 10.1152/physiolgenomics.00180.2011; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Porter GA, 2001, AM J PHYSIOL-REG I, V281, pR401, DOI 10.1152/ajpregu.2001.281.2.R401; Rahn JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059218; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Saravanan R, 2006, PHARMACOL REP, V58, P41; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmalhausen EV, 2003, BIOCHEM BIOPH RES CO, V308, P492, DOI 10.1016/S0006-291X(03)01421-9; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; SERGIENKO EA, 1992, FEBS LETT, V304, P21, DOI 10.1016/0014-5793(92)80580-A; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; WARSHAW JB, 1970, J CELL BIOL, V44, P354, DOI 10.1083/jcb.44.2.354; Xia JX, 2013, MOL BIOTECHNOL, V54, P350, DOI 10.1007/s12033-012-9570-3; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; ZIMMER HG, 1979, FEBS LETT, V106, P335, DOI 10.1016/0014-5793(79)80527-X; ZIMMER HG, 1990, CIRC RES, V67, P1525, DOI 10.1161/01.RES.67.6.1525; ZIMMER HG, 1992, CIRC RES, V71, P451, DOI 10.1161/01.RES.71.2.451	75	10	11	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6925	6941		10.1074/jbc.RA118.002566	http://dx.doi.org/10.1074/jbc.RA118.002566			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540484	Green Published, hybrid			2022-12-28	WOS:000431487300025
J	Shao, YJ; Wang, LR; Guo, NN; Wang, SF; Yang, L; Li, YJ; Wang, MS; Yin, SM; Han, HH; Zeng, L; Zhang, LD; Hui, LJ; Ding, QR; Zhang, JQ; Geng, HQ; Liu, MY; Li, DL				Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Han, Honghui; Zeng, Li; Zhang, Ludi; Hui, Lijian; Ding, Qiurong; Zhang, Jiqin; Geng, Hongquan; Liu, Mingyao; Li, Dali			Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; gene therapy; liver; fibrosis; genetic disease; Cas9 nickase; gene editing; genome editing; hereditary tyrosinemia	IN-VIVO; NTBC TREATMENT; MOUSE MODEL; MICE; VECTORS; REPAIR; PATHOPHYSIOLOGY; TYPE-1	Hereditary tyrosinemia type I (HTI) is a metabolic genetic disorder caused by mutation of fumarylacetoacetate hydrolase (FAH). Because of the accumulation of toxic metabolites, HTI causes severe liver cirrhosis, liver failure, and even hepatocellular carcinoma. HTI is an ideal model for gene therapy, and several strategies have been shown to ameliorate HTI symptoms in animal models. Although CRISPR/Cas9-mediated genome editing is able to correct the Fah mutation in mouse models, WT Cas9 induces numerous undesired mutations that have raised safety concerns for clinical applications. To develop a new method for gene correction with high fidelity, we generated a Fah mutant rat model to investigate whether Cas9 nickase (Cas9n)-mediated genome editing can efficiently correct the Fah. First, we confirmed that Cas9n rarely induces indels in both on-target and off-target sites in cell lines. Using WT Cas9 as a positive control, we delivered Cas9n and the repair donor template/single guide (sg)RNA through adenoviral vectors into HTI rats. Analyses of the initial genome editing efficiency indicated that only WT Cas9 but not Cas9n causes indels at the on-target site in the liver tissue. After receiving either Cas9n or WT Cas9-mediated gene correction therapy, HTI rats gained weight steadily and survived. Fah-expressing hepatocytes occupied over 95% of the liver tissue 9 months after the treatment. Moreover, CRISPR/Cas9-mediated gene therapy prevented the progression of liver cirrhosis, a phenotype that could not be recapitulated in the HTI mouse model. These results strongly suggest that Cas9n-mediated genome editing is a valuable and safe gene therapy strategy for this genetic disease.	[Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Zeng, Li; Zhang, Jiqin; Liu, Mingyao; Li, Dali] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Shao, Yanjiao; Wang, Liren; Guo, Nana; Wang, Shengfei; Yang, Lei; Li, Yajing; Wang, Mingsong; Yin, Shuming; Zeng, Li; Zhang, Jiqin; Liu, Mingyao; Li, Dali] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Han, Honghui; Zeng, Li] Bioray Labs Inc, Shanghai 200241, Peoples R China; [Zhang, Ludi; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Ding, Qiurong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Geng, Hongquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200092, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA	East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY; Li, DL (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Liu, MY; Li, DL (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Liu, MY (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX 77030 USA.	myliu@bio.ecnu.edu.cn; dlli@bio.ecnu.edu.cn	Wang, liren/GQQ-5391-2022	Shao, Yanjiao/0000-0001-7204-3534	National Natural Science Foundation of China [81670470, 81600149]; Shanghai Municipal Commission for Science and Technology [14140901600, 15JC1400201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	This work was supported by National Natural Science Foundation of China Grants 81670470 and 81600149 and Shanghai Municipal Commission for Science and Technology Grants 14140901600 and 15JC1400201. The authors declare that they have no conflicts of interest with the contents of this article.	Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crone J, 2003, ACTA PAEDIATR, V92, P625; de Laet C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-8; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Grompe M, 2001, SEMIN LIVER DIS, V21, P563, DOI 10.1055/s-2001-19035; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hickey RD, 2011, HEPATOLOGY, V54, P1351, DOI 10.1002/hep.24490; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Lusky M, 2005, HUM GENE THER, V16, P281, DOI 10.1089/hum.2005.16.281; Malik S, 2015, JIMD REP, V18, P13, DOI 10.1007/8904_2014_337; Masurel-Paulet A, 2008, J INHERIT METAB DIS, V31, P81, DOI 10.1007/s10545-008-0793-1; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Nygaard S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8166; Paulk NK, 2012, HUM GENE THER, V23, P658, DOI 10.1089/hum.2012.038; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Wang ZY, 2012, MOL THER, V20, P1902, DOI 10.1038/mt.2012.157; Wold WSM, 2013, CURR GENE THER, V13, P421; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31460	33	33	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6883	6892		10.1074/jbc.RA117.000347	http://dx.doi.org/10.1074/jbc.RA117.000347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29507093	Green Published, hybrid			2022-12-28	WOS:000431487300021
J	Wang, HC; Gu, CF; Rolfes, RJ; Jessen, HJ; Shears, SB				Wang, Huanchen; Gu, Chunfang; Rolfes, Ronda J.; Jessen, Henning J.; Shears, Stephen B.			Structural and biochemical characterization of Siw14: A protein-tyrosine phosphatase fold that metabolizes inositol pyrophosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol phosphate; crystal structure; enzyme mechanism; phosphatase; dual-specificity phosphoprotein phosphatase	DUAL-SPECIFICITY PHOSPHATASES; SACCHAROMYCES-CEREVISIAE; CONSERVED FAMILY; PENTAKISPHOSPHATE; COMPLEX; ENZYMES	Inositol pyrophosphates (PP-InsPs) are energetic intracellular signals that are ubiquitous in animals, plants, and fungi; structural and biochemical characterization of PP-InsP metabolic enzymes provides insight into their evolution, reaction mechanisms, and regulation. Here, we describe the 2.35--resolution structure of the catalytic core of Siw14, a 5-PP-InsP phosphatase from Saccharomyces cerevisiae and a member of the protein tyrosine-phosphatase (PTP) superfamily. Conclusions that we derive from structural data are supported by extensive site-directed mutagenesis and kinetic analyses, thereby attributing new functional significance to several key residues. We demonstrate the high activity and exquisite specificity of Siw14 for the 5-diphosphate group of PP-InsPs. The three structural elements that demarcate a 9.2--deep substrate-binding pocket each have spatial equivalents in PTPs, but we identify how these are specialized for Siw14 to bind and hydrolyze the intensely negatively charged PP-InsPs. (a) The catalytic P-loop with the CX5R(S/T) PTP motif contains additional, positively charged residues. (b) A loop between the 5 and 6 helices, corresponding to the Q-loop in PTPs, contains a lysine and an arginine that extend into the catalytic pocket due to displacement of the 5 helix orientation through intramolecular crowding caused by three bulky, hydrophobic residues. (c) The general-acid loop in PTPs is replaced in Siw14 with a flexible loop that does not use an aspartate or glutamate as a general acid. We propose that an acidic residue is not required for phosphoanhydride hydrolysis.	[Wang, Huanchen; Gu, Chunfang; Shears, Stephen B.] NIEHS, Inositol Signaling Grp, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Rolfes, Ronda J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Jessen, Henning J.] Albert Ludwigs Univ, Inst Organ Chem, D-20057 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Georgetown University; University of Freiburg	Wang, HC (corresponding author), NIEHS, Signal Transduct Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	huanchen.wang@nih.gov	Shears, Stephen B/C-6335-2019; Jessen, Henning/O-1157-2019	Shears, Stephen B/0000-0001-7309-8916; Jessen, Henning/0000-0002-1025-9484; Wang, Huanchen/0000-0003-2701-7155	Intramural Research Program of the NIH; Georgetown University Pilot Grant; National Institutes of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown University Pilot Grant; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIH, National Institutes of Environmental Health Sciences, and a Georgetown University Pilot Grant (to R. J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aceti DJ, 2008, PROTEINS, V73, P241, DOI 10.1002/prot.22041; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Chakraborty A, 2018, BIOL REV, V93, P1203, DOI 10.1111/brv.12392; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Grudzien-Nogalska E, 2016, RNA, V22, P773, DOI 10.1261/rna.055699.115; Gu CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168384; Gu CF, 2017, P NATL ACAD SCI USA, V114, P11968, DOI 10.1073/pnas.1702370114; Hobiger Kirstin, 2015, Front Pharmacol, V6, P20, DOI 10.3389/fphar.2015.00020; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Irvine RF, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150181; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187701; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Martins A, 2000, J BIOL CHEM, V275, P35070, DOI 10.1074/jbc.M005748200; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roma-Mateo C, 2007, J MOL BIOL, V374, P899, DOI 10.1016/j.jmb.2007.10.008; Roma-Mateo C, 2011, MOL GENET GENOMICS, V285, P341, DOI 10.1007/s00438-011-0611-6; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2016, BIOCHEM J, V473, P3765, DOI 10.1042/BCJ20160710C; Sankhala RS, 2014, BIOCHEMISTRY-US, V53, P862, DOI 10.1021/bi401240x; Shears SB, 2018, J CELL PHYSIOL, V233, P1897, DOI 10.1002/jcp.26017; Srouji JR, 2017, PROTEINS, V85, P775, DOI 10.1002/prot.25223; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Thota SG, 2015, J BIOSCIENCES, V40, P593, DOI 10.1007/s12038-015-9549-x; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Weaver JD, 2013, BIOSCIENCE REP, V33, P229, DOI 10.1042/BSR20120115; Wickner RB, 2017, P NATL ACAD SCI USA, V114, pE8402, DOI 10.1073/pnas.1714361114; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	46	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6905	6914		10.1074/jbc.RA117.001670	http://dx.doi.org/10.1074/jbc.RA117.001670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540476	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000431487300023
J	Akuffo, AA; Alontaga, AY; Metcalf, R; Beatty, MS; Becker, A; McDaniel, JM; Hesterberg, RS; Goodheart, WE; Gunawan, S; Ayaz, M; Yang, Y; Karim, MR; Orobello, ME; Daniel, K; Guida, W; Yoder, JA; Rajadhyaksha, AM; Schonbrunn, E; Lawrence, HR; Lawrence, NJ; Epling-Burnette, PK				Akuffo, Afua A.; Alontaga, Aileen Y.; Metcalf, Rainer; Beatty, Matthew S.; Becker, Andreas; McDaniel, Jessica M.; Hesterberg, Rebecca S.; Goodheart, William E.; Gunawan, Steven; Ayaz, Muhammad; Yang, Yan; Karim, Md Rezaul; Orobello, Morgan E.; Daniel, Kenyon; Guida, Wayne; Yoder, Jeffrey A.; Rajadhyaksha, Anjali M.; Schonbrunn, Ernst; Lawrence, Harshani R.; Lawrence, Nicholas J.; Epling-Burnette, Pearlie K.			Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; UBIQUITIN LIGASE; ANTITUMOR-ACTIVITY; MYELODYSPLASTIC SYNDROMES; THALIDOMIDE ANALOGS; DATA-BANK; T-CELLS; LENALIDOMIDE; TARGET; POMALIDOMIDE	Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereblon (CRBN) promotes proteosomal destruction by engaging the DDB1-CUL4A-Roc1-RBX1 E3 ubiquitin ligase in human cells but not in mouse cells, suggesting that sequence variations in CRBN may cause its inactivation. Therapeutically, CRBN engagers have the potential for broad applications in cancer and immune therapy by specifically reducing protein expression through targeted ubiquitin-mediated degradation. To examine the effects of defined sequence changes on CRBN's activity, we performed a comprehensive study using complementary theoretical, biophysical, and biological assays aimed at understanding CRBN's nonprimate sequence variations. With a series of recombinant thalidomide-binding domain (TBD) proteins, we show that CRBN sequence variants retain their drug-binding properties to both classical immunomodulatory drugs and dBET1, a chemical compound and targeting ligand designed to degrade bromodomain-containing4(BRD4) via a CRBN-dependent mechanism. We further show that dBET1 stimulates CRBN's E3 ubiquitin-conjugating function and degrades BRD4 in both mouse and humancells. This insight paves the way for studies of CRBN-dependent proteasome-targeting molecules in nonprimate models and provides a new understanding of CRBN's substrate-recruiting function.	[Akuffo, Afua A.; Alontaga, Aileen Y.; Beatty, Matthew S.; McDaniel, Jessica M.; Hesterberg, Rebecca S.; Goodheart, William E.; Orobello, Morgan E.; Epling-Burnette, Pearlie K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Becker, Andreas; Yang, Yan; Lawrence, Harshani R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Gunawan, Steven; Ayaz, Muhammad; Karim, Md Rezaul; Schonbrunn, Ernst; Lawrence, Nicholas J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Metcalf, Rainer; Daniel, Kenyon; Guida, Wayne] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Akuffo, Afua A.; Hesterberg, Rebecca S.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA; [Yoder, Jeffrey A.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27607 USA; [Rajadhyaksha, Anjali M.] Weill Cornell Med, Grad Program Neurosci, Brain & Mind Res Inst, Pediat Neurol,Pediat,Mol & Dev Neurosci Lab, New York, NY 10065 USA; [McDaniel, Jessica M.] Celgene Corp, 556 Morris Ave, Summit, NJ 07901 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of North Carolina; North Carolina State University; Cornell University; Bristol-Myers Squibb; Celgene Corporation	Epling-Burnette, PK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, SRB 23033, Tampa, FL 33612 USA.	Pearlie.Burnette@moffitt.org	Karim, Rezaul M./H-7930-2016	Karim, Rezaul M./0000-0002-0424-127X; Schonbrunn, Ernst/0000-0002-3589-3510; Hesterberg, Rebecca/0000-0003-0472-7517; Yoder, Jeffrey/0000-0002-6083-1311	NCI (National Institutes of Health)-designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [R50CA211447, P30CA076292] Funding Source: NIH RePORTER	NCI (National Institutes of Health)-designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	hCRBN-DDB1 protein complex and the antiCRBN antibody were generous gifts from Celgene Corp. (San Diego, CA). Multiple myeloma cell lines were provided by Drs. Kenneth Shain and Connor Lynch (Moffitt Cancer Center). Wealso thank John Cleveland, Ph.D. (Moffitt Cancer Center) for his expert opinion and assistance with manuscript preparation. The Chemical Biology Core Facility at the H. Lee Moffitt Cancer Center and Research Institute, is an NCI (National Institutes of Health)-designated Comprehensive Cancer Center (Grant P30-CA076292).	Arora M, 2016, THER ADV HEMATOL, V7, P209, DOI 10.1177/2040620716652861; Bargagna-Mohan P, 2005, BIOORG MED CHEM LETT, V15, P2724, DOI 10.1016/j.bmcl.2005.04.008; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chesi M, 2012, BLOOD, V120, P376, DOI 10.1182/blood-2012-02-412783; Diggle GE, 2001, INT J CLIN PRACT, V55, P627; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fang J, 2016, NAT MED, V22, P727, DOI 10.1038/nm.4127; Fionda C, 2015, ONCOTARGET, V6, P23609, DOI 10.18632/oncotarget.4603; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; FRATTA ID, 1965, TOXICOL APPL PHARM, V7, P268, DOI 10.1016/0041-008X(65)90095-5; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Gopalakrishnan R, 2016, ONCOGENE, V35, P1797, DOI 10.1038/onc.2015.245; Hagner PR, 2015, BLOOD, V126, P779, DOI 10.1182/blood-2015-02-628669; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lebraud H, 2016, ACS CENTRAL SCI, V2, P927, DOI 10.1021/acscentsci.6b00280; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Lindner S, 2016, J MOL MED, V94, P1327, DOI 10.1007/s00109-016-1450-z; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mailloux AW, 2012, J IMMUNOL, V189, P3198, DOI 10.4049/jimmunol.1200602; Martin MP, 2012, CHEMBIOCHEM, V13, P2128, DOI 10.1002/cbic.201200316; McDaniel JM, 2012, LEUKEMIA, V26, P1425, DOI 10.1038/leu.2011.359; Min Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.226; O'Brien S, 2014, J IMMUNOL, V192, P5118, DOI 10.4049/jimmunol.1301992; Otahal P, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1115940; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Robak T, 2016, SEMIN ONCOL, V43, P280, DOI 10.1053/j.seminoncol.2016.02.010; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Saenz DT, 2017, LEUKEMIA, V31, P1951, DOI 10.1038/leu.2016.393; Sakamoto KM, 2010, PEDIATR RES, V67, P505, DOI 10.1203/PDR.0b013e3181d35017; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneekloth JS, 2004, J AM CHEM SOC, V126, P3748, DOI 10.1021/ja039025z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sun YP, 2015, BLOOD, V125, P2724, DOI 10.1182/blood-2014-08-598037; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang X, 2016, BIOCHEM PHARMACOL, V116, P200, DOI 10.1016/j.bcp.2016.07.017; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhou B, 2018, J MED CHEM, V61, P462, DOI 10.1021/acs.jmedchem.6b01816	55	23	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6187	6200		10.1074/jbc.M117.816868	http://dx.doi.org/10.1074/jbc.M117.816868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29449372	Green Published, hybrid			2022-12-28	WOS:000430497300034
J	Wang, YC; Chuang, YH; Shao, Q; Chen, JF; Chen, SY				Wang, Yung-Chun; Chuang, Ya-Hui; Shao, Qiang; Chen, Jian-Fu; Chen, Shi-You			Brain cytoplasmic RNA 1 suppresses smooth muscle differentiation and vascular development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; DENDRITIC BC1 RNA; GROWTH-FACTOR; BC200 RNA; CELL DIFFERENTIATION; TGF-BETA; TRANSLATIONAL CONTROL; GENE; SMAD; PROTEINS	The cardiovascular system develops during the early stages of embryogenesis, and differentiation of smooth muscle cells (SMCs) is essential for that process. SMC differentiation is critically regulated by transforming growth factor (TGF)-beta/SMAD family member 3 (SMAD3) signaling, but other regulators may also play a role. For example, long noncoding RNAs (lncRNAs) regulate various cellular activities and events, such as proliferation, differentiation, and apoptosis. However, whether long noncoding RNAs also regulate SMC differentiation remains largely unknown. Here, using the murine cell line C3H10T1/2, we found that brain cytoplasmic RNA 1 (BC1) is an important regulator of SMC differentiation. BC1 overexpression suppressed, whereas BC1 knockdown promoted, TGF-beta-induced SMC differentiation, as indicated by altered cell morphology and expression of multiple SMC markers, including smooth muscle alpha-actin (alpha SMA), calponin, and smooth muscle 22 alpha (SM22 alpha). BC1 appeared to block SMAD3 activity and inhibit SMC marker gene transcription. Mechanistically, BC1 bound to SMAD3 via RNA SMAD-binding elements (rSBEs) and thus impeded TGF-beta-induced SMAD3 translocation to the nucleus. This prevented SMAD3 from binding to SBEs in SMC marker gene promoters, an essential event in SMC marker transcription. In vivo, BC1 overexpression in mouse embryos impaired vascular SMC differentiation, leading to structural defects in the artery wall, such as random breaks in the elastic lamina, abnormal collagen deposition on SM fibers, and disorganized extracellular matrix proteins in the media of the neonatal aorta. Our results suggest that BC1 is a suppressor of SMC differentiation during vascular development.	[Wang, Yung-Chun; Chuang, Ya-Hui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan 442000, Hubei, Peoples R China; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan 442000, Hubei, Peoples R China; [Shao, Qiang; Chen, Jian-Fu] Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA	University System of Georgia; University of Georgia; Hubei University of Medicine; Hubei University of Medicine; University of Southern California	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264; Wang, Yung-Chun/0000-0002-8775-3472	NHLBI, National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119053, R01HL123302, R01HL135854] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL119053, HL123302, and HL135854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Brouillard P, 2003, CLIN GENET, V63, P340, DOI 10.1034/j.1399-0004.2003.00092.x; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gitai DLG, 2011, BRAIN RES, V1367, P114, DOI 10.1016/j.brainres.2010.10.069; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jakob P, 2012, CARDIOVASC RES, V93, P614, DOI 10.1093/cvr/cvr311; Jiao J, 2016, EBIOMEDICINE, V10, P282, DOI 10.1016/j.ebiom.2016.06.045; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; MARTIGNETTI JA, 1995, MOL CELL BIOL, V15, P1642; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Mitchell M, 2000, GENE THER, V7, P1986, DOI 10.1038/sj.gt.3301332; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Sosinska P, 2015, MUTAT RES-REV MUTAT, V766, P58, DOI 10.1016/j.mrrev.2015.08.002; Souchelnytskyi S, 2000, METH MOL B, V124, P107; Tang R, 2017, J BIOL CHEM, V292, P14270, DOI 10.1074/jbc.M117.790030; Taniue K, 2016, P NATL ACAD SCI USA, V113, P1273, DOI 10.1073/pnas.1500992113; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang Q, 2012, IERI PROC, V3, P2, DOI 10.1016/j.ieri.2012.09.002; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao JJ, 2016, ARTERIOSCL THROM VAS, V36, P2088, DOI 10.1161/ATVBAHA.116.307879	52	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5668	5678		10.1074/jbc.RA117.001578	http://dx.doi.org/10.1074/jbc.RA117.001578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29467228	hybrid, Green Published			2022-12-28	WOS:000430044100027
J	Kaul, S; Mittal, SK; Roche, PA				Kaul, Sunil; Mittal, Sharad K.; Roche, Paul A.			A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; COMPLEXES; EXPRESSION; TRANSPORT; SELECTION; TURNOVER; SURFACE	Regulation of major histocompatibility complex class II (MHC-II) expression is important not only to maintain a diverse pool of MHC-II-peptide complexes but also to prevent development of autoimmunity. The membrane-associated RING-CH (March) E3 ubiquitin ligase March-I regulates ubiquitination and turnover of MHC-II-peptide complexes in resting dendritic cells (DCs) and B cells. However, activation of either cell type terminates March-I expression, thereby stabilizing MHC-II-peptide complexes. Despite March-I's important role in the biology of antigen-presenting cells (APCs), how expression of March-I mRNA is regulated remains unknown. We now show that both DCs and B cells possess a distinct isoform of March-I whose expression is regulated by a promoter located within the March-I gene. Using March-I promoter fragments to drive expression of GFP, we also identified a core promoter for expression of March-I in DCs and B cells, but not in fibroblasts, kidney cells, or epithelial cells, that contains regulatory regions that down-regulate March-I expression upon activation of DCs. Curiously, we found downstream sequence elements, present in the first coding exon of March-I in APCs, that confer regulation of March-I expression in activated APCs. In summary, our study identifies regulatory regions of the March-I gene that confer APC-specific expression and activation-induced modulation of March-I expression in DCs and B cells.	[Kaul, Sunil; Mittal, Sharad K.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mittal, Sharad K.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Roche, PA (corresponding author), NIH, Bldg 10,Rm 3N103, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011033, ZIABC009404] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health.	AIVASASHVILLI VA, 1983, FEBS LETT, V160, P124, DOI 10.1016/0014-5793(83)80950-8; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cho KJ, 2015, P NATL ACAD SCI USA, V112, P10449, DOI 10.1073/pnas.1507981112; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Lutzko C, 2003, J VIROL, V77, P7341, DOI 10.1128/JVI.77.13.7341-7351.2003; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Mittal SK, 2015, J BIOL CHEM, V290, P27158, DOI 10.1074/jbc.M115.682708; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729	30	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4478	4485		10.1074/jbc.RA118.001775	http://dx.doi.org/10.1074/jbc.RA118.001775			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378848	hybrid, Green Published			2022-12-28	WOS:000428204300019
J	Yan, MS; Turgeon, PJ; Man, HSJ; Dubinsky, MK; Ho, JJD; El-Rass, S; Wang, YD; Wen, XY; Marsden, PA				Yan, Matthew S.; Turgeon, Paul J.; Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; Ho, J. J. David; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.			Histone acetyltransferase 7 (KAT7)-dependent intragenic histone acetylation regulates endothelial cell gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EMBRYONIC STEM-CELLS; GROWTH-FACTOR; HBO1 ACETYLTRANSFERASE; DNA-REPLICATION; CODING REGIONS; ANGIOGENIC FACTOR; ZEBRAFISH EMBRYO; METHYLATION; CHROMATIN	Although the functional role of chromatin marks at promoters in mediating cell-restricted gene expression has been well characterized, the role of intragenic chromatin marks is not well understood, especially in endothelial cell (EC) gene expression. Here, we characterized the histone H3 and H4 acetylation profiles of 19 genes with EC-enriched expression via locus-wide chromatin immunoprecipitation followed by ultra-high-resolution (5 bp) tiling array analysis in ECs versus non-ECs throughout their genomic loci. Importantly, these genes exhibit differential EC enrichment of H3 and H4 acetylation in their promoter in ECs versus non-ECs. Interestingly, VEGFR-2 and VEGFR-1 show EC-enriched acetylation across broad intragenic regions and are up-regulated in non-ECs by histone deacetylase inhibition. It is unclear which histone acetyltransferases (KATs) are key to EC physiology. Depletion of KAT7 reduced VEGFR-2 expression and disrupted angiogenic potential. Microarray analysis of KAT7-depleted ECs identified 263 differentially regulated genes, many of which are key for growth and angiogenic potential. KAT7 inhibition in zebrafish embryos disrupted vessel formation and caused loss of circulatory integrity, especially hemorrhage, all of which were rescued with human KAT7. Notably, perturbed EC-enriched gene expression, especially the VEGFR-2 homologs, contributed to these vascular defects. Mechanistically, KAT7participates in VEGFR-2 transcription by mediating RNA polymerase II binding, H3 lysine 14, and H4 acetylation in its intragenic region. Collectively, our findings support the importance of differential histone acetylation at both promoter and intragenic regions of EC genes and reveal a previously underappreciated role of KAT7 and intragenic histone acetylation in regulating VEGFR-2 and endothelial function.	[Yan, Matthew S.; Marsden, Philip A.] Univ Toronto, Dept Med Biophys, Toronto, ON M5B 1T8, Canada; [Turgeon, Paul J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5B 1T8, Canada; [Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.] Univ Toronto, Inst Med Sci, Toronto, ON M5B 1T8, Canada; [Yan, Matthew S.; Turgeon, Paul J.; Man, Hon-Sum Jeffrey; Dubinsky, Michelle K.; El-Rass, Suzan; Wang, You-Dong; Wen, Xiao-Yan; Marsden, Philip A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1T8, Canada; [Marsden, Philip A.] Univ Toronto, Dept Med, Toronto, ON M5B 1T8, Canada; [Ho, J. J. David] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Ho, J. J. David] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Miami; University of Miami	Marsden, PA (corresponding author), St Michaels Hosp, 209 Victoria St, Toronto, ON M5B 1T8, Canada.	p.marsden@utoronto.ca		Wen, Xiao-Yan/0000-0001-6728-0025; , Jeffrey/0000-0001-6628-0007	Canadian Institutes of Health Research [MOP-142307]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-142307 from Canadian Institutes of Health Research (to P.A.M.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Carpentier G., 2012, IMAGEJ NEWS; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Contzler R, 2006, BIOCHEM BIOPH RES CO, V350, P208, DOI 10.1016/j.bbrc.2006.09.030; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng YP, 2016, EMBO J, V35, P176, DOI 10.15252/embj.201591293; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Gunderson FQ, 2011, P NATL ACAD SCI USA, V108, P2004, DOI 10.1073/pnas.1011982108; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li RF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0209-0; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Mun GI, 2011, J BIOL CHEM, V286, P2536, DOI 10.1074/jbc.M110.180489; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Newman DM, 2017, J LEUKOCYTE BIOL, V101, P887, DOI 10.1189/jlb.1MA0816-338R; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Pober JS, 2001, ANN NY ACAD SCI, V941, P12; Rush JWE, 2008, APPL PHYSIOL NUTR ME, V33, P162, DOI 10.1139/H07-147; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shirodkar AV, 2013, BLOOD, V121, P3531, DOI 10.1182/blood-2013-01-479170; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thisse B, 2004, ZFIN DIRECT DATA SUB; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yan KZ, 2016, J BIOL CHEM, V291, P2647, DOI 10.1074/jbc.M115.703041; Yan MS, 2015, ARTERIOSCL THROM VAS, V35, P2297, DOI 10.1161/ATVBAHA.115.305043; Zhuge X, 2005, BIOCHEM BIOPH RES CO, V331, P1295, DOI 10.1016/j.bbrc.2005.03.200	63	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4381	4402		10.1074/jbc.RA117.001383	http://dx.doi.org/10.1074/jbc.RA117.001383			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414790	Green Published, hybrid			2022-12-28	WOS:000428204300011
J	Haywood, EE; Ho, MF; Wilson, BA				Haywood, Elizabeth E.; Ho, Mengfei; Wilson, Brenda A.			Modular domain swapping among the bacterial cytotoxic necrotizing factor (CNF) family for efficient cargo delivery into mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-MULTOCIDA TOXIN; CD8(+) T-CELLS; MULTIPLE SEQUENCE ALIGNMENT; YERSINIA-PSEUDOTUBERCULOSIS; BOTULINUM NEUROTOXINS; RHO-FAMILY; ACTIVATION; TRANSLOCATION; RECEPTOR; BINDING	Modular AB-type bacterial protein toxins target mammalian host cells with high specificity and deliver their toxic cargo into the cytosol. Hence, these toxins are being explored as agents for targeted cytosolic delivery in biomedical and research applications. The cytotoxic necrotizing factor (CNF) family is unique among these toxins in that their homologous sequences are found in a wide array of bacteria, and their activity domains are packaged in various delivery systems. Here, to study how CNF cargo and delivery modules can be assembled for efficient cytosolic delivery, we generated chimeric toxins by swapping functional domains among CNF1, CNF2, CNF3, and CNFy. Chimeras with a CNFy delivery vehicle were more stably expressed, but were less efficient at cargo delivery into HEK293-T cells. We also found that CNFy cargo is the most universally compatible and that CNF3 delivery vehicle is the most flexible and efficient at delivering cargo. These findings suggest that domains within proteins can be swapped and accommodate each other for efficient function and that an individual domain could be engineered for compatibility with multiple partner domains. We anticipate that our insights could help inform chemical biology approaches to develop toxin-based cargo-delivery platforms for cytosolic cargo delivery of therapeutics or molecular probes into mammalian cells.	[Haywood, Elizabeth E.; Ho, Mengfei; Wilson, Brenda A.] Univ Illinois, Sch Mol & Cellular Biol, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Wilson, BA (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	bawilson@life.illinois.edu	Ho, Mengfei/Q-6844-2019	Ho, Mengfei/0000-0002-8315-8158	NIAID, National Institutes of Health [AI038395]; Office of the Vice Chancellor for Research, University of Illinois at Urbana-Champaign OVCR [14055]; NIAID, National Institutes of Health Chemistry-Biology Interface Training Grant [T32 GM070421]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101504, R01AI038396, R33AI101504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Vice Chancellor for Research, University of Illinois at Urbana-Champaign OVCR; NIAID, National Institutes of Health Chemistry-Biology Interface Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health Grant AI038395 (to B. A. W.), Office of the Vice Chancellor for Research, University of Illinois at Urbana-Champaign OVCR Grant 14055 (to B. A. W.), and NIAID, National Institutes of Health Chemistry-Biology Interface Training Grant T32 GM070421 (to E. E. H). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Illinois.	Alewine C, 2015, ONCOLOGIST, V20, P176, DOI 10.1634/theoncologist.2014-0358; Aminova LR, 2008, PROTEIN SCI, V17, P945, DOI 10.1110/ps.083445408; Augspach A, 2013, TOXINS, V5, P2241, DOI 10.3390/toxins5112241; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Beilhartz GL, 2017, BIOCHEM PHARMACOL, V142, P13, DOI 10.1016/j.bcp.2017.04.009; Bergmann S, 2013, INFECT IMMUN, V81, P2459, DOI 10.1128/IAI.00429-13; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Chen S, 2012, TOXINS, V4, P913, DOI 10.3390/toxins4100913; Chung JW, 2003, J BIOL CHEM, V278, P16857, DOI 10.1074/jbc.M301028200; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabbri A, 1999, MOL MICROBIOL, V33, P108, DOI 10.1046/j.1365-2958.1999.01453.x; Fabbri A, 2010, TOXINS, V2, P283, DOI [10.3390/toxins2020283, 10.3390/toxins2020282]; Fayolle C, 2001, J VIROL, V75, P7330, DOI 10.1128/JVI.75.16.7330-7338.2001; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Hoffmann C, 2007, J BIOL CHEM, V282, P10826, DOI 10.1074/jbc.M610451200; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Lemichez E, 1997, MOL MICROBIOL, V24, P1061, DOI 10.1046/j.1365-2958.1997.4151781.x; Masuyer G, 2014, ANNU REV PHARMACOL, V54, P27, DOI 10.1146/annurev-pharmtox-011613-135935; McNichol BA, 2007, INFECT IMMUN, V75, P5095, DOI 10.1128/IAI.00075-07; Munsell EV, 2016, CURR PHARM DESIGN, V22, P1227, DOI 10.2174/1381612822666151216151420; Paillard A, 2010, BIOMATERIALS, V31, P7542, DOI 10.1016/j.biomaterials.2010.06.024; Pei S, 2001, MOL MICROBIOL, V41, P1237, DOI 10.1046/j.1365-2958.2001.02596.x; Piteau M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003884; Rabideau AE, 2016, ACS CHEM BIOL, V11, P1490, DOI 10.1021/acschembio.6b00169; Repella TL, 2013, TOXINS, V5, P1167, DOI 10.3390/toxins5061167; Repella TL, 2011, TOXINS, V3, P218, DOI 10.3390/toxins3030218; Schmidt G, 1998, J BIOL CHEM, V273, P13669, DOI 10.1074/jbc.273.22.13669; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Shaw CA, 2006, INFECT IMMUN, V74, P1001, DOI 10.1128/IAI.74.2.1001-1008.2006; Shaw CA, 2008, INFECT IMMUN, V76, P2603, DOI 10.1128/IAI.01718-07; Shaw CA, 2008, INFECT IMMUN, V76, P1214, DOI 10.1128/IAI.01208-07; Stoll T, 2009, TOXICON, V54, P745, DOI 10.1016/j.toxicon.2009.05.038; Sugai M, 1999, INFECT IMMUN, V67, P6550; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wilson BA, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P3, DOI 10.1016/B978-0-12-800188-2.00001-X; Wilson BA, 2014, CURR TOP MED CHEM, V14, P2081, DOI 10.2174/1568026614666141022094517	41	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3860	3870		10.1074/jbc.RA117.001381	http://dx.doi.org/10.1074/jbc.RA117.001381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29371399	Green Published, hybrid			2022-12-28	WOS:000427030200037
J	Zhang, CX; Hoang, N; Leng, F; Saxena, L; Lee, L; Alejo, S; Qi, DD; Khal, A; Sun, H; Lu, F; Zhang, H				Zhang, Chunxiao; Hoang, Nam; Leng, Feng; Saxena, Lovely; Lee, Logan; Alejo, Salvador; Qi, Dandan; Khal, Anthony; Sun, Hong; Lu, Fei; Zhang, Hui			LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20-LIKE 1 PHF20L1; LYSINE METHYLATION; CANCER-CELLS; PHOSPHORYLATION SWITCH; REGULATES PLURIPOTENCY; HISTONE METHYLATION; GENOMIC ANALYSIS; DNMT1 STABILITY; DIFFERENTIATION; EXPRESSION	The pluripotency-controlling stem-cell protein SRY-box 2 (SOX2) plays a pivotal role in maintaining the self-renewal and pluripotency of embryonic stem cells and also of teratocarcinoma or embryonic carcinoma cells. SOX2 is monomethylated at lysine 119 (Lys-119) in mouse embryonic stem cells by the SET7 methyltransferase, and this methylation triggers ubiquit-independent SOX2 proteolysis. However, the molecular regulators and mechanisms controlling SET7-induced SOX2 proteolysis are unknown. Here, we report that in human ovarian teratocarcinoma PA-1 cells, methylation-dependent SOX2 proteolysis is dynamically regulated by the LSD1 lysine demethylase and a methyl-binding protein, PHD finger protein 20-like 1 (PHF20L1). We found that LSD1 not only removes the methyl group from monomethylated Lys-117 (equivalent to Lys-119 in mouse SOX2), but it also demethylates monomethylated Lys-42 in SOX2, a reaction that SET7 also regulated and that also triggered SOX2 proteolysis. Our studies further revealed that PHF20L1 binds both monomethylated Lys-42 and Lys-117 in SOX2 and thereby prevents SOX2 proteolysis. Down-regulation of either LSD1 or PHF20L1 promoted SOX2 proteolysis, which was prevented by SET7 inactivation in both PA-1 and mouse embryonic stem cells. Our studies also disclosed that LSD1 and PHF20L1 normally regulate the growth of pluripotent mouse embryonic stem cells and PA-1 cells by preventing methylation-dependent SOX2 proteolysis. In conclusion, our findings reveal an important mechanism by which the stability of the pluripotency-controlling stem-cell protein SOX2 is dynamically regulated by the activities of SET7, LSD1, and PHF20L1 in pluripotent stem cells.	[Zhang, Chunxiao; Hoang, Nam; Leng, Feng; Saxena, Lovely; Lee, Logan; Alejo, Salvador; Qi, Dandan; Khal, Anthony; Sun, Hong; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA; [Zhang, Chunxiao; Leng, Feng; Qi, Dandan; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Peking University; University Town of Shenzhen	Zhang, H (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA.	hui.zhang@unlv.edu	zhang, chunxiao/AAH-3229-2019; Leng, Feng/AAP-7294-2020	Zhang, Chunxiao/0000-0001-5543-4509; Alejo, Salvador/0000-0002-1390-9892	National Institutes of Health [R15GM116087, R15NS096694]; Cancer Research Gift Fund; Natural Science Foundation of Guangdong Province [2014A030313779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS096694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R15GM116087 (to H. Z.) and R15NS096694 (to H. S.), by grants from the Cancer Research Gift Fund to the College of Sciences at University of Nevada, Las Vegas (to H. Z. and H. S.), and Natural Science Foundation of Guangdong Province Grant 2014A030313779 (to L. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Driessens G, 2011, CELL STEM CELL, V9, P283, DOI 10.1016/j.stem.2011.09.007; Esteve PO, 2014, J BIOL CHEM, V289, P8277, DOI 10.1074/jbc.M113.525279; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fay David S, 2013, WormBook, P1, DOI 10.1895/wormbook.1.159.1; Fu L, 2016, ELIFE, V5, DOI 10.7554/eLife.15690; Gao C, 1999, INT J MOL MED, V4, P291; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Jiang YY, 2016, MOL ONCOL, V10, P292, DOI 10.1016/j.molonc.2015.10.013; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu F, 2016, BIOL OPEN, V5, P1449, DOI 10.1242/bio.019729; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sholl L. M., APPL IMMUNOHISTOCHEM, V18, P55; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tsukamoto T, 2005, HISTOPATHOLOGY, V46, P649, DOI 10.1111/j.1365-2559.2005.02170.x; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wang J, 2011, CANCER RES, V71, P7238, DOI 10.1158/0008-5472.CAN-11-0896; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	47	15	18	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3663	3674		10.1074/jbc.RA117.000342	http://dx.doi.org/10.1074/jbc.RA117.000342			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358331	Green Published, hybrid			2022-12-28	WOS:000427030200020
J	Beqollari, D; Dockstader, K; Bannister, RA				Beqollari, Donald; Dockstader, Karen; Bannister, Roger A.			A skeletal muscle L-type Ca2+ channel with a mutation in the selectivity filter (Ca(v)1.1 E1014K) conducts K+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CONCENTRATION CHANGES; DIHYDROPYRIDINE RECEPTOR; SARCOPLASMIC-RETICULUM; TRANSVERSE TUBULES; CALCIUM-CHANNELS; EXCITATION-FREQUENCY; CHARGE MOVEMENT; DYSGENIC MUSCLE; CONTRACTION; CURRENTS	A glutamate-to-lysine substitution at position 1014 within the selectivity filter of the skeletal muscle L-type Ca2+ channel (Ca(v)1.1) abolishes Ca2+ flux through the channel pore. Mice engineered to exclusively express the mutant channel display accelerated muscle fatigue, changes in muscle composition, and altered metabolism relative to wildtype littermates. By contrast, mice expressing another mutant Ca(v)1.1 channel that is impermeable to Ca2+ (Ca(v)1.1 N617D) have shown no detectable phenotypic differences from wildtype mice to date. The major biophysical difference between the Ca(v)1.1 E1014K and Ca(v)1.1 N617D mutants elucidated thus far is that the former channel conducts robust Ne+ and Cs+ currents in patch-clamp experiments, but neither of these monovalent conductances seems to be of relevance in vivo. Thus, the basis for the different phenotypes of these mutants has remained enigmatic. We now show that Cav1.1 E1014K readily conducts 1,4-dihydropyridine-sensitive K+ currents at depolarizing test potentials, whereas Ca(v)1.1 N617D does not. Our observations, coupled with a large body of work by others regarding the role of K+ accumulation in muscle fatigue, raise the possibility that the introduction of an additional K+ flux from the myoplasm into the transverse-tubule lumen accelerates the onset of fatigue and precipitates the metabolic changes observed in Ca(v)1.1 E1014K muscle. These results, highlighting an unexpected consequence of a channel mutation, may help define the complex mechanisms underlying skeletal muscle fatigue and related dysfunctions.	[Beqollari, Donald; Dockstader, Karen; Bannister, Roger A.] Univ Colorado, Sch Med, Dept Med, Div Cardiol, 12700 East 19th Ave,P15-8006,B-139, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bannister, RA (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Cardiol, 12700 East 19th Ave,P15-8006,B-139, Aurora, CO 80045 USA.	roger.bannister@ucdenver.edu			National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI) [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Acknowledgments We thank Drs. K.G. Beam, S.L. Hamilton, D. Oskar, S. Papadopoulos, and A.A. Voss for helpful discussions. We are also grateful to O. Moua for the generation of the YFP-Ca<INF>v</INF>1.1 N617D construct. Confocal images were acquired in the University of Colorado Advanced Light Microscopy Core with the expert assistance of Dr. R. Moldovan (who is funded in part by National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI) Grant UL1 RR025780).	ADRIAN RH, 1970, J PHYSIOL-LONDON, V208, P645, DOI 10.1113/jphysiol.1970.sp009140; ADRIAN RH, 1976, J PHYSIOL-LONDON, V254, P361, DOI 10.1113/jphysiol.1976.sp011236; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALMERS W, 1980, FED PROC, V39, P1527; ALMERS W, 1972, J PHYSIOL-LONDON, V225, P33, DOI 10.1113/jphysiol.1972.sp009928; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Bannister RA, 2016, J EXP BIOL, V219, P175, DOI 10.1242/jeb.124123; Bannister RA, 2013, BIOPHYS J, V104, P1917, DOI 10.1016/j.bpj.2013.03.035; Bannister RA, 2011, CHANNELS, V5, P262, DOI 10.4161/chan.5.3.15269; Bannister RA, 2009, CHANNELS, V3, P268, DOI 10.4161/chan.3.4.9342; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; BEAM KG, 1983, J GEN PHYSIOL, V81, P513, DOI 10.1085/jgp.81.4.513; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Benedetti B, 2015, BIOPHYS J, V108, P1072, DOI 10.1016/j.bpj.2015.01.026; Beqollari D, 2015, PFLUG ARCH EUR J PHY, V467, P2299, DOI 10.1007/s00424-015-1700-x; BIGLANDRITCHIE B, 1979, EXP NEUROL, V64, P414, DOI 10.1016/0014-4886(79)90280-2; Dayal A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00629-x; DiFranco M, 2015, J PHYSIOL-LONDON, V593, P1213, DOI 10.1113/jphysiol.2014.283648; DiFranco M, 2012, J GEN PHYSIOL, V140, P109, DOI 10.1085/jgp.201210802; Dirksen RT, 1999, J GEN PHYSIOL, V114, P393, DOI 10.1085/jgp.114.3.393; DONALDSON PL, 1983, J GEN PHYSIOL, V82, P449, DOI 10.1085/jgp.82.4.449; Filatov GN, 2005, J GEN PHYSIOL, V126, P161, DOI 10.1085/jgp.200509337; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Fortune E, 2009, ANN BIOMED ENG, V37, P2105, DOI 10.1007/s10439-009-9756-4; FREYGANG WH, 1964, J GEN PHYSIOL, V48, P235, DOI 10.1085/jgp.48.2.235; FREYGANG WH, 1964, J GEN PHYSIOL, V47, P929, DOI 10.1085/jgp.47.5.929; Georgiou DK, 2015, J BIOL CHEM, V290, P23751, DOI 10.1074/jbc.M115.643544; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JONES DA, 1979, EXP NEUROL, V64, P401, DOI 10.1016/0014-4886(79)90279-6; JUEL C, 1986, PFLUG ARCH EUR J PHY, V406, P458, DOI 10.1007/BF00583367; KIRSCH GE, 1977, J GEN PHYSIOL, V70, P1, DOI 10.1085/jgp.70.1.1; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Leuranguer V, 2003, J GEN PHYSIOL, V121, P541, DOI 10.1085/jgp.200308833; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Meza U, 2013, BIOCHEM BIOPH RES CO, V439, P270, DOI 10.1016/j.bbrc.2013.08.044; NAKAJIMA S, 1973, J PHYSIOL-LONDON, V234, P465, DOI 10.1113/jphysiol.1973.sp010355; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; PEACHEY LD, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.3.209; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Pirkmajer S, 2016, AM J PHYSIOL-ENDOC M, V311, pE1, DOI 10.1152/ajpendo.00539.2015; Polster A, 2015, P NATL ACAD SCI USA, V112, P602, DOI 10.1073/pnas.1423113112; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Robin G, 2015, J PHYSIOL-LONDON, V593, P4781, DOI 10.1113/JP270252; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Schrotter K, 2017, CELL CALCIUM, V61, P22, DOI 10.1016/j.ceca.2016.10.002; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Wallinga W, 1999, EUR BIOPHYS J BIOPHY, V28, P317, DOI 10.1007/s002490050214; WESTERBLAD H, 1990, PFLUG ARCH EUR J PHY, V415, P734, DOI 10.1007/BF02584013	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3126	3133		10.1074/jbc.M117.812446	http://dx.doi.org/10.1074/jbc.M117.812446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326166	Green Published, hybrid			2022-12-28	WOS:000426562800008
J	Nguyen, TT; Ghirlando, R; Venditti, V				Nguyen, Trang T.; Ghirlando, Rodolfo; Venditti, Vincenzo			The oligomerization state of bacterial enzyme I (EI) determines EI's allosteric stimulation or competitive inhibition by alpha-ketoglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SEDIMENTATION-VELOCITY; PHOSPHOCARRIER PROTEIN; SALMONELLA-TYPHIMURIUM; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; EQUILIBRIUM; HPR	The bacterial phosphotransferase system (PTS) is a signal transduction pathway that couples phosphoryl transfer to active sugar transport across the cell membrane. The PTS is initiated by phosphorylation of enzyme I (EI) by phosphoenolpyruvate (PEP). The EI phosphorylation state determines the phosphorylation states of all other PTS components and is thought to play a central role in the regulation of several metabolic pathways and to control the biology of bacterial cells at multiple levels, for example, affecting virulence and biofilm formation. Given the pivotal role of EI in bacterial metabolism, an improved understanding of the mechanisms controlling its activity could inform future strategies for bioengineering and antimicrobial design. Here, we report an enzymatic assay, based on Selective Optimized Flip Angle Short Transient (SOFAST) NMR experiments, to investigate the effect of the small-molecule metabolite alpha-ketoglutarate (alpha KG) on the kinetics of the EI-catalyzed phosphoryl transfer reaction. We show that at experimental conditions favoring the monomeric form of EI, alpha KG promotes dimerization and acts as an allosteric stimulator of the enzyme. However, when the oligomerization state of EI is shifted toward the dimeric species, alpha KG functions as a competitive inhibitor of EI. We developed a kinetic model that fully accounted for the experimental data and indicated that bacterial cells might use the observed interplay between allosteric stimulation and competitive inhibition of EI by alpha KG to respond to physiological fluctuations in the intracellular environment. We expect that the mechanism for regulating EI activity revealed here is common to several other oligomeric enzymes.	[Nguyen, Trang T.; Venditti, Vincenzo] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Venditti, Vincenzo] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Iowa State University; Iowa State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Venditti, V (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	venditti@iastate.edu			Roy J. Carver Charitable Trust; Iowa State University; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; Iowa State University; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Roy J. Carver Charitable Trust and Iowa State University (to V. V.) and by the Intramural Research Program of the NIDDK, National Institutes of Health (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Cabrera R, 2011, J BIOL CHEM, V286, P5774, DOI 10.1074/jbc.M110.163162; Chauvin F, 1996, RES MICROBIOL, V147, P471, DOI 10.1016/0923-2508(96)84001-0; Clore GM, 2013, TRENDS BIOCHEM SCI, V38, P515, DOI 10.1016/j.tibs.2013.08.003; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/nchembio.685, 10.1038/NCHEMBIO.685]; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Kee JM, 2013, NAT CHEM BIOL, V9, P416, DOI [10.1038/NCHEMBIO.1259, 10.1038/nchembio.1259]; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Lee CR, 2013, MOL MICROBIOL, V88, P473, DOI 10.1111/mmi.12196; MATTOO RL, 1983, CAN J BIOCHEM CELL B, V61, P29, DOI 10.1139/o83-005; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Takayama Y, 2011, J AM CHEM SOC, V133, P424, DOI 10.1021/ja109866w; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Venditti V, 2015, P NATL ACAD SCI USA, V112, P11565, DOI 10.1073/pnas.1515366112; Venditti V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6960; Venditti V, 2013, ACS CHEM BIOL, V8, P1232, DOI 10.1021/cb400027q; Venditti V, 2012, J BIOL CHEM, V287, P26989, DOI 10.1074/jbc.M112.382291; WEIGEL N, 1982, J BIOL CHEM, V257, P4499; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	34	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2631	2639		10.1074/jbc.RA117.001466	http://dx.doi.org/10.1074/jbc.RA117.001466			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29317499	Green Published, hybrid			2022-12-28	WOS:000425308300033
J	Casey, AK; Moehlman, AT; Zhang, JM; Servage, KA; Kramer, H; Orth, K				Casey, Amanda K.; Moehlman, Andrew T.; Zhang, Junmei; Servage, Kelly A.; Kramer, Helmut; Orth, Kim			Fic-mediated deAMPylation is not dependent on homodimerization and rescues toxic AMPylation in flies (vol 292, pg 21193, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Servage, Kelly/0000-0001-7183-2865				Casey AK, 2017, J BIOL CHEM, V292, P21193, DOI 10.1074/jbc.M117.799296	1	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1550	1550		10.1074/jbc.AAC118.001798	http://dx.doi.org/10.1074/jbc.AAC118.001798			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29414767	Green Published, hybrid			2022-12-28	WOS:000424201700007
J	Jacques, B; Coincon, M; Sygusch, J				Jacques, Benoit; Coincon, Mathieu; Sygusch, Jurgen			Active site remodeling during the catalytic cycle in metal-dependent fructose-1,6-bisphosphate aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; crystal structure; Helicobacter pylori; metalloenzyme; zinc; conformational change; active site remodeling; fructose-1; 6-bisphosphate aldolase	CLASS-II ALDOLASES; PREVENT GASTRIC-CANCER; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; CARBONIC-ANHYDRASE; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE-BINDING; STRUCTURAL BASIS; ESSENTIAL GENES; FUNCTIONAL-ROLE	Crystal structures of two bacterial metal (Zn2+)-dependent d-fructose-1,6-bisphosphate (FBP) aldolases in complex with substrate, analogues, and triose-P reaction products were determined to 1.5-2.0 angstrom resolution. The ligand complexes cryotrapped in native or mutant Helicobacter pylori aldolase crystals enabled a novel mechanistic description of FBP C3-C4 bond cleavage. The reaction mechanism uses active site remodeling during the catalytic cycle, implicating relocation of the Zn2+ cofactor that is mediated by conformational changes of active site loops. Substrate binding initiates conformational changes triggered upon P1 phosphate binding, which liberates the Zn2+-chelating His-180, allowing it to act as a general base for the proton abstraction at the FBP C4 hydroxyl group. A second zinc-chelating His-83 hydrogen bonds the substrate C4 hydroxyl group and assists cleavage by stabilizing the developing negative charge during proton abstraction. Cleavage is concerted with relocation of the metal cofactor from an interior to a surface-exposed site, thereby stabilizing the nascent enediolate form. Conserved residue Glu-142 is essential for protonation of the enediolate form prior to product release. A d-tagatose 1,6-bisphosphate enzymatic complex reveals how His-180-mediated proton abstraction controls stereospecificity of the cleavage reaction. Recognition and discrimination of the reaction products, dihydroxyacetone-P and d-glyceraldehyde 3-P, occurs via charged hydrogen bonds between hydroxyl groups of the triose-Ps and conserved residues, Asp-82 and Asp-255, respectively, and are crucial aspects of the enzyme's role in gluconeogenesis. Conformational changes in mobile loops 5-7 and 6-8 (containing catalytic residues Glu-142 and His-180, respectively) drive active site remodeling, enabling the relocation of the metal cofactor.	[Jacques, Benoit; Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Univ Montreal, Biochim & Med Mol, CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@umontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	Office of Biological and Environmental Research of the United States Department of Energy [DE-AC02-98CH10886]; Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-98CH10886]; National Center for Research Resources [P41RR012408]; National Institutes of Health [P41GM103473]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data for this study were collected in part on beamlines X12B, X25, and X29 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy (Contract DE-AC02-98CH10886) and from the National Center for Research Resources (Grant P41RR012408) and the National Institutes of Health (Grant P41GM103473). Kind assistance by beamline personnel, Drs. L. Flaks, D. K. Schneider, A. Soares, A. Heroux, and H. Robinson, is gratefully acknowledged. Diffraction data were also collected using beamline 08ID-1 and 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Data were collected with the assistance of Shaun Labiuk. We thank Dr. Alexandra Furtos of the Universite de Montreal Mass Spectrometry Facility for mass spectral analysis. We thank Oktavian Toka for assistance in the kinetic characterization of native and mutant H. pylori aldolases.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, LBNL60873, V42; BELASCO JG, 1983, BIOCHEMISTRY-US, V22, P122, DOI 10.1021/bi00270a018; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BOCK CW, 1995, J AM CHEM SOC, V117, P3754, DOI 10.1021/ja00118a012; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P7604, DOI 10.1021/bi501141t; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P202, DOI 10.1021/bi401022b; CHALK PA, 1994, MICROBIOL-UK, V140, P2085, DOI 10.1099/13500872-140-8-2085; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; COLLINS KD, 1974, J BIOL CHEM, V249, P136; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonvielle M, 2008, CHEM-EUR J, V14, P8521, DOI 10.1002/chem.200800857; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; Galkin A, 2009, BIOCHEMISTRY-US, V48, P3186, DOI 10.1021/bi9001166; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GINSBURG A, 1966, BIOCHEMISTRY-US, V5, P2623, DOI 10.1021/bi00872a021; Hall DR, 1999, J MOL BIOL, V287, P383, DOI 10.1006/jmbi.1999.2609; HEALY MJ, 1973, BIOCHEMISTRY-US, V12, P35, DOI 10.1021/bi00725a006; Hoffman PS, 1996, J BACTERIOL, V178, P4822, DOI 10.1128/jb.178.16.4822-4829.1996; Islam Z, 2015, J BIOL CHEM, V290, P11293, DOI 10.1074/jbc.M114.611830; Izard T, 2004, J BIOL CHEM, V279, P11825, DOI 10.1074/jbc.M311375200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimura E, 1999, J AM CHEM SOC, V121, P1267, DOI 10.1021/ja982904e; KOBES RD, 1969, BIOCHEMISTRY-US, V8, P585, DOI 10.1021/bi00830a018; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02211-3; Lee YC, 2008, J FORMOS MED ASSOC, V107, P591, DOI 10.1016/S0929-6646(08)60176-X; LEWIS DJ, 1973, J CHEM SOC CHEM COMM, P713, DOI 10.1039/c39730000713; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mabiala-Bassilou CG, 2008, BIOORG MED CHEM LETT, V18, P1735, DOI 10.1016/j.bmcl.2008.01.076; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Marshall B.J., 2001, HELICOBACTER PYLORI; MARTIN RB, 1974, P NATL ACAD SCI USA, V71, P4346, DOI 10.1073/pnas.71.11.4346; MITCHELL HM, 2001, HELICOBACTER PYLORI, P7; Motta CRA, 2008, DIGESTION, V78, P3, DOI 10.1159/000151297; Mura C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000918; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan SD, 2013, BIOCHEMISTRY-US, V52, P912, DOI 10.1021/bi300928u; Pegan SD, 2009, J MOL BIOL, V386, P1038, DOI 10.1016/j.jmb.2009.01.003; Plater AR, 1999, J MOL BIOL, V285, P843, DOI 10.1006/jmbi.1998.2376; Plaumann M, 1997, CURR GENET, V31, P430, DOI 10.1007/s002940050226; Qamar S, 1996, PROTEIN SCI, V5, P154; RICHARDS OC, 1961, J BIOL CHEM, V236, P3177; ROSE IA, 1965, J BIOL CHEM, V240, P1758; RUTTER WJ, 1964, FED PROC, V23, P1248; Sharma A, 2011, J AM CHEM SOC, V133, P20194, DOI 10.1021/ja2030646; SINGER M, 1991, J BACTERIOL, V173, P6249, DOI 10.1128/jb.173.19.6249-6257.1991; SINGER M, 1991, J BACTERIOL, V173, P6242, DOI 10.1128/jb.173.19.6242-6248.1991; SMITH GM, 1980, BIOCHEMISTRY-US, V19, P1248, DOI 10.1021/bi00547a032; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; Stingl K, 2001, INFECT IMMUN, V69, P1178, DOI 10.1128/IAI.69.2.1178-1181.2001; SZWERGOLD BS, 1995, ARCH BIOCHEM BIOPHYS, V317, P244, DOI 10.1006/abbi.1995.1159; Talley NJ, 2008, LANCET, V372, P350, DOI 10.1016/S0140-6736(08)61136-8; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; TRENTHAM DR, 1969, BIOCHEM J, V114, P19, DOI 10.1042/bj1140019; TUNG TC, 1954, BIOCHIM BIOPHYS ACTA, V14, P488, DOI 10.1016/0006-3002(54)90228-0; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Warburg O, 1943, BIOCHEM Z, V314, P149; Wehmeier UF, 2001, FEMS MICROBIOL LETT, V197, P53, DOI 10.1111/j.1574-6968.2001.tb10582.x; Zgiby S, 2002, J MOL BIOL, V315, P131, DOI 10.1006/jmbi.2001.5237; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	70	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7737	7753		10.1074/jbc.RA117.001098	http://dx.doi.org/10.1074/jbc.RA117.001098			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29593097	hybrid, Green Published			2022-12-28	WOS:000437256500023
J	Liu, K; Xu, C; Lei, M; Yang, A; Loppnau, P; Hughes, TR; Min, JR				Liu, Ke; Xu, Chao; Lei, Ming; Yang, Ally; Loppnau, Peter; Hughes, Timothy R.; Min, Jinrong			Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; epigenetics; DNA methylation; 5-methylcytosine; gene regulation; CAC motif; CpH methylation; methyl-CpG-binding domain (MBD); methyl-CpG-binding protein 2	NON-CPG METHYLATION; EMBRYONIC STEM-CELLS; RETT-SYNDROME; SEQUENCE SPECIFICITY; PROTEIN ARBP; MECP2; RECOGNITION; TRANSCRIPTION; COMPLEX; FAMILY	Cytosine methylation is a well-characterized epigenetic mark and occurs at both CG and non-CG sites in DNA. Both methylated CG (mCG)- and mCH (H = A, C, or T)-containing DNAs, especially mCAC-containing DNAs, are recognized by methyl-CpG-binding protein 2 (MeCP2) to regulate gene expression in neuron development. However, the molecular mechanism involved in the binding of methyl-CpG-binding domain (MBD) of MeCP2 to these different DNA motifs is unclear. Here, we systematically characterized the DNA-binding selectivities of the MBD domains in MeCP2 and MBD1-4 with isothermal titration calorimetry-based binding assays, mutagenesis studies, and X-ray crystallography. We found that the MBD domains of MeCP2 and MBD1-4 bind mCG-containing DNAs independently of the sequence identity outside the mCG dinucleotide. Moreover, some MBD domains bound to both methylated and unmethylated CA dinucleotide-containing DNAs, with a preference for the CAC sequence motif. We also found that the MBD domains bind to mCA or nonmethylated CA DNA by recognizing the complementary TG dinucleotide, which is consistent with an overlooked ligand of MeCP2, i.e. the matrix/scaffold attachment regions (MARs/SARs) with a consensus sequence of 5-GGTGT-3 that was identified in early 1990s. Our results also explain why MeCP2 exhibits similar binding affinity to both mCA- and hmCA-containing dsDNAs. In summary, our results suggest that in addition to mCG sites, unmethylated CA or TG sites also serve as DNA-binding sites for MeCP2 and other MBD-containing proteins. This discovery expands the genome-wide activity of MBD-containing proteins in gene regulation.	[Liu, Ke; Xu, Chao; Lei, Ming; Loppnau, Peter; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Yang, Ally; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Liu, Ke; Xu, Chao; Lei, Ming; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Min, JR (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; , KE/0000-0002-7082-262X	National Institutes of Health Grant from NCI [ACB-12002]; National Institutes of Health Grant from NIGMS [AGM-12006]; United States Department of Energy [DE-AC02-06CH11357]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen (Darmstadt, Germany); Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; SAo Paulo Research Foundation (FAPESP); Takeda; Wellcome	National Institutes of Health Grant from NCI; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen (Darmstadt, Germany); Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme(Merck & Company); Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer(Pfizer); SAo Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome	We thank Wolfram Tempel for the structure determination. We thank Chuanbing Bian for the MBD2-mCG crystal structure, Aiping Dong for a coordinate averaging program, and Amy Wernimont for some diffraction data collection and crystal structure review. Some diffraction data were collected at the Structural Biology Center and the General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA at APS) is part of the X-ray Science Division at APS, Argonne National Laboratory. GM/CA received support from National Institutes of Health Grants ACB-12002 from NCI and AGM-12006 from NIGMS. Argonne is operated by the United States Department of Energy under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the following: AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant OGI-055; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766; Janssen, Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; SAo Paulo Research Foundation (FAPESP); Takeda; and Wellcome.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; BUHRMESTER H, 1995, BIOCHEMISTRY-US, V34, P4108, DOI 10.1021/bi00012a029; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Cramer JM, 2014, J BIOL CHEM, V289, P1294, DOI 10.1074/jbc.M113.512236; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Ichiyanagi T, 2013, NUCLEIC ACIDS RES, V41, P738, DOI 10.1093/nar/gks1117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Kribelbauer JF, 2017, CELL REP, V19, P2383, DOI 10.1016/j.celrep.2017.05.069; Lagger S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006793; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lamoureux JS, 2006, STRUCTURE, V14, P555, DOI 10.1016/j.str.2005.11.017; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shin J, 2013, CELL, V152, P940, DOI 10.1016/j.cell.2013.02.017; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; VONKRIES JP, 1991, CELL, V64, P123, DOI 10.1016/0092-8674(91)90214-J; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; Xu C, 2018, STRUCTURE, V26, P85, DOI 10.1016/j.str.2017.11.022; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	60	38	40	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7344	7354		10.1074/jbc.RA118.001785	http://dx.doi.org/10.1074/jbc.RA118.001785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567833	hybrid, Green Published			2022-12-28	WOS:000432174500027
J	Ulfig, A; Freudl, R				Ulfig, Agnes; Freudl, Roland			The early mature part of bacterial twin-arginine translocation (Tat) precursor proteins contributes to TatBC receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); membrane transport; protein targeting; protein translocation; protein export; early mature region; protein folding; secretion pathway; substrate receptor; twin arginine translocation	ESCHERICHIA-COLI; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; FOLDED PROTEINS; EXPORT PATHWAY; COMPONENT; MEMBRANE; COMPLEX; MUTANT; SITE	The twin-arginine translocation (Tat) pathway transports folded proteins across bacterial membranes. Tat precursor proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is involved in the binding of the proteins to the membrane-associated TatBC receptor complex. In addition, the hydrophobic region in the Tat signal peptides also contributes to TatBC binding, but whether regions beyond the signal-peptide cleavage site are involved in this process is unknown. Here, we analyzed the contribution of the early mature protein part of the Escherichia coli trimethylamine N-oxide reductase (TorA) to productive TatBC receptor binding. We identified substitutions in the 30 amino acids immediately following the TorA signal peptide (30aa-region) that restored export of a transport-defective TorA[KQ]-30aa-MalE precursor, in which the RR residues had been replaced by a lysine-glutamine pair. Some of these substitutions increased the hydrophobicity of the N-terminal part of the 30aa-region and thereby likely enhanced hydrophobic substrate-receptor interactions within the hydrophobic TatBC substrate-binding cavity. Another class of substitutions increased the positive net charge of the region's C-terminal part, presumably leading to strengthened electrostatic interactions between the mature substrate part and the cytoplasmic TatBC regions. Furthermore, we identified substitutions in the C-terminal domains of TatB following the transmembrane segment that restored transport of various transport-defective TorA-MalE derivatives. Some of these substitutions most likely affected the orientation or conformation of the flexible, carboxy-proximal helices of TatB. Therefore, we propose that a tight accommodation of the folded mature region by TatB contributes to productive binding of Tat substrates to TatBC.	[Ulfig, Agnes; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany; [Ulfig, Agnes] Ruhr Univ Bochum, Microbial Biochem, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany	Helmholtz Association; Research Center Julich; Ruhr University Bochum	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279; Ulfig, Agnes/0000-0003-2689-6311				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chatzi KE, 2017, J CELL BIOL, V216, P1357, DOI 10.1083/jcb.201609022; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Eimer E, 2015, J BIOL CHEM, V290, P29281, DOI 10.1074/jbc.M115.696005; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENGGE R, 1983, BIOCHIM BIOPHYS ACTA, V737, P443, DOI 10.1016/0304-4157(83)90009-6; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Q, 2017, MBIO, V8, DOI 10.1128/mBio.00909-17; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; MILLER JG, 1972, SHORT COURSE BACTERI; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	52	4	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7281	7299		10.1074/jbc.RA118.002576	http://dx.doi.org/10.1074/jbc.RA118.002576			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593092	Green Published, hybrid			2022-12-28	WOS:000432174500023
J	Mugabo, Y; Sadeghi, M; Fang, NN; Mayor, T; Lim, GE				Mugabo, Yves; Sadeghi, Mina; Fang, Nancy N.; Mayor, Thibault; Lim, Gareth E.			Elucidation of the 14-3-3 interactome reveals critical roles of RNA-splicing factors during adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; adipocyte; adipogenesis; alternative splicing; scaffold protein	REGULATES ADIPOCYTE DIFFERENTIATION; CELLULAR PROCESSES; PROTEOMIC ANALYSIS; ADIPOSE-TISSUE; GAMMA-GENE; PROTEINS; PHOSPHOPROTEINS; PURIFICATION; PSPC1; NONO	Adipogenesis involves a complex signaling network requiring strict temporal and spatial organization of effector molecules. Molecular scaffolds, such as 14-3-3 proteins, facilitate such organization, and we have previously identified 14-3-3 as an essential scaffold in adipocyte differentiation. The interactome of 14-3-3 is large and diverse, and it is possible that novel adipogenic factors may be present within it, but this possibility has not yet been tested. Herein, we generated mouse embryonic fibroblasts from mice overexpressing a tandem affinity purification (TAP) epitope-tagged 14-3-3 molecule. After inducing adipogenesis, TAP-14-3-3 complexes were purified, followed by MS analysis to determine the 14-3-3 interactome. We observed more than 100 proteins that were unique to adipocyte differentiation, 56 of which were novel interacting partners. Among these, we were able to identify previously established regulators of adipogenesis (i.e. Ptrf/Cavin1) within the 14-3-3 interactome, confirming the utility of this approach to detect adipogenic factors. We found that proteins related to RNA metabolism, processing, and splicing were enriched in the interactome. Analysis of transcriptomic data revealed that 14-3-3 depletion in 3T3-L1 cells affected alternative splicing of mRNA during adipocyte differentiation. siRNA-mediated depletion of RNA-splicing factors within the 14-3-3 interactome, that is, of Hnrpf, Hnrpk, Ddx6, and Sfpq, revealed that they have essential roles in adipogenesis and in the alternative splicing of Pparg and the adipogenesis-associated gene Lpin1. In summary, we have identified novel adipogenic factors within the 14-3-3 interactome. Further characterization of additional proteins within the 14-3-3 interactome may help identify novel targets to block obesity-associated expansion of adipose tissues.	[Mugabo, Yves; Sadeghi, Mina; Lim, Gareth E.] Ctr Hosp Univ Montreal, Montreal, PQ H2X 029, Canada; [Mugabo, Yves; Sadeghi, Mina; Lim, Gareth E.] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Fang, Nancy N.; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	Universite de Montreal; Universite de Montreal; University of British Columbia	Lim, GE (corresponding author), CRCHUM, Rm 08-482,900 Rue St Denis, Montreal, PQ H2X 029, Canada.	gareth.lim@umontreal.ca	Lim, Gareth/G-9143-2017	Lim, Gareth/0000-0003-3850-3757	Canadian Institutes of Health Research [PJT-153144]; Juvenile Diabetes Research Foundation (JDRF); Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Diabetes Association	This work was supported by Canadian Institutes of Health Research Project Grant PJT-153144 (to G. E. L.). This work was supported in part by postdoctoral fellowships from the Juvenile Diabetes Research Foundation (JDRF) and the Canadian Diabetes Association (to G. E. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ande SR, 2014, DIABETES, V63, P3734, DOI 10.2337/db13-1807; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Capobianco V, 2012, J PROTEOME RES, V11, P3358, DOI 10.1021/pr300152z; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Kowalska E, 2013, P NATL ACAD SCI USA, V110, P1592, DOI 10.1073/pnas.1213317110; Li H, 2014, MOL CELL BIOL, V34, P2198, DOI 10.1128/MCB.01674-13; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Li YF, 2010, BIOTECHNOL APPL BIOC, V55, P73, DOI 10.1042/BA20090273; Lim GE, 2013, DIABETOLOGIA, V56, P825, DOI 10.1007/s00125-012-2820-x; Lim GE, 2016, ADIPOCYTE, V5, P232, DOI 10.1080/21623945.2015.1120913; Lim GE, 2016, ENDOCRINOLOGY, V157, P2649, DOI 10.1210/en.2016-1016; Lim GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8671; Lin JC, 2015, INT J MOL SCI, V16, P22169, DOI 10.3390/ijms160922169; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034315; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ng AHM, 2013, MOL CELL PROTEOMICS, V12, P2456, DOI 10.1074/mcp.M112.023416; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; Perez-Diaz S, 2014, FASEB J, V28, P3769, DOI 10.1096/fj.14-251165; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takenaka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065583; Tang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055268; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vernia S, 2016, ELIFE, V5, DOI 10.7554/eLife.17672; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang JX, 2017, J CLIN INVEST, V127, P987, DOI 10.1172/JCI89484; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	53	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6736	6750		10.1074/jbc.M117.816272	http://dx.doi.org/10.1074/jbc.M117.816272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29530978	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000431487300010
J	Sutherland, GA; Grayson, KJ; Adams, NBP; Mermans, DMJ; Jones, AS; Robertson, AJ; Auman, DB; Brindley, AA; Sterpone, F; Tuffery, P; Derreumaux, P; Dutton, PL; Robinson, C; Hitchcock, A; Hunter, CN				Sutherland, George A.; Grayson, Katie J.; Adams, Nathan B. P.; Mermans, Daphne M. J.; Jones, Alexander S.; Robertson, Angus J.; Auman, Dirk B.; Brindley, Amanda A.; Sterpone, Fabio; Tuffery, Pierre; Derreumaux, Philippe; Dutton, P. Leslie; Robinson, Colin; Hitchcock, Andrew; Hunter, C. Neil			Probing the quality control mechanism of the Escherichia coli twin-arginine translocase with folding variants of a de novo-designed heme protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein design; protein folding; Escherichia coli (E; coli); protein translocation; biotechnology; maquette; protein export; protein quality control; Tat system; twin-arginine translocase	SEC-INDEPENDENT PROTEIN; BACTERIAL TAT PATHWAY; SIGNAL PEPTIDE; BINDING PROTEIN; EXPORT PATHWAY; TRANSPORT; COMPLEX; PERIPLASM; CHARGE; MOTIF	Protein transport across the cytoplasmic membrane of bacterial cells is mediated by either the general secretion (Sec) system or the twin-arginine translocase (Tat). The Tat machinery exports folded and cofactor-containing proteins from the cytoplasm to the periplasm by using the transmembrane proton motive force as a source of energy. The Tat apparatus apparently senses the folded state of its protein substrates, a quality-control mechanism that prevents premature export of nascent unfolded or misfolded polypeptides, but its mechanistic basis has not yet been determined. Here, we investigated the innate ability of the model Escherichia coli Tat system to recognize and translocate de novo-designed protein substrates with experimentally determined differences in the extent of folding. Water-soluble, four-helix bundle maquette proteins were engineered to bind two, one, or no heme b cofactors, resulting in a concomitant reduction in the extent of their folding, assessed with temperature-dependent CD spectroscopy and one-dimensional H-1 NMR spectroscopy. Fusion of the archetypal N-terminal Tat signal peptide of the E. coli trimethylamine-N-oxide (TMAO) reductase (TorA) to the N terminus of the protein maquettes was sufficient for the Tat system to recognize them as substrates. The clear correlation between the level of Tat-dependent export and the degree of heme b-induced folding of the maquette protein suggested that the membrane-bound Tat machinery can sense the extent of folding and conformational flexibility of its substrates. We propose that these artificial proteins are ideal substrates for future investigations of the Tat system's quality-control mechanism.	[Sutherland, George A.; Grayson, Katie J.; Adams, Nathan B. P.; Robertson, Angus J.; Brindley, Amanda A.; Hitchcock, Andrew; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Mermans, Daphne M. J.; Jones, Alexander S.; Robinson, Colin] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Auman, Dirk B.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Sterpone, Fabio; Derreumaux, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, Lab Biochim Theor, CNRS,UPR 9080, F-75005 Paris, France; [Tuffery, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U973, F-75013 Paris, France	University of Sheffield; University of Kent; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	Hitchcock, Andrew/AAM-2855-2020; Tuffery, Pierre/L-6953-2017; Derreumaux, Philippe/E-9036-2019; Grayson Steel, Katie/B-1943-2016	Hitchcock, Andrew/0000-0001-6572-434X; Tuffery, Pierre/0000-0003-1033-9895; Sutherland, George/0000-0002-6319-4637; Grayson Steel, Katie/0000-0003-3764-6406; Mermans, Daphne/0000-0001-6001-5608; Adams, Nathan/0000-0003-3080-3448	Faculty of Science Studentships from The University of Sheffield; Engineering and Physical Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council (UK) [BB/M000265/1]; Marie Curie Initial Training Network Grant (Horizon, ProteinFactory) [642863]; University of Kent Graduate Training Award studentship; National Institutes of Health Graduate Fellowship [T32 GM008275]; Structural Biology & Molecular Biophysics Training Program; French "DYNAMO" Grant [ANR-11-LABX-0011-01]; European Research Council [338895]; BBSRC [BB/M000265/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	Faculty of Science Studentships from The University of Sheffield; Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Initial Training Network Grant (Horizon, ProteinFactory); University of Kent Graduate Training Award studentship; National Institutes of Health Graduate Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Biology & Molecular Biophysics Training Program; French "DYNAMO" Grant; European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Faculty of Science Studentships from The University of Sheffield.; Supported by a doctoral studentship from the Engineering and Physical Sciences Research Council (UK). Present address: School of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom.; Supported by Research Grant BB/M000265/1 from the Biotechnology and Biological Sciences Research Council (UK).; Supported by the Marie Curie Initial Training Network Grant (Horizon 2020, ProteinFactory) 642863.; Supported by a University of Kent Graduate Training Award studentship.; Supported by National Institutes of Health Graduate Fellowship T32 GM008275, the Structural Biology & Molecular Biophysics Training Program.; Supported by French "DYNAMO" Grant ANR-11-LABX-0011-01 for sabbatical year 2015-2016 at UPR9080 CNRS, IBPC.; Supported in part by Advanced Award 338895 from the European Research Council.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Browning DF, 2017, BIOTECHNOL BIOENG, V114, P2828, DOI 10.1002/bit.26434; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; DEGRADO WF, 1989, SCIENCE, V243, P622, DOI 10.1126/science.2464850; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/NCHEMBIO.1362, 10.1038/nchembio.1362]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grayson KJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13972; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Grosset AM, 2001, BIOCHEMISTRY-US, V40, P5474, DOI 10.1021/bi002504f; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jones AS, 2016, BBA-MOL CELL RES, V1863, P3116, DOI 10.1016/j.bbamcr.2016.09.006; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Lichtenstein BR, 2012, BIOCHEM SOC T, V40, P561, DOI 10.1042/BST20120067; Lindenstrauss U, 2009, FEMS MICROBIOL LETT, V295, P135, DOI 10.1111/j.1574-6968.2009.01600.x; LIU CP, 1983, PLASMID, V10, P148, DOI 10.1016/0147-619X(83)90067-7; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Patel R, 2014, BBA-MOL CELL RES, V1843, P1620, DOI 10.1016/j.bbamcr.2014.02.013; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rocco MA, 2012, P NATL ACAD SCI USA, V109, P13392, DOI 10.1073/pnas.1210140109; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550	45	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6672	6681		10.1074/jbc.RA117.000880	http://dx.doi.org/10.1074/jbc.RA117.000880			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29559557	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000431487300004
J	Li, MJ; Guttman, M; Atkins, WM				Li, Mavis Jiarong; Guttman, Miklos; Atkins, William M.			Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug transport; conformational change; protein dynamic; protein conformation; ATPase; conformational selection; multidrug resistance	EXCHANGE MASS-SPECTROMETRY; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; ATP HYDROLYSIS; INDUCED FIT; GLUTAMATE RESIDUES; ALTERNATING ACCESS; CATALYTIC CYCLE; MECHANISM; FLEXIBILITY	P-glycoprotein (P-gp) is a highly substrate-promiscuous efflux transporter that plays a critical role in drug disposition. P-gp utilizes ATP hydrolysis by nucleotide-binding domains (NBDs) to drive transitions between inward-facing (IF) conformations that bind drugs and outward-facing (OF) conformations that release them to the extracellular solution. However, the details of the protein dynamics within either macroscopic IF or OF conformation remain uncharacterized, and the functional role of local dynamics has not been determined. In this work we measured the local dynamics of the IF state of P-gp in lipid nanodiscs and in detergent solution by hydrogen-deuterium (H/D) exchange MS. We observed EX1 exchange kinetics, or bimodal kinetics, for several peptides distributed in both NBDs, particularly for P-gp in the lipid nanodiscs. Remarkably, the EX1 kinetics occurred on several time scales, ranging from seconds to hours, suggesting highly complex, and correlated, motions. The results indicate at least three distinct conformational states in the ligand-free P-gp and suggest a rough conformational landscape. Addition of excess ATP and vanadate, to favor the OF conformations, caused a generalized, but modest, decrease in H/D exchange throughout the NBDs and slowed the EX1 kinetic transitions of several peptides. The functional implications of the results are consistent with the possibility that conformational selection provides a source of substrate promiscuity.	[Li, Mavis Jiarong; Guttman, Miklos; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Atkins, WM (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.	winky@uw.edu			NIGMS NIH HHS [R01 GM121603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burkitt W, 2008, RAPID COMMUN MASS SP, V22, P3893, DOI 10.1002/rcm.3794; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Fang J, 2011, INT J MASS SPECTROM, V302, P19, DOI 10.1016/j.ijms.2010.06.039; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Honaker MT, 2013, J BIOL CHEM, V288, P18599, DOI 10.1074/jbc.M112.445767; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li MJ, 2017, BIOCHEMISTRY-US, V56, P2506, DOI 10.1021/acs.biochem.6b01245; Livnat-Levanon N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21696; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Subramanian N, 2016, NEUROCHEM INT, V98, P146, DOI 10.1016/j.neuint.2016.05.005; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Vigano C, 2002, J BIOL CHEM, V277, P5008, DOI 10.1074/jbc.M107928200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Yang ZR, 2017, BBA-BIOMEMBRANES, V1859, P48, DOI 10.1016/j.bbamem.2016.10.009	42	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6297	6307		10.1074/jbc.RA118.002190	http://dx.doi.org/10.1074/jbc.RA118.002190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511086	hybrid, Green Published			2022-12-28	WOS:000431108600007
J	Jayaraman, V; Suryavanshi, A; Kalale, P; Kunala, J; Balaram, H				Jayaraman, Vijay; Suryavanshi, Arpitha; Kalale, Pavithra; Kunala, Jyothirmai; Balaram, Hemalatha			Biochemical characterization and essentiality of Plasmodium fumarate hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL CEREBRAL MALARIA; ESCHERICHIA-COLI K-12; QUINONE OXIDOREDUCTASE; SUCCINATED PROTEOME; CRYSTAL-STRUCTURE; LIFE-CYCLE; PURIFICATION; METABOLISM; FALCIPARUM; PARASITE	Plasmodium falciparum (Pf), the causative agent of malaria, has an iron-sulfur cluster-containing class I fumarate hydratase (FH) that catalyzes the interconversion of fumarate to malate, a well-known reaction in the tricarboxylic acid cycle. In humans, the same reaction is catalyzed by class II FH that has no sequence or structural homology with the class I enzyme from Plasmodium. Fumarate is generated in large quantities in the parasite as a by-product of AMP synthesis and is converted to malate by FH and then used in the generation of the key metabolites oxaloacetate, aspartate, and pyruvate. Previous studies have identified the FH reaction as being essential to P. falciparum, but biochemical characterization of PfFH that may provide leads for the development of specific inhibitors is lacking. Here, we report on the kinetic characterization of purified recombinant PfFH, functional complementation of fh deficiency in Escherichia coli, and mitochondrial localization in the parasite. We found that the substrate analog mercaptosuccinic acid is a potent PfFH inhibitor, with a K-i value in the nanomolar range. The fh gene could not be knocked out in Plasmodium berghei when transfectants were introduced into BALB/c mice; however, fh knockout was successful when C57BL/6 mice were used as host, suggesting that the essentiality of the fh gene to the parasite was mouse strain-dependent.	[Jayaraman, Vijay; Suryavanshi, Arpitha; Kalale, Pavithra; Kunala, Jyothirmai; Balaram, Hemalatha] JNCASR, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India; [Kunala, Jyothirmai] Biocon Res Ltd, Mol Characterizat Analyt Grp, SEZ Unit, Biocon Pk,Bommasandra Jigani Link Rd, Bengaluru 560099, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Biocon Limited	Balaram, H (corresponding author), JNCASR, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India.	hb@jncasr.ac.in			Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015]; Science and Engineering Research Board, Department of Science and Technology, Government of India [EMR/2014/001276]; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC)	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India)	This work was supported in part by Department of Biotechnology, Ministry of Science and Technology, Government of India, Grants BT/PR11294/BRB/10/1291/2014 and BT/PR13760/COE/34/42/2015; Science and Engineering Research Board, Department of Science and Technology, Government of India, Grant EMR/2014/001276, and Institutional funding from Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Council of Scientific and Industrial Research (CSIR) junior and senior research fellowships.; Recipient of University Grants Commission (UGC) junior and senior research fellowships.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amani V, 1998, INFECT IMMUN, V66, P4093; Antonkine ML, 2009, BBA-BIOENERGETICS, V1787, P995, DOI 10.1016/j.bbabio.2009.03.007; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BELL PJ, 1989, J BACTERIOL, V171, P3494, DOI 10.1128/jb.171.6.3494-3503.1989; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Bulusu V, 2011, MOL BIOCHEM PARASIT, V177, P1, DOI 10.1016/j.molbiopara.2011.01.001; Bulusu V, 2011, J BIOL CHEM, V286, P9236, DOI 10.1074/jbc.M110.173328; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Carey MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3905-1; Chan A, 2012, ANGEW CHEM INT EDIT, V51, P7711, DOI 10.1002/anie.201202261; Chen BS, 2015, BIOTECHNOL ADV, V33, P526, DOI 10.1016/j.biotechadv.2015.01.007; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Padua RAP, 2017, INT J BIOL MACROMOL, V102, P42, DOI 10.1016/j.ijbiomac.2017.03.099; ELING W, 1977, Z PARASITENKD, V54, P29, DOI 10.1007/BF00380634; Feliciano PR, 2016, P NATL ACAD SCI USA, V113, P9804, DOI 10.1073/pnas.1605031113; Feliciano PR, 2012, INT J BIOL MACROMOL, V51, P25, DOI 10.1016/j.ijbiomac.2012.04.025; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Hallee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138626; Hartig S.M., 2013, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1415-102, DOI 10.1002/0471142727.MB1415S102, DOI 10.1002/0471142727.MB1415-102]; Jacot D, 2016, TRENDS PARASITOL, V32, P56, DOI 10.1016/j.pt.2015.09.001; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Kronen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145098; Kronen M, 2015, APPL ENVIRON MICROB, V81, P5632, DOI 10.1128/AEM.00822-15; Lloyd SJ, 1999, PROTEIN SCI, V8, P2655, DOI 10.1110/ps.8.12.2655; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Niikura M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1898-5; Niikura M, 2013, BIOCHEM BIOPH RES CO, V432, P504, DOI 10.1016/j.bbrc.2013.02.004; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; de Padua RAP, 2014, ACTA CRYSTALLOGR F, V70, P120, DOI 10.1107/S2053230X13033955; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Resch V, 2015, CATAL SCI TECHNOL, V5, P1385, DOI 10.1039/c4cy00692e; ROTH E, 1990, BLOOD CELLS, V16, P453; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Rug M, 2013, METHOD MOL BIOL, V923, P75, DOI [DOI 10.1007/978-1-62703-026-7_6, 10.1007/978-1-62703-026-7_6]; SACCHETTINI JC, 1986, J BIOL CHEM, V261, P5183; Sanderson T., 2017, Wellcome Open Research, V2, P45, DOI 10.12688/wellcomeopenres.11896.1; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimoyama T, 2007, FEMS MICROBIOL LETT, V270, P207, DOI 10.1111/j.1574-6968.2007.00665.x; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; TEIPEL JW, 1968, J BIOL CHEM, V243, P5684; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UEDA Y, 1991, J BIOCHEM, V109, P728, DOI 10.1093/oxfordjournals.jbchem.a123448; van Vugt-Lussenburg BMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055549; van Vugt-Lussenburg BMA, 2009, MICROBIOL-SGM, V155, P3015, DOI 10.1099/mic.0.030320-0; Weaver T, 2005, ACTA CRYSTALLOGR D, V61, P1395, DOI [10.1107/S0907444905024194, 10.1107/S090744905024194]; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; WEAVER TM, 1993, J MOL BIOL, V231, P141, DOI 10.1006/jmbi.1993.1264; Woo YH, 2015, ELIFE, V4, DOI 10.7554/eLife.06974; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yang M, 2014, METABOLITES, V4, P640, DOI 10.3390/metabo4030640	69	10	10	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5878	5894		10.1074/jbc.M117.816298	http://dx.doi.org/10.1074/jbc.M117.816298			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29449371	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000430497300011
J	Pack, TF; Orlen, MI; Ray, C; Peterson, SM; Caron, MG				Pack, Thomas F.; Orlen, Margo I.; Ray, Caroline; Peterson, Sean M.; Caron, Marc G.			The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION; FUNCTIONAL SELECTIVITY; ADP-RIBOSYLATION; ARRESTIN; KINASES; PHOSPHORYLATION; DESENSITIZATION; DISCOVERY; COMPLEX	The dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) that is critical for many central nervous system functions. The D2R carries out these functions by signaling through two transducers: G proteins and beta-arrestins (beta arrs). Selectively engaging either the G protein or beta arr pathway may be a way to improve drugs targeting GPCRs. The current model of GPCR signal transduction posits a chain of events where G protein activation ultimately leads to beta arr recruitment. GPCR kinases (GRKs), which are regulated by G proteins and whose kinase action facilitates beta arr recruitment, bridge these pathways. Therefore, beta arr recruitment appears to be intimately tied to G protein activation via GRKs. Here we sought to understand howGRK2action at theD2Rwould be disrupted whenGprotein activation is eliminated and the effect of this on beta arr recruitment. Weused two recently developed biased D2R mutants that can preferentially interact either withGproteins or beta arrs as well as a beta arr-biased D2R ligand, UNC9994. With these functionally selective tools, we investigated the mechanism whereby the beta arr-preferring D2R achieves beta arr pathway activation in the complete absence of G protein activation. We describe how direct, G protein-independent recruitment of GRK2 drives interactions at the beta arr-preferring D2R and also contributes to beta arr recruitment at the WT D2R. Additionally, we found an additive interaction between the beta arr-preferring D2R mutant and UNC9994. These results reveal that the D2R can directly recruit GRK2 without G protein activation and that this mechanism may have relevance to achieving beta arr-biased signaling.	[Pack, Thomas F.] Duke Univ, Med Ctr, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Pack, Thomas F.; Orlen, Margo I.; Ray, Caroline; Peterson, Sean M.; Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Sch Med, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	marc.caron@duke.edu		Pack, Thomas/0000-0002-1240-8324; Orlen, Margo/0000-0002-9834-6282; Peterson, Sean/0000-0003-4873-0283	National Institute on Drug Abuse Ruth L. Kirschstein National Research Service [F31 DA041160]; Duke University Biological Sciences Undergraduate Research Fellowship; National Institute of Mental Health [R37 MH073853, U19 MH082441]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA041160] Funding Source: NIH RePORTER	National Institute on Drug Abuse Ruth L. Kirschstein National Research Service; Duke University Biological Sciences Undergraduate Research Fellowship; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institute on Drug Abuse Ruth L. Kirschstein National Research Service Award F31 DA041160 (to T.F.P.), a Duke University Biological Sciences Undergraduate Research Fellowship (to M.I.O.), and National Institute of Mental Health Grants R37 MH073853 and U19 MH082441 (to M.G.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Beautrait A, 2014, J BIOL CHEM, V289, P25262, DOI 10.1074/jbc.M114.593178; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2016, PHARMACOL RES, V111, P1, DOI 10.1016/j.phrs.2016.05.010; Ikeda S., 2007, World patent, Patent No. [WO2007034846, 2007034846]; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; KATADA T, 1982, J BIOL CHEM, V257, P7210; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; Komolov KE, 2017, CELL, V169, P407, DOI 10.1016/j.cell.2017.03.047; KONG GH, 1994, J BIOL CHEM, V269, P13084; KUROSE H, 1983, J BIOL CHEM, V258, P4870; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Peterson SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141637; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urs N M, 2014, Int J Obes Suppl, V4, pS5, DOI 10.1038/ijosup.2014.3; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; Urs NM, 2017, BIOL PSYCHIAT, V81, P78, DOI 10.1016/j.biopsych.2016.10.011; Urs NM, 2015, P NATL ACAD SCI USA, V112, pE2517, DOI 10.1073/pnas.1502740112; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yao XQ, 2017, J BIOL CHEM, V292, P16032, DOI 10.1074/jbc.M117.807461	45	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6161	6171		10.1074/jbc.RA117.001300	http://dx.doi.org/10.1074/jbc.RA117.001300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487132	Green Published, hybrid			2022-12-28	WOS:000430497300032
J	Burchfield, JG; Kebede, MA; Meoli, CC; Stockli, J; Whitworth, PT; Wright, AL; Hoffman, NJ; Minard, AY; Ma, XQ; Krycer, JR; Nelson, ME; Tan, SX; Yau, B; Thomas, KC; Wee, NKY; Khor, EC; Enriquez, RF; Vissel, B; Biden, TJ; Baldock, PA; Hoehn, KL; Cantley, J; Cooney, GJ; James, DE; Fazakerley, DJ				Burchfield, James G.; Kebede, Melkam A.; Meoli, Christopher C.; Stockli, Jacqueline; Whitworth, P. Tess; Wright, Amanda L.; Hoffman, Nolan J.; Minard, Annabel Y.; Ma, Xiuquan; Krycer, James R.; Nelson, Marin E.; Tan, Shi-Xiong; Yau, Belinda; Thomas, Kristen C.; Wee, Natalie K. Y.; Khor, Ee-Cheng; Enriquez, Ronaldo F.; Vissel, Bryce; Biden, Trevor J.; Baldock, Paul A.; Hoehn, Kyle L.; Cantley, James; Cooney, Gregory J.; James, David E.; Fazakerley, Daniel J.			High dietary fat and sucrose result in an extensive and time-dependent deterioration in health of multiple physiological systems in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; BETA-CELL GROWTH; TERM HIGH-FAT; ALZHEIMERS-DISEASE; BONE MASS; GLUCOSE-HOMEOSTASIS; COGNITIVE FUNCTION; DIABETES-MELLITUS; SKELETAL-MUSCLE; CORTICAL BONE	Obesity is associated with metabolic dysfunction, including insulin resistance and hyperinsulinemia, and with disorders such as cardiovascular disease, osteoporosis, and neurodegeneration. Typically, these pathologies are examined in discrete model systems and with limited temporal resolution, and whether these disorders co-occur is therefore unclear. To address this question, here we examined multiple physiological systems in male C57BL/6J mice following prolonged exposure to a high-fat/high-sucrose diet (HFHSD). HFHSD-fed mice rapidly exhibited metabolic alterations, including obesity, hyperleptinemia, physical inactivity, glucose intolerance, peripheral insulin resistance, fasting hyperglycemia, ectopic lipid deposition, and bone deterioration. Prolonged exposure to HFHSD resulted in morbid obesity, ectopic triglyceride deposition in liver and muscle, extensive bone loss, sarcopenia, hyperinsulinemia, and impaired short-term memory. Although many of these defects are typically associated with aging, HFHSD did not alter telomere length in white blood cells, indicating that this diet did not generally promote all aspects of aging. Strikingly, glucose homeostasis was highly dynamic. Glucose intolerance was evident in HFHSD-fed mice after 1 week and was maintained for 24 weeks. Beyond 24 weeks, however, glucose tolerance improved in HFHSD-fed mice, and by 60 weeks, it was indistinguishable from that of chow-fed mice. This improvement coincided with adaptive beta-cell hyperplasia and hyperinsulinemia, without changes in insulin sensitivity in muscle or adipose tissue. Assessment of insulin secretion in isolated islets revealed that leptin, which inhibited insulin secretion in the chow-fed mice, potentiated glucose-stimulated insulin secretion in the HFHSD-fed mice after 60 weeks. Overall, the excessive calorie intake was accompanied by deteriorating function of numerous physiological systems.	[Burchfield, James G.; Kebede, Melkam A.; Meoli, Christopher C.; Stockli, Jacqueline; Hoffman, Nolan J.; Minard, Annabel Y.; Krycer, James R.; Nelson, Marin E.; Yau, Belinda; Thomas, Kristen C.; Cooney, Gregory J.; James, David E.; Fazakerley, Daniel J.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Burchfield, James G.; Meoli, Christopher C.; Stockli, Jacqueline; Whitworth, P. Tess; Wright, Amanda L.; Hoffman, Nolan J.; Minard, Annabel Y.; Ma, Xiuquan; Krycer, James R.; Tan, Shi-Xiong; Thomas, Kristen C.; Wee, Natalie K. Y.; Khor, Ee-Cheng; Enriquez, Ronaldo F.; Vissel, Bryce; Biden, Trevor J.; Baldock, Paul A.; Hoehn, Kyle L.; Cantley, James; James, David E.; Fazakerley, Daniel J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Cooney, Gregory J.; James, David E.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Wright, Amanda L.] Macquarie Univ, Dept Biomed Sci, Ctr Motor Neuron Dis Res, Fac Med, Sydney, NSW 2109, Australia; [Hoffman, Nolan J.] Australian Catholic Univ, Ctr Exercise & Nutr, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia; [Minard, Annabel Y.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Tan, Shi-Xiong] Republ Polytech, Sch Appl Sci, Singapore 738964, Singapore; [Vissel, Bryce] Univ Technol Sydney, Ctr Neurosci & Regenerat Med, Fac Sci, Sydney, NSW 2007, Australia; [Hoehn, Kyle L.] Univ New South Wales, Sch Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia; [Cantley, James] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 2JD, England	University of Sydney; Garvan Institute of Medical Research; University of Sydney; Macquarie University; Australian Catholic University; University of Iowa; University of Technology Sydney; University of New South Wales Sydney; University of Oxford	James, DE (corresponding author), Univ Sydney, D-17 Charles Perkins Ctr, Camperdown, NSW 2006, Australia.	david.james@sydney.edu.au	Stoeckli, Jacqueline/D-7053-2016; Biden, Trevor/AAW-2829-2021; Stoeckli, Jacqueline/Z-4443-2019; Nelson, Marin/AAG-6653-2021; Kebede, Melkam/AAJ-7444-2021; Burchfield, James/C-1779-2019; Baldock, Paul/B-3840-2012; Tan, Shi-Xiong/Y-3728-2019; Fazakerley, Daniel/J-2652-2019; Ma, Hugh/S-4266-2019; Wee, Natalie/AAF-2134-2019	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Kebede, Melkam/0000-0001-9686-7378; Burchfield, James/0000-0002-6609-6151; Fazakerley, Daniel/0000-0001-8241-2903; Ma, Hugh/0000-0001-7227-1289; Yau, Belinda/0000-0003-2303-7343; Nelson, Marin/0000-0001-7001-406X; Wee, Natalie/0000-0002-7314-2646; Tan, Shi-Xiong/0000-0002-0020-2572; Biden, Trevor/0000-0001-5211-0234; Hoehn, Kyle/0000-0002-0214-3238; Krycer, James/0000-0003-1536-7270; Wright, Amanda/0000-0001-7141-6212; Vissel, Bryce/0000-0001-8860-8050; Hoffman, Nolan/0000-0001-5168-7082; Minard, Annabel Yurie/0000-0003-0715-622X; Cooke, Kristen/0000-0002-3534-1660; Cantley, James/0000-0003-2509-1271; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia [1061122, 1086850, 1086851]; Australian post-graduate award; National Health and Medical Research Council of Australia Early Career Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian post-graduate award(Australian Government); National Health and Medical Research Council of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Project Grants 1061122, 1086850 and 1086851 (to D. E. J.) and an Australian post-graduate award (to C. C. M., P. T. W., A. Y. M., A. L. W., and N. K. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a National Health and Medical Research Council of Australia Early Career Fellowship.	Altunkaynak ME, 2008, J ANAT, V212, P845, DOI 10.1111/j.1469-7580.2008.00902.x; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Aslesen R, 2001, J APPL PHYSIOL, V91, P1237, DOI 10.1152/jappl.2001.91.3.1237; Ballard C, 1999, Curr Psychiatry Rep, V1, P49, DOI 10.1007/s11920-999-0010-4; Baquero AF, 2014, J NEUROSCI, V34, P9982, DOI 10.1523/JNEUROSCI.0933-14.2014; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; CHEN C, 1994, J CLIN INVEST, V94, P399, DOI 10.1172/JCI117335; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Devlin MJ, 2014, ENDOCRINOLOGY, V155, P3806, DOI 10.1210/en.2014-1041; Dineley KT, 2014, NEUROBIOL DIS, V72, P92, DOI 10.1016/j.nbd.2014.09.001; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Groop L, 2000, INT J CLIN PRACT, P3; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hamrick M.W., 2007, INT BONE MINER SCI B, V4, P99, DOI [10.1138/20070254, DOI 10.1138/20070254]; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kebede MA, 2014, J CLIN INVEST, V124, P4240, DOI 10.1172/JCI74072; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Kowalski GM, 2017, J ENDOCRINOL, V233, P269, DOI 10.1530/JOE-17-0004; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Murphy EA, 2015, CURR OPIN CLIN NUTR, V18, P515, DOI 10.1097/MCO.0000000000000209; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Oftadeh R, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029176; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rosenkranz SK, 2010, EUR J APPL PHYSIOL, V109, P499, DOI 10.1007/s00421-010-1390-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Stockli J, 2017, J BIOL CHEM, V292, P19135, DOI 10.1074/jbc.M117.818351; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Strachan MWJ, 2003, LANCET, V362, P1253, DOI 10.1016/S0140-6736(03)14615-6; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; VAAG A, 1992, DIABETOLOGIA, V35, P80, DOI 10.1007/BF00400856; van Himbergen TM, 2012, ARCH NEUROL-CHICAGO, V69, P594, DOI 10.1001/archneurol.2011.670; Wauman J, 2011, FRONT BIOSCI-LANDMRK, V16, P2771, DOI 10.2741/3885; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong IPL, 2013, J BONE MINER RES, V28, P886, DOI 10.1002/jbmr.1786; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Wongdee K, 2015, WORLD J DIABETES, V6, P673, DOI 10.4239/wjd.v6.i5.673; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920	62	44	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5731	5745		10.1074/jbc.RA117.000808	http://dx.doi.org/10.1074/jbc.RA117.000808			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440390	hybrid, Green Published			2022-12-28	WOS:000430044100032
J	Banta, KL; Wang, XY; Das, P; Winoto, A				Banta, Karl L.; Wang, Xinyue; Das, Phani; Winoto, Astar			B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2 ' s apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILIZATION; CANCER-THERAPY; BH3 DOMAIN; BH3-ONLY PROTEINS; FAMILY PROTEINS; IMMUNE-SYSTEM; DEATH; NUR77; INHIBITION; BAX	Apoptosis is mediated through the extrinsic or intrinsic pathway. Key regulators of the intrinsic apoptotic pathway are the family of B cell lymphoma 2 (Bcl-2) proteins. The activity of the prototypical Bcl-2 protein is usually considered antiapoptotic. However, under some conditions, Bcl-2 associates with the orphan nuclear hormone receptors Nur77 and Nor-1, converting Bcl-2 into a proapoptotic molecule. Expression of Nur77 and Nor-1 is induced by a variety of signals, including those leading to apoptosis. Translocation of Nur77/Nor-1 to mitochondria results in their association with Bcl-2, exposing the Bcl-2 homology (BH) 3 domain and causing apoptosis. However, the molecular details of this interaction are incompletely understood. Here, through extensive Bcl-2 mutagenesis and functional assays, we identified residues within Bcl-2 that are essential for its interaction with Nur77/Nor-1. Although an initial report has suggested that an unstructured loop region between the Bcl-2 BH4 and BH3 domains is required for Bcl-2's interaction with Nur77/Nor-1, we found that it is dispensable for this interaction. Instead, we found important interacting residues at the BH4 domain and crucial interacting residues between the BH1 and BH2 domains. Bcl-2 alanine mutants at this region could no longer interact with Nur77/Nor-1 and could not initiate Nur77/Bcl-2-mediated cell death. However, they still retained their anti-apoptotic capability in two different death assays. These results establish crucial residues in Bcl-2 required for Nur77/Nor-1-mediated apoptosis and point to potential new strategies for manipulating Bcl-2 function.	[Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu		Wang, Xinyue/0000-0002-9187-5472	National Institutes of Health [CA66236]; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA66236 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Bouillet P, 2002, J CELL SCI, V115, P1567; Burger ML, 2014, ELIFE, V3, DOI 10.7554/eLife.03468; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Godoi PHC, 2016, J BIOL CHEM, V291, P14072, DOI 10.1074/jbc.M116.715235; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kawatani M, 2003, J BIOL CHEM, V278, P19732, DOI 10.1074/jbc.M213038200; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; KINASHI T, 1988, P NATL ACAD SCI USA, V85, P4473, DOI 10.1073/pnas.85.12.4473; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Lee LC, 1996, J BIOL CHEM, V271, P23284, DOI 10.1074/jbc.271.38.23284; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Merino D, 2009, APOPTOSIS, V14, P570, DOI 10.1007/s10495-008-0308-4; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Nagata S, 2017, NAT REV IMMUNOL, V17, P333, DOI 10.1038/nri.2016.153; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Ruefli-Brasse A, 2017, BIOCHEM J, V474, P3643, DOI 10.1042/BCJ20170080; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Tischner D, 2010, Cell Death Dis, V1, pe48, DOI 10.1038/cddis.2010.27; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	61	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4724	4734		10.1074/jbc.RA117.001101	http://dx.doi.org/10.1074/jbc.RA117.001101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414782	Green Published, hybrid			2022-12-28	WOS:000428848300015
J	Clarke, BR; Ovchinnikova, OG; Kelly, SD; Williamson, ML; Butler, JE; Liu, B; Wang, L; Gou, X; Follador, R; Lowary, TL; Whitfield, C				Clarke, Bradley R.; Ovchinnikova, Olga G.; Kelly, Steven D.; Williamson, Monica L.; Butler, Jennifer E.; Liu, Bin; Wang, Lu; Gou, Xi; Follador, Rainer; Lowary, Todd L.; Whitfield, Chris			Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; D-GALACTAN-I; GENOMIC ANALYSIS; SEROTYPE O1-K20; IDENTIFICATION; BIOSYNTHESIS; GENE; RESISTANCE; VIRULENCE; MEMBRANE	Klebsiella pneumoniae is a major health threat. Vaccination and passive immunization are considered as alternative therapeutic strategies for managing Klebsiella infections. Lipopolysaccharide O antigens are attractive candidates because of the relatively small range of known O-antigen polysaccharide structures, but immunotherapeutic applications require a complete understanding of the structures found in clinical settings. Currently, the precise number of Klebsiella O antigens is unknown because available serological tests have limited resolution, and their association with defined chemical structures is sometimes uncertain. Molecular serotyping methods can evaluate clinical prevalence of Oserotypes but require a full understanding of the genetic determinants for each O-antigen structure. This is problematic with Klebsiella pneumoniae because genes outside the main rfb (O-antigen biosynthesis) locus can have profound effects on the final structure. Here, we report two new loci encoding enzymes that modify a conserved polysaccharide backbone comprising disaccharide repeat units [-> 3)-alpha-D-Galp-( 1 -> 3)-beta-D-Galf-(1 ->] (O2a antigen). We identified in serotype O2aeh a three-component system that modifies completed O2a glycan in the periplasm by adding 1,2-linked alpha-Galp side-group residues. In serotype O2ac, a polysaccharide comprising disaccharide repeat units [-> 5)-beta-D-Galf-(1 -> 3)-beta-D-GlcpNAc-(1 ->] (O2c antigen) is attached to the non-reducing termini of O2a-antigen chains. O2c-polysaccharide synthesis is dependent on a locus encoding three glycosyltransferase enzymes. The authentic O2aeh and O2c antigens were recapitulated in recombinant Escherichia coli hosts to establish the essential gene set for their synthesis. These findings now provide a complete understanding of the molecular genetic basis for the known variations in Klebsiella O-antigen carbohydrate structures based on the O2a backbone.	[Clarke, Bradley R.; Ovchinnikova, Olga G.; Kelly, Steven D.; Williamson, Monica L.; Butler, Jennifer E.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Liu, Bin; Wang, Lu; Gou, Xi] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, 23 Hongda St TEDA, Tianjin 300457, Peoples R China; [Follador, Rainer] LimmaTech Biol AG, CH-8952 Schlieren, Switzerland; [Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Guelph; Nankai University; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Kelly, Steven/0000-0003-1250-7055	National Science and Engineering Research Council of Canada; Canadian Glycomics Network	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Glycomics Network	This work was supported by Discovery Grants from the National Science and Engineering Research Council of Canada (to T. L. L. and C. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Research Chair, supported by the Canadian Glycomics Network.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ardiccioni C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10175; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bengoechea JA, 2002, MOL MICROBIOL, V44, P1045, DOI 10.1046/j.1365-2958.2002.02940.x; Bethesda Research Laboratories, 1986, BETHESDA RES LAB FOC, V8, P9; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; CLARK CA, 1991, GENE, V107, P43, DOI 10.1016/0378-1119(91)90295-M; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Davies MR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003568; Fang CT, 2016, J CLIN MICROBIOL, V54, P666, DOI 10.1128/JCM.02494-15; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Gorrie CL, 2017, CLIN INFECT DIS, V65, P208, DOI 10.1093/cid/cix270; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; The HC, 2015, EMBO MOL MED, V7, P227, DOI 10.15252/emmm.201404767; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Hsieh PF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00608; KELLY RF, 1995, J ENDOTOXIN RES, V0002; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; Kintz E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01021-16; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG B, 1973, ACTA CHEM SCAND, V27, P3787, DOI 10.3891/acta.chem.scand.27-3787; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; MACLEAN LL, 1993, CARBOHYD RES, V239, P325, DOI 10.1016/0008-6215(93)84231-T; Mann E, 2016, CAN J CHEM, V94, P883, DOI 10.1139/cjc-2015-0594; Mann E, 2015, J BIOL CHEM, V290, P25561, DOI 10.1074/jbc.M115.660803; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; Miller J. H., 1972, EXPT MOL GENETICS, P432; Nair A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-67; ORSKOV I, 1954, ACTA PATHOL MIC SC, V34, P145; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15573; Pennini ME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02223-7; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Rukavina T, 1997, INFECT IMMUN, V65, P1754, DOI 10.1128/IAI.65.5.1754-1760.1997; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Slauch JM, 1996, J BACTERIOL, V178, P5904, DOI 10.1128/jb.178.20.5904-5909.1996; Stojkovic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00684; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Sun QZ, 2014, J BACTERIOL, V196, P3656, DOI 10.1128/JB.02009-14; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wand ME, 2015, ANTIMICROB AGENTS CH, V59, P3966, DOI 10.1128/AAC.05009-14; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; WHITFIELD C, 1992, J BACTERIOL, V174, P4913, DOI 10.1128/JB.174.15.4913-4919.1992; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200; Young GM, 1997, MOL MICROBIOL, V25, P319, DOI 10.1046/j.1365-2958.1997.4661829.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LJ, 1997, MOL MICROBIOL, V23, P63, DOI 10.1046/j.1365-2958.1997.1871558.x	72	20	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4666	4679		10.1074/jbc.RA117.000646	http://dx.doi.org/10.1074/jbc.RA117.000646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602878	Green Published, hybrid			2022-12-28	WOS:000428848300010
J	Cox, D; Whiten, DR; Brown, JWP; Horrocks, MH; San Gil, R; Dobson, CM; Klenerman, D; van Oijen, AM; Ecroyd, H				Cox, Dezerae; Whiten, Daniel R.; Brown, James W. P.; Horrocks, Mathew H.; San Gil, Rebecca; Dobson, Christopher M.; Klenerman, David; van Oijen, Antoine M.; Ecroyd, Heath			The small heat shock protein Hsp27 binds alpha-synuclein fibrils, preventing elongation and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN C-II; B-CRYSTALLIN; PARKINSONS-DISEASE; AMYLOID FIBRILS; MOLECULAR CHAPERONE; LEWY BODIES; AGGREGATION; DEMENTIA; OLIGOMERS; MUTATION	Proteostasis, or protein homeostasis, encompasses the maintenance of the conformational and functional integrity of the proteome and involves an integrated network of cellular pathways. Molecular chaperones, such as the small heat shock proteins (sHsps), are key elements of the proteostasis network that have crucial roles in inhibiting the aggregation of misfolded proteins. Failure of the proteostasis network can lead to the accumulation of misfolded proteins into intracellular and extracellular deposits. Deposits containing fibrillar forms of alpha-synuclein (alpha-syn) are characteristic of neurodegenerative disorders including Parkinson's disease and dementia with Lewy bodies. Here we show that the sHsp Hsp27 (HSPB1) binds to alpha-syn fibrils, inhibiting fibril growth by preventing elongation. Using total internal reflection fluorescence (TIRF)-based imaging methods, we show that Hsp27 binds along the surface of alpha-syn fibrils, decreasing their hydrophobicity. Binding of Hsp27 also inhibits cytotoxicity of alpha-syn fibrils. Our results demonstrate that the ability of sHsps, such as Hsp27, to bind fibrils represents an important mechanism through which they may mitigate cellular toxicity associated with aberrant protein aggregation. Fibril binding may represent a generic mechanism by which chaperone-active sHsps interact with aggregation-prone proteins, highlighting the potential to target sHsp activity to prevent or disrupt the onset and progression of alpha-syn aggregation associated with alpha-synucleinopathies.	[Cox, Dezerae; Whiten, Daniel R.; Horrocks, Mathew H.; San Gil, Rebecca; van Oijen, Antoine M.; Ecroyd, Heath] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cox, Dezerae; Whiten, Daniel R.; San Gil, Rebecca; Ecroyd, Heath] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Whiten, Daniel R.; Brown, James W. P.; Horrocks, Mathew H.; Dobson, Christopher M.; Klenerman, David] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [van Oijen, Antoine M.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Horrocks, Mathew H.] Univ Edinburgh, Sch Chem, David Brewster Rd, Edinburgh EH9 3FJ, Midlothian, Scotland	University of Wollongong; University of Wollongong; University of Cambridge; University of Wollongong; University of Edinburgh	Ecroyd, H (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.; Ecroyd, H (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	heath_ecroyd@uow.edu.au	Cox, Dezerae/I-7265-2019; van Oijen, Antoine/I-3167-2014; San Gil, Rebecca/S-5661-2019	Cox, Dezerae/0000-0002-5345-8360; van Oijen, Antoine/0000-0002-1794-5161; San Gil, Rebecca/0000-0001-5725-5512; Whiten, Daniel/0000-0002-7853-3566; Klenerman, David/0000-0001-7116-6954; Brown, James/0000-0002-2731-8882; Horrocks, Mathew/0000-0001-5495-5492; Ecroyd, Heath/0000-0001-7574-0044	Faculty of Science, Medicine and Health of the University of Wollongong; Cambridge Centre for Mis-folding Diseases; Australian Postgraduate Award; Australian Research Council Future Fellowship [FT110100586]; Australian Research Council Laureate Fellowship [FL1401000027]; MRC [UKDRI-2003] Funding Source: UKRI	Faculty of Science, Medicine and Health of the University of Wollongong; Cambridge Centre for Mis-folding Diseases; Australian Postgraduate Award(Australian Government); Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council Laureate Fellowship(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Faculty of Science, Medicine and Health of the University of Wollongong and the Cambridge Centre for Mis-folding Diseases (to J.B. and C.M.D.). This work was also supported by an Australian Postgraduate Award (to D.C.), Australian Research Council Future Fellowship FT110100586 (to H.E.), and Australian Research Council Laureate Fellowship FL1401000027 (to. A.O.).	Baba M, 1998, AM J PATHOL, V152, P879; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bongiovanni MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13544; Bruinsma IB, 2011, PROTEINS, V79, P2956, DOI 10.1002/prot.23152; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Glabe C., 2009, OPEN BIOL J, V2, P222; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GREENSPAN P, 1985, J LIPID RES, V26, P781; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Horrocks MH, 2016, ACS CHEM NEUROSCI, V7, P399, DOI 10.1021/acschemneuro.5b00324; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; IWAKI T, 1992, AM J PATHOL, V140, P345; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; LOWE J, 1990, LANCET, V336, P515, DOI 10.1016/0140-6736(90)92075-S; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mizutani T, 1998, ACTA NEUROPATHOL, V95, P15, DOI 10.1007/s004010050761; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shvadchak VV, 2015, J PHYS CHEM B, V119, P1912, DOI 10.1021/jp5111604; Sot B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40859; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wang XH, 2013, J MOL MED, V91, P917, DOI 10.1007/s00109-013-1067-4; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang X., 2013, JOVE-J VIS EXP, V81; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	71	69	71	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4486	4497		10.1074/jbc.M117.813865	http://dx.doi.org/10.1074/jbc.M117.813865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382725	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000428204300020
J	Haque, MM; Tejero, J; Bayachou, M; Kenney, CT; Stuehr, DJ				Haque, Mohammad Mahfuzul; Tejero, Jesus; Bayachou, Mekki; Kenney, Claire T.; Stuehr, Dennis J.			A cross-domain charge interaction governs the activity of NO synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ELECTRON-TRANSFER; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; BILIVERDIN-REDUCTASE; FLAVOPROTEIN DOMAIN; SURFACE-CHARGE; CALMODULIN; FMN	NO synthase (NOS) enzymes perform interdomain electron transfer reactions during catalysis that may rely on complementary charge interactions at domain-domain interfaces. Guided by our previous results and a computer-generated domain-docking model, we assessed the importance of cross-domain charge interactions in the FMN-to-heme electron transfer in neuronal NOS(nNOS). We reversed the charge of three residues (Glu-762, Glu-816, and Glu-819) that form an electronegative triad on the FMN domain and then individually reversed the charges of three electropositive residues (Lys-423, Lys-620, and Lys-660) on the oxygenase domain (NOSoxy), to potentially restore a cross-domain charge interaction with the triad, but in reversed polarity. Charge reversal of the triad completely eliminated heme reduction and NO synthesis in nNOS. These functions were partly restored by the charge reversal at oxygenase residue Lys-423, but not at Lys-620 or Lys-660. Full recovery of heme reduction was probably muted by an accompanying change in FMN midpoint potential that made electron transfer to the heme thermodynamically unfavorable. Our results provide direct evidence that cross-domain charge pairing is required for the FMN-to-heme electron transfer in nNOS. The unique ability of charge reversal at position 423 to rescue function indicates that it participates in an essential cross-domain charge interaction with the FMN domain triad. This supports our domain-docking model and suggests that it may depict a productive electron transfer complex formed during nNOS catalysis.	[Haque, Mohammad Mahfuzul; Kenney, Claire T.; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA; [Tejero, Jesus] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Bayachou, Mekki] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Cleveland State University	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Kenney, Claire/0000-0003-0883-5494; HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [R15 EB019739, R01 GM051491]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB019739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R15 EB019739 (to M. B.) and R01 GM051491 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arnett DC, 2015, FEBS LETT, V589, P1173, DOI 10.1016/j.febslet.2015.03.035; Astashkin AV, 2010, J AM CHEM SOC, V132, P12059, DOI 10.1021/ja104461p; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; DeLano W.L, PYMOL MOL GRAPHICS S; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dutton P L, 1978, Methods Enzymol, V54, P411; Feng CJ, 2012, COORDIN CHEM REV, V256, P393, DOI 10.1016/j.ccr.2011.10.011; Fields JB, 2015, BIOCHEMISTRY-US, V54, P7272, DOI 10.1021/acs.biochem.5b00569; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2013, BIOCHEM J, V450, P607, DOI 10.1042/BJ20121488; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Hedison TM, 2017, NITRIC OXIDE-BIOL CH, V63, P61, DOI 10.1016/j.niox.2016.09.002; Hollingsworth SA, 2016, PROTEIN SCI, V25, P374, DOI 10.1002/pro.2824; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; KLATT P, 1992, J BIOL CHEM, V267, P11374; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Sheng YH, 2015, J INORG BIOCHEM, V153, P186, DOI 10.1016/j.jinorgbio.2015.08.006; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4545	4554		10.1074/jbc.RA117.000635	http://dx.doi.org/10.1074/jbc.RA117.000635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414777	hybrid, Green Published			2022-12-28	WOS:000428204300025
J	Xu, J; Kozlov, G; McPherson, PS; Gehring, K				Xu, Jie; Kozlov, Guennadi; McPherson, Peter S.; Gehring, Kalle			A PH-like domain of the Rab12 guanine nucleotide exchange factor DENND3 binds actin and is required for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; CRYSTAL-STRUCTURE; PROTEINS; FAMILY; GENE; GAPS; SITE; GEFS; SON	Rab GTPases are key regulators of membrane trafficking, and many are activated by guanine nucleotide exchange factors bearing a differentially expressed in normal and neoplastic cells (DENN) domain. By activating the small GTPase Rab12, DENN domain-containing protein 3 (DENND3) functions in autophagy. Here, we identified a structural domain (which we name PHenn) containing a pleckstrin homology subdomain that binds actin and is required for DENND3 function in autophagy. We found that a hydrophobic patch on an extended beta-turn of the PHenn domain mediates an intramolecular interaction with the DENN domain of DENND3. We also show that DENND3 binds actin through a surface of positively charged residues on the PHenn domain. Substitutions that blocked either DENN or actin binding compromised the role of DENND3 in autophagy. These results provide new mechanistic insight into the structural determinants regulating DENND3 in autophagy and lay the foundation for future investigations of the DENN protein family.	[Xu, Jie; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Kozlov, Guennadi; Gehring, Kalle] McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); National Institutes of Health (NIH)/NIGMS, via NSF award [DMR-0225180]; NIH/NCRR award [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)/NIGMS, via NSF award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Tin Pan, Maiwenn Beaugrand, Marie Menade and Veronique Sauve for fragment screening and identifying the crystallization conditions. Diffraction data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health (NIH)/NIGMS, via NSF award DMR-0225180, and the MacCHESS resource is supported by NIH/NCRR award RR-01646.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Caplan S, 2017, J BIOL CHEM, V292, P7283, DOI 10.1074/jbc.H116.772434; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Stiegler AL, 2014, J BIOL CHEM, V289, P25362, DOI 10.1074/jbc.M114.584011; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Xu J, 2017, J BIOL CHEM, V292, P7274, DOI 10.1074/jbc.M116.772434; Xu J, 2015, CELL CYCLE, V14, P2717, DOI 10.1080/15384101.2015.1071136; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4566	4574		10.1074/jbc.RA117.001446	http://dx.doi.org/10.1074/jbc.RA117.001446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29352104	Green Published, hybrid			2022-12-28	WOS:000428204300028
J	Cui, XW; Tan, JM; Shi, YJ; Sun, C; Li, Y; Ji, CB; Wu, J; Zhang, Z; Chen, SY; Guo, XR; Liu, C				Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Li, Yun; Ji, Chenbo; Wu, Jun; Zhang, Zhao; Chen, Siyu; Guo, Xirong; Liu, Chang			The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; SUPPRESSES GLUCONEOGENESIS; EXPRESSION; TRANSCRIPTION; LIVER; ATF4; GLUCOSE-6-PHOSPHATASE; DIFFERENTIATION; HOMEOSTASIS; PREDICTION	Overactivated hepatic gluconeogenesis contributes to the pathogenesis of metabolic disorders, including type 2 diabetes. Precise control of hepatic gluconeogenesis is thus critical for maintaining whole-body metabolic homeostasis. Long non-coding RNAs (lncRNAs) have been shown to play key roles in diseases by regulating diverse biological processes, but the function of lncRNAs in maintaining normal physiology, particularly glucose homeostasis in the liver, remains largely unexplored. We identified a novel liver-enriched long non-coding RNA, Gm10768, and examined its expression patterns under pathophysiological conditions. We further adopted gain-and loss-offunction strategies to explore the effect of Gm10768 on hepatic glucose metabolism and the possible molecular mechanism involved. Our results showed that the expression of Gm10768 was significantly increased in the liver of fasted mice and was induced by gluconeogenic hormonal stimuli. Functionally, overexpression of Gm10768 activated hepatic gluconeogenesis in a cell-autonomous manner. In contrast, depletion of Gm10768 suppressed hepatic glucose production both in vitro and in vivo. Adenovirus-mediated hepatic knockdown of Gm10768 improved glucose tolerance and hyperglycemia of diabetic db/db mice. Mechanistically, Gm10768 sequestrated microRNA-214 (miR-214) to relieve its suppression on activating transcription factor 4 (ATF4), a positive regulator of hepatic gluconeogenesis. Taken together, we identified Gm10768 as a new lncRNA activating hepatic gluconeogenesis through antagonizing miR-214 in mice.	[Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Zhang, Zhao; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Cui, Xianwei; Tan, Jingmin; Shi, Yujie; Sun, Chen; Zhang, Zhao; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Cui, Xianwei; Li, Yun; Ji, Chenbo; Guo, Xirong] Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing Maternal & Child Hlth Hosp, Nanjing 210004, Jiangsu, Peoples R China; [Wu, Jun] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr Cardiol, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Siyu; Liu, Chang] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 211198, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University	Liu, C (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Liu, C (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.; Chen, SY (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 211198, Jiangsu, Peoples R China.; Guo, XR (corresponding author), Nanjing Med Univ, Obstet & Gynecol Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing 210004, Jiangsu, Peoples R China.	chensiyujimmy@163.com; xrguo@njmu.edu.cn; changliu@njnu.edu.cn		Chen, Siyu/0000-0002-3809-1062; Wu, Jun/0000-0003-4605-1148	National Natural Science Foundation of China [31771298, 31422028, 81670773, 81770837, 81301616]; National Science Foundation of Jiangsu Province of China [BK20161057]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Jiangsu Province of China; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 31771298, 31422028, 81670773, 81770837, and 81301616, National Science Foundation of Jiangsu Province of China Grant BK20161057, the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Bantubungi K, 2014, DIABETES, V63, P3199, DOI 10.2337/db13-1921; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Cui XW, 2016, FASEB J, V30, P4301, DOI 10.1096/fj.201600694R; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Kaur K, 2015, DIABETES, V64, P3659, DOI 10.2337/db14-1924; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Li MX, 2016, BBA-GENE REGUL MECH, V1859, P871, DOI 10.1016/j.bbagrm.2016.05.003; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Li WQ, 2015, J GERONTOL A-BIOL, V70, P263, DOI 10.1093/gerona/glu040; Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024; Liu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6684; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes RK, 2014, GENE EXPRESSION, V16, P85, DOI 10.3727/105221614X13919976902093; Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151; Ruan XB, 2016, CELL REP, V14, P1867, DOI 10.1016/j.celrep.2016.01.062; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sharabi K, 2015, MOL ASPECTS MED, V46, P21, DOI 10.1016/j.mam.2015.09.003; Thiel G, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-2; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhu X, 2016, BIOCHEM BIOPH RES CO, V469, P319, DOI 10.1016/j.bbrc.2015.11.048; Zhuo S, 2016, DIABETES, V65, P3276, DOI 10.2337/db16-0166	33	20	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4097	4109		10.1074/jbc.M117.812818	http://dx.doi.org/10.1074/jbc.M117.812818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29363576	Green Published, hybrid			2022-12-28	WOS:000427587500021
J	Mann, D; Guldenhaupt, J; Schartner, J; Gerwert, K; Kotting, C				Mann, Daniel; Gueldenhaupt, Joern; Schartner, Jonas; Gerwert, Klaus; Koetting, Carsten			The protonation states of GTP and GppNHp in Ras proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY RELATIONSHIPS; P-31 NMR-SPECTROSCOPY; CONFORMATIONAL STATES; GAMMA-PHOSPHATE; MOLECULAR SIMULATION; PERTURBATION-THEORY; QM/MM SIMULATIONS; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION; HYDROGEN-BONDS	The small GTPase Ras transmits signals in a variety of cellular signaling pathways, most prominently in cell proliferation. GTP hydrolysis in the active center of Ras acts as a prototype for many GTPases and is the key to the understanding of several diseases, including cancer. Therefore, Ras has been the focus of intense research over the last decades. A recent neutron diffraction crystal structure of Ras indicated a protonated gamma-guanylyl imidodiphosphate (gamma-GppNHp) group, which has put the protonation state of GTP in question. A possible protonation of GTP was not considered in previously published mechanistic studies. To determine the detailed prehydrolysis state of Ras, we calculated infrared and NMR spectra from quantum mechanics/molecular mechanics (QM/MM) simulations and compared them with those from previous studies. Furthermore, we measured infrared spectra of GTP and several GTP analogs bound to lipidated Ras on a membrane system under near-native conditions. Our findings unify results from previous studies and indicate a structural model confirming the hypothesis that gamma-GTP is fully deprotonated in the prehydrolysis state of Ras.	[Mann, Daniel; Gueldenhaupt, Joern; Schartner, Jonas; Gerwert, Klaus; Koetting, Carsten] Ruhr Univ Bochum, Dept Biophys, D-44780 Bochum, Germany; [Gerwert, Klaus] Chinese Acad Sci, Max Planck Gesell, PICB, Shanghai 200031, Peoples R China	Ruhr University Bochum; Chinese Academy of Sciences; Max Planck Society	Gerwert, K; Kotting, C (corresponding author), Univ Str 150, D-44780 Bochum, Germany.	gerwert@bph.rub.de; carsten.koetting@rub.de	Gerwert, Klaus/G-7311-2015; Kötting, Carsten/A-8266-2008	Kötting, Carsten/0000-0002-3599-9657; Mann, Daniel/0000-0002-9106-9358	Deutsche Forschungsgemeinschaft [SFB 642]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 642, TP A1. The authors declare that they have no conflicts of interest with the contents of this article.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Broyden C. G., 1970, J I MATH ITS APPL, V6, P76, DOI [10.1093/imamat/6.1.76, DOI 10.1093/IMAMAT/6.1.76]; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; Case DA, 2014, AMBER 14; Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789; Cheng H, 2001, J BIOL CHEM, V276, P9931, DOI 10.1074/jbc.M009295200; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; DITCHFIELD R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; Frisch M.J., 2009, GAUSSIAN 09 REVISION; Glennon TM, 2000, BIOCHEMISTRY-US, V39, P9641, DOI 10.1021/bi000640e; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; Guldenhaupt J, 2008, FEBS J, V275, P5910, DOI 10.1111/j.1742-4658.2008.06720.x; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; Howeler U., 2007, MAXIMOBY 11 1; Iuga A, 2004, J MOL BIOL, V342, P1033, DOI 10.1016/j.jmb.2004.07.077; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t; Knihtila R, 2015, J BIOL CHEM, V290, P31025, DOI 10.1074/jbc.M115.679860; Kotting C, 2015, BIOL CHEM, V396, P131, DOI 10.1515/hsz-2014-0219; Kotting C, 2012, CHEM PHYS, V396, P72, DOI 10.1016/j.chemphys.2011.08.007; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; Li ZL, 2016, BIOPHYS J, V110, P1033, DOI 10.1016/j.bpj.2016.01.020; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; London F, 1937, J PHYS-PARIS, V8, P397, DOI 10.1051/jphysrad:01937008010039700; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Mann D, 2017, BIOPHYS J, V112, P66, DOI 10.1016/j.bpj.2016.11.3195; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; MCWEENY R, 1962, PHYS REV, V126, P1028, DOI 10.1103/PhysRev.126.1028; Nagele E, 1998, J AM CHEM SOC, V120, P6889, DOI 10.1021/ja9805627; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rudack T, 2015, J BIOL CHEM, V290, P24079, DOI 10.1074/jbc.M115.648071; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Spoerner M, 2005, MAGN RESON CHEM, V43, pS74, DOI 10.1002/mrc.1693; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Topol IA, 2004, BBA-PROTEINS PROTEOM, V1700, P125, DOI 10.1016/j.bbapap.2004.04.007; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VEDANI A, 1991, J AM CHEM SOC, V113, P5860, DOI 10.1021/ja00015a049; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2006, ANN REP COMP CHEM, V2, P35, DOI 10.1016/S1574-1400(06)02003-2; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Wang JH, 1998, BIOSPECTROSCOPY, V4, P219, DOI 10.1002/(SICI)1520-6343(1998)4:4<219::AID-BSPY1>3.3.CO;2-K; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Xia F, 2011, PHYS CHEM CHEM PHYS, V13, P21451, DOI 10.1039/c1cp22741f; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	61	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3871	3879		10.1074/jbc.RA117.001110	http://dx.doi.org/10.1074/jbc.RA117.001110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382720	Green Published, hybrid			2022-12-28	WOS:000427587500001
J	Arakaki, AKS; Pan, WA; Lin, HL; Trejo, J				Arakaki, Aleena K. S.; Pan, Wen-An; Lin, Huilan; Trejo, JoAnn			The alpha-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-RECEPTOR; ACTIVATED RECEPTOR-1; CANCER PROGRESSION; CELL INVASION; PROSTATE-CANCER; TUMOR INVASION; PAR1; UBIQUITINATION; METASTASIS; EXPRESSION	Aberrant G protein-coupled receptor (GPCR) expression and activation has been linked to tumor initiation, progression, invasion, and metastasis. However, compared with other cancer drivers, the exploitation of GPCRs as potential therapeutic targets has been largely ignored, despite the fact that GPCRs are highly druggable. Therefore, to advance the potential status of GPCRs as therapeutic targets, it is important to understand how GPCRs function together with other cancer drivers during tumor progression. We now report that the alpha-arrestin domain-containing protein-3 (ARRDC3) acts as a tumor suppressor in part by controlling signaling and trafficking of the GPCR, protease-activated receptor-1 (PAR1). In a series of highly invasive basal-like breast carcinomas, we found that expression of ARRDC3 is suppressed whereas PAR1 is aberrantly over-expressed because of defective lysosomal sorting that results in persistent signaling. Using a lentiviral doxycycline-inducible system, we demonstrate that re-expression of ARRDC3 in invasive breast carcinoma is sufficient to restore normal PAR1 trafficking through the ALG-interacting protein X (ALIX)-dependent lysosomal degradative pathway. We also show that ARRDC3 re-expression attenuates PAR1-stimulated persistent signaling of c-Jun N-terminal kinase (JNK) in invasive breast cancer. Remarkably, restoration of ARRDC3 expression significantly reduced activated PAR1-induced breast carcinoma invasion, which was also dependent on JNK signaling. These findings are the first to identify a critical link between the tumor suppressor ARRDC3 and regulation of GPCR trafficking and signaling in breast cancer.	[Arakaki, Aleena K. S.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Arakaki, Aleena K. S.; Pan, Wen-An; Lin, Huilan; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Arakaki, Aleena/0000-0002-2900-078X	NIGMS, National Institutes of Health [RO1 GM090689]; NIGMS, National Institutes of Health from the Pharmacological Sciences Training Program [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, T32GM007752] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health from the Pharmacological Sciences Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health, Grant RO1 GM090689 (to J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health, Grant T32 GM007752 from the Pharmacological Sciences Training Program.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bar-Shavit R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081320; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dores MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157587; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flaumenhaft R, 2017, TRENDS PHARMACOL SCI, V38, P701, DOI 10.1016/j.tips.2017.05.001; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Hamilton JR, 2017, ANNU REV PHARMACOL, V57, P349, DOI 10.1146/annurev-pharmtox-011613-140016; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Hawes BE, 2015, EUR J PHARMACOL, V762, P221, DOI 10.1016/j.ejphar.2015.05.046; Hernandez NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-47; Huan DW, 2016, INT J CLIN EXP PATHO, V9, P5588; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Juneja J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026085; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Korkola JE, 2003, CANCER RES, V63, P7167; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kuzumaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044368; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Puca L, 2014, J CELL SCI, V127, P1359, DOI 10.1242/jcs.142539; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sayyah J, 2014, J BIOL CHEM, V289, P17689, DOI 10.1074/jbc.M113.536227; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Shi XL, 2004, MOL CANCER RES, V2, P395; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh A, 2015, EUR J PHARMACOL, V763, P178, DOI 10.1016/j.ejphar.2015.05.011; Smith TH, 2017, J BIOL CHEM, V292, P13867, DOI 10.1074/jbc.M117.782359; Soung YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03846; Sriram K., 2018, MOL PHARM, DOI [10.1124/mol.117.111062CrossRefMedline, DOI 10.1124/MOL.117.111062CROSSREFMEDLINE]; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang D, 2014, MOL CELL BIOCHEM, V396, P67, DOI 10.1007/s11010-014-2143-y; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yao JJ, 2016, BIOCHEM BIOPH RES CO, V474, P213, DOI 10.1016/j.bbrc.2016.04.107; Zheng Y, 2017, CURR MOL MED, V17, P221, DOI 10.2174/1566524017666170807144711; Zhu LY, 2012, ONCOL REP, V28, P553, DOI 10.3892/or.2012.1851	67	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3350	3362		10.1074/jbc.RA117.001516	http://dx.doi.org/10.1074/jbc.RA117.001516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348172	Green Published, hybrid			2022-12-28	WOS:000426562800026
J	Okamoto, Y; Shikano, S				Okamoto, Yukari; Shikano, Sojin			Positive zip coding in small protein translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						endoplasmic reticulum (ER); translocation; signal recognition particle (SRP); secretion; ribosome; charge; positive; posttranslational; signal peptide	CONTRIBUTES	Most newly synthesized proteins destined for the secretory pathway contain a signal peptide (SP) that triggers cotranslational translocation into the endoplasmic reticulum (ER). However, how small polypeptides undergo ER translocation is not fully understood. In this issue of JBC, Guo et al. describe a mechanism for posttranslational translocation of small secretory proteins featuring a positive charge within the SP N-terminal region. Defects in this element disrupt proper secretion and explain the effects of genetic mutations associated with one type of diabetes.	[Okamoto, Yukari; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MBRB 2002, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave,MBRB 2002, Chicago, IL 60607 USA.	sshikano@uic.edu			National Institutes of Health [R01 GM099974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099974 (to S. S.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Guo H, 2018, J BIOL CHEM, V293, P1899, DOI 10.1074/jbc.RA117.000922; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson ST, 2008, APPL PHYSIOL NUTR ME, V33, P797, DOI 10.1139/H08-055; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	10	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1908	1909		10.1074/jbc.H118.001415	http://dx.doi.org/10.1074/jbc.H118.001415			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29462795	hybrid, Green Published			2022-12-28	WOS:000424948000006
J	Podar, D; Scherer, J; Noordally, Z; Herzyk, P; Nies, D; Sanders, D				Podar, Dorina; Scherer, Judith; Noordally, Zeenat; Herzyk, Pawel; Nies, Dietrich; Sanders, Dale			Metal selectivity determinants in a family of transition metal transporters (vol 287, pg 3185, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Podar, Dorina/B-8702-2012; Podar, Dorina/AAK-3437-2021; Nies, Dietrich H/H-4143-2011	Podar, Dorina/0000-0002-0955-7425; Podar, Dorina/0000-0002-0955-7425; 				Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					402	402		10.1074/jbc.AAC117.001146	http://dx.doi.org/10.1074/jbc.AAC117.001146			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29305525	Green Published, hybrid			2022-12-28	WOS:000419453200034
J	Zhang, YJ; Guan, QY; Liu, Y; Zhang, YW; Chen, YL; Chen, JL; Liu, YL; Su, ZG				Zhang, Yanjie; Guan, Qiuyue; Liu, Yin; Zhang, Yuwei; Chen, Yulong; Chen, Jinglu; Liu, Yulan; Su, Zhiguang			Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; transcription regulation; gluconeogenesis; gene knockout; mouse; CREB; G6Pase; glucagon; nuclear factor Y; PEPCK	CAMP-RESPONSIVE ELEMENT; NF-Y; GENE PROMOTER; INSULIN; CREB; IDENTIFICATION; ACTIVATION; GLUCAGON; HYPERGLYCEMIA; METABOLISM	Hepatic gluconeogenesis is essential to maintain blood glucose levels, and its abnormal activation leads to hyperglycemia and type 2 diabetes. However, the molecular mechanisms in the regulation of hepatic gluconeogenesis remain to be fully defined. In this study, using murine hepatocytes and a liver-specific knockout mouse model, we explored the physiological role of nuclear factor Y (NF-Y) in regulating hepatic glucose metabolism and the underlying mechanism. We found that NF-Y targets the gluconeogenesis pathway in the liver. Hepatic NF-Y expression was effectively induced by cAMP, glucagon, and fasting in vivo. Lentivirus-mediated NF-Y overexpression in Hepa1-6 hepatocytes markedly raised the gluconeogenic gene expression and cellular glucose production compared with empty vector control cells. Conversely, CRISPR/Cas9-mediated knockdown of NF-Y subunit A (NF-YA) attenuated gluconeogenic gene expression and glucose production. We also provide evidence indicating that CRE-loxP-mediated, liver-specific NF-YA knockout compromises hepatic glucose production. Mechanistically, luciferase reporter gene assays and ChIP analysis indicated that NF-Y activates transcription of the gluconeogenic genes Pck1 and G6pc, by encoding phosphoenolpyruvate carboxykinase (PEPCK) and the glucose-6-phosphatase catalytic subunit (G6Pase), respectively, via directly binding to the CCAAT regulatory sequence motif in their promoters. Of note, NF-Y enhanced gluconeogenesis by interacting with cAMP-responsive element-binding protein (CREB). Overall, our results reveal a previously unrecognized physiological function of NF-Y in controlling glucose metabolism by up-regulating the gluconeogenic genes Pck1 and G6pc. Modulation of hepatic NF-Y expression may therefore offer an attractive therapeutic approach to manage type 2 diabetes.	[Zhang, Yanjie; Liu, Yin; Chen, Yulong; Chen, Jinglu; Liu, Yulan; Su, Zhiguang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yanjie; Liu, Yin; Chen, Yulong; Chen, Jinglu; Liu, Yulan; Su, Zhiguang] Collaborat Innovat Ctr, Chengdu 610041, Sichuan, Peoples R China; [Guan, Qiuyue] Peoples Hosp Sichuan Prov, Dept Geriatr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yuwei] Sichuan Univ, West China Hosp, Div Endocrinol & Metab, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University	Su, ZG (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China.	zhiguang.su@scu.edu.cn	Su, Zhiguang/AFS-0022-2022	Su, Zhiguang/0000-0001-8635-9310	National Natural Science Foundation of China [81770814, 31501016]; Sichuan Province Science and Technology Support Program [2015SZ0140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Support Program	This work was supported by National Natural Science Foundation of China Grants 81770814 and 31501016 and Sichuan Province Science and Technology Support Program Grant 2015SZ0140. The authors declare that they have no conflicts of interest with the contents of this article.	An HY, 2016, J ENDOCRINOL, V228, pR97, DOI 10.1530/JOE-15-0447; Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Bhattacharya A, 2003, CANCER RES, V63, P8167; BOULARAND S, 1995, J BIOL CHEM, V270, P3757, DOI 10.1074/jbc.270.8.3757; Bungartz G, 2012, BLOOD, V119, P1380, DOI 10.1182/blood-2011-06-359406; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cluck MW, 2003, MOL CELL ENDOCRINOL, V210, P63, DOI 10.1016/j.mce.2003.08.005; Cote F, 2002, J NEUROCHEM, V81, P673, DOI 10.1046/j.1471-4159.2002.00890.x; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; Farhy LS, 2015, CURR OPIN CLIN NUTR, V18, P407, DOI 10.1097/MCO.0000000000000192; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; KINANE TB, 1993, J BIOL CHEM, V268, P24669; Kuang JY, 2014, FEBS LETT, V588, P1071, DOI 10.1016/j.febslet.2014.02.029; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Liu Y, 2017, J BIOL CHEM, V292, P13959, DOI [10.1074/jbc.M117.782391, 10.1074/jbc.m117.782391]; Luo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00136; Maity SN, 2017, BBA-GENE REGUL MECH, V1860, P598, DOI 10.1016/j.bbagrm.2016.10.014; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Osawa H, 1996, J BIOL CHEM, V271, P17296, DOI 10.1074/jbc.271.29.17296; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Rangan VS, 1996, J BIOL CHEM, V271, P2307, DOI 10.1074/jbc.271.4.2307; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; SanchezGutierrez JC, 1997, ENDOCRINOLOGY, V138, P2443, DOI 10.1210/en.138.6.2443; Su Z, 2008, INT J OBESITY, V32, P1180, DOI 10.1038/ijo.2008.56; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Tengholm A, 2017, DIABETES OBES METAB, V19, P42, DOI 10.1111/dom.12993; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316	40	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7894	7904		10.1074/jbc.RA117.000508	http://dx.doi.org/10.1074/jbc.RA117.000508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29530977	hybrid, Green Published			2022-12-28	WOS:000437256500036
J	Fazakerley, DJ; Minard, AY; Krycer, JR; Thomas, KC; Stockli, J; Harney, DJ; Burchfield, JG; Maghzal, GJ; Caldwell, ST; Hartley, RC; Stocker, R; Murphy, MP; James, DE				Fazakerley, Daniel J.; Minard, Annabel Y.; Krycer, James R.; Thomas, Kristen C.; Stockli, Jacqueline; Harney, Dylan. J.; Burchfield, James G.; Maghzal, Ghassan J.; Caldwell, Stuart T.; Hartley, Richard C.; Stocker, Roland; Murphy, Michael P.; James, David E.			Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide ion; oxidative stress; hydrogen peroxide; mitochondria; insulin resistance; insulin; adipocyte; muscle; adipose tissue; Mitochondrial dysfunction	ACTIVATED PROTEIN-KINASE; MANGANESE SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; IN-VIVO; GLUCOSE-UPTAKE; COMPLEX-III; MICE; FAT; OBESITY; GLUT4	Mitochondrial oxidative stress, mitochondrial dysfunction, or both have been implicated in insulin resistance. However, disentangling the individual roles of these processes in insulin resistance has been difficult because they often occur in tandem, and tools that selectively increase oxidant production without impairing mitochondrial respiration have been lacking. Using the dimer/monomer status of peroxiredoxin isoforms as an indicator of compartmental hydrogen peroxide burden, we provide evidence that oxidative stress is localized to mitochondria in insulin-resistant 3T3-L1 adipocytes and adipose tissue from mice. To dissociate oxidative stress from impaired oxidative phosphorylation and study whether mitochondrial oxidative stress per se can cause insulin resistance, we used mitochondria-targeted paraquat (MitoPQ) to generate superoxide within mitochondria without directly disrupting the respiratory chain. At 10 m, MitoPQ specifically increased mitochondrial superoxide and hydrogen peroxide without altering mitochondrial respiration in intact cells. Under these conditions, MitoPQ impaired insulin-stimulated glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in both adipocytes and myotubes. MitoPQ recapitulated many features of insulin resistance found in other experimental models, including increased oxidants in mitochondria but not cytosol; a more profound effect on glucose transport than on other insulin-regulated processes, such as protein synthesis and lipolysis; an absence of overt defects in insulin signaling; and defective insulin- but not AMP-activated protein kinase (AMPK)-regulated GLUT4 translocation. We conclude that elevated mitochondrial oxidants rapidly impair insulin-regulated GLUT4 translocation and significantly contribute to insulin resistance and that MitoPQ is an ideal tool for studying the link between mitochondrial oxidative stress and regulated GLUT4 trafficking.	[Fazakerley, Daniel J.; Minard, Annabel Y.; Krycer, James R.; Thomas, Kristen C.; Stockli, Jacqueline; Harney, Dylan. J.; Burchfield, James G.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW 2010, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Caldwell, Stuart T.; Hartley, Richard C.] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Minard, Annabel Y.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Sydney; University of Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Glasgow; University of Cambridge; University of Iowa	James, DE (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.	david.james@sydney.edu.au	Hartley, Richard/AAT-7834-2020; Stocker, Roland/AAV-4489-2021; Stocker, Roland/L-9157-2019; Stoeckli, Jacqueline/Z-4443-2019; Burchfield, James/C-1779-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Caldwell, Stuart/J-8863-2014; Hartley, Richard/E-3489-2010; Murphy, Michael/C-2120-2009	Hartley, Richard/0000-0003-1033-5405; Stoeckli, Jacqueline/0000-0002-6446-7350; Burchfield, James/0000-0002-6609-6151; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Caldwell, Stuart/0000-0003-1604-3462; Hartley, Richard/0000-0003-1033-5405; Murphy, Michael/0000-0003-1115-9618; Krycer, James/0000-0003-1536-7270; Minard, Annabel Yurie/0000-0003-0715-622X; Cooke, Kristen/0000-0002-3534-1660; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia (NHMRC) [1061122, 1086850]; Diabetes Australia Research Program [Y17G-BURJ]; Medical Research Council UK Grant [MC_U105663142]; Wellcome Trust Investigator Award [110159/Z/15/Z, 110158/Z/15/Z]; NHMRC Early Career Fellowship; MRC [MC_U105663142, MC_UU_00015/3] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Medical Research Council UK Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grants 1061122 and 1086850 (to D.E.J.) and Diabetes Australia Research Program Grant Y17G-BURJ (to J.G.B. and D.J.F.). This work was also supported by Medical Research Council UK Grant MC_U105663142, by Wellcome Trust Investigator Award 110159/Z/15/Z (to M.P.M.), and by Wellcome Trust Investigator Award 110158/Z/15/Z (to R.C.H.). The authors declare that they have no conflicts of interest with the contents of this article. The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of NHMRC.; Supported by an NHMRC Early Career Fellowship.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andersson S, 2009, EUR J ORG CHEM, V2009, P1163, DOI 10.1002/ejoc.200801012; Bayer SB, 2013, FASEB J, V27, P4659, DOI 10.1096/fj.13-227298.ERR; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; Burchfield JG, 2018, J BIOL CHEM, V293, P5731, DOI [10.1074/jbc.RA117.000808, 10.1074/jbc.ra117.000808]; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Dube JJ, 2014, AM J PHYSIOL-ENDOC M, V307, pE1117, DOI 10.1152/ajpendo.00257.2014; Fazakerley DJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32111; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Fletcher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095598; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kleinridders A, 2013, J CLIN INVEST, V123, P4667, DOI 10.1172/JCI67615; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krycer JR, 2017, BIOCHEM BIOPH RES CO, V489, P399, DOI 10.1016/j.bbrc.2017.05.151; KUSUNOKI M, 1993, AM J PHYSIOL, V264, pE167, DOI 10.1152/ajpendo.1993.264.2.E167; Lark DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126732; Lee HY, 2017, DIABETES, V66, P2072, DOI 10.2337/db16-1334; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; MARTIN IK, 1995, AM J PHYSIOL-ENDOC M, V269, pE583, DOI 10.1152/ajpendo.1995.269.3.E583; Martin SD, 2014, MOL METAB, V3, P408, DOI 10.1016/j.molmet.2014.02.001; Mottis A, 2014, MAMM GENOME, V25, P424, DOI 10.1007/s00335-014-9525-z; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, pE1249, DOI 10.1152/ajpendo.2001.281.6.E1249; Paglialunga S, 2015, DIABETOLOGIA, V58, P1071, DOI 10.1007/s00125-015-3531-x; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Patterson HC, 2015, P NATL ACAD SCI USA, V112, pE5679, DOI 10.1073/pnas.1517932112; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	61	68	69	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7315	7328		10.1074/jbc.RA117.001254	http://dx.doi.org/10.1074/jbc.RA117.001254			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29599292	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000432174500025
J	Wang, SJ; Mao, Y; Narimatsu, Y; Ye, ZL; Tian, WH; Goth, CK; Lira-Navarrete, E; Pedersen, NB; Benito-Vicente, A; Martin, C; Uribe, KB; Hurtado-Guerrero, R; Christoffersen, C; Seidah, NG; Nielsen, R; Christensen, EI; Hansen, L; Bennett, EP; Vakhrushev, SY; Schjoldager, KT; Clausen, H				Wang, Shengjun; Mao, Yang; Narimatsu, Yoshiki; Ye, Zilu; Tian, Weihua; Goth, Christoffer K.; Lira-Navarrete, Erandi; Pedersen, Nis B.; Benito-Vicente, Asier; Martin, Cesar; Uribe, Kepa B.; Hurtado-Guerrero, Ramon; Christoffersen, Christina; Seidah, Nabil G.; Nielsen, Rikke; Christensen, Erik I.; Hansen, Lars; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Clausen, Henrik			Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; glycosyltransferase; lipid metabolism; lipoprotein receptor; low-density lipoprotein (LDL); GALNT; O-glycosylation; lipophorin receptor	MONENSIN-RESISTANT MUTANT; LDL RECEPTOR; LINKED GLYCOSYLATION; BINDING DOMAIN; RAP COMPLEX; RECOGNITION; GLYCOPROTEOME; CELLS; EXPRESSION; DROSOPHILA	The low-density lipoprotein receptor (LDLR) and related receptors are important for the transport of diverse biomolecules across cell membranes and barriers. Their functions are especially relevant for cholesterol homeostasis and diseases, including neurodegenerative and kidney disorders. Members of the LDLR-related protein family share LDLR class A (LA) repeats providing binding properties for lipoproteins and other biomolecules. We previously demonstrated that short linker regions between these LA repeats contain conserved O-glycan sites. Moreover, we found that O-glycan modifications at these sites are selectively controlled by the GalNAc-transferase isoform, GalNAc-T11. However, the effects of GalNAc-T11-mediated O-glycosylation on LDLR and related receptor localization and function are unknown. Here, we characterized O-glycosylation of LDLR-related proteins and identified conserved O-glycosylation sites in the LA linker regions of VLDLR, LRP1, and LRP2 (Megalin) from both cell lines and rat organs. Using a panel of gene-edited isogenic cell line models, we demonstrate that GalNAc-T11-mediated LDLR and VLDLR O-glycosylation is not required for transport and cell-surface expression and stability of these receptors but markedly enhances LDL and VLDL binding and uptake. Direct ELISA-based binding assays with truncated LDLR constructs revealed that O-glycosylation increased affinity for LDL by approximate to 5-fold. The molecular basis for this observation is currently unknown, but these findings open up new avenues for exploring the roles of LDLR-related proteins in disease.	[Wang, Shengjun; Mao, Yang; Narimatsu, Yoshiki; Ye, Zilu; Tian, Weihua; Goth, Christoffer K.; Lira-Navarrete, Erandi; Pedersen, Nis B.; Hansen, Lars; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Wang, Shengjun; Mao, Yang; Narimatsu, Yoshiki; Ye, Zilu; Tian, Weihua; Goth, Christoffer K.; Lira-Navarrete, Erandi; Pedersen, Nis B.; Hansen, Lars; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Benito-Vicente, Asier; Martin, Cesar; Uribe, Kepa B.] Univ Basque Country, CSIC, Biofis Inst, Bilbao 48080, Spain; [Benito-Vicente, Asier; Martin, Cesar; Uribe, Kepa B.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, BIFI Inst Quim Fis Rocasolano IQFR, CSIC Joint Unit, Mariano Esquillor S-N,Campus Rio Ebro, E-50009 Zaragoza, Spain; [Christoffersen, Christina] Univ Copenhagen, Dept Clin Biochem, Rigshosp, DK-2100 Copenhagen, Denmark; [Christoffersen, Christina] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Nielsen, Rikke; Christensen, Erik I.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Rigshospitalet; University of Copenhagen; University of Copenhagen; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Aarhus University	Schjoldager, KT; Clausen, H (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	schjoldager@sund.ku.dk; hclau@sund.ku.dk	Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021; Seidah, Nabil/I-3596-2013; Uribe, Kepa B./AAC-2163-2019; Vakhrushev, Sergey Y/A-7638-2014; Tian, Weihua/AAC-8919-2022; marttin, cesar/GWC-4638-2022; Lira-Navarrete, Erandi/L-5359-2015; Uribe, Kepa B./AGZ-5717-2022; Borbye-Lorenzen, Nis/J-6369-2014; martin, cesar/L-1303-2014; Narimatsu, Yoshiki/G-8388-2019	Bennett, Eric/0000-0002-4976-0647; Seidah, Nabil/0000-0001-6503-9342; Uribe, Kepa B./0000-0002-4502-4853; Vakhrushev, Sergey Y/0000-0002-0418-5765; Uribe, Kepa B./0000-0002-4502-4853; Borbye-Lorenzen, Nis/0000-0003-3725-4533; Tian, Weihua/0000-0003-2357-3947; martin, cesar/0000-0002-4087-8729; Clausen, Henrik/0000-0002-0915-5055; Nielsen, Rikke/0000-0003-3105-3474; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Goth, Christoffer/0000-0002-5766-1411; Ye, Zilu/0000-0001-8829-6579; Christoffersen, Christina/0000-0003-3751-5203; Mao, Yang/0000-0002-9674-1158; Narimatsu, Yoshiki/0000-0003-1428-5695	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Mizutani Foundation; Novo Nordisk Foundation; Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation [DNRF107]; Lundbeck Foundation [R5-2006-542, R223-2016-563] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0003898, NNF17OC0026030] Funding Source: researchfish	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation(Lundbeckfonden); A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat, the Kirsten og Freddy Johansen Fonden, the Lundbeck Foundation, the A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, the Mizutani Foundation, the Novo Nordisk Foundation, the Danish Research Council Sapere Aude Research Talent Grant (to K. T. S.), and the Danish National Research Foundation (DNRF107). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; Bu GJ, 2001, INT REV CYTOL, V209, P79; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; De Nardis C, 2017, J BIOL CHEM, V292, P912, DOI 10.1074/jbc.M116.758862; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Etxebarria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112677; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Hansen L, 2015, GLYCOBIOLOGY, V25, P211, DOI 10.1093/glycob/cwu104; Huang S, 2010, J LIPID RES, V51, P297, DOI 10.1194/jlr.M000422; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; Moreira BD, 2016, CURR DIABETES REV, V12, P240, DOI 10.2174/1573399811666150615142746; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; Rodenburg KW, 2006, INSECT BIOCHEM MOLEC, V36, P250, DOI 10.1016/j.ibmb.2006.01.003; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; SEGUCHI T, 1991, ARCH BIOCHEM BIOPHYS, V284, P245, DOI 10.1016/0003-9861(91)90292-Q; SHITE S, 1988, J BIOL CHEM, V263, P19286; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	58	43	44	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7408	7422		10.1074/jbc.M117.817981	http://dx.doi.org/10.1074/jbc.M117.817981			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29559555	Green Published, hybrid			2022-12-28	WOS:000432174500033
J	Zhang, HJ; Coblentz, C; Watanabe-Smith, K; Means, S; Means, J; Maxson, JE; Tyner, JW				Zhang, Haijiao; Coblentz, Cody; Watanabe-Smith, Kevin; Means, Sophie; Means, Jasmine; Maxson, Julia E.; Tyner, Jeffrey W.			Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell signaling; cell surface receptor; signal transduction; endocytosis; CSF3R; endocytosis; mutagenesis; receptor expression; signaling transduction	SEVERE CONGENITAL NEUTROPENIA; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; LIGAND INDEPENDENCE; CYTOPLASMIC DOMAIN; DOWN-REGULATION; T618I MUTATION; BETA-SUBUNIT; GM-CSF; REGIONS	Granulocyte colony-stimulating factor (G-CSF or CSF3) and its receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of mutations in the CSF3R gene in many hematologic malignancies. To find additional CSF3R mutations that give rise to cell transformation, we performed a cellular transformation assay in which murine interleukin 3 (IL-3)-dependent Ba/F3 cells were transduced with WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in signaling activation was related to an altered CSF3R localization. We also found that CSF3R-induced STAT3 and ERK activations require CSF3R internalization, whereas STAT5 activation occurred at the cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which missense mutations exhibit leukemogenic capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation.	[Zhang, Haijiao; Coblentz, Cody; Means, Sophie; Means, Jasmine; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Watanabe-Smith, Kevin; Maxson, Julia E.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Maxson, JE (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA.; Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA.	maxsonj@ohsu.edu; tynerj@ohsu.edu		Watanabe-Smith, Kevin/0000-0003-4231-8562	Aptose; Array; AstraZeneca; Constellation; Genentech; Gilead; Incyte; Janssen; Seattle Genetics; Syros; Takeda; American Society of Hematology award; NCI, National Institutes of Health [R00CA190605-03, 5R00CA151457-04, 1R01CA183947-01]; Leukemia and Lymphoma Society; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R00CA190605, U54CA224019, U01CA217862] Funding Source: NIH RePORTER	Aptose; Array; AstraZeneca(AstraZeneca); Constellation; Genentech(Roche HoldingGenentech); Gilead(Gilead Sciences); Incyte; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Seattle Genetics; Syros; Takeda(Takeda Pharmaceutical Company Ltd); American Society of Hematology award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. W. T. receives research support from Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, and Takeda and is a member of the scientific advisory board for Leap Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Society of Hematology award and NCI, National Institutes of Health Grant R00CA190605-03.; Supported by the Leukemia and Lymphoma Society, the V Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, and NCI, National Institutes of Health Grants 5R00CA151457-04 and 1R01CA183947-01.	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; Chakraborty A, 1999, BLOOD, V93, P15, DOI 10.1182/blood.V93.1.15.401a46_15_24; Ding JM, 2009, BLOOD, V114, P3325, DOI 10.1182/blood-2008-04-149047; Dong F, 1998, J IMMUNOL, V161, P6503; Ehlers S, 2010, J CLIN ONCOL, V28, P2591, DOI 10.1200/JCO.2009.25.9010; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hendriks BS, 2003, CANCER RES, V63, P1130; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Jenkins BJ, 1998, BLOOD, V92, P1989, DOI 10.1182/blood.V92.6.1989; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Maxson JE, 2016, CLIN CANCER RES, V22, P757, DOI 10.1158/1078-0432.CCR-14-3100; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Mehta HM, 2013, LEUKEMIA, V27, P2407, DOI 10.1038/leu.2013.164; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neumann T.A., 2012, MILESTONES DRUG THER, P395, DOI DOI 10.1007/978-3-0348-0218-5; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Ohki K., 2013, BLOOD, V122, P1352; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; RAPOPORT AP, 1992, BLOOD REV, V6, P43, DOI 10.1016/0268-960X(92)90007-D; Rohrabaugh S, 2017, LEUKEMIA, V31, P1770, DOI 10.1038/leu.2016.376; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Touw IP, 2013, HEMATOL ONCOL CLIN N, V27, P61, DOI 10.1016/j.hoc.2012.10.002; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Watanabe-Smith K, 2017, ONCOTARGET, V8, P12596, DOI 10.18632/oncotarget.15392; Zhang H, 2017, LEUKEMIA, V31, P2752, DOI 10.1038/leu.2017.126; Zhang HJ, 2017, CANCER RES, V77, P4258, DOI 10.1158/0008-5472.CAN-17-1052; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	39	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7387	7396		10.1074/jbc.RA118.002417	http://dx.doi.org/10.1074/jbc.RA118.002417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29572350	Green Published, hybrid			2022-12-28	WOS:000432174500031
J	Belyaeva, OV; Wu, LZ; Shmarakov, I; Nelson, PS; Kedishvili, NY				Belyaeva, Olga V.; Wu, Lizhi; Shmarakov, Igor; Nelson, Peter S.; Kedishvili, Natalia Y.			Retinol dehydrogenase 11 is essential for the maintenance of retinol homeostasis in liver and testis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin A; carotenoid; retinoic acid; retinol; dehydrogenase; reductase; retinaldehyde	SHORT-CHAIN DEHYDROGENASE/REDUCTASE; BETA-CAROTENE 15,15'-DIOXYGENASE; RETINALDEHYDE REDUCTASE-ACTIVITY; ACID RESPONSE ELEMENT; BINDING-PROTEIN; VITAMIN-A; HUMAN TISSUES; BIOCHEMICAL-PROPERTIES; INTESTINAL-ABSORPTION; SUBSTRATE-SPECIFICITY	Retinol dehydrogenase 11 (RDH11) is a microsomal short-chain dehydrogenase/reductase that recognizes all-trans- and cis-retinoids as substrates and prefers NADPH as a cofactor. Previous work has suggested that RDH11 contributes to the oxidation of 11-cis-retinol to 11-cis-retinaldehyde during the visual cycle in the eye's retinal pigment epithelium. However, the role of RDH11 in metabolism of all-trans-retinoids remains obscure. Here, we report that microsomes isolated from the testes and livers of Rdh11(-/-) mice fed a regular diet exhibited a 3- and 1.7-fold lower rate of all-trans-retinaldehyde conversion to all-trans-retinol, respectively, than the microsomes of WT littermates. Testes and livers of Rdh11(-/-) mice fed a vitamin A-deficient diet had approximate to 35% lower levels of all-trans-retinol than those of WT mice. Furthermore, the conversion of -carotene to retinol via retinaldehyde as an intermediate appeared to be impaired in the testes of Rdh11(-/-)/retinol-binding protein 4(-/-)(Rbp4(-/-)) mice, which lack circulating holo RBP4 and rely on dietary supplementation with -carotene for maintenance of their retinoid stores. Together, these results indicate that in mouse testis and liver, RDH11 functions as an all-trans-retinaldehyde reductase essential for the maintenance of physiological levels of all-trans-retinol under reduced vitamin A availability.	[Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Shmarakov, Igor] Columbia Univ, Dept Med, New York, NY 21007 USA; [Nelson, Peter S.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kedishvili, NY (corresponding author), 720 20th St South,Kaul 440B, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X	United States Public Health Services, National Institutes of Health [R01AA012153, R01DK068437, R01DK101251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101251, R01DK068437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	United States Public Health Services, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Public Health Services, National Institutes of Health Grants R01AA012153, R01DK068437, and R01DK101251. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Belyaeva OV, 2002, FEBS LETT, V531, P489, DOI 10.1016/S0014-5793(02)03588-3; BLANER WS, 1986, J LIPID RES, V27, P1084; BLANER WS, 1985, J LIPID RES, V26, P1241; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; During A, 2001, J NUTR BIOCHEM, V12, P640, DOI 10.1016/S0955-2863(01)00184-X; Endo T, 2017, P NATL ACAD SCI USA, V114, pE10132, DOI 10.1073/pnas.1710837114; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; HUSMANN M, 1992, BIOCHEM BIOPH RES CO, V187, P1558, DOI 10.1016/0006-291X(92)90480-9; Kanan Y, 2008, INVEST OPHTH VIS SCI, V49, P1071, DOI 10.1167/iovs.07-1207; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Kasus-Jacobi A, 2003, J BIOL CHEM, V278, P32380, DOI 10.1074/jbc.M304969200; KATO M, 1985, J BIOL CHEM, V260, P4832; Kedishvili NY, 2002, J BIOL CHEM, V277, P28909, DOI 10.1074/jbc.M202588200; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lee CM, 1999, J NUTR, V129, P2271, DOI 10.1093/jn/129.12.2271; Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04; Lin BY, 2001, CANCER RES, V61, P1611; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Napoli JL, 1998, METH MOL B, V89, P29; OKUNO M, 1995, J LIPID RES, V36, P137; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; RAJAN N, 1990, J LIPID RES, V31, P821; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; SCITA G, 1993, METHOD ENZYMOL, V214, P21; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wei RR, 1998, NUTR CANCER, V30, P53, DOI 10.1080/01635589809514640; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521	47	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6996	7007		10.1074/jbc.RA117.001646	http://dx.doi.org/10.1074/jbc.RA117.001646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29567832	Green Published, hybrid			2022-12-28	WOS:000431487300030
J	Jia, XY; Yao, JY; Gao, ZQ; Liu, GF; Dong, YH; Wang, XX; Zhang, H				Jia, Xuanyan; Yao, Jianyun; Gao, Zengqiang; Liu, Guangfeng; Dong, Yu-Hui; Wang, Xiaoxue; Zhang, Heng			Structure-function analyses reveal the molecular architecture and neutralization mechanism of a bacterial HEPN-MNT toxin-antitoxin system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; crystal structure; small-angle X-ray scattering (SAXS); RNA binding protein; RNA-protein interaction; RNA ribonuclease; toxin-antitoxin system	RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; HAEMOPHILUS-INFLUENZAE; ESCHERICHIA-COLI; STRESS-RESPONSE; DOMAIN; NUCLEOTIDYLTRANSFERASE; SOFTWARE; IDENTIFICATION; PROTEINS	Toxin-antitoxin (TA) loci in bacteria are small genetic modules that regulate various cellular activities, including cell growth and death. The two-gene module encoding a HEPN (higher eukaryotes and prokaryotes nucleotide-binding) domain and a cognate MNT (minimal nucleotidyltransferase) domain have been predicted to represent a novel type II TA system prevalent in archaea and bacteria. However, the neutralization mechanism and cellular targets of the TA family remain unclear. The toxin SO_3166 having a HEPN domain and its cognate antitoxin SO_3165 with an MNT domain constitute a typical type II TA system that regulates cell motility and confers plasmid stability in the bacterium Shewanella oneidensis. Here, we report the crystal structure and solution conformation of the SO_3166-SO_3165 pair, representing the first complex structures in this TA family. The structures revealed that SO_3165 and SO_3166 form a tight heterooctamer (at a 2:6 ratio), an organization that is very rare in other TA systems. We also observed that SO_3166 dimerization enables the formation of a deep cleft at the HEPN-domain interface harboring a composite RX4-6H active site that functions as an RNA-cleaving RNase. SO_3165 bound SO_3166 mainly through its two -helices (2 and 4), functioning as molecular recognition elements. Moreover, their insertion into the SO_3166 cleft sterically blocked the RX4-6H site or narrowed the cleft to inhibit RNA substrate binding. Structure-based mutagenesis confirmed the important roles of these -helices in SO_3166 binding and inhibition. Our structure-function analysis provides first insights into the neutralization mechanism of the HEPN-MNT TA family.	[Jia, Xuanyan] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China; [Yao, Jianyun; Wang, Xiaoxue] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Key Lab Marine Mat Med, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China; [Gao, Zengqiang; Dong, Yu-Hui; Zhang, Heng] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Liu, Guangfeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China	Anhui University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, XX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Key Lab Marine Mat Med, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.; Zhang, H (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China.	xxwang@scsio.ac.cn; zhangheng@ihep.ac.cn		Dong, Yuhui/0000-0002-4422-4685; Gao, Zengqiang/0000-0002-9100-9929; Zhang, Heng/0000-0003-3208-6489; Wang, Xiaoxue/0000-0002-7257-1916	National Basic Research Program of China [2017YFA0504900]; National Natural Science Foundation of China [U1732113, 31670059, 31625001, 31290233]; Strategic Priority Research Program of CAS [XDB08030103]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of CAS	This work was supported by National Basic Research Program of China Grant 2017YFA0504900, National Natural Science Foundation of China Grants U1732113, 31670059, 31625001, and 31290233, and Strategic Priority Research Program of CAS Grant XDB08030103. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davidov E, 2008, MOL MICROBIOL, V69, P1560, DOI 10.1111/j.1365-2958.2008.06387.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lehmann C, 2005, PROTEINS, V60, P807, DOI 10.1002/prot.20586; Lehmann C, 2003, PROTEINS, V50, P249, DOI 10.1002/prot.10260; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Meineke B, 2012, VIROLOGY, V427, P144, DOI 10.1016/j.virol.2012.02.008; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yao JY, 2015, MICROB BIOTECHNOL, V8, P961, DOI 10.1111/1751-7915.12294	36	15	18	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6812	6823		10.1074/jbc.RA118.002421	http://dx.doi.org/10.1074/jbc.RA118.002421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29555683	hybrid, Green Published			2022-12-28	WOS:000431487300016
J	Noh, MY; Muthukrishnan, S; Kramer, KJ; Arakane, Y				Noh, Mi Young; Muthukrishnan, Subbaratnam; Kramer, Karl J.; Arakane, Yasuyuki			Group I chitin deacetylases are essential for higher order organization of chitin fibers in beetle cuticle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA interference (RNAi); extracellular matrix; double-stranded RNA (dsRNA); electron microscopy (EM); immunohistochemistry; chitin deacetylase (CDA); elytron; pore canal; Tribolium castaneum	TRIBOLIUM-CASTANEUM; COLLETOTRICHUM-LINDEMUTHIANUM; PHYLOGENETIC ANALYSIS; PERITROPHIC MEMBRANE; DOMAIN ORGANIZATION; INSECT; MATRIX; DROSOPHILA; PROTEINS; BINDING	Roles in the organization of the cuticle (exoskeleton) of two chitin deacetylases (CDAs) belonging to group I, TcCDA1 and TcCDA2, as well as two alternatively spliced forms of the latter, TcCDA2a and TcCDA2b, from the red flour beetle, Tribolium castaneum, were examined in different body parts using transmission EM and RNAi. Even though all TcCDAs are co-expressed in cuticle-forming cells from the hardened forewing (elytron) and ventral abdomen, as well as in the softer hindwing and dorsal abdomen, there are significant differences in the tissue specificity of expression of the alternatively spliced transcripts. Loss of either TcCDA1 or TcCDA2 protein by RNAi causes abnormalities in organization of chitinous horizontal laminae and vertical pore canals in all regions of the procuticle of both the hard and soft cuticles. Simultaneous RNAi for TcCDA1 and TcCDA2 produces the most serious abnormalities. RNAi of either TcCDA2a or TcCDA2b affects cuticle integrity to some extent. Following RNAi, there is accumulation of smaller disorganized fibers in both the horizontal laminae and pore canals, indicating that TcCDAs play a critical role in elongation/organization of smaller nanofibers into longer fibers, which is essential for structural integrity of both hard/thick and soft/thin cuticles. Immunolocalization of TcCDA1 and TcCDA2 proteins and effects of RNAi on their accumulation indicate that these two proteins function in concert exclusively in the assembly zone in a step involving the higher order organization of the procuticle.	[Noh, Mi Young; Arakane, Yasuyuki] Chonnam Natl Univ, Dept Appl Biol, Gwangju 500757, South Korea; [Muthukrishnan, Subbaratnam; Kramer, Karl J.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Arakane, Yasuyuki] Chonnam Natl Univ, Dept Forestry, Gwangju 500757, South Korea	Chonnam National University; Kansas State University; Chonnam National University	Arakane, Y (corresponding author), Chonnam Natl Univ, Dept Appl Biol, Gwangju 500757, South Korea.	arakane@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant [NRF-2015R1A2A2A01006614]; National Research Foundation - Korea government (MSIT) [2018R1A2B6005106]; Basic Science Research Program through the National Research Foundation - Ministry of Education [NRF-2015R1A6A3A04060323]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant; National Research Foundation - Korea government (MSIT); Basic Science Research Program through the National Research Foundation - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science, ICT, and Future Planning Grant NRF-2015R1A2A2A01006614; by the National Research Foundation funded by the Korea government (MSIT) Grant 2018R1A2B6005106; and by the Basic Science Research Program through the National Research Foundation funded by Ministry of Education Grant NRF-2015R1A6A3A04060323 (to M. Y. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Aruchami M., 1986, P263; BANERJEE S, 1988, INT J INSECT MORPHOL, V17, P313, DOI 10.1016/0020-7322(88)90012-8; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Chandran R, 2016, MICRON, V82, P74, DOI 10.1016/j.micron.2015.12.010; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219; GARDINER BG, 1979, ZOOL J LINN SOC-LOND, V66, P91, DOI 10.1111/j.1096-3642.1979.tb01903.x; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; Heustis RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040426; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kang LX, 2012, J MICROBIOL BIOTECHN, V22, P1202, DOI 10.4014/jmb.1112.12026; Kaya M, 2017, CARBOHYD POLYM, V176, P177, DOI 10.1016/j.carbpol.2017.08.076; LOCKE M, 1979, TISSUE CELL, V11, P277, DOI 10.1016/0040-8166(79)90042-9; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Muthukrishnan S., 2016, EXTRACELLULAR COMPOS, P31, DOI DOI 10.1007/978-3-319-40740-1; NEVILLE AC, 1976, J CELL SCI, V21, P73; Noh MY, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007307; Noh MY, 2017, INSECT BIOCHEM MOLEC, V91, P21, DOI 10.1016/j.ibmb.2017.11.003; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; Pesch YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18340; Pesch YY, 2015, J BIOL CHEM, V290, P10071, DOI 10.1074/jbc.M114.614933; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tokuyasu K, 1997, CARBOHYD RES, V303, P353, DOI 10.1016/S0008-6215(97)00166-3; Tomoyasu Y, 2009, CURR BIOL, V19, P2057, DOI 10.1016/j.cub.2009.11.014; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Xi Y, 2014, INSECT MOL BIOL, V23, P695, DOI 10.1111/imb.12113; Yu RR, 2016, J BIOL CHEM, V291, P24352, DOI 10.1074/jbc.M116.720581; Zhao Y, 2011, BIOTECHNOLOGY OF BIOPOLYMERS, P131; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946	40	22	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6985	6995		10.1074/jbc.RA117.001454	http://dx.doi.org/10.1074/jbc.RA117.001454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29567838	hybrid, Green Published			2022-12-28	WOS:000431487300029
J	Subramanian, SP; Babu, P; Palakodeti, D; Subramanian, R				Subramanian, Sabarinath Peruvemba; Babu, Ponnusamy; Palakodeti, Dasaradhi; Subramanian, Ramaswamy			Identification of multiple isomeric core chitobiose-modified high-mannose and paucimannose N-glycans in the planarian Schmidtea mediterranea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; invertebrate; mass spectrometry (MS); galactosyltransferase; antisense RNA; Gal1-4Fuc; GALT-1; O-methylation; planaria; S; mediterranea	CAENORHABDITIS-ELEGANS; ACETYLGLUCOSAMINE RESIDUE; DUGESIA-JAPONICA; REGENERATION; GLCNAC; FUCOSYLATION; SPECIFICITY; PROTEIN; OLIGOSACCHARIDES; GLYCOPROTEIN	Cell surface-associated glycans mediate many cellular processes, including adhesion, migration, signaling, and extracellular matrix organization. The galactosylation of core fucose (GalFuc epitope) in paucimannose and complex-type N-glycans is characteristic of protostome organisms, including flatworms (planarians). Although uninvestigated, the structures of these glycans may play a role in planarian regeneration. Whole-organism MALDI-MS analysis of N-linked oligosaccharides from the planarian Schmidtea mediterranea revealed the presence of multiple isomeric high-mannose and paucimannose structures with unusual mono-, di-, and polygalactosylated (n = 3-5) core fucose structures; the latter structures have not been reported in other systems. Di- and trigalactosylated core fucoses were the most dominant glycomers. N-Glycans showed extensive, yet selective, methylation patterns, ranging from non-methylated to polymethylated glycoforms. Although the majority of glycoforms were polymethylated, a small fraction also consisted of non-methylated glycans. Remarkably, monogalactosylated core fucose remained unmethylated, whereas its polygalactosylated forms were methylated, indicating structurally selective methylation. Using database searches, we identified two potential homologs of the Gal1-4Fuc-synthesizing enzyme from nematodes (GALT-1) that were expressed in the prepharyngeal, pharyngeal, and mesenchymal regions in S. mediterranea. The presence of two GALT-1 homologs suggests different requirements for mono- and polygalactosylation of core fucose for the formation of multiple isomers. Furthermore, we observed variations in core fucose glycosylation patterns in different planarian strains, suggesting evolutionary adaptation in fucose glycosylation. The various core chitobiose modifications and methylations create >60 different glycoforms in S. mediterranea. These results contribute greatly to our understanding of N-glycan biosynthesis and suggest the presence of a GlcNAc-independent biosynthetic pathway in S. mediterranea.	[Subramanian, Sabarinath Peruvemba; Palakodeti, Dasaradhi; Subramanian, Ramaswamy] GKVK Post Off, Inst Stem Cell Biol & Regenerat Med inStem, Bellary Rd, Bangalore 560065, Karnataka, India; [Babu, Ponnusamy] GKVK Post Off, C CAMP, Glyc & Glycoprote Facil, Bellary Rd, Bangalore 560065, Karnataka, India	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Subramanian, R (corresponding author), GKVK Post Off, Inst Stem Cell Biol & Regenerat Med inStem, Bellary Rd, Bangalore 560065, Karnataka, India.	ponbabu@gmail.com; ramas@instem.res.in	Subramanian, Ramaswamy/Q-8671-2019; Subramanian, Sabarinath Peruvemba/AAN-6684-2021; Subramanian, Sabarinath Peruvemba/AAN-4270-2021	Subramanian, Ramaswamy/0000-0002-6709-190X; Subramanian, Sabarinath Peruvemba/0000-0003-3146-0184; Subramanian, Sabarinath Peruvemba/0000-0003-3146-0184	Mass Spectrometry facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Sequencing facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India	Mass Spectrometry facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Sequencing facility at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India; Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India	We thank Prof. Bernard Henrissat (Architecture et Fonction des Macromolecules Biologiques, CNRS, Aix-Marseille Universite, Marseille, France) for sharing FASTA sequences of the GT-92 family of galactosyltransferase. We thank Vairavan Lakshmanan, Dr. Shaik Naseer Pasha, Dr. Praveen Anand, and Dr. Anna Protasio for help with bioinformatics. We acknowledge the support from the Mass Spectrometry facility, Sequencing facility, and Centre for Imaging and Flow cytometry facility (CIFF) at Centre for Cellular and Molecular Platforms (C-CAMP), Bangalore, India. We thank Dr. Swapna Nandakumar for editing and proofreading the manuscript.	Abnave P, 2014, CELL HOST MICROBE, V16, P338, DOI 10.1016/j.chom.2014.08.002; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; An B, 2015, ANAL CHEM, V87, P4023, DOI 10.1021/acs.analchem.5b00350; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Brandl H, 2016, NUCLEIC ACIDS RES, V44, pD764, DOI 10.1093/nar/gkv1148; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00008; Chong T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-69; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Davies EL, 2017, ELIFE, V6, DOI 10.7554/eLife.21052; Eckmair B, 2016, MOL CELL PROTEOMICS, V15, P573, DOI 10.1074/mcp.M115.051573; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hoja-Lukowicz D, 2000, GLYCOBIOLOGY, V10, P551, DOI 10.1093/glycob/10.6.551; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Resch AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034447; Rink JC, 2011, DEVELOPMENT, V138, P3769, DOI 10.1242/dev.066852; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ross KG, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.266; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; Stepan H, 2010, CARBOHYD RES, V345, P1504, DOI 10.1016/j.carres.2010.03.027; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2016, PROTEOMICS, V16, P3137, DOI 10.1002/pmic.201600001; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Williams SA, 2011, ADV EXP MED BIOL, V705, P397, DOI 10.1007/978-1-4419-7877-6_20; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004; Yan S, 2015, J PROTEOME RES, V14, P5291, DOI 10.1021/acs.jproteome.5b00746; Yan S, 2015, MOL CELL PROTEOMICS, V14, P2111, DOI 10.1074/mcp.M115.049817; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Yang Q, 2016, J BIOL CHEM, V291, P11064, DOI 10.1074/jbc.M116.720789; Zeleny R, 1997, ANAL BIOCHEM, V246, P96, DOI 10.1006/abio.1996.9973; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153	57	9	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6707	6720		10.1074/jbc.RA117.000782	http://dx.doi.org/10.1074/jbc.RA117.000782			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29475940	hybrid, Green Published			2022-12-28	WOS:000431487300008
J	Wang, SY; Shi, XH; Wei, S; Ma, D; Oyinlade, O; Lv, SQ; Ying, MY; Zhang, YA; Claypool, SM; Watkins, P; Xia, SL				Wang, Shuyan; Shi, Xiaohai; Wei, Shuang; Ma, Ding; Oyinlade, Olutobi; Lv, Sheng-Qing; Ying, Mingyao; Zhang, Yu Alex; Claypool, Steven Michael; Watkins, Paul; Xia, Shuli			Kruppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; METABOLIC-REGULATION; DYNAMICS; CANCER; DEATH; PROLIFERATION; REQUIREMENTS; INHIBITION; APOPTOSIS; FISSION	Kruppel-like factor 4 (KLF4) is a zinc finger transcription factor critical for the regulation of many cellular functions in both normal and neoplastic cells. Here, using human glioblastoma cells, we investigated KLF4's effects on cancer cell metabolism. We found that forced KLF4 expression promotes mitochondrial fusion and induces dramatic changes in mitochondrial morphology. To determine the impact of these changes on the cellular functions following, we analyzed how KLF4 alters glioblastoma cell metabolism, including glucose uptake, glycolysis, pentose phosphate pathway, and oxidative phosphorylation. We did not identify significant differences in baseline cellular metabolism between control and KLF4-expressing cells. However, when mitochondrial function was impaired, KLF4 significantly increased spare respiratory capacity and levels of reactive oxygen species in the cells. To identify the biological effects of these changes, we analyzed proliferation and survival of control and KLF4-expressing cells under stress conditions, including serum and nutrition deprivation. We found that following serum starvation, KLF4 altered cell cycle progression by arresting the cells at the G(2)/M phase and that KLF4 protected cells from nutrition deprivation-induced death. Finally, we demonstrated that methylation-dependent KLF4-binding activity mediates mitochondrial fusion. Specifically, the downstream targets of KLF4-mCpG binding, guanine nucleotide exchange factors, serve as the effector of KLF4-induced mitochondrial fusion, cell cycle arrest, and cell protection. Our experimental system provides a robust model for studying the interactions between mitochondrial morphology and function, mitochondrial dynamics and metabolism, and mitochondrial fusion and cell death during tumor initiation and progression.	[Wang, Shuyan; Zhang, Yu Alex] Capital Med Univ, Xuanwu Hosp, Cell Therapy Ctr, Beijing 100053, Peoples R China; [Wang, Shuyan; Shi, Xiaohai; Wei, Shuang; Ma, Ding; Oyinlade, Olutobi; Ying, Mingyao; Watkins, Paul; Xia, Shuli] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Wang, Shuyan; Wei, Shuang; Ma, Ding; Ying, Mingyao; Watkins, Paul; Xia, Shuli] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Claypool, Steven Michael] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Wei, Shuang] Huazhong Univ Sci & Technol, Dept Resp & Crit Care Med, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Lv, Sheng-Qing] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing 400037, Peoples R China	Capital Medical University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology; Army Medical University	Xia, SL (corresponding author), Johns Hopkins Sch Med, Hugo W Moser Res Inst Kennedy Krieger, Dept Neurol, 707 N Broadway,Rm 400C, Baltimore, MD 21205 USA.	xia@kennedykrieger.org	Wei, Shuang/AAA-4031-2019	Claypool, Steven/0000-0001-5316-1623	NICHD NIH HHS [U54 HD079123] Funding Source: Medline; NIGMS NIH HHS [T32 GM007445] Funding Source: Medline; NINDS NIH HHS [R01 NS091165, K08 NS063956] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099460, R21NS106407, R01NS091165] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Baarine M, 2015, J NEUROCHEM, V133, P380, DOI 10.1111/jnc.12992; Bergmeyer HU, 1984, METHODS ENZYMATIC AN, VII; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Farrugia MK, 2016, CANCER RES, V76, P1677, DOI 10.1158/0008-5472.CAN-15-1806; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang C, 2015, TRENDS ENDOCRIN MET, V26, P587, DOI 10.1016/j.tem.2015.08.004; JENKINS AB, 1986, INT J BIOCHEM, V18, P311, DOI 10.1016/0020-711X(86)90036-4; Kumar Hari R, 2008, Expert Rev Neurother, V8, P1497, DOI 10.1586/14737175.8.10.1497; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCOMB RB, 1976, CLIN CHEM, V22, P141; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Oanh NTK, 2017, CELL SIGNAL, V38, P67, DOI 10.1016/j.cellsig.2017.06.019; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sanchis-Gomar F, 2014, NEW ENGL J MED, V370, P1073, DOI 10.1056/NEJMc1316254; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Serasinghe MN, 2017, HANDB EXP PHARMACOL, V240, P159, DOI 10.1007/164_2016_38; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suh SW, 2003, J NEUROSCI, V23, P10681; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wan J, 2017, ELIFE, V6, DOI 10.7554/eLife.20068; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xia S, 2007, MOL CANCER RES, V5, P783, DOI 10.1158/1541-7786.MCR-06-0433; Xia SL, 2006, BIOCHEM BIOPH RES CO, V345, P1358, DOI 10.1016/j.bbrc.2006.05.064; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Xia SL, 2005, CANCER RES, V65, P5248, DOI 10.1158/0008-5472.CAN-04-4332; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441	42	17	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6544	6555		10.1074/jbc.RA117.001323	http://dx.doi.org/10.1074/jbc.RA117.001323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29507094	Green Published, hybrid			2022-12-28	WOS:000431108600025
J	Lee, JE; Morrison, W; Hollien, J				Lee, Ji Eun; Morrison, William; Hollien, Julie			Hairy and enhancer of split 1 (HES1) protects cells from endoplasmic reticulum stress-induced apoptosis through repression of GADD34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MAMMALIAN-CELLS; ER STRESS; EXPRESSION; TRANSLATION; SURVIVAL; IRE1; LOOP; ACTIVATION; RESISTANCE	Disruption in endoplasmic reticulum (ER) function, termed ER stress, occurs in many diseases, including neurodegenerative disorders, diabetes, and cancer. Cells respond to ER stress with the unfolded protein response (UPR), which triggers a broad transcriptional program to restore and enhance ER function. Here, we found that ER stress up-regulates the mRNA encoding the developmentally regulated transcriptional repressor hairy and enhancer of split 1 (HES1), in a variety cell types. Depletion of HES1 increased cell death in response to ER stress in mouse and human cells, in a manner that depended on the pro-apoptotic gene growth arrest and DNA damage-inducible protein GADD34 (also known as Protein phosphatase 1 regulatory subunit 15A, or MyD116). Furthermore, HES1 bound to the GADD34 promoter, and its depletion led to an up-regulation of GADD34 expression during ER stress. Our results identify HES1 as a repressor of GADD34 expression, and reveal that HES1 contributes to cell fate determination in response to ER stress.	[Hollien, Julie] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA; [Lee, Ji Eun] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Morrison, William] Recurs Pharmaceut, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Memorial Sloan Kettering Cancer Center	Hollien, J (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	hollien@biology.utah.edu		Hollien, Julie/0000-0003-0649-1261	General Medical Science Institute, National Institutes of Health [R35 GM119540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119540] Funding Source: NIH RePORTER	General Medical Science Institute, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by General Medical Science Institute, National Institutes of Health Grant R35 GM119540. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Gao F, 2014, SCI REP-UK, V4, DOI 10.1038/srep03963; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XY, 2010, J CANCER RES CLIN, V136, P989, DOI 10.1007/s00432-009-0744-8; Weng MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144322; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young SK, 2016, J BIOL CHEM, V291, P13780, DOI 10.1074/jbc.M116.729830; Yuan RX, 2015, CLIN EXP METASTAS, V32, P169, DOI 10.1007/s10585-015-9700-y; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	35	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5947	5955		10.1074/jbc.RA118.002124	http://dx.doi.org/10.1074/jbc.RA118.002124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491143	Green Published, hybrid			2022-12-28	WOS:000430497300016
J	Torii, S; Kubota, C; Saito, N; Kawano, A; Hou, N; Kobayashi, M; Torii, R; Hosaka, M; Kitamura, T; Takeuchi, T; Gomi, H				Torii, Seiji; Kubota, Chisato; Saito, Naoya; Kawano, Ayumi; Hou, Ni; Kobayashi, Masaki; Torii, Ryoko; Hosaka, Masahiro; Kitamura, Tadahiro; Takeuchi, Toshiyuki; Gomi, Hiroshi			The pseudophosphatase phogrin enables glucose-stimulated insulin signaling in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; RECEPTOR SUBSTRATE-2; GENE-EXPRESSION; IA-2 FAMILY; IRS-2; PROLIFERATION; PHOSPHORYLATION; DISRUPTION; DEGRADATION; MECHANISMS	Autocrine insulin signaling is critical for pancreatic beta-cell growth and activity and is at least partially controlled by protein-tyrosine phosphatases (PTPs) that act on insulin receptors (IRs). The receptor-type PTP phogrin primarily localizes on insulin secretory granules in pancreatic beta cells. We recently reported that phogrin knockdown decreases the protein levels of insulin receptor substrate 2 (IRS2), whereas high-glucose stimulation promotes formation of a phogrin-IR complex that stabilizes IRS2. However, the underlying molecular mechanisms by which phogrin affects IRS2 levels are unclear. Here, we found that relative to wildtype mice, IRS2 levels in phogrin-knockout mice islets decreased by 44%. When phogrin was silenced by shRNA in pancreatic beta-cell lines, glucose-induced insulin signaling led to proteasomal degradation of IRS2 via a negative feedback mechanism. Phogrin overexpression in a murine hepatocyte cell line consistently prevented chronic insulin treatment-induced IRS2 degradation. In vitro, phogrin directly bound the IR without the assistance of other proteins and protected recombinant PTP1B from oxidation to potentiate its activity toward the IR. Furthermore, phogrin expression suppressed insulin-induced local generation of hydrogen peroxide and subsequent PTP1B oxidation, which allowed progression of IR dephosphorylation. Together, these results suggest that a transient interaction of phogrin with the IR enables glucose-stimulated autocrine insulin signaling through the regulation of PTP1B activity, which is essential for suppressing feedback-mediated IRS2 degradation in pancreatic beta cells.	[Torii, Seiji; Kubota, Chisato; Saito, Naoya; Kawano, Ayumi; Hou, Ni; Torii, Ryoko; Takeuchi, Toshiyuki] Gunma Univ, Biosignal Res Ctr, Maebashi, Gunma 3718512, Japan; [Kobayashi, Masaki; Kitamura, Tadahiro] Gunma Univ, Metab Signal Res Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Hosaka, Masahiro] Akita Prefectural Univ, Dept Biotechnol, Akita 0100195, Japan; [Takeuchi, Toshiyuki] Gunma Univ, Adm Off, Maebashi, Gunma 3718512, Japan; [Gomi, Hiroshi] Nihon Univ, Dept Vet Anat, Coll Bioresource Sci, Fujisawa, Kanagawa 2528510, Japan; [Hou, Ni] Xi An Jiao Tong Univ, Sch Basic Med Sci, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China	Gunma University; Gunma University; Akita Prefectural University; Gunma University; Nihon University; Xi'an Jiaotong University	Torii, S (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Res Ctr, Maebashi, Gunma 3718512, Japan.	storii@gunma-u.ac.jp		Hosaka, Masahiro/0000-0002-1422-1774	Japanese Society for the Promotion of Science (JSPS KAKENHI) [24390050]; Institute for Molecular and Cellular Regulation, Gunma University [12026, 14022]; Suzuken Memorial Foundation	Japanese Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Molecular and Cellular Regulation, Gunma University; Suzuken Memorial Foundation	This work was supported by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS KAKENHI, Grant 24390050) and in part by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (Grants 12026 and 14022) and in part by the Suzuken Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Cai T, 2011, DIABETOLOGIA, V54, P2347, DOI 10.1007/s00125-011-2221-6; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gomi H, 2013, J HISTOCHEM CYTOCHEM, V61, P156, DOI 10.1369/0022155412466872; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Hou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047921; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Saito N, 2011, TRAFFIC, V12, P499, DOI 10.1111/j.1600-0854.2011.01159.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Togashi Y, 2014, ENDOCRINOLOGY, V155, P1643, DOI 10.1210/en.2013-1796; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Torkko JM, 2015, MOL CELL BIOL, V35, P914, DOI 10.1128/MCB.00994-14; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	50	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5920	5933		10.1074/jbc.RA117.000301	http://dx.doi.org/10.1074/jbc.RA117.000301			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483197	Green Published, hybrid			2022-12-28	WOS:000430497300014
J	Suginta, W; Sritho, N; Ranok, A; Bulmer, DM; Kitaoku, Y; van den Berg, B; Fukamizo, T				Suginta, Wipa; Sritho, Natchanok; Ranok, Araya; Bulmer, David Michael; Kitaoku, Yoshihito; van den Berg, Bert; Fukamizo, Tamo			Structure and function of a novel periplasmic chitooligosaccharide-binding protein from marine Vibrio bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; structure-function; isothermal titration calorimetry (ITC); carbohydrate processing; prokaryotic signal-transduction; chitin recycling; glycoside hydrolase; nutrient transport; solute-binding protein; sugar-protein interactions	CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; CHITIN; HARVEYI; HETERODISACCHARIDE; PURIFICATION; CHITOPORIN; RECEPTORS; CHOLERAE; MALTOSE	Periplasmic solute-binding proteins in bacteria are involved in the active transport of nutrients into the cytoplasm. In marine bacteria of the genus Vibrio, a chitooligosaccharide-binding protein (CBP) is thought to be the major solute-binding protein controlling the rate of chitin uptake in these bacteria. However, the molecular mechanism of the CBP involvement in chitin metabolism has not been elucidated. Here, we report the structure and function of a recombinant chitooligosaccharide-binding protein from Vibrio harveyi, namely VhCBP, expressed in Escherichia coli. Isothermal titration calorimetry revealed that VhCBP strongly binds shorter chitooligosaccharides ((GlcNAc)(n), where n = 2, 3, and 4) with affinities that are considerably greater than those for glycoside hydrolase family 18 and 19 chitinases but does not bind longer ones, including insoluble chitin polysaccharides. We also found that VhCBP comprises two domains with flexible linkers and that the domain-domain interface forms the sugar-binding cleft, which is not long extended but forms a small cavity. (GlcNAc)(2) bound to this cavity, apparently triggering a closed conformation of VhCBP. Trp-363 and Trp-513, which stack against the two individual GlcNAc rings, likely make a major contribution to the high affinity of VhCBP for (GlcNAc)(2). The strong chitobiose binding, followed by the conformational change of VhCBP, may facilitate its interaction with an active-transport system in the inner membrane of Vibrio species.	[Suginta, Wipa; Sritho, Natchanok; Fukamizo, Tamo] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Ranok, Araya] Rajamangala Univ Technol Isan, Nakhon Ratchasima 30000, Thailand; [Bulmer, David Michael; van den Berg, Bert] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kitaoku, Yoshihito; Fukamizo, Tamo] Kindai Univ, Dept Adv Biosci, Nara 6318505, Japan	Suranaree University of Technology; Rajamangala University of Technology; Newcastle University - UK; Kindai University (Kinki University)	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Chem, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th	Fukamizo, Tamo/AAY-7251-2020	Bulmer, David/0000-0003-0157-9790; van den Berg, Bert/0000-0003-1966-8804	Suranaree University of Technology; Office of the Higher Education Commission under National Research University Project of Thailand [FtR. 12/2558]; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology Grant [SUT1-102-58-36-10]	Suranaree University of Technology; Office of the Higher Education Commission under National Research University Project of Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology Grant	This work was supported by Suranaree University of Technology and by Office of the Higher Education Commission under National Research University Project of Thailand Contract FtR. 12/2558 (to W. S. and T. F.), by Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 (to W. S.), and by Suranaree University of Technology Grant SUT1-102-58-36-10 (to W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Cockerell SR, 2014, MICROBIOL-SGM, V160, P832, DOI 10.1099/mic.0.075903-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hamre AG, 2015, J PHYS CHEM B, V119, P9601, DOI 10.1021/acs.jpcb.5b03817; Hirano T, 2009, GLYCOBIOLOGY, V19, P1046, DOI 10.1093/glycob/cwp088; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Kadokura K, 2007, APPL MICROBIOL BIOT, V75, P357, DOI 10.1007/s00253-006-0831-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meekrathok P, 2015, ACTA CRYSTALLOGR F, V71, P427, DOI 10.1107/S2053230X1500415X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sritho N, 2012, APPL BIOCHEM BIOTECH, V166, P1192, DOI 10.1007/s12010-011-9504-8; Suginta W, 2016, INT J BIOL MACROMOL, V93, P1111, DOI 10.1016/j.ijbiomac.2016.09.066; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2012, BIOSCI BIOTECH BIOCH, V76, P2275, DOI 10.1271/bbb.120559; Suginta Wipa, 2009, J Chem Biol, V2, P191, DOI 10.1007/s12154-009-0021-y; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	38	8	9	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5150	5159		10.1074/jbc.RA117.001012	http://dx.doi.org/10.1074/jbc.RA117.001012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444825	hybrid, Green Published			2022-12-28	WOS:000429409300020
J	Hakala, M; Kalimeri, M; Enkavi, G; Vattulainen, I; Lappalainen, P				Hakala, Markku; Kalimeri, Maria; Enkavi, Giray; Vattulainen, Ilpo; Lappalainen, Pekka			Molecular mechanism for inhibition of twinfilin by phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN-FILAMENT; CAPPING PROTEIN; MEDIATED ENDOCYTOSIS; MEMBRANE DYNAMICS; PLASMA-MEMBRANE; CELL REGULATION; BUDDING YEAST; FORCE-FIELD	Membrane phosphoinositides control organization and dynamics of the actin cytoskeleton by regulating the activities of several key actin-binding proteins. Twinfilin is an evolutionarily conserved protein that contributes to cytoskeletal dynamics by interacting with actin monomers, filaments, and the heterodimeric capping protein. Twinfilin also binds phosphoinositides, which inhibit its interactions with actin, but the underlying mechanism has remained unknown. Here, we show that the high-affinity binding site of twinfilin for phosphoinositides is located at the C-terminal tail region, whereas the two actin-depolymerizing factor (ADF)/cofilin-like ADF homology domains of twinfilin bind phosphoinositides only with low affinity. Mutagenesis and biochemical experiments combined with atomistic molecular dynamics simulations reveal that the C-terminal tail of twinfilin interacts with membranes through a multivalent electrostatic interaction with a preference toward phosphatidylinositol 3,5-bisphosphate (PI(3,5)P-2), PI(4,5)P-2, and PI(3,4,5)P-3. This initial interaction places the actin-binding ADF homology domains of twinfilin in close proximity to the membrane and subsequently promotes their association with the membrane, thus leading to inhibition of the actin interactions. In support of this model, a twinfilin mutant lacking the C-terminal tail inhibits actin filament assembly in a phosphoinositide-insensitive manner. Our mutagenesis data also reveal that the phosphoinositide-and capping protein-binding sites overlap in the C-terminal tail of twinfilin, suggesting that phosphoinositide binding additionally inhibits the interactions of twinfilin with the heterodimeric capping protein. The results demonstrate that the conserved C-terminal tail of twinfilin is a multifunctional binding motif, which is crucial for interaction with the heterodimeric capping protein and for tethering twinfilin to phosphoinositide-rich membranes.	[Hakala, Markku; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, POB 56, FI-00014 Helsinki, Finland; [Enkavi, Giray; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Kalimeri, Maria; Vattulainen, Ilpo] Tampere Univ Technol, Lab Phys, FI-33101 Tampere, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense, Denmark	University of Helsinki; University of Helsinki; Tampere University; University of Southern Denmark	Lappalainen, P (corresponding author), Univ Helsinki, Inst Biotechnol, POB 56, FI-00014 Helsinki, Finland.	pekka.lappalainen@helsinki.fi	Vattulainen, Ilpo T/G-4224-2014	Hakala, Markku/0000-0002-3485-6080; Lappalainen, Pekka/0000-0001-6227-0354; Vattulainen, Ilpo/0000-0001-7408-3214; Kalimeri, Maria/0000-0002-6569-7553	ProLipids Centre of Excellence from the Academy of Finland [272130, 307415]; Doctoral School in Health Sciences; European Research Council Advanced Grant CROWDED-PRO-LIPIDS [290974]	ProLipids Centre of Excellence from the Academy of Finland; Doctoral School in Health Sciences; European Research Council Advanced Grant CROWDED-PRO-LIPIDS	This work was supported by ProLipids Centre of Excellence Grants 272130 and 307415 from the Academy of Finland (to P. L. and I. V.), a fellowship from the Doctoral School in Health Sciences (to M. H.), and European Research Council Advanced Grant CROWDED-PRO-LIPIDS (Grant 290974; to I. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnston AB, 2015, NAT CELL BIOL, V17, P1504, DOI 10.1038/ncb3252; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lehtimaki J, 2017, HANDB EXP PHARMACOL, V235, P123, DOI 10.1007/164_2016_28; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; MELCHIONNA S, 1993, MOL PHYS, V78, P533, DOI 10.1080/00268979300100371; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Nevalainen EM, 2009, BIOCHEM J, V417, P593, DOI 10.1042/BJ20080608; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Paavilainen VO, 2002, J BIOL CHEM, V277, P43089, DOI 10.1074/jbc.M208225200; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Pleskot R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002765; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Senju Y, 2017, P NATL ACAD SCI USA, V114, pE8977, DOI 10.1073/pnas.1705032114; Stritt S, 2017, BLOOD, V130, P1746, DOI 10.1182/blood-2017-02-770768; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; YONEZAWA N, 1991, J BIOL CHEM, V266, P17218; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Zhao HX, 2012, MOL BIOL CELL, V23, P2823, DOI 10.1091/mbc.E11-07-0645; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	68	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4818	4829		10.1074/jbc.RA117.000484	http://dx.doi.org/10.1074/jbc.RA117.000484			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425097	Green Published, hybrid			2022-12-28	WOS:000428848300022
J	Park, MJ; Shen, HL; Spaeth, JM; Tolvanen, JH; Failor, C; Knudtson, JF; McLaughlin, J; Halder, SK; Yang, QW; Bulun, SE; Al-Hendy, A; Schenken, RS; Aaltonen, LA; Boyer, TG				Park, Min Ju; Shen, Hailian; Spaeth, Jason M.; Tolvanen, Jaana H.; Failor, Courtney; Knudtson, Jennifer F.; McLaughlin, Jessica; Halder, Sunil K.; Yang, Qiwei; Bulun, Serdar E.; Al-Hendy, Ayman; Schenken, Robert S.; Aaltonen, Lauri A.; Boyer, Thomas G.			Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE FIBROIDS; KINASE MODULE; TARGET GENES; COMPLEX; REVEALS; IDENTIFICATION; TRANSCRIPTION; LEIOMYOMAS; GENOMICS; FAMILY	Somatic mutations in exon 2 of the RNA polymerase II transcriptional Mediator subunit MED12 occur at high frequency in uterine fibroids (UFs) and breast fibroepithelial tumors as well as recurrently, albeit less frequently, in malignant uterine leimyosarcomas, chronic lymphocytic leukemias, and colorectal cancers. Previously, we reported that UF-linked mutations in MED12 disrupt its ability to activate cyclin C (CycC)-dependent kinase 8 (CDK8) in Mediator, implicating impaired Mediator-associated CDK8 activity in the molecular pathogenesis of these clinically significant lesions. Notably, the CDK8 paralog CDK19 is also expressed in myometrium, and both CDK8 and CDK19 assemble into Mediator in a mutually exclusive manner, suggesting that CDK19 activity may also be germane to the pathogenesis of MED12 mutation-induced UFs. However, whether and how UF-linked mutations in MED12 affect CDK19 activation is unknown. Herein, we show that MED12 allosterically activates CDK19 and that UF-linked exon 2 mutations in MED12 disrupt its CDK19 stimulatory activity. Furthermore, we find that within the Mediator kinase module, MED13 directly binds to the MED12 C terminus, thereby suppressing an apparent UF mutation-induced conformational change in MED12 that otherwise disrupts its association with CycCCDK8/19. Thus, in the presence of MED13, mutant MED12 can bind, but cannot activate, CycC-CDK8/19. These findings indicate that MED12 binding is necessary but not sufficient for CycC-CDK8/19 activation and reveal an additional step in the MED12-dependent activation process, one critically dependent on MED12 residues altered by UF-linked exon 2 mutations. These findings confirm that UF-linked mutations in MED12 disrupt composite Mediator-associated kinase activity and identify CDK8/19 as prospective therapeutic targets in UFs.	[Park, Min Ju; Shen, Hailian; Spaeth, Jason M.; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Failor, Courtney; Knudtson, Jennifer F.; McLaughlin, Jessica; Schenken, Robert S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Tolvanen, Jaana H.; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Genome Scale Biol Program, Biomedicum, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland; [Tolvanen, Jaana H.; Aaltonen, Lauri A.] Univ Helsinki, Haartman Inst, Dept Med Genet, Biomedicum, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland; [Halder, Sunil K.; Yang, Qiwei; Al-Hendy, Ayman] Augusta Univ, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Spaeth, Jason M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Helsinki; University of Helsinki; University System of Georgia; Augusta University; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Boyer, TG (corresponding author), 8210 Floyd Curl Dr,Mail Code 8257 STRF, San Antonio, TX 78229 USA.	boyer@uthscsa.edu	Al-hendy, Ayman/J-9324-2019; Aaltonen, Lauri/A-5375-2010; Yang, Qiwei/AAI-7414-2021; Kaukomaa, Jaana/G-1040-2016	Aaltonen, Lauri/0000-0001-6839-4286; Kaukomaa, Jaana/0000-0003-1183-4943; Spaeth, Jason/0000-0002-1945-4323; , Qiwei Yang/0000-0001-7131-8946	U.S. Dept. of Health and Human Services, National Institute of Health [R01HD087417]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR001120]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD094378, R01HD087417, P01HD057877] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002646, UL1TR001120] Funding Source: NIH RePORTER	U.S. Dept. of Health and Human Services, National Institute of Health; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by U.S. Dept. of Health and Human Services, National Institute of Health Grant R01HD087417 (to T. G. B.) and the National Center for Advancing Translational Sciences, National Institutes of Health, through the Clinical and Translational Science Award (CTSA) UL1 TR001120. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hendy A, 2017, ENDOCRINOLOGY, V158, P592, DOI 10.1210/en.2016-1097; Alderton G. K., 2014, NAT REV CANCER, V14, P382; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Audetat KA, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00626-16; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Daniels D., 2013, J PROTEOM BIOINFORM, V2, P004, DOI DOI 10.4172/JPB.S2-004; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Eychenne T, 2017, TRANSCR-AUSTIN, V8, P328, DOI 10.1080/21541264.2017.1329000; Harper T. M., 2017, J BIOL CHEM; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Islam MS, 2013, J CLIN ENDOCR METAB, V98, P921, DOI 10.1210/jc.2012-3237; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Kampjarvi K, 2012, BRIT J CANCER, V107, P1761, DOI 10.1038/bjc.2012.428; Kampjarvi K, 2015, ONCOTARGET, V6, P1884; Kampjarvi K, 2014, HUM MUTAT, V35, P1136, DOI 10.1002/humu.22612; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Levy G, 2012, J ASSIST REPROD GEN, V29, P703, DOI 10.1007/s10815-012-9784-0; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin J, 2013, CARDIOVASC INTER RAD, V36, P395, DOI 10.1007/s00270-012-0505-y; Mehine M, 2016, P NATL ACAD SCI USA, V113, P1315, DOI 10.1073/pnas.1518752113; Mehine M, 2014, FERTIL STERIL, V102, P621, DOI 10.1016/j.fertnstert.2014.06.050; Mittal P, 2015, J CLIN INVEST, V125, P3280, DOI 10.1172/JCI81534; Moravek MB, 2015, CURR OPIN OBSTET GYN, V27, P276, DOI 10.1097/GCO.0000000000000185; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Parsanezhad ME, 2010, FERTIL STERIL, V93, P192, DOI 10.1016/j.fertnstert.2008.09.064; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Tan J, 2015, NAT GENET, V47, P1341, DOI 10.1038/ng.3409; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Tsai KL, 2014, CELL, V158, P463, DOI 10.1016/j.cell.2014.06.036; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tsutsui T, 2008, GENES CELLS, V13, P817, DOI 10.1111/j.1365-2443.2008.01208.x; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; van der Kooij SM, 2012, CURR OPIN OBSTET GYN, V24, P368, DOI 10.1097/GCO.0b013e328359f10a; Xu W, 2011, J GENET GENOMICS, V38, P439, DOI 10.1016/j.jgg.2011.09.002; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19763, DOI 10.1073/pnas.1121120109	53	31	31	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4870	4882		10.1074/jbc.RA118.001725	http://dx.doi.org/10.1074/jbc.RA118.001725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440396	hybrid, Green Published			2022-12-28	WOS:000428848300026
J	Riedinger, C; Mendler, M; Schlotterer, A; Fleming, T; Okun, J; Hammes, HP; Herzig, S; Nawroth, PP				Riedinger, Christin; Mendler, Michael; Schlotterer, Andrea; Fleming, Thomas; Okun, Juergen; Hammes, Hans-Peter; Herzig, Stephan; Nawroth, Peter P.			High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; LIFE-SPAN; DNA-DAMAGE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; REACTIVE METABOLITES; GENE-TRANSFER; INSULIN; NEMATODE; HYPERGLYCEMIA; RESTRICTION	The enzyme AICAR-transformylase/IMP cyclohydrolase (ATIC) catalyzes the last two steps of purine de novo synthesis. It metabolizes 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), which is an AMP analogue, leading to activation of AMP-activated kinase (AMPK). We investigated whether the AICAR-ATIC pathway plays a role in the high glucose (HG)mediated DNA damage response and AICAR-mediated AMPK activation, explaining the detrimental effects of glucose on neuronal damage and shortening of the lifespan. HG up-regulated the expression and activity of the Caenorhabditis elegans homologue of ATIC, C55F2.1 (atic-1), and increased the levels of reactive oxygen species and methylglyoxal-derived advanced glycation end products. Overexpression of atic-1 decreased the lifespan and head motility and increased neuronal damage under both standard and HG conditions. Inhibition of atic-1 expression, by RNAi, under HG was associated with increased lifespan and head motility and reduced neuronal damage, reactive oxygen species, and methylglyoxal-derived advanced glycation end product accumulation. This effect was independent of an effect on DNA damage or antioxidant defense pathways, such as superoxide dismutase (sod-3) or glyoxalase-1 (glod-4), but was dependent on AMPK and accumulation of AICAR. Through AMPK, AICAR treatment also reduced the negative effects of HG. The mitochondrial inhibitor rotenone abolished the AICAR/AMPK-induced amelioration of HG effects, pointing to mitochondria as a prime target of the glucotoxic effects in C. elegans. We conclude that atic-1 is involved in glucotoxic effects under HG conditions, either by blocked atic-1 expression or via AICAR and AMPK induction.	[Riedinger, Christin; Mendler, Michael; Schlotterer, Andrea; Fleming, Thomas; Nawroth, Peter P.] Heidelberg Univ, Dept Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Okun, Juergen] Dietmar Hopp Metab Ctr, Dept Pediat, D-69120 Heidelberg, Germany; [Hammes, Hans-Peter] Univ Hosp Mannheim, V Med Hosp, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Herzig, Stephan] Helmholtz Ctr Munich, Inst Diabet & Canc, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Herzig, Stephan; Nawroth, Peter P.] Heidelberg Univ Hosp, Joint Heidelberg Inst Diabet & Canc Translat Diab, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Herzig, Stephan; Nawroth, Peter P.] German Ctr Diabet Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg	Nawroth, PP (corresponding author), Heidelberg Univ, Dept Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Nawroth, PP (corresponding author), Heidelberg Univ Hosp, Joint Heidelberg Inst Diabet & Canc Translat Diab, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.; Nawroth, PP (corresponding author), German Ctr Diabet Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	peter.nawroth@med.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019; Schlotterer, Andrea/GWC-7442-2022		German Research Foundation (DFG) [SFB1118, TP C06, SFB1158, TP A03]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG, "SFB1118, TP C06 Reactive metabolites as cause of diabetic complications") (to M. M., C. R., T. F., S. H., and P. P. N.) and "SFB1158', TP A03" (to P. P. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bhatt S, 2015, CELL METAB, V22, P239, DOI 10.1016/j.cmet.2015.07.015; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BLACK SL, 1978, ANAL BIOCHEM, V90, P397, DOI 10.1016/0003-2697(78)90042-8; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Brenner T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0683-x; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CycLex Co. Ltd., 2016, CYCL AMPK KIN ASS KI; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dhawan A, 2003, SIGMA, V1077, P1; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Fleming T, 2014, BIOCHEM SOC T, V42, P439, DOI 10.1042/BST20130265; Ghiraldini FG, 2013, MOL BIOL CELL, V24, P2467, DOI 10.1091/mbc.E13-04-0186; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Habib SL, 2016, CELL CYCLE, V15, P3048, DOI 10.1080/15384101.2016.1231259; Hartmann S, 2006, CLIN CHEM, V52, P1127, DOI 10.1373/clinchem.2005.058842; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Imanikia S, 2016, ENVIRON TOXICOL PHAR, V45, P356, DOI 10.1016/j.etap.2016.06.020; Kasznicki J, 2009, POL ARCH MED WEWN, V119, P128, DOI 10.20452/pamw.626; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendler M, 2012, EXP CLIN ENDOCR DIAB, V120, P182, DOI 10.1055/s-0032-1304570; Mendler M, 2017, J DIABETES COMPLICAT, V31, P304, DOI 10.1016/j.jdiacomp.2016.09.014; Mendler M, 2015, DIABETOLOGIA, V58, P393, DOI 10.1007/s00125-014-3415-5; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; O'Neil N., 2006, WORMBOOK, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park S, 2016, MOL CELLS, V39, P204, DOI 10.14348/molcells.2016.2206; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schlernitzauer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078788; Schlotterer A, 2010, AGING CELL, V9, P420, DOI 10.1111/j.1474-9726.2010.00572.x; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Sliwinska A, 2008, CHEM-BIOL INTERACT, V173, P159, DOI 10.1016/j.cbi.2008.03.017; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tewari S, 2012, ANTIOXID REDOX SIGN, V17, P492, DOI 10.1089/ars.2011.4333; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Vazquez-Manrique RP, 2016, HUM MOL GENET, V25, P1043, DOI 10.1093/hmg/ddv513; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Winder WW, 2008, DIABETOLOGIA, V51, P1761, DOI 10.1007/s00125-008-1115-8; Xavier DJ, 2015, MUTAT RES-FUND MOL M, V776, P98, DOI 10.1016/j.mrfmmm.2015.01.016; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	57	5	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4845	4859		10.1074/jbc.M117.805879	http://dx.doi.org/10.1074/jbc.M117.805879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414769	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000428848300024
J	Taylor, IR; Dunyak, BM; Komiyama, T; Shao, H; Ran, X; Assimon, VA; Kalyanaraman, C; Rauch, JN; Jacobson, MP; Zuiderweg, ERP; Gestwicki, JE				Taylor, Isabelle R.; Dunyak, Bryan M.; Komiyama, Tomoko; Shao, Hao; Ran, Xu; Assimon, Victoria A.; Kalyanaraman, Chakrapani; Rauch, Jennifer N.; Jacobson, Matthew P.; Zuiderweg, Erik R. P.; Gestwicki, Jason E.			High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; SMALL MOLECULES; ATPASE; BINDING; DNAK; CHAPERONES; DOMAIN; SITE; KDA	Protein-protein interactions (PPIs) are an important category of putative drug targets. Improvements in high-throughput screening (HTS) have significantly accelerated the discovery of inhibitors for some categories of PPIs. However, methods suitable for screening multiprotein complexes (e.g. those composed of three or more different components) have been slower to emerge. Here, we explored an approach that uses reconstituted multiprotein complexes (RMPCs). As a model system, we chose heat shock protein 70 (Hsp70), which is an ATP-dependent molecular chaperone that interacts with co-chaperones, including DnaJA2 and BAG2. The PPIs between Hsp70 and its co-chaperones stimulate nucleotide cycling. Thus, to re-create this ternary protein system, we combined purified human Hsp70 with DnaJA2 and BAG2 and then screened 100,000 diverse compounds for those that inhibited co-chaperone-stimulated ATPase activity. This HTS campaign yielded two compounds with promising inhibitory activity. Interestingly, one inhibited the PPI between Hsp70 and DnaJA2, whereas the other seemed to inhibit the Hsp70-BAG2 complex. Using secondary assays, we found that both compounds inhibited the PPIs through binding to allosteric sites on Hsp70, but neither affected Hsp70's intrinsic ATPase activity. Our RMPC approach expands the toolbox of biochemical HTS methods available for studying difficult-to-target PPIs in multiprotein complexes. The results may also provide a starting point for new chemical probes of the Hsp70 system.	[Taylor, Isabelle R.; Dunyak, Bryan M.; Shao, Hao; Ran, Xu; Assimon, Victoria A.; Kalyanaraman, Chakrapani; Rauch, Jennifer N.; Jacobson, Matthew P.; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sandler Neurosc Bldg,675 Nelson Rising Lane, San Francisco, CA 94158 USA; [Komiyama, Tomoko; Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Sandler Neurosc Bldg,675 Nelson Rising Lane, San Francisco, CA 94158 USA.	jason.gestwicki@ucsf.edu	Ran, Xu/A-5841-2016; Rauch, Jennifer/AGI-2683-2022; Jacobson, Matthew/Y-5161-2018	Rauch, Jennifer/0000-0001-6853-5915; Jacobson, Matthew/0000-0001-6262-655X; Taylor, Isabelle/0000-0003-1053-5677	National Institutes of Health [R01NS059690]; Stand Up 2 Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up 2 Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS059690 (to J. E. G. and E. R. P. Z.) and Stand Up 2 Cancer (to J. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bonomo J, 2010, BIOPHYS CHEM, V149, P58, DOI 10.1016/j.bpc.2010.04.001; Cesa LC, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00119; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Gallardo-Godoy A, 2011, J MED CHEM, V54, P1010, DOI 10.1021/jm101250y; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; Goddard TD., 2000, SPARKY 3; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Kiang JG, 2000, MOL CELL BIOCHEM, V204, P169, DOI 10.1023/A:1007016822939; LEVY EJ, 1995, FEBS LETT, V368, P435, DOI 10.1016/0014-5793(95)00704-D; Li X., 2013, ACS MED CHEM LETT, V4; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Thompson AD, 2012, ACS CHEM BIOL, V7, P1311, DOI 10.1021/cb300255p; Whitmore A, 2017, FASEB J, V31; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Yue XT, 2015, ELIFE, V4, DOI 10.7554/eLife.08401	39	19	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4014	4025		10.1074/jbc.RA117.001575	http://dx.doi.org/10.1074/jbc.RA117.001575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414793	hybrid, Green Published			2022-12-28	WOS:000427587500014
J	Moriyama, K; Yoshizawa-Sugata, N; Masai, H				Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao			Oligomer formation and G-quadruplex binding by purified murine Rif1 protein, a key organizer of higher-order chromatin architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-TIMING PROGRAM; CONTROLS DNA-REPLICATION; 5' END RESECTION; MAMMALIAN-CELLS; FISSION YEAST; PHOSPHATASE 1; HUMAN GENOME; TELOMERE FUNCTION; GLOBAL REGULATOR; GEL-FILTRATION	Rap1-interacting protein 1 (Rif1) regulates telomere length in budding yeast. We previously reported that, in metazoans and fission yeast, Rif1 also plays pivotal roles in controlling genome-wide DNA replication timing. We proposed that Rif1 may assemble chromatin compartments that contain specific replication-timing domains by promoting chromatin loop formation. Rif1 also is involved in DNA lesion repair, restart after replication fork collapse, anti-apoptosis activities, replicative senescence, and transcriptional regulation. Although multiple physiological functions of Rif1 have been characterized, biochemical and structural information on mammalian Rif1 is limited, mainly because of difficulties in purifying the full-length protein. Here, we expressed and purified the 2418-amino-acid-long, full-length murine Rif1 as well as its partially truncated variants in human 293T cells. Hydrodynamic analyses indicated that Rif1 forms elongated or extended homo-oligomers in solution, consistent with the presence of a HEAT-type helical repeat segment known to adopt an elongated shape. We also observed that the purified murine Rif1 bound G-quadruplex (G4) DNA with high specificity and affinity, as was previously shown for Rif1 from fission yeast. Both the N-terminal (HEAT-repeat) and C-terminal segments were involved in oligomer formation and specifically bound G4 DNA, and the central intrinsically disordered polypeptide segment increased the affinity for G4. Of note, pulldown assays revealed that Rif1 simultaneously binds multiple G4 molecules. Our findings support a model in which Rif1 modulates chromatin loop structures through binding to multiple G4 assemblies and by holding chromatin fibers together.	[Moriyama, Kenji; Yoshizawa-Sugata, Naoko; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp		Masai, Hisao/0000-0003-1268-5302; Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	JSPS KAKENHI [23247031, 26251004]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24114520, 15K07164]; Uehara Memorial Foundation Research Support	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation Research Support	This work was supported by JSPS KAKENHI Grants-in-aid for Scientific Research (A) 23247031 and 26251004, Grant-in-aid for Scientific Research on Priority Areas ("non-coding RNA") 24114520 (to H. M.), and Grant-in-aid for Scientific Research (C) 15K07164 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. Y.), and the Uehara Memorial Foundation Research Support (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Adrian M, 2014, J AM CHEM SOC, V136, P6297, DOI 10.1021/ja4125274; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; [Anonymous], 2016, J NANOMATER, DOI [DOI 10.1016/J.FSIGEN.2016.01.005, DOI 10.1155/2016/2358276]; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Kumar S, 2012, CELL CYCLE, V11, P1183, DOI 10.4161/cc.11.6.19636; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; [李培振 Li Peizhen], 2017, [华中科技大学学报. 自然科学版, Journal of Huazhong University of Science and Technology. Nature Science], V45, P1; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Mattarocci S, 2017, NAT STRUCT MOL BIOL, V24, P588, DOI 10.1038/nsmb.3420; Mattarocci S, 2014, CELL REP, V7, P62, DOI 10.1016/j.celrep.2014.03.010; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Peace JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098501; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2005, P NATL ACAD SCI USA, V102, P634, DOI 10.1073/pnas.0406278102; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Renard-Guillet C, 2014, SEMIN CELL DEV BIOL, V30, P110, DOI 10.1016/j.semcdb.2014.04.014; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Sengar A, 2014, BIOCHEMISTRY-US, V53, P7718, DOI 10.1021/bi500990v; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Suh MH, 2005, ANAL BIOCHEM, V343, P166, DOI 10.1016/j.ab.2005.05.016; Sukackaite R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01910-1; Sukackaite R, 2014, J BIOL CHEM, V289, P13903, DOI 10.1074/jbc.M114.557843; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Tazumi A, 2012, GENE DEV, V26, P2050, DOI 10.1101/gad.194282.112; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Uno S, 2012, METHODS, V57, P214, DOI 10.1016/j.ymeth.2012.06.016; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Wang HB, 2009, CARCINOGENESIS, V30, P1314, DOI 10.1093/carcin/bgp136; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yamazaki S, 2013, TRENDS GENET, V29, P449, DOI 10.1016/j.tig.2013.05.001; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhang ZZ, 2014, NUCLEIC ACIDS RES, V42, P13186, DOI 10.1093/nar/gku1100; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	74	21	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3607	3624		10.1074/jbc.RA117.000446	http://dx.doi.org/10.1074/jbc.RA117.000446			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29348174	Green Published, hybrid			2022-12-28	WOS:000427030200016
J	Ko, CW; Counihan, D; Wu, J; Hatzoglou, M; Puchowicz, MA; Croniger, CM				Ko, Chih-Wei; Counihan, Daniel; Wu, Jing; Hatzoglou, Maria; Puchowicz, Michelle A.; Croniger, Colleen M.			Macrophages with a deletion of the phosphoenolpyruvate carboxykinase 1 (Pck1) gene have a more proinflammatory phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; ER STRESS; INFLAMMATION; OBESITY; CARBOXYKINASE; CATAPLEROSIS; EXPRESSION; SUCCINATE	Phosphoenolpyruvate carboxykinase (Pck1) is a metabolic enzyme that is integral to the gluconeogenic and glyceroneogenic pathways. However, Pck1' s role in macrophage metabolism and function is unknown. Using stable isotopomer MS analysis in a mouse model with a myeloid cell-specific Pck1 deletion, we show here that this deletion increases the proinflammatory phenotype in macrophages. Incubation of LPS-stimulated bone marrow-derived macrophages (BMDM) with [U-C-13] glucose revealed reduced C-13 labeling of citrate and malate and increased C-13 labeling of lactate in Pck1-deleted bone marrow-derived macrophages. We also found that the Pck1 deletion in the myeloid cells increases reactive oxygen species (ROS). Of note, this altered macrophage metabolism increased expression of the M1 cytokines TNF alpha, IL-1 beta, and IL-6. We therefore conclude that Pck1 contributes to M1 polarization in macrophages. Our findings provide important insights into the factors determining the macrophage inflammatory response and indicate that Pck1 activity contributes to metabolic reprogramming and polarization in macrophages.	[Ko, Chih-Wei; Counihan, Daniel; Puchowicz, Michelle A.; Croniger, Colleen M.] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Wu, Jing; Hatzoglou, Maria] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Croniger, CM (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	cmc6@case.edu			National Institutes of Health [U24 DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R37DK060596, U24DK076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Case Mouse Metabolic Phenotyping Center (MMPC) was supported by National Institutes of Health Grant U24 DK76174. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; DeSantis DA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751374; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Geeraerts X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00289; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Kombu RS, 2011, METHODS MOL BIOL, V708, P147, DOI 10.1007/978-1-61737-985-7_8; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	20	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3399	3409		10.1074/jbc.M117.819136	http://dx.doi.org/10.1074/jbc.M117.819136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317502	Green Published, hybrid			2022-12-28	WOS:000426562800030
J	Meng, FL; He, ZY; Tang, XW; Zheng, J; Jin, XF; Zhu, Y; Ren, XY; Zhou, M; Wang, M; Gong, SS; Mo, JQ; Shu, Q; Guan, MX				Meng, Feilong; He, Zheyun; Tang, Xiaowen; Zheng, Jing; Jin, Xiaofen; Zhu, Yi; Ren, Xiaoyan; Zhou, Mi; Wang, Meng; Gong, Shasha; Mo, Jun Qin; Shu, Qiang; Guan, Min-Xin			Contribution of the tRNA(Ile) 4317A -> G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A -> G mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A1555G MUTATION; NUCLEAR MODIFIER; BIOCHEMICAL-EVIDENCE; PEDIATRIC SUBJECTS; OXIDATIVE STRESS; CHINESE FAMILIES; C1494T MUTATION; DNA MUTATION; HEARING-LOSS; GENE	The 1555A -> G mutation in mitochondrial 12S rRNA has been associated with aminoglycoside-induced and non-syndromic deafness in many individuals worldwide. Mitochondrial genetic modifiers are proposed to influence the phenotypic expression of m.1555A -> G mutation. Here, we report that a deafness-susceptibility allele (m.4317A -> G) in the tRNA(Ile) gene modulates the phenotype expression of m.1555A -> G mutation. Strikingly, a large Han Chinese pedigree carrying both m.4317A -> G and m.1555A -> G mutations exhibited much higher penetrance of deafness than those carrying only the m.1555A -> G mutation. The m.4317A -> G mutation affected a highly conserved adenine at position 59 in the T-loop of tRNA(Ile). We therefore hypothesized that the m.4317A -> G mutation alters both structure and function of tRNA(Ile). Using lymphoblastoid cell lines derived from members of Chinese families (three carrying both m.1555A -> G and m.4317A -> G mutations, three harboring only m.1555A -> G mutation, and three controls lacking these mutations), we found that the cell lines bearing both m.4317A -> G and m.1555A -> G mutations exhibited more severe mitochondrial dysfunctions than those carrying only the m.1555A -> G mutation. We also found that the m.4317A -> G mutation perturbed the conformation, stability, and aminoacylation efficiency of tRNA(Ile). These m.4317A -> G mutation-induced alterations in tRNA(Ile) structure and function aggravated the defective mitochondrial translation and respiratory phenotypes associated with the m.1555A -> G mutation. Furthermore, mutant cell lines bearing both m.4317A -> G and m.1555A -> G mutations exhibited greater reductions in the mitochondrial ATP levels and membrane potentials and increasing production of reactive oxygen species than those carrying only the m.1555A -> G mutation. Our findings provide new insights into the pathophysiology of maternally inherited deafness arising from the synergy between mitochondrial 12S rRNA and tRNA mutations.	[Meng, Feilong; Zheng, Jing; Zhou, Mi; Wang, Meng; Shu, Qiang; Guan, Min-Xin] Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou 310052, Zhejiang, Peoples R China; [Meng, Feilong; Zheng, Jing; Jin, Xiaofen; Zhou, Mi; Wang, Meng; Gong, Shasha; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Hangzhou 310058, Zhejiang, Peoples R China; [He, Zheyun; Tang, Xiaowen; Ren, Xiaoyan] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Sch Life Sci, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [Zhu, Yi] Wenzhou Med Univ, Dept Otolaryngol, Affiliated Hosp 1, Wenzhou 325035, Zhejiang, Peoples R China; [He, Zheyun] Ningbo Secondary Hosp, Inst Liver Dis, Ningbo 375010, Zhejiang, Peoples R China; [Gong, Shasha] Taizhou Coll, Sch Med, Taizhou 318000, Zhejiang, Peoples R China; [Mo, Jun Qin] Univ Calif San Diego, Dept Pathol, Rady Childrens Hosp, San Diego, CA 92123 USA	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Taizhou University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Shu, Q (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, 3333 Binsheng Rd, Hangzhou 310000, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	shuqiang@zju.edu.cn; gminxin88@zju.edu.cn	he, zhe/GSJ-2307-2022	Guan, Min-Xin/0000-0001-5067-6736	National Key Technologies R&D Program from the Ministry of Science and Technology of China [2014CB541704]; National Natural Science Foundation of China [83133024, 81700922, 81500804, 81670944]	National Key Technologies R&D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Technologies R&D Program Grant 2014CB541704 from the Ministry of Science and Technology of China (to M.X.G.) and Grants 83133024, 81700922, 81500804, and 81670944 from the National Natural Science Foundation of China (to M.X.G., F.M., S.G., and X. T., respectively). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Degoul F, 1998, HUM MOL GENET, V7, P347, DOI 10.1093/hmg/7.3.347; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Matsunaga T, 2004, LARYNGOSCOPE, V114, P1085, DOI 10.1097/00005537-200406000-00024; Matthijs G, 1996, EUR J HUM GENET, V4, P46; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen ZS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-4; Subathra M, 2016, ANN HUM GENET, V80, P257, DOI 10.1111/ahg.12161; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Yuan HJ, 2005, AM J MED GENET A, V138A, P133, DOI 10.1002/ajmg.a.30952; Zhang JL, 2017, J MED IMAG HEALTH IN, V7, P1, DOI 10.1166/jmihi.2017.1978; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028	69	26	26	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3321	3334		10.1074/jbc.RA117.000530	http://dx.doi.org/10.1074/jbc.RA117.000530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348176	hybrid, Green Published			2022-12-28	WOS:000426562800024
J	Esmail, S; Kartner, N; Yao, YQ; Kim, JW; Reithmeier, RAF; Manolson, MF				Esmail, Sally; Kartner, Norbert; Yao, Yeqi; Kim, Joo Wan; Reithmeier, Reinhart A. F.; Manolson, Morris F.			Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; N-LINKED GLYCOSYLATION; A3; OSTEOPETROSIS; TRANSPORT; MEMBRANE; ACIDIFICATION; COMPLEXES; TOPOLOGY; ISOFORMS	The a subunit is the largest of 15 different subunits that make up the vacuolar H+-ATPase (V-ATPase) complex, where it functions in proton translocation. In mammals, this subunit has four paralogous isoforms, a1-a4, which may encode signals for targeting assembled V-ATPases to specific intracellular locations. Despite the functional importance of the a subunit, its structure remains controversial. By studying molecular mechanisms of human disease-causing missense mutations within a subunit isoforms, we may identify domains critical for V-ATPase targeting, activity and/or regulation. cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (a2) and ATP6V0A4 (a4) subunits and their mutants, a2(P405L) (causing cutis laxa), and a4(R449H) and a4(G820R) (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells. N-Glycosylation was assessed using endoglycosidases, revealing that a2(P405L), a4(R449H), and a4(G820R) were fully N-glycosylated. Cycloheximide (CHX) chase assays revealed that a2(P405L) and a4(R449H) were unstable relative to wildtype. a4(R449H) was degraded predominantly in the proteasomal pathway, whereas a2(P405L) was degraded in both proteasomal and lysosomal pathways. Immunofluorescence studies disclosed retention in the endoplasmic reticulum and defective cell-surface expression of a4(R449H) and defective Golgi trafficking of a2(P405L). Co-immunoprecipitation studies revealed an increase in association of a4(R449H) with the V-0 assembly factor VMA21, and a reduced association with the V-1 sector subunit, ATP6V1B1 (B1). For a4(G820R), where stability, degradation, and trafficking were relatively unaffected, 3D molecular modeling suggested that the mutation causes dRTA by blocking the proton pathway. This study provides critical information that may assist rational drug design to manage dRTA and cutis laxa.	[Esmail, Sally; Kartner, Norbert; Yao, Yeqi; Kim, Joo Wan; Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Reithmeier, Reinhart A. F.; Manolson, Morris F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@utoronto.ca	Esmail, Sally/P-1256-2019	Manolson, Morris/0000-0001-8755-5460	Canadian Institutes of Health Research [MOP-12333, PJT-148508]; Toronto Musculoskeletal Centre; Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Toronto Musculoskeletal Centre; Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research Grants MOP-12333 and PJT-148508 (to M. F. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a scholarship from the Toronto Musculoskeletal Centre.; Supported by a scholarship from the Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis.	Batlle D, 2012, NEPHROL DIAL TRANSPL, V27, P3691, DOI 10.1093/ndt/gfs442; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhargava A, 2012, J BIOL CHEM, V287, P26829, DOI 10.1074/jbc.M112.345702; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Esmail S, 2018, J CELL BIOCHEM, V119, P861, DOI 10.1002/jcb.26250; Esmail S, 2016, J CELL BIOCHEM, V117, P2757, DOI 10.1002/jcb.25574; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freeze H.H., 2010, CURR PROTOC PROTEIN; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Guevara-Coto J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S11-S4; Guillard M, 2009, BBA-MOL BASIS DIS, V1792, P903, DOI 10.1016/j.bbadis.2008.12.009; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kartner N, 2016, ADV BIOCHEM HEALTH D, V14, P407, DOI 10.1007/978-3-319-24780-9_20; Kartner N, 2013, J CELL BIOCHEM, V114, P1474, DOI 10.1002/jcb.24489; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Schep DG, 2016, P NATL ACAD SCI USA, V113, P3245, DOI 10.1073/pnas.1521990113; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003	44	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2787	2800		10.1074/jbc.M117.818872	http://dx.doi.org/10.1074/jbc.M117.818872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29311258	hybrid, Green Published			2022-12-28	WOS:000426051900015
J	Li, W; Tam, KMV; Chan, WWR; Koon, AC; Ngo, JCK; Chan, HYE; Lau, KF				Li, Wen; Tam, Ka Ming Vincent; Chan, Wai Wa Ray; Koon, Alex Chun; Ngo, Jacky Chi Ki; Chan, Ho Yin Edwin; Lau, Kwok-Fai			Neuronal adaptor FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation factor (ARF); amyloid precursor protein (APP); guanine nucleotide exchange factor (GEF); neurite outgrowth; Ras-related C3 botulinum toxin substrate 1 (Rac1); amyloid A4 precursor protein-binding family B member 1; ELMO1; FE65	AMYLOID PRECURSOR PROTEIN; DOWNSTREAM ACTIVATION; ALZHEIMERS-DISEASE; RHO GTPASES; FAMILY; COMPLEX; INTERACTS; CELLS; RAC1; ARF6	Neurite outgrowth is a crucial process in developing neurons for neural network formation. Understanding the regulatory mechanisms of neurite outgrowth is essential for developing strategies to stimulate neurite regeneration after nerve injury and in neurodegenerative disorders. FE65 is a brain-enriched adaptor that stimulates Rac1-mediated neurite elongation. However, the precise mechanism by which FE65 promotes the process remains elusive. Here, we show that ELMO1, a subunit of ELMO1-DOCK180 bipartite Rac1 guanine nucleotide exchange factor (GEF), interacts with the FE65 N-terminal region. Overexpression of FE65 and/or ELMO1 enhances, whereas knockdown of FE65 or ELMO1 inhibits, neurite outgrowth and Rac1 activation. The effect of FE65 alone or together with ELMO1 is attenuated by an FE65 double mutation that disrupts FE65-ELMO1 interaction. Notably, FE65 is found to activate ELMO1 by diminishing ELMO1 intramolecular autoinhibitory interaction and to promote the targeting of ELMO1 to the plasma membrane, where Rac1 is activated. We also show that FE65, ELMO1, and DOCK180 form a tripartite complex. Knockdown of DOCK180 reduces the stimulatory effect of FE65-ELMO1 on Rac1 activation and neurite outgrowth. Thus, we identify a novel mechanism by which FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1.	[Li, Wen; Tam, Ka Ming Vincent; Chan, Wai Wa Ray; Koon, Alex Chun; Ngo, Jacky Chi Ki; Chan, Ho Yin Edwin; Lau, Kwok-Fai] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lau, KF (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	LI, WEN/Y-6659-2018; Chan, Edwin/A-9478-2011; Ngo, Jacky C/O-8093-2017	Chan, Edwin/0000-0003-4307-474X; Ngo, Jacky C/0000-0002-6004-7041; Lau, Kwok-Fai/0000-0002-0193-1152; Chan, Wai Wa/0000-0002-3735-1985	Research Grants Council Hong Kong; Health and Medical Research Fund (Hong Kong); CUHK direct grant scheme; United College endowment fund; TUYF Charitable Trust	Research Grants Council Hong Kong(Hong Kong Research Grants Council); Health and Medical Research Fund (Hong Kong); CUHK direct grant scheme; United College endowment fund; TUYF Charitable Trust	This work was supported by funds from the Research Grants Council Hong Kong, Health and Medical Research Fund (Hong Kong), CUHK direct grant scheme, the United College endowment fund, and the TUYF Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Chow WNV, 2015, CELL MOL BIOL LETT, V20, P66, DOI 10.1515/cmble-2015-0002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gomez-Pinedo U, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00195; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hao CY, 2011, BIOCHEM J, V436, P631, DOI 10.1042/BJ20110145; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krause K, 2008, J ENDOCRINOL, V198, P291, DOI 10.1677/JOE-08-0005; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lundquist EA, 2003, CURR OPIN NEUROBIOL, V13, P384, DOI 10.1016/s0959-4388(03)00071-0; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Mauldin JP, 2013, CURR BIOL, V23, P162, DOI 10.1016/j.cub.2012.11.049; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Nensa FM, 2014, MOL CELL PROTEOMICS, V13, P475, DOI 10.1074/mcp.M113.029280; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sabo SL, 2003, J NEUROSCI, V23, P5407; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Stevenson C, 2014, J IMMUNOL, V192, P6062, DOI 10.4049/jimmunol.1303348; Stoops EH, 2016, TRAFFIC, V17, P1272, DOI 10.1111/tra.12449; Strecker P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25652; Sun YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11529; Sun YF, 2014, J BIOL CHEM, V289, P12217, DOI 10.1074/jbc.M113.526194; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	55	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7674	7688		10.1074/jbc.RA117.000505	http://dx.doi.org/10.1074/jbc.RA117.000505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615491	Green Published, hybrid			2022-12-28	WOS:000437256500018
J	Nesbitt, NM; Zheng, XL; Li, ZD; Manso, JA; Yen, WY; Malone, LE; Ripoll-Rozada, J; Pereira, PJB; Mantle, TJ; Wang, J; Bahou, WF				Nesbitt, Natasha M.; Zheng, Xiliang; Li, Zongdong; Manso, Jose A.; Yen, Wan-Yi; Malone, Lisa E.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose; Mantle, Timothy J.; Wang, Jin; Bahou, Wadie F.			In silico and crystallographic studies identify key structural features of biliverdin IX beta reductase inhibitors having nanomolar potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN REDUCTASE; PYRROLOQUINOLINE QUINONE; ALPHA REDUCTASE; CATALYTIC MECHANISM; AUTOMATED DOCKING; SUBSTRATE-BINDING; SCORING FUNCTION; WEB SERVER; BILIRUBIN; ZINC	Heme cytotoxicity is minimized by a two-step catabolic reaction that generates biliverdin (BV) and bilirubin (BR) tetrapyrroles. The second step is regulated by two non-redundant biliverdin reductases (IX beta (BLVRA) and IX beta (BLVRB)), which retain isomeric specificity and NAD(P)H-dependent redox coupling linked to BR's antioxidant function. Defective BLVRB enzymatic activity with antioxidant mishandling has been implicated in metabolic consequences of hematopoietic lineage fate and enhanced platelet counts in humans. We now outline an integrated platform of in silico and crystallographic studies for the identification of an initial class of compounds inhibiting BLVRB with potencies in the nanomolar range. We found that the most potent BLVRB inhibitors contain a tricyclic hydrocarbon core structure similar to the isoalloxazine ring of flavin mononucleotide and that both xanthene-and acridine-based compounds inhibit BLVRB's flavin and dichlorophenolindophenol (DCPIP) reductase functions. Crystallographic studies of ternary complexes with BLVRB-NADP(+)-xanthene-based compounds confirmed inhibitor binding adjacent to the cofactor nicotinamide and interactions with the Ser-111 side chain. This residue previously has been identified as critical for maintaining the enzymatic active site and cellular reductase functions in hematopoietic cells. Both acridine-and xanthene-based compounds caused selective and concentration-dependent loss of redox coupling in BLVRB-overexpressing promyelocytic HL-60 cells. These results provide promising chemical scaffolds for the development of enhanced BLVRB inhibitors and identify chemical probes to better dissect the role of biliverdins, alternative substrates, and BLVRB function in physiologically relevant cellular contexts.	[Nesbitt, Natasha M.; Li, Zongdong; Yen, Wan-Yi; Malone, Lisa E.; Bahou, Wadie F.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Zheng, Xiliang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Manso, Jose A.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose] Univ Porto, IBMC Inst Biol Mol & Celular, P-4200135 Porto, Portugal; [Manso, Jose A.; Ripoll-Rozada, Jorge; Barbosa Pereira, Pedro Jose] Univ Porto, Inst Invest & Inovaco Saude I3S, P-4200135 Porto, Portugal; [Mantle, Timothy J.] Trinity Coll Dublin, Dept Biochem, Dublin 2, Ireland	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Trinity College Dublin	Nesbitt, NM (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	natasha.nesbitt@stonybrook.edu; jin.wang.1@stonybrook.edu	Ripoll Rozada, Jorge/L-1574-2016; Rozada, Jorge Ripoll/AAA-8049-2020; Manso, José Antonio/S-3983-2019; Manso, José/GWV-5180-2022; Pereira, Pedro/F-8972-2011	Ripoll Rozada, Jorge/0000-0001-7235-317X; Rozada, Jorge Ripoll/0000-0001-7235-317X; Manso, José Antonio/0000-0002-2565-6239; Pereira, Pedro/0000-0003-0969-5438; Nesbitt, Natasha M/0000-0001-5549-0383	National Institutes of Health [HL091939, HL129545]; NewYork State Stem Cell Foundation [C026716]; National Natural Science Foundation of China [91430217]; MOST [2016YFA0203200, 2013YQ170585]; National Science Foundation [PHY-76066]; Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship [SFRH/BPD/108004/2015]; project "Institute for Research and Innovation in Health Sciences" [POCI-01-0145-FEDER-007274]; European Regional Development Fund (FEDER) through the COMPETE-Operational Programme for Competitiveness and Internationalization (POCI); European Regional Development Fund (FEDER) - Norte Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement through FEDER [Norte-01-0145-FEDER-000012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119096, R43HL129545, R01HL091939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NewYork State Stem Cell Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; National Science Foundation(National Science Foundation (NSF)); Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship; project "Institute for Research and Innovation in Health Sciences"; European Regional Development Fund (FEDER) through the COMPETE-Operational Programme for Competitiveness and Internationalization (POCI); European Regional Development Fund (FEDER) - Norte Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement through FEDER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL091939 (to W. F. B.) and HL129545 (to N. M. N.), NewYork State Stem Cell Foundation Grant C026716 (to W. F. B.), National Natural Science Foundation of China Grant 91430217, MOST Grants 2016YFA0203200 and 2013YQ170585 (to X. L. Z. and J. W.), National Science Foundation Grant PHY-76066 (to J. W.), Portuguese funds through Fundacao para a Ciencia e a Tecnologia postdoctoral fellowship SFRH/BPD/108004/2015 (to J. R.-R.) and project "Institute for Research and Innovation in Health Sciences" Grant POCI-01-0145-FEDER-007274, co-funded by the European Regional Development Fund (FEDER) through the COMPETE 2020-Operational Programme for Competitiveness and Internationalization (POCI), PORTUGAL 2020, the "Structured program on bioengineered therapies for infectious diseases and tissue regeneration" Grant Norte-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement through FEDER. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Awale M, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-014-0051-5; Awale M, 2014, NUCLEIC ACIDS RES, V42, pW234, DOI 10.1093/nar/gku379; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; Chu WT, 2017, CHEM-EUR J, V23, P1891, DOI 10.1002/chem.201604517; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Cunningham O, 2000, BIOCHEM J, V345, P393, DOI 10.1042/0264-6021:3450393; Cunningham O, 2000, J BIOL CHEM, V275, P19009, DOI 10.1074/jbc.275.25.19009; Cunningham O, 1997, BIOCHEM SOC T, V25, pS613, DOI 10.1042/bst025s613; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Franklin EM, 2009, FEBS J, V276, P4405, DOI 10.1111/j.1742-4658.2009.07148.x; Fu G, 2012, J PHYS CHEM B, V116, P9580, DOI 10.1021/jp301456j; Ganesan L, 2011, BIOCHEM PHARMACOL, V81, P810, DOI 10.1016/j.bcp.2010.12.020; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; HAGERHALL C, 1992, BIOCHEMISTRY-US, V31, P7411, DOI 10.1021/bi00147a028; Huan L, 2016, CANCER SCI, V107, P258, DOI 10.1111/cas.12869; HULTQUIST DE, 1993, AM J HEMATOL, V42, P13, DOI 10.1002/ajh.2830420105; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jordheim LP, 2013, MOL PHARMACOL, V84, P12, DOI 10.1124/mol.112.082347; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lagorce D, 2015, NUCLEIC ACIDS RES, V43, pW200, DOI 10.1093/nar/gkv353; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu XF, 2011, J CHEM INF MODEL, V51, P2372, DOI 10.1021/ci200060s; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; MACK CP, 1995, BIOCHEM BIOPH RES CO, V212, P35, DOI 10.1006/bbrc.1995.1932; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonagh AF, 2001, NAT STRUCT BIOL, V8, P198, DOI 10.1038/84915; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Mizutani T, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/953952; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; NOGUCHI M, 1979, J BIOCHEM, V86, P833, DOI 10.1093/oxfordjournals.jbchem.a132615; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Peters WHM, 2003, J HEPATOL, V38, P3, DOI 10.1016/S0168-8278(02)00306-9; Quintus F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-245; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Shalloe F, 1996, BIOCHEM J, V316, P385, DOI 10.1042/bj3160385; Smith LJ, 2008, BIOCHEM J, V411, P475, DOI 10.1042/BJ20071495; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Stivers J., 2008, U. S. Patent, Patent No. [20080020973A1, 20080020973]; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Straus OH, 1943, J GEN PHYSIOL, V26, P559, DOI 10.1085/jgp.26.6.559; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; Uesugi N, 2006, J HEALTH SCI, V52, P549, DOI 10.1248/jhs.52.549; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057288; Wu S, 2016, BLOOD, V128, P699, DOI 10.1182/blood-2016-02-696997; XU F, 1993, BIOCHEM BIOPH RES CO, V193, P434, DOI 10.1006/bbrc.1993.1642; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; YAMAGUCHI T, 1994, J BIOL CHEM, V269, P24343; YAMAGUCHI T, 1995, EUR J BIOCHEM, V233, P467, DOI 10.1111/j.1432-1033.1995.467_2.x; Yan ZH, 2007, J MED CHEM, V50, P4096, DOI 10.1021/jm070305p; YUBISUI T, 1979, J BIOCHEM, V85, P719	81	4	4	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5431	5446		10.1074/jbc.RA118.001803	http://dx.doi.org/10.1074/jbc.RA118.001803			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29487133	Green Published, hybrid			2022-12-28	WOS:000430044100008
J	Zhang, QM; Xiao, KH; Liu, HD; Song, L; McGarvey, JC; Sneddon, WB; Bisello, A; Friedman, PA				Zhang, Qiangmin; Xiao, Kunhong; Liu, Hongda; Song, Lei; McGarvey, Jennifer C.; Sneddon, W. Bruce; Bisello, Alessandro; Friedman, Peter A.			Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; UBIQUITIN-DEPENDENT REGULATION; PROXIMAL TUBULAR CELLS; TISSUE GROWTH-FACTOR; MU-OPIOID RECEPTORS; BETA-ARRESTIN; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; PTH/PTHRP RECEPTOR	Gprotein-coupled receptor (GPCR) signaling and trafficking are essential for cellular function and regulated by phosphorylation, beta-arrestin, and ubiquitination. The GPCR parathyroid hormone receptor (PTHR) exhibits time-dependent reversible ubiquitination. The exact ubiquitination sites in PTHR are unknown, but they extend upstream of its intracellular tail. Here, using tandem MS, we identified Lys(388) in the third loop and Lys(484) in the C-terminal tail as primary ubiquitination sites in PTHR. We found that PTHR ubiquitination requires beta-arrestin and does not display a preference for beta-arrestin1 or -2. PTH stimulated PTHR phosphorylation at Thr(387)/Thr(392) and within the Ser(489)-Ser(493) region. Such phosphorylation events may recruit beta-arrestin, and we observed that chemically or genetically blocking PTHR phosphorylation inhibits its ubiquitination. Specifically, Ala replacement at Thr(387)/Thr(392) suppressed beta-arrestin binding and inhibited PTHR ubiquitination, suggesting that PTHR phosphorylation and ubiquitination are interdependent. Of note, Lys-deficient PTHR mutants promoted normal cAMP formation, but exhibited differential mitogen-activated protein kinase (MAPK) signaling. Lys-deficient PTHR triggered early onset and delayed ERK1/2 signaling compared with wildtype PTHR. Moreover, ubiquitination of Lys(388) and Lys(484) in wildtype PTHR strongly decreased p38 signaling, whereas Lys-deficient PTHR retained signaling comparable to unstimulated wildtype PTHR. Lys-deficient, ubiquitination-refractory PTHR reduced cell proliferation and increased apoptosis. However, elimination of all 11 Lys residues in PTHR did not affect its internalization and recycling. These results pinpoint the ubiquitinated Lys residues in PTHR controlling MAPK signaling and cell proliferation and survival. Our findings suggest new opportunities for targeting PTHR ubiquitination to regulate MAPK signaling or manage PTHR-related disorders.	[Zhang, Qiangmin; Xiao, Kunhong; Liu, Hongda; Song, Lei; McGarvey, Jennifer C.; Sneddon, W. Bruce; Bisello, Alessandro; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15261 USA; [McGarvey, Jennifer C.] Heptares Therapeut, Welwyn Garden City AL7 3AX, Herts, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Heptares Therapeutics Ltd.	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E-1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; McGarvey, Jennifer/0000-0001-8782-267X; Liu, Hongda/0000-0002-5977-9130	National Institutes of Health [R01 DK105811-A1, R01 DK111427-A1, R01 HL136382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811, R01DK069998, R01DK111427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK105811-A1 and R01 DK111427-A1 (to P.A.F.) and R01 HL136382 (to A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Alonso V, 2011, J BONE MINER RES, V26, P2923, DOI 10.1002/jbmr.494; Arttamangkul S, 2012, MOL PHARMACOL, V81, P348, DOI 10.1124/mol.111.076208; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Binkowski BF, 2011, ACS CHEM BIOL, V6, P1193, DOI 10.1021/cb200248h; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Blind E, 1996, J BONE MINER RES, V11, P578; BLIND E, 1995, ENDOCRINOLOGY, V136, P4271, DOI 10.1210/en.136.10.4271; Bohinc BN, 2012, MINI-REV MED CHEM, V12, P856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan ASM, 2016, MOL BIOL CELL, V27, P1367, DOI 10.1091/mbc.E15-12-0851; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cheng YB, 2013, CANCER METAST REV, V32, P567, DOI 10.1007/s10555-013-9433-9; Cossa G, 2013, CURR PHARM DESIGN, V19, P883, DOI 10.2174/138161213804547187; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Flannery PJ, 2001, BIOCHEM PHARMACOL, V62, P1047, DOI 10.1016/S0006-2952(01)00749-3; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Friedman PA, 1999, ENDOCRINOLOGY, V140, P301, DOI 10.1210/en.140.1.301; Friedman PA, 2006, AM J PHYSIOL-RENAL, V290, pF975, DOI 10.1152/ajprenal.00336.2005; Gan L, 2006, PROTEIN EXPRES PURIF, V47, P296, DOI 10.1016/j.pep.2005.11.004; Gardella TJ, 2015, PHARMACOL REV, V67, P310, DOI 10.1124/pr.114.009464; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Guo YS, 2010, CHINESE MED J-PEKING, V123, P3671, DOI 10.3760/cma.j.issn.0366-6999.2010.24.029; Guo YS, 2011, NEPHROL DIAL TRANSPL, V26, P839, DOI 10.1093/ndt/gfq521; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hislop JN, 2011, J BIOL CHEM, V286, P40193, DOI 10.1074/jbc.M111.288555; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Kennedy JE, 2015, PROG MOL BIOL TRANSL, V132, P15, DOI 10.1016/bs.pmbts.2015.02.005; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maeda A, 2013, P NATL ACAD SCI USA, V110, P5864, DOI 10.1073/pnas.1301674110; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Matsumoto Y, 2017, J CLIN INVEST, V127, P2612, DOI 10.1172/JCI92233; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McGarvey JC, 2016, J BIOL CHEM, V291, P10986, DOI 10.1074/jbc.M115.697045; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Ravingerova T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033; Roy SJ, 2013, MOL ENDOCRINOL, V27, P1245, DOI 10.1210/me.2013-1091; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shirakawa J, 2016, CALCIFIED TISSUE INT, V98, P306, DOI 10.1007/s00223-015-0083-5; Skieterska K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050923; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Takeda AN, 2014, EMBO J, V33, P1784, DOI 10.15252/embj.201487808; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou AT, 2000, BIOCHEMISTRY-US, V39, P6514, DOI 10.1021/bi992706f; Zindel D, 2016, BIOCHEM J, V473, P4173, DOI 10.1042/BCJ20160740	86	8	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5556	5571		10.1074/jbc.RA118.001737	http://dx.doi.org/10.1074/jbc.RA118.001737			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29444827	Green Published, hybrid			2022-12-28	WOS:000430044100018
J	Shen, YQ; Sherman, JW; Chen, XY; Wang, RN				Shen, Yuqing; Sherman, John William; Chen, Xuyong; Wang, Ruoning			Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G(2)/M-phase transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); mitosis; protein phosphorylation; cell cycle; metabolic regulation; CDC25C; metabolic checkpoint	DNA-DAMAGE; WEE1 KINASE; XENOPUS OOCYTES; GENETIC-CONTROL; MITOTIC ENTRY; P53 PROTEINS; S-PHASE; PROLIFERATION; CANCER; GROWTH	From unicellular to multicellular organisms, cell-cycle progression is tightly coupled to biosynthetic and bioenergetic demands. Accumulating evidence has demonstrated the G(1)/S-phase transition as a key checkpoint where cells respond to their metabolic status and commit to replicating the genome. However, the mechanism underlying the coordination of metabolism and the G(2)/M-phase transition in mammalian cells remains unclear. Here, we show that the activation of AMP-activated protein kinase (AMPK), a highly conserved cellular energy sensor, significantly delays mitosis entry. The cell-cycle G(2)/M-phase transition is controlled by mitotic cyclin-dependent kinase complex (CDC2-cyclin B), which is inactivated by WEE1 family protein kinases and activated by the opposing phosphatase CDC25C. AMPK directly phosphorylates CDC25C on serine 216, a well-conserved inhibitory phosphorylation event, which has been shown to mediate DNA damage-induced G(2)-phase arrest. The acute induction of CDC25C or suppression of WEE1 partially restores mitosis entry in the context of AMPK activation. These findings suggest that AMPK-dependent phosphorylation of CDC25C orchestrates a metabolic checkpoint for the cell-cycle G(2)/M-phase transition.	[Shen, Yuqing; Sherman, John William; Chen, Xuyong; Wang, Ruoning] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis,Hematol Oncol & BM, Columbus, OH 43205 USA; [Shen, Yuqing] Southeast Univ, Key Lab Dev Genes & Human Dis, Dept Microbiol & Immunol, Minist Educ,Med Sch, Nanjing 210009, Jiangsu, Peoples R China	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Southeast University - China	Wang, RN (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis,Hematol Oncol & BM, Columbus, OH 43205 USA.	ruoning.wang@nationwidechildrens.org			National Institute of Health [1R01AI114581]; V-Foundation [V2014-001]; American Cancer Society [128436-RSG-15-180-01-LIB]; CancerFree KIDs Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114581] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V-Foundation; American Cancer Society(American Cancer Society); CancerFree KIDs Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health Grant 1R01AI114581, V-Foundation Grant V2014-001, American Cancer Society Grant 128436-RSG-15-180-01-LIB, and a research grant from the CancerFree KIDs Foundation (to R. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; BENDICK C, 1989, ARCH DERMATOL, V125, P1285, DOI 10.1001/archderm.125.9.1285; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; BRAND K, 1984, BIOCHEM J, V221, P471, DOI 10.1042/bj2210471; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buchakjian MR, 2010, NAT REV MOL CELL BIO, V11, P715, DOI 10.1038/nrm2972; Cai L, 2012, ANNU REV CELL DEV BI, V28, P59, DOI 10.1146/annurev-cellbio-092910-154010; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Goodwin GW, 2001, AM J PHYSIOL-ENDOC M, V280, pE502, DOI 10.1152/ajpendo.2001.280.3.E502; Green DR, 2016, CURR BIOL, V26, pR620, DOI 10.1016/j.cub.2016.05.023; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2016, ACTA PHARM SIN B, V6, P1, DOI 10.1016/j.apsb.2015.06.002; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; HOCHACHKA PW, 2002, BIOCH ADAPTATION MEC, P101; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawabe T, 2004, MOL CANCER THER, V3, P513; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lee IH, 2013, CURR OPIN CELL BIOL, V25, P724, DOI 10.1016/j.ceb.2013.07.002; Leijen S, 2016, J CLIN ONCOL, V34, P4371, DOI 10.1200/JCO.2016.67.5991; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; MAY E, 1991, ONCOGENE, V6, P1363; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Mitchison J. M., 1972, BIOL CELL CYCLE, P192; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Morgan D. O., 2006, CELL CYCLE PRINCIPLE, P90; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Mueller S, 2015, J CLIN ONCOL, V33, P3485, DOI 10.1200/JCO.2015.62.2290; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pederson T, 2003, TRENDS BIOCHEM SCI, V28, P125, DOI 10.1016/S0968-0004(03)00030-6; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perdiguero E, 2004, CELL CYCLE, V3, P733; Perdiguero E, 2003, EMBO J, V22, P5746, DOI 10.1093/emboj/cdg559; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; ROBBINS E, 1969, J CELL BIOL, V43, P629, DOI 10.1083/jcb.43.3.629; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shen YQ, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2517; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; SWANN MM, 1957, CANCER RES, V17, P727; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang RN, 2010, P NATL ACAD SCI USA, V107, P19885, DOI 10.1073/pnas.1003528107; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Wang YL, 2000, CELL GROWTH DIFFER, V11, P211; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WILLEMS HL, 1978, CLIN CHEM, V24, P200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	123	18	18	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5185	5199		10.1074/jbc.RA117.001379	http://dx.doi.org/10.1074/jbc.RA117.001379			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29467227	Green Published, hybrid			2022-12-28	WOS:000429409300023
J	Li, B; Tunc-Ozdemir, M; Urano, D; Jia, HY; Werth, EG; Mowrey, DD; Hicks, LM; Dokholyan, NV; Torres, MP; Jones, AM				Li, Bo; Tunc-Ozdemir, Meral; Urano, Daisuke; Jia, Haiyan; Werth, Emily G.; Mowrey, David D.; Hicks, Leslie M.; Dokholyan, Nikolay V.; Torres, Matthew P.; Jones, Alan M.			Tyrosine phosphorylation switching of a G protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; RECEPTOR-LIKE KINASES; DISCRETE MOLECULAR-DYNAMICS; LARGE GENE LISTS; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; REGULATORY ELEMENTS; STRUCTURAL-ANALYSIS; FUNCTIONAL-ANALYSIS; ALPHA-SUBUNITS	Heterotrimeric G protein complexes are molecular switches relaying extracellular signals sensed by G protein-coupled receptors (GPCRs) to downstream targets in the cytoplasm, which effect cellular responses. In the plant heterotrimeric GTPase cycle, GTP hydrolysis, rather than nucleotide exchange, is the rate-limiting reaction and is accelerated by a receptor-like regulator of G signaling (RGS) protein. We hypothesized that post-translational modification of the G alpha subunit in the G protein complex regulates the RGS-dependent GTPase cycle. Our structural analyses identified an invariant phosphorylated tyrosine residue (Tyr(166) in the Arabidopsis G alpha subunit AtGPA1) located in the intramolecular domain interface where nucleotide binding and hydrolysis occur. We also identified a receptor-like kinase that phosphorylates AtGPA1 in a Tyr(166)-dependent manner. Discrete molecular dynamics simulations predicted that phosphorylated Tyr(166) forms a salt bridge in this interface and potentially affects the RGS protein-accelerated GTPase cycle. Using a Tyr(166) phosphomimetic substitution, we found that the cognate RGS protein binds more tightly to the GDP-bound G alpha substrate, consequently reducing its ability to accelerate GTPase activity. In conclusion, we propose that phosphorylation of Tyr(166) in AtGPA1 changes the binding pattern with AtRGS1 and thereby attenuates the steady-state rate of the GTPase cycle. We coin this newly identified mechanism "substrate phosphoswitching."	[Li, Bo; Tunc-Ozdemir, Meral; Urano, Daisuke; Jia, Haiyan; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Werth, Emily G.; Hicks, Leslie M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Mowrey, David D.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem Biophys, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Urano, Daisuke] Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore; [Torres, Matthew P.] Georgia Inst Technol, Dept Biol Sci, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore; University System of Georgia; Georgia Institute of Technology	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Dokholyan, Nikolay/D-8081-2018; Hicks, Leslie M/E-8015-2010	Dokholyan, Nikolay/0000-0002-8225-4025; Hicks, Leslie M/0000-0002-8008-3998; Werth, Emily/0000-0001-8953-0611; Torres, Matthew/0000-0001-7296-4536; Urano, Daisuke/0000-0003-4541-1076; Jia, Haiyan/0000-0003-4788-6534	NCI, National Institutes of Health [CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114015, R01GM065989, R01GM080742, R01GM123247, R01GM117400, R01GM064803] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Stephen R. Sprang (University of Montana) for insightful comments; Dr. Henrik Dohlman (University of North Carolina, Chapel Hill, NC) for sharing equipment; and Kevin Knight, Jing Yang, and Catherine Jones for valuable technical assistance. This research is based in part upon work conducted using the UNC Michael Hooker Proteomics Center, which is supported in part by NCI, National Institutes of Health, Grant CA016086 (to the Lineberger Comprehensive Cancer Center).	Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen Y, 2010, PLANT J, V63, P1, DOI 10.1111/j.1365-313X.2010.04218.x; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Lorenzo L, 2009, PLANT CELL, V21, P668, DOI 10.1105/tpc.108.059576; Dewhurst HM, 2015, MOL CELL PROTEOMICS, V14, P2285, DOI 10.1074/mcp.M115.051177; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Frisch M. J., 2016, GAUSSIAN 16 REV C01; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Greeff C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00209; HAUSDORFF WP, 1992, P NATL ACAD SCI USA, V89, P5720, DOI 10.1073/pnas.89.13.5720; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kim DJ, 2015, FEBS LETT, V589, P3321, DOI 10.1016/j.febslet.2015.09.025; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li B, 2016, PROTEIN EXPRES PURIF, V126, P33, DOI 10.1016/j.pep.2016.04.016; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; MOYERS JS, 1995, BIOCHEM J, V305, P411, DOI 10.1042/bj3050411; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Aranda-Sicilia MN, 2015, J PLANT PHYSIOL, V188, P44, DOI 10.1016/j.jplph.2015.09.005; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Poppleton H, 1996, J BIOL CHEM, V271, P6947, DOI 10.1074/jbc.271.12.6947; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; Stahl Y., 2012, RECEPTOR LIKE KINASE, P23, DOI DOI 10.1007/978-3-642-23044-8_2; Stratmann JW, 1997, P NATL ACAD SCI USA, V94, P11085, DOI 10.1073/pnas.94.20.11085; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; SUZUKI K, 1995, PLANT CELL, V7, P639, DOI 10.1105/tpc.7.5.639; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torres MP, 2016, MOL CELL PROTEOMICS, V15, P3513, DOI 10.1074/mcp.M116.062331; Tunc-Ozdemir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171854; Tunc-Ozdemir M, 2016, J BIOL CHEM, V291, P13918, DOI 10.1074/jbc.C116.736702; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2016, PLANT CELL PHYSIOL, V57, P437, DOI 10.1093/pcp/pcw002; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Xu Q, 1998, PLANT CELL, V10, P849, DOI 10.1105/tpc.10.5.849; Yeh YH, 2016, PLANT CELL, V28, P1701, DOI 10.1105/tpc.16.00313; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yin SY, 2010, METHODS MOL BIOL, V634, P189, DOI 10.1007/978-1-60761-652-8_14; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809	73	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4752	4766		10.1074/jbc.RA117.000163	http://dx.doi.org/10.1074/jbc.RA117.000163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382719	hybrid, Green Published			2022-12-28	WOS:000428848300017
J	Sheikh, T; Gupta, P; Gowda, P; Patrick, S; Sen, E				Sheikh, Touseef; Gupta, Piyushi; Gowda, Pruthvi; Patrick, Shruti; Sen, Ellora			Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; OXIDATIVE STRESS; CANCER-CELLS; SACCHAROMYCES-CEREVISIAE; GLUCOSE-HOMEOSTASIS; NLRP3 INFLAMMASOME; GLIOBLASTOMA CELLS; SIGNALING PATHWAY; ROS PRODUCTION; NRF2	A dynamic network of metabolic adaptations, inflammatory responses, and redox homeostasis is known to drive tumor progression. A considerable overlap among these processes exists, but several of their key regulators remain unknown. To this end, here we investigated the role of the proinflammatory cytokine IL-1 beta in connecting these processes in glioma cells. We found that glucose starvation sensitizes glioma cells to IL-1 beta-induced apoptosis in a manner that depended on reactive oxygen species (ROS). Although IL-1 beta-induced JNK had no effect on cell viability under glucose deprivation, it mediated nuclear translocation of hexokinase 2 (HK2). This event was accompanied by increases in the levels of sirtuin 6 (SIRT6), nuclear factor erythroid 2-related factor 2 (Nrf2), and xanthine oxidoreductase (XOR). SIRT6 not only induced ROS-mediated cell death but also facilitated nuclear Nrf2-HK2 interaction. Recruitment of the Nrf2-HK2 complex to the ARE site on XOR promoter regulated its expression. Importantly, HK2 served as transcriptional coactivator of Nrf2 to regulate XOR expression, indicated by decreased XOR levels in siRNA-mediated Nrf2 and HK2 knockdown experiments. Our results highlight a non-metabolic role of HK2 as transcriptional coactivator of Nrf2 to regulate XOR expression under conditions of proinflammatory and metabolic stresses. Our insights also underscore the importance of nuclear activities of HK2 in the regulation of genes involved in redox homeostasis.	[Sheikh, Touseef; Gupta, Piyushi; Gowda, Pruthvi; Patrick, Shruti; Sen, Ellora] Natl Brain Res Ctr, Manesar 122051, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Sen, E (corresponding author), Natl Brain Res Ctr, Manesar 122051, Haryana, India.	ellora@nbrc.ac.in		Sen, Ellora/0000-0001-6842-7850; Sheikh, Dr Touseef Ahmad/0000-0002-5608-8705; Gowda, Pruthvi/0000-0002-3928-2442	Department of Biotechnology (Government of India) [BT/MED/30/SP11016/2015]	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India)	The work was supported by Department of Biotechnology (Government of India) Research Grant BT/MED/30/SP11016/2015 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.117; Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; del Rey A, 2006, P NATL ACAD SCI USA, V103, P16039, DOI 10.1073/pnas.0607076103; Dixit D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.179; Dixit D, 2009, FREE RADICAL BIO MED, V47, P364, DOI 10.1016/j.freeradbiomed.2009.04.031; Ghosh S, 2016, EXP CELL RES, V340, P116, DOI 10.1016/j.yexcr.2015.11.016; Ghosh S, 2013, MOL CELL BIOL, V33, P2718, DOI 10.1128/MCB.01254-12; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Gupta P, 2017, EXP CELL RES, V357, P98, DOI 10.1016/j.yexcr.2017.05.005; Herrero P, 1998, FEBS LETT, V434, P71, DOI 10.1016/S0014-5793(98)00872-2; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; Maksin-Matveev A, 2015, EXP CELL RES, V330, P81, DOI 10.1016/j.yexcr.2014.07.013; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Martinez-Outschoorn UE, 2013, CELL CYCLE, V12, P2580, DOI 10.4161/cc.25510; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Neary CL, 2010, BIOCHEM BIOPH RES CO, V394, P1075, DOI 10.1016/j.bbrc.2010.03.129; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Sanman LE, 2016, ELIFE, V5, DOI 10.7554/eLife.13663; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sharma V, 2007, MOL CANCER THER, V6, P2544, DOI 10.1158/1535-7163.MCT-06-0788; Sharma V, 2011, J MOL MED, V89, P123, DOI 10.1007/s00109-010-0683-5; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Vega M, 2016, J BIOL CHEM, V291, P7267, DOI 10.1074/jbc.M115.711408; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Wu RX, 2012, EMBO MOL MED, V4, P633, DOI 10.1002/emmm.201200240; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	44	17	18	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4767	4777		10.1074/jbc.M117.816785	http://dx.doi.org/10.1074/jbc.M117.816785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414774	Green Published, hybrid			2022-12-28	WOS:000428848300018
J	Caria, S; Magtoto, CM; Samiei, T; Portela, M; Lim, KYB; How, JY; Stewart, BZ; Humbert, PO; Richardson, HE; Kvansakul, M				Caria, Sofia; Magtoto, Charlene M.; Samiei, Tinaz; Portela, Marta; Lim, Krystle Y. B.; How, Jing Yuan; Stewart, Bryce Z.; Humbert, Patrick O.; Richardson, Helena E.; Kvansakul, Marc			Drosophila melanogaster Guk-holder interacts with the Scribbled PDZ1 domain and regulates epithelial development with Scribbled and Discs Large	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NANCE-HORAN-SYNDROME; CELL POLARITY; SUPERTERTIARY STRUCTURE; LIGAND SPECIFICITY; SYNDROME PROTEIN; COMPLEX; GENE; LGL; PROLIFERATION; MIGRATION	Epithelial cell polarity is controlled by components of the Scribble polarity module, and its regulation is critical for tissue architecture and cell proliferation and migration. In Drosophila melanogaster, the adaptor protein Guk-holder (Gukh) binds to the Scribbled (Scrib) and Discs Large (Dlg) components of the Scribble polarity module and plays an important role in the formation of neuromuscular junctions. However, Gukh's role in epithelial tissue formation and the molecular basis for the Scrib-Gukh interaction remain to be defined. We now show using isothermal titration calorimetry that the Scrib PDZ1 domain is the major site for an interaction with Gukh. Furthermore, we defined the structural basis of this interaction by determining the crystal structure of the Scrib PDZ1-Gukh complex. The C-terminal PDZ-binding motif of Gukh is located in the canonical ligand-binding groove of Scrib PDZ1 and utilizes an unusually extensive network of hydrogen bonds and ionic interactions to enable binding to PDZ1 with high affinity. We next examined the role of Gukh along with those of Scrib and Dlg in Drosophila epithelial tissues and found that Gukh is expressed in larval-wing and eye-epithelial tissues and co-localizes with Scrib and Dlg at the apical cell cortex. Importantly, we show that Gukh functions with Scrib and Dlg in the development of Drosophila epithelial tissues, with depletion of Gukh enhancing the eye-and wing-tissue defects caused by Scrib or Dlg depletion. Overall, our findings reveal that Scrib's PDZ1 domain functions in the interaction with Gukh and that the Scrib-Gukh interaction has a key role in epithelial tissue development in Drosophila.	[Caria, Sofia; Magtoto, Charlene M.; Samiei, Tinaz; Portela, Marta; Lim, Krystle Y. B.; How, Jing Yuan; Stewart, Bryce Z.; Humbert, Patrick O.; Richardson, Helena E.; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Samiei, Tinaz; Portela, Marta; Richardson, Helena E.] Univ Melbourne, Cell Cycle & Dev Lab, Melbourne, Vic 3002, Australia; [Magtoto, Charlene M.; Humbert, Patrick O.] Univ Melbourne, Cell Cycle & Canc Genet Lab, Res Div, Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Magtoto, Charlene M.; Humbert, Patrick O.; Richardson, Helena E.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3002, Australia; [Humbert, Patrick O.; Richardson, Helena E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Portela, Marta] CSIC, Inst Cajal, E-28002 Madrid, Spain	La Trobe University; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019; Humbert, Patrick O/L-4264-2016; Richardson, Helena E/A-8080-2013; Portela, Marta/B-2315-2018	Kvansakul, Marc/0000-0003-2639-2498; Humbert, Patrick O/0000-0002-1366-6691; Richardson, Helena E/0000-0003-3852-4953; Portela, Marta/0000-0001-7898-962X; Caria, Sofia/0000-0001-7289-2093	National Health and Medical Research Council Australia Project [APP1103871, APP1079133, APP1020056]; Australian Research Council Fellowship [FT130101349]; Cancer Council Victoria; Cancer Council Victoria [APP1041817]; La Trobe University Scholarship; La Trobe University; La Trobe School of Molecular Science funding	National Health and Medical Research Council Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); La Trobe University Scholarship; La Trobe University; La Trobe School of Molecular Science funding	This work was supported in whole or part by National Health and Medical Research Council Australia Project Grant APP1103871 (to M. K., P. O. H., and H. E. R.), Fellowship APP1079133 (to P. O. H.), and APP1020056 (to H. E. R.); Australian Research Council Fellowship FT130101349 (to M. K.); Cancer Council Victoria grant funding (to M. P.) and Project Grant APP1041817 (to H. E. R.); La Trobe University Scholarship (to C. M. M. and K. Y. B. L.), and La Trobe University and La Trobe School of Molecular Science funding (to H. E. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Arnaud C, 2009, FEBS LETT, V583, P2326, DOI 10.1016/j.febslet.2009.06.034; Arquier N, 2001, DEVELOPMENT, V128, P2209; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Brooks SP, 2010, HUM MOL GENET, V19, P2421, DOI 10.1093/hmg/ddq125; Brooks SP, 2004, J MED GENET, V41, P768, DOI 10.1136/jmg.2004.022517; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114235; Grzeschik NA, 2007, DEV BIOL, V311, P106, DOI 10.1016/j.ydbio.2007.08.025; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Gui JH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006424; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Inaki M, 2002, MECH DEVELOP, V116, P3, DOI 10.1016/S0925-4773(02)00119-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Parsons LM, 2014, CURR BIOL, V24, P2073, DOI 10.1016/j.cub.2014.07.075; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Santoni MJ, 2002, TRENDS GENET, V18, P494, DOI 10.1016/S0168-9525(02)02738-5; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stephens R., 2018, J MOL BIOL; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Walsh GS, 2011, DEVELOPMENT, V138, P3033, DOI 10.1242/dev.063842; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009; Yap AS, 2015, DEV CELL, V35, P12, DOI 10.1016/j.devcel.2015.09.012; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	55	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4519	4531		10.1074/jbc.M117.817528	http://dx.doi.org/10.1074/jbc.M117.817528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29378849	Green Published, hybrid			2022-12-28	WOS:000428204300023
J	Goemans, CV; Beaufay, F; Wahni, K; Van Molle, I; Messens, J; Collet, JF				Goemans, Camille V.; Beaufay, Francois; Wahni, Khadija; Van Molle, Inge; Messens, Joris; Collet, Jean-Francois			An essential thioredoxin is involved in the control of the cell cycle in the bacterium Caulobacter crescentus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PROTEOLYSIS; STRUCTURE REFINEMENT; PROTEASE COMPLEX; OXIDOREDUCTASE; GLUTAREDOXINS; LOCALIZATION; SPECIFICITY; REDUCTION; DIVISION; REVEALS	Thioredoxins (Trxs) are antioxidant proteins that are conserved among all species. These proteins have been extensively studied and perform reducing reactions on a broad range of substrates. Here, we identified Caulobacter crescentus Trx1 (CCNA_03653; CcTrx1) as an oxidoreductase that is involved in the cell cycle progression of this model bacterium and is required to sustain life. Intriguingly, the abundance of CcTrx1 varies throughout the C. crescentus cell cycle: although the expression of CcTrx1 is induced in stalked cells, right before DNA replication initiation, CcTrx1 is actively degraded by the ClpXP protease in predivisional cells. Importantly, we demonstrated that regulation of the abundance of CcTrx1 is crucial for cell growth and survival as modulating CcTrx1 levels leads to cell death. Finally, we also report a comprehensive biochemical and structural characterization of this unique and essential Trx. The requirement to precisely control the abundance of CcTrx1 for cell survival underlines the importance of redox control for optimal cell cycle progression in C. crescentus.	[Goemans, Camille V.; Collet, Jean-Francois] WELBIO, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Goemans, Camille V.; Beaufay, Francois; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Goemans, Camille V.; Wahni, Khadija; Van Molle, Inge; Messens, Joris; Collet, Jean-Francois] Brussels Ctr Redox Biol, B-1200 Brussels, Belgium; [Wahni, Khadija; Van Molle, Inge; Messens, Joris] VIB, Ctr Struct Biol, B-1050 Brussels, Belgium; [Wahni, Khadija; Van Molle, Inge; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Beaufay, Francois] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Messens, Joris] VIB, Brussels, Belgium; [Collet, Jean-Francois] FRS FNRS, Rech, Brussels, Belgium	WELBIO; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Michigan System; University of Michigan; Flanders Institute for Biotechnology (VIB); Fonds de la Recherche Scientifique - FNRS	Goemans, CV; Collet, JF (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.; Collet, JF (corresponding author), FRS FNRS, Rech, Brussels, Belgium.	camille.goemans@uclouvain.be; jfcollet@uclouvain.be	Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264; Goemans, Camille/0000-0002-5564-1644; Van Molle, Inge/0000-0003-0114-9379; Collet, Jean-Francois/0000-0001-8069-7036	Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO; European Research Council (FP7) ERC Independent Researcher Starting Grant [282335-Sulfenic]; Fonds de la Recherche Scientifique (FRS-FNRS); Omics@VIB Marie Curie COFUND fellowship	Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO(Fonds de la Recherche Scientifique - FNRSWELBIO); European Research Council (FP7) ERC Independent Researcher Starting Grant; Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Omics@VIB Marie Curie COFUND fellowship	This work was supported in part by grants from Fonds de la Recherche Fondamentale Strategique (FRFS)-WELBIO, European Research Council (FP7/2007-2013) ERC Independent Researcher Starting Grant 282335-Sulfenic, and grants from the Fonds de la Recherche Scientifique (FRS-FNRS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Omics@VIB Marie Curie COFUND fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alexopoulos JA, 2012, J STRUCT BIOL, V179, P202, DOI 10.1016/j.jsb.2012.05.003; Arts IS, 2016, MOL CELL PROTEOMICS, V15, P2125, DOI 10.1074/mcp.M115.056440; Beaufay F, 2015, EMBO J, V34, P1786, DOI 10.15252/embj.201490730; Berndt C, 2015, CHEM SCI, V6, P7049, DOI 10.1039/c5sc01501d; Bhat NH, 2013, MOL MICROBIOL, V88, P1083, DOI 10.1111/mmi.12241; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jenal U, 2009, RES MICROBIOL, V160, P687, DOI 10.1016/j.resmic.2009.09.006; Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044; Joshi KK, 2016, ANNU REV GENET, V50, P423, DOI 10.1146/annurev-genet-120215-035235; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lawaree E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.98, 10.1038/nmicrobiol.2016.98]; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Markovski M, 2013, MOL CELL, V52, P611, DOI 10.1016/j.molcel.2013.11.018; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Martin ME, 2004, MOL MICROBIOL, V54, P60, DOI 10.1111/j.1365-2958.2004.04251.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Narayanan S, 2015, GENE DEV, V29, P1175, DOI 10.1101/gad.257030.114; Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503	44	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3839	3848		10.1074/jbc.RA117.001042	http://dx.doi.org/10.1074/jbc.RA117.001042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29367337	Green Published, hybrid			2022-12-28	WOS:000427030200035
J	Goodman, MC; Xu, S; Rouzer, CA; Banerjee, S; Ghebreselasie, K; Migliore, M; Piomelli, D; Marnett, LJ				Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Banerjee, Surajit; Ghebreselasie, Kebreab; Migliore, Marco; Piomelli, Daniele; Marnett, Lawrence J.			Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; TIME-DEPENDENT INHIBITION; CRYSTAL-STRUCTURE; ENDOCANNABINOID OXYGENATION; GASTROINTESTINAL-TRACT; ARACHIDONIC-ACID; STRUCTURAL BASIS; MOLECULAR-BASIS; PROSTAGLANDIN; SELECTIVITY	The cyclooxygenases COX-1 and COX-2 oxygenate arachidonic acid (AA) to prostaglandin H-2 (PGH(2)). COX-2 also oxygenates the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonoylethanolamide (AEA) to the corresponding PGH2 analogs. Both enzymes are targets of nonsteroidal anti-inflammatory drugs (NSAIDs), but NSAID-mediated COX inhibition is associated with gastrointestinal toxicity. One potential strategy to counter this toxicity is to also inhibit fatty acid amide hydrolase (FAAH), which hydrolyzes bioactive fatty acid ethanolamides (FAEs) into fatty acids and ethanolamine. Here, we investigated the mechanism of COX inhibition by ARN2508, an NSAID that inhibits both COXs and FAAH with high potency, target selectivity, and decreased gastrointestinal toxicity in mouse models, presumably due to its ability to increase levels of FAEs. A 2.27-angstrom-resolution X-ray crystal structure of the COX-2.(S)-ARN2508 complex reveals that ARN2508 adopts a binding pose similar to that of its parent NSAID flurbiprofen. However, ARN2508's alkyl tail is inserted deep into the top channel, an active site region not exploited by any previously reported NSAID. As for flurbiprofen, ARN2508's potency is highly dependent on the configuration of the a-methyl group. Thus, (S)ARN2508 is more potent than (R)-ARN2508 for inhibition of AA oxygenation by both CO Xs and 2-AG oxygenation by COX-2. Also, similarly to (R)-flurbiprofen, (R)-ARN2508 exhibits substrate selectivity for inhibition of 2-AG oxygenation. Site-directed mutagenesis confirms the importance of insertion of the alkyl tail into the top channel for (S)ARN2508's potency and suggests a role for Ser-530 as a determinant of the inhibitor's slow rate of inhibition compared with that of (S)-flurbiprofen.	[Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Chem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Pharmacol, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Migliore, Marco; Piomelli, Daniele] Ist Italian Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Neurobiol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA; [Migliore, Marco] Aptuit Verona, Via Alessandro Fleming, I-37135 Verona, Italy	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; United States Department of Energy (DOE); Argonne National Laboratory	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Chem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/O-6667-2019	Xu, Shu/0000-0002-6876-7991; Rouzer, Carol/0000-0001-6827-1534	National Institute of General Medical Sciences, National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant [SI0OD021527]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030910, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Kristie Rose at the Vanderbilt Mass Spectrometry Proteomics Core for peptide adduct analysis. We thank Nathan Kett and the Vanderbilt Chemical Synthesis Core for preparation of the enantiomers ARN2508. The X-ray crystallographic work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403; the Eiger 16M detector-on 24-ID-E beam line is funded by National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant SI0OD021527). This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Callan OH, 1996, J BIOL CHEM, V271, P3548; Capone ML, 2010, PHARMACOL REP, V62, P530, DOI 10.1016/S1734-1140(10)70310-8; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; Hochgesang GP, 2000, J AM CHEM SOC, V122, P6514, DOI 10.1021/ja0003932; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Migliore M, 2016, EUR J MED CHEM, V109, P216, DOI 10.1016/j.ejmech.2015.12.036; Mileni M, 2010, J MOL BIOL, V400, P743, DOI 10.1016/j.jmb.2010.05.034; Mitchener MM, 2015, P NATL ACAD SCI USA, V112, P12366, DOI 10.1073/pnas.1507307112; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; Palermo G, 2016, CHEMMEDCHEM, V11, P1252, DOI 10.1002/cmdc.201500507; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sanger GJ, 2007, BRIT J PHARMACOL, V152, P663, DOI 10.1038/sj.bjp.0707422; Sasso O, 2015, FASEB J, V29, P2616, DOI 10.1096/fj.15-270637; Scarpignato C, 2010, GASTROENTEROL CLIN N, V39, P433, DOI 10.1016/j.gtc.2010.08.010; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Sostres C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4175; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	51	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3028	3038		10.1074/jbc.M117.802058	http://dx.doi.org/10.1074/jbc.M117.802058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326169	Green Published, hybrid			2022-12-28	WOS:000426562800001
J	Mukherjee, S; Griffin, DH; Horn, JR; Rizk, SS; Nocula-Lugowska, M; Malmqvist, M; Kim, SS; Kossiakoff, AA				Mukherjee, Somnath; Griffin, Dionne H.; Horn, James R.; Rizk, Shahir S.; Nocula-Lugowska, Malgorzata; Malmqvist, Magnus; Kim, Sangwoo S.; Kossiakoff, Anthony A.			Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY; MEMBRANE-PROTEINS; DISSECTION; INTERFACE; NANODISCS; TRANSPORT; FEATURES; RECEPTOR; DOMAINS; MAP	Conformational changes in proteins due to ligand binding are ubiquitous in biological processes and are integral to many biological systems. However, it is often challenging to link ligand-induced conformational changes to a resulting biological function because it is difficult to distinguish between the energetic components associated with ligand binding and those due to structural rearrangements. Here, we used a unique approach exploiting conformation-specific and regio-specific synthetic antibodies (sABs) to probe the energetic contributions of ligand binding to conformation changes. Using maltose-binding protein (MBP) as a model system, customized phage-display selections were performed to generate sABs that stabilize MBP in different conformational states, modulating ligand-binding affinity in competitive, allosteric, or peristeric manners. We determined that the binding of a closed conformation-specific sAB (sAB-11M) to MBP in the absence of maltose is entropically driven, providing new insight into designing antibody-stabilized protein interactions. Crystal structures of sABs bound to MBP, together with biophysical data, delineate the basis of free energy differences between different conformational states and confirm the use of the sABs as energy probes for dissecting enthalpic and entropic contributions to conformational transitions. Our work provides a foundation for investigating the energetic contributions of distinct conformational dynamics to specific biological outputs. We anticipate that our approach also may be valuable for analyzing the energy landscapes of regulatory proteins controlling biological responses to environmental changes.	[Mukherjee, Somnath; Nocula-Lugowska, Malgorzata; Kim, Sangwoo S.; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, 900 E 57th St, Chicago, IL 60637 USA; [Kossiakoff, Anthony A.] Gordon Ctr Integrat Sci, Inst Biophys Dynam, Chicago, IL 60637 USA; [Griffin, Dionne H.; Horn, James R.] Northern Illinois Univ, Dept Chem & Biochem, De Kalb, IL 60115 USA; [Rizk, Shahir S.] Indiana Univ, Dept Chem & Biochem, South Bend, IN 46615 USA; [Malmqvist, Magnus] Ridgeview Diagnost AB, Uppsala Sci Pk, S-75183 Uppsala, Sweden; [Griffin, Dionne H.] US Army, Med Res Inst Infect Dis, Div Mol & Translat Sci, Frederick, MD 21702 USA; [Nocula-Lugowska, Malgorzata] Pfizer Inc, 610 Main St, Cambridge, MA 02139 USA; [Kim, Sangwoo S.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of Chicago; Northern Illinois University; Indiana University System; Indiana University South Bend; Pfizer; University of California System; University of California San Diego	Kossiakoff, AA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 900 E 57th St, Chicago, IL 60637 USA.	koss@bsd.uchicago.edu	Horn, James/B-4011-2009		Chicago Biomedical Consortium; National Institutes of Health [GM117372, GM094588]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094588, R01GM117372] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Chicago Biomedical Consortium and the National Institutes of Health Grants GM117372 and GM094588 (to A. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delano W.L., 2017, PYMOL MOL GRAPHICS S; Dominik PK, 2015, METHOD ENZYMOL, V557, P219, DOI 10.1016/bs.mie.2014.12.032; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang J, 2006, PROTEIN EXPRES PURIF, V47, P348, DOI 10.1016/j.pep.2005.10.021; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim E, 2013, NAT CHEM BIOL, V9, P313, DOI [10.1038/nchembio.1213, 10.1038/NCHEMBIO.1213]; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043746; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Mukherjee S, 2015, J MOL BIOL, V427, P2707, DOI 10.1016/j.jmb.2015.06.018; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Peess C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116870; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rizk SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00728-1; Rizk SS, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-014-0080-8; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200	33	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2815	2828		10.1074/jbc.RA117.000656	http://dx.doi.org/10.1074/jbc.RA117.000656			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29321208	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000426051900017
J	Gijsbers, R; Vets, S; De Rijck, J; Ocwieja, KE; Ronen, K; Malani, N; Bushman, FD; Debyser, Z				Gijsbers, Rik; Vets, Sofie; De Rijck, Jan; Ocwieja, Karen E.; Ronen, Keshet; Malani, Nirav; Bushman, Frederic D.; Debyser, Zeger			RETRACTION: Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting (Retraction of Vol 286, Pg 41812, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					114	114		10.1074/jbc.W117.001458	http://dx.doi.org/10.1074/jbc.W117.001458			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29305523	Green Published, hybrid			2022-12-28	WOS:000419453200010
J	Her, J; Bunting, SF				Her, Joonyoung; Bunting, Samuel F.			How cells ensure correct repair of DNA double-strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA damage; DNA repair; BRCA1; ubiquitylation (ubiquitination); chromatin; homologous recombination; double-strand break; nonhomologous end-joining	PROMOTE HOMOLOGOUS RECOMBINATION; CTIP-MEDIATED RESECTION; PATHWAY CHOICE; END RESECTION; POLYMERASE THETA; DAMAGE SITES; IONIZING-RADIATION; GENOME MAINTENANCE; 53BP1 RECRUITMENT; TUMOR SUPPRESSION	DNA double-strand breaks (DSBs) arise regularly in cells and when left unrepaired cause senescence or cell death. Homologous recombination (HR) and nonhomologous end-joining (NHEJ) are the two major DNA-repair pathways. Whereas HR allows faithful DSB repair and healthy cell growth, NHEJ has higher potential to contribute to mutations and malignancy. Many regulatory mechanisms influence which of these two pathways is used in DSB repair. These mechanisms depend on the cell cycle, post-translational modifications, and chromatin effects. Here, we summarize current research into these mechanisms, with a focus on mammalian cells, and also discuss repair by alternative end-joining and single-strand annealing.	[Her, Joonyoung; Bunting, Samuel F.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08540 USA	Rutgers State University New Brunswick	Bunting, SF (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08540 USA.	bunting@cabm.rutgers.edu			National Institutes of Health from NCI [R01 CA190858]; NJCCR postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA190858] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NJCCR postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA190858 from NCI (to the S. F. B. laboratory) and an NJCCR postdoctoral fellowship (to J. H.). This is the first article in the Thematic Minireview series "DNA double-strand break repair and pathway choice." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Anantha RW, 2017, ELIFE, V6, DOI 10.7554/eLife.21350; Arnoult N, 2017, NATURE, V549, P548, DOI 10.1038/nature24023; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Batenburg NL, 2015, EMBO J, V34, P1399, DOI 10.15252/embj.201490041; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Biehs R, 2017, MOL CELL, V65, P671, DOI 10.1016/j.molcel.2016.12.016; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bothmer A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13905; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brown JS, 2015, CELL REP, V11, P704, DOI 10.1016/j.celrep.2015.03.058; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Buisson R, 2017, MOL CELL, V65, P336, DOI 10.1016/j.molcel.2016.12.007; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Daddacha W, 2017, CELL REP, V20, P1921, DOI 10.1016/j.celrep.2017.08.008; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; Densham RM, 2016, NAT STRUCT MOL BIOL, V23, P647, DOI 10.1038/nsmb.3236; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Drane P, 2017, NATURE, V543, P211, DOI 10.1038/nature21358; Dungrawala H, 2017, MOL CELL, V67, P374, DOI 10.1016/j.molcel.2017.06.023; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ferretti LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12628; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gong F, 2017, J CELL BIOL, V216, P1959, DOI 10.1083/jcb.201611135; Gong Y, 2017, GENE DEV, V31, P46, DOI 10.1101/gad.291807.116; Guo X, 2018, NUCLEIC ACIDS RES, V46, P689, DOI 10.1093/nar/gkx1208; Hansen RK, 2016, NAT CELL BIOL, V18, P1357, DOI 10.1038/ncb3436; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Howard SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004943; Hu Q, 2017, MOL CELL, V66, P473, DOI 10.1016/j.molcel.2017.04.009; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022; Ishida N, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00347-16; Ismail IH, 2015, NAT CELL BIOL, V17, P1446, DOI 10.1038/ncb3259; Isobe SY, 2017, CELL REP, V20, P297, DOI 10.1016/j.celrep.2017.06.056; Isono M, 2017, CELL REP, V18, P520, DOI 10.1016/j.celrep.2016.12.042; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jimeno S, 2015, NUCLEIC ACIDS RES, V43, P987, DOI 10.1093/nar/gku1384; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kakarougkas A, 2013, NUCLEIC ACIDS RES, V41, P9719, DOI 10.1093/nar/gkt729; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Kato K, 2014, MOL CELL, V53, P617, DOI 10.1016/j.molcel.2014.01.030; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kitevski-LeBlanc J, 2017, ELIFE, V6, DOI 10.7554/eLife.23872; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lee DH, 2014, MOL CELL, V54, P512, DOI 10.1016/j.molcel.2014.03.020; Lee KJ, 2016, NUCLEIC ACIDS RES, V44, P1732, DOI 10.1093/nar/gkv1499; Lemaitre C, 2014, GENE DEV, V28, P2450, DOI 10.1101/gad.248369.114; Leung JWC, 2017, GENE DEV, V31, P260, DOI 10.1101/gad.292516.116; Lou JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01151-w; Lu HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02146-3; Lu HM, 2016, CELL REP, V16, P161, DOI 10.1016/j.celrep.2016.05.079; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mujoo K, 2017, STEM CELL REP, V9, P1660, DOI 10.1016/j.stemcr.2017.10.002; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panchaksharia RA, 2018, P NATL ACAD SCI USA, V115, P762, DOI 10.1073/pnas.1719988115; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Pellegrino S, 2017, CELL REP, V19, P1819, DOI 10.1016/j.celrep.2017.05.016; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Polato F, 2014, J EXP MED, V211, P1027, DOI 10.1084/jem.20131939; Postow L, 2013, CELL CYCLE, V12, P587, DOI 10.4161/cc.23408; Pozo FM, 2017, J BIOL CHEM, V292, P5992, DOI 10.1074/jbc.M116.760645; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Rai R, 2017, MOL CELL, V65, P801, DOI 10.1016/j.molcel.2017.01.016; Reczek CR, 2013, J CELL BIOL, V201, P693, DOI 10.1083/jcb.201302145; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Schmidt CK, 2015, NAT CELL BIOL, V17, P1458, DOI 10.1038/ncb3260; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Shamanna RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13785; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Soria-Bretones I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00183-6; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Tkac J, 2016, MOL CELL, V61, P405, DOI 10.1016/j.molcel.2015.12.013; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037; Wang J, 2014, INT J ONLINE ENG, V10, P28, DOI 10.3991/ijoe.v10i4.3705; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zhang HX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10201; Zhou Y, 2017, MOL CELL, V65, P91, DOI 10.1016/j.molcel.2016.11.004	98	155	159	12	100	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10502	10511		10.1074/jbc.TM118.000371	http://dx.doi.org/10.1074/jbc.TM118.000371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29414795	Green Published, hybrid			2022-12-28	WOS:000437828400011
J	Wright, WD; Shah, SS; Heyer, WD				Wright, William Douglass; Shah, Shanaya Shital; Heyer, Wolf-Dietrich			Homologous recombination and the repair of DNA double-strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						genomic instability; DNA recombination; DNA repair; DNA topology; DNA damage; DNA endonuclease; DNA helicase; DNA polymerase; DNA topoisomerase	RAD51 FILAMENT FORMATION; REPLICATION PROTEIN-A; GENE CONVERSION TRACTS; COLI RECA-PROTEIN; SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; PRESYNAPTIC FILAMENT; NUCLEOPROTEIN FILAMENTS; ESCHERICHIA-COLI; MITOTIC RECOMBINATION	Homologous recombination enables the cell to access and copy intact DNA sequence information in trans, particularly to repair DNA damage affecting both strands of the double helix. Here, we discuss the DNA transactions and enzymatic activities required for this elegantly orchestrated process in the context of the repair of DNA double-strand breaks in somatic cells. This includes homology search, DNA strand invasion, repair DNA synthesis, and restoration of intact chromosomes. Aspects of DNA topology affecting individual steps are highlighted. Overall, recombination is a dynamic pathway with multiple metastable and reversible intermediates designed to achieve DNA repair with high fidelity.	[Wright, William Douglass; Shah, Shanaya Shital; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA; [Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Heyer, WD (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	wdheyer@ucdavis.edu			National Institutes of Health [GM58015, CA92276]; NATIONAL CANCER INSTITUTE [R01CA092276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM58015 and CA92276 (to the W. D. H. laboratory). This is the third article in the Thematic Minireview series "DNA double-strand break repair and pathway choice." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; AGUILERA A, 1989, GENETICS, V123, P683; Aihara H, 1997, J MOL BIOL, V274, P213, DOI 10.1006/jmbi.1997.1403; Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Argunhan B, 2017, FEBS LETT, V591, P2035, DOI 10.1002/1873-3468.12656; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bell JC, 2016, ANNU REV BIOCHEM, V85, P193, DOI 10.1146/annurev-biochem-060614-034352; BIANCHI M, 1983, CELL, V34, P931, DOI 10.1016/0092-8674(83)90550-0; Bizard AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016477; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHRISTIANSEN G, 1986, P NATL ACAD SCI USA, V83, P2066, DOI 10.1073/pnas.83.7.2066; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Fasching CL, 2015, MOL CELL, V57, P595, DOI 10.1016/j.molcel.2015.01.022; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Fornander LH, 2014, NUCLEIC ACIDS RES, V42, P2358, DOI 10.1093/nar/gkt1257; Fornander LH, 2012, NUCLEIC ACIDS RES, V40, P4904, DOI 10.1093/nar/gks140; Ganai RA, 2016, NUCLEIC ACIDS RES, V44, P8229, DOI 10.1093/nar/gkw556; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Her J, 2018, J BIOL CHEM, V293, P10502, DOI 10.1074/jbc.TM118.000371; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Ito K, 2018, NAT STRUCT MOL BIOL, V25, P29, DOI 10.1038/s41594-017-0002-8; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jensen RB, 2013, DNA REPAIR, V12, P306, DOI 10.1016/j.dnarep.2012.12.007; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; KADYK LC, 1992, GENETICS, V132, P387; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kowalczykowski S. C., 2016, DNA RECOMBINATION; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kuwabara N, 2012, STRUCTURE, V20, P440, DOI 10.1016/j.str.2012.01.005; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lee JY, 2016, J BIOL CHEM, V291, P22218, DOI 10.1074/jbc.M116.740563; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Liu J, 2017, ELIFE, V6, DOI 10.7554/eLife.22195; Liu J, 2011, NATURE, V479, P245, DOI 10.1038/nature10522; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; MCKEE RH, 1980, MUTAT RES, V70, P37, DOI 10.1016/0027-5107(80)90056-1; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; McVey M, 2016, ANNU REV GENET, V50, P393, DOI 10.1146/annurev-genet-120215-035243; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Natsume T, 2017, GENE DEV, V31, P816, DOI 10.1101/gad.297663.117; Neuwirth EAH, 2007, MOL CELL BIOL, V27, P5261, DOI 10.1128/MCB.01852-06; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishinaka T, 2007, J MOL BIOL, V370, P837, DOI 10.1016/j.jmb.2007.05.044; Niu HY, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fow111; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Piazza A, 2017, CELL, V170, P760, DOI 10.1016/j.cell.2017.06.052; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ramreddy T, 2003, BIOCHEMISTRY-US, V42, P12085, DOI 10.1021/bi034667k; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Ristic D, 2011, NUCLEIC ACIDS RES, V39, P155, DOI 10.1093/nar/gkq766; Robertson RB, 2009, P NATL ACAD SCI USA, V106, P12688, DOI 10.1073/pnas.0811465106; RONG L, 1991, GENETICS, V127, P75; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Sallmyr A, 2018, J BIOL CHEM, V293, P10536, DOI 10.1074/jbc.TM117.000375; Sanchez H, 2013, P NATL ACAD SCI USA, V110, P11385, DOI 10.1073/pnas.1306467110; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shor E, 2002, GENETICS, V162, P647; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sneeden JL, 2013, NUCLEIC ACIDS RES, V41, P4913, DOI 10.1093/nar/gkt192; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Spies J, 2016, MOL CELL, V62, P903, DOI 10.1016/j.molcel.2016.04.032; Spirek M, 2018, NUCLEIC ACIDS RES, V46, P3967, DOI 10.1093/nar/gky111; Su GC, 2014, NUCLEIC ACIDS RES, V42, P349, DOI 10.1093/nar/gkt879; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wong BC, 1998, J BIOL CHEM, V273, P12120, DOI 10.1074/jbc.273.20.12120; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027; Wyatt HDM, 2017, MOL CELL, V65, P848, DOI 10.1016/j.molcel.2017.01.031; Wyatt HDM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a023192; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Yuan SSF, 1999, CANCER RES, V59, P3547; Zapotoczny G, 2017, G3-GENES GENOM GENET, V7, P1191, DOI 10.1534/g3.116.037390; Zhao WX, 2017, NATURE, V550, P360, DOI 10.1038/nature24060	115	291	294	50	209	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10524	10535		10.1074/jbc.TM118.000372	http://dx.doi.org/10.1074/jbc.TM118.000372			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29599286	hybrid, Green Published			2022-12-28	WOS:000437828400013
J	Feng, ZZ; Jiang, AJ; Mao, AW; Feng, YH; Wang, WN; Li, JJ; Zhang, XY; Xing, K; Peng, X				Feng, Zhao-Zhong; Jiang, An-Jie; Mao, An-Wen; Feng, Yuhan; Wang, Weinan; Li, Jingjing; Zhang, Xiaoyan; Xing, Ke; Peng, Xue			The Salmonella effectors SseF and SseG inhibit Rab1A-mediated autophagy to facilitate intracellular bacterial survival and replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; host-pathogen interaction; Rab; Salmonella enterica; virulence factor	III SECRETION SYSTEM; TRANSLOCATED EFFECTORS; ENDOPLASMIC-RETICULUM; CONTAINING VACUOLE; ULK1 COMPLEX; RAB GTPASES; HOST-CELLS; IMMUNITY; PROTEIN; TYPHIMURIUM	In mammalian cells, autophagy plays crucial roles in restricting further spread of invading bacterial pathogens. Previous studies have established that the Salmonella virulence factors SseF and SseG are required for intracellular bacterial survival and replication. However, the underlying mechanism by which these two effectors facilitate bacterial infection remains elusive. Here, we report that SseF and SseG secreted by Salmonella Typhimurium (S. Typhimurium) inhibit autophagy in host cells and thereby establish a replicative niche for the bacteria in the cytosol. Mechanistically, SseF and SseG impaired autophagy initiation by directly interacting with the small GTPase Rab1A in the host cell. This interaction abolished Rab1A activation by disrupting the interaction with its guanine nucleotide exchange factor (GEF), the TRAPPIII (transport protein particle III) complex. This disruption of Rab1A signaling blocked the recruitment and activation of Unc-51-like autophagy-activating kinase 1 (ULK1) and decreased phosphatidylinositol 3-phosphate biogenesis, which ultimately impeded autophagosome formation. Furthermore, SseF- or SseG-deficient bacterial strains exhibited reduced survival and growth in both mammalian cell lines and mouse infection models, and Rab1A depletion could rescue these defects. These results reveal that virulence factor-dependent inactivation of the small GTPase Rab1A represents a previously unrecognized strategy of S. Typhimurium to evade autophagy and the host defense system.	[Feng, Zhao-Zhong; Jiang, An-Jie; Mao, An-Wen; Feng, Yuhan; Wang, Weinan; Li, Jingjing; Zhang, Xiaoyan; Xing, Ke; Peng, Xue] Jiangsu Normal Univ, Sch Life Sci, Xuzhou 221116, Jiangsu, Peoples R China	Jiangsu Normal University	Peng, X (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Xuzhou 221116, Jiangsu, Peoples R China.	6020100065@jsnu.edu.cn			National Natural Science Foundation of China [31400099, 31570028]; Jiangsu Natural Science Foundation Grant [BK20140235]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation Grant; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China Grants 31400099 and 31570028, Jiangsu Natural Science Foundation Grant BK20140235, and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Fig. S1.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Cadwell K, 2016, NAT REV IMMUNOL, V16, P661, DOI 10.1038/nri.2016.100; Chu YY, 2016, ONCOTARGET, V7, P8295, DOI 10.18632/oncotarget.6989; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Ganesan R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006227; Garcia Iris A, 2011, Cell Logist, V1, P159; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kern A, 2015, AUTOPHAGY, V11, P2393, DOI 10.1080/15548627.2015.1110668; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lee CH, 2014, GENE THER, V21, P309, DOI 10.1038/gt.2013.86; McQuate SE, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12641; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Muller P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035004; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Castrejon-Jimenez NS, 2015, BIOSCI TRENDS, V9, P149, DOI 10.5582/bst.2015.01035; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Slavin I, 2011, EUR J CELL BIOL, V90, P301, DOI 10.1016/j.ejcb.2010.10.001; Spano S, 2016, CELL HOST MICROBE, V19, P216, DOI 10.1016/j.chom.2016.01.004; Spano S, 2014, CELL MICROBIOL, V16, P1321, DOI 10.1111/cmi.12327; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang J, 2013, P NATL ACAD SCI USA, V110, P9800, DOI 10.1073/pnas.1302337110; Webster CP, 2016, EMBO J, V35, P1656, DOI 10.15252/embj.201694401; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Yu XJ, 2016, MBIO, V7, DOI 10.1128/mBio.00474-16; Zhang XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29774	52	31	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9662	9673		10.1074/jbc.M117.811737	http://dx.doi.org/10.1074/jbc.M117.811737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29610274	hybrid, Green Published			2022-12-28	WOS:000436102300011
J	Crooks, DR; Maio, N; Lane, AN; Jarnik, M; Higashi, RM; Haller, RG; Yang, Y; Fan, TWM; Linehan, WM; Rouault, TA				Crooks, Daniel R.; Maio, Nunziata; Lane, Andrew N.; Jarnik, Michal; Higashi, Richard M.; Haller, Ronald G.; Yang, Ye; Fan, Teresa W-M.; Linehan, W. Marston; Rouault, Tracey A.			Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; iron-sulfur protein; fatty acid metabolism; cell metabolism; metabolomics; mitochondria; lipid synthesis; iron deficiency; metabolic reprogramming; steatosis; iron; Fe-S clusters; mitochondrial disease; lipoic acid; fatty acid biosynthesis	FATTY LIVER-DISEASE; ACETYL-COA CARBOXYLASE; ACID BIOSYNTHESIS; 4FE-4S CLUSTER; HOMEOSTASIS; ISCU; PHOSPHOFRUCTOKINASE; BIOGENESIS; DEFICIENCY; MITOCHONDRIA	Iron-sulfur (Fe-S) clusters are ancient cofactors in cells and participate in diverse biochemical functions, including electron transfer and enzymatic catalysis. Although cell lines derived from individuals carrying mutations in the Fe-S cluster biogenesis pathway or siRNA-mediated knockdown of the Fe-S assembly components provide excellent models for investigating Fe-S cluster formation in mammalian cells, these experimental strategies focus on the consequences of prolonged impairment of Fe-S assembly. Here, we constructed and expressed dominant-negative variants of the primary Fe-S biogenesis scaffold protein iron-sulfur cluster assembly enzyme 2 (ISCU2) in human HEK293 cells. This approach enabled us to study the early metabolic reprogramming associated with loss of Fe-S-containing proteins in several major cellular compartments. Using multiple metabolomics platforms, we observed a approximate to 12-fold increase in intracellular citrate content in Fe-S-deficient cells, a surge that was due to loss of aconitase activity. The excess citrate was generated from glucose-derived acetyl-CoA, and global analysis of cellular lipids revealed that fatty acid biosynthesis increased markedly relative to cellular proliferation rates in Fe-S-deficient cells. We also observed intracellular lipid droplet accumulation in both acutely Fe-S-deficient cells and iron-starved cells. We conclude that deficient Fe-S biogenesis and acute iron deficiency rapidly increase cellular citrate concentrations, leading to fatty acid synthesis and cytosolic lipid droplet formation. Our findings uncover a potential cause of cellular steatosis in nonadipose tissues.	[Crooks, Daniel R.; Yang, Ye; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Maio, Nunziata; Rouault, Tracey A.] Eunice Kennedy Shriver NICHD, Sect Human Iron Metab, NIH, Bethesda, MD 20892 USA; [Jarnik, Michal] Eunice Kennedy Shriver NICHD, Sect Cell Biol & Metab, NIH, Bethesda, MD 20892 USA; [Lane, Andrew N.; Higashi, Richard M.] Univ Kentucky, Ctr Environm & Syst Biochem, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Lane, Andrew N.; Higashi, Richard M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Haller, Ronald G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Haller, Ronald G.] Vet Affairs North Texas Med Ctr, Dallas, TX 75216 USA; [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Kentucky; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rouault, TA (corresponding author), Eunice Kennedy Shriver NICHD, Sect Human Iron Metab, NIH, Bethesda, MD 20892 USA.	rouault@mail.nih.gov		Maio, Nunziata/0000-0002-6225-6058	NCI, National Institutes of Health, Cancer Center Support Grant [P30 CA177558]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814, ZIAHD001602] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA177558, ZIABC011038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022191] Funding Source: NIH RePORTER	NCI, National Institutes of Health, Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Marc Warmoes, Qiushi Sun, Teresa Cassel, and Manik Ghosh for technical expertise and Hiroshi Nakai, Thanemoji Natarajan, and Wing-Hang Tong for providing ideas and suggestions that greatly improved the quality of this work. NMR spectra were recorded at the Center for Environmental Systems Biochemistry, University of Kentucky, supported in part by NCI, National Institutes of Health, Cancer Center Support Grant P30 CA177558.	Ahmed U, 2012, WORLD J GASTROENTERO, V18, P4651, DOI 10.3748/wjg.v18.i34.4651; Boal AK, 2007, J INORG BIOCHEM, V101, P1913, DOI 10.1016/j.jinorgbio.2007.05.001; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; Crooks DR, 2014, HUM MOL GENET, V23, P24, DOI 10.1093/hmg/ddt393; Crooks DR, 2012, J BIOL CHEM, V287, P40119, DOI 10.1074/jbc.M112.418889; Fan T. W.-M., 2016, BIO-PROTOCOL, V6, pe1730, DOI [DOI 10.21769/BI0PR0T0C.1730, 10.21769/BioProtoc.1730, DOI 10.21769/BIOPROTOC.1730]; Fan TWM, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a000893; Fan TWM, 2011, J BIOMOL NMR, V49, P267, DOI 10.1007/s10858-011-9484-6; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; GARLAND PB, 1963, NATURE, V200, P169, DOI 10.1038/200169a0; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; GREGOLIN C, 1966, P NATL ACAD SCI USA, V56, P1751, DOI 10.1073/pnas.56.6.1751; Higashi Richard M, 2014, Methods Mol Biol, V1198, P147, DOI 10.1007/978-1-4939-1258-2_11; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Kim KS, 2018, HUM MOL GENET, V27, P837, DOI 10.1093/hmg/ddy004; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Krishnan B, 2002, HUM PATHOL, V33, P68, DOI 10.1053/hupa.2002.30210; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Lane AN, 2009, ANAL CHIM ACTA, V651, P201, DOI 10.1016/j.aca.2009.08.032; Lee J, 2015, BIOCHEM BIOPH RES CO, V464, P229, DOI 10.1016/j.bbrc.2015.06.121; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKENZIE CG, 1970, J LIPID RES, V11, P571; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2012, DIS MODEL MECH, V5, P860, DOI 10.1242/dmm.009829; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Obis E, 2014, FREE RADICAL BIO MED, V73, P21, DOI 10.1016/j.freeradbiomed.2014.04.016; Ollagnier-de Choudens S, 1999, FEBS LETT, V453, P25, DOI 10.1016/S0014-5793(99)00694-8; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; PARMEGGIANI A, 1963, BIOCHEM BIOPH RES CO, V12, P268, DOI 10.1016/0006-291X(63)90294-8; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Siddique A, 2014, CLIN GASTROENTEROL H, V12, P1170, DOI 10.1016/j.cgh.2013.11.017; Spengler EK, 2015, MAYO CLIN PROC, V90, P1233, DOI 10.1016/j.mayocp.2015.06.013; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Sun RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01518-z; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tort F, 2016, J INHERIT METAB DIS, V39, P781, DOI 10.1007/s10545-016-9975-4; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wettersten HI, 2015, CANCER RES, V75, P2541, DOI 10.1158/0008-5472.CAN-14-1703; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	68	48	48	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8297	8311		10.1074/jbc.RA118.001885	http://dx.doi.org/10.1074/jbc.RA118.001885			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29523684	Green Published, hybrid			2022-12-28	WOS:000433224600034
J	Chase, AJ; Wombacher, R; Fackler, OT				Chase, Amanda J.; Wombacher, Rebecka; Fackler, Oliver T.			Intrinsic properties and plasma membrane trafficking route of Src family kinase SH4 domains sensitive to retargeting by HIV-1 Nef	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; VIRUS TYPE-1 NEF; IMMUNOLOGICAL SYNAPSE; SUBCELLULAR-LOCALIZATION; DOWN-REGULATION; MAL PROTEIN; PDE-DELTA; C-SRC; INFECTION; SURFACE	The HIV type 1 pathogenicity factor Nef enhances viral replication by modulating multiple host cell pathways, including tuning the activation state of infected CD4 T lymphocytes to optimize virus spread. For this, Nef inhibits anterograde transport of the Src family kinase (SFK) Lck toward the plasma membrane (PM). This leads to retargeting of the kinase to the trans-Golgi network, whereas the intracellular transport of a related SFK, Fyn, is unaffected by Nef. The 18-amino acid Src homology 4 (SH4) domain membrane anchor of Lck is necessary and sufficient for Nef-mediated retargeting, but other details of this process are not known. The goal of this study was therefore to identify characteristics of SH4 domains responsive to Nef and the transport machinery used. Screening a panel of SFK SH4 domains revealed two groups that were sensitive or insensitive for trans-Golgi network retargeting by Nef as well as the importance of the amino acid at position 8 for determining Nef sensitivity. Anterograde transport of Nef-sensitive domains was characterized by slower delivery to the PM and initial targeting to Golgi membranes, where transport was arrested in the presence of Nef. For Nef-sensitive SH4 domains, ectopic expression of the lipoprotein binding chaperone Unc119a or the GTPase Arl3 or reduction of their endogenous expression phenocopied the effect of Nef. Together, these results suggest that, analogous to K-Ras, Nef-sensitive SH4 domains are transported to the PM by a cycle of solubilization and membrane insertion and that intrinsic properties define SH4 domains as cargo of this Nef-sensitive lipoprotein binding chaperone-GTPase transport cycle.	[Chase, Amanda J.; Wombacher, Rebecka; Fackler, Oliver T.] Univ Hosp Heidelberg, Ctr Integrat Infect Dis Res CIID, Dept Infect Dis, Integrat Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Hosp Heidelberg, Ctr Integrat Infect Dis Res CIID, Dept Infect Dis, Integrat Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de		Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [TRR83, 15]; postdoctoral program of the medical faculty of the University Hospital Heidelberg; Alexander von Humboldt postdoctoral fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); postdoctoral program of the medical faculty of the University Hospital Heidelberg; Alexander von Humboldt postdoctoral fellowship(Alexander von Humboldt Foundation)	This work was supported by Deutsche Forschungsgemeinschaft TRR83 Project 15. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the postdoctoral program of the medical faculty of the University Hospital Heidelberg and an Alexander von Humboldt postdoctoral fellowship.	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; ALLAND L, 1994, J BIOL CHEM, V269, P16701; Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Anton OM, 2011, J IMMUNOL, V186, P6345, DOI 10.4049/jimmunol.1003771; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chaudhry A, 2008, TRAFFIC, V9, P1925, DOI 10.1111/j.1600-0854.2008.00802.x; Chu PH, 2014, P NATL ACAD SCI USA, V111, P12420, DOI 10.1073/pnas.1404487111; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Galaski J, 2016, JAIDS-J ACQ IMM DEF, V72, P1, DOI 10.1097/QAI.0000000000000917; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geist MM, 2014, J BIOL CHEM, V289, P14030, DOI 10.1074/jbc.M114.563528; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Gorska MM, 2009, J IMMUNOL, V183, P1675, DOI 10.4049/jimmunol.0900792; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hill BT, 2005, J VIROL, V79, P1133, DOI 10.1128/JVI.79.2.1133-1141.2005; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2016, J BIOL CHEM, V291, P20766, DOI 10.1074/jbc.M116.741827; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Konitsiotis AD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00116-3; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Mejuch T, 2015, CHEMBIOCHEM, V16, P2460, DOI 10.1002/cbic.201500355; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; Ostalecki C, 2016, EBIOMEDICINE, V13, P294, DOI 10.1016/j.ebiom.2016.10.027; Pan XY, 2013, CELL MICROBIOL, V15, P1605, DOI 10.1111/cmi.12148; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Pujol FM, 2016, J VIROL, V90, P6709, DOI 10.1128/JVI.00504-16; Reinecke James, 2014, Biomol Concepts, V5, P143, DOI 10.1515/bmc-2014-0003; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schmick M, 2015, TRENDS CELL BIOL, V25, P190, DOI 10.1016/j.tcb.2015.02.004; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Silva JG, 2016, J IMMUNOL, V197, P4042, DOI 10.4049/jimmunol.1601132; Simmons A, 2005, IMMUNITY, V23, P621, DOI 10.1016/j.immuni.2005.11.003; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Trotard M, 2016, J VIROL, V90, P2064, DOI 10.1128/JVI.02966-15; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhu YP, 2017, CELL HOST MICROBE, V21, P220, DOI 10.1016/j.chom.2017.01.002	90	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7824	7840		10.1074/jbc.RA118.002794	http://dx.doi.org/10.1074/jbc.RA118.002794			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29588370	hybrid, Green Published			2022-12-28	WOS:000437256500030
J	Mariappa, D; Ferenbach, AT; van Aalten, DMF				Mariappa, Daniel; Ferenbach, Andrew T.; van Aalten, Daan M. F.			Effects of hypo-O-GlcNAcylation on Drosophila development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); Drosophila genetics; CRISPR; Cas; polycomb; post-translational modification (PTM); Drosophila development; Host cell factor; hypomorphic sxc mutant; Mediator complex	GLCNAC TRANSFERASE; GENE-EXPRESSION; GENOME MODIFICATION; ORGAN DEVELOPMENT; X-CHROMOSOME; CELL-GROWTH; PROTEIN; MELANOGASTER; RESISTANCE; MUTATIONS	Post-translational modification of serine/threonine residues in nucleocytoplasmic proteins with GlcNAc (O-GlcNAcylation) is an essential regulatory mechanism in many cellular processes. In Drosophila, null mutants of the Polycomb gene O-GlcNAc transferase (OGT; also known as super sex combs (sxc)) display homeotic phenotypes. To dissect the requirement for O-GlcNAc signaling in Drosophila development, we used CRISPR/Cas9 gene editing to generate rationally designed sxc catalytically hypomorphic or null point mutants. Of the fertile males derived from embryos injected with the CRISPR/Cas9 reagents, 25% produced progeny carrying precise point mutations with no detectable off-target effects. One of these mutants, the catalytically inactive sxc(K872M), was recessive lethal, whereas a second mutant, the hypomorphic sxc(H537A), was homozygous viable. We observed that reduced total protein O-GlcNAcylation in the sxc(H537A) mutant is associated with a wing vein phenotype and temperature-dependent lethality. Genetic interaction between sxc(H537A) and a null allele of Drosophila host cell factor (dHcf), encoding an extensively O-GlcNAcylated transcriptional coactivator, resulted in abnormal scutellar bristle numbers. A similar phenotype was also observed in sxc(H537A) flies lacking a copy of skuld (skd), a Mediator complex gene known to affect scutellar bristle formation. Interestingly, this phenotype was independent of OGT Polycomb function or dHcf downstream targets. In conclusion, the generation of the endogenous OGT hypomorphic mutant sxc(H537A) enabled us to identify pleiotropic effects of globally reduced protein O-GlcNAc during Drosophila development. The mutants generated and phenotypes observed in this study provide a platform for discovery of OGT substrates that are critical for Drosophila development.	[Mariappa, Daniel; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Mariappa, D; van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland.	d.mariyappa@dundee.ac.uk; d.m.f.vanaalten@dundee.ac.uk	Mariappa, Daniel/AAQ-7135-2020	Mariyappa, Daniel/0000-0003-4775-1656; Ferenbach, Andrew/0000-0002-1562-7987	Wellcome Trust [097945/B/11/Z]; MRC Next Generation Optical Microscopy Award [MR/K015869/1]; MRC [MR/K015869/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Next Generation Optical Microscopy Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Fly stocks were obtained from the Drosophila Stock Center (Bloomington, IN). Microinjections were performed at the University of Cambridge Department of Genetics Fly Facility. We thank the University Imaging Facility, Dundee, which is supported by Wellcome Trust Technology Platform Award 097945/B/11/Z and MRC Next Generation Optical Microscopy Award MR/K015869/1.	Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5640; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Biryukova I, 2008, DEV BIOL, V323, P64, DOI 10.1016/j.ydbio.2008.08.014; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Brennan K, 1999, DEV BIOL, V216, P230, DOI 10.1006/dbio.1999.9501; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chou TB, 1996, GENETICS, V144, P1673; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Douris V, 2017, INSECT BIOCHEM MOLEC, V87, P127, DOI 10.1016/j.ibmb.2017.06.013; DURA JM, 1988, DEVELOPMENT, V103, P733; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Furrer M, 2010, J BIOL CHEM, V285, P39623, DOI 10.1074/jbc.M110.140467; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guinez C, 2007, BIOCHEM BIOPH RES CO, V361, P414, DOI 10.1016/j.bbrc.2007.07.020; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Lim KH, 2006, FEBS LETT, V580, P4645, DOI 10.1016/j.febslet.2006.07.040; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Liu TW, 2017, NAT CHEM BIOL, V13, P161, DOI [10.1038/nchembio.2247, 10.1038/NCHEMBIO.2247]; Mao CX, 2017, DIS MODEL MECH, V10, P1245, DOI 10.1242/dmm.028316; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Mueller H. -Arno J., 2008, V420, P207, DOI 10.1007/978-1-59745-583-1_12; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00256; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott TE, 2016, EUR J MED GENET, V59, P367, DOI 10.1016/j.ejmg.2016.06.001; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SHELDON BL, 1972, GENETICS, V71, P567; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Treisman JE, 2001, DEVELOPMENT, V128, P603; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yin JW, 2014, DEVELOPMENT, V141, P977, DOI 10.1242/dev.098392; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007	74	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7209	7221		10.1074/jbc.RA118.002580	http://dx.doi.org/10.1074/jbc.RA118.002580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588363	Green Published, hybrid			2022-12-28	WOS:000432174500013
J	Schafer, C; Young, ZT; Makarewich, CA; Elnwasany, A; Kinter, C; Kinter, M; Szweda, LI				Schafer, Christopher; Young, Zachary T.; Makarewich, Catherine A.; Elnwasany, Abdallah; Kinter, Caroline; Kinter, Michael; Szweda, Luke I.			Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate dehydrogenase complex (PDC); pyruvate dehydrogenase kinase (PDC kinase); proteolysis; mitochondria; coenzyme A (CoA); heart; Lon protease	ACTIVATED RECEPTOR-ALPHA; HUMAN SKELETAL-MUSCLE; PHOSPHORYLATION SITES; ACID UTILIZATION; HEART; EXPRESSION; STARVATION; COMPLEX; MECHANISMS; OBESITY	Cardiac energy is produced primarily by oxidation of fatty acids and glucose, with the relative contributions of each nutrient being sensitive to changes in substrate availability and energetic demand. A major contributor to cardiac metabolic flexibility is pyruvate dehydrogenase (PDH), which converts glucose-derived pyruvate to acetyl-CoA within the mitochondria. PDH is inhibited by phosphorylation dependent on the competing activities of pyruvate dehydrogenase kinases (PDK1-4) and phosphatases (PDP1-2). A single high-fat meal increases cardiac PDK4 content and subsequently inhibits PDH activity, reducing pyruvate utilization when abundant fatty acids are available. In this study, we demonstrate that diet-induced increases in PDK4 are reversible and characterize a novel pathway that regulates PDK4 degradation in response to the cardiac metabolic environment. We found that PDK4 degradation is promoted by CoA (CoASH), the levels of which declined in mice fed a high-fat diet and normalized following transition to a control diet. We conclude that CoASH functions as a metabolic sensor linking the rate of PDK4 degradation to fatty acid availability in the heart. However, prolonged high-fat feeding followed by return to a low-fat diet resulted in persistent in vitro sensitivity of PDH to fatty acid-induced inhibition despite reductions in PDK4 content. Moreover, increases in the levels of proteins responsible for -oxidation and rates of palmitate oxidation by isolated cardiac mitochondria following long-term consumption of high dietary fat persisted after transition to the control diet. We propose that these changes prime PDH for inhibition upon reintroduction of fatty acids.	[Schafer, Christopher; Young, Zachary T.; Kinter, Caroline; Kinter, Michael; Szweda, Luke I.] Oklahoma Med Res Fdn, Aging & Metab Program, Oklahoma City, OK 73104 USA; [Makarewich, Catherine A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Elnwasany, Abdallah; Szweda, Luke I.] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Oklahoma Medical Research Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Szweda, LI (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Luke.Szweda@UTSouthwestern.edu		Elnwasany, Abdallah/0000-0002-9352-1854	NIA, National Institutes of Health [P30AG050911]; Oklahoma Medical Research Foundation; Hille Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL125247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050911] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oklahoma Medical Research Foundation; Hille Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by Grant P30AG050911 from the NIA, National Institutes of Health with additional support from the Oklahoma Medical Research Foundation and the Hille Family Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Holness MJ, 2002, BIOCHEM J, V364, P687, DOI 10.1042/bj20011841; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; ORFALI KA, 1993, FEBS LETT, V336, P501, DOI 10.1016/0014-5793(93)80864-Q; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pilegaard H, 2003, DIABETES, V52, P657, DOI 10.2337/diabetes.52.3.657; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Rindler PM, 2013, AM J PHYSIOL-HEART C, V305, pH634, DOI 10.1152/ajpheart.00799.2012; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	35	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6915	6924		10.1074/jbc.RA117.000268	http://dx.doi.org/10.1074/jbc.RA117.000268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540486	Green Published, hybrid			2022-12-28	WOS:000431487300024
J	Liu, YC; Huang, Y				Liu, Yanchao; Huang, Ying			Uncovering the mechanistic basis for specific recognition of monomethylated H3K4 by the CW domain of Arabidopsis histone methyltransferase SDG8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; histone modification; epigenetics; Arabidopsis thaliana; chromatin modification; ASHH2; CW domain; H3K4me1 reader; recognition of low methylation level; SDG8	CHROMATIN MODIFICATIONS; EPIGENETIC REGULATION; STRUCTURAL INSIGHT; GENE-EXPRESSION; METHYLATION; REPRESSION; FAMILY; TRANSCRIPTION; ENGAGEMENT; LANDSCAPE	Chromatin consists of DNA and histones, and specific histone modifications that determine chromatin structure and activity are regulated by three types of proteins, called writer, reader, and eraser. Histone reader proteins from vertebrates, vertebrate-infecting parasites, and higher plants possess a CW domain, which has been reported to read histone H3 lysine 4 (H3K4). The CW domain of Arabidopsis SDG8 (also called ASHH2), a histone H3 lysine 36 methyltransferase, preferentially binds monomethylated H3K4 (H3K4me1), unlike the mammalian CW domain protein, which binds trimethylated H3K4 (H3K4me3). However, the molecular basis of the selective binding by the CW domain of SDG8 (SDG8-CW) remains unclear. Here, we solved the 1.6--resolution structure of SDG8-CW in complex with H3K4me1, which revealed that residues in the C-terminal -helix of SDG8-CW determine binding specificity for low methylation levels at H3K4. Moreover, substitutions of key residues, specifically Ile-915 and Asn-916, converted SDG8-CW binding preference from H3K4me1 to H3K4me3. Sequence alignment and mutagenesis studies revealed that the CW domain of SDG725, the homolog of SDG8 in rice, shares the same binding preference with SDG8-CW, indicating that preference for low methylated H3K4 by the CW domain of ASHH2 homologs is conserved among higher-order plants. Our findings provide first structural insights into the molecular basis for specific recognition of monomethylated H3K4 by the H3K4me1 reader protein SDG8 from Arabidopsis.	[Liu, Yanchao; Huang, Ying] Univ Chinese Acad Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Shanghai Key Lab Mol Androl, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, Y (corresponding author), Univ Chinese Acad Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Shanghai Key Lab Mol Androl, CAS Ctr Excellence Mol Cell Sci,Chinese Acad Sci, Shanghai 201210, Peoples R China.	huangy@sibcb.ac.cn	Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874	National Natural Science Foundation of China [91640102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010202]; Ministry of Science and Technology of the People's Republic of China [2012CB910500]; Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	This work was supported by grants from the National Natural Science Foundation of China (91640102 to Y. H.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010202 to Y. H.), the Ministry of Science and Technology of the People's Republic of China (2012CB910500 to Y. H.), the Chinese Academy of Sciences Facility-based Open Research Program, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Andrews FH, 2016, CELL REP, V16, P3195, DOI 10.1016/j.celrep.2016.08.050; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Cazzonelli CI, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00533; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Cazzonelli CI, 2009, PLANT SIGNAL BEHAV, V4, P339, DOI 10.4161/psb.4.4.8193; Chen F, 2013, CELL RES, V23, P306, DOI 10.1038/cr.2013.17; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong GF, 2008, BIOCHEM BIOPH RES CO, V373, P659, DOI 10.1016/j.bbrc.2008.06.096; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; He FH, 2010, STRUCTURE, V18, P1127, DOI 10.1016/j.str.2010.06.012; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hoppmann V, 2011, EMBO J, V30, P1939, DOI 10.1038/emboj.2011.108; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0640-2; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Liu YL, 2016, CURR PROTEIN PEPT SC, V17, P497, DOI 10.2174/1389203717666160125115130; Liu YL, 2016, J BIOL CHEM, V291, P9000, DOI 10.1074/jbc.M116.718973; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel DJ, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018754; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perry J, 2003, TRENDS BIOCHEM SCI, V28, P576, DOI 10.1016/j.tibs.2003.09.007; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Sequeira-Mendes J, 2014, PLANT CELL, V26, P2351, DOI 10.1105/tpc.114.124578; Shafiq S, 2014, NEW PHYTOL, V201, P312, DOI 10.1111/nph.12493; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Tang XR, 2012, J EXP BOT, V63, P1391, DOI 10.1093/jxb/err383; Wang GL, 2010, ANAT REC, V293, P1002, DOI 10.1002/ar.21119; Wang XL, 2014, MOL PLANT, V7, P1303, DOI 10.1093/mp/ssu056; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang Z, 2017, PLANT SCI, V263, P168, DOI 10.1016/j.plantsci.2017.06.013; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	60	19	21	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6470	6481		10.1074/jbc.RA117.001390	http://dx.doi.org/10.1074/jbc.RA117.001390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29496997	hybrid, Green Published			2022-12-28	WOS:000431108600020
J	Mukaibo, T; Munemasa, T; George, AT; Tran, DT; Gao, X; Herche, JL; Masaki, C; Shull, GE; Soleimani, M; Melvin, JE				Mukaibo, Taro; Munemasa, Takashi; George, Alvin T.; Tran, Duy T.; Gao, Xin; Herche, Jesse L.; Masaki, Chihiro; Shull, Gary E.; Soleimani, Manoocher; Melvin, James E.			The apical anion exchanger Slc26a6 promotes oxalate secretion by murine submandibular gland acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						physiology; epithelial cell; anion transport; exchanger; glycoprotein	CL-/HCO3-EXCHANGER; FLUID SECRETION; HCO3-SECRETION; RENAL PHYSIOLOGY; NACL TRANSPORT; AE4 SLC4A9; IN-VIVO; CFTR; GENE; IDENTIFICATION	The solute carrier family 26 (SLC26) gene family encodes at least 10 different anion exchangers. SLC26 member 6 (SLC26A6 or CFEX/PAT-1) and the cystic fibrosis transmembrane conductance regulator (CFTR) co-localize to the apical membrane of pancreatic duct cells, where they act in concert to drive HCO3- and fluid secretion. In contrast, in the small intestine, SLC26A6 serves as the major pathway for oxalate secretion. However, little is known about the function of Slc26a6 in murine salivary glands. Here, RNA sequencing-based transcriptional profiling and Western blots revealed that Slc26a6 is highly expressed in mouse submandibular and sublingual salivary glands. Slc26a6 localized to the apical membrane of salivary gland acinar cells with no detectable immunostaining in the ducts. CHO-K1 cells transfected with mouse Slc26a6 exchanged Cl- for oxalate and HCO3-, whereas two other anion exchangers known to be expressed in salivary gland acinar cells, Slc4a4 and Slc4a9, mediated little, if any, Cl-/oxalate exchange. Of note, both Cl-/oxalate exchange and Cl-/HCO3- exchange were significantly reduced in acinar cells isolated from the submandibular glands of Slc26a6(-/-) mice. Oxalate secretion in submandibular saliva also decreased significantly in Slc26a6(-/-) mice, but HCO3- secretion was unaffected. Taken together, our findings indicate that Slc26a6 is located at the apical membrane of salivary gland acinar cells, where it mediates Cl-/oxalate exchange and plays a critical role in the secretion of oxalate into saliva.	[Mukaibo, Taro; Munemasa, Takashi; George, Alvin T.; Gao, Xin; Herche, Jesse L.; Melvin, James E.] NIDCR, Secretory Mech & Dysfunct Sect, NIH, Bethesda, MD 20892 USA; [Tran, Duy T.] NIDCR, Biol Chem Sect, NIH, Bethesda, MD 20892 USA; [Mukaibo, Taro; Munemasa, Takashi; Masaki, Chihiro] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka 8038580, Japan; [Gao, Xin] Univ Maryland, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; [Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu Dental University; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Melvin, JE (corresponding author), NIDCR, Secretory Mech & Dysfunct Sect, NIH, Bethesda, MD 20892 USA.	james.melvin@nih.gov	Mukaibo, Taro/AAR-9429-2020	Mukaibo, Taro/0000-0002-3650-9250	NIDCR, National Institutes of Health [1-ZIG-DE000740]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIGDE000740, ZIADE000738] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Yasna Jaramillo and Jaideep Honavar for technical assistance and Dr. Keitaro Satoh for generous advice regarding protein isolation. The Veterinary Research Core was supported by Core Grant 1-ZIG-DE000740 from the NIDCR, National Institutes of Health.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Aronson PS, 2006, KIDNEY INT, V70, P1207, DOI 10.1038/sj.ki.5001741; Aronson PS, 2010, J NEPHROL, V23, pS158; Aronson PS, 2002, CELL BIOCHEM BIOPHYS, V36, P147, DOI 10.1385/CBB:36:2-3:147; Catalan MA, 2015, P NATL ACAD SCI USA, V112, P2263, DOI 10.1073/pnas.1415739112; Chernova MN, 2005, J BIOL CHEM, V280, P8564, DOI 10.1074/jbc.M411703200; Corbetta S, 2009, EUR J ENDOCRINOL, V160, P283, DOI 10.1530/EJE-08-0623; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Freel RW, 2006, AM J PHYSIOL-GASTR L, V290, pG719, DOI 10.1152/ajpgi.00481.2005; Gao X, 2018, PHYSIOL GENOMICS, V50, P263, DOI 10.1152/physiolgenomics.00124.2017; Gonzalez-Begne M, 2007, J BIOL CHEM, V282, P35125, DOI 10.1074/jbc.M707266200; Hong JH, 2014, PFLUG ARCH EUR J PHY, V466, P1487, DOI 10.1007/s00424-013-1390-1; Ishiguro H, 2007, AM J PHYSIOL-GASTR L, V292, pG447, DOI 10.1152/ajpgi.00286.2006; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lohi H, 2003, AM J PHYSIOL-CELL PH, V284, pC769, DOI 10.1152/ajpcell.00270.2002; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; LUSTMANN J, 1990, INT J ORAL MAX SURG, V19, P135, DOI 10.1016/S0901-5027(05)80127-4; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Ohana E, 2013, J AM SOC NEPHROL, V24, P1617, DOI 10.1681/ASN.2013010080; Park HW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009571; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Pena-Munzenmayer G, 2015, J BIOL CHEM, V290, P10677, DOI 10.1074/jbc.M114.612895; Pena-Munzenmayer G, 2016, J GEN PHYSIOL, V147, P423, DOI 10.1085/jgp.201611571; Petrovic S, 2003, AM J PHYSIOL-CELL PH, V285, pC608, DOI 10.1152/ajpcell.00084.2003; POOLE D F G, 1970, Archives of Oral Biology, V15, P1157, DOI 10.1016/0003-9969(70)90007-5; Romanenko VG, 2007, J PHYSIOL-LONDON, V581, P801, DOI 10.1113/jphysiol.2006.127498; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Soleimani M, 2006, SEMIN NEPHROL, V26, P375, DOI 10.1016/j.semnephrol.2006.07.005; Song Y, 2012, AM J PHYSIOL-CELL PH, V303, pC815, DOI 10.1152/ajpcell.00151.2012; Stewart AK, 2009, AM J PHYSIOL-GASTR L, V296, pG1307, DOI 10.1152/ajpgi.90697.2008; Taher A A, 1989, Singapore Dent J, V14, P33; Thomson RB, 2016, AM J PHYSIOL-CELL PH, V311, pC866, DOI 10.1152/ajpcell.00171.2016; WAHL R, 1994, EUR J CLIN CHEM CLIN, V32, P821; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; Whittamore JM, 2017, AM J PHYSIOL-GASTR L, V313, pG166, DOI 10.1152/ajpgi.00079.2017; Wu CC, 2016, ACTA OTO-LARYNGOL, V136, P497, DOI 10.3109/00016489.2015.1129068; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; YAMAMOTO H, 1983, J DENT RES, V62, P16, DOI 10.1177/00220345830620010301	49	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6259	6268		10.1074/jbc.RA118.002378	http://dx.doi.org/10.1074/jbc.RA118.002378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29530983	hybrid, Green Published			2022-12-28	WOS:000431108600004
J	Purandare, N; Somayajulu, M; Huttemann, M; Grossman, LI; Aras, S				Purandare, Neeraja; Somayajulu, Mallika; Huttemann, Maik; Grossman, Lawrence I.; Aras, Siddhesh			The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; AMYOTROPHIC-LATERAL-SCLEROSIS; BI-ORGANELLAR REGULATOR; FRONTOTEMPORAL DEMENTIA; GENE-EXPRESSION; MUTATIONS; SUBUNIT; PATHOGENICITY; TRANSCRIPTION; TISSUES	Coiled-coil-helix-coiled-coil-helix domain-containing 10 (CHCHD10) and CHCHD2 (MNRR1) are homologous proteins with 58% sequence identity and belong to the twin CX9C family of proteins that mediate cellular stress responses. Despite the identification of several neurodegeneration-associated mutations in the CHCHD10 gene, few studies have assessed its physiological role. Here, we investigated CHCHD10's function as a regulator of oxidative phosphorylation in the mitochondria and the nucleus. We show that CHCHD10 copurifies with cytochrome c oxidase (COX) and up-regulates COX activity by serving as a scaffolding protein required for MNRR1 phosphorylation, mediated by ARG (ABL proto-oncogene 2, nonreceptor tyrosine kinase (ABL2)). The CHCHD10 gene was maximally transcribed in cultured cells at 8% oxygen, unlike MNRR1, which was maximally expressed at 4%, suggesting a fine-tuned oxygen-sensing system that adapts to the varying oxygen concentrations in the human body under physiological conditions. We show that nuclear CHCHD10 protein down-regulates the expression of genes harboring the oxygen-responsive element (ORE) in their promoters by interacting with and augmenting the activity of the largely uncharacterized transcriptional repressor CXXC finger protein 5 (CXXC5). We further show that two genetic CHCHD10 disease variants, G66V and P80L, in the mitochondria exhibit faulty interactions with MNRR1 and COX, reducing respiration and increasing reactive oxygen species (ROS), and in the nucleus abrogating transcriptional repression of ORE-containing genes. Our results reveal that CHCHD10 positively regulates mitochondrial respiration and contributes to transcriptional repression of ORE-containing genes in the nucleus, and that genetic CHCHD10 variants are impaired in these activities.	[Purandare, Neeraja; Somayajulu, Mallika; Huttemann, Maik; Grossman, Lawrence I.; Aras, Siddhesh] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University	Grossman, LI (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	lgrossman@wayne.edu		Huttemann, Maik/0000-0001-6310-7081	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-16-1-0516]; Henry L. Brasza endowment at Wayne State University	Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; Henry L. Brasza endowment at Wayne State University	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award W81XWH-16-1-0516 and the Henry L. Brasza endowment at Wayne State University. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the U. S. Department of Defense or the United States government.	Ait-El-Mkadem S., 2015, GENEREVIEWS; Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Aras S, 2017, BBA-MOL CELL RES, V1864, P440, DOI 10.1016/j.bbamcr.2016.11.029; Aras S, 2015, MITOCHONDRION, V20, P43, DOI 10.1016/j.mito.2014.10.003; Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022; Chio A, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.01.017; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Dols-Icardo O, 2015, BRAIN, V138, pE400, DOI 10.1093/brain/awv175; Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496; HaoWong C, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.07.014; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Jackson MJ, 2016, MOL ASPECTS MED, V50, P33, DOI 10.1016/j.mam.2016.05.002; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041; Kurzwelly D, 2015, BRAIN, V138, DOI 10.1093/brain/awv014; Li XL, 2016, AMYOTROPH LAT SCL FR, V17, P458, DOI 10.3109/21678421.2016.1170151; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034832; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marroquin N, 2016, BRAIN, V139, pE8, DOI 10.1093/brain/awv218; Martherus RSRM, 2010, BIOCHEM BIOPH RES CO, V402, P203, DOI 10.1016/j.bbrc.2010.09.109; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004; Muller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227; Pasanen P, 2016, ACTA NEUROL SCAND, V133, P361, DOI 10.1111/ane.12470; Penttila S, 2017, J NEUROL NEUROSUR PS, V88, P272, DOI 10.1136/jnnp-2016-314154; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384; Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393; Woo JAA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15558; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082; Zhou QQ, 2017, MOL NEUROBIOL, V54, P3189, DOI 10.1007/s12035-016-9888-0; Zuo L, 2013, GENE, V532, P18, DOI 10.1016/j.gene.2013.07.085	44	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6517	6529		10.1074/jbc.RA117.001073	http://dx.doi.org/10.1074/jbc.RA117.001073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29540477	Green Published, hybrid			2022-12-28	WOS:000431108600023
J	Robinson, JI; Beverley, SM				Robinson, John I.; Beverley, Stephen M.			Concentration of 2 ' C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; viral polymerase; nucleoside; nucleotide analogue; parasite metabolism; RNA virus; ds RNA virus; Totivirus; trypanosomatid protozoa	CAPSID ENDORIBONUCLEASE; SACCHAROMYCES-CEREVISIAE; CUTANEOUS LEISHMANIASIS; ADENOSINE KINASE; IN-VITRO; REPLICATION; MECHANISM; DONOVANI; ANALOGS; IDENTIFICATION	Leishmania is a widespread trypanosomatid protozoan parasite causing significant morbidity and mortality in humans. The endobiont dsRNA virus Leishmania RNA virus 1 (LRV1) chronically infects some strains, where it increases parasite numbers and virulence in murine leishmaniasis models, and correlates with increased treatment failure in human disease. Previously, we reported that 2-C-methyladenosine (2CMA) potently inhibited LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis, leading to viral eradication at concentrations above 10 m. Here we probed the cellular mechanisms of 2CMA inhibition, involving metabolism, accumulation, and inhibition of the viral RNA-dependent RNA polymerase (RDRP). Activation to 2CMA triphosphate (2CMA-TP) was required, as 2CMA showed no inhibition of RDRP activity from virions purified on cesium chloride gradients. In contrast, 2CMA-TP showed IC50 values ranging from 150 to 910 m, depending on the CsCl density of the virion (empty, ssRNA-, and dsRNA-containing). Lgy parasites incubated in vitro with 10 m 2CMA accumulated 2CMA-TP to 410 m, greater than the most sensitive RDRP IC50 measured. Quantitative modeling showed good agreement between the degree of LRV1 RDRP inhibition and LRV1 levels. These results establish that 2CMA activity is due to its conversion to 2CMA-TP, which accumulates to levels that inhibit RDRP and cause LRV1 loss. This attests to the impact of the Leishmania purine uptake and metabolism pathways, which allow even a weak RDRP inhibitor to effectively eradicate LRV1 at micromolar concentrations. Future RDRP inhibitors with increased potency may have potential therapeutic applications for ameliorating the increased Leishmania pathogenicity conferred by LRV1.	[Robinson, John I.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Sch Med, Campus Box 8230,660 S Euclid Ave, Washington, MO 63110 USA.	stephen.beverley@wustl.edu		Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [R01AI029646, R56AI099364]; Sigma-Aldrich Predoctoral fellowship; Sondra Schlesinger Graduate Student fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099364, R01AI029646, R01AI130222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigma-Aldrich Predoctoral fellowship; Sondra Schlesinger Graduate Student fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI029646 and R56AI099364 (to S. M. B.) and Sigma-Aldrich Predoctoral and Sondra Schlesinger Graduate Student fellowships (to J. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354; ADLER J, 1976, J VIROL, V17, P472, DOI 10.1128/JVI.17.2.472-476.1976; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ARMSTRONG TC, 1993, P NATL ACAD SCI USA, V90, P1736, DOI 10.1073/pnas.90.5.1736; ARMSTRONG TC, 1994, J PARASITOL, V80, P1030, DOI 10.2307/3283454; AU JLS, 1989, CLIN CHEM, V35, P48; Banuls AL, 2011, CLIN MICROBIOL INFEC, V17, P1451, DOI 10.1111/j.1469-0691.2011.03640.x; BHAUMIK D, 1988, MOL BIOCHEM PARASIT, V28, P181, DOI 10.1016/0166-6851(88)90002-3; Boitz JM, 2013, MOL BIOCHEM PARASIT, V190, P51, DOI 10.1016/j.molbiopara.2013.06.005; Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355; Brettmann EA, 2016, P NATL ACAD SCI USA, V113, P11998, DOI 10.1073/pnas.1615085113; CADD TL, 1994, J VIROL, V68, P358, DOI 10.1128/JVI.68.1.358-365.1994; Cantanhede LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004079; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Castellucci LC, 2014, MEM I OSWALDO CRUZ, V109, P279, DOI 10.1590/0074-0276140028; Castiglioni P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005240; DATTA AK, 1987, J BIOL CHEM, V262, P5515; Eldrup AB, 2004, J MED CHEM, V47, P5284, DOI 10.1021/jm040068f; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; Eren RO, 2016, CELL HOST MICROBE, V20, P318, DOI 10.1016/j.chom.2016.08.001; ESTEBAN R, 1986, MOL CELL BIOL, V6, P1552, DOI 10.1128/MCB.6.5.1552; FERNANDEZLARSSON R, 1989, ANTIMICROB AGENTS CH, V33, P1668, DOI 10.1128/AAC.33.10.1668; Fox J., 2019, R COMPANION APPL REG, V.; Freitas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124183; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Ginouves M, 2016, AM J TROP MED HYG, V94, P102, DOI 10.4269/ajtmh.15-0419; Hartley MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005852; Hartley MA, 2014, TRENDS PARASITOL, V30, P412, DOI 10.1016/j.pt.2014.05.006; Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020; Ito MM, 2015, BRAZ J OTORHINOLAR, V81, P533, DOI 10.1016/j.bjorl.2015.07.014; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kim SG, 2005, PACE, V28, P1, DOI 10.1111/j.1540-8159.2004.09533.x; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Kuhlmann FM, 2017, P NATL ACAD SCI USA, V114, pE811, DOI 10.1073/pnas.1619114114; LAFON SW, 1985, J BIOL CHEM, V260, P9660; Lee SE, 1996, J BIOCHEM-TOKYO, V120, P22, DOI 10.1093/oxfordjournals.jbchem.a021387; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; MacBeth KJ, 1997, J BIOCHEM-TOKYO, V122, P193, DOI 10.1093/oxfordjournals.jbchem.a021728; MACBETH KJ, 1995, P NATL ACAD SCI USA, V92, P8994, DOI 10.1073/pnas.92.19.8994; McGuigan C, 2010, J MED CHEM, V53, P4949, DOI 10.1021/jm1003792; MOAL J, 1989, COMP BIOCHEM PHYS B, V93, P307, DOI 10.1016/0305-0491(89)90086-2; Murakami E, 2007, ANTIMICROB AGENTS CH, V51, P503, DOI 10.1128/AAC.00400-06; OLIVER SG, 1977, J BACTERIOL, V130, P1303, DOI 10.1128/JB.130.3.1303-1309.1977; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Parmentier L, 2016, AM J TROP MED HYG, V94, P840, DOI 10.4269/ajtmh.15-0803; Pigott D. M., 2014, ELIFE, V3; RAINEY P, 1983, P NATL ACAD SCI-BIOL, V80, P288, DOI 10.1073/pnas.80.1.288; Pereira LDR, 2013, MEM I OSWALDO CRUZ, V108, P665, DOI 10.1590/0074-0276108052013021; RANKIN JT, 1989, VIROLOGY, V168, P147, DOI 10.1016/0042-6822(89)90413-3; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ro Y, 2003, J MICROBIOL, V41, P239; Ro YT, 2004, EXP MOL MED, V36, P145, DOI 10.1038/emm.2004.21; Ro YT, 1997, J VIROL, V71, P8991, DOI 10.1128/JVI.71.12.8991-8998.1997; Ro YT, 2000, J VIROL, V74, P130, DOI 10.1128/JVI.74.1.130-138.2000; Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schriefer A, 2008, CURR OPIN INFECT DIS, V21, P483, DOI 10.1097/QCO.0b013e32830d0ee8; SCOTTI PD, 1985, J VIROL METHODS, V12, P149, DOI 10.1016/0166-0934(85)90015-1; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596; TARR PI, 1988, P NATL ACAD SCI USA, V85, P9572, DOI 10.1073/pnas.85.24.9572; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; WIDMER G, 1990, J VIROL, V64, P3712, DOI 10.1128/JVI.64.8.3712-3715.1990; WIDMER G, 1995, NUCLEIC ACIDS RES, V23, P2300, DOI 10.1093/nar/23.12.2300; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979; Zangger H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002006; Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695	72	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6460	6469		10.1074/jbc.RA117.001515	http://dx.doi.org/10.1074/jbc.RA117.001515			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511088	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000431108600019
J	Trillo-Muyo, S; Nilsson, HE; Recktenwald, CV; Ermund, A; Ridley, C; Meiss, LN; Bahr, A; Klymiuk, N; Wine, JJ; Koeck, PJB; Thornton, DJ; Hebert, H; Hansson, GC				Trillo-Muyo, Sergio; Nilsson, Harriet E.; Recktenwald, Christian V.; Ermund, Anna; Ridley, Caroline; Meiss, Lauren N.; Baehr, Andrea; Klymiuk, Nikolai; Wine, Jeffrey J.; Koeck, Philip J. B.; Thornton, David J.; Hebert, Hans; Hansson, Gunnar C.			Granule-stored MUC5B mucins are packed by the non-covalent formation of N-terminal head-to-head tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; GEL-FORMING-MUCIN; CYSTIC-FIBROSIS; SECRETION; RELEASE; MUCUS; BICARBONATE; PACKING; TUBULES; DOMAIN	Most MUC5B mucin polymers in the upper airways of humans and pigs are produced by submucosal glands. MUC5B forms N-terminal covalent dimers that are further packed into larger assemblies because of low pH and high Ca2+ in the secretory granule of the mucin-producing cell. We purified the recombinant MUC5B N-terminal covalent dimer and used single-particle electron microscopy to study its structure under intracellular conditions. We found that, at intragranular pH, the dimeric MUC5B organized into head-to-head noncovalent tetramers where the von Willebrand D1-D2 domains hooked into each other. These N-terminal tetramers further formed long linear complexes from which, we suggest, the mucin domains and their C termini project radially outwards. Using conventional and video microscopy, we observed that, upon secretion into the submucosal gland ducts, a flow of bicarbonate-rich fluid passes the mucin-secreting cells. We suggest that this unfolds and pulls out the MUC5B assemblies into long linear threads. These further assemble into thicker mucin bundles in the glandular ducts before emerging at the gland duct opening. We conclude that the combination of intracellular packing of the MUC5B mucin and the submucosal gland morphology creates an efficient machine for producing linear mucin bundles.	[Trillo-Muyo, Sergio; Nilsson, Harriet E.; Recktenwald, Christian V.; Ermund, Anna; Meiss, Lauren N.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Box 440, S-40530 Gothenburg, Sweden; [Nilsson, Harriet E.; Koeck, Philip J. B.; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Nilsson, Harriet E.; Koeck, Philip J. B.; Hebert, Hans] KTH Royal Inst Technol, Sch Technol & Hlth, S-14157 Huddinge, Sweden; [Ridley, Caroline; Thornton, David J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Wellcome Trust Ctr Cell Matrix Res, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Baehr, Andrea; Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Hackerstr 27, D-85764 Oberschleissheim, Germany; [Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA	University of Gothenburg; Karolinska Institutet; Royal Institute of Technology; University of Manchester; University of Munich; Stanford University	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019; Klymiuk, Nikolai/AAB-8345-2022; Koeck, Philip/AAG-5333-2020; Ermund, Anna/AAG-3160-2020	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Klymiuk, Nikolai/0000-0003-3532-1659; Nilsson, Harriet/0000-0001-7739-4405; Ridley, Caroline/0000-0002-5483-0320; Trillo-Muyo, Sergio/0000-0002-3135-9134; Recktenwald, Christian Viktor/0000-0003-1710-1863; Thornton, David/0000-0001-7148-1970; Ermund, Anna/0000-0002-3233-043X	Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health [U01AI095473]; Erica Lederhausen Foundation; Magnus Bergvall Foundation; Swedish Heart-Lung Foundation; Center for Innovative Medicine (Karolinska Institutet); Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; Swedish Cystic Fibrosis Foundation; Cystic Fibrosis Foundation (CFFT) [Hansso14X0, Thornt077X0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Erica Lederhausen Foundation; Magnus Bergvall Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Center for Innovative Medicine (Karolinska Institutet); Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; Swedish Cystic Fibrosis Foundation; Cystic Fibrosis Foundation (CFFT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Swedish Research Council; the Swedish Cancer Foundation; the Knut and Alice Wallenberg Foundation; the Inga Britt and Arne Lundberg Foundation; Sahlgrenska University Hospital (ALF); the Wilhelm and Martina Lundgren Foundation; NIAID, National Institutes of Health Grant U01AI095473; the Erica Lederhausen Foundation; the Magnus Bergvall Foundation; the Swedish Heart-Lung Foundation; the Center for Innovative Medicine (Karolinska Institutet); the Lederhausen Center for Cystic Fibrosis Research at the University of Gothenburg; the Swedish Cystic Fibrosis Foundation; and the Cystic Fibrosis Foundation (CFFT, Hansso14X0, and Thornt077X0). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Ermund A, 2017, BIOCHEM BIOPH RES CO, V492, P331, DOI 10.1016/j.bbrc.2017.08.113; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; MEYRICK B, 1969, THORAX, V24, P729, DOI 10.1136/thx.24.6.729; Nilsson HE, 2014, J MOL BIOL, V426, P2567, DOI 10.1016/j.jmb.2014.04.027; Ostedgaard LS, 2017, P NATL ACAD SCI USA, V114, P6842, DOI 10.1073/pnas.1703228114; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; SANDERSON MJ, 1981, J CELL SCI, V47, P331; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sheehan JK, 2004, J BIOL CHEM, V279, P15698, DOI 10.1074/jbc.M313241200; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Widdicombe JH, 2015, PHYSIOL REV, V95, P1241, DOI 10.1152/physrev.00039.2014; Zheng Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8858; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	26	34	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5746	5754		10.1074/jbc.RA117.001014	http://dx.doi.org/10.1074/jbc.RA117.001014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29440393	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000430044100033
J	Bogdan, D; Falcone, J; Kanjiya, MP; Park, SH; Carbonetti, G; Studholme, K; Gomez, M; Lu, Y; Elmes, MW; Smietalo, N; Yan, S; Ojima, I; Puopolo, M; Kaczocha, M				Bogdan, Diane; Falcone, Jerome; Kanjiya, Martha P.; Park, Sang Hoon; Carbonetti, Gregory; Studholme, Keith; Gomez, Maria; Lu, Yong; Elmes, Matthew W.; Smietalo, Norbert; Yan, Su; Ojima, Iwao; Puopolo, Michelino; Kaczocha, Martin			Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid binding protein; prostaglandin; inflammation; pain; NF-B; FABP; mPGES-1	PROLIFERATOR-ACTIVATED RECEPTORS; UNITED-STATES; CHRONIC PAIN; ENDOPLASMIC-RETICULUM; NUCLEAR RECEPTORS; E-2 PRODUCTION; MICE LACKING; OPIOID USE; EXPRESSION; PREVALENCE	Fatty acid-binding proteins (FABPs) are intracellular lipid carriers that regulate inflammation, and pharmacological inhibition of FABP5 reduces inflammation and pain. The mechanism(s) underlying the anti-inflammatory effects associated with FABP5 inhibition is poorly understood. Herein, we identify a novel mechanism through which FABP5 modulates inflammation. In mice, intraplantar injection of carrageenan induces acute inflammation that is accompanied by edema, enhanced pain sensitivity, and elevations in proinflammatory cytokines and prostaglandin E-2 (PGE(2)). Inhibition of FABP5 reduced pain, edema, cytokine, and PGE(2) levels. PGE(2) is a major eicosanoid that enhances pain in the setting of inflammation, and we focused on the mechanism(s) through which FABP5 modulates PGE(2) production. Cyclooxygenase 2 (COX-2) and microsomal prostaglandin E synthase 1 (mPGES-1) are enzymes up-regulated at the site of inflammation and account for the bulk of PGE(2) biosynthesis. Pharmacological or genetic FABP5 inhibition suppressed the induction of mPGES-1 but not COX-2 in carrageenan-injected paws, which occurred predominantly in macrophages. The cytokine interleukin 1 (IL-1) is a major inducer of mPGES-1 during inflammation. Using A549 cells that express FABP5, IL-1 stimulation up-regulated mPGES-1 expression, and mPGES-1 induction was attenuated in A549 cells bearing a knockdown of FABP5. IL-1 up-regulates mPGES-1 via NF-B, which activates the mPGES-1 promoter. Knockdown of FABP5 reduced the activation and nuclear translocation of NF-B and attenuated mPGES-1 promoter activity. Deletion of NF-B-binding sites within the mPGES-1 promoter abrogated the ability of FABP5 to inhibit mPGES-1 promoter activation. Collectively, these results position FABP5 as a novel regulator of mPGES-1 induction and PGE(2) biosynthesis during inflammation.	[Bogdan, Diane; Falcone, Jerome; Kanjiya, Martha P.; Park, Sang Hoon; Studholme, Keith; Gomez, Maria; Lu, Yong; Smietalo, Norbert; Puopolo, Michelino; Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Carbonetti, Gregory; Elmes, Matthew W.; Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Yan, Su; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Yan, Su; Ojima, Iwao; Kaczocha, Martin] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Carbonetti, Gregory; Elmes, Matthew W.] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Kaczocha, M (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu	Yan, Su/J-6988-2019	Yan, Su/0000-0002-9961-471X; Ojima, Iwao/0000-0002-3628-1161; studholme, keith/0000-0002-0037-514X; Falcone, Jerome/0000-0002-0672-1226	National Institutes of Health [DA035949, DA035923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035923, R01DA035949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01 (COX-1 and COX-2, respectively) followed by microsomal DA035949 and DA035923 (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Campbell G, 2015, PAIN MED, V16, P1745, DOI 10.1111/pme.12773; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chen LH, 2013, PROSTAG OTH LIPID M, V104, P58, DOI 10.1016/j.prostaglandins.2012.08.006; Dallaglio K, 2013, EXP DERMATOL, V22, P255, DOI 10.1111/exd.12111; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deckmann K, 2010, BIOCHEM PHARMACOL, V80, P1365, DOI 10.1016/j.bcp.2010.07.032; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GARRY MG, 1992, BRAIN RES, V582, P139, DOI 10.1016/0006-8993(92)90328-7; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; Han R, 2002, J BIOL CHEM, V277, P16355, DOI 10.1074/jbc.M111246200; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Helledie T, 2000, J LIPID RES, V41, P1740; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kaczocha M, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0056-8; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kane CD, 1996, BIOCHEMISTRY-US, V35, P2894, DOI 10.1021/bi952476e; Krug LT, 2007, PLOS PATHOG, V3, P97, DOI 10.1371/journal.ppat.0030011; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Mendez M, 2003, HYPERTENSION, V42, P844, DOI 10.1161/01.HYP.0000085332.69777.D1; Miller RE, 2014, CYTOKINE, V70, P185, DOI 10.1016/j.cyto.2014.06.019; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Noma T, 2016, BIOCHEM PHARMACOL, V116, P120, DOI 10.1016/j.bcp.2016.07.014; Ogawa E, 2011, J INVEST DERMATOL, V131, P604, DOI 10.1038/jid.2010.342; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Palmer RE, 2015, PAIN, V156, P1208, DOI 10.1097/j.pain.0000000000000145; Patel KV, 2013, PAIN, V154, P2649, DOI 10.1016/j.pain.2013.07.029; Peng XX, 2017, MOL PAIN, V13, DOI 10.1177/1744806917697007; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Schou WS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0741-2; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sostres C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4175; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wobst I, 2008, BIOCHEM PHARMACOL, V76, P62, DOI 10.1016/j.bcp.2008.04.008; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang YW, 2015, IMMUNITY, V42, P953, DOI 10.1016/j.immuni.2015.04.016	51	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5295	5306		10.1074/jbc.RA118.001593	http://dx.doi.org/10.1074/jbc.RA118.001593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440395	hybrid, Green Published			2022-12-28	WOS:000429409300033
J	Saladi, SM; Javed, N; Muller, A; Clemons, WM				Saladi, Shyam M.; Javed, Nauman; Muller, Axel; Clemons, William M., Jr.			A statistical model for improved membrane protein expression using sequence-derived features	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; STRUCTURAL GENOMICS; MOLECULAR-BIOLOGY; COUPLED RECEPTOR; DATABASE; PREDICTION; TOPOLOGY; CLONING; STABILITY	The heterologous expression of integral membrane proteins (IMPs) remains a major bottleneck in the characterization of this important protein class. IMP expression levels are currently unpredictable, which renders the pursuit of IMPs for structural and biophysical characterization challenging and inefficient. Experimental evidence demonstrates that changes within the nucleotide or amino acid sequence for a given IMP can dramatically affect expression levels, yet these observations have not resulted in generalizable approaches to improve expression levels. Here, we develop a data-driven statistical predictor named IMProve that, using only sequence information, increases the likelihood of selecting an IMP that expresses in Escherichia coli. The IMProve model, trained on experimental data, combines a set of sequence-derived features resulting in an IMProve score, where higher values have a higher probability of success. The model is rigorously validated against a variety of independent data sets that contain a wide range of experimental outcomes from various IMP expression trials. The results demonstrate that use of the model can more than double the number of successfully expressed targets at any experimental scale. IMProve can immediately be used to identify favorable targets for characterization. Most notably, IMProve demonstrates for the first time that IMP expression levels can be predicted directly from sequence.	[Saladi, Shyam M.; Javed, Nauman; Muller, Axel; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009; Saladi, Shyam/B-7307-2016	Clemons, William M/0000-0002-0021-889X; Saladi, Shyam/0000-0001-9701-3059	National Science Foundation [ACI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM125063, DP1GM105385] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Daniel Daley and Thomas Miller's group for discussion, Yaser Abu-Mostafa and Yisong Yue for guidance regarding machine learning, Niles Pierce for providing NUPACK source code (33), Welison Floriano and Naveed Near-Ansari for maintaining local computing resources, and Samuel Schulte for suggesting the model's name. We thank Michiel Niesen, Stephen Marshall, Thomas Miller, Reid van Lehn, James Bowie, and Tom Rapoport for comments on the manuscript. Models and analyses were possible thanks to raw experimental data provided by Daniel Daley and Mikaela Rapp (20); Nir Fluman (29); Edda Kloppmann, Brian Kloss, and Marco Punta from NYCOMPS (2, 3); Pikyee Ma (46); Renaud Wagner (49); Florent Bernaudat (53); and Constance Jeffrey (47). Computational time was provided by Stephen Mayo and Douglas Rees. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575 (108).	Aho K., 2015, ASBIO COLLECTION STA; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bache S.M., 2020, MAGRITTR FORWARD PIP; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bertone P, 2001, NUCLEIC ACIDS RES, V29, P2884, DOI 10.1093/nar/29.13.2884; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Canty A., 2015, BOOT BOOTSTRAP R S P; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Clarke E., 2015, GGBEESWARM CATEGORIC; Cock P., 2009, DOWNLOADING CDS SEQU; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dobrovetsky Elena, 2005, Journal of Structural and Functional Genomics, V6, P33, DOI 10.1007/s10969-005-1363-5; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Garnier S, 2016, VIRIDIS DEFAULT COLO; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Hendrickson WA, 2016, NAT STRUCT MOL BIOL, V23, P464, DOI 10.1038/nsmb.3215; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Jahandideh S, 2014, ACTA CRYSTALLOGR D, V70, P627, DOI 10.1107/S1399004713032070; Joachims T., 2002, P 8 ACM SIGKDD INT C, P133, DOI [10.1145/775047.775067, DOI 10.1145/775047.775067]; Johansson LC, 2017, TRENDS BIOCHEM SCI, V42, P749, DOI 10.1016/j.tibs.2017.06.007; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lechat P, 2008, NUCLEIC ACIDS RES, V36, pD469, DOI 10.1093/nar/gkm1042; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Ma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076913; Madhavan V, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-83; Marshall SS, 2016, CELL REP, V16, P2169, DOI 10.1016/j.celrep.2016.07.042; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Mirzadeh K, 2015, ACS SYNTH BIOL, V4, P959, DOI 10.1021/acssynbio.5b00033; Nannenga BL, 2016, CURR OPIN STRUC BIOL, V40, P128, DOI 10.1016/j.sbi.2016.09.007; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Neuwirth Erich, 2014, CRAN; Niesen MJM, 2017, J BIOL CHEM, V292, P19537, DOI 10.1074/jbc.M117.813469; Norholm MHH, 2013, FEBS LETT, V587, P2352, DOI 10.1016/j.febslet.2013.05.063; Norholm MHH, 2012, BBA-BIOMEMBRANES, V1818, P1091, DOI 10.1016/j.bbamem.2011.08.018; Peden JF., 2000, THESIS U NOTTINGHAM, V90, P73; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Psakis G, 2007, PROTEIN SCI, V16, P2667, DOI 10.1110/ps.073104707; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; R Development Core Team, 2009, R LANG ENV STAT COMP; Reis A. C., 2017, BIORXIV; Revolution Analytics and Weston S., 2015, IT PROV IT CONSTR R; Revolution Analytics and Weston S., 2015, FOR PROV FOR LOOP CO; Revolution Analytics and Weston S., 2015, DOMC FOR PAR AD PAR; Revolution Analytics and Weston S., 2015, DOPARALLEL FOR PAR A; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; RStudio Team, 2015, RSTUDIO INT DEV R; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Schloerke B., 2016, GGALLY EXTENSION GGP; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuler GD, 1996, METHOD ENZYMOL, V266, P141; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Szakonyi G, 2007, J ANTIMICROB CHEMOTH, V59, P1265, DOI 10.1093/jac/dkm036; Tange O, 2011, USENIX MAG, V36, P42; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tsochantaridis I, 2005, J MACH LEARN RES, V6, P1453; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; vanRossum G., 1995, PYTHON REFERENCE MAN, pR9525; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wang HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21383; Weihs C, 2005, ST CLASS DAT ANAL, P335; Weinert K., 2014, DATAMART UNIFIED ACC; Wickham H., 2015, DPLYR GRAMMAR DATA M; Wickham H., 2015, SCALES SCALE FUNCTIO; Wickham H., MULTIDPLYR PARTITION; Wickham H., 2015, ROXYGEN2 IN SOURCE D; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilke C. O., 2015, COWPLOT STREAMLINED; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Xie Y., 2014, IMPLEMENTING REPRODU; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	108	8	10	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4913	4927		10.1074/jbc.RA117.001052	http://dx.doi.org/10.1074/jbc.RA117.001052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378850	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000428848300030
J	Soond, SM; Townsend, PA; Barry, SP; Knight, RA; Latchman, DS; Stephanou, A				Soond, Surinder M.; Townsend, Paul A.; Barry, Sean P.; Knight, Richard A.; Latchman, David S.; Stephanou, Anastasis			RETRACTION: ERK and the F-box protein beta TRCP target STAT1 for degradation (Retraction of Vol 283, Pg 16077, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Townsend, Paul/AAF-8234-2020	Townsend, Paul/0000-0001-8956-9508				Soond SM, 2008, J BIOL CHEM, V283, P16077, DOI 10.1074/jbc.M800384200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4954	4954		10.1074/jbc.W118.002740	http://dx.doi.org/10.1074/jbc.W118.002740			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602881	hybrid, Green Published			2022-12-28	WOS:000428848300035
J	Soudahome, AG; Catan, A; Giraud, P; Kouao, SA; Guerin-Dubourg, A; Debussche, X; Le Moullec, N; Bourdon, E; Bravo, SB; Paradela-Dobarro, B; Alvarez, E; Meilhac, O; Rondeau, P; Couprie, J				Soudahome, Angelique Gajahi; Catan, Aurelie; Giraud, Pierre; Kouao, Sandrine Assouan; Guerin-Dubourg, Alexis; Debussche, Xavier; Le Moullec, Nathalie; Bourdon, Emmanuel; Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel; Meilhac, Olivier; Rondeau, Philippe; Couprie, Joel			Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC BINDING; FATTY-ACIDS; NONENZYMATIC GLYCOSYLATION; CRYSTAL-STRUCTURE; FLUORINE-NMR; CO-BINDING; INSULIN; METHYLGLYOXAL; CONFORMATION; PANCREATITIS	The long-acting glucagon-like peptide-1 analogue liraglutide has proven efficiency in the management of type 2 diabetes and also has beneficial effects on cardiovascular diseases. Liraglutide's protracted action highly depends on its capacity to bind to albumin via its palmitic acid part. However, in diabetes, albumin can undergo glycation, resulting in impaired drug binding. Our objective in this study was to assess the impact of human serum albumin (HSA) glycation on liraglutide affinity. Using fluorine labeling of the drug and F-19 NMR, we determined HSA affinity for liraglutide in two glycated albumin models. We either glycated HSA in vitro by incubation with glucose (G25- or G100-HSA) or methylglyoxal (MGO-HSA) or purified in vivo glycated HSA from the plasma of diabetic patients with poor glycemic control. Nonglycated commercial HSA (G0-HSA) and HSA purified from plasma of healthy individuals served as controls. We found that glycation decreases affinity for liraglutide by 7-fold for G100-HSA and by 5-fold for MGO-HSA compared with G0-HSA. A similarly reduced affinity was observed for HSA purified from diabetic individuals compared with HSA from healthy individuals. Our results reveal that glycation significantly impairs HSA affinity to liraglutide and confirm that glycation contributes to liraglutide's variable therapeutic efficiency, depending on diabetes stage. Because diabetes is a progressive disease, the effect of glycated albumin on liraglutide affinity found here is important to consider when diabetes is managed with this drug.	[Soudahome, Angelique Gajahi; Catan, Aurelie; Giraud, Pierre; Kouao, Sandrine Assouan; Bourdon, Emmanuel; Meilhac, Olivier; Rondeau, Philippe; Couprie, Joel] Univ La Reunion, INSERM, UMR Diabet Atherothrombose Therapie Reun Ocean In, F-97490 St Denis, La Reunion, France; [Guerin-Dubourg, Alexis] Ctr Hosp Gabriel Martin, Serv Cardiol & Biol, F-97866 St Paul, France; [Debussche, Xavier; Le Moullec, Nathalie] CHU La Reunion, Serv Endocrinol Nutr & Diabetol, F-97400 St Denis, La Reunion, France; [Debussche, Xavier; Le Moullec, Nathalie] CIC1410 INSERM, F-97448 St Pierre, Reunion, France; [Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] Hosp Clin Univ Santiago, Prote Unit, Santiago De Compostela 15706, Spain; [Bravo, Susana B.; Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] Hosp Clin Univ Santiago, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela 15706, Spain; [Paradela-Dobarro, Beatriz; Alvarez, Ezequiel] CIBERCV, Av Monforte de Lemos,3-5,Pabellon 11,Planta 0, Madrid 28029, Spain; [Meilhac, Olivier] CHU La Reunion, Ctr Invest Clin, F-97448 St Pierre, Reunion, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rondeau, P; Couprie, J (corresponding author), Univ La Reunion Plateforme CYROI, UMR DeTROI INSERM 1188, 2 Rue Maxime Riviere, F-97490 St Clotilde, France.	rophil@univ-reunion.fr; joel.couprie@univ-reunion.fr	rondeau, philippe/Q-1967-2019; Meilhac, Olivier/N-4385-2017; Bourdon, Emmanuel/P-8455-2019; Debussche, Xavier/S-8185-2016; Alvarez, Ezequiel/D-8822-2011; Lopez, Susana Belén Bravo/F-8487-2016	rondeau, philippe/0000-0002-4652-1376; Debussche, Xavier/0000-0003-3087-4297; Alvarez, Ezequiel/0000-0002-2381-8425; Lopez, Susana Belén Bravo/0000-0001-7615-3079; Bourdon, Emmanuel/0000-0003-3731-150X; Meilhac, Olivier/0000-0002-3740-7539; COUPRIE, Joel/0000-0002-1212-6773	Ministere de l'Enseignement Superieur et de la Recherche; Ministere de l'Outre-Mer; Conseil Regional de La Reunion; Universite de La Reunion; Federation Environnement Biodiversite Sante [FED4126]; regional council of La Reunion et l'Europe	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Ministere de l'Outre-Mer; Conseil Regional de La Reunion; Universite de La Reunion; Federation Environnement Biodiversite Sante; regional council of La Reunion et l'Europe	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Ministere de l'Outre-Mer, the Conseil Regional de La Reunion and Europe, the Universite de La Reunion, and the Federation Environnement Biodiversite Sante-FED4126. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the regional council of La Reunion et l'Europe.	Abou-Zied OK, 2015, CURR PHARM DESIGN, V21, P1800, DOI 10.2174/1381612821666150304163447; Alves C, 2012, DIABETES RES CLIN PR, V98, P271, DOI 10.1016/j.diabres.2012.09.008; Anguizola J, 2016, J CHROMATOGR B, V1021, P175, DOI 10.1016/j.jchromb.2015.09.041; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; Anguizola JA, 2013, CURR METABOL, V1, P241, DOI 10.2174/2213235X1130100005; Arntson KE, 2016, J MED CHEM, V59, P5158, DOI 10.1021/acs.jmedchem.5b01447; Bai X, 2012, MOLECULES, V17, P8782, DOI 10.3390/molecules17088782; Baraka-Vidot J., 2015, INT J DIABETES CLIN, V2, P109, DOI DOI 10.15344/2394-1499/2015/109; Baraka-Vidot J, 2012, BIOCHIMIE, V94, P1960, DOI 10.1016/j.biochi.2012.05.017; BERDE CB, 1979, J BIOL CHEM, V254, P391; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bisgaard LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168396; Bode B, 2012, DIABETES RES CLIN PR, V97, P27, DOI 10.1016/j.diabres.2011.12.015; Bouchi R, 2017, ENDOCR J, V64, P269, DOI 10.1507/endocrj.EJ16-0449; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Cao BL, 2003, BIOORGAN MED CHEM, V11, P69, DOI 10.1016/S0968-0896(02)00324-3; Chalmer T, 2015, EXPERT OPIN DRUG SAF, V14, P171, DOI 10.1517/14740338.2015.975205; Cho HJ, 2007, PHARMACOGENOMICS, V8, P329, DOI 10.2217/14622416.8.4.329; Dalvit C, 2003, J AM CHEM SOC, V125, P7696, DOI 10.1021/ja034646d; Digilio G, 2014, EUR J MED CHEM, V79, P13, DOI 10.1016/j.ejmech.2014.03.064; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Frederiksen TM, 2015, BIOPHYS J, V109, P1202, DOI 10.1016/j.bpj.2015.07.051; GARLICK RL, 1983, J BIOL CHEM, V258, P6142; Gerig J. T., 2001, FLUORINE NMR; Gupta Vishal, 2013, Indian J Endocrinol Metab, V17, P413, DOI 10.4103/2230-8210.111625; Iacobellis G, 2017, OBESITY, V25, P311, DOI 10.1002/oby.21718; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; JENKINS BG, 1991, LIFE SCI, V48, P1227, DOI 10.1016/0024-3205(91)90517-F; JENKINS BG, 1990, MOL PHARMACOL, V37, P111; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Jonas DE, 2009, TRENDS PHARMACOL SCI, V30, P375, DOI 10.1016/j.tips.2009.05.001; Jovanovic VB, 2013, ANAL BIOCHEM, V439, P17, DOI 10.1016/j.ab.2013.03.033; Kitamura K, 2007, ANAL BIOANAL CHEM, V387, P2843, DOI 10.1007/s00216-007-1162-x; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Kong X, 2014, J DIABETES, V6, P535, DOI 10.1111/1753-0407.12160; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18039; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Mera K, 2008, ANN NY ACAD SCI, V1126, P155, DOI 10.1196/annals.1433.000; Raya PM, 2014, ENDOCRINOL NUTR, V61, P202, DOI 10.1016/j.endonu.2013.09.001; Paradela-Dobarro B, 2016, J MOL ENDOCRINOL, V56, P23, DOI 10.1530/JME-15-0031; Patche J, 2017, FREE RADICAL BIO MED, V102, P133, DOI 10.1016/j.freeradbiomed.2016.11.026; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Peters KR, 2013, AM J THER, V20, P178, DOI 10.1097/MJT.0b013e3182204c16; Peterson GE, 2010, INT J CLIN PRACT, V64, P35, DOI 10.1111/j.1742-1241.2010.02498.x; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Rehman MT, 2014, MOL PHARMACEUT, V11, P1785, DOI 10.1021/mp500116c; Rondeau P, 2008, FREE RADICAL BIO MED, V45, P799, DOI 10.1016/j.freeradbiomed.2008.06.004; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Ryan GJ, 2011, CLIN THER, V33, P793, DOI 10.1016/j.clinthera.2011.06.004; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Shikii K, 2004, ANAL SCI, V20, P1475, DOI 10.2116/analsci.20.1475; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Sonderby P., 2016, THESIS; Song SO, 2015, DIABETES THER, V6, P547, DOI 10.1007/s13300-015-0140-0; Steensgaard DB, 2008, DIABETES, V57, pA164; Suji G, 2008, PROTEIN J, V27, P205, DOI 10.1007/s10930-008-9126-3; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Verdier L, 2000, J CHEM SOC PERK T 2, P2363, DOI 10.1039/b007666j; Vlassara H, 1996, DIABETES, V45, pS65, DOI 10.2337/diab.45.3.S65; Wang Y, 2015, MOL PHARMACEUT, V12, P411, DOI 10.1021/mp500519s; Whittingham JL, 1997, BIOCHEMISTRY-US, V36, P2826, DOI 10.1021/bi9625105; Wu D, 2016, J PHARMACEUT BIOMED, V129, P15, DOI 10.1016/j.jpba.2016.06.034; Yamazaki E, 2005, J BIOSCIENCES, V30, P475, DOI 10.1007/BF02703721; Zhuang JQ, 2013, AAPS J, V15, P477, DOI 10.1208/s12248-013-9455-9	70	14	14	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4778	4791		10.1074/jbc.M117.815274	http://dx.doi.org/10.1074/jbc.M117.815274			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414771	Green Published, hybrid			2022-12-28	WOS:000428848300019
J	Christenson, ET; Gallegos, AS; Banerjee, A				Christenson, Eric T.; Gallegos, Austin S.; Banerjee, Anirban			In vitro reconstitution, functional dissection, and mutational analysis of metal ion transport by mitoferrin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CARRIERS; IRON TRANSPORT; YEAST; SUBSTRATE; MEMBRANE; PROTEINS; TRAFFICKING; SELECTIVITY; INTEGRATION; MECHANISMS	Iron is universally important to cellular metabolism, and mitoferrin-1 and -2 have been proposed to be the iron importers of mitochondria, the cell's assembly plant of heme and iron-sulfur clusters. These iron-containing prosthetic groups are critical for a host of physiological processes ranging from oxygen transport and energy consumption to maintaining protein structural integrity. Mitoferrin-1 (Mfrn1) belongs to the mitochondrial carrier (MC) family and is atypical given its putative metallic cargo; most MCs transport nucleotides, amino acids, or other small- to medium-size metabolites. Despite the clear importance of Mfrn1 in iron utilization, its transport activity has not been demonstrated unambiguously. To bridge this knowledge gap, we have purified recombinant Mfrn1 under non-denaturing conditions and probed its metal ion-binding and transport functions. Isothermal titration calorimetry indicates that Mfrn1 has micromolar affinity for Fe(II), Mn(II), Co(II), and Ni(II). Mfrn1 was incorporated into defined liposomes, and iron transport was reconstituted in vitro, demonstrating that Mfrn1 can transport iron. Mfrn1 can also transport manganese, cobalt, copper, and zinc but discriminates against nickel. Experiments with candidate ligands for cellular labile iron reveal that Mfrn1 transports free iron and not a chelated iron complex and selects against alkali divalent ions. Extensive mutagenesis identified multiple residues that are crucial for metal binding, transport activity, or both. There is a clear abundance of residues with side chains that can coordinate first-row transition metal ions, suggesting that these could form primary or auxiliary metal-binding sites during the transport process.	[Christenson, Eric T.; Gallegos, Austin S.; Banerjee, Anirban] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Struct & Chem Biol Membrane Prot, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Banerjee, A (corresponding author), NIH, Cell Biol & Neurobiol Branch, 35 Convent Dr,MSC 3758, Bethesda, MD 20892 USA.	anirban.banerjee@nih.gov	Banerjee, Anirban/AAC-4286-2020	Banerjee, Anirban/0000-0002-9314-2862; banerjee, anirban/0000-0003-1494-6801; Christenson, Eric/0000-0001-7463-7694	National Institutes of Health Intramural Research Program [ZIA HD008928-04]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008928] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Intramural Research Program Grant ZIA HD008928-04 and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreini C, 2009, J MOL BIOL, V388, P356, DOI 10.1016/j.jmb.2009.02.052; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brazzolotto X, 2014, BIOCHEM J, V460, P79, DOI 10.1042/BJ20140107; Bruschweiler S, 2015, NAT STRUCT MOL BIOL, V22, P636, DOI 10.1038/nsmb.3059; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Cheng ZY, 2007, CHEM REV, V107, P748, DOI 10.1021/cr040077w; Crichton PG, 2015, J BIOL CHEM, V290, P8206, DOI 10.1074/jbc.M114.616607; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Ferreira CMH, 2015, RSC ADV, V5, P30989, DOI 10.1039/c4ra15453c; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; Hider RC, 2013, DALTON T, V42, P3220, DOI 10.1039/c2dt32149a; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; King MS, 2016, BBA-BIOENERGETICS, V1857, P14, DOI 10.1016/j.bbabio.2015.09.013; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Monne M, 2013, MOL MEMBR BIOL, V30, P149, DOI 10.3109/09687688.2012.737936; Muhlenhoff U, 2015, EUR J CELL BIOL, V94, P292, DOI 10.1016/j.ejcb.2015.05.003; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Rouault TA, 2016, CURR OPIN GENET DEV, V38, P31, DOI 10.1016/j.gde.2016.02.004; Run CQ, 2015, STRUCTURE, V23, P1394, DOI 10.1016/j.str.2015.06.004; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sounier R, 2015, ANGEW CHEM INT EDIT, V54, P2436, DOI 10.1002/anie.201408417; Tadolini B, 1987, Free Radic Res Commun, V4, P149, DOI 10.3109/10715768709088100; Taniguchi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9545; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Whittaker MM, 2015, ARCH BIOCHEM BIOPHYS, V568, P64, DOI 10.1016/j.abb.2015.01.021; WIESENBERGER G, 1991, J MOL BIOL, V217, P23, DOI 10.1016/0022-2836(91)90608-9; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	53	30	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3819	3828		10.1074/jbc.M117.817478	http://dx.doi.org/10.1074/jbc.M117.817478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29305420	hybrid, Green Published			2022-12-28	WOS:000427030200033
J	Gao, L; Ji, Y; Lu, Y; Qiu, M; Shen, YJ; Wang, YQ; Kong, XQ; Shao, YF; Sheng, YH; Sun, W				Gao, Li; Ji, Yue; Lu, Yan; Qiu, Ming; Shen, Yejiao; Wang, Yaqing; Kong, Xiangqing; Shao, Yongfeng; Sheng, Yanhui; Sun, Wei			Low-level overexpression of p53 promotes warfarin-induced calcification of porcine aortic valve interstitial cells by activating Slug gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED VASCULAR CALCIFICATION; MATRIX GLA-PROTEIN; OSTEOBLAST MATURATION; SKELETAL DEVELOPMENT; HEART-VALVES; STEM-CELLS; RUNX2; DIFFERENTIATION; EXPRESSION; DISEASE	The most frequently used oral anti-coagulant warfarin has been implicated in inducing calcification of aortic valve interstitial cells (AVICs), whereas the mechanism is not fully understood. The low-level activation of p53 is found to be involved in osteogenic transdifferentiation and calcification of AVICs. Whether p53 participates in warfarin-induced AVIC calcification remains unknown. In this study, we investigated the role of low-level p53 overexpression in warfarin-induced porcine AVIC (pAVIC) calcification. Immunostaining, quantitative PCR, and Western blotting revealed that p53 was expressed in human and pAVICs and that p53 expression was slightly increased in calcific human aortic valves compared with non-calcific valves. Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling staining indicated that apoptosis slightly increased in calcific aortic valves than in non-calcific valves. Warfarin treatment led to a low-level increase of p53 mRNA and protein in both pAVICs and mouse aortic valves. Low-level overexpression of p53 in pAVICs via an adenovirus vector did not affect pAVIC apoptosis but promoted warfarin-induced calcium deposition and expression of osteogenic markers. shRNA-mediated p53 knockdown attenuated the pAVIC calcium deposition and osteogenic marker expression. Moreover, ChIP and luciferase assays showed that p53 was recruited to the slug promoter and activated slug expression in calcific pAVICs. Of note, overexpression of Slug increased osteogenic marker Runx2 expression, but not pAVIC calcium deposition, and Slug knockdown attenuated pAVIC calcification and p53-mediated pAVIC calcium deposition and expression of osteogenic markers. In conclusion, we found that p53 plays an important role in warfarin induced pAVIC calcification, and increased slug transcription by p53 is required for p53-mediated pAVIC calcification.	[Gao, Li; Ji, Yue; Lu, Yan; Qiu, Ming; Shen, Yejiao; Wang, Yaqing; Kong, Xiangqing; Sheng, Yanhui; Sun, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Shao, Yongfeng] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing 210029, Jiangsu, Peoples R China; [Kong, Xiangqing; Sun, Wei] Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sheng, YH; Sun, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	yhsheng@njmu.edu.cn; weisun7919@njmu.edu.cn		Sun, Wei/0000-0003-0833-0445	National Natural Science Foundation of China [81570247, 81627802, 81401121]; Natural Science Foundation of Jiangsu Province for Youth Grant [BK20141024]; Jiangsu Province Six Talent Peaks Project [2015-WSN-29]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province for Youth Grant(Natural Science Foundation of Jiangsu Province); Jiangsu Province Six Talent Peaks Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81570247, 81627802, and 81401121; Natural Science Foundation of Jiangsu Province for Youth Grant BK20141024; Jiangsu Province Six Talent Peaks Project Grant 2015-WSN-29; and funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Azechi T, 2013, J ATHEROSCLER THROMB, V20, P538, DOI 10.5551/jat.15826; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Hadji F, 2016, CIRCULATION, V134, P1848, DOI 10.1161/CIRCULATIONAHA.116.023116; Holden RM, 2007, J NEPHROL, V20, P417; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Koos R, 2005, AM J CARDIOL, V96, P747, DOI 10.1016/j.amjcard.2005.05.014; Koos R, 2009, THROMB HAEMOSTASIS, V101, P706, DOI 10.1160/TH08-09-0611; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Lambertini E, 2009, CELL MOL LIFE SCI, V66, P3641, DOI 10.1007/s00018-009-0149-5; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Li KL, 2012, CARDIOVASC J AFR, V23, pE1, DOI 10.5830/CVJA-2011-069; Li SJ, 2017, INT J CARDIOL, V232, P271, DOI 10.1016/j.ijcard.2017.01.005; Liu HJ, 2010, J CELL BIOCHEM, V111, P529, DOI 10.1002/jcb.22749; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Prives C, 1999, J PATHOL, V187, P112; Raaz U, 2015, CIRC RES, V117, P513, DOI 10.1161/CIRCRESAHA.115.306341; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Suliman Y, 2001, CANCER RES, V61, P6467; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Taylor PM, 2000, J HEART VALVE DIS, V9, P150; Torreggiani E, 2012, J CELL MOL MED, V16, P740, DOI 10.1111/j.1582-4934.2011.01352.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	40	9	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3780	3792		10.1074/jbc.M117.791145	http://dx.doi.org/10.1074/jbc.M117.791145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358327	Green Published, hybrid			2022-12-28	WOS:000427030200030
J	Manav, MC; Beljantseva, J; Bojer, MS; Tenson, T; Ingmer, H; Hauryliuk, V; Brodersen, DE				Manav, Melek Cemre; Beljantseva, Jelena; Bojer, Martin S.; Tenson, Tanel; Ingmer, Hanne; Hauryliuk, Vasili; Brodersen, Ditlev E.			Structural basis for (p)ppGpp synthesis by the Staphylococcus aureus small alarmone synthetase RelP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; RIBONUCLEIC-ACID; PROTEIN; METABOLISM; SYSTEM; ENZYME	The stringent response is a global reprogramming of bacterial physiology that renders cells more tolerant to antibiotics and induces virulence gene expression in pathogens in response to stress. This process is driven by accumulation of the intracellular alarmone guanosine-5'-di(tri)phosphate-3'-diphosphate ((p)ppGpp), which is produced by enzymes of the RelA SpoT homologue (RSH) family. The Gram-positive Firmicute pathogen, Staphylococcus aureus, encodes three RSH enzymes: a multidomain RSH (Rel) that senses amino acid starvation on the ribosome and two small alarmone synthetase (SAS) enzymes, RelQ (SAS1) and RelP (SAS2). In Bacillus subtilis, RelQ (SAS1) was shown to form a tetramer that is activated by pppGpp and inhibited by single-stranded RNA, but the structural and functional regulation of RelP (SAS2) is unexplored. Here, we present crystal structures of S. aureus RelP in two major functional states, pre-catalytic (bound to GTP and the non-hydrolyzable ATP analogue, adenosine 5'-(alpha,beta-methylene) triphosphate (AMP-CPP)), and post-catalytic (bound to pppGpp). We observed that RelP also forms a tetramer, but unlike RelQ (SAS1), it is strongly inhibited by both pppGpp and ppGpp and is insensitive to inhibition by RNA. We also identified putative metal ion-binding sites at the subunit interfaces that were consistent with the observed activation of the enzyme by Zn2+ ions. The structures reported here reveal the details of the catalytic mechanism of SAS enzymes and provide a molecular basis for understanding differential regulation of SAS enzymes in Firmicute bacteria.	[Manav, Melek Cemre; Brodersen, Ditlev E.] Ctr Bacterial Stress Response & Persistence, Dept Mol Biol & Genet, Gustav Wieds Vej 10c, DK-8000 Aarhus C, Denmark; [Beljantseva, Jelena; Tenson, Tanel; Hauryliuk, Vasili] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia; [Bojer, Martin S.; Ingmer, Hanne] Univ Copenhagen, Dept Vet & Anim Sci, DK-1870 Frederiksberg C, Denmark; [Hauryliuk, Vasili] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hauryliuk, Vasili] Umea Univ, Lab Mol Infect Med Sweden MIMS, SE-90187 Umea, Sweden	University of Tartu; University of Copenhagen; Umea University; Umea University	Brodersen, DE (corresponding author), Ctr Bacterial Stress Response & Persistence, Dept Mol Biol & Genet, Gustav Wieds Vej 10c, DK-8000 Aarhus C, Denmark.	deb@mbg.au.dk	Hauryliuk, Vasili/J-3930-2019; Brodersen, Ditlev E./AAQ-5241-2020; Tenson, Tanel/I-6431-2015	Hauryliuk, Vasili/0000-0003-2389-5057; Ingmer, Hanne/0000-0002-8350-5631; Manav, M. Cemre/0000-0003-3540-2803; Bojer, Martin Saxtorph/0000-0002-8488-9593; Tenson, Tanel/0000-0002-0260-3601; Brodersen, Ditlev/0000-0002-5413-4667	Danish National Research Foundation [DNRF120]; Estonian Research Council [IUT2-22]; European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology; Swedish Research Council Vetenskapsradet [2013-4680]; Ragnar Soderberg foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Estonian Research Council(Estonian Research Council); European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology; Swedish Research Council Vetenskapsradet(Swedish Research Council); Ragnar Soderberg foundation	This work was supported by Danish National Research Foundation Grant DNRF120 (to D.E.B.), Estonian Research Council Grant IUT2-22 (to T.T.), the European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology (to V.H. and T.T.), Swedish Research Council Vetenskapsradet Grant 2013-4680 (to V.H.), and the Ragnar Soderberg foundation (to V.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Arenz S, 2016, NUCLEIC ACIDS RES, V44, P6471, DOI 10.1093/nar/gkw470; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Beljantseva J, 2017, P NATL ACAD SCI USA, V114, P3726, DOI 10.1073/pnas.1617868114; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Brown A, 2016, NATURE, V534, P277, DOI 10.1038/nature17675; CASHEL M, 1970, J BIOL CHEM, V245, P2309; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedman YE, 2004, J BIOL CHEM, V279, P32100, DOI 10.1074/jbc.M404924200; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Harms A, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4268; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laitaoja M, 2013, INORG CHEM, V52, P10983, DOI 10.1021/ic401072d; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Loveland AB, 2016, ELIFE, V5, DOI 10.7554/eLife.17029; Luche S, 2016, J PROTEOMICS, V135, P170, DOI 10.1016/j.jprot.2015.07.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shyp V, 2012, EMBO REP, V13, P835, DOI 10.1038/embor.2012.106; Steinchen W, 2015, P NATL ACAD SCI USA, V112, P13348, DOI 10.1073/pnas.1505271112; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	32	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3254	3264		10.1074/jbc.RA117.001374	http://dx.doi.org/10.1074/jbc.RA117.001374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326162	Green Published, hybrid			2022-12-28	WOS:000426562800019
J	Augustin, P; Toplak, M; Fuchs, K; Gerstmann, EC; Prassl, R; Winkler, A; Macheroux, P				Augustin, Peter; Toplak, Marina; Fuchs, Katharina; Gerstmann, Eva Christine; Prassl, Ruth; Winkler, Andreas; Macheroux, Peter			Oxidation of the FAD cofactor to the 8-formyl-derivative in human electron-transferring flavoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE FAD; ACYL-COA DEHYDROGENASES; FORMATE OXIDASE; CRESOL METHYLHYDROXYLASE; LIVER MITOCHONDRIA; PSEUDOMONAS-PUTIDA; MEDIUM-CHAIN; FLAVIN; EXPRESSION; ENZYME	The heterodimeric human (h) electron-transferring flavoprotein (ETF) transfers electrons from at least 13 different flavin dehydrogenases to the mitochondrial respiratory chain through a non-covalently bound FAD cofactor. Here, we describe the discovery of an irreversible and pH-dependent oxidation of the 8 alpha-methyl group to 8-formyl-FAD (8f-FAD), which represents a unique chemical modification of a flavin cofactor in the human flavoproteome. Furthermore, a set of hETF variants revealed that several conserved amino acid residues in the FAD-binding pocket of electron-transferring flavoproteins are required for the conversion to the formyl group. Two of the variants generated in our study, namely alpha R249C and alpha T266M, cause glutaric aciduria type II, a severe inherited disease. Both of the variants showed impaired formation of 8f-FAD shedding new light on the potential molecular cause of disease development. Interestingly, the conversion of FAD to 8f-FAD yields a very stable flavin semiquinone that exhibited slightly lower rates of electron transfer in an artificial assay system than hETF containing FAD. In contrast, the formation of 8f-FAD enhanced the affinity to human dimethylglycine dehydrogenase 5-fold, indicating that formation of 8f-FAD modulates the interaction of hETF with client enzymes in the mitochondrial matrix. Thus, we hypothesize that the FAD cofactor bound to hETF is subject to oxidation in the alkaline (pH 8) environment of the mitochondrial matrix, which may modulate electron transport between client dehydrogenases and the respiratory chain. This discovery challenges the current concepts of electron transfer processes in mitochondria.	[Augustin, Peter; Toplak, Marina; Fuchs, Katharina; Gerstmann, Eva Christine; Winkler, Andreas; Macheroux, Peter] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Prassl, Ruth] Med Univ Graz, Inst Biophys, Neue Stiftingtalstr 6-4, A-8010 Graz, Austria	Graz University of Technology; Medical University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Prassl, Ruth/AAE-1523-2021; Macheroux, Peter/AAB-5157-2019	Macheroux, Peter/0000-0002-0242-454X; Toplak, Marina/0000-0003-2581-9082; Winkler, Andreas/0000-0001-6221-9671	Austrian Science Fund (FWF) Doctoral Program "Molecular Enzymology" [W901]	Austrian Science Fund (FWF) Doctoral Program "Molecular Enzymology"(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Doctoral Program "Molecular Enzymology" W901 (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Augustin P, 2016, FEBS J, V283, P3587, DOI 10.1111/febs.13828; Bross P, 1999, MOL GENET METAB, V67, P138, DOI 10.1006/mgme.1999.2856; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; CHRISTENSEN E, 1984, PEDIATR RES, V18, P663, DOI 10.1203/00006450-198407000-00020; CRANE FL, 1956, J BIOL CHEM, V218, P701; Doubayashi D, 2011, BIOSCI BIOTECH BIOCH, V75, P1662, DOI 10.1271/bbb.110153; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; EDMONDSON DE, 1974, BIOCHEMISTRY-US, V13, P2817, DOI 10.1021/bi00711a006; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Frerman FE, 2001, METABOLIC MOL BASES, V8, P2357; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; HARE JF, 1982, J BIOL CHEM, V257, P2950; HERRICK KR, 1994, J BIOL CHEM, V269, P32239; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; Jhulki I, 2016, J AM CHEM SOC, V138, P8324, DOI 10.1021/jacs.6b02469; KIM JH, 1994, J BACTERIOL, V176, P6349, DOI 10.1128/jb.176.20.6349-6361.1994; Konjik V, 2017, ANGEW CHEM INT EDIT, V56, P1146, DOI 10.1002/anie.201610292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN TC, 1992, ARCH BIOCHEM BIOPHYS, V292, P594, DOI 10.1016/0003-9861(92)90036-V; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Macheroux P, 1999, METH MOL B, V131, P1; Maeda Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2645, DOI 10.1271/bbb.90497; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MCINTIRE W, 1981, BIOCHEMISTRY-US, V20, P3068, DOI 10.1021/bi00514a013; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; OKAMURAIKEDA K, 1985, J BIOL CHEM, V260, P1338; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; REEVE CD, 1989, BIOCHEM J, V263, P431, DOI 10.1042/bj2630431; Robbins JM, 2017, BIOCHEMISTRY-US, V56, P3800, DOI 10.1021/acs.biochem.7b00335; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009; Schleicher E, 2009, FEBS J, V276, P4290, DOI 10.1111/j.1742-4658.2009.07141.x; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; Yorita K, 2000, P NATL ACAD SCI USA, V97, P13039, DOI 10.1073/pnas.250472297	37	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2829	2840		10.1074/jbc.RA117.000846	http://dx.doi.org/10.1074/jbc.RA117.000846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29301933	hybrid, Green Published			2022-12-28	WOS:000426051900018
J	McMillan, EA; Longo, SM; Smith, MD; Broskin, S; Lin, BC; Singh, NK; Strochlic, TI				McMillan, Emily A.; Longo, Sheila M.; Smith, Michael D.; Broskin, Sarah; Lin, Baicheng; Singh, Nisha K.; Strochlic, Todd I.			The protein kinase CK2 substrate Jabba modulates lipid metabolism during Drosophila oogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; CATALYTIC-SUBUNIT; EMBRYONIC-DEVELOPMENT; ENERGY-METABOLISM; CELL-SURVIVAL; MICE LACKING; PERILIPIN-A; DROPLETS; PHOSPHORYLATION; LOCALIZATION	Lipid metabolism plays a critical role in female reproduction. During oogenesis, maturing oocytes accumulate high levels of neutral lipids that are essential for both energy production and the synthesis of other lipid molecules. Metabolic pathways within the ovary are partially regulated by protein kinases that link metabolic status to oocyte development. Although the functions of several kinases in this process are well established, the roles that many other kinases play in coordinating metabolic state with female germ cell development are unknown. Here, we demonstrate that the catalytic activity of casein kinase 2 (CK2) is essential for Drosophila oogenesis. Using an unbiased biochemical screen that leveraged an unusual catalytic property of the kinase, we identified a novel CK2 substrate in the Drosophila ovary, the lipid droplet-associated protein Jabba. We show that Jabba is essential for modulating ovarian lipid metabolism and for regulating female fertility in the fly. Our findings shed light on a CK2-dependent signaling pathway governing lipid metabolism in the ovary and provide insight into the long-recognized but poorly understood association between energy metabolism and female reproduction.	[McMillan, Emily A.; Longo, Sheila M.; Smith, Michael D.; Broskin, Sarah; Lin, Baicheng; Singh, Nisha K.; Strochlic, Todd I.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA	Drexel University	Strochlic, TI (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	Todd.Strochlic@drexelmed.edu			Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health; Drexel University College of Medicine	Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health; Drexel University College of Medicine	This work was supported by a Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health (to T. I. S.) and by start-up funds from Drexel University College of Medicine (to T. I. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Buszczak M, 2002, GENETICS, V160, P1511; Castanieto A, 2014, ELIFE, V3, DOI 10.7554/eLife.04437; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; Della Torre S, 2014, NAT REV ENDOCRINOL, V10, P13, DOI 10.1038/nrendo.2013.203; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Dunning KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087327; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Essah PA, 2006, J ENDOCRINOL INVEST, V29, P270, DOI 10.1007/BF03345554; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Felix M, 2015, DEVELOPMENT, V142, P3692, DOI 10.1242/dev.125682; Fontana R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020087; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gupta T, 2003, DEVELOPMENT, V130, P6075, DOI 10.1242/dev.00817; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hudson AM, 2014, METHODS, V68, P207, DOI 10.1016/j.ymeth.2014.01.005; King R. C., 1970, OVARIAN DEV DROSOPHI; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kolkhof P, 2017, MOL CELL PROTEOMICS, V16, P329, DOI 10.1074/mcp.M116.061499; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Kuhn H, 2015, DEVELOPMENT, V142, P3869, DOI 10.1242/dev.125419; Lai H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120063; LANE ME, 1995, MECH DEVELOP, V49, P191, DOI 10.1016/0925-4773(94)00317-G; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; LIN WJ, 1994, J PROTEIN CHEM, V13, P217, DOI 10.1007/BF01891979; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; MAHAJANMIKLOS S, 1994, DEV BIOL, V165, P336, DOI 10.1006/dbio.1994.1257; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Pek JW, 2012, DEVELOPMENT, V139, P4505, DOI 10.1242/dev.082867; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; Schneider LE, 1997, DEVELOPMENT, V124, P2591; Schwind L, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010022; Sieber MH, 2016, CELL, V164, P420, DOI 10.1016/j.cell.2015.12.020; Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019; Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027; Strochlic TI, 2014, EMBO REP, V15, P1184, DOI 10.15252/embr.201438688; Suzuki M, 2015, MOL BIOL CELL, V26, P2333, DOI 10.1091/mbc.E14-11-1504; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tan JL, 2014, J CELL SCI, V127, P954, DOI 10.1242/jcs.129031; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilhelm N, 2012, MOL CELL BIOCHEM, V365, P37, DOI 10.1007/s11010-012-1241-y; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729	61	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2990	3002		10.1074/jbc.M117.814657	http://dx.doi.org/10.1074/jbc.M117.814657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29326167	Green Published, hybrid			2022-12-28	WOS:000426051900031
J	Lafaye, C; Van Molle, I; Dufe, VT; Wahni, K; Boudier, A; Leroy, P; Collet, JF; Messens, J				Lafaye, Celine; Van Molle, Inge; Dufe, Veronica Tamu; Wahni, Khadija; Boudier, Ariane; Leroy, Pierre; Collet, Jean-Francois; Messens, Joris			Sulfur denitrosylation by an engineered Trx-like DsbG enzyme identifies nucleophilic cysteine hydrogen bonds as key functional determinant (vol 291, pg 15020, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Messens, Joris/AAH-3008-2020	Messens, Joris/0000-0002-2128-8264; Van Molle, Inge/0000-0003-0114-9379				Lafaye C, 2016, J BIOL CHEM, V291, P15020, DOI 10.1074/jbc.M116.729426	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18831	18831		10.1074/jbc.AAC117.000526	http://dx.doi.org/10.1074/jbc.AAC117.000526			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29373864	Green Published, hybrid			2022-12-28	WOS:000415848000009
J	Luciano, AK; Zhou, WP; Santana, JM; Kyriakides, C; Velazquez, H; Sessa, WC				Luciano, Amelia K.; Zhou, Wenping; Santana, Jeans M.; Kyriakides, Cleo; Velazquez, Heino; Sessa, William C.			CLOCK phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; MOUSE CLOCK; PROTEIN; RHYTHMS; TRANSCRIPTION; RECEPTOR; DBP	Circadian locomotor output cycles kaput (CLOCK) is a transcription factor that activates transcription of clock-controlled genes by heterodimerizing with BMAL1 and binding to E-box elements on DNA. Although several phosphorylation sites on CLOCK have already been identified, this study characterizes a novel phosphorylation site at serine 845 (Ser-836 in humans). Here, we show that CLOCK is a novel AKT substrate in vitro and in cells, and this phosphorylation site is a negative regulator of CLOCK nuclear localization by acting as a binding site for 14-3-3 proteins. To examine the role of CLOCK phosphorylation in vivo, Clock(S845A) knockin mice were generated using CRISPR/Cas9 technology. Clock(S845A) mice are essentially normal with normal central circadian rhythms and hemodynamics. However, examination of core circadian gene expression from peripheral tissues demonstrated that Clock(S845A) mice have diminished expression of Per2, Reverba, Dbp, and Npas2 in skeletal muscle and Per2, Reverba, Dbp, Per1, Rora, and Npas2 in the liver during the circadian cycle. The reduction in Dbp levels is associated with reduced H3K9ac at E-boxes where CLOCK binds despite no change in total CLOCK levels. Thus, CLOCK phosphorylation by AKT on Ser-845 regulates its nuclear translocation and the expression levels of certain core circadian genes in insulin-sensitive tissues.	[Luciano, Amelia K.; Santana, Jeans M.; Kyriakides, Cleo; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Zhou, Wenping] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Luciano, Amelia K.; Zhou, Wenping; Santana, Jeans M.; Kyriakides, Cleo; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program VBT, New Haven, CT 06520 USA; [Velazquez, Heino] Vet Affairs Connecticut Healthcare Syst, Dept Internal Med, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Sessa, WC (corresponding author), Yale Univ, Dept Pharmacol, Sch Med, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Santana, Jeans/0000-0001-9933-9255; Luciano, Amelia/0000-0002-4178-3422	National Institutes of Health [R01 HL64793, R01 HL61371, HL133018, R35 HL139945, T32 GM007324]; American Heart Association MERIT; Leducq Foundation; MIRVAD network; American Heart Association [15PRE21670000]; George M. O'Brien Kidney Center Grant from National Institutes of Health [P30 DK079310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133018, R01HL064793, R01HL061371, R35HL139945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, P01DK057751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association MERIT; Leducq Foundation(Leducq Foundation); MIRVAD network; American Heart Association(American Heart Association); George M. O'Brien Kidney Center Grant from National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, HL133018, and R35 HL139945, American Heart Association MERIT and the Leducq Foundation, MIRVAD network (to W. C. S.), American Heart Association Pre-doctoral Grant 15PRE21670000, National Institutes of Health T32 Training Grant T32 GM007324 (to A. K. L.), an American Heart Association Sarnoff fellowship (to J. M. S.), and George M. O'Brien Kidney Center Grant from National Institutes of Health P30 DK079310 (to H. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dang FB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12696; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goedeke L, 2015, NAT MED, V21, P1280, DOI 10.1038/nm.3949; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee MY, 2014, P NATL ACAD SCI USA, V111, P12865, DOI 10.1073/pnas.1408472111; Marin EP, 2016, ARTERIOSCL THROM VAS, V36, P370, DOI 10.1161/ATVBAHA.115.306942; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parker BL, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3139; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tahara Y, 2016, NAT REV GASTRO HEPAT, V13, P217, DOI 10.1038/nrgastro.2016.8; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	31	37	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9126	9136		10.1074/jbc.RA117.000773	http://dx.doi.org/10.1074/jbc.RA117.000773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29588368	hybrid, Green Published			2022-12-28	WOS:000434941900034
J	Hatakeyama, D; Shoji, M; Yamayoshi, S; Yoh, R; Ohmi, N; Takenaka, S; Saitoh, A; Arakaki, Y; Masuda, A; Komatsu, T; Nagano, R; Nakano, M; Noda, T; Kawaoka, Y; Kuzuhara, T				Hatakeyama, Dai; Shoji, Masaki; Yamayoshi, Seiya; Yoh, Rina; Ohmi, Naho; Takenaka, Shiori; Saitoh, Ayaka; Arakaki, Yumie; Masuda, Aki; Komatsu, Tsugunori; Nagano, Rina; Nakano, Masahiro; Noda, Takeshi; Kawaoka, Yoshihiro; Kuzuhara, Takashi			Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; acetyltransferase; histone acetylase; influenza virus; influenza virus A; viral protein; GCN5; HAT; NP; nucleoprotein; PCAF	C-MYC; NUCLEOSOMAL HISTONES; ESSENTIAL COFACTOR; VIRAL REPLICATION; GENE-EXPRESSION; DELTA-ANTIGEN; TRANSCRIPTION; PROTEIN; P300; LOCALIZATION	Histone acetylation plays crucial roles in transcriptional regulation and chromatin organization. Viral RNA of the influenza virus interacts with its nucleoprotein (NP), whose function corresponds to that of eukaryotic histones. NP regulates viral replication and has been shown to undergo acetylation by the cAMP-response element (CRE)-binding protein (CBP) from the host. However, whether NP is the target of other host acetyltransferases is unknown. Here, we show that influenza virus NP undergoes acetylation by the two host acetyltransferases GCN5 and P300/CBP-associated factor (PCAF) and that this modification affects viral polymerase activities. Western blot analysis with anti-acetyl-lysine antibody on cultured A549 human lung adenocarcinoma epithelial cells infected with different influenza virus strains indicated acetylation of the viral NP. A series of biochemical analyses disclosed that the host lysine acetyltransferases GCN5 and PCAF acetylate NP in vitro. MS experiments identified three lysine residues as acetylation targets in the host cells and suggested that Lys-31 and Lys-90 are acetylated by PCAF and GCN5, respectively. RNAi-mediated silencing of GCN5 and PCAF did not change acetylation levels of NP. However, interestingly, viral polymerase activities were increased by the PCAF silencing and were decreased by the GCN5 silencing, suggesting that acetylation of the Lys-31 and Lys-90 residues has opposing effects on viral replication. Our findings suggest that epigenetic control of NP via acetylation by host acetyltransferases contributes to regulation of polymerase activity in the influenza A virus.	[Hatakeyama, Dai; Shoji, Masaki; Yoh, Rina; Ohmi, Naho; Takenaka, Shiori; Saitoh, Ayaka; Arakaki, Yumie; Masuda, Aki; Komatsu, Tsugunori; Nagano, Rina; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Yamayoshi, Seiya; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Nakano, Masahiro; Noda, Takeshi] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Noda, Takeshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Special Pathogens, Int Res Ctr Infect Dis,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA	Tokushima Bunri University; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Kuzuhara, T (corresponding author), Yamashiro Cho, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp	Yamayoshi, Seiya/C-1982-2013; Yamayoshi, Seiya/Y-7430-2019; ハタケヤマ, ダイ/HHS-5095-2022	Yamayoshi, Seiya/0000-0001-7768-5157; Yamayoshi, Seiya/0000-0001-7768-5157; ハタケヤマ, ダイ/0000-0001-6047-7124; Noda, Takeshi/0000-0002-0658-4663; Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [26460562, 17K08867]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by The Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research 26460562 and 17K08867 (to D.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; CHANG MF, 1988, J VIROL, V62, P2403, DOI 10.1128/JVI.62.7.2403-2410.1988; CHICOINE LG, 1987, J CELL BIOL, V105, P127, DOI 10.1083/jcb.105.1.127; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Dang CV, 1999, MOL CELL BIOL, V19, P1; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dornfeld D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20458-2; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Ghizzoni M, 2012, EUR J MED CHEM, V47, P337, DOI 10.1016/j.ejmech.2011.11.001; Giese S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01112-3; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Han QL, 2014, J VIROL, V88, P9379, DOI 10.1128/JVI.00509-14; Hancock MH, 2010, J VIROL, V84, P1366, DOI 10.1128/JVI.01727-09; Hatakeyama D, 2014, J BIOL CHEM, V289, P24980, DOI 10.1074/jbc.M114.559708; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Koutsogiannouli EA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071449; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Lin YC, 2017, MBIO, V8, DOI 10.1128/mBio.00597-17; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lu F, 2003, J VIROL, V77, P11425, DOI 10.1128/JVI.77.21.11425-11435.2003; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Mu JJ, 2004, VIROLOGY, V319, P60, DOI 10.1016/j.virol.2003.10.024; Murakami S, 2008, J VIROL, V82, P1605, DOI 10.1128/JVI.01876-07; Nailwal H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.131; Nakada R, 2015, SCI REP-UK, V5, DOI 10.1038/srep15055; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pereira JM, 2008, BIOORGAN MED CHEM, V16, P8889, DOI 10.1016/j.bmc.2008.08.057; Quinlan EJ, 2013, J VIROL, V87, P1497, DOI 10.1128/JVI.02771-12; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Schiltz RL, 2000, BBA-REV CANCER, V1470, pM37, DOI 10.1016/S0304-419X(99)00037-2; Shoemaker JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-117; Shoji M, 2015, J BIOL CHEM, V290, P28001, DOI 10.1074/jbc.M115.669465; Smallwood HS, 2017, CELL REP, V19, P1640, DOI 10.1016/j.celrep.2017.04.039; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sugita Y, 2013, J VIROL, V87, P12879, DOI 10.1128/JVI.02096-13; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Turrell L, 2015, J VIROL, V89, P1452, DOI 10.1128/JVI.02332-14; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Wooldridge TR, 2008, VIROLOGY, V374, P371, DOI 10.1016/j.virol.2007.12.011; Yan WJ, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0127-8; Ye QZ, 2013, MBIO, V4, DOI 10.1128/mBio.00467-12; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zheng WN, 2015, J VIROL, V89, P5822, DOI 10.1128/JVI.00015-15	55	27	29	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7126	7138		10.1074/jbc.RA117.001683	http://dx.doi.org/10.1074/jbc.RA117.001683			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29555684	Green Published, hybrid			2022-12-28	WOS:000432174500006
J	Lebeau, P; Platko, K; Al-Hashimi, AA; Byun, JH; Lhotak, S; Holzapfel, N; Gyulay, G; Igdoura, SA; Cool, DR; Trigatti, B; Seidah, NG; Austin, RC				Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Igdoura, Suleiman A.; Cool, David R.; Trigatti, Bernardo; Seidah, Nabil G.; Austin, Richard C.			Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); endoplasmic reticulum stress (ER stress); cardiovascular disease; hepatocyte; GRP78	AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; INTRACELLULAR RETENTION; BINDING-SPECIFICITY; LIVER-REGENERATION; AFRICAN POPULATION; CELL-PROLIFERATION; STORAGE DISEASES; LIPID-METABOLISM; LDL CHOLESTEROL; MUTATIONS	The proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR). In this study, we investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9 variants caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the UPR. Consistent with these in vitro studies, overexpression of PCSK9 in the livers of mice had no impact on UPR activation. To elucidate the cellular mechanism to explain these surprising findings, we observed that the 94-kDa glucose-regulated protein (GRP94) sequesters PCSK9 away from the 78-kDa glucose-regulated protein (GRP78), the major activator of the UPR. As a result, GRP94 knockdown increased the stability of GRP78-PCSK9 complex and resulted in UPR activation following overexpression of ER-retained PCSK9 variants relative to WT secreted controls. Given that overexpression of these LOF PCSK9 variants does not cause UPR activation under normal homeostatic conditions, therapeutic strategies aimed at blocking the autocatalytic cleavage of PCSK9 in the ER represent a viable strategy for reducing circulating PCSK9.	[Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Austin, Richard C.] Hamilton Ctr Kidney Res, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada; [Trigatti, Bernardo; Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON L8L 2X2, Canada; [Trigatti, Bernardo; Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada; [Trigatti, Bernardo] McMaster Univ, Dept Biochem, Hamilton, ON L8S 4L8, Canada; [Trigatti, Bernardo] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Cool, David R.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University System of Ohio; Wright State University Dayton; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Austin, RC (corresponding author), Hamilton Ctr Kidney Res, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.; Austin, RC (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Byun, Jae Hyun/0000-0002-1231-511X; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Heart and Stroke Foundation of Ontario Grant [T-6146]; Heart and Stroke Foundation of Canada Grant [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research (CIHR) Grant [74477]; Leducq Foundation [13 CVD 03]; CIHR Foundation [148363]; Canada Research Chair [216684]; National Institutes of Health [DK58111]; St. Joseph's Healthcare Hamilton; CIHR Team Grant in Thromboembolism [FRN-79846]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058111] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario Grant; Heart and Stroke Foundation of Canada Grant; Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Joseph's Healthcare Hamilton; CIHR Team Grant in Thromboembolism; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Heart and Stroke Foundation of Ontario Grant T-6146, Heart and Stroke Foundation of Canada Grants G-13-0003064 and G-15-0009389, Canadian Institutes of Health Research (CIHR) Grant 74477 (to R.C.A.); Leducq Foundation Grant 13 CVD 03, CIHR Foundation Grant 148363, and Canada Research Chair 216684 (to N.G.S.); National Institutes of Health Grant DK58111 (to D.R.C.); and St. Joseph's Healthcare Hamilton and CIHR Team Grant in Thromboembolism FRN-79846. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; CALLEA F, 1992, LIVER, V12, P357; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; CARLSON J, 1990, HISTOPATHOLOGY, V16, P309, DOI 10.1111/j.1365-2559.1990.tb01124.x; Chen WT, 2014, HEPATOLOGY, V59, P947, DOI 10.1002/hep.26711; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Daniels TF, 2009, INT J BIOL SCI, V5, P474; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Hooper AJ, 2013, EXPERT OPIN BIOL TH, V13, P429, DOI 10.1517/14712598.2012.748743; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Rocha CSJ, 2015, J MOL CELL CARDIOL, V82, P186, DOI 10.1016/j.yjmcc.2015.03.009; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Seidah NG, 2017, PHARMACOL REV, V69, P33, DOI 10.1124/pr.116.012989; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sirois F, 2008, GENET TEST, V12, P377, DOI 10.1089/gte.2008.0013; Takahashi K, 2010, HUM MOL GENET, V19, P79, DOI 10.1093/hmg/ddp468; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Wu FL, 2016, EXPERT REV GASTROENT, V10, P1041, DOI 10.1080/17474124.2016.1179575; Wu NQ, 2014, CLIN CHIM ACTA, V431, P148, DOI 10.1016/j.cca.2014.01.043; Yan Zhongyu, 2011, Open Neuroendocrinol J, V4, P136; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	55	20	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7329	7343		10.1074/jbc.RA117.001049	http://dx.doi.org/10.1074/jbc.RA117.001049			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593095	Green Published, hybrid			2022-12-28	WOS:000432174500026
J	Visram, M; Radulovic, M; Steiner, S; Malanovic, N; Eichmann, TO; Wolinski, H; Rechberger, GN; Tehlivets, O				Visram, Myriam; Radulovic, Maja; Steiner, Sabine; Malanovic, Nermina; Eichmann, Thomas O.; Wolinski, Heimo; Rechberger, Gerald N.; Tehlivets, Oksana			Homocysteine regulates fatty acid and lipid metabolism in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLHOMOCYSTEINE-HYDROLASE; PLASMA HOMOCYSTEINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; METHYLATION METABOLISM; DOWN-REGULATION; DEFICIENT MICE; KEY ENZYME; PHOSPHATIDYLCHOLINE; PROTEIN	S-Adenosyl-L-homocysteine hydrolase (AdoHcy hydrolase; Sah1 in yeast/AHCY in mammals) degrades AdoHcy, a by-product and strong product inhibitor of S-adenosyl-L-methionine (AdoMet)-dependent methylation reactions, to adenosine and homocysteine (Hcy). This reaction is reversible, so any elevation of Hcy levels, such as in hyperhomocysteinemia (HHcy), drives the formation of AdoHcy, with detrimental consequences for cellular methylation reactions. HHcy, a pathological condition linked to cardiovascular and neurological disorders, as well as fatty liver among others, is associated with a deregulation of lipid metabolism. Here, we developed a yeast model of HHcy to identify mechanisms that dysregulate lipid metabolism. Hcy supplementation to wildtype cells up-regulated cellular fatty acid and triacylglycerol content and induced a shift in fatty acid composition, similar to changes observed in mutants lacking Sah1. Expression of the irreversible bacterial pathway for AdoHcy degradation in yeast allowed us to dissect the impact of AdoHcy accumulation on lipid metabolism from the impact of elevated Hcy. Expression of this pathway fully suppressed the growth deficit of sah1 mutants as well as the deregulation of lipid metabolism in both the sah1 mutant and Hcy-exposed wildtype, showing that AdoHcy accumulation mediates the deregulation of lipid metabolism in response to elevated Hcy in yeast. Furthermore, Hcy supplementation in yeast led to increased resistance to cerulenin, an inhibitor of fatty acid synthase, as well as to a concomitant decline of condensing enzymes involved in very long-chain fatty acid synthesis, in line with the observed shift in fatty acid content and composition.	[Visram, Myriam; Radulovic, Maja; Steiner, Sabine; Malanovic, Nermina; Eichmann, Thomas O.; Wolinski, Heimo; Rechberger, Gerald N.; Tehlivets, Oksana] Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria; [Rechberger, Gerald N.] BioTechMed Graz, Omics Ctr Graz, A-8010 Graz, Austria	University of Graz	Tehlivets, O (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Humboldtstr 50, A-8010 Graz, Austria.	oksana.tehlivets@uni-graz.at	Steiner, Sabine/AAG-5804-2021; Malanovic, Nermina/ACF-9103-2022	Steiner, Sabine/0000-0002-5680-1072; Wolinski, Heimo/0000-0002-1583-6092; Malanovic, Nermina/0000-0002-2903-9369; Eichmann, Thomas O./0000-0002-8521-2795; Tehlivets, Oksana/0000-0003-1650-5014	Austrian Science Fund (FWF) [P24216, P18094]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) Projects P24216 and P18094 (to O.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; Finkelstein JD, 2000, INT J BIOCHEM CELL B, V32, P385, DOI 10.1016/S1357-2725(99)00138-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeda K, 2011, ANAL BIOANAL CHEM, V400, P1853, DOI 10.1007/s00216-011-4703-2; Innis SM, 2003, J PEDIATR-US, V143, P351, DOI 10.1067/S0022-3476(03)00326-3; Isa Y, 2006, J NUTR SCI VITAMINOL, V52, P479, DOI 10.3177/jnsv.52.479; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; KAWAGUCHI A, 1982, J BIOCHEM-TOKYO, V92, P7, DOI 10.1093/oxfordjournals.jbchem.a133933; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Kharbanda KK, 2007, J HEPATOL, V46, P314, DOI 10.1016/j.jhep.2006.08.024; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Leal JF, 2008, CARCINOGENESIS, V29, P2089, DOI 10.1093/carcin/bgn198; Li D, 2006, LIPIDS, V41, P85, DOI 10.1007/s11745-006-5074-x; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liu C, 2008, J NUTR, V138, P311, DOI 10.1093/jn/138.2.311; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Matthews RP, 2009, DEVELOPMENT, V136, P865, DOI 10.1242/dev.027565; Medici V, 2013, HEPATOLOGY, V57, P555, DOI 10.1002/hep.26047; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Mushegian AR, 1998, GENOME RES, V8, P590, DOI 10.1101/gr.8.6.590; Ngo S, 2014, DIABETES, V63, P2273, DOI 10.2337/db13-1640; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Ohmori O, 1996, NEUROCHEM RES, V21, P1173, DOI 10.1007/BF02532392; Pang YL, 2016, J BIOL CHEM, V291, P12336, DOI 10.1074/jbc.M115.702654; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Selley ML, 2007, NEUROBIOL AGING, V28, P1834, DOI 10.1016/j.neurobiolaging.2006.08.003; SHIMIZU S, 1984, EUR J BIOCHEM, V141, P385, DOI 10.1111/j.1432-1033.1984.tb08203.x; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	58	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5544	5555		10.1074/jbc.M117.809236	http://dx.doi.org/10.1074/jbc.M117.809236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414770	hybrid, Green Published			2022-12-28	WOS:000430044100017
J	Mitchell, AC; Kannan, D; Hunter, SA; Sperberg, RAP; Chang, CH; Cochran, JR				Mitchell, Aaron C.; Kannan, Deepti; Hunter, Sean A.; Sperberg, R. Andres Parra; Chang, Cheryl H.; Cochran, Jennifer R.			Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; hepatocyte growth factor; scatter factor (HGF; SF); protease; protease inhibitor; protein engineering; Fc fusion; HAI-1; matriptase	TRANSMEMBRANE SERINE PROTEASES; YEAST SURFACE DISPLAY; PROSTATE-CANCER; CELL-SURFACE; DIRECTED EVOLUTION; BREAST-CANCER; IN-VITRO; EXPRESSION; LIBRARIES; MET	Dysregulated matriptase activity has been established as a key contributor to cancer progression through its activation of growth factors, including the hepatocyte growth factor (HGF). Despite its critical role and prevalence in many human cancers, limitations to developing an effective matriptase inhibitor include weak binding affinity, poor selectivity, and short circulating half-life. We applied rational and combinatorial approaches to engineer a potent inhibitor based on the hepatocyte growth factor activator inhibitor type-1 (HAI-1), a natural matriptase inhibitor. The first Kunitz domain (KD1) of HAI-1 has been well established as a minimal matriptase-binding and inhibition domain, whereas the second Kunitz domain (KD2) is inactive and involved in negative regulation. Here, we replaced the inactive KD2 domain of HAI-1 with an engineered chimeric variant of KD2/KD1 domains and fused the resulting construct to an antibody Fc domain to increase valency and circulating serum half-life. The final protein variant contains four stoichiometric binding sites that we showed were needed to effectively inhibit matriptase with a K-i of 70 +/- 5 pm, an increase of 120-fold compared with the natural HAI-1 inhibitor, to our knowledge making it one of the most potent matriptase inhibitors identified to date. Furthermore, the engineered inhibitor demonstrates a protease selectivity profile similar to that of wildtype KD1 but distinct from that of HAI-1. It also inhibits activation of the natural pro-HGF substrate and matriptase expressed on cancer cells with at least an order of magnitude greater efficacy than KD1.	[Mitchell, Aaron C.; Kannan, Deepti; Sperberg, R. Andres Parra; Chang, Cheryl H.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Hunter, Sean A.; Cochran, Jennifer R.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cochran, JR (corresponding author), Stanford Univ, Shriram Bldg Rm 356,443 Via Ortega Dr, Stanford, CA 94305 USA.	jennifer.cochran@stanford.edu		CHANG, CHERYL/0000-0001-7810-0501; Kannan, Deepti/0000-0002-4416-8417; Yamada-Hunter, Sean/0000-0002-4372-6587	NIGMS, National Institutes of Health Training Grant in Biotechnology [5T32GM008412]; NCI, National Institutes of Health [R01 CA151706]; Stanford Agilent fellowship; National Institutes of Standards and Technology fellowship; Siebel Scholars graduate fellowship; National Science Foundation graduate research fellowship; Stanford graduate fellowship; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA151706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Training Grant in Biotechnology; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stanford Agilent fellowship; National Institutes of Standards and Technology fellowship; Siebel Scholars graduate fellowship; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); Stanford graduate fellowship(Stanford University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health Training Grant in Biotechnology 5T32GM008412 (to A. C. M.) and NCI, National Institutes of Health Grant R01 CA151706 (to J. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Stanford Agilent fellowship, National Institutes of Standards and Technology fellowship, and Siebel Scholars graduate fellowship.; Supported by a National Science Foundation graduate research fellowship and a Stanford graduate fellowship.	Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Aoki W, 2011, J BIOSCI BIOENG, V111, P16, DOI 10.1016/j.jbiosc.2010.08.006; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; COPELAND RA, 2005, EVALUATION ENZYME IN, P185; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Eigenbrot C, 2010, FEBS J, V277, P2215, DOI 10.1111/j.1742-4658.2010.07638.x; Fukushima T, 2011, CANCER SCI, V102, P407, DOI 10.1111/j.1349-7006.2010.01808.x; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Glotzbach B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076956; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hunter SA, 2016, METHOD ENZYMOL, V580, P21, DOI 10.1016/bs.mie.2016.05.002; Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108; Kang JY, 2003, CANCER RES, V63, P1101; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Kawaguchi M, 2014, CANCERS, V6, P1890, DOI 10.3390/cancers6041890; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Nagaike K, 2004, CANCER SCI, V95, P728, DOI 10.1111/j.1349-7006.2004.tb03253.x; Nakamura K, 2009, INT J ONCOL, V35, P239, DOI 10.3892/ijo_00000333; Owusu BY, 2016, ONCOTARGET, V7, P29492, DOI 10.18632/oncotarget.8785; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Pomothy J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6306984; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Rolland-Fourcade C, 2017, GUT, V66, P1767, DOI 10.1136/gutjnl-2016-312094; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanders AJ, 2007, INT J MOL MED, V20, P613; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Tervonen TA, 2016, ONCOGENE, V35, P1832, DOI 10.1038/onc.2015.248; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Welman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034182; Wood MP, 2014, IMMUNOLOGY, V142, P474, DOI 10.1111/imm.12278; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Ye JJ, 2014, CANCER SCI, V105, P44, DOI 10.1111/cas.12306; Zeng L, 2005, WORLD J GASTROENTERO, V11, P6202, DOI 10.3748/wjg.v11.i39.6202; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	60	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					4969	4980		10.1074/jbc.M117.815142	http://dx.doi.org/10.1074/jbc.M117.815142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29386351	Green Published, hybrid			2022-12-28	WOS:000429409300002
J	Duan, HD; Lubner, CE; Tokmina-Lukaszewska, M; Gauss, GH; Bothner, B; King, PW; Peters, JW; Miller, AF				Duan, H. Diessel; Lubner, Carolyn E.; Tokmina-Lukaszewska, Monika; Gauss, George H.; Bothner, Brian; King, Paul W.; Peters, John W.; Miller, Anne-Frances			Distinct properties underlie flavin-based electron bifurcation in a novel electron transfer flavoprotein FixAB from Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; METHYLOTROPHIC BACTERIUM W3A1; CHARGE-TRANSFER COMPLEXES; EXCITED-STATE DYNAMICS; ACYL-COA DEHYDROGENASE; METHYLOPHILUS-METHYLOTROPHUS; RIBONUCLEOTIDE REDUCTASE; MEGASPHAERA-ELSDENII; ENERGY-CONSERVATION; KINETIC-ANALYSIS	A newly recognized third fundamental mechanism of energy conservation in biology, electron bifurcation, uses free energy from exergonic redox reactions to drive endergonic redox reactions. Flavin-based electron bifurcation furnishes low-potential electrons to demanding chemical reactions, such as reduction of dinitrogen to ammonia. We employed the heterodimeric flavoenzyme FixAB from the diazotrophic bacterium Rhodopseudomonas palustris to elucidate unique properties that underpin flavin-based electron bifurcation. FixAB is distinguished from canonical electron transfer flavoproteins (ETFs) by a second FAD that replaces the AMP of canonical ETF. We exploited near-UV-visible CD spectroscopy to resolve signals from the different flavin sites in FixAB and to interrogate the putative bifurcating FAD. CD aided in assigning the measured reduction midpoint potentials (E degrees values) to individual flavins, and the E degrees values tested the accepted model regarding the redox properties required for bifurcation. We found that the higher-E degrees flavin displays sequential one-electron (1-e(-)) reductions to anionic semiquinone and then to hydroquinone, consistent with the reactivity seen in canonical ETFs. In contrast, the lower-E degrees flavin displayed a single two-electron (2-e(-)) reduction without detectable accumulation of semiquinone, consistent with unstable semiquinone states, as required for bifurcation. This is the first demonstration that a FixAB protein possesses the thermodynamic prerequisites for bifurcating activity, and the separation of distinct optical signatures for the two flavins lays a foundation for mechanistic studies to learn how electron flow can be directed in a protein environment. We propose that a novel optical signal observed at long wavelength may reflect electron delocalization between the two flavins.	[Duan, H. Diessel; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Lubner, Carolyn E.; King, Paul W.] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Tokmina-Lukaszewska, Monika; Gauss, George H.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA	University of Kentucky; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Montana State University System; Montana State University Bozeman; Washington State University	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afmill3r2@gmail.com	King, Paul W./D-9979-2011	King, Paul W./0000-0001-5039-654X	UNICAT; Murdock Charitable Trust; NIGMS, National Institutes of Health [P20GM103474]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	UNICAT; Murdock Charitable Trust; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Caroline Harwood (University of Washington) for the gift of R. palustris genomic DNA, Professor Edith Glazer (University of Kentucky) for the access to a high-capacity centrifuge, and the Montana State University Microfabrication Facility for help in preparation of gold-coated borosilicate glass capillaries for non-covalent mass spectrometry. We thank Rhesa Ledbetter, Amaya Garcia Costas, and Gerrit Schut for insightful conversations. A. F. M. acknowledges the hospitality of the Technische Universitat-Berlin and the support of UNICAT during the revision of the manuscript. The Proteomics, Metabolomics, and Mass Spectrometry Facility at Montana State University has received support from the Murdock Charitable Trust and NIGMS, National Institutes of Health, under Grant P20GM103474.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; [Anonymous], 2006, THESIS; BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2016, J BIOL CHEM, V291, P11993, DOI 10.1074/jbc.M116.726299; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Clark W. M., 1960, OXIDATION REDUCTION; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Dutton P L, 1978, Methods Enzymol, V54, P411; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; EARL CD, 1987, J BACTERIOL, V169, P1127, DOI 10.1128/jb.169.3.1127-1136.1987; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Enescu M, 1998, PHOTOCHEM PHOTOBIOL, V68, P150, DOI 10.1111/j.1751-1097.1998.tb02482.x; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; Gadda G, 1997, J BIOL CHEM, V272, P5563, DOI 10.1074/jbc.272.9.5563; Geng JF, 2013, P NATL ACAD SCI USA, V110, P9639, DOI 10.1073/pnas.1301544110; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Griffin KJ, 1997, BIOCHEMISTRY-US, V36, P4194, DOI 10.1021/bi962572v; GUSTAFSON WG, 1986, J BIOL CHEM, V261, P7733; HAID E, 1975, CLIN CHEM, V21, P884; Hardman SJO, 2013, BIOPHYS J, V105, P2549, DOI 10.1016/j.bpj.2013.10.015; Hay S, 2009, ANGEW CHEM INT EDIT, V48, P1452, DOI 10.1002/anie.200805502; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; HERRICK KR, 1994, J BIOL CHEM, V269, P32239; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hoben JP, 2017, J BIOL CHEM, V292, P14039, DOI 10.1074/jbc.M117.794214; Huang JJ, 2010, APPL ENVIRON MICROB, V76, P7717, DOI 10.1128/AEM.01143-10; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; Lin TY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.374918; Liu ZY, 2012, J AM CHEM SOC, V134, P8104, DOI 10.1021/ja2105009; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mataga N, 2002, J PHYS CHEM B, V106, P8917, DOI 10.1021/jp0205741; Mathes T, 2012, J BIOL CHEM, V287, P31725, DOI 10.1074/jbc.M112.391896; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; Mishanina TV, 2015, J BIOL CHEM, V290, P25072, DOI 10.1074/jbc.M115.682369; Morrison E, 2013, BIOCHEMISTRY-US, V52, P6063, DOI 10.1021/bi400763h; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; NORDEN B, 1982, BIOPOLYMERS, V21, P1713, DOI 10.1002/bip.360210904; O'Reilly JP, 2005, J AM CHEM SOC, V127, P1632, DOI 10.1021/ja0443326; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pudney CR, 2007, J AM CHEM SOC, V129, P13949, DOI 10.1021/ja074463h; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; RODKEY FL, 1955, J BIOL CHEM, V213, P777; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1996, J BIOCHEM-TOKYO, V120, P276; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; SATO K, 1992, J BIOCHEM-TOKYO, V112, P804, DOI 10.1093/oxfordjournals.jbchem.a123980; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Trimmer EE, 2005, BIOCHEMISTRY-US, V44, P6809, DOI 10.1021/bi0477236; Wang J, 2015, ANTIOXID REDOX SIGN, V23, P283, DOI 10.1089/ars.2013.5397; Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Westphal AH, 1998, EUR J BIOCHEM, V257, P160, DOI 10.1046/j.1432-1327.1998.2570160.x; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yee CS, 2003, J AM CHEM SOC, V125, P10506, DOI 10.1021/ja036242r; Zhang P, 2017, ACCOUNTS CHEM RES, V50, P2410, DOI 10.1021/acs.accounts.7b00327	77	14	14	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4688	4701		10.1074/jbc.RA117.000707	http://dx.doi.org/10.1074/jbc.RA117.000707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462786	Green Published, hybrid			2022-12-28	WOS:000428848300012
J	Lemieux, MJ				Lemieux, M. Joanne			Taking a position on intramembrane proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PRINCIPLES; PROTEASE; DRIVEN	Decades of work have contributed to our in-depth mechanistic understanding of soluble proteases, but much less is known about the catalytic mechanism of intramembrane proteolysis due to inherent difficulties in both preparing and analyzing integral membrane enzymes and transmembrane substrates. New work from Naing et al. tackles this challenge by examining the catalytic parameters of an aspartyl intramembrane protease homologous to the enzyme that cleaves amyloid precursor protein, finding that both chemistry and register contribute to specificity in substrate cleavage.	[Lemieux, M. Joanne] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2P5, Canada	University of Alberta	Lemieux, MJ (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2P5, Canada.	mlemieux@ualberta.ca						Arutyunova E, 2014, EMBO J, V33, P1869, DOI 10.15252/embj.201488149; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Naing SH, 2018, J BIOL CHEM, V293, P4653, DOI 10.1074/jbc.RA117.001436; Naing SH, 2018, BIOPHYS J, V114, P602, DOI 10.1016/j.bpj.2017.12.017; Strisovsky K, 2013, FEBS J, V280, P1579, DOI 10.1111/febs.12199; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4664	4665		10.1074/jbc.H118.002210	http://dx.doi.org/10.1074/jbc.H118.002210			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602877	Green Published, hybrid			2022-12-28	WOS:000428848300009
J	Winter, SV; Zychlinsky, A				Winter, Sebastian Virreira; Zychlinsky, Arturo			The bacterial pigment pyocyanin inhibits the NLRP3 inflammasome through intracellular reactive oxygen and nitrogen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA PYOCYANIN; OXIDOREDUCTASE COMPLEX-I; LUNG EPITHELIAL-CELLS; SUPEROXIDE-PRODUCTION; NEUTROPHIL APOPTOSIS; REDOX REGULATION; HOST DEFENSES; ACTIVATION; INFECTION; MEMBRANE	Inflammasomes are cytosolic complexes that mature and secrete the inflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 and induce pyroptosis. The NLRP3 (NACHT, LRR, and PYD domains-containing protein 3) inflammasome detects many pathogen-and danger-associated molecular patterns, and reactive oxygen species (ROS)/reactive nitrogen species (RNS) have been implicated in its activation. The phenazine pyocyanin (PCN) is a virulence factor of Pseudomonas aeruginosa and generates superoxide in cells. Here we report thatPCN inhibits IL-1 beta and IL-18 release and pyroptosis upon NLRP3 inflammasome activation in macrophages by preventing speck formation and Caspase-1 maturation. Of note, PCN did not regulate the AIM2 (absent in melanoma 2) or NLRC4 inflammasomes or tumor necrosis factor (TNF) secretion. Imaging of the fluorescent glutathione redox potential sensor Grx1roGFP2 indicated thatPCNprovokes cytosolic and nuclear but not mitochondrial redox changes. PCN-induced intracellular ROS/RNS inhibited the NLRP3 inflammasome posttranslationally, and hydrogen peroxide or peroxynitrite alone were sufficient to block its activation. We propose that cytosolic ROS/RNS inhibit the NLRP3 inflammasome and that PCN's anti-inflammatory activity may help P. aeruginosa evade immune recognition.	[Winter, Sebastian Virreira; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Zychlinsky, A (corresponding author), Max Planck Inst Infect Biol, Charitepl 1, D-10117 Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de		Virreira Winter, Sebastian/0000-0002-2299-8110				Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Ahmad IM, 2011, J TOXICOL ENV HEAL A, V74, P43, DOI 10.1080/15287394.2010.514233; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; BARON SS, 1981, ANTIMICROB AGENTS CH, V20, P814, DOI 10.1128/AAC.20.6.814; Bednash JS, 2016, CELL MOL IMMUNOL, V13, P722, DOI 10.1038/cmi.2016.15; de Zoete M. R., 2014, COLD SPRING HARB PER, V6; Deng QC, 2016, INFECT IMMUN, V84, P56, DOI 10.1128/IAI.00945-15; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hughes A. J., 2015, PSEUDOMONAS, P51; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Manago A, 2015, ANTIOXID REDOX SIGN, V22, P1097, DOI 10.1089/ars.2014.5979; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; Pfeiffer S, 1998, MOL PHARMACOL, V53, P795, DOI 10.1124/mol.53.4.795; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Rimessi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7201; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Yang J, 2017, CELL MOL IMMUNOL, V14, P65, DOI 10.1038/cmi.2016.29; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	48	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4893	4900		10.1074/jbc.RA117.001105	http://dx.doi.org/10.1074/jbc.RA117.001105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414783	Green Published, hybrid			2022-12-28	WOS:000428848300028
J	Gilbert, SP; Guzik-Lendrum, S; Rayment, I				Gilbert, Susan P.; Guzik-Lendrum, Stephanie; Rayment, Ivan			Kinesin-2 motors: Kinetics and biophysics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HAND-OVER-HAND; LEFT-RIGHT ASYMMETRY; NECK-LINKER; INTRACELLULAR-TRANSPORT; COILED-COIL; FRONT-HEAD; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; MICROTUBULE MOTORS; PROCESSIVE RUN	Kinesin-2s are major transporters of cellular cargoes. This subfamily contains both homodimeric kinesins whose catalytic domains result from the same gene product and heterodimeric kinesins with motor domains derived from two different gene products. In this Minireview, we focus on the progress to define the biochemical and biophysical properties of the kinesin-2 family members. Our understanding of their mechanochemical capabilities has been advanced by the ability to identify the kinesin-2 genes in multiple species, expression and purification of these motors for single-molecule and ensemble assays, and development of new technologies enabling quantitative measurements of kinesin activity with greater sensitivity.	[Gilbert, Susan P.; Guzik-Lendrum, Stephanie] Rensselaer Polytech Inst, Dept Biol Sci, 110 8th St, Troy, NY 12180 USA; [Gilbert, Susan P.; Guzik-Lendrum, Stephanie] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, 110 8th St, Troy, NY 12180 USA.; Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	sgilbert@rpi.edu; ivan_rayment@biochem.wisc.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM054141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37-GM054141 (to S. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2016, J BIOL CHEM, V291, P23248, DOI 10.1074/jbc.M116.752196; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Chana MS, 2005, J PEPT RES, V65, P209, DOI 10.1111/j.1399-3011.2005.00210.x; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; COLE DG, 1992, J CELL SCI, V101, P291; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Duselder A, 2012, J MOL BIOL, V423, P159, DOI 10.1016/j.jmb.2012.06.043; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Guzik-Lendrum S, 2017, BIOPHYS J, V113, P1845, DOI 10.1016/j.bpj.2017.09.015; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; He M, 2017, TRENDS CELL BIOL, V27, P110, DOI 10.1016/j.tcb.2016.09.010; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hirokawa N, 2015, EXP CELL RES, V334, P16, DOI 10.1016/j.yexcr.2015.02.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Isojima H, 2016, NAT CHEM BIOL, V12, P290, DOI [10.1038/NCHEMBIO.2028, 10.1038/nchembio.2028]; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lu W, 2017, TRENDS CELL BIOL, V27, P505, DOI 10.1016/j.tcb.2017.02.005; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Mickolajczyk KJ, 2017, BIOPHYS J, V112, P2615, DOI 10.1016/j.bpj.2017.05.007; Mickolajczyk KJ, 2015, P NATL ACAD SCI USA, V112, pE7186, DOI 10.1073/pnas.1517638112; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Milic B, 2017, P NATL ACAD SCI USA, V114, pE6830, DOI 10.1073/pnas.1708157114; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Phillips RK, 2016, J BIOL CHEM, V291, P20372, DOI 10.1074/jbc.M116.737577; Prevo B, 2017, FEBS J, V284, P2905, DOI 10.1111/febs.14068; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schief WR, 2004, P NATL ACAD SCI USA, V101, P1183, DOI 10.1073/pnas.0304369101; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shimizu K, 1998, J BIOL CHEM, V273, P6591, DOI 10.1074/jbc.273.12.6591; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tas RP, 2017, NEURON, V96, P1264, DOI 10.1016/j.neuron.2017.11.018; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wang Q, 2017, P NATL ACAD SCI USA, V114, pE8611, DOI 10.1073/pnas.1710328114; Wang WY, 2015, PROTEIN SCI, V24, P1047, DOI 10.1002/pro.2697; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Yu JY, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27621; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970	103	16	17	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4510	4518		10.1074/jbc.R117.001324	http://dx.doi.org/10.1074/jbc.R117.001324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29444824	Green Published, hybrid			2022-12-28	WOS:000428204300022
J	Isaac, R; Boura-Halfon, S; Gurevitch, D; Shainskaya, A; Levkovitz, Y; Zick, Y				Isaac, Roi; Boura-Halfon, Sigalit; Gurevitch, Diana; Shainskaya, Alla; Levkovitz, Yechiel; Zick, Yehiel			Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic beta cells (vol 288, pg 5682, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Zick, Yehiel/K-1479-2012					Isaac R, 2013, J BIOL CHEM, V288, P5682, DOI 10.1074/jbc.M112.408641	1	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4577	+		10.1074/jbc.AAC118.002476	http://dx.doi.org/10.1074/jbc.AAC118.002476			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572328	Green Published, hybrid			2022-12-28	WOS:000428204300030
J	Strang, KH; Croft, CL; Sorrentino, ZA; Chakrabarty, P; Golde, TE; Giasson, BI				Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.			Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies (vol 293, pg 2408, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089622, T32NS082168] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS082168, R01 NS089622] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357	1	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4579	4579		10.1074/jbc.AAC118.002657	http://dx.doi.org/10.1074/jbc.AAC118.002657			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572329	hybrid, Green Published			2022-12-28	WOS:000428204300031
J	Mikkelsen, SA; Vangheluwe, P; Andersen, JP				Mikkelsen, Stine A.; Vangheluwe, Peter; Andersen, Jens Peter			A Darier disease mutation relieves kinetic constraints imposed by the tail of sarco(endo)plasmic reticulum Ca2+-ATPase 2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; FUNCTIONAL CONSEQUENCES; STEADY-STATE; CA2+ PUMP; ATPASE; EXPRESSION; MUTANTS; CA-2+-ATPASE; ISOFORMS; ATP2A2	The sarco(endo) plasmic reticulum Ca2+-ATPase (SERCA) 2b isoform possesses an extendedCterminus (SERCA2b tail) forming an 11th transmembrane (TM) helix, which slows conformational changes of the Ca2+-pump reaction cycle. Here, we report that a Darier disease (DD) mutation of SERCA2b that changes a glutamate to a lysine in the cytoplasmic loop between TM8 and TM9 (E917K) relieves these kinetic constraints. We analyzed the effects of this mutation on the overall reaction and the individual partial reactions of the Ca2+ pump compared with the corresponding mutations of the SERCA2a and SERCA1a isoforms, lacking the SERCA2b tail. In addition to a reduced affinity for Ca2+, caused by the mutation in all three isoforms examined, we observed a unique enhancing effect on the turnover rates of ATPase activity and Ca2+ transport for the SERCA2b E917K mutation. This relief of kinetic constraints contrasted with inhibitory effects observed for the corresponding SERCA2a and SERCA1a (E918K) mutations. These observations indicated that the E917K/E918K mutations affect the rate-limiting conformational change in isoform-specific ways and that the SERCA2b mutation perturbs the interactions of TM11 with other SERCA2b regions. Mutational analysis of an arginine in TM7 that interacts with the glutamate in SERCA1a crystal structures suggested that in wildtype SERCA2b, the corresponding arginine (Arg-835) may be involved in mediating the conformational restriction by TM11. Moreover, the E917K mutation may disturb TM11 through the cytoplasmic loop between TM10 and TM11. In conclusion, our findings have identified structural elements of importance for the kinetic constraints imposed by TM11.	[Mikkelsen, Stine A.; Andersen, Jens Peter] Aarhus Univ, Dept Biomed, Ole Worms 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Leuven, Belgium	Aarhus University; KU Leuven	Andersen, JP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@biomed.au.dk	Vangheluwe, Peter/P-5476-2017	Vangheluwe, Peter/0000-0002-7822-2944; Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council, Denmark; Novo Nordisk Foundation, Denmark; Lundbeck Foundation, Denmark	Danish Medical Research Council, Denmark(Danish Medical Research Council); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Lundbeck Foundation, Denmark(Lundbeckfonden)	This work was supported in part by the Danish Medical Research Council, the Novo Nordisk Foundation, and the Lundbeck Foundation, Denmark (to J. P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Dally S, 2010, J MOL CELL CARDIOL, V48, P633, DOI 10.1016/j.yjmcc.2009.11.012; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; FORGE V, 1993, J BIOL CHEM, V268, P10961; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Ikeda S, 2003, J INVEST DERMATOL, V121, P475, DOI 10.1046/j.1523-1747.2003.12400.x; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Nellen RGL, 2017, HUM MUTAT, V38, P343, DOI 10.1002/humu.23164; Pani B, 2008, CELL MOL LIFE SCI, V65, P205, DOI 10.1007/s00018-007-7397-z; Peacocke M, 1999, NAT GENET, V21, P252, DOI 10.1038/6758; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PICK U, 1982, J BIOL CHEM, V257, P6111; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Tavadia S, 2004, BRIT J DERMATOL, V151, P440, DOI 10.1111/j.1365-2133.2004.06130.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; VERBOOMEN H, 1994, BIOCHEM J, V303, P979, DOI 10.1042/bj3030979; VILSEN B, 1989, J BIOL CHEM, V264, P21024; YU X, 1994, J BIOL CHEM, V269, P16656	48	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3880	3889		10.1074/jbc.RA117.000941	http://dx.doi.org/10.1074/jbc.RA117.000941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29363575	Green Published, hybrid			2022-12-28	WOS:000427587500002
J	Harada, Y; Kato, Y; Miyaji, T; Omote, H; Moriyama, Y; Hiasa, M				Harada, Yuika; Kato, Yuri; Miyaji, Takaaki; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki			Vesicular nucleotide transporter mediates ATP release and migration in neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; A2 RECEPTORS; P2 RECEPTORS; IDENTIFICATION; ACTIVATION; ADENOSINE; INHIBITION; CELLS; TRANSLOCATION; CHEMOTAXIS	Neutrophils migrate to sites infected by pathogenic microorganisms. This migration is regulated by neutrophil-secreted ATP, which stimulates neutrophils in an autocrine manner through purinergic receptors on the plasma membrane. Although previous studies have shown that ATP is released through channels at the plasma membrane of the neutrophil, it remains unknown whether it is also released through alternate secretory systems involving vesicular mechanisms. In this study, we investigated the possible involvement of vesicular nucleotide transporter (VNUT), a key molecule for vesicular storage and nucleotide release, in ATP secretion from neutrophils. RT-PCR and Western blotting analysis indicated that VNUT is expressed in mouse neutrophils. Immunohistochemical analysis indicated that VNUT mainly colocalized with matrix metalloproteinase-9 (MMP-9), a marker of tertiary granules, which are secretory organelles. In mouse neutrophils, ATP release was inhibited by clodronate, which is a potent VNUT inhibitor. Furthermore, neutrophils from VNUT-/- mice did not release ATP and exhibited significantly reduced migration in vitro and in vivo. These findings suggest that tertiary granule-localized VNUT is responsible for vesicular ATP release and subsequent neutrophil migration. Thus, these findings suggest an additional mechanism through which ATP is released by neutrophils.	[Harada, Yuika; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Kato, Yuri; Miyaji, Takaaki] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Moriyama, Yoshinori] Matsumoto Dent Univ, Dept Biochem, Siojiri 3990781, Japan	Okayama University; Okayama University; Matsumoto Dental University	Moriyama, Y; Hiasa, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan.; Moriyama, Y (corresponding author), Matsumoto Dent Univ, Dept Biochem, Siojiri 3990781, Japan.	moriya-y@okayama-u.ac.jp; hiasa@okayama-u.ac.jp		Miyaji, Takaaki/0000-0002-7257-7621	Japan Society for the Promotion of Science [15J03354]; Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan [26893154, 17K0733609, 25253008, 16K08230]; Japan Agency for Medical Research and Development (AMED) [JP17gm5910019]; Narishige Neuroscience Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Narishige Neuroscience Research Foundation	This work was supported in part by Japan Society for the Promotion of Science Fellows Grant-in Aid 15J03354 (to Y. H.); Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants-in-Aid 26893154 (to Y. K.), 17K0733609 (to H. O.), 25253008 (to H. O. and Y. M.), and 16K08230 (to M. H.); the Japan Agency for Medical Research and Development (AMED) Grant JP17gm5910019 (to T. M.); and funds from the Narishige Neuroscience Research Foundation (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bao Y, 2014, J BIOL CHEM, V289, P26794, DOI 10.1074/jbc.M114.572495; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Cools-Lartigue J., 2013, J CLIN INVEST, V67484; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Gernez Y, 2010, EUR RESPIR J, V35, P467, DOI 10.1183/09031936.00186109; Harada Y, 2014, BIOL PHARM BULL, V37, P1090, DOI 10.1248/bpb.b14-00275; Hiasa M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12034; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kato Y, 2017, P NATL ACAD SCI USA, V114, pE6297, DOI 10.1073/pnas.1704847114; Kato Y, 2013, BIOL PHARM BULL, V36, P1688; Kukulski F, 2009, CYTOKINE, V46, P166, DOI 10.1016/j.cyto.2009.02.011; Larsson M, 2012, CEREB CORTEX, V22, P1203, DOI 10.1093/cercor/bhr203; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Meshki J, 2004, AM J PHYSIOL-CELL PH, V286, pC264, DOI 10.1152/ajpcell.00287.2003; Moriyama S, 2016, BIOL PHARM BULL, V39, P564, DOI 10.1248/bpb.b15-00872; MORIYAMA Y, 1995, FEBS LETT, V367, P233, DOI 10.1016/0014-5793(95)00559-R; Moriyama Y, 2018, TRENDS PHARMACOL SCI, V39, P13, DOI 10.1016/j.tips.2017.10.007; Moriyama Y, 2017, PURINERG SIGNAL, V13, P387, DOI 10.1007/s11302-017-9568-1; Nakagomi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29761; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Sakamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06689; SALMON JE, 1990, J IMMUNOL, V145, P2235; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SENGELOV H, 1994, BIOCHEM J, V299, P473, DOI 10.1042/bj2990473; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; THIEL M, 1995, J LAB CLIN MED, V126, P275; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544	39	19	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3770	3779		10.1074/jbc.M117.810168	http://dx.doi.org/10.1074/jbc.M117.810168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29363573	Green Published, hybrid			2022-12-28	WOS:000427030200029
J	Libiad, M; Motl, N; Akey, DL; Sakamoto, N; Fearon, ER; Smith, JL; Banerjee, R				Libiad, Marouane; Motl, Nicole; Akey, David L.; Sakamoto, Naoya; Fearon, Eric R.; Smith, Janet L.; Banerjee, Ruma			Thiosulfate sulfurtransferase-like domain-containing 1 protein interacts with thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; MERCAPTOPYRUVATE SULFURTRANSFERASE; LIVER RHODANESE; SULFUR; H2S; BIOSYNTHESIS; OXIDATION; SEQUENCE; SYSTEM; MODEL	Rhodanese domains are structural modules present in the sulfurtransferase superfamily. These domains can exist as single units, in tandem repeats, or fused to domains with other activities. Despite their prevalence across species, the specific physiological roles of most sulfurtransferases are not known. Mammalian rhodanese and mercaptopyruvate sulfurtransferase are perhaps the best-studied members of this protein superfamily and are involved in hydrogen sulfide metabolism. The relatively unstudied human thiosulfate sulfurtransferase-like domain-containing 1 (TSTD1) protein, a single-domain cytoplasmic sulfurtransferase, was also postulated to play a role in the sulfide oxidation pathway using thiosulfate to form glutathione persulfide, for subsequent processing in the mitochondrial matrix. Prior kinetic analysis of TSTD1 was performed at pH9.2, raising questions about relevance and the proposed model for TSTD1 function. In this study, we report a 1.04 angstrom resolution crystal structure of human TSTD1, which displays an exposed active site that is distinct from that of rhodanese and mercaptopyruvate sulfurtransferase. Kinetic studies with a combination of sulfur donors and acceptors reveal that TSTD1 exhibits a low Km for thioredoxin as a sulfane sulfur acceptor and that it utilizes thiosulfate inefficiently as a sulfur donor. The active site exposure and its interaction with thioredoxin suggest that TSTD1 might play a role in sulfide-based signaling. The apical localization of TSTD1 in human colonic crypts, which interfaces with sulfide-releasing microbes, and the overexpression of TSTD1 in colon cancer provide potentially intriguing clues as to its role in sulfide metabolism.	[Libiad, Marouane; Motl, Nicole; Smith, Janet L.; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Akey, David L.] Univ Michigan, Med Ctr, Life Sci Inst, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Med Ctr, Dept Pathol, Ann Arbor, MI 48109 USA; [Sakamoto, Naoya] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348551, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hiroshima University	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Libiad, Marouane/0000-0003-1717-9206	National Institutes of Health (NIH) [GM112455]; NIGMS, NIH, Training Grant [T32GM008353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH, Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) Grant GM112455 (to R. B.) and NIGMS, NIH, Training Grant T32GM008353 (to N. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee R, 2015, METHOD ENZYMOL, V554, P189, DOI 10.1016/bs.mie.2014.11.016; Bauer M, 2002, FEBS LETT, V532, P427, DOI 10.1016/S0014-5793(02)03723-7; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; CLEMEDSON CJ, 1954, ACTA PHYSIOL SCAND, V32, P245, DOI 10.1111/j.1748-1716.1954.tb01171.x; Colnaghi R, 1996, EUR J BIOCHEM, V236, P240, DOI 10.1111/j.1432-1033.1996.00240.x; DEMARQUOY J, 1991, EXPERIENTIA, V47, P497, DOI 10.1007/BF01959954; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Edge SB, 2010, AJCC CANC STAGING MA; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Godbole GB, 2007, REPRODUCTION, V134, P513, DOI 10.1530/REP-07-0234; Ha CZ, 2015, INT J MOL MED, V35, P1657, DOI 10.3892/ijmm.2015.2183; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JARABAK R, 1974, BIOCHEMISTRY-US, V13, P3233, DOI 10.1021/bi00713a006; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; LEININGER KR, 1968, J BIOL CHEM, V243, P1892; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Motl N, 2017, J BIOL CHEM, V292, P14026, DOI 10.1074/jbc.M117.790170; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; PAGANI S, 1984, EUR J BIOCHEM, V142, P361, DOI 10.1111/j.1432-1033.1984.tb08295.x; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Ramsden JD, 2001, J CLIN ENDOCR METAB, V86, P2709, DOI 10.1210/jc.86.6.2709; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Sabelli R, 2008, FEBS J, V275, P3884, DOI 10.1111/j.1742-4658.2008.06535.x; Shen JC, 2015, BIOCHEMISTRY-US, V54, P4542, DOI 10.1021/acs.biochem.5b00584; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Sodha NR, 2009, J THORAC CARDIOV SUR, V138, P977, DOI 10.1016/j.jtcvs.2008.08.074; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Wenzel K, 2003, BIOL CHEM, V384, P763, DOI 10.1515/BC.2003.085; Westley J, 1981, Methods Enzymol, V77, P285; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	65	27	27	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2675	2686		10.1074/jbc.RA117.000826	http://dx.doi.org/10.1074/jbc.RA117.000826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29348167	Green Published, hybrid			2022-12-28	WOS:000426051900005
J	Mori, H; Sakashita, S; Ito, J; Ishii, E; Akiyama, Y				Mori, Hiroyuki; Sakashita, Sohei; Ito, Jun; Ishii, Eiji; Akiyama, Yoshinori			Identification and characterization of a translation arrest motif in VemP by systematic mutational analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-TRANSLOCATION; SECY; MEMBRANE; TUNNEL; ATPASE; EXPORT; INSIGHTS; MUTANTS; MONITOR	VemP (Vibrio protein export monitoring polypeptide) is a secretory protein comprising 159 amino acid residues, which functions as a secretion monitor in Vibrio and regulates expression of the downstream V.secDF2 genes. When VemP export is compromised, its translation specifically undergoes elongation arrest at the position where the Gln(156) codon of vemP encounters the P-site in the translating ribosome, resulting in up-regulation of V.SecDF2 production. Although our previous study suggests that many residues in a highly conserved C-terminal 20-residue region of VemP contribute to its elongation arrest, the exact role of each residue remains unclear. Here, we constructed a reporter system to easily and exactly monitor the in vivo arrest efficiency of VemP. Using this reporter system, we systematically performed a mutational analysis of the 20 residues (His(138)-Phe(157)) to identify and characterize the arrest motif. Our results show that 15 residues in the conserved region participate in elongation arrest and that multiple interactions between important residues in VemP and in the interior of the exit tunnel contribute to the elongation arrest of VemP. The arrangement of these important residues induced by specific secondary structures in the ribosomal tunnel is critical for the arrest. Pro scanning analysis of the preceding segment (Met(120)-Phe(137)) revealed a minor role of this region in the arrest. Considering these results, we conclude that the arrest motif in VemP is mainly composed of the highly conserved multiple residues in the C-terminal region.	[Mori, Hiroyuki; Sakashita, Sohei; Ito, Jun; Ishii, Eiji; Akiyama, Yoshinori] Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kawahara Cho, Kyoto 6068507, Japan	Kyoto University	Mori, H (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kawahara Cho, Kyoto 6068507, Japan.	hiromori@infront.kyoto-u.ac.jp		Ishii, Eiji/0000-0001-7899-252X; Mori, Hiroyuki/0000-0002-0429-1269	Japan Society for the Promotion of Science KAKENHI [17K07334, 17J02501]; MEXT KAKENHI [24117003, 15H01532, 17H05666, 17H05879]; Grants-in-Aid for Scientific Research [17J02501, 17K07334] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 17K07334 (to H. M.) and 17J02501 (to E. I.) and MEXT KAKENHI Grants 24117003 (to H. M.), 15H01532 (to Y. A.), 17H05666 (to H. M.), and 17H05879 (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Furukawa A, 2017, CELL REP, V19, P895, DOI 10.1016/j.celrep.2017.04.030; Ishii E, 2015, P NATL ACAD SCI USA, V112, pE5513, DOI 10.1073/pnas.1513001112; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Kato A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-224; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Matsuo E, 1998, J BIOL CHEM, V273, P18835, DOI 10.1074/jbc.273.30.18835; Mori H, 2003, J BACTERIOL, V185, P948, DOI 10.1128/JB.185.3.948-956.2003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakamori K, 2014, FEBS LETT, V588, P3098, DOI 10.1016/j.febslet.2014.06.038; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; POGLIANO KJ, 1993, GENETICS, V133, P763; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; Sohmen D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7941; Su T, 2017, ELIFE, V6, DOI 10.7554/eLife.25642; TANI K, 1989, J BIOL CHEM, V264, P18582; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Yap MN, 2011, MOL MICROBIOL, V81, P540, DOI 10.1111/j.1365-2958.2011.07713.x; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002; Yoshihisa T, 1996, J BIOL CHEM, V271, P9429, DOI 10.1074/jbc.271.16.9429; Zhang JJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06453; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	35	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2915	2926		10.1074/jbc.M117.816561	http://dx.doi.org/10.1074/jbc.M117.816561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317498	Green Published, hybrid			2022-12-28	WOS:000426051900025
J	Chen, ZZ; Liu, YT; Yao, LT; Guo, SY; Gao, YF; Zhu, PP				Chen, Zhenzhen; Liu, Yating; Yao, Lintong; Guo, Shiying; Gao, Yanfeng; Zhu, Pingping			The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; long noncoding RNA (long ncRNA; lncRNA); liver cancer; chromatin regulation; tumor promoter; tumor therapy; myristoylated alanine-rich protein kinase C substrate; protein kinase C signaling; self-renewal; tumor targeting; Zic family member 2	CANCER STEM-CELLS; IDENTIFICATION; ACTIVATION; HEDGEHOG; EXPRESSION; EVOLUTION; LNCRNAS; CD133	Liver tumor-initiating cells (TICs) form small subsets of cells in hepatocellular tumors and account for tumorigenesis, metastasis, recurrence, and drug resistance. Recently, we found that the transcription factor Zic family member 2 (ZIC2) is highly expressed in liver TICs and required for their self-renewal. However, the molecular mechanisms underlying self-renewal of liver TICs remain unclear. Here, using expression profiling and CRISPR-interference assays with clinical samples of human liver cancers, we identified a long noncoding RNA (lncRNA), lncZic2, that is located near the ZIC2 locus and was highly expressed in liver cancer and liver TICs. We found that lncZic2 is required for the self-renewal of liver TICs in a ZIC2-independent manner. lncZic2 drove the expression of myristoylated alanine-rich protein kinase C substrate (MARCKS) and MARCKS-like 1 (MARCKSL1), whose expression levels were increased during liver tumorigenesis and liver TIC self-renewal. Mechanistically, lncZic2 interacted with BRM/SWI2-related gene 1 (BRG1) and recruited this transcriptional regulator to the promoters of the MARCKS and MARCKSL1 gene, which activated expression of these genes. Moreover, we noted that depletion of lncZic2 and BRG1 decreases MARCKS and MARCKSL1 expression and diminishes liver TIC levels. In conclusion, lncZic2 is required for the self-renewal of liver TICs by up-regulating MARCKS and MARCKSL1 gene expression via the transcription factor BRG1. Our findings suggest that the lncZic2-BRG1-MARCKS/MARCKSL1 signaling cascade might be a potential target for eliminating liver TICs in the management of liver cancer.	[Chen, Zhenzhen; Liu, Yating; Yao, Lintong; Gao, Yanfeng; Zhu, Pingping] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Guo, Shiying] Wuhan Univ Technol, Sch Chem, Dept Pharmaceut Engn, Wuhan 430070, Hubei, Peoples R China	Zhengzhou University; Wuhan University of Technology	Gao, YF; Zhu, PP (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China.	gaoyf@zzu.edu.cn; pingpingchustc@hotmail.com		, Chen/0000-0003-2093-4639	National Natural Science Foundation of China [U1604286, U1704174, 81601450, 81601448]; Development Fund for Outstanding Young Teachers of Zhengzhou University [1521311059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Fund for Outstanding Young Teachers of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (U1604286, U1704174, 81601450, and 81601448) and the Development Fund for Outstanding Young Teachers of Zhengzhou University (1521311059). The authors declare that they have no conflicts of interest with the contents of this article.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen ZZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12598; Chen ZZ, 2018, ONCOGENE, V37, P3098, DOI 10.1038/s41388-018-0203-6; Chen ZZ, 2016, MOL PHARMACEUT, V13, P2749, DOI 10.1021/acs.molpharmaceut.6b00352; Chen ZZ, 2015, SMALL, V11, P952, DOI 10.1002/smll.201401397; Chen ZH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-90; Feng DF, 2015, J BIOMATER TISS ENG, V5, P635, DOI 10.1166/jbt.2015.1363; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Liu BY, 2017, NAT IMMUNOL, V18, P499, DOI 10.1038/ni.3712; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhu PP, 2017, PROG BIOCHEM BIOPHYS, V44, P697, DOI 10.16476/j.pibb.2017.0242; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608; Zhu PP, 2016, NAT STRUCT MOL BIOL, V23, P631, DOI 10.1038/nsmb.3235; Zhu PP, 2015, J CLIN INVEST, V125, P3795, DOI 10.1172/JCI81979; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122	41	25	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7982	7992		10.1074/jbc.RA117.001321	http://dx.doi.org/10.1074/jbc.RA117.001321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29588366	hybrid, Green Published			2022-12-28	WOS:000433224600006
J	Ghai, I; Bajaj, H; Bafna, J; Hussein, HAE; Winterhalter, M; Wagner, R				Ghai, Ishan; Bajaj, Harsha; Arun Bafna, Jayesh; Hussein, Hussein Ali El Damrany; Winterhalter, Mathias; Wagner, Richard			Ampicillin permeation across OmpF, the major outer-membrane channel in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; antibiotics; electrophysiology; bacteria; membrane reconstitution; ampicillin; NMR; OmpF; peniciollic acid; planar bilayer	BETA-LACTAM ANTIBIOTICS; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTION; PERMEABILITY BARRIERS; PENICILLINS; RESISTANCE; PORINS; PIPERAZINEDIONE; DEGRADATION; ORGANIZATION	The outer cell wall of the Gram-negative bacteria is a crucial barrier for antibiotics to reach their target. Here, we show that the chemical stability of the widely used antibiotic ampicillin is a major factor in the permeation across OmpF to reach the target in the periplasm. Using planar lipid bilayers we investigated the interactions and permeation of OmpF with ampicillin, its basic pH-induced primary degradation product (penicilloic acid), and the chemically more stable benzylpenicillin. We found that the solute-induced ion current fluctuation is 10 times higher with penicilloic acid than with ampicillin. Furthermore, we also found that ampicillin can easily permeate through OmpF, at an ampicillin gradient of 10 m and a conductance of G(amp) 3.8 fS, with a flux rate of roughly 237 molecules/s of ampicillin at V-m = 10 mV. The structurally related benzylpenicillin yields a lower conductance of G(amp) 2 fS, corresponding to a flux rate of approximate to 120 molecules/s. In contrast, the similar sized penicilloic acid was nearly unable to permeate through OmpF. MD calculations show that, besides their charge difference, the main differences between ampicillin and penicilloic acid are the shape of the molecules, and the strength and direction of the dipole vector. Our results show that OmpF can impose selective permeation on similar sized molecules based on their structure and their dipolar properties.	[Ghai, Ishan; Bajaj, Harsha; Arun Bafna, Jayesh; Hussein, Hussein Ali El Damrany; Winterhalter, Mathias; Wagner, Richard] Jacobs Univ Bremen, Dept Life Sci & Chem, D-28719 Bremen, Germany	Jacobs University	Wagner, R (corresponding author), Jacobs Univ Bremen GmbH, Inst Biophys Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.	ri.wagner@jacobs-university.de	Bajaj, Harsha/AAA-1483-2020	Bajaj, Harsha/0000-0001-5422-5182; Hussein, Hussein Ali El Damrany/0000-0003-2036-3557; Winterhalter, Mathias/0000-0002-1604-3318	Innovative Medicines Initiatives Joint Undertaking [115525]; , European Union's seventh framework program Grant FP7; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies	Innovative Medicines Initiatives Joint Undertaking; , European Union's seventh framework program Grant FP7; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies	This work was conducted as part of the TRANSLOCATION consortium supported by Innovative Medicines Initiatives Joint Undertaking Grant Agreement 115525, European Union's seventh framework program Grant FP7/2007-2013, and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies. The authors declare that they have no conflicts of interest with the contents of this article.	Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414; Bajaj H, 2017, ACS NANO, V11, P5465, DOI 10.1021/acsnano.6b08613; Bajaj H, 2012, BIOCHEMISTRY-US, V51, P10244, DOI 10.1021/bi301398j; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; BIRD AE, 1983, J PHARM PHARMACOL, V35, P138, DOI 10.1111/j.2042-7158.1983.tb04292.x; Bodrenko I, 2015, ANALYST, V140, P4820, DOI 10.1039/c4an02293a; BRANCH SK, 1987, J PHARMACEUT BIOMED, V5, P73, DOI 10.1016/0731-7085(87)80011-0; BRATBAK G, 1985, APPL ENVIRON MICROB, V49, P1488, DOI 10.1128/AEM.49.6.1488-1493.1985; Brittain H. G., 1993, ANAL PROFILES DRUG S; BUNDGAARD H, 1982, J PHARM PHARMACOL, V34, P304, DOI 10.1111/j.2042-7158.1982.tb04712.x; BUNDGAARD H, 1979, INT J PHARM, V3, P1, DOI 10.1016/0378-5173(79)90044-9; BUNDGAARD H, 1981, INT J PHARM, V9, P273, DOI 10.1016/0378-5173(81)90031-4; BUNDGAARD H, 1977, J CHROMATOGR, V132, P51, DOI 10.1016/S0021-9673(00)93770-1; Collignon PC, 2016, CLIN INFECT DIS, V63, P1087, DOI 10.1093/cid/ciw475; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; DEVER LA, 1991, ARCH INTERN MED, V151, P886, DOI 10.1001/archinte.151.5.886; do Nascimento TG, 2013, J PHARMACEUT BIOMED, V73, P59, DOI 10.1016/j.jpba.2012.04.010; Gallelli J F, 1967, Am J Hosp Pharm, V24, P425; Ghai I, 2017, J PHYS CHEM LETT, V8, P1295, DOI 10.1021/acs.jpclett.7b00062; Ghai I, 2017, BIOCHEM BIOPH RES CO, V484, P51, DOI 10.1016/j.bbrc.2017.01.076; Ghuysen J.-M., 1994, BACTERIAL CELL WALL; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; HANCOCK REW, 1994, N COMP BIOC, V27, P263, DOI DOI 10.1016/S0167-7306(08)60415-9; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; JAMES MJ, 1985, AM J HOSP PHARM, V42, P1095, DOI 10.1093/ajhp/42.5.1095; Khalili-Araghi F, 2013, J GEN PHYSIOL, V142, P465, DOI 10.1085/jgp.201311014; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Malloci G, 2015, MOLECULES, V20, P13997, DOI 10.3390/molecules200813997; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mouton JW, 2007, CURR OPIN CRIT CARE, V13, P598, DOI 10.1097/MCC.0b013e3282e2a98f; Munita JM, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P481, DOI 10.1128/microbiolspec.VMBF-0016-2015; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NGUYENDISTECHE M, 1974, EUR J BIOCHEM, V41, P457, DOI 10.1111/j.1432-1033.1974.tb03287.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; RAPSON HDC, 1963, J PHARM PHARMACOL, V15, pT222, DOI 10.1111/j.2042-7158.1963.tb11216.x; RAUHUT G, 1993, J COMPUT CHEM, V14, P503, DOI 10.1002/jcc.540140502; RobinsonFuentes VA, 1997, J PHARM PHARMACOL, V49, P843, DOI 10.1111/j.2042-7158.1997.tb06124.x; Roux B, 2004, Q REV BIOPHYS, V37, P15, DOI 10.1017/S0033583504003968; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Stewart J., 2009, OPEN MOPAC HOME PAGE; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Tripathi KD, 1994, INDIAN J PHARMACOL, V26, P166; Zhang Yanping, 2002, Int J Pharm Compd, V6, P226	52	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7030	7037		10.1074/jbc.RA117.000705	http://dx.doi.org/10.1074/jbc.RA117.000705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540483	Green Published, hybrid			2022-12-28	WOS:000431487300033
J	Mitsche, MA; Hobbs, HH; Cohen, JC				Mitsche, Matthew A.; Hobbs, Helen H.; Cohen, Jonathan C.			Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						triglyceride; phospholipid; phosphatidylglycerol; polyunsaturated fatty acid (PUFA); lipase; hepatic steatosis	LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; CONFERS SUSCEPTIBILITY; WIDE ASSOCIATION; FAMILY-MEMBERS; ADIPOSE-TISSUE; PNPLA3; VARIANT; I148M; ADIPONUTRIN	Fatty liver disease (FLD) is a burgeoning health problem. A missense variant (I148M) in patatin-like phospholipase domain-containing protein 3 (PNPLA3) confers susceptibility to FLD, although the mechanism is not known. To glean first insights into the physiological function of PNPLA3, we performed detailed lipidomic profiling of liver lysates and lipid droplets (LDs) from WT and Pnpla3(-/-) (KO) mice and from knock-in (ki) mice expressing either the 148M variant (IM-ki mice) or a variant (S47A) that renders the protein catalytically inactive (SA-ki mice). The four strains differed in composition of very-long-chain polyunsaturated fatty acids (vLCPUFA) in hepatic LDs. In the LDs of IM-ki mice, vLCPUFAs were depleted from triglycerides and enriched in phospholipids. Conversely, vLCPUFAs were enriched in triglycerides and depleted from phospholipids in SA-ki and Pnpla3(-/-) mice. Release of vLCPUFAs from hepatic LDs incubated ex vivo was increased in droplets from IM-ki mice and decreased from droplets isolated from Pnpla3(-/-) and SA-ki mice relative to those of WT mice. Thus, the physiological role of PNPLA3 appears to be to remodel triglycerides and phospholipids in LDs, perhaps to accommodate changes in LD size in response to feeding. Because SA-ki and IM-ki both cause FLD and yet have opposite effects on the lipidomic profile of LDs, we conclude that the FLD associated with genetic variation in PNPLA3 is not related to the enzyme's role in remodeling LD lipids.	[Mitsche, Matthew A.; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Mitsche, Matthew A.; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mitsche, Matthew A.; Cohen, Jonathan C.] Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH; Cohen, JC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Hobbs, HH; Cohen, JC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Cohen, JC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA.; Hobbs, HH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu; Jonathan.cohen@utsouthwestern.edu			NIGMS, National Institutes of Health (NIH) [K01-GM109317]; NIDDK, NIH [R01-DK090066]; NHLBI Grant [P01 HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM109317] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant K01-GM109317 and, NIDDK, NIH, Grant R01-DK090066, and NHLBI Grant P01 HL20948. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; BasuRay S, 2017, HEPATOLOGY, V66, P1111, DOI 10.1002/hep.29273; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Burza MA, 2012, DIGEST LIVER DIS, V44, P1037, DOI 10.1016/j.dld.2012.05.006; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Chorlay A, 2018, BIOPHYS J, V114, P631, DOI 10.1016/j.bpj.2017.12.014; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graff M, 2013, INT J OBESITY, V37, P432, DOI 10.1038/ijo.2012.65; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Hutchins PM, 2008, J LIPID RES, V49, P804, DOI 10.1194/jlr.M700521-JLR200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luukkonen PK, 2016, J HEPATOL, V64, P1167, DOI 10.1016/j.jhep.2016.01.002; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; NILSSON A, 1988, BIOCHIM BIOPHYS ACTA, V959, P288, DOI 10.1016/0005-2760(88)90202-0; Peter A, 2014, DIABETOLOGIA, V57, P2103, DOI 10.1007/s00125-014-3310-0; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Ruhanen H, 2014, J LIPID RES, V55, P739, DOI 10.1194/jlr.M046607; Shibusawa Y, 2006, J CHROMATOGR A, V1133, P119, DOI 10.1016/j.chroma.2006.08.004; Smagris E, 2016, J BIOL CHEM, V291, P10659, DOI 10.1074/jbc.M116.719955; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Stender S, 2017, NAT GENET, V49, P842, DOI 10.1038/ng.3855; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Yamashita A., 2017, BIOLOGY, V6, pE23; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6958	6968		10.1074/jbc.RA118.002333	http://dx.doi.org/10.1074/jbc.RA118.002333			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29555681	hybrid, Green Published			2022-12-28	WOS:000431487300027
J	Du, YY; Liu, Y; Xu, YJ; Juan, JX; Zhang, ZB; Xu, Z; Cao, BY; Wang, Q; Zeng, YY; Mao, XL				Du, Yanyun; Liu, Yan; Xu, Yujia; Juan, Jiaxiang; Zhang, Zubin; Xu, Zhuan; Cao, Biyin; Wang, Qi; Zeng, Yuanying; Mao, Xinliang			The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH-FACTOR-BETA; MULTIPLE-MYELOMA; TGF-BETA; NEDD4-BINDING PROTEIN; ANDROGEN RECEPTOR; PMEPA1; GENE; UBIQUITINATION; PROLIFERATION	TMEPAI (transmembrane prostate androgen-induced protein, also called prostate transmembrane protein, androgen-induced 1 (PMEPA1)) is a type I transmembrane (TM) protein, but its cellular function is largely unknown. Here, studying factors influencing the stability of c-Maf, a critical transcription factor in multiple myeloma (MM), we found that TMEPAI induced c-Maf degradation. We observed that TMEPAI recruited NEDD4 (neural precursor cell expressed, developmentally down-regulated 4), aWWdomain-containing ubiquitin ligase, to c-Maf, leading to its degradation through the proteasomal pathway. Further investigation revealed that TMEPAI interacts with NEDD4 via its conserved PY motifs. Alanine substitution or deletion of these motifs abrogated the TMEPAI complex formation with NEDD4, resulting in failed c-Maf degradation. Functionally, TMEPAI suppressed the transcriptional activity of c-Maf. Of note, increased TMEPAI expression was positively associated with the overall survival of MM patients. Moreover, TMEPAI was down-regulated in MMcells, and re-expression of TMEPAI induced MM cell apoptosis. In conclusion, this study highlights that TMEPAI decreases c-Maf stability by recruiting the ubiquitin ligase NEDD4 to c-Maf for proteasomal degradation. Our findings suggest that the restoration of functional TMEPAI expression may represent a promising complementary therapeutic strategy for treating patients with MM.	[Du, Yanyun; Liu, Yan; Xu, Yujia; Juan, Jiaxiang; Zhang, Zubin; Cao, Biyin; Mao, Xinliang] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Zhuan] Soochow Univ, Dept Neurol, Affiliated Hosp 1, Suzhou 215100, Peoples R China; [Zeng, Yuanying] Suzhou Municipal Hosp, Dept Oncol, Suzhou 215100, Peoples R China; [Wang, Qi; Mao, Xinliang] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou 510405, Guangdong, Peoples R China	Soochow University - China; Soochow University - China; Guangzhou University of Chinese Medicine	Zeng, YY (corresponding author), Dept Oncol, Suzhou Municipal Hosp East Campus, Suzhou 215100, Peoples R China.; Mao, XL (corresponding author), Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	zengyuanying@163.com; xinliangmao@suda.edu.cn			National Natural Science Foundation of China [81320108023, 81600171, 81770215]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant [BK2013003]; Suzhou Key Laboratory for Pediatric Leukemia Grant [SZS201615]; Suzhou Key Medical Center Grant [Szzx201506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant; Suzhou Key Laboratory for Pediatric Leukemia Grant; Suzhou Key Medical Center Grant	This work was partly supported by National Natural Science Foundation of China Grants 81320108023 (to X.M.), 81600171 (to Z.Z.), and 81770215 (to B.C.), by funds from the Priority Academic Program Development of Jiangsu Higher Education Institutions (to X.M.), and by Jiangsu Key Laboratory for Neuropsychiatric Diseases Grant BK2013003 (to X.M.). This work was also supported in part by Suzhou Key Laboratory for Pediatric Leukemia Grant SZS201615 (to X.M.) and by Suzhou Key Medical Center Grant Szzx201506 (to Y.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Azamil S, 2015, BIOCHEM BIOPH RES CO, V456, P580, DOI 10.1016/j.bbrc.2014.11.107; Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Chang H, 2007, LEUKEMIA, V21, P1572, DOI 10.1038/sj.leu.2404669; Chen GD, 2014, INT J BIOCHEM CELL B, V57, P157, DOI 10.1016/j.biocel.2014.10.024; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Li H, 2015, ONCOTARGET, V6, P15137, DOI 10.18632/oncotarget.3526; Liu R, 2011, J PATHOL, V223, P683, DOI 10.1002/path.2834; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; OHAINMHIRE E, 2014, PLOS ONE, V0009; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Singha Prajjal K, 2014, Genes Cancer, V5, P320; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Nguyen TTV, 2014, CANCER SCI, V105, P334, DOI 10.1111/cas.12355; Wang SY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.450; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203	25	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5847	5859		10.1074/jbc.RA117.000972	http://dx.doi.org/10.1074/jbc.RA117.000972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29467225	hybrid, Green Published			2022-12-28	WOS:000430497300009
J	Eaton, JRO; Alenazi, Y; Singh, K; Davies, G; Geis-Asteggiante, L; Kessler, B; Robinson, CV; Kawamura, A; Bhattacharya, S				Eaton, James R. O.; Alenazi, Yara; Singh, Kamayani; Davies, Graham; Geis-Asteggiante, Lucia; Kessler, Benedikt; Robinson, Carol V.; Kawamura, Akane; Bhattacharya, Shoumo			The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; RECEPTORS; ANTAGONISM; EXPRESSION; DISEASE; DISPLAY; UPDATE; FAMILY; CELLS; HIV	Tick chemokine-binding proteins (evasins) are an emerging class of biologicals that target multiple chemokines and show anti-inflammatory activities in preclinical disease models. Using yeast surface display, we identified a CCL8-binding evasin, P672, from the tick Rhipicephalus pulchellus. We found that P672 binds CCL8 and eight other CC-class chemokines with a K-d < 10 nM and four other CC chemokines with a K-d between 10 and 100 nM and neutralizes CCL3, CCL3L1, and CCL8 with an IC50 < 10 nM. The CC chemokine-binding profile was distinct from that of evasin 1 (EVA1), which does not bind CCL8. We also show that P672's binding activity can be markedly modulated by the location of a StrepII-His purification tag. Combining native MS and bottom-up proteomics, we further demonstrated that P672 is glycosylated and forms a 1: 1 complex with CCL8, disrupting CCL8 homodimerization. Homology modeling of P672 using the crystal structure of the EVA1 and CCL3 complex as template suggested that 44 N-terminal residues of P672 form most of the contacts with CCL8. Replacing the 29 N-terminal residues of EVA1 with the 44 N-terminal residues of P672 enabled this hybrid evasin to bind and neutralize CCL8, indicating that the CCL8-binding properties of P672 reside, in part, in its N-terminal residues. This study shows that the function of certain tick evasins can be manipulated simply by adding a tag. We conclude that homology modeling helps identify regions with transportable chemokine-binding functions within evasins, which can be used to construct hybrid evasins with altered properties.	[Eaton, James R. O.; Alenazi, Yara; Singh, Kamayani; Davies, Graham; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford OX3 7BN, England; [Eaton, James R. O.; Geis-Asteggiante, Lucia; Robinson, Carol V.; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Dept Chem, Oxford OX3 7BN, England; [Kessler, Benedikt] Univ Oxford, Radcliffe Dept Med, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford	Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	sbhattac@well.ox.ac.uk	Kawamura, Akane/I-4047-2018; Kessler, Benedikt/AAY-8614-2021; Bhattacharya, Shoumo/F-4127-2010	Kawamura, Akane/0000-0003-1169-5082; Kessler, Benedikt/0000-0002-8160-2446; Bhattacharya, Shoumo/0000-0002-5571-0478; Geis Asteggiante, Lucia/0000-0002-4305-3044; robinson, carol/0000-0001-7829-5505	British Heart Foundation (BHF) Chair Award [CH/09/003]; Oxford BHF Centre of Research Excellence Award [RE/13/1/30181]; BHF Oxbridge Centre for Regenerative Medicine Award [AVMEBCA1]; Radcliffe Department of Medicine, University of Oxford; Lab282; Oxford BHF Centre of Research Excellence; Saudi Arabian Cultural Bureau; Medical Research Council (MRC) [MR/N020413/1]; Royal Society Dorothy Hodgkin Fellowship; MRC [MR/N020413/1] Funding Source: UKRI	British Heart Foundation (BHF) Chair Award; Oxford BHF Centre of Research Excellence Award; BHF Oxbridge Centre for Regenerative Medicine Award; Radcliffe Department of Medicine, University of Oxford; Lab282; Oxford BHF Centre of Research Excellence; Saudi Arabian Cultural Bureau; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by British Heart Foundation (BHF) Chair Award CH/09/003 (to S.B.); Oxford BHF Centre of Research Excellence Award RE/13/1/30181; BHF Oxbridge Centre for Regenerative Medicine Award AVMEBCA1; and the Radcliffe Department of Medicine, University of Oxford. The CKBP sequences and hybrid CKBP concept form part of the basis of a patent application. S. B. has received funding from Lab282 for development of tick CKBPs as therapeutics in partnership with Evotec AG.; Supported by a studentship from the Oxford BHF Centre of Research Excellence.; Supported by a studentship from the Saudi Arabian Cultural Bureau.; Supported by Grant MR/N020413/1 from the Medical Research Council (MRC).; Supported by a Royal Society Dorothy Hodgkin Fellowship.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fischer R, 2015, PROTEOMICS, V15, P1224, DOI 10.1002/pmic.201400436; Garin A, 2011, EXP CELL RES, V317, P602, DOI 10.1016/j.yexcr.2010.12.021; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Gouwy M, 2012, IMMUNOL LETT, V145, P10, DOI 10.1016/j.imlet.2012.04.005; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Huma ZE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8529; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Keates T, 2012, NEW BIOTECHNOL, V29, P515, DOI 10.1016/j.nbt.2011.10.007; Krohn S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00193; Kufareva I, 2017, ANNU REV BIOPHYS, V46, P175, DOI 10.1146/annurev-biophys-051013-022942; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Lubman OY, 2016, STRUCTURE, V24, P57, DOI 10.1016/j.str.2015.10.018; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04378-1; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tiller KE, 2015, ANNU REV BIOMED ENG, V17, P191, DOI 10.1146/annurev-bioeng-071114-040733; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Yen TY, 2013, BIOMOLECULES, V3, P270, DOI 10.3390/biom3020270; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	44	15	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6134	6146		10.1074/jbc.RA117.000487	http://dx.doi.org/10.1074/jbc.RA117.000487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487134	Green Published, hybrid			2022-12-28	WOS:000430497300030
J	Nyakatura, EK; Zak, SE; Wec, AZ; Hofmann, D; Shulenin, S; Bakken, RR; Aman, MJ; Chandran, K; Dye, JM; Lai, JR				Nyakatura, Elisabeth K.; Zak, Samantha E.; Wec, Anna Z.; Hofmann, Daniel; Shulenin, Sergey; Bakken, Russell R.; Aman, M. Javad; Chandran, Kartik; Dye, John M.; Lai, Jonathan R.			Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS GLYCOPROTEIN; FAMILY FILOVIRIDAE; NONHUMAN-PRIMATES; BROAD PROTECTION; STRUCTURAL BASIS; ENTRY REQUIRES; HUMAN SURVIVOR; MARBURG VIRUS; SUDAN VIRUSES; EBOLAVIRUSES	Filoviruses (family Filoviridae) include five ebolaviruses and Marburg virus. These pathogens cause a rapidly progressing and severe viral disease with high mortality rates (generally 30-90%). Outbreaks of filovirus disease are sporadic and, until recently, were limited to less than 500 cases. However, the 2013-2016 epidemic in western Africa, caused by Ebola virus (EBOV), illustrated the potential of filovirus outbreaks to escalate to a much larger scale (over 28,000 suspected cases). mAbs against the envelope glycoprotein represent a promising therapeutic platform for managing filovirus infections. However, mAbs that exhibit neutralization or protective properties against multiple filoviruses are rare. Here we examined a panel of engineered bi- and trispecific antibodies, in which variable domains of mAbs that target epitopes from multiple filoviruses were combined, for their capacity to neutralize viral infection across filovirus species. We found that bispecific combinations targeting EBOV and Sudan virus (another ebolavirus), provide potent cross-neutralization and protection in mice. Furthermore, trispecific combinations, targeting EBOV, Sudan virus, and Marburg virus, exhibited strong neutralization potential against all three viruses. These results provide important insights into multispecific antibody engineering against filoviruses and will inform future immunotherapeutic discoveries.	[Nyakatura, Elisabeth K.; Hofmann, Daniel; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wec, Anna Z.; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Zak, Samantha E.; Bakken, Russell R.; Dye, John M.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Shulenin, Sergey; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD 20878 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lai, JR (corresponding author), Dept Biochem, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu		Dye, John/0000-0002-0883-5016	NIAID, National Institutes of Health Centers of Excellence for Translational Research [U19 AI109762]; National Institutes of Health [R01-AI125462, R41-AI122403]; Deutscher Akademischer Austauschdienst (German Academic Exchange Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109762, R01AI134824, R42AI122403, R01AI125462, R01AI132256, R41AI122403] Funding Source: NIH RePORTER	NIAID, National Institutes of Health Centers of Excellence for Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Centers of Excellence for Translational Research Grant U19 AI109762 and National Institutes of Health Grants R01-AI125462 (to J.R.L.) and R41-AI122403 (to J.R.L. and M.J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Opinions, conclusions, interpretations, and recommendations are those of the authors and are not necessarily endorsed by the United States Army. The mention of trade names or commercial products does not constitute endorsement or recommendation for use by the Department of the Army or the Department of Defense.; Supported in part by a postdoctoral fellowship from the Deutscher Akademischer Austauschdienst (German Academic Exchange Service).	Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447; Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15; Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; de La Vega MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005221; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Frei JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19193; Furuyama W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20514; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hofmann D, 2017, IMMUNOL LETT, V190, P289, DOI 10.1016/j.imlet.2017.09.002; Holtsberg FW, 2016, J VIROL, V90, P266, DOI 10.1128/JVI.02171-15; Howell KA, 2016, CELL REP, V15, P1514, DOI 10.1016/j.celrep.2016.04.026; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Keck ZY, 2016, J VIROL, V90, P279, DOI 10.1128/JVI.02172-15; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Mire CE, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8711; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Nyakatura EK, 2017, HUM VACC IMMUNOTHER, V13, P836, DOI 10.1080/21645515.2016.1251536; Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Wec AZ, 2016, SCIENCE, V354, P350, DOI 10.1126/science.aag3267; Wong AC, 2010, J VIROL, V84, P163, DOI 10.1128/JVI.01832-09; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630	38	5	5	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6201	6211		10.1074/jbc.RA117.001627	http://dx.doi.org/10.1074/jbc.RA117.001627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29500195	Green Published, hybrid			2022-12-28	WOS:000430497300035
J	Verstraete, MM; Perez-Borrajero, C; Brown, KL; Heinrichs, DE; Murphy, MEP				Verstraete, Meghan M.; Perez-Borrajero, Cecilia; Brown, Kirstin L.; Heinrichs, David E.; Murphy, Michael E. P.			SbnI is a free serine kinase that generates O-phospho-L-serine for staphyloferrin B biosynthesis in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE; CITRATE SYNTHASE; SULFINIC ACID; IRON; SIDEROPHORE; CYSTEINE; GENE; VIRULENCE; IDENTIFICATION; PEROXIREDOXIN	Staphyloferrin B (SB) is an iron-chelating siderophore produced by Staphylococcus aureus in invasive infections. Proteins for SB biosynthesis and export are encoded by the sbnABCDEF-GHI gene cluster, in which SbnI, a member of the ParB/Srx superfamily, acts as a heme-dependent transcriptional regulator of the sbn locus. However, no structural or functional information about SbnI is available. Here, a crystal structure of SbnI revealed striking structural similarity to an ADP-dependent free serine kinase, SerK, from the archaea Thermococcus kodakarensis. We found that features of the active sites are conserved, and biochemical assays and P-31 NMR and HPLC analyses indicated that SbnI is also a free serine kinase but uses ATP rather than ADP as phosphate donor to generate the SB precursor O-phospho-L-serine (OPS). SbnI consists of two domains, and elevated B-factors in domain II were consistent with the open-close reaction mechanism previously reported for SerK. Mutagenesis of Glu(20) and Asp(58) in SbnI disclosed that they are required for kinase activity. The only known OPS source in bacteria is through the phosphoserine aminotransferase activity of SerC within the serine biosynthesis pathway, and we demonstrate that an S. aureus serC mutant is a serine auxotroph, consistent with a function in L-serine biosynthesis. However, the serC mutant strain could produce SB when provided L-serine, suggesting that SbnI produces OPS for SB biosynthesis in vivo. These findings indicate that besides transcriptionally regulating the sbn locus, SbnI also has an enzymatic role in the SB biosynthetic pathway.	[Verstraete, Meghan M.; Brown, Kirstin L.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Perez-Borrajero, Cecilia] Univ British Columbia, Genome Sci & Technol Program Life Sci, Vancouver, BC V6T 1Z3, Canada; [Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	University of British Columbia; University of British Columbia; Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michael.murphy@ubc.ca	Heinrichs, David/ABD-5702-2021	Verstraete, Meghan/0000-0003-0422-2826; Perez-Borrajero, Cecilia/0000-0002-3167-7159; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research (CIHR) [MOP-49597, MOP-38002]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-49597 (to M.E.P.M) and MOP-38002 (to D.E.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arsic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045952; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beasley FC, 2011, INFECT IMMUN, V79, P2345, DOI 10.1128/IAI.00117-11; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen BW, 2015, P NATL ACAD SCI USA, V112, P6613, DOI 10.1073/pnas.1421927112; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; CLARKE SJ, 1973, J BACTERIOL, V113, P1091, DOI 10.1128/JB.113.3.1091-1095.1973; COHN M, 1960, J BIOL CHEM, V235, P3250; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fodje M, 2014, J SYNCHROTRON RADIAT, V21, P633, DOI 10.1107/S1600577514005578; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iglesias-Baena I, 2010, J EXP BOT, V61, P1509, DOI 10.1093/jxb/erq016; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kobylarz MJ, 2016, BIOCHEMISTRY-US, V55, P927, DOI 10.1021/acs.biochem.5b01045; Kobylarz MJ, 2014, J BIOL CHEM, V289, P33797, DOI 10.1074/jbc.M114.603175; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Laakso HA, 2016, J BIOL CHEM, V291, P29, DOI 10.1074/jbc.M115.696625; Lamb AL, 2015, BBA-PROTEINS PROTEOM, V1854, P1054, DOI 10.1016/j.bbapap.2015.05.001; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Maindola P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6322; Makino Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13446; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nagata R, 2017, ACS CHEM BIOL, V12, P1514, DOI 10.1021/acschembio.7b00064; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Robb Frank T., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P101; Rudolph F B, 1979, Methods Enzymol, V63, P22; Schumacher MA, 2015, SCIENCE, V349, P1120, DOI 10.1126/science.aaa9046; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smaldone GT, 2012, J BACTERIOL, V194, P2594, DOI 10.1128/JB.05990-11; Spahich NA, 2016, MOL MICROBIOL, V100, P759, DOI 10.1111/mmi.13347; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Xu YJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0695-6; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311	72	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6147	6160		10.1074/jbc.RA118.001875	http://dx.doi.org/10.1074/jbc.RA118.001875			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483190	hybrid, Green Published			2022-12-28	WOS:000430497300031
J	Giovannone, AJ; Winterstein, C; Bhattaram, P; Reales, E; Low, SH; Section, JEB; Xu, MM; Lalli, MA; Paragraph, JBH; Weimbs, T				Giovannone, Adrian J.; Winterstein, Christine; Bhattaram, Pallavi; Reales, Elena; Low, Seng Hui; Section, Julie E. Baggs; Xu, Mimi; Lalli, Matthew A.; Paragraph, John B. Hogenesch; Weimbs, Thomas			Soluble syntaxin 3 functions as a transcriptional regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE TRAFFICKING; ALTERNATIVE SPLICE VARIANT; EPITHELIAL-CELL POLARITY; HPC-1/SYNTAXIN 1A; SIGNALING PATHWAY; MAMMALIAN-CELLS; NOBEL LECTURE; FACTOR PEA3; LOCALIZATION; FUSION	Syntaxins are a conserved family of SNARE proteins and contain C-terminal transmembrane anchors required for their membrane fusion activity. Here we show that Stx3 (syntaxin 3) unexpectedly also functions as a nuclear regulator of gene expression. We found that alternative splicing creates a soluble isoform that we termed Stx3S, lacking the transmembrane anchor. Soluble Stx3S binds to the nuclear import factor RanBP5 (RAN-binding protein 5), targets to the nucleus, and interacts physically and functionally with several transcription factors, including ETV4 (ETS variant 4) and ATF2 (activating transcription factor 2). Stx3S is differentially expressed in normal human tissues, during epithelial cell polarization, and in breast cancer versus normal breast tissue. Inhibition of endogenous Stx3S expression alters the expression of cancer-associated genes and promotes cell proliferation. Similar nuclear-targeted, soluble forms of other syntaxins were identified, suggesting that nuclear signaling is a conserved, novel function common among these membrane-trafficking proteins.	[Xu, Mimi; Lalli, Matthew A.; Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Xu, Mimi; Lalli, Matthew A.; Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Section, Julie E. Baggs] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Paragraph, John B. Hogenesch] Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA; [Winterstein, Christine] Biogen GmbH, D-85737 Ismaning, Germany; [Bhattaram, Pallavi] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Reales, Elena] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Reales, Elena] Univ Autonoma Madrid, E-28049 Madrid, Spain	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Pennsylvania; Pennsylvania Medicine; Cincinnati Children's Hospital Medical Center; Cleveland Clinic Foundation; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Weimbs, T (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	weimbs@ucsb.edu		REALES RODRIGUEZ, ELENA/0000-0001-6082-3306; Weimbs, Thomas/0000-0001-9423-5561	National Institutes of Health [DK095248, DK62338]; NINDS, National Institutes of Health [1R01NS054794]; NHBLI, National Institutes of Health [1R01HL097800]; California Cancer Research Coordinating Committee; Cancer Center of Santa Barbara; Spanish Ministry of Education and Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK095248, R01DK062338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHBLI, National Institutes of Health; California Cancer Research Coordinating Committee; Cancer Center of Santa Barbara; Spanish Ministry of Education and Science(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant DK095248 and DK62338 (to T.W.); NINDS, National Institutes of Health Grant 1R01NS054794 (to J.B.H.); and NHBLI, National Institutes of Health Grant 1R01HL097800 (to J.B.H.); funds from the California Cancer Research Coordinating Committee (to T.W.); and postdoctoral fellowships from the Cancer Center of Santa Barbara (to C.W.) and the Spanish Ministry of Education and Science (to E.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Horvath A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02256; IBARAKI K, 1995, BIOCHEM BIOPH RES CO, V211, P997, DOI 10.1006/bbrc.1995.1910; Jagadish MN, 1997, BIOCHEM J, V321, P151, DOI 10.1042/bj3210151; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Keld R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-313; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kottakis F, 2014, CANCER RES, V74, P3935, DOI 10.1158/0008-5472.CAN-13-2733; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kuster A, 2015, J BIOL CHEM, V290, P28056, DOI 10.1074/jbc.M115.666362; Kuure S, 2010, DEVELOPMENT, V137, P1975, DOI 10.1242/dev.051656; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Low SH, 2002, J CELL SCI, V115, P4545, DOI 10.1242/jcs.00116; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Martin-Martin B, 1999, J LEUKOCYTE BIOL, V65, P397, DOI 10.1002/jlb.65.3.397; Nakayama T, 2004, J BIOL CHEM, V279, P23728, DOI 10.1074/jbc.M314297200; Nakayama T, 2003, FEBS LETT, V536, P209, DOI 10.1016/S0014-5793(03)00015-2; Nakayama T, 2012, J CELL SCI, V125, P817, DOI 10.1242/jcs.081943; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; OHagan RC, 1996, ONCOGENE, V13, P1323; Pereira S, 2008, GENE, V423, P160, DOI 10.1016/j.gene.2008.07.010; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; PETERSON MD, 1992, J CELL SCI, V102, P581; Quinones B, 1999, J CELL SCI, V112, P4291; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Rothman JE, 2014, ANGEW CHEM INT EDIT, V53, P12676, DOI 10.1002/anie.201402380; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Singha PK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.192; Sudhof TC, 2014, ANGEW CHEM INT EDIT, V53, P12696, DOI 10.1002/anie.201406359; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Weimbs T, 2003, METHODS, V30, P191, DOI 10.1016/S1046-2023(03)00025-2; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5478	5491		10.1074/jbc.RA117.000874	http://dx.doi.org/10.1074/jbc.RA117.000874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475951	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000430044100012
J	Fahey, JM; Stancill, JS; Smith, BC; Girotti, AW				Fahey, Jonathan M.; Stancill, Jennifer S.; Smith, Brian C.; Girotti, Albert W.			Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; photodynamic therapy; nitric oxide; nitric-oxide synthase; NF-kB transcription factor; bromodomain-containing protein 4 (BRD4); acetylation	NF-KAPPA-B; MALIGNANT BRAIN-TUMORS; LUNG-CANCER CELLS; 5-AMINOLEVULINIC ACID; UP-REGULATION; IN-VITRO; CONVENTIONAL THERAPIES; SYNTHASE INHIBITION; SELECTIVE INHIBITOR; BREAST-CANCER	Endogenous nitric oxide (NO) generated by inducible NO synthase (iNOS) promotes glioblastoma cell proliferation and invasion and also plays a key role in glioblastoma resistance to chemotherapy and radiotherapy. Non-ionizing photodynamic therapy (PDT) has anti-tumor advantages over conventional glioblastoma therapies. Our previous studies revealed that glioblastoma U87 cells up-regulate iNOS after a photodynamic challenge and that the resulting NO not only increases resistance to apoptosis but renders surviving cells more proliferative and invasive. These findings were largely based on the effects of inhibiting iNOS activity and scavenging NO. Demonstrating now that iNOS expression in photostressed U87 cells is mediated by NF-B, we hypothesized that (i) recognition of acetylated lysine (acK) on NF-B p65/RelA by bromodomain and extra-terminal (BET) protein Brd4 is crucial; and (ii) by suppressing iNOS expression, a BET inhibitor (JQ1) would attenuate the negative effects of photostress. The following evidence was obtained. (i) Like iNOS, Brd4 protein and p65-acK levels increased severalfold in photostressed cells. (ii) JQ1 at minimally toxic concentrations had no effect on Brd4 or p65-acK up-regulation after PDT but strongly suppressed iNOS, survivin, and Bcl-xL up-regulation, along with the growth and invasion spurt of PDT-surviving cells. (iii) JQ1 inhibition of NO production in photostressed cells closely paralleled that of growth/invasion inhibition. (iv) Finally, at 1% the concentration of iNOS inhibitor 1400W, JQ1 reduced post-PDT cell aggressiveness to a far greater extent. This is the first evidence for BET inhibitor targeting of iNOS expression in cancer cells and how such targeting can markedly improve therapeutic efficacy.	[Fahey, Jonathan M.; Stancill, Jennifer S.; Smith, Brian C.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Girotti, AW (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	agirotti@mcw.edu	Smith, Brian C/D-9949-2013; Girotti, Albert/AAF-6910-2020	Smith, Brian C/0000-0001-6330-2768; Stancill, Jennifer/0000-0002-1612-4695	National Institutes of Health from NCI [CA70823]; Advancing a Healthier Wisconsin Research and Education Program [5520347]; BSC from the MCW Cancer Center [3308238/9]; American Heart Association Scientist Development Grant [15SDG25830057]; American Cancer Society [14-247-29-IRG, 86-004-26-IRG]; Advancing a Healthier Wisconsin Endowment [5520310]; NATIONAL CANCER INSTITUTE [R01CA070823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134643] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Advancing a Healthier Wisconsin Research and Education Program; BSC from the MCW Cancer Center; American Heart Association Scientist Development Grant(American Heart Association); American Cancer Society(American Cancer Society); Advancing a Healthier Wisconsin Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant CA70823 from NCI (to A. W. G.). This work also was supported by Grant 5520347 from the Advancing a Healthier Wisconsin Research and Education Program (to A. W. G.), BSC Grant 3308238/9 from the MCW Cancer Center (to A. W. G.), American Heart Association Scientist Development Grant 15SDG25830057 (to B. C. S.), Institutional Research Grants 14-247-29-IRG and 86-004-26-IRG from the American Cancer Society (to B. C. S.), and Grant 5520310 from the Advancing a Healthier Wisconsin Endowment (to B. C. S.). The authors declare that they have no conflicts of interest with the contents of this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Akaike T, 1996, METHOD ENZYMOL, V268, P211; Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; Bechet D, 2014, CANCER TREAT REV, V40, P229, DOI 10.1016/j.ctrv.2012.07.004; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Benov L, 2015, MED PRIN PRACT, V24, P14, DOI 10.1159/000362416; Berenguer-Daize C, 2016, INT J CANCER, V139, P2047, DOI 10.1002/ijc.30256; Bhowmick R, 2014, CANCER LETT, V343, P115, DOI 10.1016/j.canlet.2013.09.025; Bhowmick R, 2013, FREE RADICAL BIO MED, V57, P39, DOI 10.1016/j.freeradbiomed.2012.12.005; Bhowmick R, 2011, PHOTOCHEM PHOTOBIOL, V87, P378, DOI 10.1111/j.1751-1097.2010.00877.x; Bhowmick R, 2010, FREE RADICAL BIO MED, V48, P1296, DOI 10.1016/j.freeradbiomed.2010.01.040; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Burke AJ, 2017, ANTIOXID REDOX SIGN, V26, P1078, DOI 10.1089/ars.2017.7004; Cekaite L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-273; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Fahey JM, 2017, NITRIC OXIDE-BIOL CH, V62, P52, DOI 10.1016/j.niox.2016.12.003; Fahey JM, 2016, PHOTOCHEM PHOTOBIOL, V92, P842, DOI 10.1111/php.12636; Fahey JM, 2015, NITRIC OXIDE-BIOL CH, V49, P47, DOI 10.1016/j.niox.2015.05.006; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fionda C, 2016, CURR MED CHEM, V23, P2618, DOI 10.2174/0929867323666160727105101; Fu LL, 2015, ONCOTARGET, V6, P5501, DOI 10.18632/oncotarget.3551; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hansel TT, 2003, FASEB J, V17, P1298, DOI 10.1096/fj.02-0633fje; Henderson BW, 1999, PHOTOCHEM PHOTOBIOL, V70, P64, DOI 10.1562/0031-8655(1999)070<0064:POPTAA>2.3.CO;2; Hirst D, 2010, CURR PHARM DESIGN, V16, P411, DOI 10.2174/138161210790232185; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ishida CT, 2017, ONCOTARGET, V8, P29558, DOI 10.18632/oncotarget.16365; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Kleszcz R, 2015, PHARMACOL REP, V67, P1068, DOI 10.1016/j.pharep.2015.03.021; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Korbelik M, 2000, BRIT J CANCER, V82, P1835, DOI 10.1054/bjoc.2000.1157; Kostourou V, 2011, BRIT J CANCER, V104, P83, DOI 10.1038/sj.bjc.6606034; Krishnan N, 2013, FEBS J, V280, P2830, DOI 10.1111/febs.12283; Li F, 2015, ARCH TOXICOL, V89, P711, DOI 10.1007/s00204-015-1470-4; Li WN, 2017, PHOTODIAGN PHOTODYN, V18, P83, DOI 10.1016/j.pdpdt.2017.02.001; LUNA MC, 1994, CANCER RES, V54, P1374; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Matsunaga T, 2014, FREE RADICAL RES, V48, P1371, DOI 10.3109/10715762.2014.957694; Meloche J, 2015, CIRC RES, V117, P525, DOI 10.1161/CIRCRESAHA.115.307004; Olzowy B, 2002, J NEUROSURG, V97, P970, DOI 10.3171/jns.2002.97.4.0970; Pan L, 2017, LASER SURG MED, V49, P719, DOI 10.1002/lsm.22661; Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x; Perez-Salvia M, 2017, ONCOTARGET, V8, P51621, DOI 10.18632/oncotarget.18255; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Quirk BJ, 2015, PHOTODIAGN PHOTODYN, V12, P530, DOI 10.1016/j.pdpdt.2015.04.009; Raber PL, 2014, INT J CANCER, V134, P2853, DOI 10.1002/ijc.28622; Reeves KJ, 2010, J PHOTOCH PHOTOBIO B, V101, P224, DOI 10.1016/j.jphotobiol.2010.07.007; Rollakanti KR, 2015, CANCER MED-US, V4, P633, DOI 10.1002/cam4.361; Sahni JM, 2016, J BIOL CHEM, V291, P23756, DOI 10.1074/jbc.M116.738666; Saleem W, 2011, CANCER SCI, V102, P2150, DOI 10.1111/j.1349-7006.2011.02095.x; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shu SK, 2016, COLD SH Q B, V81, P123, DOI 10.1101/sqb.2016.81.030908; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Tetard MC, 2014, PHOTODIAGN PHOTODYN, V11, P319, DOI 10.1016/j.pdpdt.2014.04.004; Uzdensky A, 2012, BBA-GEN SUBJECTS, V1820, P795, DOI 10.1016/j.bbagen.2012.03.008; Vannini F, 2015, REDOX BIOL, V6, P334, DOI 10.1016/j.redox.2015.08.009; Wali VB, 2017, CANCER RES, V77, P566, DOI 10.1158/0008-5472.CAN-16-1901; Wang J, 2017, CANCER LETT, V391, P141, DOI 10.1016/j.canlet.2017.01.031; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Whelan HT, 2012, J NATL COMPR CANC NE, V10, pS31, DOI 10.6004/jnccn.2012.0171; Wienerroither S, 2014, MOL CELL BIOL, V34, P415, DOI 10.1128/MCB.01353-13; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zanca C, 2017, GENE DEV, V31, P1212, DOI 10.1101/gad.300079.117; Zou Z, 2014, ONCOGENE, V33, P2395, DOI 10.1038/onc.2013.179	77	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5345	5359		10.1074/jbc.RA117.000443	http://dx.doi.org/10.1074/jbc.RA117.000443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440272	Green Published, hybrid			2022-12-28	WOS:000429409300037
J	Zhu, XL; Yuan, CM; Tian, CY; Li, C; Nie, F; Song, XM; Zeng, R; Wu, DQ; Hao, XJ; Li, L				Zhu, Xiaoliang; Yuan, Chunmao; Tian, Chenyang; Li, Chen; Nie, Fen; Song, Xiaomin; Zeng, Rong; Wu, Dianqing; Hao, Xiaojiang; Li, Lin			The plant sesquiterpene lactone parthenolide inhibits Wnt/beta-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibitor; protein synthesis; small molecule; T-cell factor (TCF); Wnt signaling	BETA-CATENIN; CELL-DEATH; PROTEIN; STEM; APOPTOSIS; PATHWAY; AXIN	The Wnt/-catenin pathway is essential for embryonic development and homeostasis, but excessive activation of this pathway is frequently observed in various human diseases, including cancer. Current therapeutic drugs targeting the Wnt pathway often lack sufficient efficacy, and new compounds targeting this pathway are therefore greatly needed. Here we report that the plant-derived natural product parthenolide (PTL), a sesquiterpene lactone, inhibits Wnt signaling. We found that PTL dose-dependently inhibits Wnt3a- and CHIR99021-induced transcriptional activity assessed with the T-cell factor (TCF)/lymphoid enhancer factor (LEF) firefly luciferase (TOPFlash) assay in HEK293 cells. Further investigations revealed that PTL decreases the levels of the transcription factors TCF4/LEF1 without affecting -catenin stability or subcellular distribution. Moreover, this effect of PTL on TCF4/LEF1 was related to protein synthesis rather than to proteasome-mediated degradation. Of note, siRNA-mediated knockdown of RPL10, a ribosome protein PTL binds, substantially decreased TCF4/LEF1 protein levels and also Wnt3a-induced TOPFlash activities, suggesting a potential mechanism by which PTL may repress Wnt/-catenin signaling. In summary, PTL binds RPL10 and thereby potently inhibits the Wnt/-catenin pathway.	[Zhu, Xiaoliang; Tian, Chenyang; Nie, Fen; Song, Xiaomin; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Networks,Inst Biochem, Shanghai 200031, Peoples R China; [Yuan, Chunmao; Hao, Xiaojiang] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang 550014, Guizhou, Peoples R China; [Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650204, Yunnan, Peoples R China; [Tian, Chenyang; Li, Lin] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Li, Chen; Zeng, Rong] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wu, Dianqing] Yale Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Wu, Dianqing] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Chinese Academy of Sciences; Guizhou Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Yale University	Li, L (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Networks,Inst Biochem, Shanghai 200031, Peoples R China.; Hao, XJ (corresponding author), Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang 550014, Guizhou, Peoples R China.; Hao, XJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650204, Yunnan, Peoples R China.; Li, L (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	haoxj@mail.kib.ac.cn; lli@sibs.ac.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, chen/ABG-9343-2020		National Key RAMP;D Program of China [2017YFA0503600]; National Natural Science Foundation of China [31530094, 31571456]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000, XDA12010301]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112182] Funding Source: NIH RePORTER	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Key R&D Program of China Grant 2017YFA0503600), National Natural Science Foundation of China Grants 31530094 and 31571456, and Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDB19000000 and XDA12010301. This work was also supported by the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P2543, DOI 10.1016/0031-9422(82)85253-9; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Franz A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006700; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; He XL, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.3; Hrckulak D, 2016, CANCERS, V8, DOI 10.3390/cancers8070070; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hwang SY, 2016, CELL REP, V16, P28, DOI 10.1016/j.celrep.2016.05.071; Ishiguro H, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0006-0; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; KNIGHT DW, 1995, NAT PROD REP, V12, P271, DOI 10.1039/np9951200271; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mao L, 2016, CELL RES, V26, P1067, DOI 10.1038/cr.2016.97; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Qu Y, 2018, NAT CHEM BIOL, V14, P94, DOI [10.1038/NCHEMBIO.2510, 10.1038/nchembio.2510]; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Shi C, 2017, ONCOTARGET, V8, P35009, DOI 10.18632/oncotarget.16557; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Stojakowska A, 1997, PLANT CELL TISS ORG, V47, P159, DOI 10.1023/A:1005930209494; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Uchibori R, 2013, CANCER RES, V73, P364, DOI 10.1158/0008-5472.CAN-12-0088; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Yang C, 2016, CELL PHYSIOL BIOCHEM, V40, P146, DOI 10.1159/000452532; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zuch D, 2012, J CELL BIOCHEM, V113, P1282, DOI 10.1002/jcb.24002	39	30	30	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5335	5344		10.1074/jbc.M117.819300	http://dx.doi.org/10.1074/jbc.M117.819300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462785	Green Published, hybrid			2022-12-28	WOS:000429409300036
J	Blobner, BM; Wang, XP; Kashlan, OB				Blobner, Brandon M.; Wang, Xue-Ping; Kashlan, Ossama B.			Conserved cysteines in the finger domain of the epithelial Na+ channel alpha and gamma subunits are proximal to the dynamic finger-thumb domain interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; EXTRACELLULAR LOOP; INHIBITORY DOMAIN; ENAC; AMILORIDE; EXPRESSION; RESIDUES; PEPTIDE; BINDING; IDENTIFICATION	The epithelial Na+ channel (ENaC) is a member of the ENaC/degenerin family of ion channels. In the structure of a related family member, the "thumb" domain's base interacts with the pore, and its tip interacts with the divergent "finger" domain. Between the base and tip, the thumb domain is characterized by a conserved five-rung disulfide ladder holding together two anti-parallel alpha helices. The ENaC alpha and gamma subunits' finger domains harbor autoinhibitory tracts that can be proteolytically liberated to activate the channel and also host an ENaC-specific pair of cysteines. Using a crosslinking approach, we show that one of the finger domain cysteines in the alpha subunit (alpha Cys-263) and both of the finger domain cysteines in the gamma subunit (gamma Cys-213 and gamma Cys-220) lie near the dynamic finger-thumb domain interface. Our data suggest that the alpha Cys-256/alpha Cys-263 pair is not disulfide-bonded. In contrast, we found that the gamma Cys-213/gamma Cys-220 pair is disulfide-bonded. Our data also suggest that the gamma subunit lacks the terminal rung in the thumb domain disulfide ladder, suggesting asymmetry between the subunits. We also observed functional asymmetry between the alpha and gamma subunit finger-thumb domain interfaces; crosslinks bridging the alpha subunit finger-thumb interface only inhibited ENaC currents, whereas crosslinks bridging the gamma subunit finger-thumb interface activated or inhibited currents dependent on the length of the crosslinker. Our data suggest that reactive cysteines lie at the dynamic finger-thumb interfaces of the alpha and gamma subunits and may play a yet undefined role in channel regulation.	[Blobner, Brandon M.; Wang, Xue-Ping; Kashlan, Ossama B.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu	Wang, Xueping/AAF-2215-2020	Wang, Xueping/0000-0003-1102-0392	National Institutes of Health [P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, T32DK061296, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Pittsburgh Center for Kidney Research was supported by Grant P30 DK079307 from the National Institutes of Health.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; DuVall MD, 1998, AM J PHYSIOL-CELL PH, V274, pC1417, DOI 10.1152/ajpcell.1998.274.5.C1417; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Haq IJ, 2016, THORAX, V71, P284, DOI 10.1136/thoraxjnl-2015-207588; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeggle P, 2015, BIOCHEM BIOPH RES CO, V464, P38, DOI 10.1016/j.bbrc.2015.05.091; Jensen JH, 2013, J CHEM EDUC, V90, P1093, DOI 10.1021/ed400164n; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; KOCKERLING A, 1993, AM J PHYSIOL, V264, pC1285, DOI 10.1152/ajpcell.1993.264.5.C1285; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Ray EC, 2016, AM J PHYSIOL-RENAL, V311, pF908, DOI 10.1152/ajprenal.00426.2016; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Trac PT, 2017, AM J PHYSIOL-LUNG C, V312, pL797, DOI 10.1152/ajplung.00379.2016; Xu H, 2007, AM J PHYSIOL-LUNG C, V293, pL1454, DOI 10.1152/ajplung.00248.2007	45	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4928	4939		10.1074/jbc.M117.819367	http://dx.doi.org/10.1074/jbc.M117.819367			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425099	Green Published, hybrid			2022-12-28	WOS:000428848300031
J	Peng, CN; Wang, QB; Wang, SM; Wang, WS; Jiao, RM; Han, WJ; Li, FC				Peng, Chune; Wang, Qingbin; Wang, Shumin; Wang, Wenshuang; Jiao, Runmiao; Han, Wenjun; Li, Fuchuan			A chondroitin sulfate and hyaluronic acid lyase with poor activity to glucuronyl 4,6-O-disulfated N-acetylgalactosamine (E-type)-containing structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; PROMOTES NEURITE OUTGROWTH; SIMPLEX-VIRUS INFECTIVITY; CENTRAL-NERVOUS-SYSTEM; SULFATE/DERMATAN SULFATE; MARINE BACTERIUM; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; DEGRADES HYALURONAN; CRYSTAL-STRUCTURE	GlcUA beta 1-3GalNAc(4S,6S) (E unit)-rich domains have been shown to play key roles in various biological functions of chondroitin sulfate (CS). However, an enzyme that can specifically isolate such domains through the selective digestion of other domains in polysaccharides has not yet been reported. Here, we identified a glycosaminoglycan lyase from a marine bacterium Vibrio sp. FC509. This enzyme efficiently degraded hyaluronic acid (HA) and CS variants, but not E unit-rich CS-E, into unsaturated disaccharides; therefore, we designated this enzyme a CS-E-resisted HA/CS lyase (HCLase Er). We isolated a series of resistant oligosaccharides from the final product of a low-sulfated CS-E exhaustively digested by HCLase Er and found that the E units were dramatically accumulate in these resistant oligosaccharides. By determining the structures of several resistant tetrasaccharides, we observed that all of them possessed a Delta(4,5)HexUA alpha 1-3GalNAc(4S,6S) at their non-reducing ends, indicating that the disulfation of GalNAc abrogates HCLase Er activity on the beta 1-4 linkage between the E unit and the following disaccharide. Delta(4,5)HexUA alpha 1-3GalNAc(4S,6S)beta 1-4GlcUA beta 1-3GalNAc (4S,6S) was most strongly resistant to HCLase Er. To our knowledge, this study is the first reporting a glycosaminoglycan lyase specifically inhibited by both 4-O- and 6-O-sulfation of GalNAc. Site-directed and truncation mutagenesis experiments indicated that HCLase Er may use a general acid-base catalysis mechanism and that an extra domain (Gly(739)-Gln(796)) is critical for its activity. This enzyme will be a useful tool for structural analyses and for preparing bioactive oligosaccharides of HA and CS variants, particularly from E unit-rich CS chains.	[Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China; Shandong Univ, State Key Lab Microbial Technol, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, 27 South Shanda Rd, Jinan 250100, Shandong, Peoples R China.	fuchuanli@sdu.edu.cn			National Natural Science Foundation of China [31570071, 31300664]; Science and Technology Special Project of Shandong Province [2015zdjs04002]; Science and Technology Development Project of Shandong Province [2016GGH4502]; Independent Innovation Plan of Colleges and Universities in Jinan [201401242]; Fundamental Research Funds of Shandong University [2015JC002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Special Project of Shandong Province; Science and Technology Development Project of Shandong Province; Independent Innovation Plan of Colleges and Universities in Jinan; Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grants 31570071 and 31300664, Science and Technology Special Project of Shandong Province Grant 2015zdjs04002, Science and Technology Development Project of Shandong Province Grant 2016GGH4502, Independent Innovation Plan of Colleges and Universities in Jinan Grant 201401242, and the Fundamental Research Funds of Shandong University Grant 2015JC002. The authors declare that they have no conflicts of interest with the contents of this article.	Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deepa SS, 2007, BIOCHEMISTRY-US, V46, P2453, DOI 10.1021/bi602374m; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Hamai A, 1997, J BIOL CHEM, V272, P9123; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Jinno-Oue A, 2013, AIDS RES HUM RETROV, V29, P621, DOI [10.1089/aid.2012.0156, 10.1089/AID.2012.0156]; Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koike T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08994; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li FC, 2010, J BIOL CHEM, V285, P27673, DOI 10.1074/jbc.M110.118703; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Mikami T, 2017, GLYCOCONJUGATE J, V34, P725, DOI 10.1007/s10719-016-9732-9; Miyata S, 2017, BBA-GEN SUBJECTS, V1861, P2420, DOI 10.1016/j.bbagen.2017.06.010; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Pomin VH, 2015, EUR J MED CHEM, V92, P353, DOI 10.1016/j.ejmech.2015.01.002; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Sambrook J, 2001, MOL CLONING LAB MANU; Schnadelbach O, 1998, GLIA, V23, P99, DOI 10.1002/(SICI)1098-1136(199806)23:2<99::AID-GLIA2>3.0.CO;2-Z; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, EUR J BIOCHEM, V239, P871, DOI 10.1111/j.1432-1033.1996.0871u.x; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugahara K, 2012, ADV EXP MED BIOL, V749, P33, DOI 10.1007/978-1-4614-3381-1_3; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Valcarcel J, 2017, BIOTECHNOL ADV, V35, P711, DOI 10.1016/j.biotechadv.2017.07.008; Wang WS, 2017, BIOCHEM J, V474, P3831, DOI 10.1042/BCJ20170591; Wang WS, 2015, J BIOL CHEM, V290, P7823, DOI 10.1074/jbc.M114.629154; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; YAMADA S, 1995, GLYCOBIOLOGY, V5, P335, DOI 10.1093/glycob/5.3.335; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	55	8	9	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4230	4243		10.1074/jbc.RA117.001238	http://dx.doi.org/10.1074/jbc.RA117.001238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29414785	hybrid, Green Published			2022-12-28	WOS:000428204300001
J	Goins, CM; Dajnowicz, S; Smith, MD; Parks, JM; Ronning, DR				Goins, Christopher M.; Dajnowicz, Steven; Smith, Micholas D.; Parks, Jerry M.; Ronning, Donald R.			Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into antigen 85 catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; PANCREATIC LIPASE; INHIBITOR; MECHANISM; THIOESTERASE; ORLISTAT; NEUTRON; SYSTEM	Mycobacterium tuberculosis antigen 85 (Ag85) enzymes catalyze the transfer of mycolic acid ( MA) from trehalose monomycolate to produce the mycolyl arabinogalactan (mAG) or trehalose dimycolate (TDM). These lipids define the protective mycomembrane of mycobacteria. The current model of substrate binding within the active sites of Ag85s for the production of TDM is not sterically and geometrically feasible; additionally, this model does not account for the production of mAG. Furthermore, this model does not address how Ag85s limit the hydrolysis of the acyl-enzyme intermediate while catalyzing acyl transfer. To inform an updated model, we obtained an Ag85 acyl-enzyme intermediate structure that resembles the mycolated form. Here, we present a 1.45-angstrom X-ray crystal structure of M. tuberculosis Ag85C covalently modified by tetrahydrolipstatin (THL), an esterase inhibitor that suppresses M. tuberculosis growth and mimics structural attributes of MAs. The mode of covalent inhibition differs from that observed in the reversible inhibition of the human fatty-acid synthase by THL. Similarities between the Ag85-THL structure and previously determined Ag85C structures suggest that the enzyme undergoes structural changes upon acylation, and positioning of the peptidyl arm of THL limits hydrolysis of the acyl-enzyme adduct. Molecular dynamics simulations of the modeled mycolated-enzyme form corroborate the structural analysis. From these findings, we propose an alternative arrangement of substrates that rectifies issues with the previous model and suggest a direct role for the beta-hydroxy of MA in the second half-reaction of Ag85 catalysis. This information affords the visualization of a complete mycolyltransferase catalytic cycle.	[Goins, Christopher M.; Dajnowicz, Steven; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Dajnowicz, Steven] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Smith, Micholas D.; Parks, Jerry M.] Oak Ridge Natl Lab, UT ORNL, Ctr Biophys Mol, Biosci Div, Oak Ridge, TN 37831 USA; [Smith, Micholas D.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University System of Ohio; University of Toledo; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	Donald.Ronning@utoledo.edu	Parks, Jerry M./B-7488-2009; Smith, Micholas Dean/H-5267-2019	Parks, Jerry M./0000-0002-3103-9333; Smith, Micholas Dean/0000-0002-0777-7539; Ronning, Donald/0000-0003-2583-8849	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; United States Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work used resources of the Compute and Data Environment for Science (CADES) at Oak Ridge National Laboratory, which is managed by UT-Battelle, LLC for the United States Department of Energy under Contract DE-AC05-00OR22725.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2014, J BIOL CHEM, V289, P25041, DOI 10.1074/jbc.M114.581579; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Case D. A., 2016, AMBER 2016; Chen L, 2011, J PHYS CHEM B, V115, P13019, DOI 10.1021/jp206297d; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Copeland R. A., 2005, EVALUATION ENZYME IN, P214; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fako VE, 2014, ACS CATAL, V4, P3444, DOI 10.1021/cs500956m; Favrot L, 2014, J BIOL CHEM, V289, P25031, DOI 10.1074/jbc.M114.582445; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Fisher SZ, 2010, BIOCHEMISTRY-US, V49, P415, DOI 10.1021/bi901995n; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Goins CM, 2017, ACS INFECT DIS, V3, P378, DOI 10.1021/acsinfecdis.7b00003; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Periole X, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2404954; Ravindran MS, 2014, MOL CELL PROTEOMICS, V13, P435, DOI 10.1074/mcp.M113.029942; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Tomanicek SJ, 2013, J BIOL CHEM, V288, P4715, DOI 10.1074/jbc.M112.436238; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WEIBEL EK, 1987, J ANTIBIOT, V40, P1081, DOI 10.7164/antibiotics.40.1081; Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540	48	13	13	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3651	3662		10.1074/jbc.RA117.001681	http://dx.doi.org/10.1074/jbc.RA117.001681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352107	hybrid, Green Published			2022-12-28	WOS:000427030200019
J	Shobair, M; Popov, KI; Dang, YL; He, H; Stutts, MJ; Dokholyan, NV				Shobair, Mahmoud; Popov, Konstantin I.; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.			Mapping allosteric linkage to channel gating by extracellular domains in the human epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION-CHANNEL; DISCRETE MOLECULAR-DYNAMICS; DELTA-F508 CFTR; NA+ CHANNEL; NETWORKS; MUTATION; INHIBITION; ACTIVATION; STABILITY; PROTEINS	The epithelial sodium channel (ENaC) mediates sodium absorption in lung, kidney, and colon epithelia. Channels in the ENaC/degenerin family possess an extracellular region that senses physicochemical changes in the extracellular milieu and allosterically regulates the channel opening. Proteolytic cleavage activates the ENaC opening, by the removal of specific segments in the finger domains of the alpha- and gamma ENaC-subunits. Cleavage causes perturbations in the extracellular region that propagate to the channel gate. However, it is not known how the channel structure mediates the propagation of activation signals through the extracellular sensing domains. Here, to identify the structure-function determinants that mediate allosteric ENaC activation, we performed MD simulations, thiol modification of residues substituted by cysteine, and voltage-clamp electrophysiology recordings. Our simulations of an ENaC heterotetramer, alpha(1)beta alpha(2)gamma, in the proteolytically cleaved and uncleaved states revealed structural pathways in the alpha-subunit that are responsible for ENaC proteolytic activation. To validate these findings, we performed site-directed mutagenesis to introduce cysteine substitutions in the extracellular domains of the alpha-, beta-, and gamma ENaC-subunits. Insertion of a cysteine at the alpha-subunit Glu(557) site, predicted to stabilize a closed state of ENaC, inhibited ENaC basal activity and retarded the kinetics of proteolytic activation by 2-fold. Our results suggest that the lower palm domain of alpha ENaC is essential for ENaC activation. In conclusion, our integrated computational and experimental approach suggests key structure-function determinants for ENaC proteolytic activation and points toward a mechanistic model for the allosteric communication in the extracellular domains of the ENaC/degenerin family channels.	[Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Popov, Konstantin I.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stutts, MJ (corresponding author), 1113 Marsico Hall, Chapel Hill, NC 27599 USA.; Dokholyan, NV (corresponding author), 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	jack_stutts@med.unc.edu; dokh@unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Shobair, Mahmoud/0000-0003-1684-9677	National Institutes of Health Program [P01 HL 110873-04, 110873-01]; National Institutes of Health [R01GM114015, R01GM064803, R01GM123247]; Cystic Fibrosis Foundation Award [STUTTS1610]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114015, R01GM123247, R01GM064803] Funding Source: NIH RePORTER	National Institutes of Health Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Program Project Grants P01 HL 110873-04 (to M. S.) and 110873-01 (to N. V. D. and M. J. S.), National Institutes of Health Grants R01GM114015, R01GM064803, and R01GM123247 (to N. V. D.), and Cystic Fibrosis Foundation Award STUTTS1610. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baker SE, 2011, RESP PHYSIOL NEUROBI, V179, P212, DOI 10.1016/j.resp.2011.08.007; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Berman JM, 2015, CHANNELS, V9, P281, DOI 10.1080/19336950.2015.1073869; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dokholyan NV, 1998, J STAT PHYS, V93, P603, DOI 10.1023/B:JOSS.0000033244.13545.da; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Moreau A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00053; Pedersen SF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00233; Proctor EA, 2016, CURR OPIN STRUC BIOL, V37, P9, DOI 10.1016/j.sbi.2015.11.001; Proctor EA, 2015, CHEM SCI, V6, P1237, DOI 10.1039/c4sc01320d; Ramaswamy SS, 2013, J BIOL CHEM, V288, P35896, DOI 10.1074/jbc.M113.478982; Rauh R, 2013, AM J PHYSIOL-LUNG C, V304, pL43, DOI 10.1152/ajplung.00093.2012; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ritz A, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.2; Rocks JW, 2017, P NATL ACAD SCI USA, V114, P2520, DOI 10.1073/pnas.1612139114; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Scardoni Giovanni, 2015, F1000Res, V4, P484; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Shobair M, 2016, J BIOL CHEM, V291, P3682, DOI 10.1074/jbc.M115.678052; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Swain SM, 2013, J MOL NEUROSCI, V51, P199, DOI 10.1007/s12031-013-9991-x; Yang HY, 2009, CELL RES, V19, P1035, DOI 10.1038/cr.2009.90; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	43	0	0	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3675	3684		10.1074/jbc.RA117.000604	http://dx.doi.org/10.1074/jbc.RA117.000604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358325	Green Published, hybrid			2022-12-28	WOS:000427030200021
J	Byrd, KM; Blagg, BSJ				Byrd, Katherine M.; Blagg, Brian S. J.			Chaperone substrate provides missing link for cancer drug discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HSP90; HSP70	Both Hsp70 and Hsp90 chaperones are overexpressed in cancer, making them relevant targets for the development of cancer chemotherapeutics, but a lack of biomolecular readouts for Hsp70 inhibition has limited the pursuit of specific inhibitors for this enzyme. A new study from Cesa et al. identifies two inhibitors of apoptosis proteins (IAPs) as specific client substrates of Hsp70. These results establish biomarkers that can be utilized to monitor Hsp70 inhibition and provide a framework for future efforts to deconvolute chaperone networks.	[Byrd, Katherine M.; Blagg, Brian S. J.] Univ Notre Dame, Dept Chem & Biochem, 305 McCourtney Hall, Notre Dame, IN 46545 USA	University of Notre Dame	Blagg, BSJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 305 McCourtney Hall, Notre Dame, IN 46545 USA.	bblagg@nd.edu	blagg, brian s j/X-7770-2018	blagg, brian s j/0000-0002-6200-3480				Cesa LC, 2018, J BIOL CHEM, V293, P2370, DOI 10.1074/jbc.RA117.000634; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	9	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2381	2382		10.1074/jbc.H118.001591	http://dx.doi.org/10.1074/jbc.H118.001591			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29453286	Green Published, hybrid			2022-12-28	WOS:000425308300012
J	Goodman, RP; Calvo, SE; Mootha, VK				Goodman, Russell P.; Calvo, Sarah E.; Mootha, Vamsi K.			Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; ENCODED FLUORESCENT SENSORS; REDOX STATE; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; TRIPHOSPHOPYRIDINE NUCLEOTIDE; INTRACELLULAR NADH; PPAR-ALPHA; PROTEIN; DNA	Compartmentalization is a fundamental design principle of eukaryotic metabolism. Here, we review the compartmentalization of NAD(+)/NADH and NADP(+)/NADPH with a focus on the liver, an organ that experiences the extremes of biochemical physiology each day. Historical studies of the liver, using classical biochemical fractionation and measurements of redox-coupled metabolites, have given rise to the prevailing view that mitochondrial NAD(H) pools tend to be oxidized and important for energy homeostasis, whereas cytosolic NADP(H) pools tend to be highly reduced for reductive biosynthesis. Despite this textbook view, many questions still remain as to the relative size of these subcellular pools and their redox ratios in different physiological states, and to what extent such redox ratios are simply indicators versus drivers of metabolism. By performing a bioinformatic survey, we find that the liver expresses 352 known or predicted enzymes composing the hepatic NAD(P)ome, i.e. the union of all predicted enzymes producing or consuming NADP(H) or NAD(H) or using them as a redox co-factor. Notably, less than half are predicted to be localized within the cytosol or mitochondria, and a very large fraction of these genes exhibit gene expression patterns that vary during the time of day or in response to fasting or feeding. A future challenge lies in applying emerging new genetic tools to measure and manipulate in vivo hepatic NADP(H) and NAD(H) with subcellular and temporal resolution. Insights from such fundamental studies will be crucial in deciphering the pathogenesis of very common diseases known to involve alterations in hepatic NAD(P)H, such as diabetes and fatty liver disease.	[Goodman, Russell P.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Goodman, Russell P.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Goodman, Russell P.; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Goodman, RP (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Goodman, RP; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Goodman, RP; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Mootha, VK (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	rpgoodman@mgh.harvard.edu; vamsi@hms.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK043351] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguilar-Arnal L, 2016, P NATL ACAD SCI USA, V113, P12715, DOI 10.1073/pnas.1609227113; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bailey SM, 1999, FREE RADICAL BIO MED, V27, P891, DOI 10.1016/S0891-5849(99)00138-0; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bilan DS, 2014, BBA-GEN SUBJECTS, V1840, P951, DOI 10.1016/j.bbagen.2013.11.018; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; BUBLITZ C, 1987, BIOCHEM J, V245, P263, DOI 10.1042/bj2450263; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cracan V, 2017, NAT CHEM BIOL, V13, P1088, DOI [10.1038/NCHEMBIO.2454, 10.1038/nchembio.2454]; Csala M, 2006, FEBS LETT, V580, P2160, DOI 10.1016/j.febslet.2006.03.050; DAVIS EJ, 1980, J BIOL CHEM, V255, P2277; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Glantz ST, 2016, P NATL ACAD SCI USA, V113, pE1442, DOI 10.1073/pnas.1509428113; GLOCK GE, 1955, BIOCHEM J, V61, P381, DOI 10.1042/bj0610381; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; ISSELBACHER K, 1964, NEW ENGL J MED, V270, P351, DOI 10.1056/NEJM196402132700707; ISSELBACHER KJ, 1964, NEW ENGL J MED, V270, P402, DOI 10.1056/NEJM196402202700806; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; KREBS HA, 1968, BIOCHEM J, V108, P513, DOI 10.1042/bj1080513; LANGDON RG, 1955, J AM CHEM SOC, V77, P5190, DOI 10.1021/ja01624a085; LANOUE KF, 1974, J BIOL CHEM, V249, P7522; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Madsen AS, 2016, J BIOL CHEM, V291, P7128, DOI 10.1074/jbc.M115.668699; Masia R, 2018, AM J PHYSIOL-GASTR L, V314, pG97, DOI 10.1152/ajpgi.00093.2017; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palero JA, 2011, BIOMED OPT EXPRESS, V2, P1030, DOI 10.1364/BOE.2.001030; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Qiao AJ, 2017, J CELL BIOL, V216, P723, DOI 10.1083/jcb.201607091; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROTHE F, 1995, NEUROSCIENCE, V64, pR3, DOI 10.1016/0306-4522(94)E0200-N; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; Sando R, 2013, NAT METHODS, V10, P1085, DOI [10.1038/NMETH.2640, 10.1038/nmeth.2640]; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Shi F, 2009, ACTA BIOCH BIOPH SIN, V41, P352, DOI 10.1093/abbs/gmp029; SHIMOYAMA M, 1970, BIOCHIM BIOPHYS ACTA, V215, P207, DOI 10.1016/0304-4165(70)90410-1; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Tucker KR, 2016, MOL BIOL CELL, V27, P3214, DOI 10.1091/mbc.E16-07-0479; van Diepen JA, 2014, J HEPATOL, V61, P366, DOI 10.1016/j.jhep.2014.04.013; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	86	54	54	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7508	7516		10.1074/jbc.TM117.000258	http://dx.doi.org/10.1074/jbc.TM117.000258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29514978	hybrid, Green Published			2022-12-28	WOS:000437256500004
J	Rotstein, B; Post, Y; Reinhardt, M; Lammers, K; Buhr, A; Heinisch, JJ; Meyer, H; Paululat, A				Rotstein, Barbara; Post, Yanina; Reinhardt, Marcel; Lammers, Kay; Buhr, Annika; Heinisch, Juergen J.; Meyer, Heiko; Paululat, Achim			Distinct domains in the matricellular protein Lonely heart are crucial for cardiac extracellular matrix formation and heart function in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; cardiac development; Drosophila; Drosophila genetics; extracellular matrix; extracellular matrix protein; thrombospondin; cardiogenesis; ADAMTSL; cardiac matrix; TSR repeats; GAG; cardiogenesis; Drosophila melanogaster	PERICARDIAL CELLS; TYPE-1 REPEATS; THROMBOSPONDIN; INTEGRINS; PEPTIDES; BINDING	The biomechanical properties of extracellular matrices (ECMs) are critical to many biological processes, including cell-cell communication and cell migration and function. The correct balance between stiffness and elasticity is essential to the function of numerous tissues, including blood vessels and the lymphatic system, and depends on ECM constituents (the matrisome) and on their level of interconnection. However, despite its physiological relevance, the matrisome composition and organization remain poorly understood. Previously, we reported that the ADAMTS-like protein Lonely heart (Loh) is critical for recruiting the type IV collagen-like protein Pericardin to the cardiac ECM. Here, we utilized Drosophila as a simple and genetically amenable invertebrate model for studying Loh-mediated recruitment of tissue-specific ECM components such as Pericardin to the ECM. We focused on the functional relevance of distinct Loh domains to protein localization and Pericardin recruitment. Analysis of Loh deletion constructs revealed that one thrombospondin type 1 repeat (TSR1-1), which has an embedded WXXW motif, is critical for anchoring Loh to the ECM. Two other thrombospondin repeats, TSR1-2 and TSR1-4, the latter containing a CXXTCXXG motif, appeared to be dispensable for tethering Loh to the ECM but were crucial for proper interaction with and recruitment of Pericardin. Moreover, our results also suggested that Pericardin in the cardiac ECM primarily ensures the structural integrity of the heart, rather than increasing tissue flexibility. In conclusion, our work provides new insights into the roles of thrombospondin type 1 repeats and advances our understanding of cardiac ECM assembly and function.	[Rotstein, Barbara; Post, Yanina; Reinhardt, Marcel; Lammers, Kay; Buhr, Annika; Meyer, Heiko; Paululat, Achim] Univ Osnabruck, Fac Biol & Chem, Dept Zool & Dev Biol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heinisch, Juergen J.] Univ Osnabruck, Fac Biol & Chem, Dept Genet, Barbarastr 11, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Paululat, A (corresponding author), Univ Osnabruck, Fac Biol & Chem, Dept Zool & Dev Biol, Barbarastr 11, D-49076 Osnabruck, Germany.	paululat@biologie.uni-osnabrueck.de	Heinisch, Juergen J./G-3801-2017	Reinhardt, Marcel/0000-0001-5158-7890; Harten, Heiko/0000-0002-3304-4523; Paululat, Achim/0000-0002-8845-6859	German Research Foundation [SFB 944]; State of Lower-Saxony, Hannover, Germany [11-76251-99-15/12 (ZN2832)]	German Research Foundation(German Research Foundation (DFG)); State of Lower-Saxony, Hannover, Germany	This work was supported by funding from the German Research Foundation (SFB 944: Physiology and Dynamics of Cellular Microcompartments) (to A. P.) and by State of Lower-Saxony, Hannover, Germany, Grant 11-76251-99-15/12 (ZN2832). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Asha H, 2003, GENETICS, V163, P203; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Drechsler M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003616; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; GUO NH, 1992, J BIOL CHEM, V267, P19349; Hallier B, 2016, ELIFE, V5, DOI 10.7554/eLife.19430; Hynes R.O., 2012, EXTRACELLULAR MATRIX; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivy JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134620; Kaushik G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5843; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kolsch V, 2002, DEV GENES EVOL, V212, P473, DOI 10.1007/s00427-002-0268-6; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Lammers K, 2017, J EXP BIOL, V220, P1852, DOI 10.1242/jeb.156265; Lehmacher C, 2012, ARTHROPOD STRUCT DEV, V41, P459, DOI 10.1016/j.asd.2012.02.002; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Meyer H, 2009, J EXP BIOL, V212, P3673, DOI 10.1242/jeb.034272; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Nishimura M, 2014, AGING CELL, V13, P431, DOI 10.1111/acel.12193; Ocorr K, 2014, METHODS, V68, P265, DOI 10.1016/j.ymeth.2014.03.031; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Paululat A, 2012, GENE, V511, P300, DOI 10.1016/j.gene.2012.09.058; Rasband WS, 2012, ASCL; Rotstein B, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020015; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Sessions AO, 2017, MATRIX BIOL, V62, P15, DOI 10.1016/j.matbio.2016.10.008; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Togel M, 2013, INT J DEV BIOL, V57, P13, DOI 10.1387/ijdb.120111ap; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; TUSZYNSKI GP, 1992, J CELL BIOL, V116, P209, DOI 10.1083/jcb.116.1.209; Tutor AS, 2014, DEVELOPMENT, V141, P367, DOI 10.1242/dev.099408; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Volk T, 2014, MATRIX BIOL, V37, P162, DOI 10.1016/j.matbio.2014.03.006; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wilmes AC, 2018, BIOL OPEN, V7, DOI 10.1242/bio.030361	45	8	8	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7864	7879		10.1074/jbc.M117.817940	http://dx.doi.org/10.1074/jbc.M117.817940			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599288	Green Published, hybrid			2022-12-28	WOS:000437256500033
J	Prats, C; Graham, TE; Shearer, J				Prats, Clara; Graham, Terry E.; Shearer, Jane			The dynamic life of the glycogen granule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						actin; carbohydrate; carbohydrate biosynthesis; cell compartmentalization; endoplasmic reticulum (ER); glycogen; protein complex; sarcoplasmic reticulum (SR); glycogenolysis	SKELETAL-MUSCLE GLYCOGEN; SARCOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; PHYSICAL CONSTRAINTS; PHOSPHORYLASE-KINASE; MOLECULAR-SIZE; METABOLISM; SYNTHASE; PROTEIN; LIVER	Glycogen, the primary storage form of glucose, is a rapid and accessible form of energy that can be supplied to tissues on demand. Each glycogen granule, or glycosome, is considered an independent metabolic unit composed of a highly branched polysaccharide and various proteins involved in its metabolism. In this Minireview, we review the literature to follow the dynamic life of a glycogen granule in a multicompartmentalized system, i.e. the cell, and how and where glycogen granules appear and the factors governing its degradation. A better understanding of the importance of cellular compartmentalization as a regulator of glycogen metabolism is needed to unravel its role in brain energetics.	[Prats, Clara] Univ Copenhagen, Ctr Hlth Aging, DK-2200 Copenhagen, Denmark; [Prats, Clara] Univ Copenhagen, Dept Biomed Sci, Core Facil Integrated Microscopy, DK-2200 Copenhagen, Denmark; [Graham, Terry E.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Shearer, Jane] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada	University of Copenhagen; University of Copenhagen; University of Guelph; University of Calgary; University of Calgary	Prats, C (corresponding author), Univ Copenhagen, Ctr Hlth Aging, DK-2200 Copenhagen, Denmark.; Prats, C (corresponding author), Univ Copenhagen, Dept Biomed Sci, Core Facil Integrated Microscopy, DK-2200 Copenhagen, Denmark.	cprats@sund.ku.dk		Prats, Clara/0000-0001-6465-3068	Nordea Foundation; Danish Diabetes Academy; Novo Nordisk Foundation; National Science and Engineering Research Council of Canada	Nordea Foundation; Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Nordea Foundation, the Danish Diabetes Academy, and the Novo Nordisk Foundation.; Supported by the National Science and Engineering Research Council of Canada.	Adamo KB, 1998, J APPL PHYSIOL, V84, P908, DOI 10.1152/jappl.1998.84.3.908; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baque S, 1997, FEBS LETT, V417, P355, DOI 10.1016/S0014-5793(97)01299-4; Barnes PD, 2009, METABOLISM, V58, P1832, DOI 10.1016/j.metabol.2009.06.016; Becker JA, 1998, AM J HUM GENET, V62, P991, DOI 10.1086/301788; CAO YJ, 1993, J BIOL CHEM, V268, P21717; CARDELL RR, 1990, J ELECTRON MICR TECH, V14, P126, DOI 10.1002/jemt.1060140206; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; Demetriadou A, 2017, J CELL SCI, V130, P903, DOI 10.1242/jcs.195263; DEVOS P, 1979, EUR J BIOCHEM, V99, P161, DOI 10.1111/j.1432-1033.1979.tb13242.x; DROCHMANS P, 1962, J ULTRA MOL STRUCT R, V6, P141, DOI 10.1016/S0022-5320(62)90050-3; Elsner P, 2002, J BIOL CHEM, V277, P4831, DOI 10.1074/jbc.M108226200; ENTMAN ML, 1980, J BIOL CHEM, V255, P6245; ENTMAN ML, 1977, J MOL CELL CARDIOL, V9, P515, DOI 10.1016/S0022-2828(77)80367-2; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; GEDDES R, 1977, BIOCHEM J, V163, P201, DOI 10.1042/bj1630201; GEDDES R, 1992, CARBOHYD RES, V227, P339, DOI 10.1016/0008-6215(92)85083-C; Gentry MS, 2018, J BIOL CHEM, V293, P7117, DOI 10.1074/jbc.R117.803064; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDSMITH E, 1982, J MOL BIOL, V156, P411, DOI 10.1016/0022-2836(82)90336-9; Hansen BF, 2000, AM J PHYSIOL-ENDOC M, V278, pE398, DOI 10.1152/ajpendo.2000.278.3.E398; Hurley TD, 2006, BIOCHEM BIOPH RES CO, V348, P374, DOI 10.1016/j.bbrc.2006.07.106; Jakobsen E, 2017, NEUROCHEM RES, V42, P2490, DOI 10.1007/s11064-017-2267-z; James AP, 2008, METABOLISM, V57, P535, DOI 10.1016/j.metabol.2007.11.017; JANSSON E, 1981, ACTA PHYSIOL SCAND, V113, P337, DOI 10.1111/j.1748-1716.1981.tb06904.x; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046; Lin A, 1999, ARCH BIOCHEM BIOPHYS, V363, P163, DOI 10.1006/abbi.1998.1073; LOMAKO J, 1991, FEBS LETT, V279, P223, DOI 10.1016/0014-5793(91)80154-U; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FASEB J, V7, P1386, DOI 10.1096/fasebj.7.14.8224611; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; Melendez R, 1998, BIOPHYS J, V75, P106, DOI 10.1016/S0006-3495(98)77498-3; Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; MEYER F, 1970, J BIOL CHEM, V245, P6642; Montori-Grau M, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-57; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Muller MS, 2014, GLIA, V62, P526, DOI 10.1002/glia.22623; Nakamura-Tsuruta S, 2012, CARBOHYD RES, V350, P49, DOI 10.1016/j.carres.2011.12.029; Nielsen J, 2009, J PHYSIOL-LONDON, V587, P3679, DOI 10.1113/jphysiol.2009.174862; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Oe Y, 2016, GLIA, V64, P1532, DOI 10.1002/glia.23020; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; ORRELL SA, 1964, J BIOL CHEM, V239, P4021; Ou HS, 2005, ENDOCRINOLOGY, V146, P494, DOI 10.1210/en.2004-1022; Prats C, 2005, J BIOL CHEM, V280, P23165, DOI 10.1074/jbc.M502713200; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; ROE JH, 1961, J BIOL CHEM, V236, P1244; ROSATI G, 1967, J ULTRA MOL STRUCT R, V18, P444, DOI 10.1016/S0022-5320(67)80129-1; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Schmid H, 2009, NEUROCHEM RES, V34, P581, DOI 10.1007/s11064-008-9825-3; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Serratosa J. M., 2012, JASPERS BASIC MECH E; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Skurat AV, 2006, ARCH BIOCHEM BIOPHYS, V456, P93, DOI 10.1016/j.abb.2006.09.024; Skurat AV, 1996, ARCH BIOCHEM BIOPHYS, V328, P283, DOI 10.1006/abbi.1996.0174; Skurat AV, 1997, EUR J BIOCHEM, V245, P147, DOI 10.1111/j.1432-1033.1997.t01-1-00147.x; SMYTHE C, 1989, EUR J BIOCHEM, V183, P205, DOI 10.1111/j.1432-1033.1989.tb14914.x; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; SMYTHE C, 1990, EUR J BIOCHEM, V189, P199, DOI 10.1111/j.1432-1033.1990.tb15477.x; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Sullivan MA, 2014, BIOMACROMOLECULES, V15, P660, DOI 10.1021/bm401714v; Sullivan MA, 2012, BIOMACROMOLECULES, V13, P3805, DOI 10.1021/bm3012727; Sullivan MA, 2010, BIOMACROMOLECULES, V11, P1094, DOI 10.1021/bm100074p; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Takado Y, 2015, NANOMED-NANOTECHNOL, V11, P239, DOI 10.1016/j.nano.2014.09.007; THON VJ, 1993, J BIOL CHEM, V268, P7509; THORNELL LE, 1974, J ULTRA MOL STRUCT R, V49, P157, DOI 10.1016/S0022-5320(74)80029-8; Turnbull J, 2013, J BIOL CHEM, V288, P34627, DOI 10.1074/jbc.M113.483198; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; WANSON JC, 1972, J CELL BIOL, V54, P206, DOI 10.1083/jcb.54.2.206; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; Wilstfittcr R., 1934, PHYSIOL CHEM PHYS M, V225, P103, DOI [10.1515/bchm2.1934.225.2-3.103, DOI 10.1515/BCHM2.1934.225.2-3.103]; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	82	78	78	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7089	7098		10.1074/jbc.R117.802843	http://dx.doi.org/10.1074/jbc.R117.802843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29483195	hybrid, Green Published			2022-12-28	WOS:000432174500002
J	Shiroishi, M; Ito, Y; Shimokawa, K; Lee, JM; Kusakabe, T; Ueda, T				Shiroishi, Mitsunori; Ito, Yuji; Shimokawa, Kenta; Lee, Jae Man; Kusakabe, Takahiro; Ueda, Tadashi			Structure-function analyses of a stereotypic rheumatoid factor unravel the structural basis for germline-encoded antibody autoreactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; complex; crystal structure; IgG; structural biology	B-CELLS; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCES; MOLECULAR ANALYSIS; GENE SEGMENTS; FC REVEALS; ARTHRITIS; HEAVY; NEUTRALIZATION; LYMPHOMAS	Rheumatoid factors (RFs) are autoantibodies against the fragment-crystallizable (Fc) region of IgG. In individuals with hematological diseases such as cryoglobulinemia and certain B cell lymphoma forms, the RFs derived from specific heavy- and light-chain germline pairs, so-called stereotypic RFs, are frequently produced in copious amounts and form immune complexes with IgG in serum. Of note, many structural details of the antigen recognition mechanisms in RFs are unclear. Here we report the crystal structure of the RF YES8c derived from the IGHV1-69/IGKV3-20 germline pair, the most common of the stereotypic RFs, in complex with human IgG1-Fc at 2.8 resolution. We observed that YES8c binds to the CH2-CH3 elbow in the canonical antigen-binding manner involving a large antigen-antibody interface. On the basis of this observation, combined with mutational analyses, we propose a recognition mechanism common to IGHV1-69/IGKV3-20 RFs: (1) the interaction of the Leu(432)-His(435) region of Fc enables the highly variable complementarity-determining region (CDR)-H3 to participate in the binding, (2) the hydrophobic tip in the CDR-H2 typical of IGHV1-69 antibodies recognizes the hydrophobic patch on Fc, and (3) the interaction of the highly conserved RF light chain with Fc is important for RF activity. These features may determine the putative epitope common to the IGHV1-69/IGKV3-20 RFs. We also showed that some mutations in the binding site of RF increase the affinity to Fc, which may aggravate hematological diseases. Our findings unravel the structural basis for germline-encoded antibody autoreactivity.	[Shiroishi, Mitsunori; Ito, Yuji; Shimokawa, Kenta; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Fukuoka 8128582, Japan; [Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Insect Genome Sci, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Shiroishi, M; Ueda, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Prot Struct Funct & Design, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	shiroish@phar.kyushu-u.ac.jp; ueda@phar.kyushu-u.ac.jp		Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Society for the Promotion of Science (JSPS) KAKENHI [23655160, 15K15184]; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grants 23655160 and 15K15184 (to T.U.) and the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from AMED. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; ARTANDI SE, 1991, J IMMUNOL, V146, P603; ARTANDI SE, 1992, P NATL ACAD SCI USA, V89, P94, DOI 10.1073/pnas.89.1.94; Bende RJ, 2015, ARTHRITIS RHEUMATOL, V67, P1074, DOI 10.1002/art.39002; Bende RJ, 2005, J EXP MED, V201, P1229, DOI 10.1084/jem.20050068; BONAGURA VR, 1993, J IMMUNOL, V151, P3840; BORRETZEN M, 1995, J IMMUNOL, V155, P3630; Carayannopoulos MO, 2000, SCAND J IMMUNOL, V51, P327; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Charles ED, 2013, ARTHRITIS RHEUM-US, V65, P2430, DOI 10.1002/art.38041; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; De Re V, 2002, EUR J IMMUNOL, V32, P903, DOI 10.1002/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Duquerroy S, 2007, J MOL BIOL, V368, P1321, DOI 10.1016/j.jmb.2007.02.085; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERMEL RW, 1993, ARTHRITIS RHEUM-US, V36, P380, DOI 10.1002/art.1780360314; EZAKI I, 1991, ARTHRITIS RHEUM, V34, P343, DOI 10.1002/art.1780340312; Fujii T, 2007, J BIOCHEM, V141, P699, DOI 10.1093/jb/mvm075; Ivanovski M, 1998, BLOOD, V91, P2433, DOI 10.1182/blood.V91.7.2433.2433_2433_2442; Jones JD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4152; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; MANTOVANI L, 1993, J IMMUNOL, V151, P473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; PASCUAL V, 1992, SCAND J IMMUNOL, V36, P349, DOI 10.1111/j.1365-3083.1992.tb03108.x; PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; RANDEN I, 1992, J IMMUNOL, V148, P3296; RANDEN I, 1992, IMMUNOL REV, V128, P49, DOI 10.1111/j.1600-065X.1992.tb00832.x; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; SASSO EH, 1988, J IMMUNOL, V140, P3098; Sene D, 2009, ARTHRITIS RHEUM-US, V60, P3848, DOI 10.1002/art.25000; SILVERMAN GJ, 1988, J CLIN INVEST, V82, P469, DOI 10.1172/JCI113620; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; THOMPSON KM, 1994, EUR J IMMUNOL, V24, P1771, DOI 10.1002/eji.1830240808; VICTOR KD, 1991, J CLIN INVEST, V87, P1603, DOI 10.1172/JCI115174; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeung YA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13376; Ying TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9223; YOUNGBLOOD K, 1994, J CLIN INVEST, V93, P852, DOI 10.1172/JCI117040	48	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7008	7016		10.1074/jbc.M117.814475	http://dx.doi.org/10.1074/jbc.M117.814475			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29523691	hybrid, Green Published			2022-12-28	WOS:000431487300031
J	Rasheed, M; Battu, A; Kaur, R				Rasheed, Mubashshir; Battu, Anamika; Kaur, Rupinder			Aspartyl proteases in Candida glabrata are required for suppression of the host innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; chemotaxis; interleukin 1 (IL-1); macrophage; spleen tyrosine kinase (Syk); Yapsins; cell wall remodeling; mouse organ colonization; IL-1beta; Syk; THP-1 macrophages; intracellular survival	NLRP3 INFLAMMASOME; CELL-WALL; BETA-GLUCAN; GENE LISTS; ALBICANS; DEFENSE; RECOGNITION; EXPRESSION; DECTIN-1; ADHESIN	A family of 11 cell surface-associated aspartyl proteases (CgYps1-11), also referred as yapsins, is a key virulence factor in the pathogenic yeast Candida glabrata. However, the mechanism by which CgYapsins modulate immune response and facilitate survival in the mammalian host remains to be identified. Here, using RNA-Seq analysis, we report that genes involved in cell wall metabolism are differentially regulated in the Cgyps1-11 mutant. Consistently, the mutant contained lower -glucan and mannan levels and exhibited increased chitin content in the cell wall. As cell wall components are known to regulate the innate immune response, we next determined the macrophage transcriptional response to C. glabrata infection and observed differential expression of genes implicated in inflammation, chemotaxis, ion transport, and the tumor necrosis factor signaling cascade. Importantly, the Cgyps1-11 mutant evoked a different immune response, resulting in an enhanced release of the pro-inflammatory cytokine IL-1 in THP-1 macrophages. Further, Cgyps1-11-induced IL-1 production adversely affected intracellular proliferation of co-infected WT cells and depended on activation of spleen tyrosine kinase (Syk) signaling in the host cells. Accordingly, the Syk inhibitor R406 augmented intracellular survival of the Cgyps1-11 mutant. Finally, we demonstrate that C. glabrata infection triggers elevated IL-1 production in mouse organs and that the CgYPS genes are required for organ colonization and dissemination in the murine model of systemic infection. Altogether, our results uncover the basis for macrophage-mediated killing of Cgyps1-11 cells and provide the first evidence that aspartyl proteases in C. glabrata are required for suppression of IL-1 production in macrophages.	[Rasheed, Mubashshir; Battu, Anamika; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, Andhra Pradesh, India; [Rasheed, Mubashshir; Battu, Anamika] Manipal Acad Higher Educ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Hyderabad 500039, Andhra Pradesh, India.	rkaur@cdfd.org.in		Kaur, Rupinder/0000-0003-3287-1700; Rasheed, Mubashshir/0000-0002-1597-6976	Wellcome Trust/DBT India Alliance Senior Fellowship [IA/S/15/1/501831]; Council of Scientific and Industrial Research, India; Department of Biotechnology, Government of India	Wellcome Trust/DBT India Alliance Senior Fellowship(Wellcome Trust DBT India Alliance); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Wellcome Trust/DBT India Alliance Senior Fellowship IA/S/15/1/501831 (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Junior and Senior Fellowship sponsored by the Council of Scientific and Industrial Research, India.; Recipient of a Junior Fellowship sponsored by the Department of Biotechnology, Government of India.	Amsen Derk, 2009, V511, P107, DOI 10.1007/978-1-59745-447-6_5; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Barker KS, 2005, J INFECT DIS, V192, P901, DOI 10.1086/432487; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brunke S, 2013, CELL MICROBIOL, V15, P701, DOI 10.1111/cmi.12091; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SM, 2017, VIRULENCE, V8, P1643, DOI 10.1080/21505594.2017.1346756; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Duggan S, 2015, CELL MICROBIOL, V17, P1259, DOI 10.1111/cmi.12443; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Gabaldon T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-623; Gagnon-Arsenault I, 2006, FEMS YEAST RES, V6, P966, DOI 10.1111/j.1567-1364.2006.00129.x; Garlanda C., 2008, GROWTH, V23, P1; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Kan VL, 1996, ANTIMICROB AGENTS CH, V40, P1717, DOI 10.1128/AAC.40.7.1717; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kasper L, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov042; Kasper L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096015; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kim HS, 2005, INFECT IMMUN, V73, P3714, DOI 10.1128/IAI.73.6.3714-3724.2005; Krysan DJ, 2005, EUKARYOT CELL, V4, P1364, DOI 10.1128/EC.4.8.1364-1374.2005; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Montagna MT, 2014, EUR REV MED PHARMACO, V18, P661; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pietrella D, 2013, EUR J IMMUNOL, V43, P679, DOI 10.1002/eji.201242691; Priebe S, 2015, BIOINFORMATICS, V31, P445, DOI 10.1093/bioinformatics/btu627; Quintin J, 2013, J IMMUNOL, V190, P2818, DOI 10.4049/jimmunol.1201861; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Seider K, 2014, EUKARYOT CELL, V13, P170, DOI 10.1128/EC.00262-13; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zordan RE, 2013, G3-GENES GENOM GENET, V3, P1675, DOI 10.1534/g3.113.006908	56	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6410	6433		10.1074/jbc.M117.813741	http://dx.doi.org/10.1074/jbc.M117.813741			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29491142	Green Published, hybrid			2022-12-28	WOS:000431108600016
J	Sen, M; Koksal, AC; Yuki, K; Wang, JC; Springer, TA				Sen, Mehmet; Koksal, Adem C.; Yuki, Koichi; Wang, Jianchuan; Springer, Timothy A.			Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-I DOMAIN; INTERCELLULAR-ADHESION MOLECULE-1; RAY SOLUTION SCATTERING; ELECTRON-MICROSCOPY; INTERNAL LIGAND; CELL-SURFACE; ACTIVATION; ICAM-1; ALPHA(X)BETA(2); RECOGNITION	In alpha I integrins, including leukocyte function-associated antigen 1 (LFA-1), ligand-binding function is delegated to the alpha I domain, requiring extra steps in the relay of signals that activate ligand binding and coordinate it with cytoplasmic signals. Crystal structures reveal great variation in orientation between the alpha I domain and the remainder of the integrin head. Here, we investigated the mechanisms involved in signal relay to the alpha I domain, including whether binding of the ligand intercellular adhesion molecule-1 (ICAM-1) to the alpha I domain is linked to headpiece opening and engenders a preferred alpha I domain orientation. Using small-angle X-ray scattering and negative-stain EM, we define structures of ICAM-1, LFA-1, and their complex, and the effect of activation by Mn2+. Headpiece opening was substantially stabilized by substitution of Mg2+ with Mn2+ and became complete upon ICAM-1 addition. These agents stabilized alpha I-headpiece orientation, resulting in a well-defined orientation of ICAM-1 such that its tandem Ig-like domains pointed in the opposite direction from the beta-subunit leg of LFA-1. Mutations in the integrin alpha I domain alpha 1/alpha 1' helix stabilizing either the open or the closed alpha I-domain conformation indicated that alpha 1/alpha 1' helix movements are linked to ICAM-1 binding by the alpha I domain and to the extended-open conformation of the ectodomain. The LFA-1-ICAM-1 orientation described here with ICAM-1 pointing anti-parallel to the LFA-1 beta-subunit leg is the same orientation that would be stabilized by tensile force transmitted between the ligand and the actin cytoskeleton and is consistent with the cytoskeletal force model of integrin activation.	[Sen, Mehmet; Koksal, Adem C.; Wang, Jianchuan; Springer, Timothy A.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Mol Pharmacol, Boston, MA 02115 USA; [Wang, Jianchuan; Springer, Timothy A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Sen, Mehmet] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Houston System; University of Houston	Sen, M; Springer, TA (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Mol Pharmacol, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Sen, M (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	msen2@central.uh.edu; Springer_lab@crystal.harvard.edu		Koksal, Adem/0000-0002-3163-7421	National Institutes of Health NCI Grant [CA031798]; GlaxoSmithKline fellowship; National Institutes of Health [NIGMS R01GM118277]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277] Funding Source: NIH RePORTER	National Institutes of Health NCI Grant; GlaxoSmithKline fellowship(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NCI Grant CA031798 (to T.A.S.), by a GlaxoSmithKline fellowship (to M. S.), and by National Institutes of Health Grant NIGMS R01GM118277 (to K. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057951; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BILSLAND CAG, 1994, J IMMUNOL, V152, P4582; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KIRCHHAUSEN T, 1993, J LEUKOCYTE BIOL, V53, P342, DOI 10.1002/jlb.53.3.342; Li J, 2017, P NATL ACAD SCI USA, V114, P4685, DOI 10.1073/pnas.1704171114; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nordenfelt P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01848-y; Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Recacha R, 2014, ACTA CRYSTALLOGR D, V70, P1934, DOI 10.1107/S1399004714009468; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Springer TA, 2016, P NATL ACAD SCI USA, V113, P2940, DOI 10.1073/pnas.1601379113; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Weitz-Schmidt G, 2011, J BIOL CHEM, V286, P42115, DOI 10.1074/jbc.M111.282830; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xu ST, 2017, P NATL ACAD SCI USA, V114, P3403, DOI 10.1073/pnas.1620881114; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	49	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6565	6577		10.1074/jbc.RA117.000710	http://dx.doi.org/10.1074/jbc.RA117.000710			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29507098	Green Published, hybrid			2022-12-28	WOS:000431108600027
J	Amin, MA; McKenney, RJ; Varma, D				Amin, Mohammed A.; McKenney, Richard J.; Varma, Dileep			Antagonism between the dynein and Ndc80 complexes at kinetochores controls the stability of kinetochore-microtubule attachments during mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; CENP-E; CHROMOSOME ALIGNMENT; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CONGRESSION; POLEWARD; CELLS; HEC1; MECHANISMS	Chromosome alignment and segregation during mitosis require kinetochore-microtubule (kMT) attachments that are mediated by the molecular motor dynein and the kMT-binding complex Ndc80. The Rod-ZW10-Zwilch (RZZ) complex is central to this coordination as it has an important role in dynein recruitment and has recently been reported to have a key function in the regulation of stable kMT attachments in Caenorhabditis elegans besides its role in activating the spindle assembly checkpoint (SAC). However, the mechanism by which these protein complexes control kMT attachments to drive chromosome motility during early mitosis is still unclear. Here, using in vitro total internal reflection fluorescence microscopy, we observed that higher concentrations of Ndc80 inhibited dynein binding to MTs, providing evidence that Ndc80 and dynein antagonize each other's function. High-resolution microscopy and siRNAmediated functional disruption revealed that severe defects in chromosome alignment induced by depletion of dynein or the dynein adapter Spindly are rescued by codepletion of the RZZ component Rod in human cells. Interestingly, rescue of the chromosome alignment defects was independent of Rod function in SAC activation and was accompanied by a remarkable restoration of stable kMT attachments. Furthermore, the chromosome alignment rescue depended on the plus-end-directed motility of centromere protein E (CENP-E) because cells codepleted of CENP-E, Rod, and dynein could not establish stable kMT attachments or align their chromosomes properly. Our findings support the idea that dynein may control the function of the Ndc80 complex in stabilizing kMT attachments directly by interfering with Ndc80-MTbinding or indirectly by controlling the Rod-mediated inhibition of Ndc80.	[Amin, Mohammed A.; Varma, Dileep] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [McKenney, Richard J.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Davis	Varma, D (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	dileep.varma@northwestern.edu			National Institutes of Health NCI Grant [R00CA178188]; National Institutes of Health NINDS Grant [R00NS089428]; National Institutes of Health NIGMS Grant [R35GM124889]; NATIONAL CANCER INSTITUTE [R00CA178188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS089428] Funding Source: NIH RePORTER	National Institutes of Health NCI Grant; National Institutes of Health NINDS Grant; National Institutes of Health NIGMS Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NCI Grant R00CA178188 (to D.V.), NINDS Grant R00NS089428 (to R.J.M.), and NIGMS Grant R35GM124889 (to R.J.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amin MA, 2015, FEBS LETT, V589, P2739, DOI 10.1016/j.febslet.2015.07.036; Barisic M, 2016, TRENDS CELL BIOL, V26, P766, DOI 10.1016/j.tcb.2016.06.001; Barisic M, 2015, CELL CYCLE, V14, P3356, DOI 10.1080/15384101.2015.1089369; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Bennett A, 2015, ONCOTARGET, V6, P20921, DOI 10.18632/oncotarget.4879; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Caldas GV, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150160; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiato H., 2017, BIOLOGY, V6, pE13; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; McKenney RJ, 2016, EMBO J, V35, P1175, DOI 10.15252/embj.201593071; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Silio V, 2015, DEV CELL, V35, P600, DOI 10.1016/j.devcel.2015.11.012; Simoes PA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212159; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Starr DA, 1997, J CELL BIOL, V138, P1289, DOI 10.1083/jcb.138.6.1289; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Varma D, 2013, J CELL BIOL, V202, P735, DOI 10.1083/jcb.201304197; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	60	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5755	5765		10.1074/jbc.RA117.001699	http://dx.doi.org/10.1074/jbc.RA117.001699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29475948	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000430497300001
J	Karthik, IP; Desai, P; Sukumar, S; Dimitrijevic, A; Rajalingam, K; Mahalingam, S				Karthik, Isai Pratha; Desai, Pavitra; Sukumar, Sudarkodi; Dimitrijevic, Aleksandra; Rajalingam, Krishnaraj; Mahalingam, Sundarasamy			E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTLY TARGETING RASSF8; TUMOR-SUPPRESSOR GENE; CELL LUNG-CANCER; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; SURVIVAL FACTOR; DOWN-REGULATION; KAPPA-B; PROMOTES; E4BP4	RAS proteins are major human oncogenes, and most of the studies are focused on enzymatic RAS effectors. Recently, nonenzymatic RAS effectors (RASSF, RAS association domain family) have garnered special attention because of their tumor-suppressive properties in contrast to the oncogenic potential of the classical enzymatic RAS effectors. Whereas most members of RASSF family are deregulated by promoter hypermethylation, RASSF8 promoter remains unmethylated in many cancers but the mechanism(s) of its down-regulation remains unknown. Here, we unveil E4BP4 as a critical transcriptional modulator repressing RASSF8 expression through histone methyltransferases, G9a and SUV39H1. In line with these observations, we noticed a negative correlation of RASSF8 and E4BP4 expression in primary breast tumor samples. In addition, our data provide evidence that E4BP4 attenuates RASSF8-mediated anti-proliferation and apoptosis, shedding mechanistic insights into RASSF8 down-regulation in breast cancers. Collectively, our study provides a better understanding on the epigenetic regulation of RASSF8 function and implicates the development of better treatment strategies.	[Karthik, Isai Pratha; Desai, Pavitra; Sukumar, Sudarkodi; Mahalingam, Sundarasamy] Indian Inst Technol Madras, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Natl Canc Tissue Biobank,Lab Mol Virol, Madras 600036, Tamil Nadu, India; [Dimitrijevic, Aleksandra; Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Forschungszentrum Immuntherapie, Inst Immunol,Mol Signaling Unit, D-55131 Mainz, Germany	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Johannes Gutenberg University of Mainz	Mahalingam, S (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	mahalingam@iitm.ac.in			Department of Science and Technology, Government of India [VI-D&P/411/2012-2013/TDT (G)]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Department of Science and Technology Grant VI-D&P/411/2012-2013/TDT (G), Government of India (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Chiba T, 2015, INT J CANCER, V136, P289, DOI 10.1002/ijc.28985; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; Datta D, 2015, J BIOL CHEM, V290, P21536, DOI 10.1074/jbc.M115.637280; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Deleris A, 2010, EMBO REP, V11, P950, DOI 10.1038/embor.2010.158; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Djos A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-40; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Falvella FS, 2006, ONCOGENE, V25, P3934, DOI 10.1038/sj.onc.1209422; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Gade P, 2012, METHODS MOL BIOL, V809, P85, DOI 10.1007/978-1-61779-376-9_6; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He C, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0603-1; Hesson LB, 2005, ONCOGENE, V24, P3987, DOI 10.1038/sj.onc.1208566; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Huang TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.65; Huang YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162378; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Keniry M, 2013, GENE DEV, V27, P916, DOI 10.1101/gad.214049.113; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; MacFarlane M, 2000, J CELL BIOL, V148, P1239, DOI 10.1083/jcb.148.6.1239; MacGillavry HD, 2009, J NEUROSCI, V29, P15542, DOI 10.1523/JNEUROSCI.3938-09.2009; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Richter AM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00021; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Spyropoulou A, 2014, NEUROMOL MED, V16, P70, DOI 10.1007/s12017-013-8254-x; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Twiddy D, 2006, J BIOL CHEM, V281, P3876, DOI 10.1074/jbc.M507393200; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang JH, 2015, ONCOTARGET, V6, P30165, DOI 10.18632/oncotarget.5030; Wang L, 2017, EUR REV MED PHARMACO, V21, P3223; Wang YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00350-9; Watanabe K, 2015, CANCER MED-US, V4, P1573, DOI 10.1002/cam4.505; Wei L, 2017, J HEPATOL, V67, P758, DOI 10.1016/j.jhep.2017.05.015; Wei MC, 2000, GENE DEV, V14, P2060; Weng YJ, 2010, MOL CELL BIOCHEM, V340, P187, DOI 10.1007/s11010-010-0417-6; Zhang L, 2015, ONCOTARGET, V6, P34510, DOI 10.18632/oncotarget.5923	52	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5624	5635		10.1074/jbc.RA117.000623	http://dx.doi.org/10.1074/jbc.RA117.000623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29467226	hybrid, Green Published			2022-12-28	WOS:000430044100023
J	Guo, DK; Zhang, S; Sun, HY; Xu, XY; Hao, ZB; Mu, CC; Xu, XS; Wang, GH; Ren, HG				Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Xu, Xingshun; Wang, Guanghui; Ren, Haigang			Tyrosine hydroxylase down-regulation after loss of Abelson helper integration site 1 (AHI1) promotes depression via the circadian clock pathway in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						depression; dopamine; circadian clock; Rev-ErbA alpha (NR1D1); biosynthesis; Abelson helper integration site 1; behavioral disorder; RAR-related orphan receptor alpha; transcriptional regulation; tyrosine hydroxylase	REV-ERB-ALPHA; GENE-MUTATIONS; RECEPTOR; BIPOLAR; TRANSCRIPTION; DOPAMINE; DISORDER; DYSREGULATION; METAANALYSIS; ASSOCIATION	Abelson helper integration site 1 (AHI1) is associated with several neuropsychiatric and brain developmental disorders, such as schizophrenia, depression, autism, and Joubert syndrome. Ahi1 deficiency in mice leads to behaviors typical of depression. However, the mechanisms by which AHI1 regulates behavior remain to be elucidated. Here, we found that down-regulation of expression of the rate-limiting enzyme in dopamine biosynthesis, tyrosine hydroxylase (TH), in the midbrains of Ahi1-knockout (KO) mice is responsible for Ahi1-deficiency-mediated depressive symptoms. We also found that Rev-Erb, a TH transcriptional repressor and circadian regulator, is up-regulated in the Ahi1-KO mouse midbrains and Ahi1-knockdown Neuro-2a cells. Moreover, brain and muscle Arnt-like protein 1 (BMAL1), the Rev-Erb transcriptional regulator, is also increased in the Ahi1-KO mouse midbrains and Ahi1-knockdown cells. Our results further revealed that AHI1 decreases BMAL1/Rev-Erb expression by interacting with and repressing retinoic acid receptor-related orphan receptor , a nuclear receptor and transcriptional regulator of circadian genes. Of note, Bmal1 deficiency reversed the reduction in TH expression induced by Ahi1 deficiency. Moreover, microinfusion of the Rev-Erb inhibitor SR8278 into the ventral midbrain of Ahi1-KO mice significantly increased TH expression in the ventral tegmental area and improved their depressive symptoms. These findings provide a mechanistic explanation for a link between AHI1-related behaviors and the circadian clock pathway, indicating an involvement of circadian regulatory proteins in AHI1-regulated mood and behavior.	[Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Wang, Guanghui; Ren, Haigang] Soochow Univ, Coll Pharmaceut Sci, Lab Mol Neuropathol, Jiangsu Key Lab Neuropsychiat Disorders, Suzhou 215123, Jiangsu, Peoples R China; [Guo, Dongkai; Zhang, Shun; Sun, Hongyang; Xu, Xingyun; Hao, Zongbing; Mu, Chenchen; Wang, Guanghui; Ren, Haigang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xingshun] Soochow Univ, Inst Neurosci, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xingshun] Soochow Univ, Dept Neurol, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Wang, GH; Ren, HG (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Lab Mol Neuropathol, Jiangsu Key Lab Neuropsychiat Disorders, Suzhou 215123, Jiangsu, Peoples R China.; Wang, GH; Ren, HG (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 215123, Jiangsu, Peoples R China.	wanggh@suda.edu.cn; rhg@suda.edu.cn	Wang, Guanghui/U-3979-2017; Xu, Xingshun/AAF-8183-2020; Ren, Haigang/U-6034-2017	Wang, Guanghui/0000-0001-8551-6468; Ren, Haigang/0000-0001-8844-4754; Xu, Xingshun/0000-0003-0205-6342	National Natural Sciences Foundation of China [81761148024, 31330030, 31471012]; National Key Scientific R&D Program of China [2016YFC1306000, 2012CB947602]; Suzhou Clinical Research Center of Neurological Disease [Szzx201503]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific R&D Program of China; Suzhou Clinical Research Center of Neurological Disease; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Sciences Foundation of China Grants 81761148024, 31330030, and 31471012; National Key Scientific R&D Program of China Grants 2016YFC1306000 and 2012CB947602; Suzhou Clinical Research Center of Neurological Disease Grant Szzx201503; and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Albrecht U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00030; Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Ashok AH, 2017, MOL PSYCHIATR, V22, P666, DOI 10.1038/mp.2017.16; Barandas R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0637-2; Bellivier F, 2015, EXPERT OPIN THER TAR, V19, P747, DOI 10.1517/14728222.2015.1018822; Blier P, 2013, J CLIN PSYCHIAT, V74, P19, DOI 10.4088/JCP.12084su1c.04; Bunney BG, 2015, MOL PSYCHIATR, V20, P48, DOI 10.1038/mp.2014.138; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chung S, 2014, CELL, V157, P858, DOI 10.1016/j.cell.2014.03.039; Dallaspezia S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0606-9; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; Furlong RA, 1999, AM J MED GENET, V88, P88, DOI 10.1002/(SICI)1096-8628(19990205)88:1<88::AID-AJMG16>3.0.CO;2-J; Gu C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.250; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Karatsoreos IN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00162; Kondratova AA, 2010, AGING-US, V2, P285; Korshunov KS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00091; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lemos DR, 2007, ENDOCRINOLOGY, V148, P5811, DOI 10.1210/en.2007-0610; McCarthy MJ, 2012, J BIOL RHYTHM, V27, P339, DOI 10.1177/0748730412456367; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Meyer JH, 2008, SEMIN NUCL MED, V38, P287, DOI 10.1053/j.semnuclmed.2008.02.007; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Porcelli S, 2014, PSYCHIAT INVEST, V11, P481, DOI 10.4306/pi.2014.11.4.481; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ren LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093640; Rivero O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012254; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Serretti A, 1998, AM J MED GENET, V81, P127, DOI 10.1002/(SICI)1096-8628(19980328)81:2<127::AID-AJMG1>3.3.CO;2-X; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sidor MM, 2015, MOL PSYCHIATR, V20, P1406, DOI 10.1038/mp.2014.167; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Weng L, 2013, J NEUROSCI, V33, P8172, DOI 10.1523/JNEUROSCI.0119-13.2013; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xu XS, 2010, P NATL ACAD SCI USA, V107, P19126, DOI 10.1073/pnas.1013032107; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	13	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5090	5101		10.1074/jbc.RA117.000618	http://dx.doi.org/10.1074/jbc.RA117.000618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449373	hybrid, Green Published			2022-12-28	WOS:000429409300016
J	Citterio, CE; Morishita, Y; Dakka, N; Veluswamy, B; Arvan, P				Citterio, Cintia E.; Morishita, Yoshiaki; Dakka, Nada; Veluswamy, Balaji; Arvan, Peter			Relationship between the dimerization of thyroglobulin and its ability to form triiodothyronine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; THYROXINE FORMATION; HORMONE FORMATION; IODINATION; SITES; ACETYLCHOLINESTERASE; DONOR	Thyroglobulin (TG) is the most abundant thyroid gland protein, a dimeric iodoglycoprotein (660 kDa). TG serves as the protein precursor in the synthesis of thyroid hormones tetraiodothyronine (T-4) and triiodothyronine (T-3). The primary site for T-3 synthesis in TG involves an iodotyrosine acceptor at the antepenultimate Tyr residue (at the extreme carboxyl terminus of the protein). The carboxyl-terminal region of TG comprises a cholinesterase-like (ChEL) domain followed by a short unique tail sequence. Despite many studies, the monoiodotyrosine donor residue needed for the coupling reaction to create T-3 at this evolutionarily conserved site remains unidentified. In this report, we have utilized a novel, convenient immunoblotting assay to detect T-3 formation after protein iodination in vitro, enabling the study of T-3 formation in recombinant TG secreted from thyrocytes or heterologous cells. With this assay, we confirm the antepenultimate residue of TG as a major T-3-forming site, but also demonstrate that the side chain of this residue intimately interacts with the same residue in the apposed monomer of the TG dimer. T-3 formation in TG, or the isolated carboxyl-terminal region, is inhibited by mutation of this antepenultimate residue, but we describe the first substitution mutation that actually increases T-3 hormonogenesis by engineering a novel cysteine, 10 residues upstream of the antepenultimate residue, allowing for covalent association of the unique tail sequences, and that helps to bring residues Tyr(2744) from apposed monomers into closer proximity.	[Citterio, Cintia E.; Morishita, Yoshiaki; Dakka, Nada; Veluswamy, Balaji; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Citterio, Cintia E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol, Catedra Genet, Buenos Aires C1113AAD, Buenos Aires, DF, Argentina; [Citterio, Cintia E.] Univ Buenos Aires, CONICET, Inst Inmunol Genet & Metab INIGEM, Buenos Aires C1120AAR, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Arvan, P (corresponding author), Brehm Tower Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Morishita, Yoshiaki/GWQ-6726-2022; Morishita, Yoshiaki/AAX-6552-2021; Citterio, Cintia E./AAI-4888-2021	Morishita, Yoshiaki/0000-0003-4733-7981; Citterio, Cintia E./0000-0002-3547-5458; DAKKA, NADIA/0000-0002-8265-5689	National Institutes of Health [R01 DK40344]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK40344 (to P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cetrangolo GP, 2014, BIOCHEM BIOPH RES CO, V450, P488, DOI 10.1016/j.bbrc.2014.05.144; CHANOINE JP, 1993, J CLIN INVEST, V91, P2709, DOI 10.1172/JCI116510; Citterio CE, 2017, J BIOL CHEM, V292, P15434, DOI 10.1074/jbc.M117.784447; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; DENHARTOG MT, 1995, EUR J ENDOCRINOL, V132, P611, DOI 10.1530/eje.0.1320611; Deshpande V, 1999, BBA-PROTEIN STRUCT M, V1430, P157, DOI 10.1016/S0167-4838(99)00015-1; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; DUNN JT, 1987, J BIOL CHEM, V262, P16948; EICHLER J, 1994, J BIOL CHEM, V269, P30093; FASSLER CA, 1988, J BIOL CHEM, V263, P17366; HERZOG V, 1992, J CELL BIOL, V118, P1071, DOI 10.1083/jcb.118.5.1071; Holzer G, 2016, J BIOL CHEM, V291, P16553, DOI 10.1074/jbc.M116.719047; KIM PS, 1991, J BIOL CHEM, V266, P12412; Klein M, 2000, BIOL CHEM, V381, P593, DOI 10.1515/BC.2000.076; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; LARSEN PR, 1975, J CLIN ENDOCR METAB, V41, P1098, DOI 10.1210/jcem-41-6-1098; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P33045, DOI 10.1074/jbc.M111.281337; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; LEONARDI A, 1994, BIOCHEM BIOPH RES CO, V202, P38, DOI 10.1006/bbrc.1994.1890; Liu XW, 2002, ARCH PHARM RES, V25, P485, DOI 10.1007/BF02976607; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; ROLLAND M, 1976, BIOCHIM BIOPHYS ACTA, V427, P696, DOI 10.1016/0005-2795(76)90213-0; SCHIMMEL M, 1977, ANN INTERN MED, V87, P760, DOI 10.7326/0003-4819-87-6-760; Siffo S., 2017, MOL CELL ENDOCRINOL, P30637; STERLING K, 1970, J AMER MED ASSOC, V213, P571, DOI 10.1001/jama.213.4.571; SUZUKI S, 1975, GEN COMP ENDOCR, V26, P59, DOI 10.1016/0016-6480(75)90215-4; Taurog AM, 2000, WERNER INGBARS THYRO, P61; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Woeber KA, 2006, THYROID, V16, P687, DOI 10.1089/thy.2006.16.687	32	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4860	4869		10.1074/jbc.RA118.001786	http://dx.doi.org/10.1074/jbc.RA118.001786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29440273	hybrid, Green Published			2022-12-28	WOS:000428848300025
J	Song, B; Hamdan, SM; Hingorani, MM				Song, Bo; Hamdan, Samir M.; Hingorani, Manju M.			Positioning the 5 '-flap junction in the active site controls the rate of flap endonuclease-1-catalyzed DNA cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFUSION-CONTROLLED REACTIONS; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; FEN1; CATALYSIS; ENDONUCLEASES; RECOGNITION; SUPERFAMILY; EXONUCLEASE; COMPLEXES	Flap endonucleases catalyze cleavage of single-stranded DNA flaps formed during replication, repair, and recombination and are therefore essential for genome processing and stability. Recent crystal structures of DNA-bound human flap endonuclease (hFEN1) offer new insights into how conformational changes in the DNA and hFEN1 may facilitate the reaction mechanism. For example, previous biochemical studies of DNA conformation performed under non-catalytic conditions with Ca2+ have suggested that base unpairing at the 5'-flap: template junction is an important step in the reaction, but the new structural data suggest otherwise. To clarify the role of DNA changes in the kinetic mechanism, we measured a series of transient steps, from substrate binding to product release, during the hFEN1-catalyzed reaction in the presence of Mg2+. We found that whereas hFEN1 binds and bends DNA at a fast, diffusion-limited rate, much slower Mg2+-dependent conformational changes in DNA around the active site are subsequently necessary and rate-limiting for 5'-flap cleavage. These changes are reported overall by fluorescence of 2-aminopurine at the 5'-flap: template junction, indicating that local DNA distortion (e.g. disruption of base stacking observed in structures), associated with positioning the 5'-flap scissile phosphodiester bond in the hFEN1 active site, controls catalysis. hFEN1 residues with distinct roles in the catalytic mechanism, including those binding metal ions (Asp-34 and Asp-181), steering the 5'-flap through the active site and binding the scissile phosphate (Lys-93 and Arg-100), and stacking against the base 5' to the scissile phosphate (Tyr-40), all contribute to these rate-limiting conformational changes, ensuring efficient and specific cleavage of 5'-flaps.	[Song, Bo; Hingorani, Manju M.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [Hamdan, Samir M.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	Wesleyan University; King Abdullah University of Science & Technology	Hingorani, MM (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	mhingorani@wesleyan.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [R15 GM114743]; King Abdullah University of Science and Technology [CRG3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15 GM114743 (to M. M. H.) and a Competitive Research Award (CRG3) by King Abdullah University of Science and Technology (to S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; Algasaier SI, 2016, J BIOL CHEM, V291, P8258, DOI 10.1074/jbc.M115.698993; Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; AlMalki FA, 2016, NAT STRUCT MOL BIOL, V23, P640, DOI 10.1038/nsmb.3241; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Craggs TD, 2014, NUCLEIC ACIDS RES, V42, P1857, DOI 10.1093/nar/gkt1116; Dehe PM, 2017, NAT REV MOL CELL BIO, V18, P315, DOI 10.1038/nrm.2016.177; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Liu YJ, 2015, CELL REP, V13, P2565, DOI 10.1016/j.celrep.2015.11.042; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Patel N, 2013, J BIOL CHEM, V288, P34239, DOI 10.1074/jbc.M113.509489; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Rashid F, 2017, ELIFE, V6, DOI 10.7554/eLife.21884; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shi YQ, 2017, P NATL ACAD SCI USA, V114, P6010, DOI 10.1073/pnas.1704845114; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Tarantino ME, 2015, J BIOL CHEM, V290, P21154, DOI 10.1074/jbc.M115.666438; Tsutakawa SE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15855; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zaher M. S., 2018, NUCL ACIDS IN PRESS; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; ZHOU GQ, 1982, EUR J BIOCHEM, V128, P383	35	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4792	4804		10.1074/jbc.RA117.001137	http://dx.doi.org/10.1074/jbc.RA117.001137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462789	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000428848300020
J	Bai, SM; Datta, J; Jacob, ST; Ghoshal, K				Bai, Shoumei; Datta, Jharna; Jacob, Samson T.; Ghoshal, Kalpana			RETRACTION: Treatment of PC12 cells with nerve growth factor induces proteasomal degradation of T-cadherin that requires tyrosine phosphorylation of its cadherin domain (Retraction of Vol 282, Pg 27171, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3590	3590		10.1074/jbc.W118.002432	http://dx.doi.org/10.1074/jbc.W118.002432			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523696	Green Published, hybrid			2022-12-28	WOS:000427030200012
J	Bhagyaraj, E; Tiwari, D; Ahuja, N; Nanduri, R; Saini, A; Kalra, R; Kumar, S; Janmeja, AK; Gupta, P				Bhagyaraj, Ella; Tiwari, Drishti; Ahuja, Nancy; Nanduri, Ravikanth; Saini, Ankita; Kalra, Rashi; Kumar, Sumit; Janmeja, Ashok Kumar; Gupta, Pawan			A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE X RECEPTOR; RESISTANT TUBERCULOSIS; EXTRAHEPATIC TISSUES; METABOLIZING-ENZYMES; TRANSPORTERS; SURVIVAL; CYTOCHROME-P-450; CHEMOTHERAPY; MACROPHAGES; EXPRESSION	Mycobacterium tuberculosis is the causative agent of tuberculosis (TB). It acquires phenotypic drug resistance inside macrophages, and this resistance mainly arises from host-induced stress. However, whether cellular drug-efflux mechanisms in macrophages contribute to nonresponsiveness of M. tuberculosis to anti-TB drugs is unclear. Here, we report that xenobiotic nuclear receptors mediate TB drug nonresponsiveness by modulating drug-efflux transporters in macrophages. This was evident from expression analysis of drug-efflux transporters in macrophages isolated from TB patients. Among patients harboring rifampicin-susceptible M. tuberculosis, we observed increased intracellular survival of M. tuberculosis upon rifampicin treatment of macrophages isolated from patients not responding to anti-TB drugs compared with macrophages from patients who did respond. Of note, M. tuberculosis infection and rifampicin exposure synergistically modulated macrophage drug-efflux transporters in vitro. We also found that the xenobiotic nuclear receptor pregnane X receptor (PXR) modulates macrophage drug-efflux transporter expression and activity, which compromised the anti-TB efficacy of rifampicin. We further validated this finding in a TB mouse model in which use of the PXR antagonist ketoconazole rescued rifampicin anti-TB activity. We conclude that PXR activation in macrophages compromises the efficacy of the anti-TB drug rifampicin. Alternative therapeutic strategies, such as use of the rifampicin derivatives rifapentine and rifabutin, which do not activate PXR, or of a PXR antagonist, may be effective for tackling drug nonresponsiveness of M. tuberculosis that arises from drug-efflux systems of the host.	[Bhagyaraj, Ella; Tiwari, Drishti; Ahuja, Nancy; Nanduri, Ravikanth; Saini, Ankita; Kalra, Rashi; Kumar, Sumit; Gupta, Pawan] CSIR Inst Microbial Technol, Dept Mol Biol, Sect 39 A, Chandigarh 160036, India; [Janmeja, Ashok Kumar] Govt Med Coll & Hosp, Chandigarh 160030, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR Inst Microbial Technol, Dept Mol Biol, Sect 39 A, Chandigarh 160036, India.	pawan@imtech.res.in	NANDURI, RAVIKANTH/Q-9729-2018	NANDURI, RAVIKANTH/0000-0002-0031-2333; Ella, Bhagyaraj/0000-0002-5887-9228; Tiwari, Drishti/0000-0002-5803-4073; Kumar, Sumit/0000-0001-8976-3482	Department of Biotechnology-India [BT/01/IYBA/2009, BT/HRD/NBA/37/01/2015]; Council of Scientific and Industrial research (CSIR) 12th Plan Network project Bugs to Drugs, Infectious Disease [BSC0211, BSC0210]	Department of Biotechnology-India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial research (CSIR) 12th Plan Network project Bugs to Drugs, Infectious Disease	This work was supported by Department of Biotechnology-India Project BT/01/IYBA/2009, BT/HRD/NBA/37/01/2015, and Council of Scientific and Industrial research (CSIR) 12th Plan Network project Bugs to Drugs, Infectious Disease Grants BSC0211 and BSC0210 (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Gomez MA, 2014, J ANTIMICROB CHEMOTH, V69, P139, DOI 10.1093/jac/dkt334; Ahmed S, 2016, GENOM PROTEOM BIOINF, V14, P298, DOI 10.1016/j.gpb.2016.03.008; Amacher DE, 2016, EXPERT OPIN DRUG MET, V12, P1463, DOI 10.1080/17425255.2016.1223626; Banerjee M, 2015, DRUG DISCOV TODAY, V20, P618, DOI 10.1016/j.drudis.2014.11.011; Beamer G, 2014, AM J PATHOL, V184, P3170, DOI 10.1016/j.ajpath.2014.08.024; Benson EA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00111; Bhagyaraj E, 2016, J IMMUNOL, V197, P244, DOI 10.4049/jimmunol.1600203; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Joshi JM, 2011, LUNG INDIA, V28, P193, DOI 10.4103/0970-2113.83977; Loddenkemper R, 2010, DTSCH ARZTEBL INT, V107, P10, DOI 10.3238/arztebl.2010.0010; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; MURRAY GI, 1988, BRIT J CLIN PHARMACO, V25, P465, DOI 10.1111/j.1365-2125.1988.tb03331.x; Palomino JC, 2014, ANTIBIOTICS-BASEL, V3, P317, DOI 10.3390/antibiotics3030317; Prakash Chandra, 2015, Nucl Receptor Res, V2; Roy U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00948; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Seral C, 2003, ANTIMICROB AGENTS CH, V47, P1047, DOI 10.1128/AAC.47.3.1047-1051.2003; Shehu AI, 2016, EXPERT OPIN DRUG MET, V12, P21, DOI 10.1517/17425255.2016.1121381; Sloan DJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00210-17, 10.1128/aac.00210-17]; Smith T, 2014, CURR TOP MICROBIOL, V374, P53, DOI 10.1007/82_2012_279; Sodani K, 2012, CHIN J CANCER, V31, P58, DOI 10.5732/cjc.011.10329; Srivastava S, 2011, J INFECT DIS, V204, P1951, DOI 10.1093/infdis/jir658; Swales KE, 2012, CARDIOVASC RES, V93, P674, DOI 10.1093/cvr/cvr330; Whyte-Allman SK, 2017, J PHARMACOL EXP THER, V363, P324, DOI 10.1124/jpet.117.243584; Zhang W, 2010, CURR OPIN MOL THER, V12, P695	31	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3747	3757		10.1074/jbc.M117.818377	http://dx.doi.org/10.1074/jbc.M117.818377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358328	hybrid, Green Published			2022-12-28	WOS:000427030200027
J	Isobe, M; Izawa, K; Sugiuchi, M; Sakanishi, T; Kaitani, A; Takamori, A; Maehara, A; Matsukawa, T; Takahashi, M; Yamanishi, Y; Oki, T; Uchida, S; Uchida, K; Ando, T; Maeda, K; Nakano, N; Yagita, H; Takai, T; Ogawa, H; Okumura, K; Kitamura, T; Kitaura, J				Isobe, Masamichi; Izawa, Kumi; Sugiuchi, Masahiro; Sakanishi, Tamami; Kaitani, Ayako; Takamori, Ayako; Maehara, Akie; Matsukawa, Toshihiro; Takahashi, Mariko; Yamanishi, Yoshinori; Oki, Toshihiko; Uchida, Shino; Uchida, Koichiro; Ando, Tomoaki; Maeda, Keiko; Nakano, Nobuhiro; Yagita, Hideo; Takai, Toshiyuki; Ogawa, Hideoki; Okumura, Ko; Kitamura, Toshio; Kitaura, Jiro			The CD300e molecule in mice is an immune-activating receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; BLOOD MONOCYTE SUBSETS; MAST-CELL ACTIVATION; FCR-GAMMA-CHAIN; FUNCTIONAL-ANALYSIS; LY6C(-) MONOCYTES; APOPTOTIC CELLS; DENDRITIC CELLS; EPSILON-RI; MAIR-II	CD300 molecules (CD300s) belong to paired activating and inhibitory receptor families, which mediate immune responses. Human CD300e (hCD300e) is expressed in monocytes and myeloid dendritic cells and transmits an immune-activating signal by interacting with DNAX-activating protein 12 (DAP12). However, the CD300e ortholog in mice (mCD300e) is poorly characterized. Here, we found that mCD300e is also an immune-activating receptor. We found that mCD300e engagement triggers cytokine production in mCD300e-transduced bone marrow-derived mast cells (BMMCs). Loss of DAP12 and another signaling protein, FcR gamma, did not affect surface expression of transduced mCD300e, but abrogated mCD300e-mediated cytokine production in the BMMCs. Co-immunoprecipitation experiments revealed that mCD300e physically interacts with both FcR gamma and DAP12, suggesting that mCD300e delivers an activating signal via these two proteins. Binding and reporter assays with the mCD300e extracellular domain identified sphingomyelin as a ligand of both mCD300e and hCD300e. Notably, the binding of sphingomyelin to mCD300 estimulated cytokine production in the transduced BMMCs in an FcR gamma- and DAP12-dependent manner. Flow cytometric analysis with an mCD300especific Ab disclosed that mCD300e expression is highly restricted to CD115(+)Ly-6C(low/int) peripheral blood monocytes, corresponding to CD14(dim)/(+)CD16(+) human nonclassical and intermediate monocytes. Loss of FcR gamma or DAP12 lowered the surface expression of endogenous mCD300e in the CD115(+)Ly-6C(low/int) monocytes. Stimulation with sphingomyelin failed to activate the CD115(+)Ly-6C(low/int) mouse monocytes, but induced hCD300e-mediated cytokine production in the CD14(dim)CD16(+) human monocytes. Taken together, these observations indicate that mCD300e recognizes sphingomyelin and thereby regulates nonclassical and intermediate monocyte functions through FcR gamma and DAP12.	[Isobe, Masamichi; Izawa, Kumi; Kaitani, Ayako; Takamori, Ayako; Maehara, Akie; Uchida, Shino; Uchida, Koichiro; Ando, Tomoaki; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Kitaura, Jiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Isobe, Masamichi; Izawa, Kumi; Sugiuchi, Masahiro; Kaitani, Ayako; Matsukawa, Toshihiro; Takahashi, Mariko; Yamanishi, Yoshinori; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Div Stem Cell Signaling,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Sakanishi, Tamami] Juntendo Univ, Grad Sch Med, Res Support Ctr, Lab Cell Biol,Bunkyo Ku, 2-1-1 Hongo, Tokyo, Japan; [Matsukawa, Toshihiro] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0600808, Japan; [Yamanishi, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138510, Japan; [Uchida, Shino] Juntendo Univ, Grad Sch Med, Dept Gastroenterol Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Yagita, Hideo] Juntendo Univ, Grad Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan	Juntendo University; University of Tokyo; Juntendo University; Hokkaido University; Tokyo Medical & Dental University (TMDU); Juntendo University; Juntendo University; Tohoku University	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Div Stem Cell Signaling,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.; Kitaura, J (corresponding author), Juntendo Univ, Atopy Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kitamura@ims.u-tokyo.ac.jp; j-kitaura@juntendo.ac.jp	Matsukawa, Toshihiro/A-4194-2016; Kitamura, Toshio/AAA-2071-2021	Matsukawa, Toshihiro/0000-0003-2371-3778; Nakano, Nobuhiro/0000-0002-5317-5950	Japan Society for the Promotion of Science KAKENHI [23390257, 26293231]; Grants-in-Aid for Scientific Research [15K09784] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23390257 and 26293231. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Enomoto Y, 2010, J BIOL CHEM, V285, P35274, DOI 10.1074/jbc.M110.137166; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04647-z; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Matsukawa T, 2016, GUT, V65, P777, DOI 10.1136/gutjnl-2014-308900; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; Murakami Y, 2014, CELL DEATH DIFFER, V21, P1746, DOI 10.1038/cdd.2014.86; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakahashi C, 2007, J IMMUNOL, V178, P765, DOI 10.4049/jimmunol.178.2.765; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Sakanishi T, 2010, BIOCHEM BIOPH RES CO, V393, P829, DOI 10.1016/j.bbrc.2010.02.092; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shiba E, 2017, J BIOL CHEM, V292, P2924, DOI 10.1074/jbc.M116.768366; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takahashi M, 2013, J BIOL CHEM, V288, P7662, DOI 10.1074/jbc.M112.434746; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zenarruzabeitia O, 2016, SCI REP-UK, V6, DOI 10.1038/srep32693	55	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3793	3805		10.1074/jbc.RA117.000696	http://dx.doi.org/10.1074/jbc.RA117.000696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358324	Green Published, hybrid			2022-12-28	WOS:000427030200031
J	Lu, YZ; Roy, S; Nuovo, G; Ramaswamy, B; Miller, T; Shapiro, C; Jacob, ST; Majumder, S				Lu, Yuanzhi; Roy, Satavisha; Nuovo, Gerard; Ramaswamy, Bhuvaneswari; Miller, Tyler; Shapiro, Charles; Jacob, Samson T.; Majumder, Sarmila			RETRACTION: Anti-microRNA-222 (anti-miR-222) and-181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal (Retraction of Vol 286, Pg 42292, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926	1	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3588	3588		10.1074/jbc.W118.002430	http://dx.doi.org/10.1074/jbc.W118.002430			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523694	hybrid, Green Published			2022-12-28	WOS:000427030200010
J	Rismondo, J; Percy, MG; Grundling, A				Rismondo, Jeanine; Percy, Matthew G.; Grundling, Angelika			Discovery of genes required for lipoteichoic acid glycosylation predicts two distinct mechanisms for wall teichoic acid glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; CELL-WALL; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; IDENTIFICATION; GLYCOSYLTRANSFERASE; RESISTANCE; SEQUENCE	The bacterial cell wall is an important and highly complex structure that is essential for bacterial growth because it protects bacteria from cell lysis and environmental insults. Atypical Gram-positive bacterial cell wall is composed of peptidoglycan and the secondary cell wall polymers, wall teichoic acid (WTA) and lipoteichoic acid (LTA). In many Gram-positive bacteria, LTA is a polyglycerol-phosphate chain that is decorated with D-alanine and sugar residues. However, the function of and proteins responsible for the glycosylation of LTA are either unknown or not well-characterized. Here, using bioinformatics, genetic, and NMR spectroscopy approaches, we found that the Bacillus subtilis csbB and yfhO genes are essential for LTA glycosylation. Interestingly, the Listeria monocytogenes gene lmo1079, which encodes a YfhO homolog, was not required for LTA glycosylation, but instead was essential for WTA glycosylation. LTA is polymerized on the outside of the cell and hence can only be glycosylated extracellularly. Based on the similarity of the genes coding for YfhO homologs that are required in B. subtilis for LTA glycosylation or in L. monocytogenes for WTA glycosylation, we hypothesize that WTA glycosylation might also occur extracellularly in Listeria species. Finally, we discovered that in L. monocytogenes, lmo0626 (gtlB) was required for LTA glycosylation, indicating that the encoded protein has a function similar to that of YfhO, although the proteins are not homologous. Together, our results enable us to propose an updated model for LTA glycosylation and also indicate that glycosylation of WTA might occur through two different mechanisms in Gram-positive bacteria.	[Grundling, Angelika] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Grundling, Angelika] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London; Imperial College London	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Grundling, A (corresponding author), Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.grundling@irnperial.ac.uk		Rismondo, Jeanine/0000-0001-5337-3829; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; German Research Foundation (DFG) [RI 2920/1-1]; UK Clinical Research Collaboration (Centre for Infection Prevention and Management); MRC [MR/P028225/1, G0800777] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); UK Clinical Research Collaboration (Centre for Infection Prevention and Management); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the German Research Foundation (DFG) Grant RI 2920/1-1.r Supported by a studentship provided by the UK Clinical Research Collaboration (Centre for Infection Prevention and Management).	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Akbar S, 1996, GENE, V177, P123, DOI 10.1016/0378-1119(96)00287-9; Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amer AO, 2002, MICROBIOL-SGM, V148, P571, DOI 10.1099/00221287-148-2-571; ARAKI Y, 1989, CRIT REV MICROBIOL, V17, P121, DOI 10.3109/10408418909105745; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Brauge T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv229; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 1998, J BIOCHEM, V123, P1000; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Eugster MR, 2015, MOL MICROBIOL, V97, P33, DOI 10.1111/mmi.13009; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; FISCHER W, 1994, MED MICROBIOL IMMUN, V183, P61, DOI 10.1007/BF00277157; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; FISCHER W, 1980, FEBS LETT, V119, P224, DOI 10.1016/0014-5793(80)80257-2; Fischer W., 1990, HDB LIPID RES, P123; Graves L. M., 1999, LISTERIA LISTERIOSIS, P251; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HEATON MP, 1992, J BACTERIOL, V174, P4707, DOI 10.1128/JB.174.14.4707-4717.1992; HETHER NW, 1983, J BACTERIOL, V156, P809, DOI 10.1128/JB.156.2.809-817.1983; Huang XJ, 1998, J MOL BIOL, V279, P165, DOI 10.1006/jmbi.1998.1765; Inoue H, 2013, BIOCHEM BIOPH RES CO, V436, P6, DOI 10.1016/j.bbrc.2013.04.064; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; IWASAKI H, 1986, J BACTERIOL, V167, P508, DOI 10.1128/jb.167.2.508-516.1986; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Kolly GS, 2015, J BACTERIOL, V197, P3686, DOI 10.1128/JB.00628-15; Kopp U, 1996, MICROB DRUG RESIST, V2, P29, DOI 10.1089/mdr.1996.2.29; Krawczyk-Balska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077808; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larrouy-Maumus G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400986; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Mamou G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01991; MANCUSO DJ, 1982, J BACTERIOL, V152, P616; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Ogura M, 2008, BIOSCI BIOTECH BIOCH, V72, P186, DOI 10.1271/bbb.70548; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Pasquina LW, 2013, CURR OPIN MICROBIOL, V16, P531, DOI 10.1016/j.mib.2013.06.014; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Richter SG, 2013, P NATL ACAD SCI USA, V110, P3531, DOI 10.1073/pnas.1217337110; Schirner K, 2011, ACS CHEM BIOL, V6, P407, DOI 10.1021/cb100390w; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]; Shen Y, 2017, J BIOL CHEM, V292, P17832, DOI 10.1074/jbc.M117.813964; Sobhanifar S, 2015, P NATL ACAD SCI USA, V112, pE576, DOI 10.1073/pnas.1418084112; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spears PA, 2016, MOL MICROBIOL, V101, P714, DOI 10.1111/mmi.13353; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; YOKOYAMA K, 1988, EUR J BIOCHEM, V173, P453, DOI 10.1111/j.1432-1033.1988.tb14020.x	85	27	27	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3293	3306		10.1074/jbc.RA117.001614	http://dx.doi.org/10.1074/jbc.RA117.001614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29343515	hybrid, Green Published			2022-12-28	WOS:000426562800022
J	Leiphrakpam, PD; Brattain, MG; Black, JD; Wang, J				Leiphrakpam, Premila D.; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing			TGF and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor beta (TGF-); ezrin; A-kinase anchoring protein (AKAP); X-linked inhibitor of apoptosis protein (XIAP); survivin; colon cancer; apoptosis; metastasis; IGF1R; Smad3	COLORECTAL-CANCER; CARCINOMA CELLS; ERM PROTEINS; PLASMA-MEMBRANE; MONOCLONAL-ANTIBODY; METASTASIS; EXPRESSION; RECEPTOR; BINDING; BETA	Aberrant cell survival plays a critical role in cancer progression and metastasis. We have previously shown that ezrin, a cAMP-dependent protein kinase A-anchoring protein (AKAP), is up-regulated in colorectal cancer (CRC) liver metastasis. Phosphorylation of ezrin at Thr-567 activates ezrin and plays an important role in CRC cell survival associated with XIAP and survivin up-regulation. In this study, we demonstrate that in FET and GEO colon cancer cells, knockdown of ezrin expression or inhibition of ezrin phosphorylation at Thr-567 increases apoptosis through protein kinase A (PKA) activation in a cAMP-independent manner. Transforming growth factor (TGF) signaling inhibits ezrin phosphorylation in a Smad3-dependent and Smad2-independent manner and regulates pro-apoptotic function through ezrin-mediated PKA activation. On the other hand, ezrin phosphorylation at Thr-567 by insulin-like growth factor 1 receptor (IGF1R) signaling leads to cAMP-dependent PKA activation and enhances cell survival. Further studies indicate that phosphorylated ezrin forms a complex with PKA RII, and dephosphorylated ezrin dissociates from the complex and facilitates the association of PKA RII with AKAP149, both of which activate PKA yet lead to either cell survival or apoptosis. Thus, our studies reveal a novel mechanism of differential PKA activation mediated by TGF and IGF1R signaling through regulation of ezrin phosphorylation in CRC, resulting in different cell fates. This is of significance because TGF and IGF1R signaling pathways are well-characterized tumor suppressor and oncogenic pathways, respectively, with important roles in CRC tumorigenesis and metastasis. Our studies indicate that they cross-talk and antagonize each other's function through regulation of ezrin activation. Therefore, ezrin may be a potential therapeutic target in CRC.	[Leiphrakpam, Premila D.; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Brattain, Michael G.; Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Black, Jennifer D.; Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu	Leiphrakpam, Premila/I-6685-2019	Leiphrakpam, Premila/0000-0002-2319-8844	National Institutes of Health [R01CA038173, R01CA054807, R01CA208063, R01CA212241, R01CA215389, R01CA191894]; Fred and Pamela Buffett Cancer Center [P30 CA036727]; NATIONAL CANCER INSTITUTE [R01CA038173, P30CA036727, R01CA215389, R01CA208063, R01CA054807, R01CA212241, R21CA191894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Pamela Buffett Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01CA038173 and R01CA054807 (to M.G.B.), R01CA208063, R01CA212241, and R01CA215389 (to J.W.), and R01CA191894 (to J.D.B.) and by Fred and Pamela Buffett Cancer Center Grant P30 CA036727.	Agarwal E, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-145; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Beck SE, 2007, CELL SIGNAL, V19, P1465, DOI 10.1016/j.cellsig.2007.01.017; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Grau AM, 2006, CELL SIGNAL, V18, P1041, DOI 10.1016/j.cellsig.2005.08.021; Halder SK, 2008, BRIT J CANCER, V99, P957, DOI 10.1038/sj.bjc.6604562; Hedrick Erik D, 2013, J Mol Signal, V8, P10, DOI 10.1186/1750-2187-8-10; Hogan FS, 2007, J SURG RES, V143, P58, DOI 10.1016/j.jss.2007.03.080; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Leiphrakpam PD, 2014, ONCOL REP, V31, P87, DOI 10.3892/or.2013.2819; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Mariotti E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-120; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Napolitano S, 2015, CLIN CANCER RES, V21, P2975, DOI 10.1158/1078-0432.CCR-15-0020; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; SATO N, 1992, J CELL SCI, V103, P131; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Troger J, 2012, BRIT J PHARMACOL, V166, P420, DOI 10.1111/j.1476-5381.2011.01796.x; Tynninen O, 2004, NEUROPATH APPL NEURO, V30, P472, DOI 10.1111/j.1365-2990.2004.00562.x; Wang HJ, 2009, WORLD J GASTROENTERO, V15, P2016, DOI 10.3748/wjg.15.2016; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang XZ, 2010, INT J ONCOL, V36, P1573, DOI 10.3892/ijo_00000644; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004	57	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8242	8254		10.1074/jbc.RA117.001299	http://dx.doi.org/10.1074/jbc.RA117.001299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29599290	hybrid, Green Published			2022-12-28	WOS:000433224600028
J	Meyer, T; Vigouroux, A; Aumont-Nicaise, M; Comte, G; Vial, L; Lavire, C; Morera, S				Meyer, Thibault; Vigouroux, Armelle; Aumont-Nicaise, Magali; Comte, Gilles; Vial, Ludovic; Lavire, Celine; Morera, Solange			The plant defense signal galactinol is specifically used as a nutrient by the bacterial pathogen Agrobacterium fabrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; sugar transport; bacteria; ABC transporter; microbiology; agrobacterium; galactinol; periplasmic binding protein; RFOs; plant defense; Agrobacterium fabrum	SUGAR-TRANSPORT; SYNTHASE GENE; GALACTOSIDES; RHIZOSPHERE; RESISTANCE; MELILOTI; MODEL	The bacterial plant pathogen Agrobacterium fabrum uses periplasmic-binding proteins (PBPs) along with ABC transporters to import a wide variety of plant molecules as nutrients. Nonetheless, how A. fabrum acquires plant metabolites is incompletely understood. Using genetic approaches and affinity measurements, we identified here the PBP MelB and its transporter as being responsible for the uptake of the raffinose family of oligosaccharides (RFO), which are the most widespread d-galactose-containing oligosaccharides in higher plants. We also found that the RFO precursor galactinol, recently described as a plant defense molecule, is imported into Agrobacterium via MelB with nanomolar range affinity. Structural analyses and binding mode comparisons of the X-ray structures of MelB in complex with raffinose, stachyose, galactinol, galactose, and melibiose (a raffinose degradation product) revealed how MelB recognizes the nonreducing end galactose common to all these ligands and that MelB has a strong preference for a two-unit sugar ligand. Of note, MelB conferred a competitive advantage to A. fabrum in colonizing the rhizosphere of tomato plants. Our integrative work highlights the structural and functional characteristics of melibiose and galactinol assimilation by A. fabrum, leading to a competitive advantage for these bacteria in the rhizosphere. We propose that the PBP MelB, which is highly conserved among both symbionts and pathogens from Rhizobiace family, is a major trait in these bacteria required for early steps of plant colonization.	[Meyer, Thibault; Comte, Gilles; Vial, Ludovic; Lavire, Celine] Univ Lyon, CNRS, UCBL, UMR Ecol Microbienne,INRA, F-69622 Villeurbanne, France; [Vigouroux, Armelle; Aumont-Nicaise, Magali; Morera, Solange] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Ave Terrasse, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lavire, C (corresponding author), Univ Lyon, CNRS, UCBL, UMR Ecol Microbienne,INRA, F-69622 Villeurbanne, France.; Morera, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Ave Terrasse, F-91198 Gif Sur Yvette, France.	celine.lavire@univ-lyon1.fr; solange.morera@i2bc.paris-saclay.fr	LAVIRE, Céline/D-3126-2019; COMTE, Gilles/P-5701-2016; LAVIRE, Céline/AAC-4222-2019	LAVIRE, Céline/0000-0002-0698-4683; COMTE, Gilles/0000-0003-1191-6455; LAVIRE, Céline/0000-0002-0698-4683; Vial, ludovic/0000-0001-6021-0251; MEYER, Thibault/0000-0002-8526-9804; morera, solange/0000-0001-7781-0448	FRISBI [ANR-10-INSB-05-01]	FRISBI	This work has benefited from the I2BC crystallization and microcalorimetry platforms supported by FRISBI ANR-10-INSB-05-01 as well as from the "Centre Technologique des Microstructures" and the "Serre et chambres climatiques" platforms, supported by the FR BioEnviS Research Federation. We acknowledge SOLEIL for provision of synchrotron radiation facilities (proposals ID 20130869, 20140774, and 20160782) in using Proxima beamlines. We thank Andrew Saurin for critical reading of the manuscript.	Abarca-Grau AM, 2011, PLANT PATHOL, V60, P416, DOI 10.1111/j.1365-3059.2010.02385.x; Andersen KE, 2005, J AGR FOOD CHEM, V53, P5809, DOI 10.1021/jf040471v; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Barret M, 2015, APPL ENVIRON MICROB, V81, P1257, DOI 10.1128/AEM.03722-14; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bringhurst RM, 2001, P NATL ACAD SCI USA, V98, P4540, DOI 10.1073/pnas.071375898; Charaoui-Boukerzaza S, 2013, MICROBIOL-SGM, V159, P2395, DOI 10.1099/mic.0.071407-0; Cho SM, 2010, BOTANY, V88, P452, DOI 10.1139/B10-009; CORNISH A, 1989, J GEN MICROBIOL, V135, P3001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gage DJ, 1998, J BACTERIOL, V180, P5739, DOI 10.1128/JB.180.21.5739-5748.1998; Hall BG, 2009, MOL BIOL EVOL, V26, P2487, DOI 10.1093/molbev/msp162; Ibanez C, 2013, TREES-STRUCT FUNCT, V27, P1309, DOI 10.1007/s00468-013-0879-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kemner JM, 1997, J BACTERIOL, V179, P2452, DOI 10.1128/jb.179.7.2452-2458.1997; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kristin A, 2013, PLANT SOIL, V370, P671, DOI 10.1007/s11104-013-1647-7; Lang J, 2013, MOL MICROBIOL, V90, P1178, DOI 10.1111/mmi.12423; Lassalle F, 2011, GENOME BIOL EVOL, V3, P762, DOI 10.1093/gbe/evr070; LILJESTROM PL, 1987, NUCLEIC ACIDS RES, V15, P2213, DOI 10.1093/nar/15.5.2213; Liu YB, 2017, INT J CLIN EXP PATHO, V10, P1094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer T, 2018, MOL PLANT MICROBE IN, V31, P814, DOI [10.1094/MPMI-10-17-0236-R, 10.1094/mpmi-10-17-0236-r]; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; Nelson EB, 2018, PLANT SOIL, V422, P7, DOI 10.1007/s11104-017-3289-7; Nester EW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00730; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Siddique S, 2014, NEW PHYTOL, V201, P476, DOI 10.1111/nph.12535; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Vacheron J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01212; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	40	10	11	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7930	7941		10.1074/jbc.RA118.001856	http://dx.doi.org/10.1074/jbc.RA118.001856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602905	Green Published, hybrid			2022-12-28	WOS:000433224600003
J	Maklashina, E; Rajagukguk, S; Iverson, TM; Cecchini, G				Maklashina, Elena; Rajagukguk, Sany; Iverson, T. M.; Cecchini, Gary			The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; electron transfer complex; flavoprotein; mitochondrial respiratory chain complex; protein assembly; protein domain; protein evolution	SOLUBLE FUMARATE REDUCTASE; MITOCHONDRIAL SUCCINATE-DEHYDROGENASE; FLAVINYLATION FACTOR SDH5; L-ASPARTATE OXIDASE; ESCHERICHIA-COLI; RESPIRATORY COMPLEX; SHEWANELLA-FRIGIDIMARINA; QUINOLFUMARATE REDUCTASE; DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURE	Complex II (SdhABCD) is a membrane-bound component of mitochondrial and bacterial electron transport chains, as well as of the TCA cycle. In this capacity, it catalyzes the reversible oxidation of succinate. SdhABCD contains the SDHA protein harboring a covalently bound FAD redox center and the iron-sulfur protein SDHB, containing three distinct iron-sulfur centers. When assembly of this complex is compromised, the flavoprotein SDHA may accumulate in the mitochondrial matrix or bacterial cytoplasm. Whether the unassembled SDHA has any catalytic activity, for example in succinate oxidation, fumarate reduction, reactive oxygen species (ROS) generation, or other off-pathway reactions, is not known. Therefore, here we investigated whether unassembled Escherichia coli SdhA flavoprotein, its homolog fumarate reductase (FrdA), and the human SDHA protein have succinate oxidase or fumarate reductase activity and can produce ROS. Using recombinant expression in E. coli, we found that the free flavoproteins from these divergent biological sources have inherently low catalytic activity and generate little ROS. These results suggest that the iron-sulfur protein SDHB in complex II is necessary for robust catalytic activity. Our findings are consistent with those reported for single-subunit flavoprotein homologs that are not associated with iron-sulfur or heme partner proteins.	[Maklashina, Elena; Rajagukguk, Sany; Iverson, T. M.; Cecchini, Gary] San Francisco Vet Affairs Hlth Care Syst, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cecchini, G (corresponding author), San Francisco Vet Affairs Healthcare Syst, Mol Biol Div 151 S, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu		Cecchini, Gary/0000-0002-0571-1747	National Institutes of Health [GM61606]; Department of Veterans Affairs Grant [BX001077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant GM61606 (to G. C. and T. M. I.) and Department of Veterans Affairs Grant BX001077 (to G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKRELL BAC, 1993, FEBS LETT, V326, P92, DOI 10.1016/0014-5793(93)81768-U; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Arora K, 2013, TOP CURR CHEM, V337, P165, DOI 10.1007/128_2012_408; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Bezawork-Geleta A, 2017, TRENDS BIOCHEM SCI, V42, P312, DOI 10.1016/j.tibs.2017.01.003; Bezawork-Geleta A, 2014, FASEB J, V28, P1794, DOI 10.1096/fj.13-242420; Boehr DD, 2008, BIOCHEMISTRY-US, V47, P9227, DOI 10.1021/bi801102e; BONOMI F, 1983, EUR J BIOCHEM, V134, P439, DOI 10.1111/j.1432-1033.1983.tb07586.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; CECCHINI G, 1986, J BIOL CHEM, V261, P1808; Cheng VWT, 2015, BIOCHEMISTRY-US, V54, P1043, DOI 10.1021/bi501350j; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Gill AJ, 2012, PATHOLOGY, V44, P285, DOI 10.1097/PAT.0b013e3283539932; GRIVENNIKOVA VG, 1993, BIOCHIM BIOPHYS ACTA, V1140, P282, DOI 10.1016/0005-2728(93)90067-P; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hanoian P, 2015, ACCOUNTS CHEM RES, V48, P482, DOI 10.1021/ar500390e; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hirst J, 1997, J AM CHEM SOC, V119, P7434, DOI 10.1021/ja9631413; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Inaoka DK, 2008, BIOCHEMISTRY-US, V47, P10881, DOI 10.1021/bi800413r; Ishii T, 2005, CANCER RES, V65, P203; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iverson TM, 2000, CURR OPIN STRUC BIOL, V10, P448, DOI 10.1016/S0959-440X(00)00113-5; KACZOROWSKI GJ, 1977, BIOCHEMISTRY-US, V16, P2619, DOI 10.1021/bi00631a007; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; King KS, 2014, MOL CELL ENDOCRINOL, V386, P92, DOI 10.1016/j.mce.2013.07.032; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leger C, 2001, BIOCHEMISTRY-US, V40, P11234, DOI 10.1021/bi010889b; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Maher MJ, 2018, P NATL ACAD SCI USA, V115, P2982, DOI 10.1073/pnas.1800195115; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 2016, J BIOL CHEM, V291, P2904, DOI 10.1074/jbc.M115.690396; Martucci VL, 2014, CURR PROB CANCER, V38, P7, DOI 10.1016/j.currproblcancer.2014.01.001; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mowat CG, 2002, BIOCHEMISTRY-US, V41, P11990, DOI 10.1021/bi0203177; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Na U, 2014, CELL METAB, V20, P253, DOI 10.1016/j.cmet.2014.05.014; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Ozluk Y, 2015, HUM PATHOL, V46, P1951, DOI 10.1016/j.humpath.2015.07.027; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Reid GA, 2000, BBA-BIOENERGETICS, V1459, P310, DOI 10.1016/S0005-2728(00)00166-3; Rothery EL, 2003, BIOCHEMISTRY-US, V42, P13160, DOI 10.1021/bi030159z; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Sharma P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02713-8; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Starbird CA, 2018, J STRUCT BIOL, V202, P100, DOI 10.1016/j.jsb.2017.11.004; Starbird CA, 2017, J BIOL CHEM, V292, P12921, DOI 10.1074/jbc.M117.795120; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; Tedeschi G, 2010, BIOCHIMIE, V92, P1335, DOI 10.1016/j.biochi.2010.06.015; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Yamamoto H, 2015, PATHOL INT, V65, P9, DOI 10.1111/pin.12230; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zafreen L, 2016, ARCH BIOCHEM BIOPHYS, V604, P47, DOI 10.1016/j.abb.2016.06.006	74	18	18	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7754	7765		10.1074/jbc.RA118.001977	http://dx.doi.org/10.1074/jbc.RA118.001977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610278	Green Published, hybrid			2022-12-28	WOS:000437256500024
J	Mejia, EM; Zegallai, H; Bouchard, ED; Banerji, V; Ravandi, A; Hatch, GM				Mejia, Edgard M.; Zegallai, Hana; Bouchard, Eric D.; Banerji, Versha; Ravandi, Amir; Hatch, Grant M.			Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; PLURIPOTENT STEM-CELL; CARDIOLIPIN METABOLISM; LIVER MITOCHONDRIA; COMPLEX-I; PHOSPHOLIPIDS; APOPTOSIS; TAFAZZIN; PROTEIN; HEART	The mitochondrial polyglycerophospholipid cardiolipin (CL) is remodeled to obtain specific fatty acyl chains. This is predominantly accomplished by the transacylase enzyme tafazzin (TAZ). Barth syndrome (BTHS) patients with TAZ gene mutations exhibit impaired TAZ activity and loss in mitochondrial respiratory function. Previous studies identified monolysocardiolipin acyltransferase-1 (MLCL AT-1) as a mitochondrial enzyme capable of remodeling CL with fatty acid. In this study, we analyzed what relationship, if any, exists between TAZ and MLCL AT-1 with regard to CL remodeling and whether transfection of BTHS lymphoblasts with an MLCL AT-1 expression construct improves mitochondrial respiratory function. In healthy lymphoblasts, reduction in TAZ expression through TAZ RNAi transfection resulted in a compensatory increase in MLCL AT-1 mRNA, protein, and enzyme activity, but CL mass was unaltered. In contrast, BTHS lymphoblasts exhibited decreased TAZ gene and protein expression but in addition decreased MLCL AT-1 expression and CL mass. Transfection of BTHS lymphoblasts with MLCL AT-1 expression construct increased CL, improved mitochondrial basal respiration and protein leak, and decreased the proportion of cells producing superoxide but did not restore CL molecular species composition to control levels. In addition, BTHS lymphoblasts exhibited higher rates of glycolysis compared with healthy controls to compensate for reduced mitochondrial respiratory function. Mitochondrial supercomplex assembly was significantly impaired in BTHS lymphoblasts, and transfection of BTHS lymphoblasts with MLCL AT-1 expression construct did not restore supercomplex assembly. The results suggest that expression of MLCL AT-1 depends on functional TAZ in healthy cells. In addition, transfection of BTHS lymphoblasts with an MLCL AT-1 expression construct compensates, but not completely, for loss of mitochondrial respiratory function.	[Mejia, Edgard M.; Zegallai, Hana; Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut, 715 McDermot Ave, Winnipeg, MB R3E 0T6, Canada; [Mejia, Edgard M.; Hatch, Grant M.] Univ Manitoba, Ctr Res & Treatment Atherosclerosis, Winnipeg, MB R3E 0T6, Canada; [Bouchard, Eric D.; Banerji, Versha] Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB R3E 0V9, Canada; [Ravandi, Amir] St Boniface Gen Hosp, Inst Cardiovasc Sci, Res Ctr, Winnipeg, MB R2H 2A6, Canada; [Hatch, Grant M.] Res Inst Manitoba, Childrens Hosp, DREAM, Winnipeg, MB R3E 3P4, Canada; [Bouchard, Eric D.] Univ St Boniface, Dept Sci Expt, 200 Ave Cathedrale, Winnipeg, MB R2H 0H7, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Hatch, GM (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, 715 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.	ghatch@chrim.ca	Ravandi, Amir/O-7552-2019	Bouchard, Eric/0000-0001-8567-7771	Heart and Stroke Foundation of Canada; Barth Syndrome Foundation Canada/USA; Research Manitoba	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Barth Syndrome Foundation Canada/USA; Research Manitoba	This work was supported in part by grants from the Heart and Stroke Foundation of Canada (to G.M.H. and A.R.), Barth Syndrome Foundation Canada/USA (to G. M. H.), Research Manitoba (to A. R. and V. B.), and a traineeship award from Research Manitoba (to E. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2016, J BIOL CHEM, V291, P15491, DOI 10.1074/jbc.M116.718510; Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Cade WT, 2013, J INHERIT METAB DIS, V36, P91, DOI 10.1007/s10545-012-9486-x; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Danos M, 2008, BIOCHEM CELL BIOL, V86, P11, DOI [10.1139/O07-156, 10.1139/o07-156]; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005; Ganguly R, 2018, MOL CELL BIOCHEM, V437, P163, DOI 10.1007/s11010-017-3104-z; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; LANDRISCINA C, 1976, LIPIDS, V11, P61, DOI 10.1007/BF02532585; LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Ma BJ, 1999, J LIPID RES, V40, P1837; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mejia Edgard M., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P98; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2017, J BIOL CHEM, V292, P5499, DOI 10.1074/jbc.M116.769182; Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200; Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; van Werkhoven MA, 2006, J LIPID RES, V47, P2346, DOI 10.1194/jlr.D600024-JLR200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	60	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7564	7577		10.1074/jbc.RA117.001024	http://dx.doi.org/10.1074/jbc.RA117.001024			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29563154	hybrid, Green Published			2022-12-28	WOS:000437256500010
J	Gentry, MS; Guinovart, JJ; Minassian, BA; Roach, PJ; Serratosa, JM				Gentry, Matthew S.; Guinovart, Joan J.; Minassian, Berge A.; Roach, Peter J.; Serratosa, Jose M.			Lafora disease offers a unique window into neuronal glycogen metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						E3 ubiquitin ligase; epilepsy; glycogen; glycogen storage disease; Lafora disease (Lafora progressive myoclonic epilepsy; MELF); phosphatase; phosphorylation; carbohydrate binding module	PROGRESSIVE MYOCLONUS EPILEPSY; PROTEIN-TYROSINE-PHOSPHATASE; DUAL-SPECIFICITY PHOSPHATASE; TEMPORAL-LOBE EPILEPSY; E3 UBIQUITIN LIGASE; POLYGLUCOSAN BODIES; ASTROCYTE GLYCOGEN; MEMORY FORMATION; MUSCLE GLYCOGEN; KNOCKOUT MICE	Lafora disease (LD) is a fatal, autosomal recessive, glycogen-storage disorder that manifests as severe epilepsy. LD results from mutations in the gene encoding either the glycogen phosphatase laforin or the E3 ubiquitin ligase malin. Individuals with LD develop cytoplasmic, aberrant glycogen inclusions in nearly all tissues that more closely resemble plant starch than human glycogen. This Minireview discusses the unique window into glycogen metabolism that LD research offers. It also highlights recent discoveries, including that glycogen contains covalently bound phosphate and that neurons synthesize glycogen and express both glycogen synthase and glycogen phosphorylase.	[Gentry, Matthew S.; Guinovart, Joan J.; Minassian, Berge A.; Roach, Peter J.; Serratosa, Jose M.] Univ Kentucky, Lafora Epilepsy Cure Initiat, Lexington, KY 40503 USA; [Gentry, Matthew S.] Univ Kentucky, Dept Biochem & Mol Biol, Lexington, KY 40503 USA; [Gentry, Matthew S.] Univ Kentucky, Univ Kentucky Epilepsy Res Ctr EpiC, Lexington, KY 40503 USA; [Guinovart, Joan J.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Guinovart, Joan J.] Biomed Res Networking Ctr Diabet & Associated Met, Madrid 28029, Spain; [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, E-08028 Barcelona, Spain; [Minassian, Berge A.] Univ Texas Southwestern, Dept Pediat, Dallas, TX 75390 USA; [Minassian, Berge A.] Univ Texas Southwestern, Dallas Childrens Med Ctr, Dallas, TX 75390 USA; [Minassian, Berge A.] Univ Toronto, Res Inst, Dept Pediat, Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Roach, Peter J.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Roach, Peter J.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Serratosa, Jose M.] UAM, IIS Jimenez Diaz Fdn, Lab Neurol, Madrid 28045, Spain; [Serratosa, Jose M.] Biomed Res Networking Ctr Rare Dis CIBERER, Madrid 28029, Spain	University of Kentucky; University of Kentucky; University of Kentucky; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gentry, MS (corresponding author), Univ Kentucky, Lafora Epilepsy Cure Initiat, Lexington, KY 40503 USA.; Gentry, MS (corresponding author), Univ Kentucky, Dept Biochem & Mol Biol, Lexington, KY 40503 USA.; Gentry, MS (corresponding author), Univ Kentucky, Univ Kentucky Epilepsy Res Ctr EpiC, Lexington, KY 40503 USA.	matthew.gentry@uky.edu		Serratosa, Jose/0000-0003-2239-8948	National Institutes of Health [R01NS070899, P01NS097197, R01NS056454, R01DK037221]; Mitzutani Foundation for Glycoscience award [130095]; National Science Foundation CAREER award [MCB-1252345]; Ministerio de Economia de Spain, Industria y Competitividad Grants [SAF2014-59594-R, SAF2014-55525-P]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS097197, R01NS056454, R01NS070899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitzutani Foundation for Glycoscience award; National Science Foundation CAREER award(National Science Foundation (NSF)); Ministerio de Economia de Spain, Industria y Competitividad Grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health under Award Numbers R01NS070899 (to M. S. G.), P01NS097197 (to M. S. G.), R01NS056454 (to P. J. R.), and R01DK037221 (to P. J. R.); a Mitzutani Foundation for Glycoscience award 130095 (to M. S. G.); a National Science Foundation CAREER award MCB-1252345 (to M. S. G.); and Ministerio de Economia de Spain, Industria y Competitividad Grants SAF2014-59594-R (to J. M. S.) and SAF2014-55525-P (to J. J. G.). This is the fourth article in the Thematic Minireview series "Brain glycogen metabolism." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Mitzutani Foundation, National Science Foundation, and Ministerio de Economia de Spain.	Abubakr A, 2005, J CLIN NEUROSCI, V12, P911, DOI 10.1016/j.jocn.2004.12.007; Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; BERKOVIC SF, 1991, J CLIN NEUROPHYSIOL, V8, P261, DOI 10.1097/00004691-199107010-00003; Blennow A, 2000, INT J BIOL MACROMOL, V27, P211, DOI 10.1016/S0141-8130(00)00121-5; Blennow A, 2015, STARCH METABOLISM ST, P399; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brown AM, 2015, METAB BRAIN DIS, V30, P233, DOI 10.1007/s11011-014-9588-2; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Chikwana VM, 2013, P NATL ACAD SCI USA, V110, P20976, DOI 10.1073/pnas.1310106111; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Contreras CJ, 2016, ARCH BIOCHEM BIOPHYS, V597, P21, DOI 10.1016/j.abb.2016.03.020; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; CUMMINS CJ, 1983, J NEUROCHEM, V40, P128, DOI 10.1111/j.1471-4159.1983.tb12662.x; DePaoli-Roach AA, 2015, J BIOL CHEM, V290, P841, DOI 10.1074/jbc.M114.607796; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dienel GA, 2017, J NEUROSCI RES, V95, P2103, DOI 10.1002/jnr.24015; Dienel GA, 2015, METAB BRAIN DIS, V30, P281, DOI 10.1007/s11011-014-9493-8; DiNuzzo M, 2015, METAB BRAIN DIS, V30, P307, DOI 10.1007/s11011-014-9524-5; DRINGEN R, 1993, GLIA, V8, P143, DOI 10.1002/glia.440080302; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Duran J, 2012, EMBO MOL MED, V4, P719, DOI 10.1002/emmm.201200241; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Fryer KL, 2015, METAB BRAIN DIS, V30, P299, DOI 10.1007/s11011-014-9516-5; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2016, CURR OPIN STRUC BIOL, V40, P62, DOI 10.1016/j.sbi.2016.07.015; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gibbs ME, 2012, NEUROCHEM RES, V37, P2456, DOI 10.1007/s11064-012-0805-2; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Irimia JM, 2015, J BIOL CHEM, V290, P22686, DOI 10.1074/jbc.M115.673897; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Kozlov SS, 2007, INT J BIOL MACROMOL, V40, P449, DOI 10.1016/j.ijbiomac.2006.11.001; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Lopez-Ramos JC, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00431, 10.3389/fncel.2015.00431]; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Meekins DA, 2015, J BIOL CHEM, V290, P23361, DOI 10.1074/jbc.M115.658203; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Minassian BA, 2001, ANN NEUROL, V49, P271, DOI 10.1002/1531-8249(20010201)49:2<271::AID-ANA52>3.3.CO;2-4; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Pfister B, 2016, CELL MOL LIFE SCI, V73, P2781, DOI 10.1007/s00018-016-2250-x; Prats C, 2018, J BIOL CHEM, V293, P7089, DOI 10.1074/jbc.R117.802843; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Puri R, 2010, AUTOPHAGY, V6, P1229, DOI 10.4161/auto.6.8.13307; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Raththagala M, 2015, MOL CELL, V57, P261, DOI 10.1016/j.molcel.2014.11.020; Roach PJ, 2015, MOL ASPECTS MED, V46, P78, DOI 10.1016/j.mam.2015.08.003; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach PJ, 2011, FEBS LETT, V585, P3216, DOI 10.1016/j.febslet.2011.09.009; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Roma-Mateo C, 2012, IUBMB LIFE, V64, P801, DOI 10.1002/iub.1072; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Samokhina E, 2017, J NEUROSCI RES, V95, P2195, DOI 10.1002/jnr.24019; Scharfman HE, 2015, SCIENCE, V347, P1312, DOI 10.1126/science.aaa9607; Schousboe A, 2010, NEUROTOX RES, V18, P94, DOI 10.1007/s12640-010-9171-5; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; SERRATOSA JM, 1995, HUM MOL GENET, V4, P1657; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Serratosa JM, 1999, EPILEPSIA, V40, P12, DOI 10.1111/j.1528-1157.1999.tb00893.x; Sinadinos C, 2014, AGING CELL, V13, P935, DOI 10.1111/acel.12254; Smirnova J., 2015, STARCH-STARKE, P239, DOI [DOI 10.1007/978-4-431-55495-0_7, 10.1007/978-4-431-55495-0_7]; Streichenberger N, 2001, CLIN NEUROPATHOL, V20, P172; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; TENHAM MWV, 1975, HDB CLIN NEUROLOGY, P382; Turnbull J, 2016, EPILEPTIC DISORD, V18, pS38; Turnbull J, 2014, ANN NEUROL, V75, P442, DOI 10.1002/ana.24104; Turnbull J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002037; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Verbeke J, 2016, CARBOHYD POLYM, V152, P784, DOI 10.1016/j.carbpol.2016.07.057; Vernia S, 2011, HUM MOL GENET, V20, P2571, DOI 10.1093/hmg/ddr157; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Virchow R, 1858, CELLULARPATHOLOGIE I; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Xu JN, 2013, NEUROCHEM RES, V38, P472, DOI 10.1007/s11064-012-0938-3; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125	99	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7117	7125		10.1074/jbc.R117.803064	http://dx.doi.org/10.1074/jbc.R117.803064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29483193	Green Published, hybrid			2022-12-28	WOS:000432174500005
J	Sjodt, M; Macdonald, R; Marshall, JD; Clayton, J; Olson, JS; Phillips, M; Gell, DA; Wereszczynski, J; Clubb, RT				Sjodt, Megan; Macdonald, Ramsay; Marshall, Joanna D.; Clayton, Joseph; Olson, John S.; Phillips, Martin; Gell, David A.; Wereszczynski, Jeff; Clubb, Robert T.			Energetics underlying hemin extraction from human hemoglobin by Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; receptor; hemoglobin; isothermal titration calorimetry (ITC); molecular dynamics; iron-regulated surface determinant system; IsdB; IsdH; NEAT domain; stopped-flow spectrophotometry	STABILIZING PROTEIN AHSP; MOLECULAR-DYNAMICS; ALPHA-HEMOGLOBIN; TRANSPORTER DOMAINS; HUMAN APOHEMOGLOBIN; IRON ACQUISITION; SURFACE PROTEIN; RECEPTOR ISDH; NEAT DOMAIN; CELL-WALL	Staphylococcus aureus is a leading cause of life-threatening infections in the United States. It actively acquires the essential nutrient iron from human hemoglobin (Hb) using the iron-regulated surface-determinant (Isd) system. This process is initiated when the closely related bacterial IsdB and IsdH receptors bind to Hb and extract its hemin through a conserved tri-domain unit that contains two NEAr iron Transporter (NEAT) domains that are connected by a helical linker domain. Previously, we demonstrated that the tri-domain unit within IsdH (IsdH(N2N3)) triggers hemin release by distorting Hb's F-helix. Here, we report that IsdH(N2N3) promotes hemin release from both the - and -subunits. Using a receptor mutant that only binds to the -subunit of Hb and a stopped-flow transfer assay, we determined the energetics and micro-rate constants of hemin extraction from tetrameric Hb. We found that at 37 degrees C, the receptor accelerates hemin release from Hb up to 13,400-fold, with an activation enthalpy of 19.5 +/- 1.1 kcal/mol. We propose that hemin removal requires the rate-limiting hydrolytic cleavage of the axial HisF8 NE-Fe3+ bond, which, based on molecular dynamics simulations, may be facilitated by receptor-induced bond hydration. Isothermal titration calorimetry experiments revealed that two distinct IsdH(N2N3)<bold>Hb proteinprotein interfaces promote hemin release</bold>. A high-affinity receptor<bold>Hb</bold>(A-helix) interface contributed approximate to 95% of the total binding standard free energy, enabling much weaker receptor interactions with Hb's F-helix that distort its hemin pocket and cause unfavorable changes in the binding enthalpy. We present a model indicating that receptor-introduced structural distortions and increased solvation underlie the IsdH-mediated hemin extraction mechanism.	[Sjodt, Megan; Macdonald, Ramsay; Marshall, Joanna D.; Phillips, Martin; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA; [Sjodt, Megan; Macdonald, Ramsay; Clubb, Robert T.] Univ Calif Los Angeles, Inst Genom & Prote, US DOE, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Clayton, Joseph; Wereszczynski, Jeff] IIT, Dept Phys, Chicago, IL 60616 USA; [Clayton, Joseph; Wereszczynski, Jeff] IIT, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA; [Olson, John S.] Rice Univ, Dept BioSci, Houston, TX 77251 USA; [Gell, David A.] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia; [Sjodt, Megan] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Illinois Institute of Technology; Illinois Institute of Technology; Rice University; University of Tasmania; Harvard University; Harvard Medical School	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.; Clubb, RT (corresponding author), whom correspondence should be addressed Dept Chem, UCLA, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Clayton, Joseph/0000-0002-2652-5994; Sjodt, Megan/0000-0003-0234-4336; Gell, David/0000-0003-0382-1181	shared Equipment Grant National Institutes of Health [S10OD016336]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119647, F31GM101931, T32GM007185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011994, S10OD016336] Funding Source: NIH RePORTER	shared Equipment Grant National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Robert Peterson for assistance with the NMR experiments. NMR equipment used in this research was purchased using funds from shared Equipment Grant National Institutes of Health S10OD016336.	Abaturov LV, 2006, MOL BIOL+, V40, P326; Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Andrade MA, 2002, GENOME BIOL, V3; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascoli F, 1981, Methods Enzymol, V76, P72; BENESCH RE, 1995, J BIOL CHEM, V270, P13785, DOI 10.1074/jbc.270.23.13785; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; BUNN HF, 1968, J BIOL CHEM, V243, P465; Case D. A., 2017, AMBER 2017; Centers for Disease Control Prevention, 2013, ACT BACT COR SURV AB; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P713; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dickson CF, 2013, J BIOL CHEM, V288, P19986, DOI 10.1074/jbc.M112.437509; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Dukic VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052722; Espenson JH, 1995, CHEM KINETICS REACTI; Farrand AJ, 2013, J BACTERIOL, V195, P5041, DOI 10.1128/JB.00505-13; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Frisch M.J., 2011, GAUSSIAN 09 VERSION, DOI 10.1021/ja5111392; Gattoni M, 1996, J BIOL CHEM, V271, P10130, DOI 10.1074/jbc.271.17.10130; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Haley KP, 2012, MICROBES INFECT, V14, P217, DOI 10.1016/j.micinf.2011.11.001; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; HARRINGTON JP, 1993, INT J BIOCHEM, V25, P665, DOI 10.1016/0020-711X(93)90351-E; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAWAMURAKONISHI Y, 1992, EUR BIOPHYS J BIOPHY, V21, P85; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEUTZINGER Y, 1981, P NATL ACAD SCI-BIOL, V78, P780, DOI 10.1073/pnas.78.2.780; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; Makowski L, 2011, J MOL BIOL, V408, P909, DOI 10.1016/j.jmb.2011.02.062; Malvern Instruments Limited, 2014, MICR ITC200 SYST US; Manning J M, 1981, Methods Enzymol, V76, P159; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MCGOVERN P, 1976, J BIOL CHEM, V251, P7871; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; ROSE MY, 1983, J BIOL CHEM, V258, P4298; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; Samuel PP, 2017, BIOCHEMISTRY-US, V56, P1444, DOI 10.1021/acs.biochem.6b01235; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Spirig T, 2012, BIOMOL NMR ASSIGN, V6, P169, DOI 10.1007/s12104-011-9348-8; Tame JRH, 2000, ACTA CRYSTALLOGR D, V56, P805, DOI 10.1107/S0907444900006387; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100744	85	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6942	6957		10.1074/jbc.RA117.000803	http://dx.doi.org/10.1074/jbc.RA117.000803			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540481	Green Published, hybrid			2022-12-28	WOS:000431487300026
J	Tsukamoto, H; Higashi, M; Motoki, H; Watanabe, H; Ganser, C; Nakajo, K; Kubo, Y; Uchihashi, T; Furutani, Y				Tsukamoto, Hisao; Higashi, Masahiro; Motoki, Hideyoshi; Watanabe, Hiroki; Ganser, Christian; Nakajo, Koichi; Kubo, Yoshihiro; Uchihashi, Takayuki; Furutani, Yuji			Structural properties determining low K+ affinity of the selectivity filter in the TWIK1 K+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; metal ion-protein interaction; infrared spectroscopy (IR spectroscopy); biophysics; Fourier transform IR (FTIR); ion channel; molecular dynamics; quantum chemistry; fluorescence	DOMAIN POTASSIUM CHANNELS; ATOMIC-FORCE MICROSCOPY; ION SELECTIVITY; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGE; BINDING; MECHANISM; INACTIVATION; SPECTROSCOPY; RESOLUTION	Canonical K+ channels are tetrameric and highly K+-selective, whereas two-pore-domain K+ (K2P) channels form dimers, but with a similar pore architecture. A two-pore-domain potassium channel TWIK1 (KCNK1 or K2P1) allows permeation of Na+ and other monovalent ions, resulting mainly from the presence of Thr-118 in the P1 domain. However, the mechanistic basis for this reduced selectivity is unclear. Using ion-exchange-induced difference IR spectroscopy, we analyzed WT TWIK1 and T118I (highly K+-selective) and L228F (substitution in the P2 domain) TWIK1 variants and found that in the presence of K+ ions, WT and both variants exhibit an amide-I band at 1680 cm(-1). This band corresponds to interactions of the backbone carbonyls in the selectivity filter with K+, a feature very similar to that of the canonical K+ channel KcsA. Computational analysis indicated that the relatively high frequency for the amide-I band is well explained by impairment of hydrogen bond formation with water molecules. Moreover, concentration-dependent spectral changes indicated that the K+ affinity of the WT selectivity filter was much lower than those of the variants. Furthermore, only the variants displayed a higher frequency shift of the 1680-cm(-1) band upon changes from K+ to Rb+ or Cs+ conditions. High-speed atomic force microscopy disclosed that TWIK1's surface morphology largely does not change in K+ and Na+ solutions. Our results reveal the local conformational changes of the TWIK1 selectivity filter and suggest that the amide-I bands may be useful molecular fingerprints for assessing the properties of other K+ channels.	[Tsukamoto, Hisao; Furutani, Yuji] SOKENDAI Grad Univ Adv Studies, Dept Life & Coordinat Complex Mol Sci, Inst Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Tsukamoto, Hisao; Furutani, Yuji] SOKENDAI Grad Univ Adv Studies, Dept Struct Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro; Uchihashi, Takayuki] SOKENDAI Grad Univ Adv Studies, Physiol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Higashi, Masahiro; Motoki, Hideyoshi] Univ Ryukyus, Dept Chem Biol & Marine Sci, 1 Senbaru, Okinawa 9030213, Japan; [Watanabe, Hiroki; Ganser, Christian; Uchihashi, Takayuki] Nagoya Univ, Grad Sch Sci, Dept Phys, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Watanabe, Hiroki; Ganser, Christian; Uchihashi, Takayuki] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Kubo, Yoshihiro] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol & Cellular Physiol, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Nakajo, Koichi] Osaka Med Coll, Dept Physiol, Div Life Sci, Fac Med, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Nagoya University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka Medical College	Furutani, Y (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Life & Coordinat Complex Mol Sci, Inst Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	furutani@ims.ac.jp	Furutani, Yuji/J-8337-2019; Higashi, Masahiro/O-3670-2018; Ganser, Christian/C-1741-2019; Uchihashi, Takayuki/D-5209-2011; Nakajo, Koichi/J-2601-2019	Furutani, Yuji/0000-0001-5284-8773; Higashi, Masahiro/0000-0001-9829-389X; Ganser, Christian/0000-0002-5558-3026; Uchihashi, Takayuki/0000-0002-0263-5312; Nakajo, Koichi/0000-0003-0766-7281; Kubo, Yoshihiro/0000-0001-6707-0837; Watanabe, Hiroki/0000-0001-8547-1247	Japan Society for the Promotion of Science KAKENHI [25840122, 17K15109, 16H00778, 16KT0165, 17K05757, 22247024, 22770159, 24650203, 26640047, 26708002]; NINS program for cross-disciplinary study; Cooperative Study Program of National Institute for Physiological Sciences; JST CREST [JPMJCR17N5]; Grants-in-Aid for Scientific Research [16KT0165, 17H04021, 17K05757] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NINS program for cross-disciplinary study; Cooperative Study Program of National Institute for Physiological Sciences; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grants 25840122 and 17K15109 (to H. T.); 16H00778, 16KT0165, and 17K05757 (to M. H.); and 22247024, 22770159, 24650203, 26640047, and 26708002 (to Y. F.); NINS program for cross-disciplinary study (to Y. F. and K. N.); the Cooperative Study Program of National Institute for Physiological Sciences; and JST CREST Grant JPMJCR17N5. The authors declare that they have no conflicts of interest with the contents of this article.	Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Case D. A., 2017, AMBER17; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; CHEN XG, 1995, J PHYS CHEM-US, V99, P3074, DOI 10.1021/j100010a017; Cheng WWL, 2011, P NATL ACAD SCI USA, V108, P5272, DOI 10.1073/pnas.1014186108; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Furutani Yuji, 2018, Biophys Rev, V10, P235, DOI 10.1007/s12551-017-0337-8; Furutani Y, 2015, BIOPHYS PHYSICOBIOL, V12, P37, DOI 10.2142/biophysico.12.0_37; Furutani Y, 2012, J PHYS CHEM LETT, V3, P3806, DOI 10.1021/jz301721f; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Higashi M, 2008, J CHEM THEORY COMPUT, V4, P790, DOI 10.1021/ct800004y; Inaguma A, 2015, J BIOL CHEM, V290, P11623, DOI 10.1074/jbc.M115.642256; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kasuya G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45208; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kratochvil HT, 2016, SCIENCE, V353, P1040, DOI 10.1126/science.aag1447; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lorenz-Fonfria Victor A, 2012, Methods Mol Biol, V914, P107, DOI 10.1007/978-1-62703-023-6_7; Ma LQ, 2012, J BIOL CHEM, V287, P37145, DOI 10.1074/jbc.M112.398164; Ma LQ, 2012, BIOPHYS J, V102, pL34, DOI 10.1016/j.bpj.2012.03.011; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; McCoy JG, 2012, BBA-BIOMEMBRANES, V1818, P272, DOI 10.1016/j.bbamem.2011.09.007; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Nimigean CM, 2011, J GEN PHYSIOL, V137, P405, DOI 10.1085/jgp.201010551; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Oakes V, 2016, BIOPHYS J, V111, P775, DOI 10.1016/j.bpj.2016.07.009; Ponder J. W., 1997, TINKER 3; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Stevenson P, 2015, J PHYS CHEM B, V119, P5824, DOI 10.1021/acs.jpcb.5b02223; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	55	8	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6969	6984		10.1074/jbc.RA118.001817	http://dx.doi.org/10.1074/jbc.RA118.001817			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29545310	Green Published, hybrid			2022-12-28	WOS:000431487300028
J	Hamiaux, C; Drummond, RSM; Luo, ZW; Lee, HW; Sharma, P; Janssen, BJ; Perry, NB; Denny, WA; Snowden, KC				Hamiaux, Cyril; Drummond, Revel S. M.; Luo, Zhiwei; Lee, Hui Wen; Sharma, Prachi; Janssen, Bart J.; Perry, Nigel B.; Denny, William A.; Snowden, Kimberley C.			Inhibition of strigolactone receptors by N-phenylanthranilic acid derivatives: Structural and functional insights	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; LEAF SENESCENCE; STRIGA-HERMONTHICA; PLANT HORMONES; GERMINATION; ARABIDOPSIS; KARRIKIN; DWARF14; GROWTH; OPTIMIZATION	The strigolactone (SL) family of plant hormones regulates a broad range of physiological processes affecting plant growth and development and also plays essential roles in controlling interactions with parasitic weeds and symbiotic fungi. Recent progress elucidating details of SL biosynthesis, signaling, and transport offers many opportunities for discovering new plant-growth regulators via chemical interference. Here, using high-throughput screening and downstream biochemical assays, we identified N-phenylanthranilic acid derivatives as potent inhibitors of the SL receptors from petunia (DAD2), rice (OsD14), and Arabidopsis (AtD14). Crystal structures of DAD2 and OsD14 in complex with inhibitors further provided detailed insights into the inhibition mechanism, and in silico modeling of 19 other plant strigolactone receptors suggested that these compounds are active across a large range of plant species. Altogether, these results provide chemical tools for investigating SL signaling and further define a framework for structure-based approaches to design and validate optimized inhibitors of SL receptors for specific plant targets.	[Hamiaux, Cyril; Drummond, Revel S. M.; Luo, Zhiwei; Lee, Hui Wen; Sharma, Prachi; Janssen, Bart J.; Snowden, Kimberley C.] New Zealand Inst Plant & Food Res Ltd, Private Bag 92169, Auckland 1142, New Zealand; [Lee, Hui Wen; Sharma, Prachi] Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand; [Perry, Nigel B.] Univ Otago, Dept Chem, POB 56, Dunedin 9054, New Zealand; [Perry, Nigel B.] Univ Otago, New Zealand Inst Plant & Food Res Ltd, Dept Chem, POB 56, Dunedin, New Zealand; [Denny, William A.] Univ Auckland, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland 1142, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; University of Otago; New Zealand Institute for Plant & Food Research Ltd; University of Otago; University of Auckland	Hamiaux, C; Snowden, KC (corresponding author), New Zealand Inst Plant & Food Res Ltd, Private Bag 92169, Auckland 1142, New Zealand.	cyril.hamiaux@plantandfood.co.nz; kimberley.snowden@plantandfood.co.nz	Hamiaux, Cyril/U-9978-2017; Drummond, Revel/P-6408-2019; Snowden, Kimberley C/J-8270-2012; Janssen, Bart J/J-4880-2014; Perry, Nigel/G-5574-2010	Hamiaux, Cyril/0000-0001-9198-3441; Drummond, Revel/0000-0001-5238-7604; Snowden, Kimberley C/0000-0001-9640-4015; Janssen, Bart J/0000-0002-5871-2831; Perry, Nigel/0000-0003-3196-3945; Lee, Hui Wen/0000-0002-4107-0350; Luo, Zhiwei/0000-0002-7605-9768; SHARMA, PRACHI/0000-0002-6932-8472	AGMARDT (Agribusiness Innovation) [1323]; Marsden grant [PAF1301]	AGMARDT (Agribusiness Innovation); Marsden grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by funding from AGMARDT (Agribusiness Innovation Grant 1323), Plant and Food Research, and a Marsden grant (contract PAF1301). C. H., K. C. S., and the New Zealand Institute for Plant and Food Research Limited have filed a New Zealand provisional patent application (734620) that relates to the specific topic "Strigolactone receptor antagonists."	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.74, 10.1038/nplants.2016.74]; Boyer FD, 2014, MOL PLANT, V7, P675, DOI 10.1093/mp/sst163; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Cohen M, 2013, MOL PLANT, V6, P141, DOI 10.1093/mp/sss134; de Saint Germain A, 2016, NAT CHEM BIOL, V12, P787, DOI 10.1038/nchembio.2147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukui K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00936; Gaglioti K, 2014, CRYSTENGCOMM, V16, P8252, DOI 10.1039/c4ce00549j; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Griffiths CA, 2016, NATURE, V540, P574, DOI 10.1038/nature20591; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Harrison PJ, 2015, FEBS J, V282, P3986, DOI 10.1111/febs.13400; Holbrook-Smith D, 2016, NAT CHEM BIOL, V12, P724, DOI 10.1038/nchembio.2129; James P, 1996, GENETICS, V144, P1425; Jamil M, 2018, J EXP BOT, V69, P2319, DOI 10.1093/jxb/erx438; Jamil M, 2010, ARCH BIOCHEM BIOPHYS, V504, P123, DOI 10.1016/j.abb.2010.08.005; Janssen BJ, 2014, CURR OPIN PLANT BIOL, V17, P28, DOI 10.1016/j.pbi.2013.11.004; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Khosla A, 2016, CURR OPIN PLANT BIOL, V33, P57, DOI 10.1016/j.pbi.2016.06.001; Liu Q, 2014, NEW PHYTOL, V202, P531, DOI 10.1111/nph.12692; Lumba Shelley, 2017, F1000Res, V6, P975, DOI 10.12688/f1000research.11379.1; Maier RH, 2008, BIOTECHNIQUES, V45, P235, DOI 10.2144/000112897; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1066, DOI 10.1021/jf00018a032; Mashita O, 2016, J PESTIC SCI, V41, P71, DOI 10.1584/jpestics.D16-028; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00623; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Rasmussen A, 2012, PLANT PHYSIOL, V158, P1976, DOI 10.1104/pp.111.187104; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Soundappan I, 2015, PLANT CELL, V27, P3143, DOI 10.1105/tpc.15.00562; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanga JP, 2016, PLANTA, V243, P1397, DOI 10.1007/s00425-015-2458-2; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang L, 2015, PLANT CELL, V27, P3128, DOI 10.1105/tpc.15.00605; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Xiang HB, 2017, CELL RES, V27, P1525, DOI 10.1038/cr.2017.105; Yamada Y, 2014, PLANTA, V240, P399, DOI 10.1007/s00425-014-2096-0; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zwanenburg B, 2013, BIOORG MED CHEM LETT, V23, P5182, DOI 10.1016/j.bmcl.2013.07.004	63	28	28	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6530	6543		10.1074/jbc.RA117.001154	http://dx.doi.org/10.1074/jbc.RA117.001154			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523686	Green Published, hybrid			2022-12-28	WOS:000431108600024
J	Zhang, YB; Zhang, ZW; Ge, W				Zhang, Yibo; Zhang, Zhiwei; Ge, Wei			An efficient platform for generating somatic point mutations with germline transmission in the zebrafish by CRISPR/Cas9-mediated gene editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-DIRECTED REPAIR; MEDIATED KNOCK-IN; ZINC-FINGER TARGETER; STEM-CELLS; GENOME; RECOMBINATION; TALEN; CRISPR-CAS9; PRECISE; DNA	Homology-directed recombination (HDR)-mediated genome editing is a powerful approach for both basic functional study and disease modeling. Although some studies have reported HDR-mediated precise editing in nonrodent models, the efficiency of establishing pure mutant animal lines that carry specific amino acid substitutions remains low. Furthermore, because the efficiency of nonhomologous end joining (NHEJ)-induced insertion and deletion (indel) mutations is normally much higher than that of HDR-induced point mutations, it is often difficult to identify the latter in the background of indel mutations. Using zebrafish as the model organism and Y box-binding protein 1 (Ybx1/ybx1) as the model molecule, we have established an efficient platform for precise CRISPR/Cas9-mediated gene editing in somatic cells, yielding an efficiency of up to 74% embryos. Moreover, we established a procedure for screening germline transmission of point mutations out of indel mutations even when germline transmission efficiency was low (<2%). To further improve germline transmission of HDR-induced point mutations, we optimized several key factors that may affect HDR efficiency, including the type of DNA donor, suppression of NHEJ, stimulation of HDR pathways, and use of Cas9 protein instead of mRNA. The optimized combination of these factors significantly increased the efficiency of germline transmission of point mutation up to 25%. In summary, we have developed an efficient procedure for creating point mutations and differentiating mutant individuals from those carrying knockouts of entire genes.	[Zhang, Yibo; Zhang, Zhiwei; Ge, Wei] Univ Macau, CRDA, Fac Hlth Sci, Macau 999078, Peoples R China	University of Macau	Ge, W (corresponding author), Univ Macau, CRDA, Fac Hlth Sci, Macau 999078, Peoples R China.	weige@umac.mo		Zhang, Bob/0000-0003-2497-9519; Zhang, Yibo/0000-0002-0893-4962				Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Ahrabi S, 2016, NUCLEIC ACIDS RES, V44, P5743, DOI 10.1093/nar/gkw326; Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bedell VM, 2015, METHODS MOL BIOL, V1239, P291, DOI 10.1007/978-1-4939-1862-1_17; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; de Leon VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088146; Fiala O, 2016, TUMOR BIOL, V37, P6823, DOI 10.1007/s13277-015-4523-7; Guo X, 2016, NAT CELL BIOL, V18, P202, DOI 10.1038/ncb3289; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang P, 2014, METHODS, V69, P67, DOI 10.1016/j.ymeth.2014.02.010; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jayathilaka K, 2008, P NATL ACAD SCI USA, V105, P15848, DOI 10.1073/pnas.0808046105; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumari P, 2013, ELIFE, V2, DOI 10.7554/eLife.00683; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Mao PS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12154; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Menoret S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14410; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ota S, 2014, CONGENIT ANOM, V54, P8, DOI 10.1111/cga.12040; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Petrezselyova S, 2015, CELL MOL BIOL LETT, V20, P773, DOI 10.1515/cmble-2015-0047; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Samarut E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2881-1; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sauer NJ, 2016, PLANT BIOTECHNOL J, V14, P496, DOI 10.1111/pbi.12496; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Shah AN, 2016, DEV CELL, V36, P595, DOI 10.1016/j.devcel.2016.03.004; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Shinkuma S, 2016, P NATL ACAD SCI USA, V113, P5676, DOI 10.1073/pnas.1512028113; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Sueda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep18949; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vannocci T, 2015, DIS MODEL MECH, V8, P711, DOI 10.1242/dmm.020545; Varshney GK, 2015, ADV GENET, V92, P1, DOI 10.1016/bs.adgen.2015.09.002; Vartak SV, 2015, FEBS J, V282, P4289, DOI 10.1111/febs.13416; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256; Zhu B, 2018, GEN COMP ENDOCR, V257, P3, DOI 10.1016/j.ygcen.2017.09.011	66	27	28	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6611	6622		10.1074/jbc.RA117.001080	http://dx.doi.org/10.1074/jbc.RA117.001080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29500194	Green Published, hybrid			2022-12-28	WOS:000431108600031
J	Yokoyama, CC; Baldridge, MT; Leung, DW; Zhao, GY; Desai, C; Liu, TC; Diaz-Ochoa, VE; Huynh, JP; Kimmey, JM; Sennott, EL; Hole, CR; Idol, RA; Park, S; Storek, KM; Wang, CH; Hwang, S; Milam, AV; Chen, E; Kerrinnes, T; Starnbach, MN; Handley, SA; Mysorekar, IU; Allen, PM; Monack, DM; Dinauer, MC; Doering, TL; Tsolis, RM; Dworkin, JE; Stallings, CL; Amarasinghe, GK; Micchelli, CA; Virgin, HW				Yokoyama, Christine C.; Baldridge, Megan T.; Leung, Daisy W.; Zhao, Guoyan; Desai, Chandni; Liu, Ta-Chiang; Diaz-Ochoa, Vladimir E.; Huynh, Jeremy P.; Kimmey, Jacqueline M.; Sennott, Erica L.; Hole, Camaron R.; Idol, Rachel A.; Park, Sunmin; Storek, Kelly M.; Wang, Caihong; Hwang, Seungmin; Milam, Ashley Viehmann; Chen, Eric; Kerrinnes, Tobias; Starnbach, Michael N.; Handley, Scott A.; Mysorekar, Indira U.; Allen, Paul M.; Monack, Denise M.; Dinauer, Mary C.; Doering, Tamara L.; Tsolis, Renee M.; Dworkin, Jonathan E.; Stallings, Christina L.; Amarasinghe, Gaya K.; Micchelli, Craig A.; Virgin, Herbert W.			LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE; IMMUNE-RESPONSES; GENE-EXPRESSION; T-CELLS; INNATE; AUTOPHAGY; MICE; ESTABLISHMENT; RECOGNITION; INFECTION	Germline-encoded receptors recognizing common pathogen-associated molecular patterns are a central element of the innate immune system and play an important role in shaping the host response to infection. Many of the innate immune molecules central to these signaling pathways are evolutionarily conserved. LysMD3 is a novel molecule containing a putative peptidoglycan-binding domain that has orthologs in humans, mice, zebrafish, flies, and worms. We found that the lysin motif (LysM) of LysMD3 is likely related to a previously described peptidoglycan-binding LysM found in bacteria. Mouse LysMD3 is a type II integral membrane protein that co-localizes with GM130+ structures, consistent with localization to the Golgi apparatus. We describe here two lines of mLysMD3-deficient mice for in vivo characterization of mLysMD3 function. We found that mLysMD3-deficient mice were born at Mendelian ratios and had no obvious pathological abnormalities. They also exhibited no obvious immune response deficiencies in a number of models of infection and inflammation. mLysMD3-deficient mice exhibited no signs of intestinal dysbiosis by 16S analysis or alterations in intestinal gene expression by RNA sequencing. We conclude that mLysMD3 contains a LysM with cytoplasmic orientation, but we were unable to define a physiological role for the molecule in vivo.	[Yokoyama, Christine C.; Leung, Daisy W.; Zhao, Guoyan; Desai, Chandni; Liu, Ta-Chiang; Park, Sunmin; Milam, Ashley Viehmann; Handley, Scott A.; Mysorekar, Indira U.; Allen, Paul M.; Amarasinghe, Gaya K.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Baldridge, Megan T.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Huynh, Jeremy P.; Kimmey, Jacqueline M.; Hole, Camaron R.; Doering, Tamara L.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Idol, Rachel A.; Dinauer, Mary C.; Dworkin, Jonathan E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wang, Caihong; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Micchelli, Craig A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Diaz-Ochoa, Vladimir E.; Kerrinnes, Tobias; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Sennott, Erica L.; Starnbach, Michael N.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Hwang, Seungmin] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Chen, Eric] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Dworkin, Jonathan E.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Storek, Kelly M.] Genentech Inc, San Francisco, CA 95688 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; Harvard University; Harvard Medical School; Stanford University; University of Chicago; University of California System; University of California Berkeley; Columbia University; Roche Holding; Genentech	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Kimmey, Jacqueline/GXV-9323-2022; Desai, Chandni/AAA-5477-2020; Baldridge, Megan/T-7274-2019; Mysorekar, Indira U./GRS-4574-2022	Desai, Chandni/0000-0002-3708-3634; Baldridge, Megan/0000-0002-7030-6131; Mysorekar, Indira U./0000-0003-3917-8677; Kimmey, Jacqueline M/0000-0003-1330-8525; Liu, Ta-Chiang/0000-0002-2800-9360; Hole, Camaron/0000-0002-9363-3020; Hwang, Seungmin/0000-0003-0846-5462; Allen, Paul/0000-0003-3796-6047; Zhao, Guoyan/0000-0001-5615-6774; Monack, Denise/0000-0003-3804-2209	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Crohn's and Colitis Foundation Genetics Initiative [274415]; National Science Foundation Fellowships [DGE-1143954]; National Institutes of Health [T32AI007163, T32GM007067, T32AI007172, F32AI108089, R01DK100644, R01AI24157, R01AI095396, R01AI102882, U19AI109725]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award; Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095396, F32AI108089, U19AI109725, T32AI007163, R01AI109799, T32AI007172, R01AI102882, U19AI113187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Crohn's and Colitis Foundation Genetics Initiative; National Science Foundation Fellowships; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital (to M.C.D.), Grant 274415 from the Crohn's and Colitis Foundation Genetics Initiative (to H.W.V.), National Science Foundation Fellowships DGE-1143954 (to J.P.H.) and DGE-1143954 (to J.M.K.), and National Institutes of Health Grants T32AI007163 (to C.C.Y.), T32GM007067 (to J.M.K.), T32AI007172 (to C.R.H.), F32AI108089 (to K.M.S.), R01DK100644 (to I.U.M.), R01AI24157 (to P.M.A.), R01AI095396 (to D.M.M.), R01AI102882 (to T.L.D.), and U19AI109725 (to H.W.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award.r Supported by a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation and a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease award.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Byndloss MX, 2016, ANNU REV ANIM BIOSCI, V4, P111, DOI 10.1146/annurev-animal-021815-111326; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703; Djordjevic MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112635; Dolat L, 2017, TRENDS CELL BIOL, V27, P877, DOI 10.1016/j.tcb.2017.09.004; Dziarski R, 2010, INNATE IMMUN-LONDON, V16, P168, DOI 10.1177/1753425910366059; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Laroche RJF, 2013, GENE EXPR PATTERNS, V13, P212, DOI 10.1016/j.gep.2013.02.007; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002297; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu Q, 2016, CELL HOST MICROBE, V19, P102, DOI 10.1016/j.chom.2015.12.011; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monach Paul, 2007, V136, P269; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Parikh BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116484; Park S, 2016, CELL HOST MICROBE, V19, P91, DOI 10.1016/j.chom.2015.12.010; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Redmann V, 2016, SCI REP-UK, V6, DOI 10.1038/srep23326; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; SCHAUER DB, 1993, INFECT IMMUN, V61, P4654, DOI 10.1128/IAI.61.11.4654-4661.1993; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Stemler KM, 2013, J UROLOGY, V189, P343, DOI 10.1016/j.juro.2012.08.189; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Symington JW, 2015, MUCOSAL IMMUNOL, V8, P1388, DOI 10.1038/mi.2015.7; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22598; Terlizzi ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01566; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Vance RE, 2010, J CLIN IMMUNOL, V30, P507, DOI 10.1007/s10875-010-9389-2; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Wang ZP, 2012, J IMMUNOL, V188, P3993, DOI 10.4049/jimmunol.1103301; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu M, 2004, MOL CELL BIOL, V24, P7949, DOI 10.1128/MCB.24.18.7949-7957.2004; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	87	6	6	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6022	6038		10.1074/jbc.RA117.001246	http://dx.doi.org/10.1074/jbc.RA117.001246			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496999	hybrid, Green Published			2022-12-28	WOS:000430497300022
J	Schnabel, J; Hombach, P; Waksman, T; Giuriani, G; Petersen, J; Christie, JM				Schnabel, Jonathan; Hombach, Peter; Waksman, Thomas; Giuriani, Giovanni; Petersen, Jan; Christie, John M.			A chemical genetic approach to engineer phototropin kinases for substrate labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS NPH1; VOLTAGE DOMAINS; PROTEIN; RECEPTOR; PHOTORECEPTOR; FLAVOPROTEIN; PERCEPTION; ACTIVATION	Protein kinases (PKs) control many aspects of plant physiology by regulating signaling networks through protein phosphorylation. Phototropins (phots) are plasma membrane-associated serine/threonine PKs that control a range of physiological processes that collectively serve to optimize photosynthetic efficiency in plants. These include phototropism, leaf positioning and flattening, chloroplast movement, and stomatal opening. Despite their identification over two decades ago, only a handful of substrates have been identified for these PKs. Progress in this area has been hampered by the lack of a convenient means to confirm the identity of potential substrate candidates. Here we demonstrate that the kinase domain of Arabidopsis phot1 and phot2 can be successfully engineered to accommodate non-natural ATP analogues by substituting the bulky gatekeeper residue threonine for glycine. This approach circumvents the need for radioactivity to track phot kinase activity and follow light-induced receptor autophosphorylation in vitro by incorporating thiophosphate from N-6-benzyl-ATP gamma S. Consequently, thio-phosphorylation of phot substrate candidates can be readily monitored when added or co-expressed with phots in vitro. Furthermore, gatekeeper-modified phot1 retained its functionality and its ability to accommodate N-6-benzyl-ATP gamma S as a phospho-donor when expressed in Arabidopsis. We therefore anticipate that this chemical genetic approach will provide new opportunities for labeling and identifying substrates for phots and other related AGC kinases under in vitro and near-native in vivo conditions.	[Schnabel, Jonathan; Hombach, Peter; Waksman, Thomas; Giuriani, Giovanni; Petersen, Jan; Christie, John M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Hombach, Peter] Bielefeld Univ, Fac Biol, RNA Biol & Mol Physiol, D-33615 Bielefeld, Germany; [Schnabel, Jonathan] Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England; [Petersen, Jan] Friedrich Schiller Univ, Inst Gen Bot & Plant Physiol, Planetarium 1, D-07743 Jena, Germany	University of Glasgow; University of Bielefeld; University of Cambridge; Friedrich Schiller University of Jena	Christie, JM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland.	john.christie@glasgow.ac.uk		Waksman, Thomas/0000-0001-5939-8517; Schnabel, Jonathan/0000-0002-9515-332X; Christie, John/0000-0002-9976-0055; Hombach, Peter/0000-0002-1154-5060; Petersen, Jan/0000-0002-8469-6679	United Kingdom Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1]; Dobbie Smith Scholarship; Erasmus+ Scholarship; Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow; Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128/1] Funding Source: researchfish; BBSRC [BB/J016047/1, BB/M002128/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dobbie Smith Scholarship; Erasmus+ Scholarship; Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BB/J016047/1 and BB/M002128/1 to J.M.C.). This work was also supported by a Dobbie Smith Scholarship (to G.G.), an Erasmus+ Scholarship (to P.H.), and a Doctoral Training Programme Studentship from the College of Medical, Veterinary, and Life Sciences, University of Glasgow (to T.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn NG, 2001, NAT BIOTECHNOL, V19, P317, DOI 10.1038/86687; Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Allen JJ, 2005, J AM CHEM SOC, V127, P5288, DOI 10.1021/ja050727t; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Boccalandro HE, 2008, PLANT PHYSIOL, V146, P108, DOI 10.1104/pp.107.106468; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2015, PLANT CELL PHYSIOL, V56, P401, DOI 10.1093/pcp/pcu196; Christie JM, 2013, AM J BOT, V100, P35, DOI 10.3732/ajb.1200340; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Deng ZP, 2014, J PROTEOME RES, V13, P2524, DOI 10.1021/pr500010z; Doi M, 2004, J EXP BOT, V55, P517, DOI 10.1093/jxb/erh044; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Hiyama A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01237-5; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Leissing F, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0731-6; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Petersen J, 2017, J BIOL CHEM, V292, P13843, DOI 10.1074/jbc.M117.799643; Preuten T, 2015, NEW PHYTOL, V206, P1038, DOI 10.1111/nph.13299; Rademacher EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00250; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon D, 2011, METHODS MOL BIOL, V779, P185, DOI 10.1007/978-1-61779-264-9_10; Salomon D, 2009, J BIOL CHEM, V284, P15289, DOI 10.1074/jbc.M809724200; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Sullivan S, 2016, PLANT J, V88, P907, DOI 10.1111/tpj.13313; Sullivan S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00290; Sullivan S, 2016, NEW PHYTOL, V209, P612, DOI 10.1111/nph.13640; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Takemiya A, 2016, J PLANT RES, V129, P167, DOI 10.1007/s10265-015-0780-1; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Trejo-Tapia G, 2007, BIOTECHNOL PROGR, V23, P359, DOI 10.1021/bp0602597; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; Xu J, 2014, METHODS MOL BIOL, V1171, P91, DOI 10.1007/978-1-4939-0922-3_8; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	63	7	7	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5613	5623		10.1074/jbc.RA118.001834	http://dx.doi.org/10.1074/jbc.RA118.001834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475950	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000430044100022
J	Swan, JA; Golden, SS; LiWang, A; Partch, CL				Swan, Jeffrey A.; Golden, Susan S.; LiWang, Andy; Partch, Carrie L.			Structure, function, and mechanism of the core circadian clock in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						circadian rhythm; crystallography; nuclear magnetic resonance (NMR); bacterial protein kinase; ATPases associated with diverse cellular activities (AAA); bacterial signal transduction	TRANSCRIPTION-TRANSLATION FEEDBACK; STIMULATED KAIC PHOSPHORYLATION; N-TERMINAL DOMAIN; GENE-EXPRESSION; PROTEIN KAIB; SYNECHOCOCCUS-ELONGATUS; OSCILLATOR; KAIABC; ATP; RHYTHMS	Circadian rhythms enable cells and organisms to coordinate their physiology with the cyclic environmental changes that come as a result of Earth's light/dark cycles. Cyanobacteria make use of a post-translational oscillator to maintain circadian rhythms, and this elegant system has become an important model for circadian timekeeping mechanisms. Composed of three proteins, the KaiABC system undergoes an oscillatory biochemical cycle that provides timing cues to achieve a 24-h molecular clock. Together with the input/output proteins SasA, CikA, and RpaA, these six gene products account for the timekeeping, entrainment, and output signaling functions in cyanobacterial circadian rhythms. This Minireview summarizes the current structural, functional and mechanistic insights into the cyanobacterial circadian clock.	[Swan, Jeffrey A.; Partch, Carrie L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Golden, Susan S.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Golden, Susan S.; LiWang, Andy; Partch, Carrie L.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Golden, Susan S.; LiWang, Andy; Partch, Carrie L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [LiWang, Andy] Univ Calif Merced, Dept Chem & Chem Biol, Merced, CA 95343 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Merced	Partch, CL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.; Partch, CL (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.; Partch, CL (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	cpartch@ucsc.edu	LiWang, Andy/AAE-5205-2020	LiWang, Andy/0000-0003-4741-6946; Partch, Carrie/0000-0002-4677-2861	National Institutes of Health [R35GM118290, R01GM107521, R01GM121507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121507, R01GM107521, R35GM118290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM118290 (to S. S. G.), R01GM107521 (to A. L.), and R01GM121507 (to C. L. P.). This is the second article in the Thematic Minireview series "Green biological chemistry." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe J, 2015, SCIENCE, V349, P312, DOI 10.1126/science.1261040; Ashby MK, 2006, MICROBIOL MOL BIOL R, V70, P472, DOI 10.1128/MMBR.00046-05; Bartocci E, 2013, LECT N BIOINFORMAT, V8130, P164, DOI 10.1007/978-3-642-40708-6_13; Boyd JS, 2016, J BACTERIOL, V198, P2439, DOI 10.1128/JB.00235-16; Bryant D. A., 1994, MOL BIOL CYANOBACTER, P217; Chang YG, 2015, SCIENCE, V349, P324, DOI 10.1126/science.1260031; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Chen AH, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500358; Cohen SE, 2015, MICROBIOL MOL BIOL R, V79, P373, DOI 10.1128/MMBR.00036-15; Cohen SE, 2014, CURR BIOL, V24, P1836, DOI 10.1016/j.cub.2014.07.036; Egli M, 2013, BIOCHEMISTRY-US, V52, P1208, DOI 10.1021/bi301691a; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Espinosa J, 2015, P NATL ACAD SCI USA, V112, P2198, DOI 10.1073/pnas.1424632112; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gao TY, 2007, PROTEIN SCI, V16, P465, DOI 10.1110/ps.062532007; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gutu A, 2013, MOL CELL, V50, P288, DOI 10.1016/j.molcel.2013.02.022; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Hosokawa N, 2013, P NATL ACAD SCI USA, V110, P14486, DOI 10.1073/pnas.1302243110; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hurley JM, 2016, TRENDS BIOCHEM SCI, V41, P834, DOI 10.1016/j.tibs.2016.07.009; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Johnson CH, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.196; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kim YI, 2012, P NATL ACAD SCI USA, V109, P17765, DOI 10.1073/pnas.1216401109; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Kuhlman SJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033613; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leypunskiy E, 2017, ELIFE, V6, DOI 10.7554/eLife.23539; Lin J, 2014, P NATL ACAD SCI USA, V111, pE3937, DOI 10.1073/pnas.1408692111; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Ma LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035165; Mackey SR, 2008, J BACTERIOL, V190, P3738, DOI 10.1128/JB.01721-07; Markson JS, 2013, CELL, V155, P1396, DOI 10.1016/j.cell.2013.11.005; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; Nishiwaki-Ohkawa T, 2014, P NATL ACAD SCI USA, V111, P4455, DOI 10.1073/pnas.1319353111; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; Osanai T, 2015, ENVIRON MICROBIOL, V17, P2430, DOI 10.1111/1462-2920.12715; Paijmans J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005415; Pattanayak GK, 2014, CURR BIOL, V24, P1934, DOI 10.1016/j.cub.2014.07.022; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2015, BIOCHEMISTRY-US, V54, P4575, DOI 10.1021/acs.biochem.5b00694; Pattanayek R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007529; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; Potvin-Trottier L, 2016, NATURE, V538, P514, DOI 10.1038/nature19841; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Rivera-Cancel G, 2014, P NATL ACAD SCI USA, V111, P17839, DOI 10.1073/pnas.1413983111; Rosier BJHM, 2015, ELIFE, V4, DOI 10.7554/eLife.12260; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Snijder J, 2017, SCIENCE, V355, P1181, DOI 10.1126/science.aag3218; Snijder J, 2014, P NATL ACAD SCI USA, V111, P1379, DOI 10.1073/pnas.1314326111; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sugiyama M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35567; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tseng R, 2017, SCIENCE, V355, P1174, DOI 10.1126/science.aag2516; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Vakonakis I, 2004, J MOL BIOL, V342, P9, DOI 10.1016/j.jmb.2004.07.010; Valencia J, 2012, GENES CELLS, V17, P398, DOI 10.1111/j.1365-2443.2012.01597.x; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Wojnowska M, 2013, CHEM BIOL, V20, P1411, DOI 10.1016/j.chembiol.2013.09.008; Wood TL, 2010, P NATL ACAD SCI USA, V107, P5804, DOI 10.1073/pnas.0910141107; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	91	34	36	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5026	5034		10.1074/jbc.TM117.001433	http://dx.doi.org/10.1074/jbc.TM117.001433			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440392	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000429409300008
J	Safdar, A; Little, JP; Stokl, AJ; Hettinga, BP; Akhtar, M; Tarnopolsky, MA				Safdar, Adeel; Little, Jonathan P.; Stokl, Andrew J.; Hettinga, Bart P.; Akhtar, Mahmood; Tarnopolsky, Mark A.			Exercise increases mitochondrial PGC-1 alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis (Expression of Concern of Vol 286, Pg 10605, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern													Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008				Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466	1	10	11	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4953	4953		10.1074/jbc.EC118.002682	http://dx.doi.org/10.1074/jbc.EC118.002682			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602880	Green Published, hybrid			2022-12-28	WOS:000428848300034
J	Itoh, S; Mizuno, K; Aikawa, M; Aikawa, E				Itoh, Shinsuke; Mizuno, Ken; Aikawa, Masanori; Aikawa, Elena			Dimerization of sortilin regulates its trafficking to extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR RISK; RECEPTOR SORTILIN; PROTEIN; RETROMER; ADHESION; DOMAIN; SORT1; ATHEROSCLEROSIS; CALCIFICATION; ADIPONECTIN	Extracellular vesicles (EVs) play a critical role in intercellular communication by transferring microRNAs, lipids, and proteins to neighboring cells. Sortilin, a sorting receptor that directs target proteins to the secretory or endocytic compartments of cells, is found in both EVs and cells. In many human diseases, including cancer and cardiovascular disorders, sortilin expression levels are atypically high. To elucidate the relationship between cardiovascular disease, particularly vascular calcification, and sortilin expression levels, we explored the trafficking of sortilin in both the intracellular and extracellular milieu. We previously demonstrated that sortilin promotes vascular calcification via its trafficking of tissue-nonspecific alkaline phosphatase to EVs. Although recent reports have noted that sortilin is regulated by multiple post-translational modifications, the precise mechanisms of sortilin trafficking still need to be determined. Here, we show that sortilin forms homodimers with an intermolecular disulfide bond at the cysteine 783 (Cys(783)) residue, and because Cys(783) can be palmitoylated, it could be shared via palmitoylation and an intermolecular disulfide bond. Formation of this intermolecular disulfide bond leads to trafficking of sortilin to EVs by preventing palmitoylation, which further promotes sortilin trafficking to the Golgi apparatus. Moreover, we found that sortilin-derived propeptide decreased sortilin homodimers within EVs. In conclusion, sortilin is transported to EVs via the formation of homodimers with an intermolecular disulfide bond, which is endogenously regulated by its own propeptide. Therefore, we propose that inhibiting dimerization of sortilin acts as a new therapeutic strategy for the treatment of EV-associated diseases, including vascular calcification and cancer.	[Itoh, Shinsuke; Mizuno, Ken; Aikawa, Masanori; Aikawa, Elena] Harvard Med Sch, Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA; [Aikawa, Masanori; Aikawa, Elena] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Itoh, Shinsuke; Mizuno, Ken] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo 1890022, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kowa Company, Ltd.	Aikawa, E (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 3 Blackfan St,CLS 17th Floor, Boston, MA 02115 USA.	eaikawa@bwh.harvard.edu	Aikawa, Elena/L-6173-2019	Itoh, Shinsuke/0000-0001-9567-8188; Aikawa, Elena/0000-0001-7835-2135; Aikawa, Masanori/0000-0002-9275-2079	Kowa Company, Ltd., Tokyo, Japan; National Institutes of Health [R01HL 114805, R01HL 136431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114805, R01HL136431] Funding Source: NIH RePORTER	Kowa Company, Ltd., Tokyo, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a research grant from Kowa Company, Ltd., Tokyo, Japan (to M. A.). S. I. and K. M. are employees of Kowa Company, Ltd. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants R01HL 114805 and R01HL 136431.	Andersson CH, 2016, J ALZHEIMERS DIS, V53, P1353, DOI 10.3233/JAD-160319; Beraud-Dufour S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111860; Buttenschon HN, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.167; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Carlo AS, 2014, J MOL MED, V92, P905, DOI 10.1007/s00109-014-1152-3; Carlo AS, 2013, J NEUROSCI, V33, P358, DOI 10.1523/JNEUROSCI.2425-12.2013; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Eggert S, 2018, CELL MOL LIFE SCI, V75, P301, DOI 10.1007/s00018-017-2625-7; Goettsch C, 2018, ARTERIOSCL THROM VAS, V38, P19, DOI 10.1161/ATVBAHA.117.310292; Goettsch C, 2017, ARTERIOSCL THROM VAS, V37, P1005, DOI 10.1161/ATVBAHA.116.308932; Goettsch C, 2016, J CLIN INVEST, V126, P1323, DOI 10.1172/JCI80851; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hutcheson JD, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25129; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kitago Y, 2015, NAT STRUCT MOL BIOL, V22, P199, DOI 10.1038/nsmb.2954; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li WH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0706-8; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Massa Fabienne, 2014, Genes Cancer, V5, P240; Massa F, 2013, INT J BIOCHEM CELL B, V45, P952, DOI 10.1016/j.biocel.2013.01.020; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Mortensen MB, 2014, J CLIN INVEST, V124, P5317, DOI 10.1172/JCI76002; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nyborg A. C., 2006, MOL NEURODEGENER, V13; Ogawa K, 2016, ATHEROSCLEROSIS, V249, P110, DOI 10.1016/j.atherosclerosis.2016.03.041; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Patel KM, 2015, CIRC RES, V116, P789, DOI 10.1161/CIRCRESAHA.116.305811; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roselli S, 2015, ONCOTARGET, V6, P10473, DOI 10.18632/oncotarget.3401; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Ward RJ, 2013, METHOD ENZYMOL, V521, P69, DOI 10.1016/B978-0-12-391862-8.00004-1; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Wilson Cornelia M, 2016, Commun Integr Biol, V9, pe1130192, DOI 10.1080/19420889.2015.1130192; Wilson CM, 2014, J CELL SCI, V127, P3983, DOI 10.1242/jcs.149336	49	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4532	4544		10.1074/jbc.RA117.000732	http://dx.doi.org/10.1074/jbc.RA117.000732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382723	Green Published, hybrid			2022-12-28	WOS:000428204300024
J	Wan, F; Kong, LG; Gao, HC				Wan, Fen; Kong, Linggen; Gao, Haichun			Defining the binding determinants of Shewanella oneidensis OxyR: Implications for the link between the contracted OxyR regulon and adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; NEISSERIA-GONORRHOEAE; CATALASE EXPRESSION; INDUCIBLE GENES; DNA; STRESS; ACTIVATION; MECHANISM	It is well-established that OxyR functions as a transcriptional activator of the peroxide stress response in bacteria, primarily based on studies on Escherichia coli. Recent investigations have revealed that OxyRs of some other bacteria can regulate gene expression through both repression and activation or repression only; however, the underlying mechanisms remain largely unknown. Here, we demonstrated in gamma-proteobacterium Shewanella oneidensis regulation of OxyR on expression of major catalase gene katB in a dual-control manner through interaction with a single site in the promoter region. Under non-stress conditions, katB expression was repressed by reduced OxyR (OxyR(red)), whereas when oxidized, OxyR (WOxyR(oxi)) out-competed OxyRred for the site because of substantially enhanced affinity, resulting in a graded response to oxidative stress, from repression to derepression to activation. The OxyR-binding motif is characterized as a combination of the E. coli motif (tetranucle-otides spaced by heptanucleotide) and palindromic structure. We provided evidence to suggest that the S. oneidensis OxyR regulon is significantly contracted compared with those reported, probably containing only five members that are exclusively involved in oxygen reactive species scavenging and iron sequestering. These characteristics probably reflect the adapting strategy of the bacteria that S. oneidensis represents to thrive in redox-stratified microaerobic and anaerobic environments.	[Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563; Kong, Linggen/0000-0003-4055-8626	National Natural Science Foundation of China [41476105]; Natural Science Foundation of Zhejiang Province [LZ17C010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 41476105 and Natural Science Foundation of Zhejiang Province Grant LZ17C010001. The authors declare that they have no conflicts of interest with the contents of this article.	Binnenkade L, 2014, APPL ENVIRON MICROB, V80, P5304, DOI 10.1128/AEM.01480-14; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edwards JS, 2013, P NATL ACAD SCI USA, V110, P2804, DOI 10.1073/pnas.1219701110; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu Huihui, 2014, Environ Microbiol, V16, P3181, DOI 10.1111/1462-2920.12457; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao T, 2015, MOL MICROBIOL, V98, P571, DOI 10.1111/mmi.13141; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jiang YM, 2014, J BACTERIOL, V196, P445, DOI 10.1128/JB.01077-13; Jo I, 2017, J BIOL CHEM, V292, P7223, DOI 10.1074/jbc.M116.743765; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031709; Li M, 2016, J BACTERIOL, V198, P3060, DOI 10.1128/JB.00463-16; Li N, 2014, ENVIRON MICROBIOL, V16, P1821, DOI 10.1111/1462-2920.12418; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Loprasert S, 2000, MOL MICROBIOL, V37, P1504, DOI 10.1046/j.1365-2958.2000.02107.x; Luo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062064; Maciver I, 1996, INFECT IMMUN, V64, P4618, DOI 10.1128/IAI.64.11.4618-4629.1996; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Milse J, 2014, J BIOTECHNOL, V190, P40, DOI 10.1016/j.jbiotec.2014.07.452; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schutz B, 2011, APPL ENVIRON MICROB, V77, P6172, DOI 10.1128/AEM.00606-11; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; Shi MM, 2015, J BACTERIOL, V197, P2179, DOI 10.1128/JB.00154-15; Shi MM, 2014, MOL MICROBIOL, V93, P1269, DOI 10.1111/mmi.12731; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sun LL, 2014, J BIOL CHEM, V289, P14547, DOI 10.1074/jbc.M114.552000; Sun LL, 2013, J BACTERIOL, V195, P2550, DOI 10.1128/JB.00015-13; Teramoto H, 2013, FEBS J, V280, P3298, DOI 10.1111/febs.12312; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Wan F, 2017, SCI REP-UK, V7, DOI 10.1038/srep42609; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Wilson DO, 2001, ELECTROPHORESIS, V22, P1979, DOI 10.1002/1522-2683(200106)22:10<1979::AID-ELPS1979>3.0.CO;2-A; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	47	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4085	4096		10.1074/jbc.RA117.001530	http://dx.doi.org/10.1074/jbc.RA117.001530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367341	hybrid, Green Published			2022-12-28	WOS:000427587500020
J	Zhao, XH; Lanz, J; Steinberg, D; Pease, T; Ahearn, JM; Bersonov, EE; Staguhn, ED; Eisenberg, E; Masison, DC; Greene, LE				Zhao, Xiaohong; Lanz, Jenna; Steinberg, Danielle; Pease, Tyler; Ahearn, Joseph M.; Bersonov, Evgeny E.; Staguhn, Elena D.; Eisenberg, Evan; Masison, Daniel C.; Greene, Lois E.			Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE PSI+; POLYGLUTAMINE PEPTIDES; CHAPERONE HSP104; HSP70 CHAPERONE; PROTEIN; PROPAGATION; CURE; OVEREXPRESSION; DNAJB6; SIS1	The [URE3] yeast prion is the self-propagating amyloid form of the Ure2 protein. [URE3] is cured by overexpression of several yeast proteins, including Yd11, Btn2, Curl, Hsp42, and human DnaJB6. To better understand [URE3] curing, we used real-time imaging with a yeast strain expressing a GFP-labeled full-length Ure2 construct to monitor the curing of [URE3] over time. [URE3] yeast cells exhibited numerous fluorescent foci, and expression of the GFP-labeled Ure2 affected neither mitotic stability of [URE3] nor the rate of [URE3] curing by the curing proteins. Using guanidine to cure [URE3] via Hsp104 inactivation, we found that the fluorescent foci are progressively lost as the cells divide until they are cured; the fraction of cells that retained the foci was equivalent to the [URE3] cell fraction measured by a plating assay, indicating that the foci were the prion seeds. During the curing of [URE3] by Btn2, Curl, Hsp42, or Ydj 1 overexpression, the foci formed aggregates, many of which were 0.5 pm or greater in size, and [URE3] was cured by asymmetric segregation of the aggregated seeds, In contrast, DnaJ136 overexpression first caused a loss of detectable foci in cells that were still [URE3] before there was complete dissolution of the seeds, and the cells were cured. We conclude that GFP labeling of full-length Ure2 enables differentiation among the different [URE3]-curing mechanisms, including inhibition of severing followed by seed dilution, seed clumping followed by asymmetric segregation between mother and daughter cells, and seed dissolution.	[Zhao, Xiaohong; Lanz, Jenna; Steinberg, Danielle; Pease, Tyler; Ahearn, Joseph M.; Staguhn, Elena D.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Bersonov, Evgeny E.; Masison, Daniel C.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov	Bezsonov, Evgeny/AAL-1982-2021	Bezsonov, Evgeny/0000-0002-9382-8338; Pease, Tyler/0000-0003-0372-9270	National Institutes of Health [HL000516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516, Z01HL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL000516. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Barbitoff YA, 2017, MOL MICROBIOL, V105, P242, DOI 10.1111/mmi.13697; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1996, GENETICS, V144, P1375; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fernandez-Bellot E, 2002, EMBO REP, V3, P76, DOI 10.1093/embo-reports/kvf011; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; Park YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037692; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Reidy M, 2016, J BIOL CHEM, V291, P4035, DOI 10.1074/jbc.M115.700393; Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Ripaud L, 2003, EMBO J, V22, P5251, DOI 10.1093/emboj/cdg488; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Wickner RB, 2014, P NATL ACAD SCI USA, V111, pE2711, DOI 10.1073/pnas.1409582111; Wickner RB, 2012, METHODS MOL BIOL, V849, P321, DOI 10.1007/978-1-61779-551-0_22; Zhao XH, 2017, J BIOL CHEM, V292, P8630, DOI 10.1074/jbc.M116.770719	46	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3104	3117		10.1074/jbc.M117.809079	http://dx.doi.org/10.1074/jbc.M117.809079			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330300	Green Published, hybrid			2022-12-28	WOS:000426562800006
J	Yi, MC; Melkonian, AV; Ousey, JA; Khosla, C				Yi, Michael C.; Melkonian, Arek V.; Ousey, James A.; Khosla, Chaitan			Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE EXCHANGE; QUIESCIN-SULFHYDRYL OXIDASE; TISSUE TRANSGLUTAMINASE; EXTRACELLULAR-MATRIX; THROMBUS FORMATION; CELIAC-DISEASE; SELECTIVE-INHIBITION; HUMAN THIOREDOXIN-1; ACTIVE-SITE; ISOMERASE	Transglutaminase 2 (TG2) is a ubiquitously expressed, intracellular as well as extracellular protein with multiple modes of post-translational regulation, including an allosteric disulfide bond between Cys-370-Cys-371 that renders the enzyme inactive in the extracellular matrix. Although recent studies have established that extracellular TG2 is switched "on" by the redox cofactor protein thioredoxin-1 (TRX), it is unclear how TG2 is switched "off." Here, we demonstrate that TG2 oxidation by small-molecule biological oxidants, including glutathione, cystine, and hydrogen peroxide, is unlikely to be the inactivation mechanism. Instead, endoplasmic reticulum (ER)-resident protein 57 (ERp57), a protein in the ER that promotes folding of nascent proteins and is also present in the extracellular environment, has the cellular and biochemical characteristics for inactivating TG2. We found that ERp57 colocalizes with extracellular TG2 in cultured human umbilical vein endothelial cells (HUVECs). ERp57 oxidized TG2 with a rate constant that was 400-2000-fold higher than those of the aforementioned small molecule oxidants. Moreover, its specificity for TG2 was also markedly higher than those of other secreted redox proteins, including protein disulfide isomerase (PDI), ERp72, TRX, and quiescin sulfhydryl oxidase 1 (QSOX1). Lastly, siRNA-mediated ERp57 knockdown in HUVECs increased TG2-catalyzed trans-amidation in the extracellular environment. We conclude that, to the best of our knowledge, the disulfide bond switch in human TG2 represents the first example of a post-translational redox regulatory mechanism that is reversibly and allosterically modulated by two distinct proteins (ERp57 and TRX).	[Yi, Michael C.; Melkonian, Arek V.; Ousey, James A.; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Melkonian, Arek V.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [R01 DK063158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK063158 (to C. K.). C. K. is an advisor to and shareholder of Sitari Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araujo TLS, 2017, FREE RADICAL BIO MED, V103, P199, DOI 10.1016/j.freeradbiomed.2016.12.021; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Dihazi H, 2013, J CELL SCI, V126, P3649, DOI 10.1242/jcs.125088; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; DiRaimondo TR, 2013, J MED CHEM, V56, P1301, DOI 10.1021/jm301775s; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; GILBERT HF, 1989, BIOCHEMISTRY-US, V28, P7298, DOI 10.1021/bi00444a023; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; Huang LH, 2009, KIDNEY INT, V76, P383, DOI 10.1038/ki.2009.230; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Israel BA, 2014, FREE RADICAL BIO MED, V69, P129, DOI 10.1016/j.freeradbiomed.2014.01.020; Israel BA, 2014, J BIOL CHEM, V289, P5274, DOI 10.1074/jbc.M113.536219; Jasuja R, 2007, BLOOD, V110, p1083A; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Klock C, 2012, SEMIN IMMUNOPATHOL, V34, P513, DOI 10.1007/s00281-012-0305-0; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Malorni W, 2009, CELL DEATH DIFFER, V16, P1480, DOI 10.1038/cdd.2009.100; Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007; Nadalutti CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077277; Nagy P, 2013, ANTIOXID REDOX SIGN, V18, P1623, DOI 10.1089/ars.2012.4973; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Plugis NM, 2017, J BIOL CHEM, V292, P2000, DOI 10.1074/jbc.M116.767988; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schulman S, 2016, ANTIOXID REDOX SIGN, V24, P1, DOI 10.1089/ars.2015.6530; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.318; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Watts RE, 2006, J MED CHEM, V49, P7493, DOI 10.1021/jm060839a; WEISBART RH, 1992, J IMMUNOL, V148, P3958; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Yi MC, 2016, ANNU REV CHEM BIOMOL, V7, P197, DOI 10.1146/annurev-chembioeng-080615-033553; Yi MC, 2015, BIOORG MED CHEM LETT, V25, P4922, DOI 10.1016/j.bmcl.2015.05.006; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	58	23	23	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2640	2649		10.1074/jbc.RA117.001382	http://dx.doi.org/10.1074/jbc.RA117.001382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29305423	hybrid, Green Published			2022-12-28	WOS:000426051900001
J	Dahan, P; Lu, V; Nguyen, RMT; Kennedy, SAL; Teitell, MA				Dahan, Perrine; Lu, Vivian; Nguyen, Robert M. T.; Kennedy, Stephanie A. L.; Teitell, Michael A.			Metabolism in pluripotency: Both driver and passenger?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						metabolism; mitochondria; stem cells; pluripotency; reprogramming; differentiation; cell fate; epigenetics	EMBRYONIC STEM-CELLS; ACETYLGLUCOSAMINE TRANSFERASE OGT; STRESS DEFENSE-MECHANISMS; ENERGY-METABOLISM; O-GLCNACYLATION; GLYCOLYTIC METABOLISM; DEVELOPMENTAL GENES; NAIVE PLURIPOTENCY; CORE COMPONENTS; OXYGEN-TENSION	Pluripotent stem cells (PSCs) are highly proliferative cells characterized by robust metabolic demands to power rapid division. For many years considered a passive component or passenger of cell-fate determination, cell metabolism is now starting to take center stage as a driver of cell fate outcomes. This review provides an update and analysis of our current understanding of PSC metabolism and its role in self-renewal, differentiation, and somatic cell reprogramming to pluripotency. Moreover, we present evidence on the active roles metabolism plays in shaping the epigenome to influence patterns of gene expression that may model key features of early embryonic development.	[Dahan, Perrine; Nguyen, Robert M. T.; Kennedy, Stephanie A. L.; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lu, Vivian] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Kennedy, Stephanie A. L.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California State University System; California State University Northridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Teitell, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.; Teitell, MA (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	mteitell@mednet.ucla.edu	Kennedy, Stephanie AL/AAJ-9127-2020	Dahan, Perrine/0000-0003-4738-8893	National Institutes of Health [CA90571, GM073981, CA18589, GM114188]; Air Force Office of Scientific Research [FA9550-15-1-0406]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD097960] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA185189, R21CA227480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073981, R01GM114188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA90571, GM073981, CA18589, and GM114188 and Air Force Office of Scientific Research Grant FA9550-15-1-0406 (to M. A. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bae D, 2012, STEM CELLS DEV, V21, P1344, DOI 10.1089/scd.2011.0225; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cliff TS, 2017, CELL STEM CELL, V21, P502, DOI 10.1016/j.stem.2017.08.018; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; D'Aniello C, 2017, STEM CELL REP, V8, P1, DOI 10.1016/j.stemcr.2016.11.011; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Flores A, 2017, NAT CELL BIOL, V19, P1017, DOI 10.1038/ncb3575; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hardiville S, 2016, CURR OPIN CHEM BIOL, V33, P88, DOI 10.1016/j.cbpa.2016.06.005; Hawkins KE, 2016, CELL REP, V14, P1883, DOI 10.1016/j.celrep.2016.02.003; Hayakawa K, 2013, J BIOL CHEM, V288, P17099, DOI 10.1074/jbc.M113.455899; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Kim G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09039-x; Kim H, 2015, STEM CELLS, V33, P2699, DOI 10.1002/stem.2073; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mathieu J, 2014, CELL STEM CELL, V14, P592, DOI 10.1016/j.stem.2014.02.012; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; Maurya JJP, 2015, STEM CELL RES, V15, P182, DOI 10.1016/j.scr.2015.06.007; Miura T, 2016, BIOCHEM BIOPH RES CO, V480, P655, DOI 10.1016/j.bbrc.2016.10.111; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pawlowski M, 2017, STEM CELL REP, V8, P803, DOI 10.1016/j.stemcr.2017.02.016; Pei YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16539; Pimton P, 2015, STEM CELLS DEV, V24, P663, DOI 10.1089/scd.2014.0343; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schell JC, 2017, NAT CELL BIOL, V19, P1027, DOI 10.1038/ncb3593; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Setoguchi K, 2016, J MOL BIOL, V428, P1465, DOI 10.1016/j.jmb.2015.07.019; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Son MJ, 2015, CELL DEATH DIFFER, V22, P1957, DOI 10.1038/cdd.2015.43; Son MY, 2013, STEM CELLS, V31, P2374, DOI 10.1002/stem.1509; Son MJ, 2013, INT J BIOCHEM CELL B, V45, P2512, DOI 10.1016/j.biocel.2013.07.023; Sone M, 2017, CELL METAB, V25, P1103, DOI 10.1016/j.cmet.2017.04.017; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Takashima Y, 2015, CELL, V162, P452, DOI 10.1016/j.cell.2015.06.052; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; TeSlaa T, 2016, CELL METAB, V24, P485, DOI 10.1016/j.cmet.2016.07.002; Teslaa T, 2015, EMBO J, V34, P138, DOI 10.15252/embj.201490446; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tohyama S, 2016, CELL METAB, V23, P663, DOI 10.1016/j.cmet.2016.03.001; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vazquez-Martin A, 2013, CELL CYCLE, V12, P207, DOI 10.4161/cc.23352; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang LH, 2017, EMBO J, V36, P1330, DOI 10.15252/embj.201695417; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wu Y, 2016, STEM CELLS, V34, P83, DOI 10.1002/stem.2209; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xie Y, 2014, STEM CELL REP, V3, P743, DOI 10.1016/j.stemcr.2014.09.021; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yasui T, 2017, STEM CELL REP, V8, P1743, DOI 10.1016/j.stemcr.2017.05.001; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang H, 2016, CELL REP, V16, P1536, DOI 10.1016/j.celrep.2016.06.102; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	98	39	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5420	5429		10.1074/jbc.TM117.000832	http://dx.doi.org/10.1074/jbc.TM117.000832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	29463682	Green Published, hybrid			2022-12-28	WOS:000464517500015
J	Bruinsma, S; James, DJ; Serrano, M; Esquibel, J; Woo, SS; Kielar-Grevstad, E; Crummy, E; Qurashi, R; Kowalchyk, JA; Martin, TFJ				Bruinsma, Stephen; James, Declan J.; Serrano, Melanie Quintana; Esquibel, Joseph; Woo, Sang Su; Kielar-Grevstad, Elle; Crummy, Ellen; Qurashi, Rehan; Kowalchyk, Judy A.; Martin, Thomas F. J.			Small molecules that inhibit the late stage of Munc13-4-dependent secretory granule exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; mast cell; exocytosis; small molecule; secretion; inhibitor; intracellular trafficking; Munc13-4	MEMBRANE-FUSION; SNARE COMPLEXES; REGULATED EXOCYTOSIS; VESICLE EXOCYTOSIS; PC12 CELLS; MUNC13-4; SYNAPTOTAGMIN; IDENTIFICATION; DEGRANULATION; ENDOCYTOSIS	Ca2+-dependent secretory granule fusion with the plasma membrane is the final step for the exocytic release of inflammatory mediators, neuropeptides, and peptide hormones. Secretory cells use a similar protein machinery at late steps in the regulated secretory pathway, employing protein isoforms from the Rab, Sec1/Munc18, Munc13/CAPS, SNARE, and synaptotagmin protein families. However, no small-molecule inhibitors of secretory granule exocytosis that target these proteins are currently available but could have clinical utility. Here we utilized a high-throughput screen of a 25,000-compound library that identified 129 small-molecule inhibitors of Ca2+-triggered secretory granule exocytosis in RBL-2H3 mast cells. These inhibitors broadly fell into six different chemical classes, and follow-up permeable cell and liposome fusion assays identified the target for one class of these inhibitors. A family of 2-aminobenzothiazoles (termed benzothiazole exocytosis inhibitors or bexins) was found to inhibit mast cell secretory granule fusion by acting on a Ca2+-dependent, C2 domain-containing priming factor, Munc13-4. Our findings further indicated that bexins interfere with Munc13-4-membrane interactions and thereby inhibit Munc13-4-dependent membrane fusion. We conclude that bexins represent a class of specific secretory pathway inhibitors with potential as therapeutic agents.	[Bruinsma, Stephen; James, Declan J.; Serrano, Melanie Quintana; Esquibel, Joseph; Woo, Sang Su; Kielar-Grevstad, Elle; Crummy, Ellen; Qurashi, Rehan; Kowalchyk, Judy A.; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Bruinsma, Stephen] Illumina Inc, 5602 Res Pk Blvd, Madison, WI 53719 USA; [Serrano, Melanie Quintana] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Esquibel, Joseph] Lansing Community Coll, 309 N Washington Sq, Lansing, MI 48933 USA; [Woo, Sang Su] NINDS, NIH, 35 Convent Dr, Bethesda, MD 20892 USA; [Qurashi, Rehan] Univ Chicago, Graham Sch, 1427 E 60th St, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; Illumina; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Chicago	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@wisc.edu	; Martin, Thomas F/A-6962-2009	Woo, Sang Su/0000-0002-8712-9530; Martin, Thomas F/0000-0002-5204-0202	NIH [R01 DK025861, R21 NS064833]; American Heart Association [0825742G]; National Science Foundation [DBI 1063085]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grants R01 DK025861 and R21 NS064833 (to T. F. J. M.), American Heart Association Grant 0825742G (to S. B.), and National Science Foundation Grant DBI 1063085 (to M. Q. S.) for summer fellowship support.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Blank U, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00453; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; Chicka MC, 2016, BIOCHEM J, V473, P627, DOI 10.1042/BJ20151150; Cukalevski R, 2012, ACS CHEM NEUROSCI, V3, P1008, DOI 10.1021/cn300073s; D'Angelo ND, 2011, J MED CHEM, V54, P1789, DOI 10.1021/jm1014605; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Harvima IT, 2014, J ALLERGY CLIN IMMUN, V134, P530, DOI 10.1016/j.jaci.2014.03.007; He J, 2016, MOL BIOL CELL, V27, P572, DOI 10.1091/mbc.E15-05-0283; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Hong WJ, 2014, TRENDS CELL BIOL, V24, P35, DOI 10.1016/j.tcb.2013.09.006; HOWELL TW, 1987, J CELL BIOL, V105, P191, DOI 10.1083/jcb.105.1.191; Ivanov AI, 2014, METHODS MOL BIOL, V1174, P3, DOI 10.1007/978-1-4939-0944-5_1; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Johnson JL, 2016, J BIOL CHEM, V291, P25965, DOI 10.1074/jbc.M116.741884; Keri RS, 2015, EUR J MED CHEM, V89, P207, DOI 10.1016/j.ejmech.2014.10.059; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Matsuda H, 2016, CHEM PHARM BULL, V64, P96, DOI 10.1248/cpb.c15-00781; McShane MP, 2015, J BIOMOL SCREEN, V20, P720, DOI 10.1177/1087057115579613; Milovanovic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00089; Mishev K, 2013, CHEM BIOL, V20, P475, DOI 10.1016/j.chembiol.2013.03.009; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Noel S, 2013, CHEM SOC REV, V42, P7747, DOI 10.1039/c3cs60086f; Pinheiro PS, 2016, J NEUROCHEM, V139, P943, DOI 10.1111/jnc.13865; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Vukman K. V., 2014, BIOPROTOCOL, V4, pe1053; Wang CX, 2012, NANOSCALE, V4, P1895, DOI 10.1039/c2nr11508e; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woo SS, 2017, MOL BIOL CELL, V28, P792, DOI 10.1091/mbc.E16-08-0617; Yang Y, 2013, BIOCHEM J, V450, P537, DOI 10.1042/BJ20121256; Yang Y, 2010, P NATL ACAD SCI USA, V107, P22145, DOI 10.1073/pnas.1006899108; Zhang CH, 2016, P NATL ACAD SCI USA, V113, pE41, DOI 10.1073/pnas.1521248112; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8217	8229		10.1074/jbc.RA117.001547	http://dx.doi.org/10.1074/jbc.RA117.001547			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29615494	hybrid, Green Published			2022-12-28	WOS:000433224600026
J	Crespillo-Casado, A; Claes, Z; Choy, MS; Peti, W; Bollen, M; Ron, D				Crespillo-Casado, Ana; Claes, Zander; Choy, Meng S.; Peti, Wolfgang; Bollen, Mathieu; Ron, David			A Sephin1-insensitive tripartite holophosphatase dephosphorylates translation initiation factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoprotein phosphatase 1 (PP1); eukaryotic initiation factor 2 (eIF2); enzyme inhibitor; G-actin; proteostasis; guanabenz; integrated stress response; protein synthesis; Sephin1	INTEGRATED STRESS-RESPONSE; PROTEIN PHOSPHATASE 1; ENDOPLASMIC-RETICULUM; REGULATORY SUBUNIT; SELECTIVE-INHIBITION; GROWTH ARREST; EIF2-ALPHA; PHOSPHORYLATION; MUSCLE; CELLS	The integrated stress response (ISR) is regulated by kinases that phosphorylate the subunit of translation initiation factor 2 and phosphatases that dephosphorylate it. Genetic and biochemical observations indicate that the eIF2(P)-directed holophosphatase, a therapeutic target in diseases of protein misfolding, is comprised of a regulatory subunit, PPP1R15, and a catalytic subunit, protein phosphatase 1 (PP1). In mammals, there are two isoforms of the regulatory subunit, PPP1R15A and PPP1R15B, with overlapping roles in the essential function of eIF2(P) dephosphorylation. However, conflicting reports have appeared regarding the requirement for an additional co-factor, G-actin, in enabling substrate-specific dephosphorylation by PPP1R15-containing PP1 holoenzymes. An additional concern relates to the sensitivity of the holoenzyme to the [(o-chlorobenzylidene)amino]guanidines Sephin1 or guanabenz, putative small-molecule proteostasis modulators. It has been suggested that the source and method of purification of the PP1 catalytic subunit and the presence or absence of an N-terminal repeat-containing region in the PPP1R15A regulatory subunit might influence the requirement for G-actin and sensitivity of the holoenzyme to inhibitors. We found that eIF2(P) dephosphorylation by PP1 was moderately stimulated by repeat-containing PPP1R15A in an unphysiological low ionic strength buffer, whereas stimulation imparted by the co-presence of PPP1R15A and G-actin was observed under a broad range of conditions, low and physiological ionic strength, regardless of whether the PPP1R15A regulatory subunit had or lacked the N-terminal repeat-containing region and whether it was paired with native PP1 purified from rabbit muscle or recombinant PP1 purified from bacteria. Furthermore, none of the PPP1R15A-containing holophosphatases tested were inhibited by Sephin1 or guanabenz.	[Crespillo-Casado, Ana; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England; [Claes, Zander; Bollen, Mathieu] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Choy, Meng S.; Peti, Wolfgang] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Cambridge; KU Leuven; University of Arizona	Crespillo-Casado, A; Ron, D (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	ac880@cam.ac.uk; dr360@medschl.cam.ac.uk		Ron, David/0000-0002-3014-5636	Wellcome Trust principal research fellowship [Wellcome 200848/Z/16/Z]; Wellcome Trust strategic award [Wellcome 100140]; National Institute of Health [R01NS091336]; American Diabetes Association Pathway to Stop Diabetes [1-14-ACN-31]; Flemish Concerted Research Action [GOA15/016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER	Wellcome Trust principal research fellowship(Wellcome Trust); Wellcome Trust strategic award(Wellcome Trust); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes; Flemish Concerted Research Action; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Wellcome Trust principal research fellowship (Wellcome 200848/Z/16/Z) to D. R. and a Wellcome Trust strategic award to the Cambridge Institute for Medical Research (Wellcome 100140). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institute of Health Grant R01NS091336 and American Diabetes Association Pathway to Stop Diabetes Grant 1-14-ACN-31.; Supported by a Flemish Concerted Research Action (GOA15/016).	Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carrara M, 2017, NAT STRUCT MOL BIOL, V24, P708, DOI 10.1038/nsmb.3443; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Crespillo-Casado A, 2017, ELIFE, V6, DOI 10.7554/eLife.26109; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P711, DOI 10.1111/j.1432-1033.1989.tb15264.x; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kelker MS, 2009, J MOL BIOL, V385, P11, DOI 10.1016/j.jmb.2008.10.053; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mikami S, 2010, BIOTECHNOL LETT, V32, P897, DOI 10.1007/s10529-010-0251-7; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Perego J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8104; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Schneider K, 2015, J CELL SCI, V128, P3861, DOI 10.1242/jcs.173047; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Verbinnen I, 2017, BIOCHEM SOC T, V45, P89, DOI 10.1042/BST20160154; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	35	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7766	7776		10.1074/jbc.RA118.002325	http://dx.doi.org/10.1074/jbc.RA118.002325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618508	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000437256500025
J	Hosios, AM; Vander Heiden, MG				Hosios, Aaron M.; Vander Heiden, Matthew G.			The redox requirements of proliferating mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELECTRON-TRANSPORT CHAIN; RAS-TRANSFORMED CELLS; CANCER METABOLISM; FATTY-ACIDS; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; PENTOSE CYCLE; TRIACYLGLYCEROL METABOLISM; LYMPHOCYTE-PROLIFERATION; GLUTAMINE-METABOLISM	Cell growth and division require nutrients, and proliferating cells use a variety of sources to acquire the amino acids, lipids, and nucleotides that support macromolecule synthesis. Lipids are more reduced than other nutrients, whereas nucleotides and amino acids are typically more oxidized. Cells must therefore generate reducing and oxidizing (redox) equivalents to convert consumed nutrients into biosynthetic precursors. To that end, redox cofactor metabolism plays a central role in meeting cellular redox requirements. In this Minireview, we highlight the biosynthetic pathways that involve redox reactions and discuss their integration with metabolism in proliferating mammalian cells.	[Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	mvh@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AGRANOFF BW, 1956, J BIOL CHEM, V219, P221; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; ARDAWI MSM, 1984, BIOCHEM J, V221, P255, DOI 10.1042/bj2210255; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Balaban S, 2017, CANCER METAB, V5, DOI 10.1186/s40170-016-0163-7; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; CALDER PC, 1994, BIOCHEM J, V298, P605, DOI 10.1042/bj2980605; CHUANG JC, 1990, CLIN EXP IMMUNOL, V81, P173; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DELAPP NW, 1976, J INVEST DERMATOL, V66, P306, DOI 10.1111/1523-1747.ep12482292; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; EAGLE H, 1958, J BIOL CHEM, V233, P551; EAGLE H, 1956, J BIOL CHEM, V218, P607; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Franklin Renty B., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-10; HARDING JW, 1975, BIOCHEM J, V148, P545, DOI 10.1042/bj1480545; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; HOLTEN D, 1976, BIOCHEM BIOPH RES CO, V68, P436, DOI 10.1016/0006-291X(76)91164-5; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Hosios AM, 2014, CANCER METAB, V2, DOI 10.1186/s40170-014-0027-y; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HUME DA, 1979, JNCI-J NATL CANCER I, V62, P3; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17206; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; MEDES G, 1953, CANCER RES, V13, P27; Meiser J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601273; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; ORAM JF, 1980, BIOCHIM BIOPHYS ACTA, V619, P214, DOI 10.1016/0005-2760(80)90070-3; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; REITZER LJ, 1980, J BIOL CHEM, V255, P5616; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Svensson RU, 2016, COLD SH Q B, V81, P93, DOI [10.1101/sqb.2016.81.030874, 10.1101/sqb.2016.81.030574]; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wu GY, 1996, ARCH BIOCHEM BIOPHYS, V336, P224, DOI 10.1006/abbi.1996.0552; WUNTCH T, 1970, SCIENCE, V167, P63, DOI 10.1126/science.167.3914.63; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zhao YZ, 2016, NAT PROTOC, V11, P1345, DOI 10.1038/nprot.2016.074; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	91	66	66	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7490	7498		10.1074/jbc.TM117.000239	http://dx.doi.org/10.1074/jbc.TM117.000239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29339555	Green Published, hybrid			2022-12-28	WOS:000437256500002
J	King, SL; Goth, CK; Eckhard, U; Joshi, HJ; Haue, AD; Vakhrushev, SY; Schjoldager, KT; Overall, CM; Wandall, HH				King, Sarah L.; Goth, Christoffer K.; Eckhard, Ulrich; Joshi, Hiren J.; Haue, Amalie D.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Overall, Christopher M.; Wandall, Hans H.			TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE GENE FAMILY; C-TERMINAL REGION; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; SUBSTRATE SPECIFICITIES; CASPASE CLEAVAGE; PROTEIN TERMINI; CEREBRAL-CORTEX; GLYCOPROTEOME; GENERATION; DISCOVERY	Proteolytic processing is an irreversible post-translational modification functioning as a ubiquitous regulator of cellular activity. Protease activity is tightly regulated via control of gene expression, enzyme and substrate compartmentalization, zymogen activation, enzyme inactivation, and substrate availability. Emerging evidence suggests that proteolysis can also be regulated by substrate glycosylation and that glycosylation of individual sites on a substrate can decrease or, in rare cases, increase its sensitivity to proteolysis. Here, we investigated the relationship between site-specific, mucin-type (or GalNAc-type) O-glycosylation and proteolytic cleavage of extracellular proteins. Using in silico analysis, we found that O-glycosylation and cleavage sites are significantly associated with each other. We then used a positional proteomic strategy, terminal amine isotopic labeling of substrates (TAILS), to map the in vivo cleavage sites in HepG2 SimpleCells with and without one of the key initiating GalNAc transferases, GalNAc-T2, and after treatment with exogenous matrix metalloproteinase 9 (MMP9) or neutrophil elastase. Surprisingly, we found that loss of GalNAc-T2 not only increased cleavage, but also decreased cleavage across a broad range of other substrates, including key regulators of the protease network. We also found altered processing of several central regulators of lipid homeostasis, including apolipoprotein B and the phospholipid transfer protein, providing new clues to the previously reported link between GALNT2 and lipid homeostasis. In summary, we show that loss of GalNAc-T2 O-glycosylation leads to a general decrease in cleavage and that GalNAc-T2 O-glycosylation affects key regulators of the cellular proteolytic network, including multiple members of the serpin family.	[King, Sarah L.; Goth, Christoffer K.; Joshi, Hiren J.; Haue, Amalie D.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Wandall, Hans H.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Eckhard, Ulrich; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Eckhard, Ulrich; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Copenhagen; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.; Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Fac Dent, Vancouver, BC V6T 1Z3, Canada.; Wandall, HH (corresponding author), Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.	chris.overall@ubc.ca; hhw@sund.ku.dk	Eckhard, Ulrich/L-3733-2016; Vakhrushev, Sergey Y/A-7638-2014; Joshi, Hiren/B-5739-2016	Eckhard, Ulrich/0000-0001-5863-4514; Vakhrushev, Sergey Y/0000-0002-0418-5765; Wandall, Hans H./0000-0003-0240-9232; Haue, Amalie Dahl/0000-0001-7656-7976; Goth, Christoffer/0000-0002-5766-1411; Joshi, Hiren/0000-0002-8192-2829	CIHR [MOP-37937] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BIRCH NP, 1991, FEBS LETT, V290, P191, DOI 10.1016/0014-5793(91)81257-9; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Ding YY, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad5578; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Eckhard U, 2016, BIOCHIMIE, V122, P110, DOI 10.1016/j.biochi.2015.10.018; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fortelny N, 2015, NUCLEIC ACIDS RES, V43, pD290, DOI 10.1093/nar/gku1012; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Ha S, 2017, J NEUROSCI, V37, P960, DOI 10.1523/JNEUROSCI.1826-16.2016; Herbert E, 1980, Ann N Y Acad Sci, V343, P79, DOI 10.1111/j.1749-6632.1980.tb47244.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihara S, 2004, GLYCOBIOLOGY, V14, P139, DOI 10.1093/glycob/cwh013; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P131, DOI 10.1093/glycob/cwx104; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Kohno T, 2015, J NEUROSCI, V35, P4776, DOI 10.1523/JNEUROSCI.4119-14.2015; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Lange PF, 2012, NUCLEIC ACIDS RES, V40, pD351, DOI 10.1093/nar/gkr1025; Lau HT, 2014, J PROTEOME RES, V13, P4164, DOI 10.1021/pr500630a; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Maddelein D, 2015, NUCLEIC ACIDS RES, V43, pW543, DOI 10.1093/nar/gkv385; MAINS RE, 1981, J BIOL CHEM, V256, P5683; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; MELDAL M, 1994, GLYCOCONJUGATE J, V11, P59, DOI 10.1007/BF00731144; Minond D, 2012, J BIOL CHEM, V287, P36473, DOI 10.1074/jbc.M112.389114; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Shirakabe K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46174; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stavenhagen K, 2013, J MASS SPECTROM, V48, P627, DOI [10.1002/jms.3189, 10.1002/jms.3210]; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tseng WL, 2014, J THROMB HAEMOST, V12, P2054, DOI 10.1111/jth.12736; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turowec JP, 2014, MOL CELL PROTEOMICS, V13, P1184, DOI 10.1074/mcp.M113.037374; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang L, 2015, HEPATOB PANCREAT DIS, V14, P361, DOI 10.1016/S1499-3872(15)60396-4; Wasser CR, 2017, J BIOL CHEM, V292, P1330, DOI 10.1074/jbc.R116.766782; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Wen W, 1999, CANCER RES, V59, P6052; Wigle TJ, 2010, CHEM BIOL, V17, P695, DOI 10.1016/j.chembiol.2010.04.014	81	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7629	7644		10.1074/jbc.RA118.001978	http://dx.doi.org/10.1074/jbc.RA118.001978			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29593093	Green Published, hybrid			2022-12-28	WOS:000437256500015
J	Cherian, MA; Olson, S; Sundaramoorthi, H; Cates, K; Cheng, XG; Harding, J; Martens, A; Challen, GA; Ratner, MTPL; Ratner, L; Rauch, D				Cherian, Mathew A.; Olson, Sydney; Sundaramoorthi, Hemalatha; Cates, Kitra; Cheng, Xiaogang; Harding, John; Martens, Andrew; Challen, Grant A.; Tyagi, Manoj; Ratner, Lee; Rauch, Daniel			An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon regulatory factor (IRF); retrovirus; chromatin immunoprecipitation (ChiP); NF-kappaB transcription factor; cancer biology; ATL; HTLV; driver mutation	VIRUS TYPE-I; CUTTING EDGE; CLONAL EXPANSION; GENE-EXPRESSION; NUCLEAR-FACTOR; LYMPHOMA; TRANSCRIPTION; INDUCTION; IL-2; HTLV	The human T-cell leukemia virus-1 (HTLV-1) oncoprotein Tax drives cell proliferation and resistance to apoptosis early in the pathogenesis of adult T-cell leukemia (ATL). Subsequently, probably as a result of specific immunoediting, Tax expression is down-regulated and functionally replaced by somatic driver mutations of the host genome. Both amplification and point mutations of interferon regulatory factor 4 (IRF4) have been previously detected in ATL., K59R is the most common single-nucleotide variation of IRF4 and is found exclusively in ATL. High-throughput whole-exome sequencing revealed recurrent activating genetic alterations in the T-cell receptor, CD28, and NF-B pathways. We found that IRF4, which is transcriptionally activated downstream of these pathways, is frequently mutated in ATL. IRF4 RNA, protein, and IRF4 transcriptional targets are uniformly elevated in HTLV-1-transformed cells and ATL cell lines, and IRF4 was bound to genomic regulatory DNA of many of these transcriptional targets in HTLV-1-transformed cell lines. We further noted that the K59R IRF4 mutant is expressed at higher levels in the nucleus than WT IRF4 and is transcriptionally more active. Expression of both WT and the K59R mutant of IRF4 from a constitutive promoter in retrovirally transduced murine bone marrow cells increased the abundance of T lymphocytes but not myeloid cells or B lymphocytes in mice. IRF4 may represent a therapeutic target in ATL because ATL cells select for a mutant of IRF4 with higher nuclear expression and transcriptional activity, and overexpression of IRF4 induces the expansion of T lymphocytes in vivo.	[Cherian, Mathew A.; Sundaramoorthi, Hemalatha; Cates, Kitra; Cheng, Xiaogang; Harding, John; Martens, Andrew; Challen, Grant A.; Ratner, Lee; Rauch, Daniel] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Olson, Sydney] Univ Wisconsin, Dept Biol, Madison, WI 53706 USA; [Tyagi, Manoj] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8069, St Louis, MO 63110 USA.	lratner@wustl.edu		Cates, Kitra/0000-0001-7716-153X; Cherian, Mathew/0000-0002-0380-2012; Ratner, Lee/0000-0003-2744-7294	NCI, National Institutes of Health (NIH), Cancer Center Support Grant [P30 CA91842]; ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of NIH [UL1 TR000448]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [R01CA063417, P01CA100730, P50CA094056, P30CA091842, K12CA167540] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH), Cancer Center Support Grant; ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Juan Carlos Ramos (University of Miami), Stefan Barta (Montefiore Hospital), and Ariela Noy (Memorial Sloan Kettering Hospital) for providing samples from ATL patients. We thank the McDonnell Genome Institute and the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The center is partially supported by NCI, National Institutes of Health (NIH), Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant UL1 TR000448 from the National Center for Research Resources (NCRR), a component of NIH and NIH Roadmap for Medical Research.	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Aldinucci D, 2011, BRIT J HAEMATOL, V152, P182, DOI 10.1111/j.1365-2141.2010.08497.x; Alizadeh AA, 2010, LEUKEMIA LYMPHOMA, V51, P1200, DOI 10.3109/10428191003728628; Asanuma S, 2013, CANCER SCI, V104, P1097, DOI 10.1111/cas.12181; Bae J, 2015, J LEUK, V3, P178, DOI DOI 10.4172/2329-6917.1000178; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Care MA, 2014, NUCLEIC ACIDS RES, V42, P7588, DOI 10.1093/nar/gku451; Chen J, 2008, BLOOD, V111, P5163, DOI 10.1182/blood-2007-09-113654; Cherian MA, 2015, J BIOL CHEM, V290, P26270, DOI 10.1074/jbc.M115.684746; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Davis AM, 2008, J IMMUNOL, V181, P8204, DOI 10.4049/jimmunol.181.12.8204; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Fabbri G, 2013, J EXP MED, V210, P2273, DOI 10.1084/jem.20131448; FARCET JP, 1991, CLIN EXP IMMUNOL, V84, P415; Forero A, 2013, J IMMUNOL, V191, P1476, DOI 10.4049/jimmunol.1202514; Fujii K, 2003, BRIT J HAEMATOL, V120, P986, DOI 10.1046/j.1365-2141.2003.04216.x; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Hasegawa H, 1996, BIOCHEM BIOPH RES CO, V222, P164, DOI 10.1006/bbrc.1996.0700; Havelange V, 2011, BLOOD, V118, P2827, DOI 10.1182/blood-2011-04-350579; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hu DY, 2017, CELL DEATH DIFFER, V24, P1007, DOI 10.1038/cdd.2017.38; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Ishida T, 2016, J CLIN ONCOL, V34, P4086, DOI 10.1200/JCO.2016.67.7732; Ishida T, 2015, BRIT J HAEMATOL, V169, P672, DOI 10.1111/bjh.13338; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; Isomoto H, 2001, J CLIN GASTROENTEROL, V33, P241, DOI 10.1097/00004836-200109000-00017; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Lavorgna A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004418; Lee CG, 2011, CELL IMMUNOL, V268, P97, DOI 10.1016/j.cellimm.2011.02.008; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Luptakova K, 2013, CANCER IMMUNOL IMMUN, V62, P39, DOI 10.1007/s00262-012-1308-3; Ma WL, 2014, CASE REP HEMATOL, V2014, DOI 10.1155/2014/917369; Mamane Y, 2005, J INTERF CYTOK RES, V25, P43, DOI 10.1089/jir.2005.25.43; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Mamane Y, 2002, ONCOGENE, V21, P6751, DOI 10.1038/sj.onc.1205843; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Melchor L, 2014, LEUKEMIA, V28, P1705, DOI 10.1038/leu.2014.13; Miyazaki M, 2007, J VIROL, V81, P5714, DOI 10.1128/JVI.02511-06; Morelli E, 2015, LEUKEMIA, V29, P2173, DOI 10.1038/leu.2015.124; Mori N, 1996, BLOOD, V88, P1035; Nakagawa M, 2014, J EXP MED, V211, P2497, DOI 10.1084/jem.20140987; Nosaka K, 2002, BLOOD, V99, P634, DOI 10.1182/blood.V99.2.634; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Ratner L, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.21; Remesh SG, 2015, J BIOL CHEM, V290, P27779, DOI 10.1074/jbc.M115.678789; Richard V, 2005, LEUKEMIA, V19, P1175, DOI 10.1038/sj.leu.2403787; Robek MD, 2000, J VIROL, V74, P11988, DOI 10.1128/JVI.74.24.11988-11992.2000; Salaverria I, 2011, BLOOD, V118, P139, DOI 10.1182/blood-2011-01-330795; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Shindo H, 2011, CYTOKINE, V56, P564, DOI 10.1016/j.cyto.2011.08.014; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sugio T, 2016, BIOL BLOOD MARROW TR, V22, P1608, DOI 10.1016/j.bbmt.2016.05.017; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Tamiya S, 1996, BLOOD, V88, P3065, DOI 10.1182/blood.V88.8.3065.bloodjournal8883065; Tamiya T, 2013, J IMMUNOL, V191, P2360, DOI 10.4049/jimmunol.1301276; Tamura K, 1996, Rinsho Byori, V44, P19; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64; TESHIMA T, 1990, CANCER, V65, P327, DOI 10.1002/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106788; Wang L, 2013, J VIROL, V87, P9672, DOI 10.1128/JVI.01435-13; Xu DS, 2011, J BIOL CHEM, V286, P18261, DOI 10.1074/jbc.M110.210542; Zhang LH, 2013, BRIT J HAEMATOL, V160, P487, DOI 10.1111/bjh.12172	81	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6844	6858		10.1074/jbc.RA117.000164	http://dx.doi.org/10.1074/jbc.RA117.000164			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29540473	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000431487300018
J	Campbell, GR; Bruckman, RS; Herns, SD; Joshi, S; Durden, DL; Spector, SA				Campbell, Grant R.; Bruckman, Rachel S.; Herns, Shayna D.; Joshi, Shweta; Durden, Donald L.; Spector, Stephen A.			Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; IMMUNODEFICIENCY-VIRUS TYPE-1; RAPAMYCIN INHIBITOR; CELL-DEATH; MAMMALIAN TARGET; TUMOR-GROWTH; PHASE-II; NVP-BEZ235; PI3K; APOPTOSIS	In this study, we investigated the effects of the dual phosphatidylinositol 3-kinase/mechanistic target of rapamycin (PI3K/MTOR) inhibitor dactolisib (NVP-BEZ235), the PI3K/MTOR/bromodomain-containing protein 4 (BRD4) inhibitor SF2523, and the bromodomain and extra terminal domain inhibitor JQ1 on the productive infection of primary macrophages with human immunodeficiency type-1 (HIV). These inhibitors did not alter the initial susceptibility of macrophages to HIV infection. However, dactolisib, JQ1, and SF2523 all decreased HIV replication in macrophages in a dose-dependent manner via degradation of intracellular HIV through autophagy. Macrophages treated with dactolisib, JQ1, or SF2523 displayed an increase in LC3B lipidation combined with SQSTM1 degradation without inducing increased cell death. LC3B-II levels were further increased in the presence of pepstatin A suggesting that these inhibitors induce autophagic flux. RNA interference for ATG5 and ATG7 and pharmacological inhibitors of autophagosome- lysosome fusion and of lysosomal hydrolases all blocked the inhibition of HIV. Thus, we demonstrate that the mechanism of PI3K/MTOR and PI3K/MTOR/BRD4 inhibitor suppression of HIV requires the formation of autophagosomes, as well as their subsequent maturation into autolysosomes. These data provide further evidence in support of a role for autophagy in the control of HIV infection and open new avenues for the use of this class of drugs in HIV therapy.	[Campbell, Grant R.; Bruckman, Rachel S.; Herns, Shayna D.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Joshi, Shweta; Durden, Donald L.] Univ Calif San Diego, Dept Pediat, Div Pediat Hematol Oncol, La Jolla, CA 92093 USA; [Joshi, Shweta; Durden, Donald L.; Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Durden, Donald L.] SignalRx Pharmaceut Inc, San Diego, CA 92130 USA; [Bruckman, Rachel S.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Chicago Medical School; Rosalind Franklin University Medical & Science	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health Awards from NIAID [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver NICHD; Eunice Kennedy Shriver NIMH; NATIONAL CANCER INSTITUTE [R42CA192656, R01CA172513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069536, UM1AI106716, UM1AI068632, UM1AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS104015, R01NS084912] Funding Source: NIH RePORTER	National Institutes of Health Awards from NIAID; Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver NIMH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network was provided by the National Institutes of Health Awards UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), and UM1AI106716 (IMPAACT LC) from NIAID, with co-funding from the Eunice Kennedy Shriver NICHD and the NIMH.	Andrews FH, 2017, P NATL ACAD SCI USA, V114, pE1072, DOI 10.1073/pnas.1613091114; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bendell JC, 2015, INVEST NEW DRUG, V33, P187, DOI 10.1007/s10637-014-0177-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borel S, 2015, AIDS, V29, P275, DOI 10.1097/QAD.0000000000000554; Button RW, 2016, ONCOTARGET, V7, P5157, DOI 10.18632/oncotarget.6986; Calcagno A, 2014, CLIN PHARMACOKINET, V53, P891, DOI 10.1007/s40262-014-0171-0; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005018; Campbell GR, 2015, J BIOL CHEM, V290, P5028, DOI 10.1074/jbc.M114.605428; Campbell GR, 2011, AIDS RES HUM RETROV, V27, P647, DOI [10.1089/aid.2010.0192, 10.1089/AID.2010.0192]; Campbell GR, 2013, CURR OPIN MICROBIOL, V16, P349, DOI 10.1016/j.mib.2013.05.006; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003017; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Herrero-Sanchez MC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0343-5; Cerniglia GJ, 2012, MOL PHARMACOL, V82, P1230, DOI 10.1124/mol.112.080408; Chang ZX, 2013, INT J MOL MED, V31, P1449, DOI 10.3892/ijmm.2013.1351; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Donia M, 2010, BRIT J CLIN PHARMACO, V70, P784, DOI 10.1111/j.1365-2125.2010.03735.x; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Fazio N, 2016, ANTICANCER RES, V36, P713; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Frankfurt OS, 2001, J IMMUNOL METHODS, V253, P133, DOI 10.1016/S0022-1759(01)00387-8; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gomez-Mora E, 2017, JAIDS-J ACQ IMM DEF, V74, P201, DOI 10.1097/QAI.0000000000001201; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ji YH, 2015, CLIN LAB, V61, P1043, DOI 10.7754/Clin.Lab.2015.150144; Joshi S, 2014, MOL CANCER RES, V12, P1520, DOI 10.1158/1541-7786.MCR-13-0682; Kandathil AJ, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0323-4; Karn J, 2013, CELL CYCLE, V12, P545, DOI 10.4161/cc.23679; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuger S, 2014, BREAST CANCER-BASIC, V8, P39, DOI 10.4137/BCBCR.S13693; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; Lu PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep24100; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morales GA, 2013, J MED CHEM, V56, P1922, DOI 10.1021/jm301522m; Nardacci R, 2014, AUTOPHAGY, V10, P1167, DOI 10.4161/auto.28678; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popovic M., 1988, RETROVIRUSES HUMAN A, P21; Rahmani M, 2013, CANCER RES, V73, P1340, DOI 10.1158/0008-5472.CAN-12-1365; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Seront E, 2016, BJU INT, V118, P408, DOI 10.1111/bju.13415; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Singh A, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-2142; Smallwood HS, 2017, CELL REP, V19, P1640, DOI 10.1016/j.celrep.2017.04.039; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Urata S, 2012, J VIROL, V86, P4578, DOI 10.1128/JVI.06604-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wise-Draper TM, 2017, TARGET ONCOL, V12, P323, DOI 10.1007/s11523-017-0482-9; Yang XY, 2016, ONCOL LETT, V12, P102, DOI 10.3892/ol.2016.4590; Yu XL, 2015, AUTOPHAGY, V11, P1711, DOI 10.1080/15548627.2015.1043076; Yu Y, 2016, INT J ONCOL, V49, P285, DOI 10.3892/ijo.2016.3507; Zheng YH, 2012, J MOL MED, V90, P695, DOI 10.1007/s00109-011-0849-9; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	78	37	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5808	5820		10.1074/jbc.RA118.002353	http://dx.doi.org/10.1074/jbc.RA118.002353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29475942	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000430497300006
J	Montgomery, NT; Zientek, KD; Pokidysheva, EN; Bachinger, HP				Montgomery, Nathan T.; Zientek, Keith D.; Pokidysheva, Elena N.; Bachinger, Hans Peter			Post-translational modification of type IV collagen with 3-hydroxyproline affects its interactions with glycoprotein VI and nidogens 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; PROLYL 3-HYDROXYLASE; HIGH MYOPIA; OSTEOGENESIS IMPERFECTA; INHIBITORY RECEPTOR; STRUCTURAL BASIS; 4-HYDROXYLASE; MUTATIONS; PROTEIN; ENZYME	Type IV collagen is a major component of the basement membrane and interacts with numerous other basement membrane proteins. Many of these interactions are poorly characterized. Type IV collagen is abundantly post-translationally modified with 3-hydroxyproline (3-Hyp), but 3-Hyp's biochemical role in type IV collagen's interactions with other proteins is not well established. In this work, we present binding data consistent with a major role of 3-Hyp in interactions of collagen IV with glycoprotein VI and nidogens 1 and 2. The increased binding interaction between type IV collagen without 3-Hyp and glycoprotein VI has been the subject of some controversy, which we sought to explore, whereas the lack of binding of nidogens to type IV collagen without 3-Hyp is novel. Using tandem MS, we show that the putative glycoprotein VI-binding site is 3-Hypmodified in WT PFHR-9 type IV collagen, but not in PFHR-9 cells in which prolyl-3-hydroxylase 2 (P3H2) has been knocked out (KO). Moreover, we observed altered 3-Hyp occupancy across many other sites. Using amino acid analysis of type IV collagen from the WT and P3H2 KO cell lines, we confirm that P3H2 is the major, but not the only 3-Hyp-modifying enzyme of type IV collagen. These findings underscore the importance of post-translational modifications of type IV collagen for interactions with other proteins.	[Montgomery, Nathan T.; Zientek, Keith D.; Bachinger, Hans Peter] Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Montgomery, Nathan T.; Bachinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Pokidysheva, Elena N.] Vanderbilt Univ, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA	Oregon Health & Science University; Vanderbilt University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org			Shriners Hospital for Children [85100, 85500]	Shriners Hospital for Children	This work was supported by Shriners Hospital for Children Grants 85100 and 85500 (to H. P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aro E, 2015, J BIOL CHEM, V290, P16964, DOI 10.1074/jbc.M115.662635; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Basak T, 2016, J PROTEOME RES, V15, P245, DOI 10.1021/acs.jproteome.5b00767; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Guo H, 2015, GENET MED, V17, P300, DOI 10.1038/gim.2015.28; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Kang SH, 2000, MOL BIOL CELL, V11, P3911, DOI 10.1091/mbc.11.11.3911; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kurban G, 2008, ONCOGENE, V27, P1004, DOI 10.1038/sj.onc.1210709; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; SCHUPPAN D, 1984, BIOCHEM J, V220, P227, DOI 10.1042/bj2200227; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; TRYGGVASON K, 1977, BIOCHEM BIOPH RES CO, V76, P275, DOI 10.1016/0006-291X(77)90722-7; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Watkins NA, 2006, J THROMB HAEMOST, V4, P1197, DOI 10.1111/j.1538-7836.2006.01937.x; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Zahid M, 2012, J THROMB HAEMOST, V10, P2418, DOI 10.1111/jth.12009	40	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5987	5999		10.1074/jbc.RA117.000406	http://dx.doi.org/10.1074/jbc.RA117.000406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491144	hybrid, Green Published			2022-12-28	WOS:000430497300019
J	Park, KT; Dajkovic, A; Wissel, M; Du, SS; Lutkenhaus, J				Park, Kyung-Tae; Dajkovic, Alex; Wissel, Mark; Du, Shishen; Lutkenhaus, Joe			MinC and FtsZ mutant analysis provides insight into MinC/MinD-mediated Z ring disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION-INHIBITION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; SPATIAL REGULATION; SITE; POLYMERIZATION; LOCALIZATION; PROTEINS; SYSTEM	The Min system negatively regulates the position of the Z ring, which serves as a scaffold for the divisome that mediates bacterial cytokinesis. In Escherichia coli, this system consists of MinC, which antagonizes assembly of the tubulin homologue FtsZ. MinC is recruited to the membrane by MinD and induced by MinE to oscillate between the cell poles. MinC is a dimer with each monomer consisting of functionally distinct MinC(N) and MinC(C) domains, both of which contact FtsZ. According to one model, MinC(C)/MinD binding to the FtsZ tail positionsMinC(N) at the junction of two GDP-containing subunits in the filament, leading to filament breakage. Others posit that MinC sequesters FtsZ-GDP monomers or that MinC(N) caps the minus end of FtsZ polymers and that MinC(C) interferes with lateral interactions between FtsZ filaments. Here, we isolated minC mutations that impair MinC(N)function and analyzed FtsZ mutants resistant to MinC/MinD. Surprisingly, we found mutations in both minC and ftsZ that differentiate inhibition by MinC from inhibition by MinC/MinD. Analysis of these mutations suggests that inhibition of the Z ring by MinC alone is due to sequestration, whereas inhibition by MinC/MinD is not. In conclusion, our genetic and biochemical data support the model that MinC/MinD fragments FtsZ filaments	[Park, Kyung-Tae; Dajkovic, Alex; Wissel, Mark; Du, Shishen; Lutkenhaus, Joe] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Lutkenhaus, J (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.; Dajkovic, A (corresponding author), Biomillenia, 6 Rue Jean Calvin, F-75005 Paris, France.; Wissel, M (corresponding author), Viracor Eurofins Clin Diagnost, 951 NW Technol Dr, Lees Summit, MO 64086 USA.	alexdajkovic@gmail.com; MarkWissel@viracor-eurofins.com; jlutkenh@kumc.edu		Du, Shishen/0000-0002-9809-8653	National Institutes of Health [GM29764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM29764 (to J.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An JY, 2013, J SYNCHROTRON RADIAT, V20, P984, DOI 10.1107/S0909049513022760; Arumugam S, 2014, P NATL ACAD SCI USA, V111, pE1192, DOI 10.1073/pnas.1317764111; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bisson AW, 2015, P NATL ACAD SCI USA, V112, pE2130, DOI 10.1073/pnas.1414242112; Cho H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003304; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Fujita J, 2017, J STRUCT BIOL, V198, P65, DOI 10.1016/j.jsb.2017.04.008; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Johnson JE, 2004, J BACTERIOL, V186, P2418, DOI 10.1128/JB.186.8.2418-2429.2004; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lutkenhaus J, 2017, SUBCELL BIOCHEM, V84, P27, DOI 10.1007/978-3-319-53047-5_2; MAGUIN E, 1986, J BACTERIOL, V166, P733, DOI 10.1128/jb.166.3.733-738.1986; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; MULDER E, 1992, J BACTERIOL, V174, P35, DOI 10.1128/jb.174.1.35-39.1992; Park KT, 2015, MOL MICROBIOL, V98, P895, DOI 10.1111/mmi.13164; Pichoff S, 2001, J BACTERIOL, V183, P6630, DOI 10.1128/JB.183.22.6630-6635.2001; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P4988, DOI 10.1073/pnas.1602327113; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005	43	11	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5834	5846		10.1074/jbc.M117.815894	http://dx.doi.org/10.1074/jbc.M117.815894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29414773	Green Published, hybrid			2022-12-28	WOS:000430497300008
J	Jones, RB; Dorsett, KA; Hjelmeland, AB; Bellis, SL				Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.			The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 alpha signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTORS; PROMOTES CHEMORESISTANCE; TRANSCRIPTION FACTORS; CANCER CELLS; STEM-CELLS; EXPRESSION; HIF-1; GLYCOSYLATION; SIALYLATION	Aberrant cell surface glycosylation is prevalent in tumor cells, and there is ample evidence that glycans have functional roles in carcinogenesis. Nonetheless, many molecular details remain unclear. Tumor cells frequently exhibit increased alpha 2-6 sialylation on N-glycans, a modification that is added by the ST6Gal-I sialyltransferase, and emerging evidence suggests that ST6Gal-I-mediated sialylation promotes the survival of tumor cells exposed to various cell stressors. Here we report that ST6Gal-I protects cancer cells from hypoxic stress. It is well known that hypoxia-inducible factor 1 alpha (HIF-1 alpha) is stabilized in hypoxic cells, and, in turn, HIF-1 alpha directs the transcription of genes important for cell survival. To investigate a putative role for ST6Gal-I in the hypoxic response, we examined HIF-1 alpha accumulation in ovarian and pancreatic cancer cells in ST6Gal-I overexpression or knockdown experiments. We found that ST6Gal-I activity augmented HIF-1 alpha accumulation in cells grown in a hypoxic environment or treated with two chemical hypoxia mimetics, deferoxamine and dimethyloxalylglycine. Correspondingly, hypoxic cells with high ST6Gal-I expression had increased mRNA levels of HIF-1 alpha transcriptional targets, including the glucose transporter genes GLUT1 and GLUT3 and the glycolytic enzyme gene PDHK1. Interestingly, high ST6Gal-I-expressing cells also had an increased pool of HIF-1 alpha mRNA, suggesting that ST6Gal-I may influence HIF-1 alpha expression. Finally, cells grown in hypoxia for several weeks displayed enriched ST6Gal-I expression, consistent with a pro-survival function. Taken together, these findings unravel a glycosylation-dependent mechanism that facilitates tumor cell adaptation to a hypoxic milieu.	[Jones, Robert B.; Dorsett, Kaitlyn A.; Hjelmeland, Anita B.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,350 MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu			University of Alabama at Birmingham Flow Cytometry Core Facility [P30AR048311, P30AI027767]; National Institutes of Health [R01 GM111093]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111, R01GM111093] Funding Source: NIH RePORTER	University of Alabama at Birmingham Flow Cytometry Core Facility; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Alabama at Birmingham Flow Cytometry Core Facility (P30AR048311 and P30AI027767) for assistance.; This work was supported by National Institutes of Health Grant R01 GM111093 (to S. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Chakraborty A, 2018, J BIOL CHEM, V293, P984, DOI 10.1074/jbc.M117.808584; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dhani N, 2015, SEMIN NUCL MED, V45, P110, DOI 10.1053/j.semnuclmed.2014.11.002; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Jiang BH, 1997, CANCER RES, V57, P5328; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li S, 2015, CANCER BIOL THER, V16, P866, DOI 10.1080/15384047.2015.1040958; Lim CS, 2012, J VASC SURG, V55, P1427, DOI 10.1016/j.jvs.2011.10.111; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Munkley J, 2016, ONCOTARGET, V7, P35478, DOI 10.18632/oncotarget.8155; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Qin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09244-8; Recchi MA, 1998, CANCER RES, V58, P4066; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Sowa T, 2017, CANCER MED-US, V6, P288, DOI 10.1002/cam4.991; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	65	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5659	5667		10.1074/jbc.RA117.001194	http://dx.doi.org/10.1074/jbc.RA117.001194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475939	hybrid, Green Published			2022-12-28	WOS:000430044100026
J	Mercer, TJ; Gubas, A; Tooze, SA				Mercer, Thomas J.; Gubas, Andrea; Tooze, Sharon A.			A molecular perspective of mammalian autophagosome biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BECLIN 1; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; ULK1 COMPLEX; KINASE ULK1; ULK1-MEDIATED PHOSPHORYLATION; REGULATES AUTOPHAGY; INHIBITS AUTOPHAGY; PROMOTES AUTOPHAGY; VPS34 COMPLEXES; NUTRIENT STRESS	Autophagy is a highly conserved process and is essential for the maintenance of cellular homeostasis. Autophagy occurs at a basal level in all cells, but it can be up-regulated during stress, starvation, or infection. Misregulation of autophagy has been linked to various disorders, including cancer, neurodegeneration, and immune diseases. Here, we discuss the essential proteins acting in the formation of an autophagosome, with a focus on the ULK and VPS34 kinase complexes, phosphatidylinositol 3-phosphate effector proteins, and the transmembrane autophagy-related protein ATG9. The function and regulation of these and other autophagy-related proteins acting during formation will be addressed, in particular during amino acid starvation.	[Mercer, Thomas J.; Gubas, Andrea; Tooze, Sharon A.] Francis Crick Inst, Mol Cell Biol Autophagy Lab, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute	Tooze, SA (corresponding author), Francis Crick Inst, Mol Cell Biol Autophagy Lab, 1 Midland Rd, London NW1 1AT, England.	sharon.tooze@crick.ac.uk		Tooze, Sharon/0000-0002-2182-3116	Francis Crick Institute from Cancer Research UK [FC001187]; UK Medical Research Council Grant [FC001187]; Wellcome Trust Grant [FC001187]; Cancer Research UK [15153] Funding Source: researchfish; The Francis Crick Institute [10187] Funding Source: researchfish	Francis Crick Institute from Cancer Research UK; UK Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Grant(Wellcome Trust); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (Grant FC001187), the UK Medical Research Council Grant FC001187, and Wellcome Trust Grant FC001187 (to the S. A. T. laboratory). This is the first article in the Thematic Minireview series "Autophagy." The authors declare that they have no conflicts of interest with the contents of this article.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027; Antonioli M, 2014, DEV CELL, V31, P734, DOI 10.1016/j.devcel.2014.11.013; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bakula D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15637; Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chen S, 2016, GENE DEV, V30, P856, DOI 10.1101/gad.276428.115; Chen YD, 2017, J MOL BIOL, V429, P142, DOI 10.1016/j.jmb.2016.11.009; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dite TA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00628-y; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Dunlop EA, 2014, AUTOPHAGY, V10, P1749, DOI 10.4161/auto.29640; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fujiwara N, 2016, J BIOL CHEM, V291, P10858, DOI 10.1074/jbc.M115.704908; Gan WJ, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-017-0138-8; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gaugel Anja, 2012, J Mol Signal, V7, P16, DOI 10.1186/1750-2187-7-16; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haack TB, 2013, INT REV NEUROBIOL, V110, P85, DOI 10.1016/B978-0-12-410502-7.00005-3; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Hieke N, 2015, AUTOPHAGY, V11, P1471, DOI 10.1080/15548627.2015.1068488; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jiao H, 2015, CELL DEATH DIFFER, V22, P1812, DOI [10.1038/cdd.2015.34, 10.1038/xyza.2015.34]; Joachim J, 2015, MOL CELL, V60, P899, DOI 10.1016/j.molcel.2015.11.018; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Jung J, 2017, ELIFE, V6, DOI [10.7554/eLife.23063, 10.75554/eLife.23063]; Karanasios E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12420; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim YM, 2015, MOL CELL, V57, P207, DOI 10.1016/j.molcel.2014.11.013; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Lazarus MB, 2015, ACS CHEM BIOL, V10, P257, DOI 10.1021/cb500835z; Li J, 2015, AUTOPHAGY, V11, P1216, DOI 10.1080/15548627.2015.1017180; Li R, 2017, J BIOL CHEM, V292, P2830, DOI 10.1074/jbc.M116.762443; Li TY, 2016, MOL CELL, V62, P359, DOI 10.1016/j.molcel.2016.04.009; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu CC, 2016, MOL CELL, V61, P84, DOI 10.1016/j.molcel.2015.11.001; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4920; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Ma BY, 2014, CELL RES, V24, P912, DOI 10.1038/cr.2014.84; Ma X, 2017, AUTOPHAGY, V13, P592, DOI 10.1080/15548627.2016.1269988; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Munson MJ, 2015, EMBO J, V34, P2272, DOI 10.15252/embj.201590992; Nazio F, 2016, J CELL BIOL, V215, P841, DOI 10.1083/jcb.201605089; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Ohashi Y, 2016, AUTOPHAGY, V12, P2129, DOI 10.1080/15548627.2016.1226736; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Panaretou C, 1997, J BIOL CHEM, V272, P2477; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Pengo N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00303-2; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Puente C, 2016, J BIOL CHEM, V291, P6026, DOI 10.1074/jbc.M115.689646; Rajesh S, 2011, J BIOL CHEM, V286, P39606, DOI 10.1074/jbc.M111.262402; Ro SH, 2014, FEBS J, V281, P3816, DOI 10.1111/febs.12905; Ro SH, 2013, AUTOPHAGY, V9, P2103, DOI 10.4161/auto.26563; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Tabora LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166499; Tan XJ, 2016, P NATL ACAD SCI USA, V113, P10896, DOI 10.1073/pnas.1523145113; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Torii S, 2016, EMBO REP, V17, P1552, DOI 10.15252/embr.201642565; Ugolino J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006443; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang J, 2016, AUTOPHAGY, V12, P1791, DOI 10.1080/15548627.2016.1203483; Webster CP, 2016, EMBO J, V35, P1656, DOI 10.15252/embj.201694401; Wei YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05289; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Xu DQ, 2016, EMBO J, V35, P496, DOI 10.15252/embj.201592864; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yang M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601167; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Young LN, 2016, P NATL ACAD SCI USA, V113, P8224, DOI 10.1073/pnas.1603650113; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang DY, 2016, AUTOPHAGY, V12, P1447, DOI 10.1080/15548627.2016.1185576; Zhao YW, 2015, CELL REP, V13, P1407, DOI 10.1016/j.celrep.2015.10.011; Zhong Y, 2014, J BIOL CHEM, V289, P26021, DOI 10.1074/jbc.M114.561134; Zhou CQ, 2017, CELL RES, V27, P184, DOI 10.1038/cr.2016.146; Zhou XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016358	128	148	151	6	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5386	5395		10.1074/jbc.R117.810366	http://dx.doi.org/10.1074/jbc.R117.810366			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29371398	Green Published, hybrid			2022-12-28	WOS:000430044100003
J	Tamura, I; Jozaki, K; Sato, S; Shirafuta, Y; Shinagawa, M; Maekawa, R; Taketani, T; Asada, H; Tamura, H; Sugino, N				Tamura, Isao; Jozaki, Kosuke; Sato, Shun; Shirafuta, Yuichiro; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Tamura, Hiroshi; Sugino, Norihiro			The distal upstream region of insulin-like growth factor-binding protein-1 enhances its expression in endometrial stromal cells during decidualization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocrinology; epigenetics; histone acetylation; CCAAT-enhancer-binding protein (C; EBP); cyclic AMP (cAMP)	HISTONE ACETYLATION STATUS; MANGANESE SUPEROXIDE-DISMUTASE; C/EBP-BETA; PROGESTERONE-RECEPTOR; FORKHEAD TRANSCRIPTION; PROMOTER REGION; HUMAN GENOME; DISTINCT FUNCTIONS; DNA METHYLATION; GRANULOSA-CELLS	We have previously shown that decidualization of human endometrial stromal cells (ESCs) causes a genome-wide increase in the levels of acetylation of histone-H3 Lys-27 (H3K27ac). We also reported that the distal gene regions, more than 3 kb up- or downstream of gene transcription start sites have increased H3K27ac levels. Insulin-like growth factor-binding protein-1 (IGFBP-1) is a specific decidualization marker and has increased H3K27ac levels in its distal upstream region (-4701 to -7501 bp). Here, using a luciferase reporter gene construct containing this IGFBP-1 upstream region, we tested the hypothesis that it is an IGFBP-1 enhancer. To induce decidualization, we incubated ESCs with cAMP and found that cAMP increased luciferase expression, indicating that decidualization increased the transcriptional activity from the IGFBP-1 upstream region. Furthermore, CRISPR/Cas9-mediated deletion of this region in HepG2 cells significantly reduced IGFBP-1 expression, confirming its role as an IGFBP-1 enhancer. A ChIP assay revealed that cAMP increased the recruitment of the transcriptional regulators CCAAT enhancer-binding protein (C/EBP), forkhead box O1 (FOXO1), and p300 to the IGFBP-1 enhancer in ESCs. Of note, C/EBP knockdown inhibited the stimulatory effects of cAMP on the levels of H3K27ac, chromatin opening, and p300 recruitment at the IGFBP-1 enhancer. These results indicate that the region -4701 to -7501 bp upstream of IGFBP-1 functions as an enhancer for IGFBP-1 expression in ESCs undergoing decidualization, that C/EBP and FOXO1 bind to the enhancer region to up-regulate IGFBP-1 expression, and that C/EBP induces H3K27ac by recruiting p300 to the IGFBP-1 enhancer.	[Tamura, Isao; Jozaki, Kosuke; Sato, Shun; Shirafuta, Yuichiro; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan	Yamaguchi University	Sugino, N (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	sugino@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Japan Society for the Promotion of Science KAKENHI [15K10720, 15K20146, 16K11091, 16K11142, 16K20191, 16K20194, 17K11240, 17K11239]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 15K10720, 15K20146, 16K11091, 16K11142, 16K20191, 16K20194, 17K11240, and 17K11239. The authors declare that they have no conflicts of interest with the contents of this article.	Aghajanova L, 2010, ENDOCRINOLOGY, V151, P1341, DOI 10.1210/en.2009-0923; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Gao JG, 1999, MOL CELL ENDOCRINOL, V153, P11, DOI 10.1016/S0303-7207(99)00096-9; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Hatta M, 2009, BIOCHEM BIOPH RES CO, V379, P1005, DOI 10.1016/j.bbrc.2009.01.014; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Qiu X, 2008, J BIOL CHEM, V283, P25774, DOI 10.1074/jbc.M801178200; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Yalley A, 2016, J BIOL CHEM, V291, P8848, DOI 10.1074/jbc.M115.677583; Zhang Qian, 2016, Reproductive Medicine and Biology, V15, P95, DOI 10.1007/s12522-015-0226-4; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	45	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5270	5280		10.1074/jbc.RA117.000234	http://dx.doi.org/10.1074/jbc.RA117.000234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453285	Green Published, hybrid			2022-12-28	WOS:000429409300031
J	Pagani, G; Pereira, JPV; Stoldt, VR; Beck, A; Scharf, RE; Gohlke, H				Pagani, Giulia; Pereira, Joana P. V.; Stoldt, Volker R.; Beck, Andreas; Scharf, Ruediger E.; Gohlke, Holger			The human platelet antigen-1b (Pro(33)) variant of alpha(IIb)beta(3) allosterically shifts the dynamic conformational equilibrium of this integrin toward the active state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHERITED RISK-FACTOR; MOLECULAR-DYNAMICS; OUTSIDE-IN; STRUCTURAL BASIS; MYOCARDIAL-INFARCTION; FORCE-FIELDS; SIDE-CHAIN; PSI DOMAIN; ACTIVATION; POLYMORPHISM	Integrins are heterodimeric cell-adhesion receptors comprising alpha and beta subunits that transmit signals allosterically in both directions across the membrane by binding to intra- and extracellular components. The human platelet antigen-1 (HPA-1) polymorphism in alpha(IIb)beta(3) arises from a Leu -> Pro exchange at residue 33 in the genu of the beta(3) subunit, resulting in Leu(33) (HPA-1a) or Pro(33) (HPA-1b) isoforms. Although clinical investigations have provided conflicting results, some studies have suggested that Pro(33) platelets exhibit increased thrombogenicity. Under flow-dynamic conditions, the Pro(33) variant displays prothrombotic properties, characterized by increased platelet adhesion, aggregate/thrombus formation, and outside-in signaling. However, the molecular events underlying this prothrombotic phenotype have remained elusive. As residue 33 is located > 80 angstrom away from extracellular binding sites or transmembrane domains, we hypothesized that the Leu -> Pro exchange allosterically shifts the dynamic conformational equilibrium of alpha(IIb)beta(3) toward an active state. Multiple microsecondlong, all-atom molecular dynamics simulations of the ectodomain of the Leu(33) and Pro(33) isoforms provided evidence that the Leu -> Pro exchange weakens interdomain interactions at the genu and alters the structural dynamics of the integrin to a more unbent and splayed state. Using FRET analysis of fluorescent proteins fused with alpha(IIb)beta(3) in transfected HEK293 cells, we found that the Pro33 variant in its resting state displays a lower energy transfer than the Leu(33) isoform. This finding indicated a larger spatial separation of the cytoplasmic tails in the Pro(33) variant. Together, our results indicate that the Leu -> Pro exchange allosterically shifts the dynamic conformational equi-librium of alpha(IIb)beta(3) to a structural state closer to the active one, promoting the fully active state and fostering the prothrombotic phenotype of Pro(33) platelets.	[Pagani, Giulia; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany; [Beck, Andreas] Heinrich Heine Univ Dusseldorf, Inst Informat, D-40225 Dusseldorf, Germany; [Scharf, Ruediger E.] Heinrich Heine Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.; Scharf, Ruediger E.] Heinrich Heine Univ, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, Div Expt & Clin Hemostasis Hemotherapy & Transfus, D-40225 Dusseldorf, Germany; [Gohlke, Holger] Forschungszentrum Julich, JSC, John von Neumann Inst Comp NIC, D-52425 Julich, Germany; [Gohlke, Holger] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, D-52425 Julich, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.] Heinrich Heine Univ, Med Ctr, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Pereira, Joana P. V.; Stoldt, Volker R.] Heinrich Heine Univ, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	Portugal-Pereira, Joana/ABF-1654-2020	Portugal-Pereira, Joana/0000-0003-1260-6950	Julich Supercomputing Center (JSC) [6710, 8348, 10307]	Julich Supercomputing Center (JSC)	We are grateful for computational support and infrastructure provided by the Zentrum fur Informations und Medientechnologie (ZIM) at the Heinrich Heine University Dusseldorf and the computing time provided by the John von Neumann Institute for Computing (NIC) to H. G. on the supercomputers JUROPA and JURECA at Julich Supercomputing Center (JSC) (Projects 6710, 8348, and 10307; user, HDD11). We thank Dr. Rainer B. Zotz and Beate Maruhn-Dembowski for genotyping HPA-1 of alpha<INF>IIb</INF>beta<INF>3</INF> and alpha<INF>2</INF>C807T of alpha<INF>2</INF>beta<INF>1</INF>. The assistance of Bianca Maassen-Weingart and Jan Peveling-Oberhag in the platelet experiments is also gratefully acknowledged. The FRET measurements were performed at the Center of Advanced Imaging at Heinrich Heine University Dusseldorf. We thank Dr. Stefanie Weidtkamp-Peters for scientific assistance.	Abraham DG, 1997, MOL PHARMACOL, V52, P227, DOI 10.1124/mol.52.2.227; [Anonymous], 2010, R LANG ENV STAT COMP; AQVIST J, 1992, J MOL STRUC-THEOCHEM, V88, P135, DOI 10.1016/0166-1280(92)87163-T; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; Aurich V., 2002, BILDVERARBEITUNG MED, P389; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Chodera JD, 2016, J CHEM THEORY COMPUT, V12, P1799, DOI 10.1021/acs.jctc.5b00784; Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Donner L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6240; El Khattouti A, 2010, BLOOD, V116, P843; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Gohlke H, 2013, HEPATOLOGY, V57, P1117, DOI 10.1002/hep.25992; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hermans M. A., 2017, REV COMPUT MOL SCI, V7, pe1311; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jallu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047304; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kelley C., 2011, GNUPLOT 4 5 INTERACT; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Loncar R., 2007, THROMB J, DOI [10.1186/1477-9560-1185-1182, DOI 10.1186/1477-9560-1185-1182]; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mould AP, 1996, J CELL SCI, V109, P2613; Perez A, 2015, J CHEM THEORY COMPUT, V11, P4770, DOI 10.1021/acs.jctc.5b00662; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Reinehr R, 2010, J BIOL CHEM, V285, P29348, DOI 10.1074/jbc.M110.155135; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Savage B., 2013, HEMOSTASIS THROMBOSI, P400; Scharf R. E., 2009, 22 C INT SOC THORMB; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stoldt VR, 2005, BLOOD, V106, p70B; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Thorpe M., 1996, CONDENSED MATTER THE, V11, P407; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Vijayan KV, 2005, J BIOL CHEM, V280, P21756, DOI 10.1074/jbc.M500872200; Watson S. P., 2013, HAEMOSTASIS THROMBOS, P420; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Whiteley W, 2005, PHYS BIOL, V2, pS116, DOI 10.1088/1478-3975/2/4/S06; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zotz RB, 2005, J THROMB HAEMOST, V3, P1522, DOI 10.1111/j.1538-7836.2005.01432.x; Zotz RB, 1998, THROMB HAEMOSTASIS, V79, P731, DOI 10.1055/s-0037-1615054; Zotz RB, 2000, THROMB HAEMOSTASIS, V83, P404	80	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4830	4844		10.1074/jbc.RA118.002149	http://dx.doi.org/10.1074/jbc.RA118.002149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462793	hybrid, Green Published			2022-12-28	WOS:000428848300023
J	Lloyd-Lewis, B; Krueger, CC; Sargeant, TJ; D'Angelo, ME; Deery, MJ; Feret, R; Howard, JA; Lilley, KS; Watson, CJ				Lloyd-Lewis, Bethan; Krueger, Caroline C.; Sargeant, Timothy J.; D'Angelo, Michael E.; Deery, Michael J.; Feret, Renata; Howard, Julie A.; Lilley, Kathryn S.; Watson, Christine J.			Stat3-mediated alterations in lysosomal membrane protein composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MASS-SPECTROMETRY; FUNCTIONAL-CHARACTERIZATION; LATE ENDOSOMES; NPC2 PROTEIN; IN-VIVO; IDENTIFICATION; TRANSPORTER; ACID; TRAFFICKING	Lysosome function is essential in cellular homeostasis. In addition to its recycling role, the lysosome has recently been recognized as a cellular signaling hub. We have shown in mammary epithelial cells, both in vivo and in vitro, that signal transducer and activator of transcription 3 (Stat3) modulates lysosome biogenesis and can promote the release of lysosomal proteases that culminates in cell death. To further investigate the impact of Stat3 on lysosomal function, we conducted a proteomic screen of changes in lysosomal membrane protein components induced by Stat3 using an iron nanoparticle enrichment strategy. Our results show that Stat3 activation not only elevates the levels of known membrane proteins but results in the appearance of unexpected factors, including cell surface proteins such as annexins and flotillins. These data suggest that Stat3 may coordinately regulate endocytosis, intracellular trafficking, and lysosome biogenesis to drive lysosome-mediated cell death in mammary epithelial cells. The methodologies described in this study also provide significant improvements to current techniques used for the purification and analysis of the lysosomal proteome.	[Lloyd-Lewis, Bethan; Krueger, Caroline C.; D'Angelo, Michael E.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Sargeant, Timothy J.] South Australian Hlth & Med Res Inst, Lysosomal Dis Res Unit, Adelaide, SA 5000, Australia; [Deery, Michael J.; Feret, Renata; Howard, Julie A.; Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge Ctr Prote, Tennis Court Rd, Cambridge CB2 1QR, England; [Krueger, Caroline C.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Immunol,Univ Clin Rheumatol Immunol & Allerg, CH-3010 Bern, Switzerland	University of Cambridge; South Australian Health & Medical Research Institute (SAHMRI); University of Cambridge; University of Bern; University Hospital of Bern	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.; Lloyd-Lewis, B (corresponding author), Inst Curie, Dept Genet & Dev Biol, Paris 05, France.	bethan.lloyd-lewis@curie.fr; cjw53@cam.ac.uk	Lilley, Kathryn/ABF-5787-2020; watson, Christine J/B-1431-2012; Sargeant, Timothy/K-8144-2018	Lilley, Kathryn/0000-0003-0594-6543; Sargeant, Timothy/0000-0003-1254-4390; Kruger, Caroline/0000-0002-2889-526X; Lloyd-Lewis, Bethan/0000-0001-6511-1818; D'Angelo, Michael/0000-0001-9342-0132	Medical Research Council [MR/J001023/1]; MRC [MR/J001023/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant MR/J001023/1 from the Medical Research Council (to C.J.W., B.L., M.E.D., and T.J.S.). All data supporting the findings of this study are available in the manuscript and its supporting data files and are available from the corresponding author upon request. The authors declare that they have no conflicts of interest with the contents of this article.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Becken U, 2010, P NATL ACAD SCI USA, V107, P20726, DOI 10.1073/pnas.1007295107; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Chapuy B, 2009, HAEMATOL-HEMATOL J, V94, P1528, DOI 10.3324/haematol.2009.008631; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; Christoforou A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9992; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; CORNILLON S, 1994, J CELL SCI, V107, P2691; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; HILDRETH J, 1986, BIOCHEM BIOPH RES CO, V139, P838, DOI 10.1016/S0006-291X(86)80066-3; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hofmann D, 2014, ACS NANO, V8, P10077, DOI 10.1021/nn502754c; Hulsbusch N, 2015, EUR J CELL BIOL, V94, P531, DOI 10.1016/j.ejcb.2015.07.003; IMAI K, 1985, J BIOCHEM, V98, P1405, DOI 10.1093/oxfordjournals.jbchem.a135408; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kieffer-Jaquinod Sylvie, 2008, V432, P243, DOI 10.1007/978-1-59745-028-7_17; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miyaji T, 2011, J NEUROCHEM, V119, P1, DOI 10.1111/j.1471-4159.2011.07388.x; Nakamura H, 2012, MOL HUM REPROD, V18, P204, DOI 10.1093/molehr/gar070; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pensa S, 2014, FEBS J, V281, P4557, DOI 10.1111/febs.13035; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; Resemann HK, 2014, MOL CELL ENDOCRINOL, V382, P603, DOI 10.1016/j.mce.2013.06.029; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Sakata K, 2001, BIOCHEM J, V356, P53, DOI 10.1042/0264-6021:3560053; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sargeant TJ, 2014, NAT CELL BIOL, V16, P1057, DOI 10.1038/ncb3043; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Sickmann A, 2002, IUBMB LIFE, V54, P51, DOI 10.1080/15216540214314; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2013, MOL CELL PROTEOMICS, V12, P1806, DOI 10.1074/mcp.M112.026179; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tan KP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.243; Tharkeshwar A. K., 2017, SCI REP, V7, P565; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Walker MW, 2015, METHOD CELL BIOL, V126, P21, DOI 10.1016/bs.mcb.2014.10.019; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004	89	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4244	4261		10.1074/jbc.RA118.001777	http://dx.doi.org/10.1074/jbc.RA118.001777			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29343516	Green Published, hybrid			2022-12-28	WOS:000428204300002
J	Shah, CA; Broglie, L; Hu, LP; Bei, L; Huang, WQ; Dressler, DB; Eklund, EA				Shah, Chirag A.; Broglie, Larisa; Hu, Liping; Bei, Ling; Huang, Weiqi; Dressler, Danielle B.; Eklund, Elizabeth A.			Stat3 and CCAAT enhancer-binding protein beta (C/ebp beta) activate Fanconi C gene transcription during emergency granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; BCR-ABL; ANEMIA PATHWAY; IN-VITRO; EXPRESSION; CELLS; ICSBP; LEUKEMIA; PHOSPHORYLATION; SPECIFICITY	Interferon consensus sequence-binding protein (Icsbp) is required for terminating emergency granulopoiesis, an episodic event responsible for granulocyte production in response to infections and a key component of the innate immune response. Icsbp inhibits the expression of Stat3 and C/ebp beta, transcription factors essential for initiating and sustaining granulopoiesis, and activates transcription of Fanconi C (FANCC), a DNA repair protein. In prior studies, we noted accelerated bone marrow failure in Fancc(-/-) mice undergoing multiple episodes of emergency granulopoiesis, associated with apoptosis of bone marrow cells with unrepaired DNA damage. Additionally, we found increased expression of Fanconi C and F proteins during emergency granulopoiesis. These findings suggest that Icsbp protects the bone marrow from DNA damage by increasing activity of the Fanconi DNA repair pathway, but the mechanisms for FANCC activation during initiation of emergency granulopoiesis are unclear. In this study, we observed that Stat3 and C/ebp beta activate FANCC transcription and contribute to DNA repair. Our findings indicate that FancC expression is increased during Stat3-and C/ebp beta-induced initiation of emergency granulopoiesis by these transcription factors and is maintained through termination by Icsbp. Our work reveals that Stat3-and C/ebp beta-mediated FancC expression is a critical component for initiating and sustaining key innate immune responses.	[Shah, Chirag A.; Hu, Liping; Bei, Ling; Huang, Weiqi; Dressler, Danielle B.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60605 USA; [Shah, Chirag A.; Bei, Ling; Huang, Weiqi; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Broglie, Larisa] Med Coll Wisconsin, Childrens Hosp Wisconsin, Milwaukee, WI 53213 USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Children's Hospital of Wisconsin; Medical College of Wisconsin	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60605 USA.; Eklund, EA (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	e-eklund@northwestern.edu			Department of Veterans Affairs Merit Review Grant [BX002067]; NIDDK, National Institutes of Health Grant [R01-DK098812]; NCI, National Institutes of Health Grant [R01-CA174205]; NATIONAL CANCER INSTITUTE [R01CA174205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812, R01DK121354] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001864, I01BX004635, I01BX002067] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); NIDDK, National Institutes of Health Grant; NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Merit Review Grant BX002067; NIDDK, National Institutes of Health Grant R01-DK098812; and NCI, National Institutes of Health Grant R01-CA174205 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2001, ONCOGENE, V20, P3464, DOI 10.1038/sj.onc.1204461; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; Cioc AM, 2010, AM J CLIN PATHOL, V133, P92, DOI 10.1309/AJCP7W9VMJENZOVG; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hayashi Y, 2013, LEUKEMIA, V27, P619, DOI 10.1038/leu.2012.258; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hjort EE, 2016, ONCOTARGET, V7, P77635, DOI 10.18632/oncotarget.12749; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Hu LP, 2016, J BIOL CHEM, V291, P4107, DOI 10.1074/jbc.M115.681361; Hu LP, 2013, J CLIN INVEST, V123, P3952, DOI 10.1172/JCI69032; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; LARRICK JW, 1980, J IMMUNOL, V125, P6; LORD BI, 1991, BLOOD, V77, P2154; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Osada S, 1996, J BIOL CHEM, V271, P3891; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Resende C, 2016, GASTRIC CANCER, V19, P74, DOI 10.1007/s10120-014-0448-x; Saberwal G, 2009, J BIOL CHEM, V284, P33242, DOI 10.1074/jbc.M109.010231; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Wang H, 2015, J IMMUNOL, V194, P5375, DOI 10.4049/jimmunol.1401909; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	41	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3937	3948		10.1074/jbc.RA117.000528	http://dx.doi.org/10.1074/jbc.RA117.000528			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382715	Green Published, hybrid			2022-12-28	WOS:000427587500008
J	Ye, QL; Campbell, RL; Davies, PL				Ye, Qilu; Campbell, Robert L.; Davies, Peter L.			Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; P94; CALPASTATIN; MUTATIONS; PROTEINS; 2A	Limb-girdle muscular dystrophy type 2a arises from mutations in the Ca2+-activated intracellular cysteine protease calpain-3. This calpain isoform is abundant in skeletal muscle and differs from the main isoforms, calpain-1 and -2, in being a homodimer and having two short insertion sequences. The first of these, IS1, interrupts the protease core and must be cleaved for activation and substrate binding. Here, to learn how calpain-3 can be regulated and inhibited, we determined the structures of the calpain-3 protease core with IS1 present or proteolytically excised. To prevent intramolecular IS1 autoproteolysis, we converted the active-site Cys to Ala. Small-angle X-ray scattering (SAXS) analysis of the C129A mutant suggested that IS1 is disordered and mobile enough to occupy several locations. Surprisingly, this was also true for the apo version of this mutant. We therefore concluded that IS1 might have a binding partner in the sarcomere and is unstructured in its absence. After autoproteolytic IS1 removal from the active Cys(129) calpain-3 protease core, we could solve its crystal structures with and without the cysteine protease inhibitors E-64 and leupeptin covalently bound to the active-site cysteine. In each structure, the active state of the protease core was assembled by the cooperative binding of two Ca2+ ions to the equivalent sites used in calpain-1 and -2. These structures of the calpain-3 active site with residual IS1 and with bound E-64 and leupeptin may help guide the design of calpain-3-specific inhibitors.	[Ye, Qilu; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	daviesp@queensu.ca		Campbell, Robert/0000-0002-5473-5876	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to P.L.D., who holds the Canada Research Chair in Protein Engineering). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukiage C, 2002, J BIOL CHEM, V277, P20678, DOI 10.1074/jbc.M200697200; Garnham CP, 2009, BIOCHEMISTRY-US, V48, P3457, DOI 10.1021/bi900130u; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khoutorsky A, 2009, LEARN MEMORY, V16, P129, DOI 10.1101/lm.1275709; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 1999, EXP EYE RES, V69, P155, DOI 10.1006/exer.1998.0686; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Ono Y, 2015, DATA BRIEF, V5, P366, DOI 10.1016/j.dib.2015.09.021; Ono Y, 2016, BIOCHIMIE, V122, P169, DOI 10.1016/j.biochi.2015.09.010; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	55	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4056	4070		10.1074/jbc.RA117.001097	http://dx.doi.org/10.1074/jbc.RA117.001097			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382717	Green Published, hybrid			2022-12-28	WOS:000427587500018
J	Laursen, L; Severinsen, K; Kristensen, KB; Periole, X; Overby, M; Muller, HK; Schiott, B; Sinning, S				Laursen, Louise; Severinsen, Kasper; Kristensen, Kristina Birch; Periole, Xavier; Overby, Malene; Mueller, Heidi Kaastrup; Schiott, Birgit; Sinning, Steffen			Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; MEMBRANE CHOLESTEROL; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; FORCE-FIELD; NEUROTRANSMITTER; MECHANISM; DYNAMICS; PROTEIN; NA+	The serotonin transporter (SERT) is important for reuptake of the neurotransmitter serotonin from the synaptic cleft and is also the target of most antidepressants. It has previously been shown that cholesterol in the membrane bilayer affects the conformation of SERT. Although recent crystal structures have identified several potential cholesterol-binding sites, it is unclear whether any of these potential cholesterol sites are occupied by cholesterol and functionally relevant. In the present study, we focus on the conserved cholesterol site 1 (CHOL1) located in a hydrophobic groove between TM1a, TM5, and TM7. By molecular dynamics simulations, we demonstrate a strong binding of cholesterol to CHOL1 in a membrane bilayer environment. In biochemical experiments, we find that cholesterol depletion induces a more inward-facing conformation favoring substrate analog binding. Consistent with this, we find that mutations in CHOL1 with a negative impact on cholesterol binding induce a more inward-facing conformation, and, vice versa, mutations with a positive impact on cholesterol binding induce a more outward-facing conformation. This shift in transporter conformation dictated by the ability to bind cholesterol in CHOL1 affects the apparent substrate affinity, maximum transport velocity, and turnover rates. Taken together, we show that occupation of CHOL1 by cholesterol is of major importance in the transporter conformational equilibrium, which in turn dictates ligand potency and serotonin transport activity. Based on our findings, we propose a mechanistic model that incorporates the role of cholesterol binding to CHOL1 in the function of SERT.	[Laursen, Louise; Severinsen, Kasper; Kristensen, Kristina Birch; Overby, Malene; Mueller, Heidi Kaastrup; Sinning, Steffen] Aarhus Univ, Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Skovagervej 2, DK-8240 Risskov, Denmark; [Periole, Xavier; Schiott, Birgit] Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus C, Denmark; [Periole, Xavier; Schiott, Birgit] Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, Langelandsgade 140, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Sinning, S (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	steffen.sinning@clin.au.dk	Schiott, Birgit/F-5067-2011	Schiott, Birgit/0000-0001-9937-1562; Laursen, Louise/0000-0001-7758-4487; Overby, Malene/0000-0001-5448-722X; Periole, Xavier/0000-0002-2087-5061; Sinning, Steffen/0000-0001-6971-6929	Lundbeck Foundation; Danish Council for Independent Research, Natural Sciences; Lundbeck Foundation [R34-2011-3868, R126-2012-12576, R126-2012-12453] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation and the Danish Council for Independent Research, Natural Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Bjerregaard H, 2015, J BIOL CHEM, V290, P7747, DOI 10.1074/jbc.M114.573477; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GUILLOT F, 1993, J CARDIOVASC PHARM, V21, P339, DOI 10.1097/00005344-199302000-00022; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hedger G, 2016, J PHYS CHEM B, V120, P8154, DOI 10.1021/acs.jpcb.6b01387; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingolfsson HI, 2016, J CELL SCI, V129, P257, DOI 10.1242/jcs.176040; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Narayan S, 2011, FRONT BIOSCI-LANDMRK, V16, P1797, DOI 10.2741/3822; NORTH P, 1983, J BIOL CHEM, V258, P1242; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papakostas GI, 2004, EUR NEUROPSYCHOPHARM, V14, P135, DOI 10.1016/S0924-977X(03)00099-3; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Periole X, 2017, CHEM REV, V117, P156, DOI 10.1021/acs.chemrev.6b00344; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Renshaw PF, 2009, PHARMACOL BIOCHEM BE, V92, P88, DOI 10.1016/j.pbb.2008.10.017; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; SEEMAN P, 1973, J CELL BIOL, V56, P519, DOI 10.1083/jcb.56.2.519; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sooksawate T, 2001, NEUROPHARMACOLOGY, V40, P178, DOI 10.1016/S0028-3908(00)00159-3; Stolzenberg S, 2017, J BIOL CHEM, V292, P7372, DOI 10.1074/jbc.M116.757153; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; WHITTAKE.VP, 1966, ANN NY ACAD SCI, V137, P982, DOI 10.1111/j.1749-6632.1966.tb50211.x; Wustner D, 2007, MOL BIOL CELL, V18, P211, DOI 10.1091/mbc.E06-05-0445; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	57	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3510	3523		10.1074/jbc.M117.809046	http://dx.doi.org/10.1074/jbc.M117.809046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352106	Green Published, hybrid			2022-12-28	WOS:000427030200005
J	Hong, S; Ka, D; Yoon, SJ; Suh, N; Jeong, M; Suh, JY; Bae, E				Hong, Suji; Ka, Donghyun; Yoon, Seo Jeong; Suh, Nayoung; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung			CRISPR RNA and anti-CRISPR protein binding to the Xanthomonas albilineans Csy1-Csy2 heterodimer in the type I-F CRISPR-Cas system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL SUPPRESSORS; IMMUNE-SYSTEM; INHIBITION; REPEATS; CLASSIFICATION; MECHANISMS; EVOLUTION; BACTERIA; COMPLEX; ADAPTATION	Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins provide microbial adaptive immunity against bacteriophages. In type I-F CRISPR-Cas systems, multiple Cas proteins (Csy1-4) compose a surveillance complex (Csy complex) with CRISPR RNA (crRNA) for target recognition. Here, we report the biochemical characterization of the Csy1-Csy2 subcomplex from Xanthomonas albilineans, including the analysis of its interaction with crRNA and AcrF2, an anti-CRISPR (Acr) protein from a phage that infects Pseudomonas aeruginosa. The X. albilineans Csy1 and Csy2 proteins (XaCsy1 and XaCsy2, respectively) formed a stable heterodimeric complex that specifically bound the 8-nucleotide (nt) 5'-handle of the crRNA. In contrast, the XaCsy1-XaCsy2 heterodimer exhibited reduced affinity for the 28-nt X. albilineans CRISPR repeat RNA containing the 5'-handle sequence. Chromatographic and calorimetric analyses revealed tight binding between the Acr protein from the P. aeruginosa phage and the heterodimeric subunit of the X. albilineans Csy complex, suggesting that AcrF2 recognizes conserved features of Csy1-Csy2 heterodimers. We found that neither XaCsy1 nor XaCsy2 alone forms a stable complex with AcrF2 and the 5'-handle RNA, indicating that XaCsy1-XaCsy2 heterodimerization is required for binding them. We also solved the crystal structure of AcrF2 to a resolution of 1.34 angstrom, enabling a more detailed structural analysis of the residues involved in the interactions with the Csy1-Csy2 heterodimer. Our results provide information about the order of events during the formation of the multisubunit crRNA-guided surveillance complex and suggest that the Acr protein inactivating type I-F CRISPR-Cas systems has broad specificity.	[Hong, Suji; Ka, Donghyun; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Yoon, Seo Jeong] Seoul Natl Univ, Dept Appl Biol Chem, Seoul 08826, South Korea; [Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Suh, Nayoung] Soon Chun Hyang Univ, Dept Pharmaceut Engn, Asan 31538, South Korea; [Suh, Jeong-Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Nagano 3994598, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Soonchunhyang University; Shinshu University	Bae, E (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.	bae@snu.ac.kr			Cooperative Research Program for Agricultural Science and Technology Development - Rural Development Administration [PJ01111201]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2016R1D1A1A09916821]	Cooperative Research Program for Agricultural Science and Technology Development - Rural Development Administration; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Cooperative Research Program for Agricultural Science and Technology Development funded by Rural Development Administration (Grant PJ01111201) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant NRF-2016R1D1A1A09916821). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006; Harrington LB, 2017, CELL, V170, P1224, DOI 10.1016/j.cell.2017.07.037; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Hynes AP, 2017, NAT MICROBIOL, V2, P1374, DOI 10.1038/s41564-017-0004-7; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Maxwell KL, 2017, MOL CELL, V68, P8, DOI 10.1016/j.molcel.2017.09.002; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Maxwell KL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005282; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Peng RC, 2017, CELL RES, V27, P853, DOI 10.1038/cr.2017.79; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Shabbir MAB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01292; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sontheimer EJ, 2017, CURR OPIN MICROBIOL, V37, P120, DOI 10.1016/j.mib.2017.06.003; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yang H, 2017, MOL CELL, V67, P117, DOI 10.1016/j.molcel.2017.05.024	57	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2744	2754		10.1074/jbc.RA117.001611	http://dx.doi.org/10.1074/jbc.RA117.001611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29348170	Green Published, hybrid			2022-12-28	WOS:000426051900011
J	Zhang, LP; Ten Hagen, KG				Zhang, Liping; Ten Hagen, Kelly G.			Pleiotropic effects of O-glycosylation in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SECRETION; MUTATIONS	Changes in the O-glycosylation of proteins have long been associated with the development of cancer, but establishing causal relationships between altered glycosylation and cancer progression remains incomplete. In this study, the authors perform comparative analyses of the cellular phenotypes, transcriptional changes, and alterations in the glycoproteome in colon cancer cells that differentially express one glycosyltransferase. Their results provide a wealth of data on which future studies can be based.	[Zhang, Liping; Ten Hagen, Kelly G.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zhang, LP; Ten Hagen, KG (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	Liping.Zhang@nih.gov; Kelly.Tenhagen@nih.gov			Intramural Research Program of the National Institutes of Health, NIDCR Grant [Z01-DE-000713]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000713] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIDCR Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIDCR Grant Z01-DE-000713 (to K. G. T. H.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arndt S, 2007, ONCOL REP, V18, P885; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	10	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1315	1316		10.1074/jbc.H117.812826	http://dx.doi.org/10.1074/jbc.H117.812826			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29374084	Green Published, hybrid			2022-12-28	WOS:000423515000017
J	Mayran, A; Drouin, J				Mayran, Alexandre; Drouin, Jacques			Pioneer transcription factors shape the epigenetic landscape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chromatin remodeling; epigenetics; cell differentiation; DNA demethylation; gene transcription; development	PLURIPOTENT STEM-CELLS; DNA METHYLATION; GENE-EXPRESSION; CHROMATIN LANDSCAPE; REGULATORY ELEMENTS; RECEPTOR-BINDING; PROSTATE-CANCER; REPROGRAMMING FACTORS; MITOTIC BOOKMARKING; HUMAN FIBROBLASTS	Pioneer transcription factors have the unique and important role of unmasking chromatin domains during development to allow the implementation of new cellular programs. Compared with those of other transcription factors, this activity implies that pioneer factors can recognize their target DNA sequences in so-called compacted or closed heterochromatin and can trigger remodeling of the adjoining chromatin landscape to provide accessibility to nonpioneer transcription factors. Recent studies identified several steps of pioneer action, namely rapid but weak initial binding to heterochromatin and stabilization of binding followed by chromatin opening and loss of cytosine-phosphate-guanine (CpG) methylation that provides epigenetic memory. Whereas CpG demethylation depends on replication, chromatin opening does not. In this Minireview, we highlight the unique properties of this transcription factor class and the challenges of understanding their mechanism of action.	[Mayran, Alexandre; Drouin, Jacques] Inst Rech Clin Montreal, Lab Mol Genet, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Drouin, J (corresponding author), Inst Rech Clin Montreal, Lab Mol Genet, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	jacques.drouin@ircm.qc.ca		Drouin, Jacques/0000-0001-8226-5691; Mayran, Alexandre/0000-0002-1228-0308				Almouzni G, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019372; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Bossard P, 1998, DEVELOPMENT, V125, P4909; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; de Dieuleveult M, 2016, NATURE, V530, P113, DOI 10.1038/nature16505; Deluz C, 2016, GENE DEV, V30, P2538, DOI 10.1101/gad.289256.116; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Donaghey J, 2018, NAT GENET, V50, P250, DOI 10.1038/s41588-017-0034-3; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Festuccia N, 2016, NAT CELL BIOL, V18, P1139, DOI 10.1038/ncb3418; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Green MR, 2011, GENE CHROMOSOME CANC, V50, P313, DOI 10.1002/gcc.20856; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Hagey DW, 2016, GENOME RES, V26, P908, DOI 10.1101/gr.203513.115; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Hsu HT, 2015, SCIENCE, V348, P1372, DOI 10.1126/science.aab1223; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; King HW, 2017, ELIFE, V6, DOI 10.7554/eLife.22631; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mayran A, 2018, NAT GENET, V50, P259, DOI 10.1038/s41588-017-0035-2; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Menet JS, 2014, GENE DEV, V28, P8, DOI 10.1101/gad.228536.113; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pataskar A, 2016, EMBO J, V35, P24, DOI 10.15252/embj.201591206; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Raposo AASF, 2015, CELL REP, V10, P1544, DOI 10.1016/j.celrep.2015.02.025; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takaku M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0897-0; Teves SS, 2016, ELIFE, V5, DOI 10.7554/eLife.22280; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wapinski OL, 2017, CELL REP, V20, P3236, DOI 10.1016/j.celrep.2017.09.011; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Younger ST, 2017, NUCLEIC ACIDS RES, V45, P9889, DOI 10.1093/nar/gkx577; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhang Y, 2016, NAT GENET, V48, P1003, DOI 10.1038/ng.3635; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005	107	104	108	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13795	13804		10.1074/jbc.R117.001232	http://dx.doi.org/10.1074/jbc.R117.001232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29507097	Green Published, hybrid			2022-12-28	WOS:000444070700005
J	Huang, HY; Wang, P; Bian, L; Osawa, M; Erickson, HP; Chen, YD				Huang, Haiyan; Wang, Ping; Bian, Li; Osawa, Masaki; Erickson, Harold P.; Chen, Yaodong			The cell division protein MinD from Pseudomonas aeruginosa dominates the assembly of the MinC-MinD copolymers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cell division; electron microscopy (EM); protein dynamic; cytoskeleton; FtsZ; min system; MinC-MinD copolymer; MinCDE proteins; Z-ring	ESCHERICHIA-COLI; POLE OSCILLATION; INHIBITOR MINC; RAPID POLE; FTSZ; MEMBRANE; CYTOKINESIS; REGULATORS; FILAMENTS; SEQUENCE	Cell division of rod-shaped bacteria requires the Z ring, a ring of FtsZ filaments associated with the inner-membrane wall. The MinCDE proteins help localize the Z ring to the center of the Escherichia coli cell. MinC, which inhibits Z-ring assembly, is a passenger on MinD. Previous studies have shown that MinC-MinD from E. coli and Aquifex aeolicus assemble in vitro into extended filaments with a 1:1 stoichiometry. However, a recent study has raised questions about the function of the MinC-MinD copolymer in vivo, because its assembly appears to require a high concentration of these two proteins and has a long lag time, and its blockade does not affect in vivo activities. Here, we found that MinC and MinD from Pseudomonas aeruginosa coassemble into filaments with a 1:1 stoichiometry. We also found that the minimal concentration of approximate to 4 m required for assembly applies only to MinD because above 4 m MinD, even very low MinC concentrations sustained coassembly. As previously reported, the MinC-MinD coassembly exhibited a long lag of approximate to 100 s when initiated by ATP. Premixing MinD with ATP eliminated this lag, suggesting that it may be due to slow MinD dimerization following ATP activation. We also discovered that MinC-MinD copolymers quickly bound FtsZ filaments and formed huge bundles. Our results resolve previous questions about the low concentration of MinC and the lag time, insights that may inform future investigations into the exact role of the MinC-MinD copolymer in vivo.	[Huang, Haiyan; Bian, Li; Chen, Yaodong] Northwest Univ, Coll Life Sci, Key Lab Resources Biol & Biotechnol Western China, Minist Educ, Xian 710069, Shaanxi, Peoples R China; [Wang, Ping] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Osawa, Masaki; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Northwest University Xi'an; Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.; Chen, YD (corresponding author), Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China.	h.erickson@cellbio.duke.edu; ydchen@nwu.edu.cn	Chen, Yaodong/X-8923-2019	Chen, Yaodong/0000-0002-3751-0923	NIGMS NIH HHS [R01 GM066014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004504; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Conti J, 2015, FEBS LETT, V589, P201, DOI 10.1016/j.febslet.2014.11.047; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Erickson HP, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700045; Erickson HP, 2017, SUBCELL BIOCHEM, V84, P139, DOI 10.1007/978-3-319-53047-5_5; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Kretschmer S, 2016, CURR OPIN CELL BIOL, V38, P52, DOI 10.1016/j.ceb.2016.02.005; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lutkenhaus J, 2017, SUBCELL BIOCHEM, V84, P27, DOI 10.1007/978-3-319-53047-5_2; Park KT, 2015, MOL MICROBIOL, V98, P895, DOI 10.1111/mmi.13164; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Schumacher MA, 2017, SUBCELL BIOCHEM, V84, P267, DOI 10.1007/978-3-319-53047-5_9; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szwedziak P, 2017, SUBCELL BIOCHEM, V84, P213, DOI 10.1007/978-3-319-53047-5_7; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113	30	9	9	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7786	7795		10.1074/jbc.RA117.001513	http://dx.doi.org/10.1074/jbc.RA117.001513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610277	Green Published, hybrid			2022-12-28	WOS:000437256500027
J	Wan, QW; Okashah, N; Inoue, A; Nehme, R; Carpenter, B; Tate, CG; Lambert, NA				Wan, Qingwen; Okashah, Najeah; Inoue, Asuka; Nehme, Rony; Carpenter, Byron; Tate, Christopher G.; Lambert, Nevin A.			Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; arrestin; biosensor; molecular pharmacology; BRET; mini G protein; NanoLuc; protein complementation	FLUORESCENT PROTEIN; LIVING CELLS; ACTIVATION; REVEAL; BRET	G protein-coupled receptors (GPCRs) are key signaling proteins that regulate nearly every aspect of cell function. Studies of GPCRs have benefited greatly from the development of molecular tools to monitor receptor activation and downstream signaling. Here, we show that mini G proteins are robust probes that can be used in a variety of assay formats to report GPCR activity in living cells. Mini G (mG) proteins are engineered GTPase domains of G subunits that were developed for structural studies of active-state GPCRs. Confocal imaging revealed that mG proteins fused to fluorescent proteins were located diffusely in the cytoplasm and translocated to sites of receptor activation at the cell surface and at intracellular organelles. Bioluminescence resonance energy transfer (BRET) assays with mG proteins fused to either a fluorescent protein or luciferase reported agonist, superagonist, and inverse agonist activities. Variants of mG proteins (mGs, mGsi, mGsq, and mG12) corresponding to the four families of G subunits displayed appropriate coupling to their cognate GPCRs, allowing quantitative profiling of subtype-specific coupling to individual receptors. BRET between luciferase-mG fusion proteins and fluorescent markers indicated the presence of active GPCRs at the plasma membrane, Golgi apparatus, and endosomes. Complementation assays with fragments of NanoLuc luciferase fused to GPCRs and mG proteins reported constitutive receptor activity and agonist-induced activation with up to 20-fold increases in luminescence. We conclude that mG proteins are versatile tools for studying GPCR activation and coupling specificity in cells and should be useful for discovering and characterizing G protein subtype-biased ligands.	[Wan, Qingwen; Okashah, Najeah; Lambert, Nevin A.] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Nehme, Rony; Carpenter, Byron; Tate, Christopher G.] MRC Lab Mol Biol, Cambridge CB20QH, England; [Nehme, Rony] Creoptix AG, Einsiedlerstr 34, CH-8820 Wadenswil, Switzerland; [Carpenter, Byron] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England	University System of Georgia; Augusta University; Tohoku University; University of Warwick	Lambert, NA (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA.	nelambert@augusta.edu	Carpenter, Byron/S-5206-2019	Carpenter, Byron/0000-0003-1712-3528	National Institutes of Health [GM078319, GM109879]; Medical Research Council; European Research Council; Heptares Therapeutics [MC_U105197215, EMPSI 339995]; Japan Science and Technology Agency (JST) [JPMJPR1331]; Japan Agency for Medical Research and Development (AMED) [JP17gm5910013]; MRC [MC_U105197215] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109879, R01GM078319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Heptares Therapeutics; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM078319 and GM109879 (to N. A. L.) and Medical Research Council, European Research Council, and Heptares Therapeutics Grants MC_U105197215 and EMPSI 339995 (to C. G. T.). C. G. T. is a shareholder and member of the scientific advisory board of Heptares Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Japan Science and Technology Agency (JST) Grant JPMJPR1331 and Japan Agency for Medical Research and Development (AMED) Grant JP17gm5910013.	Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS17, DOI 10.1111/bph.13878; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin BR, 2016, J BIOL CHEM, V291, P20295, DOI 10.1074/jbc.M116.729731; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Schrage R, 2013, BRIT J PHARMACOL, V169, P357, DOI 10.1111/bph.12003; SIDHU A, 1991, J NEUROCHEM, V57, P1445, DOI 10.1111/j.1471-4159.1991.tb08312.x; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038	26	129	130	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7466	7473		10.1074/jbc.RA118.001975	http://dx.doi.org/10.1074/jbc.RA118.001975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29523687	Green Published, hybrid			2022-12-28	WOS:000432174500037
J	Li, QJ; Alsaidan, OA; Ma, YJ; Kim, S; Liu, JC; Albers, T; Liu, KB; Beharry, Z; Zhao, SY; Wang, F; Lebedyeva, I; Cai, HJ				Li, Qianjin; Alsaidan, Omar Awad; Ma, Yongjie; Kim, Sungjin; Liu, Junchen; Albers, Thomas; Liu, Kebin; Beharry, Zanna; Zhao, Shaying; Wang, Fen; Lebedyeva, Iryna; Cai, Houjian			Pharmacologically targeting the myristoylation of the scaffold protein FRS2 alpha inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); fibroblast growth factor (FGF); cancer; drug action; protein acylation; myristoylation; FRS2; B13	RECEPTOR SUBSTRATE 2; PROSTATE-CANCER; N-MYRISTOYLTRANSFERASE; ENDOMETRIAL CARCINOMA; ANDROGEN RECEPTOR; ADAPTER PROTEINS; FRS2 FAMILY; MAP KINASE; GROWTH; MUTATIONS	Fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling facilitates tumor initiation and progression. Although currently approved inhibitors of FGFR kinase have shown therapeutic benefit in clinical trials, overexpression or mutations of FGFRs eventually confer drug resistance and thereby abrogate the desired activity of kinase inhibitors in many cancer types. In this study, we report that loss of myristoylation of fibroblast growth factor receptor substrate 2 (FRS2), a scaffold protein essential for FGFR signaling, inhibits FGF/FGFR-mediated oncogenic signaling and FGF10-induced tumorigenesis. Moreover, a previously synthesized myristoyl-CoA analog, B13, which targets the activity of N-myristoyltransferases, suppressed FRS2 myristoylation and decreased the phosphorylation with mild alteration of FRS2 localization at the cell membrane. B13 inhibited oncogenic signaling induced by WT FGFRs or their drug-resistant mutants (FGFRs(DRM)). B13 alone or in combination with an FGFR inhibitor suppressed FGF-induced WT FGFR- or FGFR(DRM)-initiated phosphoinositide 3-kinase (PI3K) activity or MAPK signaling, inducing cell cycle arrest and thereby inhibiting cell proliferation and migration in several cancer cell types. Finally, B13 significantly inhibited the growth of xenograft tumors without pathological toxicity to the liver, kidney, or lung in vivo. In summary, our study suggests a possible therapeutic approach for inhibiting FGF/FGFR-mediated cancer progression and drug-resistant FGF/FGFR mutants.	[Li, Qianjin; Alsaidan, Omar Awad; Ma, Yongjie; Kim, Sungjin; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Zhao, Shaying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Liu, Junchen; Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Albers, Thomas; Lebedyeva, Iryna] Augusta Univ, Dept Chem & Phys, Augusta, GA 30912 USA; [Liu, Kebin] Augusta Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University System of Georgia; Augusta University; University System of Georgia; Augusta University; State University System of Florida; Florida Gulf Coast University	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu	Alsaidan, Omar/AAB-6106-2021; Cai, Houjian/AAJ-1290-2020	Alsaidan, Omar/0000-0002-2848-2932; Liu, Junchen/0000-0003-2765-9780; Beharry, Zanna/0000-0002-3900-8523	National Institutes of Health [R01CA172495]; Department of Defense [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA182093, R01CA172495, R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA172495 and Department of Defense Grant W81XWH-15-1-0507 (to H.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bielawska A, 2008, BIOORGAN MED CHEM, V16, P1032, DOI 10.1016/j.bmc.2007.08.032; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Byron SA, 2013, NEOPLASIA, V15, P975, DOI 10.1593/neo.121106; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Corn PG, 2013, CLIN CANCER RES, V19, P5856, DOI 10.1158/1078-0432.CCR-13-1550; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Easton JB, 1999, J BIOL CHEM, V274, P11321, DOI 10.1074/jbc.274.16.11321; Ebara S, 2005, BIOL PHARM BULL, V28, P591, DOI 10.1248/bpb.28.591; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FELSTED RL, 1995, J NATL CANCER I, V87, P1571, DOI 10.1093/jnci/87.21.1571; Feng S, 2015, ONCOTARGET, V6, P17291, DOI 10.18632/oncotarget.4174; French KJ, 2004, J PHARMACOL EXP THER, V309, P340, DOI 10.1124/jpet.103.061572; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Gatius S, 2011, MODERN PATHOL, V24, P1500, DOI 10.1038/modpathol.2011.110; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Guy GR, 2002, CELL SIGNAL, V14, P11, DOI 10.1016/S0898-6568(01)00227-3; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; HUANG JT, 1995, J BIOL CHEM, V270, P5065, DOI 10.1074/jbc.270.10.5065; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim S, 2017, J BIOL CHEM, V292, P18422, DOI [10.1074/jbc.M117.798827, 10.1074/jbc.m117.798827]; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kumar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127661; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Luo LY, 2015, MOL CANCER RES, V13, P502, DOI 10.1158/1541-7786.MCR-14-0407; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nagamatsu H, 2015, PROSTATE, V75, P1092, DOI 10.1002/pros.22994; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Renhowe PA, 2009, J MED CHEM, V52, P278, DOI 10.1021/jm800790t; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Sato T, 2009, EXPERT OPIN THER TAR, V13, P689, DOI 10.1517/14728220902942330; Selzner M, 2001, CANCER RES, V61, P1233; Stoletov KV, 2002, FASEB J, V16, P1283, DOI 10.1096/fj.01-0835fje; Szulc ZM, 2008, BIOORGAN MED CHEM, V16, P1015, DOI 10.1016/j.bmc.2007.08.033; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Touat M, 2015, CLIN CANCER RES, V21, P2684, DOI 10.1158/1078-0432.CCR-14-2329; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Zhang KQ, 2013, CANCER RES, V73, P1298, DOI 10.1158/0008-5472.CAN-12-2086; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910; Zhao C, 2014, CHEMMEDCHEM, V9, P2425, DOI 10.1002/cmdc.201402174	59	15	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6434	6448		10.1074/jbc.RA117.000940	http://dx.doi.org/10.1074/jbc.RA117.000940			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29540482	hybrid, Green Published			2022-12-28	WOS:000431108600017
J	Kim, HY; Go, J; Lee, KM; Oh, YT; Yoon, SS				Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Oh, Young Taek; Yoon, Sang Sun			Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EL-TOR STRAINS; TOXIN-COREGULATED PILUS; STRINGENT RESPONSE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; ANTIMICROBIAL AGENTS; STRESS-RESPONSE; RESISTANCE; (P)PPGPP; PPGPP	The pathogen Vibrio cholerae is the causative agent of cholera. Emergence of antibiotic-resistant V. cholerae strains is increasing, but the underlying mechanisms remain unclear. Herein, we report that the stringent response regulator and stress alarmone guanosinetetra- and pentaphosphate ((p)ppGpp) significantly contributes to antibiotic tolerance in V. cholerae. We found that N16961, a pandemic V. cholerae strain, and its isogenic (p)ppGpp-overexpressing mutant Delta relA Delta spoT are both more antibiotic-resistant than (p)ppGpp(o) (Delta relA Delta relV Delta spoT) and Delta dksA mutants, which cannot produce or utilize (p)ppGpp, respectively. We also found that additional disruption of the aconitase B-encoding and tricarboxylic acid (TCA) cycle gene acnB in the (p)ppGpp(o) mutant increases its antibiotic tolerance. Moreover, expression of TCA cycle genes, including acnB, was increased in (p)ppGpp(o), but not in the antibiotic-resistant Delta relA Delta spoT mutant, suggesting that (p)ppGpp suppresses TCA cycle activity, thereby entailing antibiotic resistance. Importantly, when grown anaerobically or incubated with an iron chelator, the (p)ppGpp(o) mutant became antibiotic-tolerant, suggesting that reactive oxygen species (ROS) are involved in antibiotic-mediated bacterial killing. Consistent with that hypothesis, tetracycline treatment markedly increased ROS production in the antibiotic-susceptible mutants. Interestingly, expression of the Fe(III) ABC transporter substrate-binding protein FbpA was increased 10-fold in (p)ppGpp(o), and fbpA gene deletion restored viability of tetracycline-exposed (p)ppGpp(o) cells. Of note, FbpA expression was repressed in the (p)ppGpp-accumulating mutant, resulting in a reduction of intracellular free iron, required for the ROS-generating Fenton reaction. Our results indicate that (p)ppGpp-mediated suppression of central metabolism and iron uptake reduces antibiotic-induced oxidative stress in V. cholerae.	[Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Oh, Young Taek; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol & Immunol, Seoul 03722, South Korea; [Kim, Hwa Young; Go, Junhyeok; Lee, Kang-Mu; Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul 03722, South Korea; [Oh, Young Taek] Nakdonggang Natl Inst Biol Resources, Freshwater Bioresources Utilizat Div, Sangju 37242, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Oh, YT (corresponding author), Nakdonggang Natl Inst Biol Resources, Freshwater Bioresources Utilizat Div, Sangju 37242, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, 250 Seongsanno, Seoul 120752, South Korea.	ohyt@nnibr.re.kr; sangsun_yoon@yuhs.ac		Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea - Korean government [2017R1A2A2A05019987, 2015M3C9A2054024, 2014R1A1A2056139, 2014R1A4A1008625, 2017M3A9F3041233]	National Research Foundation (NRF) of Korea - Korean government	This work was supported by National Research Foundation (NRF) of Korea Grants 2017R1A2A2A05019987, 2015M3C9A2054024, 2014R1A1A2056139, 2014R1A4A1008625, and 2017M3A9F3041233, funded by the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Aedo S, 2016, ANTIMICROB AGENTS CH, V60, P2311, DOI 10.1128/AAC.02697-15; [Anonymous], 2012, Wkly Epidemiol Rec, V87; Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; Brandt KG, 2015, J PEDIAT-BRAZIL, V91, pS36, DOI 10.1016/j.jped.2015.06.002; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Chomvarin C, 2013, J MED MICROBIOL, V62, P599, DOI 10.1099/jmm.0.053801-0; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S10; Dasgupta S, 2014, MICROBIOL-SGM, V160, P1855, DOI 10.1099/mic.0.079319-0; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DE S, 1976, B WORLD HEALTH ORGAN, V54, P177; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; Gaca AO, 2015, J BACTERIOL, V197, P1146, DOI 10.1128/JB.02577-14; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; GREENOUGH WB, 1964, LANCET, V1, P355; Greenway DLA, 1999, LETT APPL MICROBIOL, V29, P323, DOI 10.1046/j.1472-765X.1999.00642.x; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; HEATH RJ, 1994, J BIOL CHEM, V269, P26584; Hesketh A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-226; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; ISHIGURO EE, 1980, CAN J MICROBIOL, V26, P1514, DOI 10.1139/m80-253; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Jesudason M V, 2006, Indian J Med Microbiol, V24, P152; Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; Kaushik JS, 2010, INDIAN PEDIATR, V47, P309, DOI 10.1007/s13312-010-0059-5; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Kim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082814; Klontz EH, 2014, CLIN INFECT DIS, V58, pE133, DOI 10.1093/cid/ciu040; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Krebs SJ, 2011, J BACTERIOL, V193, P5260, DOI 10.1128/JB.00378-11; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Leibovici-Weissman Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008625.pub2; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mandal J, 2012, J HEALTH POPUL NUTR, V30, P12; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mey AR, 2002, INFECT IMMUN, V70, P3419, DOI 10.1128/IAI.70.7.3419-3426.2002; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Oh YT, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00156; Oh YT, 2015, J BIOL CHEM, V290, P13178, DOI 10.1074/jbc.M115.640466; Oh YT, 2014, J BIOL CHEM, V289, P13232, DOI 10.1074/jbc.M113.540088; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; PATRA FC, 1989, BMJ-BRIT MED J, V298, P1353, DOI 10.1136/bmj.298.6684.1353; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; RODIONOV DG, 1995, J BACTERIOL, V177, P4224, DOI 10.1128/jb.177.15.4224-4229.1995; Rogers MB, 2000, J BACTERIOL, V182, P2350, DOI 10.1128/JB.182.8.2350-2353.2000; Ronayne EA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005797; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; TOWNER KJ, 1980, B WORLD HEALTH ORGAN, V58, P747; Wang RB, 2012, INT J ANTIMICROB AG, V40, P361, DOI 10.1016/j.ijantimicag.2012.06.010; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; WEBER JT, 1994, EPIDEMIOL INFECT, V112, P1, DOI 10.1017/S0950268800057368; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345; Wu J, 2010, J CELL PHYSIOL, V224, P300, DOI 10.1002/jcp.22158; Wyckoff EE, 1999, J BACTERIOL, V181, P7588, DOI 10.1128/JB.181.24.7588-7596.1999; Wyckoff EE, 2006, J BACTERIOL, V188, P6515, DOI 10.1128/JB.00626-06; Yoon MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11606; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon MY, 2014, J MICROBIOL, V52, P983, DOI 10.1007/s12275-014-4655-2	81	23	23	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5679	5694		10.1074/jbc.RA117.000383	http://dx.doi.org/10.1074/jbc.RA117.000383			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475943	Green Published, hybrid			2022-12-28	WOS:000430044100028
J	Susorov, D; Zakharov, N; Shuvalova, E; Ivanov, A; Egorova, T; Shuvalov, A; Shatsky, IN; Alkalaeva, E				Susorov, Denis; Zakharov, Nikita; Shuvalova, Ekaterina; Ivanov, Alexander; Egorova, Tatiana; Shuvalov, Alexey; Shatsky, Ivan N.; Alkalaeva, Elena			Eukaryotic translation elongation factor 2 (eEF2) catalyzes reverse translocation of the eukaryotic ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome function; translation elongation factor; translocation; ribosome; ADP-ribosylation	TRANSFER-RNA TRANSLOCATION; STRUCTURAL BASIS; 70S RIBOSOME; AMINOGLYCOSIDE ANTIBIOTICS; CONFORMATIONAL-CHANGES; PROTEIN-BIOSYNTHESIS; ADP-RIBOSYLATION; DIPHTHERIA-TOXIN; GTP HYDROLYSIS; FACTOR-II	During protein synthesis, a ribosome moves along the mRNA template and, using aminoacyl-tRNAs, decodes the template nucleotide triplets to assemble a protein amino acid sequence. This movement is accompanied by shifting of mRNA-tRNA complexes within the ribosome in a process called translocation. In living cells, this process proceeds in a unidirectional manner, bringing the ribosome to the 3 end of mRNA, and is catalyzed by the GTPase translation elongation factor 2 (EF-G in prokaryotes and eEF2 in eukaryotes). Interestingly, the possibility of spontaneous backward translocation has been shown in vitro for bacterial ribosomes, suggesting a potential reversibility of this reaction. However, this possibility has not yet been tested for eukaryotic ribosomes. Here, using a reconstituted mammalian translation system, we show that the eukaryotic elongation factor eEF2 catalyzes ribosomal reverse translocation at one mRNA triplet. We found that this process requires a cognate tRNA in the ribosomal E-site and cannot occur spontaneously without eEF2. The efficiency of this reaction depended on the concentrations of eEF2 and cognate tRNAs and increased in the presence of nonhydrolyzable GTP analogues. Of note, ADP-ribosylation of eEF2 domain IV blocked reverse translocation, suggesting a crucial role of interactions of this domain with the ribosome for the catalysis of the reaction. In summary, our findings indicate that eEF2 is able to induce ribosomal translocation in forward and backward directions, highlighting the universal mechanism of tRNA-mRNA movements within the ribosome.	[Susorov, Denis; Shuvalova, Ekaterina; Ivanov, Alexander; Egorova, Tatiana; Shuvalov, Alexey; Alkalaeva, Elena] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Susorov, Denis; Ivanov, Alexander] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119234, Russia; [Zakharov, Nikita] Moscow Inst Phys & Technol, Dept Biol & Med Phys, Dolgoprudnyi 141700, Russia; [Egorova, Tatiana] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Shatsky, Ivan N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119992, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Moscow Institute of Physics & Technology; Pirogov Russian National Research Medical University; Lomonosov Moscow State University	Alkalaeva, E (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.	alkalaeva@eimb.ru	Alkalaeva, Elena/ABC-3888-2021; Ivanov, Alexandr/AAM-6231-2021; Egorova, Tatiana/P-9982-2017; Shuvalova, Ekaterina/F-2469-2019; Ivanov, Alexander V/Q-9672-2017; Zakharov, Nikita/AGN-6144-2022	Alkalaeva, Elena/0000-0003-2078-7261; Ivanov, Alexandr/0000-0002-0000-0401; Ivanov, Alexander V/0000-0002-0000-0401; Zakharov, Nikita/0000-0003-0096-1824; Shuvalova, Ekaterina/0000-0003-2379-4328	Russian Foundation for Basic Research [16-34-00406]; Russian Science Foundation [14-14-00487]; Russian Science Foundation [17-14-00106] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The study of reverse translocation of the eukaryotic ribosome was supported by Russian Foundation for Basic Research Grant 16-34-00406. The study of the influence of different tRNAs on reverse translocation was supported by Russian Science Foundation Grant 14-14-00487. The authors declare that they have no conflicts of interest with the contents of this article.	Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Atkinson GC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1289-7; Behrmann E, 2015, CELL, V161, P845, DOI 10.1016/j.cell.2015.03.052; Belardinelli R, 2016, RNA BIOL, V13, P1197, DOI 10.1080/15476286.2016.1240140; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; DAVIES J, 1965, MOL PHARMACOL, V1, P93; DAVYDOVA EK, 1990, FEBS LETT, V261, P350, DOI 10.1016/0014-5793(90)80589-B; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; Dmitriev SE, 2006, MOL BIOL+, V40, P25; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Gould PS, 2005, BIOTECHNIQUES, V38, P397, DOI 10.2144/05383ST02; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Li W, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500169; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Liu GQ, 2014, NAT STRUCT MOL BIOL, V21, P817, DOI 10.1038/nsmb.2869; Mateyak MK, 2013, J BIOL CHEM, V288, P24647, DOI 10.1074/jbc.M113.488783; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MORIMOTO H, 1992, J IMMUNOL, V149, P2089; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; RHEINBERGER HJ, 1987, J BIOMOL STRUCT DYN, V5, P435, DOI 10.1080/07391102.1987.10506403; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Sharma H, 2016, CELL REP, V16, P2187, DOI 10.1016/j.celrep.2016.07.051; Shirokikh NE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1025; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Stepanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020991; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Susorov D, 2015, NUCLEIC ACIDS RES, V43, P3332, DOI 10.1093/nar/gkv171; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wasserman MR, 2016, NAT STRUCT MOL BIOL, V23, P333, DOI 10.1038/nsmb.3177; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Youngman EM, 2007, CURR BIOL, V17, pR136, DOI 10.1016/j.cub.2006.12.029; Zhang DJ, 2016, NAT STRUCT MOL BIOL, V23, P125, DOI 10.1038/nsmb.3160; Zhou J, 2014, SCIENCE, V345, P1188, DOI 10.1126/science.1255030	52	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5220	5229		10.1074/jbc.RA117.000761	http://dx.doi.org/10.1074/jbc.RA117.000761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453282	hybrid, Green Published			2022-12-28	WOS:000429409300026
J	Burgin, T; Stahlberg, J; Mayes, HB				Burgin, Tucker; Stahlberg, Jerry; Mayes, Heather B.			Advantages of a distant cellulase catalytic base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY 6 CELLOBIOHYDROLASE; SUBSTRATE RING DISTORTION; TRICHODERMA-REESEI; GLYCOSIDE HYDROLASES; HUMICOLA-INSOLENS; CRYSTAL-STRUCTURE; ACTIVE-SITE; THERMOMONOSPORA-FUSCA; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS	The inverting glycoside hydrolase Trichoderma reesei (Hypocrea jecorina) Cel6A is a promising candidate for protein engineering for more economical production of biofuels. Until recently, its catalytic mechanism had been uncertain: The best candidate residue to serve as a catalytic base, Asp-175, is farther from the glycosidic cleavage site than in other glycoside hydrolase enzymes. Recent unbiased transition path sampling simulations revealed the hydrolytic mechanism for this more distant base, employing a water wire; however, it is not clear why the enzyme employs a more distant catalytic base, a highly conserved feature among homologs across different kingdoms. In this work, we describe molecular dynamics simulations designed to uncover how a base with a longer side chain, as in a D175E mutant, affects procession and active site alignment in the Michaelis complex. We show that the hydrogen bond network is tuned to the shorter aspartate side chain, and that a longer glutamate side chain inhibits procession as well as being less likely to adopt a catalytically productive conformation. Furthermore, we draw comparisons between the active site in Trichoderma reesei Cel6A and another inverting, processive cellulase to deduce the contribution of the water wire to the overall enzyme function, revealing that the more distant catalytic base enhances product release. Our results can inform efforts in the study and design of enzymes by demonstrating how counterintuitive sacrifices in chemical reactivity can have worthwhile benefits for other steps in the catalytic cycle.	[Burgin, Tucker; Mayes, Heather B.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Sci, SE-75007 Uppsala, Sweden	University of Michigan System; University of Michigan; Swedish University of Agricultural Sciences	Mayes, HB (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	hbmayes@umich.edu	Stahlberg, Jerry/D-4163-2013; Mayes, Heather/D-8755-2016	Mayes, Heather/0000-0001-9373-0106; Burgin, Tucker/0000-0002-3714-3537	National Science Foundation [ACI-1548562]	National Science Foundation(National Science Foundation (NSF))	This work used the Extreme Science and Engineering Discovery Environment (XSEDE) (47), which is supported by National Science Foundation Grant ACI-1548562. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biddy MJ, 2016, ACS SUSTAIN CHEM ENG, V4, P3196, DOI 10.1021/acssuschemeng.6b00243; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465; Case D.A, 2014, AMBER 14; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Garcia-Guevara F., 2015, BIOCATALYSIS, V1, P109, DOI DOI 10.1515/BOCA-2015-0009; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206775; Kastner J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052648; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayes HB, 2016, CHEM SCI, V7, P5955, DOI 10.1039/c6sc00571c; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; Mertz B, 2005, BIOPOLYMERS, V79, P197, DOI 10.1002/bip.20347; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Riccardi D, 2008, BIOCHEMISTRY-US, V47, P2369, DOI 10.1021/bi701950j; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sandgren M, 2013, J MOL BIOL, V425, P622, DOI 10.1016/j.jmb.2012.11.039; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Thompson AJ, 2012, ACTA CRYSTALLOGR D, V68, P875, DOI 10.1107/S0907444912016496; Varrot A, 1999, BIOCHEM J, V337, P297, DOI 10.1042/0264-6021:3370297; Wolfgang DE, 1999, BIOCHEMISTRY-US, V38, P9746, DOI 10.1021/bi990401v; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	47	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4680	4687		10.1074/jbc.RA117.001186	http://dx.doi.org/10.1074/jbc.RA117.001186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29321205	Green Published, hybrid			2022-12-28	WOS:000428848300011
J	Sherp, AM; Westfall, CS; Alvarez, S; Jez, JM				Sherp, Ashley M.; Westfall, Corey S.; Alvarez, Sophie; Jez, Joseph M.			Arabidopsis thaliana GH3.15 acyl acid amido synthetase has a highly specific substrate preference for the auxin precursor indole-3-butyric acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATES AMINO-ACIDS; LATERAL ROOT-FORMATION; PLANT HORMONES; ENZYME ACTION; FAMILY; HYPOCOTYL; RESPONSES; VECTORS; REVEALS; GROWTH	Various phytohormones control plant growth and development and mediate biotic and abiotic stress responses. Gretchen Hagen 3 (GH3) acyl acid amido synthetases are plant enzymes that typically conjugate amino acids to indole-3-acetic acid (IAA) or jasmonic acid (JA) to inactivate or activate these phytohormones, respectively; however, the physiological and biological roles of many of these enzymes remain unclear. Using a biochemical approach, we found that the Arabidopsis thaliana GH3.15 (AtGH3.15) preferentially uses indole-3-butyric acid (IBA) and glutamine as substrates. The X-ray crystal structure of the AtGH3.15 center dot AMP complex, modeling of IBA in the active site, and biochemical analysis of site-directed mutants provide insight on active site features that lead to AtGH3.15's preference for IBA. Assay-based in planta analysis of AtGH3.15-overexpressing lines indicated that their root elongation and lateral root density were resistant to IBA treatment but not to treatment with either IAA or JA. These findings suggest that AtGH3.15 may play a role in auxin homeostasis by modulating the levels of IBA for peroxisomal conversion to IAA. Analysis of AtGH3.15 promoter-driven yellow fluorescent protein reporter lines revealed that AtGH3.15 is expressed at significant levels in seedlings, roots, and parts of the siliques. We conclude that AtGH3.15 is unique in the GH3 protein family for its role in modifying IBA in auxin homeostasis and that it is the first GH3 protein shown to primarily modify a plant growth regulator other than IAA and JA.	[Sherp, Ashley M.; Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Alvarez, Sophie] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	Washington University (WUSTL); University of Nebraska System; University of Nebraska Lincoln	Jez, JM (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	jjez@wustl.edu			National Science Foundation [DBI-1427621]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE))	The mass spectrometry measurement was performed at the Proteomics and Mass Spectrometry Facility at the Danforth Plant Science Center based upon work supported by National Science Foundation Grant DBI-1427621 for acquisition of the 6500 QTRAP LC-MS/MS. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; Bartel B, 2001, J PLANT GROWTH REGUL, V20, P198, DOI 10.1007/s003440010025; Basu MM, 2013, PLANT PHYSIOL, V162, P96, DOI 10.1104/pp.113.216234; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kroin J., 1992, COMB P INT PLANT PRO, V42, P489; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ludwig-Muller J, 2000, PLANT GROWTH REGUL, V32, P219, DOI 10.1023/A:1010746806891; Michniewicz Marta, 2015, BMC Res Notes, V8, P63, DOI 10.1186/s13104-015-1010-6; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Round A, 2013, ACTA CRYSTALLOGR D, V69, P2072, DOI 10.1107/S0907444913019276; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Schlicht M, 2013, NEW PHYTOL, V200, P473, DOI 10.1111/nph.12377; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Spiess Gretchen M, 2013, Subcell Biochem, V69, P257, DOI 10.1007/978-94-007-6889-5_14; STASINOPOULOS TC, 1990, PLANT PHYSIOL, V93, P1365, DOI 10.1104/pp.93.4.1365; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2011, MOL PLANT, V4, P477, DOI 10.1093/mp/ssr006; Sugawara S, 2015, PLANT CELL PHYSIOL, V56, P1641, DOI 10.1093/pcp/pcv088; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; van Gelderen K, 2016, MOL PLANT, V9, P857, DOI 10.1016/j.molp.2016.03.005; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zheng ZY, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.25, 10.1038/nplants.2016.25]; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2000, GENETICS, V156, P1323	46	20	21	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4277	4288		10.1074/jbc.RA118.002006	http://dx.doi.org/10.1074/jbc.RA118.002006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462792	Green Published, hybrid			2022-12-28	WOS:000428204300004
J	Zhang, J; Ye, ZW; Chen, W; Manevich, Y; Mehrotra, S; Ball, L; Janssen-Heininger, Y; Tew, KD; Townsend, DM				Zhang, Jie; Ye, Zhi-wei; Chen, Wei; Manevich, Yefim; Mehrotra, Shikhar; Ball, Lauren; Janssen-Heininger, Yvonne; Tew, Kenneth D.; Townsend, Danyelle M.			S-Glutathionylation of estrogen receptor alpha affects dendritic cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; IMMUNE-RESPONSES; DIFFERENTIATION; ACTIVATION; NICHE; IDENTIFICATION; PROLIFERATION; LOCALIZATION; TRANSFERASES	Glutathione S-transferase Pi (GSTP) is a thiolase that catalyzes the addition of glutathione (GSH) to receptive cysteines in target proteins, producing an S-glutathionylated residue. Accordingly, previous studies have reported that S-glutathionylation is constitutively decreased in cells from mice lacking GSTP (Gstp1/p2(-/-)). Here, we found that bone marrow-derived dendritic cells (BMDDCs) from Gstp1/p2(-/-) mice have proliferation rates that are greater than those in their WT counterparts (Gstp1/p2(-/-)). Moreover, Gstp1/p2(-/-) BMDDCs had increased reactive oxygen species (ROS) levels and decreased GSH:glutathione disulfide (GSSG) ratios. Estrogen receptor alpha (ER alpha) is linked to myeloproliferation and differentiation, and we observed that its steady-state levels are elevated in Gstp1/p2(-/-) BMDDCs, indicating a link betweenGSTPand ER alpha activities. BMDDCs differentiated by granulocyte-macrophage colony-stimulating factor had elevated ER alpha levels, which were more pronounced in Gstp1/p2(-/-) thanWTmice. When stimulated with lipopolysaccharide for maturation, Gstp1/p2(-/-) BMDDCs exhibited augmented endocytosis, maturation rate, cytokine secretion, and T-cell activation; heightened glucose uptake and glycolysis; increased Akt signaling (in the mTOR pathway); and decreased AMPK-mediated phosphorylation of proteins. Of note, GSTP formed a complex with ER alpha, stimulating ER alpha S-glutathionylation at cysteines 221, 245, 417, and 447; altering ER alpha's binding affinity for estradiol; and reducing overall binding potential (receptor density and affinity) 3-fold. Moreover, in Gstp1/p2(-/-) BMDDCs, ER alpha S-glutathionylation was constitutively decreased. Taken together, these findings suggest that GSTP-mediated S-glutathionylation of ER alpha controls BMDDC differentiation and affects metabolic function in dendritic cells.	[Zhang, Jie; Ye, Zhi-wei; Manevich, Yefim; Ball, Lauren; Tew, Kenneth D.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 70 President St,DDB410, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ South Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Mehrotra, Shikhar] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Chen, Wei] Southeast Univ, Med Sch, Affiliated Hosp 2, Dept Infect Dis, 1-1 Zhongfu Rd, Nanjing 210003, Jiangsu, Peoples R China; [Janssen-Heininger, Yvonne] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Southeast University - China; University of Vermont	Tew, KD (corresponding author), Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 70 President St,DDB410, Charleston, SC 29425 USA.	tewk@musc.edu	Chen, Wei/AAG-9952-2021; Zhang, Jie/F-1540-2011	Chen, Wei/0000-0003-1526-4677; Zhang, Jie/0000-0002-0466-2955; Ball, Lauren/0000-0001-6780-1679	National Institutes of Health [C06 RR015455]; Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Aliau S, 1997, BIOCHEMISTRY-US, V36, P5861, DOI 10.1021/bi963111c; Arai F, 2009, ANN NY ACAD SCI, V1176, P36, DOI 10.1111/j.1749-6632.2009.04561.x; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carreras E, 2008, J IMMUNOL, V180, P727, DOI 10.4049/jimmunol.180.2.727; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dasgupta RK, 2003, BLOOD, V102, P2345, DOI 10.1182/blood-2003-02-0444; Everts B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00203; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; EYLAR E, 1993, INT IMMUNOL, V5, P97, DOI 10.1093/intimm/5.1.97; Gate L, 2004, J BIOL CHEM, V279, P8608, DOI 10.1074/jbc.M308613200; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grek CL, 2011, PHARMACOL THERAPEUT, V129, P172, DOI 10.1016/j.pharmthera.2010.09.008; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lin AHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063199; List AF, 1997, BLOOD, V90, P3364, DOI 10.1182/blood.V90.9.3364; Lyons RM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-43; Manevich Y, 2013, FREE RADICAL BIO MED, V54, P62, DOI 10.1016/j.freeradbiomed.2012.10.556; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Murata Y, 2002, INT IMMUNOL, V14, P201, DOI 10.1093/intimm/14.2.201; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Otsuki T, 2000, CANCER RES, V60, P1434; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Raza A, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-20; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Townsend DM, 2014, ADV CANCER RES, V122, P177, DOI 10.1016/B978-0-12-420117-0.00005-0; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Ye ZW, 2017, ANTIOXID REDOX SIGN, V26, P248, DOI 10.1089/ars.2015.6486; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107478	48	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4366	4380		10.1074/jbc.M117.814327	http://dx.doi.org/10.1074/jbc.M117.814327			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29374060	Green Published, hybrid			2022-12-28	WOS:000428204300010
J	Chen, X; Liu, ZH; Shan, ZL; Yao, WY; Gu, AH; Wen, WY				Chen, Xing; Liu, Ziheng; Shan, Zelin; Yao, Weiyi; Gu, Aihong; Wen, Wenyu			Structural determinants controlling 14-3-3 recruitment to the endocytic adaptor Numb and dissociation of the Numb center dot alpha-adaptin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; MAMMALIAN NUMB; PHOSPHORYLATION; PROTEINS; BINDING; LOCALIZATION; DOMAIN; FATE; RECOGNITION; ACTIVATION	Traffic of cargo across membranes helps establish, maintain, and reorganize distinct cellular compartments and is fundamental to many metabolic processes. The cargo-selective endocytic adaptor Numb participates in clathrin-dependent endocytosis by attaching cargoes to the clathrin adaptor alpha-adaptin. The phosphorylation of Numb at Ser(265) and Ser(284) recruits the regulatory protein 14-3-3, accompanied by the dissociation of Numb from alpha-adaptin and Numb's translocation from the cortical membrane to the cytosol. However, the molecular mechanisms underlying the Numb-alpha-adaptin interaction and its regulation by Numb phosphorylation and 14-3-3 recruitment remain poorly understood. Here, biochemical and structural analyses of the Numb.14-3-3 complex revealed that Numb phosphorylation at both Ser(265) and Ser(284) is required for Numb's efficient interaction with 14-3-3. We also discovered that an RQFRF motif surrounding Ser(265) in Numb functions together with the canonical C-terminal DPF motif, required for Numb's interaction with alpha-adaptin, to form a stable complex with alpha-adaptin. Of note, we provide evidence that the phosphorylation-induced binding of 14-3-3 to Numb directly competes with the binding of alpha-adaptin to Numb. Our findings suggest a potential mechanism governing the dynamic assembly of Numb with alpha-adaptin or 14-3-3. This dual-site recognition of Numb by alpha-adaptin may have implications for other alpha-adaptin targets. We propose that the newly identified alpha-adaptin-binding site surrounding Ser(265) in Numb functions as a triggering mechanism for the dynamic dissociation of the Numb.alpha-adaptin complex.	Fudan Univ, Huashan Hosp, State Key Lab Med Neurobiol, Dept Neurosurg,Inst Biomed Sci, Shanghai 200032, Peoples R China; Fudan Univ, Sch Basic Med Sci, Shanghai Med Coll, Dept Syst Biol Med, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Wen, WY (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200032, Peoples R China.	wywen@fudan.edu.cn			Ministry of Science and Technology of the People's Republic of China [2014CB910201]; National Natural Science Foundation of China [31422015, 31670730, 31270778]; Shanghai Municipal Education Commission [14SG06]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by Grant 2014CB910201 from the Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China Grants 31422015, 31670730, and 31270778; and Shanghai Municipal Education Commission Grant 14SG06 (to W.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hirai M, 2017, J CLIN INVEST, V127, P569, DOI 10.1172/JCI91081; Jia M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9381; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Ma L, 2016, DEV CELL, V37, P428, DOI 10.1016/j.devcel.2016.05.003; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Ormancey M, 2017, TRENDS PLANT SCI, V22, P263, DOI 10.1016/j.tplants.2016.11.007; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salle J, 2017, EMBO J, V36, P1928, DOI 10.15252/embj.201695622; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shao XM, 2016, CELL RES, V26, P593, DOI 10.1038/cr.2016.34; Siddique HR, 2015, HEPATOLOGY, V62, P1466, DOI 10.1002/hep.27987; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Tokumitsu H, 2005, J BIOL CHEM, V280, P35108, DOI 10.1074/jbc.M503912200; Tokumitsu H, 2006, FEBS LETT, V580, P5797, DOI 10.1016/j.febslet.2006.09.043; Tosoni D, 2017, EMBO MOL MED, V9, P655, DOI 10.15252/emmm.201606940; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	44	5	5	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4149	4158		10.1074/jbc.RA117.000897	http://dx.doi.org/10.1074/jbc.RA117.000897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382713	Green Published, hybrid			2022-12-28	WOS:000427587500025
J	Frei, B; Eisenach, C; Martinoia, E; Hussein, S; Chen, XZ; Arrivault, S; Neuhaus, HE				Frei, Benedikt; Eisenach, Cornelia; Martinoia, Enrico; Hussein, Shaimaa; Chen, Xing-Zhen; Arrivault, Stephanie; Neuhaus, H. Ekkehard			Purification and functional characterization of the vacuolar malate transporter tDT from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-METABOLISM; DICARBOXYLATE TRANSPORTER; SULFATE TRANSPORTERS; ALUMINUM TOLERANCE; CITRATE SYNTHASE; PLANT-METABOLISM; SALINITY STRESS; SLC13 FAMILY; ION CHANNELS; TONOPLAST	The exact transport characteristics of the vacuolar dicarboxylate transporter tDT from Arabidopsis are elusive. To overcome this limitation, we combined a range of experimental approaches comprising generation/analysis of tDT overexpressors, (CO2)-C-13 feeding and quantification of C-13 enrichment, functional characterization of tDT in proteoliposomes, and electrophysiological studies on vacuoles. tdt knockout plants showed decreased malate and increased citrate concentrations in leaves during the diurnal light-dark rhythm and after onset of drought, when compared with wildtypes. Interestingly, under the latter two conditions, tDT overexpressors exhibited malate and citrate levels opposite to tdt knockout plants. Highly purified tDT protein transports malate and citrate in a 1: 1 antiport mode. The apparent affinity for malate decreased with decreasing pH, whereas citrate affinity increased. This observation indicates that tDT exhibits a preference for dianion substrates, which is supported by electrophysiological analysis on intact vacuoles. tDT also accepts fumarate and succinate as substrates, but not alpha-ketoglutarate, gluconate, sulfate, or phosphate. Taking tDT as an example, we demonstrated that it is possible to reconstitute a vacuolar metabolite transporter functionally in proteoliposomes. The displayed, so far unknown counterexchange properties of tDT now explain the frequently observed reciprocal concentration changes of malate and citrate in leaves from various plant species. tDT from Arabidopsis is the first member of the well-known and widely present SLC13 group of carrier proteins, exhibiting an antiport mode of transport.	[Frei, Benedikt; Neuhaus, H. Ekkehard] Univ Kaiserslautern, Pflanzenphysiol, Erwin Schrodinger Str, D-67653 Kaiserslautern, Germany; [Eisenach, Cornelia; Martinoia, Enrico] Univ Zurich, Inst Pflanzenbiol, CH-8008 Zurich, Switzerland; [Hussein, Shaimaa; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Arrivault, Stephanie] Max Planck Inst Mol Plant Physiol, Wissenschaftspk Potsdam Golm,Muhlenberg 1, D-14476 Potsdam, Germany	University of Kaiserslautern; University of Zurich; University of Alberta; Max Planck Society	Neuhaus, HE (corresponding author), Univ Kaiserslautern, Erwin Schrodinger Str, D-67653 Kaiserslautern, Germany.	neuhaus@rhrk.uni-kl.de	Hussein, Shaimaa/HHZ-5533-2022; Martinoia, Enrico/AAH-8712-2021	Hussein, Shaimaa/0000-0003-0849-9670	Deutsche Forschungsgemeinschaft (DFG) [IRTG 1830]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the International Research Training Group 1830 (IRTG 1830). The authors declare that they have no conflicts of interest with the contents of this article.	Baetz U, 2016, PLANT PHYSIOL, V172, P1167, DOI 10.1104/pp.16.00183; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Canel C, 1996, PLANT MOL BIOL, V31, P143, DOI 10.1007/BF00020613; CERANA R, 1995, AUST J PLANT PHYSIOL, V22, P115, DOI 10.1071/PP9950115; CHANG KJ, 1991, BIOCHIM BIOPHYS ACTA, V1092, P29, DOI 10.1016/0167-4889(91)90174-V; Cheffings CM, 1997, J EXP BOT, V48, P623, DOI 10.1093/jxb/48.Special_Issue.623; Cheung CYM, 2014, PLANT PHYSIOL, V165, P917, DOI 10.1104/pp.113.234468; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Emmerlich V, 2003, P NATL ACAD SCI USA, V100, P11122, DOI 10.1073/pnas.1832002100; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Finkemeier Iris, 2009, F1000 Biol Rep, V1, P47, DOI 10.3410/B1-47; GERHARDT R, 1987, PLANT PHYSIOL, V83, P399, DOI 10.1104/pp.83.2.399; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hafke JB, 2003, PLANT J, V35, P116, DOI 10.1046/j.1365-313X.2003.01781.x; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hurth MA, 2005, PLANT PHYSIOL, V137, P901, DOI 10.1104/pp.104.058453; Igamberdiev AU, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01042; IWASAKI I, 1992, PLANT PHYSIOL, V98, P1494, DOI 10.1104/pp.98.4.1494; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Liu JL, 2015, P NATL ACAD SCI USA, V112, pE6571, DOI 10.1073/pnas.1514598112; Liu RL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00186; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; Medeiros DB, 2017, PLANT PHYSIOL, V175, P1068, DOI 10.1104/pp.17.00971; Neuhaus HE, 2007, FEBS LETT, V581, P2223, DOI 10.1016/j.febslet.2007.02.003; Oxender D. L., 1972, METABOLIC TRANSPORT, P133; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pantoja O, 2002, J MEMBRANE BIOL, V186, P31, DOI 10.1007/s00232-001-0132-z; Popova TN, 1998, BBA-BIOENERGETICS, V1364, P307, DOI 10.1016/S0005-2728(98)00008-5; RAVEN JA, 1990, PLANT CELL ENVIRON, V13, P721, DOI 10.1111/j.1365-3040.1990.tb01086.x; RENTSCH D, 1991, PLANTA, V184, P532, DOI 10.1007/BF00197903; Rienmuller F, 2012, J BIOL CHEM, V287, P8986, DOI 10.1074/jbc.M111.310367; Scheible WR, 2000, PLANT CELL ENVIRON, V23, P1155, DOI 10.1046/j.1365-3040.2000.00634.x; Schulze WX, 2012, PLANT J, V69, P529, DOI 10.1111/j.1365-313X.2011.04812.x; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; WHITE PJ, 1989, PLANTA, V179, P265, DOI 10.1007/BF00393698; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yao XZ, 2000, AM J PHYSIOL-RENAL, V279, pF54, DOI 10.1152/ajprenal.2000.279.1.F54; Ye J, 2017, PLANT CELL, V29, P2249, DOI 10.1105/tpc.17.00211	50	13	13	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4180	4190		10.1074/jbc.RA117.000851	http://dx.doi.org/10.1074/jbc.RA117.000851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367340	Green Published, hybrid			2022-12-28	WOS:000427587500028
J	Croft, T; Raj, CJT; Salemi, M; Phinney, BS; Lin, SJ				Croft, Trevor; Raj, Christol James Theoga; Salemi, Michelle; Phinney, Brett S.; Lin, Su-Ju			A functional link between NAD(+) homeostasis and N-terminal protein acetylation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; CALORIE RESTRICTION; NMN ADENYLYLTRANSFERASE; CELLULAR-PROTEINS; GENE DISRUPTION; ACTIN CABLES; YEAST; TROPOMYOSIN; ACETYLTRANSFERASE	Nicotinamide adenine dinucleotide (NAD(+)) is an essential metabolite participating in cellular redox chemistry and signaling, and the complex regulation of NAD(+) metabolism is not yet fully understood. To investigate this, we established a NAD(+) intermediate specific reporter system to identify factors required for salvage of metabolically linked nicotinamide (NAM) and nicotinic acid (NA). Mutants lacking components of the NatB complex, NAT3 and MDM20, appeared as hits in this screen. NatB is an N-alpha-terminal acetyltransferase responsible for acetylation of the N terminus of specific Met-retained peptides. In NatB mutants, increased NA/NAM levels were concomitant with decreased NAD(+). We identified the vacuolar pool of nicotinamide riboside (NR) as the source of this increased NA/NAM. This NR pool is increased by nitrogen starvation, suggesting NAD(+) and related metabolites may be trafficked to the vacuole for recycling. Supporting this, increased NA/NAM release in NatB mutants was abolished by deleting the autophagy protein ATG14. We next examined Tpm1 (tropomyosin), whose function is regulated by NatB-mediated acetylation, and Tpm1 overexpression (TPM1-oe) was shown to restore some NatB mutant defects. Interestingly, although TPM1-oe largely suppressed NA/NAM release in NatB mutants, it did not restore NAD(+) levels. We showed that decreased nicotinamide mononucleotide adenylyltransferase (Nma1/Nma2) levels probably caused the NAD(+) defects, and NMA1-oe was sufficient to restore NAD(+). NatB-mediated N-terminal acetylation of Nma1 and Nma2 appears essential for maintaining NAD(+) levels. In summary, our results support a connection between NatB-mediated protein acetylation and NAD(+) homeostasis. Our findings may contribute to understanding the molecular basis and regulation of NAD(+) metabolism.	[Croft, Trevor; Raj, Christol James Theoga; Lin, Su-Ju] Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA; [Salemi, Michelle; Phinney, Brett S.] Univ Calif Davis, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302	NIGMS, National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS, National Institutes of Health, Grant GM102297. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; An ZY, 2014, AUTOPHAGY, V10, P1702, DOI 10.4161/auto.32122; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Brachmann CB, 1998, YEAST, V14, P115; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke D., 2000, METHODS YEAST GENETI, P171; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Delorme-Axford E, 2015, METHODS, V75, P3, DOI 10.1016/j.ymeth.2014.12.008; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Effelsberg D, 2015, J BIOL CHEM, V290, P25333, DOI 10.1074/jbc.M115.653451; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Giardina BJ, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-9; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; HERMANN GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hong HY, 2017, STRUCTURE, V25, P641, DOI 10.1016/j.str.2017.03.003; Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kulikova V, 2015, J BIOL CHEM, V290, P27124, DOI 10.1074/jbc.M115.664458; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; LIU HP, 1992, J CELL BIOL, V118, P285, DOI 10.1083/jcb.118.2.285; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; NATALINI P, 1986, BIOCHEMISTRY-US, V25, P3725, DOI 10.1021/bi00360a037; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Singer JM, 2000, GENETICS, V156, P523; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Steiger MA, 2005, RNA, V11, P99, DOI 10.1261/rna.7194605; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Tsang F, 2015, J BIOL CHEM, V290, P12753, DOI 10.1074/jbc.M115.644534; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	75	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2927	2938		10.1074/jbc.M117.807214	http://dx.doi.org/10.1074/jbc.M117.807214			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317496	Green Published, hybrid			2022-12-28	WOS:000426051900026
J	Lopez, J; Feldman, MF				Lopez, Juvenal; Feldman, Mario F.			Expanding the molecular weaponry of bacterial species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						protein secretion; toxicity; bacteria; Pseudomonas; NAD	SECRETION SYSTEM	The type VI secretion system (T6SS) delivers toxic effectors between Gram-negative bacteria. Most antibacterial T6SS effectors are peptidoglycanases, nucleases, or lipases. In the current work, Tang et al. structurally and functionally characterize a novel family of NAD(P)(+)-hydrolyzing effectors (NADases), thus expanding the documented types of T6SS substrates. Bioinformatic identification of NADase family members putatively secreted by the bacteriolytic type VII secretion system (T7SS) of Gram-positive bacteria further points to NADases as a diverse and important class of effectors.	[Lopez, Juvenal; Feldman, Mario F.] Washington Univ, Dept Mol Microbiol, Sch Med St Louis, Campus Box 8230, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Feldman, MF (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med St Louis, Campus Box 8230, St Louis, MO 63110 USA.	mariofeldman@wustl.edu		Lopez, Juvenal/0000-0002-3433-2412	National Institutes of Health [1R01AI125363-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the Feldman lab is supported by National Institutes of Health Grant 1R01AI125363-01.	Cao ZP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.183; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Lazzaro M, 2017, MBIO, V8, DOI 10.1128/mBio.00559-17; Lien YW, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00254; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Tang JY, 2018, J BIOL CHEM, V293, P1504, DOI 10.1074/jbc.RA117.000178; Weber BS, 2016, MBIO, V7, DOI 10.1128/mBio.01253-16; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027	10	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1515	1516		10.1074/jbc.H118.001463	http://dx.doi.org/10.1074/jbc.H118.001463			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29414766	Green Published, hybrid			2022-12-28	WOS:000424201700003
J	Yi, L; Kaler, SG				Yi, Ling; Kaler, Stephen G.			Interaction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; TOUCH-TURN MOTIF; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; VCP MUTATIONS; P97 ATPASE; DISEASE; DEGRADATION; COFACTOR	The copper-transporting ATPase ATP7A contains eight transmembrane domains and is required for normal human copper homeostasis. Mutations in the ATP7A gene may lead to infantile-onset cerebral degeneration (Menkes disease); occipital horn syndrome (OHS), a related but much milder illness; or an adult-onset isolated distal motor neuropathy. The ATP7A missense mutation T994I is located in the sixth transmembrane domain of ATP7A, represents one of the variants associated with the latter phenotype, and is associated with an abnormal interaction with p97/valosin-containing protein (VCP), a hexameric AAA ATPase (ATPase associated with diverse cellular activities) with multiple biological functions. In this study, we further characterized this interaction and discovered a concealed UBX domain in the third lumenal loop of ATP7A, between its fifth and sixth transmembrane domains. We show that the T994I substitution results in conformational exposure of the UBX domain, which then binds the N-terminal domain of p97/VCP. We also show that this abnormal interaction occurs at or near the cell plasma membrane. The UBX domain has a conserved hydrophobic FP (Phe-Pro) motif, and substitution with di-alanine abrogated the interaction and restored the proper intracellular localization of ATP7A in the trans-Golgi network. Using protein MS, we identified potential coordinating components of the ATP7A(T994I)-p97 complex, including NSFL1 cofactor (NSF1C or p47) that may be relevant to the pathophysiology and clinical effects associated with ATP7A(T994I). Our study represents the first report of p97/VCP binding to a UBX domain that is not normally exposed, resulting in an aberrant protein-protein interaction leading to motor neuron degeneration.	[Yi, Ling; Kaler, Stephen G.] Eunice Kennedy Shriver NICHD, Sect Translat Neurosci, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kaler, SG (corresponding author), Eunice Kennedy Shriver NICHD, Sect Translat Neurosci, Mol Med Branch, NIH,Porter Neurosci Res Ctr, Bldg 35,Rm 2D-971,35A Convent Dr,MSC 3754, Bethesda, MD 20892 USA.	kalers@mail.nih.gov	Kaler, Stephen/GPT-3845-2022		Eunice Kennedy Shriver NICHD, National Institutes of Health [1ZIA HD008892]; National Institutes of Health Office of Dietary Supplements; National Institutes of Health Clinical Center Bench-to-Bedside Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008892] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Clinical Center Bench-to-Bedside Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the intramural research program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (Project 1ZIA HD008892) and a National Institutes of Health Clinical Center Bench-to-Bedside Award supported by the National Institutes of Health Office of Dietary Supplements. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Bodnar Nicholas, 2017, F1000Res, V6, P1318, DOI 10.12688/f1000research.11683.1; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Chen XQ, 2010, J BIOL CHEM, V285, P7197, DOI 10.1074/jbc.M109.047084; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Gonzalez MA, 2014, BRAIN, V137, P2897, DOI 10.1093/brain/awu224; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Jerath N. U., 2015, CASE REP GENET, V2015, DOI [10.1155/2015/239167, DOI 10.1155/2015/239167]; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kang W, 2011, BIOCHEM BIOPH RES CO, V407, P531, DOI 10.1016/j.bbrc.2011.03.052; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; Kim KH, 2011, PROTEINS, V79, P2583, DOI 10.1002/prot.23073; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Qiu LY, 2010, J BIOL CHEM, V285, P365, DOI 10.1074/jbc.M109.044685; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yi L, 2015, HUM MOL GENET, V24, P2411, DOI 10.1093/hmg/ddv002; Yi L, 2012, HUM MOL GENET, V21, P1794, DOI 10.1093/hmg/ddr612; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	36	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7606	7617		10.1074/jbc.RA117.000686	http://dx.doi.org/10.1074/jbc.RA117.000686			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599289	Green Published, hybrid			2022-12-28	WOS:000437256500013
J	Briot, J; Mailhot, O; Bourdin, B; Tetreault, MP; Najmanovich, R; Parent, L				Briot, Julie; Mailhot, Olivier; Bourdin, Benoite; Tetreault, Marie-Philippe; Najmanovich, Rafael; Parent, Lucie			A three-way inter-molecular network accounts for the Ca(V)21-induced functional modulation of the pore-forming Ca(V)1.2 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homology modeling; molecular dynamics; patch clamp; protein-protein interaction; calcium channel; channel activation; Western blot; protein structure; structure-function; coimmunoprecipitation; MIDAS; von Willebrand factor type A domain	VON-WILLEBRAND-FACTOR; DEPENDENT ADHESION SITE; MOLECULAR-DYNAMICS SIMULATIONS; GATED CALCIUM-CHANNELS; FACTOR-A DOMAIN; INTEGRIN REGULATION; I-DOMAIN; CA-V-ALPHA-2-DELTA-1 SUBUNIT; ALPHA(2)DELTA SUBUNITS; CA2+ CHANNELS	L-type Ca(V)1.2 channels are essential for the excitation-contraction coupling in cardiomyocytes and are hetero-oligomers of a pore-forming Ca(V)1C assembled with Ca-V and Ca(V)21 subunits. A direct interaction between Ca(V)21 and Asp-181 in the first extracellular loop of Ca(V)1 reproduces the native properties of the channel. A 3D model of the von Willebrand factor type A (VWA) domain of Ca(V)21 complexed with the voltage sensor domain of Ca(V)1C suggests that Ser-261 and Ser-263 residues in the metal ion-dependent adhesion site (MIDAS) motif are determinant in this interaction, but this hypothesis is untested. Here, coimmunoprecipitation assays and patch-clamp experiments of single-substitution variants revealed that Ca(V)21 Asp-259 and Ser-261 are the two most important residues in regard to protein interactions and modulation of Ca(V)1.2 currents. In contrast, mutating the side chains of Ca(V)21 Ser-263, Thr-331, and Asp-363 with alanine did not completely prevent channel function. Molecular dynamics simulations indicated that the carboxylate side chain of Ca(V)21 Asp-259 coordinates the divalent cation that is further stabilized by the oxygen atoms from the hydroxyl side chain of Ca(V)21 Ser-261 and the carboxylate group of Ca(V)1C Asp-181. In return, the hydrogen atoms contributed by the side chain of Ser-261 and the main chain of Ser-263 bonded the oxygen atoms of Ca(V)1.2 Asp-181. We propose that Ca(V)21 Asp-259 promotes Ca2+ binding necessary to produce the conformation of the VWA domain that locks Ca(V)21 Ser-261 and Ser-263 within atomic distance of Ca(V)1C Asp-181. This three-way network appears to account for the Ca(V)21-induced modulation of Ca(V)1.2 currents.	[Briot, Julie; Mailhot, Olivier; Najmanovich, Rafael; Parent, Lucie] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H1T 1C8, Canada; [Mailhot, Olivier] Univ Montreal, Fac Med, Dept Biochim & Med Mol, Montreal, PQ H1T 1C8, Canada; [Briot, Julie; Bourdin, Benoite; Tetreault, Marie-Philippe; Parent, Lucie] Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Dept Pharmacol & Physiol, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	lucie.parent@umontreal.ca	Mailhot, Olivier/AAQ-5942-2021	Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]; Fonds de la Recherche du Quebec en Nature et Technologie	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Fonds de la Recherche du Quebec en Nature et Technologie	This work was supported in part by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant G-15-0009329 from the Canadian Heart and Stroke Foundation (to L.P.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. award from "Fonds de la Recherche du Quebec en Nature et Technologie."	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Becker AKA, 2015, PROTEIN EXPRES PURIF, V107, P20, DOI 10.1016/j.pep.2014.11.005; BERGELSON JM, 1995, CURR BIOL, V5, P615, DOI 10.1016/S0960-9822(95)00124-2; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bourdin B, 2017, J BIOL CHEM, V292, P17236, DOI 10.1074/jbc.M117.806893; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Briot J., 2016, BIOCH MOL BIOL J, V2, P3, DOI [10.21767/2471-8084.100025, DOI 10.21767/2471-8084.100025]; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; COLOMBATTI A, 1991, BLOOD, V77, P2305; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; EDWARDS YJK, 1995, FEBS LETT, V358, P283, DOI 10.1016/0014-5793(94)01447-9; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; Kwasigroch JM, 1996, J MOL BIOL, V259, P855, DOI 10.1006/jmbi.1996.0363; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; NAGLE JF, 1993, BIOPHYS J, V64, P1476, DOI 10.1016/S0006-3495(93)81514-5; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pereverzev A, 2002, MOL CELL NEUROSCI, V21, P352, DOI 10.1006/mcne.2002.1179; Pihlajamaa T, 2013, BIOCHEM J, V450, P469, DOI 10.1042/BJ20121058; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sala-Rabanal M, 2017, J BIOL CHEM, V292, P9164, DOI 10.1074/jbc.M117.788232; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Segura E, 2017, J BIOL CHEM, V292, P11109, DOI 10.1074/jbc.M117.784355; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	48	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7176	7188		10.1074/jbc.RA118.001902	http://dx.doi.org/10.1074/jbc.RA118.001902			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588365	Green Published, hybrid			2022-12-28	WOS:000432174500010
J	Furlong, EJ; Choudhury, HG; Kurth, F; Duff, AP; Whitten, AE; Martin, JL				Furlong, Emily J.; Choudhury, Hassanul G.; Kurth, Fabian; Duff, Anthony P.; Whitten, Andrew E.; Martin, Jennifer L.			Disulfide isomerase activity of the dynamic, trimeric Proteus mirabilis ScsC protein is primed by the tandem immunoglobulin-fold domain of ScsB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; NEUTRON-SCATTERING; BOND ISOMERASE; DSBA; OXIDOREDUCTASE; ISOMERIZATION; MEMBRANE; SOFTWARE	Correct disulfide bond formation is essential for proper folding of many proteins, including bacterial virulence factors. The suppressor of copper sensitivity (Scs) proteins have roles in dithiol/disulfide interchange and the bacterial response to copper stress. Encoded in a four-gene cassette (ScsABCD) present in many Gram-negative bacteria, the Scs proteins are enigmatic and poorly characterized. Here, we show that the periplasmic alpha-domain of the membrane protein ScsB in the Gram-negative bacterium Proteus mirabilis forms a redox relay with the soluble periplasmic protein PmScsC. We also found that the periplasmic alpha-domain is sufficient to activate the disulfide isomerase activity of PmScsC. The crystal structure of PmScsB alpha at a resolution of 1.54 angstrom revealed that it comprises two structurally similar immunoglobulin-like folds, one of which includes a putative redox-active site with the sequence CXXXC. We confirmed the importance of these cysteine residues for PmScsB alpha function, and in addition, we engineered cysteine variants that produced a stable complex between PmScsC and PmScsB alpha. Using smallangle X-ray and neutron scattering analyses with contrast variation, we determined a low-resolution structure of the PmScsC-PmScsB alpha complex. The structural model of this complex suggested that PmScsB alpha uses both of its immunoglobulinlike folds to interact with PmScsC and revealed that the highly dynamic PmScsC becomes ordered upon PmScsB alpha binding. These findings add to our understanding of the poorly characterized Scs proteins.	[Furlong, Emily J.; Choudhury, Hassanul G.; Kurth, Fabian; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Furlong, Emily J.; Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia; [Duff, Anthony P.; Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia; [Choudhury, Hassanul G.] Cello Hlth Consulting, Farnham GU9 7DN, Surrey, England; [Kurth, Fabian] Bristol Myers Squibb Co, Arnulfstr 29, D-80636 Munich, Germany	University of Queensland; Griffith University; Australian Nuclear Science & Technology Organisation; Bristol-Myers Squibb	Martin, JL (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld 4111, Australia.; Whitten, AE (corresponding author), Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia.	awh@ansto.gov.au; jlm@griffith.edu.au	Furlong, Emily J/S-5044-2016; Martin, Jennifer L./A-6039-2010	Furlong, Emily J/0000-0002-9086-2979; Duff, Anthony/0000-0003-3586-360X; Whitten, Andrew/0000-0001-8856-3120; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council [FL0992138, DP130100576]; Australian postgraduate award; Institute for Molecular Bioscience research advancement award	Australian Research Council(Australian Research Council); Australian postgraduate award(Australian Government); Institute for Molecular Bioscience research advancement award	This work was supported by Australian Research Council Laureate Fellowship FL0992138 (to J.L.M.), Australian Research Council Discovery Project DP130100576 (to J.L.M.; H.G.C. salary), an Australian postgraduate award (to E.J.F.), and an Institute for Molecular Bioscience research advancement award (to E.J.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Duff AP, 2015, METHOD ENZYMOL, V565, P3, DOI 10.1016/bs.mie.2015.06.014; Edeling MA, 2004, J BACTERIOL, V186, P4030, DOI 10.1128/JB.186.12.4030-4033.2004; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilbert EP, 2006, PHYSICA B, V385-86, P1180, DOI 10.1016/j.physb.2006.05.385; Goldstone D, 2001, P NATL ACAD SCI USA, V98, P9551, DOI 10.1073/pnas.171315498; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krupp R, 2001, J BIOL CHEM, V276, P3696, DOI 10.1074/jbc.M009500200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mudie S, 2015, SCATTERBRAIN SOFTWAR; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepherd M, 2013, ANTIOXID REDOX SIGN, V19, P1494, DOI 10.1089/ars.2012.4939; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5793	5805		10.1074/jbc.RA118.001860	http://dx.doi.org/10.1074/jbc.RA118.001860			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29491145	Green Published, hybrid			2022-12-28	WOS:000430497300004
J	Eckersley, A; Mellody, KT; Pilkington, S; Griffiths, CEM; Watson, REB; O'Cualain, R; Baldock, C; Knight, D; Sherratt, MJ				Eckersley, Alexander; Mellody, Kieran T.; Pilkington, Suzanne; Griffiths, Christopher E. M.; Watson, Rachel E. B.; O'Cualain, Ronan; Baldock, Clair; Knight, David; Sherratt, Michael J.			Structural and compositional diversity of fibrillin microfibrils in human tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; skin; eye; fibroblast; proteomics; atomic force microscopy (AFM); protein structure; collagen VI; fibrillin microfibril	EXTRACELLULAR-MATRIX ASSEMBLIES; COLLAGEN VI MICROFIBRILS; TGF-BETA ACTIVATION; TIGHT-SKIN MOUSE; MARFAN-SYNDROME; ELASTIC FIBERS; RICH MICROFIBRILS; SUPRAMOLECULAR ORGANIZATION; DEVELOPMENTAL EXPRESSION; RELATIVE ABUNDANCE	Elastic fibers comprising fibrillin microfibrils and elastin are present in many tissues, including the skin, lungs, and arteries, where they confer elasticity and resilience. Although fibrillin microfibrils play distinct and tissue-specific functional roles, it is unclear whether their ultrastructure and composition differ between elastin-rich (skin) and elastin-poor (ciliary body and zonule) organs or after in vitro synthesis by cultured cells. Here, we used atomic force microscopy, which revealed that the bead morphology of fibrillin microfibrils isolated from the human eye differs from those isolated from the skin. Using newly developed pre-MS preparation methods and LC-MS/MS, we detected tissue-specific regions of the fibrillin-1 primary structure that were differentially susceptible to proteolytic extraction. Comparing tissue- and culture-derived microfibrils, we found that dermis- and dermal fibroblast-derived fibrillin microfibrils differ in both bead morphology and periodicity and also exhibit regional differences in fibrillin-1 proteolytic susceptibility. In contrast, collagen VI microfibrils from the same dermal or fibroblast samples were invariant in ultrastructure (periodicity) and protease susceptibility. Finally, we observed that skin- and eye-derived microfibril suspensions were enriched in elastic fiber- and basement membrane-associated proteins, respectively. LC-MS/MS also identified proteins (such as calreticulin and protein-disulfide isomerase) that are potentially fundamental to fibrillin microfibril biology, regardless of their tissue source. Fibrillin microfibrils synthesized in cell culture lacked some of these key proteins (MFAP2 and -4 and fibrillin-2). These results showcase the structural diversity of these key extracellular matrix assemblies, which may relate to their distinct roles in the tissues where they reside.	[Eckersley, Alexander; Mellody, Kieran T.; Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Div Cell Matrix Biol & Regenerat Med, Manchester M13 9PT, Lancs, England; [Pilkington, Suzanne; Griffiths, Christopher E. M.; Watson, Rachel E. B.] Univ Manchester, Fac Biol Med & Hlth, Div Musculoskeletal & Dermatol Sci, Manchester M13 9PT, Lancs, England; [O'Cualain, Ronan; Knight, David; Sherratt, Michael J.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Baldock, Clair] Univ Manchester, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Griffiths, Christopher E. M.; Watson, Rachel E. B.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Sherratt, MJ (corresponding author), Univ Manchester, 1-529 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	michael.sherratt@manchester.ac.uk	Watson, Rachel E B/F-1090-2013; Eckersley, Alexander/AAH-6975-2020	Watson, Rachel E B/0000-0002-5162-7503; Eckersley, Alexander/0000-0003-1602-4851; Pilkington, Suzanne/0000-0002-0426-1414; O'Cualain, Ronan/0000-0002-4767-6142; Baldock, Clair/0000-0003-3497-1959	Wellcome Trust Centre for Cell-Matrix Research; Walgreens Boots Alliance (Nottingham, UK); Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N015398/1]; BBSRC [BB/N015398/1] Funding Source: UKRI; MRC [MR/L016540/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N015398/1] Funding Source: researchfish; Medical Research Council [MR/L016540/1] Funding Source: researchfish	Wellcome Trust Centre for Cell-Matrix Research(Wellcome Trust); Walgreens Boots Alliance (Nottingham, UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a program grant from Walgreens Boots Alliance (Nottingham, UK). The authors declare that they have no conflicts of interest with the contents of this article. Walgreens Boots Alliance has approved this manuscript's submission but exerted no editorial control over the content.; Supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N015398/1.	Ashworth JL, 2000, BRIT J OPHTHALMOL, V84, P1312, DOI 10.1136/bjo.84.11.1312; Ashworth JL, 1999, J CELL SCI, V112, P3549; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Atanasova M, 2009, GERONTOLOGY, V55, P73, DOI 10.1159/000157436; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldwin AK, 2014, J CELL SCI, V127, P158, DOI 10.1242/jcs.134270; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beecher N, 2011, J BIOL CHEM, V286, P40266, DOI 10.1074/jbc.M111.265595; Buckley M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2671; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Cain SA, 2009, MOL CELL PROTEOMICS, V8, P2715, DOI 10.1074/mcp.M900008-MCP200; COTTAPEREIRA G, 1976, J INVEST DERMATOL, V66, P143, DOI 10.1111/1523-1747.ep12481882; DAHLBACK K, 1990, J INVEST DERMATOL, V94, P284, DOI 10.1111/1523-1747.ep12874430; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; Dziadek M, 2002, MATRIX BIOL, V21, P227, DOI 10.1016/S0945-053X(02)00009-4; Erickson B, 2013, BIOTECHNOL J, V8, P117, DOI 10.1002/biot.201200174; Fang M, 2012, ACS NANO, V6, P9503, DOI 10.1021/nn302483x; Fang M, 2012, J INVEST DERMATOL, V132, P1791, DOI 10.1038/jid.2012.47; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Haynes SL, 1997, BRIT J DERMATOL, V137, P17, DOI 10.1046/j.1365-2133.1997.1762185.x; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Hibbert SA, 2017, J PHOTOCH PHOTOBIO B, V175, P58, DOI 10.1016/j.jphotobiol.2017.08.020; Hibbert SA, 2015, REDOX BIOL, V5, P101, DOI 10.1016/j.redox.2015.04.003; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hustoft HK, 2012, INTEGRATIVE PROTEOMICS, P73; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P10155, DOI 10.1073/pnas.1401697111; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kielty CM, 1998, ANAL BIOCHEM, V255, P108, DOI 10.1006/abio.1997.2442; KIELTY CM, 1995, J MED GENET, V32, P1, DOI 10.1136/jmg.32.1.1; KIELTY CM, 1991, J CELL SCI, V99, P797; KIELTY CM, 1993, MATRIX, V13, P103, DOI 10.1016/S0934-8832(11)80069-7; Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159; KIELTY CM, 1993, FEBS LETT, V336, P323, DOI 10.1016/0014-5793(93)80829-J; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Lennon R, 2014, J AM SOC NEPHROL, V25, P939, DOI 10.1681/ASN.2013030233; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; Lu YH, 2006, J STRUCT BIOL, V155, P285, DOI 10.1016/j.jsb.2006.03.021; MARIENCHECK MC, 1995, CONNECT TISSUE RES, V31, P87, DOI 10.3109/03008209509028396; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; Meirelles T, 2016, INT J BIOCHEM CELL B, V71, P81, DOI 10.1016/j.biocel.2015.12.009; Moore R., 2016, GENET ENG BIOTECHNOL, V36, P20; Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohno-Jinno A, 2008, INVEST OPHTH VIS SCI, V49, P2870, DOI 10.1167/iovs.07-1488; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Ponamarczuk H, 2018, FRONT BIOSCI-LANDMRK, V23, P1612, DOI 10.2741/4663; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Rietschel B, 2009, MOL CELL PROTEOMICS, V8, P1029, DOI 10.1074/mcp.M800223-MCP200; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Schiavinato A, 2016, J INVEST DERMATOL, V136, P1150, DOI 10.1016/j.jid.2016.02.021; Schilling B, 2015, ANAL CHEM, V87, P10222, DOI 10.1021/acs.analchem.5b02983; Sell D.R., 2010, COMPREHENSIVE PHYSL, P235; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sherratt MJ, 2007, MATRIX BIOL, V26, P156, DOI 10.1016/j.matbio.2006.10.015; Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730; Sherratt MJ, 1997, INT J BIOCHEM CELL B, V29, P1063, DOI 10.1016/S1357-2725(97)00028-9; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stahnke T, 2012, EXP EYE RES, V100, P88, DOI 10.1016/j.exer.2012.04.015; SZIEGOLEIT A, 1985, EUR J BIOCHEM, V151, P595, DOI 10.1111/j.1432-1033.1985.tb09145.x; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Walji TA, 2016, MATRIX BIOL, V55, P63, DOI 10.1016/j.matbio.2016.02.006; Wang Z, 2014, AGING CELL, V13, P226, DOI 10.1111/acel.12164; Watson REB, 1999, J INVEST DERMATOL, V112, P782, DOI 10.1046/j.1523-1747.1999.00562.x; Watson REB, 2001, BRIT J DERMATOL, V144, P751, DOI 10.1046/j.1365-2133.2001.04012.x; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; WRIGHT RR, 1961, AM J PATHOL, V39, P355; Yamanouchi K, 2012, CONNECT TISSUE RES, V53, P14, DOI 10.3109/03008207.2011.602767; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	94	29	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5117	5133		10.1074/jbc.RA117.001483	http://dx.doi.org/10.1074/jbc.RA117.001483			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29453284	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000429409300018
J	Jung, J; Nidetzky, B				Jung, Jihye; Nidetzky, Bernd			Evidence of a sequestered imine intermediate during reduction of nitrile to amine by the nitrile reductase QueF from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; HMG-COA REDUCTASE; STRUCTURAL BASIS; MECHANISM; BIOSYNTHESIS; QUEUOSINE; OXIDOREDUCTASE; DEHYDROGENASE; SUBSTRATE; CATALYSIS	In the biosynthesis of the tRNA-inserted nucleoside queuosine, the nitrile reductase QueF catalyzes conversion of 7-cyano-7-deazaguanine (preQ(0)) to 7-aminomethyl-7-deazaguanine (preQ(1)), a biologically unique four-electron reduction of a nitrile to an amine. The QueF mechanism involves a covalent thioimide adduct between the enzyme and preQ0 that undergoes reduction to preQ1 in two NADPH-dependent steps, presumably via an imine intermediate. Protecting a labile imine from interception by water is fundamental to QueF catalysis for proper enzyme function. In the QueF from Escherichia coli, the conserved Glu(89) and Phe(228) residues together with a mobile structural element composing the catalytic Cys(190) form a substrate-binding pocket that secludes the bound preQ(0) completely from solvent. We show here that residue substitutions (E89A, E89L, and F228A) targeted at opening up the binding pocket weakened preQ(0) binding at the preadduct stage by up to +10 kJ/mol and profoundly affected catalysis. Unlike wildtype enzyme, the QueF variants, including L191A and I192A, were no longer selective for preQ(1) formation. The E89A, E89L, and F228A variants performed primarily (>= 90%) a two-electron reduction of preQ(0), releasing hydrolyzed imine (7-formyl-7-deazaguanine) as the product. The preQ(0) reduction by L191A and I192A gave preQ(1) and 7-formyl-7-deazaguanine at a 4:1 and 1: 1 ratio, respectively. The proportion of 7- formyl-7-deazaguanine in total product increased with increasing substrate concentration, suggesting a role for preQ(0) in a competitor-induced release of the imine intermediate. Collectively, these results provide direct evidence for the intermediacy of an imine in the QueF-catalyzed reaction. They reveal determinants of QueF structure required for imine sequestration and hence for a complete nitrile-to-amine conversion by this class of enzymes.	[Jung, Jihye; Nidetzky, Bernd] Graz Univ Technol, Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria; [Jung, Jihye; Nidetzky, Bernd] Graz Univ Technol, NAWI Graz, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria	Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Graz Univ Technol, Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria.; Nidetzky, B (corresponding author), Graz Univ Technol, NAWI Graz, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643; Jung, Jihye/0000-0001-9186-7176	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program	This work has been supported by the Federal Ministry of Economy, Family and Youth (BMWFW), the Federal Ministry for Transport, Innovation and Technology (BMVIT), the Styrian Business Promotion Agency SFG, the Vienna Business Agency, the Standortagentur Tirol, the Government of Lower Austria, and Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. The authors declare that they have no conflicts of interest with the contents of this article.	Barajas JF, 2015, CHEM BIOL, V22, P1018, DOI 10.1016/j.chembiol.2015.06.022; BRUNHUBER NMW, 1994, CRIT REV BIOCHEM MOL, V29, P415, DOI 10.3109/10409239409083486; Brunhuber NMW, 2000, BIOCHEMISTRY-US, V39, P9174, DOI 10.1021/bi000494c; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; de Maria PD, 2011, CHEMCATCHEM, V3, P1683, DOI 10.1002/cctc.201100220; Dineshkumar TK, 2002, MICROBIOL-SGM, V148, P3779, DOI 10.1099/00221287-148-12-3779; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Gjonaj L, 2016, CATAL SCI TECHNOL, V6, P7391, DOI 10.1039/c6cy01140c; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Haines BE, 2013, ACCOUNTS CHEM RES, V46, P2416, DOI 10.1021/ar3003267; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Jung JY, 2016, J BIOL CHEM, V291, P25411, DOI 10.1074/jbc.M116.747014; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Klepper F, 2005, HELV CHIM ACTA, V88, P2610, DOI 10.1002/hlca.200590201; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Li M, 2016, J MOL CATAL B-ENZYM, V131, P47, DOI 10.1016/j.molcatb.2016.06.001; Moeller K, 2013, ENZYME MICROB TECH, V52, P129, DOI 10.1016/j.enzmictec.2012.12.003; Mohammad A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010030; Oliveira EF, 2016, CATAL SCI TECHNOL, V6, P7172, DOI 10.1039/c6cy00356g; Paramanathan T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6207; RAGG E, 1991, BIOCHIM BIOPHYS ACTA, V1076, P49, DOI 10.1016/0167-4838(91)90218-O; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Ribeiro AJM, 2015, ACS CATAL, V5, P3740, DOI 10.1021/acscatal.5b00528; Richard JP, 2014, CURR OPIN CHEM BIOL, V21, P1, DOI 10.1016/j.cbpa.2014.03.001; Schmolzer K, 2014, FEBS LETT, V588, P2978, DOI 10.1016/j.febslet.2014.05.053; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Vinayak M, 2010, BIOSCIENCE REP, V30, P135, DOI 10.1042/BSR20090057; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilding B, 2013, CHEM-EUR J, V19, P7007, DOI 10.1002/chem.201300163; Wilding B, 2012, ADV SYNTH CATAL, V354, P2191, DOI 10.1002/adsc.201200109	38	4	4	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3720	3733		10.1074/jbc.M117.804583	http://dx.doi.org/10.1074/jbc.M117.804583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29339556	Green Published, hybrid			2022-12-28	WOS:000427030200025
J	Kong, QR; Banaszynski, LA; Geng, FQ; Zhang, XL; Zhang, JM; Zhang, H; O'Neill, CL; Yan, PD; Liu, ZH; Shido, K; Palermo, GD; Allis, CD; Rafii, S; Rosenwaks, Z; Wen, DC				Kong, Qingran; Banaszynski, Laura A.; Geng, Fuqiang; Zhang, Xiaolei; Zhang, Jiaming; Zhang, Heng; O'Neill, Claire L.; Yan, Peidong; Liu, Zhonghua; Shido, Koji; Palermo, Gianpiero D.; Allis, C. David; Rafii, Shahin; Rosenwaks, Zev; Wen, Duancheng			Histone variant H3.3-mediated chromatin remodeling is essential for paternal genome activation in mouse preimplantation embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3.3 INCORPORATION; GENE-EXPRESSION; SPERM CHROMATIN; FERTILIZATION; OOCYTE; TRANSCRIPTION; REPLACEMENT; METHYLATION; REPLICATION; INHERITANCE	Derepression of chromatin-mediated transcriptional repression of paternal and maternal genomes is considered the first major step that initiates zygotic gene expression after fertilization. The histone variant H3.3 is present in both male and female gametes and is thought to be important for remodeling the paternal and maternal genomes for activation during both fertilization and embryogenesis. However, the underlying mechanisms remain poorly understood. Using our H3.3B-HA-tagged mouse model, engineered to report H3.3 expression in live animals and to distinguish different sources of H3.3 protein in embryos, we show here that sperm-derived H3.3 (sH3.3) protein is removed from the sperm genome shortly after fertilization and extruded from the zygotes via the second polar bodies (PBII) during embryogenesis. We also found that the maternal H3.3 (mH3.3) protein is incorporated into the paternal genome as early as 2 h postfertilization and is detectable in the paternal genome until the morula stage. Knockdown of maternal H3.3 resulted in compromised embryonic development both of fertilized embryos and of androgenetic haploid embryos. Furthermore, we report that mH3.3 depletion in oocytes impairs both activation of the Oct4 pluripotency marker gene and global de novo transcription from the paternal genome important for early embryonic development. Our results suggest that H3.3-mediated paternal chromatin remodeling is essential for the development of preimplantation embryos and the activation of the paternal genome during embryogenesis.	[Kong, Qingran; O'Neill, Claire L.; Palermo, Gianpiero D.; Rosenwaks, Zev; Wen, Duancheng] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Geng, Fuqiang; Shido, Koji; Rafii, Shahin] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Kong, Qingran; Zhang, Xiaolei; Zhang, Jiaming; Zhang, Heng; Yan, Peidong; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin 150030, Heilongjiang, Peoples R China; [Banaszynski, Laura A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Banaszynski, Laura A.] Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Cornell University; Cornell University; Northeast Agricultural University - China; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wen, DC (corresponding author), Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	duw2001@med.cornell.edu		Wen, Duancheng/0000-0002-3160-6289	Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant; National Key Research and Development program of China-Stem cell and Translational Research Grant [2016YFA0100200]; "Academic Backbone" Project of Northeast Agricultural University [15XG19]; China Scholarship Council [201606615019]	Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant; National Key Research and Development program of China-Stem cell and Translational Research Grant; "Academic Backbone" Project of Northeast Agricultural University; China Scholarship Council(China Scholarship Council)	This work was supported in part by a Starr Foundation Tri-Institutional Stem Cell Core and Derivation grant (to D. W., Z. R., and S. R.), the National Key Research and Development program of China-Stem cell and Translational Research Grant 2016YFA0100200 (to Q. K. and Z. L.), and "Academic Backbone" Project of Northeast Agricultural University Grant 15XG19 (to Q. K. and Z. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Scholarship Council Grant 201606615019.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; Castillo J, 2015, ASIAN J ANDROL, V17, P601, DOI 10.4103/1008-682X.153302; Chang CC, 2005, DEV BIOL, V278, P367, DOI 10.1016/j.ydbio.2004.11.032; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Farley BM, 2008, CRIT REV BIOCHEM MOL, V43, P135, DOI [10.1080/10409230801921338, 10.1080/10409230801921338 ]; Frank D, 2003, GENE, V312, P135, DOI 10.1016/S0378-1119(03)00609-7; Gao SR, 2004, DEV BIOL, V266, P62, DOI 10.1016/j.ydbio.2003.10.003; Gunes S, 2013, TURK J UROL, V39, P181, DOI 10.5152/tud.2013.037; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Henikoff S, 2004, COLD SPRING HARB SYM, V69, P235, DOI 10.1101/sqb.2004.69.235; Henikoff S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019364; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Lin CJ, 2013, DEVELOPMENT, V140, P3624, DOI 10.1242/dev.095513; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Neri QV, 2014, CELL CALCIUM, V55, P24, DOI 10.1016/j.ceca.2013.10.006; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Saade E, 2015, AGING CELL, V14, P322, DOI 10.1111/acel.12332; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Teperek Marta, 2013, Reproductive Medicine and Biology, V12, P133, DOI 10.1007/s12522-013-0155-z; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; WELLMAN SE, 1987, GENE, V59, P29, DOI 10.1016/0378-1119(87)90263-0; Wen DC, 2014, GENESIS, V52, P959, DOI 10.1002/dvg.22827; Wen DC, 2014, NUCLEUS-AUSTIN, V5, P369, DOI 10.4161/nucl.36231; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Yang P, 2015, BIOESSAYS, V37, P52, DOI 10.1002/bies.201400072; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zheng JK, 2008, DEV DYNAM, V237, P1463, DOI 10.1002/dvdy.21499	52	24	27	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3829	3838		10.1074/jbc.RA117.001150	http://dx.doi.org/10.1074/jbc.RA117.001150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358330	Green Published, hybrid			2022-12-28	WOS:000427030200034
J	Zheng, RC; Hachisuka, S; Tomita, H; Imanaka, T; Zheng, YG; Nishiyama, M; Atomi, H				Zheng, Ren-Chao; Hachisuka, Shin-ichi; Tomita, Hiroya; Imanaka, Tadayuki; Zheng, Yu-Guo; Nishiyama, Makoto; Atomi, Haruyuki			An ornithine omega-aminotransferase required for growth in the absence of exogenous proline in the archaeon Thermococcus kodakarensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; AMINO-ACID RACEMASE; BIOCHEMICAL-CHARACTERIZATION; DELTA-AMINOTRANSFERASE; SUBSTRATE-SPECIFICITY; ASPARTATE-AMINOTRANSFERASE; GENE-CLUSTER; PURIFICATION; LYSINE; IDENTIFICATION	Aminotransferases are pyridoxal 5'-phosphate-dependent enzymes that catalyze reversible transamination reactions between amino acids and alpha-keto acids, and are important for the cellular metabolism of nitrogen. Many bacterial and eukaryotic omega-aminotransferases that use L-ornithine (Orn), L-lysine (Lys), or gamma-aminobutyrate (GABA) have been identified and characterized, but the corresponding enzymes from archaea are unknown. Here, we examined the activity and function of TK2101, a gene annotated as a GABA aminotransferase, from the hyperthermophilic archaeon Thermococcus kodakarensis. We overexpressed the TK2101 gene in T. kodakarensis and purified and characterized the recombinant protein and found that it displays only low levels of GABA aminotransferase activity. Instead, we observed a relatively high omega-aminotransferase activity with L-Orn and L-Lys as amino donors. The most preferred amino acceptor was 2-oxoglutarate. To examine the physiological role of TK2101, we created a TK2101 gene-disruption strain (Delta TK2101), which was auxotrophic for proline. Growth comparison with the parent strain KU216 and the biochemical characteristics of the protein strongly suggested that TK2101 encodes an Orn aminotransferase involved in the biosynthesis of L-Pro. Phylogenetic comparisons of the TK2101 sequence with related sequences retrieved from the databases revealed the presence of several distinct protein groups, some of which having no experimentally studied member. We conclude that TK2101 is part of a novel group of Orn aminotransferases that are widely distributed at least in the genus Thermococcus, but perhaps also throughout the Archaea.	[Zheng, Ren-Chao; Hachisuka, Shin-ichi; Tomita, Hiroya; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ Noji Higashi, Coll Life Sci, Dept Biotechnol, Kusatsu 5258577, Japan; [Zheng, Ren-Chao; Zheng, Yu-Guo] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, Hangzhou 310032, Zhejiang, Peoples R China; [Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Hachisuka, Shin-ichi; Imanaka, Tadayuki; Atomi, Haruyuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan	Kyoto University; Zhejiang University of Technology; University of Tokyo; Japan Science & Technology Agency (JST)	Atomi, H (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.; Atomi, H (corresponding author), Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan.	atomi@sbchem.kyoto-u.ac.jp	Tomita, Hiroya/GQY-9725-2022; Hachisuka, Shin-ichi/P-8984-2019	Hachisuka, Shin-ichi/0000-0001-8339-7717; Nishiyama, Makoto/0000-0001-8143-8052; Atomi, Haruyuki/0000-0001-9687-6426	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to H. A.) within the research area "Creation of Basic Technology for Improved Bioenergy Production through Functional Analysis and Regulation of Algae and Other Aquatic Microorganisms." The authors declare that they have no conflicts of interest with the contents of this article.	ANDREOTTI G, 1994, EUR J BIOCHEM, V220, P543, DOI 10.1111/j.1432-1033.1994.tb18654.x; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gafan C, 2001, MOL BIOCHEM PARASIT, V118, P1, DOI 10.1016/S0166-6851(01)00357-7; He M, 2006, J IND MICROBIOL BIOT, V33, P401, DOI 10.1007/s10295-006-0078-3; Ishibashi T, 2012, EXTREMOPHILES, V16, P819, DOI 10.1007/s00792-012-0477-5; JHEE KH, 1995, J BIOCHEM-TOKYO, V118, P101, DOI 10.1093/oxfordjournals.jbchem.a124863; Kawakami R, 2017, J BIOSCI BIOENG, V124, P23, DOI 10.1016/j.jbiosc.2017.02.004; Kawakami R, 2015, AMINO ACIDS, V47, P1579, DOI 10.1007/s00726-015-2001-6; Lee H, 2015, MED RES REV, V35, P286, DOI 10.1002/med.21328; Legrain C, 2001, METHOD ENZYMOL, V331, P227; MARINO G, 1988, J BIOL CHEM, V263, P12305; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Meng ZH, 2009, PROTEIN EXPRES PURIF, V64, P125, DOI 10.1016/j.pep.2008.10.018; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Rajaram V, 2008, PROTEINS, V70, P429, DOI 10.1002/prot.21567; Rausch C, 2013, PROTEINS, V81, P774, DOI 10.1002/prot.24233; Sakuraba H, 2004, J BACTERIOL, V186, P5513, DOI 10.1128/JB.186.16.5513-5518.2004; Santangelo TJ, 2008, APPL ENVIRON MICROB, V74, P3099, DOI 10.1128/AEM.00305-08; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583; SODA K, 1968, BIOCHEMISTRY-US, V7, P4102, DOI 10.1021/bi00851a045; Stranska J, 2010, BIOCHIMIE, V92, P940, DOI 10.1016/j.biochi.2010.03.026; TAKECHI M, 1994, J BIOCHEM-TOKYO, V116, P955, DOI 10.1093/oxfordjournals.jbchem.a124652; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1994, J BIOCHEM-TOKYO, V115, P309, DOI 10.1093/oxfordjournals.jbchem.a124334; Tomita H, 2014, J BACTERIOL, V196, P1222, DOI 10.1128/JB.01327-13; Tomita H, 2013, MOL MICROBIOL, V90, P307, DOI 10.1111/mmi.12363; Tomita H, 2012, J BACTERIOL, V194, P5434, DOI 10.1128/JB.06624-11; Uchida Y, 2014, EXTREMOPHILES, V18, P589, DOI 10.1007/s00792-014-0642-0; Valmaseda EMMD, 2005, MOL GENET GENOMICS, V274, P272, DOI 10.1007/s00438-005-0018-3; VOELLMY R, 1975, J BACTERIOL, V122, P799, DOI 10.1128/JB.122.3.799-809.1975; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Ward Donald E., 2002, Archaea, V1, P133, DOI 10.1155/2002/959031; XING RY, 1992, J BACTERIOL, V174, P541, DOI 10.1128/jb.174.2.541-548.1992; YASUDA M, 1981, J BACTERIOL, V148, P43, DOI 10.1128/JB.148.1.43-50.1981; Yokooji Y, 2009, J BIOL CHEM, V284, P28137, DOI 10.1074/jbc.M109.009696; YONAHA K, 1992, J BIOL CHEM, V267, P12506; Yoshida A, 2016, J BIOL CHEM, V291, P21630, DOI 10.1074/jbc.M116.743021	43	5	6	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3625	3636		10.1074/jbc.RA117.001222	http://dx.doi.org/10.1074/jbc.RA117.001222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29352105	Green Published, hybrid			2022-12-28	WOS:000427030200017
J	Del Vecchio, K; Frick, CT; Gc, JB; Oda, SI; Gerstman, BS; Saphire, EO; Chapagain, PP; Stahelin, RV				Del Vecchio, Kathryn; Frick, Cary T.; Gc, Jeevan B.; Oda, Shun-ichiro; Gerstman, Bernard S.; Saphire, Erica Ollmann; Chapagain, Prem P.; Stahelin, Robert V.			A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; MOLECULAR-DYNAMICS; BINDING PROPERTIES; CRYSTAL-STRUCTURE; NUCLEAR IMPORT; VIRAL-EGRESS; OLIGOMERIZATION; ASSOCIATION; DOMAINS; LOCALIZATION	Ebola virus (EBOV) is a filamentous lipid-enveloped virus that causes hemorrhagic fever with a high fatality rate. Viral protein 40 (VP40) is the major EBOV matrix protein and regulates viral budding from the plasma membrane. VP40 is a transformer/morpheein that can structurally rearrange its native homodimer into either a hexameric filament that facilitates viral budding or an RNA-binding octameric ring that regulates viral transcription. VP40 associates with plasma-membrane lipids such as phosphatidylserine (PS), and this association is critical to budding from the host cell. However, it is poorly understood how different VP40 structures interact with PS, what essential residues are involved in this association, and whether VP40 has true selectivity for PS among different glycerophospholipid head-groups. In this study, we used lipid-binding assays, MD simulations, and cellular imaging to investigate the molecular basis of VP40-PS interactions and to determine whether different VP40 structures (i.e. monomer, dimer, and octamer) can interact with PS-containing membranes. Results from quantitative analysis indicated that VP40 associates with PS vesicles via a cationic patch in the C-terminal domain (Lys(224, 225) and Lys(274, 275)). Substitutions of these residues with alanine reduced PS-vesicle binding by >40-fold and abrogated VP40 localization to the plasma membrane. Dimeric VP40 had 2-fold greater affinity for PS-containing membranes than the monomer, whereas binding of the VP40 octameric ring was reduced by nearly 10-fold. Taken together, these results suggest the different VP40 structures known to form in the viral life cycle harbor different affinities for PS-containing membranes.	[Del Vecchio, Kathryn; Frick, Cary T.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Gc, Jeevan B.; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Oda, Shun-ichiro; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Oda, Shun-ichiro; Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Stahelin, Robert V.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	University of Notre Dame; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Scripps Research Institute; Scripps Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stahelin, RV (corresponding author), Purdue Univ, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	rstaheli@purdue.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863; Saphire, Erica Ollmann/0000-0002-1206-7451; Chapagain, Prem/0000-0002-0999-4975	National Institutes of Health [AI081077, AI121841]; National Institutes of Health CBBI Predoctoral Training Fellowship [T32GM075762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121841, R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health CBBI Predoctoral Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	( This work was supported by National Institutes of Health Grants AI081077 and AI121841 (to R.V.S.) and National Institutes of Health CBBI Predoctoral Training Fellowship T32GM075762 (to K.D. and C.T.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Movies S1 and S2.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2014, VIRUSES-BASEL, V6, P3837, DOI 10.3390/v6103837; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; BROOKS MM, 1995, STAT MED, V14, P2227, DOI 10.1002/sim.4780142006; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Chlibek R., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P99; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Dick RA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00187; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Gc JB, 2016, PROTEIN SCI, V25, P1648, DOI 10.1002/pro.2969; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Han ZY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005220; Han ZY, 2015, J INFECT DIS, V212, pS138, DOI 10.1093/infdis/jiu838; Han ZY, 2003, J VIROL, V77, P1793, DOI 10.1128/JVI.77.3.1793-1800.2003; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jeevan BGC, 2017, BBA-BIOMEMBRANES, V1859, P2012, DOI 10.1016/j.bbamem.2017.07.007; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Lucas N, 2011, J BIOL CHEM, V286, P41265, DOI 10.1074/jbc.M111.300806; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Nanbo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01206; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Radzimanowski J, 2014, PROTEIN SCI, V23, P1519, DOI 10.1002/pro.2541; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Robinson BA, 2014, J VIROL, V88, P5718, DOI 10.1128/JVI.03609-13; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Silva LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039978; Soni SP, 2014, J BIOL CHEM, V289, P33590, DOI 10.1074/jbc.M114.586396; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001	66	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3335	3349		10.1074/jbc.M117.816280	http://dx.doi.org/10.1074/jbc.M117.816280			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348171	Green Published, hybrid			2022-12-28	WOS:000426562800025
J	Zeden, MS; Schuster, CF; Bowman, L; Zhong, QY; Williams, HD; Grundling, A				Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Williams, Huw D.; Grundling, Angelika			Cyclic di-adenosine monophosphate (c-di-AMP) is required for osmotic regulation in Staphylococcus aureus but dispensable for viability in anaerobic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; BETAINE TRANSPORT-SYSTEM; GRAM-POSITIVE BACTERIA; SMALL-COLONY-VARIANT; LISTERIA-MONOCYTOGENES; STRESS RESISTANCE; BACILLUS-SUBTILIS; GLYCINE BETAINE; GENE-EXPRESSION; HEMB MUTANT	Cyclic di-adenosine monophosphate (c-di-AMP) is a recently discovered signaling molecule important for the survival of Firmicutes, a large bacterial group that includes notable pathogens such as Staphylococcus aureus. However, the exact role of this molecule has not been identified. dacA, the S. aureus gene encoding the diadenylate cyclase enzyme required for c-di-AMP production, cannot be deleted when bacterial cells are grown in rich medium, indicating that c-di-AMP is required for growth in this condition. Here, we report that an S. aureus dacA mutant can be generated in chemically defined medium. Consistent with previous findings, this mutant had a severe growth defect when cultured in rich medium. Using this growth defect in rich medium, we selected for suppressor strains with improved growth to identify c-di-AMP-requiring pathways. Mutations bypassing the essentiality of dacA were identified in alsT and opuD, encoding a predicted amino acid and osmolyte transporter, the latter of which we show here to be the main glycine betaine-uptake system in S. aureus. Inactivation of these transporters likely prevents the excessive osmolyte and amino acid accumulation in the cell, providing further evidence for a key role of c-di-AMP in osmotic regulation. Suppressor mutations were also obtained in hepS, hemB, ctaA, and qoxB, coding proteins required for respiration. Furthermore, we show that dacA is dispensable for growth in anaerobic conditions. Together, these findings reveal an essential role for the c-di-AMP signaling network in aerobic, but not anaerobic, respiration in S. aureus.	[Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Grundling, Angelika] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Williams, Huw D.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Bowman, Lisa] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland	Imperial College London; Imperial College London; Imperial College London; University of Dundee	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Grundling, A (corresponding author), Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Zeden, Merve/GXF-9824-2022; Schuster, Christopher F./J-9904-2015	Grundling, Angelika/0000-0002-6235-8687; Schuster, Christopher F./0000-0002-4566-7226; Zhong, Qiyun/0000-0001-7053-9640; Williams, Huw/0000-0003-2225-6413; Zeden, Merve Suzan/0000-0003-3636-700X	European Research Council [260371]; Wellcome Trust [100289]; Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship; German Research Foundation (DFG) [SCHU 3159/1-1]; BBSRC [BB/L024209/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship.; Supported by German Research Foundation (DFG) Grant SCHU 3159/1-1.	Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bowman L, 2016, J BIOL CHEM, V291, P26970, DOI 10.1074/jbc.M116.747709; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chin KH, 2015, BIOCHEMISTRY-US, V54, P4936, DOI 10.1021/acs.biochem.5b00633; Choi PH, 2015, MICROBIOLOGYOPEN, V4, P361, DOI 10.1002/mbo3.243; Choi S, 2014, APPL MICROBIOL BIOT, V98, P807, DOI 10.1007/s00253-013-5436-2; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Commichau F. M., 2017, TRENDS MICROBIOL; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Ferreira MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058277; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gotz F, 2013, MBIO, V4, DOI 10.1128/mBio.00976-13; Gries CM, 2013, MOL MICROBIOL, V89, P760, DOI 10.1111/mmi.12312; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gundlach J., 2017, CURR GENET; Gundlach J, 2017, MBIO, V8, DOI 10.1128/mBio.00861-17; Gundlach J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3011; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Hammer N. D., 2013, MBIO, V4, DOI DOI 10.1128/MBIO.00241-13; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hiron A, 2007, J BACTERIOL, V189, P5119, DOI 10.1128/JB.00274-07; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KAFALA B, 1994, CAN J MICROBIOL, V40, P651, DOI 10.1139/m94-103; Kim H, 2015, J BIOL CHEM, V290, P16393, DOI 10.1074/jbc.M115.641340; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Li GQ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140167; Mayer S, 2015, J BACTERIOL, V197, P794, DOI 10.1128/JB.02127-14; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; Muller M, 2015, FEBS LETT, V589, P45, DOI 10.1016/j.febslet.2014.11.022; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pader V, 2014, INFECT IMMUN, V82, P4337, DOI 10.1128/IAI.02254-14; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Shapiro Howard M., 2008, V142, P175, DOI 10.1007/978-1-59745-246-5_14; Sleator RD, 1999, APPL ENVIRON MICROB, V65, P2078; Tavares AFN, 2011, J BIOL CHEM, V286, P26708, DOI 10.1074/jbc.M111.255752; TOWNSEND DE, 1992, J BACTERIOL, V174, P2702, DOI 10.1128/jb.174.8.2702-2710.1992; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Tynecka Z, 1999, RES MICROBIOL, V150, P555, DOI 10.1016/S0923-2508(99)00102-3; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wetzel KJ, 2011, FEMS IMMUNOL MED MIC, V61, P346, DOI 10.1111/j.1574-695X.2011.00781.x; Whiteley AT, 2017, MOL MICROBIOL, V104, P212, DOI 10.1111/mmi.13622; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yu DL, 2014, GENOMICS, V104, P8, DOI 10.1016/j.ygeno.2014.04.003; Zamboni N, 2003, FEMS MICROBIOL LETT, V226, P121, DOI 10.1016/S0378-1097(03)00614-1	75	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3180	3200		10.1074/jbc.M117.818716	http://dx.doi.org/10.1074/jbc.M117.818716			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326168	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000426562800013
J	Clayton, SA; Jones, SW; Kurowska-Stolarska, M; Clark, AR				Clayton, Sally A.; Jones, Simon W.; Kurowska-Stolarska, Mariola; Clark, Andrew R.			The role of microRNAs in glucocorticoid action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						epigenetics; microRNA (miRNA); glucocorticoid; glucocorticoid receptor; apoptosis; inflammation; epigenetics	ACUTE LYMPHOBLASTIC-LEUKEMIA; SPECIFICITY PHOSPHATASE 1; TARGET MESSENGER-RNAS; INDUCED CELL-DEATH; DOWN-REGULATION; MIR-17-92 EXPRESSION; RECEPTOR; RESISTANCE; REGULATOR; MECHANISMS	Glucocorticoids (GCs) are steroids with profound anti-inflammatory and immunomodulatory activities. Synthetic GCs are widely used for managing chronic inflammatory and autoimmune conditions, as immunosuppressants in transplantation, and as anti-tumor agents in certain hematological cancers. However, prolonged GC exposure can cause adverse effects. A detailed understanding of GCs' mechanisms of action may enable harnessing of their desirable actions while minimizing harmful effects. Here, we review the impact on the GC biology of microRNAs, small non-coding RNAs that post-transcriptionally regulate gene expression. Emerging evidence indicates that microRNAs modulate GC production by the adrenal glands and the cells' responses to GCs. Furthermore, GCs influence cell proliferation, survival, and function at least in part by regulating microRNA expression. We propose that the beneficial effects of GCs may be enhanced through combination with reagents targeting specific microRNAs.	[Clayton, Sally A.; Jones, Simon W.; Clark, Andrew R.] Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham B15 2WB, W Midlands, England; [Kurowska-Stolarska, Mariola] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Clayton, Sally A.; Jones, Simon W.; Kurowska-Stolarska, Mariola; Clark, Andrew R.] Glasgow Univ, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland; [Clayton, Sally A.; Jones, Simon W.; Kurowska-Stolarska, Mariola; Clark, Andrew R.] Univ Birmingham, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland; [Clayton, Sally A.; Jones, Simon W.; Kurowska-Stolarska, Mariola; Clark, Andrew R.] Newcastle Univ, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland	University of Birmingham; University of Glasgow; University of Glasgow; University of Birmingham; Newcastle University - UK	Clark, AR (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Coll Med & Dent Sci, Birmingham B15 2WB, W Midlands, England.; Clark, AR (corresponding author), Glasgow Univ, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland.; Clark, AR (corresponding author), Univ Birmingham, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland.; Clark, AR (corresponding author), Newcastle Univ, Arthrit Res UK Rheumatoid Arthrit Pathogenesis Ct, Glasgow G12 8TA, Lanark, Scotland.	a.r.clark@bham.ac.uk	Jones, Simon W/ABB-8625-2020; Clayton, Sally Anne/ABD-5243-2020; Clark, Andrew/AAN-4043-2021; Jones, Simon W/AAN-4513-2021; Kurowska-Stolarska, Mariola/AAD-1683-2019	Clayton, Sally Anne/0000-0001-8609-9539; Jones, Simon W/0000-0001-6785-2310; 	Arthritis Research UK within the Rheumatoid Arthritis Centre of Excellence (RACE) consortium [20298]; Arthritis Research UK [19614]; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; Versus Arthritis [19614] Funding Source: researchfish; MRC [MR/K00414X/1] Funding Source: UKRI	Arthritis Research UK within the Rheumatoid Arthritis Centre of Excellence (RACE) consortium; Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Ph.D. studentship from Arthritis Research UK within the Rheumatoid Arthritis Centre of Excellence (RACE) consortium between the Universities of Birmingham, Glasgow, and Newcastle, Grant 20298.; Supported by Programme Grant 19614 from Arthritis Research UK. To whom correspondence should be addressed. Tel.: 44 121 371 3244; E-mail: a.r.clark@bham.ac.uk.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Baschant U, 2013, MOL CELL ENDOCRINOL, V380, P108, DOI 10.1016/j.mce.2013.06.009; Baschant U, 2012, NAT REV RHEUMATOL, V8, P645, DOI 10.1038/nrrheum.2012.166; Belaya ZE, 2018, OSTEOPOROSIS INT, V29, P211, DOI 10.1007/s00198-017-4241-7; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chapman KE, 2013, J STEROID BIOCHEM, V137, P82, DOI 10.1016/j.jsbmb.2013.02.002; Chen Y, 2016, EXP THER MED, V12, P3723, DOI 10.3892/etm.2016.3825; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Curtale G, 2017, EUR J IMMUNOL, V47, P2080, DOI 10.1002/eji.201747044; Davis TE, 2013, ARTHRITIS RHEUM-US, V65, P1882, DOI 10.1002/art.37966; de Kloet ER, 2009, BRAIN RES, V1293, P129, DOI 10.1016/j.brainres.2009.03.039; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Dwivedi Y, 2017, EXPERT OPIN THER TAR, V21, P653, DOI 10.1080/14728222.2017.1328501; Elmesmari A, 2016, RHEUMATOLOGY, V55, P2056, DOI 10.1093/rheumatology/kew272; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukao A, 2014, MOL CELL, V56, P79, DOI 10.1016/j.molcel.2014.09.005; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2013, J CELL SCI, V126, P978, DOI 10.1242/jcs.117515; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han YY, 2013, J STEROID BIOCHEM, V133, P129, DOI 10.1016/j.jsbmb.2012.09.005; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Hollins SL, 2016, PROG NEUROBIOL, V143, P61, DOI 10.1016/j.pneurobio.2016.06.005; Hong YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069926; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Jubb AW, 2016, J IMMUNOL, V196, P813, DOI 10.4049/jimmunol.1502009; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Karo-Atar D, 2015, J ASTHMA, V52, P545, DOI 10.3109/02770903.2014.988222; Kim J, 2015, GENE, V558, P173, DOI 10.1016/j.gene.2015.01.001; Kobayashi Y, 2016, J BIOCHEM, V159, P387, DOI 10.1093/jb/mvv124; Korhonen R, 2014, BASIC CLIN PHARMACOL, V114, P24, DOI 10.1111/bcpt.12141; Kotani A, 2009, BLOOD, V114, P4169, DOI 10.1182/blood-2008-12-191619; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Laxman N, 2016, BONE, V84, P181, DOI 10.1016/j.bone.2015.12.053; Ledderose C, 2012, CRIT CARE MED, V40, P2745, DOI 10.1097/CCM.0b013e31825b8ebc; Li JJ, 2015, J ALLERGY CLIN IMMUN, V136, P462, DOI 10.1016/j.jaci.2014.11.044; Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024; Liang YN, 2017, J STEROID BIOCHEM, V172, P62, DOI 10.1016/j.jsbmb.2017.05.014; Liu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32112; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mahmood S, 2016, J RECEPT SIG TRANSD, V36, P310, DOI 10.3109/10799893.2015.1080273; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Morgan SA, 2014, P NATL ACAD SCI USA, V111, pE2482, DOI 10.1073/pnas.1323681111; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Murray MY, 2013, CELL CYCLE, V12, P2144, DOI 10.4161/cc.25251; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Nusrin S, 2014, MAR POLLUT BULL, V85, P344, DOI 10.1016/j.marpolbul.2014.04.002; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Palagani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113842; Puimege L, 2015, EMBO MOL MED, V7, P1004, DOI 10.15252/emmm.201405010; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Robertson S, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/2021903; Robertson S, 2013, HYPERTENSION, V62, P572, DOI 10.1161/HYPERTENSIONAHA.113.01102; Roy B, 2017, NEUROPSYCHOPHARMACOL, V42, P864, DOI 10.1038/npp.2016.175; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Shi CG, 2015, J MOL ENDOCRINOL, V54, P325, DOI 10.1530/JME-14-0314; Shi CG, 2014, BONE, V68, P67, DOI 10.1016/j.bone.2014.08.004; Sionov Ronit Vogt, 2013, ISRN Hematol, V2013, P348212, DOI 10.1155/2013/348212; Smith LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078316; Smith LK, 2010, J BIOL CHEM, V285, P36698, DOI 10.1074/jbc.M110.162123; Smith SS, 2016, J BIOL CHEM, V291, P21717, DOI 10.1074/jbc.M116.737890; Squadrito ML, 2012, CELL REPORTS, V1, P141, DOI 10.1016/j.celrep.2011.12.005; Sun Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00193; Tang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04100-1; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; Tessel Michael A., 2011, Hormones & Cancer, V2, P182, DOI 10.1007/s12672-011-0072-8; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wang FS, 2013, ARTHRITIS RHEUM-US, V65, P1530, DOI 10.1002/art.37948; Wang HM, 2017, J CANCER RES CLIN, V143, P1005, DOI 10.1007/s00432-017-2388-4; Wang SS, 2017, PROG NEURO-PSYCHOPH, V79, P417, DOI 10.1016/j.pnpbp.2017.07.024; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080547; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xing WH, 2014, MOL MED REP, V10, P881, DOI 10.3892/mmr.2014.2253; Xu JJ, 2017, J PSYCHIATR RES, V95, P102, DOI 10.1016/j.jpsychires.2017.08.010; Zhao JJ, 2015, CANCER RES, V75, P4384, DOI 10.1158/0008-5472.CAN-15-0457; Zheng DL, 2016, J BIOL CHEM, V291, P17897, DOI 10.1074/jbc.M116.727941; Zheng YJ, 2012, FREE RADICAL BIO MED, V52, P1307, DOI 10.1016/j.freeradbiomed.2012.01.031; Zhou H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101773; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	98	39	42	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1865	1874		10.1074/jbc.R117.000366	http://dx.doi.org/10.1074/jbc.R117.000366			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29301941	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000424948000001
J	Appikonda, S; Thakkar, KN; Shah, PK; Dent, SYR; Andersen, JN; Barton, MC				Appikonda, Srikanth; Thakkar, Kaushik N.; Shah, Parantu K.; Dent, Sharon Y. R.; Andersen, Jannik N.; Barton, Michelle C.			Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SUMOylation; chromatin modification; histone acetylation; cell adhesion; breast cancer; epigenetics; bromodomain; histone reader; reader protein; TRIM24	NUCLEAR RECEPTORS; HISTONE; GROWTH; METABOLISM; MECHANISMS; CANCER; POTENT; LINKS	Proteins with domains that recognize and bind post-translational modifications (PTMs) of histones are collectively termed epigenetic readers. Numerous interactions between specific reader protein domains and histone PTMs and their regulatory outcomes have been reported, but little is known about how reader proteins may in turn be modulated by these interactions. Tripartite motif-containing protein 24 (TRIM24) is a histone reader aberrantly expressed in multiple cancers. Here, our investigation revealed functional cross-talk between histone acetylation and TRIM24 SUMOylation. Binding of TRIM24 to chromatin via its tandem PHD-bromodomain, which recognizes unmethylated lysine 4 and acetylated lysine 23 of histone H3 (H3K4me0/K23ac), led to TRIM24 SUMOylation at lysine residues 723 and 741. Inactivation of the bromodomain, either by mutation or with a small-molecule inhibitor, IACS-9571, abolished TRIM24 SUMOylation. Conversely, inhibition of histone deacetylation markedly increased TRIM24's interaction with chromatin and its SUMOylation. Of note, gene expression profiling of MCF7 cells expressing WT versus SUMO-deficient TRIM24 identified cell adhesion as the major pathway regulated by the cross-talk between chromatin acetylation and TRIM24 SUMOylation. In conclusion, our findings establish a new link between histone H3 acetylation and SUMOylation of the reader protein TRIM24, a functional connection that may bear on TRIM24's oncogenic function and may inform future studies of PTM cross-talk between histones and epigenetic regulators.	[Appikonda, Srikanth; Thakkar, Kaushik N.; Dent, Sharon Y. R.; Barton, Michelle C.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Thakkar, Kaushik N.; Dent, Sharon Y. R.; Barton, Michelle C.] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Shah, Parantu K.; Andersen, Jannik N.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Appikonda, Srikanth] Counsyl, 180 Kimball Way, San Francisco, CA 94080 USA; [Shah, Parantu K.] EMD Serono Res & Dev Inst Inc, 45A Middlesex Turnpike, Billerica, MA 01821 USA; [Andersen, Jannik N.] Xios Therapeut, 465 Waverley Oaks Rd, Waltham, MA 02452 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Merck KGaA; EMD Serono Inc.	Barton, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Unit 1011,1515 Holcombe Blvd, Houston, TX 77030 USA.	mbarton@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269	Innovation Award from the Center for Cancer Epigenetics; University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant [CA016672];  [CPRIT RP110471]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Innovation Award from the Center for Cancer Epigenetics; University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by CPRIT RP110471 and an Innovation Award from the Center for Cancer Epigenetics (to M.C.B.) and University of Texas M.D. Anderson Cancer Center NCI, National Institutes of Health, Support Grant CA016672. The authors declare that they have no conflicts of interest with the contents of this article.	Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appikonda Srikanth, 2016, Drug Discov Today Technol, V19, P57, DOI 10.1016/j.ddtec.2016.05.001; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Cui ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063887; Delhomme N, 2012, BIOINFORMATICS, V28, P2532, DOI 10.1093/bioinformatics/bts477; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Demont EH, 2014, ACS MED CHEM LETT, V5, P1190, DOI 10.1021/ml5002932; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2011, CELL, V146, P709, DOI 10.1016/j.cell.2011.07.025; LeDouarin B, 1996, PHILOS T R SOC B, V351, P569, DOI 10.1098/rstb.1996.0056; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; Liu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085462; Miao ZF, 2015, VIRCHOWS ARCH, V466, P525, DOI 10.1007/s00428-015-1737-4; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Palmer WS, 2016, J MED CHEM, V59, P1440, DOI 10.1021/acs.jmedchem.5b00405; Pathiraja TN, 2015, ONCOGENE, V34, P2836, DOI 10.1038/onc.2014.220; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; Thakkar KN, 2015, AGING-US, V7, P736, DOI 10.18632/aging.100822; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhan YN, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0026-4	41	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7476	7485		10.1074/jbc.RA118.002233	http://dx.doi.org/10.1074/jbc.RA118.002233			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29523690	Green Published, hybrid			2022-12-28	WOS:000432174500039
J	Greitzer-Antes, D; Xie, L; Qin, TR; Xie, HL; Zhu, D; Dolai, S; Liang, T; Kang, F; Hardy, AB; He, Y; Kang, YH; Gaisano, HY				Greitzer-Antes, Dafna; Xie, Li; Qin, Tairan; Xie, Huanli; Zhu, Dan; Dolai, Subhankar; Liang, Tao; Kang, Fei; Hardy, Alexandre B.; He, Yan; Kang, Youhou; Gaisano, Herbert Y.			K(v)2.1 clusters on -cell plasma membrane act as reservoirs that replenish pools of newcomer insulin granule through their interaction with syntaxin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasma membrane; pancreatic islet; potassium channel; insulin secretion; vesicles; Kv2; 1; newcomer insulin granule; syntaxin-3	GATED POTASSIUM CHANNEL; DEPENDENT K+ CHANNELS; PANCREATIC BETA-CELLS; C-TERMINUS; SURFACE MICRODOMAINS; KV2.1 CHANNEL; ION-CHANNEL; N-TERMINUS; EXOCYTOSIS; SECRETION	The voltage-dependent K+ (K-v) channel K(v)2.1 is a major delayed rectifier in many secretory cells, including pancreatic cells. In addition, K(v)2.1 has a direct role in exocytosis at an undefined step, involving SNARE proteins, that is independent of its ion-conducting pore function. Here, we elucidated the precise step in exocytosis. We previously reported that syntaxin-3 (Syn-3) is the key syntaxin that mediates exocytosis of newcomer secretory granules that spend minimal residence time on the plasma membrane before fusion. Using high-resolution total internal reflection fluorescence microscopy, we now show that K(v)2.1 forms reservoir clusters on the -cell plasma membrane and binds Syn-3 via its C-terminal C1b domain, which recruits newcomer insulin secretory granules into this large reservoir. Upon glucose stimulation, secretory granules were released from this reservoir to replenish the pool of newcomer secretory granules for subsequent fusion, occurring just adjacent to the plasma membrane K(v)2.1 clusters. C1b deletion blocked the aforementioned K(v)2.1-Syn-3-mediated events and reduced fusion of newcomer secretory granules. These insights have therapeutic implications, as K(v)2.1 overexpression in type-2 diabetes rat islets restored biphasic insulin secretion.	[Greitzer-Antes, Dafna; Xie, Li; Qin, Tairan; Xie, Huanli; Zhu, Dan; Dolai, Subhankar; Liang, Tao; Kang, Fei; Hardy, Alexandre B.; Kang, Youhou; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Greitzer-Antes, Dafna; Xie, Li; Qin, Tairan; Xie, Huanli; Zhu, Dan; Dolai, Subhankar; Liang, Tao; Kang, Fei; Hardy, Alexandre B.; Kang, Youhou; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [He, Yan] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing 100050, Peoples R China	University of Toronto; University of Toronto; Capital Medical University	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada.; Gaisano, HY (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation; Ontario Research Fund [19442]	3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation; Ontario Research Fund	Some equipment used in this study was supported by the 3D (Diet, Digestive Tract, and Disease) Centre funded by Canadian Foundation for Innovation and Ontario Research Fund, project number 19442. We thank Jocelyn Manning-Fox and Patrick MacDonald (University of Alberta) and Christopher Newgard and Mette Jensen (Duke University) for providing the adenoviruses.	Baver SB, 2012, NEUROSCIENCE, V217, P56, DOI 10.1016/j.neuroscience.2012.04.054; Chao C, 2011, J MOL CELL CARDIOL, V51, P790, DOI 10.1016/j.yjmcc.2011.08.011; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Feinshreiber L, 2010, J CELL SCI, V123, P1940, DOI 10.1242/jcs.063719; Feinshreiber L, 2009, ANN NY ACAD SCI, V1152, P87, DOI 10.1111/j.1749-6632.2008.03997.x; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; Fox PD, 2013, J NEUROSCI, V33, P1259, DOI 10.1523/JNEUROSCI.3008-12.2013; Fu JY, 2017, DIABETES, V66, P1890, DOI 10.2337/db16-1170; Gaisano HY, 2017, DIABETES OBES METAB, V19, P115, DOI 10.1111/dom.13001; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Grizel A, 2014, J NEUROIMMUNE PHARM, V9, P727, DOI 10.1007/s11481-014-9565-x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jensen MV, 2013, J BIOL CHEM, V288, P23128, DOI 10.1074/jbc.M113.491654; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Kang YH, 2011, J BIOL CHEM, V286, P5876, DOI 10.1074/jbc.M109.089607; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Liang T, 2014, J BIOL CHEM, V289, P6028, DOI 10.1074/jbc.M113.511808; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Qin TR, 2017, EBIOMEDICINE, V16, P262, DOI 10.1016/j.ebiom.2017.01.030; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xie LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161397; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	40	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6893	6904		10.1074/jbc.RA118.002703	http://dx.doi.org/10.1074/jbc.RA118.002703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29549124	hybrid, Green Published			2022-12-28	WOS:000431487300022
J	Chia, J; Louber, J; Glauser, I; Taylor, S; Bass, GT; Dower, SK; Gleeson, PA; Verhagen, AM				Chia, Jenny; Louber, Jade; Glauser, Isabelle; Taylor, Shirley; Bass, Greg T.; Dower, Steve K.; Gleeson, Paul A.; Verhagen, Anne M.			Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; coagulation factor; endocytosis; Fc receptor; intracellular trafficking; Hemophilia B; extended half-life; factor IX; neonatal Fc receptor (FcRn); recombinant coagulation factor IX albumin-fusion protein (rIX-FP)	RECEPTOR-RELATED PROTEIN; HEMOPHILIA-B PATIENTS; RIX-FP; STRUCTURAL INSIGHTS; IGG HOMEOSTASIS; SERUM IGG; TRANSPORT; PHARMACOKINETICS; DYNAMICS; ANTIBODY	The neonatal Fc receptor (FcRn) has a pivotal role in albumin and IgG homeostasis. Internalized IgG captured by FcRn under acidic endosomal conditions is recycled to the cell surface where exocytosis and a shift to neutral pH promote extracellular IgG release. Although a similar mechanism is proposed for FcRn-mediated albumin intracellular trafficking and recycling, this pathway is less well defined but is relevant to the development of therapeutics exploiting FcRn to extend the half-life of short-lived plasma proteins. Recently, a long-acting recombinant coagulation factor IX-albumin fusion protein (rIX-FP) has been approved for the management of hemophilia B. Fusion to albumin potentially enables internalized proteins to engage FcRn and escape lysosomal degradation. In this study, we present for the first time a detailed investigation of the FcRn-mediated recycling of albumin and the albumin fusion protein rIX-FP. We demonstrate that following internalization via FcRn at low pH, rIX-FP, like albumin, is detectable within the early endosome and rapidly (within 10-15 min) traffics into the Rab11+ recycling endosomes, from where it is exported from the cell. Similarly, rIX-FP and albumin taken up by fluid-phase endocytosis at physiological pH traffics into the Rab11+ recycling compartment in FcRn-positive cells but into the lysosomal compartment in FcRn-negative cells. As expected, recombinant factor IX (without albumin fusion) and an FcRn interaction-defective albumin variant localized to the lysosomal compartments of both FcRn-expressing and nonexpressing cells. These results indicate that FcRn-mediated recycling via the albumin moiety is a mechanism for the half-life extension of rIX-FP observed in clinical studies.	[Chia, Jenny; Glauser, Isabelle; Taylor, Shirley; Bass, Greg T.; Dower, Steve K.; Verhagen, Anne M.] CSL Ltd, Mol Sci & Biotechnol Inst Bio21, Res, Melbourne, Vic 3010, Australia; [Louber, Jade; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Bass, Greg T.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic 3010, Australia	CSL; University of Melbourne; University of Melbourne	Verhagen, AM (corresponding author), CSL Ltd, Inst Bio21, Res, 30 Flemington Rd, Parkville, Vic 3010, Australia.	Anne.Verhagen@csl.com.au		Gleeson, Paul/0000-0002-5336-6503; dower, steve/0000-0002-4675-4225	Australian Research Council [LP130100531]; Internship Scholarship AMSIIntern [INT-0265]; CSL Limited through Australian Research Council	Australian Research Council(Australian Research Council); Internship Scholarship AMSIIntern; CSL Limited through Australian Research Council	This work was supported in part by Linkage Grant LP130100531 from the Australian Research Council and by Internship Scholarship AMSIIntern INT-0265 (to G. T. B.). J. C., I. G., S. T., S. K. D., and A. M. V. are employees of CSL Limited and are able to partake in employee share option schemes. J. L. and P. A. G. are supported by research funding from CSL Limited through an Australian Research Council linkage grant collaboration.	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Anderson CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00540; Bjorkman S, 2001, HAEMOPHILIA, V7, P133, DOI 10.1046/j.1365-2516.2001.00465.x; Blasko E, 2013, BIOCHEM BIOPH RES CO, V440, P485, DOI 10.1016/j.bbrc.2013.09.001; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; Challa DK, 2014, CURR TOP MICROBIOL, V382, P249, DOI 10.1007/978-3-319-07911-0_12; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Ewenstein BM, 2002, TRANSFUSION, V42, P190, DOI 10.1046/j.1537-2995.2002.00039.x; Fujimoto K, 2015, MOL PHARMACOL, V88, P660, DOI 10.1124/mol.115.099184; Gailani D, 2009, J THROMB HAEMOST, V7, P1840, DOI 10.1111/j.1538-7836.2009.03591.x; Gan Z, 2013, J CELL SCI, V126, P1176, DOI 10.1242/jcs.116327; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Herzog E, 2014, THROMB RES, V133, P900, DOI 10.1016/j.thromres.2014.02.010; Jerdeva GV, 2010, TRAFFIC, V11, P1205, DOI 10.1111/j.1600-0854.2010.01083.x; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Martinowitz U, 2015, HAEMOPHILIA, V21, P784, DOI 10.1111/hae.12721; Mathur A, 2013, J IMMUNOL METHODS, V390, P81, DOI 10.1016/j.jim.2013.01.011; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Metzner HJ, 2009, THROMB HAEMOSTASIS, V102, P634, DOI 10.1160/TH09-04-0255; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; Nolte MW, 2012, J THROMB HAEMOST, V10, P1591, DOI 10.1111/j.1538-7836.2012.04826.x; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Panousis C., 2015, MABS, V8, P436, DOI DOI 10.1080/19420862.2015.1119352; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Pyzik M, 2017, P NATL ACAD SCI USA, V114, pE2862, DOI 10.1073/pnas.1618291114; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Rath T, 2015, CRIT REV BIOTECHNOL, V35, P235, DOI 10.3109/07388551.2013.834293; Sand KMK, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00682; Santagostino E, 2016, BLOOD, V127, P1761, DOI 10.1182/blood-2015-09-669234; Santagostino E, 2012, BLOOD, V120, P2405, DOI 10.1182/blood-2012-05-429688; Sarav M, 2009, J AM SOC NEPHROL, V20, P1941, DOI 10.1681/ASN.2008090976; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Schulte S, 2009, THROMB RES, V124, pS6, DOI 10.1016/S0049-3848(09)70157-4; Seested T, 2011, NEPHRON EXP NEPHROL, V117, pE82, DOI 10.1159/000321161; Sleep D, 2015, EXPERT OPIN DRUG DEL, V12, P793, DOI 10.1517/17425247.2015.993313; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Trujillo JM, 2014, ANN PHARMACOTHER, V48, P1494, DOI 10.1177/1060028014545807; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Ward ES, 2015, MOL IMMUNOL, V67, P131, DOI 10.1016/j.molimm.2015.02.007; Ward ES, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00351; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Ward ES, 2003, INT IMMUNOL, V15, P187, DOI 10.1093/intimm/dxg018; Watson D, 1965, Adv Clin Chem, V8, P237; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; White GC, 1997, THROMB HAEMOSTASIS, V78, P261; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	58	20	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6363	6373		10.1074/jbc.M117.817064	http://dx.doi.org/10.1074/jbc.M117.817064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523681	Green Published, hybrid			2022-12-28	WOS:000431108600012
J	Jensen, RK; Pihl, R; Gadeberg, TAF; Jensen, JK; Andersen, KR; Thiel, S; Laursen, NS; Andersen, GR				Jensen, Rasmus K.; Pihl, Rasmus; Gadeberg, Trine A. F.; Jensen, Jan K.; Andersen, Kasper R.; Thiel, Steffen; Laursen, Nick S.; Andersen, Gregers R.			A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; complement; convertase; antibody; inhibitor; structural biology; alternative pathway	STRUCTURAL BASIS; FACTOR-H; C3B; BINDING; COMPSTATIN; ACTIVATION; DISEASE; SYSTEM; CONVERTASE; THERAPY	The complement system is a complex, carefully regulated proteolytic cascade for which suppression of aberrant activation is of increasing clinical relevance, and inhibition of the complement alternative pathway is a subject of intense research. Here, we describe the nanobody hC3Nb1 that binds to multiple functional states of C3 with subnanomolar affinity. The nanobody causes a complete shutdown of alternative pathway activity in human and murine serum when present in concentrations comparable with that of C3, and hC3Nb1 is shown to prevent proconvertase assembly, as well as binding of the C3 substrate to C3 convertases. Our crystal structure of the C3b-hC3Nb1 complex and functional experiments demonstrate that proconvertase formation is blocked by steric hindrance between the nanobody and an Asn-linked glycan on complement factor B. In addition, hC3Nb1 is shown to prevent factor H binding to C3b, rationalizing its inhibition of factor I activity. Our results identify hC3Nb1 as a versatile, inexpensive, and powerful inhibitor of the alternative pathway in both human and murine in vitro model systems of complement activation.	[Jensen, Rasmus K.; Gadeberg, Trine A. F.; Jensen, Jan K.; Andersen, Kasper R.; Laursen, Nick S.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark; [Pihl, Rasmus; Thiel, Steffen] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	gra@mbg.au.dk	Laursen, Nick Stub/Q-5051-2017; Jensen, Rasmus Kjeldsen/T-9219-2019	Laursen, Nick Stub/0000-0002-7512-2649; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Andersen, Gregers Rom/0000-0001-6292-3319; Thiel, Steffen/0000-0002-4817-155X; Jensen, Rasmus Kjeldsen/0000-0001-5472-4862	Lundbeck Foundation BRAIN-STRUC Centre [R155-2015-2666]; Danscatt; Novo Nordisk Foundation; Danish Research Council for Nature and Universe; Lundbeck Foundation; Danish Council for Independent Research, Medical Sciences; Lundbeck Foundation [R155-2015-2666, R192-2015-726] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0022058] Funding Source: researchfish	Lundbeck Foundation BRAIN-STRUC Centre; Danscatt; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council for Nature and Universe; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by funds from the Lundbeck Foundation BRAIN-STRUC Centre (R155-2015-2666), Danscatt, the Novo Nordisk Foundation, and the Danish Research Council for Nature and Universe (to G. R. A.); from the Lundbeck Foundation (to N. S. L. and K. R. A.); and from the Danish Council for Independent Research, Medical Sciences (to R. P. and S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZA, 2016, MOL CELL PROTEOMICS, V15, P2730, DOI 10.1074/mcp.M115.056473; Croll TI, 2016, ACTA CRYSTALLOGR D, V72, P1006, DOI 10.1107/S2059798316012201; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Hansen SB, 2017, ACTA CRYSTALLOGR D, V73, P804, DOI 10.1107/S2059798317013171; Harboe M, 2017, P NATL ACAD SCI USA, V114, pE534, DOI 10.1073/pnas.1612385114; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Konning D, 2017, CURR OPIN STRUC BIOL, V45, P10, DOI 10.1016/j.sbi.2016.10.019; Kolev M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00001; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Krishna M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00021; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastellos DC, 2017, TRENDS IMMUNOL, V38, P383, DOI 10.1016/j.it.2017.03.003; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nilsson B, 1998, BLOOD, V92, P1661, DOI 10.1182/blood.V92.5.1661; Pedersen DV, 2017, EMBO J, V36, P1084, DOI 10.15252/embj.201696173; Pleiner T, 2015, ELIFE, V4, DOI [10.7554/eLife.11349, 10.7554/eLife.15597]; Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003; Ricklin D, 2016, IMMUNOL REV, V274, P33, DOI 10.1111/imr.12500; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Rodriguez E, 2015, J BIOL CHEM, V290, P2334, DOI 10.1074/jbc.M114.605691; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schroedinger LLC, 2015, THE PYMOL MOLECULAR; Sottrup-Jensen L, 2014, METHODS MOL BIOL, V1100, P93, DOI 10.1007/978-1-62703-724-2_7; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	63	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6269	6281		10.1074/jbc.RA117.001179	http://dx.doi.org/10.1074/jbc.RA117.001179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29497000	Green Published, hybrid			2022-12-28	WOS:000431108600005
J	Lee, JS; Wang, RX; Alexeev, EE; Lanis, JM; Battista, KD; Glover, LE; Colgan, SP				Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Glover, Louise E.; Colgan, Sean P.			Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; INTESTINAL EPITHELIA; ESCHERICHIA-COLI; TIGHT JUNCTION; ACTIN CYTOSKELETON; ATP DEPLETION; BRUSH-BORDER; FACTOR-I; CHARGE; PHOSPHORYLASE	Intestinal epithelial cells form a selectively permeable barrier to protect colon tissues from luminal microbiota and antigens and to mediate nutrient, fluid, and waste flux in the intestinal tract. Dysregulation of the epithelial cell barrier coincides with profound shifts in metabolic energy, especially in the colon, which exists in an energetically depleting state of physiological hypoxia. However, studies that systematically examine energy flux and adenylate metabolism during intestinal epithelial barrier development and restoration after disruption are lacking. Here, to delineate barrier-related energy flux, we developed an HPLC-based profiling method to track changes in energy flux and adenylate metabolites during barrier development and restoration. Cultured epithelia exhibited pooling of phosphocreatine and maintained ATP during barrier development. EDTA-induced epithelial barrier disruption revealed that hypoxanthine levels correlated with barrier resistance. Further studies uncovered that hypoxanthine supplementation improves barrier function and wound healing and that hypoxanthine appears to do so by increasing intracellular ATP, which improved cytoskeletal G- to F-actin polymerization. Hypoxanthine supplementation increased the adenylate energy charge in the murine colon, indicating potential to regulate adenylate energy charge-mediated metabolism in intestinal epithelial cells. Moreover, experiments in a murine colitis model disclosed that hypoxanthine loss during active inflammation correlates with markers of disease severity. In summary, our results indicate that hypoxanthine modulates energy metabolism in intestinal epithelial cells and is critical for intestinal barrier function.	[Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Colgan, Sean P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Lee, J. Scott; Wang, Ruth X.; Alexeev, Erica E.; Lanis, Jordi M.; Battista, Kayla D.; Colgan, Sean P.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Aurora, CO 80045 USA; [Glover, Louise E.] Univ Coll Dublin, Sch Med, Dublin, Ireland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University College Dublin	Colgan, SP (corresponding author), Univ Colorado, Mucosal Inflammat Program, Anschutz Med Campus,12700 East 19th Ave MS B-146, Aurora, CO 80045 USA.	sean.colgan@ucdenver.edu		Lee, J. Scott/0000-0001-7151-9828	National Institutes of Health [DK050189, DK095491, DK104713, DK103712]; Veterans Affairs Merit Award [BX002182]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK104713, R01DK103712, R01DK095491, R37DK050189] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK050189, DK095491, DK104713, and DK103712 and Veterans Affairs Merit Award BX002182. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Aschauer L, 2013, MOL CELL BIOL, V33, P2535, DOI 10.1128/MCB.01435-12; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; ATKINSON DE, 1977, CELLULAR ENERGY META, P85; BACALLAO R, 1994, J CELL SCI, V107, P3301; BALL WJ, 1975, J BACTERIOL, V121, P975, DOI 10.1128/JB.121.3.975-982.1975; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; Capaldo CT, 2015, SEMIN CELL DEV BIOL, V42, P22, DOI 10.1016/j.semcdb.2015.04.003; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Chouraki V, 2017, ALZHEIMERS DEMENT, V13, P1327, DOI 10.1016/j.jalz.2017.04.009; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; Colgan SP, 2016, ANNU REV PATHOL-MECH, V11, P77, DOI 10.1146/annurev-pathol-012615-044231; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; De la Fuente IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108676; Elion GB, 1978, URIC ACID, P485, DOI [10.1007/978-3-642-66867-8_2, DOI 10.1007/978-3-642-66867-8_2]; Ercan N, 1996, ARCH BIOCHEM BIOPHYS, V328, P255, DOI 10.1006/abbi.1996.0171; Ercan-Fang N, 2002, AM J PHYSIOL-ENDOC M, V283, pE29, DOI 10.1152/ajpendo.00425.2001; FORSCHER P, 1992, NATURE, V357, P515, DOI 10.1038/357515a0; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Glover LE, 2016, J CLIN INVEST, V126, P3680, DOI 10.1172/JCI84429; Glover LE, 2013, P NATL ACAD SCI USA, V110, P19820, DOI 10.1073/pnas.1302840110; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; GRIMBLE GK, 1994, GUT, V35, pS46, DOI 10.1136/gut.35.1_Suppl.S46; HIROKAWA N, 1983, J CELL BIOL, V96, P1325, DOI 10.1083/jcb.96.5.1325; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ibla JC, 2006, AM J PHYSIOL-CELL PH, V291, pC282, DOI 10.1152/ajpcell.00564.2005; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Karhausen J, 2005, CELL CYCLE, V4, P256; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; KRENITSKY TA, 1967, J BIOL CHEM, V242, P2675; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; Lazzarino G, 2017, MOL NEUROBIOL, V54, P7520, DOI 10.1007/s12035-016-0257-9; Long Y, 2017, CANCER-AM CANCER SOC, V123, P4066, DOI 10.1002/cncr.30829; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; MACKINNON AM, 1973, BIOCHIM BIOPHYS ACTA, V319, P1, DOI 10.1016/0005-2787(73)90034-8; MADARA JL, 1987, J MEMBRANE BIOL, V100, P149, DOI 10.1007/BF02209147; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; MATTHEWS JB, 1992, J CLIN INVEST, V90, P1608, DOI 10.1172/JCI116030; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; NISHIDA Y, 1979, AGENTS ACTIONS, V9, P549, DOI 10.1007/BF01968126; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; REITER S, 1983, BIOCHEM PHARMACOL, V32, P2167, DOI 10.1016/0006-2952(83)90222-8; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; SAVAIANO DA, 1981, J NUTR, V111, P1816, DOI 10.1093/jn/111.10.1816; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; SHEPHERD AP, 1982, FED PROC, V41, P2084; Sun XF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170104; SWEDES JS, 1975, J BIOL CHEM, V250, P6930; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; WALKERSIMMONS M, 1977, J BACTERIOL, V130, P676, DOI 10.1128/JB.130.2.676-683.1977; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015	66	60	61	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6039	6051		10.1074/jbc.RA117.000269	http://dx.doi.org/10.1074/jbc.RA117.000269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487135	Green Published, hybrid			2022-12-28	WOS:000430497300023
J	Lin, YB; Bogdanov, M; Lu, S; Guan, ZQ; Margolin, W; Weiss, J; Zheng, L				Lin, Yibin; Bogdanov, Mikhail; Lu, Shuo; Guan, Ziqiang; Margolin, William; Weiss, Jerrold; Zheng, Lei			The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A(2) attack	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY-INCREASING PROTEIN; GROUP IIA PHOSPHOLIPASE-A2; ESCHERICHIA-COLI; HUMAN NEUTROPHILS; OUTER-MEMBRANE; INFLAMMATORY FLUID; LIPID ASYMMETRY; GROUP-X; GROUP-V; DETERMINANTS	Secretory phospholipases A(2) (sPLA(2)s) are potent components of mammalian innate-immunity antibacterial mechanisms. sPLA(2) enzymes attack bacteria by hydrolyzing bacterial membrane phospholipids, causing membrane disorganization and cell lysis. However, most Gram-negative bacteria are naturally resistant to sPLA(2). Here we report a novel resistance mechanism to mammalian sPLA(2) in Escherichia coli, mediated by a phospholipid repair system consisting of the lysophospholipid transporter LplT and the acyltransferase Aas in the cytoplasmic membrane. Mutation of the lplT or aas gene abolished bacterial lysophospholipid acylation activity and drastically increased bacterial susceptibility to the combined actions of inflammatory fluid components and sPLA(2), resulting in bulk phospholipid degradation and loss of colony-forming ability. sPLA(2)-mediated hydrolysis of the three major bacterial phospholipids exhibited distinctive kinetics and deacylation of cardiolipin to its monoacyl-derivative closely paralleled bacterial death. Characterization of the membrane envelope in lplT-or aas-knockout mutant bacteria revealed reduced membrane packing and disruption of lipid asymmetry with more phosphatidylethanolamine present in the outer leaflet of the outer membrane. Moreover, modest accumulation of lysophospholipids in these mutant bacteria destabilized the inner membrane and rendered outer membrane-depleted spheroplasts much more sensitive to sPLA(2). These findings indicated that LplT/Aas inactivation perturbs both the outer and inner membranes by bypassing bacterial membrane maintenance mechanisms to trigger specific interfacial activation of sPLA(2). We conclude that the LplT/Aas system is important for maintaining the integrity of the membrane envelope in Gram-negative bacteria. Our insights may help inform new therapeutic strategies to enhance host sPLA(2) antimicrobial activity.	[Lin, Yibin; Lu, Shuo; Zheng, Lei] Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Bogdanov, Mikhail] Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Margolin, William] Univ Texas McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Guan, Ziqiang] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Weiss, Jerrold] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	Baylor College of Medicine; Duke University; University of Iowa; University of Iowa; University of Iowa	Zheng, L (corresponding author), Univ Texas McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Guan, Ziqiang/AAE-5110-2019	Weiss, Jerrold/0000-0003-1476-4485	National Institutes of Health [R01 GM097290, R01GM098572, R01GM61074]; European Union Marie Sklodowska-Curie Grant [H2020-MSCA-RISE-2015-690853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061074, R01GM098572, R01GM097290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Marie Sklodowska-Curie Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM097290 and R01GM098572 (to L. Z.) and R01GM61074 (to W. M.), and European Union Marie Sklodowska-Curie Grant H2020-MSCA-RISE-2015-690853 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dekker N, 2000, MOL MICROBIOL, V35, P711, DOI 10.1046/j.1365-2958.2000.01775.x; Elsbach Peter, 1994, Trends in Microbiology, V2, P324, DOI 10.1016/0966-842X(94)90449-9; Femling JK, 2005, J IMMUNOL, V175, P4653, DOI 10.4049/jimmunol.175.7.4653; FORST S, 1987, BIOCHIM BIOPHYS ACTA, V920, P221, DOI 10.1016/0005-2760(87)90098-1; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gronroos JO, 2002, J INFECT DIS, V185, P1767, DOI 10.1086/340821; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henderson JC, 2016, ANNU REV MICROBIOL, V70, P255, DOI 10.1146/annurev-micro-102215-095308; HSU L, 1991, J BIOL CHEM, V266, P13783; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kucherak OA, 2010, J AM CHEM SOC, V132, P4907, DOI 10.1021/ja100351w; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lin YB, 2016, J BIOL CHEM, V291, P2136, DOI 10.1074/jbc.M115.700419; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Machaidze G, 2003, BIOCHEMISTRY-US, V42, P12570, DOI 10.1021/bi035225b; Madsen LM, 1996, INFECT IMMUN, V64, P2425, DOI 10.1128/IAI.64.7.2425-2430.1996; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Sachdeva S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00070; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; WEINRAUCH Y, 1995, J CLIN INVEST, V95, P1916, DOI 10.1172/JCI117873; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; WEISS J, 1991, J BIOL CHEM, V266, P4162; WEISS J, 1994, J BIOL CHEM, V269, P26331; Weiss JP, 2015, BBA-BIOMEMBRANES, V1848, P3072, DOI 10.1016/j.bbamem.2015.05.018; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Wu YZ, 2010, BIOCHIMIE, V92, P583, DOI 10.1016/j.biochi.2010.01.024; Zarember K, 1997, BLOOD, V89, P672, DOI 10.1182/blood.V89.2.672; Zheng L, 2017, BBA-MOL CELL BIOL L, V1862, P1404, DOI 10.1016/j.bbalip.2016.11.015	44	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3386	3398		10.1074/jbc.RA117.001231	http://dx.doi.org/10.1074/jbc.RA117.001231			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29348168	Green Published, hybrid			2022-12-28	WOS:000426562800029
J	Roy, AR; Ahmed, A; DiStefano, PV; Chi, LJ; Khyzha, N; Galjart, N; Wilson, MD; Fish, JE; Delgado-Olguin, P				Roy, Anna R.; Ahmed, Abdalla; DiStefano, Peter V.; Chi, Lijun; Khyzha, Nadiya; Galjart, Niels; Wilson, Michael D.; Fish, Jason E.; Delgado-Olguin, Paul			The transcriptional regulator CCCTC-binding factor limits oxidative stress in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; embryo; endothelial cell; frataxin; gene expression; gene regulation; placenta; reactive oxygen species (ROS); vascular; CTCF; vascular biology; oxidative stress; Friedreich's ataxia	HISTONE DEACETYLASE INHIBITORS; FRIEDREICH ATAXIA; VASCULAR DEVELOPMENT; FRATAXIN DEFICIENCY; MULTIPLE FUNCTIONS; CTCF; GENE; MOUSE; ANGIOGENESIS; EXPRESSION	The CCCTC-binding factor (CTCF) is a versatile transcriptional regulator required for embryogenesis, but its function in vascular development or in diseases with a vascular component is poorly understood. Here, we found that endothelial Ctcf is essential for mouse vascular development and limits accumulation of reactive oxygen species (ROS). Conditional knockout of Ctcf in endothelial progenitors and their descendants affected embryonic growth, and caused lethality at embryonic day 10.5 because of defective yolk sac and placental vascular development. Analysis of global gene expression revealed Frataxin (Fxn), the gene mutated in Friedreich's ataxia (FRDA), as the most strongly down-regulated gene in Ctcf-deficient placental endothelial cells. Moreover, in vitro reporter assays showed that Ctcf activates the Fxn promoter in endothelial cells. ROS are known to accumulate in the endothelium of FRDA patients. Importantly, Ctcf deficiency induced ROS-mediated DNA damage in endothelial cells in vitro, and in placental endothelium in vivo. Taken together, our findings indicate that Ctcf promotes vascular development and limits oxidative stress in endothelial cells. These results reveal a function for Ctcf in vascular development, and suggest a potential mechanism for endothelial dysfunction in FRDA.	[Roy, Anna R.; Ahmed, Abdalla; Chi, Lijun; Delgado-Olguin, Paul] Hosp Sick Children, Translat Med Res Program, Toronto, ON M5G 0A4, Canada; [Roy, Anna R.; Ahmed, Abdalla; Wilson, Michael D.; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [DiStefano, Peter V.; Khyzha, Nadiya; Fish, Jason E.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada; [Galjart, Niels] Erasmus MC, Dept Cell Biol & Genet, NL-3015 CN Rotterdam, Netherlands; [Wilson, Michael D.] Hosp Sick Children, Genet & Genome Biol Res Program, Toronto, ON M5G 0A4, Canada; [Fish, Jason E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Fish, Jason E.; Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3H2, Canada; [Fish, Jason E.] Canadian Inst Hlth Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Institute for Work & Health	Delgado-Olguin, P (corresponding author), 686 Bay St, Toronto, ON M5G 0A4, Canada.	paul.delgadoolguin@sickkids.ca	Olguin, Paul Delgado/H-9293-2019; Galjart, Niels/D-1146-2010; Wilson, Michael/K-6294-2014	Olguin, Paul Delgado/0000-0002-5355-247X; Galjart, Niels/0000-0003-1964-3607; Fish, Jason/0000-0003-0640-7277; Wilson, Michael/0000-0002-4015-3066; Khyzha, Nadiya/0000-0001-8804-0039	Natural Sciences and Engineering Research Council of Canada (NSERC) [500865]; Heart and Stroke Foundation of Canada [G-17-0018613]; Canadian Institutes of Health Research (CIHR) [PJT-149046, MOP-119506]; Hospital for Sick Children	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 500865 (to P.D.O). This work was also supported by the Heart and Stroke Foundation of Canada Grant G-17-0018613, the Canadian Institutes of Health Research (CIHR) Grant PJT-149046, and Operational Funds from the Hospital for Sick Children (to P.D.O.) and from the Canadian Institutes of Health Research (CIHR) Grant MOP-119506 (to J.E.F). The authors declare that they have no conflicts of interest with the contents of this article.	Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Battistelli C, 2014, J CELL SCI, V127, P3757, DOI 10.1242/jcs.149427; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Chi LJ, 2018, METHODS MOL BIOL, V1752, P101, DOI 10.1007/978-1-4939-7714-7_10; Chi LJ, 2017, DEVELOPMENT, V144, P1976, DOI 10.1242/dev.148916; Chutake YK, 2014, J BIOL CHEM, V289, P15194, DOI 10.1074/jbc.M114.566414; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Delgado-Olguin P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.164574; Demicheva E, 2014, FETAL DIAGN THER, V36, P143, DOI 10.1159/000353633; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fish JE, 2015, DEV DYNAM, V244, P391, DOI 10.1002/dvdy.24252; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garcia MD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00308; Gomez-Velazquez M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006985; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lake RJ, 2016, NUCLEIC ACIDS RES, V44, P2125, DOI 10.1093/nar/gkv1219; Lee YK, 2016, INT J CARDIOL, V203, P964, DOI 10.1016/j.ijcard.2015.11.101; Lefevre S, 2012, BIOCHEM BIOPH RES CO, V418, P336, DOI 10.1016/j.bbrc.2012.01.022; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Lu JR, 2012, TRANSCR-AUSTIN, V3, P73, DOI 10.4161/trns.19634; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nachbauer W, 2012, J NEUROPATH EXP NEUR, V71, P708, DOI 10.1097/NEN.0b013e31825fed76; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Narendra V, 2016, GENE DEV, V30, P2657, DOI 10.1101/gad.288324.116; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Panth N., 2016, ADV MED, V2016, P9152732, DOI [10.1155/2016/9152732, DOI 10.1155/2016/9152732]; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Roy AR, 2018, METHODS MOL BIOL, V1752, P11, DOI 10.1007/978-1-4939-7714-7_2; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Siasos G., 2011, CIRCULATION S21, V124; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Tang M, 2011, P NATL ACAD SCI USA, V108, P15231, DOI 10.1073/pnas.1104662108; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301; Vuong S, 2018, METHODS MOL BIOL, V1752, P1, DOI 10.1007/978-1-4939-7714-7_1; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Yan HR, 2012, J INSECT PHYSIOL, V58, P782, DOI 10.1016/j.jinsphys.2012.02.003; Yandim C, 2013, J NEUROCHEM, V126, P21, DOI 10.1111/jnc.12254; Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	89	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8449	8461		10.1074/jbc.M117.814699	http://dx.doi.org/10.1074/jbc.M117.814699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29610276	Green Published, hybrid			2022-12-28	WOS:000434205700010
J	Gutierrez, BA; Chavez, MA; Rodarte, AI; Ramos, MA; Dominguez, A; Petrova, Y; Davalos, AJ; Costa, RM; Elizondo, R; Tuvim, MJ; Dickey, BF; Burns, AR; Heidelberger, R; Adachi, R				Gutierrez, Berenice A.; Chavez, Miguel A.; Rodarte, Alejandro I.; Ramos, Marco A.; Dominguez, Andrea; Petrova, Youlia; Davalos, Alfredo J.; Costa, Renan M.; Elizondo, Ramon; Tuvim, Michael J.; Dickey, Burton F.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Munc18-2, but not Munc18-1 or Munc18-3, controls compound and single-vesicle-regulated exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mast cell; exocytosis; SNARE proteins; patch clamp; allergy; secretion; electrophysiology; anaphylaxis; Munc18; syntaxin-binding protein	SYNTAXIN 4; CAPACITANCE MEASUREMENTS; GLUT4 TRANSLOCATION; SECRETORY RESPONSES; SNARE; FUSION; MICE; PROTEIN; DEGRANULATION; ACTIVATION	Mast cells (MCs) play pivotal roles in many inflammatory conditions including infections, anaphylaxis, and asthma. MCs store immunoregulatory compounds in their large cytoplasmic granules and, upon stimulation, secrete them via regulated exocytosis. Exocytosis in many cells requires the participation of Munc18 proteins (also known as syntaxin-binding proteins), and we found that mature MCs express all three mammalian isoforms: Munc18-1, -2, and -3. To study their functions in MC effector responses and test the role of MC degranulation in anaphylaxis, we used conditional knockout (cKO) mice in which each Munc18 protein was deleted exclusively in MCs. Using recordings of plasma membrane capacitance for high-resolution analysis of exocytosis in individual MCs, we observed an almost complete absence of exocytosis in Munc18-2-deficient MCs but intact exocytosis in MCs lacking Munc18-1 or Munc18-3. Stereological analysis of EM images of stimulated MCs revealed that the deletion of Munc18-2 also abolishes the homotypic membrane fusion required for compound exocytosis. We confirmed the severe defect in regulated exocytosis in the absence of Munc18-2 by measuring the secretion of mediators stored in MC granules. Munc18-2 cKO mice had normal morphology, development, and distribution of their MCs, indicating that Munc18-2 is not essential for the migration, retention, and maturation of MC-committed progenitors. Despite that, we found that Munc18-2 cKO mice were significantly protected from anaphylaxis. In conclusion, MC-regulated exocytosis is required for the anaphylactic response, and Munc18-2 is the sole Munc18 isoform that mediates membrane fusion during MC degranulation.	[Gutierrez, Berenice A.; Chavez, Miguel A.; Rodarte, Alejandro I.; Ramos, Marco A.; Petrova, Youlia; Davalos, Alfredo J.; Tuvim, Michael J.; Dickey, Burton F.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Gutierrez, Berenice A.] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey 64849, NL, Mexico; [Chavez, Miguel A.; Rodarte, Alejandro I.; Dominguez, Andrea; Elizondo, Ramon] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, NL, Mexico; [Costa, Renan M.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, McGovern Med Sch, Houston, TX 77030 USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Tecnologico de Monterrey; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Heidelberger, Ruth/0000-0002-8033-2050; Adachi, Roberto/0000-0002-0146-0768; Tuvim, Michael/0000-0001-8126-7716; Costa, Renan/0000-0001-7195-5259	National Institutes of Health [AI093533, HL129795, CA016672, EY012128, EY007551]; Cancer Prevention Research Institute of Texas Grant [RP110166]; Mexican National Council for Science and Technology Ph.D. Grant Scholarship [448085]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY012128, P30EY007551, R01EY012128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas Grant; Mexican National Council for Science and Technology Ph.D. Grant Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI093533, HL129795, CA016672, EY012128, and EY007551; Cancer Prevention Research Institute of Texas Grant RP110166; and Mexican National Council for Science and Technology Ph.D. Grant Scholarship 448085. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; BROCK TA, 1988, AM J PHYSIOL, V255, pC667, DOI 10.1152/ajpcell.1988.255.5.C667; BUGAJSKI J, 1981, AGENTS ACTIONS, V11, P443, DOI 10.1007/BF02004704; Christie MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187302; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gillis Kevin D., 1995, P155; GINSBURG H, 1982, IMMUNOLOGY, V45, P371; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Innocenti B, 2008, J NEUROPHYSIOL, V99, P25, DOI 10.1152/jn.00737.2007; IRANI AMA, 1987, J IMMUNOL, V138, P4381; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00256; Lieberman P, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0598-5; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0; Salinas E, 2008, J INVEST ALLERG CLIN, V18, P366; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; TATHAM PER, 1991, J CELL SCI, V98, P217; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Wu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058560; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038	86	14	14	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7148	7159		10.1074/jbc.RA118.002455	http://dx.doi.org/10.1074/jbc.RA118.002455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29599294	Green Published, hybrid			2022-12-28	WOS:000432174500008
J	Liu, XY; Farnung, L; Wigge, C; Cramer, P				Liu, Xiangyang; Farnung, Lucas; Wigge, Christoph; Cramer, Patrick			Cryo-EM structure of a mammalian RNA polymerase II elongation complex inhibited by -amanitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; RNA polymerase II; RNA polymerase; cryo-electron microscopy; structural biology	ALPHA-AMANITIN; TRANSCRIPTION; MOUSE	RNA polymerase II (Pol II) is the central enzyme that transcribes eukaryotic protein-coding genes to produce mRNA. The mushroom toxin -amanitin binds Pol II and inhibits transcription at the step of RNA chain elongation. Pol II from yeast binds -amanitin with micromolar affinity, whereas metazoan Pol II enzymes exhibit nanomolar affinities. Here, we present the high-resolution cryo-EM structure of -amanitin bound to and inhibited by its natural target, the mammalian Pol II elongation complex. The structure revealed that the toxin is located in a pocket previously identified in yeast Pol II but forms additional contacts with metazoan-specific residues, which explains why its affinity to mammalian Pol II is approximate to 3000 times higher than for yeast Pol II. Our work provides the structural basis for the inhibition of mammalian Pol II by the natural toxin -amanitin and highlights that cryo-EM is well suited to studying interactions of a small molecule with its macromolecular target.	[Liu, Xiangyang; Farnung, Lucas; Wigge, Christoph; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany.	pcramer@mpibpc.mpg.de		Farnung, Lucas/0000-0002-8200-2493	Deutsche Forschungsgemeinschaft [SFB860, SPP1935]; European Research Council Advanced Investigator Grant TRANSREGULON Grant [693023]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Investigator Grant TRANSREGULON Grant; Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB860 and SPP1935 (to P.C.), European Research Council Advanced Investigator Grant TRANSREGULON Grant Agreement 693023 (to P.C.), and funds from the Volkswagen Foundation (to P.C.). The authors declare that they have no conflicts of interest with the contents of this article.	BARTOLOMEI MS, 1987, MOL CELL BIOL, V7, P586, DOI 10.1128/MCB.7.2.586; BARTOLOMEI MS, 1995, MOL GEN GENET, V246, P778, DOI 10.1007/BF00290727; BAUMANN K, 1994, PROTEIN SCI, V3, P750; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bernecky C, 2017, NAT STRUCT MOL BIOL, V24, P809, DOI 10.1038/nsmb.3465; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; COCHETME.M, 1974, BIOCHIM BIOPHYS ACTA, V353, P185, DOI 10.1016/0005-2787(74)90183-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Hubbard R.E., 2010, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.A0003011.PUB2; Klebe G, 2015, NAT REV DRUG DISCOV, V14, P95, DOI 10.1038/nrd4486; Schlesinger H, 1907, J BIOL CHEM, V3, P279; Torices R, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400104; WIELAND T, 1991, EXPERIENTIA, V47, P1186, DOI 10.1007/BF01918382; Wieland T., 1986, PEPTIDES POISONOUS A; Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	23	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7189	7194		10.1074/jbc.RA118.002545	http://dx.doi.org/10.1074/jbc.RA118.002545			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29550768	hybrid, Green Published			2022-12-28	WOS:000432174500011
J	Santos, ARS; Gerhardt, ECM; Moure, VR; Pedrosa, FO; Souza, EM; Diamanti, R; Hogbom, M; Huergo, LF				Schenberger Santos, Adrian Richard; Marques Gerhardt, Edileusa Cristina; Moure, Vivian Rotuno; Pedrosa, Fabio Oliveira; Souza, Emanuel Maltempi; Diamanti, Riccardo; Hogbom, Martin; Huergo, Luciano Fernandes			Kinetics and structural features of dimeric glutamine-dependent bacterial NAD(+) synthetases suggest evolutionary adaptation to available metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; nitrogen metabolism; glutamine; glutamine synthase; ammonia; ammonia assimilation; NadE; nitrogenase	ESCHERICHIA-COLI; ADP-RIBOSYLATION; NITROGEN ASSIMILATION; BACILLUS-SUBTILIS; BINDING; PROTEIN; AMTB	NADH (NAD(+)) and its reduced form NADH serve as cofactors for a variety of oxidoreductases that participate in many metabolic pathways. NAD(+) also is used as substrate by ADP-ribosyl transferases and by sirtuins. NAD(+) biosynthesis is one of the most fundamental biochemical pathways in nature, and the ubiquitous NAD(+) synthetase (NadE) catalyzes the final step in this biosynthetic route. Two different classes of NadE have been described to date: dimeric single-domain ammonium-dependent NadE(NH3) and octameric glutamine-dependent NadE(Gln), and the presence of multiple NadE isoforms is relatively common in prokaryotes. Here, we identified a novel dimeric group of NadE(Gln) in bacteria. Substrate preferences and structural analyses suggested that dimeric NadE(Gln) enzymes may constitute evolutionary intermediates between dimeric NadE(NH3) and octameric NadE(Gln). The characterization of additional NadE isoforms in the diazotrophic bacterium Azospirillum brasilense along with the determination of intracellular glutamine levels in response to an ammonium shock led us to propose a model in which these different NadE isoforms became active accordingly to the availability of nitrogen. These data may explain the selective pressures that support the coexistence of multiple isoforms of NadE in some prokaryotes.	[Schenberger Santos, Adrian Richard; Marques Gerhardt, Edileusa Cristina; Moure, Vivian Rotuno; Pedrosa, Fabio Oliveira; Souza, Emanuel Maltempi; Huergo, Luciano Fernandes] Univ Fed Parana UFPR, Dept Biochem & Mol Biol, BR-512 Curitiba, Parana, Brazil; [Huergo, Luciano Fernandes] Univ Fed Parana UFPR, Setor Litoral, BR-512 Curitiba, PR, Brazil; [Diamanti, Riccardo; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Universidade Federal do Parana; Universidade Federal do Parana; Stockholm University	Huergo, LF (corresponding author), UFPR, Setor Litoral, Rua Jaguariaiva 512, Matinhos, PR, Brazil.	luciano.huergo@gmail.com		Rotuno Moure, Vivian/0000-0003-0968-8190; Hogbom, Martin/0000-0001-5574-9383; Schenberger Santos, Adrian Richard/0000-0002-5788-2193	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Araucaria, Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), and CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT). The authors declare that they have no conflicts of interest with the contents of this article.	Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Chuenchor W, 2012, BIOCHEM J, V443, P417, DOI 10.1042/BJ20112210; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Floquet N, 2007, FEBS LETT, V581, P2981, DOI 10.1016/j.febslet.2007.05.068; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Laskoski K, 2016, ARCH MICROBIOL, V198, P307, DOI 10.1007/s00203-016-1190-z; Li J, 2017, SCIENCE, V355, P1312, DOI 10.1126/science.aad8242; Moure VR, 2015, CURR TOP MICROBIOL, V384, P89, DOI 10.1007/82_2014_380; Okano H, 2010, J MOL BIOL, V404, P522, DOI 10.1016/j.jmb.2010.09.046; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Resto M, 2009, BBA-PROTEINS PROTEOM, V1794, P1648, DOI 10.1016/j.bbapap.2009.07.014; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Rodrigues TE, 2014, MOL MICROBIOL, V91, P751, DOI 10.1111/mmi.12493; Symersky J, 2002, ACTA CRYSTALLOGR D, V58, P1138, DOI 10.1107/S0907444902006698; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60	31	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7397	7407		10.1074/jbc.RA118.002241	http://dx.doi.org/10.1074/jbc.RA118.002241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581233	Green Published, hybrid			2022-12-28	WOS:000432174500032
J	Baranovskiy, AG; Duong, VN; Babayeva, ND; Zhang, YB; Pavlov, YI; Anderson, KS; Tahirov, TH				Baranovskiy, Andrey G.; Duong, Vincent N.; Babayeva, Nigar D.; Zhang, Yinbo; Pavlov, Youri I.; Anderson, Karen S.; Tahirov, Tahir H.			Activity and fidelity of human DNA polymerase depend on primer structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA polymerase; human; crystal structure; DNA-protein interaction; RNA; conformational change; chimeric RNA-DNA primer; Pol; Pol; Pol epsilon; pre-steady-state kinetics	C-TERMINAL DOMAIN; POL ALPHA; CRYSTAL-STRUCTURE; CONSERVED REGION; CATALYTIC SUBUNIT; KINETIC-ANALYSIS; B-SUBUNIT; REPLICATION; MECHANISM; COMPLEX	DNA polymerase (Pol) plays an important role in genome replication. In a complex with primase, Pol synthesizes chimeric RNA-DNA primers necessary for replication of both chromosomal DNA strands. During RNA primer extension with deoxyribonucleotides, Pol needs to use double-stranded helical substrates having different structures. Here, we provide a detailed structure-function analysis of human Pol's interaction with dNTPs and DNA templates primed with RNA, chimeric RNA-DNA, or DNA. We report the crystal structures of two ternary complexes of the Pol catalytic domain containing dCTP, a DNA template, and either a DNA or an RNA primer. Unexpectedly, in the ternary complex with a DNA:DNA duplex and dCTP, the fingers subdomain of Pol is in the open conformation. Pol induces conformational changes in the DNA and hybrid duplexes to produce the universal double helix form. Pre-steady-state kinetic studies indicated for both duplex types that chemical catalysis rather than product release is the rate-limiting step. Moreover, human Pol extended DNA primers with higher efficiency but lower processivity than it did with RNA and chimeric primers. Pol has a substantial propensity to make errors during DNA synthesis, and we observed that its fidelity depends on the type of sugar at the primer 3-end. A detailed structural comparison of Pol with other replicative DNA polymerases disclosed common features and some differences, which may reflect the specialization of each polymerase in genome replication.	[Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Genet & Anat, Omaha, NE 68198 USA; [Duong, Vincent N.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Duong, Vincent N.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Mol Biophys, New Haven, CT 06510 USA; [Duong, Vincent N.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Biochem, New Haven, CT 06510 USA; [Zhang, Yinbo] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Yale University; Yale University; Yale University; University of Washington; University of Washington Seattle	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.; Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.; Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys, New Haven, CT 06510 USA.; Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Biochem, New Haven, CT 06510 USA.	karen.anderson@yale.edu; ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069	NCI, National Institutes of Health (NIH), Cancer Center Support Grant [P30CA036727]; NIGMS, NIH [P41 GM103403, INBRE-P20GM103427-14, COBRE-1P30GM110768-01]; Department of Energy [DE-AC02-06CH11357]; Fred and Pamela Buffett Cancer Center Support Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P30GM110768, P20GM103427, R01GM049551, R35GM127085, R01GM101167, T32GM067543] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH), Cancer Center Support Grant; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); Fred and Pamela Buffett Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Eppley Institute's X-ray Crystallography Core Facility is supported by NCI, National Institutes of Health (NIH), Cancer Center Support Grant P30CA036727. This work is also based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT) beamline at the Advanced Photon Source at Argonne National Laboratory, which is supported by NIGMS, NIH, Grant P41 GM103403. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by Department of Energy Contract DE-AC02-06CH11357. The University of Nebraska DNA Sequencing Core receives partial support from NIGMS, NIH, Grants INBRE-P20GM103427-14 and COBRE-1P30GM110768-01 as well as Fred and Pamela Buffett Cancer Center Support Grant P30CA036727.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; ARNOTT S, 1986, J MOL BIOL, V188, P631, DOI 10.1016/S0022-2836(86)80011-0; Baranovskiy AG, 2017, J BIOL CHEM, V292, P15717, DOI 10.1074/jbc.M117.792705; Baranovskiy AG, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020062; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Coloma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23784; COPELAND WC, 1993, J BIOL CHEM, V268, P11041; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Dawson R.M.C., 1986, DATA BIOCH RES, P399; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; DONG Q, 1995, J BIOL CHEM, V270, P21563, DOI 10.1074/jbc.270.37.21563; DONG Q, 1993, J BIOL CHEM, V268, P24163; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P6751, DOI 10.1021/bi049975c; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; FUJIWARA T, 1985, BIOCHEMISTRY-US, V24, P896, DOI 10.1021/bi00325a013; Gandhi VV, 2011, NUCLEOS NUCLEOT NUCL, V30, P317, DOI 10.1080/15257770.2011.586955; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Han T, 2016, NAT CHEM BIOL, V12, P511, DOI [10.1038/NCHEMBIO.2082, 10.1038/nchembio.2082]; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Jain R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094835; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kilkenny ML, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170217; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; KUNKEL TA, 1991, MUTAT RES, V250, P175, DOI 10.1016/0027-5107(91)90174-M; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012; Maga G, 2000, J MOL BIOL, V295, P791, DOI 10.1006/jmbi.1999.3394; Mislak AC, 2016, ANTIMICROB AGENTS CH, V60, P561, DOI 10.1128/AAC.02270-15; Niimi A, 2004, MOL CELL BIOL, V24, P2734, DOI 10.1128/MCB.24.7.2734-2746.2004; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Ogawa M, 2003, J BIOL CHEM, V278, P19071, DOI 10.1074/jbc.M208605200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Priyakumar UD, 2008, J PHYS CHEM B, V112, P1515, DOI 10.1021/jp709827m; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Shimizu K, 2002, J BIOL CHEM, V277, P37422, DOI 10.1074/jbc.M204476200; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Starokadomskyy P, 2016, NAT IMMUNOL, V17, P495, DOI 10.1038/ni.3409; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Tanaka S, 2010, DNA REPAIR, V9, P534, DOI 10.1016/j.dnarep.2010.02.002; THOMPSON HC, 1995, BIOCHEMISTRY-US, V34, P11198, DOI 10.1021/bi00035a027; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zafar MK, 2014, BIOCHEMISTRY-US, V53, P6584, DOI 10.1021/bi501024u; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v; Zhang YB, 2016, DNA REPAIR, V43, P24, DOI 10.1016/j.dnarep.2016.05.017; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; ZINNEN S, 1994, J BIOL CHEM, V269, P24195	69	17	17	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6824	6843		10.1074/jbc.RA117.001074	http://dx.doi.org/10.1074/jbc.RA117.001074			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29555682	hybrid, Green Published			2022-12-28	WOS:000431487300017
J	Akama, T; Chun, TH				Akama, Takeshi; Chun, Tae-Hwa			Transcription factor 21 (TCF21) promotes proinflammatory interleukin 6 expression and extracellular matrix remodeling in visceral adipose stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC INFLAMMATION; GLUCOSE-UPTAKE; TISSUE; OBESITY; FAT; ACTIVATION; ONSET	The visceral (VIS) and subcutaneous (SQ) fat pads are developmentally distinct white adipose tissue depots and contribute differently to inflammation and insulin resistance associated with obesity. The basic helix-loop-helix transcriptional regulator, transcription factor 21 (TCF21), is a marker gene for white adipose tissues and is abundantly expressed in VIS-derived adipose stem cells (ASCs), but not in SQ-derived ASCs. However, TCF21's role in regulating fat depot-specific gene expression and function is incompletely understood. Here, using siRNA-mediated Tcf21 knockdowns and lentiviral gene transfer of TCF21 in mouse ASCs, we demonstrate that TCF21 is required for the VIS ASC-specific expression of interleukin 6 (IL6), a key cytokine that contributes to the proinflammatory nature of VIS depots. Concurrently, TCF21 promotes MMP-dependent collagen degradation and type IV collagen deposition through the regulation of the extracellular matrix (ECM) modifiers, matrix metalloproteinase (MMP) 2, MMP13, and tissue inhibitor of MMP1(TIMP1), as well as collagen type IV alpha 1 chain (COL4A1) in VIS ASCs. We also found that although IL6 mediates the expression of Mmp13 and Timp1 in VIS ASCs, the TCF21-dependent expression of Mmp2 and Col4a1 is IL6-independent. These results suggest that TCF21 contributes to the proinflammatory environment in VIS fat depots and to active ECM remodeling of these depots by regulating IL6 expression and MMP-dependent ECM remodeling in a spatiotemporally coordinated manner.	[Akama, Takeshi; Chun, Tae-Hwa] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Akama, Takeshi; Chun, Tae-Hwa] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chun, TH (corresponding author), 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	taehwa@umich.edu	Chun, Tae-Hwa/H-5959-2019; Akama, Takeshi/C-9392-2011	Chun, Tae-Hwa/0000-0001-9333-2589; Akama, Takeshi/0000-0002-6470-7174	NIDDK, National Institutes of Health [DK095137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095137, P30DK020572] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK095137. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Barnes RH, 2016, JOVE-J VIS EXP, DOI 10.3791/53890; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chun TH, 2010, DIABETES, V59, P2484, DOI 10.2337/db10-0073; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002705; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hastbacka J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125918; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Starr ME, 2009, J GERONTOL A-BIOL, V64, P723, DOI 10.1093/gerona/glp046; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun CY, 2017, DEVELOPMENT, V144, P83, DOI 10.1242/dev.135962; Tokunaga M, 2014, MATRIX BIOL, V36, P28, DOI 10.1016/j.matbio.2014.03.005; Uitto VJ, 1998, AM J PATHOL, V152, P1489; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324	29	15	15	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6603	6610		10.1074/jbc.RA117.000456	http://dx.doi.org/10.1074/jbc.RA117.000456			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29540474	Green Published, hybrid			2022-12-28	WOS:000431108600030
J	Jin, H; Roy, U; Lee, G; Scharer, OD; Cho, Y				Jin, Hyeonseok; Roy, Upasana; Lee, Gwangrog; Scharer, Orlando D.; Cho, Yunje			Structural mechanism of DNA interstrand cross-link unhooking by the bacterial FAN1 nuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; protein-nucleic acid interaction; enzyme mechanism; molecular biology; DNA repair; protein structure; bacterial FAN1; basic pocket; DNA interstrand cross-link; FANCD2-FANCI-associated nuclease; ICL unhooking	KARYOMEGALIC INTERSTITIAL NEPHRITIS; ANEMIA-ASSOCIATED NUCLEASE; SINGLE-STRANDED-DNA; FANCONI-ANEMIA; SENSITIZES CELLS; IDENTIFIES FAN1; EXONUCLEASE 1; REPAIR; DAMAGE; KIAA1018/FAN1	DNA interstrand cross-links (ICLs) block the progress of the replication and transcription machineries and can weaken chromosomal stability, resulting in various diseases. FANCD2-FANCI-associated nuclease (FAN1) is a conserved structure-specific nuclease that unhooks DNA ICLs independently of the Fanconi anemia pathway. Recent structural studies have proposed two different mechanistic features for ICL unhooking by human FAN1: a specific basic pocket that recognizes the terminal phosphate of a 1-nucleotide (nt) 5 flap or FAN1 dimerization. Herein, we show that despite lacking these features, Pseudomonas aeruginosa FAN1 (PaFAN1) cleaves substrates at approximate to 3-nt intervals and resolves ICLs. Crystal structures of PaFAN1 bound to various DNA substrates revealed that its conserved basic Arg/Lys patch comprising Arg-228 and Lys-260 recognizes phosphate groups near the 5 terminus of a DNA substrate with a 1-nt flap or a nick. Substitution of Lys-260 did not affect PaFAN1's initial endonuclease activity but significantly decreased its subsequent exonuclease activity and ICL unhooking. The Arg/Lys patch also interacted with phosphates at a 3-nt gap, and this interaction could drive movement of the scissile phosphates into the PaFAN1-active site. In human FAN1, the ICL-resolving activity was not affected by individual disruption of the Arg/Lys patch or basic pocket. However, simultaneous substitution of both FAN1 regions significantly reduced its ICL-resolving activity, suggesting that these two basic regions play a complementary role in ICL repair. On the basis of these findings, we propose a conserved role for two basic regions in FAN1 to guide ICL unhooking and to maintain genomic stability.	[Jin, Hyeonseok; Cho, Yunje] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Roy, Upasana; Scharer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Roy, Upasana; Scharer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Lee, Gwangrog] Gwangju Inst Sci & Technol, Dept Biol, Gwangju 61005, South Korea; [Scharer, Orlando D.] Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Scharer, Orlando D.] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Dept Biol Sci, Ulsan 44919, South Korea	Pohang University of Science & Technology (POSTECH); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gwangju Institute of Science & Technology (GIST); Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Cho, Y (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	yunje@postech.ac.kr	Schärer, Orlando D./AAF-8613-2021		National Research Foundation of Korea (NRF) - Korea government (Ministry of Education, Science, and Technology) [2015R1A2A1A05001694, 2017M3A9F6029733, NRF-2013M3A6A4044580]; BK21 Program from the Ministry of Education; National Institutes of Health [CA165911]; Korean Institute for Basic Science [IBS-R022-A1-2017]; NATIONAL CANCER INSTITUTE [R01CA165911] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government (Ministry of Education, Science, and Technology); BK21 Program from the Ministry of Education(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Institute for Basic Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Research Foundation of Korea (NRF), funded by the Korea government (Ministry of Education, Science, and Technology), Grants 2015R1A2A1A05001694, 2017M3A9F6029733, and NRF-2013M3A6A4044580, BK21 Program from the Ministry of Education (to Y. C.), National Institutes of Health Grant CA165911, and Korean Institute for Basic Science Grant IBS-R022-A1-2017 (to O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Bettencourt C, 2016, ANN NEUROL, V79, P983, DOI 10.1002/ana.24656; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gwon GH, 2014, GENE DEV, V28, P2276, DOI 10.1101/gad.248492.114; Hodskinson MRG, 2014, MOL CELL, V54, P472, DOI 10.1016/j.molcel.2014.03.014; Huang J, 2013, MOL CELL, V52, P434, DOI 10.1016/j.molcel.2013.09.021; Huang YL, 2013, TRANSL CANCER RES, V2, P144, DOI 10.3978/j.issn.2218-676X.2013.03.01; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Jin H, 2017, DNA REPAIR, V56, P135, DOI 10.1016/j.dnarep.2017.06.016; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Klein D. D., 2014, CELL, V54, P460, DOI DOI 10.1016/j.molcel.2014.03.015; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lachaud C, 2016, GENE DEV, V30, P639, DOI 10.1101/gad.276287.115; Lachaud C, 2016, SCIENCE, V351, P846, DOI 10.1126/science.aad5634; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mukherjee S, 2014, NUCLEIC ACIDS RES, V42, P7429, DOI 10.1093/nar/gku328; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myler LR, 2016, P NATL ACAD SCI USA, V113, pE1170, DOI 10.1073/pnas.1516674113; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pizzolato J, 2015, J BIOL CHEM, V290, P22602, DOI 10.1074/jbc.M115.663666; Porro A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02130-x; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rolseth V, 2013, BBA-MOL CELL RES, V1833, P1157, DOI 10.1016/j.bbamcr.2012.12.024; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Segui N, 2015, GASTROENTEROLOGY, V149, P563, DOI 10.1053/j.gastro.2015.05.056; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Smith AL, 2016, CANCER LETT, V370, P302, DOI 10.1016/j.canlet.2015.10.030; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Thongthip S, 2016, GENE DEV, V30, P645, DOI 10.1101/gad.276261.115; VOSBERG HP, 1982, J BIOL CHEM, V257, P6595; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Wang S, 2016, NUCLEIC ACIDS RES, V44, P187, DOI 10.1093/nar/gkv949; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6726; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	52	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6482	6496		10.1074/jbc.RA118.002171	http://dx.doi.org/10.1074/jbc.RA118.002171			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29514982	Green Published, hybrid			2022-12-28	WOS:000431108600021
J	Gosney, JA; Wilkey, DW; Merchant, ML; Ceresa, BP				Gosney, Julie A.; Wilkey, Daniel W.; Merchant, Michael L.; Ceresa, Brian P.			Proteomics reveals novel protein associations with early endosomes in an epidermal growth factor-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; STOMATIN-LIKE PROTEIN-2; NA+-K+-ATPASE; FACTOR RECEPTOR; EGF-RECEPTOR; HELA-CELLS; TRAFFICKING; PATHWAY; EXPRESSION; CANCER	The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is an integral component of proliferative signaling. EGFRs on the cell surface become activated upon EGF binding and have an increased rate of endocytosis. Once in the cytoplasm, the EGF.EGFR complex is trafficked to the lysosome for degradation, and signaling is terminated. During trafficking, the EGFR kinase domain remains active, and the internalized EGFR can continue signaling to downstream effectors. Although effector activity varies based on the EGFR's endocytic location, it is not clear how this occurs. In an effort to identify proteins that uniquely associate with the internalized, liganded EGFR in the early endosome, we developed an early endosome isolation strategy to analyze their protein composition. Post-nuclear supernatant from HeLa cells stimulated with and without EGF were separated on an isotonic 17% Percoll gradient. The gradient was fractionated, and early endosomal fractions were pooled and immunoisolated with an EEA1 mAb. The isolated endosomes were validated by immunoblot using antibodies against organelle-specific marker proteins and transmission EM. These early endosomes were also subjected to LC-MS/MS for proteomic analysis. Five proteins were detected in endosomes in a ligand-dependent manner: EGFR, RUFY1, STOML2, PTPN23, and CCDC51. Knockdown of RUFY1 or PTPN23 by RNAi indicated that both proteins play a role in EGFR trafficking. These experiments indicate that endocytic trafficking of activated EGFR changes the protein composition, membrane trafficking, and signaling potential of the early endosome.	[Gosney, Julie A.; Ceresa, Brian P.] Univ Louisville, Dept Pharmacol & Toxicol, 505 S Hancock St,Ste 305, Louisville, KY 40202 USA; [Wilkey, Daniel W.; Merchant, Michael L.] Univ Louisville, Dept Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Ceresa, BP (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, 505 S Hancock St,Ste 305, Louisville, KY 40202 USA.	brian.ceresa@louisville.edu	Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Merchant, Michael/0000-0003-4128-4057	NEI, National Institutes of Health [EY027032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024337] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded in part by NEI, National Institutes of Health Grant EY027032 (to B. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; BERGERON JJM, 1986, BIOCHEMISTRY-US, V25, P1756, DOI 10.1021/bi00355a046; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Cao WF, 2007, AM J CLIN PATHOL, V128, P430, DOI 10.1309/C6X54HRB580EP2NQ; Cao WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063890; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gosney JA, 2017, METHODS MOL BIOL, V1652, P145, DOI 10.1007/978-1-4939-7219-7_11; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hashimoto A, 1999, J BIOL CHEM, V274, P20139, DOI 10.1074/jbc.274.29.20139; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Jackson NM, 2016, EXP CELL RES, V346, P224, DOI 10.1016/j.yexcr.2016.07.001; Jensen ON, 1999, METH MOL B, V112, P513; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Khundmiri SJ, 2004, J BIOL CHEM, V279, P17418, DOI 10.1074/jbc.M311715200; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oksvold MP, 2001, EUR J CELL BIOL, V80, P285, DOI 10.1078/0171-9335-00160; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rush JS, 2014, INVEST OPHTH VIS SCI, V55, P4691, DOI 10.1167/iovs.14-14133; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Song LB, 2012, J PATHOL, V226, P534, DOI 10.1002/path.3008; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vendeville A, 2009, J VIROL, V83, P4678, DOI 10.1128/JVI.02401-08; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vukmirica J, 2006, J BIOL CHEM, V281, P36360, DOI 10.1074/jbc.M602920200; WALLACH DFH, 1966, J CELL BIOL, V30, P601, DOI 10.1083/jcb.30.3.601; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; [Злобина М.В. Zlobina M.V.], 2014, [Цитология, Cell and Tissue Biology, Tsitologiya], V56, P741	53	14	15	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5895	5908		10.1074/jbc.RA117.000632	http://dx.doi.org/10.1074/jbc.RA117.000632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29523688	Green Published, hybrid			2022-12-28	WOS:000430497300012
J	Williams, AH; Wheeler, R; Rateau, L; Malosse, C; Chamot-Rooke, J; Haouz, A; Taha, MK; Boneca, IG				Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Malosse, Christian; Chamot-Rooke, Julia; Haouz, Ahmed; Taha, Muhamed-Kheir; Boneca, Ivo Gomperts			A step-by-step in crystallo guide to bond cleavage and 1,6-anhydro-sugar product synthesis by a peptidoglycan-degrading lytic transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BULGECIN; GONORRHOEAE; BINDING; SLT35; MLTA; MECHANISM; FAMILIES; REVEALS; COMPLEX	Lytic transglycosylases (LTs) are a class of enzymes important for the recycling and metabolism of peptidoglycan (PG). LTs cleave the beta-1,4-glycosidic bond between N-acetylmuramic acid (MurNAc) and GlcNAc in the PG glycan strand, resulting in the concomitant formation of 1,6-anhydro-N-acetylmuramic acid and GlcNAc. No LTs reported to date have utilized chitins as substrates, despite the fact that chitins are GlcNAc polymers linked via beta-1,4-glycosidic bonds, which are the known site of chemical activity for LTs. Here, we demonstrate enzymatically that LtgA, a non-canonical, substrate-permissive LT from Neisseria meningitidis utilizes chitopentaose ((GlcNAc)(5)) as a substrate to produce three newly identified sugars: 1,6-anhydro-chitobiose, 1,6-anhydro-chitotriose, and 1,6-anhydro-chitotetraose. Although LTs have been widely studied, their complex reactions have not previously been visualized in the crystalline state because macromolecular PG is insoluble. Here, we visualized the cleavage of the glycosidic bond and the liberation of GlcNAc-derived residues by LtgA, followed by the synthesis of atypical 1,6-anhydro-GlcNAc derivatives. In addition to the newly identified anhydro-chitin products, we identified trapped intermediates, unpredicted substrate rearrangements, sugar distortions, and a conserved crystallographic water molecule bound to the catalytic glutamate of a high-resolution native LT. This study enabled us to propose a revised alternative mechanism for LtgA that could also be applicable to other LTs. Our work contributes to the understanding of the mechanisms of LTs in bacterial cell wall biology.	[Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Boneca, Ivo Gomperts] Inst Pasteur, Dept Microbiol, Unite Biol & Genet Paroi Bacterienne, F-75015 Paris, France; [Williams, Allison H.; Wheeler, Richard; Rateau, Lesly; Boneca, Ivo Gomperts] INSERM, F-75015 Paris, France; [Wheeler, Richard] Gustave Roussy Comprehens Canc Ctr, Tumour Immunol & Immunotherapy, F-94805 Villejuif, France; [Malosse, Christian; Chamot-Rooke, Julia] Inst Pasteur, CNRS, USR 2000, Unite Spectrometrie Masse Struct & Proteom, F-75015 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plate Forme Cristallog, CNRS, UMR3528, F-75724 Paris, France; [Taha, Muhamed-Kheir] Inst Pasteur, Dept Infect & Epidemiol, Unite Infect Bacteriennes Invas, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Williams, AH; Boneca, IG (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol & Genet Paroi Bacterienne, F-75015 Paris, France.; Williams, AH; Boneca, IG (corresponding author), INSERM, F-75015 Paris, France.	awilliam@pasteur.fr; bonecai@pasteur.fr	WHEELER, Richard/AAB-8262-2022; Boneca, Ivo G/H-1677-2014; Chamot-Rooke, Julia/F-3644-2014	WHEELER, Richard/0000-0002-9249-2377; Boneca, Ivo G/0000-0001-8122-509X; Chamot-Rooke, Julia/0000-0002-9427-543X; HAOUZ, Ahmed/0000-0003-1196-1635	EMBO long-term fellowship [ALTF 732-2010]; Institut Carnot-Pasteur Maladies Infectieuses fellowship; ERC starting grant (PGN from SHAPE) [VIR 202283]; Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence [DBF20160635726]; Agence National de la Recherche [ANR-14-CE14-0003]; Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" from the French government's Investissement d'Avenir program [ANR-10-LABX-62-IBEID]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Institut Carnot-Pasteur Maladies Infectieuses fellowship; ERC starting grant (PGN from SHAPE); Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence; Agence National de la Recherche(French National Research Agency (ANR)); Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" from the French government's Investissement d'Avenir program(French National Research Agency (ANR))	This work was supported by EMBO long-term fellowship ALTF 732-2010 (to A. H. W.), an Institut Carnot-Pasteur Maladies Infectieuses fellowship (to A. H. W.), ERC starting grant (PGN from SHAPE to VIR 202283) (to I. G. B.), Fondation pour la Recherche Medicale (FRM) Grant programme d'urgence (DBF20160635726) (to I. G. B.), Agence National de la Recherche Grant ANR-14-CE14-0003 (to M. K. T.), and Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID from the French government's Investissement d'Avenir program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artola-Recolons C, 2014, ACS CHEM BIOL, V9, P2058, DOI 10.1021/cb500439c; Artola-Recolons C, 2011, BIOCHEMISTRY-US, V50, P2384, DOI 10.1021/bi200085y; Artola-Recolons C, 2011, ACTA CRYSTALLOGR F, V67, P161, DOI 10.1107/S1744309110049171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Bonis M, 2012, MICROB DRUG RESIST, V18, P230, DOI 10.1089/mdr.2011.0231; Chan YA, 2012, MICROB DRUG RESIST, V18, P271, DOI 10.1089/mdr.2012.0001; Cloud-Hansen KA, 2008, J BACTERIOL, V190, P5989, DOI 10.1128/JB.00506-08; DIJKSTRA AJ, 1995, FEBS LETT, V366, P115, DOI 10.1016/0014-5793(95)00505-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGEL H, 1992, J BACTERIOL, V174, P6394, DOI 10.1128/JB.174.20.6394-6403.1992; Fibriansah G, 2012, BIOCHEMISTRY-US, V51, P9164, DOI 10.1021/bi300900t; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V250, P312, DOI 10.1016/0003-9861(86)90732-0; FUKAMIZO T, 1982, J BIOCHEM-TOKYO, V92, P709, DOI 10.1093/oxfordjournals.jbchem.a133982; Holtje J V, 1996, EXS, V75, P425; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kohler PL, 2007, J BACTERIOL, V189, P5421, DOI 10.1128/JB.00531-07; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; Powell AJ, 2006, J MOL BIOL, V359, P122, DOI 10.1016/j.jmb.2006.03.023; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; ROMEIS T, 1993, FEMS MICROBIOL LETT, V111, P141; Schaub RE, 2016, MOL MICROBIOL, V102, P865, DOI 10.1111/mmi.13496; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skalweit MJ, 2016, DRUG DES DEV THER, V10, P3013, DOI 10.2147/DDDT.S110193; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TEMPLIN MF, 1992, J BIOL CHEM, V267, P20039; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; van Asselt EJ, 1999, STRUCT FOLD DES, V7, P1167, DOI 10.1016/S0969-2126(00)80051-9; van Asselt EJ, 1999, FEBS LETT, V458, P429, DOI 10.1016/S0014-5793(99)01198-9; van Asselt EJ, 2000, BIOCHEMISTRY-US, V39, P1924, DOI 10.1021/bi992161p; van Straaten KE, 2007, J BIOL CHEM, V282, P21197, DOI 10.1074/jbc.M701818200; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Williams AH, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6010008	43	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6000	6010		10.1074/jbc.RA117.001095	http://dx.doi.org/10.1074/jbc.RA117.001095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483188	Green Published, hybrid			2022-12-28	WOS:000430497300020
J	Delorme-Axford, E; Klionsky, DJ				Delorme-Axford, Elizabeth; Klionsky, Daniel J.			Transcriptional and post-transcriptional regulation of autophagy in the yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VACUOLE TARGETING PATHWAY; RPD3 HISTONE DEACETYLASE; AMINO-ACID STARVATION; SELECTIVE AUTOPHAGY; GENE-EXPRESSION; PIECEMEAL MICROAUTOPHAGY; ENDOPLASMIC-RETICULUM; ATG12-ATG5 CONJUGATE; PROTEIN LIPIDATION; SIGNALING PATHWAY	Autophagy is a highly conserved catabolic pathway that is vital for development, cell survival, and the degradation of dysfunctional organelles and potentially toxic aggregates. Dysregulation of autophagy is associated with cancer, neurodegeneration, and lysosomal storage diseases. Accordingly, autophagy is precisely regulated at multiple levels (transcriptional, post-transcriptional, translational, and post-translational) to prevent aberrant activity. Various model organisms are used to study autophagy, but the baker's yeast Saccharomyces cerevisiae continues to be advantageous for genetic and biochemical analysis of non-selective and selective autophagy. In this Minireview, we focus on the cellular mechanisms that regulate autophagy transcriptionally and post-transcriptionally in S. cerevisiae.	[Delorme-Axford, Elizabeth; Klionsky, Daniel J.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Klionsky, Daniel J./ABD-5189-2021; Delorme-Axford, Elizabeth/AAL-4641-2020; Delorme-Axford, Elizabeth/AGR-6955-2022	Klionsky, Daniel J./0000-0002-7828-8118; Delorme-Axford, Elizabeth/0000-0002-7455-7616	National Institutes of Health [GM053396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM053396.	Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernard A, 2015, AUTOPHAGY, V11, P2114, DOI 10.1080/15548627.2015.1099796; Bernard A, 2015, AUTOPHAGY, V11, P718, DOI 10.1080/15548627.2015.1018503; Bernard A, 2015, CURR BIOL, V25, P546, DOI 10.1016/j.cub.2014.12.049; BLINDER D, 1995, J BACTERIOL, V177, P4190, DOI 10.1128/jb.177.14.4190-4193.1995; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chan TF, 2001, J BIOL CHEM, V276, P6463, DOI 10.1074/jbc.M008162200; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Delorme-Axford E., 2018, AUTOPHAGY, V14; Delorme-Axford E, 2015, METHODS, V75, P3, DOI 10.1016/j.ymeth.2014.12.008; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Devenish RJ, 2015, CURR BIOL, V25, pR238, DOI 10.1016/j.cub.2015.01.045; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Farre JC, 2016, NAT REV MOL CELL BIO, V17, P537, DOI 10.1038/nrm.2016.74; Feng YC, 2016, AUTOPHAGY, V12, P648, DOI 10.1080/15548627.2016.1157237; Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Frankel LB, 2017, AUTOPHAGY, V13, P3, DOI 10.1080/15548627.2016.1222992; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Galeote VA, 2007, CURR GENET, V52, P55, DOI 10.1007/s00294-007-0136-z; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; Hu GW, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1078923; Hu GW, 2015, NAT CELL BIOL, V17, P930, DOI 10.1038/ncb3189; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Hutchins MU, 1999, J CELL SCI, V112, P4079; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jin MY, 2014, CURR BIOL, V24, P1314, DOI 10.1016/j.cub.2014.04.048; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Liang CY, 2013, MOL BIOL CELL, V24, P3251, DOI 10.1091/mbc.E12-11-0820; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mao K, 2013, P NATL ACAD SCI USA, V110, pE2875, DOI 10.1073/pnas.1300064110; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Popelka H, 2015, FEBS J, V282, P3474, DOI 10.1111/febs.13356; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Ramya V, 2016, FEBS LETT, V590, P3155, DOI 10.1002/1873-3468.12369; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sawa-Makarska J, 2014, NAT CELL BIOL, V16, P425, DOI 10.1038/ncb2935; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450; Steber CM, 1995, P NATL ACAD SCI USA, V92, P12490, DOI 10.1073/pnas.92.26.12490; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Vevea JD, 2015, DEV CELL, V35, P584, DOI 10.1016/j.devcel.2015.11.010; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wen X, 2016, J MOL BIOL, V428, P1681, DOI 10.1016/j.jmb.2016.02.021; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yao ZY, 2015, AUTOPHAGY, V11, P2288, DOI 10.1080/15548627.2015.1107692; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yuan WJ, 2017, J BIOL CHEM, V292, P2660, DOI 10.1074/jbc.M116.772194; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	100	34	35	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5396	5403		10.1074/jbc.R117.804641	http://dx.doi.org/10.1074/jbc.R117.804641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29371397	Green Published, hybrid			2022-12-28	WOS:000430044100004
J	Ozdemir, AY; Rusanov, T; Kent, T; Siddique, LA; Pomerantz, RT				Ozdemir, Ahmet Y.; Rusanov, Timur; Kent, Tatiana; Siddique, Labiba A.; Pomerantz, Richard T.			Polymerase -helicase efficiently unwinds DNA and RNA-DNA hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA enzyme; DNA repair; DNA polymerase; DNA damage; DNA damage response; DNA replication; alternative end-joining; double-strand break repair; microhomology-mediated end-joining; replication fork repair; helicase; polymerase	STRAND BREAK REPAIR; POL-THETA; HOMOLOGOUS-RECOMBINATION; HUMAN-CELLS; REPLICATION; PROTEIN; LESION; DOMAIN; MECHANISM; REVEALS	POLQ is a unique multifunctional replication and repair gene that encodes for a N-terminal superfamily 2 helicase and a C-terminal A-family polymerase. Although the function of the polymerase domain has been investigated, little is understood regarding the helicase domain. Multiple studies have reported that polymerase -helicase (Pol-helicase) is unable to unwind DNA. However, it exhibits ATPase activity that is stimulated by single-stranded DNA, which presents a biochemical conundrum. In contrast to previous reports, we demonstrate that Pol-helicase (residues 1-894) efficiently unwinds DNA with 3-5 polarity, including DNA with 3 or 5 overhangs, blunt-ended DNA, and replication forks. Pol-helicase also efficiently unwinds RNA-DNA hybrids and exhibits a preference for unwinding the lagging strand at replication forks, similar to related HELQ helicase. Finally, we find that Pol-helicase can facilitate strand displacement synthesis by Pol-polymerase, suggesting a plausible function for the helicase domain. Taken together, these findings indicate nucleic acid unwinding as a relevant activity for Pol in replication repair.	[Ozdemir, Ahmet Y.; Rusanov, Timur; Kent, Tatiana; Siddique, Labiba A.; Pomerantz, Richard T.] Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Pomerantz, RT (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, Fels Inst Canc Res, Philadelphia, PA 19140 USA.	richard.pomerantz@temple.edu		KENT, Tatiana/0000-0001-8237-0184; Rusanov, Timur/0000-0002-4054-3611	National Institutes of Health [1R01GM115472-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM115472-01 (to R. T. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman CA, 2013, NATURE, V502, P381, DOI 10.1038/nature12565; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Campbell JL, 2017, NAT STRUCT MOL BIOL, V24, P1007, DOI 10.1038/nsmb.3510; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fernandez-Vidal A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5285; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P6651, DOI 10.1093/nar/gkv625; Hogg M, 2011, J MOL BIOL, V405, P642, DOI 10.1016/j.jmb.2010.10.041; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khadka P, 2016, DNA REPAIR, V37, P53, DOI 10.1016/j.dnarep.2015.11.005; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Newman JA, 2015, STRUCTURE, V23, P2319, DOI 10.1016/j.str.2015.10.014; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Plosky BS, 2016, MOL CELL, V64, P643, DOI 10.1016/j.molcel.2016.11.010; Popuri V, 2013, NUCLEIC ACIDS RES, V41, P881, DOI 10.1093/nar/gks1134; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; Saito S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16112; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Tafel AA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228189; Takata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3338; Thyme SB, 2016, CELL REP, V15, P1611, DOI 10.1016/j.celrep.2016.04.089; Wood RD, 2016, DNA REPAIR, V44, P22, DOI 10.1016/j.dnarep.2016.05.003; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zelensky AN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00124-3; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	44	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5259	5269		10.1074/jbc.RA117.000565	http://dx.doi.org/10.1074/jbc.RA117.000565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29444826	hybrid, Green Published			2022-12-28	WOS:000429409300030
J	Wong, SSW; Rani, M; Dodagatta-Marri, E; Ibrahim-Granet, O; Kishore, U; Bayry, J; Latge, JP; Sahu, A; Madan, T; Aimanianda, V				Wong, Sarah Sze Wah; Rani, Manjusha; Dodagatta-Marri, Eswari; Ibrahim-Granet, Oumaima; Kishore, Uday; Bayry, Jagadeesh; Latge, Jean-Paul; Sahu, Arvind; Madan, Taruna; Aimanianda, Vishukumar			Fungal melanin stimulates surfactant protein D-mediated opsonization of and host immune response to Aspergillus fumigatus spores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG COLLECTINS; ALVEOLAR MACROPHAGES; PNEUMOCYSTIS-CARINII; LIGAND-BINDING; LECTIN PATHWAY; SP-A; ALPHA; RECOGNITION; DEFENSE; MICE	Surfactant protein D (SP-D), a C-type lectin and pattern-recognition soluble factor, plays an important role in immune surveillance to detect and eliminate human pulmonary pathogens. SP-D has been shown to protect against infections with the most ubiquitous airborne fungal pathogen, Aspergillus fumigatus, but the fungal surface component(s) interacting with SP-D is unknown. Here, we show that SP-D binds to melanin pigment on the surface of A. fumigatus dormant spores (conidia). SP-D also exhibited an affinity to two cell-wall polysaccharides of A. fumigatus, galactomannan (GM) and galactosaminogalactan (GAG). The immunolabeling pattern of SP-D was punctate on the conidial surface and was uniform on germinating conidia, in accordance with the localization of melanin, GM, and GAG. We also found that the collagen-like domain of SP-D is involved in its interaction with melanin, whereas its carbohydrate-recognition domain recognized GM and GAG. Unlike un-opsonized conidia, SP-D-opsonized conidia were phagocytosed more efficiently and stimulated the secretion of proinflammatory cytokines by human monocyte-derived macrophages. Furthermore, SP-D-/- mice challenged intranasally with wildtype conidia or melanin ghosts (i.e. hollow melanin spheres) displayed significantly reduced proinflammatory cytokines in the lung compared with wildtype mice. In summary, SP-D binds to melanin presenton the dormant A. fumigatus conidial surface, facilitates conidial phagocytosis, and stimulates the host immune response.	[Wong, Sarah Sze Wah; Latge, Jean-Paul; Aimanianda, Vishukumar] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Rech Cytokines & Inflammat, F-75015 Paris, France; [Rani, Manjusha; Madan, Taruna] ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India; [Dodagatta-Marri, Eswari; Kishore, Uday] Brunel Univ London, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England; [Bayry, Jagadeesh] INSERM, Unite 1138, F-75006 Paris, France; [Sahu, Arvind] Natl Ctr Cell Sci, Complement Biol Lab, Pune 411007, Maharashtra, India	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Brunel University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Aimanianda, V (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.; Madan, T (corresponding author), ICMR Natl Inst Res Reprod Hlth, Bombay 400012, Maharashtra, India.	taruna_m@hotmail.com; vkumar@pasteur.fr	Wong, Sarah/AAX-5103-2020; Aimanianda, Vishukumar/E-9204-2011; Bayry, Jagadeesh/A-6589-2011; Wong, Sarah/DOH-8455-2022	Wong, Sarah/0000-0002-9440-1774; Aimanianda, Vishukumar/0000-0001-5813-7497; Bayry, Jagadeesh/0000-0003-0498-9808; Sahu, Arvind/0000-0003-1664-2422	ANR (L'Agence Nationale de la Recherche) France; Department of Science and Technology (DST) India	ANR (L'Agence Nationale de la Recherche) France(French National Research Agency (ANR)); Department of Science and Technology (DST) India(Department of Science & Technology (India))	This work was supported in part by the bilateral COMASPIN grant from ANR (L'Agence Nationale de la Recherche) France and the Department of Science and Technology (DST) India to (V. A., A. S., and T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a post-doctoral fellowship from ANR (L'Agence Nationale de la Recherche) France.; Supported by a post-doctoral fellowship from the Department of Science and Technology (DST) India.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Alsteens D, 2013, BIOPHYS J, V105, P320, DOI 10.1016/j.bpj.2013.05.040; Bayry J, 2014, INFECT IMMUN, V82, P3141, DOI 10.1128/IAI.01726-14; Becker KL, 2016, MBIO, V7, DOI 10.1128/mBio.01823-15; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Brummer E, 2010, MED MYCOL, V48, P16, DOI 10.3109/13693780903117473; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Crouch E C, 2000, Respir Res, V1, P93; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Eda S, 1997, BIOCHEM J, V323, P393, DOI 10.1042/bj3230393; Feofilova EP, 2010, MICROBIOLOGY+, V79, P711, DOI 10.1134/S0026261710060019; Ferguson JS, 1999, J IMMUNOL, V163, P312; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Gafa V, 2007, MICROBES INFECT, V9, P971, DOI 10.1016/j.micinf.2007.03.015; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Haase G., 2004, MYCOTA, P67; Heinekamp T, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00440; Hickling TP, 2004, J LEUKOCYTE BIOL, V75, P27, DOI 10.1189/jlb.0703304; Jahn B, 2000, INFECT IMMUN, V68, P3736, DOI 10.1128/IAI.68.6.3736-3739.2000; Kay S, 2016, MOL IMMUNOL, V71, P87, DOI 10.1016/j.molimm.2016.01.002; KING RJ, 1972, AM J PHYSIOL, V223, P707, DOI 10.1152/ajplegacy.1972.223.3.707; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; LEE RT, 1991, J BIOL CHEM, V266, P4810; Lekkala M, 2006, INFECT IMMUN, V74, P4549, DOI 10.1128/IAI.00243-06; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Madan T, 2001, INFECT IMMUN, V69, P2728, DOI 10.1128/IAI.69.4.2728-2731.2001; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Margalit A, 2015, FEMS MICROBIOL REV, V39, P670, DOI 10.1093/femsre/fuv018; Mehrad B, 1999, J IMMUNOL, V162, P1633; NAGAI H, 1995, J INFECT DIS, V172, P1554, DOI 10.1093/infdis/172.6.1554; Nessa K, 1997, ENVIRON RES, V75, P141, DOI 10.1006/enrs.1997.3788; Palaniyar N, 2002, J BIOL CHEM, V277, P26971, DOI 10.1074/jbc.M110080200; PERSSON A, 1990, J BIOL CHEM, V265, P5755; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Rambach G, 2015, J INFECT DIS, V212, P1140, DOI 10.1093/infdis/jiv191; Roilides E, 1999, INFECT IMMUN, V67, P3047, DOI 10.1128/IAI.67.6.3047-3050.1999; Rokade S, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12629; Saitoh M, 2000, BIOCHEMISTRY-US, V39, P1059, DOI 10.1021/bi9917939; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Segal BH, 2006, CLIN INFECT DIS, V42, P507, DOI 10.1086/499811; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; van Rozendaal BAWM, 2000, J INFECT DIS, V182, P917, DOI 10.1086/315799; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vuk-Pavlovic Z, 2001, AM J RESP CELL MOL, V24, P475, DOI 10.1165/ajrcmb.24.4.3504; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; ZIMMERMAN PE, 1992, J CLIN INVEST, V89, P143, DOI 10.1172/JCI115554	61	25	26	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4901	4912		10.1074/jbc.M117.815852	http://dx.doi.org/10.1074/jbc.M117.815852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414772	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000428848300029
J	Hackett, JC				Hackett, John C.			Membrane-embedded substrate recognition by cytochrome P450 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCELERATED MOLECULAR-DYNAMICS; ALPHA-NAPHTHOFLAVONE; LIGAND-BINDING; ACTIVE-SITE; FORCE-FIELD; HETEROTROPIC COOPERATIVITY; SCANNING MUTAGENESIS; INVIVO ACTIVATION; LIPID NANODISCS; METABOLISM	Cytochrome P450 3A4 (CYP3A4) is the dominant xenobiotic-metabolizing enzyme in the liver and intestine and is involved in the disposition of more than 50% of drugs. Because of its ability to bind multiple substrates, its reaction kinetics are complex, and its association with the microsomal membrane confounds our understanding of how this enzyme recognizes and recruits diverse substrates. Testosterone (TST) hydroxylation is the prototypical CYP3A4 reaction, displaying positive homotropic cooperativity with three binding sites. Here, exploiting the capability of accelerated molecular dynamics (aMD) to sample events in the millisecond regime, I performed >25-mu s a MD simulations in the presence of three TST molecules. These simulations identified high-occupancy surface-binding sites as well as a pathway for TST ingress into the CYP3A4 active site originating in the membrane. Adaptive biasing force analysis of the latter pathway revealed a metastable intermediate that could constitute a third binding site at high TST concentrations. Prompted by the observation that interactions between TST and the G'-helix mobilize the ligand into the active site, a free-energy analysis of TST distribution in the membrane was conducted and revealed that the depth of the G'-helix is optimal for extracting TST. In summary, these simulations confirm separate, but adjacent substrate-binding sites within the enzyme and the existence of an auxiliary TST-binding site. The broader impact of these simulations is that they support a mechanism in which cytochromes P450 directly recruit membrane-solubilized substrates.	[Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Goodwin Res Lab, 401 Coll St, Richmond, VA 23298 USA.	john.hackett@vcuhealth.org	Hackett, John/J-3871-2019	Hackett, John/0000-0002-4923-2668	National Institutes of Health [R01GM114168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114168 (to J. C. H.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Berka K, 2013, J PHYS CHEM B, V117, P11556, DOI 10.1021/jp4059559; Cameron MD, 2007, CHEM RES TOXICOL, V20, P1434, DOI 10.1021/tx7000702; Comer J, 2015, J PHYS CHEM B, V119, P1129, DOI 10.1021/jp506633n; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Frank DJ, 2011, J BIOL CHEM, V286, P5540, DOI 10.1074/jbc.M110.182055; Frank DJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P146, DOI 10.1016/j.abb.2009.06.013; Giorgino T, 2014, COMPUT PHYS COMMUN, V185, P317, DOI 10.1016/j.cpc.2013.08.022; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Kapelyukh Y, 2008, DRUG METAB DISPOS, V36, P2136, DOI 10.1124/dmd.108.021733; Kappel K, 2015, Q REV BIOPHYS, V48, P479, DOI 10.1017/S0033583515000153; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; LASKER JM, 1984, J PHARMACOL EXP THER, V229, P162; LASKER JM, 1982, SCIENCE, V216, P1419, DOI 10.1126/science.7089530; Lonsdale R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003714; Luthra A, 2013, Methods Mol Biol, V987, P115, DOI 10.1007/978-1-62703-321-3_10; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mak PJ, 2008, BIOCHEMISTRY-US, V47, P3950, DOI 10.1021/bi800034b; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; McClary WD, 2016, BIOCHEMISTRY-US, V55, P6258, DOI 10.1021/acs.biochem.6b00715; Miao YL, 2016, P NATL ACAD SCI USA, V113, P12162, DOI 10.1073/pnas.1614538113; Miao YL, 2014, PHYS CHEM CHEM PHYS, V16, P6398, DOI 10.1039/c3cp53962h; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; Oda Y, 2001, J PHARMACOL EXP THER, V298, P1021; Ohkubo YZ, 2012, BIOPHYS J, V102, P2130, DOI 10.1016/j.bpj.2012.03.015; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Ramirez CL, 2016, METHOD ENZYMOL, V578, P123, DOI 10.1016/bs.mie.2016.05.029; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Sevrioukova IF, 2015, BIOCHEMISTRY-US, V54, P4083, DOI 10.1021/acs.biochem.5b00510; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Treuheit NA, 2016, BIOCHEMISTRY-US, V55, P1058, DOI 10.1021/acs.biochem.5b01313; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vijayan R, 2008, BIOPHYS J, V95, pL45, DOI [10.1529/biophysj.108.140087, 10.1529/biophysj.l08.140087]; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Woods CM, 2011, BIOCHEMISTRY-US, V50, P10041, DOI 10.1021/bi2013454; Yang J, 2012, CLIN PHARMACOL THER, V91, P442, DOI 10.1038/clpt.2011.178; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	58	25	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4037	4046		10.1074/jbc.RA117.000961	http://dx.doi.org/10.1074/jbc.RA117.000961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29382727	Green Published, hybrid			2022-12-28	WOS:000427587500016
J	Huang, QQ; Stalnecker, C; Zhang, CL; McDermott, LA; Iyer, P; O'Neill, J; Reimer, S; Cerione, RA; Katt, WP				Huang, Qingqiu; Stalnecker, Clint; Zhang, Chengliang; McDermott, Lee A.; Iyer, Prema; O'Neill, Jason; Reimer, Shawn; Cerione, Richard A.; Katt, William P.			Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; RENAL MITOCHONDRIAL GLUTAMINASE; MECHANISM; EXPRESSION; DESIGN; GROWTH	Altered glycolytic flux in cancer cells (the "Warburg effect") causes their proliferation to rely upon elevated glutamine metabolism ("glutamine addiction"). This requirement is met by the overexpression of glutaminase C (GAC), which catalyzes the first step in glutamine metabolism and therefore represents a potential therapeutic target. The small molecule CB-839 was reported to be more potent than other allosteric GAC inhibitors, including the parent compound bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl (BPTES), and is in clinical trials. Recently, we described the synthesis of BPTES analogs having distinct saturated heterocyclic cores as a replacement for the flexible chain moiety, with improved microsomal stability relative to CB-839 and BPTES. Here, we show that one of these new compounds, UPGL00004, like CB-839, more potently inhibits the enzymatic activity of GAC, compared with BPTES. We also compare the abilities of UPGL00004, CB-839, and BPTES to directly bind to recombinant GAC and demonstrate that UPGL00004 has a similar binding affinity as CB-839 for GAC. We also show that UPGL00004 potently inhibits the growth of triple-negative breast cancer cells, as well as tumor growth when combined with the anti-vascular endothelial growth factor antibody bevacizumab. Finally, we compare the X-ray crystal structures for UPGL00004 and CB-839 bound to GAC, verifying that UPGL00004 occupies the same binding site as CB-839 or BPTES and that all three inhibitors regulate the enzymatic activity of GACvia a similar allosteric mechanism. These results provide insights regarding the potency of these inhibitors that will be useful in designing novel small-molecules that target a key enzyme in cancer cell metabolism.	[Huang, Qingqiu; Cerione, Richard A.] Cornell Univ, CHESS, Ithaca, NY 14853 USA; [Stalnecker, Clint; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Zhang, Chengliang; Cerione, Richard A.; Katt, William P.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [McDermott, Lee A.; Iyer, Prema; O'Neill, Jason; Reimer, Shawn] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [McDermott, Lee A.; Iyer, Prema] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15261 USA; [Stalnecker, Clint] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	Cornell University; Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Katt, William/0000-0001-5104-7667; Stalnecker, Clint/0000-0002-0570-4416; Zhang, Chengliang/0000-0001-6999-4670	National Institutes of Health [GM040654, CA210184, GM122575]; University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE [U54CA210184, R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, P41GM103485, R35GM122575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM040654, CA210184, and GM122575 and by a grant from the University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERNDT KD, 1993, BIOCHEMISTRY-US, V32, P4564, DOI 10.1021/bi00068a012; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chen L. J., 2013, Heterocyclic Inhibitors of Glutaminase., Patent No. [US 8604016B2, 8604016]; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englich U, 2011, J SYNCHROTRON RADIAT, V18, P70, DOI 10.1107/S0909049510036010; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Feng QY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14450; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Holcomb T, 2000, MOL BRAIN RES, V76, P56, DOI 10.1016/S0169-328X(99)00331-9; Huang QQ, 2016, J APPL CRYSTALLOGR, V49, P149, DOI 10.1107/S1600576715023195; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; Mates JM, 2013, CURR MOL MED, V13, P514; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mcdermott LA, 2016, Patent No. [WO2016054388 A1, 2016054388, WO2016054388]; McDermott LA, 2016, BIOORGAN MED CHEM, V24, P1819, DOI 10.1016/j.bmc.2016.03.009; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERERA SY, 1990, J BIOL CHEM, V265, P17764; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Ramachandran S, 2016, ONCOTARGET, V7, P57943, DOI 10.18632/oncotarget.10791; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shukla K, 2012, J MED CHEM, V55, P10551, DOI 10.1021/jm301191p; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1185, DOI 10.1074/jbc.270.3.1185; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1191, DOI 10.1074/jbc.270.3.1191; Stalnecker CA, 2017, J BIOL CHEM, V292, P6095, DOI 10.1074/jbc.M116.758219; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009	46	47	51	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3535	3545		10.1074/jbc.M117.810101	http://dx.doi.org/10.1074/jbc.M117.810101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29317493	Green Published, hybrid			2022-12-28	WOS:000427030200007
J	Lee, JG; Jung, E; Heur, M				Lee, Jeong Goo; Jung, Eric; Heur, Martin			Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FGF-2-MEDIATED CELL-PROLIFERATION; IDIOPATHIC PULMONARY-FIBROSIS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; TUMOR-CELLS; I COLLAGEN; EXPRESSION; TRANSFORMATION; FGF-2	Investigating stimulation of endogenous wound healing in corneal endothelial cells (CECs) may help address the global shortage of donor corneas by decreasing the number of transplants performed for blindness because of endothelial dysfunction. We previously reported that IL-1 beta stimulation leads to fibroblast growth factor (FGF2) expression, enhancing migration and proliferation of mammalian CECs. However, FGF2 also promotes the endothelial-mesenchymal transition, which can lead to retrocorneal membrane formation and blindness. This prompted us to investigate downstream FGF2 signaling targets that could be manipulated to prevent retrocorneal membrane formation. FGF2 stimulation altered cell morphology and induced expression of mesenchymal transition marker genes such as snail family transcriptional repressor 1 (SNAI1), SNAI2, zinc finger E-box-binding homeobox 1 (ZEB1), and ZEB2. This, in turn, induced expression of fibronectin, vimentin, and type I collagen, and suppressed E-cadherin in CECs in vitro and ex vivo. siRNA-mediated SNAI1 knockdown revealed that SNAI1 induces ZEB1 expression, in turn inducing expression of type I collagen, the major component of retrocorneal membranes, and of cyclin-dependent kinase 2 (CDK2) and cyclin E1, promoting cell proliferation. siRNA-mediated knockdown of SNAI1 or ZEB1, but not of CDK2, inhibited FGF2-dependent expression of fibronectin, vimentin, and type I collagen and of suppression of E-cadherin expression. We conclude that SNAI1 is a key regulator of FGF2-dependent mesenchymal transition in human ex vivo corneal endothelium, with ZEB1 regulating type I collagen expression and CDK2 regulating cell proliferation. These results suggest that SNAI1 promotes fibrosis and cell proliferation in human corneal endothelium through ZEB1 and CDK2.	[Lee, Jeong Goo; Jung, Eric; Heur, Martin] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Los Angeles, CA 90033 USA	University of Southern California	Heur, M (corresponding author), 1450 San Pablo St,Rm 4802, Los Angeles, CA 90033 USA.	heur@usc.edu			NEI, National Institutes of Health [EY021485]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K08EY021485] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the NEI, National Institutes of Health Grant EY021485 (to M. H.) and a Career Development Award (to M. H.) and an unrestricted grant from Research to Prevent Blindness (to the Department of Ophthalmology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blake DA, 1997, INVEST OPHTH VIS SCI, V38, P1119; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; GEROSKI DH, 1984, INVEST OPHTH VIS SCI, V25, P1056; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Jagle S, 2017, BIOCHEM BIOPH RES CO, V482, P1226, DOI 10.1016/j.bbrc.2016.12.017; Jakobiec FA, 2010, AM J OPHTHALMOL, V150, P230, DOI 10.1016/j.ajo.2010.03.011; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KAY EDP, 1994, INVEST OPHTH VIS SCI, V35, P2427; KAY EP, 1993, INVEST OPHTH VIS SCI, V34, P663; KAY EP, 1982, INVEST OPHTH VIS SCI, V22, P200; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; KREUTZIGER GO, 1976, EXP EYE RES, V23, P285, DOI 10.1016/0014-4835(76)90129-9; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lau MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059083; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Lee JG, 2007, J BIOL CHEM, V282, P6444, DOI 10.1074/jbc.M607808200; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lee JG, 2015, J BIOL CHEM, V290, P26752, DOI 10.1074/jbc.M115.677245; Lee JG, 2014, MOL CELL BIOL, V34, P3535, DOI 10.1128/MCB.01572-13; Lee JG, 2013, BIOL CELL, V105, P175, DOI 10.1111/boc.201200077; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146051; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Okumura N, 2015, LAB INVEST, V95, P1291, DOI 10.1038/labinvest.2015.111; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Pipparelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062095; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P2930; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; YUE BYJT, 1989, INVEST OPHTH VIS SCI, V30, P248; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhu C, 2008, MOL VIS, V14, P1805	60	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3758	3769		10.1074/jbc.RA117.000295	http://dx.doi.org/10.1074/jbc.RA117.000295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29363574	Green Published, hybrid			2022-12-28	WOS:000427030200028
J	Hop, HT; Reyes, AWB; Huy, TXN; Arayan, LT; Min, W; Lee, HJ; Rhee, MH; Chang, HH; Kim, S				Hop, Huynh Tan; Reyes, Alisha Wehdnesday Bernardo; Huy, Tran Xuan Ngoc; Arayan, Lauren Togonon; Min, WonGi; Lee, Hu Jang; Rhee, Man Hee; Chang, Hong Hee; Kim, Suk			Interleukin 10 suppresses lysosome-mediated killing of Brucella abortus in cultured macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR REPLICATION; ACTIVATION; INFECTION; SURVIVAL; TRAFFICKING; IMMUNITY; PROTEIN; FUSION; IL-10	Brucella abortus is a Gram-negative zoonotic pathogen for which there is no 100% effective vaccine. Phagosomes in B. abortus infected cells fail to mature, allowing the pathogen to survive and proliferate. Interleukin 10 (IL10) promotes B. abortus persistence in macrophages by mechanisms that are not fully understood. In this study, we investigated the regulatory role of IL10 in the immune response to B. abortus infection. B. abortus infected macrophages were treated with either IL10 s1RNA or recombinant IL10 (rIL10), and the expression of phagolysosome- or inflammation-related genes was evaluated by qRT-PCR and Western blotting. Phagolysosome fusion was monitored by fluorescence microscopy. We found that the synthesis of several membrane-trafficking regulators and lysosomal enzymes was suppressed by IL10 during infection, resulting in a significant increase in the recruitment of hydrolytic enzymes by Brucella-containing phagosomes (BCPs) when IL10 signaling was blocked. Moreover, blocking IL10 signaling also enhanced proinflammatory cytokine production. Finally, concomitant treatment with STAT3 siRNA significantly reduced the suppression of proinflammatory brucellacidal activity but not phagolysosome fusion by rIL10. Thus, our data provide the first evidence that clearly indicates the suppressive role of IL10 on phagolysosome fusion and inflammation in response to B. abortus infection through two distinct mechanisms, STAT3-independent and-dependent pathways, respectively, in murine macrophages.	[Hop, Huynh Tan; Reyes, Alisha Wehdnesday Bernardo; Huy, Tran Xuan Ngoc; Arayan, Lauren Togonon; Min, WonGi; Lee, Hu Jang; Kim, Suk] Gyeongsang Natl Univ, Coll Vet Med, Inst Anim Med, Jinju 52828, South Korea; [Chang, Hong Hee; Kim, Suk] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 52828, South Korea; [Rhee, Man Hee] Kyungpook Natl Univ, Coll Vet Med, Daegu 41566, South Korea	Gyeongsang National University; Gyeongsang National University; Kyungpook National University	Kim, S (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Inst Anim Med, Jinju 52828, South Korea.; Kim, S (corresponding author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 52828, South Korea.	kimsuk@gnu.ac.kr	Huy, Nguyen Tien/B-2573-2010; Rhee, Man Hee/O-5705-2016	Huy, Nguyen Tien/0000-0002-9543-9440; Rhee, Man Hee/0000-0002-3088-1318; Huynh, Tan Hop/0000-0003-2812-7444; REYES, ALISHA WEHDNESDAY/0000-0001-9837-9378; Hop, Huynh Tan/0000-0003-1480-8193	Korea Health Technology Research and Development (R&D) Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea [HI16C2130]	Korea Health Technology Research and Development (R&D) Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare, Republic of Korea	This work was supported by Korea Health Technology Research and Development (R&D) Project Grant HI16C2130 through the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare, Republic of Korea. The authors declare that they have no conflicts of inter est with the contents of this article.	Bewley MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001262; Bhattacharyya S, 2001, INFECT IMMUN, V69, P1499, DOI 10.1128/IAI.69.3.1499-1507.2001; Corsetti PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074729; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; Guo MM, 2015, PROTEOMICS, V15, P3169, DOI 10.1002/pmic.201400431; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Gutierrez Maximiliano Gabriel, 2013, Small GTPases, V4, P148, DOI 10.4161/sgtp.25604; Hop HT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00437; Hop HT, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv003; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hop HT, 2017, MICROB PATHOGENESIS, V113, P57, DOI 10.1016/j.micpath.2017.10.029; Kim S, 2004, FEMS MICROBIOL LETT, V234, P289, DOI [10.1111/j.1574-6968.2004.tb09546.x, 10.1016/j.femsle.2004.03.038]; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; Lee JJ, 2013, J BIOL CHEM, V288, P28049, DOI 10.1074/jbc.M113.491555; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pires D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32247; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; Rivera-Marrero CA, 2004, INFECT IMMUN, V72, P5712, DOI 10.1128/IAI.72.10.5712-5721.2004; Sangari Felix J., 1996, Microbiologia (Madrid), V12, P207; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Verma R, 2016, J CELL COMMUN SIGNAL, V10, P61, DOI 10.1007/s12079-015-0302-x; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454	28	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3134	3144		10.1074/jbc.M117.805556	http://dx.doi.org/10.1074/jbc.M117.805556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29301939	hybrid, Green Published			2022-12-28	WOS:000426562800009
J	Wolf, MJ				Wolf, Matthew J.			"HETE"ing up mitochondria in human heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PERMEABILITY TRANSITION PORE; PHOSPHOLIPASE A(2)GAMMA IPLA(2)GAMMA; GENETIC ABLATION; ACTIVATION; SYNTHASE; ROLES; ACIDS	A decade of research has established the phospholipase iPLA(2)gamma as being involved in cardiomyocyte dysfunction and necrosis leading to heart failure, but the mechanisms by which iPLA(2)gamma acts and its interaction with the mitochondrial permeability transition pore (mPTP) that is critical for cardiac homeostasis are unclear. New investigations by Moon et al. demonstrate that mitochondria in failing hearts undergo dynamic shifts in PLA(2) isoform expression, leading to a redistribution of eicosanoid composition that contributes to pathologic mPTP opening.	[Wolf, Matthew J.] Univ Virginia, Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA	University of Virginia	Wolf, MJ (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Div Cardiovasc Med,Dept Med, Med Res Bldg 5,415 Lane Rd, Charlottesville, VA 22908 USA.	MJW5MC@Virginia.edu	WOLF, MATTHEW/AHC-5201-2022	Wolf, Matthew/0000-0001-8004-4852	University of Virginia Center for Excellence in Cardiovascular Genetics	University of Virginia Center for Excellence in Cardiovascular Genetics	This work was supported by the University of Virginia Center for Excellence in Cardiovascular Genetics. The author declares that he has no conflicts of interests with the contents of this article.	Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Gross GJ, 2013, J MOL CELL CARDIOL, V59, P20, DOI 10.1016/j.yjmcc.2013.02.003; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Moon SH, 2018, J BIOL CHEM, V293, P115, DOI 10.1074/jbc.RA117.000405; Moon SH, 2016, J BIOL CHEM, V291, P19687, DOI 10.1074/jbc.M116.740597; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776	9	1	1	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					130	131		10.1074/jbc.H117.001021	http://dx.doi.org/10.1074/jbc.H117.001021			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29305524	Green Published, hybrid			2022-12-28	WOS:000419453200012
J	Langini, C; Caflisch, A; Vitalis, A				Langini, Cassiano; Caflisch, Amedeo; Vitalis, Andreas			The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes (vol 292, pg 16734, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Langini C, 2017, J BIOL CHEM, V292, P16734, DOI 10.1074/jbc.M117.786350	1	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19121	19121		10.1074/jbc.AAC117.000630	http://dx.doi.org/10.1074/jbc.AAC117.000630			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29373865	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000415848000034
J	Hou, B; Heidrich, ES; Mehner-Breitfeld, D; Bruser, T				Hou, Bo; Heidrich, Eyleen S.; Mehner-Breitfeld, Denise; Brueser, Thomas			The TatA component of the twin-arginine translocation system locally weakens the cytoplasmic membrane of Escherichia coli upon protein substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT-SYSTEM; SIGNAL PEPTIDE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; PRECURSOR PROTEINS; FOLDED PROTEINS; THA4; PATHWAY; COMPLEX; STATE	The twin-arginine translocation (Tat) system that comprises the TatA, TatB, and TatC components transports folded proteins across energized membranes of prokaryotes and plant plastids. It is not known, however, how the transport of this protein cargo is achieved. Favored models suggest that the TatA component supports transport by weakening the membrane upon full translocon assembly. Using Escherichia coli as a model organism, we now demonstrate in vivo that the N terminus of TatA can indeed destabilize the membrane, resulting in a lowered membrane energization in growing cells. We found that in full-length TatA, this effect is counterbalanced by its amphipathic helix. Consistent with these observations, the TatA N terminus induced proton leakage in vitro, indicating membrane destabilization. Fluorescence quenching data revealed that substrate binding causes the TatA hinge region and the N-terminal part of the TatA amphipathic helix to move toward the membrane surface. In the presence of TatBC, substrate binding also reduced the exposure of a specific region in the amphipathic helix, indicating a participation of TatBC. Of note, the substrate-induced reorientation of the TatA amphipathic helix correlated with detectable membrane weakening. We therefore propose a two-state model in which membrane-destabilizing effects of the short TatA membrane anchor are compensated by the membrane-immersed N-terminal part of the amphipathic helix in a resting state. We conclude that substrate binding to TatABC complexes switches the position of the amphipathic helix, which locally weakens the membrane on demand to allow substrate translocation across the membrane.	[Hou, Bo; Heidrich, Eyleen S.; Mehner-Breitfeld, Denise; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany	Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306; Mehner-Breitfeld, Denise/0000-0002-6785-898X	DFG [BR2285/4-2]	DFG(German Research Foundation (DFG))	This work was supported by DFG Grant BR2285/4-2. The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Brehmer T, 2012, LANGMUIR, V28, P3534, DOI 10.1021/la204473t; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Carrie C, 2016, J CELL SCI, V129, P3935, DOI 10.1242/jcs.190975; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Habersetzer J, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170091; Hackeng TM, 2000, BIOCHEM J, V349, P757, DOI 10.1042/bj3490757; Hamsanathan S, 2017, BIOPHYS J, V113, P2650, DOI 10.1016/j.bpj.2017.09.036; Hauer RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08818-w; Hauer RS, 2013, BBA-MOL CELL RES, V1833, P957, DOI 10.1016/j.bbamcr.2013.01.030; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; JOHNSON AE, 1976, BIOCHEMISTRY-US, V15, P569, DOI 10.1021/bi00648a018; KEEGSTRA K, 1984, J CELL BIOCHEM, V24, P55, DOI 10.1002/jcb.240240105; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mehner D, 2012, J BIOL CHEM, V287, P27834, DOI 10.1074/jbc.M112.374983; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Pal D, 2013, PLANT PHYSIOL, V161, P990, DOI 10.1104/pp.112.207522; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stolle P, 2016, J BIOL CHEM, V291, P13520, DOI 10.1074/jbc.M116.729103; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; Taubert J, 2014, BIOL CHEM, V395, P827, DOI 10.1515/hsz-2014-0170; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; WARNOCK DG, 1982, AM J PHYSIOL, V242, pF733, DOI 10.1152/ajprenal.1982.242.6.F733; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103157	62	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7592	7605		10.1074/jbc.RA118.002205	http://dx.doi.org/10.1074/jbc.RA118.002205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29535185	Green Published, hybrid			2022-12-28	WOS:000437256500012
J	Carlson, GM; Dienel, GA; Colbran, RJ				Carlson, Gerald M.; Dienel, Gerald A.; Colbran, Roger J.			Introduction to the Thematic Minireview Series: Brain glycogen metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						Lafora disease (Lafora progressive myoclonic epilepsy; MELF); glycogen; astrocyte; neuron; neurochemistry	CARBOHYDRATE-METABOLISM; LOCALIZATION; NEURONS; RAT	The synthesis of glycogen allows for efficient intracellular storage of glucose molecules in a soluble form that can be rapidly released to enter glycolysis in response to energy demand. Intensive studies of glucose and glycogen metabolism, predominantly in skeletal muscle and liver, have produced innumerable insights into the mechanisms of hormone action, resulting in the award of several Nobel Prizes over the last one hundred years. Glycogen is actually present in all cells and tissues, albeit at much lower levels than found in muscle or liver. However, metabolic and physiological roles of glycogen in other tissues are poorly understood. This series of Minireviews summarizes what is known about the enzymes involved in brain glycogen metabolism and studies that have linked glycogen metabolism to multiple brain functions involving metabolic communication between astrocytes and neurons. Recent studies unexpectedly linking some forms of epilepsy to mutations in two poorly understood proteins involved in glycogen metabolism are also reviewed.	[Carlson, Gerald M.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Dienel, Gerald A.] Univ Arkansas Med Sci, Dept Neurol, 4301 W Markham St,Slot 500, Little Rock, AR 72201 USA; [Colbran, Roger J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Sch Med, Nashville, TN 37232 USA	University of Kansas; University of Kansas Medical Center; University of Arkansas System; University of Arkansas Medical Sciences; Vanderbilt University; Vanderbilt University	Carlson, GM (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Dienel, GA (corresponding author), Univ Arkansas Med Sci, Dept Neurol, 4301 W Markham St,Slot 500, Little Rock, AR 72201 USA.; Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Rm 702 Light Hall, Nashville, TN 37232 USA.	gcarlson@kumc.edu; gadienel@uams.edu; roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244	NICHD NIH HHS [U54 HD083211] Funding Source: Medline; NINDS NIH HHS [R01 NS078291] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bak LK, 2018, J BIOL CHEM, V293, P7108, DOI 10.1074/jbc.R117.803239; Gentry MS, 2018, J BIOL CHEM, V293, P7117, DOI 10.1074/jbc.R117.803064; Kerr SE, 1938, J BIOL CHEM, V123, P443; Kerr SE, 1936, J BIOL CHEM, V116, P1; Nadeau OW, 2018, J BIOL CHEM, V293, P7099, DOI 10.1074/jbc.R117.803023; Pfeiffer-Guglielmi B, 2000, NEUROCHEM RES, V25, P1485, DOI 10.1023/A:1007676109206; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Prats C, 2018, J BIOL CHEM, V293, P7089, DOI 10.1074/jbc.R117.802843; Psarra AMG, 1998, J NEUROCYTOL, V27, P779, DOI 10.1023/A:1006970429961; Richter K, 1996, GLIA, V17, P263, DOI 10.1002/(SICI)1098-1136(199608)17:4<263::AID-GLIA1>3.0.CO;2-0; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; SOTELO C, 1968, J CELL BIOL, V36, P151, DOI 10.1083/jcb.36.1.151	12	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7087	7088		10.1074/jbc.TM118.002642	http://dx.doi.org/10.1074/jbc.TM118.002642			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29514979	Green Published, hybrid			2022-12-28	WOS:000432174500001
J	Zeng, LX; Mathew, AV; Byun, J; Atkins, KB; Brosius, FC; Pennathur, S				Zeng, Lixia; Mathew, Anna V.; Byun, Jaeman; Atkins, Kevin B.; Brosius, Frank C., III; Pennathur, Subramaniam			Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; 3-chlorotyrosine; atherosclerosis; mass spectrometry (MS); macrophage; oxidative stress; 3-nitrotyrosine; Chronic Kidney Disease; oxidized amino acids	LOW-DENSITY-LIPOPROTEIN; MASS-SPECTROMETRIC QUANTIFICATION; RENIN-ANGIOTENSIN SYSTEM; CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; PROGNOSTIC VALUE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION	Increased myeloperoxidase (MPO) levels and activity are associated with increased cardiovascular risk among individuals with chronic kidney disease (CKD). However, a lack of good animal models for examining the presence and catalytic activity of MPO in vascular lesions has impeded mechanistic studies into CKD-associated cardiovascular diseases. Here, we show for the first time that exaggerated atherosclerosis in a pathophysiologically relevant CKD mouse model is associated with increased macrophage-derived MPO activity. Male 7-week-old LDL receptor-deficient mice underwent sham (control mice) or 5/6 nephrectomy and were fed either a low-fat or high-fat, high-cholesterol diet for 24 weeks, and the extents of atherosclerosis and vascular reactivity were assessed. MPO expression and oxidation productsprotein-bound oxidized tyrosine moieties 3-chlorotyrosine, 3-nitrotyrosine, and o,o-dityrosinewere examined with immunoassays and confirmed with mass spectrometry (MS). As anticipated, the CKD mice had significantly higher plasma creatinine, urea nitrogen, and intact parathyroid hormone along with lower hematocrit and body weight. On both the diet regimens, CKD mice did not have hypertension but had lower cholesterol and triglyceride levels than the control mice. Despite the lower cholesterol levels, CKD mice had increased aortic plaque areas, fibrosis, and luminal narrowing. They also exhibited increased MPO expression and activity (i.e. increased oxidized tyrosines) that co-localized with infiltrating lesional macrophages and diminished vascular reactivity. In summary, unlike non-CKD mouse models of atherosclerosis, CKD mice exhibit increased MPO expression and catalytic activity in atherosclerotic lesions, which co-localize with lesional macrophages. These results implicate macrophage-derived MPO in CKD-accelerated atherosclerosis.	[Zeng, Lixia; Mathew, Anna V.; Byun, Jaeman; Atkins, Kevin B.; Brosius, Frank C., III; Pennathur, Subramaniam] Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48105 USA; [Brosius, Frank C., III; Pennathur, Subramaniam] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pennathur, S (corresponding author), Univ Michigan, Div Nephrol, Brehm Ctr 5309, 1000 Wall St, Ann Arbor, MI 48105 USA.	spennath@umich.edu	Mathew, Anna V/V-2511-2018	Mathew, Anna/0000-0002-7043-4221	National Institutes of Health Grants from NIDDK [P30DK081943, P30DK089503]; NHLBI [K08HL130944]; Renal Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL130944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK081943, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health Grants from NIDDK; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Renal Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported National Institutes of Health Grants P30DK081943 and P30DK089503 from NIDDK (to S.P.) and Grant K08HL130944 from NHLBI (to A.V.M.), and a grant from the Renal Research Institute (to K.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Afshinnia F, 2017, AM J NEPHROL, V46, P73, DOI 10.1159/000477766; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Atkins KB, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12299; Baldus S, 2002, FREE RADICAL BIO MED, V33, P1010, DOI 10.1016/S0891-5849(02)00993-0; Bansal V, 2007, FASEB J, V21, pA438; Bisgaard LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168396; Bouali H, 2007, J RHEUMATOL, V34, P2028; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Bro S, 2008, SCAND J CLIN LAB INV, V68, P660, DOI 10.1080/00365510802037272; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Bro S, 2009, DAN MED BULL, V56, P177; Bro S, 2008, ATHEROSCLEROSIS, V201, P274, DOI 10.1016/j.atherosclerosis.2008.01.015; BROWN MS, 1992, CELL, V71, P187, DOI 10.1016/0092-8674(92)90346-E; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Cayley WE, 2004, NEW ENGL J MED, V350, P516; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Chumakov AM, 2000, INT J ONCOL, V16, P401; Csanyi G, 2012, PROSTAG OTH LIPID M, V98, P107, DOI 10.1016/j.prostaglandins.2012.02.002; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MR, 2003, J AM SOC NEPHROL, V14, P1559, DOI 10.1097/01.ASN.0000068404.57780.DD; Davies MR, 2001, KIDNEY INT, V60, P472, DOI 10.1046/j.1523-1755.2001.060002472.x; Doi K, 2007, HYPERTENS RES, V30, P1193, DOI 10.1291/hypres.30.1193; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Duzguncinar O, 2008, ACTA CARDIOL, V63, P147, DOI 10.2143/AC.63.2.2029520; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eraranta A, 2014, AM J NEPHROL, V39, P400, DOI 10.1159/000362507; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; Gluba-Brzozka A, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0191-x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Grahl DA, 2007, BLOOD PURIFICAT, V25, P210, DOI 10.1159/000100419; Guilgen G, 2011, BLOOD PURIFICAT, V32, P296, DOI 10.1159/000330327; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Heller JI, 2000, J BIOL CHEM, V275, P9957, DOI 10.1074/jbc.275.14.9957; Hostetter TH, 2004, NEW ENGL J MED, V351, P1344, DOI 10.1056/NEJMe048211; Jaisson S, 2011, CLIN CHEM, V57, P1499, DOI 10.1373/clinchem.2011.163188; Ketonen J, 2008, HEART VESSELS, V23, P420, DOI 10.1007/s00380-008-1066-5; Kisic Bojana, 2016, Oxid Med Cell Longev, V2016, P1069743, DOI 10.1155/2016/1069743; Klebanoff S J, 1978, Ciba Found Symp, P263; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kon V, 2015, ARCH MED RES, V46, P379, DOI 10.1016/j.arcmed.2015.05.009; Kon V, 2011, NAT REV NEPHROL, V7, P45, DOI 10.1038/nrneph.2010.157; Kumar AP, 2005, BIOCHEM BIOPH RES CO, V331, P442, DOI 10.1016/j.bbrc.2005.03.204; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Landmesser U, 2003, EUR HEART J SUPPL, V5, pA3, DOI 10.1016/S1520-765X(03)90057-5; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Mathew AV, 2015, J PROTEOMICS BIO S14; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Pecoits R, 2003, KIDNEY INT, V63, pS172, DOI 10.1046/j.1523-1755.63.s84.32.x; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; Pennathur S, 2001, J CLIN INVEST, V107, P853, DOI 10.1172/JCI11194; Pennathur S, 2016, AM J RESP CRIT CARE, V193, P861, DOI 10.1164/rccm.201505-0992OC; Penno G, 2011, J HYPERTENS, V29, P1802, DOI 10.1097/HJH.0b013e3283495cd6; Phan O, 2005, CIRCULATION, V112, P2875, DOI 10.1161/CIRCULATIONAHA105.541854; Phan O, 2008, NEPHROL DIAL TRANSPL, V23, P82, DOI 10.1093/ndt/gfm699; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Rao AM, 2011, INDIAN J CLIN BIOCHE, V26, P28, DOI 10.1007/s12291-010-0075-1; Reynolds WF, 2006, BIOCHEM BIOPH RES CO, V349, P846, DOI 10.1016/j.bbrc.2006.08.119; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samak MJ, 2002, CLIN NEPHROL, V57, P327; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Shishehbor MH, 2003, CIRCULATION, V108, P426, DOI 10.1161/01.CIR.0000080895.05158.8B; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Tang WHW, 2013, J CARD FAIL, V19, P219, DOI 10.1016/j.cardfail.2013.02.001; USRDS, 2017, ANN DAT REP ATL CHRO; Vaziri ND, 2004, CURR OPIN NEPHROL HY, V13, P93, DOI 10.1097/00041552-200401000-00013; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Vivekanandan-Giri A, 2011, METHOD ENZYMOL, V491, P73, DOI 10.1016/B978-0-12-385928-0.00005-5; Wang AYM, 2010, AM J KIDNEY DIS, V56, P937, DOI 10.1053/j.ajkd.2010.05.008; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wolfle SE, 2005, J VASC RES, V42, P475, DOI 10.1159/000088101; Wu-Wong JR, 2015, J STEROID BIOCHEM, V148, P202, DOI 10.1016/j.jsbmb.2014.12.002; Yamamoto Y, 2010, THROMB RES, V125, P246, DOI 10.1016/j.thromres.2009.11.008; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zalba G, 2006, NEPHROL DIAL TRANSPL, V21, P2686, DOI 10.1093/ndt/gfl398; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	100	17	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7238	7249		10.1074/jbc.RA117.000559	http://dx.doi.org/10.1074/jbc.RA117.000559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581235	Green Published, hybrid			2022-12-28	WOS:000432174500015
J	Ramirez, MLG; Poreba, M; Snipas, SJ; Groborz, K; Drag, M; Salvesen, GS				Ramirez, Monica L. Gonzalez; Poreba, Marcin; Snipas, Scott J.; Groborz, Katarzyna; Drag, Marcin; Salvesen, Guy S.			Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; caspase; fluorescence; cell death; enzyme kinetics; GSDMD; proptosis	INTERLEUKIN-1-BETA CONVERTING-ENZYME; NONCANONICAL INFLAMMASOME ACTIVATION; PYROPTOTIC CELL-DEATH; GAMMA-INDUCING FACTOR; NLRP3 INFLAMMASOME; COMBINATORIAL APPROACH; CYSTEINE PROTEASE; GASDERMIN D; LPS; FAMILY	Inflammatory cell death, or pyroptosis, is triggered by pathogenic infections or events. It is executed by caspase-1 (in the canonical pyroptosis pathway) or caspase-11 (noncanonical pathway), each via production of a cell-lytic domain from the pyroptosis effector protein gasdermin D through specific and limited proteolysis. Pyroptosis is accompanied by the release of inflammatory mediators, including the proteolytically processed forms of interleukin-1 (IL-1) and IL-18. Given the similar inflammatory outcomes of the canonical and noncanonical pyroptosis pathways, we hypothesized that caspase-1 and -11 should have very similar activities and substrate specificities. To test this hypothesis, we purified recombinant murine caspases and analyzed their primary specificities by massive hybrid combinatorial substrate library (HyCoSuL) screens. We correlated the substrate preferences of each caspase with their activities on the recombinant natural substrates IL-1, IL-18, and gasdermin D. Although we identified highly selective and robust peptidyl substrates for caspase-1, we were unable to do so for caspase-11, because caspase-1 cleaved even the best caspase-11 substrates equally well. Caspase-1 rapidly processed pro-IL-1 and -18, but caspase-11 processed these two pro-ILs extremely poorly. However, both caspase-1 and -11 efficiently produced the cell-lytic domain from the gasdermin D precursor. We hypothesize that caspase-11 may have evolved a specific exosite to selectively engage pyroptosis without directly activating pro-IL-1 or -18. In summary, comparing the activities of caspase-1 and -11 in HyCoSuL screens and with three endogenous protein substrates, we conclude that caspase-11 has highly restricted substrate specificity, preferring gasdermin D over all other substrates examined.	[Ramirez, Monica L. Gonzalez; Poreba, Marcin; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, La Jolla, CA 92037 USA; [Ramirez, Monica L. Gonzalez] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Groborz, Katarzyna; Drag, Marcin] Wroclaw Univ Sci & Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Wroclaw University of Science & Technology	Salvesen, GS (corresponding author), 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gsalvesen@sbp.edu			National Institutes of Health [R01 GM99040, P30 CA30199]; National Science Center in Poland Grant OPUS [UMO-2011/03/B/ST5/01048]; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant [661187]; Genentech; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center in Poland Grant OPUS; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant; Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM99040 and P30 CA30199 (to G. S. S.), National Science Center in Poland Grant OPUS, UMO-2011/03/B/ST5/01048 (to M. D.), and the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie Grant 661187 (to M. P.). This work was supported in part by a fellowship from Genentech. G. S. S. consults for Genentech. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; AURON PE, 1987, J IMMUNOL, V138, P1447; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; FENTON JW, 1988, BIOCHEMISTRY-US, V27, P7106, DOI 10.1021/bi00418a066; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lechtenberg BC, 2015, ACS CHEM BIOL, V10, P945, DOI 10.1021/cb500909n; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pop C, 2008, METHOD ENZYMOL, V446, P351, DOI 10.1016/S0076-6879(08)01621-2; Poreba M, 2010, CURR MED CHEM, V17, P3968, DOI 10.2174/092986710793205381; Poreba M, 2017, NAT PROTOC, V12, P2189, DOI 10.1038/nprot.2017.091; Poreba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43135; Poreba M, 2015, CHEM REV, V115, P12546, DOI 10.1021/acs.chemrev.5b00434; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Shen Weiping, 2005, Proteome Sci, V3, P3, DOI 10.1186/1477-5956-3-3; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THORNBERRY NA, 1995, PROTEIN SCI, V4, P3; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zamboni DS, 2015, IMMUNOL REV, V265, P156, DOI 10.1111/imr.12291	57	52	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7058	7067		10.1074/jbc.RA117.001329	http://dx.doi.org/10.1074/jbc.RA117.001329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29414788	Green Published, hybrid			2022-12-28	WOS:000431487300037
J	Itou, J; Li, WZ; Ito, S; Tanaka, S; Matsumoto, Y; Sato, F; Toi, M				Itou, Junji; Li, Wenzhao; Ito, Shinji; Tanaka, Sunao; Matsumoto, Yoshiaki; Sato, Fumiaki; Toi, Masakazu			Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; GENE; LOCALIZATION; HOMEOSTASIS; METASTASIS; MUTATIONS; CARCINOMA; TRIM21; SIGNAL	Sal-like 4 (SALL4) is a transcription factor that enhances proliferation and migration in breast cancer cells. SALL4 expression therefore has the potential to promote cancer malignancy. However, the regulatory mechanisms involved in SALL4 protein expression have not been thoroughly elucidated. In this study, we observed that treating MCF-7 and SUM159 breast cancer cell lines with a proteasome inhibitor increases SALL4 protein levels, suggesting that SALL4 is degraded by the ubiquitin-proteasome system. Using immunoprecipitation to uncover SALL4-binding proteins, we identified an E3 ubiquitin-protein ligase, tripartite motif-containing 21 (TRIM21). Using an EGFP reporter probe of the major SALL4 isoform SALL4B, we observed that shRNA-mediated knockdown of TRIM21 increases cellular SALL4B levels. Immunostaining experiments revealed that TRIM21 localizes to the nucleus, and a K64R substitution in the nuclear localization motif in SALL4B increased SALL4B levels in the cytoplasm. These results suggested that TRIM21 is involved in nuclear SALL4 degradation. To identify the amino acid residue that is targeted by TRIM21, we fragmented the SALL4B sequence, fused it to EGFP, and identified Lys-190 in SALL4B as TRIM21's target residue. Amino acid sequence alignments of SALL family members indicated that the region around SALL4 Lys-190 is conserved in both SALL1 and SALL3. Because SALL1 and SALL4 have similar functions, we constructed a SALL1-EGFP probe and found that the TRIM21 knockdown increases SALL1 levels, indicating that TRIM21 degrades both SALL1 and SALL4. Our findings extend our understanding of SALL4 and SALL1 regulation and may contribute to the development of SALL4-targeting therapies.	[Itou, Junji; Li, Wenzhao; Tanaka, Sunao; Matsumoto, Yoshiaki; Sato, Fumiaki; Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Ito, Shinji] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Itou, J (corresponding author), Kyoto Univ, Grad Sch Med, Dept Breast Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	junji-itou@umin.ac.jp			Taiho Pharmaceutical Co., Ltd.; Japan Society for the Promotion of Science [25870384]	Taiho Pharmaceutical Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Taiho Pharmaceutical Co., Ltd. and by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 25870384. J. I. is an employee of Kyoto University's Sponsored Research Program funded by Taiho Pharmaceutical Co., Ltd. M. T. received research funding from Taiho Pharmaceutical Co., Ltd.	Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; Bohm J, 2006, BIOCHEM BIOPH RES CO, V348, P898, DOI 10.1016/j.bbrc.2006.07.124; Dirican E, 2016, TUMOR BIOL, V37, P11701, DOI 10.1007/s13277-016-5150-7; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; He J, 2013, INT J BIOCHEM CELL B, V45, P1962, DOI 10.1016/j.biocel.2013.06.008; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Itou J, 2017, BBA-MOL CELL RES, V1864, P76, DOI 10.1016/j.bbamcr.2016.10.012; Itou J, 2013, FEBS LETT, V587, P3115, DOI 10.1016/j.febslet.2013.07.049; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Lazzari E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103609; Lin YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09995; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015006; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Nicole L, 2017, ONCOTARGET, V8, P22968, DOI 10.18632/oncotarget.14952; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Tatetsu H, 2016, GENE, V584, P111, DOI 10.1016/j.gene.2016.02.019; Wang MC, 2015, ONCOL LETT, V10, P583, DOI 10.3892/ol.2015.3361; Wilson CH, 2012, EMBO J, V31, P2486, DOI 10.1038/emboj.2012.91; Wu M, 2014, CELL CYCLE, V13, P1456, DOI 10.4161/cc.28418; Yang FK, 2012, J BIOL CHEM, V287, P38600, DOI 10.1074/jbc.M112.391441; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang MY, 2016, ONCOL REP, V35, P1796, DOI 10.3892/or.2016.4545; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297	29	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6556	6564		10.1074/jbc.RA117.000245	http://dx.doi.org/10.1074/jbc.RA117.000245			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29511085	Green Published, hybrid			2022-12-28	WOS:000431108600026
J	Madukwe, JC; Garland-Kuntz, EE; Lyon, AM; Smrcka, AV				Madukwe, Jerry C.; Garland-Kuntz, Elisabeth E.; Lyon, Angeline M.; Smrcka, Alan V.			G protein beta gamma subunits directly interact with and activate phospholipase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipase C; G protein; phosphatidylinositol signaling; Ras homolog gene family; member A (RhoA); Ras protein	PHOSPHATIDYLINOSITOL 4-PHOSPHATE; DEPENDENT ACTIVATION; CARDIAC-HYPERTROPHY; ALPHA-SUBUNITS; PLC-EPSILON; RAS; ISOZYME; PATHWAY; CELLS; RHO	Phospholipase C (PLC) enzymes hydrolyze membrane phosphatidylinositol 4,5 bisphosphate (PIP2) and regulate Ca2+ and protein kinase signaling in virtually all mammalian cell types. Chronic activation of the PLCE isoform downstream of G protein-coupled receptors (GPCRs) contributes to the development of cardiac hypertrophy. We have previously shown that PLCE-catalyzed hydrolysis of Golgi-associated phosphatidylinositol 4-phosphate (PI4P) in cardiac myocytes depends on G protein subunits released upon stimulation with endothelin-1. PLCE binds and is directly activated by Ras family small GTPases, but whether they directly interact with G has not been demonstrated. To identify PLCE domains that interact with G, here we designed various single substitutions and truncations of WT PLCE and tested them for activation by G in transfected COS-7 cells. Deletion of only a single domain in PLCE was not sufficient to completely block its activation by G, but blocked activation by Ras. Simultaneous deletion of the C-terminal RA2 domain and the N-terminal CDC25 and cysteine-rich domains completely abrogated PLCE activation by G, but activation by the GTPase Rho was retained. In vitro reconstitution experiments further revealed that purified G directly interacts with a purified fragment of PLCE (PLCE-PH-RA2) and increases PIP2 hydrolysis. Deletion of the RA2 domain decreased G binding and eliminated G stimulation of PIP2 hydrolysis. These results provide first evidence that G directly interacts with PLCE and yield insights into the mechanism by which subunits activate PLCE.	[Madukwe, Jerry C.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14267 USA; [Garland-Kuntz, Elisabeth E.; Lyon, Angeline M.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Madukwe, Jerry C.; Smrcka, Alan V.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Rochester; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Michigan System; University of Michigan	Smrcka, AV (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	avsmrcka@umich.edu			NIGMS NIH HHS [R01 GM053536] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; BOYER JL, 1992, J BIOL CHEM, V267, P25451; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Gandarillas Natalia Lamuno, 2009, V462, P379, DOI 10.1007/978-1-60327-115-8_24; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Lehmann DM, 2007, METHOD ENZYMOL, V434, P29, DOI 10.1016/S0076-6879(07)34003-2; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1992, J BIOL CHEM, V267, P1811; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047	28	21	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6387	6397		10.1074/jbc.RA118.002354	http://dx.doi.org/10.1074/jbc.RA118.002354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29535186	hybrid, Green Published			2022-12-28	WOS:000431108600014
J	Bonnard, D; Le Rouzic, E; Eiler, S; Amadori, C; Orlov, I; Bruneau, JM; Brias, J; Barbion, J; Chevreuil, F; Spehner, D; Chasset, S; Ledoussal, B; Moreau, F; Saib, A; Klaholz, BP; Emiliani, S; Ruff, M; Zamborlini, A; Benarous, R				Bonnard, Damien; Le Rouzic, Erwann; Eiler, Sylvia; Amadori, Celine; Orlov, Igor; Bruneau, Jean-Michel; Brias, Julie; Barbion, Julien; Chevreuil, Francis; Spehner, Daniele; Chasset, Sophie; Ledoussal, Benoit; Moreau, Francois; Saib, Ali; Klaholz, Bruno P.; Emiliani, Stephane; Ruff, Marc; Zamborlini, Alessia; Benarous, Richard			Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ANTIVIRAL ACTIVITY; BI 224436; PROTEIN; REPLICATION; LEDGF/P75; SITE; MULTIMERIZATION; RESISTANCE; POTENCY	Recently, a new class of HIV-1 integrase (IN) inhibitors with a dual mode of action, called IN-LEDGF/p75 allosteric inhibitors (INLAIs), was described. Designed to interfere with the IN-LEDGF/p75 interaction during viral integration, unexpectedly, their major impact was on virus maturation. This activity has been linked to induction of aberrant IN multimerization, whereas inhibition of the IN-LEDGF/p75 interaction accounts for weaker antiretroviral effect at integration. Because these dual activities result from INLAI binding to IN at a single binding site, we expected that these activities co-evolved together, driven by the affinity for IN. Using an original INLAI, MUT-A, and its activity on an Ala-125 (A125) IN variant, we found that these two activities on A125-IN can be fully dissociated: MUT-A-induced IN multimerization and the formation of eccentric condensates in viral particles, which are responsible for inhibition of virus maturation, were lost, whereas inhibition of the IN-LEDGF/p75 interaction and consequently integration was fully retained. Hence, the mere binding of INLAI to A125 IN is insufficient to promote the conformational changes of IN required for aberrant multimerization. By analyzing the X-ray structures of MUT-A bound to the IN catalytic core domain (CCD) with or without the Ala-125 polymorphism, we discovered that the loss of IN multimerization is due to stabilization of the A125-IN variant CCD dimer, highlighting the importance of the CCD dimerization energy for IN multimerization. Our study reveals that affinity for the LEDGF/p75-binding pocket is not sufficient to induce INLAI-dependent IN multimerization and the associated inhibition of viral maturation.	[Bonnard, Damien; Le Rouzic, Erwann; Amadori, Celine; Bruneau, Jean-Michel; Brias, Julie; Barbion, Julien; Chevreuil, Francis; Chasset, Sophie; Ledoussal, Benoit; Moreau, Francois; Benarous, Richard] Biodim Mutabilis, F-93230 Romainville, France; [Bonnard, Damien; Saib, Ali; Zamborlini, Alessia] Univ Paris Diderot, Conservatoire Natl Arts & Metiers, Inserm U944, CNRS UMR 7212, F-75010 Paris, France; [Eiler, Sylvia; Orlov, Igor; Spehner, Daniele; Klaholz, Bruno P.; Ruff, Marc] Univ Strasbourg, CNRS, INSERM, IGBMC,Ctr Integrat Biol, F-67404 Illkirch Graffenstaden, France; [Amadori, Celine; Emiliani, Stephane] INSERM, Inst Cochin, U1016, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bonnard, D (corresponding author), 102 Ave Gaston Roussel, F-93230 Romainville, France.; Ruff, M (corresponding author), LGBS IGBMC, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.; Zamborlini, A (corresponding author), UMR7212, 16 Rue Grange Belles, F-75010 Paris, France.; Benarous, R (corresponding author), 19 Rue Croulebarbe, F-75013 Paris, France.	damien.bonnard@mutabilis.fr; ruff@igbmc.fr; alessia.zamborlini@lecnam.net; benarous.r@wanadoo.fr	ruff, marc/J-3011-2013; Zamborlini, Alessia/ABE-2256-2021	ruff, marc/0000-0001-5451-6377; Zamborlini, Alessia/0000-0002-8902-1996; Bonnard, Damien/0000-0001-9529-5785	Biodim Mutabilis under Authorization [DUO 2145]; EU [305137]; Eurostars Grant ResistAids [E!10239]; French National Research Agency against AIDS (ANRS); SIDACTION; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct-ERIC; French National Association for Research and Technology (ANRT)	Biodim Mutabilis under Authorization; EU(European Commission); Eurostars Grant ResistAids; French National Research Agency against AIDS (ANRS)(ANRSFrench National Research Agency (ANR)); SIDACTION; French Infrastructure for Integrated Structural Biology (FRISBI); Instruct-ERIC; French National Association for Research and Technology (ANRT)(French National Research Agency (ANR))	This work was supported in part by Biodim Mutabilis under Authorization Number DUO 2145, assigned by the French Ministry of Research for work with genetically modified organisms, by Grants EU FP7 (to Biodim, S. Emiliani, A. S., and A. Z.) under the HIVINNOV Consortium, Grant Agreement 305137, and by Eurostars Grant ResistAids (to Biodim), Grant Agreement E!10239. D. B., E. L. R., C. A., J. -M. B., J. Brias, J. Barbion, F. C., F. L. S., S. C., B. L., F. M., R. B. are or were employees of Biodim Mutabilis at the time of this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the French National Research Agency against AIDS (ANRS) and SIDACTION.; Supported by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by Instruct-ERIC.; Supported by the French National Association for Research and Technology (ANRT).	Amadori C, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0373-2; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Benarous R., 2014, Patent No. [2014053666 A1, 2014053666]; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DeLano W.L, PYMOL MOL GRAPHICS S; Demeulemeester J, 2014, EXPERT OPIN THER PAT, V24, P609, DOI 10.1517/13543776.2014.898753; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fader LD, 2016, ACS MED CHEM LETT, V7, P797, DOI 10.1021/acsmedchemlett.6b00194; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2016, ACS CHEM BIOL, V11, P1313, DOI 10.1021/acschembio.6b00167; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fenwick C, 2014, ANTIMICROB AGENTS CH, V58, P3233, DOI 10.1128/AAC.02719-13; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Hazuda DJ, 2012, CURR OPIN HIV AIDS, V7, P383, DOI 10.1097/COH.0b013e3283567309; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Kvaratskhelia M, 2014, NUCLEIC ACIDS RES, V42, P10209, DOI 10.1093/nar/gku769; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lataillade M, 2007, ANTIVIR THER, V12, P563; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Madison MK, 2017, J VIROL, V91, DOI 10.1128/JVI.00821-17; Metifiot M, 2011, AIDS, V25, P1175, DOI 10.1097/QAD.0b013e3283473599; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shkriabai N, 2014, J BIOL CHEM, V289, P26430, DOI 10.1074/jbc.M114.589572; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; Vranckx LS, 2016, EBIOMEDICINE, V8, P248, DOI 10.1016/j.ebiom.2016.04.039; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wares M, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-7	55	23	24	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6172	6186		10.1074/jbc.M117.816793	http://dx.doi.org/10.1074/jbc.M117.816793			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29507092	hybrid, Green Published			2022-12-28	WOS:000430497300033
J	Dickmanns, A; Zschiedrich, CP; Arens, J; Parfentev, I; Gundlach, J; Hofele, R; Neumann, P; Urlaub, H; Gorke, B; Ficner, R; Stulke, J				Dickmanns, Achim; Zschiedrich, Christopher P.; Arens, Johannes; Parfentev, Iwan; Gundlach, Jan; Hofele, Romina; Neumann, Piotr; Urlaub, Henning; Goerke, Boris; Ficner, Ralf; Stuelke, Joerg			Structural basis for the regulatory interaction of the methylglyoxal synthase MgsA with the carbon flux regulator Crh in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HPR-LIKE PROTEIN; CATABOLITE REPRESSION; ESCHERICHIA-COLI; ANTITERMINATOR PROTEIN; CRYSTAL-STRUCTURE; CCPA; PHOSPHORYLATION; IDENTIFICATION; BIOSYNTHESIS; BACILLITHIOL	Utilization of energy-rich carbon sources such as glucose is fundamental to the evolutionary success of bacteria. Glucose can be catabolized via glycolysis for feeding the intermediary metabolism. The methylglyoxal synthase MgsA produces methylglyoxal from the glycolytic intermediate dihydroxyacetone phosphate. Methylglyoxal is toxic, requiring stringent regulation of MgsA activity. In the Gram-positive bacterium Bacillus subtilis, an interaction with the phosphoprotein Crh controls MgsA activity. In the absence of preferred carbon sources, Crh is present in the nonphosphorylated state and binds to and thereby inhibits MgsA. To better understand the mechanism of regulation of MgsA, here we performed biochemical and structural analyses of B. subtilis MgsA and of its interaction with Crh. Our results indicated thatMgsAforms a hexamer (i.e. a trimer of dimers) in the crystal structure, whereas it seems to exist in an equilibrium between a dimer and hexamer in solution. In the hexamer, two alternative dimers could be distinguished, but only one appeared to prevail in solution. Further analysis strongly suggested that the hexamer is the biologically active form. In vitro cross-linking studies revealed that Crh interacts with the N-terminal helices of MgsA and that the Crh-MgsA binding inactivates MgsA by distorting and thereby blocking its active site. In summary, our results indicate that dimeric and hexameric MgsA species exist in an equilibrium in solution, that the hexameric species is the active form, and that binding to Crh deforms and blocks the active site in MgsA.	[Dickmanns, Achim; Arens, Johannes; Neumann, Piotr; Ficner, Ralf] Georg August Univ Gottingen, GZMB, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Zschiedrich, Christopher P.; Gundlach, Jan; Goerke, Boris; Stuelke, Joerg] Georg August Univ Gottingen, GZMB, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Parfentev, Iwan; Hofele, Romina; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Parfentev, Iwan; Hofele, Romina; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, D-37075 Gottingen, Germany; [Goerke, Boris] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, A-1030 Vienna, Austria	University of Gottingen; University of Gottingen; Max Planck Society; University of Gottingen; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Dickmanns, A (corresponding author), Georg August Univ Gottingen, Dept Mol Struct Biol, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.; Stulke, J (corresponding author), Georg August Univ Gottingen, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390; Gorke, Boris/0000-0002-1682-5387; Parfentev, Iwan/0000-0002-0203-2167	Deutsche Forschungsgemeinschaft (DFG) [HI 291/13-1, SFB860]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant HI 291/13-1 and SFB860. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bachem S, 1998, J BACTERIOL, V180, P5319, DOI 10.1128/JB.180.20.5319-5326.1998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; BOCK A, 1966, J BACTERIOL, V92, P470; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chandrangsu P, 2014, MOL MICROBIOL, V91, P706, DOI 10.1111/mmi.12489; Christian H, 2014, NUCLEIC ACIDS RES, V42, P1162, DOI 10.1093/nar/gkt985; COOPER RA, 1974, EUR J BIOCHEM, V44, P81, DOI 10.1111/j.1432-1033.1974.tb03459.x; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falahati H, 2013, PROTEIN ENG DES SEL, V26, P445, DOI 10.1093/protein/gzt014; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Gaballa A, 2013, MICROBIOL-SGM, V159, P2025, DOI 10.1099/mic.0.070482-0; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorke B, 2004, J BACTERIOL, V186, P2992, DOI 10.1128/JB.186.10.2992-2995.2004; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; Hatti K, 2017, J STRUCT BIOL, V197, P372, DOI 10.1016/j.jsb.2017.01.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPPER DJ, 1972, BIOCHEM J, V128, P321, DOI 10.1042/bj1280321; Huang KX, 1999, APPL ENVIRON MICROB, V65, P3244; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landmann JJ, 2012, FEMS MICROBIOL LETT, V327, P47, DOI 10.1111/j.1574-6968.2011.02456.x; Landmann JJ, 2011, MOL MICROBIOL, V82, P770, DOI 10.1111/j.1365-2958.2011.07857.x; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; Maass S, 2014, MOL CELL PROTEOMICS, V13, P2260, DOI 10.1074/mcp.M113.035741; Marks GT, 2001, BIOCHEMISTRY-US, V40, P6805, DOI 10.1021/bi0028237; Merzbacher M, 2004, EUR J BIOCHEM, V271, P367, DOI 10.1046/j.1432-1033.2003.03935.x; Meyer FM, 2011, J BACTERIOL, V193, P6939, DOI 10.1128/JB.06197-11; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pazhang M, 2010, APPL BIOCHEM BIOTECH, V162, P1519, DOI 10.1007/s12010-010-8933-0; Penin F, 2001, J MOL MICROB BIOTECH, V3, P429; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saadat D, 1999, STRUCT FOLD DES, V7, P309, DOI 10.1016/S0969-2126(99)80041-0; Saadat D, 2000, BIOCHEMISTRY-US, V39, P2950, DOI 10.1021/bi992666f; Saadat D, 1998, BIOCHEMISTRY-US, V37, P10074, DOI 10.1021/bi980409p; Sambrook J., 2001, MOL CLONING LAB MANU; Schmalisch MH, 2003, J BIOL CHEM, V278, P51108, DOI 10.1074/jbc.M309972200; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Seidel G, 2005, FEBS J, V272, P2566, DOI 10.1111/j.1742-4658.2005.04682.x; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Shin SM, 2017, INT J BIOCHEM CELL B, V91, P14, DOI 10.1016/j.biocel.2017.08.005; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	73	2	2	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5781	5792		10.1074/jbc.RA117.001289	http://dx.doi.org/10.1074/jbc.RA117.001289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29514981	hybrid, Green Published			2022-12-28	WOS:000430497300003
J	Van Bael, S; Watteyne, J; Boonen, K; De Haes, W; Menschaert, G; Ringstad, N; Horvitz, HR; Schoofs, L; Husson, SJ; Temmerman, L				Van Bael, Sven; Watteyne, Jan; Boonen, Kurt; De Haes, Wouter; Menschaert, Gerben; Ringstad, Niels; Horvitz, H. Robert; Schoofs, Liliane; Husson, Steven J.; Temmerman, Liesbet			Mass spectrometric evidence for neuropeptide-amidating enzymes in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYLATING MONOOXYGENASE; BIOACTIVE PEPTIDES; CONVERTASE-2; PITUITARY; BEHAVIOR; PROTEIN; PROFILE; LACKING; CLONING; DOMAIN	Neuropeptides constitute a vast and functionally diverse family of neurochemical signaling molecules and are widely involved in the regulation of various physiological processes. The nematode Caenorhabditis elegans is well-suited for the study of neuropeptide biochemistry and function, as neuropeptide biosynthesis enzymes are not essential for C. elegans viability. This permits the study of neuropeptide biosynthesis in mutants lacking certain neuropeptide-processing enzymes. Mass spectrometry has been used to study the effects of proprotein convertase and carboxypeptidase mutations on proteolytic processing of neuropeptide precursors and on the peptidome in C. elegans. However, the enzymes required for the last step in the production of many bioactive peptides, the carboxyl-terminal amidation reaction, have not been characterized in this manner. Here, we describe three genes that encode homologs of neuropeptide amidation enzymes in C. elegans and used tandem LC-MS to compare neuropeptides in WT animals with those in newly generated mutants for these putative amidation enzymes. We report that mutants lacking both a functional peptidylglycine alpha-hydroxylating monooxygenase and a peptidylglycine alpha-amidating monooxygenase had a severely altered neuropeptide profile and also a decreased number of offspring. Interestingly, single mutants of the amidation enzymes still expressed some fully processed amidated neuropeptides, indicating the existence of a redundant amidation mechanism in C. elegans. All MS data are available via ProteomeXchange with the identifier PXD008942. In summary, the key steps in neuropeptide processing in C. elegans seem to be executed by redundant enzymes, and loss of these enzymes severely affects brood size, supporting the need of amidated peptides for C. elegans reproduction.	[Van Bael, Sven; Watteyne, Jan; Boonen, Kurt; De Haes, Wouter; Schoofs, Liliane; Temmerman, Liesbet] Univ Leuven, KU Leuven, Dept Biol, Naamsestr 59, B-3000 Leuven, Belgium; [Menschaert, Gerben] Univ Ghent, Dept Math Modelling, Lab Bioinformat & Computat Genom BioBix, B-9000 Ghent, Belgium; [Ringstad, Niels] NYU, Langone Med Ctr, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY 10016 USA; [Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Husson, Steven J.] Univ Antwerp, Dept Biol, SPHERE Syst Physiol & Ecotoxicol Res, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Van Bael, Sven] Agcy Innovat Sci & Technol Flanders IWT, Brussels, Belgium	KU Leuven; Ghent University; New York University; NYU Langone Medical Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Antwerp	Van Bael, S; Temmerman, L (corresponding author), Univ Leuven, KU Leuven, Mol & Funct Neurobiol, Naamsestr 59 Box 2465, B-3000 Leuven, Belgium.	sven.vanbael@kuleuven.be; liesbet.temmerman@kuleuven.be	schoofs, liliane/ABD-2943-2020; Schoofs, Liliane/F-2815-2010	Temmerman, Liesbet/0000-0002-1249-3995; Boonen, Kurt/0000-0002-6252-7065; Schoofs, Liliane/0000-0002-1673-432X	KU Leuven Grant [C14/15/049]; FWO Grants [1511512N, G069713N, G052217N]; Belspo Grant [IAP-P7/44]; European Research Council (ERC) Advanced Grant [ERC-2013-ADG-340318]; H Grant [633589]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024663] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	KU Leuven Grant; FWO Grants(FWO); Belspo Grant; European Research Council (ERC) Advanced Grant(European Research Council (ERC)); H Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by KU Leuven Grant C14/15/049, FWO Grants 1511512N, G069713N, and G052217N, and Belspo Grant IAP-P7/44. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Fellows of the Fund for Scientific Research Flanders (FWO Flanders).; Recipient of European Research Council (ERC) Advanced Grant ERC-2013-ADG-340318.; Recipients of H2020 Grant 633589.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; [Anonymous], 2021, LANG ENV STAT COMP; Asada A, 2005, FEBS J, V272, P942, DOI 10.1111/j.1742-4658.2004.04528.x; Atkinson LE, 2010, MOL BIOCHEM PARASIT, V173, P97, DOI 10.1016/j.molbiopara.2010.05.009; Attenborough RMF, 2012, MOL BIOL EVOL, V29, P3095, DOI 10.1093/molbev/mss114; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135164; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Chufan EE, 2009, STRUCTURE, V17, P965, DOI 10.1016/j.str.2009.05.008; Churgin MA, 2017, J NEUROSCI, V37, P7811, DOI [10.1523/JNEUROSCI.2636-16.2017, 10.1523/jneurosci.2636-16.2017]; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; De Haes W, 2015, BBA-PROTEINS PROTEOM, V1854, P812, DOI 10.1016/j.bbapap.2014.12.011; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fan XM, 2000, MOL BRAIN RES, V82, P25, DOI 10.1016/S0169-328X(00)00173-X; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Han M, 2004, J NEUROCHEM, V90, P129, DOI 10.1111/j.1471-4159.2004.02464.x; Hardiman A, 2005, J MOL ENDOCRINOL, V34, P739, DOI 10.1677/jme.1.01812; Hauser F, 1997, BIOCHEM BIOPH RES CO, V241, P509, DOI 10.1006/bbrc.1997.7854; Hobert O., 2013, WORMBOOK 2013; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2014, EUPA OPEN PROTEOMICS, V3, P280, DOI [10.1016/j.euprot.2014.04.005, DOI 10.1016/J.EUPROT.2014.04.005]; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Husson SJ, 2010, METHODS MOL BIOL, V615, P29, DOI 10.1007/978-1-60761-535-4_3; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li C, 2010, ADV EXP MED BIOL, V692, P98; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Spijker S, 1999, FASEB J, V13, P735, DOI 10.1096/fasebj.13.6.735; TRENT C, 1983, GENETICS, V104, P619; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waggoner LF, 2000, GENETICS, V154, P1181	49	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6052	6063		10.1074/jbc.RA117.000731	http://dx.doi.org/10.1074/jbc.RA117.000731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29487130	Green Published, hybrid			2022-12-28	WOS:000430497300024
J	Sandmark, J; Dahl, G; Oster, L; Xu, BZ; Johansson, P; Akerud, T; Aagaard, A; Davidsson, P; Bigalke, JM; Winzell, MS; Rainey, GJ; Roth, RG				Sandmark, Jenny; Dahl, Goran; Oster, Linda; Xu, Bingze; Johansson, Patrik; Akerud, Tomas; Aagaard, Anna; Davidsson, Pia; Bigalke, Janna M.; Winzell, Maria Sorhede; Rainey, G. Jonah; Roth, Robert G.			Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MIDBRAIN DOPAMINERGIC-NEURONS; GDNF LIGAND FAMILY; NEUROTROPHIC FACTOR; LIPID RAFTS; PARKINSONS-DISEASE; RECEPTOR COMPLEX; RET RECEPTOR; IN-VIVO; C-RET	Neurturin (NRTN) provides trophic support to neurons and is considered a therapeutic agent for neurodegenerative diseases, such as Parkinson's disease. It binds to its co-receptor GFRa2, and the resulting NRTN-GFRa2 complex activates the transmembrane receptors rearranged during transfection (RET) or the neural cell adhesion molecule (NCAM). We report the crystal structure of NRTN, alone and in complex with GFRa2. This is the first crystal structure of a GFRa with all three domains and shows that domain 1 does not interact directly with NRTN, but it may support an interaction with RET and/or NCAM, via a highly conserved surface. In addition, biophysical results show that the relative concentration of GFRa2 on cell surfaces can affect the functional affinity of NRTN through avidity effects. We have identified a heparan sulfate-binding site on NRTN and a putative binding site in GFRa2, suggesting that heparan sulfate has a role in the assembly of the signaling complex. We further show that mutant NRTN with reduced affinity for heparan sulfate may provide a route forward for delivery of NRTN with increased exposure in preclinical in vivo models and ultimately to Parkinson's patients.	[Sandmark, Jenny; Dahl, Goran; Oster, Linda; Johansson, Patrik; Akerud, Tomas; Aagaard, Anna; Bigalke, Janna M.] AstraZeneca, Dept Struct Biophys & Fragment Based Lead Generat, Discovery Sci, S-43183 Gothenburg, Sweden; [Davidsson, Pia; Winzell, Maria Sorhede] AstraZeneca, Dept Biosci Cardiovasc & Metab Dis, S-43183 Gothenburg, Sweden; [Xu, Bingze; Roth, Robert G.] AstraZeneca, Discovery Sci, IMED Biotech Unit, Dept Discovery Biol, S-43183 Gothenburg, Sweden; [Rainey, G. Jonah] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Xu, Bingze] Karolinska Inst, Div Med Inflammat Res, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Medimmune; Karolinska Institutet	Roth, RG (corresponding author), AstraZeneca, IMED Biotech Unit, Discovery Sci, Dept Discovery Biol, Pepparedsleden 1, S-43183 Molndal, Sweden.	robert.roth@astrazeneca.com						Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Atanasova M., 2015, FASEB J S1, V29; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Barker RA, 2015, NAT REV NEUROL, V11, P492, DOI 10.1038/nrneurol.2015.123; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bartus RT, 2017, NEUROBIOL DIS, V97, P169, DOI 10.1016/j.nbd.2016.03.026; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Cik M, 2000, J BIOL CHEM, V275, P27505; Daramola O, 2014, BIOTECHNOL PROGR, V30, P132, DOI 10.1002/btpr.1809; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fjord-Larsen L, 2005, EXP NEUROL, V195, P49, DOI 10.1016/j.expneurol.2005.03.006; Gash DM, 2005, ANN NEUROL, V58, P224, DOI 10.1002/ana.20549; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Horger BA, 1998, J NEUROSCI, V18, P4929; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirik D, 2017, NEUROBIOL DIS, V97, P179, DOI 10.1016/j.nbd.2016.09.008; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Kulahin N, 2005, J NEUROCHEM, V95, P46, DOI 10.1111/j.1471-4159.2005.03338.x; Li L, 2017, MOL NEUROBIOL, V54, P2739, DOI 10.1007/s12035-016-9749-x; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LIN LFH, 1994, J NEUROCHEM, V63, P758; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Masure S, 2000, J BIOL CHEM, V275, P39427, DOI 10.1074/jbc.M003867200; Mauffray M, 2015, J IMMUNOL, V194, P1423, DOI 10.4049/jimmunol.1402496; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Piltonen M, 2009, EXP NEUROL, V219, P499, DOI 10.1016/j.expneurol.2009.07.002; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; Runeberg-Roos P, 2016, NEUROBIOL DIS, V96, P335, DOI 10.1016/j.nbd.2016.07.008; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sjostrand D, 2008, J BIOL CHEM, V283, P13792, DOI 10.1074/jbc.M800283200; Smith RC, 2015, EXP NEUROL, V267, P165, DOI 10.1016/j.expneurol.2015.03.002; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Tanaka M, 2003, BRAIN RES PROTOC, V11, P119, DOI 10.1016/S1385-299X(03)00023-0; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trevaskis JL, 2017, DIABETES, V66, P2007, DOI 10.2337/db16-0916; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Tsui CC, 2015, J NEUROSCI, V35, P13233, DOI 10.1523/JNEUROSCI.2935-14.2015; Vance D, 2008, BIOTECHNOL BIOENG, V101, P429, DOI 10.1002/bit.22056; Vauquelin G, 2013, BRIT J PHARMACOL, V168, P1771, DOI 10.1111/bph.12106; Virtanen H, 2005, BIOCHEM J, V387, P817, DOI 10.1042/BJ20041257; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394	72	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5492	5508		10.1074/jbc.RA117.000820	http://dx.doi.org/10.1074/jbc.RA117.000820			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29414779	Green Published, hybrid			2022-12-28	WOS:000430044100013
J	Chen, Y; Bensing, BA; Seepersaud, R; Mi, W; Liao, MF; Jeffrey, PD; Shajahan, A; Sonon, RN; Azadi, P; Sullam, PM; Rapoport, TA				Chen, Yu; Bensing, Barbara A.; Seepersaud, Ravin; Mi, Wei; Liao, Maofu; Jeffrey, Philip D.; Shajahan, Asif; Sonon, Roberto N.; Azadi, Parastoo; Sullam, Paul M.; Rapoport, Tom A.			Unraveling the sequence of cytosolic reactions in the export of GspB adhesin from Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; glycosylation; adhesin; crystallography; protein export; protein secretion; glycosyltransferase	CARBOHYDRATE-BINDING MODULES; ACCESSORY SEC SYSTEM; SWISS-MODEL; PROTEIN-TRANSLOCATION; CONSERVED DOMAIN; O-GLYCOSYLATION; BIOGENESIS; COMPLEX; SUBSTRATE; FAMILY	Many pathogenic bacteria, including Streptococcus gordonii, possess a pathway for the cellular export of a single serine-rich-repeat protein that mediates the adhesion of bacteria to host cells and the extracellular matrix. This adhesin protein is O-glycosylated by several cytosolic glycosyltransferases and requires three accessory Sec proteins (Asp1-3) for export, but how the adhesin protein is processed for export is not well understood. Here, we report that the S. gordonii adhesin GspB is sequentially O-glycosylated by three enzymes (GtfA/B, Nss, and Gly) that attach N-acetylglucosamine and glucose to Ser/Thr residues. We also found that modified GspB is transferred from the last glycosyltransferase to the Asp1/2/3 complex. Crystal structures revealed that both Asp1 and Asp3 are related to carbohydrate-binding proteins, suggesting that they interact with carbohydrates and bind glycosylated adhesin, a notion that was supported by further analyses. We further observed that Asp1 also has an affinity for phospholipids, which is attenuated by Asp2. In summary, our findings support a model in which the GspB adhesin is sequentially glycosylated by GtfA/B, Nss, and Gly and then transferred to the Asp1/2/3 complex in which Asp1 mediates the interaction of the Asp1/2/3 complex with the lipid bilayer for targeting of matured GspB to the export machinery.	[Chen, Yu; Mi, Wei; Liao, Maofu; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Bensing, Barbara A.; Seepersaud, Ravin; Sullam, Paul M.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Jeffrey, Philip D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Shajahan, Asif; Sonon, Roberto N.; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Princeton University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Liao, Maofu/AAD-7333-2021; Shajahan, Asif/J-2941-2019	Liao, Maofu/0000-0002-3481-450X; Shajahan, Asif/0000-0002-4804-1130; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health ORIP HEI [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586, P41GM103490, P20GM103542, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health ORIP HEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source of the Northeastern Collaborative Access Team (NE-CAT) beamline for help with data collection. NE-CAT is supported by National Institutes of Health Grant P41 GM103403 from NIGMS. The Pilatus 6Mdetector on 24-ID-C beam line is funded by National Institutes of Health ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2014, BBA-MOL CELL RES, V1843, P1674, DOI 10.1016/j.bbamcr.2013.10.019; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Jiang YL, 2017, J BIOL CHEM, V292, P6213, DOI 10.1074/jbc.M116.770446; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Lee IC, 2014, J BACTERIOL, V196, P1671, DOI 10.1128/JB.01401-13; Li YR, 2014, CURR MICROBIOL, V69, P121, DOI 10.1007/s00284-014-0563-2; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nagae M, 2014, INT J MOL SCI, V15, P3768, DOI 10.3390/ijms15033768; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; TROMBE MC, 1979, BIOCHIM BIOPHYS ACTA, V574, P290, DOI 10.1016/0005-2760(79)90010-9; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998; Zhu F, 2015, J BACTERIOL, V197, P510, DOI 10.1128/JB.02267-14; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	55	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5360	5373		10.1074/jbc.RA117.000963	http://dx.doi.org/10.1074/jbc.RA117.000963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29462788	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000429409300038
J	Madan, E; Parker, TM; Bauer, MR; Dhiman, A; Pelham, CJ; Nagane, M; Kuppusamy, ML; Holmes, M; Holmes, TR; Shaik, K; Shee, K; Kiparoidze, S; Smith, SD; Park, YSA; Gomm, JJ; Jones, LJ; Tomas, AR; Cunha, AC; Selvendiran, K; Hansen, LA; Fersht, AR; Hideg, K; Gogna, R; Kuppusamy, P				Madan, Esha; Parker, Taylor M.; Bauer, Matthias R.; Dhiman, Alisha; Pelham, Christopher J.; Nagane, Masaki; Kuppusamy, M. Lakshmi; Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Shee, Kevin; Kiparoidze, Salome; Smith, Sean D.; Park, Yu-Soon A.; Gomm, Jennifer J.; Jones, Louise J.; Tomas, Ana R.; Cunha, Ana C.; Selvendiran, Karuppaiyah; Hansen, Laura A.; Fersht, Alan R.; Hideg, Kalman; Gogna, Rajan; Kuppusamy, Periannan			The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE RITA; TUMOR SUPPRESSION; STAT3 INHIBITOR; MUTATIONS; BINDING; SURVIVAL; PHOSPHORYLATION; ADENOVIRUS; APOPTOSIS; GROWTH	p53 is an important tumor-suppressor protein that is mutated in more than 50% of cancers. Strategies for restoring normal p53 function are complicated by the oncogenic properties of mutant p53 and have not met with clinical success. To counteract mutant p53 activity, a variety of drugs with the potential to reconvert mutant p53 to an active wildtype form have been developed. However, these drugs are associated with various negative effects such as cellular toxicity, nonspecific binding to other proteins, and inability to induce a wildtype p53 response in cancer tissue. Here, we report on the effects of a curcumin analog, HO-3867, on p53 activity in cancer cells from different origins. We found that HO-3867 covalently binds to mutant p53, initiates a wildtype p53-like anticancer genetic response, is exclusively cytotoxic toward cancer cells, and exhibits high anticancer efficacy in tumor models. In conclusion, HO-3867 is a p53 mutant-reactivating drug with high clinical anticancer potential.	[Madan, Esha; Tomas, Ana R.; Cunha, Ana C.; Gogna, Rajan] Champalimaud Ctr Unknown, Champalimaud Res, P-1400038 Lisbon, Portugal; [Madan, Esha; Gogna, Rajan] Amity Univ, Amity Inst Mol Med & Stem Cell Res, Gautam Buddha Nagar Sect 125, Noida 201301, India; [Parker, Taylor M.] Indiana Univ Sch Med, Simon Canc Res Ctr, Dept Surg, Indianapolis, IN 46202 USA; [Bauer, Matthias R.; Fersht, Alan R.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Dhiman, Alisha] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Pelham, Christopher J.] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63104 USA; [Nagane, Masaki] Azabu Univ, Sch Vet Med, Dept Biochem, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan; [Kuppusamy, M. Lakshmi; Shee, Kevin; Kuppusamy, Periannan] Dartmouth Coll, Norris Cotton Canc Ctr, Geisel Sch Med, Dept Radiol & Med, Lebanon, NH 03756 USA; [Holmes, Matti; Holmes, Thomas R.; Shaik, Kranti; Smith, Sean D.; Park, Yu-Soon A.; Hansen, Laura A.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Kiparoidze, Salome] Tbilisi State Med Univ, Tbilisi 0179, Georgia; [Gomm, Jennifer J.; Jones, Louise J.] Barts Canc Inst, Ctr Tumour Biol, Charterhouse Sq, London EC1M 6BQ, England; [Selvendiran, Karuppaiyah] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Hideg, Kalman] Univ Pecs, Fac Sci, Inst Organ & Med Chem, H-7624 Pecs, Hungary	Fundacao Champalimaud; Amity University Noida; Indiana University System; Indiana University Bloomington; MRC Laboratory Molecular Biology; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Saint Louis University; Azabu University; Dartmouth College; Norris Cotton Cancer Center; Creighton University; Tbilisi State Medical University; University of London; Queen Mary University London; University System of Ohio; Ohio State University; University of Pecs	Gogna, R (corresponding author), Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal.; Kuppusamy, P (corresponding author), Dartmouth Coll, Norris Cotton Canc Ctr, Geisel Sch Med, 601 Rubin Bldg,1 Med Ctr Dr, Lebanon, NH 03756 USA.	rajan.gogna@research.fchampalimaud.org; periannan.kuppusamy@dartmouth.edu	Shee, Kevin/V-6803-2019; Smith, Sean/GYJ-6782-2022; Dhiman, Alisha/ABY-2171-2022; Fersht, Alan R/B-2189-2008; Nagane, Masaki/K-3431-2013	Shee, Kevin/0000-0001-5378-7650; Dhiman, Alisha/0000-0002-4395-9292; GOGNA, RAJAN/0000-0001-7304-7692; MADAN, ESHA/0000-0002-4941-0612; Nagane, Masaki/0000-0002-3408-7656; Bauer, Matthias/0000-0003-4015-6483; Cunha, Ana/0000-0001-9382-6511	Hungarian National, Research, Development and Innovation Office [OTKA 104956]; Swiss Cancer Leagu [LB692]; Seeds of Science; Winthrop P. Rockefeller Cancer Institute; Creighton University; MRC [MC_EX_G0901534] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016058, F30CA216966] Funding Source: NIH RePORTER; Medical Research Council [MC_EX_G0901534] Funding Source: researchfish	Hungarian National, Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Swiss Cancer Leagu; Seeds of Science; Winthrop P. Rockefeller Cancer Institute; Creighton University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a research grant (OTKA 104956) from the Hungarian National, Research, Development and Innovation Office (to K.H.) and by the Swiss Cancer League, LB692, Seeds of Science, the Winthrop P. Rockefeller Cancer Institute, and Creighton University startup funds (to R.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Bauer MR, 2016, P NATL ACAD SCI USA, V113, pE5271, DOI 10.1073/pnas.1610421113; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brazdova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059567; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Coates AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3348; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Gogna R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.15; Gogna R, 2013, EMBO MOL MED, V5, P1662, DOI 10.1002/emmm.201202055; Gogna R, 2012, J BIOL CHEM, V287, P2907, DOI 10.1074/jbc.M111.317354; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hiraki M, 2015, CHEM BIOL, V22, P1206, DOI 10.1016/j.chembiol.2015.07.016; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hu Y, 2017, FUEL CELLS, V17, P3, DOI 10.1002/fuce.201600172; Hu Y, 2017, ANTI-CANCER DRUG, V28, P392, DOI 10.1097/CAD.0000000000000470; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kamada R, 2011, J BIOL CHEM, V286, P252, DOI 10.1074/jbc.M110.174698; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Liang YY, 2009, INT J ONCOL, V35, P1015, DOI 10.3892/ijo_00000416; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Madan E, 2012, BRIT J CANCER, V107, P516, DOI 10.1038/bjc.2012.260; Madan E, 2013, MOL CELL BIOL, V33, P1285, DOI 10.1128/MCB.06798-11; Madan E, 2012, BIOCHEM J, V443, P811, DOI 10.1042/BJ20111627; Madan E, 2011, ONCOTARGET, V2, P948; Makower D, 2003, CLIN CANCER RES, V9, P693; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Peraud A, 2002, CLIN CANCER RES, V8, P1117; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Rippin TM, 2002, ONCOGENE, V21, P2119, DOI 10.1038/sj.onc.1205362; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Selvendiran K, 2010, MOL CANCER RES, V8, P1188, DOI 10.1158/1541-7786.MCR-10-0201; Selvendiran K, 2010, MOL CANCER THER, V9, P1169, DOI 10.1158/1535-7163.MCT-09-1207; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tierney BJ, 2012, CANCER BIOL THER, V13, P766, DOI 10.4161/cbt.20559; Timofeev O, 2013, CELL REP, V3, P1512, DOI 10.1016/j.celrep.2013.04.008; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Trbusek M, 2011, J CLIN ONCOL, V29, P2703, DOI 10.1200/JCO.2011.34.7872; Turin I., 2014, MED SCI, V2, P70, DOI DOI 10.3390/medsci2020070; VOJTESEK B, 1995, ONCOGENE, V10, P389; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yang P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02246; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042	63	30	30	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4262	4276		10.1074/jbc.RA117.000950	http://dx.doi.org/10.1074/jbc.RA117.000950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29382728	Green Published, hybrid			2022-12-28	WOS:000428204300003
J	Stakaityte, G; Nwogu, N; Lippiat, JD; Blair, GE; Poterlowicz, K; Boyne, JR; Macdonald, A; Mankouri, J; Whitehouse, A				Stakaityte, Gabriele; Nwogu, Nnenna; Lippiat, Jonathan D.; Blair, G. Eric; Poterlowicz, Krzysztof; Boyne, James R.; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian			The cellular chloride channels CLIC1 and CLIC4 contribute to virus-mediated cell motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL T-ANTIGEN; CARCINOMA CELLS; POLYOMAVIRUS; CANCER; EXPRESSION; MIGRATION; INVASION; PATHWAY; TARGETS; PROTEIN	Ion channels regulate many aspects of cell physiology, including cell proliferation, motility, and migration, and aberrant expression and activity of ion channels is associated with various stages of tumor development, with K+ and Cl- channels now being considered the most active during tumorigenesis. Accordingly, emerging in vitro and preclinical studies have revealed that pharmacological manipulation of ion channel activity offers protection against several cancers. Merkel cell polyomavirus (MCPyV) is a major cause of Merkel cell carcinoma (MCC), primarily because of the expression of two early regulatory proteins termed small and large tumor antigens (ST and LT, respectively). Several molecular mechanisms have been attributed to MCPyV-mediated cancer formation but, thus far, no studies have investigated any potential link to cellular ion channels. Here we demonstrate that Cl- channel modulation can reduce MCPyV ST-induced cell motility and invasiveness. Proteomic analysis revealed that MCPyV ST up-regulates two Cl- channels, CLIC1 and CLIC4, which when silenced, inhibit MCPyV ST-induced motility and invasiveness, implicating their function as critical to MCPyV-induced metastatic processes. Consistent with these data, we confirmed that CLIC1 and CLIC4 are up-regulated in primary MCPyV-positive MCC patient samples. We therefore, for the first time, implicate cellular ion channels as a key host cell factor contributing to virus-mediated cellular transformation. Given the intense interest in ion channel modulating drugs for human disease. This highlights CLIC1 and CLIC4 activity as potential targets for MCPyV-induced MCC.	[Stakaityte, Gabriele; Nwogu, Nnenna; Blair, G. Eric; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Stakaityte, Gabriele; Nwogu, Nnenna; Macdonald, Andrew; Mankouri, Jamel; Whitehouse, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Lippiat, Jonathan D.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Poterlowicz, Krzysztof; Boyne, James R.] Univ Bradford, Fac Life Sci, Sch Chem & Biosci, Ctr Skin Sci, Bradford BD7 1DP, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Bradford	Mankouri, J; Whitehouse, A (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Mankouri, J; Whitehouse, A (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.mankouri@leeds.ac.uk; a.whitehouse@leeds.ac.uk	Boyne, James/AAU-6616-2021; Poterlowicz, Krzysztof/AAS-2395-2020; Blair, George Eric/A-5906-2008	Boyne, James/0000-0003-1219-6453; Poterlowicz, Krzysztof/0000-0001-6173-5674; Blair, George Eric/0000-0003-0440-1795; Mankouri, Jamel/0000-0002-4325-3687; `Nwogu, Nnenna/0000-0002-1075-2914; Whitehouse, Adrian/0000-0003-3866-7110; Lippiat, Jonathan/0000-0003-3748-7345	BBSRC DTP Studentship [BB/J014443/1]; Royal Society University Research Fellowship [UF100419]; Kidney Research UK [RP_022_20170302, ST_006_20151127] Funding Source: researchfish	BBSRC DTP Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London); Kidney Research UK(Kidney Research UK (KRUK))	The work was funded in part by BBSRC DTP Studentship BB/J014443/1 and Royal Society University Research Fellowship UF100419 (to J.M.). The authors declare no conflicts of interest with the contents of this article.	Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Baquero-Perez B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005274; Becker J, 2009, CELL MOL LIFE SCI, V66, P1, DOI 10.1007/s00018-008-8483-6; Berrios C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006020; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; Griffiths DA, 2013, J VIROL, V87, P13853, DOI 10.1128/JVI.02159-13; Harms PW, 2013, J INVEST DERMATOL, V133, P936, DOI 10.1038/jid.2012.445; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Hughes DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004771; Igloi Z, 2015, J VIROL, V89, P4023, DOI 10.1128/JVI.02946-14; Jackson BR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004098; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Knight LM, 2015, J VIROL, V89, P35, DOI 10.1128/JVI.02317-14; Knips J, 2017, INT J CANCER, V141, P160, DOI 10.1002/ijc.30723; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Li XH, 2002, ANNU REV PHYSIOL, V64, P609, DOI 10.1146/annurev.physiol.64.090501.145429; Malik M, 2012, P NATL ACAD SCI USA, V109, P6130, DOI 10.1073/pnas.1201351109; Mao JW, 2013, J CELL PHYSIOL, V228, P991, DOI 10.1002/jcp.24245; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Moens U, 2015, VIRUSES-BASEL, V7, P1871, DOI 10.3390/v7041871; Peretti M, 2015, BBA-BIOMEMBRANES, V1848, P2523, DOI 10.1016/j.bbamem.2014.12.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Royle J, 2015, VIRUSES-BASEL, V7, P5375, DOI 10.3390/v7102880; Schumann S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.201; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Smith PG, 2001, GENE THER, V8, P1762, DOI 10.1038/sj.gt.3301595; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stakaityte G, 2018, J VIROL, V92, DOI 10.1128/JVI.00940-17; Stakaityte G, 2014, CANCERS, V6, P1267, DOI 10.3390/cancers6031267; Starrett GJ, 2017, MBIO, V8, DOI 10.1128/mBio.02079-16; Wang P, 2014, WORLD J GASTROENTERO, V20, P2071, DOI 10.3748/wjg.v20.i8.2071; Wheat R, 2014, CANCERS, V6, P1047, DOI 10.3390/cancers6021047; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Zhao W, 2015, MOL MED REP, V12, P8041, DOI 10.3892/mmr.2015.4459; Zheng DL, 2012, J CELL BIOCHEM, V113, P1537, DOI 10.1002/jcb.24022	41	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4582	4590		10.1074/jbc.RA117.001343	http://dx.doi.org/10.1074/jbc.RA117.001343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462791	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000428204300034
J	Bule, P; Cameron, K; Prates, JAM; Ferreira, LMA; Smith, SP; Gilbert, HJ; Bayer, EA; Najmudin, S; Fontes, CMGA; Alves, VD				Bule, Pedro; Cameron, Kate; Prates, Jose A. M.; Ferreira, Luis M. A.; Smith, Steven P.; Gilbert, Harry J.; Bayer, Edward A.; Najmudin, Shabir; Fontes, Carlos M. G. A.; Alves, Victor D.			Structure-function analyses generate novel specificities to assemble the components of multienzyme bacterial cellulosome complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COHESIN-DOCKERIN INTERACTION; DUAL BINDING MODE; ACETIVIBRIO-CELLULOLYTICUS; PROTEIN; SCAFFOLDIN; SURFACE; DOMAIN; NANOMACHINES; CONTAINS	The cellulosome is a remarkably intricate multienzyme nano-machine produced by anaerobic bacteria to degrade plant cell wall polysaccharides. Cellulosome assembly is mediated through binding of enzyme-borne dockerin modules to cohesin modules of the primary scaffoldin subunit. The anaerobic bacterium Acetivibrio cellulolyticus produces a highly intricate cellulosome comprising an adaptor scaffoldin, ScaB, whose cohesins interact with the dockerin of the primary scaffoldin (ScaA) that integrates the cellulosomal enzymes. The ScaB dockerin selectively binds to cohesin modules in ScaC that anchors the cellulosome onto the cell surface. Correct cellulosome assembly requires distinct specificities displayed by structurally related type-I cohesin-dockerin pairs that mediate ScaC-ScaB and ScaA-enzyme assemblies. To explore the mechanism by which these two critical protein interactions display their required specificities, we determined the crystal structure of the dockerin of a cellulosomal enzyme in complex with a ScaA cohesin. The data revealed that the enzyme-borne dockerin binds to the ScaA cohesin in two orientations, indicating two identical cohesin-binding sites. Combined mutagenesis experiments served to identify amino acid residues that modulate type-I cohesin-dockerin specificity in A. cellulolyticus. Rational design was used to test the hypothesis that the ligand-binding surfaces of ScaA-and ScaB-associated dockerins mediate cohesin recognition, independent of the structural scaffold. Novel specificities could thus be engineered into one, but not both, of the ligand-binding sites of ScaB, whereas attempts at manipulating the specificity of the enzyme-associated dockerin were unsuccessful. These data indicate that dockerin specificity requires critical interplay between the ligand-binding surface and the structural scaffold of these modules.	[Bule, Pedro; Cameron, Kate; Prates, Jose A. M.; Ferreira, Luis M. A.; Najmudin, Shabir; Fontes, Carlos M. G. A.; Alves, Victor D.] ULisboa, CIISA Fac Med Vet, Polo Univ Alto do Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Universidade de Lisboa; Queens University - Canada; Newcastle University - UK; Weizmann Institute of Science	Fontes, CMGA; Alves, VD (corresponding author), ULisboa, CIISA Fac Med Vet, Polo Univ Alto do Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt; vdalves@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Bule, Pedro/W-6838-2019	Prates, José A M/0000-0003-1032-5987; Bule, Pedro/0000-0003-2531-9926; Fontes, Carlos/0000-0002-1219-9753; Alves, Victor Diogo/0000-0002-8430-4380; Smith, Steven/0000-0003-2710-4400; Najmudin, Shabir/0000-0002-0429-5454	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012, PTDC/BIA-MIC/5947/2014]; European Union Seventh Framework Programme under the WallTraC project [263916]; BioStruct-X [283570]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/86821/2012]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Union Seventh Framework Programme under the WallTraC project; BioStruct-X; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) through Grants PTDC/BIA-PRO/103980/2008, EXPL/BIA-MIC/1176/2012, and PTDC/BIA-MIC/5947/2014, from the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (Grant Agreement 263916) and from BioStruct-X (Grant Agreement 283570). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by individual fellowships SFRH/BD/86821/2012 from Fundacao para a Ciencia e Tecnologia.	Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bras JLA, 2012, J BIOL CHEM, V287, P44394, DOI 10.1074/jbc.M112.407700; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dassa B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-210; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Ding SY, 1999, J BACTERIOL, V181, P6720, DOI 10.1128/JB.181.21.6720-6729.1999; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2007, MOL MICROBIOL, V63, P1568, DOI 10.1111/j.1365-2958.2007.05640.x; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KHAN AW, 1980, J GEN MICROBIOL, V121, P499; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m; Stahl SW, 2012, P NATL ACAD SCI USA, V109, P20431, DOI 10.1073/pnas.1211929109; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2004, J BACTERIOL, V186, P5782, DOI 10.1128/JB.186.17.5782-5789.2004; Xu Q, 2003, J BACTERIOL, V185, P4548, DOI 10.1128/JB.185.15.4548-4557.2003	33	8	8	2	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4201	4212		10.1074/jbc.RA117.001241	http://dx.doi.org/10.1074/jbc.RA117.001241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29367338	hybrid, Green Published			2022-12-28	WOS:000427587500030
J	Monne, M; Daddabbo, L; Gagneul, D; Obata, T; Hielscher, B; Palmieri, L; Miniero, DV; Fernie, AR; Weber, APM; Palmieri, F				Monne, Magnus; Daddabbo, Lucia; Gagneul, David; Obata, Toshihiro; Hielscher, Bjoern; Palmieri, Luigi; Miniero, Daniela Valeria; Fernie, Alisdair R.; Weber, Andreas P. M.; Palmieri, Ferdinando			Uncoupling proteins 1 and 2 (UCP1 and UCP2) from Arabidopsis thaliana are mitochondrial transporters of aspartate, glutamate, and dicarboxylates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; CARRIER FAMILY 25; BASIC-AMINO-ACIDS; BACTERIAL EXPRESSION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; MALATE-DEHYDROGENASE; TISSUE DISTRIBUTION; ORGAN DISTRIBUTION; COENZYME-A	The Arabidopsis thaliana genome contains 58 members of the solute carrier family SLC25, also called the mitochondrial carrier family, many of which have been shown to transport specific metabolites, nucleotides, and cofactors across the mitochondrial membrane. Here, two Arabidopsis members of this family, AtUCP1 and AtUCP2, which were previously thought to be uncoupling proteins and hence named UCP1/PUMP1 and UCP2/PUMP2, respectively, are assigned with a novel function. They were expressed in bacteria, purified, and reconstituted in phospholipid vesicles. Their transport properties demonstrate that they transport amino acids (aspartate, glutamate, cysteine sulfinate, and cysteate), dicarboxylates (malate, oxaloacetate, and 2-oxoglutarate), phosphate, sulfate, and thiosulfate. Transport was saturable and inhibited by mercurials and other mitochondrial carrier inhibitors to various degrees. AtUCP1 and AtUCP2 catalyzed a fast counterexchange transport as well as a low uniport of substrates, with transport rates of AtUCP1 being much higher than those of AtUCP2 in both cases. The aspartate/glutamate heteroexchange mediated by AtUCP1 and AtUCP2 is electroneutral, in contrast to that mediated by the mammalian mitochondrial aspartate glutamate carrier. Furthermore, both carriers were found to be targeted to mitochondria. Metabolite profiling of single and double knockouts shows changes in organic acid and amino acid levels. Notably, AtUCP1 and AtUCP2 are the first reported mitochondrial carriers in Arabidopsis to transport aspartate and glutamate. It is proposed that the primary function of AtUCP1 and AtUCP2 is to catalyze an aspartate(out)/glutamate(in) exchange across the mitochondrial membrane and thereby contribute to the export of reducing equivalents from the mitochondria in photorespiration.	[Monne, Magnus; Daddabbo, Lucia; Palmieri, Luigi; Miniero, Daniela Valeria; Palmieri, Ferdinando] Univ Bari, Lab Biochem & Mol Biol, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy; [Monne, Magnus] Univ Basilicata, Dept Sci, Via Ateneo Lucano 10, I-85100 Potenza, Italy; [Gagneul, David; Hielscher, Bjoern; Weber, Andreas P. M.] Heinrich Heine Univ, Inst Plant Biochem, Cluster Excellence Plant Sci CEPLAS, Univ Str 1, D-40225 Dusseldorf, Germany; [Obata, Toshihiro; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, Dept Willmitzer, Muhlenberg 1, D-14476 Potsdam, Germany; [Palmieri, Luigi; Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom, Via Orabona 4, I-70125 Bari, Italy; [Gagneul, David] Univ Lille, INRA, ISA, Univ Artois,Univ Littoral Cote Opale,EA 7394,ICV, F-59000 Lille, France	Universita degli Studi di Bari Aldo Moro; Italfarmaco; University of Basilicata; Heinrich Heine University Dusseldorf; University of Cologne; Max Planck Society; Universita degli Studi di Bari Aldo Moro; INRAE; Universite d'Artois; Universite de Lille - ISITE; Universite de Lille	Palmieri, F (corresponding author), Univ Bari, Lab Biochem & Mol Biol, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	ferdpalmieri@gmail.com	Miniero, Daniela Valeria/P-9786-2019; Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011; Obata, Toshihiro/AAX-4353-2020; Monné, Magnus/D-5642-2012	Miniero, Daniela Valeria/0000-0002-3324-9692; Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672; Obata, Toshihiro/0000-0001-8931-7722; Monné, Magnus/0000-0003-2344-3878	Italian Human ProteomeNet Grant [RBRN07BMCT_009]; iGRAD-Plant doctoral fellowship [IRTG 1525]; Max-Planck-Society; Cluster of Excellence on Plant Science CEPLAS [EXC 1028]; CRC [1208]; Center of Excellence on Comparative Genomics	Italian Human ProteomeNet Grant; iGRAD-Plant doctoral fellowship; Max-Planck-Society(Max Planck Society); Cluster of Excellence on Plant Science CEPLAS; CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Center of Excellence on Comparative Genomics	This work was supported by grants from the Center of Excellence on Comparative Genomics and Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an iGRAD-Plant doctoral fellowship (IRTG 1525).; Work in the laboratory of this author was supported by the Max-Planck-Society.; Supported by the Cluster of Excellence on Plant Science CEPLAS (EXC 1028) and CRC 1208.	Agrimi G, 2012, J BIOENERG BIOMEMBR, V44, P333, DOI 10.1007/s10863-012-9445-0; Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; Bernhardt K, 2012, PLANT J, V69, P1, DOI 10.1111/j.1365-313X.2011.04775.x; Borecky J, 2001, FEBS LETT, V505, P240, DOI 10.1016/S0014-5793(01)02835-6; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Cavero S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/j.1365-2958.2003.03742.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cousins AB, 2008, PLANT PHYSIOL, V148, P786, DOI 10.1104/pp.108.122622; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; DRY IB, 1987, BIOCHEM J, V245, P669, DOI 10.1042/bj2450669; Elia G, 2003, J VIROL METHODS, V109, P139, DOI 10.1016/S0166-0934(03)00064-8; Vercesi AE, 2006, ANNU REV PLANT BIOL, V57, P383, DOI 10.1146/annurev.arplant.57.032905.105335; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Forner J, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-28; Gigolashvili T, 2012, PLANT CELL, V24, P4187, DOI 10.1105/tpc.112.101964; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; JOURNET EP, 1981, PLANT PHYSIOL, V67, P467, DOI 10.1104/pp.67.3.467; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Krebs M, 2012, PLANT J, V69, P181, DOI 10.1111/j.1365-313X.2011.04780.x; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Linden P, 2016, J EXP BOT, V67, P3123, DOI 10.1093/jxb/erw030; Linka M, 2005, TRENDS PLANT SCI, V10, P461, DOI 10.1016/j.tplants.2005.08.002; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Monne M, 2015, BBA-BIOENERGETICS, V1847, P1220, DOI 10.1016/j.bbabio.2015.06.015; Monne M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Nikolovski N, 2012, PLANT PHYSIOL, V160, P1037, DOI 10.1104/pp.112.204263; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Palmieri L, 2006, BBA-BIOENERGETICS, V1757, P1277, DOI 10.1016/j.bbabio.2006.03.025; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Picault N, 2002, J BIOL CHEM, V277, P24204, DOI 10.1074/jbc.M202702200; Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448; Rieder B, 2011, PLANT CELL, V23, P1932, DOI 10.1105/tpc.111.084574; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stael S, 2011, FEBS LETT, V585, P3935, DOI 10.1016/j.febslet.2011.10.039; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Waadt R., 2008, CSH PROTOC, V2008; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558	75	51	53	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4213	4227		10.1074/jbc.RA117.000771	http://dx.doi.org/10.1074/jbc.RA117.000771			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29371401	Green Published, hybrid			2022-12-28	WOS:000427587500031
J	Janjanam, J; Zhang, BL; Mani, AM; Singh, NK; Traylor, JG; Orr, AW; Rao, GN				Janjanam, Jagadeesh; Zhang, Baolin; Mani, Arul M.; Singh, Nikhlesh K.; Traylor, James G., Jr.; Orr, A. Wayne; Rao, Gadiparthi N.			LIM and cysteine-rich domains 1 is required for thrombin induced smooth muscle cell proliferation and promotes atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR AGONISTS; CYCLIN-A; PROTEIN; GROWTH; GENE; ACTIVATION; EXPRESSION; KINASE; INJURY	Restenosis arises after vascular injury and is characterized by arterial wall thickening and decreased arterial lumen space. Vascular injury induces the production of thrombin, which in addition to its role in blood clotting acts as a mitogenic and chemotactic factor. In exploring the molecular mechanisms underlying restenosis, here we identified LMCD1 (LIM and cysteine-rich domains 1) as a gene highly responsive to thrombin in human aortic smooth muscle cells (HASMCs). Of note, LMCD1 depletion inhibited proliferation of human but not murine vascular smooth muscle cells. We also found that by physically interacting with E2F transcription factor 1, LMCD1 mediates thrombin-induced expression of the CDC6 (cell division cycle 6) gene in the stimulation of HASMC proliferation. Thrombin-induced LMCD1 and CDC6 expression exhibited a requirement for protease-activated receptor 1-mediated Gaq-dependent activation of phospholipase C beta 3. Moreover, the expression of LMCD1 was highly induced in smooth muscle cells located at human atherosclerotic lesions and correlated with CDC6 expression and that of the proliferation marker Ki67. Furthermore, the LMCD1- and SMC alpha actin-positive cells had higher cholesterol levels in the atherosclerotic lesions. In conclusion, these findings indicate that by acting as a co-activator with E2F transcription factor 1 in CDC6 expression, LMCD1 stimulates HASMC proliferation and thereby promotes human atherogenesis, suggesting an involvement of LMCD1 in restenosis.	[Janjanam, Jagadeesh; Zhang, Baolin; Mani, Arul M.; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA; [Traylor, James G., Jr.; Orr, A. Wayne] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71103 USA	University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Rao, GN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020; Orr, Anthony/P-8927-2015	Singh, Nikhlesh/0000-0002-3665-6023; Mani, Arul Murugan/0000-0002-8943-7406; Orr, Anthony/0000-0002-2377-213X	NHLBI, National Institutes of Health [HL069908, HL103575, HL098435, HL133497]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908, R01HL098435, R01HL133497, R01HL103575] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL069908 and HL103575 (to G.N.R.) and HL098435 and HL133497 (to A.W.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Austin KM, 2013, J BIOL CHEM, V288, P23105, DOI 10.1074/jbc.M113.467019; Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; BARSHAVIT R, 1983, J CELL BIOL, V96, P282, DOI 10.1083/jcb.96.1.282; Bauters C, 1997, PROG CARDIOVASC DIS, V40, P107, DOI 10.1016/S0033-0620(97)80003-5; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bespalova IN, 2000, GENOMICS, V63, P69, DOI 10.1006/geno.1999.6049; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Chellan B, 2016, ARTERIOSCL THROM VAS, V36, P1101, DOI 10.1161/ATVBAHA.116.307306; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen TC, 2014, J PROTEOME RES, V13, P5339, DOI 10.1021/pr5002737; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; IP JH, 1990, J AM COLL CARDIOL, V15, P1667, DOI 10.1016/0735-1097(90)92845-S; Janjanam J, 2015, MOL BIOL CELL, V26, P4589, DOI 10.1091/mbc.E15-08-0570; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P22150, DOI 10.1074/jbc.M113.454082; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; LIU MW, 1989, CIRCULATION, V79, P1374, DOI 10.1161/01.CIR.79.6.1374; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tanski WJ, 2004, J VASC SURG, V39, P639, DOI 10.1016/j.jvs.2003.10.052; WALZ DA, 1985, P SOC EXP BIOL MED, V180, P518; Wang DJ, 2005, ARTERIOSCL THROM VAS, V25, P2094, DOI 10.1161/01.ATV.0000179602.85797.3f; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; WILNER GD, 1981, J LAB CLIN MED, V97, P403	40	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3088	3103		10.1074/jbc.RA117.000866	http://dx.doi.org/10.1074/jbc.RA117.000866			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326163	Green Published, hybrid			2022-12-28	WOS:000426562800005
J	South, K; Freitas, MO; Lane, DA				South, Kieron; Freitas, Marta O.; Lane, David A.			A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor (vol 292, pg 5760, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		South K, 2017, J BIOL CHEM, V292, P5760, DOI 10.1074/jbc.M117.776732	1	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1149	1150		10.1074/jbc.AAC117.001638	http://dx.doi.org/10.1074/jbc.AAC117.001638			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29374083	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000423515000004
J	Huang, YP; Gu, LY; Li, GM				Huang, Yaping; Gu, Liya; Li, Guo-Min			H3K36me3-mediated mismatch repair preferentially protects actively transcribed genes from mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTL-ALPHA ENDONUCLEASE; SHORT READ ALIGNMENT; DNA-DAMAGE; HUMAN GENOME; HUMAN-CELLS; INDUCED APOPTOSIS; EXCISION-REPAIR; CANCER GENOMES; COUPLED REPAIR; HISTONE H3	Histone H3 trimethylation at lysine 36 (H3K36me3) is an important histone mark involved in both transcription elongation and DNA mismatch repair (MMR). It is known that H3K36me3 recruits the mismatch-recognition protein MutS to replicating chromatin via its physical interaction with MutS's PWWP domain, but the exact role of H3K36me3 in transcription is undefined. Using ChIP combined with whole-genome DNA sequencing analysis, we demonstrate here that H3K36me3, together with MutS, is involved in protecting against mutation, preferentially in actively transcribed genomic regions. We found that H3K36me3 and MutS are much more co-enriched in exons and actively transcribed regions than in introns and nontranscribed regions. The H3K36me3-MutS co-enrichment correlated with a much lower mutation frequency in exons and actively transcribed regions than in introns and nontranscribed regions. Correspondingly, depleting H3K36me3 or disrupting the H3K36me3-MutS interaction elevated the spontaneous mutation frequency in actively transcribed genes, but it had little influence on the mutation frequency in nontranscribed or transcriptionally inactive regions. Similarly, H2O2-induced mutations, which mainly cause base oxidations, preferentially occurred in actively transcribed genes in MMR-deficient cells. The data presented here suggest that H3K36me3-mediated MMR preferentially safeguards actively transcribed genes not only during replication by efficiently correcting mispairs in early replicating chromatin but also during transcription by directly or indirectly removing DNA lesions associated with a persistently open chromatin structure.	[Huang, Yaping; Li, Guo-Min] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Gu, Liya; Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Tsinghua University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Li, GM (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Li, GM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	guo-min.li@utsouthwestern.edu		Huang, Yaping/0000-0002-3928-5272	National Natural Science Foundation of China [31370766, 31570814, 81630077]; National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program [31461143005]; National Key R&D Program of China [2016YFC1303300]; National Institutes of Health [GM112702, CA192003]; Tsinghua-Peking Joint Center for Life Sciences; NATIONAL CANCER INSTITUTE [R21CA192003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112702] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program; National Key R&D Program of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tsinghua-Peking Joint Center for Life Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Natural Science Foundation of China Grants 31370766, 31570814, and 81630077; National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program Grant 31461143005; National Key R&D Program of China Grant 2016YFC1303300; National Institutes of Health Grants GM112702 and CA192003; and funds from Tsinghua-Peking Joint Center for Life Sciences. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; Crouse GF, 2016, DNA REPAIR, V38, P102, DOI 10.1016/j.dnarep.2015.11.020; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frigola J, 2017, NAT GENET, V49, P1684, DOI 10.1038/ng.3991; Gu LY, 2002, J NUTR BIOCHEM, V13, P355, DOI 10.1016/S0955-2863(02)00178-X; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Ikehata H, 2007, PHOTOCHEM PHOTOBIOL, V83, P196, DOI 10.1562/2006-02-28-IR-822; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kawasoe Y, 2016, ELIFE, V5, DOI 10.7554/eLife.15155; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li GM, 1999, ONCOL RES, V11, P393; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pluciennik A, 2013, P NATL ACAD SCI USA, V110, P12277, DOI 10.1073/pnas.1311325110; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Rodriguez GP, 2012, P NATL ACAD SCI USA, V109, P6153, DOI 10.1073/pnas.1115361109; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shah KA, 2014, CELL REP, V9, P1594, DOI 10.1016/j.celrep.2014.10.048; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Sonneveld E, 2001, ONCOGENE, V20, P538, DOI 10.1038/sj.onc.1204125; Sun L, 2016, J BIOL CHEM, V291, P17692, DOI 10.1074/jbc.M116.719971; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031	67	40	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7811	7823		10.1074/jbc.RA118.002839	http://dx.doi.org/10.1074/jbc.RA118.002839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610279	Green Published, hybrid			2022-12-28	WOS:000437256500029
J	Mondal, N; Dykstra, B; Lee, J; Ashline, DJ; Reinhold, VN; Rossi, DJ; Sackstein, R				Mondal, Nandini; Dykstra, Brad; Lee, Jungmin; Ashline, David J.; Reinhold, Vernon N.; Rossi, Derrick J.; Sackstein, Robert			Distinct human (1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; fucosyltransferase; mesenchymal stem cells (MSCs); mRNA; mass spectrometry (MS); glycoengineering; Lewis-X; modified mRNA; sialyl Lewis-X; E-selectin ligand	HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; SELECTIN LIGAND EXPRESSION; MOLECULAR-CLONING; STEM-CELLS; FUC-TVII; FUCOSYL-TRANSFERASE; EMBRYONIC ANTIGEN; SUBSTRATE SPECIFICITIES; DETERMINES EXPRESSION; MASS-SPECTROMETRY	In humans, six (1,3)-fucosyltransferases ((1,3)-FTs: FT3/FT4/FT5/FT6/FT7/FT9) reportedly fucosylate terminal lactosaminyl glycans yielding Lewis-X (Le(X); CD15) and/or sialyl Lewis-X (sLe(X); CD15s), structures that play key functions in cell migration, development, and immunity. Prior studies analyzing (1,3)-FT specificities utilized either purified and/or recombinant enzymes to modify synthetic substrates under nonphysiological reaction conditions or molecular biology approaches wherein (1,3)-FTs were expressed in mammalian cell lines, notably excluding investigations using primary human cells. Accordingly, although significant insights into (1,3)-FT catalytic properties have been obtained, uncertainty persists regarding their human Le(X)/sLe(X) biosynthetic range across various glycoconjugates. Here, we undertook a comprehensive evaluation of the lactosaminyl product specificities of intracellularly expressed (1,3)-FTs using a clinically relevant primary human cell type, mesenchymal stem cells. Cells were transfected with modified mRNA encoding each human (1,3)-FT, and the resultant (1,3)-fucosylated lactosaminyl glycoconjugates were analyzed using a combination of flow cytometry and MS. The data show that biosynthesis of sLe(X) is driven by FTs-3, -5, -6, and -7, with FT6 and FT7 having highest potency. FT4 and FT9 dominantly biosynthesize Le(X), and, among all FTs, FT6 holds a unique capacity in creating sLe(X) and Le(X) determinants across protein and lipid glycoconjugates. Surprisingly, FT4 does not generate sLe(X) on glycolipids, and neither FT4, FT6, nor FT9 synthesizes the internally fucosylated sialyllactosamine VIM-2 (CD65s). These results unveil the relevant human lactosaminyl glycans created by human (1,3)-FTs, providing novel insights on how these isoenzymes stereoselectively shape biosynthesis of vital glycoconjugates, thereby biochemically programming human cell migration and tuning human immunologic and developmental processes.	[Mondal, Nandini; Dykstra, Brad; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Mondal, Nandini; Dykstra, Brad; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Mondal, Nandini; Dykstra, Brad; Ashline, David J.; Reinhold, Vernon N.; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Program Excellence Glycosci, Boston, MA 02115 USA; [Lee, Jungmin; Rossi, Derrick J.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lee, Jungmin; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ashline, David J.; Reinhold, Vernon N.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Glyc Ctr, Durham, NH 03828 USA; [Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dykstra, Brad] Platelet Biogenesis, Boston, MA 02125 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; University System Of New Hampshire; University of New Hampshire; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sackstein, R (corresponding author), Harvard Inst Med, 77 Ave Louis Pasteur,Rm 671, Boston, MA 02115 USA.	rsackstein@partners.org			National Institutes of Health [RO1HL107630, UO1HL107440, UC4DK104218, U19HL129903]; Program of Excellence in Glycosciences; National Institutes of Health NHLBI [PO1 HL107146]; Team Jobie Fund; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146, U01HL107440, U19HL129903, R01HL107630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Excellence in Glycosciences; National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Team Jobie Fund; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants RO1HL107630, UO1HL107440, UC4DK104218, and U19HL129903, The Leona M. and Harry B. Helmsley Charitable Trust, and the New York Stem Cell Foundation.; Supported by the National Institutes of Health NHLBI Grant PO1 HL107146, the Program of Excellence in Glycosciences, and the Team Jobie Fund.	Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Ashline DJ, 2017, ANAL BIOANAL CHEM, V409, P439, DOI 10.1007/s00216-016-0018-7; Ashline DJ, 2014, J AM SOC MASS SPECTR, V25, P444, DOI 10.1007/s13361-013-0776-9; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; BASU M, 1991, Glycobiology, V1, P527, DOI 10.1093/glycob/1.5.527; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; Canis K, 2010, J THROMB HAEMOST, V8, P137, DOI 10.1111/j.1538-7836.2009.03665.x; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; CARLSON DM, 1966, J BIOL CHEM, V241, P2984; Chou MY, 1996, J BIOL CHEM, V271, P19219, DOI 10.1074/jbc.271.32.19219; Dykstra B, 2016, STEM CELLS, V34, P2501, DOI 10.1002/stem.2435; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FUKUSHI Y, 1984, J BIOL CHEM, V259, P511; Garner B, 2002, J LIPID RES, V43, P205; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Gruss HJ, 1996, BAILLIERE CLIN HAEM, V9, P417, DOI 10.1016/S0950-3536(96)80019-9; Handa K, 1997, BIOCHEMISTRY-US, V36, P12412, DOI 10.1021/bi971181t; Homeister JW, 2004, ARTERIOSCL THROM VAS, V24, P1897, DOI 10.1161/01.ATV.0000141844.28073.df; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Huang MC, 2002, J BIOL CHEM, V277, P47786, DOI 10.1074/jbc.M208283200; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kaneko M, 1999, FEBS LETT, V452, P237, DOI 10.1016/S0014-5793(99)00640-7; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kimura H, 1997, BIOCHEM BIOPH RES CO, V237, P131, DOI 10.1006/bbrc.1997.7100; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; Knibbs RN, 1996, J CELL BIOL, V133, P911, DOI 10.1083/jcb.133.4.911; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Kumar A, 2013, J BIOL CHEM, V288, P28859, DOI 10.1074/jbc.M113.469403; KUMAR R, 1991, J BIOL CHEM, V266, P21777; Liang JX, 2016, ONCOTARGETS THER, V9, P3113, DOI 10.2147/OTT.S102389; LOWE JB, 1991, J BIOL CHEM, V266, P17467; Madeira C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/735349; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Mollicone R, 2009, J BIOL CHEM, V284, P4723, DOI 10.1074/jbc.M809312200; Mondal N, 2016, ARTERIOSCL THROM VAS, V36, P718, DOI 10.1161/ATVBAHA.115.306748; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Sackstein R, 2004, J INVEST DERMATOL, V122, P1061, DOI 10.1111/j.0022-202X.2004.09301.x; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sackstein R, 2012, EXP HEMATOL, V40, P518, DOI 10.1016/j.exphem.2012.03.004; Sackstein R, 2009, IMMUNOL REV, V230, P51, DOI 10.1111/j.1600-065X.2009.00792.x; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Seidmann L, 2016, PLACENTA, V38, P93, DOI 10.1016/j.placenta.2015.12.013; Shetterly S, 2007, J BIOL CHEM, V282, P24882, DOI 10.1074/jbc.M702395200; Silva M, 2017, J IMMUNOL, V198, P3576, DOI 10.4049/jimmunol.1601636; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; St Hill CA, 2011, FRONT BIOSCI-LANDMRK, V16, P3233, DOI 10.2741/3909; Stolfa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30392; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	72	39	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7300	7314		10.1074/jbc.RA117.000775	http://dx.doi.org/10.1074/jbc.RA117.000775			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593094	hybrid, Green Published			2022-12-28	WOS:000432174500024
J	Bareja, A; Hodgkinson, CP; Soderblom, E; Waitt, G; Dzau, VJ				Bareja, Akshay; Hodgkinson, Conrad P.; Soderblom, Erik; Waitt, Greg; Dzau, Victor J.			The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth factor; cell signaling; Akt PKB; extracellular-signal-regulated kinase (ERK); insulin-like growth factor (IGF); BioID; IGF1R; retromer; SNX6	PROTEIN-PROTEIN INTERACTIONS; QUANTITATIVE PHOSPHOPROTEOMICS; AFFINITY PURIFICATION; TYROSINE KINASE; LIVING CELLS; INTERACTOME; INSULIN-LIKE-GROWTH-FACTOR-1; BIOTINYLATION; TRAFFICKING; COMPLEXES	The insulin-like growth factor 1 receptor (IGF1R) is a receptor tyrosine kinase with critical roles in various biological processes. Recent results from clinical trials targeting IGF1R indicate that IGF1R signaling pathways are more complex than previously thought. Moreover, it has become increasingly clear that the function of many proteins can be understood only in the context of a network of interactions. To that end, we sought to profile IGF1R-protein interactions with the proximity-labeling technique BioID. We applied BioID by generating a HEK293A cell line that stably expressed the BirA* biotin ligase fused to the IGF1R. Following stimulation by IGF1, biotinylated proteins were analyzed by MS. This screen identified both known and previously unknown interactors of IGF1R. One of the novel interactors was sorting nexin 6 (SNX6), a protein that forms part of the retromer complex, which is involved in intracellular protein sorting. Using co-immunoprecipitation, we confirmed that IGF1R and SNX6 physically interact. SNX6 knockdown resulted in a dramatic diminution of IGF1-mediated ERK1/2 phosphorylation, but did not affect IGF1R internalization. Bioluminescence resonance energy transfer experiments indicated that the SNX6 knockdown perturbed the association between IGF1R and the key adaptor proteins insulin receptor substrate 1 (IRS1) and SHC adaptor protein 1 (SHC1). Intriguingly, even in the absence of stimuli, SNX6 overexpression significantly increased Akt phosphorylation. Our study confirms the utility of proximity-labeling methods, such as BioID, to screen for interactors of cell-surface receptors and has uncovered a role of one of these interactors, SNX6, in the IGF1R signaling cascade.	[Bareja, Akshay; Hodgkinson, Conrad P.; Dzau, Victor J.] Duke Univ, Mandel Ctr Hypertens & Atherosclerosis Res, Duke Cardiovasc Res Ctr, Durham, NC 27710 USA; [Soderblom, Erik; Waitt, Greg] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC 27710 USA	Duke University; Duke University	Bareja, A (corresponding author), Duke Univ, GSRBII, 210 Res Dr,Rm 4035, Durham, NC 27710 USA.; Dzau, VJ (corresponding author), Duke Univ, GSRBII, 210 Res Dr,Rm 4022, Durham, NC 27710 USA.	akshay.bareja@duke.edu; victor.dzau@duke.edu	Bareja, Akshay/AAD-2842-2019		Edna and Fred L. Mandel, Jr. Foundation	Edna and Fred L. Mandel, Jr. Foundation	This work was supported by the Edna and Fred L. Mandel, Jr. Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Accorsi A, 2016, HUM MOL GENET, V25, P4624, DOI 10.1093/hmg/ddw291; Bareja A, 2017, BIOCHEM J, V474, P771, DOI 10.1042/BCJ20160976; Beckwith H, 2015, MOL ENDOCRINOL, V29, P1549, DOI 10.1210/me.2015-1157; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dupont J, 2001, J CLIN PATHOL-MOL PA, V54, P149, DOI 10.1136/mp.54.3.149; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Hung V, 2017, ELIFE, V6, DOI 10.7554/eLife.24463; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Khoury E, 2014, J BIOL CHEM, V289, P23302, DOI 10.1074/jbc.M114.568147; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lambert JP, 2015, J PROTEOMICS, V118, P81, DOI 10.1016/j.jprot.2014.09.011; Li XW, 2014, J BIOL CHEM, V289, P14434, DOI 10.1074/jbc.M113.529578; Lobingier BT, 2017, CELL, V169, P350, DOI 10.1016/j.cell.2017.03.022; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Mehus AA, 2016, METHOD ENZYMOL, V569, P3, DOI 10.1016/bs.mie.2015.08.008; Morris JH, 2014, NAT PROTOC, V9, P2539, DOI 10.1038/nprot.2014.164; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Murphy JP, 2010, PROTEOMICS, V10, P1847, DOI 10.1002/pmic.200900711; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Rodriguez-Fraticelli AE, 2015, NAT CELL BIOL, V17, P241, DOI 10.1038/ncb3106; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schmidt K, 2011, J CACHEXIA SARCOPENI, V2, P105, DOI 10.1007/s13539-011-0029-3; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Martins AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019846; Steed E, 2014, J CELL BIOL, V204, P821, DOI 10.1083/jcb.201304115; Takada Y, 2017, CYTOKINE GROWTH F R, V34, P67, DOI 10.1016/j.cytogfr.2017.01.003; Wang J, 2015, MOL CELL PROTEOMICS, V14, P1104, DOI 10.1074/mcp.M114.045468; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302	41	10	10	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6449	6459		10.1074/jbc.RA118.002406	http://dx.doi.org/10.1074/jbc.RA118.002406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29530981	hybrid, Green Published			2022-12-28	WOS:000431108600018
J	Mitok, KA; Freiberger, EC; Schueler, KL; Rabaglia, ME; Stapleton, DS; Kwiecien, NW; Malec, PA; Hebert, AS; Broman, AT; Kennedy, RT; Keller, MP; Coon, JJ; Attie, AD				Mitok, Kelly A.; Freiberger, Elyse C.; Schueler, Kathryn L.; Rabaglia, Mary E.; Stapleton, Donald S.; Kwiecien, Nicholas W.; Malec, Paige A.; Hebert, Alexander S.; Broman, Aimee T.; Kennedy, Robert T.; Keller, Mark P.; Coon, Joshua J.; Attie, Alan D.			Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; TYROSINE-HYDROXYLASE; MASS-SPECTROMETRY; NEUROPEPTIDE-Y; TYPE-2; ARCHITECTURE; RESPONSES; IDENTIFICATION	The mouse is a critical model in diabetes research, but most research in mice has been limited to a small number of mouse strains and limited genetic variation. Using the eight founder strains and both sexes of the Collaborative Cross (C57BL/6J (B6), A/J, 129S1/SvImJ (129), NOD/ShiLtJ (NOD), NZO/HILtJ (NZO), PWK/PhJ (PWK), WSB/EiJ (WSB), and CAST/EiJ (CAST)), we investigated the genetic dependence of diabetesrelated metabolic phenotypes and insulin secretion. We found that strain background is associated with an extraordinary range in body weight, plasma glucose, insulin, triglycerides, and insulin secretion. Our whole-islet proteomic analysis of the eight mouse strains demonstrates that genetic background exerts a strong influence on the islet proteome that can be linked to the differences in diabetes-related metabolic phenotypes and insulin secretion. We computed protein modules consisting of highly correlated proteins that enrich for biological pathways and provide a searchable database of the islet protein expression profiles. To validate the data resource, we identified tyrosine hydroxylase (Th), a key enzyme in catecholamine synthesis, as a protein that is highly expressed in beta-cells of PWK and CAST islets. We show that CAST islets synthesize elevated levels of dopamine, which suppresses insulin secretion. Prior studies, using only the B6 strain, concluded that adult mouse islets do not synthesize L-3,4-dihydroxyphenylalanine (L-DOPA), the product of Th and precursor of dopamine. Thus, the choice of the CAST strain, guided by our islet proteomic survey, was crucial for these discoveries. In summary, we provide a valuable data resource to the research community, and show that proteomic analysis identified a strain-specific pathway by which dopamine synthesized in beta-cells inhibits insulin secretion.	[Mitok, Kelly A.; Freiberger, Elyse C.; Schueler, Kathryn L.; Rabaglia, Mary E.; Stapleton, Donald S.; Keller, Mark P.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, 543A HF Deluca Biochem Labs,433 Babcock Dr, Madison, WI 53706 USA; [Kwiecien, Nicholas W.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 4426 Genet Biotechnol Ctr,425 Henry Mall, Madison, WI 53706 USA; [Broman, Aimee T.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [Hebert, Alexander S.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Malec, Paige A.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, 543A HF Deluca Biochem Labs,433 Babcock Dr, Madison, WI 53706 USA.; Coon, JJ (corresponding author), Univ Wisconsin, Dept Chem, 4426 Genet Biotechnol Ctr,425 Henry Mall, Madison, WI 53706 USA.	jcoon@chem.wisc.edu; adattie@wisc.edu			University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101573, P30DK020572, R01DK102948, R01DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118110, P41GM108538] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy was performed at the University of Wisconsin-Madison Biochemistry Optical Core, which was established with support from the University of Wisconsin-Madison Department of Biochemistry Endowment.	Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bader E, 2016, NATURE, V535, P430, DOI 10.1038/nature18624; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Baughman JM, 2016, CELL REP, V16, P583, DOI 10.1016/j.celrep.2016.05.096; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; CEGRELL L, 1968, ACTA PHYSIOL SCAND, VS, P1; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Cirulli V, 2015, DIABETES, V64, P709, DOI 10.2337/db14-1662; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruciani-Guglielmacci C, 2017, MOL METAB, V6, P340, DOI 10.1016/j.molmet.2017.01.009; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dorrell C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11756; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; El Ouaamari A, 2015, J PROTEOME RES, V14, P3111, DOI 10.1021/acs.jproteome.5b00587; ERICSON LE, 1977, DIABETOLOGIA, V13, P117, DOI 10.1007/BF00745138; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; FELDMAN JM, 1970, DIABETES, V19, P480, DOI 10.2337/diab.19.7.480; Ferris ST, 2017, J EXP MED, V214, P2369, DOI 10.1084/jem.20170074; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LINDSTROM P, 1986, BIOCHIM BIOPHYS ACTA, V884, P276, DOI 10.1016/0304-4165(86)90174-1; LUNDQUIST I, 1991, PANCREAS, V6, P522, DOI 10.1097/00006676-199109000-00004; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Marullo L, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0551-8; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Omikorede O, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.35; Osterburg AR, 2013, P NATL ACAD SCI USA, V110, pE3370, DOI 10.1073/pnas.1306033110; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Parnaud G, 2015, DIABETES, V64, P887, DOI 10.2337/db14-0257; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Rackham CL, 2016, DIABETES, V65, P129, DOI 10.2337/db15-0990; Raffo A, 2008, J ENDOCRINOL, V198, P41, DOI 10.1677/JOE-07-0632; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Richards AL, 2015, NAT PROTOC, V10, P701, DOI 10.1038/nprot.2015.040; Riley NM, 2016, CELL SYST, V2, P142, DOI 10.1016/j.cels.2016.03.002; Roat R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086815; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Saisho Y, 2008, J MOL HISTOL, V39, P543, DOI 10.1007/s10735-008-9195-9; Schwetz TA, 2013, AM J PHYSIOL-ENDOC M, V304, pE211, DOI 10.1152/ajpendo.00374.2012; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shishkova E, 2016, CELL SYST, V3, P321, DOI 10.1016/j.cels.2016.10.007; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; SORENSON RL, 1979, DIABETES, V28, P899, DOI 10.2337/diabetes.28.10.899; Stefely JA, 2016, NAT BIOTECHNOL, V34, P1191, DOI 10.1038/nbt.3683; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Tekin I, 2014, J NEURAL TRANSM, V121, P1451, DOI 10.1007/s00702-014-1238-7; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang YJ, 2016, CELL METAB, V24, P616, DOI 10.1016/j.cmet.2016.09.007; Wieczorek G, 1998, EXP TOXICOL PATHOL, V50, P151, DOI 10.1016/S0940-2993(98)80078-X; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Wood AR, 2017, DIABETES, V66, P2296, DOI 10.2337/db16-1452; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	89	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5860	5877		10.1074/jbc.RA117.001102	http://dx.doi.org/10.1074/jbc.RA117.001102			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496998	Green Published, hybrid			2022-12-28	WOS:000430497300010
J	Narasimhulu, VGS; Bellamy-McIntyre, AK; Laumaea, AE; Lay, CS; Harrison, DN; King, HAD; Drummer, HE; Poumbourios, P				Narasimhulu, Vani G. S.; Bellamy-McIntyre, Anna K.; Laumaea, Annamarie E.; Lay, Chan-Sien; Harrison, David N.; King, Hannah A. D.; Drummer, Heidi E.; Poumbourios, Pantelis			Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; VIROLOGICAL SYNAPSE FORMATION; HUMAN MONOCLONAL-ANTIBODIES; ENV-MEDIATED FUSION; ENVELOPE GLYCOPROTEIN; T-CELLS; CYTOPLASMIC TAIL; EXTERNAL REGION; DENDRITIC CELLS	HIV-1 is spread by cell-free virions and by cell-cell viral transfer. We asked whether the structure and function of a broad neutralizing antibody (bNAb) epitope, the membrane-proximal ectodomain region (MPER) of the viral gp41 transmembrane glycoprotein, differ in cell-free and cell-cell-transmitted viruses and whether this difference could be related to Ab neutralization sensitivity. Whereas cell-free viruses bearing W666A and I675A substitutions in the MPER lacked infectivity, cell-associated mutant viruses were able to initiate robust spreading infection. Infectivity was restored to cell-free viruses by additional substitutions in the cytoplasmic tail (CT) of gp41 known to disrupt interactions with the viral matrix protein. We observed contrasting effects on cell-free virus infectivity when W666A was introduced to two transmitted/founder isolates, but both mutants could still mediate cell-cell spread. Domain swapping indicated that the disparate W666A phenotypes of the cell-free transmitted/founder viruses are controlled by sequences in variable regions 1, 2, and 4 of gp120. The sequential passaging of an MPER mutant (W672A) in peripheral blood mononuclear cells enabled selection of viral revertants with loss-of-glycan suppressor mutations in variable region 1, suggesting a functional interaction between variable region 1 and the MPER. An MPER-directed bNAb neutralized cell-free virus but not cell-cell viral spread. Our results suggest that the MPER of cell-cell-transmitted virions has a malleable structure that tolerates mutagenic disruption but is not accessible to bNAbs. In cell-free virions, interactions mediated by the CT impose an alternative MPER structure that is less tolerant of mutagenic alteration and is efficiently targeted by bNAbs.	[Narasimhulu, Vani G. S.; Bellamy-McIntyre, Anna K.; Laumaea, Annamarie E.; Harrison, David N.; King, Hannah A. D.; Drummer, Heidi E.; Poumbourios, Pantelis] Burnet Inst, Virus Entry & Vaccines Lab, Melbourne, Vic 3004, Australia; [Narasimhulu, Vani G. S.; Laumaea, Annamarie E.; King, Hannah A. D.; Drummer, Heidi E.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Bellamy-McIntyre, Anna K.; Drummer, Heidi E.; Poumbourios, Pantelis] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Lay, Chan-Sien; Poumbourios, Pantelis] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Burnet Institute; University of Melbourne; Monash University; Monash University	Poumbourios, P (corresponding author), Burnet Inst, Virus Entry & Vaccines Lab, GPO Box 2284, Melbourne, Vic 3001, Australia.	andy.poumbourios@burnet.edu.au		Laumaea, Annemarie/0000-0002-4934-597X; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council of Australia Grants [1070890, 1125822, 1041897]; Australian Centre for HIV and Hepatitis Virology Research; Australian Postgraduate Awards	National Health and Medical Research Council of Australia Grants(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; Australian Postgraduate Awards(Australian Government)	This work was supported by National Health and Medical Research Council of Australia Grants 1070890 and 1125822 (to P.P.) and 1041897 (to H.E.D.) and the Australian Centre for HIV and Hepatitis Virology Research (to P.P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Postgraduate Awards.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2016, J VIROL, V90, P5657, DOI 10.1128/JVI.00509-16; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; Bauby H, 2010, TRAFFIC, V11, P455, DOI 10.1111/j.1600-0854.2010.01036.x; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bjorndal A, 1997, J VIROL, V71, P7478; Blanchet F, 2011, CURR OPIN HIV AIDS, V6, P391, DOI 10.1097/COH.0b013e328349b0a0; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bracq L, 2017, J VIROL, V91, DOI 10.1128/JVI.01237-17; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Checkley MA, 2013, J VIROL, V87, P3561, DOI 10.1128/JVI.03299-12; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dev J, 2016, SCIENCE, V353, P172, DOI 10.1126/science.aaf7066; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Drummer HE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003218; Duncan CJA, 2014, J VIROL, V88, P2025, DOI 10.1128/JVI.03245-13; Duncan CJA, 2013, AIDS, V27, P2201, DOI 10.1097/QAD.0b013e3283632ec4; Durham ND, 2015, J VIROL, V89, P9324, DOI 10.1128/JVI.00655-15; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1990, BIOPOLYMERS, V29, P171, DOI 10.1002/bip.360290122; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gardiner JC, 2016, J VIROL, V90, P6583, DOI 10.1128/JVI.00600-16; Gombos RB, 2015, J VIROL, V89, P7813, DOI 10.1128/JVI.00783-15; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Groppelli E, 2015, J VIROL, V89, P14, DOI 10.1128/JVI.02425-14; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iwami S, 2015, ELIFE, V4, DOI 10.7554/eLife.08150; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Jolly C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002226; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Khasawneh AI, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-44; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; KONDO S, 1994, BRIT J CANCER, V69, P627, DOI 10.1038/bjc.1994.123; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Law KM, 2016, CELL REP, V15, P2771, DOI 10.1016/j.celrep.2016.05.059; Lay CS, 2011, J BIOL CHEM, V286, P41331, DOI 10.1074/jbc.M111.299826; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lineberger JE, 2002, J VIROL, V76, P3522, DOI 10.1128/JVI.76.7.3522-3533.2002; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Murakami T, 2004, J VIROL, V78, P1026, DOI 10.1128/JVI.78.2.1026-1031.2004; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murphy RE, 2017, STRUCTURE, V25, P1708, DOI 10.1016/j.str.2017.09.010; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Orenstein JM, 2008, AIDS RES HUM RETROV, V24, P947, DOI 10.1089/aid.2008.0265; Orenstein JM, 2000, J INFECT DIS, V182, P338, DOI 10.1086/315640; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Putcharoen O, 2012, J VIROL, V86, P1119, DOI 10.1128/JVI.06421-11; Qi ML, 2015, P NATL ACAD SCI USA, V112, P7575, DOI 10.1073/pnas.1504174112; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reh L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004966; ROWELL JF, 1995, J IMMUNOL, V155, P473; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Russell RA, 2013, VIROLOGY, V443, P143, DOI 10.1016/j.virol.2013.05.005; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stauffer S, 2014, J VIROL, V88, P7893, DOI 10.1128/JVI.00428-14; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Sun ZYJ, 2014, J MOL BIOL, V426, P1095, DOI 10.1016/j.jmb.2013.09.030; Symeonides M, 2015, VIRUSES-BASEL, V7, P6590, DOI 10.3390/v7122959; Takikawa S, 2000, J VIROL, V74, P5066, DOI 10.1128/JVI.74.11.5066-5074.2000; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Tencza SB, 1997, ANTIMICROB AGENTS CH, V41, P2394, DOI 10.1128/AAC.41.11.2394; Do T, 2014, J VIROL, V88, P10327, DOI 10.1128/JVI.00788-14; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Titanji BK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-161; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; VENABLE RM, 1989, AIDS RES HUM RETROV, V5, P7, DOI 10.1089/aid.1989.5.7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang LL, 2017, J VIROL, V91, DOI 10.1128/JVI.01605-16; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Zhang CL, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/918305; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	145	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					6099	6120		10.1074/jbc.RA117.000537	http://dx.doi.org/10.1074/jbc.RA117.000537			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29496992	hybrid, Green Published			2022-12-28	WOS:000430497300028
J	Sakabe, T; Sakai, K; Maeda, T; Sunaga, A; Furuta, N; Schweitzer, R; Sasaki, T; Sakai, T				Sakabe, Tomoya; Sakai, Keiko; Maeda, Toru; Sunaga, Ataru; Furuta, Nao; Schweitzer, Ronen; Sasaki, Takako; Sakai, Takao			Transcription factor scleraxis vitally contributes to progenitor lineage direction in wound healing of adult tendon in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MOUSE ACHILLES-TENDON; EXTRACELLULAR-MATRIX; HETEROTOPIC OSSIFICATION; COLLAGEN-SYNTHESIS; CRUCIATE LIGAMENT; GROWTH-FACTOR; EXPRESSION; GENE; DIFFERENTIATION	Tendon is a dense connective tissue that transmits high mechanical forces from skeletal muscle to bone. The transcription factor scleraxis (Scx) is a highly specific marker of both precursor and mature tendon cells (tenocytes). Mice lacking scx exhibit a specific and virtually complete loss of tendons during development. However, the functional contribution of Scx to wound healing in adult tendon has not yet been fully characterized. Here, using ScxGFP-tracking and loss-of-function systems, we show in an adult mouse model of Achilles tendon injury that paratenon cells, representing a stem cell antigen-1 (Sca-1)positive and Scx-negative progenitor subpopulation, display Scx induction, migrate to the wound site, and produce extracellular matrix (ECM) to bridge the defect, whereas resident tenocytes exhibit a delayed response. Scx induction in the progenitors is initiated by transforming growth factor beta (TGF-beta) signaling. scx-deficient mice had migration of Sca-1-positive progenitor cell to the lesion site but impaired ECM assembly to bridge the defect. Mechanistically, scx-null progenitors displayed higher chondrogenic potential with up-regulation of SRY-box 9 (Sox9) coactivator PPAR-gamma coactivator-1 alpha (PGC-1 alpha) in vitro, and knock-in analysis revealed that forced expression of full-length scx significantly inhibited Sox9 expression. Accordingly, scxnull wounds formed cartilage-like tissues that developed ectopic ossification. Our findings indicate a critical role of Scx in a progenitor-cell lineage in wound healing of adult mouse tendon. These progenitor cells could represent targets in strategies to facilitate tendon repair. We propose that this lineage-regulatory mechanism in tissue progenitors could apply to a broader set of tissues or biological systems in the body.	[Sakabe, Tomoya; Sakai, Keiko; Furuta, Nao; Sakai, Takao] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC,Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England; [Sakabe, Tomoya; Sakai, Keiko; Maeda, Toru; Sunaga, Ataru; Sakai, Takao] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Schweitzer, Ronen] Shriners Hosp Children, Res Div, Portland, OR 97239 USA; [Sasaki, Takako] Oita Univ, Dept Biochem, Fac Med, Oita 8795593, Japan	University of Liverpool; Cleveland Clinic Foundation; Oita University	Sakai, T (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, MRC,Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	sakait@liverpool.ac.uk	Schweitzer, Ronen/AAY-2127-2020	Schweitzer, Ronen/0000-0002-7425-5028	National Institutes of Health [DK074538]; Institute of Translational Medicine, University of Liverpool	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Translational Medicine, University of Liverpool	This work was supported by National Institutes of Health Grant DK074538 and the Institute of Translational Medicine, University of Liverpool (to T. Sakai). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Asai S, 2014, STEM CELLS, V32, P3266, DOI 10.1002/stem.1847; Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; Dyment NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096113; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; GREENBERGER JS, 1979, IN VITRO CELL DEV B, V15, P823; Gross G, 2013, PATHOBIOLOGY, V80, P203, DOI 10.1159/000347059; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hsieh CF, 2016, NANOMEDICINE-UK, V11, P1153, DOI 10.2217/nnm.16.34; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Jann HW, 1999, VET SURG, V28, P268, DOI 10.1053/jvet.1999.0268; Jozsa L.G., 1997, HUMAN TENDONS ANATOM; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kumagai K, 2012, OSTEOARTHR CARTILAGE, V20, P1258, DOI 10.1016/j.joca.2012.07.013; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lin L, 2010, BONE, V46, P425, DOI 10.1016/j.bone.2009.08.057; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mienaltowski MJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt475; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.tea.2012.0182, 10.1089/ten.TEA.2012.0182]; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; O'Brien EJO, 2012, INT J EXP PATHOL, V93, P319, DOI 10.1111/j.1365-2613.2012.00829.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; ROONEY P, 1992, MATRIX, V12, P274, DOI 10.1016/S0934-8832(11)80079-X; Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suzuki H, 2016, P NATL ACAD SCI USA, V113, P7840, DOI 10.1073/pnas.1522054113; Takimoto A, 2015, DEVELOPMENT, V142, P787, DOI 10.1242/dev.116228; Takimoto A, 2012, EXP CELL RES, V318, P1492, DOI 10.1016/j.yexcr.2012.04.002; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Yoshikawa T, 2006, KNEE SURG SPORT TR A, V14, P804, DOI 10.1007/s00167-006-0051-8; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang K, 2016, MATRIX BIOL, V52-54, P315, DOI 10.1016/j.matbio.2016.01.015	63	47	49	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5766	5780		10.1074/jbc.RA118.001987	http://dx.doi.org/10.1074/jbc.RA118.001987			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29507095	Green Published, hybrid			2022-12-28	WOS:000430497300002
J	Garcia-Guerrero, AE; Camacho-Villasana, Y; Zamudio-Ochoa, A; Winge, DR; Perez-Martinez, X				Garcia-Guerrero, Aldo E.; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Winge, Dennis R.; Perez-Martinez, Xochitl			Cbp3 and Cbp6 are dispensable for synthesis regulation of cytochrome b in yeast mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; COENZYME QH2-CYTOCHROME-C REDUCTASE; RIESKE FE/S PROTEIN; MESSENGER-RNA; NUCLEAR GENE; BC(1) COMPLEX; MEMBRANE SYSTEM; TRANSLATIONAL ACTIVATION; EXPRESSION; COX1	Cytochrome b (Cytb) is the only mitochondrial encoded subunit from the bc(1) complex. Cbp3 and Cbp6 are chaperones necessary for translation of the COB mRNA and Cytb hemylation. Here we demonstrate that their role in translation is dispensable in some laboratory strains, whereas their role in Cytb hemylation seems to be universally conserved. BY4742 yeast requires Cbp3 and Cbp6 for efficient COB mRNA translation, whereas the D273-10b strain synthesizes Cytb at wildtype levels in the absence of Cbp3 and Cbp6. Steady-state levels of Cytb are close to wildtype in mutant D273-10b cells, and Cytb forms non-functional, supercomplex-like species with cytochrome c oxidase, in which at least core 1, cytochrome c(1), and Rieske iron-sulfur subunits are present. We demonstrated that Cbp3 interacts with the mitochondrial ribosome and with the COB mRNA in both BY4742 and D273-10b strains. The polymorphism( s) causing the differential function of Cbp3, Cbp6, and the assembly feedback regulation of Cytb synthesis is of nuclear origin rather than mitochondrial, and Smt1, a COB mRNA-binding protein, does not seem to be involved in the observed differential phenotype. Our results indicate that the essential role of Cbp3 and Cbp6 is to assist Cytb hemylation and demonstrate that in the absence of heme b, Cytb can form non-functional supercomplexes with cytochrome c oxidase. Our observations support that an additional protein or proteins are involved in Cytb synthesis in some yeast strains.	[Garcia-Guerrero, Aldo E.; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico; [Winge, Dennis R.] Univ Utah, Dept Med & Biochem, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Zamudio-Ochoa, Angelica] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA	Universidad Nacional Autonoma de Mexico; Utah System of Higher Education; University of Utah; Rowan University; Rowan University School of Osteopathic Medicine	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Zamudio-Ochoa, Angelica/AAC-3684-2020	Zamudio-Ochoa, Angelica/0000-0002-6347-5789	Consejo Nacional de Ciencia y Tecnologia [47514, 255917]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN204414, IN209217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 47514 (to X.P.-M.) and Fellowship 255917 (to A.E. G.-G.) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico Grants IN204414 and IN209217 (to X.P.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Brachmann CB, 1998, YEAST, V14, P115; BRANDT U, 1994, J BIOL CHEM, V269, P12947; Burke D., 2000, METHODS YEAST GENETI, P39; Conte A, 2015, BBA-MOL CELL RES, V1853, P987, DOI 10.1016/j.bbamcr.2015.02.006; COSTANZO MC, 1988, P NATL ACAD SCI USA, V85, P2677, DOI 10.1073/pnas.85.8.2677; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DIECKMANN CL, 1984, J BIOL CHEM, V259, P4722; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Garcia-Villegas R, 2017, J BIOL CHEM, V292, P10912, DOI 10.1074/jbc.M116.773077; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Guthrie C., 2002, GUIDE YEAST GENETICS, P23; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Islas-Osuna MA, 2002, J BIOL CHEM, V277, P37987, DOI 10.1074/jbc.M206132200; Kehrein K, 2015, ONCOTARGET, V6, P16806, DOI 10.18632/oncotarget.4783; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; Krause-Buchholz U, 2004, CURR GENET, V46, P20, DOI 10.1007/s00294-004-0503-y; Kuhl I, 2012, MITOCHONDRION, V12, P381, DOI 10.1016/j.mito.2012.02.002; LABOUESSE M, 1984, EUR J BIOCHEM, V144, P85, DOI 10.1111/j.1432-1033.1984.tb08434.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Ostojic J, 2016, NUCLEIC ACIDS RES, V44, P5785, DOI 10.1093/nar/gkw490; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Rak M, 2016, MOL BIOL CELL, V27, P919, DOI 10.1091/mbc.E15-09-0642; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; RODEL G, 1986, CURR GENET, V11, P47, DOI 10.1007/BF00389425; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SHERMAN F, 1963, GENETICS, V48, P375; Shingu-Vazquez M, 2010, J BIOL CHEM, V285, P34382, DOI 10.1074/jbc.M110.161976; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WU M, 1989, J BIOL CHEM, V264, P11122; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zamudio-Ochoa A, 2014, RNA BIOL, V11, P953, DOI 10.4161/rna.29780; Zara V, 2004, EUR J BIOCHEM, V271, P1209, DOI 10.1111/j.1432-1033.2004.04024.x; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	58	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5585	5599		10.1074/jbc.RA117.000547	http://dx.doi.org/10.1074/jbc.RA117.000547			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475949	Green Published, hybrid			2022-12-28	WOS:000430044100020
J	Sarikhani, M; Maity, S; Mishra, S; Jain, A; Tamta, AK; Ravi, V; Kondapalli, MS; Desingu, PA; Khan, D; Kumar, S; Rao, S; Inbaraj, M; Pandit, AS; Sundaresan, NR				Sarikhani, Mohsen; Maity, Sangeeta; Mishra, Sneha; Jain, Aditi; Tamta, Ankit K.; Ravi, Venkatraman; Kondapalli, Mrudula S.; Desingu, Perumal A.; Khan, Danish; Kumar, Shweta; Rao, Swathi; Inbaraj, Meena; Pandit, Anwit S.; Sundaresan, Nagalingam Ravi			SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart failure; cardiac hypertrophy; sirtuin; NFAT transcription factor; cardiomyocyte; SIRT2; lysine acetylation	HEART-FAILURE; GENE-EXPRESSION; PROTEIN-SYNTHESIS; CALORIE RESTRICTION; IN-VITRO; KAPPA-B; HYPERTROPHY; CALCINEURIN; CARDIOMYOCYTES; CARDIOMYOPATHY	Heart failure is an aging-associated disease that is the leading cause of death worldwide. Sirtuin family members have been largely studied in the context of aging and aging-associated diseases. Sirtuin 2 (SIRT2) is a cytoplasmic protein in the family of sirtuins that are NAD(+)-dependent class III histone deacetylases. In this work, we studied the role of SIRT2 in regulating nuclear factor of activated T-cells (NFAT) transcription factor and the development of cardiac hypertrophy. Confocal microscopy analysis indicated that SIRT2 is localized in the cytoplasm of cardiomyocytes and SIRT2 levels are reduced during pathological hypertrophy of the heart. SIRT2-deficient mice develop spontaneous pathological cardiac hypertrophy, remodeling, fibrosis, and dysfunction in an age-dependent manner. Moreover, young SIRT2-deficient mice develop exacerbated agonist-induced hypertrophy. In contrast, SIRT2 overexpression attenuated agonist-induced cardiac hypertrophy in cardiomyocytes in a cell-autonomous manner. Mechanistically, SIRT2 binds to and deacetylates NFATc2 transcription factor. SIRT2 deficiency stabilizes NFATc2 and enhances nuclear localization of NFATc2, resulting in increased transcription activity. Our results suggest that inhibition of NFAT rescues the cardiac dysfunction in SIRT2-deficient mice. Thus, our study establishes SIRT2 as a novel endogenous negative regulator of NFAT transcription factor.	[Sarikhani, Mohsen; Maity, Sangeeta; Mishra, Sneha; Jain, Aditi; Tamta, Ankit K.; Ravi, Venkatraman; Kondapalli, Mrudula S.; Desingu, Perumal A.; Khan, Danish; Kumar, Shweta; Rao, Swathi; Inbaraj, Meena; Pandit, Anwit S.; Sundaresan, Nagalingam Ravi] Indian Inst Sci, Dept Microbiol & Cell Biol, Bengaluru 560012, India	Indian Institute of Science (IISC) - Bangalore	Sundaresan, NR (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Div Biol Sci, Lab SB 02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Desingu, P./AGM-5446-2022; Ravi, Venkatraman/C-7967-2014; Jain, Aditi/AAD-8922-2019; Desingu, Perumal/AGH-9777-2022	Desingu, P./0000-0003-4395-4472; Maity, Sangeeta/0000-0003-4426-1715; Ravi, Venkatraman/0000-0002-1409-682X	Department of Science and Technology Extra Mural Research Funding [EMR/2014/000065]; Department of Biotechnology Extramural Research Grants [BRB/10/1294/2014, MED/30/1454/2014]; Council for Scientific and Industrial Research [37(1646)/15/EMR-II]; SERB-National Post-Doctoral Fellowship (N-PDF); Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India	Department of Science and Technology Extra Mural Research Funding; Department of Biotechnology Extramural Research Grants; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); SERB-National Post-Doctoral Fellowship (N-PDF); Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India	This work was supported by research funding from the Department of Science and Technology Extra Mural Research Funding EMR/2014/000065, the Department of Biotechnology Extramural Research Grants BRB/10/1294/2014 and MED/30/1454/2014, and the Council for Scientific and Industrial Research extramural research support 37(1646)/15/EMR-II (to N. R. S.). This work was supported by the SERB-National Post-Doctoral Fellowship (N-PDF) (to M. S. K. and S. M.) and by the Ramalingaswami Re-entry Fellowship and the Innovative Young Biotechnologist Award (IYBA) from the Department of Biotechnology, Government of India (to N. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dirkx E, 2013, BBA-MOL BASIS DIS, V1832, P2414, DOI 10.1016/j.bbadis.2013.07.023; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Dolinsky VW, 2011, BBA-MOL BASIS DIS, V1812, P1477, DOI 10.1016/j.bbadis.2011.06.010; Fang J, 2017, HYPERTENSION, V70, P515, DOI 10.1161/HYPERTENSIONAHA.116.08728; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2007, COLD SH Q B, V72, P483, DOI 10.1101/sqb.2007.72.024; Han XF, 2010, ACTA PHARMACOL SIN, V31, P1111, DOI 10.1038/aps.2010.146; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jain A, 2017, INT J CARDIOL, V232, P160, DOI 10.1016/j.ijcard.2017.01.036; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mittmann C, 1998, CARDIOVASC RES, V39, P267, DOI 10.1016/S0008-6363(98)00139-4; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park SH, 2012, TRANSL CANCER RES, V1, P15, DOI 10.3978/j.issn.2218-676X.2012.05.01; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Pina IL, 1996, CHEST, V110, P1317, DOI 10.1378/chest.110.5.1317; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tang XQ, 2017, CIRCULATION, V136, P2051, DOI 10.1161/CIRCULATIONAHA.117.028728; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Wen HY, 2002, J CELL MOL MED, V6, P235, DOI 10.1111/j.1582-4934.2002.tb00190.x; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Yang XY, 2017, J CLIN INVEST, V127, P1505, DOI 10.1172/JCI88574; Yu W, 2014, MOL MED REP, V9, P1218, DOI 10.3892/mmr.2014.1944; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045	60	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5281	5294		10.1074/jbc.RA117.000915	http://dx.doi.org/10.1074/jbc.RA117.000915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29440391	Green Published, hybrid			2022-12-28	WOS:000429409300032
J	Kofler, N; Corti, F; Rivera-Molina, F; Deng, Y; Toomre, D; Simons, M				Kofler, Natalie; Corti, Federico; Rivera-Molina, Felix; Deng, Yong; Toomre, Derek; Simons, Michael			The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLATERAL CIRCULATION; ANGIOGENESIS; KINASE; CELLS; INTERNALIZATION; ARTERIOGENESIS; MORPHOGENESIS; ACTIVATION; LETHALITY; DOMAIN	As a master regulator of endothelial cell function, vascular endothelial growth factor receptor-2 (VEGFR2) activates multiple downstream signaling pathways that are critical for vascular development and normal vessel function. VEGFR2 trafficking through various endosomal compartments modulates its signaling output. Accordingly, proteins that regulate the speed and direction by which VEGFR2 traffics through endosomes have been demonstrated to be particularly important for arteriogenesis. However, little is known about how these proteins control VEGFR2 trafficking and about the implications of this control for endothelial cell function. Here, we show that Rab GTPase-binding effector protein 2 (RABEP2), a Rab-effector protein implicated in arteriogenesis, modulates VEGFR2 trafficking. By employing high-resolution microscopy and biochemical assays, we demonstrate that RABEP2 interacts with the small GTPase Rab4 and regulates VEGFR2 endosomal trafficking to maintain cell-surface expression of VEGFR2 and VEGF signaling. Lack of RABEP2 also led to prolonged retention of VEGFR2 in Rab5-positive sorting endosomes, which increased VEGFR2' s exposure to phosphotyrosine phosphatase 1b (PTP1b), causing diminished VEGFR2 signaling. Finally, the loss of RABEP2 increased VEGFR2 degradation by diverting VEGFR2 to Rab7positive endosomes destined for the lysosome. These results implicate RABEP2 as a key modulator of VEGFR2 endosomal trafficking, and demonstrate the importance of RABEP2 and Rab4 for VEGFR2 signaling in endothelial cells.	[Kofler, Natalie; Corti, Federico; Deng, Yong; Simons, Michael] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med,Yale Cardiovasc Res Ctr, New Haven, CT 06520 USA; [Rivera-Molina, Felix; Toomre, Derek; Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Simons, M (corresponding author), 300 George St,Rm 759, New Haven, CT 06511 USA.	michael.simons@yale.edu	Corti, Federico/R-6262-2016	Corti, Federico/0000-0003-2160-245X	National Institutes of Health [T32 HL007778-20, R01 HL053793, HL084619, PO1 5P01HL107205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793, R01HL084619, P01HL107205, T32HL007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by National Institutes of Health Training Grant T32 HL007778-20 (to N. K.) and National Institutes of Health Grants R01 HL053793, HL084619, and PO1 5P01HL107205 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bautch VL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a008268; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Boucher JM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15699; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Heinolainen K, 2017, CIRC RES, V120, P1414, DOI 10.1161/CIRCRESAHA.116.310477; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; Jeltsch M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009183; Jopling HM, 2014, CELLS-BASEL, V3, P363, DOI 10.3390/cells3020363; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Jopling HM, 2009, ARTERIOSCL THROM VAS, V29, P1119, DOI 10.1161/ATVBAHA.109.186239; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kofler Natalie M, 2015, F1000Prime Rep, V7, P26, DOI 10.12703/P7-26; Kofler Natalie M, 2011, Genes Cancer, V2, P1106, DOI 10.1177/1947601911423030; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lucitti JL, 2016, STROKE, V47, P3022, DOI 10.1161/STROKEAHA.116.014160; Moraes F, 2013, CIRC RES, V113, P1076, DOI 10.1161/CIRCRESAHA.113.301340; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pardanaud L, 2016, CIRC RES, V119, P607, DOI 10.1161/CIRCRESAHA.116.308473; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ren B, 2010, J CLIN INVEST, V120, P1217, DOI 10.1172/JCI39837; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sealock R, 2014, CIRC RES, V114, P660, DOI 10.1161/CIRCRESAHA.114.302931; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; van Lessen M, 2015, ARTERIOSCL THROM VAS, V35, P1815, DOI 10.1161/ATVBAHA.115.305473; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6	44	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4805	4817		10.1074/jbc.M117.812172	http://dx.doi.org/10.1074/jbc.M117.812172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29425100	Green Published, hybrid			2022-12-28	WOS:000428848300021
J	Toth, EN; Lohith, A; Mondal, M; Guo, J; Fukamizu, A; Pourmand, N				Toth, Eszter N.; Lohith, Akshar; Mondal, Manas; Guo, Jia; Fukamizu, Akiyoshi; Pourmand, Nader			Single-cell nanobiopsy reveals compartmentalization of mRNAs within neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL PROTEIN-SYNTHESIS; INTRAAXONAL TRANSLATION; TRANSCRIPTOME ANALYSIS; LOCAL TRANSLATION; LOCALIZATION; TRANSPORT; EXPRESSION; IDENTIFICATION; REPERTOIRE; MECHANISMS	In highly polarized cells such as neurons, compartmentalization of mRNA and of local protein synthesis enables remarkably fast, precise, and local responses to external stimuli. These responses are highly important for neuron growth cone guidance, synapse formation, and regeneration following injury. Because an altered spatial distribution of mRNA can result in mental retardation or neurodegenerative diseases, subcellular transcriptome analysis of neurons could be a useful tool for studying these conditions, but current techniques, such as in situ hybridization, bulk microarray, and RNA-Seq, impose tradeoffs between spatial resolution and multiplexing. To obtain a comprehensive analysis of the cell body versus neurite transcriptome from the same neuron, we have recently developed a label-free, single-cell nanobiopsy platform based on scanning ion conductance microscopy that uses electrowetting within a quartz nanopipette to extract cellular material from living cells with minimal disruption of the cellular membrane and milieu. In this study, we used this platform to collect samples from the cell bodies and neurites of human neurons and analyzed the mRNA pool with multiplex RNA sequencing. The minute volume of a nanobiopsy sample allowed us to extract samples from several locations in the same cell and to map the various mRNA species to specific subcellular locations. In addition to previously identified transcripts, we discovered new sets of mRNAs localizing to neurites, including nuclear genes such as Eomes and Hmgb3. In summary, our single-neuron nanobiopsy analysis provides opportunities to improve our understanding of intracellular mRNA transport and local protein composition in neuronal growth, connectivity, and function.	[Toth, Eszter N.; Fukamizu, Akiyoshi] Univ Tsukuba, Sch Integrat & Global Majors, PhD Program Human Biol, Ibaraki 3058577, Japan; [Toth, Eszter N.; Fukamizu, Akiyoshi] Univ Tsukuba, Dept Life & Environm Sci, Tsukuba Adv Res Alliance, Life Sci Ctr, Ibaraki 3058577, Japan; [Toth, Eszter N.; Lohith, Akshar; Pourmand, Nader] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Biomol Engn, 1156 High St, Santa Cruz, CA 95064 USA; [Mondal, Manas; Guo, Jia] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Mondal, Manas; Guo, Jia] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA	University of Tsukuba; University of Tsukuba; University of California System; University of California Santa Cruz; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Pourmand, N (corresponding author), Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Biomol Engn, 1156 High St, Santa Cruz, CA 95064 USA.	pourmand@soe.ucsc.edu		Pourmand, Nader/0000-0003-0251-9060; Lohith, Akshar/0000-0001-7523-5259; Guo, Jia/0000-0001-8036-5349; Toth, Eszter/0000-0002-4262-1695	National Institutes of Health [P01-35HG000205]; NINDS, National Institutes of Health [R21NS082927]; National Institutes of Health's Follow the Same Cell Prize; MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan [23116001, 23116004]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000205, P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health's Follow the Same Cell Prize(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant P01-35HG000205; NINDS, National Institutes of Health Grant R21NS082927; the National Institutes of Health's Follow the Same Cell Prize; and Grants-in-Aid for Scientific Research on Innovative Areas (23116001 and 23116004) from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Actis P, 2014, ACS NANO, V8, P546, DOI 10.1021/nn405097u; Ainsley JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5510; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Condeelis J, 2005, BIOL CELL, V97, P97; Cosker KE, 2013, J NEUROSCI, V33, P5195, DOI 10.1523/JNEUROSCI.3862-12.2013; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Crino P, 1998, P NATL ACAD SCI USA, V95, P2313, DOI 10.1073/pnas.95.5.2313; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Francis C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-883; Gomes C, 2014, DEV NEUROBIOL, V74, P218, DOI 10.1002/dneu.22123; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Katz ZB, 2016, ELIFE, V5, DOI 10.7554/eLife.10415; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; Kratz A, 2014, GENOME RES, V24, P1396, DOI 10.1101/gr.164095.113; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Minis A, 2014, DEV NEUROBIOL, V74, P365, DOI 10.1002/dneu.22140; Moccia R, 2003, J NEUROSCI, V23, P9409; Muslimov IA, 2004, J BIOL CHEM, V279, P52613, DOI 10.1074/jbc.M409240200; OKAZAKI T, 1995, NEUROBIOL AGING, V16, P883, DOI 10.1016/0197-4580(95)02001-2; Pfeiffer-Guglielmi B, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-70; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Radeva MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106733; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Weatheritt RJ, 2014, NAT STRUCT MOL BIOL, V21, P833, DOI 10.1038/nsmb.2876; Wehrens R, 2007, J STAT SOFTW, V21, P1; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Xiao L, 2015, ANAL METHODS-UK, V7, P7290, DOI 10.1039/c5ay00500k; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	67	23	24	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4940	4951		10.1074/jbc.M117.800763	http://dx.doi.org/10.1074/jbc.M117.800763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29378846	hybrid, Green Published			2022-12-28	WOS:000428848300032
J	Xu, YC; Lin, JX; Cui, T; Srinivas, S; Feng, YJ				Xu, Yongchang; Lin, Jingxia; Cui, Tao; Srinivas, Swaminath; Feng, Youjun			Mechanistic insights into transferable polymyxin resistance among gut bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED COLISTIN-RESISTANCE; ESCHERICHIA-COLI; PHOSPHOETHANOLAMINE TRANSFERASE; LIPID-A; CARBAPENEM-RESISTANT; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GENE; IDENTIFICATION	Polymyxins such as colistin are antibiotics used as a final line of defense in the management of infections with multidrug-resistant Gram-negative bacteria. Although natural resistance to polymyxins is rare, the discovery of a mobilized colistin resistance gene (mcr-1) in gut bacteria has raised significant concern. As an intramembrane enzyme, MCR-1 catalyzes the transfer of phosphoethanolamine (PEA) to the 1 (or 4')-phosphate group of the lipid A moiety of lipopolysaccharide, thereby conferring colistin resistance. However, the structural and biochemical mechanisms used by this integral membrane enzyme remain poorly understood. Here, we report the modeled structure of the full-length MCR-1 membrane protein. Together with molecular docking, our structural and functional dissection of the complex of MCR-1 with its phosphatidylethanolamine (PE) substrate suggested the presence of a 12 residue-containing cavity for substrate entry, which is critical for both enzymatic activity and its resultant phenotypic resistance to colistin. More importantly, two periplasm-facing helices (PH2 and PH2') of the trans-membrane domain were essential for MCR-1 activity. MALDI-TOF MS and thin-layer chromatography assays provide both in vivo and in vitro evidence that MCR-1 catalyzes the transfer of PEA from the PE donor substrate to its recipient substrate lipid A. Also, the chemical modification of lipid A species was detected in clinical species of bacteria carrying mcr-1. Our results provide mechanistic insights into transferable MCR-1 polymyxin resistance, raising the prospect of rational design of small molecules that reverse bacterial polymyxin resistance, as a last-resort clinical option to combat pathogens with carbapenem resistance.	[Xu, Yongchang; Lin, Jingxia; Feng, Youjun] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Youjun] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Cui, Tao] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Shaanxi, Peoples R China; [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Zhejiang University; Zhejiang University; Northwestern Polytechnical University; University of Illinois System; University of Illinois Urbana-Champaign	Feng, YJ (corresponding author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Zhejiang, Peoples R China.	fengyj@zju.edu.cn	Srinivas, Swaminath/AAK-7213-2021	Srinivas, Swaminath/0000-0002-7210-5122	National Key RAMP;D Program of China [2017YFD0500202]; National Key Basic Research Program of China [2016YFC1200100]; National Natural Science Foundation of China [31570027, 81772142]; Fundamental Research Funds for the Central Universities [3102016QD022]	National Key RAMP;D Program of China; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key R&D Program of China Grant 2017YFD0500202 (to Y.F.), National Key Basic Research Program of China Grant 2016YFC1200100 (to Y.F.), National Natural Science Foundation of China Grants 31570027 and 81772142 (to Y.F.), and Fundamental Research Funds for the Central Universities Grant 3102016QD022 (to T.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; Alves AL, 2017, COSMETICS-BASEL, V4, P39, DOI [DOI 10.3390/COSMETICS4040039, 10.3390/cosmetics4040039]; Anandan A, 2017, P NATL ACAD SCI USA, V114, P2218, DOI 10.1073/pnas.1612927114; Baron S, 2016, INT J ANTIMICROB AG, V48, P583, DOI 10.1016/j.ijantimicag.2016.06.023; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borowiak M, 2017, J ANTIMICROB CHEMOTH, V72, P3317, DOI 10.1093/jac/dkx327; Carattoli A, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.31.30589; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; CDC, 2013, ANTIBIOTIC RESISTANC; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Delgado-Blas JF, 2016, ANTIMICROB AGENTS CH, V60, P6356, DOI 10.1128/AAC.01319-16; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Du H, 2016, LANCET INFECT DIS, V16, P287, DOI 10.1016/S1473-3099(16)00056-6; El Garch F, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.08.033; El Hamidi A, 2005, J LIPID RES, V46, P1773, DOI 10.1194/jlr.D500014-JLR200; Feng YJ, 2015, MICROBIOLOGYOPEN, V4, P644, DOI 10.1002/mbo3.270; Feng YJ, 2013, J BACTERIOL, V195, P3451, DOI 10.1128/JB.00378-13; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Gao RS, 2016, SCI CHINA LIFE SCI, V59, P732, DOI 10.1007/s11427-016-5070-1; Gros M, 2013, J CHROMATOGR A, V1292, P173, DOI 10.1016/j.chroma.2012.12.072; Haenni M, 2016, ANTIMICROB AGENTS CH, V60, P6433, DOI 10.1128/AAC.01147-16; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hinchliffe P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39392; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laxminarayan R, 2016, LANCET, V388, P218, DOI 10.1016/S0140-6736(16)31079-0; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Li RC, 2017, J ANTIMICROB CHEMOTH, V72, P393, DOI 10.1093/jac/dkw411; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Li ZC, 2016, SCI CHINA LIFE SCI, V59, P971, DOI 10.1007/s11427-016-5111-9; Liu L., 2017, ATMOS CHEM PHYS DISC, V2017, P1, DOI DOI 10.1002/EJLT.201500463; Liu Y., 2017, MATH PROBLEMS ENG, V2017, P1, DOI DOI 10.1111/0DI.12660.[; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Loeschner K, 2015, ANAL BIOANAL CHEM, V407, P4541, DOI 10.1007/s00216-015-8631-4; Lu X, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.02632-16, 10.1128/AAC.02632-16]; Ma GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39540; Monte DF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02718-16; Paterson DL, 2016, LANCET INFECT DIS, V16, P132, DOI 10.1016/S1473-3099(15)00463-6; Petrou VI, 2016, SCIENCE, V351, P608, DOI 10.1126/science.aad1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirel L, 2017, J ANTIMICROB CHEMOTH, V72, P2947, DOI 10.1093/jac/dkx225; Poirel L, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00127-17, 10.1128/AAC.00127-17]; Powl AM, 2010, P NATL ACAD SCI USA, V107, P14064, DOI 10.1073/pnas.1001793107; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Roer L, 2017, EURO SURVEILL, V22; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; Sun J, 2017, MBIO, V8, DOI 10.1128/mBio.00625-17; Sun J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.176, 10.1038/nmicrobiol.2016.176]; Tijet N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180347; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang QJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00361-17; Wang QJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0288-0; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; Wei PC, 2018, FASEB J, V32, P1085, DOI 10.1096/fj.201700705R; World Health Organization, 2016, ANTIMICROBIAL RESIST; Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yao X, 2016, LANCET INFECT DIS, V16, P288, DOI 10.1016/S1473-3099(16)00057-8; Ye HY, 2016, MBIO, V7, DOI 10.1128/mBio.00177-16; Yin WJ, 2017, MBIO, V8, DOI 10.1128/mBio.00543-17; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhang HM, 2016, SCI BULL, V61, P875, DOI 10.1007/s11434-016-1086-y; Zhang XF, 2016, EMERG INFECT DIS, V22, P1679, DOI 10.3201/eid2209.160464; Zhao FF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02229-16; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	76	36	41	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4350	4365		10.1074/jbc.RA117.000924	http://dx.doi.org/10.1074/jbc.RA117.000924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29462787	Green Published, hybrid			2022-12-28	WOS:000428204300009
J	Jung, TW; Kim, HC; Abd El-Aty, AM; Jeong, JH				Jung, Tae Woo; Kim, Hyoung-Chun; Abd El-Aty, A. M.; Jeong, Ji Hoon			Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; HEPATIC STEATOSIS; ER STRESS; INSULIN SENSITIVITY; LIPID-ACCUMULATION; INHIBITS INSULIN; ADIPOSE-TISSUE; UP-REGULATION; CELL-DEATH; ACTIVATION	Maresin 1 (MAR1), which is derived from docosahexaenoic acid biosynthesized by macrophages, has been reported to improve insulin resistance. Recently, it has been documented that MAR1 could ameliorate inflammation and insulin resistance in obese mice. These findings led us to investigate the effects of MAR1 on hepatic lipid metabolism. We found that MAR1 could stimulate AMP-activated protein kinase (AMPK), thereby augmenting sarcoendoplasmic reticulum Ca2+-ATPase 2b (SERCA2b) expression. This stimulation suppressed lipid accumulation by attenuating the endoplasmic reticulum (ER) stress in hepatocytes under hyperlipidemic conditions. Attenuation was mitigated by knockdown of AMPK or thapsigargin, a SERCA2b inhibitor. We also demonstrated that MAR1 administration resulted in increased hepatic AMPK phosphorylation and Serca2b mRNA expression, whereas hepatic ER stress was reduced in high-fat diet (HFD)-fed mice. Moreover, MAR1 treatment suppressed hepatic lipid synthesis, thereby attenuating hepatic steatosis in HFD-fed mice. In conclusion, our results suggest that MAR1 ameliorates hepatic steatosis via AMPK/SERCA2b-mediated suppression of ER stress. Therefore, MAR1 may be an effective therapeutic strategy for treating non-alcoholic fatty liver disease (NAFLD) via regulation of ER stress-induced hepatic lipogenesis.	[Jung, Tae Woo] Seoul Natl Univ, Bundang Hosp, Res Adm Team, Gyeonggi 13620, South Korea; [Kim, Hyoung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 24341, South Korea; [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt; [Jeong, Ji Hoon] Chung Ang Univ, Dept Pharmacol, Coll Med, Seoul 06974, South Korea; [Abd El-Aty, A. M.] Ataturk Univ, Med Fac, Dept Med Pharmacol, TR-25240 Erzurum, Turkey	Seoul National University (SNU); Kangwon National University; Egyptian Knowledge Bank (EKB); Cairo University; Chung Ang University; Chung Ang University Hospital; Ataturk University	Jeong, JH (corresponding author), Chung Ang Univ, Dept Pharmacol, Coll Med, 221 Heuksuk Dong, Seoul 156756, South Korea.	jhjeong3@cau.ac.kr	El-Aty, A. M. Abd/H-8216-2018	El-Aty, A. M. Abd/0000-0001-6596-7907	Basic Science Research Program through National Research Foundation of Korea - Korean Ministry of Education [2017R1D1A1B03028892]	Basic Science Research Program through National Research Foundation of Korea - Korean Ministry of Education	This work was supported by the Basic Science Research Program through National Research Foundation of Korea Grant 2017R1D1A1B03028892 funded by the Korean Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Bai YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100864; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Deng X, 2015, BBA-MOL CELL BIOL L, V1851, P1521, DOI 10.1016/j.bbalip.2015.08.007; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Fang DL, 2013, MOL CELL BIOCHEM, V381, P127, DOI 10.1007/s11010-013-1694-7; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Haas MJ, 2016, FREE RADICAL BIO MED, V99, P1, DOI 10.1016/j.freeradbiomed.2016.07.020; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jung TW, 2015, MOL CELL ENDOCRINOL, V417, P131, DOI 10.1016/j.mce.2015.09.027; Jung TW, 2013, BIOCHEM PHARMACOL, V86, P960, DOI 10.1016/j.bcp.2013.07.034; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kopach O, 2016, CELL CALCIUM, V59, P251, DOI 10.1016/j.ceca.2016.02.014; Lee YH, 2016, INT J OBESITY, V40, P356, DOI 10.1038/ijo.2015.173; Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002; Li RD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9203716; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Martinez-Fernandez L, 2017, FASEB J, V31, P2135, DOI 10.1096/fj.201600859R; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Moura-Assis A, 2018, J NUTR BIOCHEM, V53, P9, DOI 10.1016/j.jnutbio.2017.09.015; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Rius B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00257; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wang YZ, 2017, P NATL ACAD SCI USA, V114, pE1500, DOI 10.1073/pnas.1612991114; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang J, 2014, AM J PHYSIOL-CELL PH, V306, pC279, DOI 10.1152/ajpcell.00117.2013	45	46	47	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3981	3988		10.1074/jbc.RA117.000885	http://dx.doi.org/10.1074/jbc.RA117.000885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414781	Green Published, hybrid			2022-12-28	WOS:000427587500011
J	Mackie, TD; Kim, BY; Subramanya, AR; Bain, DJ; O'Donnell, AF; Welling, PA; Brodsky, JL				Mackie, Timothy D.; Kim, Bo-Young; Subramanya, Arohan R.; Bain, Daniel J.; O'Donnell, Allyson F.; Welling, Paul A.; Brodsky, Jeffrey L.			The endosomal trafficking factors CORVET and ESCRT suppress plasma membrane residence of the renal outer medullary potassium channel (ROMK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; K+ CHANNEL; QUALITY-CONTROL; CYSTIC-FIBROSIS; SURFACE EXPRESSION; SECRETORY PATHWAY; UBIQUITIN LIGASE; WILD-TYPE	Protein trafficking can act as the primary regulatory mechanism for ion channels with high open probabilities, such as the renal outer medullary (ROMK) channel. ROMK, also known as Kir1.1 (KCNJ1), is the major route for potassium secretion into the pro-urine and plays an indispensable role in regulating serum potassium and urinary concentrations. However, the cellular machinery that regulates ROMK trafficking has not been fully defined. To identify regulators of the cell-surface population of ROMK, we expressed a pH-insensitive version of the channel in the budding yeast Saccharomyces cerevisiae. We determined that ROMK primarily resides in the endoplasmic reticulum (ER), as it does in mammalian cells, and is subject to ER-associated degradation (ERAD). However, sufficient ROMK levels on the plasma membrane rescued growth on low-potassium medium of yeast cells lacking endogenous potassium channels. Next, we aimed to identify the biological pathways most important for ROMK regulation. Therefore, we used a synthetic genetic array to identify non-essential genes that reduce the plasma membrane pool of ROMK in potassium-sensitive yeast cells. Genes identified in this screen included several members of the endosomal complexes required for transport (ESCRT) and the class-C core vacuole/endosome tethering (CORVET) complexes. Mass spectroscopy analysis confirmed that yeast cells lacking an ESCRT component accumulate higher potassium concentrations. Moreover, silencing of ESCRT and CORVET components increased ROMK levels at the plasma membrane in HEK293 cells. Our results indicate that components of the post-endocytic pathway influence the cell-surface density of ROMK and establish that components in this pathway modulate channel activity.	[Mackie, Timothy D.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Bain, Daniel J.] Univ Pittsburgh, Dept Geol & Environm Sci, Pittsburgh, PA 15260 USA; [Kim, Bo-Young; Welling, Paul A.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Med Serv, Pittsburgh, PA 15240 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Res Serv, Pittsburgh, PA 15240 USA; [O'Donnell, Allyson F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Duquesne University	Brodsky, JL (corresponding author), A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Bain, Daniel J/G-3055-2013; Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; Bain, Daniel/0000-0003-1979-7016; O'Donnell, Allyson/0000-0003-0966-288X	National Institutes of Health [GM75061, DK79307, R01DK098145, DK054231]; National Science Foundation MCB CAREER [1553143]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK098145, R01DK054231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MCB CAREER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM75061 cystic fibrosis transmembrane conductance regulator (CFTR) and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J.L.B.), R01DK098145 (to A.R.S.), and DK054231 (to P.A.W.) and by National Science Foundation MCB CAREER Grant 1553143 (to A.F.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Qusairi L, 2017, J AM SOC NEPHROL, V28, P2431, DOI 10.1681/ASN.2016070732; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Apaja PM, 2014, PHYSIOLOGY, V29, P265, DOI 10.1152/physiol.00058.2013; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Bundis F, 2006, CELL PHYSIOL BIOCHEM, V17, P1, DOI 10.1159/000091454; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fallen K, 2009, CHANNELS, V3, P57, DOI 10.4161/chan.3.1.7817; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Frindt G, 2009, AM J PHYSIOL-RENAL, V296, pF347, DOI 10.1152/ajprenal.90527.2008; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Galmes R, 2015, TRAFFIC, V16, P1288, DOI 10.1111/tra.12334; Gao YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044150; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057282; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gottschling DE, 2017, CELL, V169, P24, DOI 10.1016/j.cell.2017.02.030; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Guiney EL, 2016, MOL BIOL CELL, V27, P4043, DOI 10.1091/mbc.E16-08-0570; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hirota Y, 2008, BIOCHEM BIOPH RES CO, V372, P469, DOI 10.1016/j.bbrc.2008.05.068; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kampmeyer C, 2017, J BIOL CHEM, V292, P15240, DOI 10.1074/jbc.M117.789867; Kingsbury JM, 2014, GENETICS, V196, P1077, DOI 10.1534/genetics.114.161646; Kojima A, 2012, BBA-MOL CELL RES, V1823, P534, DOI 10.1016/j.bbamcr.2011.12.004; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Leung YM, 2000, J BIOL CHEM, V275, P10182, DOI 10.1074/jbc.275.14.10182; Li K., 2016, MOL CELL, V65, P1; Lin DH, 2009, J BIOL CHEM, V284, P29614, DOI 10.1074/jbc.M109.041582; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MacDonald C, 2016, BIOCHEM SOC T, V44, P474, DOI 10.1042/BST20150263; MacGurn JA, 2014, CURR OPIN CELL BIOL, V29, P92, DOI 10.1016/j.ceb.2014.05.001; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; O'Donnell BM, 2017, J BIOL CHEM, V292, P12813, DOI 10.1074/jbc.M117.786376; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Pols MS, 2013, TRAFFIC, V14, P219, DOI 10.1111/tra.12027; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Raphemot R, 2013, JOVE-J VIS EXP, V71, P4209; Renigunta A, 2011, CELL PHYSIOL BIOCHEM, V28, P663, DOI 10.1159/000335761; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Seaayfan E, 2016, J BIOL CHEM, V291, P4487, DOI 10.1074/jbc.M115.702514; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shin ME, 2001, J BIOL CHEM, V276, P41388, DOI 10.1074/jbc.M105665200; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wade JB, 2011, AM J PHYSIOL-RENAL, V300, pF1385, DOI 10.1152/ajprenal.00592.2010; WANG WH, 1990, AM J PHYSIOL, V259, pF494, DOI 10.1152/ajprenal.1990.259.3.F494; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; WARD CL, 1994, J BIOL CHEM, V269, P25710; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Wiederkehr A, 2001, YEAST, V18, P759, DOI 10.1002/yea.726; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	106	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3201	3217		10.1074/jbc.M117.819086	http://dx.doi.org/10.1074/jbc.M117.819086			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29311259	Green Published, hybrid			2022-12-28	WOS:000426562800014
J	Tumelty, KE; Higginson-Scott, N; Fan, XP; Bajaj, P; Knowlton, KM; Shamashkin, M; Coyle, AJ; Lu, W; Berasi, SP				Tumelty, Kathleen E.; Higginson-Scott, Nathan; Fan, Xueping; Bajaj, Piyush; Knowlton, Kelly M.; Shamashkin, Michael; Coyle, Anthony J.; Lu, Weining; Berasi, Stephen P.			Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; PLURIPOTENT STEM-CELLS; URETERAL BUD OUTGROWTH; CONGENITAL-ANOMALIES; NEUROTROPHIC FACTOR; IN-VIVO; EXTRACELLULAR PROTEIN; NEURONAL MIGRATION; SECRETED PROTEINS; VERTEBRATE SLIT	Slit guidance ligand 2 (SLIT2) is a large, secreted protein that binds roundabout (ROBO) receptors on multiple cell types, including neurons and kidney podocytes. S LIT2-ROBO mediated signaling regulates neuronal migration and ureteric bud (UB) outgrowth during kidney development as well as glomerular filtration in adult kidneys. Additionally, SLIT2 binds Gremlin, an antagonist of bone morphogenetic proteins (BMPs), and BMP Gremlin signaling also regulates UB formation. However, direct cross-talk between the ROBO2-SLIT2 and BMP Gremlin signaling pathways has not been established. Here, we report the discovery of negative feedback between the SLIT2 and BMP Gremlin signaling pathways. We found that the SLIT2 Gremlin interaction inhibited both SLIT2-ROBO2 signaling in neurons and Gremlin antagonism of BMP activity in myoblasts and fibroblasts. Furthermore, BMP2 down-regulated SLIT2 expression and promoter activity through canonical BMP signaling. Gremlin treatment, BMP receptor inhibition, and SMAD family member 4 (SMAD4) knockdown rescued BMPmediated repression of SLIT2. BMP2 treatment of nephron progenitor cells derived from human embryonic stem cells decreased SLIT2 expression, further suggesting an interaction between the BMP2 Gremlin and SLIT2 pathways in human kidney cells. In conclusion, our study has revealed direct negative cross-talk between two pathways, previously thought to be unassociated, that may regulate both kidney development and adult tissue maintenance.	[Tumelty, Kathleen E.; Higginson-Scott, Nathan; Knowlton, Kelly M.; Shamashkin, Michael; Coyle, Anthony J.; Berasi, Stephen P.] Pfizer Inc, Ctr Therapeut Innovat, 610 Main St, Cambridge, MA 02139 USA; [Fan, Xueping; Lu, Weining] Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02118 USA; [Bajaj, Piyush] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA	Pfizer; Boston University; Pfizer	Berasi, SP (corresponding author), Pfizer Inc, Ctr Therapeut Innovat, 610 Main St, Cambridge, MA 02139 USA.	stephen.berasi@pfizer.com	Higginson-Scott, Nathan/GZA-4941-2022	Lu, Weining/0000-0002-6570-3044	Pfizer Worldwide Research and Development; National Institutes of Health [R01DK078226]; Pfizer Centers for Therapeutic Innovation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078226] Funding Source: NIH RePORTER	Pfizer Worldwide Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Centers for Therapeutic Innovation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Pfizer Worldwide Research and Development and in part by National Institutes of Health Grant R01DK078226 (to W.L.) and a research grant from the Pfizer Centers for Therapeutic Innovation (to W.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chang JL, 2015, J HEPATOL, V63, P1413, DOI 10.1016/j.jhep.2015.07.033; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Ciampi O, 2016, STEM CELL RES, V17, P130, DOI 10.1016/j.scr.2016.06.001; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2012, WIRES DEV BIOL, V1, P693, DOI 10.1002/wdev.52; Delloye-Bourgeois C, 2015, NAT NEUROSCI, V18, P36, DOI 10.1038/nn.3893; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fan XP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86934; Fan XP, 2012, CELL REPORTS, V2, P52, DOI 10.1016/j.celrep.2012.06.002; Feng YY, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0469-x; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Gu F, 2015, FRONT MED-PRC, V9, P431, DOI 10.1007/s11684-015-0416-9; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hwang DY, 2015, HUM GENET, V134, P905, DOI 10.1007/s00439-015-1570-5; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Katagiri T, 2016, COLD SPRING HARB PER, V8; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kinameri E, 2003, MOL BRAIN RES, V117, P221, DOI 10.1016/S0169-328X(03)00326-7; Kohl S, 2014, J AM SOC NEPHROL, V25, P1917, DOI 10.1681/ASN.2013101103; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lewis TC, 2013, BBA-GENE REGUL MECH, V1829, P1147, DOI 10.1016/j.bbagrm.2013.08.002; Li GY, 2013, J CELL BIOCHEM, V114, P2101, DOI 10.1002/jcb.24559; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li SS, 2015, INVEST OPHTH VIS SCI, V56, P5210, DOI 10.1167/iovs-14-16184; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Morin-Poulard I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11634; Morizane R, 2017, TRENDS MOL MED, V23, P246, DOI 10.1016/j.molmed.2017.01.001; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Nie XG, 2011, DEV BIOL, V352, P141, DOI 10.1016/j.ydbio.2011.01.027; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pilling D, 2014, P NATL ACAD SCI USA, V111, P18291, DOI 10.1073/pnas.1417426112; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Piper M, 2002, INT J DEV BIOL, V46, P545; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sainio K, 1997, DEVELOPMENT, V124, P4077; Saunders J, 2016, CELL MOL NEUROBIOL, V36, P955, DOI 10.1007/s10571-015-0281-8; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Towers PR, 1998, EXP NEPHROL, V6, P337; Wainwright EN, 2015, DEV BIOL, V404, P88, DOI 10.1016/j.ydbio.2015.05.023; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang ZH, 2010, TOXICOL LETT, V198, P348, DOI 10.1016/j.toxlet.2010.07.018; Ward Michael E., 2004, V294, P137; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu YF, 2009, J NEPHROL, V22, P403; Yuen DA, 2016, J AM SOC NEPHROL, V27, P2609, DOI 10.1681/ASN.2015040356; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhou XJ, 2017, EXP CELL RES, V352, P123, DOI 10.1016/j.yexcr.2017.02.001; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	87	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3039	3055		10.1074/jbc.M117.804021	http://dx.doi.org/10.1074/jbc.M117.804021			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317497	Green Published, hybrid			2022-12-28	WOS:000426562800002
J	Ellwanger, K; Becker, E; Kienes, I; Sowa, A; Postma, Y; Gloria, YC; Weber, ANR; Kufer, TA				Ellwanger, Kornelia; Becker, Emily; Kienes, Ioannis; Sowa, Anna; Postma, Yvonne; Gloria, Yamel Cardona; Weber, Alexander N. R.; Kufer, Thomas A.			The NLR family pyrin domain-containing 11 protein contributes to the regulation of inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOD-LIKE RECEPTORS; NF-KAPPA-B; MHC CLASS-I; NEGATIVE REGULATOR; GENE-EXPRESSION; RECOGNITION; IMMUNE; MEMBER; ROLES	Mammalian Nod-like receptor (NLR) proteins contribute to the regulation and induction of innate and adaptive immunity in mammals, although the function of about half of the currently identified NLR proteins remains poorly characterized. Here we analyzed the function of the primate-specific NLRP11 gene product. We show that NLRP11 is highly expressed in immune cells, including myeloid cells, B cells, and some B cell lymphoma lines. Overexpression of NLRP11 in human cells did not trigger key innate immune signaling pathways, including NF-kappa B and type I interferon responses. NLRP11 harbors a pyrin domain, which is responsible for inflammasome formation in related NLR proteins. However, NLRP11 did not interact with the inflammasome adaptor protein ASC, and it did not trigger caspase-1 activation. By contrast, expression of NLRP11 specifically repressed NF-kappa B and type I interferon responses, two key innate immune pathways involved in inflammation. This effect was independent of the pyrin domain and ATPase activity of NLRP11. siRNA-mediated knockdown of NLRP11 in human myeloid THP1 cells validated these findings and revealed enhanced lipopolysaccharide and Sendai virus-induced cytokine and interferon responses, respectively, in cells with reduced NLRP11 expression. In summary, our work identifies a novel role of NLRP11 in the regulation of inflammatory responses in human cells.	[Ellwanger, Kornelia; Becker, Emily; Kienes, Ioannis; Sowa, Anna; Postma, Yvonne; Kufer, Thomas A.] Univ Hohenheim, Inst Nutr Med, Dept Immunol, Fruwirthstr 12, D-70593 Stuttgart, Germany; [Gloria, Yamel Cardona; Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany	University Hohenheim; Eberhard Karls University of Tubingen	Kufer, TA (corresponding author), Univ Hohenheim, Inst Nutr Med, Dept Immunol, Fruwirthstr 12, D-70593 Stuttgart, Germany.	thomas.kufer@uni-hohenheim.de	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412; Ellwanger, Kornelia/0000-0003-4845-5795	University of Hohenheim; University of Tubingen Junior Professorship Program of the Federal State Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [CRC/SFB685]	University of Hohenheim; University of Tubingen Junior Professorship Program of the Federal State Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the University of Hohenheim. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the University of Tubingen Junior Professorship Program of the Federal State Baden-Wurttemberg and Deutsche Forschungsgemeinschaft CRC/SFB685 "Immunotherapy."	Abe T, 2017, IMMUNITY, V46, P621, DOI 10.1016/j.immuni.2017.03.020; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Charoenthongtrakul S, 2012, CELL MOL IMMUNOL, V9, P431, DOI 10.1038/cmi.2012.49; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lian YG, 2017, BIOMED PHARMACOTHER, V91, P590, DOI 10.1016/j.biopha.2017.04.120; McDaniel P, 2009, MOL REPROD DEV, V76, P151, DOI 10.1002/mrd.20937; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meunier E, 2017, TRENDS IMMUNOL, V38, P744, DOI 10.1016/j.it.2017.04.005; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Neerincx A, 2014, J IMMUNOL, V193, P3090, DOI 10.4049/jimmunol.1401065; Neerincx A, 2012, J IMMUNOL, V188, P4940, DOI 10.4049/jimmunol.1103136; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Sasaki Y, 2016, CURR TOP MICROBIOL, V393, P177, DOI 10.1007/82_2015_479; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058766; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Tadaki H, 2011, J HUM GENET, V56, P343, DOI 10.1038/jhg.2011.16; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Van Gorp H, 2014, FEBS J, V281, P4568, DOI 10.1111/febs.13014; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhong Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00333; Zhu LC, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0426-5	29	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2701	2710		10.1074/jbc.RA117.000152	http://dx.doi.org/10.1074/jbc.RA117.000152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29301940	Green Published, hybrid			2022-12-28	WOS:000426051900007
J	Zhang, N; Du, B				Zhang, Na; Du, Bing			Reply to Rubinstein: Is Lgr4 essential for VSV- and VSV-G-pseudotyped lentiviral vector entry to cells?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Letter							VESICULAR STOMATITIS-VIRUS; GLYCOPROTEIN; RECEPTOR; BINDING		[Du, Bing] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University	Du, B (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	bdu.ecnu@gmail.com						Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Liu BY, 2017, NAT IMMUNOL, V18, P214, DOI 10.1038/ni.3641; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Rubinstein M, 2018, J BIOL CHEM, V293, P112, DOI 10.1074/jbc.L117.000471; Zhang N, 2017, J BIOL CHEM, V292, P16527, DOI [10.1074/jbc.M117.802090, 10.1074/jbc.m117.802090]; Zhang N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1571	6	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					113	113		10.1074/jbc.RL117.000979	http://dx.doi.org/10.1074/jbc.RL117.000979			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29305522	Green Published, hybrid			2022-12-28	WOS:000419453200009
J	Wang, XK; Li, JS				Wang, Xiukun; Li, Jinsong			An intermediate cell state allows rerouting of cell fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							XEN-LIKE STATE	Somatic cell reprogramming into pluripotent stem cells using transcriptional factors or chemical compounds has been shown to include an intermediate cell state with epithelial features. Two recent papers show that this intermediate state can be redirected to create other differentiated cell typesspecifically hepatocytes and neuronsusing chemical cocktails. These results shed new light on a critical intermediate in cell fate conversion with mechanistic and practical implications.	[Wang, Xiukun; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Xiukun; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, Jinsong] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Li, JS (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Li, JS (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Li, JS (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	jsli@sibcb.ac.cn		li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2014CB964803, 2015AA020307]; National Natural Science Foundation of China [31530048, 31601163, 81672117]; Chinese Academy of Sciences [XDB19010204, OYZDJ-SSW-SMC023]; Shanghai Municipal Commission for Science and Technology [16JC1420500, 17JC1400900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology	This work was supported by grants from the Ministry of Science and Technology of China (2014CB964803 and 2015AA020307), National Natural Science Foundation of China (31530048, 31601163, and 81672117), Chinese Academy of Sciences (XDB19010204 and OYZDJ-SSW-SMC023), and Shanghai Municipal Commission for Science and Technology (16JC1420500 and 17JC1400900). The authors declare that they have no conflicts of interest with the contents of this article.	Cao ST, 2017, J BIOL CHEM, V292, P19122, DOI 10.1074/jbc.M117.812537; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2017, CELL STEM CELL, V21, P264, DOI 10.1016/j.stem.2017.05.019; Li X, 2017, NATL SCI REV, V4, P7, DOI 10.1093/nsr/nww060; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Smith ZD, 2016, NAT REV MOL CELL BIO, V17, P139, DOI 10.1038/nrm.2016.6; Xie X, 2017, CURR OPIN GENET DEV, V46, P104, DOI 10.1016/j.gde.2017.07.003; Zhao Y, 2015, CELL, V163, P1678, DOI 10.1016/j.cell.2015.11.017	10	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19133	19134		10.1074/jbc.H117.812537	http://dx.doi.org/10.1074/jbc.H117.812537			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29373866	hybrid, Green Published			2022-12-28	WOS:000415848000036
J	Hawk, MA; Schafer, ZT				Hawk, Mark A.; Schafer, Zachary T.			Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BREAST-CANCER; REDUCTIVE CARBOXYLATION; MAMMALIAN-CELLS; ANOIKIS; GROWTH; SUPPORTS; SERINE; GLYCINE; DEATH; FERROPTOSIS	Nontransformed cells that become detached from the extracellular matrix (ECM) undergo dysregulation of redox homeostasis and cell death. In contrast, cancer cells often acquire the ability to mitigate programmed cell death pathways and recalibrate the redox balance to survive after ECM detachment, facilitating metastatic dissemination. Accordingly, recent studies of the mechanisms by which cancer cells overcome ECM detachment-induced metabolic alterations have focused on mechanisms in redox homeostasis. The insights into these mechanisms may inform the development of therapeutics that manipulate redox homeostasis to eliminate ECM-detached cancer cells. Here, we review how ECM-detached cancer cells balance redox metabolism for survival.	[Hawk, Mark A.; Schafer, Zachary T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Schafer, ZT (corresponding author), 222 Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA.	zschafe1@nd.edu			American Cancer Society; Susan G. Komen; Phi Beta Psi Sorority; National Science Foundation; Boler-Parseghian Center for Rare and Neglected Diseases; Coleman Foundation	American Cancer Society(American Cancer Society); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Phi Beta Psi Sorority; National Science Foundation(National Science Foundation (NSF)); Boler-Parseghian Center for Rare and Neglected Diseases; Coleman Foundation	This work was supported by The American Cancer Society, Susan G. Komen, Phi Beta Psi Sorority, National Science Foundation, Boler-Parseghian Center for Rare and Neglected Diseases, Coleman Foundation, and funds from Ron and Rosemarie Malanga. This is the sixth article in the Thematic Minireview Series "Redox metabolism and signaling." The authors declare that they have no conflicts of interest with the contents of this article.	Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Bizjak M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01801-5; Buchheit CL, 2015, CELL DEATH DIFFER, V22, P1275, DOI 10.1038/cdd.2014.209; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Buchheit CL, 2012, SEMIN CELL DEV BIOL, V23, P402, DOI 10.1016/j.semcdb.2012.04.007; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Elia I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15267; Florey O, 2015, CURR MOL MED, V15, P861, DOI 10.2174/1566524015666151026100042; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Kamarajugadda S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.20; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kim SE, 2016, NAT NANOTECHNOL, V11, P977, DOI 10.1038/nnano.2016.164; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Madajewski B, 2016, MOL CANCER RES, V14, P14, DOI 10.1158/1541-7786.MCR-15-0207-T; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Mason JA, 2016, CELL DEATH DIFFER, V23, P1271, DOI 10.1038/cdd.2016.15; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Owens TW, 2009, CELL DEATH DIFFER, V16, P1551, DOI 10.1038/cdd.2009.102; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rayavarapu RR, 2015, J BIOL CHEM, V290, P8722, DOI 10.1074/jbc.M114.612754; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sundararaman A, 2016, J BIOL CHEM, V291, P14410, DOI 10.1074/jbc.M116.731257; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Weigel KJ, 2014, MOL CANCER RES, V12, P855, DOI 10.1158/1541-7786.MCR-14-0090; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	62	41	43	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7531	7537		10.1074/jbc.TM117.000260	http://dx.doi.org/10.1074/jbc.TM117.000260			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29339552	Green Published, hybrid			2022-12-28	WOS:000437256500007
J	Narayanan, A; Vago, FS; Li, KP; Qayyum, MZ; Yernool, D; Jiang, W; Murakami, KS				Narayanan, Anoop; Vago, Frank S.; Li, Kunpeng; Qayyum, M. Zuhaib; Yernool, Dinesh; Jiang, Wen; Murakami, Katsuhiko S.			Cryo-EM structure of Escherichia coli sigma(70) RNA polymerase and promoter DNA complex revealed a role of sigma non-conserved region during the open complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-electron microscopy; RNA polymerase; structural biology; promoter; transcription; cryo-EM; sigma non-conserved region; promoter DNA; open complex	TRANSCRIPTION INITIATION; X-RAY; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURES; MICROSCOPY	First step of gene expression is transcribing the genetic information stored in DNA to RNA by the transcription machinery including RNA polymerase (RNAP). In Escherichia coli, a primary sigma(70) factor forms the RNAP holoenzyme to express housekeeping genes. The sigma(70) contains a large insertion between the conserved regions 1.2 and 2.1, the sigma non-conserved region (sigma(NCR)), but its function remains to be elucidated. In this study, we determined the cryo-EM structures of the E. coli RNAP sigma(70) holoenzyme and its complex with promoter DNA (open complex, RPo) at 4.2 and 5.75 angstrom resolutions, respectively, to reveal native conformations of RNAP and DNA. The RPo structure presented here found an interaction between the sigma(NCR) and promoter DNA just upstream of the -10 element, which was not observed in a previously determined E. coli RNAP transcription initiation complex (RPo plus short RNA) structure by X-ray crystallography because of restraint of crystal packing effects. Disruption of the sigma(NCR) and DNA interaction by the amino acid substitutions (R157A/R157E) influences the DNA opening around the transcription start site and therefore decreases the transcription activity of RNAP. We propose that the sigma(NCR) and DNA interaction is conserved in proteobacteria, and RNAP in other bacteria replaces its role with a transcription factor.	[Narayanan, Anoop; Qayyum, M. Zuhaib; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Narayanan, Anoop; Vago, Frank S.; Li, Kunpeng; Yernool, Dinesh; Jiang, Wen] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47906 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.; Jiang, W (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47906 USA.	jiang12@purdue.edu; kum14@psu.edu	jiang, wen/GYI-9662-2022; Qayyum, Mohammad Zuhaib/AAD-8672-2022	Qayyum, Mohammad Zuhaib/0000-0003-2442-4812; Jiang, Wen/0000-0002-1292-2411	National Institutes of Health [GM087350, GM093142]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350, R01GM093142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM087350 (to K. S. M.) and GM093142 (to D. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Chen J, 2017, MOL CELL, V68, P388, DOI 10.1016/j.molcel.2017.09.006; Davis E, 2015, NUCLEIC ACIDS RES, V43, P433, DOI 10.1093/nar/gku1231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glyde R, 2017, MOL CELL, V67, P106, DOI 10.1016/j.molcel.2017.05.010; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Kang JY, 2017, ELIFE, V6, DOI 10.7554/eLife.25478; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Lin W, 2017, MOL CELL, V66, P169, DOI 10.1016/j.molcel.2017.03.001; Liu B, 2017, SCIENCE, V358, P947, DOI 10.1126/science.aao1923; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Molodtsov V, 2017, MOL MICROBIOL, V103, P1034, DOI 10.1111/mmi.13606; Molodtsov V, 2015, J MED CHEM, V58, P3156, DOI 10.1021/acs.jmedchem.5b00050; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Narayanan A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4282; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruff EF, 2015, J MOL BIOL, V427, P2435, DOI 10.1016/j.jmb.2015.05.024; Ruff EF, 2015, BIOMOLECULES, V5, P1035, DOI 10.3390/biom5021035; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	27	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7367	7375		10.1074/jbc.RA118.002161	http://dx.doi.org/10.1074/jbc.RA118.002161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581236	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000432174500029
J	Rodriguez, Y; Duan, MR; Wyrick, JJ; Smerdon, MJ				Rodriguez, Yesenia; Duan, Mingrui; Wyrick, John J.; Smerdon, Michael J.			A cassette of basic amino acids in histone H2B regulates nucleosome dynamics and access to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleosome; base excision repair (BER); DNA repair; chromatin; histone modification; glycosylase; HBR domain; histone H2B repression; polymerase beta	SITE-SPECIFIC ACETYLATION; EXCISION-REPAIR ENZYMES; CORE PARTICLES; POSTTRANSLATIONAL MODIFICATIONS; SACCHAROMYCES-CEREVISIAE; SEQUENCE; DOMAIN; STABILITY; BINDING; TAIL	Nucleosome dynamics, such as spontaneous DNA unwrapping, are postulated to have a critical role in regulating the access of DNA repair machinery to DNA lesions within nucleosomes. However, the specific histone domains that regulate nucleosome dynamics and the impact of such changes in intrinsic nucleosome dynamics on DNA repair are not well understood. Previous studies identified a highly conserved region in the N-terminal tail of histone H2B known as the histone H2B repression (or HBR) domain, which has a significant influence on gene expression, chromatin assembly, and DNA damage formation and repair. However, the molecular mechanism(s) that may account for these observations are limited. In this study, we characterized the stability and dynamics of HBR mutant nucleosome core particles (NCPs) in vitro by restriction enzyme accessibility (REA), FRET, and temperature-induced sliding of histone octamers. Our results indicate that HBR-NCPs are more dynamic, with a larger steady-state fraction of the NCP population occupying the unwrapped state than for WT-NCPs. Additionally, HBR-histone octamers are more susceptible to temperature-induced sliding on DNA than WT histone octamers. Furthermore, we show that the activity of base excision repair enzymes at uracil lesions and single nucleotide gaps is enhanced in a site-specific manner in HBR-NCPs. This enhanced activity correlates well with regions exhibiting increased DNA unwrapping. Finally, removal of the HBR domain is not sufficient to completely alleviate the structural constraints imposed by histone octamers on the activity of base excision repair enzymes.	[Rodriguez, Yesenia; Duan, Mingrui; Wyrick, John J.; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Biochem & Biophys, Pullman, WA 99164 USA; [Wyrick, John J.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Rodriguez, Yesenia] NIEHS, NIH, Genome Integr & Struct Biol Lab, POB 12233,Mail Drop F3-01, Res Triangle Pk, NC 27709 USA	Washington State University; Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health from the NIEHS, National Institutes of Health [ES002614, R21ES027937, ES004106]; National Institute of General Medical Sciences Training Grant [T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106, R21ES027937, R01ES002614, R37ES002614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS, National Institutes of Health; National Institute of General Medical Sciences Training Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES002614 (to M. J. S. and J. J. W.), R21ES027937 (to J. J. W.), and ES004106 (to M. J. S.) from the NIEHS, National Institutes of Health, and by National Institute of General Medical Sciences Training Grant T32GM008336 (to Y. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Guintini L, 2015, DNA REPAIR, V36, P98, DOI 10.1016/j.dnarep.2015.09.012; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kelbauskas L, 2009, BIOCHEM CELL BIOL, V87, P323, DOI 10.1139/O08-126; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mao P, 2017, GENOME RES, V27, P1674, DOI 10.1101/gr.225771.117; Mao P, 2017, PHOTOCHEM PHOTOBIOL, V93, P216, DOI 10.1111/php.12646; Mao P, 2016, NUCLEIC ACIDS RES, V44, P9142, DOI 10.1093/nar/gkw588; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Nag R, 2010, NUCLEIC ACIDS RES, V38, P1450, DOI 10.1093/nar/gkp1074; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Olmon ED, 2017, ACS CHEM BIOL, V12, P692, DOI 10.1021/acschembio.6b00921; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; PENNINGS S, 1991, J MOL BIOL, V220, P101, DOI 10.1016/0022-2836(91)90384-I; Rodriguez Y, 2016, J BIOL CHEM, V291, P11434, DOI 10.1074/jbc.M116.725788; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Schermerhorn KM, 2014, ACCOUNTS CHEM RES, V47, P1238, DOI 10.1021/ar400275a; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; Sivolob A, 2003, J MOL BIOL, V326, P49, DOI 10.1016/S0022-2836(02)01372-4; Sugiyama M, 2014, BIOPHYS J, V106, P2206, DOI 10.1016/j.bpj.2014.04.007; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wyrick JJ, 2012, BBA-GENE REGUL MECH, V1819, P892, DOI 10.1016/j.bbagrm.2012.04.001; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Zheng S, 2014, MOL CELL BIOL, V34, P303, DOI 10.1128/MCB.00478-13	51	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7376	7386		10.1074/jbc.RA117.000358	http://dx.doi.org/10.1074/jbc.RA117.000358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588367	Green Published, hybrid			2022-12-28	WOS:000432174500030
J	Vinberg, F; Peshenko, IV; Chen, J; Dizhoor, AM; Kefalov, VJ				Vinberg, Frans; Peshenko, Igor V.; Chen, Jeannie; Dizhoor, Alexander M.; Kefalov, Vladimir J.			Guanylate cyclase-activating protein 2 contributes to phototransduction and light adaptation in mouse cone photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; calcium; guanylate cyclase (guanylyl cyclase); retina; vision; calcium; cone photoreceptor; guanylate cyclase activating proteins; light adaptation; phototransduction; light activation; photoresponse; color vision	AUTOSOMAL-DOMINANT CONE; CYTOPLASMIC CALCIUM-CONCENTRATION; OUTER SEGMENT MEMBRANE; CYCLIC-GMP; ROD DYSTROPHY; GENE; MUTATION; GCAP1; BINDING; EXPRESSION	Light adaptation of photoreceptor cells is mediated by Ca2+-dependent mechanisms. In darkness, Ca2+ influx through cGMP-gated channels into the outer segment of photoreceptors is balanced by Ca2+ extrusion via Na+/Ca2+, K+ exchangers (NCKXs). Light activates a G protein signaling cascade, which closes cGMP-gated channels and decreases Ca2+ levels in photoreceptor outer segment because of continuing Ca2+ extrusion by NCKXs. Guanylate cyclase-activating proteins (GCAPs) then up-regulate cGMP synthesis by activating retinal membrane guanylate cyclases (RetGCs) in low Ca2+. This activation of RetGC accelerates photoresponse recovery and critically contributes to light adaptation of the nighttime rod and daytime cone photoreceptors. In mouse rod photoreceptors, GCAP1 and GCAP2 both contribute to the Ca2+-feedback mechanism. In contrast, only GCAP1 appears to modulate RetGC activity in mouse cones because evidence of GCAP2 expression in cones is lacking. Surprisingly, we found that GCAP2 is expressed in cones and can regulate light sensitivity and response kinetics as well as light adaptation of GCAP1-deficient mouse cones. Furthermore, we show that GCAP2 promotes cGMP synthesis and cGMP-gated channel opening in mouse cones exposed to low Ca2+. Our biochemical model and experiments indicate that GCAP2 significantly contributes to the activation of RetGC1 at low Ca2+ when GCAP1 is not present. Of note, in WT mouse cones, GCAP1 dominates the regulation of cGMP synthesis. We conclude that, under normal physiological conditions, GCAP1 dominates the regulation of cGMP synthesis in mouse cones, but if its function becomes compromised, GCAP2 contributes to the regulation of phototransduction and light adaptation of cones.	[Vinberg, Frans; Kefalov, Vladimir J.] Washington Univ, Sch Med, Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Chen, Jeannie] Univ Southern Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Vinberg, Frans] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA	Washington University (WUSTL); University of Southern California; Utah System of Higher Education; University of Utah	Kefalov, VJ (corresponding author), Washington Univ, Sch Med, Ophthalmol & Visual Sci, St Louis, MO 63110 USA.; Kefalov, VJ (corresponding author), Washington Univ, Dept Ophthalmol & Visual Sci, 660 South Euclid Ave, St Louis, MO 63110 USA.	kefalov@wustl.edu	Vinberg, Frans/AAK-8615-2021	Vinberg, Frans/0000-0003-3439-4979; Kefalov, Vladimir/0000-0002-1659-008X; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY026651, EY019312, EY027387, EY012155, EY027193, EY011522, EY02687]; Research to Prevent Blindness; Ella and Georg Ehrnrooth Foundation; NATIONAL EYE INSTITUTE [R01EY012155, P30EY002687, K99EY026651, R01EY027387, R01EY027193, R01EY019312, R00EY026651, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ella and Georg Ehrnrooth Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY026651 (to F. V.), EY019312 (to V. J. K.), EY027387 (to V. J. K. and J. C.), EY012155 and EY027193 (to J. C.), EY011522 (to A. M. D.), and EY02687 (to Washington University, Department Ophthalmology); Research to Prevent Blindness; and the Ella and Georg Ehrnrooth Foundation (to F. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BASTIAN BL, 1982, J PHYSIOL-LONDON, V330, P307, DOI 10.1113/jphysiol.1982.sp014343; Boye SL, 2015, HUM GENE THER, V26, P575, DOI 10.1089/hum.2015.053; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Gross OP, 2012, BIOPHYS J, V102, P1775, DOI 10.1016/j.bpj.2012.03.035; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jiang L, 2005, MOL VIS, V11, P143; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LIPTON SA, 1977, J GEN PHYSIOL, V70, P747, DOI 10.1085/jgp.70.6.747; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037832; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Sakurai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32521; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Vinberg F, 2017, ELIFE, V6, DOI 10.7554/eLife.24550; Vinberg F, 2015, J GEN PHYSIOL, V146, P307, DOI 10.1085/jgp.201511412; Vinberg F, 2015, HUM MOL GENET, V24, P5915, DOI 10.1093/hmg/ddv319; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Vinberg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013025; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wang T, 2014, J BIOL CHEM, V289, P29310, DOI 10.1074/jbc.M114.595207; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; YAU KW, 1981, NATURE, V292, P502, DOI 10.1038/292502a0; Zhu XM, 2002, MOL VIS, V8, P462	59	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7457	7465		10.1074/jbc.RA117.001574	http://dx.doi.org/10.1074/jbc.RA117.001574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29549122	Green Published, hybrid			2022-12-28	WOS:000432174500036
J	Huang, XJ; Zhu, HW; Gao, ZM; Li, JZ; Zhuang, JL; Dong, Y; Shen, B; Li, MQ; Zhou, H; Guo, HQ; Huang, RM; Yan, J				Huang, Xiaojing; Zhu, Hongwen; Gao, Zemin; Li, Junzun; Zhuang, Junlong; Dong, Yu; Shen, Bing; Li, Meiqian; Zhou, Hu; Guo, Hongqian; Huang, Ruimin; Yan, Jun			Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; cancer biology; invasion; mass spectrometry (MS); microRNA (miRNA); metalloprotease; bladder cancer; miR-370-3p; MMP10; Wnt7a	OVARIAN-CANCER; BETA-CATENIN; LUNG-CANCER; MOLECULAR CHARACTERIZATION; EPIGENETIC INACTIVATION; UP-REGULATION; TUMOR-GROWTH; EXPRESSION; PATHWAY; DIFFERENTIATION	Once urinary bladder cancer (UBC) develops into muscle-invasive bladder cancer, its mortality rate increases dramatically. However, the molecular mechanisms of UBC invasion and metastasis remain largely unknown. Herein, using 5637 UBC cells, we generated two sublines with low (5637 NMI) and high (5637 HMI) invasive capabilities. Mass spectrum analyses revealed that the Wnt family protein Wnt7a is more highly expressed in 5637 HMI cells than in 5637 NMI cells. We also found that increased Wnt7a expression is associated with UBC metastasis and predicted worse clinical outcome in UBC patients. Wnt7a depletion in 5637 HMI and T24 cells reduced UBC cell invasion and decreased levels of active -catenin and its downstream target genes involved in the epithelial-to-mesenchymal transition (EMT) and extracellular matrix (ECM) degradation. Consistently, treating 5637 NMI and J82 cells with recombinant Wnt7a induced cell invasion, EMT, and expression of ECM degradation-associated genes. Moreover, TOP/FOPflash luciferase assays indicated that Wnt7a activated canonical -catenin signaling in UBC cells, and increased Wnt7a expression was associated with nuclear -catenin in UBC samples. Wnt7a ablation suppressed matrix metalloproteinase 10 (MMP10) expression, and Wnt7a overexpression increased MMP10 promoter activity through two TCF/LEF promoter sites, confirming that Wnt7a-mediated MMP10 activation is mediated by the canonical Wnt/-catenin pathway. Of note, the microRNA miR-370-3p directly repressed Wnt7a expression and thereby suppressed UBC cell invasion, which was partially restored by Wnt7a overexpression. Our results have identified an miR-370-3p/Wnt7a axis that controls UBC invasion through canonical Wnt/-catenin signaling, which may offer prognostic and therapeutic opportunities.	[Huang, Xiaojing; Gao, Zemin; Li, Junzun; Li, Meiqian; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu 210061, Peoples R China; [Huang, Xiaojing; Gao, Zemin; Li, Junzun; Li, Meiqian; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu 210061, Peoples R China; [Zhu, Hongwen; Dong, Yu; Zhou, Hu] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Huang, Ruimin; Yan, Jun] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Zhuang, Junlong; Guo, Hongqian] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China; [Dong, Yu] Shanghai Univ, Shanghai 200444, Peoples R China; [Shen, Bing] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Shanghai 200080, Peoples R China	Nanjing University; Nanjing University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University; Shanghai University; Shanghai Jiao Tong University	Yan, J (corresponding author), Nanjing Univ, Lab Canc Epigenet, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	dr.ghq@nju.edu.cn; rmhuang@simm.ac.cn; yanjun@nju.edu.cn	Yan, Jun/Q-3031-2017	Yan, Jun/0000-0002-1303-1952	National Natural Science Foundation of China [81372168, 81572519, 81672873, 81771890]; Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University [KF-GN-201602]; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences [SIMM1705KF-02, SIMM1705KF-06]; One Hundred Talent Program of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences(Chinese Academy of Sciences); One Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation of China Grants 81372168, 81572519, 81672873, and 81771890; Open Foundation of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University Grant KF-GN-201602, and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Grant SIMM1705KF-02 and SIMM1705KF-06. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by One Hundred Talent Program of Chinese Academy of Sciences.	Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Avgustinova A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10305; Bikkavilli RK, 2015, ONCOGENE, V34, P5317, DOI 10.1038/onc.2015.2; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Howe LR, 2003, CANCER RES, V63, P1906; Jean C, 2009, CANCER RES, V69, P3291, DOI 10.1158/0008-5472.CAN-08-1909; Jung DB, 2015, ONCOTARGET, V6, P4992, DOI 10.18632/oncotarget.3214; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; King ML, 2015, ONCOGENE, V34, P3452, DOI 10.1038/onc.2014.277; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kondratov AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047012; Lim SY, 2016, ONCOGENE, V35, P5735, DOI 10.1038/onc.2016.107; Lindberg D, 2007, CLIN ENDOCRINOL, V66, P110, DOI 10.1111/j.1365-2265.2006.02694.x; Liu YD, 2013, INT J GYNECOL CANCER, V23, P304, DOI 10.1097/IGC.0b013e31827c7708; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Flores CP, 2017, INT J ONCOL, V50, P1461, DOI 10.3892/ijo.2017.3948; Panani AD, 2004, ANTICANCER RES, V24, P2967; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peng ZS, 2016, BRAIN RES, V1644, P53, DOI 10.1016/j.brainres.2016.04.066; Pierzynski JA, 2015, J UROLOGY, V194, P1771, DOI 10.1016/j.juro.2015.07.032; Rohani MG, 2015, J INVEST DERMATOL, V135, P2377, DOI 10.1038/jid.2015.167; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Shi XJ, 2016, ONCOTARGET, V7, P36407, DOI 10.18632/oncotarget.9239; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simon R, 2001, CANCER RES, V61, P4514; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Stoehr R, 2002, INT J ONCOL, V20, P905; Sundqvist A, 2018, NUCLEIC ACIDS RES, V46, P1180, DOI 10.1093/nar/gkx1190; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Urakami S, 2006, CLIN CANCER RES, V12, P383, DOI 10.1158/1078-0432.CCR-05-1344; Wang CH, 2014, FEBS LETT, V588, P4654, DOI 10.1016/j.febslet.2014.10.037; Wang RYR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022060; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177; Zhang Q, 2015, ONCOTARGET, V6, P37335, DOI 10.18632/oncotarget.6135; Zhao L, 2017, ONCOGENE, V36, P3384, DOI 10.1038/onc.2016.487; Zhao W, 2014, J BIOL CHEM, V289, P11219, DOI 10.1074/jbc.M113.535989; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542	48	69	74	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6693	6706		10.1074/jbc.RA118.001689	http://dx.doi.org/10.1074/jbc.RA118.001689			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29549123	Green Published, hybrid			2022-12-28	WOS:000431487300007
J	Prasad, H; Rao, R				Prasad, Hari; Rao, Rajini			Histone deacetylase-mediated regulation of endolysosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase (V-ATPase); pH regulation; endosome; apoE4; histone deacetylase (HDAC); amyloid-beta (AB); transporter; yeast physiology; yeast; Na; H plus exchanger; sodium; hydrogen exchanger; CREB; antifungal; trichostatin A; rolipram	GENOME-WIDE ANALYSIS; ALZHEIMERS-DISEASE; NA+/H+ EXCHANGER; CHRISTIANSON SYNDROME; SYNAPTIC PLASTICITY; COGNITIVE FUNCTIONS; PRECURSOR PROTEIN; CELLULAR PH; LIFE-SPAN; V-ATPASE	The pH of the endolysosomal system is tightly regulated by a balance of proton pump and leak mechanisms that are critical for storage, recycling, turnover, and signaling functions in the cell. Dysregulation of endolysosomal pH has been linked to aging, amyloidogenesis, synaptic dysfunction, and various neurodegenerative disorders, including Alzheimer's disease. Therefore, understanding the mechanisms that regulate luminal pH may be key to identifying new targets for managing these disorders. Meta-analysis of yeast microarray databases revealed that nutrient-limiting conditions inhibited the histone deacetylase (HDAC) Rpd3 and thereby up-regulated transcription of the endosomal Na+/H+ exchanger Nhx1, resulting in vacuolar alkalinization. Consistent with these findings, Rpd3 inhibition by the HDAC inhibitor and antifungal drug trichostatin A induced Nhx1 expression and vacuolar alkalinization. Bioinformatics analysis of Drosophila and mouse databases revealed that caloric control of the Nhx1 orthologs DmNHE3 and NHE6, respectively, is also mediated by HDACs. We show that NHE6 is a target of the transcription factor cAMP-response element-binding protein (CREB), a known regulator of cellular responses to low-nutrient conditions, providing a molecular mechanism for nutrient- and HDAC-dependent regulation of endosomal pH. Of note, pharmacological targeting of the CREB pathway to increase NHE6 expression helped regulate endosomal pH and correct defective clearance of amyloid A in an apoE4 astrocyte model of Alzheimer's disease. These observations from yeast, fly, mouse, and cell culture models point to an evolutionarily conserved mechanism for HDAC-mediated regulation of endosomal NHE expression. Our insights offer new therapeutic strategies for modulation of endolysosomal pH in fungal infection and human disease.	[Prasad, Hari; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu			Johns Hopkins Medicine Discovery Fund; National Institutes of Health [DK054214]; International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER	Johns Hopkins Medicine Discovery Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Fulbright Science and Technology Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Johns Hopkins Medicine Discovery Fund (to R. R.). This work was also supported by National Institutes of Health Grant DK054214 (to R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; A Fulbright Fellow supported by the International Fulbright Science and Technology Award.	Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bosio MC, 2017, NUCLEIC ACIDS RES, V45, P4493, DOI 10.1093/nar/gkx058; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; da Silva CR, 2013, ANTIMICROB AGENTS CH, V57, P1691, DOI 10.1128/AAC.00966-12; Davey HM, 2012, ENVIRON MICROBIOL, V14, P1249, DOI 10.1111/j.1462-2920.2012.02705.x; Deckert J, 2002, MOL CELL BIOL, V22, P6458, DOI 10.1128/MCB.22.18.6458-6470.2002; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Esmail S, 2018, J BIOL CHEM, V293, P2787, DOI 10.1074/jbc.M117.818872; Fermi B, 2016, NUCLEIC ACIDS RES, V44, P6113, DOI 10.1093/nar/gkw194; Fusco S, 2016, CELL REP, V14, P1195, DOI 10.1016/j.celrep.2015.12.092; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Johnson ML, 2016, DIABETES, V65, P74, DOI 10.2337/db15-0675; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kim J, 2016, J BIOL CHEM, V291, P18591, DOI 10.1074/jbc.C116.744037; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kondapalli KC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7289; Kondapalli KC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00172; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Leonov A, 2017, ONCOTARGET, V8, P69328, DOI 10.18632/oncotarget.20614; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Makena MR, 2017, MOL CANCER THER, V16, P649, DOI 10.1158/1535-7163.MCT-16-0749; Maxfield FR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016931; Mignot C, 2013, BRAIN DEV-JPN, V35, P172, DOI 10.1016/j.braindev.2012.03.010; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Nibuya M, 1996, J NEUROSCI, V16, P2365; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Patenaude C, 2013, J BIOL CHEM, V288, P26256, DOI 10.1074/jbc.M113.494815; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Prasad H., 2018, BIORXIV, DOI [https://doi.org/10.1101/243097, 10. 1101/243097, DOI 10.1101/243097]; Prasad Hari, 2017, Matters (Zur), V2017, DOI 10.19185/matters.201704000009; Prasad H, 2015, FUTURE ONCOL, V11, P1847, DOI [10.2217/FON.15.93, 10.2217/fon.15.93]; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Qiao F, 2014, J ALZHEIMERS DIS, V41, P1165, DOI 10.3233/JAD-140375; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; Schwede M, 2014, MOL PSYCHIATR, V19, P277, DOI 10.1038/mp.2013.28; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; SILVE S, 1992, MOL CELL BIOL, V12, P4197, DOI 10.1128/MCB.12.9.4197; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Ulici V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008866; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Westmark CJ, 2016, MOL PSYCHIATR, V21, P1333, DOI 10.1038/mp.2016.134; Wheatley KE, 2011, J OBES, V2011, DOI 10.1155/2011/265417; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhang Yong-Qiang, 2010, Virulence, V1, P551, DOI 10.4161/viru.1.6.13802	76	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6721	6735		10.1074/jbc.RA118.002025	http://dx.doi.org/10.1074/jbc.RA118.002025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29567836	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000431487300009
J	Yang, Z; Follett, J; Kerr, MC; Clairfeuille, T; Chandra, M; Collins, BM; Teasdale, RD				Yang, Zhe; Follett, Jordan; Kerr, Markus C.; Clairfeuille, Thomas; Chandra, Mintu; Collins, Brett M.; Teasdale, Rohan D.			Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sorting nexin (SNX); glutamine; lysosome; plasma membrane; mammalian target of rapamycin (mTOR); autophagy; cell cycle	AMINO-ACID; CANCER-CELLS; BREAST-CANCER; SLC1A5; SURFACE; GROWTH; MTORC1; ASCT2/SLC1A5; DEGRADATION; ACTIVATION	Alanine-, serine-, cysteine-preferring transporter 2 (ASCT2, SLC1A5) is responsible for the uptake of glutamine into cells, a major source of cellular energy and a key regulator of mammalian target of rapamycin (mTOR) activation. Furthermore, ASCT2 expression has been reported in several human cancers, making it a potential target for both diagnostic and therapeutic purposes. Here we identify ASCT2 as a membrane-trafficked cargo molecule, sorted through a direct interaction with the PDZ domain of sorting nexin 27 (SNX27). Using both membrane fractionation and subcellular localization approaches, we demonstrate that the majority of ASCT2 resides at the plasma membrane. This is significantly reduced within CrispR-mediated SNX27 knockout (KO) cell lines, as it is missorted into the lysosomal degradation pathway. The reduction of ASCT2 levels in SNX27 KO cells leads to decreased glutamine uptake, which, in turn, inhibits cellular proliferation. SNX27 KO cells also present impaired activation of the mTOR complex 1 (mTORC1) pathway and enhanced autophagy. Taken together, our data reveal a role for SNX27 in glutamine uptake and amino acid-stimulated mTORC1 activation via modulation of ASCT2 intracellular trafficking.	[Yang, Zhe; Teasdale, Rohan D.] Univ Queensland, Fac Med, Sch Biomed Sci, William MacGregor Bld,Rm 420, Brisbane, Qld 4072, Australia; [Yang, Zhe; Follett, Jordan; Kerr, Markus C.; Clairfeuille, Thomas; Chandra, Mintu; Collins, Brett M.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Teasdale, RD (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, William MacGregor Bld,Rm 420, Brisbane, Qld 4072, Australia.	R.Teasdale@uq.edu.au	CHANDRA, MINTU/GLQ-8529-2022; Teasdale, Rohan/AAD-6698-2019; Teasdale, Rohan D/B-2538-2009; Yang, Zhe/O-3489-2019; Collins, Brett/J-1563-2014	CHANDRA, MINTU/0000-0003-2382-5024; Teasdale, Rohan/0000-0001-7455-5269; Teasdale, Rohan D/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Collins, Brett/0000-0002-6070-3774	Australian Research Council [DP160101573]; National Health and Medical Research Council [APP1058734]; National Health and Medical Research Council Career Development Fellowship [APP1061574]; National Health and Medical Research Council Senior Research Fellowship [APP1041929]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Australian Research Council (DP160101573) and National Health and Medical Research Council (APP1058734). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Career Development Fellowship APP1061574.; Supported by National Health and Medical Research Council Senior Research Fellowship APP1041929.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Avissar NE, 2008, DIGEST DIS SCI, V53, P2113, DOI 10.1007/s10620-007-0120-y; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Console L, 2015, BBA-MOL CELL RES, V1853, P1636, DOI 10.1016/j.bbamcr.2015.03.017; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Ghai R, 2015, J CELL SCI, V128, P553, DOI 10.1242/jcs.158204; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kvainickas A, 2017, J CELL SCI, V130, P382, DOI 10.1242/jcs.196758; Lu HQ, 2016, CANCER LETT, V381, P23, DOI 10.1016/j.canlet.2016.07.020; Marshall AD, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.70; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; McGough IJ, 2014, J CELL SCI, V127, P4940, DOI 10.1242/jcs.156299; Murray M, 2017, BRIT J PHARMACOL, V174, P1908, DOI 10.1111/bph.13785; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Palmada M, 2005, BIOCHEM BIOPH RES CO, V331, P272, DOI 10.1016/j.bbrc.2005.03.159; Pochini L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00061; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scalise M, 2014, AMINO ACIDS, V46, P2463, DOI 10.1007/s00726-014-1808-x; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Suzuki M, 2017, BIOCHEM BIOPH RES CO, V482, P651, DOI 10.1016/j.bbrc.2016.11.089; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Teo WX, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00091; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Yang Z, 2016, FASEB J, V30, P1037, DOI 10.1096/fj.15-274704; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151	36	22	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6802	6811		10.1074/jbc.RA117.000735	http://dx.doi.org/10.1074/jbc.RA117.000735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29563155	hybrid, Green Published			2022-12-28	WOS:000431487300015
J	Aguirre, JD; Dunkerley, KM; Lam, R; Rusal, M; Shaw, GS				Aguirre, Jacob D.; Dunkerley, Karen M.; Lam, Rica; Rusal, Michele; Shaw, Gary S.			Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; PTEN-induced putative kinase 1 (PINK1); protein structure; protein folding; protein-protein interaction; ubiquitylation (ubiquitination); Parkinson's disease (autosomal recessive early onset) 7 (PARK7)	UBIQUITIN-LIKE DOMAIN; PINK1-DEPENDENT PHOSPHORYLATION; PATHOGENIC MUTATIONS; PROTEIN-DEGRADATION; UBL DOMAIN; ACTIVATION; DISEASE; MECHANISM; PINK1; PROTEASOME	Autosomal recessive juvenile Parkinsonism (ARJP) is an inherited neurodegenerative disease in which 50% of affected individuals harbor mutations in the gene encoding the E3 ligase parkin. Parkin regulates the mitochondrial recycling pathway, which is induced by oxidative stress. In its native state, parkin is auto-inhibited by its N-terminal ubiquitin-like (Ubl) domain, which blocks the binding site for an incoming E2 similar to ubiquitin conjugate, needed for parkin's ubiquitination activity. Parkin is activated via phosphorylation of Ser-65 in its Ubl domain by PTEN-induced putative kinase 1 (PINK1) and a ubiquitin molecule phosphorylated at a position equivalent to Ser-65 in parkin. Here we have examined the underlying molecular mechanism of phosphorylation of parkin's Ubl domain carrying ARJP-associated substitutions and how altered phosphorylation modulates parkin activation and ubiquitination. We found that three substitutions in the Ubl domain (G12R, R33Q, and R42P) significantly decrease PINK1's ability to phosphorylate the Ubl domain. We noted that two basic loss-of-function substitutions (R33Q and R42P) are close to acidic patches in the proposed PINK1-parkin interface, indicating that ionic interactions at this site may be important for efficient parkin phosphorylation. Increased auto-ubiquitination with unique ubiquitin chain patterns was observed for two other Ubl domain substitutions (G12R and T55I), suggesting that these substitutions, along with phosphorylation, increase parkin degradation. Moreover, Ubl domain phosphorylation decreased its affinity for the potential effector protein ataxin-3, which edits ubiquitin chain building by parkin. Overall, our work provides a framework for the mechanisms of parkin's loss-of-function, indicating an interplay between ARJP-associated substitutions and phosphorylation of its Ubl domain.	[Aguirre, Jacob D.; Dunkerley, Karen M.; Lam, Rica; Rusal, Michele; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca			Ontario graduate scholarship; Parkinson Canada scholarship; Canadian Institutes of Health Research [MOP 14606]	Ontario graduate scholarship(Ontario Graduate Scholarship); Parkinson Canada scholarship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an Ontario graduate scholarship (to K. M. D.), a Parkinson Canada scholarship (to J. D. A.), and research grant MOP 14606 from the Canadian Institutes of Health Research (to G. S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguileta MA, 2015, J BIOL CHEM, V290, P7492, DOI 10.1074/jbc.M114.614925; Aguirre JD, 2017, P NATL ACAD SCI USA, V114, P298, DOI 10.1073/pnas.1613040114; Bai JJ, 2013, BIOCHEMISTRY-US, V52, P7369, DOI 10.1021/bi400780v; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Cookson MR, 2003, NEUROMOL MED, V3, P1, DOI 10.1385/NMM:3:1:1; Dong X, 2017, P NATL ACAD SCI USA, V114, P6770, DOI 10.1073/pnas.1705718114; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fiesel FC, 2015, HUM MUTAT, V36, P774, DOI 10.1002/humu.22808; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klosowiak JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33019; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Kumar A, 2017, ELIFE, V6, DOI 10.7554/eLife.29985; Kumar A, 2017, NAT STRUCT MOL BIOL, V24, P475, DOI 10.1038/nsmb.3400; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Liu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep12088; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Safadi SS, 2011, BIOCHEMISTRY-US, V50, P2603, DOI 10.1021/bi200065g; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Schubert AF, 2017, NATURE, V552, P51, DOI 10.1038/nature24645; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Tang MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14697; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	61	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6337	6348		10.1074/jbc.RA117.000605	http://dx.doi.org/10.1074/jbc.RA117.000605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29530980	Green Published, hybrid			2022-12-28	WOS:000431108600010
J	Zhao, XP; Zhao, L; Yang, H; Li, JJ; Min, XJ; Yang, FJ; Liu, JJ; Huang, G				Zhao, Xiaoping; Zhao, Li; Yang, Hao; Li, Jiajin; Min, Xuejie; Yang, Fajun; Liu, Jianjun; Huang, Gang			Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid metabolism; gene transcription; hepatocellular carcinoma; lipid synthesis; lipogenesis; cell proliferation; liver cancer; pyruvate kinase; PKM2; SREBP-1a; sterol regulatory element-binding protein	LIPID-METABOLISM; GENE-TRANSCRIPTION; CANCER-CELLS; TUMOR-GROWTH; TUMORIGENESIS; PATHWAY; EXPRESSION; PROGNOSIS; ISOFORM; SREBP1	Dysregulation of lipid metabolism is common in cancer cells, but the underlying mechanisms are poorly understood. Sterol regulatory element-binding proteins (SREBPs) stimulate lipid biosynthesis through transcriptional activation of lipogenic enzymes. However, SREBPs' roles and potential interacting partners in cancer cells are not fully defined. Using a biochemical approach, we found here that pyruvate kinase M2 (PKM2) physically interacts with the nuclear form of SREBP-1a (nBP1a), by binding to amino acids 43-56 in nBP1a. We also found that PKM2 activates SREBP target gene expression and lipid biosynthesis by stabilizing nBP1a proteins. Using a competitive peptide inhibitor to block the formation of the SREBP-1a/PKM2 complex, we observed that this blockade inhibited lipogenic gene expression. Of note, nBP1a phosphorylation at Thr-59 enhanced the binding to PKM2 and promoted cancer cell growth. Moreover, we show that PKM2 phosphorylates Thr-59 in vitro. Lastly, in human patients with hepatocellular carcinoma, nBP1a phosphorylation at Thr-59 was negatively correlated with clinical outcomes. Together, our results reveal that nBP1a/PKM2 interaction activates lipid metabolism genes in cancer cells and that Thr-59 phosphorylation of SREBP-1a plays an important role in cancer cell proliferation.	[Zhao, Xiaoping; Zhao, Li; Li, Jiajin; Min, Xuejie; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Dept Nucl Med, Ren Ji Hosp, Sch Med, Shanghai 200127, Peoples R China; [Yang, Hao; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200025, Peoples R China; [Yang, Fajun] Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, New York, NY 10461 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Yeshiva University	Zhao, XP; Liu, JJ; Huang, G (corresponding author), Shanghai Jiao Tong Univ, Dept Nucl Med, Ren Ji Hosp, Sch Med, Shanghai 200127, Peoples R China.; Huang, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200025, Peoples R China.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, New York, NY 10461 USA.	zxp0856@sina.com; fajun.yang@einstein.yu.edu; nuclearj@163.com; huang2802@163.com		Li, Jiajin/0000-0003-1300-6025	NIDDK NIH HHS [P30 DK026687, R01 DK098439, R01 DK110063, P60 DK020541, P30 DK020541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110063, P30DK026687, P30DK020541, R01DK098439, P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bluemlein K, 2011, ONCOTARGET, V2, P393; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Desai S, 2014, ONCOTARGET, V5, P8202, DOI 10.18632/oncotarget.1159; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Li N, 2017, HEPATOLOGY, V65, P1936, DOI 10.1002/hep.29018; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MEDES G, 1953, CANCER RES, V13, P27; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Sun Y, 2015, TUMOR BIOL, V36, P4133, DOI 10.1007/s13277-015-3047-5; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	29	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6623	6634		10.1074/jbc.RA117.000100	http://dx.doi.org/10.1074/jbc.RA117.000100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29514980	Green Published, hybrid			2022-12-28	WOS:000431108600032
J	Li, MS; Cowley, EA; El Hiani, Y; Linsdell, P				Li, Man-Song; Cowley, Elizabeth A.; El Hiani, Yassine; Linsdell, Paul			Functional organization of cytoplasmic portals controlling access to the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; POSITIVE CHARGES; ABC TRANSPORTER; BINDING-SITE; ATP-BINDING; ARCHITECTURE; VESTIBULE; LOCATION; SEGMENT; PATHWAY	The cystic fibrosis transmembrane conductance regulator (CFTR) is a Cl- channel that apparently has evolved from an ancestral active transporter. Key to the CFTR's switch from pump to channel function may have been the appearance of one or more "lateral portals." Such portals connect the cytoplasm to the transmembrane channel pore, allowing a continuous pathway for the electrodiffusional movement of Cl- ions. However, these portals remain the least well-characterized part of the Cl- transport pathway; even the number of functional portals is uncertain, and if multiple portals do exist, their relative functional contributions are unknown. Here, we used patch-clamp recording to identify the contributions of positively charged amino acid side chains located in CFTR's cytoplasmic transmembrane extensions to portal function. Mutagenesis-mediated neutralization of several charged side chains reduced single-channel Cl- conductance. However, these same mutations differentially affected channel blockade by cytoplasmic suramin and Pt(NO2)(4)(2-) anions. We considered and tested several models by which the contribution of these positively charged side chains to one or more independent or non-independent portals to the pore could affect Cl- conductance and interactions with blockers. Overall, our results suggest the existence of a single portal that is lined by several positively charged side chains that interact electrostatically with both Cl- and blocking anions. We further propose that mutations at other sites indirectly alter the function of this single portal. Comparison of our functional results with recent structural information on CFTR completes our picture of the overall molecular architecture of the Cl- permeation pathway.	[Li, Man-Song; Cowley, Elizabeth A.; El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273; Cowley, Elizabeth/0000-0002-5839-5549	Cystic Fibrosis Canada	Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Callebaut I, 2017, CELL MOL LIFE SCI, V74, P3, DOI 10.1007/s00018-016-2385-9; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; El Hiani Y, 2016, CELL MOL LIFE SCI, V73, P1917, DOI 10.1007/s00018-015-2113-x; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell Paul, 2017, Adv Exp Med Biol, V925, P13, DOI 10.1007/5584_2016_33; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Linsdell P, 2016, BBA-BIOMEMBRANES, V1858, P740, DOI 10.1016/j.bbamem.2016.01.009; Linsdell P, 2015, BBA-BIOMEMBRANES, V1848, P1573, DOI 10.1016/j.bbamem.2015.04.004; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Negoda A, 2017, BBA-BIOMEMBRANES, V1859, P1049, DOI 10.1016/j.bbamem.2017.02.014; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang JY, 2015, BIOCHEMISTRY-US, V54, P3839, DOI 10.1021/acs.biochem.5b00427; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	28	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5649	5658		10.1074/jbc.RA117.001373	http://dx.doi.org/10.1074/jbc.RA117.001373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29475947	hybrid, Green Published			2022-12-28	WOS:000430044100025
J	Freeman, SL; Martel, A; Devos, JM; Basran, J; Raven, EL; Roberts, GCK				Freeman, Samuel L.; Martel, Anne; Devos, Juliette M.; Basran, Jaswir; Raven, Emma L.; Roberts, Gordon C. K.			Solution structure of the cytochrome P450 reductase-cytochrome c complex determined by neutron scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neutron scattering; protein-protein interaction; cytochrome P450; cytochrome c; electron transfer; protein structure; cytochrome P450 reductase; SANS; transient complex; solution structure; protein structural dynamics	SMALL-ANGLE SCATTERING; NITRIC-OXIDE SYNTHASE; FMN-BINDING DOMAIN; ELECTRON-TRANSFER; P450 OXIDOREDUCTASE; COENZYME BINDING; 3-DIMENSIONAL STRUCTURE; DIFLAVIN REDUCTASES; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE	Electron transfer in all living organisms critically relies on formation of complexes between the proteins involved. The function of these complexes requires specificity of the interaction to allow for selective electron transfer but also a fast turnover of the complex, and they are therefore often transient in nature, making them challenging to study. Here, using small-angle neutron scattering with contrast matching with deuterated protein, we report the solution structure of the electron transfer complex between cytochrome P450 reductase (CPR) and its electron transfer partner cytochrome c. This is the first reported solution structure of a complex between CPR and an electron transfer partner. The structure shows that the interprotein interface includes residues from both the FMN- and FAD-binding domains of CPR. In addition, the FMN is close to the heme of cytochrome c but distant from the FAD, indicating that domain movement is required between the electron transfer steps in the catalytic cycle of CPR. In summary, our results reveal key details of the CPR catalytic mechanism, including interactions of two domains of the reductase with cytochrome c and motions of these domains relative to one another. These findings shed light on interprotein electron transfer in this system and illustrate a powerful approach for studying solution structures of protein-protein complexes.	[Freeman, Samuel L.; Basran, Jaswir; Raven, Emma L.] Univ Leicester, Dept Chem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England; [Basran, Jaswir; Roberts, Gordon C. K.] Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England; [Freeman, Samuel L.; Basran, Jaswir; Raven, Emma L.; Roberts, Gordon C. K.] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester LE1 7RH, Leics, England; [Freeman, Samuel L.; Martel, Anne; Devos, Juliette M.] Inst Laue Langevin, 71 Ave Martyrs, F-38042 Grenoble, France	University of Leicester; University of Leicester; University of Leicester; Institut Laue-Langevin (ILL)	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England.; Roberts, GCK (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; gcr@le.ac.uk		Martel, Anne/0000-0002-1232-8519; Freeman, Samuel/0000-0002-1467-5282	Institut Laue-Langevin; University of Leicester; Engineering and Physical Sciences Research Council	Institut Laue-Langevin; University of Leicester; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by a studentship from the Institut Laue-Langevin, the University of Leicester, and the Engineering and Physical Sciences Research Council (through a doctoral training account). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Aigrain L, 2012, INT J MOL SCI, V13, P15012, DOI 10.3390/ijms131115012; Bashir Q, 2011, FEBS J, V278, P1391, DOI 10.1111/j.1742-4658.2011.08062.x; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Dunne O, 2017, EUR BIOPHYS J BIOPHY, V46, P425, DOI 10.1007/s00249-016-1186-2; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Farooq Y, 2010, BIOCHEM J, V432, P485, DOI 10.1042/BJ20100744; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freeman SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09840-8; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haertlein M, 2016, METHOD ENZYMOL, V566, P113, DOI 10.1016/bs.mie.2015.11.001; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2014, FEBS J, V281, P5325, DOI 10.1111/febs.13073; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Hedison TM, 2015, FEBS J, V282, P4357, DOI 10.1111/febs.13501; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; HORECKER BL, 1950, J BIOL CHEM, V183, P593; Huang R, 2015, J BIOL CHEM, V290, P4843, DOI 10.1074/jbc.M114.582700; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; JACROT B, 1976, PHILOS T ROY SOC B, V276, P109, DOI 10.1098/rstb.1976.0101; Jang HH, 2010, BBA-PROTEINS PROTEOM, V1804, P1285, DOI 10.1016/j.bbapap.2010.02.003; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059; Konarev PV, 2016, J APPL CRYSTALLOGR, V49, P953, DOI 10.1107/S1600576716005793; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Makris TM., 2005, CYTOCHROME P450, P149; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; Panjkovich A, 2016, BIOINFORMATICS, V32, P2062, DOI 10.1093/bioinformatics/btw071; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; STUHRMANN HB, 1974, J APPL CRYSTALLOGR, V7, P173, DOI 10.1107/S0021889874009071; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Svergun D., 2013, SMALL ANGLE XRAY NEU, P65; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Volkov AN, 2015, ACCOUNTS CHEM RES, V48, P3036, DOI 10.1021/acs.accounts.5b00343; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waskell L., 2015, CYTOCHROME P450 STRU, P33, DOI [DOI 10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6_9]; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P11833, DOI 10.1021/bi701209p; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Zhao Q, 1999, PROTEIN SCI, V8, P298	59	13	13	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5210	5219		10.1074/jbc.RA118.001941	http://dx.doi.org/10.1074/jbc.RA118.001941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29475945	Green Published, hybrid			2022-12-28	WOS:000429409300025
J	Zhu, YM; Zhang, XJ; Ding, XH; Chong, HH; Cui, S; He, JS; Wang, XQ; He, YX				Zhu, Yuanmei; Zhang, Xiujuan; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Jinsheng; Wang, Xinquan; He, Yuxian			Exceptional potency and structural basis of a T1249-derived lipopeptide fusion inhibitor against HIV-1, HIV-2, and simian immunodeficiency virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); HIV-1; HIV-2; antiviral agent; membrane fusion; inhibitor; peptides; structure-function; crystal structure; fusion inhibitor; lipopeptide; T1249; T20	ENFUVIRTIDE-RESISTANT HIV-1; VIRAL MEMBRANE-FUSION; ANTIRETROVIRAL ACTIVITY; SYNTHETIC PEPTIDE; ENVELOPE PROTEIN; ATOMIC-STRUCTURE; COILED-COIL; TYPE-1 GP41; DRUG TARGET; WILD-TYPE	Enfuvirtide (T20) is the only viral fusion inhibitor approved for clinical use, but it has relatively weak anti-HIV activity and easily induces drug resistance. In succession to T20, T1249 has been designed as a 39-mer peptide composed of amino acid sequences derived from HIV-1, HIV-2, and simian immunodeficiency virus (SIV); however, its development has been suspended due to formulation difficulties. We recently developed a T20-based lipopeptide (LP-40) showing greatly improved pharmaceutical properties. Here, we generated a T1249-based lipopeptide, termed LP-46, by replacing its C-terminal tryptophan-rich sequence with fatty acid. As compared with T20, T1249, and LP-40, the truncated LP-46 (31-mer) had dramatically increased activities in inhibiting a large panel of HIV-1 subtypes, with IC50 values approaching low picomolar concentrations. Also, LP-46 was an exceptionally potent inhibitor against HIV-2, SIV, and T20-resistant variants, and it displayed obvious synergistic effects with LP-40. Furthermore, we showed that LP-46 had increased helical stability and binding affinity with the target site. The crystal structure of LP-46 in complex with a target surrogate revealed its critical binding motifs underlying the mechanism of action. Interestingly, it was found that the introduced pocket-binding domain in LP-46 did not interact with the gp41 pocket as expected; instead, it adopted a mode similar to that of LP-40. Therefore, our studies have provided an exceptionally potent and broad fusion inhibitor for developing new anti-HIV drugs, which can also serve as a tool to exploit the mechanisms of viral fusion and inhibition.	[Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhu, Yuanmei; Ding, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China; [Zhang, Xiujuan; He, Jinsheng] Beijing Jiaotong Univ, Sch Sci, Coll Life Sci & Bioengn, Beijing 100044, Peoples R China; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Jiaotong University; Tsinghua University	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; He, YX (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.; He, YX (corresponding author), Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China.	yhe@ipbcams.ac.cn	Cui, Sheng/AAQ-1721-2020; HE, Jin-Sheng/G-4585-2011; Zhang, Xiujuan/AAG-9780-2020; Sheng, CUI/M-6405-2013	HE, Jin-Sheng/0000-0002-6592-0540; Sheng, CUI/0000-0001-6329-3582	National Natural Science Foundation of China [81630061, 81473255, 81673484]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences	This work was supported by National Natural Science Foundation of China Grants 81630061, 81473255, and 81673484 and Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences Grant 2017-I2M-1-014. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ashkenazi A, 2012, FASEB J, V26, P4628, DOI 10.1096/fj.12-215111; Augusto MT, 2014, J ANTIMICROB CHEMOTH, V69, P1286, DOI 10.1093/jac/dkt529; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Borrego P, 2013, AIDS, V27, P1081, DOI 10.1097/QAD.0b013e32835edc1d; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong H., 2017, J VIROL, V91; Chong HH, 2016, AIDS, V30, P1187, DOI 10.1097/QAD.0000000000001073; Chong HH, 2015, AIDS, V29, P13, DOI 10.1097/QAD.0000000000000498; Chong HH, 2013, FASEB J, V27, P1203, DOI 10.1096/fj.12-222547; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu SD, 2013, BIOORG MED CHEM LETT, V23, P5114, DOI 10.1016/j.bmcl.2013.07.026; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Crespillo S, 2014, P NATL ACAD SCI USA, V111, P18207, DOI 10.1073/pnas.1413592112; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Ding X., 2017, J VIROL, V91; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Peterson K, 2012, ANTIVIR THER, V17, P435, DOI 10.3851/IMP2031; Qiu ZL, 2015, AIDS, V29, P1015, DOI 10.1097/QAD.0000000000000683; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wexler-Cohen Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000509; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Xiong S, 2017, J VIROL, V91; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005; YAHI N, 1995, P NATL ACAD SCI USA, V92, P4867, DOI 10.1073/pnas.92.11.4867	59	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5323	5334		10.1074/jbc.RA118.001729	http://dx.doi.org/10.1074/jbc.RA118.001729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29425101	Green Published, hybrid			2022-12-28	WOS:000429409300035
J	Houtman, CJ; Maligaspe, E; Hunt, CG; Fernandez-Fueyo, E; Martinez, AT; Hammel, KE				Houtman, Carl J.; Maligaspe, Eranda; Hunt, Christopher G.; Fernandez-Fueyo, Elena; Martinez, Angel T.; Hammel, Kenneth E.			Fungal lignin peroxidase does not produce the veratryl alcohol cation radical as a diffusible ligninolytic oxidant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE-ROT FUNGUS; PHANEROCHAETE-CHRYSOSPORIUM; CERIPORIOPSIS-SUBVERMISPORA; HORSERADISH-PEROXIDASE; MANGANESE PEROXIDASE; COMPARATIVE GENOMICS; HYDROGEN-PEROXIDE; STEADY-STATE; COMPOUND-II; OXIDATION	Peroxidases are considered essential agents of lignin degradation by white-rot basidiomycetes. However, low-molecular-weight oxidants likely have a primary role in lignin breakdown because many of these fungi delignify wood before its porosity has sufficiently increased for enzymes to infiltrate. It has been proposed that lignin peroxidases (LPs, EC 1.11.1.14) fulfill this role by oxidizing the secreted fungal metabolite veratryl alcohol (VA) to its aryl cation radical (VA(+center dot)), releasing it to act as a one-electron lignin oxidant within woody plant cell walls. Here, we attached the fluorescent oxidant sensor BODIPY 581/591 throughout beads with a nominal porosity of 6 kDa and assessed whether peroxidase-generated aryl cation radical systems could oxidize the beads. As positive control, we used the 1,2,4,5-tetra-methoxybenzene (TMB) cation radical, generated from TMB by horseradish peroxidase. This control oxidized the beads to depths that increased with the amount of oxidant supplied, ultimately resulting in completely oxidized beads. A reaction-diffusion computer model yielded oxidation profiles that were within the 95% confidence intervals for the data. By contrast, bead oxidation caused by VA and the LPA isozyme of Phanerochaete chrysosporium was confined to a shallow shell of LP-accessible volume at the bead surface, regardless of how much oxidant was supplied. This finding contrasted with the modeling results, which showed that if the LP/VA system were to release VA(+center dot), it would oxidize the bead interiors. We conclude that LPA releases insignificant quantities of VA(+center dot) and that a different mechanism produces small ligninolytic oxidants during white rot.	[Houtman, Carl J.; Maligaspe, Eranda; Hunt, Christopher G.; Hammel, Kenneth E.] US Forest Serv, Madison, WI 53726 USA; [Fernandez-Fueyo, Elena; Martinez, Angel T.] CSIC, Ctr Invest Biol, Madrid, Spain; [Hammel, Kenneth E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Maligaspe, Eranda] St Johns Univ, Dept Chem, Queens, NY 11439 USA; [Fernandez-Fueyo, Elena] Delft Univ Technol, Dept Biotechnol, NL-2628 CD Delft, Netherlands	United States Department of Agriculture (USDA); United States Forest Service; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Wisconsin System; University of Wisconsin Madison; Saint John's University; Delft University of Technology	Hammel, KE (corresponding author), US Forest Serv, Madison, WI 53726 USA.	kehammel@wisc.edu	Hunt, Christopher G/D-6339-2011; Hammel, Kenneth E/G-1890-2011	Hunt, Christopher G/0000-0002-4799-7085; Hammel, Kenneth E/0000-0002-2935-5847; Houtman, Carl/0000-0001-8139-6673	United States Department of Energy, Office of Biological and Environmental Research [DE-SC0006929]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Biological and Environmental Research Grant DE-SC0006929 (to K. E. H., C. J. H., and C. G H.). The authors declare that they have no conflicts of interest with the contents of this article.	Acebes S, 2017, J PHYS CHEM B, V121, P3946, DOI 10.1021/acs.jpcb.7b00835; Baciocchi E, 2002, BIOCHEM BIOPH RES CO, V293, P832, DOI 10.1016/S0006-291X(02)00306-6; Bietti M, 1998, J PHYS CHEM A, V102, P7337, DOI 10.1021/jp9812482; BLANCHETTE RA, 1992, HOLZFORSCHUNG, V46, P109, DOI 10.1515/hfsg.1992.46.2.109; Blanchette RA, 1997, J BIOTECHNOL, V53, P203, DOI 10.1016/S0168-1656(97)01674-X; BONO JJ, 1990, EUR J BIOCHEM, V192, P189, DOI 10.1111/j.1432-1033.1990.tb19213.x; Branchi B, 2005, ORG BIOMOL CHEM, V3, P2604, DOI 10.1039/b504199f; CAI DY, 1992, J BIOL CHEM, V267, P11149; Camarero S, 1999, J BIOL CHEM, V274, P10324, DOI 10.1074/jbc.274.15.10324; CANDEIAS LP, 1995, J BIOL CHEM, V270, P16745, DOI 10.1074/jbc.270.28.16745; Cussler E.L., 2009, DIFFUSION MASS TRANS; DEJONG E, 1994, FEMS MICROBIOL REV, V13, P153, DOI 10.1016/0168-6445(94)90078-7; DIMONIE MV, 1982, EUR POLYM J, V18, P639, DOI 10.1016/0014-3057(82)90043-X; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; Doyle WA, 1996, BIOCHEM J, V315, P15, DOI 10.1042/bj3150015; Drummen GPC, 2004, FREE RADICAL BIO MED, V36, P1635, DOI 10.1016/j.freeradbiomed.2004.03.014; FARRELL RL, 1989, ENZYME MICROB TECH, V11, P322, DOI 10.1016/0141-0229(89)90014-8; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Filley TR, 2002, ORG GEOCHEM, V33, P111, DOI 10.1016/S0146-6380(01)00144-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; FORNEY LJ, 1982, J BIOL CHEM, V257, P1455; GOEZ M, 1991, BER BUNSEN PHYS CHEM, V95, P1179, DOI 10.1002/bbpc.19910951004; GOODWIN DC, 1995, BIOCHEMISTRY-US, V34, P5060, DOI 10.1021/bi00015a017; GORREBEECK C, 1991, RECL TRAV CHIM PAY B, V110, P231; Guyer JE, 2009, COMPUT SCI ENG, V11, P6, DOI 10.1109/MCSE.2009.52; HAMMEL KE, 1986, P NATL ACAD SCI USA, V83, P3708, DOI 10.1073/pnas.83.11.3708; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; HAMMEL KE, 1985, J BIOL CHEM, V260, P8348; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; HARVEY PJ, 1989, BIOCHIM BIOPHYS ACTA, V994, P59, DOI 10.1016/0167-4838(89)90062-9; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Hunt CG, 2013, ENVIRON MICROBIOL, V15, P956, DOI 10.1111/1462-2920.12039; INMAN JK, 1969, BIOCHEMISTRY-US, V8, P4074, DOI 10.1021/bi00838a026; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; Khindaria A, 1995, BIOCHEMISTRY-US, V34, P16860, DOI 10.1021/bi00051a037; Khindaria A, 1996, BIOCHEMISTRY-US, V35, P6418, DOI 10.1021/bi9601666; KHINDARIA A, 1995, BIOCHEMISTRY-US, V34, P6020, DOI 10.1021/bi00018a003; KIRK TK, 1986, BIOCHEM J, V236, P279, DOI 10.1042/bj2360279; KODURI RS, 1995, J BIOL CHEM, V270, P22254, DOI 10.1074/jbc.270.38.22254; Koduri RS, 1996, ARCH BIOCHEM BIOPHYS, V326, P261, DOI 10.1006/abbi.1996.0074; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Mester T, 1998, J BIOL CHEM, V273, P15412, DOI 10.1074/jbc.273.25.15412; Nagy LG, 2016, MOL BIOL EVOL, V33, P959, DOI 10.1093/molbev/msv337; Niesner R, 2000, J CHEM ENG DATA, V45, P1121, DOI 10.1021/je0000569; PASZCZYNSKI A, 1986, ARCH BIOCHEM BIOPHYS, V244, P750, DOI 10.1016/0003-9861(86)90644-2; Recabarren R, 2016, THEOR CHEM ACC, V135, DOI 10.1007/s00214-016-1828-6; Saez-Jimenez V, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0615-x; Saez-Jimenez V, 2015, J BIOL CHEM, V290, P23201, DOI 10.1074/jbc.M115.665919; Stone J.E., 1968, CELLUL CHEM TECHNOL, V2, P343; Tien M, 1997, J BIOL CHEM, V272, P8912; TIEN M, 1988, METHOD ENZYMOL, V161, P238; TIEN M, 1986, J BIOL CHEM, V261, P1687; Urano Y, 1996, J CHEM SOC PERK T 2, P1169, DOI 10.1039/p29960001169; VANSTROEBIEZEN SAM, 1993, ANAL CHIM ACTA, V273, P553, DOI 10.1016/0003-2670(93)80202-V	58	18	19	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4702	4712		10.1074/jbc.RA117.001153	http://dx.doi.org/10.1074/jbc.RA117.001153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29462790	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000428848300013
J	Hu, K; Jastrab, JB; Zhang, SS; Kovach, A; Zhao, GP; Darwin, KH; Li, HL				Hu, Kuan; Jastrab, Jordan B.; Zhang, Susan; Kovach, Amanda; Zhao, Gongpu; Darwin, K. Heran; Li, Huilin			Proteasome substrate capture and gate opening by the accessory factor PafE from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; COMPLEX; SYSTEM; ACTIVATION; MECHANISMS; INSIGHTS; BINDING	In all domains of life, proteasomes are gated, chambered proteases that require opening by activators to facilitate protein degradation. Twelve proteasome accessory factor E (PafE) monomers assemble into a single dodecameric ring that promotes proteolysis required for the full virulence of the human bacterial pathogen Mycobacterium tuberculosis. Whereas the best characterized proteasome activators use ATP to deliver proteins into a proteasome, PafE does not require ATP. Here, to unravel the mechanism of PafE-mediated protein targeting and proteasome activation, we studied the interactions of PafE with native substrates, including a newly identified proteasome substrate, the ParA-like protein, Rv3213c, and with proteasome core particles. We characterized the function of a highly conserved feature in bacterial proteasome activator proteins: a glycine-glutamine-tyrosine-leucine (GQYL) motif at their C termini that is essential for stimulating proteolysis. Using cryoelectron microscopy (cryo-EM), we found that the GQYL motif of PafE interacts with specific residues in the alpha subunits of the proteasome core particle to trigger gate opening and degradation. Finally, we also found that PafE rings have 40-angstrom openings lined with hydrophobic residues that form a chamber for capturing substrates before they are degraded, suggesting PafE has a previously unrecognized chaperone activity. In summary, we have identified the interactions between PafE and the proteasome core particle that cause conformational changes leading to the opening of the proteasome gate and have uncovered a mechanism of PafE-mediated substrate degradation. Collectively, our results provide detailed insights into the mechanism of ATP-independent proteasome degradation in bacteria.	[Hu, Kuan; Kovach, Amanda; Zhao, Gongpu; Li, Huilin] Van Andel Res Inst, Cryo EM Struct Biol Lab, Grand Rapids, MI 49503 USA; [Jastrab, Jordan B.; Zhang, Susan; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Van Andel Institute; New York University	Li, HL (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	Heran.Darwin@med.nyu.edu; Huilin.Li@vai.org		Darwin, K Heran/0000-0002-5043-7548; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [AI070285, AI088075, T32 AI007180, F30 AI110067]; Van Andel Research Institute; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI110067, T32AI007180, R01AI088075, R01AI070285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Research Institute; Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI070285 (to H. L.), AI088075 (to K. H. D.), and T32 AI007180 and F30 AI110067 (to J. B. J.), and the Van Andel Research Institute (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai L, 2016, P NATL ACAD SCI USA, V113, pE1983, DOI 10.1073/pnas.1512094113; Becker SH, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-16; Bolten M, 2016, STRUCTURE, V24, P2138, DOI 10.1016/j.str.2016.10.008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Das Gupta T, 2008, MICROBIOL-SGM, V154, P484, DOI 10.1099/mic.0.2007/012294-0; Delley CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114348; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Huber EM, 2017, STRUCTURE, V25, P1473, DOI 10.1016/j.str.2017.07.013; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Jastrab J. B., 2017, J BACTERIOL, V199; Jastrab JB, 2015, ANNU REV MICROBIOL, V69, P109, DOI 10.1146/annurev-micro-091014-104201; Jastrab JB, 2015, P NATL ACAD SCI USA, V112, pE1763, DOI 10.1073/pnas.1423319112; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li DY, 2010, EMBO J, V29, P2037, DOI 10.1038/emboj.2010.95; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Samanovic MI, 2016, TRENDS MICROBIOL, V24, P26, DOI 10.1016/j.tim.2015.10.001; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu YJ, 2017, MOL MICROBIOL, V105, P227, DOI 10.1111/mmi.13695; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	40	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4713	4723		10.1074/jbc.RA117.001471	http://dx.doi.org/10.1074/jbc.RA117.001471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29414791	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000428848300014
J	Chen, TY; Lee, SH; Dhar, SS; Lee, MG				Chen, Tsai-Yu; Lee, Sung-Hun; Dhar, Shilpa S.; Lee, Min Gyu			Protein arginine methyltransferase 7-mediated microRNA-221 repression maintains Oct4, Nanog, and Sox2 levels in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; POSTTRANSCRIPTIONAL REGULATION; HEPATOCELLULAR-CARCINOMA; PLURIPOTENCY FACTORS; ANIMAL DEVELOPMENT; EXPRESSION; DIFFERENTIATION; MIR-221; PROLIFERATION; RESISTANCE	The stemness maintenance of embryonic stem cells (ESCs) requires pluripotency transcription factors, including Oct4, Nanog, and Sox2. We have previously reported that protein arginine methyltransferase 7 (PRMT7), an epigenetic modifier, is an essential pluripotency factor that maintains the stemness of mouse ESCs, at least in part, by down-regulating the expression of the anti-stemness microRNA (miRNA) miR-24-2. To gain greater insight into the molecular basis underlying PRMT7-mediated maintenance of mouse ESC stemness, we searched for new PRMT7-down-regulated anti-stemness miRNAs. Here, we show that miR-221 gene-encoded miR-221-3p and miR-221-5p are anti-stemness miRNAs whose expression levels in mouse ESCs are directly repressed by PRMT7. Notably, both miR-221-3p and miR-221-5p targeted the 3'untranslated regions of mRNA transcripts of the major pluripotency factors Oct4, Nanog, and Sox2 to antagonize mouse ESC stemness. Moreover, miR-221-5p silenced also the expression of its own transcriptional repressor PRMT7. Transfection of miR-221-3p and miR-221-5p mimics induced spontaneous differentiation of mouse ESCs. CRISPR-mediated deletion of the miR-221 gene, as well as specific antisense inhibitors of miR-221-3p and miR221-5p, inhibited the spontaneous differentiation of PRMT7depleted mouse ESCs. Taken together, these findings reveal that the PRMT7-mediated repression of miR-221-3p and miR221- 5p expression plays a critical role in maintaining mouse ESC stemness. Our results also establish miR-221-3p and miR221- 5p as anti-stemness miRNAs that target Oct4, Nanog, and Sox2 mRNAs in mouse ESCs.	[Chen, Tsai-Yu; Lee, Sung-Hun; Dhar, Shilpa S.; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Chen, Tsai-Yu; Lee, Min Gyu] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lee, MG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mglee@mdanderson.org		Chen, Tsai-Yu/0000-0001-6150-6361	National Institutes of Health through M. D. Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA207109, R01CA207098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095659] Funding Source: NIH RePORTER	National Institutes of Health through M. D. Anderson's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the research staff in the Flow Cytometry & Cellular Imaging Facility, which is supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA016672. We also thank Ann Sutton (Department of Scientific Publications, M. D. Anderson) for the editorial assistance.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dhar SS, 2016, NUCLEIC ACIDS RES, V44, P3659, DOI 10.1093/nar/gkv1516; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Fornari F, 2014, MOL CANCER RES, V12, P203, DOI 10.1158/1541-7786.MCR-13-0312-T; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gulla A, 2016, CLIN CANCER RES, V22, P1222, DOI 10.1158/1078-0432.CCR-15-0489; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Hamada N, 2012, NEUROCHEM INT, V60, P743, DOI 10.1016/j.neuint.2012.03.010; Howe EN, 2012, J MAMMARY GLAND BIOL, V17, P65, DOI 10.1007/s10911-012-9244-6; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee SH, 2016, NUCLEIC ACIDS RES, V44, P10603, DOI 10.1093/nar/gkw788; Li J, 2015, STEM CELL REV REP, V11, P39, DOI 10.1007/s12015-014-9543-y; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Li N, 2016, MOL CELL, V63, P470, DOI 10.1016/j.molcel.2016.06.035; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Ma YN, 2015, EMBO J, V34, P361, DOI 10.15252/embj.201489957; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pandey A, 2015, J NEUROCHEM, V133, P640, DOI 10.1111/jnc.13089; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	52	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3925	3936		10.1074/jbc.RA117.000425	http://dx.doi.org/10.1074/jbc.RA117.000425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29378844	Green Published, hybrid			2022-12-28	WOS:000427587500007
J	Cormerais, Y; Massard, PA; Vucetic, M; Giuliano, S; Tambutte, E; Durivault, J; Vial, V; Endou, H; Wempe, MF; Parks, SK; Pouyssegur, J				Cormerais, Yann; Massard, Pierre Andre; Vucetic, Milica; Giuliano, Sandy; Tambutte, Eric; Durivault, Jerome; Vial, Valerie; Endou, Hitoshi; Wempe, Michael F.; Parks, Scott K.; Pouyssegur, Jacques			The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LUNG-CANCER; NUTRIENT TRANSPORTERS; GENETIC DISRUPTION; PROSTATE-CANCER; MTORC1 PATHWAY; METABOLISM; EXPRESSION; SURVIVAL; HYPOXIA; CYCLE	The transporters for glutamine and essential amino acids, ASCT2 (solute carrier family 1 member 5, SLC1A5) and LAT1 (solute carrier family 7 member 5, SLC7A5), respectively, are overexpressed in aggressive cancers and have been identified as cancer-promoting targets. Moreover, previous work has suggested that glutamine influx via ASCT2 triggers essential amino acids entry via the LAT1 exchanger, thus activating mechanistic target of rapamycin complex 1 (mTORC1) and stimulating growth. Here, to further investigate whether these two transporters are functionally coupled, we compared the respective knockout (KO) of either LAT1 or ASCT2 in colon (LS174T) and lung (A549) adenocarcinoma cell lines. Although ASCT2(KO) significantly reduced glutamine import (>60% reduction), no impact on leucine uptake was observed in both cell lines. Although an in vitro growth-reduction phenotype was observed in A549-ASCT2(KO) cells only, we found that genetic disruption of ASCT2 strongly decreased tumor growth in both cell lines. However, in sharp contrast to LAT1(KO) cells, ASCT2(KO) cells displayed no amino acid (AA) stress response (GCN2/EIF2a/ATF4) or altered mTORC1 activity (S6K1/S6). We therefore conclude that ASCT2(KO) reduces tumor growth by limiting AA import, but that this effect is independent of LAT1 activity. These data were further supported by in vitro cell proliferation experiments performed in the absence of glutamine. Together these results confirm and extend ASCT2's pro-tumoral role and indicate that the proposed functional coupling model of ASCT2 and LAT1 is not universal across different cancer types.	[Cormerais, Yann; Massard, Pierre Andre; Vucetic, Milica; Giuliano, Sandy; Tambutte, Eric; Durivault, Jerome; Vial, Valerie; Parks, Scott K.; Pouyssegur, Jacques] CSM, Med Biol Dept, MC-98000 Monaco, Monaco; [Endou, Hitoshi] J Pharma Co Ltd, Yokohama, Kanagawa 2300046, Japan; [Wempe, Michael F.] Univ Colorado Denver, Sch Pharm, Anschutz Med Campus, Aurora, CO 80045 USA; [Pouyssegur, Jacques] Univ Nice Sophia Antipolis, CNRS, INSERM, Inst Res Canc & Aging IRCAN,Ctr A Lacassagne, F-06088 Nice, France	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Parks, SK; Pouyssegur, J (corresponding author), CSM, Med Biol Dept, MC-98000 Monaco, Monaco.; Pouyssegur, J (corresponding author), Univ Nice Sophia Antipolis, CNRS, INSERM, Inst Res Canc & Aging IRCAN,Ctr A Lacassagne, F-06088 Nice, France.	sparks@centrescientifique.mc; jpouyssegur@centrescientifique.mc	Cormerais, Yann/GVU-4134-2022; Giuliano, Sandy/U-2498-2019		government of Monaco; 'Le Groupement des Entreprises Monegasques dans la Lutte contre le cancer' (GEMLUC); Ligue Nationale Contre le Cancer; IRCAN, University Cote d'Azur and Centre A. Lacassagne	government of Monaco; 'Le Groupement des Entreprises Monegasques dans la Lutte contre le cancer' (GEMLUC); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); IRCAN, University Cote d'Azur and Centre A. Lacassagne	This work was supported by the government of Monaco and 'Le Groupement des Entreprises Monegasques dans la Lutte contre le cancer' (GEMLUC) including Master (to P. A. M.) and post-doctoral (to Y. C., M. V., and S. P.) fellowships. This project has also been, in part, supported by the Ligue Nationale Contre le Cancer (to J. P., Equipe labelisee), IRCAN, University Cote d'Azur and Centre A. Lacassagne, Nice. H. E. is the CEO at, and has ownership interest (including patents) in, J-Pharma. M. F. W. has ownership interest (including patents) in, and is a consultant/advisory board member for, J-Pharma.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bilton R, 2005, J BIOL CHEM, V280, P31132, DOI 10.1074/jbc.M504482200; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Cormerais Y, 2016, CANCER RES, V76, P4481, DOI 10.1158/0008-5472.CAN-15-3376; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Fenczik CA, 2001, J BIOL CHEM, V276, P8746, DOI 10.1074/jbc.M011239200; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Hayashi K, 2012, ONCOL REP, V28, P862, DOI 10.3892/or.2012.1878; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Huang F, 2014, INT J CLIN EXP PATHO, V7, P6006; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Lukey MJ, 2017, DRUG DISCOV TODAY, V22, P796, DOI 10.1016/j.drudis.2016.12.003; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Parks SK, 2017, J PHYSIOL-LONDON, V595, P2439, DOI 10.1113/JP273309; Parks SK, 2016, MOL ASPECTS MED, V47-48, P3, DOI 10.1016/j.mam.2015.12.001; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; Rosilio C, 2015, LEUKEMIA, V29, P1253, DOI 10.1038/leu.2014.338; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Shimobayashi M, 2016, CELL RES, V26, P7, DOI 10.1038/cr.2015.146; Tsun ZY, 2015, SEMIN CELL DEV BIOL, V43, P22, DOI 10.1016/j.semcdb.2015.08.002; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Willems L, 2013, BLOOD, V122, P3521, DOI 10.1182/blood-2013-03-493163; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	47	92	93	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2877	2887		10.1074/jbc.RA117.001342	http://dx.doi.org/10.1074/jbc.RA117.001342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29326164	Green Published, hybrid			2022-12-28	WOS:000426051900022
J	Mapes, J; Anandan, L; Li, QX; Neff, A; Clevenger, CV; Bagchi, IC; Bagchi, MK				Mapes, Janelle; Anandan, Lavanya; Li, Quanxi; Neff, Alison; Clevenger, Charles V.; Bagchi, Indrani C.; Bagchi, Milan K.			Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLAND DEVELOPMENT; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; SIGNAL TRANSDUCER; CROHNS-DISEASE; PROLACTIN GENE; ERBB RECEPTORS; CANCER; STAT5; MOUSE	The peptide hormone prolactin (PRL) and certain members of the epidermal growth factor (EGF) family play central roles in mammary gland development and physiology, and their dysregulation has been implicated in mammary tumorigenesis. Our recent studies have revealed that the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) is a critical factor for PRL-mediated activation of the transcription factor STAT5 in mouse mammary epithelium. Of note, CUZD1 controls production of a specific subset of the EGF family growth factors and consequent activation of their receptors. Here, we found that consistent with this finding, CUZD1 overexpression in non-transformed mammary epithelial HC11 cells increases their proliferation and induces tumorigenic characteristics in these cells. When introduced orthotopically in mouse mammary glands, these cells formed adenocarcinomas, exhibiting elevated levels of STAT5 phosphorylation and activation of the EGF signaling pathway. Selective blockade of STAT5 phosphorylation by pimozide, a small-molecule inhibitor, markedly reduced the production of the EGF family growth factors and inhibited PRL-induced tumor cell proliferation in vitro. Pimozide administration to mice also suppressed CUZD1-driven mammary tumorigenesis in vivo. Analysis of human MCF7 breast cancer cells indicated that CUZD1 controls the production of the same subset of EGF family members in these cells as in the mouse. Moreover, pimozide treatment reduced the proliferation of these cancer cells. Collectively, these findings indicate that overexpression of CUZD1, a regulator of growth factor pathways controlled by PRL and STAT5, promotes mammary tumorigenesis. Blockade of the STAT5 signaling pathway downstream of CUZD1 may offer a therapeutic strategy for managing these breast tumors.	[Mapes, Janelle; Anandan, Lavanya; Neff, Alison; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Li, Quanxi; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Clevenger, Charles V.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Virginia Commonwealth University	Bagchi, MK (corresponding author), Univ Illinois, Sch Mol & Cellular Biol, 534 Burrill Hall,407 S Goodwin, Urbana, IL 61801 USA.	mbagchi@life.illinois.edu		Mapes, Janelle/0000-0002-9609-1255	Eunice Kennedy Shriver NICHD/National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 1998, J BIOL CHEM, V273, P7709, DOI 10.1074/jbc.273.13.7709; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Atalay G, 2003, ANN ONCOL, V14, P1346, DOI 10.1093/annonc/mdg365; Bar-Natan M, 2012, LEUKEMIA, V26, P1407, DOI 10.1038/leu.2011.338; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brink TC, 2008, CELLS TISSUES ORGANS, V188, P9, DOI 10.1159/000112843; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Carver KC, 2009, MOL CELL ENDOCRINOL, V307, P1, DOI 10.1016/j.mce.2009.03.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DH, 1999, J BIOL CHEM, V274, P32215, DOI 10.1074/jbc.274.45.32215; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Clevenger CV, 2008, J MAMMARY GLAND BIOL, V13, P147, DOI 10.1007/s10911-008-9074-8; Clevenger CV, 1997, J MAMMARY GLAND BIOL, V2, P59, DOI 10.1023/A:1026325630359; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DANIELSON KG, 1989, IN VITRO CELL DEV B, V25, P535; DASILVA L, 1994, J BIOL CHEM, V269, P18267; FUH G, 1995, J BIOL CHEM, V270, P13133, DOI 10.1074/jbc.270.22.13133; Gao J, 1996, MOL ENDOCRINOL, V10, P847, DOI 10.1210/me.10.7.847; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 1997, J BIOL CHEM, V272, P7567, DOI 10.1074/jbc.272.12.7567; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Howell SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2129; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Imamura T, 2002, J BIOL CHEM, V277, P50725, DOI 10.1074/jbc.M204159200; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kasik JW, 1998, BIOCHEM J, V330, P947; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Komorowski L, 2013, J CROHNS COLITIS, V7, P780, DOI 10.1016/j.crohns.2012.10.011; Leong CTC, 2007, ONCOGENE, V26, P870, DOI 10.1038/sj.onc.1209836; Leong CTC, 2004, ONCOGENE, V23, P5707, DOI 10.1038/sj.onc.1207754; Leung F, 2012, CLIN BIOCHEM, V45, P1543, DOI 10.1016/j.clinbiochem.2012.08.011; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Liaskos C., 2013, CLIN DEV IMMUNOL, V2013; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Mapes J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006654; Maskery SM, 2006, IEEE T INF TECHNOL B, V10, P497, DOI 10.1109/TITB.2005.863863; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Michaels MA, 2015, INFLAMM BOWEL DIS, V21, P2864, DOI 10.1097/MIB.0000000000000564; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nevalainen MT, 2002, MOL ENDOCRINOL, V16, P1108, DOI 10.1210/mend.16.5.0839; Papp M, 2015, J CROHNS COLITIS, V9, P659, DOI 10.1093/ecco-jcc/jjv087; Pavlidis P, 2016, CLIN CHEM LAB MED, V54, P249, DOI 10.1515/cclm-2015-0376; Prassas I, 2014, CLIN CHEM, V60, P381, DOI 10.1373/clinchem.2013.215236; RILLEMA JA, 1994, TRENDS ENDOCRIN MET, V5, P149, DOI 10.1016/1043-2760(94)90011-6; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; SAINSBURY JRC, 1987, LANCET, V1, P1398; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Scotti ML, 2008, BREAST CANCER RES TR, V111, P241, DOI 10.1007/s10549-007-9789-z; ShawBruha CM, 1997, BREAST CANCER RES TR, V44, P243, DOI 10.1023/A:1005879103367; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; STROBL JS, 1990, CANCER RES, V50, P5399; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visvader JE, 2003, INT J BIOCHEM CELL B, V35, P1034, DOI 10.1016/S1357-2725(03)00030-X; Vomachka AJ, 2000, ONCOGENE, V19, P1077, DOI 10.1038/sj.onc.1203348; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wagner Kay-Uwe, 2011, J Carcinog, V10, P32, DOI 10.4103/1477-3163.90677; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wiklund ED, 2010, INT J CANCER, V126, P28, DOI 10.1002/ijc.24813; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yamazaki K, 2006, BIOL REPROD, V75, P462, DOI 10.1095/biolreprod.105.048058; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	88	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2850	2864		10.1074/jbc.RA117.000162	http://dx.doi.org/10.1074/jbc.RA117.000162			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29321207	hybrid, Green Published			2022-12-28	WOS:000426051900020
J	Yoon, JH; Hodge, RP; Hackfeld, LC; Park, J; Choudhury, JR; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Hodge, Richard P.; Hackfeld, Linda C.; Park, Jeseong; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise			Genetic control of predominantly error-free replication through an acrolein-derived minor-groove DNA adduct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST REV1 PROTEIN; POLYMERASE-IOTA; HUMAN-CELLS; 1,N(2)-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; PROMOTES REPLICATION; LIPID-PEROXIDATION; THYMINE GLYCOL; TEMPLATE; LESIONS	Acrolein, an alpha,beta-unsaturated aldehyde, is generated in vivo as the end product of lipid peroxidation and from metabolic oxidation of polyamines, and it is a ubiquitous environmental pollutant. The reaction of acrolein with the N-2 of guanine in DNA leads to the formation of gamma-hydroxy-1-N-2-propano-2' deoxyguanosine (gamma-HOPdG), which can exist in DNA in a ring-closed or a ring-opened form. Here, we identified the translesion synthesis (TLS) DNA polymerases (Pols) that conduct replication through the permanently ring-opened reduced form of gamma-HOPdG ((r) gamma-HOPdG) and show that replication through this adduct is mediated via Rev1/Pol eta-, Pol iota/Pol kappa-, and Pol theta-dependent pathways, respectively. Based on biochemical and structural studies, we propose a role for Rev1 and Pol iota in inserting a nucleotide (nt) opposite the adduct and for Pols eta and kappa in extending synthesis from the inserted nt in the respective TLS pathway. Based on genetic analyses and biochemical studies with Pol theta, we infer a role for Pol theta at both the nt insertion and extension steps of TLS. Whereas purified Rev1 and Pol theta primarily incorporate a C opposite (r) gamma-HOPdG, Pol iota incorporates a C or a T opposite the adduct; nevertheless, TLS mediated by the Pol iota-dependent pathway as well as by other pathways occurs in a predominantly error-free manner in human cells. We discuss the implications of these observations for the mechanisms that could affect the efficiency and fidelity of TLS Pols.	[Yoon, Jung-Hoon; Park, Jeseong; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA; [Hodge, Richard P.; Hackfeld, Linda C.] Univ Texas Med Branch, Sealy Ctr Environm Hlth & Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	l.prakash@utmb.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	National Institutes of Health (NIH) [ES022948, ES020833]; NIEHS, NIH, Center Grant [P30 ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020833, R01ES022948, P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, NIH, Center Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) Grants ES022948 and ES020833 and in part by NIEHS, NIH, Center Grant P30 ES06676. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BORYSKI J, 1985, NUCLEOS NUCLEOT, V4, P595, DOI 10.1080/07328318508081892; CASALE R, 1990, J AM CHEM SOC, V112, P5264, DOI 10.1021/ja00169a039; Choi JS, 2004, J AM CHEM SOC, V126, P8606, DOI 10.1021/ja048537q; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chung FL, 1999, IARC SCI PUBL, P45; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; de los Santos C, 2001, J BIOL CHEM, V276, P9077, DOI 10.1074/jbc.M009028200; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Hofmann T, 2005, SYNTHESIS-STUTTGART, P1797, DOI 10.1055/s-2005-869905; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kim HYH, 2002, J AM CHEM SOC, V124, P9324, DOI 10.1021/ja020333r; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Levene PA, 1930, ORG SYNTH, V10, P12; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; NATH RG, 1994, P NATL ACAD SCI USA, V91, P7491, DOI 10.1073/pnas.91.16.7491; Nath RG, 1996, CANCER RES, V56, P452; Nechev LV, 2000, CHEM RES TOXICOL, V13, P421, DOI 10.1021/tx990167+; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Tissier A, 2000, GENE DEV, V14, P1642; VACA CE, 1988, MUTAT RES, V195, P137, DOI 10.1016/0165-1110(88)90022-X; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	39	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2949	2958		10.1074/jbc.RA117.000962	http://dx.doi.org/10.1074/jbc.RA117.000962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29330301	Green Published, hybrid			2022-12-28	WOS:000426051900028
J	Zach, F; Polzer, F; Mueller, A; Gessner, A				Zach, Frank; Polzer, Franziska; Mueller, Alexandra; Gessner, Andre			p62/sequestosome 1 deficiency accelerates osteoclastogenesis in vitro and leads to Paget's disease-like bone phenotypes in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoclast; bone marrow; osteoporosis; genetic disease; bone; CT; bone turnover; p62; sequestosome 1; Paget's disease; osteoclastogenesis	NF-KAPPA-B; UBIQUITIN-ASSOCIATED DOMAIN; P62 SQSTM1; UBA DOMAIN; MUTATIONS; DIFFERENTIATION; BINDING; PATHOGENESIS; INCREASES	The sequestosome 1 gene encodes the p62 protein and is the major genetic risk factor associated with Paget's disease of bone. In 2004, p62 was reported to up-regulate osteoclast differentiation by activating the transcription factors Nfatc1 and NF-B. Here, we characterized the osteoclastogenic potential of murine p62(-/-)-derived cells compared with WT cells. Our data confirmed previous findings indicating that p62 is induced during murine osteoclast differentiation. Surprisingly, an indispensable role for p62 in in vitro osteoclast differentiation was not reproducible because p62-deficient osteoclasts exhibited robust activation of Nfatc1, NF-B, and osteoclast marker enzymes. Thus, we concluded that in vitro osteoclast differentiation is not negatively influenced by knocking out p62. On the contrary, our results revealed that p62 deficiency accelerates osteoclastogenesis. Differentiation potential, multinucleation status, and soluble receptor activator of NF-B ligand (sRANKL) sensitivity were significantly elevated in p62-deficient, murine bone marrow-derived stem cells. Moreover, femur ultrastructures visualized by micro-computed tomography revealed pronounced accumulation of adipocytes and trabecular bone material in distal femora of obese p62(-/-) mice. Increased tartrate-resistant acid phosphatase activity, along with increased trabecular bone and accumulation of adipocytes, was confirmed in both paraffin-embedded decalcified and methyl methacrylate-embedded nondecalcified bones from p62(-/-) mice. Of note, Paget's disease-like osteolytic lesions and increased levels of the bone turnover markers CTX-I and PINP were also observed in the p62(-/-) mice. Our results indicate that p62 predominantly suppresses murine in vitro osteoclast differentiation and highlight previously undetected Paget's disease-like phenotypes in p62(-/-) mice in vivo.	[Zach, Frank; Polzer, Franziska; Mueller, Alexandra; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany	University of Regensburg	Gessner, A (corresponding author), Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	andre.gessner@ukr.de			Bayerische Forschungsstiftung Grant [AZ 1070-13]; Deutsche Forschungsgemeinschaft Grants [GE671/14-2, INST 102/11-1 FUGG]	Bayerische Forschungsstiftung Grant; Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG))	This work was supported by Bayerische Forschungsstiftung Grant AZ 1070-13 (to A.G.) and Deutsche Forschungsgemeinschaft Grants GE671/14-2 (to A.G.) and INST 102/11-1 FUGG (to Prof. Dr. Lars Krenkel). The authors declare that they have no conflicts of interest with the contents of this article.	Albagha OME, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.125; Cavey JR, 2006, CALCIFIED TISSUE INT, V78, P271, DOI 10.1007/s00223-005-1299-6; Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205; Chamoux E, 2009, MOL ENDOCRINOL, V23, P1668, DOI 10.1210/me.2009-0066; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Daroszewska A, 2011, HUM MOL GENET, V20, P2734, DOI 10.1093/hmg/ddr172; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Gerlag DM, 2000, J IMMUNOL, V165, P1652, DOI 10.4049/jimmunol.165.3.1652; Hiruma Y, 2008, HUM MOL GENET, V17, P3708, DOI 10.1093/hmg/ddn266; Hocking LJ, 2004, J BONE MINER RES, V19, P1122, DOI 10.1359/JBMR.0403015; Ikeda K, 2016, J BIOCHEM, V159, P1, DOI 10.1093/jb/mvv112; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Layfield R, 2004, BIOCHEM SOC T, V32, P728, DOI 10.1042/BST0320728; Maria SM, 2014, J BIOMED MATER RES B, V102, P903, DOI 10.1002/jbm.b.33071; Obaid R, 2015, CELL REP, V13, P1096, DOI 10.1016/j.celrep.2015.09.071; Paget J, 1877, Med Chir Trans, V60, P37; Pang X, 2009, ACTA PHARMACOL SIN, V30, P537, DOI 10.1038/aps.2009.28; Patntirapong S, 2009, BIOMATERIALS, V30, P548, DOI 10.1016/j.biomaterials.2008.09.062; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Rea SL, 2013, ENDOCR REV, V34, P501, DOI 10.1210/er.2012-1034; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sundaram K, 2011, ENDOCRINOLOGY, V152, P4180, DOI 10.1210/en.2011-1225; Tan A, 2014, QJM-INT J MED, V107, P865, DOI 10.1093/qjmed/hcu075; Vallet ME, 2016, J CELL BIOCHEM, V117, P289, DOI 10.1002/jcb.25291; Xia M, 2014, J VIROL, V88, P5152, DOI 10.1128/JVI.03851-13; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960; Zach F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142211	34	15	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9530	9541		10.1074/jbc.RA118.002449	http://dx.doi.org/10.1074/jbc.RA118.002449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29555685	hybrid, Green Published			2022-12-28	WOS:000435441400035
J	Jenkins, CM; Yang, K; Liu, GY; Moon, SH; Dilthey, BG; Gross, RW				Jenkins, Christopher M.; Yang, Kui; Liu, Gaoyuan; Moon, Sung Ho; Dilthey, Beverly G.; Gross, Richard W.			Cytochrome c is an oxidative stress-activated plasmalogenase that cleaves plasmenylcholine and plasmenylethanolamine at the sn-1 vinyl ether linkage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasmalogen; cytochrome c; lysophospholipid; hydrogen peroxide; lipid peroxidation; oxidative stress; cardiolipin; phosphatidylinositol; lipid signaling; shotgun lipidomics	INDEPENDENT PHOSPHOLIPASE A(2)GAMMA; SHOTGUN LIPIDOMICS; MYELOPEROXIDASE TARGET; OXIDIZED PHOSPHOLIPIDS; ANIONIC PHOSPHOLIPIDS; MYOCARDIAL-ISCHEMIA; ALZHEIMERS-DISEASE; ARACHIDONIC-ACID; CELL-DEATH; MITOCHONDRIA	Plasmalogens are phospholipids critical for cell function and signaling that contain a vinyl ether linkage at the sn-1 position and are highly enriched in arachidonic acid (AA) at the sn-2 position. However, the enzyme(s) responsible for the cleavage of the vinyl ether linkage in plasmalogens has remained elusive. Herein, we report that cytochrome c, in the presence of either cardiolipin (CL), O-2 and H2O2, or oxidized CL and O-2, catalyzes the oxidation of the plasmalogen vinyl ether linkage, promoting its hydrolytic cleavage and resultant production of 2-AA-lysolipids and highly reactive -hydroxy fatty aldehydes. Using stable isotope labeling in synergy with strategic chemical derivatizations and high-mass-accuracy MS, we deduced the chemical mechanism underlying this long sought-after reaction. Specifically, labeling with either O-18(2) or (H2O)-O-18, but not with (H2O2)-O-18, resulted in M + 2 isotopologues of the -hydroxyaldehyde, whereas reactions with both O-18(2) and (H2O)-O-18 identified the M + 4 isotopologue. Furthermore, incorporation of O-18 from O-18(2) was predominantly located at the -carbon. In contrast, reactions with (H2O)-O-18 yielded O-18 linked to the aldehyde carbon. Importantly, no significant labeling of 2-AA-lysolipids with O-18(2), (H2O)-O-18, or (H2O2)-O-18 was present. Intriguingly, phosphatidylinositol phosphates (PIP2 and PIP3) effectively substituted for cardiolipin. Moreover, cytochrome c released from myocardial mitochondria subjected to oxidative stress cleaved plasmenylcholine in membrane bilayers, and this was blocked with a specific mAb against cytochrome c. Collectively, these results identify the first plasmalogenase in biology, reveal the production of previously unanticipated signaling lipids by cytochrome c, and present new perspectives on cellular signaling during oxidative stress.	[Jenkins, Christopher M.; Yang, Kui; Liu, Gaoyuan; Moon, Sung Ho; Dilthey, Beverly G.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA; [Jenkins, Christopher M.; Liu, Gaoyuan; Moon, Sung Ho; Dilthey, Beverly G.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Liu, Gaoyuan; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Yang, Kui] US FDA, Div Pharmaceut Anal, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); US Food & Drug Administration (FDA)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [RO1HL118639, RO1HL133178]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639, R01HL133178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1HL118639 and RO1HL133178. R. W. G. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert CJ, 2002, J BIOL CHEM, V277, P4694, DOI 10.1074/jbc.M110875200; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Albert CJ, 2001, J BIOL CHEM, V276, P23733, DOI 10.1074/jbc.M101447200; Albi E, 2004, J CELL PHYSIOL, V201, P439, DOI 10.1002/jcp.20086; Ascenzi P, 2015, IUBMB LIFE, V67, P98, DOI 10.1002/iub.1350; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Bakan A, 2015, MOL PHARMACOL, V88, P421, DOI 10.1124/mol.115.097816; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Belikova NA, 2009, J AM CHEM SOC, V131, P11288, DOI 10.1021/ja904343c; Borutaite V, 2013, FEBS J, V280, P4999, DOI 10.1111/febs.12353; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; CADENAS E, 1980, BIOCHEM J, V187, P131, DOI 10.1042/bj1870131; Chemin J, 2014, PFLUG ARCH EUR J PHY, V466, P689, DOI 10.1007/s00424-014-1467-5; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Correia SC, 2016, BBA-MOL BASIS DIS, V1862, P1909, DOI 10.1016/j.bbadis.2016.07.010; CREER MH, 1985, J CHROMATOGR, V338, P61, DOI 10.1016/0378-4347(85)80070-0; CREER MH, 1985, LIPIDS, V20, P922, DOI 10.1007/BF02534778; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; Dorninger F, 2017, FEBS LETT, V591, P2761, DOI 10.1002/1873-3468.12788; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Feulgen R, 1924, PFLUG ARCH GES PHYS, V206, P389, DOI 10.1007/BF01722779; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; GROSS RW, 1982, CIRC RES, V51, P27, DOI 10.1161/01.RES.51.1.27; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; HAGIHARA B, 1958, J BIOCHEM-TOKYO, V45, P565, DOI 10.1093/oxfordjournals.jbchem.a126901; Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Han XL, 2005, J LIPID RES, V46, P1548, DOI 10.1194/jlr.D500007-JLR200; Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; Heffern CTR, 2013, CHEM PHYS LIPIDS, V175, P9, DOI 10.1016/j.chemphyslip.2013.07.003; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Honsho M, 2017, FEBS LETT, V591, P2720, DOI 10.1002/1873-3468.12743; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Iwase H, 1996, BIOCHEM BIOPH RES CO, V222, P83, DOI 10.1006/bbrc.1996.0701; JAIN V, 1995, J CHROMATOGR A, V709, P387, DOI 10.1016/0021-9673(95)00422-J; Kadenbach B, 2011, MITOCHONDRION, V11, P700, DOI 10.1016/j.mito.2011.06.001; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kayama Y, 2015, INT J MOL SCI, V16, P25234, DOI 10.3390/ijms161025234; KAYAR SR, 1987, RESP PHYSIOL, V70, P275, DOI 10.1016/0034-5687(87)90010-7; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; Liu XP, 2016, CELL CHEM BIOL, V23, P1217, DOI 10.1016/j.chembiol.2016.08.009; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Moon SH, 2018, J BIOL CHEM, V293, P115, DOI 10.1074/jbc.RA117.000405; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Ong SB, 2012, CARDIOVASC RES, V94, P190, DOI 10.1093/cvr/cvr312; PALMER JW, 1986, AM J PHYSIOL, V250, pH741, DOI 10.1152/ajpheart.1986.250.5.H741; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; RAPPORT MM, 1957, J BIOL CHEM, V225, P859; Samhan-Arias AK, 2012, BBA-BIOMEMBRANES, V1818, P2413, DOI 10.1016/j.bbamem.2012.03.014; Santucci R, 2014, CURR MED CHEM, V21, P2702, DOI 10.2174/0929867321666140414112156; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SCHERRER LA, 1989, MOL CELL BIOCHEM, V88, P97; Shah MS, 2016, CIRC RES, V118, P1808, DOI 10.1161/CIRCRESAHA.116.306923; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Stadelmann-Ingrand S, 2001, FREE RADICAL BIO MED, V31, P1263, DOI 10.1016/S0891-5849(01)00720-1; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Thukkani AK, 2002, J BIOL CHEM, V277, P3842, DOI 10.1074/jbc.M109489200; Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wang M, 2014, ANAL CHEM, V86, P2146, DOI 10.1021/ac403798q; WARNER HR, 1961, J BIOL CHEM, V236, P2404; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Weisser M, 1997, CHEM PHYS LIPIDS, V90, P135, DOI 10.1016/S0009-3084(97)00089-3; Wu LC, 2011, J BIOL CHEM, V286, P24916, DOI 10.1074/jbc.M111.247163; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yang K, 2009, J CHROMATOGR B, V877, P2924, DOI 10.1016/j.jchromb.2009.01.016; Yoda E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109409	87	41	41	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8693	8709		10.1074/jbc.RA117.001629	http://dx.doi.org/10.1074/jbc.RA117.001629			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29530984	Green Published, hybrid			2022-12-28	WOS:000434205700031
J	McNitt, DH; Choi, SJ; Keene, DR; Van De Water, L; Squeglia, F; Berisio, R; Lukomski, S				McNitt, Dudley H.; Choi, Soo Jeon; Keene, Douglas R.; Van De Water, Livingston; Squeglia, Flavia; Berisio, Rita; Lukomski, Slawomir			Surface-exposed loops and an acidic patch in the Scl1 protein of group A Streptococcus enable Scl1 binding to wound-associated fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE PROTEIN; CRYSTAL-STRUCTURE; BACILLUS-ANTHRACIS; INTEGRIN ALPHA-9-BETA-1; CELLULAR FIBRONECTIN; DENSITY-LIPOPROTEIN; ELECTRON-MICROSCOPY; VIRULENCE FACTOR; VARIABLE DOMAIN; TRIPLE-HELICES	Keratinized epidermis constitutes a powerful barrier of the mucosa and skin, effectively preventing bacterial invasion, unless it is wounded and no longer protective. Wound healing involves deposition of distinct extracellular matrix (ECM) proteins enriched in cellular fibronectin (cFn) isoforms containing extra domain A (EDA). The streptococcal collagen-like protein 1 (Scl1) is a surface adhesin of group A Streptococcus (GAS), which contains an N-terminal variable (V) domain and a C-terminally located collagen-like domain. During wound infection, Scl1 selectively binds EDA/cFn isoforms and laminin, as well as low-density lipoprotein (LDL), through its V domain. The trimeric V domain has a six-helical bundle fold composed of three pairs of anti-parallel -helices interconnected by hypervariable loops, but the roles of these structures in EDA/cFn binding are unclear. Here, using recombinant Scl (rScl) constructs to investigate structure-function determinants of the Scl1-EDA/cFn interaction, we found that full-length rScl1, containing both the globular V and the collagen domains, is necessary for EDA/cFn binding. We established that the surface-exposed loops, interconnecting conserved -helices, guide recognition and binding of Scl1-V to EDA and binding to laminin and LDL. Moreover, electrostatic surface potential models of the Scl1-V domains pointed to a conserved, negatively charged pocket, surrounded by positively charged and neutral regions, as a determining factor for the binding. In light of these findings, we propose an updated model of EDA/cFn recognition by the Scl1 adhesin from GAS, representing a significant step in understanding the Scl1-ECM interactions within the wound microenvironment that underlie GAS pathogenesis.	[McNitt, Dudley H.; Choi, Soo Jeon; Lukomski, Slawomir] West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, 2095 Heath Sci North,POB 9177, Morgantown, WV 26506 USA; [Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97239 USA; [Van De Water, Livingston] Albany Med Coll, Dept Surg & Regenerat & Canc Cell Biol, Albany, NY 12208 USA; [Squeglia, Flavia; Berisio, Rita] Italian Natl Res Council, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy	West Virginia University; Albany Medical College; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Lukomski, S (corresponding author), West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, 2095 Heath Sci North,POB 9177, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Squeglia, Flavia/ABC-6150-2020; Squeglia, Flavia/AAA-8152-2019	Squeglia, Flavia/0000-0001-9142-3313; McNitt, Dudley/0000-0001-8592-4015	National Institutes of Health (NIH) Equipment Grant [S10OD016165]; NIGMS, NIH, Grant [P30GM103488]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050666, R21AI083683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016165] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH, Grant; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Paolo Fagone for assistance with rEDA purification, Kathleen Brundage for flow cytometry assistance, and Janusz Bujnicki for initial bioinformatic analyses. We thank Nyles Charon for critical reading of the manuscript. We especially thank the Shriners Hospital for Children for support of the Micro-Imaging Center in the Portland Research Unit. Flow cytometry experiments were performed in the West Virginia University Flow Cytometry and Single Cell Core Facility, which is supported by National Institutes of Health (NIH) Equipment Grant S10OD016165 and NIGMS, NIH, Grant P30GM103488 (CoBRE).	Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Bachert BA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00090; Back CR, 2017, J BIOL CHEM, V292, P1538, DOI 10.1074/jbc.M116.760975; Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chen SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-320; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Coito AJ, 1997, AM J PATHOL, V150, P1757; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Efstratiou A., 2016, STREPTOCOCCUS PYOGEN, P1; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Flores AR, 2015, INFECT IMMUN, V83, P1122, DOI 10.1128/IAI.02860-14; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Gao YM, 2010, FEMS MICROBIOL LETT, V309, P55, DOI 10.1111/j.1574-6968.2010.02013.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hynes RO, 1990, FIBRONECTINS; Kanwal S, 2017, MOL MICROBIOL, V105, P839, DOI 10.1111/mmi.13740; Kelsh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102974; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu CQ, 2008, BIOTECHNOL BIOENG, V99, P774, DOI 10.1002/bit.21637; Longmate WM, 2017, J CELL BIOL, V216, P1473, DOI 10.1083/jcb.201510042; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Lukomski S, 2017, MOL MICROBIOL, V103, P919, DOI 10.1111/mmi.13604; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mullen LM, 2008, INFECT IMMUN, V76, P1093, DOI 10.1128/IAI.01349-07; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; Oliver-Kozup H, 2013, MOL MICROBIOL, V87, P672, DOI 10.1111/mmi.12125; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Pavone P, 2006, J CHILD NEUROL, V21, P727, DOI 10.1177/08830738060210091401; Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Shinde AV, 2015, MATRIX BIOL, V41, P26, DOI 10.1016/j.matbio.2014.11.004; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Squeglia F, 2014, J BIOL CHEM, V289, P5122, DOI 10.1074/jbc.M113.523597; Squeglia F, 2013, ACTA CRYSTALLOGR F, V69, P1023, DOI 10.1107/S174430911302068X; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Tsang TM, 2012, J BIOL CHEM, V287, P16759, DOI 10.1074/jbc.M112.358978; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yamaguchi M, 2013, CELL MICROBIOL, V15, P503, DOI 10.1111/cmi.12083; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	74	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7796	7810		10.1074/jbc.RA118.002250	http://dx.doi.org/10.1074/jbc.RA118.002250			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615492	hybrid, Green Published			2022-12-28	WOS:000437256500028
J	Adrian-Segarra, JM; Schindler, N; Gajawada, P; Lorchner, H; Braun, T; Poling, J				Adrian-Segarra, Juan M.; Schindler, Natalie; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen			The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; signal transduction; STAT3; protein-protein interaction; leukemia inhibitory factor; LIF; Oncostatin M; OSM; OSMR	LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; SIGNAL-TRANSDUCING RECEPTOR; CRYSTAL-STRUCTURE; FACTOR LIF; HUMAN CHROMOSOME-22; HEPG2 CELLS; CYTOKINE; GENES; GP130	Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are closely related members of the interleukin-6 (IL-6) cytokine family. Both cytokines share a common origin and structure, and both interact through a specific region, termed binding site III, to activate a dimeric receptor complex formed by glycoprotein 130 (gp130) and LIF receptor (LIFR) in humans. However, only OSM activates the OSM receptor (OSMR)-gp130 complex. The molecular features that enable OSM to specifically activate the OSMR are currently unknown. To define specific sequence motifs within OSM that are critical for initiating signaling via OSMR, here we generated chimeric OSM-LIF cytokines and performed alanine-scanning experiments. Replacement of the OSM AB loop within OSM's binding site III with that of LIF abrogated OSMR activation, measured as STAT3 phosphorylation at Tyr-705, but did not compromise LIFR activation. Correspondingly, substitution of the AB loop and D-helix in LIF with their OSM counterparts was sufficient for OSMR activation. The alanine-scanning experiments revealed that residues Tyr-34, Gln-38, Gly-39, and Leu-45 (in the AB loop) and Pro-153 (in the D-helix) had specific roles in activating OSMR but not LIFR signaling, whereas Leu-40 and Cys-49 (in the AB loop), and Phe-160 and Lys-163 (in the D-helix) were required for activation of both receptors. Because most of the key amino acid residues identified here are conserved between LIF and OSM, we concluded that comparatively minor differences in a few amino acid residues within binding site III account for the differential biological effects of OSM and LIF.	[Adrian-Segarra, Juan M.; Schindler, Natalie; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Schindler, Natalie] Johannes Gutenberg Univ Mainz, Inst Entwicklungsbiol & Neurobiol IDN, Fachbereich Biol FB 10, Inst Mol Biol gGmbH IMB, D-55128 Mainz, Germany	Max Planck Society; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz	Braun, T; Poling, J (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de; jochen.poeling@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804; Adrian-Segarra, Juan M./0000-0002-3712-0554	Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants [SFB1213, TP A02, TP B02]; Foundation Leducq Grant [3CVD01]; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY; CardioNeT (Marie Curie) [ITN-2011-GA: 289600]; Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC)	Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants; Foundation Leducq Grant; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY; CardioNeT (Marie Curie); Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC)	This work was supported by the Max Planck Society, the Excellence Initiative "Cardiopulmonary System"; Deutsche Forschungsgemeinschaft Collaborative Research Center Pulmonary Hypertension and Core Pulmonale Grants SFB1213, TP A02, and TP B02; Foundation Leducq Grant 3CVD01; the German Center for Cardiovascular Research; and European Research Area Network on Cardiovascular Diseases Grant CLARIFY. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by CardioNeT (Marie Curie ITN-2011-GA: 289600) and the Loewe-Zentrum Universities of Giessen and Marburg Lung Center (UGMLC).	Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Chollangi S, 2012, J BIOL CHEM, V287, P32848, DOI 10.1074/jbc.M112.387324; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drechsler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043155; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; GROVE RI, 1991, J BIOL CHEM, V266, P18194; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Guo S, 2015, J NEUROSCI, V35, P12047, DOI 10.1523/JNEUROSCI.1800-15.2015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Hu JQ, 2017, BBA-MOL BASIS DIS, V1863, P1951, DOI 10.1016/j.bbadis.2016.11.004; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Ichihara M, 1997, BLOOD, V90, P165; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; Jahani-Asl A, 2016, NAT NEUROSCI, V19, P798, DOI 10.1038/nn.4295; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KALLESTAD JC, 1991, J BIOL CHEM, V266, P8940; Khrustalev VV, 2012, BIOCHIMIE, V94, P2706, DOI 10.1016/j.biochi.2012.08.008; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Levy G, 2015, NAT BIOTECHNOL, V33, P1264, DOI 10.1038/nbt.3377; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SPORENO E, 1994, CYTOKINE, V6, P255, DOI 10.1016/1043-4666(94)90021-3; Sun DD, 2015, J CELL MOL MED, V19, P1296, DOI 10.1111/jcmm.12501; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Wang YP, 2000, J BIOL CHEM, V275, P25273, DOI 10.1074/jbc.M002296200; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; YIN TG, 1993, J IMMUNOL, V151, P2555; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; Zhang X., 2015, BIOMED RES INT, V2015	60	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					7017	7029		10.1074/jbc.RA118.001920	http://dx.doi.org/10.1074/jbc.RA118.001920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29511087	Green Published, hybrid			2022-12-28	WOS:000431487300032
J	West-Foyle, H; Kothari, P; Osborne, J; Robinson, DN				West-Foyle, Hoku; Kothari, Priyanka; Osborne, Jonathan; Robinson, Douglas N.			14-3-3 proteins tune non-muscle myosin II assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; cytoskeleton; Dictyostelium; fluorescence correlation spectroscopy (FCS); human; myosin; surface plasmon resonance (SPR); bipolar filament assembly	CELL MECHANICS; SIGMA GENE; IN-VITRO; EXPRESSION; CANCER; HYPERMETHYLATION; PHOSPHORYLATION; CYTOKINESIS; IDENTIFICATION; ACTIVATION	The 14-3-3 family comprises a group of small proteins that are essential, ubiquitous, and highly conserved across eukaryotes. Overexpression of the 14-3-3 proteins sigma, E, , and correlates with high metastatic potential in multiple cancer types. In Dictyostelium, 14-3-3 promotes myosin II turnover in the cell cortex and modulates cortical tension, cell shape, and cytokinesis. In light of the important roles of 14-3-3 proteins across a broad range of eukaryotic species, we sought to determine how 14-3-3 proteins interact with myosin II. Here, conducting in vitro and in vivo studies of both Dictyostelium (one 14-3-3 and one myosin II) and human proteins (seven 14-3-3s and three nonmuscle myosin IIs), we investigated the mechanism by which 14-3-3 proteins regulate myosin II assembly. Using in vitro assembly assays with purified myosin II tail fragments and 14-3-3, we demonstrate that this interaction is direct and phosphorylation-independent. All seven human 14-3-3 proteins also altered assembly of at least one paralog of myosin II. Our findings indicate a mechanism of myosin II assembly regulation that is mechanistically conserved across a billion years of evolution from amebas to humans. We predict that altered 14-3-3 expression in humans inhibits the tumor suppressor myosin II, contributing to the changes in cell mechanics observed in many metastatic cancers.	[West-Foyle, Hoku; Kothari, Priyanka; Osborne, Jonathan; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 Wolfe St, Baltimore, MD 21205 USA; [Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 Wolfe St, Baltimore, MD 21205 USA; [Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Robinson, DN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 Wolfe St, Baltimore, MD 21205 USA.; Robinson, DN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 Wolfe St, Baltimore, MD 21205 USA.	dnr@jhmi.edu		Robinson, Douglas/0000-0003-1236-4891; Kothari, Priyanka/0000-0002-1791-5093	National Institutes of Health [S10 OD016374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066817, T32GM007445] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Johns Hopkins University Microscope Facility, particularly Barbara Smith, for providing equipment and technical assistance for the EM and FCS experiments. We thank Vasudha Srivastava for FCS training and experimental suggestions. We thank Robert Bloch and Yinghua Zhang at the University of Maryland Biosensor Core, who performed the SPR studies. We would also like to thank all D. N. R. laboratory members for their help and feedback. The FCS instrument was purchased using National Institutes of Health Shared Instrumentation Grant S10 OD016374.	Bordeleau F, 2014, AM J PHYSIOL-CELL PH, V306, pC110, DOI 10.1152/ajpcell.00283.2013; Bosgraaf L, 2006, EUR J CELL BIOL, V85, P969, DOI 10.1016/j.ejcb.2006.04.004; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Calverley DC, 1998, BLOOD, V91, P1295, DOI 10.1182/blood.V91.4.1295; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; Chi QJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1072; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Elliott H, 2015, NAT CELL BIOL, V17, P137, DOI 10.1038/ncb3092; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fitzpatrick JAJ, 2011, CURR OPIN STRUC BIOL, V21, P650, DOI 10.1016/j.sbi.2011.06.006; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323; Gal N, 2012, CELL BIOCHEM BIOPHYS, V63, P199, DOI 10.1007/s12013-012-9356-z; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kee YS, 2008, CURR BIOL, V18, pR860, DOI 10.1016/j.cub.2008.07.071; Kothari P, 2017, METHOD CELL BIOL, V137, P307, DOI 10.1016/bs.mcb.2016.03.038; Lee S, 2010, MOL BIOL CELL, V21, P1810, DOI 10.1091/mbc.E10-01-0009; Li YL, 2015, ONCOL LETT, V9, P290, DOI 10.3892/ol.2014.2676; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; OHALLORAN TJ, 1990, J CELL BIOL, V110, P63, DOI 10.1083/jcb.110.1.63; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ostergaard M, 1997, CANCER RES, V57, P4111; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Press W., 1992, NUMERICAL RECIPES C, P663; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Robinson DN, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-4; Robinson Douglas N, 2010, Small GTPases, V1, P165, DOI 10.4161/sgtp.1.3.14432; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Slone SR, 2015, NEUROBIOL DIS, V79, P1, DOI 10.1016/j.nbd.2015.02.032; Srivastava V, 2015, CURR BIOL, V25, P663, DOI 10.1016/j.cub.2015.01.025; Surcel A, 2017, BIORXIV, DOI [10.1101/190553, DOI 10.1101/190553]; Surcel A, 2015, P NATL ACAD SCI USA, V112, P1428, DOI 10.1073/pnas.1412592112; Suzuki H, 2000, CANCER RES, V60, P4353; Vazquez RM, 2015, INTEGR BIOL-UK, V7, P477, DOI 10.1039/c5ib00023h; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wu K, 1997, ARCH BIOCHEM BIOPHYS, V339, P2, DOI 10.1006/abbi.1996.9841; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102; Zhou QQ, 2010, CURR BIOL, V20, P1881, DOI 10.1016/j.cub.2010.09.048	51	18	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6751	6761		10.1074/jbc.M117.819391	http://dx.doi.org/10.1074/jbc.M117.819391			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29549125	Green Published, hybrid			2022-12-28	WOS:000431487300011
J	Lokau, J; Garbers, C				Lokau, Juliane; Garbers, Christoph			The length of the interleukin-11 receptor stalk determines its capacity for classic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; STAT3; cytokine; proliferation; signal transduction; interleukin-11; interleukin-11 receptor; gp130; stalk region	IL-11 RECEPTOR; MOLECULAR-CLONING; GP130; CYTOKINE; BINDING; CELLS; TUMORIGENESIS; INFLAMMATION; INHIBITION; ACTIVATION	Interleukin (IL)-11 is a multifunctional cytokine that was traditionally recognized for its hematopoietic and anti-inflammatory functions, but has recently been shown also to be involved in tumorigenesis. IL-11 signaling is initiated by binding of the cytokine to the IL-11 receptor (IL-11R), which is not directly involved in signaling but required for IL-11 binding to the signal-transducing receptor glycoprotein (gp) 130. In classic signaling, IL-11 binds to the membrane-bound IL-11R to initiate signal transduction. Additionally, IL-11 signaling can be initiated via soluble IL-11R, known as trans-signaling, and this pathway only requires the three extracellular domains of the IL-11R, but not stalk, transmembrane, or intracellular region. Here, we analyzed the role of the IL-11R stalk region, a 55 amino acid stretch connecting the extracellular domains with the transmembrane helix, in classic IL-11 signaling with the help of cytokine-dependent cell lines. We showed that the stalk region is crucial for IL-11 signaling via the membrane-bound IL-11R. Using different deletion variants, we found that a minimal length of 23 amino acid residues is required for efficient signal transduction. We further found that classic IL-11 signaling depended solely on the length, but not the sequence, of the IL-11R stalk region, suggesting that the stalk functions as a spacer in the signaling complex. We previously described the IL-11R stalk region as determinant of proteolysis and regulator of IL-11 trans-signaling. The results presented here reveal an additional function in classic IL-11 signaling, highlighting the importance of the IL-11R stalk in IL-11 signaling.	[Lokau, Juliane; Garbers, Christoph] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	University of Kiel	Garbers, C (corresponding author), Rudolf Hoeber Str 1, D-24118 Kiel, Germany.	cgarbers@biochem.uni-kiel.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Lokau, Juliane/0000-0002-2573-7282	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was funded by Deutsche Forschungsgemeinschaft Grants SFB877 project A10 (Bonn, Germany) and the Cluster of Excellence "Inflammation at Interfaces." The authors declare that they have no conflicts of interest with the contents of this article.	Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Baumann H, 1996, J IMMUNOL, V157, P284; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Ernst M, 2014, CLIN CANCER RES, V20, P5579, DOI 10.1158/1078-0432.CCR-13-2492; Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2013, BIOL CHEM, V394, P1145, DOI 10.1515/hsz-2013-0166; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Lokau J, 2016, CELL REP, V14, P1761, DOI 10.1016/j.celrep.2016.01.053; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Monhasery N, 2016, CELL REP, V16, P1067, DOI 10.1016/j.celrep.2016.06.062; Nandurkar HH, 1996, ONCOGENE, V12, P585; Nitz R, 2015, BIOCHIMIE, V119, P175, DOI 10.1016/j.biochi.2015.11.005; Orazi A, 1996, EXP HEMATOL, V24, P1289; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Pflanz S, 1999, FEBS LETT, V450, P117, DOI 10.1016/S0014-5793(99)00477-9; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Trepicchio WL, 1997, J IMMUNOL, V159, P5661; Xu DH, 2016, CANCER LETT, V373, P156, DOI 10.1016/j.canlet.2016.01.004; Xu YB, 2010, J BIOL CHEM, V285, P21214, DOI 10.1074/jbc.C110.129502	33	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6398	6409		10.1074/jbc.RA118.001879	http://dx.doi.org/10.1074/jbc.RA118.001879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29523682	Green Published, hybrid			2022-12-28	WOS:000431108600015
J	Prakash, P; Punekar, NS; Bhaumik, P				Prakash, Prem; Punekar, Narayan S.; Bhaumik, Prasenjit			Structural basis for the catalytic mechanism and alpha-ketoglutarate cooperativity of glutamate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dehydrogenase; cooperativity; crystal structure; enzyme mechanism; allosteric regulation; enzyme catalysis; Aspergillus niger; fungal GDH; glutamate dehydrogenase; reaction mechanism	CRYSTAL-STRUCTURE; COENZYME SPECIFICITY; CORYNEBACTERIUM-GLUTAMICUM; COFACTOR SPECIFICITY; MOLECULAR-PROPERTIES; SUBSTRATE-BINDING; PROTEINS; IMINOGLUTARATE; IDENTIFICATION; PURIFICATION	Glutamate dehydrogenase (GDH) is a key enzyme connecting carbon and nitrogen metabolism in all living organisms. Despite extensive studies on GDHs from both prokaryotic and eukaryotic organisms in the last 40 years, the structural basis of the catalytic features of this enzyme remains incomplete. This study reports the structural basis of the GDH catalytic mechanism and allosteric behavior. We determined the first high-resolution crystal structures of glutamate dehydrogenase from the fungus Aspergillus niger (AnGDH), a unique NADP(+)-dependent allosteric enzyme that is forward-inhibited by the formation of mixed disulfide. We determined the structures of the active enzyme in its apo form and in binary/ternary complexes with bound substrate (alpha-ketoglutarate), inhibitor (isophthalate), coenzyme (NADPH), or two reaction intermediates (alpha-iminoglutarate and 2-amino-2-hydroxyglutarate). The structure of the forward-inhibited enzyme (fiAnGDH) was also determined. The hexameric AnGDH had three open subunits at one side and three partially closed protomers at the other, a configuration not previously reported. The AnGDH hexamers having subunits with different conformations indicated that its alpha-ketoglutarate-dependent homotropic cooperativity follows the Monod-Wyman-Changeux (MWC) model. Moreover, the position of the water attached to Asp-154 and Gly-153 defined the previously unresolved ammonium ion-binding pocket, and the binding site for the 2-phosphate group of the coenzyme was also better defined by our structural data. Additional structural and mutagenesis experiments identified the residues essential for coenzyme recognition. This study reveals the structural features responsible for positioning alpha-ketoglutarate, NADPH, ammonium ion, and the reaction intermediates in the GDH active site.	[Prakash, Prem; Punekar, Narayan S.; Bhaumik, Prasenjit] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Bhaumik, P (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	pbhaumik@iitb.ac.in	Prakash, Prem/GLU-9573-2022	Prakash, Prem/0000-0001-6507-7875	Ramalingaswami Re-entry Fellowship (Department of Biotechnology, Ministry of Science and Technology, India); IRCC, IIT Bombay	Ramalingaswami Re-entry Fellowship (Department of Biotechnology, Ministry of Science and Technology, India); IRCC, IIT Bombay	This work was supported by Ramalingaswami Re-entry Fellowship (Department of Biotechnology, Ministry of Science and Technology, India) and a research seed grant from IRCC, IIT Bombay (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	ALCALA R, 1972, ACTA CRYSTALL B-STRU, VB 28, P1671, DOI 10.1107/S0567740872004844; Baker PJ, 1998, NAT STRUCT BIOL, V5, P561, DOI 10.1038/817; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; Bhuiya MW, 2005, J MOL BIOL, V345, P325, DOI 10.1016/j.jmb.2004.10.063; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britton KL, 1999, J MOL BIOL, V293, P1121, DOI 10.1006/jmbi.1999.3205; Cardoza RE, 1998, CURR GENET, V34, P50, DOI 10.1007/s002940050365; Choudhury R, 2008, ENZYME MICROB TECH, V42, P151, DOI 10.1016/j.enzmictec.2007.08.011; Choudhury R, 2007, FEBS LETT, V581, P2733, DOI 10.1016/j.febslet.2007.05.032; COLMAN RF, 1966, J BIOL CHEM, V241, P3661; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui Q, 2002, J PHYS CHEM B, V106, P2721, DOI 10.1021/jp013012v; Dean JLE, 1997, EUR BIOPHYS J BIOPHY, V25, P417, DOI 10.1007/s002490050055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel PC, 2014, NEUROCHEM RES, V39, P426, DOI 10.1007/s11064-013-1089-x; Engel PC, 2011, NEUROCHEM INT, V59, P489, DOI 10.1016/j.neuint.2011.03.014; FEENEY R, 1990, BIOCHEM BIOPH RES CO, V166, P667, DOI 10.1016/0006-291X(90)90861-G; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; FISHER HF, 1984, P NATL ACAD SCI-BIOL, V81, P2747, DOI 10.1073/pnas.81.9.2747; HOCHREITER MC, 1972, J BIOL CHEM, V247, P6271; HOLBROOK JJ, 1969, BIOCHEM J, V111, P689, DOI 10.1042/bj1110689; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015; Maniscalco SJ, 1998, BIOCHEMISTRY-US, V37, P14585, DOI 10.1021/bi980923v; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; Oliveira T, 2016, ACTA CRYSTALLOGR F, V72, P462, DOI 10.1107/S2053230X16007305; Oliveira T, 2012, J STRUCT BIOL, V177, P543, DOI 10.1016/j.jsb.2011.10.006; PISZKIEWD, 1970, J BIOL CHEM, V245, P2622; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Prakash P, 2014, ACTA CRYSTALLOGR F, V70, P1508, DOI 10.1107/S2053230X14021499; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RASCHED I, 1974, EUR J BIOCHEM, V41, P603, DOI 10.1111/j.1432-1033.1974.tb03302.x; RIFE JE, 1980, BIOCHEMISTRY-US, V19, P2328, DOI 10.1021/bi00552a008; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Sharkey MA, 2013, FEBS J, V280, P4681, DOI 10.1111/febs.12439; Sharkey MA, 2009, PROTEINS, V77, P268, DOI 10.1002/prot.22433; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Son HF, 2015, BIOCHEM BIOPH RES CO, V459, P387, DOI 10.1016/j.bbrc.2015.02.109; SRINIVASAN R, 1988, J BIOL CHEM, V263, P2304; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Sundaramoorthy R, 2007, FEBS J, V274, P275, DOI 10.1111/j.1742-4658.2006.05585.x; Tomita T, 2017, FEBS LETT, V591, P1611, DOI 10.1002/1873-3468.12667; VERONESE FM, 1974, J BIOL CHEM, V249, P7922; VISWANATHAN TS, 1982, BIOCHEMISTRY-US, V21, P339, DOI 10.1021/bi00531a022; Walvekar AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101662; WANG XG, 1995, BIOCHEMISTRY-US, V34, P11417, DOI 10.1021/bi00036a014; Werner C, 2005, J MOL BIOL, V349, P597, DOI 10.1016/j.jmb.2005.03.077; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; Wilmouth RC, 2001, NAT STRUCT BIOL, V8, P689, DOI 10.1038/90401; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZEELEN JP, 1994, ACTA CRYSTALLOGR D, V50, P443, DOI 10.1107/S0907444994001277	64	24	24	5	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6241	6258		10.1074/jbc.RA117.000149	http://dx.doi.org/10.1074/jbc.RA117.000149			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29540480	hybrid, Green Published			2022-12-28	WOS:000431108600003
J	Tian, SQ; Ohta, A; Horiuchi, H; Fukuda, R				Tian, Siqi; Ohta, Akinori; Horiuchi, Hiroyuki; Fukuda, Ryouichi			Oxysterol-binding protein homologs mediate sterol transport from the endoplasmic reticulum to mitochondria in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLSERINE TRANSPORT; ER-MITOCHONDRIA; CONTACT SITES; CHOLESTEROL; GOLGI; MOVEMENT; METABOLISM; PURIFICATION; MECHANISM	Sterols are present in eukaryotic membranes and significantly affect membrane fluidity, permeability, and microdomain formation. They are synthesized in the endoplasmic reticulum (ER) and transported to other organelles and the plasma membrane. Sterols play important roles in the biogenesis and maintenance of mitochondrial membranes. However, the mechanisms underlying ER-to-mitochondrion sterol transport remain to be identified. Here, using purified yeast membrane fractions enriched in ER and mitochondria, we show that the oxysterol-binding protein homologs encoded by the OSH genes in the yeast Saccharomyces cerevisiae mediate sterol transport from the ER to mitochondria. Combined depletion of all seven Osh proteins impaired sterol transport from the ER to mitochondria in vitro; however, sterol transport was recovered at different levels upon adding one of the Osh proteins. Of note, the sterol content in the mitochondrial fraction was significantly decreased in vivo after Osh4 inactivation in a genetic background in which all the other OSH genes were deleted. We also found that Osh5-Osh7 bind cholesterol in vitro. We propose a model in which Osh proteins share a common function to transport sterols between membranes, with varying contributions by these proteins, depending on the target membranes. In summary, we have developed an in vitro system to examine intracellular sterol transport and provide evidence for involvement of Osh proteins in sterol transport from the ER to mitochondria in yeast.	[Tian, Siqi; Horiuchi, Hiroyuki; Fukuda, Ryouichi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan; [Ohta, Akinori] Chubu Univ, Coll Biosci & Biotechnol, Dept Biol Chem, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan	University of Tokyo; Chubu University	Fukuda, R (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	afukuda@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [17688005, 20580072, 16J00457]; Asahi Group Foundation; Public Foundation of Elizabeth Arnold-Fuji	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Asahi Group Foundation; Public Foundation of Elizabeth Arnold-Fuji	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 17688005, 20580072, and 16J00457; a grant from Asahi Group Foundation; and a grant from the Public Foundation of Elizabeth Arnold-Fuji. The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowden K, 2008, J BIOL CHEM, V283, P18210, DOI 10.1074/jbc.M800918200; BUCKLEY JT, 1982, J BIOL CHEM, V257, P3320; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Deng L, 2010, BBA-MOL CELL BIOL L, V1801, P635, DOI 10.1016/j.bbalip.2010.02.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Galmes R, 2016, EMBO REP, V17, P800, DOI 10.15252/embr.201541108; Gatta AT, 2015, ELIFE, V4, DOI 10.7554/eLife.07253; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kajiwara K, 2014, J CELL SCI, V127, P376, DOI 10.1242/jcs.132001; Kentala H, 2016, INT REV CEL MOL BIO, V321, P299, DOI 10.1016/bs.ircmb.2015.09.006; Kobayashi S, 2014, BBA-MOL CELL BIOL L, V1841, P1264, DOI 10.1016/j.bbalip.2014.05.003; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Martin LA, 2016, J BIOENERG BIOMEMBR, V48, P137, DOI 10.1007/s10863-014-9592-6; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Murley A, 2015, J CELL BIOL, V209, P539, DOI 10.1083/jcb.201502033; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Soffientini U, 2016, CLIN SCI, V130, P1843, DOI 10.1042/CS20160339; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Tian SQ, 2015, BIOSCI BIOTECH BIOCH, V79, P1608, DOI 10.1080/09168451.2015.1058702; TOKUNAGA M, 1992, J BIOL CHEM, V267, P17553; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; URBANI L, 1990, J BIOL CHEM, V265, P1919; Venkateswarlu K, 1998, J BIOL CHEM, V273, P4492, DOI 10.1074/jbc.273.8.4492; Vipond R, 1998, INFECT IMMUN, V66, P1990, DOI 10.1128/IAI.66.5.1990-1998.1998; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	63	21	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5636	5648		10.1074/jbc.RA117.000596	http://dx.doi.org/10.1074/jbc.RA117.000596			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29487131	hybrid, Green Published			2022-12-28	WOS:000430044100024
J	Anderson, LA; Islam, MA; Prather, KLJ				Anderson, Lisa A.; Islam, M. Ahsanul; Prather, Kristala L. J.			Synthetic biology strategies for improving microbial synthesis of "green" biopolymers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						metabolic engineering; synthetic biology; polysaccharide; biomaterials; secretion	BACTERIAL CELLULOSE; ALGINATE PRODUCTION; HYALURONIC-ACID; ESCHERICHIA-COLI; IN-VITRO; N-ACETYLGLUCOSAMINE; BACILLUS-SUBTILIS; AZORHIZOBIUM-CAULINODANS; ACETOBACTER-XYLINUM; BIOSYNTHESIS	Polysaccharide-based biopolymers have many material properties relevant to industrial and medical uses, including as drug delivery agents, wound-healing adhesives, and food additives and stabilizers. Traditionally, polysaccharides are obtained from natural sources. Microbial synthesis offers an attractive alternative for sustainable production of tailored biopolymers. Here, we review synthetic biology strategies for select green biopolymers: cellulose, alginate, chitin, chitosan, and hyaluronan. Microbial production pathways, opportunities for pathway yield improvements, and advances in microbial engineering of biopolymers in various hosts are discussed. Taken together, microbial engineering has expanded the repertoire of green biological chemistry by increasing the diversity of biobased materials.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, CISB, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Islam, M. Ahsanul] Loughborough Univ, Dept Chem Engn, Loughborough LE11 3TU, Leics, England	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Loughborough University	Prather, KLJ (corresponding author), 77 Massachusetts Ave,Rm E17-504G, Cambridge, MA 02139 USA.	kljp@mit.edu		Islam, M. Ahsanul/0000-0001-9585-6263	National Institutes of Health from NIGMS [P50 GM098792]; National Science Foundation [MCB-1517913]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P50 GM098792 from NIGMS and National Science Foundation Grant MCB-1517913. This is the fifth article in the Thematic Minireview series "Green biological chemistry." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00313; Azuma K, 2015, J FUNCT BIOMATER, V6, P104, DOI 10.3390/jfb6010104; Basu S, 2016, ACS NANO, V10, P1896, DOI 10.1021/acsnano.5b05648; Bettler E, 1999, GLYCOCONJUGATE J, V16, P205, DOI 10.1023/A:1007024320183; Bhatnagar A, 2009, ADV COLLOID INTERFAC, V152, P26, DOI 10.1016/j.cis.2009.09.003; BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565; Cheng FY, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700191; Chien LJ, 2006, BIOTECHNOL PROGR, V22, P1598, DOI 10.1021/bp060157g; CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x; Cottaz S, 2005, METAB ENG, V7, P311, DOI 10.1016/j.ymben.2005.05.004; Criddle CS, 2014, RENEWABLE BIOPLASTIC; Dayal MS, 2016, CARBOHYD POLYM, V144, P447, DOI 10.1016/j.carbpol.2016.02.055; de Oliveira JD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0517-4; Deng MD, 2005, METAB ENG, V7, P201, DOI 10.1016/j.ymben.2005.02.001; Draget K. I., 2005, Polysaccharides and polyamides in the food industry: properties, production, and patents, P1; Dutta U, 2005, ANAL BIOCHEM, V343, P237, DOI 10.1016/j.ab.2005.05.026; Ertesvag H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3467-7; Fernandez JG, 2014, MACROMOL MATER ENG, V299, P932, DOI 10.1002/mame.201300426; Florea M, 2016, P NATL ACAD SCI USA, V113, pE3431, DOI 10.1073/pnas.1522985113; Garcia-Gonzalez L, 2015, CATAL TODAY, V257, P237, DOI 10.1016/j.cattod.2014.05.025; Gaytan I, 2012, WORLD J MICROB BIOT, V28, P2731, DOI 10.1007/s11274-012-1084-4; GEREMIA RA, 1994, P NATL ACAD SCI USA, V91, P2669, DOI 10.1073/pnas.91.7.2669; Goncalves IR, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0815-9; Gupta A, 2017, NAT BIOTECHNOL, V35, P273, DOI 10.1038/nbt.3796; Hamer SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08716; Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076; Hossain GS, 2016, APPL MICROBIOL BIOT, V100, P2523, DOI 10.1007/s00253-015-7215-8; Huang Y, 2014, CELLULOSE, V21, P1, DOI 10.1007/s10570-013-0088-z; Hwang JW, 1999, J BIOSCI BIOENG, V88, P183, DOI 10.1016/S1389-1723(99)80199-6; Imai T, 2014, BIOMACROMOLECULES, V15, P4206, DOI 10.1021/bm501217g; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeong E, 2014, J BIOTECHNOL, V185, P28, DOI 10.1016/j.jbiotec.2014.05.018; Jia YN, 2013, BIORESOURCE TECHNOL, V132, P427, DOI 10.1016/j.biortech.2012.12.150; Jin P, 2016, METAB ENG, V35, P21, DOI 10.1016/j.ymben.2016.01.008; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Juodeikiene G, 2015, CATAL TODAY, V239, P11, DOI 10.1016/j.cattod.2014.05.039; Kadgwaki S., 1997, J FERMENT BIOENG, V4, P341, DOI [10.1016/S0922-338X(97)80139-0, DOI 10.1016/S0922-338X(97)80139-0]; Kamst E, 1997, J BACTERIOL, V179, P2103, DOI 10.1128/jb.179.7.2103-2108.1997; Kaur Mandeep, 2016, Metab Eng Commun, V3, P15, DOI 10.1016/j.meteno.2016.01.003; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lee SW, 2016, BIOTECHNOL BIOENG, V113, P2524, DOI 10.1002/bit.26014; Lee SW, 2015, METAB ENG, V28, P143, DOI 10.1016/j.ymben.2015.01.004; Lee SM, 2015, BIOTECHNOL J, V10, P575, DOI 10.1002/biot.201400622; Lien SK, 2013, METABOLOMICS, V9, P403, DOI 10.1007/s11306-012-0454-0; Liu L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-99; Liu YF, 2014, METAB ENG, V24, P61, DOI 10.1016/j.ymben.2014.04.004; Liu YF, 2014, METAB ENG, V23, P42, DOI 10.1016/j.ymben.2014.02.005; Liu YL, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/6269302; Maleki S, 2015, APPL ENVIRON MICROB, V81, P3349, DOI 10.1128/AEM.03653-14; Marcellin E, 2014, APPL MICROBIOL BIOT, V98, P6947, DOI 10.1007/s00253-014-5853-x; MERGAERT P, 1995, J BIOL CHEM, V270, P29217, DOI 10.1074/jbc.270.49.29217; Mitrousis N, 2016, ADV FUNCT MATER, V26, P1975, DOI 10.1002/adfm.201504024; Moon TS, 2009, APPL ENVIRON MICROB, V75, P589, DOI 10.1128/AEM.00973-08; Morais ARC, 2015, CATAL TODAY, V239, P38, DOI 10.1016/j.cattod.2014.05.033; Morouco P, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00061; Naqvi S, 2017, CRIT REV BIOTECHNOL, V37, P11, DOI 10.3109/07388551.2015.1104289; Ng A., 2017, ISWC 17 P 2017 ACM I, P209; Oliver JWK, 2013, P NATL ACAD SCI USA, V110, P1249, DOI 10.1073/pnas.1213024110; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Patel K. G., 2016, METABOLIC ENG BIOPRO; Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004; Pena C, 2002, J IND MICROBIOL BIOT, V29, P209, DOI 10.1038/sj.jim.7000310; Pourzardosht N, 2017, MOL BIOTECHNOL, V59, P192, DOI 10.1007/s12033-017-0005-z; Qian ZG, 2009, BIOTECHNOL BIOENG, V104, P651, DOI 10.1002/bit.22502; Qin Y, 2010, GREEN CHEM, V12, P968, DOI 10.1039/c003583a; Rehm BHA, 2015, MICROB BIOTECHNOL, V8, P19, DOI 10.1111/1751-7915.12241; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; Rehm BHA, 2009, MICROBIOL MONOGR, V13, P55, DOI 10.1007/978-3-540-92679-5_2; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Rothschild LJ, 2016, BIOCHEM SOC T, V44, P1158, DOI 10.1042/BST20160067; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Schmid J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00496; Seviour RJ, 2011, CRIT REV BIOTECHNOL, V31, P170, DOI 10.3109/07388551.2010.505909; Sheldon RA, 2015, CATAL TODAY, V239, P3, DOI 10.1016/j.cattod.2014.03.032; Sitanggang AB, 2010, BIORESOURCE TECHNOL, V101, P3595, DOI 10.1016/j.biortech.2009.12.084; Skj?k-Br?k G., 2012, POLYM SCI COMPREHENS, V10, P213, DOI [DOI 10.1016/B978-0-444-53349-4.00261-2, 10.1016/B978-0-444-53349-4.00261-2]; Southwick AM, 2002, J BACTERIOL, V184, P4039, DOI 10.1128/JB.184.14.4039-4043.2002; Stephanopoulos G., 1998, METABOLIC ENG PRINCI, piii; Taguchi S, 2017, FRONT CHEM SCI ENG, V11, P139, DOI 10.1007/s11705-017-1636-0; Tam RY, 2016, CHEM MATER, V28, P3762, DOI 10.1021/acs.chemmater.6b00627; de Lima FDT, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5828-9; Thuronyi BW, 2017, ANGEW CHEM INT EDIT, V56, P13637, DOI 10.1002/anie.201706696; Trombotto S, 2008, BIOMACROMOLECULES, V9, P1731, DOI 10.1021/bm800157x; Trujillo-Roldan MA, 2003, APPL MICROBIOL BIOT, V60, P733, DOI 10.1007/s00253-002-1173-7; Vasquez-Ponce F, 2017, ELECTRON J BIOTECHN, V28, P27, DOI 10.1016/j.ejbt.2017.05.001; Wang SL, 2002, ENZYME MICROB TECH, V31, P337, DOI 10.1016/S0141-0229(02)00135-7; Wayman J.A., 2017, BIORXIV, DOI [10.1101/160853, DOI 10.1101/160853]; Yadav V, 2015, J TISSUE ENG REGEN M, V9, pE276, DOI 10.1002/term.1644; Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10; Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804; Zhao X, 2016, J CARBOHYD CHEM, V35, P201, DOI 10.1080/07328303.2016.1205597	93	32	32	6	91	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5053	5061		10.1074/jbc.TM117.000368	http://dx.doi.org/10.1074/jbc.TM117.000368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29339554	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000429409300011
J	Nikonorova, IA; Mirek, ET; Signore, CC; Goudie, MP; Wek, RC; Anthony, TG				Nikonorova, Inna A.; Mirek, Emily T.; Signore, Christina C.; Goudie, Michael P.; Wek, Ronald C.; Anthony, Tracy G.			Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic initiation factor 2 (eIF2); mTOR complex (mTORC); liver; endoplasmic reticulum stress (ER stress); amino acid; translation regulation; ATF4; GCN2; PERK	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; TRANSCRIPTION FACTOR ATF4; PEGYLATED ARGINASE I; CELL-DEATH; LEUCINE DEPRIVATION; GENE-EXPRESSION; KINASE GCN2; PATHWAY	Amino acid availability is sensed by GCN2 (general control nonderepressible 2) and mechanistic target of rapamycin complex 1 (mTORC1), but how these two sensors coordinate their respective signal transduction events remains mysterious. In this study we utilized mouse genetic models to investigate the role of GCN2 in hepatic mTORC1 regulation upon amino acid stress induced by a single injection of asparaginase. We found that deletion of Gcn2 prevented hepatic phosphorylation of eukaryotic initiation factor 2 to asparaginase and instead unleashed mTORC1 activity. This change in intracellular signaling occurred within minutes and resulted in increased 5-terminal oligopyrimidine mRNA translation instead of activating transcription factor 4 synthesis. Asparaginase also promoted hepatic mRNA levels of several genes which function as mTORC1 inhibitors, and these genes were blunted or blocked in the absence of Gcn2, but their timing could not explain the early discordant effects in mTORC1 signaling. Preconditioning mice with a chemical endoplasmic reticulum stress agent before amino acid stress rescued normal mTORC1 repression in the liver of Gcn2(-/-) mice but not in livers with both Gcn2 and the endoplasmic reticulum stress kinase, Perk, deleted. Furthermore, treating wildtype and Gcn2(-/-) mice with ISRIB, an inhibitor of PERK signaling, also failed to alter hepatic mTORC1 responses to asparaginase, although administration of ISRIB alone had an inhibitory GCN2-independent effect on mTORC1 activity. Taken together, the data show that activating transcription factor 4 is not required, but eukaryotic initiation factor 2 phosphorylation is necessary to prevent mTORC1 activation during amino acid stress.	[Nikonorova, Inna A.; Mirek, Emily T.; Signore, Christina C.; Goudie, Michael P.; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Rutgers State University New Brunswick; Indiana University System; Indiana University Bloomington	Anthony, TG (corresponding author), 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu		Mirek, Emily/0000-0002-9683-8216; Nikonorova, Inna/0000-0001-8498-848X	National Institutes of Health [HD070487, DK109714]; Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant [K12GM093854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HD070487 (to T. G. A.) and DK109714 (to T. G. A. and R. C. W.). This work was also supported by Institutional Research and Academic Career Development Awards (IRACDA) New Jersey-New York for Science Partnerships in Research and Education National Institutes of Health postdoctoral training Grant K12GM093854 (to I. A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Al-Baghdadi RJT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01041-7; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Averous J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27698; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hadinnapola C, 2017, CIRCULATION, V136, P2022, DOI 10.1161/CIRCULATIONAHA.117.028351; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Kardos GR, 2015, MOL CANCER RES, V13, P1408, DOI 10.1158/1541-7786.MCR-15-0048; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; Mazor KM, 2016, AMINO ACIDS, V48, P2831, DOI 10.1007/s00726-016-2318-9; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Morrow K, 2013, LEUKEMIA, V27, P569, DOI 10.1038/leu.2012.247; Ng S, 2011, AUTOPHAGY, V7, P1173, DOI 10.4161/auto.7.10.16681; Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038; Nikonorova IA, 2017, J BIOL CHEM, V292, P6786, DOI [10.1074/jbc.m116.768408, 10.1074/jbc.M116.768408]; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Patil MD, 2016, ONCOGENE, V35, P4957, DOI 10.1038/onc.2016.37; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Sabatini DM, 2017, P NATL ACAD SCI USA, V114, P11818, DOI 10.1073/pnas.1716173114; Shan JX, 2016, NUCLEIC ACIDS RES, V44, P9719, DOI 10.1093/nar/gkw667; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yau T, 2013, INVEST NEW DRUG, V31, P99, DOI 10.1007/s10637-012-9807-9; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	48	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5005	5015		10.1074/jbc.RA117.001625	http://dx.doi.org/10.1074/jbc.RA117.001625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449374	hybrid, Green Published			2022-12-28	WOS:000429409300005
J	Naing, SH; Kalyoncu, S; Smalley, DM; Kim, H; Tao, XJ; George, JB; Jonke, AP; Oliver, RC; Urban, VS; Torres, MP; Lieberman, RL				Naing, Swe-Htet; Kalyoncu, Sibel; Smalley, David M.; Kim, Hyojung; Tao, Xingjian; George, Josh B.; Jonke, Alex P.; Oliver, Ryan C.; Urban, Volker S.; Torres, Matthew P.; Lieberman, Raquel L.			Both positional and chemical variables control in vitro proteolytic cleavage of a presenilin ortholog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; FAMILIAL ALZHEIMERS-DISEASE; CARBOXYL TERMINAL FRAGMENT; GAMMA-SECRETASE CLEAVAGE; INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN; SUBSTRATE-SPECIFICITY; ASPARTIC PROTEASES; HELIX PROPENSITY	Mechanistic details of intramembrane aspartyl protease (IAP) chemistry, which is central to many biological and pathogenic processes, remain largely obscure. Here, we investigated the in vitro kinetics of a microbial intramembrane aspartyl protease (mIAP) fortuitously acting on the renin substrate angiotensinogen and the C-terminal transmembrane segment of amyloid precursor protein (C100), which is cleaved by the presenilin subunit of gamma-secretase, an Alzheimer disease (AD)-associated IAP. mIAP variants with substitutions in active-site and putative substrate-gating residues generally exhibit impaired, but not abolished, activity toward angiotensinogen and retain the predominant cleavage site (His-Thr). The aromatic ring, but not the hydroxyl substituent, within Tyr of the catalytic Tyr-Asp (YD) motif plays a catalytic role, and the hydrolysis reaction incorporates bulk water as in soluble aspartyl proteases. mIAP hydrolyzes the transmembrane region of C100 at two major presenilin cleavage sites, one corresponding to the AD-associated A beta 42 peptide (Ala-Thr) and the other to the non-pathogenic A beta 48 (Thr-Leu). For the former site, we observed more favorable kinetics in lipid bilayer-mimicking bicelles than in detergent solution, indicating that substrate-lipid and substrate-enzyme interactions both contribute to catalytic rates. High-resolution MS analyses across four substrates support a preference for threonine at the scissile bond. However, results from threonine-scanning mutagenesis of angiotensinogen demonstrate a competing positional preference for cleavage. Our results indicate that IAP cleavage is controlled by both positional and chemical factors, opening up new avenues for selective IAP inhibition for therapeutic interventions.	[Naing, Swe-Htet; Kalyoncu, Sibel; Kim, Hyojung; Tao, Xingjian; George, Josh B.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Smalley, David M.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Kim, Hyojung; Jonke, Alex P.; Torres, Matthew P.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Oliver, Ryan C.; Urban, Volker S.] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	raquel.lieberman@chemistry.gatech.edu	Urban, Volker S/N-5361-2015; Kalyoncu, Sibel/H-3225-2019	Urban, Volker S/0000-0002-7962-3408; Kalyoncu, Sibel/0000-0003-2264-0757; Torres, Matthew/0000-0001-7296-4536; Oliver, Ryan/0000-0003-4489-0861	National Science Foundation [MCB 0845445]; National Institutes of Health [R01GM112662, R01GM118744]; College of Sciences at Georgia Tech; Office of Biological and Environmental Research; Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112662, R01GM118744] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Sciences at Georgia Tech; Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation Grant MCB 0845445 (to R. L. L.) and National Institutes of Health Grants R01GM112662 and R01GM118744 (to M. P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a travel grant from the College of Sciences at Georgia Tech to collect data at ORNL.; Supported by the Office of Biological and Environmental Research and by the Scientific User Facilities Division, Office of Basic Energy Sciences of the United States Department of Energy.	Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Dang SY, 2015, P NATL ACAD SCI USA, V112, P3344, DOI 10.1073/pnas.1502150112; De Jonghe C, 1999, NEUROBIOL DIS, V6, P280, DOI 10.1006/nbdi.1999.0247; Deatherage CL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602794; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HOLZMAN TF, 1991, J PROTEIN CHEM, V10, P553, DOI 10.1007/BF01025483; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Khelashvili G, 2010, J PHYS CHEM B, V114, P12046, DOI 10.1021/jp106373r; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kroos L, 2013, BBA-BIOMEMBRANES, V1828, P2873, DOI 10.1016/j.bbamem.2013.03.032; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Morishima-Kawashima M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00463; Naing SH, 2015, ACS CHEM BIOL, V10, P2166, DOI 10.1021/acschembio.5b00305; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Theron LW, 2014, APPL MICROBIOL BIOT, V98, P8853, DOI 10.1007/s00253-014-6035-6; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tong BCK, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1371; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	72	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4653	4663		10.1074/jbc.RA117.001436	http://dx.doi.org/10.1074/jbc.RA117.001436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29382721	Green Published, hybrid			2022-12-28	WOS:000428848300008
J	Jiang, LY; Jiang, W; Tian, N; Xiong, YN; Liu, J; Wei, J; Wu, KY; Luo, J; Shi, XJ; Song, BL				Jiang, Lu-Yi; Jiang, Wei; Tian, Na; Xiong, Yan-Ni; Liu, Jie; Wei, Jian; Wu, Kai-Yue; Luo, Jie; Shi, Xiong-Jie; Song, Bao-Liang			Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; CHOLESTEROL-METABOLISM; ENDOPLASMIC-RETICULUM; SENSING DOMAIN; INSIG-1; GP78; CELLS; ABSORPTION; TRANSPORT	Cholesterol biosynthesis is tightly regulated in the cell. For example, high sterol concentrations can stimulate degradation of the rate-limiting cholesterol biosynthetic enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase, HMGCR). HMGCR is broken down by the endoplasmic reticulum membrane-associated protein complexes consisting of insulin-induced genes (Insigs) and the E3 ubiquitin ligase gp78. Here we found that HMGCR degradation is partially blunted in Chinese hamster ovary (CHO) cells lacking gp78 (gp78-KO). To identify other ubiquitin ligase(s) that may function together with gp78 in triggering HMGCR degradation, we performed a small-scale short hairpin RNA-based screening targeting endoplasmic reticulum-localized E3s. We found that knockdown of both ring finger protein 145 (Rnf145) and gp78 genes abrogates sterol-induced degradation of HMGCR in CHO cells. We also observed that RNF145 interacts with Insig-1 and -2 proteins and ubiquitinates HMGCR. Moreover, the tetrapeptide sequence YLYF in the sterol-sensing domain and the Cys-537 residue in the RING finger domain were essential for RNF145 binding to Insigs and RNF145 E3 activity, respectively. Of note, amino acid substitutions in the YLYF or of Cys-537 completely abolished RNF145-mediated HMGCR degradation. In summary, our study reveals that RNF145, along with gp78, promotes HMGCR degradation in response to elevated sterol levels and identifies residues essential for RNF145 function.	[Jiang, Lu-Yi; Jiang, Wei; Tian, Na; Xiong, Yan-Ni; Liu, Jie; Wei, Jian; Wu, Kai-Yue; Luo, Jie; Shi, Xiong-Jie; Song, Bao-Liang] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Shi, XJ; Song, BL (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Hubei, Peoples R China.	xjshi@whu.edu.cn; blsong@whu.edu.cn	tian, na/GVR-9226-2022	Wei, Jian/0000-0002-4368-9763; Song, Bao-Liang/0000-0002-6397-5935; Luo, Jie/0000-0003-1899-3111	Ministry of Science and Technology of China [2016YFA0500100]; National Natural Science Foundation of China [31600651, 31430044, 31690102, 31771568, 31701030]; China Postdoctoral Science Foundation [2016M592380]; 111 Project of the Ministry of Education of China [B16036]; Natural Science Foundation of Hubei Province [2016CFA012, 2017CFB617]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0500100), the National Natural Science Foundation of China (31600651, 31430044, 31690102, 31771568, and 31701030), the China Postdoctoral Science Foundation (2016M592380), the 111 Project of the Ministry of Education of China (B16036), and the Natural Science Foundation of Hubei Province (2016CFA012 and 2017CFB617). The authors declare that they have no conflicts of interest with the contents of this article.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Cook ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172721; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jiang W, 2014, DIABETES METAB J, V38, P171, DOI 10.4093/dmj.2014.38.3.171; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zhang L., 2017, ELIFE, V6	36	39	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4047	4055		10.1074/jbc.RA117.001260	http://dx.doi.org/10.1074/jbc.RA117.001260			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29374057	Green Published, hybrid			2022-12-28	WOS:000427587500017
J	Pritzkow, S; Morales, R; Lyon, A; Concha-Marambio, L; Urayama, A; Soto, C				Pritzkow, Sandra; Morales, Rodrigo; Lyon, Adam; Concha-Marambio, Luis; Urayama, Akihiko; Soto, Claudio			Efficient prion disease transmission through common environmental materials	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; INFECTIOUS PRIONS; SCRAPIE PRIONS; STEEL-SURFACE; PROTEIN; BARRIER; SOIL; FATE	Prion diseases are a group of fatal neurodegenerative diseases associated with a protein-based infectious agent, termed prion. Compelling evidence suggests that natural transmission of prion diseases is mediated by environmental contamination with infectious prions. We hypothesized that several natural and man-made materials, commonly found in the environments of wild and captive animals, can bind prions and may act as vectors for disease transmission. To test our hypothesis, we exposed surfaces composed of various common environmental materials (i.e. wood, rocks, plastic, glass, cement, stainless steel, aluminum, and brass) to hamster-adapted 263K scrapie prions and studied their attachment and retention of infectivity in vitro and in vivo. Our results indicated that these surfaces, with the sole exception of brass, efficiently bind, retain, and release prions. Prion replication was studied in vitro using the protein mis-folding cyclic amplification technology, and infectivity of surface-bound prions was analyzed by intracerebrally challenging hamsters with contaminated implants. Our results revealed that virtually all prion-contaminated materials transmitted the disease at high rates. To investigate a more natural form of exposure to environmental contamination, we simply housed animals with large contaminated spheres made of the different materials under study. Strikingly, most of the hamsters developed classical clinical signs of prion disease and typical disease-associated brain changes. Our findings suggest that prion contamination of surfaces commonly present in the environment can be a source of disease transmission, thus expanding our understanding of the mechanisms for prion spreading in nature.	[Pritzkow, Sandra; Morales, Rodrigo; Lyon, Adam; Concha-Marambio, Luis; Urayama, Akihiko; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Concha-Marambio, Luis; Soto, Claudio] Univ Los Andes, Fac Med, Ave San Carlos de Apoquindo 2200, Santiago 2, Chile	University of Texas System; University of Texas Health Science Center Houston; Universidad de los Andes - Chile	Soto, C (corresponding author), Univ Texas Med Sch, Dept Neurol, 6431 Fannin St,MSE R422, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Morales, Rodrigo/K-7173-2015; Concha-Marambio, Luis/V-3247-2019	Concha-Marambio, Luis/0000-0002-9454-8389	National Institutes of Health [P01 AI07774, R01 AI132695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132695, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01 AI07774 (to C. S.) and R01 AI132695 (to R. M.). Dr. Soto is inventor on several patents related to the PMCA technology and is currently founder, chief scientific officer, and vice president of Amprion Inc., a biotech company focusing on the commercial utilization of PMCA for diagnosis of various neurodegenerative diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Bartelt-Hunt SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003113; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; BERNOULLI C, 1977, LANCET, V1, P478; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Cassard H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6821; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; David Walter W, 2011, Nat Commun, V2, P200, DOI 10.1038/ncomms1203; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Hawkins SAC, 2015, VET REC, V176, DOI 10.1136/vr.102743; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Konold T, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00032; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Melchior MB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-24; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2015, VIRUS RES, V207, P47, DOI 10.1016/j.virusres.2014.11.007; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Uehlinger FD, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0804-7; Urayama A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32338; Urayama A, 2011, FASEB J, V25, P2792, DOI 10.1096/fj.11-180729; VerCauteren KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045774; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	39	27	27	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3363	3373		10.1074/jbc.M117.810747	http://dx.doi.org/10.1074/jbc.M117.810747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330304	hybrid, Green Published			2022-12-28	WOS:000426562800027
J	Omelchenko, A; Firestein, BL				Omelchenko, Anton; Firestein, Bonnie L.			Lipids and phosphates at odds in synaptic depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							KINASE ANCHORING PROTEIN; PLASTICITY	Long-term depression (LTD) is a reduction in the efficacy of neuronal synapses, but the molecular basis of LTD signaling and how these signals lead to phenotypic outcomes, such as the shrinkage of synaptic regions, is not clear. In a new report, Woolfrey et al. use chemically-induced LTD and a multitude of in vitro biochemical assays to provide evidence that synaptic removal of the scaffolding protein AKAP79/150 promotes LTD-induced spine shrinkage. The further identification of CaMKII, a kinase primarily associated with long-term potentiation (LTP), as a requirement for AKAP79/150 removal, uncovers unexpected interplay between different post-translational modifications and points to a new model of LTD.	[Omelchenko, Anton; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565; Omelchenko, Anton/0000-0001-7396-2815	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Woolfrey KM, 2018, J BIOL CHEM, V293, P1551, DOI 10.1074/jbc.M117.813808	8	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1568	1569		10.1074/jbc.H117.813808	http://dx.doi.org/10.1074/jbc.H117.813808			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29414768	hybrid, Green Published			2022-12-28	WOS:000424201700009
J	Lim, JM; Lim, JC; Kim, G; Levine, RL				Lim, Jung Mi; Lim, Jung Chae; Kim, Geumsoo; Levine, Rodney L.			Myristoylated methionine sulfoxide reductase A is a late endosomal protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; methionine; oxidation-reduction (redox); oxidative stress; protein myristoylation; methionine sulfoxide reductase A; STARD3	HIGH-DENSITY-LIPOPROTEINS; OXIDATIVE STRESS; APOLIPOPROTEINS AI; ESCHERICHIA-COLI; DAMAGE; CELLS; RESIDUES; COMPLEX; DOMAIN; ACTIN	Methionine residues in proteins provide antioxidant defense by reacting with oxidizing species, which oxidize methionine to methionine sulfoxide. Reduction of the sulfoxide back to methionine is catalyzed by methionine sulfoxide reductases, essential for protection against oxidative stress. The nonmyristoylated form of methionine sulfoxide reductase A (MSRA) is present in mitochondria, whereas the myristoylated form has been previously reported to be cytosolic. Despite the importance of MSRA in antioxidant defense, its in vivo binding partners and substrates have not been identified. Starting with a protein array, and followed by immunoprecipitation experiments, colocalization studies, and subcellular fractionation, we identified the late endosomal protein, StAR-related lipid transfer domain-containing 3 (STARD3), as a binding partner of myristoylated MSRA, but not of nonmyristoylated MSRA. STARD3 is known to have both membrane-binding and cytosolic domains that are important in STARD3-mediated transport of cholesterol from the endoplasmic reticulum to the endosome. We found that the STARD3 cytosolic domain localizes MSRA to the late endosome. We propose that the previous conclusion that myristoylated MSRA is strictly a cytosolic protein is artifactual and likely due to vigorous overexpression of MSRA. We conclude that myristoylated MSRA is a late endosomal protein that may play a role in lipid metabolism or may protect endosomal proteins from oxidative damage.	[Lim, Jung Mi; Lim, Jung Chae; Kim, Geumsoo; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bldg 3, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, NIH, Bldg 50 Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov			National Institutes of Health NHLBI intramural research program [ZIA HL000225]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER	National Institutes of Health NHLBI intramural research program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health NHLBI intramural research program (Grant ZIA HL000225). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alpy F, 2005, J BIOL CHEM, V280, P17945, DOI 10.1074/jbc.M500723200; Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105; Benoit SL, 2016, J BIOL CHEM, V291, P23366, DOI 10.1074/jbc.M116.747881; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Chen J, 2014, FREE RADICAL BIO MED, V77, P57, DOI 10.1016/j.freeradbiomed.2014.08.016; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Garcia-Bermudez M, 2012, SCAND J RHEUMATOL, V41, P350, DOI 10.3109/03009742.2012.677063; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Gu HY, 2013, CLIN BIOCHEM, V46, P1668, DOI 10.1016/j.clinbiochem.2013.07.011; Horvath MP, 2016, ACTA CRYSTALLOGR F, V72, P609, DOI 10.1107/S2053230X16010694; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2006, RAPID COMMUN MASS SP, V20, P1828, DOI 10.1002/rcm.2519; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lim JC, 2013, FREE RADICAL BIO MED, V61, P257, DOI 10.1016/j.freeradbiomed.2013.04.004; Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Perricone N, 1999, ARCH GERONTOL GERIAT, V29, P45, DOI 10.1016/S0167-4943(99)00022-9; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Sigalov AB, 1998, FEBS LETT, V433, P196, DOI 10.1016/S0014-5793(98)00908-9; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Thermo Fisher Scientific, 2015, PROTOARRAY APPL GUID; Toennies G, 1939, J BIOL CHEM, V128, P399; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Walker LR, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-015-0066-2; Wang XY, 2016, ADV NUTR, V7, p773S, DOI 10.3945/an.115.010991; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wilhelm LP, 2017, EMBO J, V36, P1412, DOI 10.15252/embj.201695917; Xu YY, 2015, J LIPID RES, V56, P1891, DOI 10.1194/jlr.M058776; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zhao H, 2011, AM J PHYSIOL-HEART C, V301, pH1513, DOI 10.1152/ajpheart.00441.2011	58	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7355	7366		10.1074/jbc.RA117.000473	http://dx.doi.org/10.1074/jbc.RA117.000473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593096	Green Published, hybrid			2022-12-28	WOS:000432174500028
J	Mathew, MP; Donaldson, JG				Mathew, Mohit P.; Donaldson, Julie G.			Distinct cargo-specific response landscapes underpin the complex and nuanced role of galectin-glycan interactions in clathrin-independent endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; endocytosis; membrane trafficking; major histocompatibility complex (MHC); galectin; CD59; clathrin-independent endocytosis (CIE); galectin 3; galectin lattice; macropinocytosis	PLASMA-MEMBRANE; CANCER BIOMARKERS; UNIQUE PLATFORM; GLYCOSYLATION; METASTASIS; EXPRESSION; CELLS; SECRETION; BETA-1-INTEGRINS; MACROPHAGES	Clathrin-independent endocytosis (CIE) is a form of endocytosis that lacks a defined cytoplasmic machinery. Here, we asked whether glycan interactions, acting from the outside, could be a part of that endocytic machinery. We show that the perturbation of global cellular patterns of protein glycosylation by modulation of metabolic flux affects CIE. Interestingly, these changes in glycosylation had cargo-specific effects. For example, in HeLa cells, GlcNAc treatment, which increases glycan branching, increased major histocompatibility complex class I (MHCI) internalization but inhibited CIE of the glycoprotein CD59 molecule (CD59). The effects of knocking down the expression of galectin 3, a carbohydrate-binding protein and an important player in galectin-glycan interactions, were also cargo-specific and stimulated CD59 uptake. By contrast, inhibition of all galectin-glycan interactions by lactose inhibited CIE of both MHCI and CD59. None of these treatments affected clathrin-mediated endocytosis, implying that glycosylation changes specifically affect CIE. We also found that the galectin lattice tailors membrane fluidity and cell spreading. Furthermore, changes in membrane dynamics mediated by the galectin lattice affected macropinocytosis, an altered form of CIE, in HT1080 cells. Our results suggest that glycans play an important and nuanced role in CIE, with each cargo being affected uniquely by alterations in galectin and glycan profiles and their interactions. We conclude that galectin-driven effects exist on a continuum from stimulatory to inhibitory, with distinct CIE cargo proteins having unique response landscapes and with different cell types starting at different positions on these conceptual landscapes.	[Mathew, Mohit P.; Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mathew, MP (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	mohit.mathew@nih.gov		Mathew, Mohit/0000-0001-7049-6660	NHLBI, National Institutes of Health, Intramural Research Program Grant [HL006130]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006130] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health, Intramural Research Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Intramural Research Program Grant HL006130. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Day CA, 2012, CURR PROTOC CYTOM, V2, DOI DOI 10.1002/0471142956.CY0219S62; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Fritsch K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2546-0; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Hakomori S, 1996, CANCER RES, V56, P5309; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Huang EY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.120; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Johannes L, 2016, J MOL BIOL, V428, P4792, DOI 10.1016/j.jmb.2016.10.027; Johannes L, 2015, NAT REV MOL CELL BIO, V16, P311, DOI 10.1038/nrm3968; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mathew MP, 2016, ONCOTARGET, V7, P66491, DOI 10.18632/oncotarget.11582; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mechref Y, 2012, BIOANALYSIS, V4, P2457, DOI 10.4155/bio.12.246; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Santiago-Gomez A, 2013, BBA-MOL CELL RES, V1833, P2045, DOI 10.1016/j.bbamcr.2013.04.017; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026	48	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7222	7237		10.1074/jbc.RA118.001802	http://dx.doi.org/10.1074/jbc.RA118.001802			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581232	Green Published, hybrid			2022-12-28	WOS:000432174500014
J	Bruegger, JJ; Smith, BC; Wynia-Smith, SL; Marletta, MA				Bruegger, Joel J.; Smith, Brian C.; Wynia-Smith, Sarah L.; Marletta, Michael A.			Comparative and integrative metabolomics reveal that S-nitrosation inhibits physiologically relevant metabolic enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; metabolism; metabolomics; nitric oxide; proteomics; S-nitrosylation	NITRIC-OXIDE; NITROSOTHIOL FORMATION; PROTEIN; NITROSYLATION; SELECTIVITY; TARGET; SIGNAL; GAPDH; XCMS; ACID	Cysteine S-nitrosation is a reversible post-translational modification mediated by nitric oxide ((NO)-N-center dot)-derived agents. S-Nitrosation participates in cellular signaling and is associated with several diseases such as cancer, cardiovascular diseases, and neuronal disorders. Despite the physiological importance of this nonclassical (NO)-N-center dot-signaling pathway, little is understood about how much S-nitrosation affects protein function. Moreover, identifying physiologically relevant targets of S-nitrosation is difficult because of the dynamics of transnitrosation and a limited understanding of the physiological mechanisms leading to selective protein S-nitrosation. To identify proteins whose activities are modulated by S-nitrosation, we performed a metabolomics study comparing WT and endothelial nitric-oxide synthase knockout mice. We integrated our results with those of a previous proteomics study that identified physiologically relevant S-nitrosated cysteines, and we found that the activity of at least 21 metabolic enzymes might be regulated by S-nitrosation. We cloned, expressed, and purified four of these enzymes and observed that S-nitrosation inhibits the metabolic enzymes 6-phosphogluconate dehydrogenase, 1-pyrroline-5-carboxylate dehydrogenase, catechol-O-methyltransferase, and d-3-phosphoglycerate dehydrogenase. Furthermore, using site-directed mutagenesis, we identified the predominant cysteine residue influencing the observed activity changes in each enzyme. In summary, using an integrated metabolomics approach, we have identified several physiologically relevant S-nitrosation targets, including metabolic enzymes, which are inhibited by this modification, and we have found the cysteines modified by S-nitrosation in each enzyme.	[Bruegger, Joel J.; Smith, Brian C.; Wynia-Smith, Sarah L.; Marletta, Michael A.] Univ Calif Berkeley, Inst QB3, 374B Stanley Hall, Berkeley, CA 94720 USA; [Marletta, Michael A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Marletta, Michael A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Smith, Brian C.; Wynia-Smith, Sarah L.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Medical College of Wisconsin	Marletta, MA (corresponding author), Univ Calif Berkeley, Inst QB3, 374B Stanley Hall, Berkeley, CA 94720 USA.	marletta@berkeley.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768; Wynia-Smith, Sarah/0000-0003-0985-2843	George E. Hewitt Foundation for Medical Research; National Institutes of Health Postdoctoral Fellowship from NIGMS [5F32GM095023]; American Heart Association Scientist Development Grant [15SDG25830057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095023] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; National Institutes of Health Postdoctoral Fellowship from NIGMS; American Heart Association Scientist Development Grant(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the George E. Hewitt Foundation for Medical Research (to J. J. B.), National Institutes of Health Postdoctoral Fellowship 5F32GM095023 from NIGMS (to B. C. S.), and American Heart Association Scientist Development Grant 15SDG25830057 (to B. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Broniowska KA, 2012, ANTIOXID REDOX SIGN, V17, P969, DOI 10.1089/ars.2012.4590; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Doulias PT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003252; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Ivanisevic J, 2014, CHEM BIOL, V21, P1575, DOI 10.1016/j.chembiol.2014.09.016; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keszler A, 2010, FREE RADICAL BIO MED, V48, P55, DOI 10.1016/j.freeradbiomed.2009.10.026; Kolesnik B, 2013, FREE RADICAL BIO MED, V63, P51, DOI 10.1016/j.freeradbiomed.2013.04.034; Leader DP, 2011, RAPID COMMUN MASS SP, V25, P3422, DOI 10.1002/rcm.5245; Liang XQ, 2013, BIOTECHNIQUES, V55, P267, DOI 10.2144/000114101; Lim CH, 2008, CHEM RES TOXICOL, V21, P2134, DOI 10.1021/tx800213b; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Maron BA, 2013, ANTIOXID REDOX SIGN, V18, P270, DOI 10.1089/ars.2012.4744; Mattaini KR, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0131-7; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; O'Brian CA, 2005, FREE RADICAL RES, V39, P471, DOI 10.1080/10715760500073931; Serafim RAM, 2012, CURR MED CHEM, V19, P386, DOI 10.2174/092986712803414321; Sinha V, 2010, ACS CHEM BIOL, V5, P667, DOI 10.1021/cb100054m; Smith BC, 2012, CURR OPIN CHEM BIOL, V16, P498, DOI 10.1016/j.cbpa.2012.10.016; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; TOLAN DR, 1987, AM J HUM GENET, V41, P907; Tsikas D, 2012, J PHYSIOL-LONDON, V590, P6247, DOI 10.1113/jphysiol.2012.237412; Venerando A, 2017, FEBS J, V284, P1936, DOI 10.1111/febs.14014; Wang YT, 2014, ACS CHEM BIOL, V9, P821, DOI 10.1021/cb400547u; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Wynia-Smith SL, 2017, NITRIC OXIDE-BIOL CH, V63, P52, DOI 10.1016/j.niox.2016.10.001; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yang XB, 2013, FREE RADICAL BIO MED, V56, P1, DOI 10.1016/j.freeradbiomed.2012.12.002; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	54	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6282	6296		10.1074/jbc.M117.817700	http://dx.doi.org/10.1074/jbc.M117.817700			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29483187	Green Published, hybrid			2022-12-28	WOS:000431108600006
J	Banjara, S; Mao, JH; Ryan, TM; Caria, S; Kvansakul, M				Banjara, Suresh; Mao, Jiahao; Ryan, Timothy M.; Caria, Sofia; Kvansakul, Marc			Grouper iridovirus GIV66 is a Bcl-2 protein that inhibits apoptosis by exclusively sequestering Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STRUCTURAL BIOLOGY; PEPTIDE COMPLEX; VIRUS; BAX; HOMOLOG; CONSERVATION; BIOMOLECULES; PUBLICATION; ACTIVATION	Programmed cell death or apoptosis is a critical mechanism for the controlled removal of damaged or infected cells, and proteins of the Bcl-2 family are important arbiters of this process. Viruses have been shown to encode functional and structural homologs of Bcl-2 to counter premature host-cell apoptosis and ensure viral proliferation or survival. Grouper iridovirus (GIV) is a large DNA virus belonging to the Iridoviridae family and harbors GIV66, a putative Bcl-2-like protein and mitochondrially localized apoptosis inhibitor. However, the molecular and structural basis of GIV66-mediated apoptosis inhibition is currently not understood. To gain insight into GIV66's mechanism of action, we systematically evaluated its ability to bind peptides spanning the BH3 domain of pro-apoptotic Bcl-2 family members. Our results revealed that GIV66 harbors an unusually high level of specificity for pro-apoptotic Bcl-2 and displays affinity only for Bcl-2-like 11 (Bcl2L11 or Bim). Using crystal structures of both apo-GIV66 and GIV66 bound to the BH3 domain from Bim, we unexpectedly found that GIV66 forms dimers via an interface that results in occluded access to the canonical Bcl-2 ligand-binding groove, which breaks apart upon Bim binding. This observation suggests that GIV66 dimerization may affect GIV66's ability to bind host pro-death Bcl-2 proteins and enables highly targeted virus-directed suppression of host apoptosis signaling. Our findings provide a mechanistic understanding for the potent anti-apoptotic activity of GIV66 by identifying it as the first single-specificity, pro-survival Bcl-2 protein and identifying a pivotal role of Bim in GIV-mediated inhibition of apoptosis.	[Banjara, Suresh; Mao, Jiahao; Caria, Sofia; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Ryan, Timothy M.] Australian Synchrotron, SAXS WAXS, 800 Blackburn Rd, Clayton, Vic 3168, Australia	La Trobe University	Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019	Kvansakul, Marc/0000-0003-2639-2498; Caria, Sofia/0000-0001-7289-2093; Banjara, Suresh/0000-0002-2123-8101	Australian Research Council Fellowship [FT130101349]; La Trobe University scholarship	Australian Research Council Fellowship(Australian Research Council); La Trobe University scholarship	This work was supported in whole or part by Australian Research Council Fellowship FT130101349 (to M.K.) and a La Trobe University scholarship (to S.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anasir MI, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100305; Anasir MI, 2017, J BIOL CHEM, V292, P9010, DOI 10.1074/jbc.M116.768879; Banadyga L, 2011, J VIROL, V85, P1922, DOI 10.1128/JVI.01959-10; Banjara S, 2017, J VIROL, V91, DOI 10.1128/JVI.02228-16; Bellows DS, 2002, J VIROL, V76, P2469, DOI 10.1128/JVI.76.5.2469-2479.2002; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Burton DR, 2015, ACTA CRYSTALLOGR D, V71, P1593, DOI 10.1107/S1399004715009402; Campbell S, 2014, J VIROL, V88, P8667, DOI 10.1128/JVI.01092-14; Caria S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.469; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; CHIOU SK, 1994, J VIROL, V68, P6553, DOI 10.1128/JVI.68.10.6553-6566.1994; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Desbien AL, 2009, P NATL ACAD SCI USA, V106, P5663, DOI 10.1073/pnas.0901036106; Eimon PM, 2014, METHOD ENZYMOL, V544, P395, DOI 10.1016/B978-0-12-417158-9.00016-9; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jette CA, 2008, CELL DEATH DIFFER, V15, P1063, DOI 10.1038/cdd.2008.42; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2014, CURR OPIN STRUC BIOL, V28, P41, DOI 10.1016/j.sbi.2014.07.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; KVANSAKUL M, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100290; Kvansakul M, 2007, MOL CELL, V25, P933, DOI 10.1016/j.molcel.2007.02.004; Kvansakul M, 2016, METHODS MOL BIOL, V1491, P213, DOI 10.1007/978-1-4939-3581-9_16; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kvansakul M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001236; Lin PW, 2008, APOPTOSIS, V13, P165, DOI 10.1007/s10495-007-0152-y; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Luna-Vargas MPA, 2016, FEBS J, V283, P2676, DOI 10.1111/febs.13624; Marshall B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.52; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Muppidi A, 2012, J AM CHEM SOC, V134, P14734, DOI 10.1021/ja306864v; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; van Regenmortel M. H. V., 2000, VIRUS TAXONOMY CLASS; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Westphal D, 2007, J VIROL, V81, P7178, DOI 10.1128/JVI.00404-07; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002	67	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5464	5477		10.1074/jbc.RA117.000591	http://dx.doi.org/10.1074/jbc.RA117.000591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29483196	Green Published, hybrid			2022-12-28	WOS:000430044100011
J	Kwon, A; John, M; Ruan, Z; Kannan, N				Kwon, Annie; John, Mihir; Ruan, Zheng; Kannan, Natarajan			Coupled regulation by the juxtamembrane and sterile motif (SAM) linker is a hallmark of ephrin tyrosine kinase evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; receptor tyrosine kinase; structure-function; protein sequence; bioinformatics; protein evolution	C-TERMINAL TAIL; CRYSTAL-STRUCTURE; PROTEIN-KINASES; EPHB2 RECEPTOR; DOMAIN; ACTIVATION; BINDING; MECHANISM; RESIDUES; EPHA3	Ephrin (Eph) receptor tyrosine kinases have evolutionarily diverged from other tyrosine kinases to respond to specific activation and regulatory signals that require close coupling of kinase catalytic and regulatory functions. However, the evolutionary basis for such functional coupling is not fully understood. We employed an evolutionary systems approach involving statistical mining of large sequence and structural data sets to define the hallmarks of Eph kinase evolution and functional specialization. We found that some of the most distinguishing Eph-specific residues structurally tether the flanking juxtamembrane and sterile motif (SAM) linker regions to the kinase domain, and substitutions of these residues in EphA3 resulted in faster kinase activation. We report for the first time that the SAM domain linker is functionally coupled to the juxtamembrane through co-conserved residues in the kinase domain and that together these residues provide a structural framework for coupling catalytic and regulatory functions. The unique organization of Eph-specific tethering networks and the identification of other Eph-specific sequence features of unknown functions provide new hypotheses for future functional studies and new clues to disease mutations altering Eph kinase-specific functions.	[Kwon, Annie; Ruan, Zheng; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [John, Mihir; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kannan, N (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA.	nkannan@uga.edu		Ruan, Zheng/0000-0002-4412-4916	National Institutes of Health [5RO1GM114409]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5RO1GM114409 (to N. K). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Brunet FG, 2016, GENOME BIOL EVOL, V8, P1600, DOI 10.1093/gbe/evw103; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Davis TL, 2008, STRUCTURE, V16, P873, DOI 10.1016/j.str.2008.03.008; Drescher U, 2002, CURR OPIN GENET DEV, V12, P397, DOI 10.1016/S0959-437X(02)00316-7; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mohanty S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005885; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Neuwald AF, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-66; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Plaza-Menacho I, 2016, CELL REP, V17, P3319, DOI 10.1016/j.celrep.2016.11.061; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schulze JO, 2016, CELL CHEM BIOL, V23, P1193, DOI 10.1016/j.chembiol.2016.06.017; Shi GF, 2010, CELL RES, V20, P1263, DOI 10.1038/cr.2010.115; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Singla N, 2011, CHEM BIOL, V18, P361, DOI 10.1016/j.chembiol.2011.01.011; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Nguyen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119636; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xi G, 2010, J BIOL CHEM, V285, P6937, DOI 10.1074/jbc.M109.069872; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	56	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5102	5116		10.1074/jbc.RA117.001296	http://dx.doi.org/10.1074/jbc.RA117.001296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29432127	Green Published, hybrid			2022-12-28	WOS:000429409300017
J	Partovi, SE; Mus, F; Gutknecht, AE; Martinez, HA; Tripet, BP; Lange, BM; DuBois, JL; Peters, JW				Partovi, Sarah E.; Mus, Florence; Gutknecht, Andrew E.; Martinez, Hunter A.; Tripet, Brian P.; Lange, Bernd Markus; DuBois, Jennifer L.; Peters, John W.			Coenzyme M biosynthesis in bacteria involves phosphate elimination by a functionally distinct member of the aspartase/fumarase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme purification; bacteria; bacterial metabolism; NMR; MS; coenzyme M	XANTHOBACTER STRAIN PY2; M 2-MERCAPTOETHANESULFONIC ACID; SITE-DIRECTED MUTAGENESIS; ASPARTATE AMMONIA-LYASE; ADENYLOSUCCINATE LYASE; ESCHERICHIA-COLI; ARGININOSUCCINATE LYASE; ALKALINE-PHOSPHATASE; PHOSPHOSULFOLACTATE SYNTHASE; METHANOBACTERIUM-RUMINANTIUM	For nearly 30 years, coenzyme M (CoM) was assumed to be present solely in methanogenic archaea. In the late 1990s, CoM was reported to play a role in bacterial propene metabolism, but no biosynthetic pathway for CoM has yet been identified in bacteria. Here, using bioinformatics and proteomic approaches in the metabolically versatile bacterium Xanthobacter autotrophicus Py2, we identified four putative CoM biosynthetic enzymes encoded by the xcbB1, C1, D1, and E1 genes. Only XcbB1 was homologous to a known CoM biosynthetic enzyme (ComA), indicating that CoM biosynthesis in bacteria involves enzymes different from those in archaea. We verified that the ComA homolog produces phosphosulfolactate from phosphoenolpyruvate (PEP), demonstrating that bacterial CoM biosynthesis is initiated similarly as the phosphoenolpyruvate-dependent methanogenic archaeal pathway. The bioinformatics analysis revealed that XcbC1 and D1 are members of the aspartase/fumarase superfamily (AFS) and that XcbE1 is a pyridoxal 5-phosphate-containing enzyme with homology to d-cysteine desulfhydrases. Known AFS members catalyze -elimination reactions of succinyl-containing substrates, yielding fumarate as the common unsaturated elimination product. Unexpectedly, we found that XcbC1 catalyzes -elimination on phosphosulfolactate, yielding inorganic phosphate and a novel metabolite, sulfoacrylic acid. Phosphate-releasing -elimination reactions are unprecedented among the AFS, indicating that XcbC1 is an unusual phosphatase. Direct demonstration of phosphosulfolactate synthase activity for XcbB1 and phosphate -elimination activity for XcbC1 strengthened their hypothetical assignment to a CoM biosynthetic pathway and suggested functions also for XcbD1 and E1. Our results represent a critical first step toward elucidating the CoM pathway in bacteria.	[Partovi, Sarah E.; Gutknecht, Andrew E.; Martinez, Hunter A.; Tripet, Brian P.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Mus, Florence; Lange, Bernd Markus; Peters, John W.] Washington State Univ, Inst Biol Chem, 287 Clark Hall,100 Dairy Rd, Pullman, WA 99164 USA; [Lange, Bernd Markus] Washington State Univ, MJ Murdock Metabol Lab, Pullman, WA 99164 USA	Montana State University System; Montana State University Bozeman; Washington State University; Washington State University	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, 287 Clark Hall,100 Dairy Rd, Pullman, WA 99164 USA.	jw.peters@wsu.edu		Mus, Florence/0000-0002-1655-1267	National Institutes of Health Shared Instrumentation Grant Program [1S10RR13878, 1S10RR026659]; National Science Foundation MRI Program [DBI-1532078]; Murdock Charitable Trust; Montana State University's Vice President for Research Economic Development's office; NIGMS, National Institutes of Health [P20GM103474]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	National Institutes of Health Shared Instrumentation Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI Program(National Science Foundation (NSF)); Murdock Charitable Trust; Montana State University's Vice President for Research Economic Development's office; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for the NMR instrument console upgrades and Montana State University's NMR Center has been provided by the National Institutes of Health Shared Instrumentation Grant Program (1S10RR13878 and 1S10RR026659), the National Science Foundation MRI Program (DBI-1532078), the Murdock Charitable Trust, and Montana State University's Vice President for Research Economic Development's office. The Proteomics, Metabolomics, and Mass Spectrometry facility at Montana State University received support from the Murdock Charitable Trust and NIGMS, National Institutes of Health (P20GM103474). We thank Dr. George Gauss for technical support and helpful suggestions. We also thank Garrett Moraski and Dr. Robert White for insightful advice.	Allen JR, 1999, P NATL ACAD SCI USA, V96, P8432, DOI 10.1073/pnas.96.15.8432; Allen JR, 1999, BIOCHEMISTRY-US, V38, P247, DOI 10.1021/bi982114h; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BALCH WE, 1979, J BACTERIOL, V137, P256, DOI 10.1128/JB.137.1.256-263.1979; Banerjee S, 2014, FEBS J, V281, P1642, DOI 10.1111/febs.12730; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bhaumik P, 2004, ACTA CRYSTALLOGR D, V60, P1964, DOI 10.1107/S0907444904021912; Broberg CA, 2010, ARCH MICROBIOL, V192, P945, DOI 10.1007/s00203-010-0623-3; Brosius JL, 2002, BIOCHEMISTRY-US, V41, P2217, DOI 10.1021/bi011998t; Bull H, 2002, J CLIN PATHOL-MOL PA, V55, P65; Bulusu V, 2009, BBA-PROTEINS PROTEOM, V1794, P642, DOI 10.1016/j.bbapap.2008.11.021; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; Coleman NV, 2002, APPL ENVIRON MICROB, V68, P6162, DOI 10.1128/AEM.68.12.6162-6171.2002; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENSIGN SA, 1992, APPL ENVIRON MICROB, V58, P3038, DOI 10.1128/AEM.58.9.3038-3046.1992; Ensign SA, 2001, BIOCHEMISTRY-US, V40, P5845, DOI 10.1021/bi015523d; FARRELL K, 1987, BIOCHEM J, V242, P261, DOI 10.1042/bj2420261; Fibriansah G, 2011, BIOCHEMISTRY-US, V50, P6053, DOI 10.1021/bi200497y; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fyfe PK, 2010, ACTA CRYSTALLOGR D, V66, P881, DOI 10.1107/S0907444910020081; GARRARD LJ, 1985, J BIOL CHEM, V260, P5548; Graham DE, 2009, BIOCHEM J, V424, P467, DOI 10.1042/BJ20090999; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; Graham DE, 2001, EUR J BIOCHEM, V268, P5176, DOI 10.1046/j.0014-2956.2001.02451.x; Graupner M, 2000, J BACTERIOL, V182, P3688, DOI 10.1128/JB.182.13.3688-3692.2000; Graupner M, 2000, J BACTERIOL, V182, P4862, DOI 10.1128/JB.182.17.4862-4867.2000; Ke ZH, 2011, J AM CHEM SOC, V133, P11103, DOI 10.1021/ja204378q; KELLER JW, 1990, J BIOL CHEM, V265, P5531; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; Kozlov G, 2009, ACTA CRYSTALLOGR F, V65, P857, DOI 10.1107/S1744309109029674; Krishnakumar AM, 2008, MICROBIOL MOL BIOL R, V72, P445, DOI 10.1128/MMBR.00005-08; Krum JG, 2002, BIOCHEMISTRY-US, V41, P5005, DOI 10.1021/bi0255221; Krum JG, 2001, J BACTERIOL, V183, P2172, DOI 10.1128/JB.183.7.2172-2177.2001; Krum JG, 2000, J BACTERIOL, V182, P2629, DOI 10.1128/JB.182.9.2629-2634.2000; Lee TT, 1999, BIOCHEMISTRY-US, V38, P22, DOI 10.1021/bi982299s; Liu XK, 2016, APPL ENVIRON MICROB, V82, P3269, DOI 10.1128/AEM.00673-16; Mattes TE, 2005, ARCH MICROBIOL, V183, P95, DOI 10.1007/s00203-004-0749-2; MCBRIDE BC, 1971, BIOCHEMISTRY-US, V10, P2317; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; PALMER RE, 1985, J CHEM EDUC, V62, P898, DOI 10.1021/ed062p898; Pandey AS, 2011, FEBS LETT, V585, P459, DOI 10.1016/j.febslet.2010.12.035; PATEJUNAS G, 1995, EXP EYE RES, V61, P151, DOI 10.1016/S0014-4835(05)80034-X; Paul A, 2013, ACTA CRYSTALLOGR F, V69, P1422, DOI 10.1107/S1744309113031138; Sampaleanu LM, 2004, BIOCHEM J, V384, P437, DOI 10.1042/BJ20040656; Sampaleanu LM, 2001, BIOCHEMISTRY-US, V40, P2732, DOI 10.1021/bi002272k; Sharma U, 2014, INDIAN J CLIN BIOCHE, V29, P269, DOI 10.1007/s12291-013-0408-y; SIMOPOULOS TT, 1994, BIOCHEMISTRY-US, V33, P10375, DOI 10.1021/bi00200a018; Small FJ, 1997, J BIOL CHEM, V272, P24913, DOI 10.1074/jbc.272.40.24913; SMALL FJ, 1995, APPL ENVIRON MICROB, V61, P1507, DOI 10.1128/AEM.61.4.1507-1513.1995; Soutourina J, 2001, J BIOL CHEM, V276, P40864, DOI 10.1074/jbc.M102375200; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Tabaldi LA, 2007, ENVIRON EXP BOT, V59, P43, DOI 10.1016/j.envexpbot.2005.10.009; TAYLOR CD, 1974, J BACTERIOL, V120, P974, DOI 10.1128/JB.120.2.974-975.1974; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toth EA, 2000, STRUCT FOLD DES, V8, P163, DOI 10.1016/S0969-2126(00)00092-7; Tsai M, 2007, J MOL BIOL, V370, P541, DOI 10.1016/j.jmb.2007.04.052; VANGINKEL CG, 1987, APPL ENVIRON MICROB, V53, P2903, DOI 10.1128/AEM.53.12.2903-2907.1987; Veetil VP, 2012, BIOCHEMISTRY-US, V51, P4237, DOI 10.1021/bi300430j; Veetil VP, 2009, FEBS J, V276, P2994, DOI 10.1111/j.1742-4658.2009.07015.x; Viola RE, 2000, ADV ENZYMOL RAMB, V74, P295; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; WATANABE Y, 1956, J BIOCHEM-TOKYO, V43, P283, DOI 10.1093/oxfordjournals.jbchem.a126629; Westphal A. H., 2013, EUR J BIOCHEM, V257, P160; WHITE RH, 1988, BIOCHEMISTRY-US, V27, P7458, DOI 10.1021/bi00419a043; WHITE RH, 1986, BIOCHEMISTRY-US, V25, P5304, DOI 10.1021/bi00366a047; WHITE RH, 1985, BIOCHEMISTRY-US, V24, P6487, DOI 10.1021/bi00344a027; WIEGANT WM, 1980, J GEN MICROBIOL, V120, P325; Wise EL, 2003, J BIOL CHEM, V278, P45858, DOI 10.1074/jbc.M307486200; Wolfe R. S., 1990, MOL BASIS BACTERIAL, P1; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7; Yang J, 2004, BIOCHEMISTRY-US, V43, P10424, DOI 10.1021/bi036205c; YOON MY, 1995, ARCH BIOCHEM BIOPHYS, V320, P115, DOI 10.1006/abbi.1995.1348; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	75	7	8	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5236	5246		10.1074/jbc.RA117.001234	http://dx.doi.org/10.1074/jbc.RA117.001234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29414784	Green Published, hybrid			2022-12-28	WOS:000429409300028
J	Su, ZH; Zhang, YQ; Liao, BJ; Zhong, XF; Chen, X; Wang, HT; Guo, YP; Shan, YL; Wang, LH; Pan, GJ				Su, Zhenghui; Zhang, Yanqi; Liao, Baojian; Zhong, Xiaofen; Chen, Xin; Wang, Haitao; Guo, Yiping; Shan, Yongli; Wang, Lihui; Pan, Guangjin			Antagonism between the transcription factors NANOG and OTX2 specifies rostral or caudal cell fate during neural patterning transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; VERTEBRATE NERVOUS-SYSTEM; HUMAN ES; SUBTYPE SPECIFICATION; PLURIPOTENCY; DIFFERENTIATION; PROGENITORS; INDUCTION; NEURONS; INHIBITION	During neurogenesis, neural patterning is a critical step during which neural progenitor cells differentiate into neurons with distinct functions. However, the molecular determinants that regulate neural patterning remain poorly understood. Here we optimized the "dual SMAD inhibition" method to specifically promote differentiation of human pluripotent stem cells (hPSCs) into forebrain and hindbrain neural progenitor cells along the rostral-caudal axis. We report that neural patterning determination occurs at the very early stage in this differentiation. Undifferentiated hPSCs expressed basal levels of the transcription factor orthodenticle homeobox 2 (OTX2) that dominantly drove hPSCs into the "default" rostral fate at the beginning of differentiation. Inhibition of glycogen synthase kinase 3 beta (GSK3 beta) through CHIR99021 application sustained transient expression of the transcription factor NANOG at early differentiation stages through Wnt signaling. Wnt signaling and NANOG antagonized OTX2 and, in the later stages of differentiation, switched the default rostral cell fate to the caudal one. Our findings have uncovered a mutual antagonism between NANOG and OTX2 underlying cell fate decisions during neural patterning, critical for the regulation of early neural development in humans.	[Su, Zhenghui; Wang, Haitao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Su, Zhenghui; Zhang, Yanqi; Liao, Baojian; Zhong, Xiaofen; Guo, Yiping; Shan, Yongli; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Su, Zhenghui; Liao, Baojian; Pan, Guangjin] Hefei Inst Stem Cell & Regenerat Med, Hefei 230088, Anhui, Peoples R China; [Chen, Xin] Guangdong Univ Technol, Sch Automat, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Lihui] Jinan Univ, Med Coll, Dept Pathol, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangdong University of Technology; Jinan University	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Su, Zhenghui/ABB-9503-2021; Liao, Baojian/AAI-6286-2021; Wang, Haitao/GYV-1262-2022	Wang, Haitao/0000-0002-2436-113X; Pan, Guangjin/0000-0002-2378-7198; Zhang, Yanqi/0000-0001-6896-8657	National Key Research and Development Program of China, Stem Cell and Translational Research [2017YFA0102601]; Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province [2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, 2016B030229008]; Natural Science Foundation of Guangdong Province, China [2016A030313167]; National Basic Research Program of China, 973 Program of China [2015CB964901]; National Natural Science Foundation of China [31371514, 31421004]; Cooperation Grants of the Natural Science Foundation of Guangdong Province [2014A030313801, 2014A030312012, 2015A030310229]; Science and Information Technology of Guangzhou Key Project [201508020258, 201506010092, 2015A030310254]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015293]; "Hundred Talents Program" of the Chinese Academy of Science; Science and Technology Planning Project of Guangdong Province, China [2014B030301058]; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation [2014TQ01R746, 2015TX01R203]	National Key Research and Development Program of China, Stem Cell and Translational Research; Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China, 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cooperation Grants of the Natural Science Foundation of Guangdong Province; Science and Information Technology of Guangzhou Key Project; Youth Innovation Promotion Association of the Chinese Academy of Sciences; "Hundred Talents Program" of the Chinese Academy of Science(Chinese Academy of Sciences); Science and Technology Planning Project of Guangdong Province, China; Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation	This work was supported by the National Key Research and Development Program of China, Stem Cell and Translational Research (2017YFA0102601); Frontier and Key Technology Innovation Special Grants from the Department of Science and Technology of Guangdong Province (2014B020225006, 2014B020225002, 2014B050504008, 2015B020228003, 2016B030230002, and 2016B030229008); the Natural Science Foundation of Guangdong Province, China (2016A030313167); the National Basic Research Program of China, 973 Program of China (2015CB964901); the National Natural Science Foundation of China (31371514 and 31421004); Cooperation Grants of the Natural Science Foundation of Guangdong Province (2014A030313801, 2014A030312012, and 2015A030310229); Science and Information Technology of Guangzhou Key Project (201508020258, 201506010092, and 2015A030310254); the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015293); the "Hundred Talents Program" of the Chinese Academy of Science (to X.Z.); the Science and Technology Planning Project of Guangdong Province, China (2014B030301058); and the Guangdong Province Special Program for Elite Scientists in Science and Technology Innovation (2014TQ01R746 to B.L. and 2015TX01R203 to G.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 2016, CELL REP, V15, P2651, DOI 10.1016/j.celrep.2016.05.041; Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5; Becker CG, 2015, DEVELOPMENT, V142, P811, DOI 10.1242/dev.121053; Bier E, 2015, SCIENCE, V348, DOI 10.1126/science.aaa5838; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Caronia-Brown G, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0065-y; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Kicheva A, 2015, TRENDS CELL BIOL, V25, P579, DOI 10.1016/j.tcb.2015.07.006; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Leung AW, 2016, DEVELOPMENT, V143, P398, DOI 10.1242/dev.130849; Li JYH, 2001, DEVELOPMENT, V128, P4979; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Lupo G, 2014, CELL MOL LIFE SCI, V71, P2917, DOI 10.1007/s00018-014-1596-1; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Ozair MZ, 2013, STEM CELLS, V31, P35, DOI 10.1002/stem.1246; Pere EM, 2014, EXP CELL RES, V321, P25, DOI 10.1016/j.yexcr.2013.11.018; Sanchez-Arrones L, 2009, DEV BIOL, V335, P43, DOI 10.1016/j.ydbio.2009.08.012; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Sunmonu NA, 2011, DEVELOPMENT, V138, P725, DOI 10.1242/dev.055665; Surmacz B, 2012, STEM CELLS, V30, P1875, DOI 10.1002/stem.1166; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yaguchi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou SL, 2016, DIFFERENTIATION, V92, P183, DOI 10.1016/j.diff.2016.06.002; Zirra A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8291260	56	8	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4445	4455		10.1074/jbc.M117.815449	http://dx.doi.org/10.1074/jbc.M117.815449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29386354	Green Published, hybrid			2022-12-28	WOS:000428204300016
J	Lao, YM; Yang, K; Wang, ZJ; Sun, XQ; Zou, Q; Yu, XY; Cheng, JK; Tong, XM; Yeh, ETH; Yang, J; Yi, J				Lao, Yimin; Yang, Kai; Wang, Zhaojun; Sun, Xueqing; Zou, Qiang; Yu, Xiaoyan; Cheng, Jinke; Tong, Xuemei; Yeh, Edward T. H.; Yang, Jie; Yi, Jing			DeSUMOylation of MKK7 kinase by the SUMO2/3 protease SENP3 potentiates lipopolysaccharide-induced inflammatory signaling in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MILD OXIDATIVE STRESS; TOLL-LIKE RECEPTORS; REACTIVE OXYGEN; INNATE IMMUNITY; GENE-EXPRESSION; RESPONSE GENES; DE-SUMOYLATION; TRANSCRIPTION FACTORS	Protein SUMOylation has been reported to play a role in innate immune response, but the enzymes, substrates, and consequences of the specific inflammatory signaling events are largely unknown. Reactive oxygen species (ROS) are abundantly produced during macrophage activation and required for Toll-like receptor 4 (TLR4)-mediated inflammatory signaling. Previously, we demonstrated that SENP3 is a redox-sensitive SUMO2/3 protease. To explore any links between reversible SUMOylation and ROS-related inflammatory signaling in macrophage activation, we generated mice with Senp3 conditional knock-out in myeloid cells. In bacterial lipopolysaccharide (LPS)-induced in vitro and in vivo inflammation models, we found that SENP3 deficiency markedly compromises the activation of TLR4 inflammatory signaling and the production of proinflammatory cytokines in macrophages exposed to LPS. Moreover, Senp3 conditional knock-out mice were significantly less susceptible to septic shock. Of note, SENP3 deficiency was associated with impairment in JNK phosphorylation. We found that MKK7, which selectively phosphorylates JNK, is a SENP3 substrate and that SENP3-mediated deSUMOylation of MKK7 may favor its binding to JNK. Importantly, ROS-dependent SENP3 accumulation and MKK7 deSUMOylation rapidly occurred after LPS stimulation. In conclusion, our findings indicate that SENP3 potentiates LPS-induced TLR4 signaling via deSUMOylation of MKK7 leading to enhancement in JNK phosphorylation and the downstream events. Therefore this work provides novel mechanistic insights into redox regulation of innate immune responses.	[Lao, Yimin; Yang, Kai; Sun, Xueqing; Cheng, Jinke; Tong, Xuemei; Yang, Jie; Yi, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai 200025, Peoples R China; [Wang, Zhaojun; Zou, Qiang; Yu, Xiaoyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China; [Yeh, Edward T. H.] Univ Missouri, Dept Internal Med, Columbia, MO 65211 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol,Inst Med Sci, Shanghai 200025, Peoples R China.; Yi, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Inst Med Sci, 280 S Chongqing Rd, Shanghai 200025, Peoples R China.	yangjieyj@shsmu.edu.cn; yijing@shsmu.edu.cn	Wang, Zhaojun/GKS-9141-2022	Wang, Zhaojun/0000-0003-2853-1850	National Natural Science Foundation of China [31230037, 31471263]; Ministry of Science and Technology of China [2013CB910900]; Ministry of Education of China [20130073110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 31230037 and 31471263, Ministry of Science and Technology of China Grant 2013CB910900, and the Ministry of Education of China Grant 20130073110002. The authors declare that they have no conflicts of interest with the contents of this article.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Barnett TC, 2015, CURR OPIN IMMUNOL, V36, P1, DOI 10.1016/j.coi.2015.04.002; Begitt A, 2011, BLOOD, V118, P1002, DOI 10.1182/blood-2011-04-347930; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bogachek MV, 2015, CANCER RES, V75, P11, DOI 10.1158/0008-5472.CAN-14-2824; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Chattopadhyay S, 2015, EMBO REP, V16, P1535, DOI 10.15252/embr.201540337; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheng CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S1; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cui Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006156; Decque A, 2016, NAT IMMUNOL, V17, P140, DOI 10.1038/ni.3342; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doiron K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00151-6; Domingues P, 2015, CELL REP, V13, P1467, DOI 10.1016/j.celrep.2015.10.001; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fu JH, 2011, MOL IMMUNOL, V48, P415, DOI 10.1016/j.molimm.2010.09.003; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Hu MM, 2017, J EXP MED, V214, P973, DOI 10.1084/jem.20161015; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE635, DOI 10.1073/pnas.1522826113; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim DH, 2015, EMBO J, V34, P184, DOI 10.15252/embj.201489527; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leavy O, 2014, NAT REV IMMUNOL, V14, P357, DOI 10.1038/nri3685; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu X, 2013, ACTA BIOMATER, V9, P7506, DOI 10.1016/j.actbio.2013.03.039; Liu Y, 2012, J CHENGDU MED COLL, V7, P3, DOI DOI 10.1371/J0URNAL.P0NE.0042332; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Murofushi Y, 2015, MOL IMMUNOL, V64, P63, DOI 10.1016/j.molimm.2014.10.027; Murphy M, 2015, J BIOL CHEM, V290, P19218, DOI 10.1074/jbc.M115.640128; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Ren YH, 2014, ONCOTARGET, V5, P7093, DOI 10.18632/oncotarget.2197; Rosonina E, 2017, TRANSCR-AUSTIN, V8, P220, DOI 10.1080/21541264.2017.1311829; Sahin U, 2014, NUCLEUS-PHILA, V5, P499, DOI 10.4161/19491034.2014.970104; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sarkar K, 2015, BLOOD, V126, P1670, DOI 10.1182/blood-2015-05-646182; Schilling EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02049-16; Shao L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9917; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Sun H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5980; Tempe D, 2014, ONCOGENE, V33, P921, DOI 10.1038/onc.2013.4; Tomasi ML, 2016, AM J PATHOL, V186, P2326, DOI 10.1016/j.ajpath.2016.05.007; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Ungureanu D, 2005, BLOOD, V106, P224, DOI 10.1182/blood-2004-11-4514; Wang M., 2016, COMPUT VIS MEDIA, V2, P3, DOI DOI 10.1007/s41095-016-0037-5; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xia PY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9132; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou Z, 2016, ONCOGENE, V35, P5826, DOI 10.1038/onc.2016.124	87	21	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3965	3980		10.1074/jbc.M117.816769	http://dx.doi.org/10.1074/jbc.M117.816769			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29352108	Green Published, hybrid			2022-12-28	WOS:000427587500010
J	Lei, L; Bandola-Simon, J; Roche, PA				Lei, Lei; Bandola-Simon, Joanna; Roche, Paul A.			Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; DENDRITIC CELLS; ANTIGEN PRESENTATION; DOWN-REGULATION; PROTEIN; DEGRADATION; UBIQUITYLATION; ACTIVATION; MECHANISMS; RESIDUES	March-I is a membrane-bound E3 ubiquitin ligase belonging to the membrane-associated RING-CH (March) family. March-I ubiquitinates and down-regulates the expression of major histocompatibility complex (MHC) class II and cluster of differentiation 86 (CD86) in antigen-presenting cells. March-I expression is regulated both transcriptionally and posttranslationally, and it has been reported that March-I is ubiquitinated and that this ubiquitination contributes to March-I turnover. However, the molecular mechanism regulating March-I ubiquitination and the importance of March-I's E3 ligase activity for March-I ubiquitination are not fully understood. Here we confirmed that, although March-I is ubiquitinated, it is not ubiquitinated on a lysine residue, as a lysine-less March-I variant was ubiquitinated similarly as wildtype March-I. We found that March-I E3 ligase activity is not required for its ubiquitination and does not regulate March-I protein expression, suggesting that March-I does not undergo autoubiquitination. Knocking down ubiquitin- conjugating enzyme E2 D1 (Ube2D1) impaired March-I ubiquitination, increased March-I expression, and enhanced March-I-dependent down-regulation of MHC-II proteins. Taken together, our results suggest that March-I undergoes lysine-independent ubiquitination by an as yet unidentified E3 ubiquitin ligase that, together with Ube2D1, regulates March-I expression.	[Lei, Lei; Bandola-Simon, Joanna; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NIH, Bldg 10,Rm 3N103, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011033] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bourgeois-Daigneault MC, 2013, J CELL SCI, V126, P989, DOI 10.1242/jcs.117804; Bourgeois-Daigneault MC, 2012, J IMMUNOL, V188, P4959, DOI 10.4049/jimmunol.1102708; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Khandelwal S, 2010, J BIOL CHEM, V285, P35303, DOI 10.1074/jbc.M110.147793; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mittal SK, 2015, J BIOL CHEM, V290, P27158, DOI 10.1074/jbc.M115.682708; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	31	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3904	3912		10.1074/jbc.RA117.001322	http://dx.doi.org/10.1074/jbc.RA117.001322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29414787	Green Published, hybrid			2022-12-28	WOS:000427587500005
J	Oliva, KD; Cavanaugh, JM; Cobb, BA				Oliva, Kelsey D.; Cavanaugh, Jill M.; Cobb, Brian A.			Antibody receptors steal the sweet spotlight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Immunoglobulin G (IgG) antibodies function, in part, through ligation of cell- surface Fc receptors such as Fc gamma RIIIA ( also known as CD16A). IgG glycosylation is known to impact antibody function, but the role of Fc gamma RIIIA glycans, if any, is unclear. Patel et al. now reveal that these glycans do impact protein conformation and IgG affinity and display cell-specific glycosylation patterns, leading to a potential model in which the affinity and possibly function of Fc receptors is dictated by the cell type and its surface glycome.	[Oliva, Kelsey D.; Cavanaugh, Jill M.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44107 USA	Case Western Reserve University	Cobb, BA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44107 USA.	brian.cobb@case.edu			NIGMS, National Institutes of Health [GM115234, GM082916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115234, R01GM082916] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM115234 and GM082916 (to B. A. C.). The authors declare that they have no conflicts of interest with any of the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DR, 1997, BIOCHEM SOC T, V25, P705, DOI 10.1042/bst0250705; Baum LG, 2009, IMMUNOL REV, V230, P5, DOI 10.1111/j.1600-065X.2009.00800.x; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Sondermann P, 2013, P NATL ACAD SCI USA, V110, P9868, DOI 10.1073/pnas.1307864110	10	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3490	3491		10.1074/jbc.H118.001955	http://dx.doi.org/10.1074/jbc.H118.001955			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29523693	hybrid, Green Published			2022-12-28	WOS:000427030200003
J	Ozdemir, ES; Jang, H; Gursoy, A; Keskin, O; Li, ZG; Sacks, DB; Nussinov, R				Ozdemir, E. Sila; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem; Li, Zhigang; Sacks, David B.; Nussinov, Ruth			Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; CELL MOTILITY; RAS; DOMAIN; CALMODULIN; COMPLEXES; CANCER; BINDS; DIMERIZATION; ACTIVATION	IQ motif-containing GTPase-activating proteins (IQGAPs) are scaffolding proteins playing central roles in cell-cell adhesion, polarity, and motility. The Rho GTPases Cdc42 and Rac1, in their GTP-bound active forms, interact with all three human IQGAPs. The IQGAP-Cdc42 interaction promotes metastasis by enhancing actin polymerization. However, despite their high sequence identity, Cdc42 and Rac1 differ in their interactions with IQGAP. Two Cdc42 molecules can bind to the Ex-domain and the RasGAP site of the GTPase-activating protein (GAP)related domain (GRD) of IQGAP and promote IQGAP dimerization. Only one Rac1 molecule might bind to the RasGAP site of GRD and may not facilitate the dimerization, and the exact mechanism of Cdc42 and Rac1 binding to IQGAP is unclear. Using all-atom molecular dynamics simulations, site-directed mutagenesis, and Western blotting, we unraveled the detailed mechanisms of Cdc42 and Rac1 interactions with IQGAP2. We observed that Cdc42 binding to the Ex-domain of GRD of IQGAP2 (GRD2) releases the Ex-domain at the C-terminal region of GRD2, facilitating IQGAP2 dimerization. Cdc42 binding to the Ex-domain promoted allosteric changes in the RasGAP site, providing a binding site for the second Cdc42 in the RasGAP site. Of note, the Cdc42 "insert loop" was important for the interaction of the first Cdc42 with the Ex-domain. By contrast, differences in Rac1 insert-loop sequence and structure precluded its interaction with the Ex-domain. Rac1 could bind only to the RasGAP site of apo-GRD2 and could not facilitate IQGAP2 dimerization. Our detailed mechanistic insights help decipher how Cdc42 can stimulate actin polymerization in metastasis.	[Ozdemir, E. Sila; Keskin, Ozlem] Koc Univ, Dept Chem & Biol Engn, TR-34450 Istanbul, Turkey; [Gursoy, Attila] Koc Univ, Dept Comp Engn, TR-34450 Istanbul, Turkey; [Jang, Hyunbum; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Koc University; Koc University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Tel Aviv University; Sackler Faculty of Medicine	Gursoy, A (corresponding author), Koc Univ, Dept Comp Engn, TR-34450 Istanbul, Turkey.; Nussinov, R (corresponding author), NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	agursoy@ku.edu.tr; nussinor@mail.nih.gov	Ozdemir, E Sila/A-6619-2019; Gursoy, Attila/Z-4394-2019; Gursoy, Attila/E-9565-2015	Ozdemir, E Sila/0000-0003-0046-0667; Gursoy, Attila/0000-0002-2297-2113; Gursoy, Attila/0000-0002-2297-2113; Sacks, David/0000-0003-3100-0735; Nussinov, Ruth/0000-0002-8115-6415	TUBITAK (Scientific and Technological Research Council of Turkey) [114M196]; Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of National Institutes of Health; Frederick National Laboratory; Center for Cancer Research; Intramural Research Program of the National Institutes of Health Clinical Center; TUBITAK [2211-E]; NATIONAL CANCER INSTITUTE [ZIABC010440, ZIABC010442] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	TUBITAK (Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick National Laboratory; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported in part by TUBITAK (Scientific and Technological Research Council of Turkey) Research Grant 114M196. This project was funded in whole or in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under Contract HHSN261200800001E. This research was supported in part by the Intramural Research Program of National Institutes of Health, Frederick National Laboratory, Center for Cancer Research, and the Intramural Research Program of the National Institutes of Health Clinical Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of TUBITAK Scholarship 2211-E.	BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Baspinar A, 2014, NUCLEIC ACIDS RES, V42, pW285, DOI 10.1093/nar/gku397; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlier MF, 2017, NAT REV MOL CELL BIO, V18, P389, DOI 10.1038/nrm.2016.172; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Cheung KL, 2013, J BIOL CHEM, V288, P22378, DOI 10.1074/jbc.M112.444182; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Kazanietz MG, 2017, CANCER RES, V77, P5445, DOI 10.1158/0008-5472.CAN-17-1456; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; LeCour L, 2016, STRUCTURE, V24, P1499, DOI 10.1016/j.str.2016.06.016; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Nussinov R, 2014, PROG BIOPHYS MOL BIO, V116, P158, DOI 10.1016/j.pbiomolbio.2014.07.002; Nussinov R, 2013, BBA-PROTEINS PROTEOM, V1834, P820, DOI 10.1016/j.bbapap.2012.12.014; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tanos Barbara E, 2018, Small GTPases, V9, P375, DOI 10.1080/21541248.2016.1244440; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	59	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3685	3699		10.1074/jbc.RA117.001596	http://dx.doi.org/10.1074/jbc.RA117.001596			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29358323	hybrid, Green Published			2022-12-28	WOS:000427030200022
J	Patel, KR; Roberts, JT; Subedi, GP; Barb, AW				Patel, Kashyap R.; Roberts, Jacob T.; Subedi, Ganesh P.; Barb, Adam W.			Restricted processing of CD16a/Fc gamma receptor IIIa N-glycans from primary human NK cells impacts structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; HIGH-AFFINITY BINDING; THERAPEUTIC ANTIBODIES; GLYCOSYLATION; EXPRESSION; RIIIA; TISSUES; CARBOHYDRATE; GLYCOFORMS; CANCER	CD16a/Fc gamma receptor IIIa is the most abundant antibody Fc receptor expressed on human natural killer (NK) cells and activates a protective cytotoxic response following engagement with antibody clustered on the surface of a pathogen or diseased tissue. Therapeutic monoclonal antibodies (mAbs) with greater Fc-mediated affinity for CD16a show superior therapeutic outcome; however, one significant factor that promotes antibody-CD16a interactions, the asparagine-linked carbohydrates (N-glycans), remains undefined. Here, we purified CD16a from the primary NK cells of three donors and identified a large proportion of hybrid (22%) and oligomannose N-glycans (23%). These proportions indicated restrictedN-glycan processing and were unlike those of the recombinant CD16a forms, which have predominantly complex-type N-glycans (82%). Tethering recombinant CD16a to the membrane by including the transmembrane and intracellular domains and via coexpression with the Fc epsilon receptor gamma -chain in HEK293F cells was expected to produce N-glycoforms similar to NK cell-derived CD16a but yielded N-glycoforms different from NK cell-derived CD16a and recombinant soluble CD16a. Of note, these differences in CD16aN-glycan composition affected antibody binding: CD16a with oligomannose N-glycans bound IgG1 Fc with 12-fold greater affinity than did CD16a having primarily complex-type and highly branched N-glycans. The changes in binding activity mirrored changes inNMRspectra of the two CD16a glycoforms, indicating that CD16a glycan composition also affects the glycoprotein's structure. These results indicated that CD16a from primary humanNKcells is compositionally, and likely also functionally, distinct from commonly used recombinant forms. Furthermore, our study provides critical evidence that cell lineage determines CD16a N-glycan composition and antibody-binding affinity.	[Patel, Kashyap R.; Roberts, Jacob T.; Subedi, Ganesh P.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Mol Biol Bldg,Rm 4210,2437 Pammel Dr, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Mol Biol Bldg,Rm 4210,2437 Pammel Dr, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	National Institutes of Health from NIGMS [R01 GM115489]; Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Award R01 GM115489 from NIGMS and by funds from the Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barb AW, 2015, BIOCHEMISTRY-US, V54, P313, DOI 10.1021/bi501380t; Battella S, 2016, J LEUKOCYTE BIOL, V99, P87, DOI 10.1189/jlb.5VMR0415-141R; Blazquez-Moreno A, 2017, P NATL ACAD SCI USA, V114, pE5645, DOI 10.1073/pnas.1706483114; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Congy-Jolivet N, 2008, CANCER RES, V68, P976, DOI 10.1158/0008-5472.CAN-07-6523; Cosgrave EFJ, 2013, J PROTEOME RES, V12, P3721, DOI 10.1021/pr400344h; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; EDBERG JC, 1989, J IMMUNOL, V143, P1642; Edberg JC, 1997, J IMMUNOL, V159, P3849; EDBERG JC, 1990, J IMMUNOL, V144, P4729; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hayes JM, 2014, J PROTEOME RES, V13, P5471, DOI 10.1021/pr500414q; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Huan-Chu Huang, 2015, 2015 Asia-Pacific Microwave Conference (APMC). Proceedings, P1, DOI 10.1109/APMC.2015.7411775; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Izumi Y, 2006, J LAB CLIN MED, V147, P242, DOI 10.1016/j.lab.2006.01.001; Jonsen A, 2007, RHEUMATOLOGY, V46, P1417, DOI 10.1093/rheumatology/kem167; Kaburagi T, 2017, J BIOL CHEM, V292, P2278, DOI 10.1074/jbc.M116.747667; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; LANIER LL, 1988, J IMMUNOL, V141, P3478; LANIER LL, 1986, J IMMUNOL, V136, P4480; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Loke I, 2017, MOL CELL PROTEOMICS, V16, P1507, DOI 10.1074/mcp.M116.066746; Marcella AM, 2017, APPL MICROBIOL BIOT, V101, P8431, DOI 10.1007/s00253-017-8586-9; Medzihradszky KF, 2015, MOL CELL PROTEOMICS, V14, P2103, DOI 10.1074/mcp.M115.050393; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M, 2012, INT J MOL SCI, V13, P8398, DOI 10.3390/ijms13078398; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Neron S, 2007, TRANSFUSION, V47, P1042, DOI 10.1111/j.1537-2995.2007.01233.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Schepis D, 2009, IMMUNOLOGY, V126, P140, DOI 10.1111/j.1365-2567.2008.02887.x; Sethi MK, 2015, GLYCOBIOLOGY, V25, P1064, DOI 10.1093/glycob/cwv042; Subedi GP, 2017, BIOCHEMISTRY-US, V56, P3174, DOI 10.1021/acs.biochem.7b00392; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Takahashi N, 2002, GLYCOBIOLOGY, V12, P507, DOI 10.1093/glycob/cwf063; Taniguchi T, 2017, J BIOL CHEM, V292, P11079, DOI 10.1074/jbc.M116.770123; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Varki A., 2017, ESSENTIALS GLYCOBIOL; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Yamamoto M, 2003, ELECTROPHORESIS, V24, P2295, DOI 10.1002/elps.200305459; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653	57	49	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3477	3489		10.1074/jbc.RA117.001207	http://dx.doi.org/10.1074/jbc.RA117.001207			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29330305	Green Published, hybrid			2022-12-28	WOS:000427030200002
J	Lopes, F; Keita, AV; Saxena, A; Reyes, JL; Mancini, NL; Al Rajabi, A; Wang, A; Baggio, CH; Dicay, M; van Dalen, R; Ahn, Y; Carneiro, MBH; Peters, NC; Rho, JM; MacNaughton, WK; Girardin, SE; Jijon, H; Philpott, DJ; Soderholm, JD; McKay, DM				Lopes, Fernando; Keita, Asa V.; Saxena, Alpana; Reyes, Jose Luis; Mancini, Nicole L.; Al Rajabi, Ala; Wang, Arthur; Baggio, Cristiane H.; Dicay, Michael; van Dalen, Rob; Ahn, Younghee; Carneiro, Matheus B. H.; Peters, Nathan C.; Rho, Jong M.; MacNaughton, Wallace K.; Girardin, Stephen E.; Jijon, Humberto; Philpott, Dana J.; Soderholm, Johan D.; McKay, Derek M.			ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FOLLICLE-ASSOCIATED EPITHELIUM; CROHNS-DISEASE; ANTIINFLAMMATORY DRUGS; ESCHERICHIA-COLI; DAP-KINASE; ACTIVATION; EXPRESSION; AUTOPHAGY; BACTERIA	The gut microbiome contributes to inflammatory bowel disease (IBD), in which bacteria can be present within the epithelium. Epithelial barrier function is decreased in IBD, and dysfunctional epithelial mitochondria and endoplasmic reticulum (ER) stress have been individually associated with IBD. We therefore hypothesized that the combination of ER and mitochondrial stresses significantly disrupt epithelial barrier function. Here, we treated human colonic biopsies, epithelial colonoids, and epithelial cells with an uncoupler of oxidative phosphorylation, dinitrophenol (DNP), with or without the ER stressor tunicamycin and assessed epithelial barrier function by monitoring internalization and translocation of commensal bacteria. We also examined barrier function and colitis in mice exposed to dextran sodium sulfate (DSS) or DNP and co-treated with DAPK6, an inhibitor of death-associated protein kinase 1 (DAPK1). Contrary to our hypothesis, induction of ER stress (i.e. the unfolded protein response) protected against decreased barrier function caused by the disruption of mitochondrial function. ER stress did not prevent DNP-driven uptake of bacteria; rather, specific mobilization of the ATF6 arm of ER stress and recruitment of DAP K1 resulted in enhanced autophagic killing (xenophagy) of bacteria. Of note, epithelia with a Crohn's disease susceptibility mutation in the autophagy gene ATG16L.1 exhibited less xenophagy. Systemic delivery of the DAPK1 inhibitor DAPK6 increased bacterial translocation in DSS- or DNP-treated mice. We conclude that promoting ER stress ATF6 DAPK1 signaling in transporting enterocytes counters the transcellular passage of bacteria evoked by dysfunctional mitochondria, thereby reducing the potential for metabolic stress to reactivate or perpetuate inflammation.	[Lopes, Fernando; Saxena, Alpana; Reyes, Jose Luis; Mancini, Nicole L.; Al Rajabi, Ala; Wang, Arthur; Baggio, Cristiane H.; Dicay, Michael; MacNaughton, Wallace K.; McKay, Derek M.] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Jijon, Humberto] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Gastrointestinal Res Grp, Dept Med, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Carneiro, Matheus B. H.; Peters, Nathan C.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Keita, Asa V.; Soderholm, Johan D.] Linkoping Univ, Dept Clin & Expt Med, Div Surg, S-58183 Linkoping, Sweden; [van Dalen, Rob; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Linkoping University; University of Toronto; University of Toronto	Lopes, F; McKay, DM (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hsc 1877,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	flopes77@gmail.com; dmckay@ucalgary.ca	Mir, Rashid/AAH-1895-2019; van Dalen, Rob/ABA-8185-2020; McKay, Derek/HCH-3240-2022; Mir, Rashid/GOV-3522-2022; Rajabi, Ala/AAX-7743-2020; Peters, Nathan/AAW-8289-2020; van Dalen, Rob/HHM-8915-2022; Baggio, Cristiane H/C-5633-2013; Wang, Arthur/AAE-3368-2019; Reyes, Jose Luis/D-8322-2018	Mir, Rashid/0000-0003-2068-3075; Rajabi, Ala/0000-0003-2426-6279; Peters, Nathan/0000-0002-2548-9581; van Dalen, Rob/0000-0002-0436-6048; Baggio, Cristiane H/0000-0001-5536-7561; Reyes, Jose Luis/0000-0003-0089-0261; Keita, Asa/0000-0002-6820-0215	Canadian Institutes for Health Research Operating Grant [MPO-126005]; Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc.; Alberta Innovates-Health Solutions post-doctoral fellowships; Alberta Innovates [201500767] Funding Source: researchfish	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc.(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions post-doctoral fellowships; Alberta Innovates	This work was supported in part by Canadian Institutes for Health Research Operating Grant MPO-126005 (to D.M.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc., and Alberta Innovates-Health Solutions post-doctoral fellowships.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Begun J, 2015, CELL REP, V11, P1905, DOI 10.1016/j.celrep.2015.05.045; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Diamanti MA, 2017, J EXP MED, V214, P423, DOI 10.1084/jem.20161867; Drion CM, 2016, EPILEPSIA, V57, P688, DOI 10.1111/epi.13345; Elliott TR, 2013, INFLAMM BOWEL DIS, V19, P2326, DOI 10.1097/MIB.0b013e3182a38a92; Fernando EH, 2017, AM J PHYSIOL-GASTR L, V313, pG467, DOI 10.1152/ajpgi.00152.2017; Gade P, 2016, J BIOL CHEM, V291, P22030, DOI 10.1074/jbc.M116.725796; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Inoue Y, 2017, FEBS LETT, V591, P3682, DOI 10.1002/1873-3468.12869; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaur M, 2016, INFLAMM BOWEL DIS, V22, P862, DOI 10.1097/MIB.0000000000000705; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Keita AC, 2008, J PATHOL, V215, P135, DOI 10.1002/path.2337; Keita AV, 2006, LAB INVEST, V86, P504, DOI 10.1038/labinvest.3700397; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klein A, 2010, PHARMACEUTICALS, V3, P1084, DOI 10.3390/ph3041084; Kuoa SY, 2015, P NATL ACAD SCI USA, V112, pE4281, DOI 10.1073/pnas.1512289112; Kvasnovsky CL, 2015, SCAND J GASTROENTERO, V50, P255, DOI 10.3109/00365521.2014.966753; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Ling YH, 2009, CANCER CHEMOTH PHARM, V64, P539, DOI 10.1007/s00280-008-0902-8; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Matsuzawa-Ishimoto Y, 2017, J EXP MED, V214, P3687, DOI 10.1084/jem.20170558; Merrill NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184909; Mitsui Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1951-0; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Oancea I, 2017, GUT, V66, P59, DOI 10.1136/gutjnl-2015-310874; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath E, 2012, INFLAMM BOWEL DIS, V18, P1364, DOI 10.1002/ibd.21944; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Russell RK, 2006, GUT, V55, P1114, DOI 10.1136/gut.2005.082107; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Saxena A, 2017, AM J PHYSIOL-GASTR L, V313, pG26, DOI 10.1152/ajpgi.00070.2017; Schoultz I, 2012, AM J PHYSIOL-GASTR L, V303, pG536, DOI 10.1152/ajpgi.00125.2012; Schoultz I, 2011, INFLAMM BOWEL DIS, V17, P2008, DOI 10.1002/ibd.21556; Shen T, 2017, INT J BIOCHEM CELL B, V89, P207, DOI 10.1016/j.biocel.2017.06.012; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Somasundaram S, 2000, ALIMENT PHARM THER, V14, P639; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tschurtschenthaler M, 2017, J EXP MED, V214, P401, DOI 10.1084/jem.20160791; van de Beek MC, 2017, BBA-MOL BASIS DIS, V1863, P2255, DOI 10.1016/j.bbadis.2017.06.003; Wallon C, 2005, SCAND J GASTROENTERO, V40, P586, DOI 10.1080/00365520510012235; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00358; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179042; Zhang HS, 2015, J BIOL CHEM, V290, P15327, DOI 10.1074/jbc.M114.633560; Zhang QW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02142	61	21	21	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3073	3087		10.1074/jbc.RA117.000809	http://dx.doi.org/10.1074/jbc.RA117.000809			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317503	Green Published, hybrid			2022-12-28	WOS:000426562800004
J	Cheng, QW; Danao, J; Talreja, S; Wen, P; Yin, J; Sun, N; Li, CM; Chui, D; Tran, D; Koirala, S; Chen, H; Foltz, IN; Wang, SL; Sambashivan, S				Cheng, Qingwen; Danao, Jean; Talreja, Santosh; Wen, Paul; Yin, Jun; Sun, Ning; Li, Chi-Ming; Chui, Danny; Tran, David; Koirala, Samir; Chen, Hang; Foltz, Ian N.; Wang, Songli; Sambashivan, Shilpa			TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2(R47H) on murine myeloid cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroinflammation; neurodegeneration; Alzheimer's disease; microglia; antibody; myeloid cell; genetics; gene knockout; R47H TREM2	TREM2 DEFICIENCY; MOUSE MODEL; MICROGLIA; NEURODEGENERATION; MACROPHAGES; PROGRESSION; EXPRESSION; LIGAND; BINDS; DAP12	Triggering receptor expressed on myeloid cells 2 (TREM2) is an orphan immune receptor expressed on cells of myeloid lineage such as macrophages and microglia. The rare variant R47H TREM2 is associated with an increased risk for Alzheimer's disease, supporting the hypothesis that TREM2 loss of function may exacerbate disease progression. However, a complete knockout of the TREM2 gene in different genetic models of neurodegenerative diseases has been reported to result in both protective and deleterious effects on disease-related end points and myeloid cell function. Here, we describe a Trem2(R47H) transgenic mouse model and report that even in the absence of additional genetic perturbations, this variant clearly confers a loss of function on myeloid cells. The Trem2(R47H) variant-containing myeloid cells exhibited subtle defects in survival and migration and displayed an unexpected dysregulation of cytokine responses in a lipopolysaccharide challenge environment. These subtle phenotypic defects with a gradation in severity across genotypes were confirmed in whole-genome RNA-Seq analyses of WT, Trem2(-/-), and Trem2(R47H) myeloid cells under challenge conditions. Of note, TREM2-activating antibodies that boost proximal signaling abrogated survival defects conferred by the variant and also modulated migration and cytokine responses in an antibody-, ligand-, and challenge-dependent manner. In some instances, these antibodies also boosted WT myeloid cell function. Our studies provide a first glimpse into the boost in myeloid cell function that can be achieved by pharmacological modulation of TREM2 activity that can potentially be ameliorative in neurodegenerative diseases such as Alzheimer's disease.	[Cheng, Qingwen; Danao, Jean; Talreja, Santosh; Yin, Jun; Li, Chi-Ming; Chen, Hang; Wang, Songli; Sambashivan, Shilpa] Amgen Inc, Dept Discovery Res, San Francisco, CA 94080 USA; [Wen, Paul; Sun, Ning; Tran, David; Koirala, Samir] Amgen Inc, Dept Discovery Res, Thousand Oaks, CA 91320 USA; [Chui, Danny; Foltz, Ian N.] Amgen Inc, Dept Discovery Res, Burnaby, BC V5A 1V7, Canada; [Chui, Danny] Zymeworks, 540-1385 W 8th Ave, Vancouver, BC V6H 3V9, Canada; [Koirala, Samir] Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA; [Chen, Hang] Denali Therapeut Inc, 151 Oyster Point Blvd, San Francisco, CA 94080 USA	Amgen; Amgen; Biogen	Sambashivan, S (corresponding author), Proneurotech Inc, 171 Oyester Point Blvd,Ste 400, San Francisco, CA 94080 USA.	shilpashivan@gmail.com	Li, Chi-Ming/ABA-6457-2020		Amgen Inc.	Amgen Inc.(Amgen)	This work was supported by Amgen Inc., and all authors were employees of Amgen at the time the research was conducted.	Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Benitez BA, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.010; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Guedes Joana R, 2016, Alzheimers Dement (Amst), V3, P7, DOI 10.1016/j.dadm.2015.11.004; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V92, P252, DOI 10.1016/j.neuron.2016.09.016; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	37	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12620	12633		10.1074/jbc.RA118.001848	http://dx.doi.org/10.1074/jbc.RA118.001848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29599291	hybrid, Green Published			2022-12-28	WOS:000441408500026
J	Esquirol, L; Peat, TS; Wilding, M; Liu, JW; French, NG; Hartley, CJ; Onagi, H; Nebl, T; Easton, CJ; Newman, J; Scott, C				Esquirol, Lygie; Peat, Thomas S.; Wilding, Matthew; Liu, Jian-Wei; French, Nigel G.; Hartley, Carol J.; Onagi, Hideki; Nebl, Thomas; Easton, Christopher J.; Newman, Janet; Scott, Colin			An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein evolution; xenobiotic; enzyme catalysis; bacterial metabolism; Pseudomonas; enzyme; enzyme structure; bacteria; complex; protein complex; amidase; biuret; cyanuric acid; small protein; triazine; transamidosome; low-molecular-weight protein	ALLOPHANATE HYDROLASE; PSEUDOMONAS SP; AMIDASE DOMAIN; AMIDOHYDROLASE; SUPERFAMILY; REFINEMENT; SEQUENCE; PLASMID; CLONING; GENES	Cyanuric acid is a metabolic intermediate of s-triazines, such as atrazine (a common herbicide) and melamine (used in resins and plastics). Cyanuric acid is mineralized to ammonia and carbon dioxide by the soil bacterium Pseudomonas sp. strain ADP via three hydrolytic enzymes (AtzD, AtzE, and AtzF). Here, we report the purification and biochemical and structural characterization of AtzE. Contrary to previous reports, we found that AtzE is not a biuret amidohydrolase, but instead it catalyzes the hydrolytic deamination of 1-carboxybiuret. X-ray crystal structures of apo AtzE and AtzE bound with the suicide inhibitor phenyl phosphorodiamidate revealed that the AtzE enzyme complex consists of two independent molecules in the asymmetric unit. We also show that AtzE forms an 22 heterotetramer with a previously unidentified 68-amino acid-long protein (AtzG) encoded in the cyanuric acid mineralization operon from Pseudomonas sp. strain ADP. Moreover, we observed that AtzG is essential for the production of soluble, active AtzE and that this obligate interaction is a vestige of their shared evolutionary origin. We propose that AtzEG was likely recruited into the cyanuric acid-mineralizing pathway from an ancestral glutamine transamidosome that required protein-protein interactions to enforce the exclusion of solvent from the transamidation reaction.	[Esquirol, Lygie; Liu, Jian-Wei; French, Nigel G.; Hartley, Carol J.; Scott, Colin] CSIRO Land & Water, Biocatalysis & Synthet Biol Team, Canberra, ACT 2601, Australia; [Scott, Colin] CSIRO Land & Water, Synthet Biol Future Sci Platform, Canberra, ACT 2601, Australia; [Esquirol, Lygie; Wilding, Matthew; Onagi, Hideki; Easton, Christopher J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Peat, Thomas S.; Wilding, Matthew; Nebl, Thomas; Newman, Janet] CSIRO Biomed Mfg, Melbourne, Vic 3052, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scott, C (corresponding author), CSIRO Land & Water, Fdn Bldg,Black Mt Sci & Innovat Pk, Canberra, ACT 2601, Australia.	colin.scott@csiro.au	Scott, Colin/A-4682-2009; Peat, Thomas S/F-9817-2010; Liu, Jian-Wei/C-3313-2009; Hartley, Carol J/C-2255-2008; Easton, Chris J/K-3531-2014; Newman, Janet M/D-1857-2011; Wilding, Matthew A/D-4173-2012; Onagi, Hideki/O-6978-2019; Nebl, Thomas/N-1620-2017	Scott, Colin/0000-0001-6110-6982; Peat, Thomas S/0000-0002-6488-0831; Hartley, Carol J/0000-0002-1927-8040; Easton, Chris J/0000-0002-2263-1204; Newman, Janet M/0000-0003-2666-3219; Wilding, Matthew A/0000-0002-3921-7771; Onagi, Hideki/0000-0003-0085-7349; Esquirol, Lygie/0000-0002-4887-3260; Nebl, Thomas/0000-0003-4003-9340				Baek J, 2017, G3-GENES GENOM GENET, V7, P983, DOI 10.1534/g3.116.036939; Balotra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137700; Balotra S, 2015, APPL ENVIRON MICROB, V81, P470, DOI 10.1128/AEM.02783-14; Balotra S, 2014, ACTA CRYSTALLOGR F, V70, P310, DOI 10.1107/S2053230X13034705; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cameron SM, 2011, ACS CATAL, V1, P1075, DOI 10.1021/cs200295n; Case D.A., 2017, AMBER16; Cheng G, 2005, APPL ENVIRON MICROB, V71, P4437, DOI 10.1128/AEM.71.8.4437-4445.2005; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; DESOUZA ML, 1995, APPL ENVIRON MICROB, V61, P3373, DOI 10.1128/AEM.61.9.3373-3378.1995; EATON RW, 1991, J BACTERIOL, V173, P1363, DOI 10.1128/jb.173.3.1363-1366.1991; Esquirol L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192736; Hucker SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184119; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUTZI K, 1982, BIOCHEM J, V208, P679, DOI 10.1042/bj2080679; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Parkhurst JM, 2016, J APPL CRYSTALLOGR, V49, P1912, DOI 10.1107/S1600576716013595; Pavelka A, 2016, IEEE ACM T COMPUT BI, V13, P505, DOI 10.1109/TCBB.2015.2459680; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Peat TS, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03365-16; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Rosa N, 2015, J BIOMOL SCREEN, V20, P898, DOI 10.1177/1087057115584059; Sadowsky MJ, 1998, J BACTERIOL, V180, P152, DOI 10.1128/JB.180.1.152-158.1998; Seffernick JL, 2007, J BACTERIOL, V189, P6989, DOI 10.1128/JB.00630-07; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; Suzuki T, 2015, P NATL ACAD SCI USA, V112, P382, DOI 10.1073/pnas.1423314112; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	45	12	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7880	7891		10.1074/jbc.RA118.001996	http://dx.doi.org/10.1074/jbc.RA118.001996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29523689	Green Published, hybrid			2022-12-28	WOS:000437256500034
J	Sipila, KH; Drushinin, K; Rappu, P; Jokinen, J; Salminen, TA; Salo, AM; Kapyla, J; Myllyharju, J; Heino, J				Sipila, Kalle H.; Drushinin, Kati; Rappu, Pekka; Jokinen, Johanna; Salminen, Tiina A.; Salo, Antti M.; Kapyla, Jarmo; Myllyharju, Johanna; Heino, Jyrki			Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; MEDIATED CELL-ADHESION; ALPHA-SUBUNIT ISOFORM; RECOGNITION SITE; I COLLAGEN; ALPHA-1-BETA-1; MICE; ALPHA(2)BETA(1); ALPHA-2-BETA-1; SEQUENCE	Collagens are the most abundant extracellular matrix proteins in vertebrates and have a characteristic triple-helix structure. Hydroxylation of proline residues is critical for helix stability, and diminished prolyl hydroxylase activity causes wide-spread defects in connective tissues. Still, the role of proline hydroxylation in the binding of collagen receptors such as integrins is unclear. Here, we isolated skin collagen from genetically modified mice having reduced prolyl 4-hydroxylase activity. At room temperature, the reduced proline hydroxylation did not affect interactions with the recombinant integrin 2I domain, but at 37 degrees C, collagen hydroxylation correlated with the avidity of 2I domain binding. Of note, LC-MS/MS analysis of isolated skin collagens revealed no major changes in the hydroxyproline content of the main integrin-binding sites. Thus, the disrupted 2I domain binding at physiological temperatures was most likely due to structural destabilization of the collagenous helix. Integrin 2I binding to the triple-helical GFPGER motif was slightly weaker than to GFOGER (O = hydroxyproline). This phenomenon was more prominent when 1 integrin was tested. Integrin 11 expressed on CHO cells and recombinant 1I domain showed remarkably slower binding velocity and weaker avidity to GFPGER when compared with GFOGER. Structural modeling revealed the critical interaction between Arg-218 in 1I and the hydroxyproline residue in the integrin-binding motif. The role of Arg-218 was further validated by testing a variant R218D 1I domain in solid-phase binding assays. Thus, our results show that the lack of proline hydroxylation in collagen can affect integrin binding by a direct mechanism and via structural destabilization of the triple helix.	[Sipila, Kalle H.; Rappu, Pekka; Jokinen, Johanna; Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem, FI-20014 Turku, Finland; [Drushinin, Kati; Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Drushinin, Kati; Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, FI-20520 Turku, Finland; [Sipila, Kalle H.] Kings Coll London, London WC2R 2LS, England	Finland National Institute for Health & Welfare; University of Turku; University of Oulu; University of Oulu; Abo Akademi University; University of London; King's College London	Heino, J (corresponding author), Univ Turku, Dept Biochem, FI-20014 Turku, Finland.	jyrki.heino@utu.fi	Salminen, Tiina A./AAM-5443-2021; Salminen, Tiina A/G-7492-2019	Salminen, Tiina A./0000-0002-4135-8020; Salminen, Tiina A/0000-0002-4135-8020; Kapyla, Jarmo/0000-0003-3036-713X; Rappu, Pekka/0000-0002-5068-2842	University of Oulu; Biocenter Finland	University of Oulu; Biocenter Finland	We thank Anne Kokko and Maria Tuominen for excellent technical assistance and Dr. Hongmin Tu from the Biocenter Oulu core facility for protein analysis (co-funded by the University of Oulu and Biocenter Finland) for help in CD analyses. We thank the bioinformatics (J.V. Lehtonen), translational activities, and structural biology infrastructure support from the Biocenter Finland, and the CSC IT Center for Science for computational infrastructure support at the Structural Bioinformatics Laboratory, Abo Akademi University. We also thank the University of Oulu Laboratory Animal Center.	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Aro E, 2015, J BIOL CHEM, V290, P16964, DOI 10.1074/jbc.M115.662635; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Blumbach K, 2012, J BIOL CHEM, V287, P6431, DOI 10.1074/jbc.M111.283119; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251; DeLano W.L, PYMOL MOL GRAPHICS S; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Gardner H, 1999, J CELL SCI, V112, P263; Ghatak S, 2016, AM J PATHOL, V186, P3011, DOI 10.1016/j.ajpath.2016.06.021; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Grosso G, 2013, FRONT BIOSCI-LANDMRK, V18, P1017, DOI 10.2741/4160; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Johnson MS, 2013, EVOLUTION EXTRACELLU, P243; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sipila K, 2014, FASEB J, V28, P3758, DOI 10.1096/fj.13-247767; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Woltersdorf C, 2017, MATRIX BIOL, V63, P91, DOI 10.1016/j.matbio.2017.02.001; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zou YQ, 2017, HUM MOL GENET, V26, P2207, DOI 10.1093/hmg/ddx110; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546; Zwolanek D, 2014, BIOCHEM J, V459, P217, DOI 10.1042/BJ20130642	52	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7645	7658		10.1074/jbc.RA118.002200	http://dx.doi.org/10.1074/jbc.RA118.002200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615493	hybrid, Green Published			2022-12-28	WOS:000437256500016
J	Galera-Prat, A; Morais, S; Vazana, Y; Bayer, EA; Carrion-Vazquez, M				Galera-Prat, Albert; Morais, Sarah; Vazana, Yael; Bayer, Edward A.; Carrion-Vazquez, Mariano			The cohesin module is a major determinant of cellulosome mechanical stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); cellulosome; scaffold protein; single-molecule biophysics; protein stability; dockerin; linkers; nanomechanics; scaffoldin; single-molecule force spectroscopy	CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN; DOMAIN; DEGRADATION; CELLULASE; CHIMERAS	Cellulosomes are bacterial protein complexes that bind and efficiently degrade lignocellulosic substrates. These are formed by multimodular scaffolding proteins known as scaffoldins, which comprise cohesin modules capable of binding dockerin-bearing enzymes and usually a carbohydrate-binding module that anchors the system to a substrate. It has been suggested that cellulosomes bound to the bacterial cell surface might be exposed to significant mechanical forces. Accordingly, the mechanical properties of these anchored cellulosomes may be important to understand and improve cellulosome function. Here we used single-molecule force spectroscopy to study the mechanical properties of selected cohesin modules from scaffoldins of different cellulosomes. We found that cohesins located in the region connecting the cell and the substrate are more robust than those located outside these two anchoring points. This observation applies to cohesins from primary scaffoldins (i.e. those that directly bind dockerin-bearing enzymes) from different cellulosomes despite their sequence differences. Furthermore, we also found that cohesin nanomechanics (specifically, mechanostability and the position of the mechanical clamp of cohesin) are not significantly affected by other cellulosomal components, including linkers between cohesins, multiple cohesin repeats, and dockerin binding. Finally, we also found that cohesins (from both the connecting and external regions) have poor refolding efficiency but similar refolding rates, suggesting that the high mechanostability of connecting cohesins may be an evolutionarily conserved trait selected to minimize the occurrence of cohesin unfolding, which could irreversibly damage the cellulosome. We conclude that cohesin mechanostability is a major determinant of the overall mechanical stability of the cellulosome.	[Galera-Prat, Albert; Carrion-Vazquez, Mariano] CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain; [Galera-Prat, Albert; Carrion-Vazquez, Mariano] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain; [Morais, Sarah; Vazana, Yael; Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Weizmann Institute of Science	Carrion-Vazquez, M (corresponding author), CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain.; Carrion-Vazquez, M (corresponding author), Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain.	mcarrion@cajal.csic.es	Carrion-Vazquez, Mariano/Y-3741-2018	Carrion-Vazquez, Mariano/0000-0001-7319-406X; Morais, Sarah/0000-0001-9026-2386	Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies [7PM-NMP 2013-17, 604530-2]; ERA-IB-ERANET through the Spanish MINECO [EIB.12.022, PCIN-2013-011-C02-01]; FPU fellowship from the Spanish MECD	Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies; ERA-IB-ERANET through the Spanish MINECO; FPU fellowship from the Spanish MECD(German Research Foundation (DFG))	This work was supported by a Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies (7PM-NMP 2013-17 and 604530-2) and ERA-IB-ERANET-2013-16 (EIB.12.022) through the Spanish MINECO (PCIN-2013-011-C02-01). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an FPU fellowship from the Spanish MECD.	Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA., 2009, BIOTECHNOLOGY LIGNOC, P183; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chwastyk M, 2014, PROTEINS, V82, P717, DOI 10.1002/prot.24436; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; GERWIG GJ, 1993, J BIOL CHEM, V268, P26956; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; Hervas R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001335; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Li HB, 2008, J MOL BIOL, V379, P871, DOI 10.1016/j.jmb.2008.04.018; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Noach I, 2010, J MOL BIOL, V399, P294, DOI 10.1016/j.jmb.2010.04.013; Oroz J, 2011, J BIOL CHEM, V286, P9405, DOI 10.1074/jbc.M110.170399; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Salama-Alber O, 2013, J BIOL CHEM, V288, P16827, DOI 10.1074/jbc.M113.466672; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoeler C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6635; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Valbuena A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2794732; Vera AM, 2016, ANGEW CHEM INT EDIT, V55, P13970, DOI 10.1002/anie.201605284; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Wojciechowski M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4904726; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Zhang MM, 2013, PHYS CHEM CHEM PHYS, V15, P6508, DOI 10.1039/c3cp51072g	46	10	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7139	7147		10.1074/jbc.RA117.000644	http://dx.doi.org/10.1074/jbc.RA117.000644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567834	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000432174500007
J	Wai, DCC; Szyszka, TN; Campbell, AE; Kwong, C; Wilkinson-White, LE; Silva, APG; Low, JKK; Kwan, AH; Gamsjaeger, R; Chalmers, JD; Patrick, WM; Lu, B; Vakoc, CR; Blobel, GA; Mackay, JP				Wai, Dorothy C. C.; Szyszka, Taylor N.; Campbell, Amy E.; Kwong, Cherry; Wilkinson-White, Lorna E.; Silva, Ana P. G.; Low, Jason K. K.; Kwan, Ann H.; Gamsjaeger, Roland; Chalmers, James D.; Patrick, Wayne M.; Lu, Bin; Vakoc, Christopher R.; Blobel, Gerd A.; Mackay, Joel P.			The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcriptional coactivator; acetylation; nuclear magnetic resonance (NMR); protein structure; protein; protein interaction; AF9; BET family proteins; bromodomain; extraterminal domain	BROMODOMAIN PROTEIN BRD3; AF9 YEATS DOMAIN; SELECTIVE-INHIBITION; EXTRATERMINAL DOMAIN; HISTONE ACETYLATION; MITOTIC CHROMOSOMES; BET BROMODOMAINS; TARGET GENES; COMPLEX; NURD	Members of the bromodomain and extra-terminal domain (BET) family of proteins (bromodomain-containing (BRD) 2, 3, 4, and T) are widely expressed and highly conserved regulators of gene expression in eukaryotes. These proteins have been intimately linked to human disease, and more than a dozen clinical trials are currently underway to test BET-protein inhibitors as modulators of cancer. However, although it is clear that these proteins use their bromodomains to bind both histones and transcription factors bearing acetylated lysine residues, the molecular mechanisms by which BET family proteins regulate gene expression are not well defined. In particular, the functions of the other domains such as the ET domain have been less extensively studied. Here, we examine the properties of the ET domain of BRD3 as a protein/protein interaction module. Using a combination of pulldown and biophysical assays, we demonstrate that BRD3 binds to a range of chromatin-remodeling complexes, including the NuRD, BAF, and INO80 complexes, via a short linear KIKL motif in one of the complex subunits. NMR-based structural analysis revealed that, surprisingly, this mode of interaction is shared by the AF9 and ENL transcriptional coregulators that contain an acetyl-lysine-binding YEATS domain and regulate transcriptional elongation. This observation establishes a functional commonality between these two families of cancer-related transcriptional regulators. In summary, our data provide insight into the mechanisms by which BET family proteins might link chromatin acetylation to transcriptional outcomes and uncover an unexpected functional similarity between BET and YEATS family proteins.	[Wai, Dorothy C. C.; Szyszka, Taylor N.; Kwong, Cherry; Wilkinson-White, Lorna E.; Silva, Ana P. G.; Low, Jason K. K.; Kwan, Ann H.; Gamsjaeger, Roland; Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Campbell, Amy E.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Campbell, Amy E.; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chalmers, James D.; Patrick, Wayne M.] Univ Otago, Dept Biochem, Dunedin 9016, New Zealand; [Lu, Bin; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Otago; Cold Spring Harbor Laboratory	Mackay, JP (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Szyszka, Taylor/0000-0002-9921-3086; Wai, Dorothy Che Ching/0000-0002-3871-9980; Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Patrick, Wayne/0000-0002-2718-8053; Campbell, Amy E./0000-0001-6513-5836; Low, Jason/0000-0003-0862-0012	Australian National Health and Medical Research Council [APP1063301, APP1058916]; National Institutes of Health Grant [R01DK054937]; National Institutes of Health Training Grant [T32 DK07780]; Australian National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA174793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054937] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Australian National Health and Medical Research Council Grants APP1063301 and APP1058916 (to J.P.M.) and National Institutes of Health Grant R01DK054937 (to G.A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 DK07780.; Supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council.	Aiyer S, 2014, NUCLEIC ACIDS RES, V42, P5917, DOI 10.1093/nar/gku175; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brand M, 2015, ACS CHEM BIOL, V10, P22, DOI 10.1021/cb500996u; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Crowe BL, 2016, P NATL ACAD SCI USA, V113, P2086, DOI 10.1073/pnas.1516813113; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Gamsjaeger R, 2011, MOL CELL BIOL, V31, P2632, DOI 10.1128/MCB.05413-11; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Goddard T. D., 2006, SPARKY 3; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hellert J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003640; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Kuntimaddi A, 2015, CELL REP, V11, P808, DOI 10.1016/j.celrep.2015.04.004; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Liu ZQ, 2017, J MED CHEM, V60, P4533, DOI 10.1021/acs.jmedchem.6b01761; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Matangkasombut O, 2000, GENE DEV, V14, P951; McBride AA, 2013, VIRUSES-BASEL, V5, P1374, DOI 10.3390/v5061374; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Roberts TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06483-7; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Silva APG, 2016, J BIOL CHEM, V291, P924, DOI 10.1074/jbc.M115.683227; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Tang LL, 2010, PROG BIOPHYS MOL BIO, V102, P122, DOI 10.1016/j.pbiomolbio.2010.05.001; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Tsume M, 2012, BIOCHEM BIOPH RES CO, V425, P762, DOI 10.1016/j.bbrc.2012.07.149; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zhang Q, 2016, STRUCTURE, V24, P1201, DOI 10.1016/j.str.2016.04.019; Zhang W, 2016, J MOL BIOL, V428, P2931, DOI 10.1016/j.jmb.2016.04.025; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	82	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7160	7175		10.1074/jbc.RA117.000678	http://dx.doi.org/10.1074/jbc.RA117.000678			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567837	Green Published, hybrid			2022-12-28	WOS:000432174500009
J	Halaby, SL; Fromme, JC				Halaby, Steve L.; Fromme, J. Christopher			The HUS box is required for allosteric regulation of the Sec7 Arf-GEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Golgi; guanine nucleotide exchange factor (GEF); intracellular trafficking; ADP ribosylation factor (ARF); allosteric regulation	GUANINE-NUCLEOTIDE-EXCHANGE; ADP-RIBOSYLATION FACTOR; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; BREFELDIN-A; FACTOR GBF1; PROTEIN; ACTIVATION; DOMAIN	The Golgi complex is the central membrane and protein-sorting station in eukaryotic cells. Activation of Arf (ADP-ribosylation factor) GTPases is essential for vesicle formation via recruitment of cargo adaptors and coat proteins necessary for Golgi trafficking. Arf activation is spatially and temporally regulated by distinct guanine nucleotide exchange factors (GEFs) at different Golgi compartments. The yeast Arf-GEF Sec7 is a conserved and essential activator of Arf1 at the trans-Golgi network. Sec7 contains a highly conserved regulatory region, the homology upstream of Sec7 (HUS) box, with an unknown mechanistic role. In this study we explore how the HUS box, which is N-terminal to the catalytic domain, acts together with C-terminal regulatory domains in the allosteric activation of Sec7. We report that mutation of the HUS box disrupts positive feedback and allosteric activation of Sec7 by the GTPase Ypt31, a yeast Rab11 homolog. Taken together, our results support a model in which the inter- and intramolecular interactions of the HUS box and the C terminus are necessary for the allosteric activation of Sec7.	[Halaby, Steve L.; Fromme, J. Christopher] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Fromme, JC (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jcf14@cornell.edu		Fromme, J. Christopher/0000-0002-8837-0473; Halaby, Steve/0000-0001-7724-8176	NIGMS, National Institutes of Health [R01GM09861, T32GM007273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, R01GM098621] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM09861 (to J.C.F.) and NIGMS, National Institutes of Health Training Grant T32GM007273 (to S.L.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bhatt JM, 2016, AM J PHYSIOL-CELL PH, V310, pC456, DOI 10.1152/ajpcell.00185.2015; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Dehring DAK, 2008, J BIOL CHEM, V283, P34188, DOI 10.1074/jbc.M806023200; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Galindo A, 2016, CELL REP, V16, P839, DOI 10.1016/j.celrep.2016.06.022; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grebe M, 2000, PLANT CELL, V12, P343, DOI 10.1105/tpc.12.3.343; Gustafson MA, 2017, MOL BIOL CELL, V28, P3660, DOI 10.1091/mbc.E17-06-0370; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lowery J, 2013, J BIOL CHEM, V288, P11532, DOI 10.1074/jbc.M112.438481; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Marino-Ramirez L, 2002, YEAST, V19, P641, DOI 10.1002/yea.867; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McDonold CM, 2014, DEV CELL, V30, P759, DOI 10.1016/j.devcel.2014.07.016; Meissner JM, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210245; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Paczkowski JE, 2016, METHODS MOL BIOL, V1496, P41, DOI 10.1007/978-1-4939-6463-5_4; Park SK, 2005, MOL BIOL CELL, V16, P3786, DOI 10.1091/mbc.E05-04-0289; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Qiu BA, 2014, BIOCHEM BIOPH RES CO, V446, P380, DOI 10.1016/j.bbrc.2014.02.125; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Richardson BC, 2016, ELIFE, V5, DOI [10.7554/eLife.12411, 10.7554/eLife.18204]; Richardson BC, 2015, METHOD CELL BIOL, V130, P101, DOI 10.1016/bs.mcb.2015.03.020; Richardson BC, 2012, DEV CELL, V22, P799, DOI 10.1016/j.devcel.2012.02.006; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Wang R, 2016, J MOL CELL BIOL, V8, P459, DOI 10.1093/jmcb/mjw033; WEISS O, 1989, J BIOL CHEM, V264, P21066; Wessels E, 2007, J VIROL, V81, P5238, DOI 10.1128/JVI.02680-06	46	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6682	6691		10.1074/jbc.RA117.001318	http://dx.doi.org/10.1074/jbc.RA117.001318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29514977	Green Published, hybrid			2022-12-28	WOS:000431487300005
J	Paredes-Amaya, CC; Valdes-Garcia, G; Juarez-Gonzalez, VR; Rudino-Pinera, E; Bustamante, VH				Paredes-Amaya, Claudia C.; Valdes-Garcia, Gilberto; Juarez-Gonzalez, Victor R.; Rudino-Pinera, Enrique; Bustamante, Victor H.			The Hcp-like protein HilE inhibits homodimerization and DNA binding of the virulence-associated transcriptional regulator HilD in Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; INVASION GENE-EXPRESSION; FUNCTIONAL DOMAINS; ESCHERICHIA-COLI; ARAC/XYLS FAMILY; DOWN-REGULATION; H-NS; IDENTIFICATION; CELLS	HilD is an AraC-like transcriptional regulator that plays a central role in Salmonella virulence. HilD controls the expression of the genes within the Salmonella pathogenicity island 1 (SPI-1) and of several genes located outside SPI-1, which are mainly required for Salmonella invasion of host cells. The expression, amount, and activity of HilD are tightly controlled by the activities of several factors. The HilE protein represses the expression of the SPI-1 genes through its interaction with HilD; however, the mechanism by which HilE affects HilD is unknown. In this study, we used genetic and biochemical assays revealing how HilE controls the transcriptional activity of HilD. We found that HilD needs to assemble in homodimers to induce expression of its target genes. Our results further indicated that HilE individually interacts with each the central and the C-terminal HilD regions, mediating dimerization and DNA binding, respectively. We also observed that these interactions consistently inhibit HilD dimerization and DNA binding. Interestingly, a computational analysis revealed that HilE shares sequence and structural similarities with Hcp proteins, which act as structural components of type 6 secretion systems in Gram-negative bacteria. In conclusion, our results uncover the molecular mechanism by which the Hcp-like protein HilE controls dimerization and DNA binding of the virulence-promoting transcriptional regulator HilD. Our findings may indicate that HilE's activity represents a functional adaptation during the evolution of Salmonella pathogenicity.	[Paredes-Amaya, Claudia C.; Bustamante, Victor H.] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Cuernavaca 62210, Morelos, Mexico; [Valdes-Garcia, Gilberto; Juarez-Gonzalez, Victor R.; Rudino-Pinera, Enrique] Univ Nacl Autonoma Mexico, Dept Mol Med & Bioproc, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Bustamante, VH (corresponding author), Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico.	victor@ibt.unam.mx	Bustamante, Victor/GXF-0780-2022; Valdes-Garcia, Gilberto/K-3889-2014	Paredes, Claudia/0000-0002-6697-8007; Rudino-Pinera, Enrique/0000-0001-8170-6379; Valdes-Garcia, Gilberto/0000-0001-8322-0284	Consejo Nacional de Ciencia y Tecnologia [254531, 290934]; Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico [IN203415]; Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico; Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico	This work was supported by Grant 254531 (to V. H. B.) and Predoctoral Fellowship 290934 (to C. C. P.-A.) from Consejo Nacional de Ciencia y Tecnologia, Grant IN203415 (to V. H. B.) and a postdoctoral fellowship (to G. V.-G.) from Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico, and funds from the Posgrado en Ciencias Biologicas of the Universidad Nacional Autonoma de Mexico (to C. C. P.-A.). The authors declare that they have no conflicts of interest with the contents of this article.	Baxter MA, 2015, INFECT IMMUN, V83, P978, DOI 10.1128/IAI.02506-14; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; Brutinel ED, 2010, J BACTERIOL, V192, P1479, DOI 10.1128/JB.01457-09; Brutinel ED, 2009, J BACTERIOL, V191, P3811, DOI 10.1128/JB.00002-09; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; Chubiz JEC, 2010, J BACTERIOL, V192, P6261, DOI 10.1128/JB.00635-10; Colgan AM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006258; Cordero-Alba M, 2014, J BACTERIOL, V196, P3912, DOI 10.1128/JB.02158-14; Daines DA, 2000, J BACTERIOL, V182, P5267, DOI 10.1128/JB.182.18.5267-5270.2000; De la Cruz MA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00807; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Eade CR, 2016, INFECT IMMUN, V84, P2198, DOI 10.1128/IAI.00177-16; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Espinosa E, 2014, MOL MICROBIOL, V91, P1057, DOI 10.1111/mmi.12500; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Folkesson A, 2002, RES MICROBIOL, V153, P537, DOI 10.1016/S0923-2508(02)01348-7; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gallique M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01454; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Golubeva YA, 2016, MBIO, V7, DOI 10.1128/mBio.02170-15; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; Grenz JR, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00750-17; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Hung CC, 2013, MOL MICROBIOL, V87, P1045, DOI 10.1111/mmi.12149; Ilyas B, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00428; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Leon E, 2010, NUCLEIC ACIDS RES, V38, P5226, DOI 10.1093/nar/gkq277; Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060; Lin QP, 2017, ACTA CRYSTALLOGR F, V73, P463, DOI 10.1107/S2053230X17010512; Lopez-Garrido J, 2015, GENETICS, V200, P807, DOI 10.1534/genetics.115.178103; Main-Hester KL, 2008, INFECT IMMUN, V76, P1024, DOI 10.1128/IAI.01224-07; Martinez LC, 2014, J BACTERIOL, V196, P3746, DOI 10.1128/JB.01799-14; Martinez LC, 2014, J BACTERIOL, V196, P325, DOI 10.1128/JB.00806-13; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Martinez-Flores I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37858; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Moest TP, 2013, CURR OPIN MICROBIOL, V16, P38, DOI 10.1016/j.mib.2012.11.006; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Oropeza R, 1999, MOL MICROBIOL, V32, P243, DOI 10.1046/j.1365-2958.1999.01329.x; Petrone BL, 2014, J BACTERIOL, V196, P1094, DOI 10.1128/JB.01449-13; Poore CA, 2001, J BACTERIOL, V183, P4526, DOI 10.1128/JB.183.15.4526-4535.2001; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Prouty MG, 2005, MOL MICROBIOL, V58, P1143, DOI 10.1111/j.1365-2958.2005.04897.x; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129691; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Santiago AE, 2016, MOL MICROBIOL, V101, P314, DOI 10.1111/mmi.13392; Sato Y, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.593749; Schechter LM, 2001, MOL MICROBIOL, V40, P1289, DOI 10.1046/j.1365-2958.2001.02462.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Smith C, 2016, MBIO, V7, DOI 10.1128/mBio.01024-16; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Takaya A, 2005, MOL MICROBIOL, V55, P839, DOI 10.1111/j.1365-2958.2004.04425.x; Thibault J, 2009, J BIOL CHEM, V284, P15762, DOI 10.1074/jbc.M109.003533; Thijs IMV, 2007, J BACTERIOL, V189, P4587, DOI 10.1128/JB.00178-07; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	73	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2018	293	17					6578	6592		10.1074/jbc.RA117.001421	http://dx.doi.org/10.1074/jbc.RA117.001421			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE3JC	29535187	hybrid, Green Published			2022-12-28	WOS:000431108600028
J	Bryant, JD; Sweeney, SR; Sentandreu, E; Shin, M; Ipas, H; Xhemalce, B; Momb, J; Tiziani, S; Appling, DR				Bryant, Joshua D.; Sweeney, Shannon R.; Sentandreu, Enrique; Shin, Minhye; Ipas, Helene; Xhemalce, Blerta; Momb, Jessica; Tiziani, Stefano; Appling, Dean R.			Deletion of the neural tube defect-associated gene Mthfd1l disrupts one-carbon and central energy metabolism in mouse embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSURE DEFECTS; MURINE EMBRYOS; FOLATE; MICE; SERINE; CYCLE; SUPPRESSION; DATABASE; HUMANS; UNITS	One-carbon (1C) metabolism is a universal folate-dependent pathway essential for de novo purine and thymidylate synthesis, amino acid interconversion, universal methyl-donor production, and regeneration of redox cofactors. Homozygous deletion of the 1C pathway gene Mthfd1l encoding methylenetetrahydrofolate dehydrogenase (NADP(+)-dependent) 1-like, which catalyzes mitochondrial formate production from 10-formyltetrahydrofolate, results in 100% penetrant embryonic neural tube defects (NTDs), underscoring the central role of mitochondrially derived formate in embryonic development and providing a mechanistic link between folate and NTDs. However, the specific metabolic processes that are perturbed by Mthfd1l deletion are not known. Here, we performed untargeted metabolomics on whole Mthfd1l-null and wildtype mouse embryos in combination with isotope tracer analysis in mouse embryonic fibroblast (MEF) cell lines to identify Mthfd1l deletion-induced disruptions in 1C metabolism, glycolysis, and the TCA cycle. We found that maternal formate supplementation largely corrects these disruptions in Mthfd1l-null embryos. Serine tracer experiments revealed that Mthfd1l-null MEFs have altered methionine synthesis, indicating that Mthfd1l deletion impairs the methyl cycle. Supplementation of Mthfd1l-null MEFs with formate, hypoxanthine, or combined hypoxanthine and thymidine restored their growth to wildtype levels. Thymidine addition alone was ineffective, suggesting a purine synthesis defect in Mthfd1l-null MEFs. Tracer experiments also revealed lower proportions of labeled hypoxanthine and inosine monophosphate in Mthfd1l-null than in wildtype MEFs, suggesting that Mthfd1l deletion results in increased reliance on the purine salvage pathway. These results indicate that disruptions of mitochondrial 1C metabolism have wide-ranging consequences for many metabolic processes, including those that may not directly interact with 1C metabolism.	[Bryant, Joshua D.; Shin, Minhye; Ipas, Helene; Xhemalce, Blerta; Momb, Jessica; Appling, Dean R.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Sweeney, Shannon R.; Sentandreu, Enrique; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Sweeney, Shannon R.; Sentandreu, Enrique; Tiziani, Stefano] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, 100 East 24th St,Stop A5000, Austin, TX 78712 USA.	dappling@austin.utexas.edu	Sentandreu, Enrique/ABH-4264-2020; Sentandreu, Enrique/L-8684-2013	Sentandreu, Enrique/0000-0002-4157-580X; Xhemalce, Blerta/0000-0002-0517-9607	National Institutes of Health, NCI Grant [P30 CA54174]; University of Texas Health Science Center at San Antonio (UTHSCSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074428, R01HD083809] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health, NCI Grant; University of Texas Health Science Center at San Antonio (UTHSCSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Sergey Krupenko for the generous gift of the antibodies against ALDH1L2. Support for the NMR facility was provided by the University of Texas Health Science Center at San Antonio (UTHSCSA) and National Institutes of Health, NCI Grant P30 CA54174 (CTRC at UTHSCSA).	Akimova D, 2017, BIRTH DEFECTS RES, V109, P106, DOI 10.1002/bdra.23583; Au KS, 2017, AM J MED GENET A, V173, P3042, DOI 10.1002/ajmg.a.38478; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; BARLOWE C K, 1988, Biofactors, V1, P171; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Dunlevy LPE, 2006, BIRTH DEFECTS RES A, V76, P544, DOI 10.1002/bdra.20286; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hansler A, 2014, BIRTH DEFECTS RES A, V100, P623, DOI 10.1002/bdra.23272; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hunter ES, 1995, TERATOLOGY, V52, P317, DOI 10.1002/tera.1420520602; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Leung KY, 2017, CELL REP, V21, P1795, DOI 10.1016/j.celrep.2017.10.072; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lodi A, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0024-z; Lu XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03108-x; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; MATSUDA M, 1990, TERATOLOGY, V41, P147, DOI 10.1002/tera.1420410204; Michalska A.E., 2007, CURR PROTOC STEM CEL; Miyazawa H, 2017, DEVELOPMENT, V144, P63, DOI 10.1242/dev.138545; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Strickland KC, 2011, CHEM-BIOL INTERACT, V191, P129, DOI 10.1016/j.cbi.2011.01.008; Sudiwala S, 2016, BIOCHIMIE, V126, P63, DOI 10.1016/j.biochi.2016.02.010; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tiziani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082859; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xu L, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0114-x	41	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5821	5833		10.1074/jbc.RA118.002180	http://dx.doi.org/10.1074/jbc.RA118.002180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29483189	Green Published, hybrid			2022-12-28	WOS:000430497300007
J	Huehn, A; Cao, WX; Elam, WA; Liu, XQ; De La Cruz, EM; Sindelar, CV				Huehn, Andrew; Cao, Wenxiang; Elam, W. Austin; Liu, Xueqi; De La Cruz, Enrique M.; Sindelar, Charles V.			The actin filament twist changes abruptly at boundaries between bare and cofilin-decorated segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ADF/COFILIN FAMILY; HELICAL FILAMENTS; DYNAMICS; RECONSTRUCTION; RESOLUTION; MECHANISM; KINETICS; BINDING; STATE	Cofilin/ADF proteins are actin-remodeling proteins, essential for actin disassembly in various cellular processes, including cell division, intracellular transport, and motility. Cofilins bind actin filaments cooperatively and sever them preferentially at boundaries between bare and cofilin-decorated (cofilactin) segments. The cooperative binding to actin has been proposed to originate from conformational changes that propagate allosterically from clusters of bound cofilin to bare actin segments. Estimates of the lengths over which these cooperative conformational changes propagate vary dramatically, ranging from 2 to > 100 subunits. Here, we present a general, structure-based method for detecting from cryo-EM micrographs small variations in filament geometry (i.e. twist) with single-subunit precision. How these variations correlate with regulatory protein occupancy reveals how far allosteric, conformational changes propagate along filaments. We used this method to determine the effects of cofilin on the actin filament twist. Our results indicate that cofilin-induced changes in filament twist propagate only 1-2 subunits from the boundary into the bare actin segment, independently of the boundary polarity (i.e. irrespective of whether or not the bare actin segment flanks the pointed or barbed-end side of the boundary) and the pyrene fluorophore labeling of actin. These observations indicate that the filament twist changes abruptly at boundaries between bare and cofilin-decorated segments, thereby constraining mechanistic models of cooperative actin filament interactions and severing by cofilin. The methods presented here extend the capability of cryo-EM to analyze biologically relevant deviations from helical symmetry in actin as well as other classes of linear polymers.	[Huehn, Andrew; Cao, Wenxiang; Elam, W. Austin; Liu, Xueqi; De La Cruz, Enrique M.; Sindelar, Charles V.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Elam, W. Austin] C4 Therapeut, 675 W Kendall St, Cambridge, MA 02142 USA	Yale University	De La Cruz, EM; Sindelar, CV (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu; charles.sindelar@yale.edu			National Institutes of Health R01 Grant [GM097348, GM110533001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110530, R01GM097348, T32GM008283] Funding Source: NIH RePORTER	National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants GM097348 (to E. M. D. L. C.) and GM110533001 (to C. V. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Elam WA, 2017, J BIOL CHEM, V292, P19565, DOI 10.1074/jbc.M117.808378; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayakawa K, 2014, P NATL ACAD SCI USA, V111, P9810, DOI 10.1073/pnas.1321451111; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mentes A, 2018, P NATL ACAD SCI USA, V115, P1292, DOI 10.1073/pnas.1718316115; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Yu JY, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27621; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	41	30	31	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5377	5383		10.1074/jbc.AC118.001843	http://dx.doi.org/10.1074/jbc.AC118.001843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29463680	hybrid, Green Published			2022-12-28	WOS:000430044100001
J	Soliman, C; Walduck, AK; Yuriev, E; Richards, JS; Cywes-Bentley, C; Pier, GB; Ramsland, PA				Soliman, Caroline; Walduck, Anna K.; Yuriev, Elizabeth; Richards, Jack S.; Cywes-Bentley, Colette; Pier, Gerald B.; Ramsland, Paul A.			Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetylglucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; carbohydrate-binding protein; crystal structure; vaccine development; monoclonal antibody; Staphylococcus aureus (S; aureus); biofilm; antibody structure; poly-N-acetyl-D-glucosamine	MONOCLONAL-ANTIBODIES; SHIGELLA-FLEXNERI; RECOGNITION; LIPOPOLYSACCHARIDE; RESISTANCE; FRAGMENTS; ANTIGEN; PNAG; FAB	In response to the widespread emergence of antibiotic-resistant microbes, new therapeutic agents are required for many human pathogens. A non-mammalian polysaccharide, poly-N-acetyl-d-glucosamine (PNAG), is produced by bacteria, fungi, and protozoan parasites. Antibodies that bind to PNAG and its deacetylated form (dPNAG) exhibit promising in vitro and in vivo activities against many microbes. A human IgG1 mAb (F598) that binds both PNAG and dPNAG has opsonic and protective activities against multiple microbial pathogens and is undergoing preclinical and clinical assessments as a broad-spectrum antimicrobial therapy. Here, to understand how F598 targets PNAG, we determined crystal structures of the unliganded F598 antigen-binding fragment (Fab) and its complexes with N-acetyl-d-glucosamine (GlcNAc) and a PNAG oligosaccharide. We found that F598 recognizes PNAG through a large groove-shaped binding site that traverses the entire light- and heavy-chain interface and accommodates at least five GlcNAc residues. The Fab-GlcNAc complex revealed a deep binding pocket in which the monosaccharide and a core GlcNAc of the oligosaccharide were almost identically positioned, suggesting an anchored binding mechanism of PNAG by F598. The Fab used in our structural analyses retained binding to PNAG on the surface of an antibiotic-resistant, biofilm-forming strain of Staphylococcus aureus. Additionally, a model of intact F598 binding to two pentasaccharide epitopes indicates that the Fab arms can span at least 40 GlcNAc residues on an extended PNAG chain. Our findings unravel the structural basis for F598 binding to PNAG on microbial surfaces and biofilms.	[Soliman, Caroline; Walduck, Anna K.; Ramsland, Paul A.] RMIT Univ, Sch Sci, Plenty Rd, Bundoora, Vic 3083, Australia; [Yuriev, Elizabeth] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia; [Richards, Jack S.; Ramsland, Paul A.] Burnet Inst, Dis Eliminat Program, Melbourne, Vic 3004, Australia; [Richards, Jack S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia; [Richards, Jack S.] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Richards, Jack S.] Alfred Hosp, Dept Infect Dis, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Cywes-Bentley, Colette; Pier, Gerald B.] Harvard Med Sch, Div Infect Dis, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg, Austin Hlth, Heidelberg, Vic 3084, Australia	Royal Melbourne Institute of Technology (RMIT); Monash University; Burnet Institute; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Ramsland, PA (corresponding author), RMIT Univ, Sch Sci, Plenty Rd, Bundoora, Vic 3083, Australia.	paul.ramsland@rmit.edu.au	Yuriev, Elizabeth/A-7132-2016; Pier, Gerald/AAO-2692-2021	Yuriev, Elizabeth/0000-0002-3909-0379; Pier, Gerald/0000-0002-9112-2331; Soliman, Caroline/0000-0003-2714-5341; Ramsland, Paul/0000-0002-2107-2738; Walduck, Anna/0000-0002-9624-4370; Cywes Bentley, Colette/0000-0002-6301-0930	National Health and Medical Research Council of Australia [GNT1125788, GNT1037722]; Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Alopexx Vaccine, LLC; Morris Animal Foundation; National Institutes of Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC; Alopexx Vaccine, LLC; Morris Animal Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant GNT1125788 and Research Fellowship GNT1037722 (to J. S. R.). G. B. P. is an inventor of intellectual properties (human monoclonal antibody to PNAG and PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC, entities in which G. B. P. also holds equity. As an inventor of intellectual properties, G. B. P. also has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC. G. B. P.'s interests were reviewed and are managed by the Brigham and Women's Hospital and Partners Healthcare in accordance with their conflict of interest policies. G. B. P. has received funding from the Morris Animal Foundation and National Institutes of Health to conduct studies on the development of vaccines and antibody therapies targeting the microbial antigen PNAG. C. C.-B. is an inventor of intellectual properties (use of human monoclonal antibody to PNAG and use of PNAG vaccines) that are licensed by Brigham and Women's Hospital to Alopexx Vaccine, LLC, and Alopexx Pharmaceuticals, LLC. As an inventor of intellectual properties, C. C.-B. has the right to receive a share of licensing-related income (royalties, fees) through Brigham and Women's Hospital from Alopexx Pharmaceuticals, LLC, and Alopexx Vaccine, LLC.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Anish C, 2014, CHEM BIOL, V21, P38, DOI 10.1016/j.chembiol.2014.01.002; Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Banin E, 2017, FEMS MICROBIOL REV, V41, P450, DOI 10.1093/femsre/fux016; Carboni F, 2017, P NATL ACAD SCI USA, V114, P5017, DOI 10.1073/pnas.1701885114; Coleman J. P., 2011, XPHARM COMPREHENSIVE, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CYGLER M, 1993, BIOCHEM SOC T, V21, P437, DOI 10.1042/bst0210437; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Dubel S., 2012, HDB THERAPEUTIC ANTI; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan ZC, 1999, J MOL RECOGNIT, V12, P19, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y; Franca A, 2013, INT J BIOL SCI, V9, P518, DOI 10.7150/ijbs.6102; Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010; Gening ML, 2013, PURE APPL CHEM, V85, P1879, DOI 10.1351/PAC-CON-12-09-06; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Haji-Ghassemi O, 2015, GLYCOBIOLOGY, V25, P920, DOI 10.1093/glycob/cwv037; Haji-Ghassemi O, 2014, J BIOL CHEM, V289, P16644, DOI 10.1074/jbc.M113.528224; Hutter Julia, 2015, Methods Mol Biol, V1331, P1, DOI 10.1007/978-1-4939-2874-3_1; Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Parker MJ, 2014, GLYCOBIOLOGY, V24, P442, DOI 10.1093/glycob/cwu009; Reichert JM, 2017, MABS-AUSTIN, V9, P167, DOI 10.1080/19420862.2016.1269580; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Roux D, 2012, J ANTIMICROB CHEMOTH, V67, P2785, DOI 10.1093/jac/dks335; Skurnik D, 2016, EXPERT REV VACCINES, V15, P1041, DOI 10.1586/14760584.2016.1159135; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; The Antibody Society, 2017, APPR ANT THER MON AN; Vlock D., 2010, 50 ICAAC 2010; Vulliez-Le Normand B, 2008, P NATL ACAD SCI USA, V105, P9976, DOI 10.1073/pnas.0801711105; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Weaver LG, 2013, CARBOHYD RES, V371, P68, DOI 10.1016/j.carres.2013.01.008; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao G, 2016, INVEST OPHTH VIS SCI, V57, P6797, DOI 10.1167/iovs.16-20358	45	20	21	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5079	5089		10.1074/jbc.RA117.001170	http://dx.doi.org/10.1074/jbc.RA117.001170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29449370	Green Published, hybrid			2022-12-28	WOS:000429409300015
J	Kenney, GE; Rosenzweig, AC				Kenney, Grace E.; Rosenzweig, Amy C.			Methanobactins: Maintaining copper homeostasis in methanotrophs and beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							METHYLOSINUS-TRICHOSPORIUM OB3B; SOLUBLE METHANE MONOOXYGENASE; METHYLOCOCCUS-CAPSULATUS BATH; TRANSCRIPTIONAL REGULATION; THERMODYNAMIC PROPERTIES; GOLD BIOMINERALIZATION; MEDIATED SYNTHESIS; BINDING PROTEIN; GENE-EXPRESSION; SIDEROPHORE	Methanobactins (Mbns) are ribosomally produced, post-translationally modified natural products that bind copper with high affinity and specificity. Originally identified in methanotrophic bacteria, which have a high need for copper, operons encoding these compounds have also been found in many non-methanotrophic bacteria. The proteins responsible for Mbn biosynthesis include several novel enzymes. Mbn transport involves export through a multidrug efflux pump and re-internalization via a TonB-dependent transporter. Release of copper from Mbn and the molecular basis for copper regulation of Mbn production remain to be elucidated. Future work is likely to result in the identification of new enzymatic chemistry, opportunities for bioengineering and drug targeting of copper metabolism, and an expanded understanding of microbial metal homeostasis.	[Kenney, Grace E.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	amyr@northwestern.edu		Kenney, Grace/0000-0002-9579-3351	National Institutes of Health [GM118035]; Department of Energy [DE-SC0016284]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM118035 and Department of Energy Grant DE-SC0016284 (to A. C. R.). This is the first article in the Thematic Minireview series "Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and Department of Energy.	[Anonymous], 2006, THESIS; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Balasubramanian R, 2011, J BIOL CHEM, V286, P37313, DOI 10.1074/jbc.M111.284984; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Bandow N, 2012, J INORG BIOCHEM, V110, P72, DOI 10.1016/j.jinorgbio.2012.02.002; Baral BS, 2014, J INORG BIOCHEM, V141, P161, DOI 10.1016/j.jinorgbio.2014.09.004; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Burkhart BJ, 2015, NAT CHEM BIOL, V11, P564, DOI 10.1038/nchembio.1856; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Choi DW, 2008, J INORG BIOCHEM, V102, P1571, DOI 10.1016/j.jinorgbio.2008.02.003; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2006, J INORG BIOCHEM, V100, P2150, DOI 10.1016/j.jinorgbio.2006.08.017; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; Dassama LMK, 2017, METALLOMICS, V9, P7, DOI 10.1039/c6mt00208k; Dassama LMK, 2016, P NATL ACAD SCI USA, V113, P13027, DOI 10.1073/pnas.1603578113; Delangle P, 2012, DALTON T, V41, P6359, DOI 10.1039/c2dt12188c; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; DiSpirito AA, 2007, US Patent, Patent No. 7199099; DiSpirito AA, 2016, MICROBIOL MOL BIOL R, V80, P387, DOI 10.1128/MMBR.00058-15; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; El Ghazouani A, 2012, P NATL ACAD SCI USA, V109, P8400, DOI 10.1073/pnas.1112921109; El Ghazouani A, 2011, INORG CHEM, V50, P1378, DOI 10.1021/ic101965j; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; FITCH MW, 1993, APPL ENVIRON MICROB, V59, P2771, DOI 10.1128/AEM.59.9.2771-2776.1993; Groom K, 2011, CHEMBIOCHEM, V12, P396, DOI 10.1002/cbic.201000580; Gu WY, 2017, APPL MICROBIOL BIOT, V101, P8499, DOI 10.1007/s00253-017-8572-2; Gu WY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02619-16; Gu WY, 2016, APPL ENVIRON MICROB, V82, P1917, DOI 10.1128/AEM.03884-15; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Hakemian AS, 2005, J AM CHEM SOC, V127, P17142, DOI 10.1021/ja0558140; Hannauer M, 2010, J BACTERIOL, V192, P1212, DOI 10.1128/JB.01539-09; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Imperi F, 2009, P NATL ACAD SCI USA, V106, P20440, DOI 10.1073/pnas.0908760106; Johnston CW, 2013, NAT CHEM BIOL, V9, P241, DOI [10.1038/NCHEMBIO.1179, 10.1038/nchembio.1179]; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Jones CM, 2014, P NATL ACAD SCI USA, V111, P1945, DOI 10.1073/pnas.1311402111; Kalidass B., 2015, THESIS; Kalidass B, 2015, APPL ENVIRON MICROB, V81, P1024, DOI 10.1128/AEM.03151-14; Kao WC, 2004, J BIOL CHEM, V279, P51554, DOI 10.1074/jbc.M408013200; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Kenney GE, 2016, J AM CHEM SOC, V138, P11124, DOI 10.1021/jacs.6b06821; Kenney GE, 2016, METALLOMICS, V8, P931, DOI 10.1039/c5mt00289c; Kenney GE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-17; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Knapp CW, 2007, P NATL ACAD SCI USA, V104, P12040, DOI 10.1073/pnas.0702879104; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kraemer SM, 2015, AQUAT GEOCHEM, V21, P159, DOI 10.1007/s10498-014-9246-7; Krentz BD, 2010, BIOCHEMISTRY-US, V49, P10117, DOI 10.1021/bi1014375; Kulczycki E, 2007, GEOBIOLOGY, V5, P251, DOI 10.1111/j.1472-4669.2007.00102.x; Kulczycki E, 2011, GEOMICROBIOL J, V28, P1, DOI 10.1080/01490451003614971; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Larsen O, 2016, MICROBIOLOGYOPEN, V5, P254, DOI 10.1002/mbo3.324; Lawton TJ, 2016, BIOCHEMISTRY-US, V55, P2278, DOI 10.1021/acs.biochem.6b00175; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Lichtmannegger J, 2016, J CLIN INVEST, V126, P2721, DOI 10.1172/JCI85226; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Long CP, 2018, P NATL ACAD SCI USA, V115, P222, DOI 10.1073/pnas.1716056115; Lu X, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700041; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; McCabe JW, 2017, J AM SOC MASS SPECTR, V28, P2588, DOI 10.1007/s13361-017-1778-9; Merkx M, 2002, J BIOL CHEM, V277, P5858, DOI 10.1074/jbc.M107712200; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miethke M, 2011, BIOCHEMISTRY-US, V50, P10951, DOI 10.1021/bi201517h; Nielsen AK, 1996, MICROBIOL-UK, V142, P1289, DOI 10.1099/13500872-142-5-1289; Nielsen AK, 1997, MOL MICROBIOL, V25, P399, DOI 10.1046/j.1365-2958.1997.4801846.x; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Novikova M, 2007, J BACTERIOL, V189, P8361, DOI 10.1128/JB.01028-07; Ochs M, 1996, MOL GEN GENET, V250, P455; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Pesch ML, 2013, GEOBIOLOGY, V11, P44, DOI 10.1111/gbi.12010; Pesch ML, 2012, J INORG BIOCHEM, V116, P55, DOI 10.1016/j.jinorgbio.2012.07.008; PHELPS PA, 1992, APPL ENVIRON MICROB, V58, P3701, DOI 10.1128/AEM.58.11.3701-3708.1992; PRIOR SD, 1985, J GEN MICROBIOL, V131, P155; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Sardar D, 2015, CHEM BIOL, V22, P907, DOI 10.1016/j.chembiol.2015.06.014; Sazinsky Matthew H, 2015, Met Ions Life Sci, V15, P205, DOI 10.1007/978-3-319-12415-5_6; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCOTT D, 1981, J GEN MICROBIOL, V125, P63; Semrau JD, 2013, ENVIRON MICROBIOL, V15, P3077, DOI 10.1111/1462-2920.12150; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; Springer SD, 2016, COORDIN CHEM REV, V306, P628, DOI 10.1016/j.ccr.2015.03.013; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; Thomson AJ, 1998, CURR OPIN CHEM BIOL, V2, P155, DOI 10.1016/S1367-5931(98)80056-2; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vorobev A, 2013, APPL ENVIRON MICROB, V79, P5918, DOI 10.1128/AEM.01673-13; Xin JY, 2015, FOOD CHEM, V174, P473, DOI 10.1016/j.foodchem.2014.11.098; Xin JY, 2014, INT J MOL SCI, V15, P21603, DOI 10.3390/ijms151221603; Xin JY, 2013, INT J MOL SCI, V14, P21676, DOI 10.3390/ijms141121676; Yan X, 2016, APPL ENVIRON MICROB, V82, P2062, DOI 10.1128/AEM.03724-15	98	29	29	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4606	4615		10.1074/jbc.TM117.000185	http://dx.doi.org/10.1074/jbc.TM117.000185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29348173	Green Published, hybrid			2022-12-28	WOS:000428848300003
J	Chandrannowlishwaran, P; Sun, M; Casey, KL; Romanyuk, AV; Grizel, AV; Sopova, JV; Rubel, AA; Nussbaum-Krammer, C; Vorberg, IM; Chernoff, YO				Chandrannowlishwaran, Pavithra; Sun, Meng; Casey, Kristin L.; Romanyuk, Andrey V.; Grizel, Anastasiya V.; Sopova, Julia V.; Rubel, Aleksandr A.; Nussbaum-Krammer, Carmen; Vorberg, Ina M.; Chernoff, Yury O.			Mammalian amyloidogenic proteins promote prion nucleation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION STRUCTURE; DE-NOVO APPEARANCE; ALZHEIMERS-DISEASE; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; PSI+ PRION; TRANSLATION TERMINATION; SECONDARY STRUCTURE; ACTIN CYTOSKELETON; BETA-PROTEIN	Fibrous cross-beta aggregates (amyloids) and their transmissible forms (prions) cause diseases in mammals (including humans) and control heritable traits in yeast. Initial nucleation of a yeast prion by transiently overproduced prion-forming protein or its (typically, QN-rich) prion domain is efficient only in the presence of another aggregated (in most cases, QN-rich) protein. Here, we demonstrate that a fusion of the prion domain of yeast protein Sup35 to some non-QN-rich mammalian proteins, associated with amyloid diseases, promotes nucleation of Sup35 prions in the absence of pre-existing aggregates. In contrast, both a fusion of the Sup35 prion domain to a multimeric non-amyloidogenic protein and the expression of a mammalian amyloidogenic protein that is not fused to the Sup35 prion domain failed to promote prion nucleation, further indicating that physical linkage of a mammalian amyloidogenic protein to the prion domain of a yeast protein is required for the nucleation of a yeast prion. Biochemical and cytological approaches confirmed the nucleation of protein aggregates in the yeast cell. Sequence alterations antagonizing or enhancing amyloidogenicity of human amyloid-beta (associated with Alzheimer's disease) and mouse prion protein (associated with prion diseases), respectively, antagonized or enhanced nucleation of a yeast prion by these proteins. The yeast-based prion nucleation assay, developed in our work, can be employed for mutational dissection of amyloidogenic proteins. We anticipate that it will aid in the identification of chemicals that influence initial amyloid nucleation and in searching for new amyloidogenic proteins in a variety of proteomes.	[Chandrannowlishwaran, Pavithra; Sun, Meng; Casey, Kristin L.; Romanyuk, Andrey V.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Grizel, Anastasiya V.; Sopova, Julia V.; Rubel, Aleksandr A.; Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia; [Grizel, Anastasiya V.; Rubel, Aleksandr A.; Chernoff, Yury O.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia; [Sopova, Julia V.; Rubel, Aleksandr A.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Sopova, Julia V.] Russian Acad Sci, St Petersburg Branch, NI Vavilov Inst Gen Genet, St Petersburg 199034, Russia; [Nussbaum-Krammer, Carmen] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Vorberg, Ina M.] Deutsch Zentrum Neurodegenerat Erkrankungen, D-53175 Bonn, Germany; [Sun, Meng] Antise Biotech Co Ltd, Bldg A, Beijing 101318, Peoples R China; [Romanyuk, Andrey V.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Ruprecht Karls University Heidelberg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University System of Georgia; Georgia Institute of Technology	Chernoff, YO (corresponding author), Georgia Inst Technol, 950 Atlantic Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu	Sopova, Julia/N-5112-2015; Chernoff, Yury O/J-2833-2014; Rubel, Aleksandr A/D-2903-2013; Nussbaum-Krammer, Carmen/AAY-3081-2020; Sopova, Julia/AAE-8214-2021; Grizel, Anastasia V/A-4415-2015	Sopova, Julia/0000-0002-7825-273X; Rubel, Aleksandr A/0000-0001-6203-2006; Nussbaum-Krammer, Carmen/0000-0002-8689-1363; Sopova, Julia/0000-0002-7825-273X; Grizel, Anastasia V/0000-0003-4875-8171; Chernoff, Yury/0000-0002-8934-9051	Emory Alzheimer's Disease Research Center from the National Institutes of Health [P50AG025688]; Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation); Russian Science Foundation (RSF) [14-50-00069]; Russian Foundation for Basic Research (RFBR) [15-04-08159]; Scheller College of Business, Georgia Institute of Technology; Institute for Bioengineering and Bioscience, Georgia Institute of Technology; St. Petersburg State University Postdoctoral Fellowship [1.50.1038.2014]; St. Petersburg State University [15.61.2218.2013]; Russian Science Foundation [14-50-00069] Funding Source: Russian Science Foundation; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Emory Alzheimer's Disease Research Center from the National Institutes of Health; Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation); Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Scheller College of Business, Georgia Institute of Technology; Institute for Bioengineering and Bioscience, Georgia Institute of Technology; St. Petersburg State University Postdoctoral Fellowship; St. Petersburg State University; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Emory Alzheimer's Disease Research Center Grant P50AG025688 from the National Institutes of Health, a Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation) grant (to Y. O. C.), Russian Science Foundation (RSF) Grant 14-50-00069 (to Y. O. C.), and Russian Foundation for Basic Research (RFBR) Grant 15-04-08159 (to A. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, CJD Foundation, RSF, or RFBR.; 'Recipient of a Ti:GER Fellowship from Scheller College of Business, Georgia Institute of Technology.; 'Recipient of a Parker H. Petit Scholarship from the Institute for Bioengineering and Bioscience, Georgia Institute of Technology.; Recipient of St. Petersburg State University Postdoctoral Fellowship 1.50.1038.2014.; Supported in part by St. Petersburg State University (Project 15.61.2218.2013).	Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32; Bartz JC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024349; Benetti F, 2015, PRION, V9, P119, DOI 10.1080/19336896.2015.1022023; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2017, CELL REP, V18, P751, DOI 10.1016/j.celrep.2016.12.082; Chernova TA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023663; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Choe YJ, 2009, EUKARYOT CELL, V8, P968, DOI 10.1128/EC.00353-08; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen M, 2016, PRION, V10, P9, DOI 10.1080/19336896.2015.1123371; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2004, CURR MOL MED, V4, P337, DOI 10.2174/1566524043360645; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Ghaemmaghami S., 2016, COLD SPRING HARB PER, V6; Ghahramani S., 2005, FUNDAMENTALS PROBABI; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Goehler H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009642; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Groveman BR, 2015, J BIOL CHEM, V290, P1119, DOI 10.1074/jbc.M114.619627; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones RW, 2015, ALZHEIMERS DEMENT, V11, P280, DOI 10.1016/j.jalz.2014.03.001; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kaiser C., 1994, METHODS YEAST GENETI; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kochneva-Pervukhova NV, 1998, CURR GENET, V34, P146, DOI 10.1007/s002940050379; Kovac V, 2016, BIOCHEM BIOPH RES CO, V481, P1, DOI 10.1016/j.bbrc.2016.11.036; Krammer C, 2008, FASEB J, V22, P762, DOI 10.1096/fj.07-8733com; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; Kutzler MA, 2006, VACCINE, V24, P4630, DOI 10.1016/j.vaccine.2005.08.036; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; MORI H, 1992, J BIOL CHEM, V267, P17082; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Newby GA, 2017, CELL, V171, P966, DOI 10.1016/j.cell.2017.09.041; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Nizhnikov AA, 2016, PRION, V10, P182, DOI 10.1080/19336896.2016.1181253; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Porzoor A, 2016, METHODS MOL BIOL, V1303, P217, DOI 10.1007/978-1-4939-2627-5_12; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; PRUSINER SB, 1993, ARCH NEUROL-CHICAGO, V50, P1129, DOI 10.1001/archneur.1993.00540110011002; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Rubel' A A, 2008, Mol Biol (Mosk), V42, P123; Rubel AA, 2013, PRION, V7, P469, DOI 10.4161/pri.26867; Saijo E, 2016, J VIROL, V90, P4905, DOI 10.1128/JVI.00088-16; Sambrook J., 2001, MOL CLONING LAB MANU; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stefanis L., 2014, COLD SPRING HARB PER, V2; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Theint T, 2017, BIOMOL NMR ASSIGN, V11, P75, DOI 10.1007/s12104-016-9723-6; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; WESTERMARK P, 1994, AMYLOID, V1, P47, DOI 10.3109/13506129409148624; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	94	13	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3436	3450		10.1074/jbc.M117.809004	http://dx.doi.org/10.1074/jbc.M117.809004			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330303	Green Published, hybrid			2022-12-28	WOS:000426562800033
J	Graf, L; Dick, A; Sendker, F; Barth, E; Marz, M; Daumke, O; Kochs, G				Graf, Laura; Dick, Alexej; Sendker, Franziska; Barth, Emanuel; Marz, Manja; Daumke, Oliver; Kochs, Georg			Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MXA PROTEIN; DYNAMIN-LIKE MXA; INNATE IMMUNITY; DOMAIN DIMERIZATION; VIRAL NUCLEOPROTEIN; GTPASE ACTIVATION; VIRUS-REPLICATION; GENETIC-VARIATION; INFLUENZA; INHIBIT	Only a minority of patients infected with seasonal influenza A viruses exhibit a severe or fatal outcome of infection, but the reasons for this inter-individual variability in influenza susceptibility are unclear. To gain further insights into the molecular mechanisms underlying this variability, we investigated naturally occurring allelic variations of the myxovirus resistance 1 (MX1) gene coding for the influenza restriction factor MxA. The interferon-induced dynamin-like GTPase consists of an N-terminal GTPase domain, a bundle signaling element, and a C-terminal stalk responsible for oligomerization and viral target recognition. We used online databases to search for variations in the MX1 gene. Deploying in vitro approaches, we found that non-synonymous variations in the GTPase domain cause the loss of antiviral and enzymatic activities. Furthermore, we showed that these amino acid substitutions disrupt the interface for GTPase domain dimerization required for the stimulation of GTP hydrolysis. Variations in the stalk were neutral or slightly enhanced or abolished MxA antiviral function. Remarkably, two other stalk variants altered MxA's antiviral specificity. Variations causing the loss of antiviral activity were found only in heterozygous carriers. Interestingly, the inactive stalk variants blocked the antiviral activity of WT MxA in a dominant-negative way, suggesting that heterozygotes are phenotypically MxA-negative. In contrast, the GTPase-deficient variants showed no dominant-negative effect, indicating that heterozygous carriers should remain unaffected. Our results demonstrate that naturally occurring mutations in the human MX1 gene can influence MxA function, which may explain individual variations in influenza virus susceptibility in the human population.	[Graf, Laura; Sendker, Franziska; Kochs, Georg] Univ Freiburg, Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany; [Graf, Laura; Kochs, Georg] Univ Freiburg, Spemann Grad Sch Biol & Med, Albertstr 19a, D-79104 Freiburg, Germany; [Dick, Alexej; Daumke, Oliver] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Dick, Alexej; Daumke, Oliver] Free Univ Berlin, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany; [Barth, Emanuel; Marz, Manja] Friedrich Schiller Univ Jena, Bioinformat High Throughput Anal, Leutragraben 1, D-07743 Jena, Germany; [Marz, Manja] Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany; [Marz, Manja] European Virus Bioinformat Ctr, Leutragraben 1, D-07743 Jena, Germany; [Kochs, Georg] Univ Freiburg, Fac Med, D-79085 Freiburg, Germany; [Graf, Laura] Univ Freiburg, Fac Biol, Spemann Grad Sch Biol & Med, Freiburg, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Freiburg; University of Freiburg	Kochs, G (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.; Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	oliver.daumke@mdc-berlin.de; georg.kochs@uniklinik-freiburg.de		Marz, Manja/0000-0003-4783-8823; Barth, Emanuel/0000-0003-0803-8858; Dick, Alexej/0000-0003-0580-1897	Deutsche Forschungsgemeinschaft [KO 1579/8-2, DA 1127/1, MA 5082/7-1]; Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG) [RegenerAging-FSU-I-03/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG)	This work was supported by Deutsche Forschungsgemeinschaft Grants KO 1579/8-2 (to G.K.), DA 1127/1 (to O.D.), and MA 5082/7-1 (to M.M.) and the Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG; RegenerAging-FSU-I-03/14) (to E.B.).The authors declare that they have no conflicts of interest with the contents of this article.	Abel L, 2014, CURR OPIN IMMUNOL, V30, P72, DOI 10.1016/j.coi.2014.07.002; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15744; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Ciencewicki JM, 2014, FASEB J, V28, P1947, DOI 10.1096/fj.13-239855; Deeg CM, 2017, J EXP MED, V214, P1239, DOI 10.1084/jem.20161033; Dick A, 2015, J BIOL CHEM, V290, P12779, DOI 10.1074/jbc.M115.650325; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Habjan M, 2009, VIROLOGY, V385, P400, DOI 10.1016/j.virol.2008.12.011; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matzinger SR, 2013, J VIROL, V87, P1150, DOI 10.1128/JVI.02271-12; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Nigg PE, 2015, J BIOL CHEM, V290, P29893, DOI 10.1074/jbc.M115.681494; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Shendure J, 2016, NATURE, V536, P277, DOI 10.1038/536277a; STAEHELI P, 1991, J VIROL, V65, P4498, DOI 10.1128/JVI.65.8.4498-4501.1991; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Tam TTD, 2012, MOL BIOL REP, V39, P8533, DOI 10.1007/s11033-012-1708-7; To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; World Health Organization, 2010, WHO PUBL HLTH RES AG; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Yu ZJ, 2008, ARCH VIROL, V153, P1677, DOI 10.1007/s00705-008-0168-9; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	46	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3056	3072		10.1074/jbc.M117.812784	http://dx.doi.org/10.1074/jbc.M117.812784			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330299	Green Published, hybrid			2022-12-28	WOS:000426562800003
J	Schaal, JB; Maretzky, T; Tran, DQ; Tran, PA; Tongaonkar, P; Blobel, CP; Ouellette, AJ; Selsted, ME				Schaal, Justin B.; Maretzky, Thorsten; Tran, Dat Q.; Tran, Patti A.; Tongaonkar, Prasad; Blobel, Carl P.; Ouellette, Andre J.; Selsted, Michael E.			Macrocyclic theta-defensins suppress tumor necrosis factor-alpha ( TNF-alpha) shedding by inhibition of TNF-alpha-converting enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; ANTIMICROBIAL ACTIVITIES; THERAPEUTIC TARGETS; SIGNALING PATHWAY; INDUCED ARTHRITIS; CYCLIC-PEPTIDES; TACE; ADAM17; EGFR	Theta-defensins (theta-defensins) are macrocyclic peptides expressed exclusively in granulocytes and selected epithelia of Old World monkeys. They contribute to anti-pathogen host defense responses by directly killing a diverse range of microbes. Of note, theta-defensins also modulate microbe-induced inflammation by affecting the production of soluble tumor necrosis factor (sTNF) and other proinflammatory cytokines. Here, we report that natural rhesus macaque theta-defensin (RTD) isoforms regulate sTNF cellular release by inhibiting TNF-alpha-converting enzyme (TACE; also known as a disintegrin and metalloprotease 17; ADAM17), the primary pro-TNF sheddase. Dose-dependent inhibition of cellular TACE activity by RTDs occurred when leukocytes were stimulated with live Escherichia coli cells as well as numerous Toll-like receptor agonists. Moreover, the relative inhibitory potencies of the RTD isoforms strongly correlated with their suppression of TNF release by stimulated blood leukocytes and THP-1 monocytes. RTD isoforms also inhibited ADAM10, a sheddase closely related to TACE. TACE inhibition was abrogated by introducing a single opening in the RTD-1 backbone, demonstrating that the intact macrocycle is required for enzyme inhibition. Enzymologic analyses showed that RTD-1 is a fast binding, reversible, non-competitive inhibitor of TACE. We conclude that theta-defensin-mediated inhibition of pro-TNF proteolysis by TACE represents a rapid mechanism for the regulation of sTNF and TNF-dependent inflammatory pathways. Molecules with structural and functional features mimicking those of theta-defensins may have clinical utility as TACE inhibitors for managing TNF-driven diseases.	[Schaal, Justin B.; Tran, Dat Q.; Tran, Patti A.; Tongaonkar, Prasad; Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90089 USA; [Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Maretzky, Thorsten; Blobel, Carl P.] Weill Cornell Med, Hosp Special Surg, New York, NY 10021 USA; [Maretzky, Thorsten] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Maretzky, Thorsten] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of Southern California; University of Southern California; Cornell University; University of Iowa; University of Iowa	Selsted, ME (corresponding author), Univ Southern Calif, Dept Pathol & Lab Med, Keck Sch Med, Hoffman Med Res, 2011 Zonal Ave, Los Angeles, CA 90089 USA.	selsted@usc.edu	Maretzky, Thorsten/AEN-1915-2022; Maretzky, Thorsten/GSN-2981-2022	Maretzky, Thorsten/0000-0003-1282-6080; 	National Institutes of Health [AR068833, AI22931, DE021341, GM64750]; Arthritis Foundation [5997]; NATIONAL CANCER INSTITUTE [P30CA014089, P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001855, UL1TR000130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022931, R37AI022931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR068833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR068833 (to D. Q. T.), Grants AI22931 and DE021341 (to M. E. S.), and GM64750 (to C. P. B.) and Arthritis Foundation Grant 5997 (to M. E. S.). The following authors declare competing interests in relationship to their affiliations with Oryn Therapeutics: D. Q. T. is Scientific Director, M. E. S. is Chief Scientific Officer, A. J. O. is a minority investor. Oryn Therapeutics has licensed technologies disclosed in US patents 6,335,318; 6,514,727; 6,890,537; 7,119,070; 7,399,823 B1, 7,462,598, and 9,346,866 B2. The affiliation of the authors with Oryn Therapeutics does not alter author adherence to JBC policies on sharing data and materials. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Alvarez-Iglesias M, 2005, LAB INVEST, V85, P1440, DOI 10.1038/labinvest.3700340; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Bensman TJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00154-17; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257; DasGupta S, 2009, BIOORGAN MED CHEM, V17, P444, DOI 10.1016/j.bmc.2008.11.067; de Meijer VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011256; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Floriano Garcia A, 2011, THESIS; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Haudek SB, 2003, SHOCK, V20, P431, DOI 10.1097/01.shk.0000090843.66556.74; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi Keisuke, 2013, Keio Journal of Medicine, V62, P29, DOI 10.2302/kjm.2012-0003-RE; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Jayne J. G., 2017, AM J RESP CELL MOL B; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Kirkegaard T, 2004, CLIN EXP IMMUNOL, V135, P146, DOI 10.1111/j.1365-2249.2004.02348.x; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Li X, 2015, P NATL ACAD SCI USA, V112, P6080, DOI 10.1073/pnas.1505649112; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Mahmoodi M, 2005, AM J PATHOL, V166, P1733, DOI 10.1016/S0002-9440(10)62483-2; Maretzky T, 2009, BIOCHEM J, V420, P105, DOI 10.1042/BJ20082127; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Niu XD, 2006, ARCH BIOCHEM BIOPHYS, V451, P43, DOI 10.1016/j.abb.2006.03.034; Ohta S, 2001, J RHEUMATOL, V28, P1756; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Patten C, 2004, ARTHRITIS RHEUM-US, V50, P3334, DOI 10.1002/art.20507; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; Richards FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040597; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schaal JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187868; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Selsted ME, 2007, CURR PHARM DESIGN, V13, P3061, DOI 10.2174/138161207782110363; Sengupta P, 2011, EUR J MED CHEM, V46, P5549, DOI 10.1016/j.ejmech.2011.09.018; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Tai KP, 2015, INNATE IMMUN-LONDON, V21, P17, DOI 10.1177/1753425913514784; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tongaonkar P, 2015, J LEUKOCYTE BIOL, V98, P1061, DOI 10.1189/jlb.3A0315-102R; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tran D, 2008, ANTIMICROB AGENTS CH, V52, P944, DOI 10.1128/AAC.01090-07; vanWetering S, 1997, AM J PHYSIOL-LUNG C, V272, pL888, DOI 10.1152/ajplung.1997.272.5.L888; Wang ZT, 2016, COMPUT BIOL CHEM, V61, P15, DOI 10.1016/j.compbiolchem.2015.12.003; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Xue CB, 2001, J MED CHEM, V44, P3351, DOI 10.1021/jm0155502; Zhang YC, 2015, INT IMMUNOPHARMACOL, V27, P156, DOI 10.1016/j.intimp.2015.05.013; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	78	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2725	2734		10.1074/jbc.RA117.000793	http://dx.doi.org/10.1074/jbc.RA117.000793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317500	hybrid, Green Published			2022-12-28	WOS:000426051900009
